PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	McKee, M; Hurst, L; Aldridge, RW; Raine, R; Mindell, JS; Wolfe, I; Holland, WW				McKee, Martin; Hurst, Louise; Aldridge, Robert W.; Raine, Rosalind; Mindell, Jennifer S.; Wolfe, Ingrid; Holland, Walter W.			Public health in England: an option for the way forward?	LANCET			English	Editorial Material									[McKee, Martin; Wolfe, Ingrid] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1H 9SH, England; [Hurst, Louise; Aldridge, Robert W.; Raine, Rosalind; Mindell, Jennifer S.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Holland, Walter W.] Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; London School Economics & Political Science	McKee, M (corresponding author), London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, 15-17 Tavistock Pl, London WC1H 9SH, England.	martin.mckee@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mindell, Jennifer S/G-2241-2011; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mindell, Jennifer S/0000-0002-7604-6131; McKee, Martin/0000-0002-0121-9683; Wolfe, Ingrid/0000-0002-4717-7634; Aldridge, Robert/0000-0003-0542-0816; Raine, Rosalind/0000-0003-0904-749X	National Institute for Health Research [ACF-2009-18-028] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Appleby J, 2011, BMJ-BRIT MED J, V342, P310; Bonell C, 2011, LANCET, V377, P2158, DOI 10.1016/S0140-6736(11)60063-9; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Casiday R, 2006, VACCINE, V24, P177, DOI 10.1016/j.vaccine.2005.07.063; Department of Health, 2010, EQ EXC LIB NHS; Department of Health, 2002, GETT AH CURV STRAT C; Department of Health and Social Care, 2022, GOV DEL RESTR MULT D; Fulop N, 2005, SOC SCI MED, V60, P119, DOI 10.1016/j.socscimed.2004.04.017; Haroun D, 2011, PUBLIC HEALTH NUTR, V14, P209, DOI 10.1017/S1368980010002132; Healthy People 2020, 2010, FDN HLTH MEAS REP HE; House of Commons Committee of Public Accounts, 2010, TACKL IN LIF EXP AR; Kmietowicz Z, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7306; Local Government Group, 2010, HLTH PUBL LOC GOV GR; Maguire H, 2010, PUBLIC HEALTH, V124, P313, DOI 10.1016/j.puhe.2010.03.023; Marmot M., 2014, STRATEGIC REV HLTH I; McKee M, 1996, BRIT MED J, V312, P455, DOI 10.1136/bmj.312.7029.455; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Stuckler D, 2010, BMJ-BRIT MED J, V341, P77; The Lancet, 2011, LANCET, V377, P353; UK Parliament, 2011, HLTH SOC CAR BILL; Wikinson A, 2011, BMA NEWS        0105; Wintour P, NHS CUTS SCALE SHAKE	22	21	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2011	378	9790					536	539		10.1016/S0140-6736(11)60241-9	http://dx.doi.org/10.1016/S0140-6736(11)60241-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	809SO	21354610				2022-12-28	WOS:000294077200033
J	Bauer, KA				Bauer, Kenneth A.			Long-term Management of Venous Thromboembolism A 61-Year-Old Woman With Unprovoked Venous Thromboembolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEEP-VEIN-THROMBOSIS; FACTOR-V-LEIDEN; ORAL ANTICOAGULANT-THERAPY; LOW-INTENSITY WARFARIN; COAGULATION-FACTOR-V; D-DIMER; PULMONARY-EMBOLISM; RISK-FACTORS; FACTOR-VIII; HETEROZYGOUS CARRIERS	Numerous randomized clinical trials have compared various durations of anticoagulant therapy with a vitamin K antagonist (ie, warfarin) for an initial episode of venous thromboembolism (VTE). Despite major advances in understanding the pathophysiology of thrombosis and its genetic basis, clinical risk factors at presentation have emerged as the primary determinant of recurrence risk. Following a minimum of 3 months of anticoagulant therapy, patients with VTE in association with transient risk factors (eg, major surgery, trauma, pregnancy) have a low annual recurrence risk, while patients without identifiable provocative risk factors have a recurrence risk of approximately 25% at 4 years with the highest annual rates occurring in the first 2 years. Extending warfarin therapy is highly effective in preventing recurrences but is associated with increased rates of major and minor bleeding. Clinical decision making therefore requires individualized assessment of recurrence and bleeding risk, coupled with patient preference. After 3 months of anticoagulant therapy for a first episode of unprovoked VTE, male sex, age older than 65 years, and an elevated D-dimer level 1 month after discontinuing anticoagulant therapy are useful parameters in identifying patients with an increased recurrence risk. The case of Ms W, a woman with unprovoked venous thromboembolism and hemorrhagic event while receiving anticoagulation, is used to illustrate clinical decision making to determine ongoing treatment. JAMA. 2011;305(13):1336-1345 www.jama.com	[Bauer, Kenneth A.] Beth Israel Deaconess Med Ctr, Boston, MA 02492 USA; [Bauer, Kenneth A.] Harvard Univ, Sch Med, Boston, MA USA; [Bauer, Kenneth A.] VA Boston Healthcare Syst, Hematol Sect, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Bauer, KA (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02492 USA.	kbauer@bidmc.harvard.edu						Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Ansell J, 2007, J THROMB THROMBOLYS, V23, P83, DOI 10.1007/s11239-006-9022-7; Baglin T, 2008, J THROMB HAEMOST, V6, P577, DOI 10.1111/j.1538-7836.2008.02889.x; Baglin T, 2010, J THROMB HAEMOST, V8, P2436, DOI 10.1111/j.1538-7836.2010.04022.x; Bauer KA, 2009, HEMATOLOGY BASIC PRI, P2021; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Becker RC, 2008, CHEST, V133, p776S, DOI 10.1378/chest.08-0685; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; Bounameaux Henri, 2008, Hematology Am Soc Hematol Educ Program, P252, DOI 10.1182/asheducation-2008.1.252; Campbell A, 2007, BMJ-BRIT MED J, V334, P674, DOI 10.1136/bmj.39098.583356.55; Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; Christiansen SC, 2005, JAMA-J AM MED ASSOC, V293, P2352, DOI 10.1001/jama.293.19.2352; Cornuz J, 1996, ANN INTERN MED, V125, P785, DOI 10.7326/0003-4819-125-10-199611150-00001; Cosmi B, 2010, J THROMB HAEMOST, V8, P1933, DOI 10.1111/j.1538-7836.2010.03955.x; Cosmi B, 2010, EUR J VASC ENDOVASC, V39, P356, DOI 10.1016/j.ejvs.2009.11.022; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; den Heijer M, 2007, BLOOD, V109, P139, DOI 10.1182/blood-2006-04-014654; Douketis J, 2010, ANN INTERN MED, V153, P523, DOI 10.7326/0003-4819-153-8-201010190-00009; Douketis JD, 2007, ANN INTERN MED, V147, P766, DOI 10.7326/0003-4819-147-11-200712040-00007; Eichinger S, 2003, JAMA-J AM MED ASSOC, V290, P1071, DOI 10.1001/jama.290.8.1071; Emmerich J, 2001, THROMB HAEMOSTASIS, V86, P809; Fowkes FJI, 2003, EUR J VASC ENDOVASC, V25, P1, DOI 10.1053/ejvs.2002.1778; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Glynn RJ, 2007, ANN INTERN MED, V147, P525, DOI 10.7326/0003-4819-147-8-200710160-00004; Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545; Ho WK, 2006, ARCH INTERN MED, V166, P729, DOI 10.1001/archinte.166.7.729; Holst AG, 2010, CIRCULATION, V121, P1896, DOI 10.1161/CIRCULATIONAHA.109.921460; Jimenez D, 2006, THROMB HAEMOSTASIS, V95, P562, DOI 10.1160/TH05-10-0677; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Kyrle PA, 2010, LANCET, V376, P2032, DOI 10.1016/S0140-6736(10)60962-2; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Lijfering WM, 2010, BRIT J HAEMATOL, V149, P824, DOI 10.1111/j.1365-2141.2010.08206.x; Lijfering WM, 2010, CIRCULATION, V121, P1706, DOI 10.1161/CIRCULATIONAHA.109.906347; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Matchar DB, 2010, NEW ENGL J MED, V363, P1608, DOI 10.1056/NEJMoa1002617; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Murin S, 2002, THROMB HAEMOSTASIS, V88, P407; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Pinede L, 2001, CIRCULATION, V103, P2453; Poli D, 2008, J THROMB HAEMOST, V6, P708, DOI 10.1111/j.1538-7836.2008.02900.x; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Prandoni P, 2009, ANN INTERN MED, V150, P577, DOI 10.7326/0003-4819-150-9-200905050-00003; Ray JG, 2007, ANN INTERN MED, V146, P761, DOI 10.7326/0003-4819-146-11-200706050-00157; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Schulman S, 1998, AM J MED, V104, P332, DOI 10.1016/S0002-9343(98)00060-6; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Segal JB, 2009, JAMA-J AM MED ASSOC, V301, P2472, DOI 10.1001/jama.2009.853; Shrivastava S, 2006, J THROMB HAEMOST, V4, P1208, DOI 10.1111/j.1538-7836.2006.01935.x; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Siragusa S, 2008, BLOOD, V112, P511, DOI 10.1182/blood-2008-01-131656; Spyropoulos AC, 2010, CURR OPIN HEMATOL, V17, P444, DOI 10.1097/MOH.0b013e32833c077b; Tait R, 2007, J THROMB HAEMOST, V5, P060; US Department of Health and Human Services, 2008, SURG GEN CALL ACT PR; Verhovsek M, 2008, ANN INTERN MED, V149, P481, DOI 10.7326/0003-4819-149-7-200810070-00008; White RH, 1998, ANN INTERN MED, V128, P737, DOI 10.7326/0003-4819-128-9-199805010-00006; Zhu TN, 2009, ARTERIOSCL THROM VAS, V29, P298, DOI 10.1161/ATVBAHA.108.182428	72	5	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1336	1345		10.1001/jama.2011.361	http://dx.doi.org/10.1001/jama.2011.361			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21386068				2022-12-28	WOS:000289162400023
J	Standfuss, J; Edwards, PC; D'Antona, A; Fransen, M; Xie, GF; Oprian, DD; Schertler, GFX				Standfuss, Jorg; Edwards, Patricia C.; D'Antona, Aaron; Fransen, Maikel; Xie, Guifu; Oprian, Daniel D.; Schertler, Gebhard F.X.			The structural basis of agonist-induced activation in constitutively active rhodopsin	NATURE			English	Article							CRYSTAL-STRUCTURE; OPSIN; BINDING; INTERMEDIATE; COUNTERION; MECHANISM; MOVEMENT; REVEALS; FAMILY; ROD	G-protein-coupled receptors (GPCRs) comprise the largest family of membrane proteins in the human genome and mediate cellular responses to an extensive array of hormones, neurotransmitters and sensory stimuli. Although some crystal structures have been determined for GPCRs, most are for modified forms, showing little basal activity, and are bound to inverse agonists or antagonists. Consequently, these structures correspond to receptors in their inactive states. The visual pigment rhodopsin is the only GPCR for which structures exist that are thought to be in the active state(1),(2). However, these structures are for the apoprotein, or opsin, form that does not contain the agonist all-trans retinal. Here we present a crystal structure at a resolution of 3 angstrom for the constitutively active rhodopsin mutant Glu 113 Gln(3-5) in complex with a peptide derived from the carboxy terminus of the alpha-subunit of the G protein transducin. The protein is in an active conformation that retains retinal in the binding pocket after photoactivation. Comparison with the structure of ground-state rhodopsin(6) suggests how translocation of the retinal beta-ionone ring leads to a rotation of transmembrane helix 6, which is the critical conformational change on activation(7). A key feature of this conformational change is a reorganization of water-mediated hydrogen-bond networks between the retinal-binding pocket and three of the most conserved GPCR sequence motifs. We thus show how an agonist ligand can activate its GPCR.	[Standfuss, Jorg; Fransen, Maikel; Schertler, Gebhard F.X.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Standfuss, Jorg; Edwards, Patricia C.; Schertler, Gebhard F.X.] MRC, Lab Mol Biol, Cambridge CB2 0QH, England; [D'Antona, Aaron; Xie, Guifu; Oprian, Daniel D.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [D'Antona, Aaron; Xie, Guifu; Oprian, Daniel D.] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; MRC Laboratory Molecular Biology; Brandeis University; Brandeis University	Standfuss, J (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.		Schertler, Gebhard/M-9512-2014; Standfuss, Joerg/G-5126-2011	Schertler, Gebhard F.X./0000-0002-5846-6810	Medical Research Council [MC_U105178937, MC_U105197215] Funding Source: Medline; NEI NIH HHS [R01 EY007965, EY007965] Funding Source: Medline; NINDS NIH HHS [T32 NS007292] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER; MRC [MC_U105178937, MC_U105197215] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahuja S, 2009, J BIOL CHEM, V284, P10190, DOI 10.1074/jbc.M805725200; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; GROENENDIJK GWT, 1980, EUR J BIOCHEM, V106, P119; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kono M, 2008, BIOCHEMISTRY-US, V47, P7567, DOI 10.1021/bi800357b; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Pardo L, 2007, CHEMBIOCHEM, V8, P19, DOI 10.1002/cbic.200600429; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Standfuss J, 2008, J MOL BIOL, V380, P145, DOI 10.1016/j.jmb.2008.04.055; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	30	366	373	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					656	660		10.1038/nature09795	http://dx.doi.org/10.1038/nature09795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21389983	Green Accepted			2022-12-28	WOS:000288951200049
J	Palfrey, S				Palfrey, Sean			Daring to Practice Low-Cost Medicine in a High-Tech Era	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Palfrey, S (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.								0	12	14	2	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					E21	U21		10.1056/NEJMp1101392	http://dx.doi.org/10.1056/NEJMp1101392			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735SX	21366468				2022-12-28	WOS:000288439000004
J	Ingelfinger, JR				Ingelfinger, Julie R.			Preemptive Olmesartan for the Delay or Prevention of Microalbuminuria in Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLOOD-PRESSURE; NEPHROPATHY; DISEASE; TRIAL; RISK											Barrios V, 2010, EXPERT OPIN PHARMACO, V11, P1549, DOI 10.1517/14656566.2010.484020; BM B, 2001, NEW ENGL J MED, V345, P861; *FOOD DRUG ADM, 2010, BEN OLM ONG SAF REV; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Ikeda H, 2009, DIABETES RES CLIN PR, V83, P117, DOI 10.1016/j.diabres.2008.10.013; Imai E, 2006, HYPERTENS RES, V29, P703, DOI 10.1291/hypres.29.703; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Nakamura T, 2010, KIDNEY BLOOD PRESS R, V33, P213, DOI 10.1159/000316707; Sleight P, 2009, J HYPERTENS, V27, P1360, DOI 10.1097/HJH.0b013e32832d7370	10	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					970	971		10.1056/NEJMe1014147	http://dx.doi.org/10.1056/NEJMe1014147			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21388316				2022-12-28	WOS:000288170300016
J	House, J				House, John			UK National Health Service reforms mobilise doctors	LANCET			English	News Item																			0	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 5	2011	377	9768					797	800		10.1016/S0140-6736(11)60291-2	http://dx.doi.org/10.1016/S0140-6736(11)60291-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GO	21391315				2022-12-28	WOS:000288628500011
J	Smith, LB; Saunders, PTK				Smith, Lee B.; Saunders, Philippa T. K.			The Skeleton: The New Controller of Male Fertility?	CELL			English	Editorial Material								Sex steroids, including testosterone, regulate the development and function of the male skeleton. Oury et al. (2011) identify a surprising new connection between the skeleton and the testis, which has implications for male fertility. They show that testosterone production in the testis is directly influenced by the bone-derived hormone osteocalcin.	[Smith, Lee B.; Saunders, Philippa T. K.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Saunders, PTK (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	p.saunders@ed.ac.uk	Saunders, Philippa TK/C-7489-2013; Smith, Lee B/J-4861-2013	Saunders, Philippa TK/0000-0001-9051-9380; Smith, Lee/0000-0002-4103-3074	MRC [G1002033, G1100354, MC_U127685844, G1100356, MC_U127685841] Funding Source: UKRI; Medical Research Council [G1100354, U.1276.00.002.00003.01 (85841), MC_U127685841, G1002033, G1100356, MC_U127685844] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		MA PH, 2010, MOL CELL ENDOCRINOL, V316, P180; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Tena-Sempere M, 2002, MOL CELL ENDOCRINOL, V188, P9, DOI 10.1016/S0303-7207(02)00008-4; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	6	10	12	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					642	+		10.1016/j.cell.2011.02.028	http://dx.doi.org/10.1016/j.cell.2011.02.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376228	Bronze			2022-12-28	WOS:000288007100005
J	Zhang, HM; Landmann, F; Zahreddine, H; Rodriguez, D; Koch, M; Labouesse, M				Zhang, Huimin; Landmann, Frederic; Zahreddine, Hala; Rodriguez, David; Koch, Marc; Labouesse, Michel			A tension-induced mechanotransduction pathway promotes epithelial morphogenesis	NATURE			English	Article							CYTOPLASMIC INTERMEDIATE-FILAMENT; CAENORHABDITIS-ELEGANS CUTICLE; MUSCLE DEVELOPMENT; C.-ELEGANS; IN-VIVO; GENE; ELONGATION; EMBRYO; MUTATIONS; EPIDERMIS	Mechanotransduction refers to the transformation of physical forces into chemical signals. It generally involves stretch-sensitive channels or conformational change of cytoskeleton-associated proteins(1). Mechanotransduction is crucial for the physiology of several organs and for cell migration(2,3). The extent to which mechanical inputs contribute to development, and how they do this, remains poorly defined. Here we show that a mechanotransduction pathway operates between the body-wall muscles of Caenorhabditis elegans and the epidermis. This pathway involves, in addition to a Rac GTPase, three signalling proteins found at the hemidesmosome: p21-activated kinase (PAK-1), the adaptor GIT-1 and its partner PIX-1. The phosphorylation of intermediate filaments is one output of this pathway. Tension exerted by adjacent muscles or externally exerted mechanical pressure maintains GIT-1 at hemidesmosomes and stimulates PAK-1 activity through PIX-1 and Rac. This pathway promotes the maturation of a hemidesmosome into a junction that can resist mechanical stress and contributes to coordinating the morphogenesis of epidermal and muscle tissues. Our findings suggest that the C. elegans hemidesmosome is not only an attachment structure, but also a mechanosensor that responds to tension by triggering signalling processes. We suggest that similar pathways could promote epithelial morphogenesis or wound healing in other organisms in which epithelial cells adhere to tension-generating contractile cells.	[Zhang, Huimin; Landmann, Frederic; Zahreddine, Hala; Rodriguez, David; Labouesse, Michel] Univ Strasbourg, Dev & Stem Cells Program, IGBMC, CNRS,INSERM,UMR7104,U964, F-67400 Illkirch Graffenstaden, France; [Koch, Marc] Univ Strasbourg, Imaging Ctr, IGBMC, CNRS,INSERM,UMR7104,U964, F-67400 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Labouesse, M (corresponding author), Univ Strasbourg, Dev & Stem Cells Program, IGBMC, CNRS,INSERM,UMR7104,U964, 1 Rue Laurent Fries,BP 10142, F-67400 Illkirch Graffenstaden, France.	lmichel@igbmc.fr		Koch, Marc/0000-0002-2678-235X; Zhang, Huimin/0000-0002-2167-9644; Zahreddine Fahs, Hala/0000-0003-0720-2484	ANR; ARC; EU; CNRS; INSERM	ANR(French National Research Agency (ANR)); ARC(Australian Research Council); EU(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We are grateful to H.-J. Cheng, the CGC and NBP-Japan, L. Lim, J. Nance, C. Gally and L. Broday for reagents, as well as M. Argentini for technical advice. We thank J. Ahringer for a discussion, and O. Pourquie, J.-L. Bessereau, S. Jarriault and members of the Labouesse laboratory (C. Gally, I. Kolotueva, N. Osmani and S. Quintin) for critical reading of the manuscript. This work was supported by grants from the ANR, ARC and EU (STREP-FP6 programme) (M. L.) and by institutional funds from the CNRS and INSERM.	Anderson DC, 2008, SCIENCE, V320, P1771, DOI 10.1126/science.1156063; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRENNER S, 1974, GENETICS, V77, P71; Chen WN, 1996, J BIOL CHEM, V271, P26362, DOI 10.1074/jbc.271.42.26362; CHISHOLM AD, 2005, WORMBOOK, DOI DOI 10.1895/WORMBOOK.1.7.1; Costa M, 1997, DEV BIOL, V184, P373, DOI 10.1006/dbio.1997.8530; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Gally C, 2009, DEVELOPMENT, V136, P3109, DOI 10.1242/dev.039412; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Gilleard JS, 1999, DEV BIOL, V208, P265, DOI 10.1006/dbio.1999.9202; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Goto H, 2002, GENES CELLS, V7, P91, DOI 10.1046/j.1356-9597.2001.00504.x; Hapiak V, 2003, DEV BIOL, V263, P330, DOI 10.1016/j.ydbio.2003.08.001; HODGKIN J, 1983, GENETICS, V103, P43; Hresko MC, 1999, J CELL BIOL, V146, P659, DOI 10.1083/jcb.146.3.659; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaminsky R, 2009, DEV CELL, V17, P724, DOI 10.1016/j.devcel.2009.10.005; Karabinos A, 2003, J MOL BIOL, V333, P307, DOI 10.1016/j.jmb.2003.08.041; Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Lucanic M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000269; Orr AW, 2008, CIRC RES, V103, P671, DOI 10.1161/CIRCRESAHA.108.182097; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; SCHNABEL R, 1995, DEVELOPMENT, V121, P2219; WILLIAMS BD, 1994, J CELL BIOL, V124, P475, DOI 10.1083/jcb.124.4.475; Woo WM, 2004, DEV BIOL, V267, P216, DOI 10.1016/j.ydbio.2003.11.007; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Zahreddine H, 2010, CURR BIOL, V20, P322, DOI 10.1016/j.cub.2009.12.061; Zhang HM, 2010, DEV DYNAM, V239, P1465, DOI 10.1002/dvdy.22255; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	41	183	205	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					99	U120		10.1038/nature09765	http://dx.doi.org/10.1038/nature09765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368832				2022-12-28	WOS:000287924100042
J	Manning, CE				Manning, Craig E.			Sulfur Surprises in Deep Geological Fluids	SCIENCE			English	Editorial Material							WATER; TEMPERATURES; SOLUBILITY; PINATUBO; BLUE		Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Manning, CE (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	manning@ess.ucla.edu	Manning, Craig E/A-1118-2009	Manning, Craig E/0000-0002-1463-3701				BELICHENKO VP, 1973, AKAD NAUK UKR RSR B, V35, P99; Binder B, 2011, EARTH PLANET SC LETT, V301, P190, DOI 10.1016/j.epsl.2010.10.042; BROGGER WC, 1891, Z KRISTALLOGR, V18, P231; CLARK RJH, 1975, CHEM PHYS LETT, V34, P69, DOI 10.1016/0009-2614(75)80202-8; Dolejs D, 2010, GEOFLUIDS, V10, P20, DOI 10.1111/j.1468-8123.2010.00282.x; FRANTZ JD, 1993, CHEM GEOL, V106, P9, DOI 10.1016/0009-2541(93)90163-D; GIGGENBACH W, 1971, INORG CHEM, V10, P1306, DOI 10.1021/ic50100a043; HATTORI K, 1993, GEOLOGY, V21, P1083, DOI 10.1130/0091-7613(1993)021<1083:HSMAPO>2.3.CO;2; HEDENQUIST JW, 1994, NATURE, V370, P519, DOI 10.1038/370519a0; KOHL W, 1991, BER BUNSEN PHYS CHEM, V95, P1586, DOI 10.1002/bbpc.19910951202; Mandeville CW, 2010, ELEMENTS, V6, P75, DOI 10.2113/gselements.6.2.75; MCCORMICK MP, 1995, NATURE, V373, P399, DOI 10.1038/373399a0; Metrich N, 2009, GEOCHIM COSMOCHIM AC, V73, P2382, DOI 10.1016/j.gca.2009.01.025; Newton RC, 2005, J PETROL, V46, P701, DOI 10.1093/petrology/egh094; Pokrovski GS, 2011, SCIENCE, V331, P1052, DOI 10.1126/science.1199911; Pokrovski GS, 2009, GEOCHIM COSMOCHIM AC, V73, P5406, DOI 10.1016/j.gca.2009.06.007; Seward T.M., 1989, ECON GEOL, V6, P398	17	10	12	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1018	1019		10.1126/science.1202468	http://dx.doi.org/10.1126/science.1202468			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350156				2022-12-28	WOS:000287699000040
J	Barley, S				Barley, Shanta			THE RADICAL	NATURE			English	News Item																			0	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					454	456		10.1038/470454a	http://dx.doi.org/10.1038/470454a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350462	Bronze			2022-12-28	WOS:000287652900012
J	Black, B; Cleveland, DW				Black, Ben E.; Cleveland, Don W.			Epigenetic Centromere Propagation and the Nature of CENP-A Nucleosomes	CELL			English	Article							E3 UBIQUITIN LIGASE; FISSION YEAST SCM3; HISTONE H3 VARIANT; CHROMATIN REQUIRES; MAINTENANCE; DOMAIN; CSE4; ORGANIZATION; REPLICATION; RECOGNITION	Centromeres direct chromosome inheritance, but in multicellular organisms their positions on chromosomes are primarily specified epigenetically rather than by a DNA sequence. The major candidate for the epigenetic mark is chromatin assembled with the histone H3 variant CENP-A. Recent studies offer conflicting evidence for the structure of CENP-A-containing chromatin, including the histone composition and handedness of the DNA wrapped around the histones. We present a model for the assembly and deposition of centromeric nucleosomes that couples these processes to the cell cycle. This model reconciles divergent data for CENP-A-containing nucleosomes and provides a basis for how centromere identity is stably inherited.	[Black, Ben E.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of Pennsylvania; Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Black, B (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	blackbe@mail.med.upenn.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	National Institutes of Health [GM82989, GM74150]; Burroughs Wellcome Fund; Rita Allen Foundation; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082989, R01GM074150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Rita Allen Foundation; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank members of their laboratories for many discussions of centromere inheritance and anonymous reviewers for helpful comments. This work was supported by grants from the National Institutes of Health to B. E. B. (GM82989) and D. W. C. (GM74150). B. E. B. is also supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund and a Rita Allen Foundation Scholar Award. D. W. C. receives salary support from the Ludwig Institute for Cancer Research.	Amor DJ, 2004, P NATL ACAD SCI USA, V101, P6542, DOI 10.1073/pnas.0308637101; Bancaud A, 2007, MOL CELL, V27, P135, DOI 10.1016/j.molcel.2007.05.037; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; Dimitriadis EK, 2010, P NATL ACAD SCI USA, V107, P20317, DOI 10.1073/pnas.1009563107; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; duSart D, 1997, NAT GENET, V16, P144; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kingston IJ, 2011, J BIOL CHEM, V286, P4021, DOI 10.1074/jbc.M110.189340; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; Lavelle C, 2009, CELL, V139, P1216, DOI 10.1016/j.cell.2009.12.014; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; Lo AWI, 2001, EMBO J, V20, P2087, DOI 10.1093/emboj/20.8.2087; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Maggert KA, 2001, GENETICS, V158, P1615; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Ranjitkar P, 2010, MOL CELL, V40, P455, DOI 10.1016/j.molcel.2010.09.025; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106	53	237	239	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					471	479		10.1016/j.cell.2011.02.002	http://dx.doi.org/10.1016/j.cell.2011.02.002			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335232	Green Accepted, Bronze			2022-12-28	WOS:000287473100004
J	Fujiwara, H; Ferreira, M; Donati, G; Marciano, DK; Linton, JM; Sato, Y; Hartner, A; Sekiguchi, K; Reichardt, LF; Watt, FM				Fujiwara, Hironobu; Ferreira, Manuela; Donati, Giacomo; Marciano, Denise K.; Linton, James M.; Sato, Yuya; Hartner, Andrea; Sekiguchi, Kiyotoshi; Reichardt, Louis F.; Watt, Fiona M.			The Basement Membrane of Hair Follicle Stem Cells Is a Muscle Cell Niche	CELL			English	Article							ARRECTOR PILI MUSCLE; BETA-CATENIN; INTEGRIN ALPHA-8-BETA-1; MOUSE EPIDERMIS; DIFFERENTIATED PHENOTYPE; KIDNEY MORPHOGENESIS; PROTEIN NEPHRONECTIN; MAMMALIAN EPIDERMIS; ADULT EPIDERMIS; SKIN	The hair follicle bulge in the epidermis associates with the arrector pili muscle (APM) that is responsible for piloerection ("goosebumps''). We show that stem cells in the bulge deposit nephronectin into the underlying basement membrane, thus regulating the adhesion of mesenchymal cells expressing the nephronectin receptor, alpha 8 beta 1 integrin, to the bulge. Nephronectin induces alpha 8 integrin-positive mesenchymal cells to upregulate smooth muscle markers. In nephronectin knockout mice, fewer arrector pili muscles form in the skin, and they attach to the follicle above the bulge, where there is compensatory upregulation of the nephronectin family member EGFL6. Deletion of alpha 8 integrin also abolishes selective APM anchorage to the bulge. Nephronectin is a Wnt target; epidermal beta-catenin activation upregulates epidermal nephronectin and dermal alpha 8 integrin expression. Thus, bulge stem cells, via nephronectin expression, create a smooth muscle cell niche and act as tendon cells for the APM. Our results reveal a functional role for basement membrane heterogeneity in tissue patterning.	[Fujiwara, Hironobu; Ferreira, Manuela; Donati, Giacomo; Watt, Fiona M.] Li Ka Shing Ctr, Cancer Res UK Cambridge Res Inst, Cambridge CB2 0RE, England; [Marciano, Denise K.] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94158 USA; [Reichardt, Louis F.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Linton, James M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Sato, Yuya; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Hartner, Andrea] Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, D-91054 Erlangen, Germany	Cancer Research UK; CRUK Cambridge Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Osaka University; University of Erlangen Nuremberg	Watt, FM (corresponding author), Li Ka Shing Ctr, Cancer Res UK Cambridge Res Inst, Robinson Way, Cambridge CB2 0RE, England.	fiona.watt@cancer.org.uk	Fujiwara, Hironobu/A-5971-2016; Ferreira, Manuela/AAF-5299-2020; Watt, Fiona/AHB-0226-2022; Ferreira, Manuela/I-7904-2018	Fujiwara, Hironobu/0000-0003-0883-3384; Ferreira, Manuela/0000-0001-9498-8061; Watt, Fiona/0000-0001-9151-5154; Ferreira, Manuela/0000-0001-9498-8061; DONATI, Giacomo/0000-0002-0370-8288; Marciano, Denise/0000-0003-0612-4664; Ferreira, Manuela/0000-0002-0075-2400	Cancer Research UK; University of Cambridge and Hutchison Whampoa Ltd.; NIH [NS19090]; Uehara Memorial Foundation; EU; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); University of Cambridge and Hutchison Whampoa Ltd.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); EU(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Vladimir Botchkarev for K14-Noggin skin and Takako Sasaki for Fibulin-1 antibody. We gratefully acknowledge the technical assistance of the core resources of the CRUK Cambridge Research Institute. We thank the entire Watt lab for valuable reagents, suggestions, and advice. This work was funded by Cancer Research UK and supported by the University of Cambridge and Hutchison Whampoa Ltd. We also gratefully acknowledge financial support from the NIH (NS19090 to L. F. R.), from the Uehara Memorial Foundation (H. F.), and from EU FP7 (Optistem).	AKIYAMA M, 1995, J INVEST DERMATOL, V105, P844, DOI 10.1111/1523-1747.ep12326649; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Baker CM, 2010, DEV BIOL, V343, P40, DOI 10.1016/j.ydbio.2010.04.005; Barcaui CB, 2002, BRIT J DERMATOL, V146, P657, DOI 10.1046/j.1365-2133.2002.04541.x; Bolcato-Bellemin AL, 2003, DEV BIOL, V260, P376, DOI 10.1016/S0012-1606(03)00254-9; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Christiano AM, 2004, CELL, V118, P530, DOI 10.1016/j.cell.2004.08.024; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; HALL PA, 1989, DEVELOPMENT, V106, P619; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kuroda K, 2004, J CUTAN PATHOL, V31, P241, DOI 10.1111/j.0303-6987.2003.00166.x; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Niemann C, 2002, DEVELOPMENT, V129, P95; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Osada A, 2005, EXP CELL RES, V303, P148, DOI 10.1016/j.yexcr.2004.04.053; Poblet E, 2004, J AM ACAD DERMATOL, V51, P217, DOI 10.1016/j.jaad.2004.01.054; RODRIGO FG, 1975, BRIT J DERMATOL, V93, P631, DOI 10.1111/j.1365-2133.1975.tb05112.x; Sato Y, 2009, J BIOL CHEM, V284, P14524, DOI 10.1074/jbc.M900200200; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; Sharov AA, 2009, AM J PATHOL, V175, P1303, DOI 10.2353/ajpath.2009.090163; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Watt FM, 2008, COLD SH Q B, V73, P503, DOI 10.1101/sqb.2008.73.011; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Zargham R, 2007, ATHEROSCLEROSIS, V195, P303, DOI 10.1016/j.atherosclerosis.2007.01.005; Zargham R, 2006, CARDIOVASC RES, V71, P170, DOI 10.1016/j.cardiores.2006.03.003	54	215	224	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					577	589		10.1016/j.cell.2011.01.014	http://dx.doi.org/10.1016/j.cell.2011.01.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335239	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000287473100012
J	Mair, W; Morantte, I; Rodrigues, APC; Manning, G; Montminy, M; Shaw, RJ; Dillin, A				Mair, William; Morantte, Ianessa; Rodrigues, Ana P. C.; Manning, Gerard; Montminy, Marc; Shaw, Reuben J.; Dillin, Andrew			Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; CAENORHABDITIS-ELEGANS; C-ELEGANS; INSULIN-RESISTANCE; COACTIVATOR CRTC2; GENE-REGULATION; ER STRESS; PATHWAY; KINASE; TORC2	Activating AMPK or inactivating calcineurin slows ageing in Caenorhabditis elegans(1,2) and both have been implicated as therapeutic targets for age-related pathology in mammals(3-5). However, the direct targets that mediate their effects on longevity remain unclear. In mammals, CREB-regulated transcriptional coactivators (CRTCs)(6) are a family of cofactors involved in diverse physiological processes including energy homeostasis(7-9), cancer(10) and endoplasmic reticulum stress(11). Here we show that both AMPK and calcineurin modulate longevity exclusively through post-translational modification of CRTC-1, the sole C. elegans CRTC. We demonstrate that CRTC-1 is a direct AMPK target, and interacts with the CREB homologue-1 (CRH-1) transcription factor in vivo. The pro-longevity effects of activating AMPK or deactivating calcineurin decrease CRTC-1 and CRH-1 activity and induce transcriptional responses similar to those of CRH-1 null worms. Downregulation of crtc-1 increases lifespan in a crh-1-dependent manner and directly reducing crh-1 expression increases longevity, substantiating a role for CRTCs and CREB in ageing. Together, these findings indicate a novel role for CRTCs and CREB in determining lifespan downstream of AMPK and calcineurin, and illustrate the molecular mechanisms by which an evolutionarily conserved pathway responds to low energy to increase longevity.	[Mair, William; Morantte, Ianessa; Shaw, Reuben J.; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Mair, William; Morantte, Ianessa; Montminy, Marc; Shaw, Reuben J.; Dillin, Andrew] Salk Inst Biol Studies, Glenn Fdn Med Res, La Jolla, CA 92037 USA; [Rodrigues, Ana P. C.; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu; dillin@salk.edu	Rodrigues, Ana/B-7446-2011; Manning, Gerard/C-8308-2009	Mair, William/0000-0002-0661-1342; Grant, Ana/0000-0002-5439-9331; Manning, Gerard/0000-0002-5087-9151	George E. Hewitt Foundation for Medical Research; American Federation for Aging Research; Glenn Foundation for Medical Research; National Institutes of Health (NIH) [R01 DK080425, P01 CA120964, R01 HG004164, AG031097, CA14195, R01 DK070696, AG027463]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA014195] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425, R01DK070696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027463, P01AG031097] Funding Source: NIH RePORTER	George E. Hewitt Foundation for Medical Research; American Federation for Aging Research; Glenn Foundation for Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	W.M. is funded by the George E. Hewitt Foundation for Medical Research, the American Federation for Aging Research and the Glenn Foundation for Medical Research. R.J.S. is funded by National Institutes of Health (NIH) R01 DK080425 and P01 CA120964. A.P.C.R. and G.M. are funded by NIH R01 HG004164, AG031097 and CA14195. A.D. is supported by NIH R01 DK070696 and AG027463. We thank the Caenorhabditis Genetics Center, the National Bioresource Project for the Nematode and Mark Alkema for providing worm strains. We are grateful to M. Raices and M. D'Angelo for critical analysis of the manuscript, DAPI images and the NUP-160::GFP construct. We also thank members of the A.D. laboratory and M. Hansen for comments on the manuscript and discussion and K. Butler for technical assistance in the early stages of this project.	*AFF, 2004, GENECHIP EXPR AN; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Dwivedi M, 2009, AUTOPHAGY, V5, P604, DOI 10.4161/auto.5.5.8157; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Hope IA., 1999, C ELEGANS PRACTICAL; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Komiya T, 2010, ONCOGENE, V29, P1672, DOI 10.1038/onc.2009.453; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Leffler A, 2008, J CLIN INVEST, V118, P763, DOI 10.1172/JCI32751; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; MAIR W, 2009, WORM BREED GAZ, V18, P33; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Supnet C, 2010, J ALZHEIMERS DIS, V20, pS487, DOI 10.3233/JAD-2010-100306; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wang WF, 1997, J MOL BIOL, V268, P619, DOI 10.1006/jmbi.1997.1002; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xiao X, 2010, CURR CANCER DRUG TAR, V10, P384, DOI 10.2174/156800910791208535	41	264	279	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2011	470	7334					404	U179		10.1038/nature09706	http://dx.doi.org/10.1038/nature09706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331044	Green Accepted			2022-12-28	WOS:000287409100044
J	Schrag, SJ				Schrag, Stephanie J.		Global Grp B Streptococcal Vaccine	Group B streptococcal vaccine for resource-poor countries	LANCET			English	Editorial Material							CONJUGATE VACCINE; DISEASE; MORTALITY; INFANTS		[Schrag, Stephanie J.; Global Grp B Streptococcal Vaccine] Ctr Dis Control & Prevent CDC, Div Bacterial Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Schrag, SJ (corresponding author), Ctr Dis Control & Prevent CDC, Div Bacterial Dis, Atlanta, GA 30333 USA.	sschrag@cdc.gov						Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8; DEVANI, 2010, VACC NEON INF DES VA; Gray KJ, 2007, EMERG INFECT DIS, V13, P223, DOI 10.3201/eid1302.060680; Hillier S, 2009, INFECT DIS SOC AM, P186; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; Lee CH, 2009, VACCINE, V27, P726, DOI 10.1016/j.vaccine.2008.11.065; Lin FYC, 2004, J INFECT DIS, V190, P928, DOI 10.1086/422756; Madhi SA, 2003, ANN TROP PAEDIATR, V23, P15, DOI 10.1179/000349803125002814; Moore MR, 2003, LANCET INFECT DIS, V3, P201, DOI 10.1016/S1473-3099(03)00577-2; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Saleem S, 2010, OBSTET GYNECOL, V115, P1225, DOI 10.1097/AOG.0b013e3181e00ff0	14	12	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 2	2011	378	9785					11	12		10.1016/S0140-6736(10)61932-0	http://dx.doi.org/10.1016/S0140-6736(10)61932-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791IU	21377722				2022-12-28	WOS:000292659700008
J	Stager, JC; Ryves, DB; Chase, BM; Pausata, FSR				Stager, J. Curt; Ryves, David B.; Chase, Brian M.; Pausata, Francesco S. R.			Catastrophic Drought in the Afro-Asian Monsoon Region During Heinrich Event 1	SCIENCE			English	Article							CLIMATE; AFRICA; RECORD; OCEAN; VARIABILITY; RAINFALL; DYNAMICS; ATLANTIC	Between 15,000 and 18,000 years ago, large amounts of ice and meltwater entered the North Atlantic during Heinrich stadial 1. This caused substantial regional cooling, but major climatic impacts also occurred in the tropics. Here, we demonstrate that the height of this stadial, about 16,000 to 17,000 years ago ( Heinrich event 1), coincided with one of the most extreme and widespread megadroughts of the past 50,000 years or more in the Afro-Asian monsoon region, with potentially serious consequences for Paleolithic cultures. Late Quaternary tropical drying commonly is attributed to southward drift of the intertropical convergence zone, but the broad geographic range of the Heinrich event 1 megadrought suggests that severe, systemic weakening of Afro-Asian rainfall systems also occurred, probably in response to sea surface cooling.	[Stager, J. Curt] Paul Smiths Coll, Paul Smiths, NY 12970 USA; [Stager, J. Curt] Univ Maine, Climate Change Inst, Orono, ME 04469 USA; [Ryves, David B.] Univ Loughborough, Dept Geog, Ctr Hydrol & Ecosyst Sci, Loughborough LE11 3TU, Leics, England; [Chase, Brian M.] Univ Montpellier 2, UMR 5554, Inst Sci Evolut Montpellier, F-34095 Montpellier 5, France; [Chase, Brian M.] Univ Bergen, Dept Archaeol Hist Cultural Studies & Relig, N-5020 Bergen, Norway; [Pausata, Francesco S. R.] Univ Bergen, Inst Geophys, N-5007 Bergen, Norway; [Pausata, Francesco S. R.] Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; [Pausata, Francesco S. R.] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Climate Change Unit, I-21020 Ispra, Italy	University of Maine System; University of Maine Orono; Loughborough University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Bergen; University of Bergen; Bjerknes Centre for Climate Research; European Commission Joint Research Centre; EC JRC ISPRA Site	Stager, JC (corresponding author), Paul Smiths Coll, Paul Smiths, NY 12970 USA.	cstager@paulsmiths.edu	Ryves, David/D-6434-2011; Chase, Brian/A-1202-2010	Chase, Brian/0000-0001-6987-1291	National Science Foundation [EAR-0822922 (P2C2)]; Norwegian Research Council through the Decadal to Century-Scale Variability in East Asia Climate (DecCen); Arctic Records of Climate Change (ARCTREC); Natural Environment Research Council [ceh010010] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); Norwegian Research Council through the Decadal to Century-Scale Variability in East Asia Climate (DecCen); Arctic Records of Climate Change (ARCTREC); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by National Science Foundation grant EAR-0822922 (P2C2). F. S. R. P. has been supported by the Norwegian Research Council through the Decadal to Century-Scale Variability in East Asia Climate (DecCen) and Arctic Records of Climate Change (ARCTREC) projects. Sediment core samples were provided by D. Livingstone, T. Johnson, and C. Scholz.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; Broecker WS, 1998, QUATERNARY RES, V50, P12, DOI 10.1006/qres.1998.1973; Burrough SL, 2009, EARTH-SCI REV, V96, P313, DOI 10.1016/j.earscirev.2009.07.001; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; Chase BM, 2011, GEOLOGY, V39, P19, DOI 10.1130/G31129.1; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; DUPONT L, 2010, GEOPH RES ABSTR, V12; Dupont LM, 2008, CLIM PAST, V4, P107, DOI 10.5194/cp-4-107-2008; Fleitmann D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040050; Gasse F, 2002, ADV GLOB CHANGE RES, V12, P393; Holmgren K, 2003, QUATERNARY SCI REV, V22, P2311, DOI 10.1016/S0277-3791(03)00204-X; Kageyama M, 2009, CLIM PAST, V5, P551, DOI 10.5194/cp-5-551-2009; Kumar S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-230; Lamb HF, 2007, QUATERNARY SCI REV, V26, P287, DOI 10.1016/j.quascirev.2006.11.020; Partin JW, 2007, NATURE, V449, P452, DOI 10.1038/nature06164; Peck JA, 2004, PALAEOGEOGR PALAEOCL, V215, P37, DOI 10.1016/j.palaeo.2004.08.003; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Rashid H, 2007, QUATERNARY SCI REV, V26, P2586, DOI 10.1016/j.quascirev.2007.07.002; Stuut JBW, 2002, MAR GEOL, V180, P221, DOI 10.1016/S0025-3227(01)00215-8; Thomas DSG, 2009, QUATERNARY SCI REV, V28, P526, DOI 10.1016/j.quascirev.2008.10.023; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Verschuren D, 2009, NATURE, V462, P637, DOI 10.1038/nature08520; WANG Y, 2010, GEOPH RES ABSTR, V12; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Weijers JWH, 2007, SCIENCE, V315, P1701, DOI 10.1126/science.1138131; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220	29	173	182	4	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1299	1302		10.1126/science.1198322	http://dx.doi.org/10.1126/science.1198322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21350124	Green Accepted, Green Published			2022-12-28	WOS:000288215200039
J	Hughes, JM				Hughes, James M.			Preserving the Lifesaving Power of Antimicrobial Agents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTIOUS-DISEASES SOCIETY; AMERICA		[Hughes, James M.] Infect Dis Soc Amer, Arlington, VA USA; [Hughes, James M.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Hughes, James M.] Emory Univ, Hubert Dept Global Hlth, Sch Med, Atlanta, GA 30322 USA; [Hughes, James M.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Rollins School Public Health	Hughes, JM (corresponding author), Emory Univ, Dept Med, 1462 Clifton Rd,Ste 446 Mailstop 1370-004-1AD, Atlanta, GA 30322 USA.	jmhughe@emory.edu						Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Infectious Diseases Society of America, 2004, BAD BUGS NO DRUGS; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Garcia MS, 2010, JAMA-J AM MED ASSOC, V303, P2260, DOI 10.1001/jama.2010.757; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891	7	71	72	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1027	1028		10.1001/jama.2011.279	http://dx.doi.org/10.1001/jama.2011.279			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21343545				2022-12-28	WOS:000288129600022
J	Shema, R; Haramati, S; Ron, S; Hazvi, S; Chen, A; Sacktor, TC; Dudai, Y				Shema, Reut; Haramati, Sharon; Ron, Shiri; Hazvi, Shoshi; Chen, Alon; Sacktor, Todd Charlton; Dudai, Yadin			Enhancement of Consolidated Long-Term Memory by Overexpression of Protein Kinase M zeta in the Neocortex	SCIENCE			English	Article							PKM-ZETA; FACILITATION; MAINTENANCE; POTENTIATION; STORAGE; CORTEX; LTP	Memories are more easily disrupted than improved. Many agents can impair memories during encoding and consolidation. In contrast, the armamentarium of potential memory enhancers is so far rather modest. Moreover, the effect of the latter appears to be limited to enhancing new memories during encoding and the initial period of cellular consolidation, which can last from a few minutes to hours after learning. Here, we report that overexpression in the rat neocortex of the protein kinase C isozyme protein kinase M zeta (PKM zeta) enhances long-term memory, whereas a dominant negative PKM zeta disrupts memory, even long after memory has been formed.	[Shema, Reut; Haramati, Sharon; Ron, Shiri; Hazvi, Shoshi; Chen, Alon; Dudai, Yadin] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Pharmacol, Brooklyn, NY 11203 USA; [Sacktor, Todd Charlton] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Neurol, Brooklyn, NY 11203 USA	Weizmann Institute of Science; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Dudai, Y (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	yadin.dudai@weizmann.ac.il		Haramati, Sharon/0000-0002-7496-5214; Chen, Alon/0000-0003-3625-8233	Israel-U.S. Binational Science Foundation; Nella and Leon Benoziyo Center for Neurologica Diseases; NIH [R01 MH53576, MH57068]; Israeli Academy of Sciences and Humanities; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057068, R01MH057068, R01MH053576] Funding Source: NIH RePORTER	Israel-U.S. Binational Science Foundation(US-Israel Binational Science Foundation); Nella and Leon Benoziyo Center for Neurologica Diseases; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli Academy of Sciences and Humanities; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The support of the Israel-U.S. Binational Science Foundation (Y.D and T.C.S), the Nella and Leon Benoziyo Center for Neurologica Diseases (Y.D.), and of NIH R01 MH53576 and MH57068 (T.C.S.) is gratefully acknowledged. R.S. is supported by the Adams Fellowship program of the Israeli Academy of Sciences and Humanities. We thank R. Eilam for providing invaluable assistance in histochemistry.	[Anonymous], 1983, CANADIAN PSYCHOL; Aydin A, 1997, ANIM LEARN BEHAV, V25, P108, DOI 10.3758/BF03199029; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Berman DE, 2003, LEARN MEMORY, V10, P16, DOI 10.1101/lm.53703; Drier EA, 2002, NAT NEUROSCI, V5, P316, DOI 10.1038/nn820; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y., 2002, MEMORY KEYWORDS CONC; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GIURGEA C, 1973, Conditional Reflex, V8, P108; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shema R, 2009, LEARN MEMORY, V16, P122, DOI 10.1101/lm.1183309; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; STERNBERG DB, 1985, BEHAV NEURAL BIOL, V44, P447, DOI 10.1016/S0163-1047(85)90856-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935	24	139	151	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1207	1210		10.1126/science.1200215	http://dx.doi.org/10.1126/science.1200215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385716				2022-12-28	WOS:000287971200046
J	Yavuz, DD				Yavuz, Deniz D.			Toward Synthesis of Arbitrary Optical Waveforms	SCIENCE			English	Editorial Material							NOBEL LECTURE; GENERATION		Univ Wisconsin, Dept Phys, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Yavuz, DD (corresponding author), Univ Wisconsin, Dept Phys, 1150 Univ Ave, Madison, WI 53706 USA.	yavuz@wisc.edu						Bucksbaum PH, 2007, SCIENCE, V317, P766, DOI 10.1126/science.1142135; Chan HS, 2011, SCIENCE, V331, P1165, DOI 10.1126/science.1198397; Chen WJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.163906; Couny F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.143903; Goulielmakis E, 2007, SCIENCE, V317, P769, DOI 10.1126/science.1142855; Green JT, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.011805; Hansch TW, 2006, REV MOD PHYS, V78, P1297, DOI 10.1103/RevModPhys.78.1297; Hall JL, 2006, REV MOD PHYS, V78, P1279, DOI 10.1103/RevModPhys.78.1279; Harris SE, 1998, PHYS REV LETT, V81, P2894, DOI 10.1103/PhysRevLett.81.2894; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Kapteyn H, 2007, SCIENCE, V317, P775, DOI 10.1126/science.1143679; Liang JQ, 2000, PHYS REV LETT, V85, P2474, DOI 10.1103/PhysRevLett.85.2474; Shapiro M, 2003, REP PROG PHYS, V66, P859, DOI 10.1088/0034-4885/66/6/201; Shverdin MY, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.033904; Sokolov AV, 2000, PHYS REV LETT, V85, P562, DOI 10.1103/PhysRevLett.85.562; Suzuki T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.243602	16	11	13	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1142	1143		10.1126/science.1203018	http://dx.doi.org/10.1126/science.1203018			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385702				2022-12-28	WOS:000287971200026
J	Inuzuka, H; Shaik, S; Onoyama, I; Gao, DM; Tseng, A; Maser, RS; Zhai, B; Wan, LX; Gutierrez, A; Lau, AW; Xiao, YH; Christie, AL; Aster, J; Settleman, J; Gygi, SP; Kung, AL; Look, T; Nakayama, KI; DePinho, RA; Wei, WY				Inuzuka, Hiroyuki; Shaik, Shavali; Onoyama, Ichiro; Gao, Daming; Tseng, Alan; Maser, Richard S.; Zhai, Bo; Wan, Lixin; Gutierrez, Alejandro; Lau, Alan W.; Xiao, Yonghong; Christie, Amanda L.; Aster, Jon; Settleman, Jeffrey; Gygi, Steven P.; Kung, Andrew L.; Look, Thomas; Nakayama, Keiichi I.; DePinho, Ronald A.; Wei, Wenyi			SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction	NATURE			English	Article							FBW7 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; PHOSPHORYLATION; DEGRADATION; DIFFERENTIATION; COMPLEX; CANCERS; PROTEIN	The effective use of targeted therapy is highly dependent on the identification of responder patient populations. Loss of FBW7, which encodes a tumour-suppressor protein, is frequently found in various types of human cancer, including breast cancer, colon cancer(1) and T-cell acute lymphoblastic leukaemia (T-ALL)(2). In line with these genomic data, engineered deletion of Fbw7 in mouse T cells results in T-ALL(3-5), validating FBW7 as a T-ALL tumour suppressor. Determining the precise molecular mechanisms by which FBW7 exerts antitumour activity is an area of intensive investigation. These mechanisms are thought to relate in part to FBW7-mediated destruction of key proteins relevant to cancer, including Jun(6), Myc(7), cyclin E-8 and notch 1 (ref. 9), all of which have oncoprotein activity and are overexpressed in various human cancers, including leukaemia. In addition to accelerating cell growth(10), overexpression of Jun, Myc or notch 1 can also induce programmed cell death(11). Thus, considerable uncertainty surrounds how FBW7-deficient cells evade cell death in the setting of upregulated Jun, Myc and/or notch 1. Here we show that the E3 ubiquitin ligase SCFFBW7 (a SKP1-cullin-1-F-box complex that contains FBW7 as the F-box protein) governs cellular apoptosis by targeting MCL1, a pro-survival BCL2 family member, for ubiquitylation and destruction in a manner that depends on phosphorylation by glycogen synthase kinase 3. Human T-ALL cell lines showed a close relationship between FBW7 loss and MCL1 overexpression. Correspondingly, T-ALL cell lines with defective FBW7 are particularly sensitive to the multi-kinase inhibitor sorafenib but resistant to the BCL2 antagonist ABT-737. On the genetic level, FBW7 reconstitution or MCL1 depletion restores sensitivity to ABT-737, establishing MCL1 as a therapeutically relevant bypass survival mechanism that enables FBW7-deficient cells to evade apoptosis. Therefore, our work provides insight into the molecular mechanism of direct tumour suppression by FBW7 and has implications for the targeted treatment of patients with FBW7-deficient T-ALL.	[Inuzuka, Hiroyuki; Shaik, Shavali; Gao, Daming; Tseng, Alan; Wan, Lixin; Lau, Alan W.; Wei, Wenyi] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Onoyama, Ichiro; Nakayama, Keiichi I.] Kyushu Univ, Dept Mol & Cellular Biol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Maser, Richard S.; Xiao, Yonghong; DePinho, Ronald A.] Harvard Univ, Belfer Inst Appl Canc Sci, Dana Farber Canc Inst, Dept Med Oncol,Sch Med, Boston, MA 02115 USA; [Maser, Richard S.] Jackson Lab, Bar Harbor, ME 04609 USA; [Zhai, Bo; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Gutierrez, Alejandro; Christie, Amanda L.; Kung, Andrew L.; Look, Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Christie, Amanda L.; Kung, Andrew L.] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Aster, Jon] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Settleman, Jeffrey] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc,Dept Med, Boston, MA 02129 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Jackson Laboratory; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wei, WY (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	wwei2@bidmc.harvard.edu	Kung, Andrew/AAL-2384-2020; Wan, Lixin/F-2124-2011; Kung, Andrew L/AEU-0826-2022; Maser, Richard/B-2970-2012	Kung, Andrew L/0000-0002-9091-488X; DePinho, Ronald/0000-0002-5625-577X; Gutierrez, Alejandro/0000-0002-0249-9007; Gao, Daming/0000-0003-4374-1055	Emerald Foundation; Leukemia and Lymphoma Society; National Institutes of Health [GM089763]; Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089763] Funding Source: NIH RePORTER	Emerald Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lawler, C. Schorl, Q. Zhang and S. Glueck for critical reading of the manuscript, J. DeCaprio, M.-C. Hung, M. A. Kelliher, W. Harper and W. Hahn for providing reagents, L. Cantley and A. Toker for suggestions, I. Wertz and V. Dixit for sharing unpublished data, and members of the Wei and DePinho labs for useful discussions. W.W. is a Kimmel Scholar and V Scholar. This work was supported in part by the Emerald Foundation New Investigator award (W.W.), the Leukemia and Lymphoma Society Special Fellow award (W.W.) and a grant from the National Institutes of Health (W.W.; GM089763). R.A.D. is an American Cancer Society Research Professor and is supported by the Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science.	Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Konopleva M, 2008, CANCER RES, V68, P3413, DOI 10.1158/0008-5472.CAN-07-1919; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Panka DJ, 2008, J BIOL CHEM, V283, P726, DOI 10.1074/jbc.M705343200; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Sanchez I, 2001, NEURON, V29, P563, DOI 10.1016/S0896-6273(01)00232-X; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	29	486	504	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					104	U128		10.1038/nature09732	http://dx.doi.org/10.1038/nature09732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368833	Green Accepted			2022-12-28	WOS:000287924100043
J	Laepple, T; Werner, M; Lohmann, G				Laepple, Thomas; Werner, Martin; Lohmann, Gerrit			Synchronicity of Antarctic temperatures and local solar insolation on orbital timescales	NATURE			English	Article							VOSTOK ICE CORE; SOUTHERN-HEMISPHERE; CLIMATE SENSITIVITY; RECORDS; CO2; ACCUMULATION; SEASONALITY; CYCLES; OCEAN; RISE	The Milankovitch theory states that global climate variability on orbital timescales from tens to hundreds of thousands of years is dominated by the summer insolation at high northern latitudes(1,2). The supporting evidence includes reconstructed air temperatures in Antarctica that are nearly in phase with boreal summer insolation and out of phase with local summer insolation(3-5). Antarctic climate is therefore thought to be driven by northern summer insolation(5). A clear mechanism that links the two hemispheres on orbital timescales is, however, missing. We propose that key Antarctic temperature records derived from ice cores are biased towards austral winter because of a seasonal cycle in snow accumulation. Using present-day estimates of this bias in the 'recorder' system, here we show that the local insolation can explain the orbital component of the temperature record without having to invoke a link to the Northern Hemisphere. Therefore, the Antarctic ice-core-derived temperature record, one of the best-dated records of the late Pleistocene temperature evolution, cannot be used to support or contradict the Milankovitch hypothesis that global climate changes are driven by Northern Hemisphere summer insolation variations.	[Laepple, Thomas; Werner, Martin; Lohmann, Gerrit] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Laepple, T (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	thomas.laepple@awi.de	Lohmann, Gerrit/M-7453-2016; Laepple, Thomas/M-8783-2015; Werner, Martin/C-8067-2014	Lohmann, Gerrit/0000-0003-2089-733X; Laepple, Thomas/0000-0001-8108-7520; Werner, Martin/0000-0002-6473-0243				BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BROMWICH DH, 1988, REV GEOPHYS, V26, P149, DOI 10.1029/RG026i001p00149; EKAYKIN AA, 2003, THESIS U J FOURIER; Gildor H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013781; HANSEN J, 1985, SCIENCE, V229, P857, DOI 10.1126/science.229.4716.857; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Joussaume S, 1997, J GEOPHYS RES-ATMOS, V102, P1943, DOI 10.1029/96JD01989; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Jouzel J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002677; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Keller L.M., 2007, ANTARCTIC AUTOMATIC; King AL, 2001, DEEP-SEA RES PT I, V48, P1687, DOI 10.1016/S0967-0637(00)00106-0; Laepple T, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001674; Lisiecki LE, 2008, NATURE, V456, P85, DOI 10.1038/nature07425; LORIUS C, 1990, NATURE, V347, P139, DOI 10.1038/347139a0; LORIUS C, 1985, NATURE, V316, P591, DOI 10.1038/316591a0; MANABE S, 1985, J GEOPHYS RES-ATMOS, V90, P2167, DOI 10.1029/JD090iD01p02167; McConnell JR, 1997, J GEOPHYS RES-ATMOS, V102, P21947, DOI 10.1029/97JD00848; Milankovitch M., 1941, AKAD ROYALE SERBE, V33, P1; Noone D, 1999, J GEOPHYS RES-ATMOS, V104, P19191, DOI 10.1029/1999JD900376; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Schulz KG, 2006, EARTH PLANET SC LETT, V249, P326, DOI 10.1016/j.epsl.2006.07.004; Schwerdtfeger W., 1984, WEATHER CLIMATE ANTA; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; STEIG EJ, 1994, SCIENCE, V266, P1885, DOI 10.1126/science.266.5192.1885; Stocker TF, 1998, SCIENCE, V282, P61, DOI 10.1126/science.282.5386.61; Stott L, 2007, SCIENCE, V318, P435, DOI 10.1126/science.1143791; Suwa M, 2008, QUATERNARY SCI REV, V27, P1093, DOI 10.1016/j.quascirev.2008.02.017; Timmermann A, 2009, J CLIMATE, V22, P1626, DOI 10.1175/2008JCLI2161.1; Werner M, 2000, GEOPHYS RES LETT, V27, P723, DOI 10.1029/1999GL006075	32	56	59	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					91	94		10.1038/nature09825	http://dx.doi.org/10.1038/nature09825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368830				2022-12-28	WOS:000287924100040
J	Robert, T; Vanoli, F; Chiolo, I; Shubassi, G; Bernstein, KA; Rothstein, R; Botrugno, OA; Parazzoli, D; Oldani, A; Minucci, S; Foiani, M				Robert, Thomas; Vanoli, Fabio; Chiolo, Irene; Shubassi, Ghadeer; Bernstein, Kara A.; Rothstein, Rodney; Botrugno, Oronza A.; Parazzoli, Dario; Oldani, Amanda; Minucci, Saverio; Foiani, Marco			HDACs link the DNA damage response, processing of double-strand breaks and autophagy	NATURE			English	Article							VALPROIC ACID; END RESECTION; CHECKPOINT; ACETYLATION; ACTIVATION; YEAST; SAE2; HELICASE; SGS1; SRS2	Protein acetylation is mediated by histone acetyltransferases (HATs) and deacetylases (HDACs), which influence chromatin dynamics, protein turnover and the DNA damage response. ATM and ATR mediate DNA damage checkpoints by sensing double-strand breaks and single-strand-DNA-RFA nucleofilaments, respectively. However, it is unclear how acetylation modulates the DNA damage response. Here we show that HDAC inhibition/ablation specifically counteracts yeast Mec1 (orthologue of human ATR) activation, double-strand-break processing and single-strand-DNA-RFA nucleofilament formation. Moreover, the recombination protein Sae2 (human CtIP) is acetylated and degraded after HDAC inhibition. Two HDACs, Hda1 and Rpd3, and one HAT, Gcn5, have key roles in these processes. We also find that HDAC inhibition triggers Sae2 degradation by promoting autophagy that affects the DNA damage sensitivity of hda1 and rpd3 mutants. Rapamycin, which stimulates autophagy by inhibiting Tor, also causes Sae2 degradation. We propose that Rpd3, Hda1 and Gcn5 control chromosome stability by coordinating the ATR checkpoint and double-strand-break processing with autophagy.	[Robert, Thomas; Vanoli, Fabio; Chiolo, Irene; Shubassi, Ghadeer; Foiani, Marco] Fdn IFOM, I-20139 Milan, Italy; [Chiolo, Irene] LBNL, Dept Genome Biol, Berkeley, CA 94710 USA; [Bernstein, Kara A.; Rothstein, Rodney] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10032 USA; [Botrugno, Oronza A.; Minucci, Saverio] European Inst Oncol, I-20139 Milan, Italy; [Parazzoli, Dario; Oldani, Amanda] Cogentech, I-20139 Milan, Italy; [Minucci, Saverio; Foiani, Marco] Univ Milan, DSBB, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Columbia University; IRCCS European Institute of Oncology (IEO); University of Milan	Foiani, M (corresponding author), Fdn IFOM, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	saverio.minucci@ifom-ieo-campus.it; marco.foiani@ifom-ieo-campus.it	Bernstein, Kara Anne/S-4943-2016; Botrugno, Oronza Antonietta/P-2065-2017; Foiani, Marco/M-8234-2014; Minucci, Saverio/J-9669-2012	Bernstein, Kara Anne/0000-0003-2247-6459; Botrugno, Oronza Antonietta/0000-0002-2568-9815; Foiani, Marco/0000-0003-4795-834X; Robert, Thomas/0000-0002-2458-7454; Rothstein, Rodney/0000-0002-4107-9654; Chiolo, Irene/0000-0002-3080-550X	Italian Association for Cancer Research; Telethon; European Community (GENICA); Italian Ministry of Health; FRM; EMBO; HFSP; FIRC;  [GM50237];  [GM67055];  [GM088413]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050237, R01GM067055, R00GM088413, R37GM050237, K99GM088413] Funding Source: NIH RePORTER	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); European Community (GENICA)(European Commission); Italian Ministry of Health(Ministry of Health, Italy); FRM(Fondation pour la Recherche Medicale); EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); FIRC(Fondazione AIRC per la ricerca sul cancro); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Piatti, M. P. Longhese, M. Grunstein, J. K. Tyler, A. Pellicioli, M. Costanzo, R. Brost, M. Vogelauer, D. Klionsky, T. Roberts and C. Bertoli for reagents and technical suggestions, J. Barlow for DNA damage foci analysis, A. Sartori and S. Ferrari for communicating unpublished results, C. Lucca, D. Branzei, R. Bermejo and the members of our laboratories for comments. Work in M. F. laboratory was supported by grants from the Italian Association for Cancer Research and partially from Telethon, European Community (GENICA) and the Italian Ministry of Health. T. R. was supported by fellowships from FRM and EMBO and I.C. was supported by a short fellowship from HFSP and from FIRC. This work was also supported by GM50237 (to R.R.), GM67055 (to R.R.) and GM088413 (to K.B.).	Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Fiorani S, 2008, CELL CYCLE, V7, P493, DOI 10.4161/cc.7.4.5323; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Fu J, 2010, NEURO-ONCOLOGY, V12, P328, DOI 10.1093/neuonc/nop005; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Liberi G, 2000, EMBO J, V19, P5027, DOI 10.1093/emboj/19.18.5027; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Neecke H, 1999, EMBO J, V18, P4485, DOI 10.1093/emboj/18.16.4485; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Robert T, 2006, EMBO J, V25, P2837, DOI 10.1038/sj.emboj.7601158; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Scott KL, 2003, MOL CELL BIOL, V23, P4522, DOI 10.1128/MCB.23.13.4522-4531.2003; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shintani T, 2008, METHOD ENZYMOL, V451, P43, DOI 10.1016/S0076-6879(08)03204-7; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	47	302	313	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					74	79		10.1038/nature09803	http://dx.doi.org/10.1038/nature09803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368826	Green Accepted			2022-12-28	WOS:000287924100036
J	Sekercioglu, CH				Sekercioglu, Cagan H.			Functional Extinctions of Bird Pollinators Cause Plant Declines	SCIENCE			English	Editorial Material									Univ Utah, Dept Biol, Salt Lake City, UT 84105 USA	Utah System of Higher Education; University of Utah	Sekercioglu, CH (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84105 USA.	c.s@utah.edu	Sekercioglu, Cagan H/A-2331-2013	Sekercioglu, Cagan H/0000-0001-9639-294X; Sekercioglu, Cagan H./0000-0003-3193-0377				Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cox PA, 2000, CONSERV BIOL, V14, P1237, DOI 10.1046/j.1523-1739.2000.00017.x; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Ford H.A., 1985, Proceedings of the Ecological Society of Australia, V14, P153; Kelly D, 2004, NEW ZEAL J BOT, V42, P89, DOI 10.1080/0028825X.2004.9512892; LADLEY JJ, 1995, NATURE, V378, P766, DOI 10.1038/378766a0; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Mortensen HS, 2008, BIOL CONSERV, V141, P2146, DOI 10.1016/j.biocon.2008.06.014; Nabhan G. P., 1997, Nature's services: societal dependence on natural ecosystems., P133; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Renner SS, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P123; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2010, CONSERVATION BIOLOGY FOR ALL, P45, DOI 10.1093/acprof:oso/9780199554232.003.0004; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sodhi N.S., 2011, CONSERVATION TROPICA; Wenny DG, 2011, AUK, V128, P1, DOI 10.1525/auk.2011.10248; Whelan CJ, 2008, ANN NY ACAD SCI, V1134, P25, DOI 10.1196/annals.1439.003; Wormworth J, 2011, WINGED SENTINELS: BIRDS AND CLIMATE CHANGE, P1, DOI 10.1017/CBO9781139150026	20	51	53	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1019	1020		10.1126/science.1202389	http://dx.doi.org/10.1126/science.1202389			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350157				2022-12-28	WOS:000287699000041
J	Brien, SE; Ronksley, PE; Turner, BJ; Mukamal, KJ; Ghali, WA				Brien, Susan E.; Ronksley, Paul E.; Turner, Barbara J.; Mukamal, Kenneth J.; Ghali, William A.			Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; RANDOMIZED CONTROLLED-TRIAL; MODERATE BEER CONSUMPTION; RED WINE CONSUMPTION; APOLIPOPROTEIN A-I; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; HEALTHY-VOLUNTEERS; POSTMENOPAUSAL WOMEN; INFLAMMATORY MARKERS	Objective To systematically review interventional studies of the effects of alcohol consumption on 21 biological markers associated with risk of coronary heart disease in adults without known cardiovascular disease. Design Systematic review and meta-analysis. Data sources Medline (1950 to October 2009) and Embase (1980 to October 2009) without limits. Study selection Two reviewers independently selected studies that examined adults without known cardiovascular disease and that compared fasting levels of specific biological markers associated with coronary heart disease after alcohol use with those after a period of no alcohol use (controls). 4690 articles were screened for eligibility, the full texts of 124 studies reviewed, and 63 relevant articles selected. Results Of 63 eligible studies, 44 on 13 biomarkers were meta-analysed in fixed or random effects models. Quality was assessed by sensitivity analysis of studies grouped by design. Analyses were stratified by type of beverage (wine, beer, spirits). Alcohol significantly increased levels of high density lipoprotein cholesterol (pooled mean difference 0.094 mmol/L, 95% confidence interval 0.064 to 0.123), apolipoprotein A1 (0.101 g/L, 0.073 to 0.129), and adiponectin (0.56 mg/L, 0.39 to 0.72). Alcohol showed a dose-response relation with high density lipoprotein cholesterol (test for trend P=0.013). Alcohol decreased fibrinogen levels (-0.20 g/L, -0.29 to -0.11) but did not affect triglyceride levels. Results were similar for crossover and before and after studies, and across beverage types. Conclusions Favourable changes in several cardiovascular biomarkers (higher levels of high density lipoprotein cholesterol and adiponectin and lower levels of fibrinogen) provide indirect pathophysiological support for a protective effect of moderate alcohol use on coronary heart disease.	[Brien, Susan E.; Ronksley, Paul E.; Ghali, William A.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary Inst Populat & Publ Hlth, Calgary, AB T2N 4Z6, Canada; [Turner, Barbara J.] Univ Texas Hlth Sci Ctr San Antonio, REACH Ctr, San Antonio, TX 78229 USA; [Mukamal, Kenneth J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Ghali, William A.] Univ Calgary, Dept Med, Calgary, AB T2N 4Z6, Canada	University of Calgary; University of Texas System; University of Texas Health San Antonio; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Calgary	Ghali, WA (corresponding author), Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary Inst Populat & Publ Hlth, Calgary, AB T2N 4Z6, Canada.	wghali@ucalgary.ca	Mukamal, Kenneth/GVR-7978-2022	Ronksley, Paul/0000-0002-3958-7561	Robert Wood Johnson Foundation [58529]; Substance Abuse and Mental Health Services; Administration Center for Substance Abuse Treatment; Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research; Canada research chair in health services research	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Substance Abuse and Mental Health Services; Administration Center for Substance Abuse Treatment; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada research chair in health services research(Canada Research Chairs)	This work was supported by a contracted operating grant from Program of Research Integrating Substance Use Information into Mainstream Healthcare (PRISM) funded by the Robert Wood Johnson Foundation project No 58529, with cofunding by the Substance Abuse and Mental Health Services and the Administration Center for Substance Abuse Treatment. SB is supported by a postdoctoral fellowship award from the Alberta Heritage Foundation for Medical Research. PR is supported by a Frederick Banting and Charles Best Canada graduate scholarship from the Canadian Institutes of Health Research. WG is supported by a Canada research chair in health services research and by a senior health scholar award from the Alberta Heritage Foundation for Medical Research. Other than funding, research in this manuscript was done independent of funding agencies. None of the funding agencies played an active role in the preparation, review, or editing of this manuscript.	[Anonymous], 2000, ALCOHOL RES HEALTH, V24, P5; [Anonymous], 2005, ALCOHOLIC BEVERAGES; Baer DJ, 2002, AM J CLIN NUTR, V75, P593, DOI 10.1093/ajcn/75.3.593; Bantle AE, 2008, METABOLISM, V57, P241, DOI 10.1016/j.metabol.2007.09.007; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BELFRAGE P, 1977, EUR J CLIN INVEST, V7, P127, DOI 10.1111/j.1365-2362.1977.tb01584.x; Belfrage P, 1973, Acta Med Scand Suppl, V552, P1; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; BERTIERE MC, 1986, ATHEROSCLEROSIS, V61, P7, DOI 10.1016/0021-9150(86)90108-5; Beulens JWJ, 2008, EUR J CLIN NUTR, V62, P1098, DOI 10.1038/sj.ejcn.1602821; Beulens JWJ, 2007, DIABETOLOGIA, V50, P1388, DOI 10.1007/s00125-007-0699-8; Beulens JWJ, 2008, NUTR METAB CARDIOVAS, V18, P539, DOI 10.1016/j.numecd.2007.07.002; Beulens JWJ, 2006, OBESITY, V14, P60, DOI 10.1038/oby.2006.8; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Brien SE, 2009, J GEN INTERN MED, V24, P65; BURR ML, 1986, BRIT J NUTR, V56, P81, DOI 10.1079/BJN19860087; Cartron E, 2003, FREE RADICAL RES, V37, P1021, DOI 10.1080/10715760310001598097; CLEVIDENCE BA, 1995, ARTERIOSCL THROM VAS, V15, P179, DOI 10.1161/01.ATV.15.2.179; CONTALDO F, 1989, METABOLISM, V38, P166, DOI 10.1016/0026-0495(89)90257-6; COUZIGOU P, 1984, ANN NUTR METAB, V28, P377, DOI 10.1159/000176849; CROUSE JR, 1984, J LIPID RES, V25, P486; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Deeks JJ, 2007, SYSTEMATIC REV HLTH; Djurovic S, 2007, ALCOHOL ALCOHOLISM, V42, P525, DOI 10.1093/alcalc/agm056; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2001, SYSTEMATIC REV HLTH, V2nd ed., P23, DOI DOI 10.1002/9780470693926.CH2; Estruch R, 2004, ATHEROSCLEROSIS, V175, P117, DOI 10.1016/j.atherosclerosis.2004.03.006; FRASER GE, 1983, ATHEROSCLEROSIS, V46, P275, DOI 10.1016/0021-9150(83)90178-8; FRIMPONG NA, 1989, AM J CLIN NUTR, V50, P987, DOI 10.1093/ajcn/50.5.987; GLUECK CJ, 1980, AM J CLIN NUTR, V33, P2287, DOI 10.1093/ajcn/33.11.2287; Goldberg DM, 1996, CLIN CHIM ACTA, V246, P183, DOI 10.1016/0009-8981(96)06229-8; Gorinstein S, 2003, J NUTR BIOCHEM, V14, P710, DOI 10.1016/j.jnutbio.2003.09.002; Gottrand F, 1999, EUR J CLIN INVEST, V29, P387, DOI 10.1046/j.1365-2362.1999.00484.x; HAGIAGE M, 1992, METABOLISM, V41, P856, DOI 10.1016/0026-0495(92)90167-9; Hansen AS, 2005, EUR J CLIN NUTR, V59, P449, DOI 10.1038/sj.ejcn.1602107; HARTUNG GH, 1986, AM J CARDIOL, V58, P148, DOI 10.1016/0002-9149(86)90259-6; HARTUNG GH, 1983, JAMA-J AM MED ASSOC, V249, P747, DOI 10.1001/jama.249.6.747; HARTUNG GH, 1990, METABOLISM, V39, P81, DOI 10.1016/0026-0495(90)90152-3; Heidemann C, 2008, ANN INTERN MED, V149, P307, DOI 10.7326/0003-4819-149-5-200809020-00005; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Imhof A, 2009, DIABETES CARE, V32, P1101, DOI 10.2337/dc08-1723; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jensen T, 2006, BLOOD COAGUL FIBRIN, V17, P471, DOI 10.1097/01.mbc.0000240920.72930.63; Joosten MM, 2008, DIABETOLOGIA, V51, P1375, DOI 10.1007/s00125-008-1031-y; Juni P, 2007, SYSTEMATIC REV HLTH; Kannel WB, 2005, LIPIDS, V40, P1215, DOI 10.1007/s11745-005-1488-8; KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183; Kaptoge S, 2007, AM J EPIDEMIOL, V166, P867, DOI 10.1093/aje/kwm191; Karlsen A, 2007, E SPEN EUR E J CLIN, V2, pe127, DOI DOI 10.1016/j.eclnm.2007.09.002; Lewington S, 2005, JAMA-J AM MED ASSOC, V294, P2848; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; MALMENDIER CL, 1985, CLIN CHIM ACTA, V152, P281, DOI 10.1016/0009-8981(85)90103-2; McConnell MV, 1997, AM J CARDIOL, V80, P1226, DOI 10.1016/S0002-9149(97)00647-4; Mezzano D, 2003, EUR J CLIN NUTR, V57, P439, DOI 10.1038/sj.ejcn.1601558; Mezzano D, 2001, EUR J CLIN NUTR, V55, P444, DOI 10.1038/sj.ejcn.1601202; Mukamal KJ, 2001, CIRCULATION, V104, P1367, DOI 10.1161/hc3701.096067; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; Naissides M, 2006, ATHEROSCLEROSIS, V185, P438, DOI 10.1016/j.atherosclerosis.2005.06.027; NISHIWAKI M, 1994, ATHEROSCLEROSIS, V111, P99, DOI 10.1016/0021-9150(94)90195-3; PaceAsciak CR, 1996, CLIN CHIM ACTA, V246, P163, DOI 10.1016/0009-8981(96)06236-5; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; PIKAAR NA, 1987, METABOLISM, V36, P538, DOI 10.1016/0026-0495(87)90163-6; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Retterstol L, 2005, ALCOHOL ALCOHOLISM, V40, P102, DOI 10.1093/alcalc/agh132; Riera-Guardia N, 2008, DIABETES OBES METAB, V10, P367, DOI 10.1111/j.1463-1326.2007.00755.x; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Romeo J, 2007, J PHYSIOL BIOCHEM, V63, P153, DOI 10.1007/BF03168226; Romeo J, 2007, ANN NUTR METAB, V51, P359, DOI 10.1159/000107679; Ronksley PE, 2009, J GEN INTERN MED, V24, P28; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Roth MJ, 2003, J NATL CANCER I, V95, P1722, DOI 10.1093/jnci/djg090; SCHNEIDER J, 1985, ATHEROSCLEROSIS, V57, P281, DOI 10.1016/0021-9150(85)90040-1; Senault C, 2000, NUTR METAB CARDIOVAS, V10, P63; SHARPE PC, 1995, QJM-INT J MED, V88, P101; Sierksma A, 2004, ALCOHOL CLIN EXP RES, V28, P662, DOI 10.1097/01.ALC.0000122763.30770.F5; Sierksma A, 2004, DIABETES CARE, V27, P184, DOI 10.2337/diacare.27.1.184; Sierksma A, 2002, EUR J CLIN NUTR, V56, P1130, DOI 10.1038/sj.ejcn.1601459; Sierksma A, 2002, ALCOHOL CLIN EXP RES, V26, P1430, DOI 10.1097/01.ALC.0000030639.57507.60; Sierksma A, 2001, ANN NY ACAD SCI, V936, P630; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; SUZUKAWA M, 1994, J AM COLL NUTR, V13, P237, DOI 10.1080/07315724.1994.10718403; TASKINEN MR, 1987, AM HEART J, V113, P458, DOI 10.1016/0002-8703(87)90614-4; THORNTON J, 1983, LANCET, V2, P819; Tsang C, 2005, BRIT J NUTR, V93, P233, DOI 10.1079/BJN20041311; TURNER C, 1990, BRIT J ADDICT, V85, P1171; VALIMAKI M, 1988, EUR J CLIN INVEST, V18, P472, DOI 10.1111/j.1365-2362.1988.tb01042.x; VALIMAKI M, 1991, METABOLISM, V40, P1168, DOI 10.1016/0026-0495(91)90211-E; van der Gaag MS, 1999, ATHEROSCLEROSIS, V147, P405, DOI 10.1016/S0021-9150(99)00243-9; van der Gaag MS, 2001, J LIPID RES, V42, P2077; van Golde PM, 2002, NETH J MED, V60, P285; Vazquez-Agell M, 2007, J NUTR, V137, P2279, DOI 10.1093/jn/137.10.2279; Watzl B, 2004, EUR J CLIN NUTR, V58, P40, DOI 10.1038/sj.ejcn.1601742	93	473	491	2	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2011	342								d636	10.1136/bmj.d636	http://dx.doi.org/10.1136/bmj.d636			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729AS	21343206	Green Published, hybrid			2022-12-28	WOS:000287919000005
J	Nesbit, J; Norman, C; Konstantinov, I; Stefanov, Y; Kovalevsky, A; Voronin, Y; Lee, I; Ahn, M; Marcotte, E; Rhee, SY; Heras, J; Elliot, K; Fayyaz, M; Crnokrak, P; Darling, SB; Sibener, SJ; Belliveau, RR; Hoffman, KL; Wood, RJ; Pope, D; Dick, G; Bradley, S; Kelley, S; Chourasia, A; Mcquinn, E; Minster, B; Schulze, J; Cox, TJ; Berry, D; Ellisman, M; Tetaz, F				Nesbit, Jeff; Norman, Colin; Konstantinov, Ivan; Stefanov, Yury; Kovalevsky, Aleksander; Voronin, Yegor; Lee, Insuk; Ahn, Michael; Marcotte, Edward; Rhee, Seung Yon; Heras, Jonathan; Elliot, Kandis; Fayyaz, Mo; Crnokrak, Peter; Darling, Seth B.; Sibener, Steven J.; Belliveau, Robert Rock; Hoffman, Katie L.; Wood, Robert J.; Pope, Damian; Dick, Greg; Bradley, Sean; Kelley, Steve; Chourasia, Amit; Mcquinn, Emmett; Minster, Bernard; Schulze, Jurgen; Cox, Thomas J.; Berry, Drew; Ellisman, Mark; Tetaz, Francois			2010 VISUALIZATION CHALLENGE	SCIENCE			English	Editorial Material									[Elliot, Kandis; Fayyaz, Mo] Univ Wisconsin, Madison, WI 53706 USA; [Darling, Seth B.] Argonne Natl Lab, Argonne, IL 60439 USA; [Sibener, Steven J.] Univ Chicago, Chicago, IL 60637 USA; [Hoffman, Katie L.; Wood, Robert J.] Harvard Univ, Cambridge, MA 02138 USA; [Chourasia, Amit; Mcquinn, Emmett; Minster, Bernard; Schulze, Jurgen] UCSD, San Diego Supercomp Ctr, San Diego, CA USA; [Berry, Drew; Ellisman, Mark; Tetaz, Francois] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Harvard University; University of California System; University of California San Diego; Walter & Eliza Hall Institute			Darling, Seth/AAJ-4847-2020	Darling, Seth/0000-0002-5461-6965					0	3	3	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					847	856		10.1126/science.331.6019.847	http://dx.doi.org/10.1126/science.331.6019.847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330509				2022-12-28	WOS:000287455100023
J	Olson, MV				Olson, Maynard V.			What Does a "Normal" Human Genome Look Like?	SCIENCE			English	Editorial Material									Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Olson, MV (corresponding author), Univ Washington, Seattle, WA 98195 USA.								0	5	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					872	872		10.1126/science.1203236	http://dx.doi.org/10.1126/science.1203236			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330527				2022-12-28	WOS:000287455100040
J	Vacic, V; McCarthy, S; Malhotra, D; Murray, F; Chou, HH; Peoples, A; Makarov, V; Yoon, S; Bhandari, A; Corominas, R; Iakoucheva, LM; Krastoshevsky, O; Krause, V; Larach-Walters, V; Welsh, DK; Craig, D; Kelsoe, JR; Gershon, ES; Leal, SM; Aquila, MD; Morris, DW; Gill, M; Corvin, A; Insel, PA; McClellan, J; King, MC; Karayiorgou, M; Levy, DL; DeLisi, LE; Sebat, J				Vacic, Vladimir; McCarthy, Shane; Malhotra, Dheeraj; Murray, Fiona; Chou, Hsun-Hua; Peoples, Aine; Makarov, Vladimir; Yoon, Seungtai; Bhandari, Abhishek; Corominas, Roser; Iakoucheva, Lilia M.; Krastoshevsky, Olga; Krause, Verena; Larach-Walters, Veronica; Welsh, David K.; Craig, David; Kelsoe, John R.; Gershon, Elliot S.; Leal, Suzanne M.; Aquila, Marie Dell; Morris, Derek W.; Gill, Michael; Corvin, Aiden; Insel, Paul A.; McClellan, Jon; King, Mary-Claire; Karayiorgou, Maria; Levy, Deborah L.; DeLisi, Lynn E.; Sebat, Jonathan			Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia	NATURE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; MICRODELETIONS; 7Q	Rare copy number variants (CNVs) have a prominent role in the aetiology of schizophrenia and other neuropsychiatric disorders(1). Substantial risk for schizophrenia is conferred by large (>500-kilobase) CNVs at several loci, including microdeletions at 1q21.1 (ref. 2), 3q29 (ref. 3), 15q13.3 (ref. 2) and 22q11.2 (ref. 4) and microduplication at 16p11.2 (ref. 5). However, these CNVs collectively account for a small fraction (2-4%) of cases, and the relevant genes and neurobiological mechanisms are not well understood. Here we performed a large two-stage genome-wide scan of rare CNVs and report the significant association of copy number gains at chromosome 7q36.3 with schizophrenia. Microduplications with variable breakpoints occurred within a 362-kilobase region and were detected in 29 of 8,290 (0.35%) patients versus 2 of 7,431 (0.03%) controls in the combined sample. All duplications overlapped or were located within 89 kilobases upstream of the vasoactive intestinal peptide receptor gene VIPR2. VIPR2 transcription and cyclic-AMP signalling were significantly increased in cultured lymphocytes from patients with microduplications of 7q36.3. These findings implicate altered vasoactive intestinal peptide signalling in the pathogenesis of schizophrenia and indicate the VPAC2 receptor as a potential target for the development of new antipsychotic drugs.	[Vacic, Vladimir; McCarthy, Shane; Malhotra, Dheeraj; Bhandari, Abhishek; Sebat, Jonathan] Cold Spring Harbor Lab, Stanley Inst Cognit Genom, Cold Spring Harbor, NY 12824 USA; [Vacic, Vladimir] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Malhotra, Dheeraj; Chou, Hsun-Hua; Bhandari, Abhishek; Sebat, Jonathan] Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA USA; [Malhotra, Dheeraj; Chou, Hsun-Hua; Bhandari, Abhishek; Corominas, Roser; Iakoucheva, Lilia M.; Welsh, David K.; Kelsoe, John R.; Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA USA; [Murray, Fiona; Aquila, Marie Dell; Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA USA; [Murray, Fiona; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA USA; [Peoples, Aine; Morris, Derek W.; Gill, Michael; Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin 2, Ireland; [Peoples, Aine; Morris, Derek W.; Gill, Michael; Corvin, Aiden] Trinity Coll Dublin, Dept Psychiat, Dublin 2, Ireland; [Makarov, Vladimir; Yoon, Seungtai] Mt Sinai Sch Med, Seaver Autism Ctr, New York, NY 10029 USA; [Makarov, Vladimir; Yoon, Seungtai] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Krastoshevsky, Olga; Krause, Verena; Levy, Deborah L.] McLean Hosp, Belmont, MA 02478 USA; [Larach-Walters, Veronica] Univ Andres Bello, Fac Med, Santiago, Chile; [Welsh, David K.; Kelsoe, John R.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Welsh, David K.] Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA USA; [Craig, David] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; [Kelsoe, John R.; Sebat, Jonathan] Univ Calif San Diego, Inst Genom Med, La Jolla, CA USA; [Gershon, Elliot S.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77025 USA; [Aquila, Marie Dell] Univ Calif San Diego, Div Med Genet, La Jolla, CA USA; [McClellan, Jon] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [DeLisi, Lynn E.] Boston VA Healthcare Syst, Dept Psychiat, Brockton, MA 02301 USA; [DeLisi, Lynn E.] Harvard Univ, Sch Med, Brockton, MA 02301 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA USA	Cold Spring Harbor Laboratory; Columbia University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Trinity College Dublin; Trinity College Dublin; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; McLean Hospital; Universidad Andres Bello; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Translational Genomics Research Institute; University of California System; University of California San Diego; University of Chicago; Baylor College of Medicine; University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Columbia University; Harvard University; University of California System; University of California San Diego	Sebat, J (corresponding author), Cold Spring Harbor Lab, Stanley Inst Cognit Genom, Cold Spring Harbor, NY 12824 USA.	jsebat@ucsd.edu	Morris, Derek/AAW-8343-2021; Welsh, David K/G-2277-2011; Corominas, Roser/H-4163-2016; Craig, David Wesley/K-6961-2019	Morris, Derek/0000-0002-3413-570X; Corominas, Roser/0000-0001-8888-5402; Craig, David Wesley/0000-0003-2040-1955; King, Mary-Claire/0000-0001-9426-1743; Corvin, Aiden/0000-0001-6717-4089; Iakoucheva, Lilia/0000-0002-4542-5219; Sebat, Jonathan/0000-0002-9087-526X; Walters, James/0000-0002-6980-4053; Murray, Fiona/0000-0002-5572-4810; Gill, Michael/0000-0003-0206-5337; Vacic, Vladimir/0000-0001-6571-2293	Beyster family foundation; NIH [MH076431, HG04222, MH071523, MH083989, GM66232, HL091061, MH082945, MH061399, MH044245]; NARSAD; Wellcome Trust [072894/Z/03/Z]; Science Foundation Ireland [08INIB1916]; Sidney R. Baer, Jr Foundation; Essel Foundation; Veterans Administration; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL091061] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071523, R01MH082945, R01MH044245, R01MH083989, R01MH091350, R01MH076431, R01MH061399] Funding Source: NIH RePORTER	Beyster family foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Sidney R. Baer, Jr Foundation; Essel Foundation; Veterans Administration(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a gift from Ted and Vada Stanley to the Cold Spring Harbor Laboratory, a gift to J.S. from the Beyster family foundation, NIH grants to J.S. (MH076431, HG04222), D.L.L. (MH071523), M.-C.K. (MH083989), P.A.I. (GM66232), F.M. (HL091061), D.K.W. (MH082945), M.K. (MH061399), L.E.D. (MH044245), grants to J.S., D.K.W., D.L.L. and M.-C.K from NARSAD, grants to A.C., M.G., D.M. from the Wellcome Trust (072894/Z/03/Z) and Science Foundation Ireland (08INIB1916), a career development award to D.K.W. by the Veterans Administration, and grants to D.L.L. from the Sidney R. Baer, Jr Foundation and Essel Foundation. We wish to thank the Genetic Association Information Network (GAIN), Molecular Genetics of Schizophrenia (MGS) and the Bipolar Genome Study (BiGS) for providing data for this study (investigators listed in the Supplementary Note). We wish to thank B. Trask, R. Malinow and J. Gleeson for discussions.	Bartsch O, 2007, CYTOGENET GENOME RES, V119, P158, DOI 10.1159/000109634; Braun MM, 2010, NAT REV DRUG DISCOV, V9, P519, DOI 10.1038/nrd3160; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Chauhan D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S1; Chu A, 2010, MOL PHARMACOL, V77, P95, DOI 10.1124/mol.109.060137; FAHRENKRUG J, 1993, PHARMACOL TOXICOL, V72, P354, DOI 10.1111/j.1600-0773.1993.tb01344.x; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Morava E, 2003, CLIN DYSMORPHOL, V12, P123, DOI 10.1097/01.mcd.0000059768.40218.9b; Moreno D, 2000, PEPTIDES, V21, P1543, DOI 10.1016/S0196-9781(00)00309-0; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; SHEWARD WJ, 1995, NEUROSCIENCE, V67, P409, DOI 10.1016/0306-4522(95)00048-N; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Turetsky BI, 2009, AM J PSYCHIAT, V166, P226, DOI 10.1176/appi.ajp.2008.07071210; Tyson C, 2005, AM J MED GENET A, V139A, P173, DOI 10.1002/ajmg.a.31015; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; WASCHEK JA, 1995, DEV NEUROSCI-BASEL, V17, P1, DOI 10.1159/000111268; Wu Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-72; Yang K, 2009, HIPPOCAMPUS, V19, P779, DOI 10.1002/hipo.20559; Zaben M, 2009, STEM CELLS, V27, P2539, DOI 10.1002/stem.184; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144	30	239	251	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					499	503		10.1038/nature09884	http://dx.doi.org/10.1038/nature09884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21346763	Green Accepted, Green Submitted			2022-12-28	WOS:000288702200059
J	Fogle, KJ; Parson, KG; Dahm, NA; Holmes, TC				Fogle, Keri J.; Parson, Kelly G.; Dahm, Nicole A.; Holmes, Todd C.			CRYPTOCHROME Is a Blue-Light Sensor That Regulates Neuronal Firing Rate	SCIENCE			English	Article							DROSOPHILA CRYPTOCHROME; CIRCADIAN CLOCK; PDF CELLS; PHOTORECEPTOR; SLEEP; AROUSAL	Light-responsive neural activity in central brain neurons is generally conveyed through opsin-based signaling from external photoreceptors. Large lateral ventral arousal neurons (lLNvs) in Drosophila melanogaster increase action potential firing within seconds in response to light in the absence of all opsin-based photoreceptors. Light-evoked changes in membrane resting potential occur in about 100 milliseconds. The light response is selective for blue wavelengths corresponding to the spectral sensitivity of CRYPTOCHROME (CRY). cry-null lines are light-unresponsive, but restored CRY expression in the lLNv rescues responsiveness. Furthermore, expression of CRY in neurons that are normally unresponsive to light confers responsiveness. The CRY-mediated light response requires a flavin redox-based mechanism and depends on potassium channel conductance, but is independent of the classical circadian CRY-TIMELESS interaction.	[Fogle, Keri J.; Parson, Kelly G.; Dahm, Nicole A.; Holmes, Todd C.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine	Holmes, TC (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	tholmes@uci.edu		Holmes, Todd/0000-0001-8152-8832	NIH [NS046750]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107405, R01GM102965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank P. Hardin (anti-CRY), D. O'Dowd (gh146GAL4), J. Hall (cry<SUP>01</SUP> and cry<SUP>02</SUP>), S. Reppert (UAS-dpCRY1 and UAS-dpCRY2), P. Emery (UAS-cry<SUP>m</SUP>), and the Bloomington Stock Center for reagents; S. Vasu, M. Digman, and A. Starr for helpful discussion and technical advice; B. Horne for helpful comments on the manuscript and technical assistance; and S. DeGroot and D. Mumford for technical assistance. This work was funded by NIH grant NS046750 to T. C. H. The authors have no competing financial interests.	Benito J, 2008, J BIOL RHYTHM, V23, P296, DOI 10.1177/0748730408318588; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Helfrich-Forster C, 1998, CHRONOBIOL INT, V15, P567, DOI 10.3109/07420529808993195; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hirsh J, 2010, CURR BIOL, V20, P209, DOI 10.1016/j.cub.2009.11.037; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Park D, 2006, J NEUROPHYSIOL, V95, P3955, DOI 10.1152/jn.00117.2006; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011	23	141	144	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1409	1413		10.1126/science.1199702	http://dx.doi.org/10.1126/science.1199702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21385718	Green Accepted			2022-12-28	WOS:000288504000033
J	Lin, NU; Burstein, HJ				Lin, Nancy U.; Burstein, Harold J.			EMBRACE, eribulin, and new realities of advanced breast cancer	LANCET			English	Editorial Material							HALICHONDRIN B ANALOG; PHASE-II; ANTHRACYCLINE; CHEMOTHERAPY; MESYLATE; TAXANE		[Burstein, Harold J.] Dana Farber Canc Inst, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Burstein, HJ (corresponding author), Dana Farber Canc Inst, Boston, MA 02215 USA.	hburstein@partners.org						Cardoso F, 2002, ANN ONCOL, V13, P197, DOI 10.1093/annonc/mdf101; Chia SK, 2007, CANCER, V110, P973, DOI 10.1002/cncr.22867; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Cortes J, 2010, J CLIN ONCOL, V28, P3922, DOI 10.1200/JCO.2009.25.8467; McLachlan SA, 1999, BREAST CANCER RES TR, V54, P213, DOI 10.1023/A:1006123721205; Sheik-Yousouf A, 2010, EJC SUPPL, V8, P77, DOI 10.1016/S1359-6349(10)70094-X; Vahdat LT, 2009, J CLIN ONCOL, V27, P2954, DOI 10.1200/JCO.2008.17.7618	7	9	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2011	377	9769					878	880		10.1016/S0140-6736(11)60280-8	http://dx.doi.org/10.1016/S0140-6736(11)60280-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GR	21376386				2022-12-28	WOS:000288628800005
J	Gao, YK; Katyal, S; Lee, YS; Zhao, JF; Rehg, JE; Russell, HR; McKinnon, PJ				Gao, Yankun; Katyal, Sachin; Lee, Youngsoo; Zhao, Jingfeng; Rehg, Jerold E.; Russell, Helen R.; McKinnon, Peter J.			DNA ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair	NATURE			English	Article							BASE EXCISION-REPAIR; STRAND BREAK REPAIR; MITOCHONDRIAL-DNA; MOUSE CELLS; DISEASE; XRCC1; DAMAGE; INACTIVATION; POLYMERASE; EXPRESSION	DNA replication and repair in mammalian cells involves three distinct DNA ligases: ligase I (Lig1), ligase III (Lig3) and ligase IV (Lig4)(1). Lig3 is considered a key ligase during base excision repair because its stability depends upon its nuclear binding partner Xrcc1, a critical factor for this DNA repair pathway(2,3). Lig3 is also present in the mitochondria, where its role in mitochondrial DNA (mtDNA) maintenance is independent of Xrcc1 (ref. 4). However, the biological role of Lig3 is unclear as inactivation of murine Lig3 results in early embryonic lethality(5). Here we report that Lig3 is essential for mtDNA integrity but dispensable for nuclear DNA repair. Inactivation of Lig3 in the mouse nervous system resulted in mtDNA loss leading to profound mitochondrial dysfunction, disruption of cellular homeostasis and incapacitating ataxia. Similarly, inactivation of Lig3 in cardiac muscle resulted in mitochondrial dysfunction and defective heart-pump function leading to heart failure. However, Lig3 inactivation did not result in nuclear DNA repair deficiency, indicating essential DNA repair functions of Xrcc1 can occur in the absence of Lig3. Instead, we found that Lig1 was critical for DNA repair, but acted in a cooperative manner with Lig3. Additionally, Lig3 deficiency did not recapitulate the hallmark features of neural Xrcc1 inactivation such as DNA damage-induced cerebellar interneuron loss(6), further underscoring functional separation of these DNA repair factors. Therefore, our data reveal that the critical biological role of Lig3 is to maintain mtDNA integrity and not Xrcc1-dependent DNA repair.	[Gao, Yankun; Katyal, Sachin; Lee, Youngsoo; Zhao, Jingfeng; Russell, Helen R.; McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	McKinnon, PJ (corresponding author), St Jude Childrens Hosp, Dept Genet, Memphis, TN 38105 USA.	peter.mckinnon@stjude.org	Rehg, Jerold E/N-8111-2018	Lee, Youngsoo/0000-0003-4773-6464; Katyal, Sachin/0000-0002-7790-4054	National Institutes of Health [NS-37956, CA-21765]; Cancer Center [P30 CA21765]; American Lebanese and Syrian Associated Charities of St Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P01CA096832, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037956, R56NS037956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese and Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Hartwell Center for biotechnology support, the Transgenic Core Facility for blastocyst injections and the Animal Resources Center for animal husbandry. We also acknowledge the Light Microscopy Core, the Electron Microscopy Core and C. Calabrese and the Animal Imaging Core for magnetic resonance imaging and echocardiography analysis. P.J.M. is supported by the National Institutes of Health (NS-37956, CA-21765), a Cancer Center Support Grant (P30 CA21765) and the American Lebanese and Syrian Associated Charities of St Jude Children's Research Hospital. S.K. is a Neoma Boadway AP Endowed Fellow.	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Bentley DJ, 2002, J CELL SCI, V115, P1551; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040; Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lakshmipathy U, 2001, NUCLEIC ACIDS RES, V29, P668, DOI 10.1093/nar/29.3.668; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; LJUNGQUIST S, 1994, MUTAT RES, V314, P177, DOI 10.1016/0921-8777(94)90081-7; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Nakai A, 2000, DEV BRAIN RES, V121, P67, DOI 10.1016/S0165-3806(00)00025-0; Pinz KG, 1998, MOL CELL BIOL, V18, P1257, DOI 10.1128/MCB.18.3.1257; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Reynolds JJ, 2009, MOL CELL BIOL, V29, P1354, DOI 10.1128/MCB.01471-08; Sleeth KM, 2004, BIOCHEMISTRY-US, V43, P12924, DOI 10.1021/bi0492612; TOMKINSON AE, 1988, J BIOL CHEM, V263, P12532; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyynismaa H, 2009, EMBO REP, V10, P137, DOI 10.1038/embor.2008.242; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089	30	134	135	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					240	U134		10.1038/nature09773	http://dx.doi.org/10.1038/nature09773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390131	Green Accepted			2022-12-28	WOS:000288170200042
J	Ong, HS; Moosavi, AH; Althauser, SR				Ong, Hon Shing; Moosavi, Areeb H; Althauser, Susanne R			Picture Quiz: A typical diabetic retinopathy	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEMORRHAGES		[Ong, Hon Shing; Moosavi, Areeb H; Althauser, Susanne R] Royal Free Hosp, Hampstead NHS Trust, Dept Ophthalmol, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Ong, HS (corresponding author), Royal Free Hosp, Hampstead NHS Trust, Dept Ophthalmol, London, England.	honshing@gmail.com	Ong, Shing/AAH-7512-2019	Ong, Shing/0000-0001-5475-8712				DUANE TD, 1980, OPHTHALMOLOGY, V87, P66; DUKELEDER S, 1967, DIS RETINA SYSTEM OP, V10, P206; Ling R, 1998, POSTGRAD MED J, V74, P581, DOI 10.1136/pgmj.74.876.581; Litten M., 1878, CHARITE ANN, V3, P135; Roth M., 1872, DTSCH Z CHIR, V1, P471, DOI 10.1007/bf02800420; VONBARSEWISCH B, 1979, PERINATAL RETINAL HA, P51; WONG VG, 1968, ARCH OPHTHALMOL-CHIC, V80, P433	7	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2011	342								d678	10.1136/bmj.d678	http://dx.doi.org/10.1136/bmj.d678			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UZ	21389068				2022-12-28	WOS:000288446900007
J	Perrings, C; Duraiappah, A; Larigauderie, A; Mooney, H				Perrings, Charles; Duraiappah, Anantha; Larigauderie, Anne; Mooney, Harold			The Biodiversity and Ecosystem Services Science-Policy Interface	SCIENCE			English	Editorial Material							GLOBAL BIODIVERSITY		[Perrings, Charles] Arizona State Univ, Sch Life Sci, IPBES Proc, ICSU, Tempe, AZ 85287 USA; [Duraiappah, Anantha] United Nations Univ, IHDP, D-53113 Bonn, Germany; [Larigauderie, Anne] Museum Natl Hist Nat, DIVERSITAS, F-75231 Paris, France; [Mooney, Harold] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Arizona State University; Arizona State University-Tempe; Museum National d'Histoire Naturelle (MNHN); Stanford University	Perrings, C (corresponding author), Arizona State Univ, Sch Life Sci, IPBES Proc, ICSU, Tempe, AZ 85287 USA.	charles.perrings@asu.edu			Division Of Behavioral and Cognitive Sci [1134890] Funding Source: National Science Foundation	Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Andrefouet S, 2008, GEO BIODIVERSITY OBS; [Anonymous], 1995, GLOBAL BIODIVERSITY; Bolin B, 2007, HISTORY OF THE SCIENCE AND POLITICS OF CLIMATE CHANGE: THE ROLE OF THE INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, P1, DOI 10.1017/CBO9780511721731; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; *CBD, 2010, C PART 10 CBD DOC, P10; Convention on Biological Diversity, 2010, GLOB BIOD OUTL; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Kumar P., 2010, EC ECOSYSTEMS BIODIV; Larigauderie A, 2010, CURR OPIN ENV SUST, V2, P9, DOI 10.1016/j.cosust.2010.02.006; *MILL EC ASS, 2005, EC HUM WELL BEING GE; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Reid WV, 2010, SCIENCE, V330, P916, DOI 10.1126/science.1196263; Reid WV, 2009, SCIENCE, V325, P245, DOI 10.1126/science.1178591; Shapiro H. T., 2010, CLIMATE CHANGE ASSES; *UN GEN ASS, GEN ASS UN RES 64 SE; UNEP, 2010, GREEN EC DRIV GREEN; Van Kersberen K, 2004, COMP EUROPEAN POLITI, V2, P142, DOI DOI 10.1057/PALGRAVE.CEP.6110033; BUSAN OUTCOME; STRATEGIC PLAN INCLU	23	212	230	2	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1139	1140		10.1126/science.1202400	http://dx.doi.org/10.1126/science.1202400			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729SN	21330488				2022-12-28	WOS:000287971200024
J	Suzuki, A; Stern, SA; Bozdagi, O; Huntley, GW; Walker, RH; Magistretti, PJ; Alberini, CM				Suzuki, Akinobu; Stern, Sarah A.; Bozdagi, Ozlem; Huntley, George W.; Walker, Ruth H.; Magistretti, Pierre J.; Alberini, Cristina M.			Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation	CELL			English	Article							ELEMENT-BINDING PROTEIN; IMMEDIATE-EARLY GENE; D-SERINE; RAT HIPPOCAMPUS; GLYCOGEN; GLUCOSE; POTENTIATION; PLASTICITY; ACTIN; CONSOLIDATION	We report that, in the rat hippocampus, learning leads to a significant increase in extracellular lactate levels that derive from glycogen, an energy reserve selectively localized in astrocytes. Astrocytic glycogen breakdown and lactate release are essential for long-term but not short-term memory formation, and for the maintenance of long-term potentiation (LTP) of synaptic strength elicited in vivo. Disrupting the expression of the astrocytic lactate transporters monocarboxylate transporter 4 (MCT4) or MCT1 causes amnesia, which, like LTP impairment, is rescued by L-lactate but not equicaloric glucose. Disrupting the expression of the neuronal lactate transporter MCT2 also leads to amnesia that is unaffected by either L-lactate or glucose, suggesting that lactate import into neurons is necessary for long-term memory. Glycogenolysis and astrocytic lactate transporters are also critical for the induction of molecular changes required for memory formation, including the induction of phospho-CREB, Arc, and phospho-cofilin. We conclude that astrocyte-neuron lactate transport is required for long-term memory formation.	[Magistretti, Pierre J.] Univ Lausanne CHUV, Lab Neuroenerget & Cellular Dynam, Brain Mind Inst, EPFL, Lausanne, Switzerland; [Magistretti, Pierre J.] Univ Lausanne CHUV, Ctr Psychiat Neurosci, Lausanne, Switzerland; [Suzuki, Akinobu; Stern, Sarah A.; Bozdagi, Ozlem; Huntley, George W.; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Bozdagi, Ozlem; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Walker, Ruth H.] James J Peters VAMC, Dept Neurol, Bronx, NY 10468 USA; [Walker, Ruth H.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai	Magistretti, PJ (corresponding author), Univ Lausanne CHUV, Lab Neuroenerget & Cellular Dynam, Brain Mind Inst, EPFL, Lausanne, Switzerland.	pierre.magistretti@epfl.ch; cristina.alberini@mssm.edu	Stern, Sarah/AAV-6019-2021	Stern, Sarah/0000-0002-3033-8251; Magistretti, Pierre Julius/0000-0002-6678-320X; Huntley, George W./0000-0003-3645-6192	Department of Veterans Affairs;  [R01-MH065635];  [R01-MH074736];  [T32-MH087004]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065635, R01MH074736, T32MH087004] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants R01-MH065635 and R01-MH074736 to C. M. A., Department of Veterans Affairs Merit Award to R. H. W. and T32-MH087004 to S. A. S. We thank Rick Koch, Dhananjay Bambah-Mukku, Dillon Chen, Gabriella Pollonini, and Virginia Gao for technical support; and Reginald Miller and the Center for Comparative Medicine and Surgery facility at Mount Sinai School of Medicine for technical support. P.J.M. is the recipient of the Asterion Chair at Ecole Polytechnique Federale de Lausanne (EPFL).	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bozdagi O, 2007, J NEUROPHYSIOL, V98, P334, DOI 10.1152/jn.00202.2007; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Clarke Donald D., 1994, P645; DiNuzzo M, 2010, J CEREBR BLOOD F MET, V30, P1895, DOI 10.1038/jcbfm.2010.151; DRINGEN R, 1993, BRAIN RES, V623, P208, DOI 10.1016/0006-8993(93)91429-V; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fedulov V, 2007, J NEUROSCI, V27, P8031, DOI 10.1523/JNEUROSCI.2003-07.2007; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fray AE, 1996, J PHYSIOL-LONDON, V496, P49, DOI 10.1113/jphysiol.1996.sp021664; Ghosh A, 2005, J BIOL CHEM, V280, P11114, DOI 10.1074/jbc.M410894200; Gibbs ME, 2007, J NEUROSCI RES, V85, P3326, DOI 10.1002/jnr.21307; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hamprecht B., 2005, NEUROGLIA, V2, P202, DOI [10.1093/acprof:oso/9780195152227.003.0015, DOI 10.1093/ACPROF:OSO/9780195152227.003.0015]; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Jahanshahi M, 2008, SINGAP MED J, V49, P388; Jahanshahi M., 2008, AM J ANIM VET SCI, V3, P28; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kettenmann H, 2005, NEUROGLIA, DOI Oxford University Press; Klann E, 2008, NEUROBIOL LEARN MEM, V89, P247, DOI 10.1016/j.nlm.2007.08.009; Leutgeb JK, 2005, NEUROSCIENCE, V131, P601, DOI 10.1016/j.neuroscience.2004.12.002; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; MAGISTRETTI PJ, 1988, NEUROSCIENCE, V24, P367, DOI 10.1016/0306-4522(88)90338-7; MAGISTRETTI PJ, 2008, FUNDAMENTAL NEUROSCI, P271; Mantzur L, 2009, NEUROBIOL LEARN MEM, V91, P85, DOI 10.1016/j.nlm.2008.09.001; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McKenna M.C., 2006, BASIC NEUROCHEMISTRY, P531; McNay Ewan C, 2002, Behav Cogn Neurosci Rev, V1, P264, DOI 10.1177/1534582302238337; Messier C, 2004, EUR J PHARMACOL, V490, P33, DOI 10.1016/j.ejphar.2004.02.043; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Rex A, 2009, PHYSIOL BEHAV, V98, P467, DOI 10.1016/j.physbeh.2009.07.015; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; SOTELO C, 1968, J CELL BIOL, V36, P151, DOI 10.1083/jcb.36.1.151; Swanson RA, 1992, CAN J PHYSIOL PHARM, V70, P138; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; Urrila AS, 2004, J SLEEP RES, V13, P111, DOI 10.1111/j.1365-2869.2004.00401.x; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Villasana LE, 2006, J NEUROSCI METH, V158, P30, DOI 10.1016/j.jneumeth.2006.05.008; Waagepetersen HS, 2000, NEUROCHEM INT, V36, P435, DOI 10.1016/S0197-0186(99)00146-1; Walls AB, 2008, J NEUROCHEM, V105, P1462, DOI 10.1111/j.1471-4159.2008.05250.x; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Williams C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004936; Zhang Z, 2008, CEREB CORTEX, V18, P2391, DOI 10.1093/cercor/bhn008	64	938	970	13	134	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					810	823		10.1016/j.cell.2011.02.018	http://dx.doi.org/10.1016/j.cell.2011.02.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376239	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000288007100018
J	Afshar, M; Raju, M; Ansell, D; Bleck, TP				Afshar, Majid; Raju, Mahesh; Ansell, David; Bleck, Thomas P.			Narrative Review: Tetanus-A Health Threat After Natural Disasters in Developing Countries	ANNALS OF INTERNAL MEDICINE			English	Review							UNITED-STATES; MORTALITY; MANAGEMENT; BACLOFEN; DIAZEPAM; THERAPY	Tetanus is an expected complication when disasters strike in developing countries, where tetanus immunization coverage is often low or nonexistent. Collapsing structures and swirling debris inflict numerous crush injuries, fractures, and serious wounds. Clostridium tetani infects wounds contaminated with dirt, feces, or saliva and releases neurotoxins that may cause fatal disease. Clusters of infections have recently occurred after tsunamis and earthquakes in Indonesia, Kashmir, and Haiti. The emergency response to clusters of tetanus infections in developing countries after a natural disaster requires a multidisciplinary approach in the absence of an intensive care unit, readily available resources, and a functioning cold-chain system. It is essential that injured people receive immediate surgical and medical care of contaminated, open wounds with immunization and immunoglobulin therapy. Successful treatment of tetanus depends on prompt diagnosis of clinical tetanus, treatment to ensure neutralization of circulating toxin and elimination of C. tetani infection, control of spasms and convulsions, maintenance of the airway, and management of respiratory failure and autonomic dysfunction.	[Bleck, Thomas P.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; Univ Maryland, Med Ctr, Baltimore, MD 21201 USA	Rush University; University System of Maryland; University of Maryland Baltimore	Bleck, TP (corresponding author), Rush Univ, Med Ctr, 600 S Paulina St,544 AF, Chicago, IL 60612 USA.		Afshar, Majid/AAD-8365-2019; Bleck, Thomas/D-3772-2009; Ibrahim, Essam Hassan/G-1960-2018; Bleck, Thomas/R-2286-2019	Afshar, Majid/0000-0002-6368-4652; Ibrahim, Essam Hassan/0000-0003-0130-2257; Bleck, Thomas/0000-0002-8267-9787				Ablett J., 1967, S TETANUS GREAT BRIT, P1; Aceh Epidemiology Group, 2006, Glob Public Health, V1, P173, DOI 10.1080/17441690600652803; ADAMS E B, 1968, South African Medical Journal, V42, P739; [Anonymous], WHO VACC PREV DIS MO; Attygalle D, 2002, ANAESTHESIA, V57, P811; BIGLAN AW, 1978, AM J OPHTHALMOL, V86, P666, DOI 10.1016/0002-9394(78)90187-3; Bleck TP, 2004, INFECT CENTRAL NERVO, P625; Brauner JS, 2002, INTENS CARE MED, V28, P930, DOI 10.1007/s00134-002-1332-4; Campbell JI, 2009, AM J TROP MED HYG, V80, P827, DOI 10.4269/ajtmh.2009.80.827; *CDCP, 2005, EP PREV VACC PREV DI, P65; Chapman Louisa E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Chukwubike OA, 2009, ANN AFR MED, V8, P168, DOI 10.4103/1596-3519.57239; Engrand N, 1999, ANESTHESIOLOGY, V90, P1773, DOI 10.1097/00000542-199906000-00036; Farrar JJ, 2000, J NEUROL NEUROSUR PS, V69, P292, DOI 10.1136/jnnp.69.3.292; Gibson K, 2009, CAN J ANAESTH, V56, P307, DOI 10.1007/s12630-009-9058-1; GOULON M, 1972, NOUV PRESSE MED, V1, P3049; HEYMANN DL, 2004, CONTROL COMMUNICABLE, P528; Joshi S, 2007, Kathmandu Univ Med J (KUMJ), V5, P378; KAPOOR W, 1981, ARCH INTERN MED, V141, P944, DOI 10.1001/archinte.141.7.944; Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P36, DOI 10.1053/j.spid.2006.01.002; Martinelli R, 1993, Rev Soc Bras Med Trop, V26, P1; Ojini FI, 2005, TROP DOCT, V35, P178, DOI 10.1258/0049475054620806; Okafor UV, 2009, INDIAN J CRIT CARE M, V13, P25, DOI 10.4103/0972-5229.53112; Oladiran I, 2002, WORLD J SURG, V26, P1282, DOI 10.1007/s00268-002-6497-z; *PAN HLTH ORG, 2010, SPEC REP UPD HLTH RE; *PAN HLTH ORG, HLTH TOP COLD CHAIN; Parashar UD, 1998, INT J EPIDEMIOL, V27, P904, DOI 10.1093/ije/27.5.904; Pascual F Brian, 2003, MMWR Surveill Summ, V52, P1; Patel J C, 1999, Indian J Med Sci, V53, P393; PICKERING LK, 2003, 2003 REPORT COMMITTE, P611; RIE MA, 1978, ANN INTERN MED, V88, P653, DOI 10.7326/0003-4819-88-5-653; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6; SAISSY JM, 1992, INTENS CARE MED, V18, P241, DOI 10.1007/BF01709840; SALTISSI S, 1976, BRIT MED J, V1, P437, DOI 10.1136/bmj.1.6007.437; Sutiono Agung Budi, 2009, BMC Res Notes, V2, P34, DOI 10.1186/1756-0500-2-34; SUTTER RW, 1990, AM J EPIDEMIOL, V131, P132, DOI 10.1093/oxfordjournals.aje.a115466; SYAM B, 1992, POSTGRAD MED J, V68, P279, DOI 10.1136/pgmj.68.798.279; TRUJILLO MH, 1987, CHEST, V92, P63, DOI 10.1378/chest.92.1.63; VASSA NT, 1974, POSTGRAD MED J, V50, P755, DOI 10.1136/pgmj.50.590.755; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; Whitman Cynthia, 1992, World Health Statistics Quarterly, V45, P248; *WHO, 2005, WKLY EPIDEMIOL REC, V18, P160; *WHO, IMM SURV ASS MON MAT; World Health Organization, 2010, CURR REC TREATM TET; World Health Organization (WHO), 2010, EXP ARS MAJ PUBL HLT, P1; YEN LM, 1994, LANCET, V344, P786, DOI 10.1016/S0140-6736(94)92342-6	46	61	73	1	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					329	+		10.7326/0003-4819-154-5-201103010-00007	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357910				2022-12-28	WOS:000287799900005
J	Li, B; Piriz, J; Mirrione, M; Chung, CH; Proulx, CD; Schulz, D; Henn, F; Malinow, R				Li, Bo; Piriz, Joaquin; Mirrione, Martine; Chung, ChiHye; Proulx, Christophe D.; Schulz, Daniela; Henn, Fritz; Malinow, Roberto			Synaptic potentiation onto habenula neurons in the learned helplessness model of depression	NATURE			English	Article							MIDBRAIN DOPAMINE NEURONS; DORSAL RAPHE NUCLEUS; LATERAL HABENULA; ANIMAL-MODEL; TRYPTOPHAN DEPLETION; RESPONSES; BEHAVIOR; STRESS; RAT; STIMULATION	The cellular basis of depressive disorders is poorly understood(1). Recent studies in monkeys indicate that neurons in the lateral habenula (LHb), a nucleus that mediates communication between forebrain and midbrain structures, can increase their activity when an animal fails to receive an expected positive reward or receives a stimulus that predicts aversive conditions (that is, disappointment or anticipation of a negative outcome)(2-4). LHb neurons project to, and modulate, dopamine-rich regions, such as the ventral tegmental area (VTA)(2,5), that control reward-seeking behaviour(6) and participate in depressive disorders(7). Here we show that in two learned helplessness models of depression, excitatory synapses onto LHb neurons projecting to the VTA are potentiated. Synaptic potentiation correlates with an animal's helplessness behaviour and is due to an enhanced presynaptic release probability. Depleting transmitter release by repeated electrical stimulation of LHb afferents, using a protocol that can be effective for patients who are depressed(8,9), markedly suppresses synaptic drive onto VTA-projecting LHb neurons in brain slices and can significantly reduce learned helplessness behaviour in rats. Our results indicate that increased presynaptic action onto LHb neurons contributes to the rodent learned helplessness model of depression.	[Li, Bo; Piriz, Joaquin; Chung, ChiHye; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Neurosci, La Jolla, CA 92093 USA; [Li, Bo; Piriz, Joaquin; Chung, ChiHye; Proulx, Christophe D.; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Biol Sci, La Jolla, CA 92093 USA; [Li, Bo; Mirrione, Martine; Henn, Fritz] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Mirrione, Martine; Schulz, Daniela; Henn, Fritz] Brookhaven Natl Lab, Upton, NY 11973 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory	Li, B (corresponding author), Univ Calif San Diego, Ctr Neural Circuits & Behav, Dept Neurosci, 9500 Gilman Dr 0634, La Jolla, CA 92093 USA.	bli@cshl.edu; rmalinow@ucsd.edu	Schulz, Daniela/H-5625-2011	Li, Bo/0000-0002-0154-3088; Chung, ChiHye/0000-0002-3104-2399; Proulx, Christophe/0000-0001-6484-9677; Piriz, Joaquin/0000-0002-4588-6568	Dana Foundation; National Institute of Mental Health, National Institutes of Health [1R01MH091903-01]; Shiley-Marcos Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091119, R01MH049159, R01MH091903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	Dana Foundation; National Institute of Mental Health, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Shiley-Marcos Endowment; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Deisseroth for help and suggestions, A. Gifford and A. Biegon for sharing equipment and laboratory space, and members of the Malinow Lab and Li Lab for discussions. This study was supported by the Dana Foundation (B. L.), the Biobehavioral Research Awards for Innovative New Scientists (BRAINS) from the National Institute of Mental Health, National Institutes of Health (1R01MH091903-01) (B. L.) and the Shiley-Marcos Endowment (R.M.).	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kaufling J, 2009, J COMP NEUROL, V513, P597, DOI 10.1002/cne.21983; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/0278-5846(84)90120-9; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; Mill J, 2007, MOL PSYCHIATR, V12, P799, DOI 10.1038/sj.mp.4001992; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Roiser JP, 2009, BIOL PSYCHIAT, V66, P441, DOI 10.1016/j.biopsych.2009.05.002; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Schulz D, 2010, NEUROBIOL LEARN MEM, V93, P291, DOI 10.1016/j.nlm.2009.11.003; Shumake J, 2003, Behav Cogn Neurosci Rev, V2, P198, DOI 10.1177/1534582303259057; Vollmayr B, 2001, BRAIN RES PROTOC, V8, P1, DOI 10.1016/S1385-299X(01)00067-8; Winter C, 2011, BEHAV BRAIN RES, V216, P463, DOI 10.1016/j.bbr.2010.07.034; Yang LM, 2008, BEHAV BRAIN RES, V188, P84, DOI 10.1016/j.bbr.2007.10.022; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	34	401	423	3	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					535	U125		10.1038/nature09742	http://dx.doi.org/10.1038/nature09742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350486	Green Accepted			2022-12-28	WOS:000287652900042
J	Solit, DB; Rosen, N				Solit, David B.; Rosen, Neal			Resistance to BRAF Inhibition in Melanomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RAF; PATHWAY; CRAF		[Solit, David B.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.		Rosen, Neal/ABF-2677-2020; Solit, David B./AAC-5309-2019					Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Whittaker S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000758	8	185	191	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					772	774		10.1056/NEJMcibr1013704	http://dx.doi.org/10.1056/NEJMcibr1013704			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345109				2022-12-28	WOS:000287652500016
J	Braganza, JM; Lee, SH; McCloy, RF; McMahon, MJ				Braganza, Joan M.; Lee, Stephen H.; McCloy, Rory F.; McMahon, Michael J.			Chronic pancreatitis	LANCET			English	Article							QUALITY-OF-LIFE; ANTIOXIDANT THERAPY; OXIDATIVE STRESS; MAST-CELLS; HEREDITARY PANCREATITIS; FOLLOW-UP; AUTOIMMUNE PANCREATITIS; RECURRENT PANCREATITIS; METABOLIZING-ENZYMES; ENDOSCOPIC TREATMENT	Chronic pancreatitis is a progressive fibroinflammatory disease that exists in large-duct (often with intraductal calculi) or small-duct form. In many patients this disease results from a complex mix of environmental (eg, alcohol, cigarettes, and occupational chemicals) and genetic factors (eg, mutation in a trypsin-controlling gene or the cystic fibrosis transmembrane conductance regulator); a few patients have hereditary or autoimmune disease. Pain in the form of recurrent attacks of pancreatitis (representing paralysis of apical exocytosis in acinar cells) or constant and disabling pain is usually the main symptom. Management of the pain is mainly empirical, involving potent analgesics, duct drainage by endoscopic or surgical means, and partial or total pancreatectomy. However, steroids rapidly reduce symptoms in patients with autoimmune pancreatitis, and micronutrient therapy to correct electrophilic stress is emerging as a promising treatment in the other patients. Steatorrhoea, diabetes, local complications, and psychosocial issues associated with the disease are additional therapeutic challenges.	[Braganza, Joan M.] Manchester Royal Infirm, Dept Gastroenterol, Manchester M13 9WL, Lancs, England; [Lee, Stephen H.] Manchester Royal Infirm, Dept Radiol, Manchester M13 9WL, Lancs, England; [McCloy, Rory F.] Lancashire Teaching Hosp, Dept Educ, Preston, Lancs, England; [McMahon, Michael J.] Univ Leeds, Leeds, W Yorkshire, England; [McMahon, Michael J.] Nuffield Hosp, Leeds, W Yorkshire, England	University of Manchester; University of Manchester; University of Leeds	Braganza, JM (corresponding author), Care of Parr J, Core Technol Facil, 3rd Floor,Grafton St, Manchester M13 9NT, Lancs, England.							Ammann RW, 2006, SWISS MED WKLY, V136, P166; Andersen DK, 2010, ANN SURG, V251, P18, DOI 10.1097/SLA.0b013e3181ae3471; Archer H, 2006, GASTROENTEROLOGY, V131, P1844, DOI 10.1053/j.gastro.2006.09.049; Baghdadi S, 2008, SURG ENDOSC, V22, P580, DOI 10.1007/s00464-007-9730-x; Balakrishnan V, 1987, CHRONIC PANCREATITIS, P81; Balakrishnan V, 2008, J PANCREAS, V9, P593; Balci NC, 2010, J MAGN RESON IMAGING, V31, P601, DOI 10.1002/jmri.22085; Balci Numan Cem, 2009, Top Magn Reson Imaging, V20, P43, DOI 10.1097/RMR.0b013e3181b48667; Barman KK, 2003, POSTGRAD MED J, V79, P606, DOI 10.1136/pmj.79.937.606; BEGER HG, 1989, ANN SURG, V209, P273, DOI 10.1097/00000658-198903000-00004; Bhardwaj P, 2009, GASTROENTEROLOGY, V136, P149, DOI 10.1053/j.gastro.2008.09.028; BILTON D, 1994, DRUG INVEST, V8, P10, DOI 10.1007/BF03257422; BRAGANZA JM, 1991, PATHOGENESIS OF PANCREATITIS, P19; BRAGANZA JM, 1988, INT J PANCREATOL, V3, P209; BRAGANZA JM, 1995, INT J PANCREATOL, V17, P69; Braganza JM, 2001, DIGESTION, V63, P69, DOI 10.1159/000051875; Braganza JM, 1998, DIGESTION, V59, P1, DOI 10.1159/000051438; Braganza JM, 1990, INT J PANCREATOL, V7, P231; Braganza JM., 1996, RECENT ADV GASTROENT, V6, P251; Braganza JM, 2010, PANCREAS, V39, P1303, DOI 10.1097/MPA.0b013e3181e2d567; Braganza JM, 2010, J PANCREAS, V11, P99; Buchler MW, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-93; Cahen DL, 2007, NEW ENGL J MED, V356, P676, DOI 10.1056/NEJMoa060610; Capdevila A, 1997, ARCH BIOCHEM BIOPHYS, V345, P47, DOI 10.1006/abbi.1997.0249; Casini A, 2000, J PATHOL, V192, P81; Castano GD, 2000, REV ESP ENFERM DIG, V92, P381; Catalano MF, 2009, GASTROINTEST ENDOSC, V69, P1251, DOI 10.1016/j.gie.2008.07.043; Chen JM, 2009, ANNU REV GENOM HUM G, V10, P63, DOI 10.1146/annurev-genom-082908-150009; Chvanov M, 2005, PHILOS T R SOC B, V360, P2273, DOI 10.1098/rstb.2005.1757; Cohn JA, 2005, J CLIN GASTROENTEROL, V39, pS70, DOI 10.1097/01.mcg.0000155522.89005.bf; Cook LJ, 1996, SCAND J GASTROENTERO, V31, P1, DOI 10.3109/00365529609104990; Czako L, 2007, J GASTROENTEROL, V42, P113, DOI 10.1007/s00535-006-1919-6; Dabrowski A, 2000, PANCREAS, V21, P376, DOI 10.1097/00006676-200011000-00008; Di Bello MG, 1998, INFLAMM RES, V47, P122, DOI 10.1007/s000110050299; Di Magno MJ, 2010, BMJ BEST PRACTICE; Dite P, 2003, GASTROENTEROLOGIA PO, V10, P379; Dominguez-Munoz JE, 2010, J PANCREAS, V11, P158; Dufour MC, 2003, PANCREAS, V27, P286, DOI 10.1097/00006676-200311000-00002; Dumonceau JM, 2007, GUT, V56, P545, DOI 10.1136/gut.2006.096883; FOSTER JR, 1993, J PATHOL, V169, P457, DOI 10.1002/path.1711690412; Foster JR, 2009, GEN APPL TOXICOLOGY, P1411; FREEDMAN SD, 1993, J CLIN INVEST, V92, P83, DOI 10.1172/JCI116602; Frulloni L, 2009, DIGEST LIVER DIS, V41, P311, DOI 10.1016/j.dld.2008.07.316; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Gaisano HY, 2009, GASTROENTEROLOGY, V136, P2040, DOI 10.1053/j.gastro.2009.04.023; Garcea G, 2009, PANCREAS, V38, P1, DOI 10.1097/MPA.0b013e3181825c00; Gardner TB, 2010, PANCREAS, V39, P498, DOI 10.1097/MPA.0b013e3181c5c693; Garg PK, 2004, J GASTROEN HEPATOL, V19, P998, DOI 10.1111/j.1440-1746.2004.03426.x; Girdwood AH, 1982, SURG GASTROENTEROL, V1, P5; Girish BN, 2009, INDIAN J GASTROENTER, V28, P201, DOI 10.1007/s12664-009-0079-z; Girish BN, 2010, PANCREAS, V39, pE11, DOI 10.1097/MPA.0b013e3181bc0f85; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Graf R, 2006, J SURG RES, V133, P113, DOI 10.1016/j.jss.2005.09.030; Gupta V, 2005, POSTGRAD MED J, V81, P491, DOI 10.1136/pgmj.2003.009761; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367, DOI 10.1152/ajpgi.00315.2001; Heyries L, 2007, WORLD J GASTROENTERO, V13, P6127, DOI 10.3748/wjg.v13.i46.6127; Ho HS, 2001, ARCH SURG-CHICAGO, V136, P1353, DOI 10.1001/archsurg.136.12.1353; Hoogerwerf WA, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-8; Jeppe CY, 2008, J PANCREAS, V9, P235; Jianyu-Hao, 2009, INHAL TOXICOL, V21, P1007, DOI 10.1080/08958370802665937; Jin CX, 2009, J PANCREAS, V10, P237; Kahl S, 2002, GASTROINTEST ENDOSC, V55, P507, DOI 10.1067/mge.2002.122610; Kamisawa T, 2009, ABDOM IMAGING, V34, P381, DOI 10.1007/s00261-008-9401-y; Kawa S, 2009, CLIN GASTROENTEROL H, V7, pS18, DOI 10.1016/j.cgh.2009.07.041; Kirk GR, 2006, J GASTROINTEST SURG, V10, P499, DOI 10.1016/j.gassur.2005.08.035; Kloppel G, 2007, MODERN PATHOL, V20, pS113, DOI 10.1038/modpathol.3800690; Ko SBH, 2010, GASTROENTEROLOGY, V138, P1988, DOI 10.1053/j.gastro.2010.01.001; Kotzampassi K, 2004, ANN GASTROENTEROL, V17, P402; Kowalczyk LM, 2008, CURR GASTROENTEROL R, V11, P111; Kumar R, 2009, J NUCL MED, V50; LANKISCH PG, 1993, DIGESTION, V54, P148, DOI 10.1159/000201029; LAYER P, 1994, GASTROENTEROLOGY, V107, P1481, DOI 10.1016/0016-5085(94)90553-3; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Levenick John M, 2009, Pancreas, V38, pe169, DOI 10.1097/MPA.0b013e3181ac73f1; Levy P, 2006, GASTROEN CLIN BIOL, V30, P838, DOI 10.1016/S0399-8320(06)73330-9; Li J, 2008, PANCREAS, V37, P189, DOI 10.1097/MPA.0b013e31816459b7; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Lieb JG, 2009, ALIMENT PHARM THER, V29, P706, DOI 10.1111/j.1365-2036.2009.03931.x; Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441; Lindstedt KA, 2001, FASEB J, V15, P1377, DOI 10.1096/fj.00-0273com; LONGNECKER DS, 1982, AM J PATHOL, V107, P103; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Mahurkar S, 2009, WORLD J GASTROENTERO, V21, P256; MARTENSSON J, 1986, AM J GASTROENTEROL, V81, P1179; McCloy R, 1998, DIGESTION, V59, P36, DOI 10.1159/000051441; MCNAMEE R, 1994, OCCUP ENVIRON MED, V51, P631, DOI 10.1136/oem.51.9.631; Zeron HM, 2009, FUTURE ONCOL, V5, P657, DOI 10.2217/FON.09.32; Merkord J, 1998, HUM EXP TOXICOL, V17, P144, DOI 10.1191/096032798678908431; Midha S, 2010, GUT, V59, P800, DOI 10.1136/gut.2009.191239; Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X; Monfared SSMS, 2009, WORLD J GASTROENTERO, V15, P4481, DOI 10.3748/wjg.15.4481; Muller MW, 2008, AM J SURG, V196, P364, DOI 10.1016/j.amjsurg.2007.08.065; Nakamura H, 2009, SURGERY, V145, P168, DOI 10.1016/j.surg.2008.08.013; Nishimura S, 2009, GUT, V58, P762, DOI 10.1136/gut.2008.151910; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ooi CY, 2010, GASTROENTEROLOGY, V138, P2202, DOI 10.1053/j.gastro.2010.04.022; Otsuki M, 2003, J GASTROENTEROL, V38, P315, DOI 10.1007/s005350300058; Pai CG, 2009, J GASTROEN HEPATOL, V24, P1198, DOI 10.1111/j.1440-1746.2009.05796.x; Pandol SJ, 2007, PANCREATOLOGY, V7, P105, DOI 10.1159/000104235; Park DH, 2009, GUT, V58, P1680, DOI 10.1136/gut.2008.155853; Pezzilli Raffaele, 2004, JOP, V5, P53; Pezzilli R, 2009, WORLD J GASTROENTERO, V15, P4737, DOI 10.3748/wjg.15.4737; Rahman SH, 2009, DIGEST DIS SCI, V54, P675, DOI 10.1007/s10620-008-0382-z; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Rebours V, 2009, AM J GASTROENTEROL, V104, P2312, DOI 10.1038/ajg.2009.363; Rinderknecht Heinrich, 1993, P219; Rosendahl J, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-1; Rosso E, 2003, DIGEST SURG, V20, P397, DOI 10.1159/000072706; Sah RP, 2010, GASTROENTEROLOGY, V139, P140, DOI 10.1053/j.gastro.2010.03.054; Sai JK, 2008, WORLD J GASTROENTERO, V14, P1218, DOI 10.3748/wjg.14.1218; SANFEY H, 1984, ANN SURG, V200, P405, DOI 10.1097/00000658-198410000-00003; Santini SA, 2003, DIGEST LIVER DIS, V35, P888, DOI 10.1016/j.dld.2003.09.004; SARLES H, 1986, DIGEST DIS SCI, V31, pS91; Segal I, 1998, DIGESTION, V59, P25, DOI 10.1159/000051440; Segal I, PANCREAS IN PRESS; Shafiq N, 2009, COCHRANE DB SYST REV; Shah NS, 2010, WORLD J GASTROENTERO, V16, P4066, DOI 10.3748/wjg.v16.i32.4066; Shah NS, 2009, J PANCREAS, V10, P30; SHARER NM, 1995, CLIN DRUG INVEST, V10, P310, DOI 10.2165/00044011-199510050-00009; Shimosegawa T, 2009, J GASTROENTEROL, V44, P503, DOI 10.1007/s00535-009-0054-6; Shrikhande SV, 2003, BRIT J SURG, V90, P1565, DOI 10.1002/bjs.4353; Spanler BWM, 2008, EUR J GASTROEN HEPAT, V20, P653, DOI 10.1097/MEG.0b013e3282f52f83; Standop J, 2003, TOXICOL PATHOL, V31, P506, DOI 10.1080/01926230390226041; STEVEN FS, 1979, BIOCHIM BIOPHYS ACTA, V568, P408, DOI 10.1016/0005-2744(79)90309-7; Stevens T, 2004, AM J GASTROENTEROL, V99, pS57, DOI 10.14309/00000434-200410001-00174; STRUBELT O, 1980, BIOCHEM PHARMACOL, V29, P1445, DOI 10.1016/0006-2952(80)90591-2; SYROTA A, 1981, GUT, V22, P907, DOI 10.1136/gut.22.11.907; Tamura R, 2006, RADIOLOGY, V238, P920, DOI 10.1148/radiol.2382041527; UDEN S, 1992, ALIMENT PHARM THERAP, V6, P229; UDEN S, 1990, ALIMENT PHARM THERAP, V4, P357; Uomo G, 2001, DIGEST LIVER DIS, V33, P58, DOI 10.1016/S1590-8658(01)80136-5; Wacke R, 1998, PANCREAS, V16, P521, DOI 10.1097/00006676-199805000-00011; Wagner ACC, 2002, CHRONIC PANCREATITIS, P217; Wallig MA, 1998, DIGESTION, V59, P13, DOI 10.1159/000051439; WALSH TN, 1992, GUT, V33, P1566, DOI 10.1136/gut.33.11.1566; Whitcomb DC, 2004, NAT CLIN PRACT GASTR, V1, P46, DOI 10.1038/ncpgasthep0025; *WHO, 1990, WHO TECHN REP SER, V804; Winstead NS, 2009, PANCREATOLOGY, V9, P344, DOI 10.1159/000212086; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Wittel UA, 2008, LANGENBECK ARCH SURG, V393, P581, DOI 10.1007/s00423-007-0273-3; Yadav D, 2010, NAT REV GASTRO HEPAT, V7, P131, DOI 10.1038/nrgastro.2010.6; Yan MX, 2006, POSTGRAD MED J, V82, P254, DOI 10.1136/pgmj.2005.037192; Yang AL, 2008, ARCH INTERN MED, V168, P649, DOI 10.1001/archinte.168.6.649; Zimnoch L, 2002, HEPATO-GASTROENTEROL, V49, P1135	146	332	362	1	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1184	1197		10.1016/S0140-6736(10)61852-1	http://dx.doi.org/10.1016/S0140-6736(10)61852-1			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21397320				2022-12-28	WOS:000289539300035
J	Resnik, DB; Koski, G				Resnik, David B.; Koski, Greg			A National Registry for Healthy Volunteers in Phase 1 Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Resnik, David B.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Koski, Greg] Harvard Univ, Massachusetts Gen Hosp, Sch Med, James Mongan Inst Hlth Policy, Boston, MA USA; [Koski, Greg] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Resnik, DB (corresponding author), NIEHS, NIH, POB 12233,Mail Drop CU03, Res Triangle Pk, NC 27709 USA.	resnikd@niehs.nih.gov			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102646] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA ES102646-02, ZIA ES102646-01] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abadie R., 2010, PROFESSIONAL GUINEA; Almeida L, 2007, EUR J CLIN PHARMACOL, V63, P1085, DOI 10.1007/s00228-007-0368-3; [Anonymous], WHAT IS TOPS VOLUNTE; Boyar D., 2010, J CLIN RES BEST PRAC, V6; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; JAILLON P, 1990, FUNDAM CLIN PHARM, V4, pS177, DOI 10.1111/j.1472-8206.1990.tb00076.x; Motluk A, 2009, NEW SCI, V203, P40, DOI 10.1016/S0262-4079(09)61971-0; Shamoo AE, 2006, AM J BIOETHICS, V6, pW1, DOI 10.1080/15265160600686281; Zanini GM, 2005, SWISS MED WKLY, V135, P315	9	32	33	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1236	1237		10.1001/jama.2011.354	http://dx.doi.org/10.1001/jama.2011.354			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21406636	Green Accepted			2022-12-28	WOS:000288652100020
J	Janssens, ACJW; Ioannidis, JPA; van Duijn, CM; Little, J; Khoury, MJ				Janssens, A. Cecile J. W.; Ioannidis, John P. A.; van Duijn, Cornelia M.; Little, Julian; Khoury, Muin J.		GRIPS Grp	Strengthening the Reporting of Genetic Risk Prediction Studies: The GRIPS Statement	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER; EPIDEMIOLOGY; ASSOCIATION; MARKER; CURVE		[Janssens, A. Cecile J. W.; van Duijn, Cornelia M.] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; [Khoury, Muin J.] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Atlanta, GA 30333 USA	Erasmus University Rotterdam; Erasmus MC; University of Ioannina; University of Ottawa; Centers for Disease Control & Prevention - USA	Janssens, ACJW (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.janssens@erasmusmc.nl	Little, Julian/AAR-6117-2020; Ioannidis, John P. A./G-9836-2011; janssens, cecile c/L-1075-2015	Little, Julian/0000-0001-5026-5531; Van Duijn, Cornelia/0000-0002-2374-9204; Dolan, Siobhan/0000-0001-8890-8045; Janssens, A Cecile/0000-0002-6153-4976	Centers for Disease Control and Prevention; Erasmus University Medical Center; Center for Medical Systems Biology in the framework of the Netherlands Genomics Initiative; Netherlands Organisation for Scientific Research; Tufts Clinical and Translational Science Institute; National Institutes of Health, National Center for Research Resources [UL1 RR025752]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Erasmus University Medical Center; Center for Medical Systems Biology in the framework of the Netherlands Genomics Initiative; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Tufts Clinical and Translational Science Institute; National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The Centers for Disease Control and Prevention sponsored the workshop on behalf of the Human Genome Epidemiology Network. Dr. Janssens is supported by grants from Erasmus University Medical Center, the Center for Medical Systems Biology in the framework of the Netherlands Genomics Initiative, and the VIDI grant of the Netherlands Organisation for Scientific Research. Dr. Ioannidis is supported by Tufts Clinical and Translational Science Institute, which is supported by the National Institutes of Health, National Center for Research Resources (UL1 RR025752). Dr. Little holds a Canada Research Chair in Human Genome Epidemiology. The funding sources had no role in the study design, data collection, analysis, preparation of the manuscript, or decision to submit the manuscript for publication.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Janssens ACJW, 2010, CIRC-CARDIOVASC GENE, V3, P3, DOI 10.1161/CIRCGENETICS.110.938092; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Khoury MJ, 1998, AM J EPIDEMIOL, V148, P1; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Kyzas PA, 2007, JNCI-J NATL CANCER I, V99, P236, DOI 10.1093/jnci/djk032; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Vandenbrouke JP, 2009, J CLIN EPIDEMIOL, V62, P594, DOI 10.1016/j.jclinepi.2008.12.003; von Elm E, 2004, BMJ-BRIT MED J, V329, P868, DOI 10.1136/bmj.329.7471.868; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	24	16	16	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					421	+		10.7326/0003-4819-154-6-201103150-00008	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734WA	21403077				2022-12-28	WOS:000288370000006
J	Merugu, S				Merugu, Srinivas			Physical examination and classification of murmur findings into patterns improved diagnosis of systolic murmurs in adult inpatients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									St Vincent Char Med Ctr, Cleveland, OH 44115 USA		Merugu, S (corresponding author), St Vincent Char Med Ctr, Cleveland, OH 44115 USA.							Fred HL, 2005, TEX HEART I J, V32, P255; Grais IM, 2010, TEX HEART I J, V37, P629	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-12	10.7326/0003-4819-154-6-201103150-02012	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403063				2022-12-28	WOS:000208886200011
J	Malfertheiner, P; Bazzoli, F; Delchier, JC; Celinski, K; Giguere, M; Riviere, M; Megraud, F				Malfertheiner, Peter; Bazzoli, Franco; Delchier, Jean-Charles; Celinski, Krysztof; Giguere, Monique; Riviere, Marc; Megraud, Francis		Pylera Study Grp	Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial	LANCET			English	Article							ANTIBIOTIC-RESISTANCE; QUADRUPLE THERAPY; INFECTION; METAANALYSIS; MULTICENTER; PREVALENCE; MANAGEMENT; EFFICACY; BISKALCITRATE; AMOXICILLIN	Background Helicobacter pylori is associated with benign and malignant diseases of the upper gastrointestinal tract, and increasing antibiotic resistance has made alternative treatments necessary. Our aim was to assess the efficacy and safety of a new, single-capsule treatment versus the gold standard for H pylori eradication. Methods We did a randomised, open-label, non-inferiority, phase 3 trial in 39 sites in Europe, comparing the efficacy and safety of 10 days of quadruple therapy with omeprazole plus a single three-in-one capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline (quadruple therapy) versus 7 days of omeprazole, amoxicillin, and clarithromycin (standard therapy) in adults with recorded H pylori infection. Patients were randomly assigned treatment according to a predetermined list independently generated by Quintiles Canada (Ville St-Laurent, QC, Canada). Our study was designed as a non-inferiority trial but was powered to detect superiority. Our primary outcome was H pylori eradication, established by two negative (13)C urea breath tests at a minimum of 28 and 56 days after the end of treatment. Our assessment for non-inferiority was in the per-protocol population, with subsequent assessment for superiority in the intention-to-treat population (ie, all participants randomly assigned treatment). This study is registered with ClinicalTrials.gov, number NCT00669955. Findings 12 participants were lost to follow-up and 101 were excluded from the per-protocol analysis. In the perprotocol population (n=339), the lower bound of the CI for treatment with quadruple therapy was greater than the pre-established non-inferiority margin of 10% (95% CI 15.1-32.3; p<0.0001). In the intention-to-treat population (n=440), eradication rates were 80% (174 of 218 participants) in the quadruple therapy group versus 55% (123 of 222) in the standard therapy group (p<0.0001). Safety profiles for both treatments were similar; main adverse events were gastrointestinal and CNS disorders. Interpretation Quadruple therapy should be considered for first-line treatment in view of the rising prevalence of clarithromycin-resistant H pylori, especially since quadruple therapy provides superior eradication with similar safety and tolerability to standard therapy.	[Malfertheiner, Peter] Otto Von Guericke Univ, D-39120 Magdeburg, Germany; [Bazzoli, Franco] Univ Bologna, Dept Clin Med, Bologna, Italy; [Delchier, Jean-Charles] Grp Hosp Henri Mondor, AP HP, Ctr Invest Clin 006, Creteil, France; [Delchier, Jean-Charles] Grp Hosp Henri Mondor, AP HP, Serv Hepatogastroenterol, Creteil, France; [Celinski, Krysztof] Med Univ Lublin, Dept Gastroenterol, Lublin, Poland; [Giguere, Monique; Riviere, Marc] Axcan Pharma Inc, Mt St Hilaire, PQ, Canada; [Megraud, Francis] Univ Bordeaux 2, INSERM, U853, F-33076 Bordeaux, France	Otto von Guericke University; University of Bologna; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Medical University of Lublin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Malfertheiner, P (corresponding author), Otto Von Guericke Univ, D-39120 Magdeburg, Germany.	peter.malfertheiner@med.ovgu.de	Gisbert, Javier P/ABB-7531-2021; Calvet, Xavier/H-3288-2019	Gisbert, Javier P/0000-0003-2090-3445; Calvet, Xavier/0000-0002-6278-9663; Calvet, Xavier/0000-0002-4413-4209	Axcan Pharma	Axcan Pharma	The authors thank Jonathan M Wert for editorial assistance in the preparation of this report, which was supported by Axcan Pharma.	Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; BADER JP, 1987, DIGESTION, V37, P53, DOI 10.1159/000199559; Blaser MJ, 2002, NEW ENGL J MED, V346, P2083, DOI 10.1056/NEJMcibr020229; Boyanova L, 2009, J MED MICROBIOL, V58, P930, DOI 10.1099/jmm.0.009993-0; Buge A, 1974, ANN MED INTERNE, V124, P877; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Chiba N, 2000, CAN J GASTROENTEROL, V14, P885, DOI 10.1155/2000/709640; De Francesco V, 2007, J ANTIMICROB CHEMOTH, V59, P783, DOI 10.1093/jac/dkm005; De Francesco V, 2010, J ANTIMICROB CHEMOTH, V65, P327, DOI 10.1093/jac/dkp445; Essa AS, 2009, HELICOBACTER, V14, P109, DOI 10.1111/j.1523-5378.2009.00671.x; Fischbach L, 2007, ALIMENT PHARM THER, V26, P343, DOI 10.1111/j.1365-2036.2007.03386.x; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Ford AC, 2008, WORLD J GASTROENTERO, V14, P7361, DOI 10.3748/wjg.14.7361; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Gisbert JP, 2010, J CLIN GASTROENTEROL, V44, P313, DOI 10.1097/MCG.0b013e3181c8a1a3; Glupczynski Y, 2002, EUR J CLIN MICROBIOL, V21, P549, DOI 10.1007/s10096-002-0757-6; GOODWIN CS, 1988, J CLIN PATHOL, V41, P207, DOI 10.1136/jcp.41.2.207; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Graham DY, 2005, ALIMENT PHARM THERAP, V21, P165, DOI 10.1111/j.1365-2036.2005.02322.x; Graham DY, 2000, ALIMENT PHARM THER, V14, P745; HILLEMAND P, 1977, SEM HOP PARIS, V53, P1663; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Koletzko S, 2006, GUT, V55, P1711, DOI 10.1136/gut.2006.091272; Laine L, 2003, AM J GASTROENTEROL, V98, P562, DOI [10.1016/S0002-9270(02)06010-0, 10.1111/j.1572-0241.2003.t01-1-07288.x]; Luther J, 2010, AM J GASTROENTEROL, V105, P65, DOI 10.1038/ajg.2009.508; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Megraud F, 2004, GUT, V53, P1374, DOI 10.1136/gut.2003.022111; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Megraud Francis, 2005, Curr Infect Dis Rep, V7, P115, DOI 10.1007/s11908-005-0071-4; Moayyedi P, 2004, HELICOBACTER, V9, P67, DOI 10.1111/j.1083-4389.2004.00250.x; O'Morain C, 2003, ALIMENT PHARM THER, V17, P415, DOI 10.1046/j.1365-2036.2003.01434.x; Saad RJ, 2006, AM J GASTROENTEROL, V101, P488, DOI 10.1111/j.1572-0241.2006.00637.x; SLIKKERVEER A, 1989, MED TOXICOL ADV DRUG, V4, P303, DOI 10.1007/BF03259915; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tsugawa H, 2011, ANTIOXID REDOX SIGN, V14, P15, DOI 10.1089/ars.2010.3146; Zagari RM, 2007, GUT, V56, P475, DOI 10.1136/gut.2006.102269	39	339	382	2	54	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					905	913		10.1016/S0140-6736(11)60020-2	http://dx.doi.org/10.1016/S0140-6736(11)60020-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GR	21345487				2022-12-28	WOS:000288628800033
J	Erlandson, JM; Rick, TC; Braje, TJ; Casperson, M; Culleton, B; Fulfrost, B; Garcia, T; Guthrie, DA; Jew, N; Kennett, DJ; Moss, ML; Reeder, L; Skinner, C; Watts, J; Willis, L				Erlandson, Jon M.; Rick, Torben C.; Braje, Todd J.; Casperson, Molly; Culleton, Brendan; Fulfrost, Brian; Garcia, Tracy; Guthrie, Daniel A.; Jew, Nicholas; Kennett, Douglas J.; Moss, Madonna L.; Reeder, Leslie; Skinner, Craig; Watts, Jack; Willis, Lauren			Paleoindian Seafaring, Maritime Technologies, and Coastal Foraging on California's Channel Islands	SCIENCE			English	Article							CLOVIS; ARCHAEOLOGY	Three archaeological sites on California's Channel Islands show that Paleoindians relied heavily on marine resources. The Paleocoastal sites, dated between similar to 12,200 and 11,200 years ago, contain numerous stemmed projectile points and crescents associated with a variety of marine and aquatic faunal remains. At site CA-SRI-512 on Santa Rosa Island, Paleocoastal peoples used such tools to capture geese, cormorants, and other birds, along with marine mammals and finfish. At Cardwell Bluffs on San Miguel Island, Paleocoastal peoples collected local chert cobbles, worked them into bifaces and projectile points, and discarded thousands of marine shells. With bifacial technologies similar to those seen in Western Pluvial Lakes Tradition assemblages of western North America, the sites provide evidence for seafaring and island colonization by Paleoindians with a diversified maritime economy.	[Erlandson, Jon M.; Casperson, Molly; Garcia, Tracy; Jew, Nicholas; Moss, Madonna L.; Willis, Lauren] Univ Oregon, Museum Nat & Cultural Hist, Eugene, OR 97403 USA; [Erlandson, Jon M.; Casperson, Molly; Culleton, Brendan; Garcia, Tracy; Jew, Nicholas; Kennett, Douglas J.; Moss, Madonna L.; Willis, Lauren] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Rick, Torben C.] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Program Human Ecol & Archaeobiol, Washington, DC 20013 USA; [Braje, Todd J.] Humboldt State Univ, Dept Anthropol, Arcata, CA USA; [Fulfrost, Brian] San Francisco State Univ, Dept Geog, San Francisco, CA 94132 USA; [Guthrie, Daniel A.] Claremont Mckenna Coll, Joint Sci Dept, Claremont, CA 91711 USA; [Guthrie, Daniel A.] Scripps Coll, Joint Sci Dept, Claremont, CA 91711 USA; [Guthrie, Daniel A.] Pitzer Coll, Joint Sci Dept, Claremont, CA 91711 USA; [Reeder, Leslie] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Skinner, Craig] NW Res Obsidian Studies Lab, Corvallis, OR 97330 USA; [Watts, Jack] Univ Oxford, Kellogg Coll, Oxford OX2 6PN, England	University of Oregon; University of Oregon; Smithsonian Institution; Smithsonian National Museum of Natural History; California State University System; California State Polytechnic University, Humboldt; California State University System; San Francisco State University; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Claremont Colleges; Scripps College; Claremont Colleges; Pitzer College; Southern Methodist University; University of Oxford	Erlandson, JM (corresponding author), Univ Oregon, Museum Nat & Cultural Hist, Eugene, OR 97403 USA.	jerland@uoregon.edu	Kennett, Douglas J/I-7613-2015	Kennett, Douglas J/0000-0001-5133-9010; Rick, Torben/0000-0002-8254-5885; Erlandson, Jon/0000-0002-4705-4319	NSF [EAR 0746314, BCS 0917677]; Channel Islands National Park; Watts Family Foundation	NSF(National Science Foundation (NSF)); Channel Islands National Park; Watts Family Foundation	Supported by NSF grants EAR 0746314 (J.M.E.) and BCS 0917677 (J.M.E. and T.C.R.), Channel Islands National Park, our home institutions, D. Dana, D. Easly, and the Watts Family Foundation. Work at SRI-512 was conducted under ARPA permit PWR-1979-09-CA-04. We thank A. Huston, K. Minas, M. Senning, and I. Williams of Channel Islands National Park for logistical support; D. L. Johnson, D. Muhs, N. Pinter, and T. Rockwell for insights into the geology of the area; C. Billings, C. Buell, T. Davis, N. Dwyer, E. Erlandson, B. Fernandes, K. Hamm, C. Lopez, P. Pugh, J. Rizzi, Q. Shup, and J. Southon for help in the field or lab; and the editors and anonymous reviewers for their constructive comments and editorial suggestions.	Beck C, 2010, AM ANTIQUITY, V75, P81, DOI 10.7183/0002-7316.75.1.81; Bellrose F. C., 1976, DUCKS GEESE SWANS N; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Erlandson J. M, 2002, 1 AM PLEISTOCENE COL, V27, P59; Erlandson JM, 2008, QUATERNARY SCI REV, V27, P2232, DOI 10.1016/j.quascirev.2008.08.014; Erlandson JonM., 1994, EARLY HUNTER GATHERE; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Goebel T, 2003, SCIENCE, V301, P501, DOI 10.1126/science.1086555; Johnson J. R., 2002, P 5 CAL ISL S, V5, P541; Jones TL, 2008, P NATL ACAD SCI USA, V105, P4105, DOI 10.1073/pnas.0711140105; Justice NoelD., 2002, STONE AGE SPEAR ARRO; Keefer DK, 1998, SCIENCE, V281, P1833, DOI 10.1126/science.281.5384.1833; Kennett DJ, 2008, QUATERNARY SCI REV, V27, P2530, DOI 10.1016/j.quascirev.2008.09.006; Masters P.M., 2007, CALIFORNIA PREHISTOR, P35; Meltzer D. J., 2009, 1 PEOPLES NEW WORLD; Orr P.C., 1968, PREHISTORY SANTA ROS; Rick TC, 2005, J WORLD PREHIST, V19, P169, DOI 10.1007/s10963-006-9004-x; Rogers David Banks, 1929, PREHISTORIC MAN SANT; Roosevelt Anna C., 2002, 1 AM PLEISTOCENE COL, P159; Sandweiss DH, 1998, SCIENCE, V281, P1830, DOI 10.1126/science.281.5384.1830; Stuiver M., 2010, CALIB RADIOCARBON CA; TADLOCK WL, 1966, AM ANTIQUITY, V31, P662, DOI 10.2307/2694491; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Yesner DR, 2004, SETTLEMENT OF THE AMERICAN CONTINENTS, P196	24	227	232	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1181	1185		10.1126/science.1201477	http://dx.doi.org/10.1126/science.1201477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	729SN	21385713				2022-12-28	WOS:000287971200039
J	Struck, TH; Paul, C; Hill, N; Hartmann, S; Hosel, C; Kube, M; Lieb, B; Meyer, A; Tiedemann, R; Purschke, G; Bleidorn, C				Struck, Torsten H.; Paul, Christiane; Hill, Natascha; Hartmann, Stefanie; Hoesel, Christoph; Kube, Michael; Lieb, Bernhard; Meyer, Achim; Tiedemann, Ralph; Purschke, Guenter; Bleidorn, Christoph			Phylogenomic analyses unravel annelid evolution	NATURE			English	Article							POLYCHAETES ANNELIDA; CHARACTER LOSS; LOPHOTROCHOZOA; POSITION; MYZOSTOMIDA; RECONSTRUCTION; SEGMENTATION; CLITELLATA; ACCURACY; MODELS	Annelida, the ringed worms, is a highly diverse animal phylum that includes more than 15,000 described species and constitutes the dominant benthic macrofauna from the intertidal zone down to the deep sea. A robust annelid phylogeny would shape our understanding of animal body-plan evolution and shed light on the bilaterian ground pattern. Traditionally, Annelida has been split into two major groups: Clitellata (earthworms and leeches) and polychaetes (bristle worms), but recent evidence suggests that other taxa that were once considered to be separate phyla (Sipuncula, Echiura and Siboglinidae (also known as Pogonophora)) should be included in Annelida(1-4). However, the deep-level evolutionary relationships of Annelida are still poorly understood, and a robust reconstruction of annelid evolutionary history is needed. Here we show that phylogenomic analyses of 34 annelid taxa, using 47,953 amino acid positions, recovered a well-supported phylogeny with strong support for major splits. Our results recover chaetopterids, myzostomids and sipunculids in the basal part of the tree, although the position of Myzostomida remains uncertain owing to its long branch. The remaining taxa are split into two clades: Errantia (which includes the model annelid Platynereis), and Sedentaria (which includes Clitellata). Ancestral character trait reconstructions indicate that these clades show adaptation to either an errant or a sedentary lifestyle, with alteration of accompanying morphological traits such as peristaltic movement, parapodia and sensory perception. Finally, life history characters in Annelida seem to be phylogenetically informative.	[Struck, Torsten H.; Hoesel, Christoph; Purschke, Guenter] Univ Osnabruck, Biol Chem FB05, AG Zool, D-49069 Osnabruck, Germany; [Paul, Christiane; Tiedemann, Ralph; Bleidorn, Christoph] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, D-14476 Potsdam, Germany; [Hill, Natascha; Hartmann, Stefanie] Univ Potsdam, Inst Biochem & Biol, Unit Bioinformat, D-14476 Potsdam, Germany; [Kube, Michael] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Lieb, Bernhard; Meyer, Achim] Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany; [Bleidorn, Christoph] Univ Leipzig, Inst Biol Mol Evolut & Systemat Anim 2, D-04103 Leipzig, Germany	University Osnabruck; University of Potsdam; University of Potsdam; Max Planck Society; Johannes Gutenberg University of Mainz; Leipzig University	Struck, TH (corresponding author), Univ Osnabruck, Biol Chem FB05, AG Zool, Barbarastr 11, D-49069 Osnabruck, Germany.	struck@biologie.uni-osnabrueck.de; bleidorn@uni-leipzig.de	Meyer, Achim/AAE-9061-2021; Lieb, Bernhard/AFT-2157-2022; Hartmann, Stefanie/H-4413-2011; Purschke, Guenter/AAU-9660-2021	Purschke, Guenter/0000-0002-2572-3390; Tiedemann, Ralph/0000-0002-2604-6336; Bleidorn, Christoph/0000-0001-7295-6616; Meyer, Achim/0000-0002-4345-274X	marine biological stations in Bamfield; Helgoland; List and Roscoff for collection of annelids; Deutsche Forschungsgemeinschaft [DFG-STR 683/5-2, DFG-Pu-84/5-1, DFG-TI-349/4-1, DFG Li 998/3-1, DFG-HA 5744/1-1, DFG-BL-787/2-1]	marine biological stations in Bamfield; Helgoland; List and Roscoff for collection of annelids; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to I. Ebersberger, S. Strauss and A. von Haeseler for the processing of our raw EST libraries. We also thank M. Aguado for species identification of Typosyllis pigmentata, as well as K. M. Halanych and P. A. Ramey-Balci for suggestions. T.H.S. and C.B. acknowledge support from the marine biological stations in Bamfield, Helgoland, List and Roscoff for collection of annelids. This work was funded by the priority programme 'Deep Metazoan Phylogeny' of the Deutsche Forschungsgemeinschaft by grants DFG-STR 683/5-2 (T.H.S.), DFG-Pu-84/5-1 (G.P. and T.H.S.), DFG-TI-349/4-1 (R.T.), DFG Li 998/3-1 (B.L.), DFG-HA 5744/1-1 (S.H.) and DFG-BL-787/2-1 (C.B.).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; [Anonymous], 1967, MONOGRAPH POLYCHAE 1; [Anonymous], 2010, NCBI DBEST EXPR SEQ; [Anonymous], 2010, RIBOSOMAL PROTEIN GE; [Anonymous], 2010, EUK ORTH GROUPS 100; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bleidorn C, 2007, J ZOOL SYST EVOL RES, V45, P299, DOI 10.1111/j.1439-0469.2007.00425.x; Bleidorn C, 2007, MOL BIOL EVOL, V24, P1690, DOI 10.1093/molbev/msm086; Bleidorn C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-150; Bleidorn C, 2009, MOL PHYLOGENET EVOL, V52, P57, DOI 10.1016/j.ympev.2009.03.022; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Dordel J, 2010, J ZOOL SYST EVOL RES, V48, P197, DOI 10.1111/j.1439-0469.2010.00567.x; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Eeckhaut I, 2003, J MORPHOL, V258, P269, DOI 10.1002/jmor.10160; Eibye-Jacobsen D, 2004, LETHAIA, V37, P317, DOI 10.1080/00241160410002027; Erseus C, 2005, HYDROBIOLOGIA, V535, P357, DOI 10.1007/s10750-004-4426-x; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Fauvel P., 1923, Faune de France Paris, V5, P1; FAUVEL PIERRE, 1927, FAUNE DE FRANCE, V16, P1; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Hartmann-Schru┬der, 1996, ANNELIDA BORSTENW 58; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Helmkampf M, 2008, P ROY SOC B-BIOL SCI, V275, P1927, DOI 10.1098/rspb.2008.0372; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Maddison WP., 2019, MESQUITE MODULAR SYS; McHugh D, 2005, HYDROBIOLOGIA, V535, P309, DOI 10.1007/s10750-004-4414-1; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Pattengale ND, 2009, LECT NOTES COMPUT SC, V5541, P184, DOI 10.1007/978-3-642-02008-7_13; Purschke G, 2000, J ZOOL SYST EVOL RES, V38, P165, DOI 10.1046/j.1439-0469.2000.383146.x; Purschke G, 2006, ARTHROPOD STRUCT DEV, V35, P211, DOI 10.1016/j.asd.2006.07.005; Quatrefages A. de, 1866, HIST NATURELLE ANNEL, V1; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Rambaut A., 2014, TRACER V16; Rivera AS, 2009, DEV GENES EVOL, V219, P37, DOI 10.1007/s00427-008-0264-6; Rouse G. W., 2001, POLYCHAETES; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Rouse GW, 1999, BIOL J LINN SOC, V66, P411, DOI 10.1006/bijl.1998.0278; Shain DH, 2009, ANNELIDS IN MODERN BIOLOGY, P1, DOI 10.1002/9780470455203; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Struck TH, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-22; Struck TH, 2008, MOL PHYLOGENET EVOL, V48, P628, DOI 10.1016/j.ympev.2008.05.015; Struck TH, 2008, MOL BIOL EVOL, V25, P728, DOI 10.1093/molbev/msn019; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Struck TH, 2006, INTEGR COMP BIOL, V46, P558, DOI 10.1093/icb/icj055; Suschenko D, 2009, ZOOMORPHOLOGY, V128, P75, DOI 10.1007/s00435-008-0075-3; Tessmar-Raible K, 2003, CURR OPIN GENET DEV, V13, P331, DOI 10.1016/S0959-437X(03)00086-8; Westheide W, 1997, J NAT HIST, V31, P1, DOI 10.1080/00222939700770011; Westheide W., 1996, SPEZIELLE ZOOLOGIE E; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; Wiens JJ, 1998, SYST BIOL, V47, P625, DOI 10.1080/106351598260635; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	55	323	342	7	263	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					95	U113		10.1038/nature09864	http://dx.doi.org/10.1038/nature09864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368831				2022-12-28	WOS:000287924100041
J	Wake, DB; Wake, MH; Specht, CD				Wake, David B.; Wake, Marvalee H.; Specht, Chelsea D.			Homoplasy: From Detecting Pattern to Determining Process and Mechanism of Evolution	SCIENCE			English	Review							NATURAL-SELECTION; PELVIC REDUCTION; DOLLOS LAW; DIGIT LOSS; EVO-DEVO; GENETICS; CONVERGENCE; HOMOLOGY; PARALLELISM; ADAPTATION	Understanding the diversification of phenotypes through time-"descent with modification"-has been the focus of evolutionary biology for 150 years. If, contrary to expectations, similarity evolves in unrelated taxa, researchers are guided to uncover the genetic and developmental mechanisms responsible. Similar phenotypes may be retained from common ancestry (homology), but a phylogenetic context may instead reveal that they are independently derived, due to convergence or parallel evolution, or less likely, that they experienced reversal. Such examples of homoplasy present opportunities to discover the foundations of morphological traits. A common underlying mechanism may exist, and components may have been redeployed in a way that produces the "same" phenotype. New, robust phylogenetic hypotheses and molecular, genomic, and developmental techniques enable integrated exploration of the mechanisms by which similarity arises.	[Wake, David B.; Wake, Marvalee H.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Wake, David B.; Wake, Marvalee H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Specht, Chelsea D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wake, DB (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	davidbwake@gmail.com		Specht, Chelsea/0000-0001-7746-512X	U.S. National Science Foundation [EF 034939, IOS 0845641, DEB 0816661]; Hellman Faculty	U.S. National Science Foundation(National Science Foundation (NSF)); Hellman Faculty	Supported by the U.S. National Science Foundation (EF 034939 to D.B.W. and M.H.W., IOS 0845641 and DEB 0816661 to C.D.S.) and the Hellman Faculty Fund (C.D.S.). We thank R. Mueller, P. O'Grady, and E. Rosenblum for comments; Y. Zeng, M. Koo, and T. Renner for assistance with Figs. 1 (A and B), 2, and 3 (A to D), respectively; and many colleagues and students for discussions of principles of evolutionary biology.	Abouheif E, 2008, EVOL DEV, V10, P3, DOI 10.1111/j.1525-142X.2007.00208.x; ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Albert AYK, 2008, EVOLUTION, V62, P76, DOI 10.1111/j.1558-5646.2007.00259.x; Arendt J, 2008, TRENDS ECOL EVOL, V23, P483, DOI 10.1016/j.tree.2008.06.002; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Bateman Richard M., 1996, P91, DOI 10.1016/B978-012618030-5/50006-X; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Collin R, 2008, TRENDS ECOL EVOL, V23, P602, DOI 10.1016/j.tree.2008.06.013; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; De Craene LPR, 2007, ANN BOT-LONDON, V100, P621, DOI 10.1093/aob/mcm076; Diogo R, 2005, BIOL PHILOS, V20, P735, DOI 10.1007/s10539-004-1604-1; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Donoghue MJ, 2000, AM ZOOL, V40, P759, DOI 10.1668/0003-1569(2000)040[0759:HADCAM]2.0.CO;2; Galis F, 2010, EVOLUTION, V64, P2466, DOI 10.1111/j.1558-5646.2010.01041.x; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Gower DJ, 2008, J EVOLUTION BIOL, V21, P1220, DOI 10.1111/j.1420-9101.2008.01577.x; Gregory TR, 2003, BIOL J LINN SOC, V79, P329, DOI 10.1046/j.1095-8312.2003.00191.x; Hall BK, 2003, BIOL REV, V78, P409, DOI 10.1017/S1464793102006097; Hall BK, 2007, J HUM EVOL, V52, P473, DOI 10.1016/j.jhevol.2006.11.010; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; Irish VF, 2009, J EXP BOT, V60, P2517, DOI 10.1093/jxb/erp159; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kirchoff BK, 2009, AM J BOT, V96, P580, DOI 10.3732/ajb.0800305; Kohlsdorf T, 2006, EVOLUTION, V60, P1896; Kohlsdorf T, 2010, EVOLUTION, V64, P2477, DOI 10.1111/j.1558-5646.2010.01042.x; Kramer EM, 2009, ANNU REV PLANT BIOL, V60, P261, DOI 10.1146/annurev.arplant.043008.092051; Leander BS, 2008, TRENDS ECOL EVOL, V23, P481, DOI 10.1016/j.tree.2008.04.012; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; MARSHALL CR, 1994, P NATL ACAD SCI USA, V91, P12283, DOI 10.1073/pnas.91.25.12283; Mueller RL, 2004, P NATL ACAD SCI USA, V101, P13820, DOI 10.1073/pnas.0405785101; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Parra-Olea G, 2001, P NATL ACAD SCI USA, V98, P7888, DOI 10.1073/pnas.131203598; Piatigorsky Joram, 2008, Evolution Education and Outreach, V1, P403, DOI 10.1007/s12052-008-0077-0; Preston JC, 2009, TRENDS PLANT SCI, V14, P147, DOI 10.1016/j.tplants.2008.12.005; Roth G, 1997, BRAIN BEHAV EVOLUT, V50, P50, DOI 10.1159/000113321; Schluter D, 2010, PHILOS T R SOC B, V365, P2479, DOI 10.1098/rstb.2010.0036; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Wake D.B., 2003, KEYWORDS CONCEPTS EV, P191, DOI [10.2307/j.ctv228vqrq.32, DOI 10.2307/J.CTV228VQRQ.32]; WAKE DB, 1987, SCIENCE, V238, P42, DOI 10.1126/science.238.4823.42; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; Wake Marvalee H., 2008, Biological Theory, V3, P213, DOI 10.1162/biot.2008.3.3.213; Wilkinson M, 2006, REPROD BIOL PHYLOGEN, V5, P39; Zanis MJ, 2003, ANN MO BOT GARD, V90, P129, DOI 10.2307/3298579; Zufall RA, 2004, NATURE, V428, P847, DOI 10.1038/nature02489	52	284	287	7	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1032	1035		10.1126/science.1188545	http://dx.doi.org/10.1126/science.1188545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350170				2022-12-28	WOS:000287699000053
J	Olnes, MJ; Sloand, EM				Olnes, Matthew J.; Sloand, Elaine M.			Targeting Immune Dysregulation in Myelodysplastic Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUMOR-NECROSIS-FACTOR; ANTITHYMOCYTE GLOBULIN; APLASTIC-ANEMIA; INTERFERON-GAMMA; SCORING SYSTEM; MDS PATIENTS; T-CELLS; EXPRESSION; LYMPHOCYTES; SURVIVAL	Myelodysplastic syndromes (MDS) are a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis and a tendency to develop leukemia. In some patients, laboratory and clinical evidence supports a role for the immune system in the pathogenesis of early MDS. Many younger patients who respond to immunosuppressive therapy with drugs such as antithymocyte globulin and cyclosporine have clonal expansions of cytotoxic CD8(+) T cells that suppress normal hematopoiesis, as well as expansion of CD4(+) helper T-cell subsets that promote and sustain autoimmunity. Immunosuppressive therapy can produce hematologic responses in some patients and may improve survival and halt leukemic progression. In this report, we describe a 56-year-old woman who presented with fatigue and easy bruising, eventually became pancytopenic, and was diagnosed with MDS. After treatment with a clinical protocol using alemtuzumab, an anti-CD52 antibody, her blood cell counts returned to normal and she has remained in complete remission for more than 2 years of follow-up. In this article, we review the pathobiology of immune dysregulation in MDS and summarize the role of immunosuppressive therapy in MDS. JAMA. 2011; 305(8): 814-819	[Olnes, Matthew J.; Sloand, Elaine M.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Olnes, Matthew J.] NIH, Ctr Human Immunol Autoimmun & Inflammat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA	Olnes, MJ (corresponding author), NHLBI, Hematol Branch, NIH, Bldg 10,CRC 3-1341, Bethesda, MD 20892 USA.	olnesmj@nhlbi.nih.gov			Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI); Center for Human Immunology, Autoimmunity, and Inflammation; National Institutes of Health; NHLBI	Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Human Immunology, Autoimmunity, and Inflammation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Olnes is supported by Intramural funding from the Hematology Branch, National Heart, Lung, and Blood Institute (NHLBI); and the Center for Human Immunology, Autoimmunity, and Inflammation; National Institutes of Health. Dr Sloand was supported by the Intramural NHLBI.	Aivado M, 2002, EUR J HAEMATOL, V68, P210, DOI 10.1034/j.1600-0609.2002.01625.x; Bagby Grover C, 2004, Hematology Am Soc Hematol Educ Program, P318; Benesch M, 2003, LEUKEMIA, V17, P2460, DOI 10.1038/sj.leu.2403180; Broliden PA, 2006, HAEMATOLOGICA, V91, P667; Chamuleau MED, 2009, HAEMATOL-HEMATOL J, V94, P496, DOI 10.3324/haematol.13612; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Cilloni D, 2004, ACTA HAEMATOL-BASEL, V112, P79, DOI 10.1159/000077562; Cilloni D, 2003, J CLIN ONCOL, V21, P1988, DOI 10.1200/JCO.2003.10.503; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Dunn DE, 1999, ANN INTERN MED, V131, P401, DOI 10.7326/0003-4819-131-6-199909210-00002; Epling-Burnette PK, 2007, BLOOD, V109, P4816, DOI 10.1182/blood-2006-07-035519; Epperson DE, 2001, LEUKEMIA RES, V25, P1075, DOI 10.1016/S0145-2126(01)00083-2; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Goldberg SL, 2010, J CLIN ONCOL, V28, P2847, DOI 10.1200/JCO.2009.25.2395; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greiner J, 2010, HAEMATOL-HEMATOL J, V95, P1191, DOI 10.3324/haematol.2009.014704; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Inoue K, 1998, BLOOD, V91, P2969, DOI 10.1182/blood.V91.8.2969.2969_2969_2976; Jadersten M, 2008, J CLIN ONCOL, V26, P3607, DOI 10.1200/JCO.2007.15.4906; Jonasova A, 1998, BRIT J HAEMATOL, V100, P304, DOI 10.1046/j.1365-2141.1998.00551.x; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Killick SB, 2003, BRIT J HAEMATOL, V120, P679, DOI 10.1046/j.1365-2141.2003.04136.x; Kochenderfer JN, 2002, BLOOD, V100, P3639, DOI 10.1182/blood-2002-01-0155; Kook H, 2002, BLOOD, V99, P3668, DOI 10.1182/blood.V99.10.3668; Kordasti SY, 2007, BLOOD, V110, P847, DOI 10.1182/blood-2007-01-067546; Lim ZY, 2007, LEUKEMIA, V21, P1436, DOI 10.1038/sj.leu.2404747; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Ma X, 2007, CANCER-AM CANCER SOC, V109, P1536, DOI 10.1002/cncr.22570; MACIEJEWSKI J, 1995, BLOOD, V85, P3183, DOI 10.1182/blood.V85.11.3183.bloodjournal85113183; Melenhorst JJ, 2002, BRIT J HAEMATOL, V119, P97, DOI 10.1046/j.1365-2141.2002.03802.x; Molldrem JJ, 1999, CANCER RES, V59, P2675; Molldrem JJ, 1998, BRIT J HAEMATOL, V102, P1314, DOI 10.1046/j.1365-2141.1998.00920.x; Molldrem JJ, 2002, ANN INTERN MED, V137, P156, DOI 10.7326/0003-4819-137-3-200208060-00007; Plasilova Magdalena, 2003, Hematology, V8, P173, DOI 10.1080/1024533031000107505; Ravandi F, 2006, CANCER INVEST, V24, P718, DOI 10.1080/07357900600981414; Risitano AM, 2002, BLOOD, V100, P178, DOI 10.1182/blood-2002-01-0236; Sato T, 1997, BRIT J HAEMATOL, V97, P356, DOI 10.1046/j.1365-2141.1997.562704.x; Saunthararajah Y, 2002, BLOOD, V100, P1570, DOI 10.1182/blood.V100.5.1570.h81702001570_1570_1574; SH Swerdlow, 2010, WHO CLASSIFICATION T; Sloand EM, 2008, J CLIN ONCOL, V26, P2505, DOI 10.1200/JCO.2007.11.9214; Sloand EM, 2010, J CLIN ONCOL, V28, P5166, DOI 10.1200/JCO.2010.29.7010; Sloand EM, 2005, BLOOD, V106, P841, DOI 10.1182/blood-2004-05-2017; Sloand EM, BLOOD, DOI [10.1182/blood-2010-04-277921, DOI 10.1182/BLOOD-2010-04-277021]; Stadler M, 2004, LEUKEMIA, V18, P460, DOI 10.1038/sj.leu.2403239; Steensma DP, 2003, BLOOD, V101, P2156, DOI 10.1182/blood-2002-09-2867; tenBosch GJA, 1996, BLOOD, V88, P3522, DOI 10.1182/blood.V88.9.3522.bloodjournal8893522; Wagner KD, 2003, J CELL SCI, V116, P1653, DOI 10.1242/jcs.00405; Yazji S, 2003, LEUKEMIA, V17, P2101, DOI 10.1038/sj.leu.2403124; Yue G, 2008, LEUKEMIA RES, V32, P553, DOI 10.1016/j.leukres.2007.08.006; Zang YCQ, 2003, INT IMMUNOL, V15, P1073, DOI 10.1093/intimm/dxg105	50	42	44	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					814	819		10.1001/jama.2011.194	http://dx.doi.org/10.1001/jama.2011.194			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21343581				2022-12-28	WOS:000287594300025
J	Fenstermacher, N; Levin, M; Ward, T				Fenstermacher, Nathan; Levin, Morris; Ward, Thomas			Pharmacological prevention of migraine	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOUBLE-BLIND; PROPHYLACTIC TREATMENT; HEADACHE; PREVALENCE; GUIDELINES; EFFICACY; BURDEN					nathan.p.fenstermacher@hitchcock.org			Merck; Allergan; GSK; NMT Medical; Solstice	Merck(Merck & Company); Allergan(AbbVieAllergan); GSK(GlaxoSmithKline); NMT Medical; Solstice	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; ML has received honorariums for lectures from NuPathe, Merck, and Allergan and has served as a consultant for NuPathe in the past year. He has been on the Speaker's Bureau with Merck and Astellas; TW has consulted with NuPathe, MAP Pharma, and Pfizer in the past year; he has been on the Speaker's Bureau with Merck, Zogenix/Astrellen, Allergan, and Valeant; he has received research support from Merck, Allergan, GSK, NMT Medical, and Solstice within the past three years; no other relationships or activities that could appear to have influenced the submitted work.	Antonaci F, 2010, J HEADACHE PAIN, V11, P13, DOI 10.1007/s10194-009-0179-2; COUCH JR, 1979, ARCH NEUROL-CHICAGO, V36, P695, DOI 10.1001/archneur.1979.00500470065013; Diener HC, 2010, CEPHALALGIA, V30, P804, DOI 10.1177/0333102410364677; Evers S, 2004, CEPHALALGIA, V24, P838, DOI 10.1111/j.1468-2982.2004.00754.x; Evers S, 2009, EUR J NEUROL, V16, P968, DOI 10.1111/j.1468-1331.2009.02748.x; JENSEN R, 1994, NEUROLOGY, V44, P647, DOI 10.1212/WNL.44.4.647; Linde K, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003225.PUB2; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Lipton RB, 2004, NEUROLOGY, V63, P2240, DOI 10.1212/01.WNL.0000147290.68260.11; MATHEW NT, 1990, HEADACHE, V30, P634, DOI 10.1111/j.1526-4610.1990.hed3010634.x; Moja PL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002919.pub2; Mulleners WM, 2008, CEPHALALGIA, V28, P585, DOI 10.1111/j.1468-2982.2008.01571.x; Ozyalcin SN, 2005, HEADACHE, V45, P144, DOI 10.1111/j.1526-4610.2005.05029.x; Peikert A, 1996, CEPHALALGIA, V16, P257, DOI 10.1046/j.1468-2982.1996.1604257.x; PITTLER MH, 2004, COCHRANE DB SYST REV, V1; Reveix Herault L, 2003, REV NEUROL, V36, P907; Sandor PS, 2005, NEUROLOGY, V64, P713, DOI 10.1212/01.WNL.0000151975.03598.ED; Schoener J, 1998, NEUROLOGY, V50, P65; Schrader H, 2001, BMJ-BRIT MED J, V322, P19, DOI 10.1136/bmj.322.7277.19; Silberstein S, 2008, WOLFFS HEADACHE OTHE; Silberstein SD, 2004, ARCH NEUROL-CHICAGO, V61, P490, DOI 10.1001/archneur.61.4.490; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Tronvik E, 2003, JAMA-J AM MED ASSOC, V289, P65, DOI 10.1001/jama.289.1.65	25	16	17	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2011	342								d583	10.1136/bmj.d583	http://dx.doi.org/10.1136/bmj.d583			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725PE	21335409				2022-12-28	WOS:000287657000007
J	Gohler, B; Hamelbeck, V; Markus, TZ; Kettner, M; Hanne, GF; Vager, Z; Naaman, R; Zacharias, H				Goehler, B.; Hamelbeck, V.; Markus, T. Z.; Kettner, M.; Hanne, G. F.; Vager, Z.; Naaman, R.; Zacharias, H.			Spin Selectivity in Electron Transmission Through Self-Assembled Monolayers of Double-Stranded DNA	SCIENCE			English	Article							LOW-ENERGY ELECTRONS; SCATTERING; POLARIZATION; FILMS; GOLD; SPINTRONICS; METALS	In electron-transfer processes, spin effects normally are seen either in magnetic materials or in systems containing heavy atoms that facilitate spin-orbit coupling. We report spin-selective transmission of electrons through self-assembled monolayers of double-stranded DNA on gold. By directly measuring the spin of the transmitted electrons with a Mott polarimeter, we found spin polarizations exceeding 60% at room temperature. The spin-polarized photoelectrons were observed even when the photoelectrons were generated with unpolarized light. The observed spin selectivity at room temperature was extremely high as compared with other known spin filters. The spin filtration efficiency depended on the length of the DNA in the monolayer and its organization.	[Markus, T. Z.; Naaman, R.] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Goehler, B.; Hamelbeck, V.; Kettner, M.; Hanne, G. F.; Zacharias, H.] Univ Munster, Inst Phys, D-48149 Munster, Germany; [Vager, Z.] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel	Weizmann Institute of Science; University of Munster; Weizmann Institute of Science	Naaman, R (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.	ron.naaman@weizmann.ac.il	Markus, Tal Z/C-8905-2011	Zacharias, Helmut/0000-0001-9807-1103	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	T.Z.M. and R.N. acknowledge the partial support from the Israel Science Foundation.	Aqua T, 2003, LANGMUIR, V19, P10573, DOI 10.1021/la035116y; Awschalom DD, 2007, NAT PHYS, V3, P153, DOI 10.1038/nphys551; Brede J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.047204; Brinkman A, 2007, NAT MATER, V6, P493, DOI 10.1038/nmat1931; Cacho C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.066601; Drouhin HJ, 1997, PHYS REV B, V56, P14886, DOI 10.1103/PhysRevB.56.14886; GELLRICH A, 1991, PHYS REV A, V43, P204, DOI 10.1103/PhysRevA.43.204; GETZLAFF M, 1993, SOLID STATE COMMUN, V87, P467, DOI 10.1016/0038-1098(93)90799-S; Grobli C., 1995, PHYS REV B, V51, P2945; LASSAILLY Y, 1994, PHYS REV B, V50, P13054, DOI 10.1103/PhysRevB.50.13054; Levy N, 2010, SCIENCE, V329, P544, DOI 10.1126/science.1191700; Markus TZ, 2009, J AM CHEM SOC, V131, P89, DOI 10.1021/ja804177j; MARUYAMA T, 1991, PHYS REV LETT, V66, P2376, DOI 10.1103/PhysRevLett.66.2376; MAYER S, 1995, PHYS REV LETT, V74, P4803, DOI 10.1103/PhysRevLett.74.4803; Mott NF, 1932, P R SOC LOND A-CONTA, V135, P429, DOI 10.1098/rspa.1932.0044; Mott NF, 1929, P R SOC LOND A-CONTA, V124, P425, DOI 10.1098/rspa.1929.0127; Naaman R, 2010, MRS BULL, V35, P429, DOI 10.1557/mrs2010.580; Oberli D, 1998, PHYS REV LETT, V81, P4228, DOI 10.1103/PhysRevLett.81.4228; PAPPAS DP, 1991, PHYS REV LETT, V66, P504, DOI 10.1103/PhysRevLett.66.504; Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660; Qi XL, 2010, PHYS TODAY, V63, P33, DOI 10.1063/1.3293411; Ray K, 1999, SCIENCE, V283, P814, DOI 10.1126/science.283.5403.814; Ray SG, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036101; Ron H, 1998, LANGMUIR, V14, P1116, DOI 10.1021/la970785v; SCHONHENSE G, 1993, ANN PHYS-LEIPZIG, V2, P465, DOI 10.1002/andp.19935050504; Skourtis SS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238103; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Yeganeh S, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3167404	29	451	457	22	339	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					894	897		10.1126/science.1199339	http://dx.doi.org/10.1126/science.1199339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330541				2022-12-28	WOS:000287455100052
J	Li, QX; Kannan, A; DeMayo, FJ; Lydon, JP; Cooke, PS; Yamagishi, H; Srivastava, D; Bagchi, MK; Bagchi, IC				Li, Quanxi; Kannan, Athilakshmi; DeMayo, Francesco J.; Lydon, John P.; Cooke, Paul S.; Yamagishi, Hiroyuki; Srivastava, Deepak; Bagchi, Milan K.; Bagchi, Indrani C.			The Antiproliferative Action of Progesterone in Uterine Epithelium Is Mediated by Hand2	SCIENCE			English	Article							GROWTH-FACTOR; MOUSE UTERUS; IMPLANTATION; INHIBITION; RECEPTOR; PROLIFERATION; CANCER	During pregnancy, progesterone inhibits the growth-promoting actions of estrogen in the uterus. However, the mechanism for this is not clear. The attenuation of estrogen-mediated proliferation of the uterine epithelium by progesterone is a prerequisite for successful implantation. Our study reveals that progesterone-induced expression of the basic helix-loop-helix transcription factor Hand2 in the uterine stroma suppresses the production of several fibroblast growth factors (FGFs) that act as paracrine mediators of mitogenic effects of estrogen on the epithelium. In mouse uteri lacking Hand2, continued induction of these FGFs in the stroma maintains epithelial proliferation and stimulates estrogen-induced pathways, resulting in impaired implantation. Thus, Hand2 is a critical regulator of the uterine stromal-epithelial communication that directs proper steroid regulation conducive for the establishment of pregnancy.	[Bagchi, Milan K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61820 USA; [DeMayo, Francesco J.; Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Yamagishi, Hiroyuki] Keio Univ, Sch Med, Tokyo 1608582, Japan; [Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Li, Quanxi; Kannan, Athilakshmi; Cooke, Paul S.; Bagchi, Indrani C.] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; Keio University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Illinois System; University of Illinois Urbana-Champaign	Bagchi, MK (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61820 USA.	mbagchi@life.illinois.edu; ibagchi@illinois.edu	Yamagishi, Hiroyuki/A-6345-2017; DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Cooke, Paul/0000-0002-9370-4896	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH [U54HD055787]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055787] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Laws for genotyping and Y. Li for immunohistochemistry. This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, through U54HD055787 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research. The Gene Expression Omnibus (GEO) microarray accession number is GSE25881.	Bagchi IC, 2005, SEMIN REPROD MED, V23, P38, DOI 10.1055/s-2005-864032; Bagchi IC, 2003, FRONT BIOSCI-LANDMRK, V8, pS852, DOI 10.2741/1148; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FINN CA, 1974, J REPROD FERTIL, V39, P195, DOI 10.1530/jrf.0.0390195; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kim JJ, 2010, SEMIN REPROD MED, V28, P81, DOI 10.1055/s-0029-1242998; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; MARTIN L, 1973, J ENDOCRINOL, V57, P549, DOI 10.1677/joe.0.0570549; Pan HY, 2006, P NATL ACAD SCI USA, V103, P14021, DOI 10.1073/pnas.0601271103; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; SURVEYOR GA, 1995, ENDOCRINOLOGY, V136, P3639, DOI 10.1210/en.136.8.3639	18	243	257	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					912	916		10.1126/science.1197454	http://dx.doi.org/10.1126/science.1197454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330545	Green Accepted			2022-12-28	WOS:000287455100058
J	Tyrer, P; Crawford, M; Mulder, R				Tyrer, Peter; Crawford, Michael; Mulder, Roger		ICD-11 Working Grp Revision Classi	Reclassifying personality disorders	LANCET			English	Editorial Material							CLASSIFICATION		[Tyrer, Peter; Crawford, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Mental Hlth, London W6 8RP, England; [Mulder, Roger] Univ Otago, Dept Psychol Med, Christchurch, New Zealand	Imperial College London; University of Otago	Tyrer, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Mental Hlth, London W6 8RP, England.	p.tyrer@imperial.ac.uk		Crawford, Mike/0000-0003-3137-5772				American Psychiatric Association, 2010, PROP DRAFT REV DSM D; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bernstein DP, 2007, J PERS DISORD, V21, P536, DOI 10.1521/pedi.2007.21.5.536; Huang YQ, 2009, BRIT J PSYCHIAT, V195, P46, DOI 10.1192/bjp.bp.108.058552; Kim YR, 2010, PSYCHIAT INVEST, V7, P1, DOI [10.4306/pi.2010.7.1.1, 10.1186/1743-8977-7-20]; LIVESLEY WJ, 1994, J ABNORM PSYCHOL, V103, P6, DOI 10.1037/0021-843X.103.1.6; Newton-Howes G, 2008, AUST NZ J PSYCHIAT, V42, P572, DOI 10.1080/00048670802119739; Shedler J, 2010, AM J PSYCHIAT, V167, P1026, DOI 10.1176/appi.ajp.2010.10050746; Verheul R, 2007, J PERS DISORD, V21, P359, DOI 10.1521/pedi.2007.21.4.359; Watson D, 2008, J PERS, V76, P1545, DOI 10.1111/j.1467-6494.2008.00531.x; *WHO, 1992, INT CLASS DIS 10 REV, pF60; Yang M, 2010, BRIT J PSYCHIAT, V197, P193, DOI 10.1192/bjp.bp.110.078956	12	93	94	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2011	377	9780					1814	1815		10.1016/S0140-6736(10)61926-5	http://dx.doi.org/10.1016/S0140-6736(10)61926-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774UI	21353696				2022-12-28	WOS:000291411700007
J	Bell, RE; Ferraccioli, F; Creyts, TT; Braaten, D; Corr, H; Das, I; Damaske, D; Frearson, N; Jordan, T; Rose, K; Studinger, M; Wolovick, M				Bell, Robin E.; Ferraccioli, Fausto; Creyts, Timothy T.; Braaten, David; Corr, Hugh; Das, Indrani; Damaske, Detlef; Frearson, Nicholas; Jordan, Thomas; Rose, Kathryn; Studinger, Michael; Wolovick, Michael			Widespread Persistent Thickening of the East Antarctic Ice Sheet by Freezing from the Base	SCIENCE			English	Article							LAKE VOSTOK	An International Polar Year aerogeophysical investigation of the high interior of East Antarctica reveals widespread freeze-on that drives substantial mass redistribution at the bottom of the ice sheet. Although the surface accumulation of snow remains the primary mechanism for ice sheet growth, beneath Dome A, 24% of the base by area is frozen-on ice. In some places, up to half of the ice thickness has been added from below. These ice packages result from the conductive cooling of water ponded near the Gamburtsev Subglacial Mountain ridges and the supercooling of water forced up steep valley walls. Persistent freeze-on thickens the ice column, alters basal ice rheology and fabric, and upwarps the overlying ice sheet, including the oldest atmospheric climate archive, and drives flow behavior not captured in present models.	[Bell, Robin E.; Creyts, Timothy T.; Das, Indrani; Frearson, Nicholas; Wolovick, Michael] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Ferraccioli, Fausto; Corr, Hugh; Jordan, Thomas; Rose, Kathryn] British Antarctic Survey, Cambridge CB3 0ET, England; [Braaten, David] Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA; [Damaske, Detlef] Bundesanstalt Geowissensch & Rohstoffe, D-3000 Hannover, Germany; [Studinger, Michael] Univ Maryland Baltimore Cty, Goddard Earth Sci & Technol Ctr, Baltimore, MD 21228 USA; [Studinger, Michael] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA	Columbia University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Kansas; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Bell, RE (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	robinb@ldeo.columbia.edu	Corr, Hugh/C-5398-2011	Creyts, Timothy/0000-0003-1756-5211; Studinger, Michael/0000-0003-1265-4741; Ferraccioli, Fausto/0000-0002-9347-4736; Jordan, Tom/0000-0003-2780-1986	Natural Environment Research Council [bas0100026] Funding Source: researchfish; NERC [bas0100026] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alley RB, 1998, J GLACIOL, V44, P563, DOI 10.3189/S0022143000002070; Bell RE, 2002, NATURE, V416, P307, DOI 10.1038/416307a; BELL RES, 2009, 2009 FULL M AM GEOPH; CREYTS TT, 2010, 2010 FALL M AM GEOPH; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Drews R, 2009, CRYOSPHERE, V3, P195, DOI 10.5194/tc-3-195-2009; Fujita S, 1999, J GEOPHYS RES-SOL EA, V104, P13013, DOI 10.1029/1999JB900034; Heliere F, 2007, IEEE T GEOSCI REMOTE, V45, P2573, DOI 10.1109/TGRS.2007.897433; MacGregor JA, 2009, EARTH PLANET SC LETT, V282, P222, DOI 10.1016/j.epsl.2009.03.018; Pattyn F, 2010, EARTH PLANET SC LETT, V295, P451, DOI 10.1016/j.epsl.2010.04.025; Robin G. de Q., 1970, INT ASS SCI HYDROLOG, V86, P97; ROBIN GDQ, 1977, PHILOS T ROY SOC B, V279, P185, DOI 10.1098/rstb.1977.0081; SUGDEN DE, 1987, NATURE, V328, P238, DOI 10.1038/328238a0	13	119	131	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1592	1595		10.1126/science.1200109	http://dx.doi.org/10.1126/science.1200109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21385719				2022-12-28	WOS:000288754500052
J	Beckman, HB				Beckman, Howard B.			Lost in Translation: Physicians' Struggle With Cost-Reduction Programs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERFORMANCE; CARE	Relationships between health plans and the medical profession are often strained, leading to the inability to create a shared vision for the health care redesign needed to more effectively care for our population. Because of their respective stakeholders, health plans and providers naturally differ in perspective. However, this article suggests that it is the inability of stakeholders to find a common language to effectively communicate interests, needs, and proposed interventions that often derails progress toward common goals. The business and health plan leaders' focus on cost-containment and cost-efficiency predictably results in physician defensiveness and disengagement. At the same time, physicians' limited focus on improving quality to only reducing underuse, which in the short term increases costs, does not acknowledge cost concerns of business leaders and health plan executives. However, as divergent as these emphases might seem, there is potential for common ground with effective language translation. Effective translation has been proposed through the Institute of Medicine's definition of quality as reducing overuse, misuse, and underuse. Creating a common language provides seemingly opposing groups an opportunity to explore a shared vision. Using the language of clinical appropriateness and reducing unnecessary variation has resulted in agreement on clinical quality improvement projects from which each group can return to its own organizations and translate back into its familiar "stakeholder" language.			Beckman, HB (corresponding author), 125 Sullys Trail,Suite 8, Pittsford, NY 14534 USA.	hbeckman@fma-us.com						BECKMAN HB, 1994, ARCH INTERN MED, V154, P1365, DOI 10.1001/archinte.154.12.1365; Beckman H, 2006, AM J MED QUAL, V21, P192, DOI 10.1177/1062860606287577; Cammisa Chris, 2011, Am J Med Qual, V26, P26, DOI 10.1177/1062860610373380; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; *COMM FUND COMM HI, PATH HIGH PERF US HL; Curtin K, 2006, J HEALTHC MANAG, V51, P365, DOI 10.1097/00115514-200611000-00005; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Fisher ES, 2009, NEW ENGL J MED, V360, P2495, DOI 10.1056/NEJMp0903923; Fisher ES, 2003, NEW ENGL J MED, V349, P1665, DOI 10.1056/NEJMe038149; Gawande A., 2009, NEW YORKER; Greene RA, 2004, AM J MANAG CARE, V10, P670; Greene RA, 2008, HEALTH AFFAIR, V27, pW250, DOI 10.1377/hlthaff.27.4.w250; Institute of Medicine, 2006, PERF MEAS ACC IMPR	13	9	9	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					430	433		10.7326/0003-4819-154-6-201103150-00010	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734WA	21403079				2022-12-28	WOS:000288370000008
J	Chessman, AW				Chessman, Alexander W.			Review: Acetaminophen reduces acute migraine pain in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Chessman, AW (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.							McCrory DC, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002915, DOI 10.1002/14651858.CD002915]	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-9	10.7326/0003-4819-154-6-201103150-02009	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403072				2022-12-28	WOS:000208886200008
J	Fedorkow, D				Fedorkow, Donna			Hormone therapy increased risk for kidney stones in healthy postmenopausal women	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Fedorkow, D (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Romero Victoriano, 2010, Rev Urol, V12, pe86; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-10	10.7326/0003-4819-154-6-201103150-02010	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403061				2022-12-28	WOS:000208886200009
J	Wirgin, I; Roy, NK; Loftus, M; Chambers, RC; Franks, DG; Hahn, ME				Wirgin, Isaac; Roy, Nirmal K.; Loftus, Matthew; Chambers, R. Christopher; Franks, Diana G.; Hahn, Mark E.			Mechanistic Basis of Resistance to PCBs in Atlantic Tomcod from the Hudson River	SCIENCE			English	Article							ARYL-HYDROCARBON RECEPTOR; FISH FUNDULUS-HETEROCLITUS; DIOXIN SENSITIVITY; MICROGADUS-TOMCOD; INDUCTION; CYTOCHROME-P4501A; POPULATIONS; KILLIFISH; AHR2	The mechanistic basis of resistance of vertebrate populations to contaminants, including Atlantic tomcod from the Hudson River (HR) to polychlorinated biphenyls (PCBs), is unknown. HR tomcod exhibited variants in the aryl hydrocarbon receptor 2 (AHR2) that were nearly absent elsewhere. In ligand-binding assays, AHR2-1 protein (common in the HR) was impaired as compared to widespread AHR2-2 in binding TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) and in driving expression in reporter gene assays in AHR-deficient cells treated with TCDD or PCB126. We identified a six-base deletion in AHR2 as the basis of resistance and suggest that the HR population has undergone rapid evolution, probably due to contaminant exposure. This mechanistic basis of resistance in a vertebrate population provides evidence of evolutionary change due to selective pressure at a single locus.	[Wirgin, Isaac; Roy, Nirmal K.; Loftus, Matthew] NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA; [Franks, Diana G.; Hahn, Mark E.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Chambers, R. Christopher] NOAA, Howard Marine Sci Lab, NE Fisheries Sci Ctr, Fisheries Serv, Highlands, NJ 07732 USA	New York University; Woods Hole Oceanographic Institution; National Oceanic Atmospheric Admin (NOAA) - USA	Wirgin, I (corresponding author), NYU, Dept Environm Med, Sch Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	Isaac.wirgin@nyumc.org	Hahn, Mark/AAV-7516-2020	Hahn, Mark/0000-0003-4358-2082	Hudson River Foundation; Northeast Fisheries Science Center;  [R01ES015447];  [P42ES007381];  [ES00260]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381, P30ES000260, R01ES015447, P42ES010344] Funding Source: NIH RePORTER	Hudson River Foundation; Northeast Fisheries Science Center; ; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We acknowledge support of R01ES015447, P42ES007381, ES00260, the Hudson River Foundation, and the Northeast Fisheries Science Center. We thank M. Mattson, K. Sullivan, D. Danila, S. Courtenay, C. Burnett, L. Upchurch, P. Roy, S. Karchner, and A. Nadas for assistance. Accession nos. FJ215751 to FJ215756.	Able K. W., 1998, 1 YEAR LIFE ESTUARIN; Fernandez MP, 2004, ENVIRON SCI TECHNOL, V38, P976, DOI 10.1021/es034177f; Hahn ME, 2004, PHARMACOGENETICS, V14, P131, DOI 10.1097/00008571-200402000-00007; Hahn ME, 1997, P NATL ACAD SCI USA, V94, P13743, DOI 10.1073/pnas.94.25.13743; Head JA, 2008, ENVIRON SCI TECHNOL, V42, P7535, DOI 10.1021/es801082a; Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; Ma Q, 2001, CURR DRUG METAB, V2, P149, DOI 10.2174/1389200013338603; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Nacci D, 2005, MECH PCB DIOXIN RESI; Nacci DE, 2010, ESTUAR COAST, V33, P853, DOI 10.1007/s12237-009-9257-6; POLAND A, 1994, MOL PHARMACOL, V46, P915; Powell WH, 2000, TOXICOL SCI, V57, P229, DOI 10.1093/toxsci/57.2.229; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; van Straalen N. M., 2000, DEMOGRAPHY ECOTOXICO, P147; Van Veld Peter A., 2008, P597, DOI 10.1201/9780203647295.ch13; WIRGIN I, 2004, MUTAT RES, V55, P1897; WIRGIN II, 1992, MAR ENVIRON RES, V34, P103, DOI 10.1016/0141-1136(92)90091-Y; Wirgin I, 2006, AM FISH S S, V51, P331; Yuan ZP, 2006, AQUAT TOXICOL, V76, P306, DOI 10.1016/j.aquatox.2005.10.006; Yuan ZP, 2006, ENVIRON HEALTH PERSP, V114, P77, DOI 10.1289/ehp.8255	21	146	152	4	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1322	1325		10.1126/science.1197296	http://dx.doi.org/10.1126/science.1197296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21330491	Green Accepted			2022-12-28	WOS:000288215200046
J	Cutler, D; Dafny, L				Cutler, David; Dafny, Leemore			Designing Transparency Systems for Medical Care Prices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cutler, David] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Cutler, David; Dafny, Leemore] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Dafny, Leemore] Northwestern Univ, Kellogg Sch Management, Evanston, IL USA	Harvard University; National Bureau of Economic Research; Northwestern University	Cutler, D (corresponding author), Harvard Univ, Dept Econ, Cambridge, MA 02138 USA.			Cutler, David/0000-0002-4949-8917				Albaek S, 1997, J IND ECON, V45, P429, DOI 10.1111/1467-6451.00057; Austin A, 2008, REPORT C DOES PRICE; COOPER TE, 1986, RAND J ECON, V17, P377, DOI 10.2307/2555718; VARNEY CA, 2010, COMMUNICATION   0426	4	31	31	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					894	895		10.1056/NEJMp1100540	http://dx.doi.org/10.1056/NEJMp1100540			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732FL	21388307	Green Published			2022-12-28	WOS:000288170300003
J	Gaskell, G; Gottweis, H				Gaskell, George; Gottweis, Herbert			Biobanks need publicity	NATURE			English	Editorial Material									[Gaskell, George] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England; [Gottweis, Herbert] Univ Vienna, Dept Polit Sci, Vienna, Austria	University of London; London School Economics & Political Science; University of Vienna	Gaskell, G (corresponding author), Univ London London Sch Econ & Polit Sci, Houghton St, London WC2A 2AE, England.	g.gaskell@lse.ac.uk; herbert.gottweis@univie.ac.at						Gaskell G., 2010, EUROPEANS BIOTECHNOL, DOI DOI 10.2777/23393; Palsson G, 2008, BIOBANKS GOVERNANCE, P41; Smith GD, 2005, LANCET, V366, P1484, DOI 10.1016/S0140-6736(05)67601-5; Trinidad SB, 2011, SCIENCE, V331, P287, DOI 10.1126/science.1199000; TUPASELA A, 2008, CONSENT PRACTICES BI	5	51	51	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					159	160		10.1038/471159a	http://dx.doi.org/10.1038/471159a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FK	21390108	Bronze			2022-12-28	WOS:000288170200014
J	Nabel, GJ; Wei, CJ; Ledgerwood, JE				Nabel, Gary J.; Wei, Chih-Jen; Ledgerwood, Julie E.			Vaccinate for the next H2N2 pandemic now	NATURE			English	Editorial Material							INFLUENZA-VIRUSES		[Nabel, Gary J.; Wei, Chih-Jen; Ledgerwood, Julie E.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Nabel, GJ (corresponding author), NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA.	gnabel@nih.gov	Wei, Chih/GVT-5734-2022		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005047] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen GL, 2010, J VIROL, V84, P7695, DOI 10.1128/JVI.00511-10; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; Kaverin NV, 2000, ARCH VIROL, V145, P1059, DOI 10.1007/s007050070109; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; Stohr K, 2010, NATURE, V465, P161, DOI 10.1038/465161a; Webster Robert G., 1997, Journal of Infectious Diseases, V176, pS14, DOI 10.1086/514168; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	10	53	55	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					157	158		10.1038/471157a	http://dx.doi.org/10.1038/471157a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FK	21390107	Bronze			2022-12-28	WOS:000288170200013
J	Pallais, JC; Mackool, BT; Pitman, MB				Pallais, J. Carl; Mackool, Bonnie T.; Pitman, Martha Bishop			Case 7-2011: A 52-Year-Old Man with Upper Respiratory Symptoms and Low Oxygen Saturation Levels	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUTEN-FREE DIET; DERMATITIS-HERPETIFORMIS; DIABETIC-PATIENT; CELIAC-DISEASE; BLOOD-GLUCOSE; DAPSONE; METHEMOGLOBINEMIA; TRANSGLUTAMINASE; FRUCTOSAMINE; DIAGNOSIS		[Pallais, J. Carl] Massachusetts Gen Hosp, Dept Med, Div Endocrinol, Boston, MA 02114 USA; [Mackool, Bonnie T.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Pitman, Martha Bishop] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mackool, Bonnie T.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Pallais, J. Carl] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Pitman, Martha Bishop] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Pallais, JC (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Endocrinol, Boston, MA 02114 USA.							Albright Eric S, 2002, Endocr Pract, V8, P370; Alonso-Llamazares J, 2007, INT J DERMATOL, V46, P910, DOI 10.1111/j.1365-4632.2007.03214.x; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153; Ash-Bernal R, 2004, MEDICINE, V83, P265, DOI 10.1097/01.md.0000141096.00377.3f; BARKER SJ, 1989, ANESTHESIOLOGY, V70, P112, DOI 10.1097/00000542-198901000-00021; BERTHOLON M, 1994, DIABETES CARE, V17, P1364, DOI 10.2337/diacare.17.11.1364a; Bloomgarden Zachary T, 2009, Diabetes Care, V32, pe141, DOI 10.2337/dc09-zb12; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; Caproni M, 2009, J EUR ACAD DERMATOL, V23, P633, DOI 10.1111/j.1468-3083.2009.03188.x; CHORZELSKI TP, 1979, BRIT J DERMATOL, V101, P535, DOI 10.1111/j.1365-2133.1979.tb11882.x; Cohen RM, 2008, CURR OPIN CLIN NUTR, V11, P512, DOI 10.1097/MCO.0b013e32830467bd; COLEMAN MD, 1993, BRIT J DERMATOL, V129, P507, DOI 10.1111/j.1365-2133.1993.tb00476.x; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Duhring LA, 1884, JAMA-J AM MED ASSOC, VIII, P225; Egan CA, 1997, IRISH J MED SCI, V166, P241, DOI 10.1007/BF02944243; Froud T, 2007, TRANSPLANTATION, V83, P824, DOI 10.1097/01.tp.0000257918.71325.07; FRY L, 1974, BRIT J DERMATOL, V90, P137, DOI 10.1111/j.1365-2133.1974.tb06377.x; FRY L, 1969, ARCH DERMATOL, V100, P129, DOI 10.1001/archderm.100.2.129; FRY L, 1967, LANCET, V2, P729; FRY L, 1968, LANCET, V1, P557; FRY L, 1972, BMJ-BRIT MED J, V3, P371, DOI 10.1136/bmj.3.5823.371; GALVEZ L, 1991, CLIN DERMATOL, V9, P325, DOI 10.1016/0738-081X(91)90023-E; GARIOCH JJ, 1994, BRIT J DERMATOL, V131, P541; GAWKRODGER DJ, 1993, BRIT J DERMATOL, V129, P694, DOI 10.1111/j.1365-2133.1993.tb03333.x; GAWKRODGER DJ, 1984, GUT, V25, P151, DOI 10.1136/gut.25.2.151; Guay J, 2009, ANESTH ANALG, V108, P837, DOI 10.1213/ane.0b013e318187c4b1; Hardman CMJ, 1997, NEW ENGL J MED, V337, P1884, DOI 10.1056/NEJM199712253372604; Haymond S, 2005, CLIN CHEM, V51, P434, DOI 10.1373/clinchem.2004.035154; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; JOLLOW DJ, 1995, DRUG METAB REV, V27, P107, DOI 10.3109/03602539509029818; KATZ SI, 1980, ANN INTERN MED, V93, P857, DOI 10.7326/0003-4819-93-6-857; KK T, 1989, ANESTHESIOLOGY, V70, P98; LEONARD JN, 1991, CLIN DERMATOL, V9, P403, DOI 10.1016/0738-081X(91)90032-G; Lewis HM, 1996, BRIT J DERMATOL, V135, P363; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; Marietta EV, 2008, J INVEST DERMATOL, V128, P332, DOI 10.1038/sj.jid.5701041; Mendlovic D B, 1992, Henry Ford Hosp Med J, V40, P149; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nathan DM, 2009, DIABETES CARE, V32, P207; *NGSP, 2010, FACT INT GHB HBA1C T; Paniker U, 2001, DERMATOL CLIN, V19, P79, DOI 10.1016/S0733-8635(05)70231-X; Pierson D J, 2000, Respir Care, V45, P39; PINK IJ, 1967, LANCET, V1, P300; Sardy M, 2002, J EXP MED, V195, P747, DOI 10.1084/jem.20011299; Saudek CD, 2006, JAMA-J AM MED ASSOC, V295, P1688, DOI 10.1001/jama.295.14.1688; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Serratrice J, 2002, DIABETES METAB, V28, P508; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; STALEY MJ, 1987, CLIN CHEM, V33, P2326; Tack CJJ, 1996, DIABETES CARE, V19, P775, DOI 10.2337/diacare.19.7.775; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Wright RO, 1999, ANN EMERG MED, V34, P646, DOI 10.1016/S0196-0644(99)70167-8; Zur B, 2008, CLIN CHEM, V54, P594, DOI 10.1373/clinchem.2007.095158; 2004, N ENGL J MED, V351, P380	58	13	13	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					957	966		10.1056/NEJMcpc1013923	http://dx.doi.org/10.1056/NEJMcpc1013923			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21388314				2022-12-28	WOS:000288170300014
J	Pasqualucci, L; Dominguez-Sola, D; Chiarenza, A; Fabbri, G; Grunn, A; Trifonov, V; Kasper, LH; Lerach, S; Tang, HY; Ma, J; Rossi, D; Chadburn, A; Murty, VV; Mullighan, CG; Gaidano, G; Rabadan, R; Brindle, PK; Dalla-Favera, R				Pasqualucci, Laura; Dominguez-Sola, David; Chiarenza, Annalisa; Fabbri, Giulia; Grunn, Adina; Trifonov, Vladimir; Kasper, Lawryn H.; Lerach, Stephanie; Tang, Hongyan; Ma, Jing; Rossi, Davide; Chadburn, Amy; Murty, Vundavalli V.; Mullighan, Charles G.; Gaidano, Gianluca; Rabadan, Raul; Brindle, Paul K.; Dalla-Favera, Riccardo			Inactivating mutations of acetyltransferase genes in B-cell lymphoma	NATURE			English	Article							CREB-BINDING-PROTEIN; ACUTE MYELOID-LEUKEMIA; CYCLE ARREST; CBP; P300; P53; TRANSCRIPTION; COACTIVATOR; ACETYLATION; HEMATOPOIESIS	B-cell non-Hodgkin's lymphoma comprises biologically and clinically distinct diseases the pathogenesis of which is associated with genetic lesions affecting oncogenes and tumour-suppressor genes. We report here that the two most common types-follicular lymphoma and diffuse large B-cell lymphoma-harbour frequent structural alterations inactivating CREBBP and, more rarely, EP300, two highly related histone and non-histone acetyltransferases (HATs) that act as transcriptional co-activators in multiple signalling pathways. Overall, about 39% of diffuse large B-cell lymphoma and 41% of follicular lymphoma cases display genomic deletions and/or somatic mutations that remove or inactivate the HAT coding domain of these two genes. These lesions usually affect one allele, suggesting that reduction in HAT dosage is important for lymphomagenesis. We demonstrate specific defects in acetylation-mediated inactivation of the BCL6 oncoprotein and activation of the p53 tumour suppressor. These results identify CREBBP/EP300 mutations as a major pathogenetic mechanism shared by common forms of B-cell non-Hodgkin's lymphoma, with direct implications for the use of drugs targeting acetylation/deacetylation mechanisms.	[Pasqualucci, Laura; Dominguez-Sola, David; Chiarenza, Annalisa; Fabbri, Giulia; Grunn, Adina; Tang, Hongyan; Murty, Vundavalli V.; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Pasqualucci, Laura; Dominguez-Sola, David; Chiarenza, Annalisa; Fabbri, Giulia; Grunn, Adina; Tang, Hongyan; Murty, Vundavalli V.; Dalla-Favera, Riccardo] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Pasqualucci, Laura; Murty, Vundavalli V.; Dalla-Favera, Riccardo] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Trifonov, Vladimir; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Trifonov, Vladimir; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Kasper, Lawryn H.; Lerach, Stephanie; Brindle, Paul K.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, Div Hematol, Dept Clin & Expt Med, I-28100 Novara, Italy; [Rossi, Davide; Gaidano, Gianluca] Amedeo Avogadro Univ Eastern Piedmont, IRCAD, I-28100 Novara, Italy; [Chadburn, Amy] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Dalla-Favera, Riccardo] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Northwestern University; Feinberg School of Medicine; St Jude Children's Research Hospital; Columbia University	Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	lp171@columbia.edu; rd10@columbia.edu	Gaidano, Gianluca/AAW-2773-2021; Rabadan, Raul/AAZ-7367-2020; Mullighan, Charles/H-3253-2011; Chiarenza, Annalisa/AAC-2013-2019; Kasper, Lawryn/GWV-5700-2022	Gaidano, Gianluca/0000-0002-4681-0151; Mullighan, Charles/0000-0002-1871-1850; Chiarenza, Annalisa/0000-0002-8759-4854; Dominguez-Sola, David/0000-0001-9569-8402; Brindle, Paul/0000-0001-7172-8478; Rabadan, Raul/0000-0001-7946-9255	NIH [PO1-CA092625, RO1-CA37295, DE018183]; Leukemia and Lymphoma Society; Cancer Center (CORE) [P30 CA021765]; American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital; Northeast Biodefence Center [U54-AI057158]; National Library of Medicine [1R01LM010140-01]; AIRC [10007]; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA037295, R37CA037295, P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018183] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cancer Center (CORE); American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Northeast Biodefence Center; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Q. Shen and the Molecular Pathology Shared Resource of the Herbert Irving Comprehensive Cancer Center at Columbia University for histology service; W. Gu for discussions and reagents; Y. Tang, M. Li and D. Chao for suggestions; V. Bardwell for the Bcl6 reporter construct; and R. S. K. Chaganti for sharing unpublished information. Whole-exome capture and sequencing were conducted at Roche NimbleGen and 454 Life Sciences. Automated DNA sequencing was performed at Genewiz Inc. This work was supported by NIH grants PO1-CA092625 and RO1-CA37295 (to R.D.-F.), a Specialized Center of Research grant from the Leukemia and Lymphoma Society (to R.D.-F.), NIH grant DE018183, a Cancer Center (CORE) support grant P30 CA021765, and the American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital (to P.K.B.), the Northeast Biodefence Center (U54-AI057158) and the National Library of Medicine(1R01LM010140-01) (to R.R.), and the AIRC Special Program Molecular Clinical Oncology-5 per mille (contract number 10007, Milan) (to G.G.). A. Chiarenza is on leave from the Division of Hematology, Ospedale Ferrarotto, University of Catania, Catania, Italy. L.P. is on leave from the University of Perugia Medical School, Perugia, Italy.	Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bieber T, 2001, BIOTECHNIQUES, V30, P74, DOI 10.2144/01301st03; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Bordoli L, 2001, NUCLEIC ACIDS RES, V29, P4462, DOI 10.1093/nar/29.21.4462; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Downing JR, 2009, NEW ENGL J MED, V361, P1111, DOI 10.1056/NEJMe0906090; Garbati MR, 2010, CANCER LETT, V291, P237, DOI 10.1016/j.canlet.2009.10.018; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Huynh KD, 2000, GENE DEV, V14, P1810; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kung AL, 2000, GENE DEV, V14, P272; Kuninger D, 2007, J BIOTECHNOL, V131, P253, DOI 10.1016/j.jbiotec.2007.07.498; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; MILLER RW, 1995, AM J MED GENET, V56, P112, DOI 10.1002/ajmg.1320560125; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oike Y, 1999, BLOOD, V93, P2771; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Roelfsema Jeroen H., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000415; Rowley JD, 1997, BLOOD, V90, P535; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Shigeno K, 2004, CANCER LETT, V213, P11, DOI 10.1016/S0304-3835(03)00442-7; Sobulo OM, 1997, P NATL ACAD SCI USA, V94, P8732, DOI 10.1073/pnas.94.16.8732; Stimson L, 2009, ANN ONCOL, V20, P1293, DOI 10.1093/annonc/mdn792; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Ward R, 2005, J MED GENET, V42, P514, DOI 10.1136/jmg.2004.025080; Xu W, 2006, BLOOD, V107, P4407, DOI 10.1182/blood-2005-08-3263; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	49	633	660	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					189	U75		10.1038/nature09730	http://dx.doi.org/10.1038/nature09730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390126	Green Published, Green Accepted			2022-12-28	WOS:000288170200031
J	Nuesch, E; Dieppe, P; Reichenbach, S; Williams, S; Iff, S; Juni, P				Nueesch, Eveline; Dieppe, Paul; Reichenbach, Stephan; Williams, Susan; Iff, Samuel; Jueni, Peter			All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RHEUMATOID-ARTHRITIS; CARDIOVASCULAR-DISEASE; MULTIPLE IMPUTATION; REPLACEMENT SURGERY; ASSOCIATION; PAIN; PREVALENCE; DISABILITY; INFLAMMATION; REQUIREMENT	Objective To examine all cause and disease specific mortality in patients with osteoarthritis of the knee or hip. Design Population based cohort study. Setting General practices in the southwest of England. Participants 1163 patients aged 35 years or over with symptoms and radiological confirmation of osteoarthritis of the knee or hip. Main outcome measures Age and sex standardised mortality ratios and multivariable hazard ratios of death after a median of 14 years' follow-up. Results Patients with osteoarthritis had excess all cause mortality compared with the general population (standardised mortality ratio 1.55, 95% confidence interval 1.41 to 1.70). Excess mortality was observed for all disease specific causes of death but was particularly pronounced for cardiovascular (standardised mortality ratio 1.71, 1.49 to 1.98) and dementia associated mortality (1.99, 1.22 to 3.25). Mortality increased with increasing age (P for trend <0.001), male sex (adjusted hazard ratio 1.59, 1.30 to 1.96), self reported history of diabetes (1.95, 1.31 to 2.90), cancer (2.28, 1.50 to 3.47), cardiovascular disease (1.38, 1.12 to 1.71), and walking disability (1.48, 1.17 to 1.86). However, little evidence existed for increased mortality associated with previous joint replacement, obesity, depression, chronic inflammatory disease, eye disease, or presence of pain at baseline. The more severe the walking disability, the higher was the risk of death (P for trend <0.001). Conclusion Patients with osteoarthritis are at higher risk of death compared with the general population. History of diabetes, cancer, or cardiovascular disease and the presence of walking disability are major risk factors. Management of patients with osteoarthritis and walking disability should focus on effective treatment of cardiovascular risk factors and comorbidities, as well as on increasing physical activity.	[Nueesch, Eveline; Reichenbach, Stephan; Iff, Samuel; Jueni, Peter] Univ Bern, ISPM, CH-3012 Bern, Switzerland; [Nueesch, Eveline; Iff, Samuel; Jueni, Peter] Univ Hosp Bern, CTU Bern, CH-3010 Bern, Switzerland; [Dieppe, Paul] Univ Exeter, Peninsula Med Sch, Inst Clin Educ, Exeter EX4 4QJ, Devon, England; [Dieppe, Paul] Univ Plymouth, Peninsula Med Sch, Inst Clin Educ, Plymouth PL4 8AA, Devon, England; [Reichenbach, Stephan] Univ Hosp Bern, Dept Rheumatol Clin Immunol & Allergol, CH-3010 Bern, Switzerland; [Williams, Susan] Univ Bristol, Dept Social Med, Bristol, Avon, England	University of Bern; University of Bern; University Hospital of Bern; University of Exeter; University of Plymouth; University of Bern; University Hospital of Bern; University of Bristol	Juni, P (corresponding author), Univ Bern, ISPM, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Juni, Peter/Q-8700-2016; Iff, Samuel/AAJ-4998-2020; Hug, Balthasar L./G-1568-2010	Juni, Peter/0000-0002-5985-0670; Iff, Samuel/0000-0002-4441-5465; Reichenbach, Stephan/0000-0001-8098-6567	Department of Health; South and West NHS Research and Development Directorate; Swiss National Science Foundation [3233-066377, 3200-066378]; Arthritis Research UK	Department of Health; South and West NHS Research and Development Directorate; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Arthritis Research UK(Versus Arthritis)	The Somerset and Avon Survey of Health was originally funded by the Department of Health and the South and West NHS Research and Development Directorate. This work was funded by the Swiss National Science Foundation (grant numbers 3233-066377 and 3200-066378) and by Arthritis Research UK. The funding bodies had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Abramson SB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2655; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bellocco R, 2010, EUR J EPIDEMIOL, V25, P777, DOI 10.1007/s10654-010-9497-6; CERHAN JR, 1995, AM J EPIDEMIOL, V141, P225, DOI 10.1093/oxfordjournals.aje.a117424; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Cisternas MG, 2009, ARTHRIT RHEUM-ARTHR, V61, P1694, DOI 10.1002/art.24897; Couzin-Frankel J, 2010, SCIENCE, V330, P1621, DOI 10.1126/science.330.6011.1621; Eachus J, 1996, BMJ-BRIT MED J, V312, P287; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Frankel S, 1999, LANCET, V353, P1304, DOI 10.1016/S0140-6736(98)06451-4; Fransen M, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004376.PUB2; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Haara MM, 2004, J BONE JOINT SURG AM, V86A, P1452, DOI 10.2106/00004623-200407000-00013; Haara MM, 2003, ANN RHEUM DIS, V62, P151, DOI 10.1136/ard.62.2.151; Hernandez-Molina G, 2008, ARTHRIT RHEUM-ARTHR, V59, P1221, DOI 10.1002/art.24010; Hochber MC, 2008, CLIN EXP RHEUMATOL, V26, pS120; Holtermann A, 2010, SCAND J WORK ENV HEA, V36, P366, DOI 10.5271/sjweh.2914; Jenkinson CM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3170; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Juni P, 2010, OSTEOARTHR CARTILAGE, V18, P640, DOI 10.1016/j.joca.2009.12.010; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Juni P, 2003, RHEUMATOLOGY, V42, P516, DOI 10.1093/rheumatology/keg196; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kumar N, 2007, J RHEUMATOL, V34, P1695; Landi F, 2010, J CLIN EPIDEMIOL, V63, P752, DOI 10.1016/j.jclinepi.2009.09.007; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lawrence RC, 1990, HLTH STATUS WELL BEI, P136; MCALINDON TE, 1992, BRIT J RHEUMATOL, V31, P189; MONSON RR, 1976, J CHRON DIS, V29, P459, DOI 10.1016/0021-9681(76)90086-2; Myasoedova Elena, 2010, Curr Rheumatol Rep, V12, P379, DOI 10.1007/s11926-010-0117-y; Penninx BWJH, 2002, J GERONTOL B-PSYCHOL, V57, pP124, DOI 10.1093/geronb/57.2.P124; Reichenbach S, 2011, ANN RHEUM DIS, V70, P293, DOI 10.1136/ard.2010.132985; Robertsson O, 2007, J BONE JOINT SURG BR, V89B, P599, DOI 10.1302/0301-620X.89B5.18355; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Snow MH, 2005, CURR OPIN RHEUMATOL, V17, P234; Stannus O, 2010, OSTEOARTHR CARTILAGE, V18, P1441, DOI 10.1016/j.joca.2010.08.016; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Wagenmakers R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-141; Wagner P, 2011, EUR J CANC      0110; Watson DJ, 2003, J RHEUMATOL, V30, P1196; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	45	426	432	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2011	342								d1165	10.1136/bmj.d1165	http://dx.doi.org/10.1136/bmj.d1165			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UY	21385807	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000288446800005
J	Rosenheck, RA; Krystal, JH; Lew, R; Barnett, PG; Fiore, L; Valley, D; Thwin, SS; Vertrees, JE; Liang, MH				Rosenheck, Robert A.; Krystal, John H.; Lew, Robert; Barnett, Paul G.; Fiore, Louis; Valley, Danielle; Thwin, Soe Soe; Vertrees, Julia E.; Liang, Matthew H.		CSP555 Res Grp	Long-Acting Risperidone and Oral Antipsychotics in Unstable Schizophrenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INJECTABLE RISPERIDONE; OPEN-LABEL; SCALE; EFFICACY; SAFETY; RELIABILITY; RELAPSE; ACCEPTABILITY; INSTRUMENT; MEDICATION	BACKGROUND Long-acting injectable risperidone, a second-generation antipsychotic agent, may improve adherence to treatment and outcomes in schizophrenia, but it has not been tested in a long-term randomized trial involving patients with unstable disease. METHODS We randomly assigned patients in the Veterans Affairs (VA) system who had schizophrenia or schizoaffective disorder and who had been hospitalized within the previous 2 years or were at imminent risk for hospitalization to 25 to 50 mg of long-acting injectable risperidone every two weeks or to a psychiatrist's choice of an oral antipsychotic. All patients were followed for up to 2 years. The primary end point was hospitalization in a VA or non-VA psychiatric hospital. Symptoms, quality of life, and functioning were assessed in blinded videoconference interviews. RESULTS Of 369 participants, 40% were hospitalized at randomization, 55% were hospitalized within the previous 2 years, and 5% were at risk for hospitalization. The rate of hospitalization after randomization was not significantly lower among patients who received long-acting injectable risperidone than among those who received oral antipsychotics (39% after 10.8 months vs. 45% after 11.3 months; hazard ratio, 0.87; 95% confidence interval, 0.63 to 1.20). Psychiatric symptoms, quality of life, scores on the Personal and Social Performance scale of global functioning, and neurologic side effects were not significantly improved with long-acting injectable risperidone as compared with control treatments. Patients who received long-acting injectable risperidone reported more adverse events at the injection site and more extrapyramidal symptoms. CONCLUSIONS Long-acting injectable risperidone was not superior to a psychiatrist's choice of oral treatment in patients with schizophrenia and schizoaffective disorder who were hospitalized or at high risk for hospitalization, and it was associated with more local injection-site and extrapyramidal adverse effects.	[Rosenheck, Robert A.; Krystal, John H.] VA Connecticut Healthcare Syst, Res Educ & Clin Ctr, VA New England Mental Illness, West Haven, CT USA; [Rosenheck, Robert A.; Krystal, John H.] Yale Univ, Sch Med, New Haven, CT USA; [Lew, Robert; Fiore, Louis; Valley, Danielle; Thwin, Soe Soe; Liang, Matthew H.] Massachusetts Vet Epidemiol & Res Informat Ctr, VA Cooperat Studies Program, Coordinating Ctr, Boston, MA USA; [Barnett, Paul G.] VA Hlth Econ Resource Ctr, Menlo Pk, CA USA; [Vertrees, Julia E.] Clin Res Pharm Coordinating Ctr, VA Cooperat Studies Program, Albuquerque, NM USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Rosenheck, RA (corresponding author), VA Connecticut Healthcare Syst 151D, Res Educ & Clin Ctr, VA New England Mental Illness, 950 Campbell Ave, West Haven, CT 06516 USA.	robert.rosenheck@va.gov			Veterans Affairs Cooperative Studies Program; Ortho-McNeil Janssen Scientific Affairs	Veterans Affairs Cooperative Studies Program(US Department of Veterans Affairs); Ortho-McNeil Janssen Scientific Affairs(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Supported by the Veterans Affairs Cooperative Studies Program and an unrestricted grant from Ortho-McNeil Janssen Scientific Affairs.	Adams CE, 2001, BRIT J PSYCHIAT, V179, P290, DOI 10.1192/bjp.179.4.290; Angus J, 1970, ACTA PSYCHIAT SCAND, V212, pS11; Bai YM, 2007, J CLIN PSYCHIAT, V68, P1218, DOI 10.4088/JCP.v68n0808; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; Chue P, 2005, EUR NEUROPSYCHOPHARM, V15, P111, DOI 10.1016/j.euroneuro.2004.07.003; Csernansky JG, 2002, NEW ENGL J MED, V346, P16, DOI 10.1056/NEJMoa002028; DAVIS JM, 1994, DRUGS, V47, P741, DOI 10.2165/00003495-199447050-00004; Derogatis LR, 1982, BRIEF SYMPTOM INDEX; First M.B., 2014, STRUCTURED CLIN INTE; Fleischhacker WW, 2009, BRIT J PSYCHIAT, V195, pS29, DOI 10.1192/bjp.195.52.s29; Fleischhacker WW, 2003, J CLIN PSYCHIAT, V64, P1250, DOI 10.4088/JCP.v64n1017; GRISSO T, 1995, MACARTHUR COMPETENCE; Guy W., 1976, ECDEU ASSESSMENT MAN, P534; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; HERZ MI, 1991, ARCH GEN PSYCHIAT, V48, P333; HOGAN TP, 1983, PSYCHOL MED, V13, P177, DOI 10.1017/S0033291700050182; HOGARTY GE, 1979, ARCH GEN PSYCHIAT, V36, P1283; Kane JM, 2003, AM J PSYCHIAT, V160, P1125, DOI 10.1176/appi.ajp.160.6.1125; KAPLAN RM, 1996, QUALITY LIFE PHARMAC, P309; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keith SJ, 2004, PSYCHIAT SERV, V55, P997, DOI 10.1176/appi.ps.55.9.997; Keks NA, 2007, BRIT J PSYCHIAT, V191, P131, DOI 10.1192/bjp.bp.105.017020; Lehman AF, 2004, SCHIZOPHRENIA BULL, V30, P193, DOI 10.1093/oxfordjournals.schbul.a007071; Lindenmayer JP, 2004, J CLIN PSYCHIAT, V65, P1084; MARDER SR, 1994, AM J PSYCHIAT, V151, P825; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Miyamoto S., 2002, NEUROPSYCHOPHARMACOL, P775; Moller HJ, 2005, INT CLIN PSYCHOPHARM, V20, P121; Morosini PL, 2000, ACTA PSYCHIAT SCAND, V101, P323, DOI 10.1111/j.1600-0447.2000.tb10933.x; Nesvag R, 2005, NORD J PSYCHIAT, V59, P51, DOI 10.1080/08039480510018832; Pyne JM, 2003, MED CARE, V41, P208, DOI 10.1097/00005650-200302000-00003; Rosenheck R, 1998, ARCH GEN PSYCHIAT, V55, P618, DOI 10.1001/archpsyc.55.7.618; Ruskin PE, 1998, PSYCHIATR SERV, V49, P1086, DOI 10.1176/ps.49.8.1086; Thieda P, 2003, PSYCHIAT SERV, V54, P508, DOI 10.1176/appi.ps.54.4.508; WEIDEN PJ, 1995, SCHIZOPHRENIA BULL, V21, P419, DOI 10.1093/schbul/21.3.419; Young J L, 1986, Bull Am Acad Psychiatry Law, V14, P105	36	184	188	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					842	851		10.1056/NEJMoa1005987	http://dx.doi.org/10.1056/NEJMoa1005987			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366475				2022-12-28	WOS:000287928400009
J	Appleby, J				Appleby, John			Data briefing What's happening to waiting times?	BRITISH MEDICAL JOURNAL			English	Editorial Material												j.appleby@kingsfund.org.uk						Appleby J, 2010, BRIT SOCIAL ATTITUDE; Burge P, 2006, UNDERSTANDING PATIEN; *DEP HLTH, 2011, DIAGN LAT DAT; *DEP HLTH, 2011, REF TREATM WAIT TIM; *DEP HLTH, 2011, HIST TIM SER WAIT TI; Department of Health, 2010, NHS CONST; Department of Health, 2010, REV OP FRAM NHS ENGL; Department of Health, 2009, HDB NHS CONST; *KINGS FUND, 2011, HOSP WAIT TIM TRACK	9	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 1	2011	342								d1235	10.1136/bmj.d1235	http://dx.doi.org/10.1136/bmj.d1235			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732ED	21363866				2022-12-28	WOS:000288166600001
J	Ruan, YJ				Ruan, Yijun			Presenting the Human Genome: Now in 3D!	SCIENCE			English	Editorial Material									Genome Inst Singapore, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ruan, YJ (corresponding author), Genome Inst Singapore, Singapore, Singapore.								0	1	3	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1025	1026		10.1126/science.1203602	http://dx.doi.org/10.1126/science.1203602			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350163				2022-12-28	WOS:000287699000047
J	Douketis, J; Tosetto, A; Marcucci, M; Baglin, T; Cosmi, B; Cushman, M; Kyrle, P; Poli, D; Tait, RC; Iorio, A				Douketis, James; Tosetto, Alberto; Marcucci, Maura; Baglin, Trevor; Cosmi, Benilde; Cushman, Mary; Kyrle, Paul; Poli, Daniela; Tait, R. Campbell; Iorio, Alfonso			Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORAL ANTICOAGULANT-THERAPY; DEEP-VEIN THROMBOSIS; D-DIMER; 1ST EPISODE; METABOLIC SYNDROME; PULMONARY-EMBOLISM; GENDER BIAS; SEX; DURATION; WARFARIN	Objective To determine the effect of sex on the risk of recurrent venous thromboembolism in all patients and in patients with venous thromboembolism that was unprovoked or provoked (by non-hormonal factors). Data source Comprehensive search of electronic databases (Medline, Embase, CINAHL, Cochrane Central Register of Controlled Trials) until July 2010, supplemented by review of conference abstracts and contact with content experts. Study selection Seven prospective studies investigating an association between D-dimer, measured after anticoagulation was stopped, and disease recurrence in patients with venous thromboembolism. Data extraction Patient level databases were obtained, transferred to a central database, checked, and completed with further information provided by authors. Data synthesis 2554 patients with a first venous thromboembolism had follow-up for a mean of 27.1 (SD 19.6) months. The one year incidence of recurrent venous thromboembolism was 5.3% (95% confidence interval 4.1% to 6.7%) in women and 9.5% (7.9% to 11.4%) in men, and the three year incidence of recurrence was 9.1% (7.3% to 11.3%) in women and 19.7% (16.5% to 23.4%) in men. Among patients with unprovoked venous thromboembolism, men had a higher risk of recurrence than did women (hazard ratio 2.2, 95% confidence interval 1.7 to 2.8). After adjustment for women with hormone associated initial venous thromboembolism, the risk of recurrence remained higher in men (hazard ratio 1.8, 1.4 to 2.5). In patients with provoked venous thromboembolism, occurring after exposure to a major risk factor, recurrence of disease did not differ between men and women (hazard ratio 1.2, 0.6 to 2.4). In women with hormone associated venous thromboembolism and no other risk factors, recurrence was lower than that in women with unprovoked venous thromboembolism and no previous hormone use (hazard ratio 0.5, 0.3 to 0.8). Conclusion In patients with a first unprovoked venous thromboembolism, men have a 2.2-fold higher risk of recurrent venous thromboembolism than do women, which remained 1.8-fold higher in men after adjustment for previous hormone associated venous thromboembolism in women. In patients with a first provoked venous thromboembolism, risk of recurrence does not differ between men and women with or without hormone associated venous thromboembolism. Indefinite anticoagulation may be given greater consideration in men than in women after a first venous thromboembolism.				jdouket@mcmaster.ca	Cosmi, Benilde/K-9459-2016; Douketis, James/AAO-5659-2021; Tait, Robert/AAC-6541-2022; Tosetto, Alberto/AAB-9320-2022; Iorio, Alfonso/B-9478-2013; Tosetto, Alberto/AAM-3200-2020; Tait, Campbell/AFQ-8204-2022	Cosmi, Benilde/0000-0003-0606-6038; Tait, Robert/0000-0003-4842-6783; Iorio, Alfonso/0000-0002-3331-8766; Tosetto, Alberto/0000-0002-0119-5204; Tait, Campbell/0000-0003-4842-6783; Cushman, Mary/0000-0002-7871-6143	FCSA (Federazione dei Centri di Sorveglianza e Monitoraggio della Terapie Antitrombotiche) [4924, 4925]; Oesterreichische Nationalbank (Jubilaeumsfonds); Medizinisch-Wissenschaftlicher Fonds des Buergermeisters der Bundeshauptstadt Wien; Wiener Staedtische Versicherung [4923]; Chief Scientist Office, Scottish Executive Health Department [CZB/4/24, 4934]; US National Heart, Lung, and Blood Institute [HL-58036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058036, R01HL057951] Funding Source: NIH RePORTER	FCSA (Federazione dei Centri di Sorveglianza e Monitoraggio della Terapie Antitrombotiche); Oesterreichische Nationalbank (Jubilaeumsfonds); Medizinisch-Wissenschaftlicher Fonds des Buergermeisters der Bundeshauptstadt Wien; Wiener Staedtische Versicherung; Chief Scientist Office, Scottish Executive Health Department; US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Clive Kearon and Shannon Bates for their review of this manuscript. The authors reported the following sources of funding for the studies included in this meta-analysis: FCSA (Federazione dei Centri di Sorveglianza e Monitoraggio della Terapie Antitrombotiche)cit_bcit_af ref_bf(Palareti, 2003 ref_num4924 / Palareti, 2006 #4925)ref_af; Oesterreichische Nationalbank (Jubilaeumsfonds), the Medizinisch-Wissenschaftlicher Fonds des Buergermeisters der Bundeshauptstadt Wien, and the Wiener Staedtische Versicherungcit_cit_af ref_bf(Eichinger, 2003 ref_num4923)ref_af; Chief Scientist Office, Scottish Executive Health Department (grant CZB/4/24)cit_cit_af ref_bf(Tait, 2007 ref_num4934)ref_af; HL-57951 and HL-58036 from the US National Heart, Lung, and Blood Institute.	Ageno W, 2009, J THROMB HAEMOST, V7, P736, DOI 10.1111/j.1538-7836.2009.03327.x; Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Agnelli G, 2004, NEW ENGL J MED, V351, P2015; Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Agnelli G, 2008, J THROMB THROMBOLYS, V25, P37, DOI 10.1007/s11239-007-0103-z; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6; Andreou ER, 2008, J THROMB HAEMOST, V6, P1713, DOI 10.1111/j.1538-7836.2008.03110.x; Baglin T, 2008, J THROMB HAEMOST, V6, P577, DOI 10.1111/j.1538-7836.2008.02889.x; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016/S0140-6736(97)10018-6; BEEBE HG, 1995, J VASC SURG, V22, P538, DOI 10.1016/S0741-5214(95)70034-X; Borch KH, 2009, J THROMB HAEMOST, V7, P739, DOI 10.1111/j.1538-7836.2008.03234.x; Canonico M, 2008, BMJ-BRIT MED J, V336, P1227, DOI 10.1136/bmj.39555.441944.BE; Chan WS, 2009, ANN INTERN MED, V151, P85, DOI 10.7326/0003-4819-151-2-200907210-00004; Chang AM, 2007, ACAD EMERG MED, V14, P599, DOI 10.1197/j.aem.2007.03.1355; Christiansen SC, 2010, J THROMB HAEMOST, V8, P2159, DOI 10.1111/j.1538-7836.2010.03994.x; ClinicalTrials.gov, 2011, CLIN DEC RUL VAL STU; Cushman M, 2006, J THROMB HAEMOST, V4, P2199, DOI 10.1111/j.1538-7836.2006.02140.x; Douketis JD, 2009, J THROMB HAEMOST, V7, P546, DOI 10.1111/j.1538-7836.2008.03268.x; Douketis J, 2010, ANN INTERN MED, V153, P523, DOI 10.7326/0003-4819-153-8-201010190-00009; Douketis JD, 1997, ARCH INTERN MED, V157, P1522, DOI 10.1001/archinte.157.14.1522; Eichinger S, 2003, JAMA-J AM MED ASSOC, V290, P1071, DOI 10.1001/jama.290.8.1071; Eichinger S, 2009, J THROMB HAEMOST, V7, P291, DOI 10.1111/j.1538-7836.2009.03383.x; Franzeck UK, 1996, CIRCULATION, V93, P74, DOI 10.1161/01.CIR.93.1.74; GILLUM RF, 1987, AM HEART J, V114, P1262, DOI 10.1016/0002-8703(87)90212-2; Gjores JE, 1993, ACTA CHIR SCAND S206, V111, P16; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Kahn SR, 1999, THROMB HAEMOSTASIS, V81, P353; Kearon C, 2004, J THROMB HAEMOST, V2, P743, DOI 10.1046/j.1538-7836.2004.00698.x; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Le Gal G, 2010, THROMB HAEMOSTASIS, V104, P498, DOI 10.1160/TH09-10-0685; LEVINE MN, 1995, THROMB HAEMOSTASIS, V74, P606; Lijfering WM, 2009, BLOOD, V114, P2031, DOI 10.1182/blood-2009-04-215418; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; Merlin T, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-34; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Oger E, 2006, J THROMB HAEMOST, V4, P793, DOI 10.1111/j.1538-7836.2006.01856.x; Oudega R, 2005, FAM PRACT, V22, P86, DOI 10.1093/fampra/cmh718; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Pengo V, 2006, LANCET, V368, P342, DOI 10.1016/S0140-6736(06)69083-1; Piccioli A, 2004, J THROMB HAEMOST, V2, P884, DOI 10.1111/j.1538-7836.2004.00720.x; Piovella F, 2002, HAEMATOLOGICA, V87, P515; Poli D, 2008, J THROMB HAEMOST, V6, P708, DOI 10.1111/j.1538-7836.2008.02900.x; Prandoni P, 2007, J THROMB HAEMOST, V5, P270, DOI 10.1111/j.1538-7836.2007.02467.x; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Schulman S, 2000, NEW ENGL J MED, V342, P1953, DOI 10.1056/NEJM200006293422604; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Shrivastava S, 2006, J THROMB HAEMOST, V4, P1208, DOI 10.1111/j.1538-7836.2006.01935.x; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; Spencer FA, 2009, J THROMB THROMBOLYS, V28, P401, DOI 10.1007/s11239-009-0378-3; Spencer FA, 2009, THROMB HAEMOSTASIS, V101, P878, DOI 10.1160/TH08-06-0352; Steffen LM, 2009, J THROMB HAEMOST, V7, P746, DOI 10.1111/j.1538-7836.2009.03295.x; Sud S, 2009, ANN INTERN MED, V151, DOI 10.7326/0003-4819-151-2-200907210-02002; Tait R, 2007, J THROMB HAEMOST S2, V5, pO; Tosetto A, 2009, J THROMB HAEMOST S2, V7, pOC; Verhovsek M, 2008, ANN INTERN MED, V149, P481, DOI 10.7326/0003-4819-149-7-200810070-00008; White RH, 2005, THROMB HAEMOSTASIS, V93, P298, DOI 10.1160/TH04-08-0506; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; White RH, 2009, THROMB RES, V123, pS11, DOI 10.1016/S0049-3848(09)70136-7	70	169	174	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2011	342								d813	10.1136/bmj.d813	http://dx.doi.org/10.1136/bmj.d813			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729BE	21349898	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000287920900011
J	Nolan, T				Nolan, Tom			Technology A smarter way to practise	BRITISH MEDICAL JOURNAL			English	Editorial Material												tom@tnolan.co.uk						*APPL, DOYL HOSP; Department of Health, 2009, US MOB PHON NHS HOSP; *ENGADG, 2011, IDC SAYS 100 9M SMAR; *MED HEALTHC PROD, MED MOB COMM INT; Morgan M, 2010, BRIT J HOSP MED, V71, P461, DOI 10.12968/hmed.2010.71.8.77670; Research2Guidance, 2010, GLOB SMARTPH APPL MA; 2009, MOBIHEALTHNEWS  0209	7	14	14	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 22	2011	342								d1124	10.1136/bmj.d1124	http://dx.doi.org/10.1136/bmj.d1124			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AS	21343189				2022-12-28	WOS:000287919000002
J	Hersh, W				Hersh, William			Time to catch up with the pack	NATURE			English	Editorial Material									Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Hersh, W (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.		Hersh, William/AAH-6106-2019; Embi, Peter J/J-5078-2012	Hersh, William/0000-0002-4114-5148; Payne, Philip/0000-0002-9532-2998					0	13	14	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2011	470	7334					327	328		10.1038/470327a	http://dx.doi.org/10.1038/470327a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722CS	21331020				2022-12-28	WOS:000287409100012
J	Williams, SE; Beronja, S; Pasolli, HA; Fuchs, E				Williams, Scott E.; Beronja, Slobodan; Pasolli, H. Amalia; Fuchs, Elaine			Asymmetric cell divisions promote Notch-dependent epidermal differentiation	NATURE			English	Article							REGULATES SPINDLE ORIENTATION; STEM-CELLS; PLANAR DIVISIONS; DROSOPHILA; PROTEIN; NUMA; LGN; POLARITY; FATE; PINS	Stem and progenitor cells use asymmetric cell divisions to balance proliferation and differentiation. Evidence from invertebrates shows that this process is regulated by proteins asymmetrically distributed at the cell cortex during mitosis: Par3-Par6-aPKC, which confer polarity, and G alpha(i)-LGN/AGS3-NuMA-dynein/dynactin, which govern spindle positioning. Here we focus on developing mouse skin, where progenitor cells execute a switch from symmetric to predominantly asymmetric divisions concomitant with stratification. Using in vivo skin-specific lentiviral RNA interference, we investigate spindle orientation regulation and provide direct evidence that LGN (also called Gpsm2), NuMA and dynactin (Dctn1) are involved. In compromising asymmetric cell divisions, we uncover profound defects in stratification, differentiation and barrier formation, and implicate Notch signalling as an important effector. Our study demonstrates the efficacy of applying RNA interference in vivo to mammalian systems, and the ease of uncovering complex genetic interactions, here to gain insights into how changes in spindle orientation are coupled to establishing proper tissue architecture during skin development.	[Williams, Scott E.; Beronja, Slobodan; Pasolli, H. Amalia; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Beronja, Slobodan/0000-0002-6769-9261; Pasolli, Hilda Amalia/0000-0003-3899-3530; Williams, Scott/0000-0001-9975-7334	National Institutes of Health [R01AR27883]; American Cancer Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452, R01AR027883, R37AR027883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank N. Stokes, L. Polak and D. Oristian for their assistance in the mouse facility; S. Lanier and T. Gettys for providing AGS3 and G alpha<INF>i</INF> antibodies; N. Gaiano and C. Cepko for constructs; D. Melton and T. Honjo for mice; S. Chai for Numb constructs; E. Ezhkova for sharing microarray data; and J. Knoblich for sharing unpublished results and reagents. We are grateful to M. Schober, D. Devenport, E. Ezratty, C. Luxenburg and members of the Fuchs laboratory for discussions and critical reading of the manuscript. We thank S. Mazel and the RU Flow Cytometry Resource Center for assistance with cell sorting, A. North and the RU Bioimaging Resource Center for assistance with image acquisition and the Comparative Biology Center (AAALAC accredited) for veterinary care of our mice. S.E.W. was supported by an American Cancer Society postdoctoral fellowship and S.B. was a Human Frontier Science Program postdoctoral fellow. E.F. is an investigator in the Howard Hughes Medical Institute. Work in the Fuchs laboratory was supported by a grant from the National Institutes of Health (E.F. R01AR27883).	Adams RJ, 1996, J NEUROSCI, V16, P7610; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Poulson ND, 2010, J CELL BIOL, V191, P915, DOI 10.1083/jcb.201008001; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SMART IHM, 1970, BRIT J DERMATOL, V82, P276, DOI 10.1111/j.1365-2133.1970.tb12437.x; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	49	310	316	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					353	358		10.1038/nature09793	http://dx.doi.org/10.1038/nature09793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331036	Green Accepted			2022-12-28	WOS:000287409100033
J	Moynier, F; Yin, QZ; Schauble, E				Moynier, Frederic; Yin, Qing-Zhu; Schauble, Edwin			Isotopic Evidence of Cr Partitioning into Earth's Core	SCIENCE			English	Article							INNER SOLAR-SYSTEM; OXYGEN-ISOTOPE; CARBONACEOUS CHONDRITE; OXIDATION-STATE; ORIGIN; CONSTRAINTS; ACCRETION; MOON; MN; SILICATE	The distribution of chemical elements in primitive meteorites (chondrites), as building blocks of terrestrial planets, provides insight into the formation and early differentiation of Earth. The processes that resulted in the depletion of some elements [such as chromium (Cr)] in the bulk silicate Earth relative to chondrites, however, remain debated between leading candidate causes: volatility versus core partitioning. We show through high-precision measurements of Cr stable isotopes in a range of meteorites, which deviate by up to similar to 0.4 per mil from those of the bulk silicate Earth, that Cr depletion resulted from its partitioning into Earth's core, with a preferential enrichment in light isotopes. Ab initio calculations suggest that the isotopic signature was established at mid-mantle magma ocean depth as Earth accreted planetary embryos and progressively became more oxidized.	[Moynier, Frederic; Yin, Qing-Zhu] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Moynier, Frederic] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Moynier, Frederic] Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA; [Schauble, Edwin] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	University of California System; University of California Davis; Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Los Angeles	Moynier, F (corresponding author), Univ Calif Davis, Dept Geol, 1 Shields Ave, Davis, CA 95616 USA.	moynier@levee.wustl.edu; qyin@ucdavis.edu	Moynier, Frederic/AAH-1235-2022; Moynier, Frederic/AFL-9257-2022; Yin, Qing-Zhu/B-8198-2009; Schauble, Edwin A/E-7812-2012; Moynier, Frederic/I-2785-2012	Moynier, Frederic/0000-0003-4321-5581; Moynier, Frederic/0000-0003-4321-5581; Yin, Qing-Zhu/0000-0002-4445-5096; 	NASA [NNX09AM64G, NNX08AG57G, NNX09AC93G]; NSF [EAR0643286, EAR0711411]	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We acknowledge NASA funding (LASER grant NNX09AM64G to F. M. and Cosmochemistry grant NNX08AG57G and Origins of Solar Systems grant NNX09AC93G to Q.-Z.Y.) and NSF funding (grants EAR0643286 and EAR0711411 to E. S.). We thank B. Jacobsen for his assistance in the laboratory; J. Wasson, A. Rubin, and J. Wimpenny for helpful discussions; and two reviewers for their insightful and constructive comments.	ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; Chabot NL, 2003, GEOCHIM COSMOCHIM AC, V67, P2077, DOI [10.1016/S0016-7037(02)01272-3, 10.1016/S0016-7037(02)012723]; Chakrabarti R, 2010, GEOCHIM COSMOCHIM AC, V74, P6921, DOI 10.1016/j.gca.2010.08.034; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; Corgne A, 2008, GEOCHIM COSMOCHIM AC, V72, P574, DOI 10.1016/j.gca.2007.10.006; Dahl TW, 2010, EARTH PLANET SC LETT, V295, P177, DOI 10.1016/j.epsl.2010.03.038; DRAKE MJ, 1989, GEOCHIM COSMOCHIM AC, V53, P2101, DOI 10.1016/0016-7037(89)90328-1; Ellis AS, 2002, SCIENCE, V295, P2060, DOI 10.1126/science.1068368; Fitoussi C, 2009, EARTH PLANET SC LETT, V287, P77, DOI 10.1016/j.epsl.2009.07.038; Gessmann CK, 2000, EARTH PLANET SC LETT, V184, P95, DOI 10.1016/S0012-821X(00)00323-X; KALLEMEYN GW, 1981, GEOCHIM COSMOCHIM AC, V45, P1217, DOI 10.1016/0016-7037(81)90145-9; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Lodders K., 1998, PLANETARY SCI COMPAN; Luck JM, 2005, GEOCHIM COSMOCHIM AC, V69, P5351, DOI 10.1016/j.gca.2005.06.018; Luck JM, 2003, GEOCHIM COSMOCHIM AC, V67, P143, DOI 10.1016/S0016-7037(02)01038-4; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; Monteux J, 2009, EARTH PLANET SC LETT, V287, P353, DOI 10.1016/j.epsl.2009.08.020; Moynier F, 2006, GEOCHIM COSMOCHIM AC, V70, P6103, DOI 10.1016/j.gca.2006.02.030; MOYNIER F, 2007, LUNAR PLANET SCI C, V38, P1406; Moynier F, 2010, CHEM GEOL, V276, P374, DOI 10.1016/j.chemgeo.2010.07.005; Moynier F, 2010, ASTROPHYS J LETT, V718, pL7, DOI 10.1088/2041-8205/718/1/L7; Moynier F, 2009, EARTH PLANET SC LETT, V277, P482, DOI 10.1016/j.epsl.2008.11.020; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; Ricard Y, 2009, EARTH PLANET SC LETT, V284, P144, DOI 10.1016/j.epsl.2009.04.021; RINGWOOD AE, 1990, NATURE, V347, P174, DOI 10.1038/347174a0; Rudge JF, 2010, NAT GEOSCI, V3, P439, DOI 10.1038/NGEO872; Schauble E, 2004, CHEM GEOL, V205, P99, DOI 10.1016/j.chemgeo.2003.12.015; Schoenberg R, 2008, CHEM GEOL, V249, P294, DOI 10.1016/j.chemgeo.2008.01.009; Trinquier A, 2007, ASTROPHYS J, V655, P1179, DOI 10.1086/510360; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; Walter M., 2000, ORIGIN EARTH MOON, P265; Wang Y, 2009, METEORIT PLANET SCI, V44, P763, DOI 10.1111/j.1945-5100.2009.tb00767.x; Wood BJ, 2008, PHILOS T R SOC A, V366, P4339, DOI 10.1098/rsta.2008.0115; Wood BJ, 2008, GEOCHIM COSMOCHIM AC, V72, P1415, DOI 10.1016/j.gca.2007.11.036; Yin Q.-Z., 2009, P 40 LUNAR PLANE TAR; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989	38	80	85	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1417	1420		10.1126/science.1199597	http://dx.doi.org/10.1126/science.1199597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21350126				2022-12-28	WOS:000288504000035
J	Wickliffe, KE; Lorenz, S; Wemmer, DE; Kuriyan, J; Rape, M				Wickliffe, Katherine E.; Lorenz, Sonja; Wemmer, David E.; Kuriyan, John; Rape, Michael			The Mechanism of Linkage-Specific Ubiquitin Chain Elongation by a Single-Subunit E2	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; DEGRADATION; INSIGHTS; REVEALS; POLYUBIQUITINATION; PERFORMANCE; ACTIVATION; TARGETS; ENZYMES	Ubiquitin chains of different topologies trigger distinct functional consequences, including protein degradation and reorganization of complexes. The assembly of most ubiquitin chains is promoted by E2s, yet how these enzymes achieve linkage specificity is poorly understood. We have discovered that the K11-specific Ube2S orients the donor ubiquitin through an essential noncovalent interaction that occurs in addition to the thioester bond at the E2 active site. The E2-donor ubiquitin complex transiently recognizes the acceptor ubiquitin, primarily through electrostatic interactions. The recognition of the acceptor ubiquitin surface around Lys11, but not around other lysines, generates a catalytically competent active site, which is composed of residues of both Ube2S and ubiquitin. Our studies suggest that monomeric E2s promote linkage-specific ubiquitin chain formation through substrate-assisted catalysis.	[Wickliffe, Katherine E.; Lorenz, Sonja; Wemmer, David E.; Kuriyan, John; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wemmer, David E.; Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Lorenz, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	slorenz@berkeley.edu; mrape@berkeley.edu	Lorenz, Sonja/AAL-4499-2020	Lorenz, Sonja/0000-0002-9639-2381; Rape, Michael/0000-0003-4849-6343	NIH [GM 68933, GM68933, RR15756, GM83064]; NSF [BBS 0119304, BBS 8720134]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM068933, R01GM083064] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003088] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. J. Meyer for Ub-L-cycA; A. Williamson for golden extracts; members of the Rape and Kuriyan labs, J. Winger, S. Kassube, and J. Kirsch for discussions; J. Schaletzky for reading the manuscript and suggestions; J. Pelton for help with NMR experiments; D. King and T. Iavarone for mass spectrometry; and the staff at beamline 12.3.1 at LBNL for technical support. NMR instrumentation and operation were supported by NIH-GM 68933, NIH GM68933, NSF BBS 0119304 and NIH RR15756, and NSF BBS 8720134. S. L. is a fellow of The Leukemia & Lymphoma Society. M. R. is a Pew fellow and is supported by NIH GM83064 and an NIH New Innovator Award.	Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Sheinerman FB, 2002, J MOL BIOL, V318, P161, DOI 10.1016/S0022-2836(02)00030-X; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	30	213	216	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					769	781		10.1016/j.cell.2011.01.035	http://dx.doi.org/10.1016/j.cell.2011.01.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376237	Green Accepted, Bronze			2022-12-28	WOS:000288007100015
J	Rohn, J				Rohn, Jennifer			Give postdocs a career, not empty promises	NATURE			English	Editorial Material									[Rohn, Jennifer] UCL, London, England	University of London; University College London	Rohn, J (corresponding author), UCL, London, England.	jenny@lablit.com		Rohn, Jennifer/0000-0001-8766-6056					0	11	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					7	7		10.1038/471007a	http://dx.doi.org/10.1038/471007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368781	Bronze			2022-12-28	WOS:000287924100049
J	Sare, J				Sare, Jeremy			Medicine and the Media How the media helped ban mephedrone	BRITISH MEDICAL JOURNAL			English	Editorial Material												jeremysare@btinternet.com							0	4	4	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2011	342								d1138	10.1136/bmj.d1138	http://dx.doi.org/10.1136/bmj.d1138			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729BE	21349891				2022-12-28	WOS:000287920900004
J	Breen, DP; Rowe, JB; Barker, RA				Breen, David P.; Rowe, James B.; Barker, Roger A.			Practice Rational Imaging Role of brain imaging in early parkinsonism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOPAMINE TRANSPORTERS; DISEASE; DIAGNOSIS; MOVEMENT; SPECT; DEMENTIA; MRI					davebreen@excite.co.uk	rowe, james B/C-3661-2013; Tick, Beata/ABA-1728-2020	rowe, james B/0000-0001-7216-8679; Barker, Roger Alistair/0000-0001-8843-7730	Medical Research Council [MC_U105597119] Funding Source: Medline; Wellcome Trust [088324] Funding Source: Medline; MRC [MC_U105597119] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2010, DIAGN PHARM MAN PARK, V113; Bohnen NI, 1999, NEUROLOGY, V52, P541, DOI 10.1212/WNL.52.3.541; Booij J, 1998, J NUCL MED, V39, P1879; Brooks DJ, 2008, NAT CLIN PRACT NEURO, V4, P267, DOI 10.1038/ncpneuro0773; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; Edison P, 2008, J NEUROL NEUROSUR PS, V79, P1331, DOI 10.1136/jnnp.2007.127878; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hu MTM, 2000, BRAIN, V123, P340, DOI 10.1093/brain/123.2.340; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Kagi G, 2010, J NEUROL NEUROSUR PS, V81, P5, DOI 10.1136/jnnp.2008.157370; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; National Collaborating Centre for Chronic Conditions, 2006, PARK DIS NAT CLIN GU; Oba H, 2005, NEUROLOGY, V64, P2050, DOI 10.1212/01.WNL.0000165960.04422.D0; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Rowe JB, 2008, BRAIN, V131, P2094, DOI 10.1093/brain/awn112; Seibyl JP, 1997, J NUCL MED, V38, P1453; Spiegel J, 2007, J NEURAL TRANSM, V114, P331, DOI 10.1007/s00702-006-0518-2; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; Vlaar AMM, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-27; Yekhlef F, 2003, J NEURAL TRANSM, V110, P151, DOI 10.1007/s00702-002-0785-5	21	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2011	342								d638	10.1136/bmj.d638	http://dx.doi.org/10.1136/bmj.d638			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729AZ	21345904				2022-12-28	WOS:000287920100018
J	Deutsch, GB; Zielonka, EM; Coutandin, D; Weber, TA; Schafer, B; Hannewald, J; Luh, LM; Durst, FG; Ibrahim, M; Hoffmann, J; Niesen, FH; Senturk, A; Kunkel, H; Brutschy, B; Schleiff, E; Knapp, S; Acker-Palmer, A; Grez, M; McKeon, F; Dotsch, V				Deutsch, Gregor B.; Zielonka, Elisabeth M.; Coutandin, Daniel; Weber, Tobias A.; Schaefer, Birgit; Hannewald, Jens; Luh, Laura M.; Durst, Florian G.; Ibrahim, Mohamed; Hoffmann, Jan; Niesen, Frank H.; Sentuerk, Aycan; Kunkel, Hana; Brutschy, Bernd; Schleiff, Enrico; Knapp, Stefan; Acker-Palmer, Amparo; Grez, Manuel; McKeon, Frank; Doetsch, Volker			DNA Damage in Oocytes Induces a Switch of the Quality Control Factor TAp63 alpha from Dimer to Tetramer	CELL			English	Article							P53 TUMOR-SUPPRESSOR; STRUCTURAL EVOLUTION; MASS-SPECTROMETRY; MUTANT P53; GERM-LINE; P63; PROTEIN; DOMAIN; HOMOLOG; P73	TAp63 alpha, a homolog of the p53 tumor suppressor, is a quality control factor in the female germline. Remarkably, already undamaged oocytes express high levels of the protein, suggesting that TAp63 alpha's activity is under tight control of an inhibitory mechanism. Biochemical studies have proposed that inhibition requires the C-terminal transactivation inhibitory domain. However, the structural mechanism of TAp63 alpha inhibition remains unknown. Here, we show that TAp63 alpha is kept in an inactive dimeric state. We reveal that relief of inhibition leads to tetramer formation with similar to 20-fold higher DNA affinity. In vivo, phosphorylation-triggered tetramerization of TAp63 alpha is not reversible by dephosphorylation. Furthermore, we show that a helix in the oligomerization domain of p63 is crucial for tetramer stabilization and competes with the transactivation domain for the same binding site. Our results demonstrate how TAp63 alpha is inhibited by complex domain-domain interactions that provide the basis for regulating quality control in oocytes.	[Deutsch, Gregor B.; Coutandin, Daniel; Weber, Tobias A.; Schaefer, Birgit; Luh, Laura M.; Durst, Florian G.; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Deutsch, Gregor B.; Coutandin, Daniel; Weber, Tobias A.; Schaefer, Birgit; Luh, Laura M.; Durst, Florian G.; Doetsch, Volker] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Zielonka, Elisabeth M.; McKeon, Frank] Univ Strasbourg, ISIS, F-67000 Strasbourg, France; [Zielonka, Elisabeth M.; McKeon, Frank] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Hannewald, Jens] Merck KGaA, MS DTB C Prot Purificat, D-64293 Darmstadt, Germany; [Ibrahim, Mohamed; Schleiff, Enrico] Goethe Univ Frankfurt, Inst Mol & Cell Biol Plants, D-60438 Frankfurt, Germany; [Hoffmann, Jan; Brutschy, Bernd] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany; [Sentuerk, Aycan; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci FMLS, D-60438 Frankfurt, Germany; [Sentuerk, Aycan; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, D-60438 Frankfurt, Germany; [Niesen, Frank H.; Knapp, Stefan] Univ Oxford, Nuffield Dept Med, Oxford OX3 7DQ, England; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Struct Genom Consortium, Oxford OX3 7DQ, England; [McKeon, Frank] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Goethe University Frankfurt; Goethe University Frankfurt; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Merck KGaA; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; University of Oxford; University of Oxford; Harvard University; Harvard Medical School	Dotsch, V (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany.	vdoetsch@em.uni-frankfurt.de	Doetsch, Volker/D-5697-2011; Ibrahim, Mohamed/AAH-8007-2019; Schleiff, Enrico/C-5105-2017; Coutandin, Daniel/O-8449-2016; Knapp, Stefan/AAG-2347-2019	Schleiff, Enrico/0000-0002-0518-3489; Coutandin, Daniel/0000-0003-4537-1393; Knapp, Stefan/0000-0001-5995-6494; Dotsch, Volker/0000-0001-5720-212X	DFG [DO 545/2-1]; EU [LSHB-CT-019067]; Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); ANR; ERC; Boehringer Ingelheim Fonds PhD Fellowship; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	DFG(German Research Foundation (DFG)); EU(European Commission); Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	The research was funded by the DFG (DO 545/2-1), EU-Grant EPISTEM (LSHB-CT-019067), the Centre for Biomolecular Magnetic Resonance (BMRZ), and the Cluster of Excellence Frankfurt (Macromolecular Complexes). F. M. acknowledges support by ANR and ERC. D. C. was supported by a Boehringer Ingelheim Fonds PhD Fellowship. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. J. Hannewald is an employee of Merck KGaA, Darmstadt.	Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Burge S, 2009, P NATL ACAD SCI USA, V106, P3142, DOI 10.1073/pnas.0900383106; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Coutandin D, 2009, CELL DEATH DIFFER, V16, P1582, DOI 10.1038/cdd.2009.139; Coutandin D, 2010, P NATL ACAD SCI USA, V107, P15318, DOI 10.1073/pnas.1001069107; Davison TS, 2001, J MOL BIOL, V307, P605, DOI 10.1006/jmbi.2001.4450; De Laurenzi V, 1999, CELL DEATH DIFFER, V6, P389, DOI 10.1038/sj.cdd.4400521; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hoffmann J, 2009, RAPID COMMUN MASS SP, V23, P2176, DOI 10.1002/rcm.4129; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Schleiff E, 2003, P NATL ACAD SCI USA, V100, P4604, DOI 10.1073/pnas.0730860100; Schmale H, 1997, ONCOGENE, V15, P1363, DOI 10.1038/sj.onc.1201500; Senoo M, 1998, BIOCHEM BIOPH RES CO, V248, P603, DOI 10.1006/bbrc.1998.9013; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Straub WE, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.1; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Ying HQ, 2005, MOL CELL BIOL, V25, P6154, DOI 10.1128/MCB.25.14.6154-6164.2005	44	97	101	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					566	576		10.1016/j.cell.2011.01.013	http://dx.doi.org/10.1016/j.cell.2011.01.013			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335238	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000287473100011
J	Hewitt, SC; Korach, KS				Hewitt, Sylvia C.; Korach, Kenneth S.			A Hand to Support the Implantation Window	SCIENCE			English	Editorial Material							EMBRYO IMPLANTATION; MOUSE MODELS; RESPONSES; PROLIFERATION; ALPHA		[Hewitt, Sylvia C.; Korach, Kenneth S.] Natl Inst Environm Hlth Sci, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hewitt, SC (corresponding author), Natl Inst Environm Hlth Sci, NIH, Res Triangle Pk, NC 27709 USA.	korach@niehs.nih.gov	Hewitt, Sylvia/W-8752-2019	Hewitt, Sylvia/0000-0001-7713-0805; Korach, Kenneth/0000-0002-7765-418X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA ES070065-35] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bazer FW, 2009, REPRODUCTION, V138, P195, DOI 10.1530/REP-09-0158; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; Kim TH, 2010, BIOL REPROD, V82, P706, DOI 10.1095/biolreprod.109.081307; Krejci P, 2009, HUM MUTAT, V30, P1245, DOI 10.1002/humu.21067; Lee DK, 2010, MOL ENDOCRINOL, V24, P930, DOI 10.1210/me.2009-0531; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; MURPHY LJ, 1990, ENDOCR REV, V11, P443, DOI 10.1210/edrv-11-3-443; Paria BC, 2001, P NATL ACAD SCI USA, V98, P1047, DOI 10.1073/pnas.98.3.1047; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Schindler AE, 2009, MATURITAS, V62, P334, DOI 10.1016/j.maturitas.2008.12.018; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107	13	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					863	864		10.1126/science.1202372	http://dx.doi.org/10.1126/science.1202372			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722SO	21330520	Green Accepted			2022-12-28	WOS:000287455100032
J	Huang, WD; Ghisletti, S; Saijo, KR; Gandhi, M; Aouadi, M; Tesz, GJ; Zhang, DX; Yao, J; Czech, MP; Goode, BL; Rosenfeld, MG; Glass, CK				Huang, Wendy; Ghisletti, Serena; Saijo, Kaoru; Gandhi, Meghal; Aouadi, Myriam; Tesz, Greg J.; Zhang, Dawn X.; Yao, Joyee; Czech, Michael P.; Goode, Bruce L.; Rosenfeld, Michael G.; Glass, Christopher K.			Coronin 2A mediates actin-dependent de-repression of inflammatory response genes	NATURE			English	Article							PPAR-GAMMA; NUCLEAR; RECEPTOR; PATHWAYS; TRANSREPRESSION; INTEGRATION; ACTIVATION; CHECKPOINT; EXPRESSION; ROLES	Toll-like receptors (TLRs) function as initiators of inflammation through their ability to sense pathogen-associated molecular patterns and products of tissue damage(1,2). Transcriptional activation of many TLR-responsive genes requires an initial de-repression step in which nuclear receptor co-repressor (NCoR) complexes are actively removed from the promoters of target genes to relieve basal repression(3,4). Ligand-dependent SUMOylation of liver X receptors (LXRs) has been found to suppress TLR4-induced transcription potently by preventing the NCoR clearance step(5-7), but the underlying mechanisms remain enigmatic. Here we provide evidence that coronin 2A (CORO2A), a component of the NCoR complex of previously unknown function(8,9), mediates TLR-induced NCoR turnover by a mechanism involving interaction with oligomeric nuclear actin. SUMOylated LXRs block NCoR turnover by binding to a conserved SUMO2/SUMO3-interaction motif in CORO2A and preventing actin recruitment. Intriguingly, the LXR transrepression pathway can itself be inactivated by inflammatory signals that induce calcium/calmodulin-dependent protein kinase II gamma (CaMKII gamma)-dependent phosphorylation of LXRs, leading to their deSUMOylation by the SUMO protease SENP3 and release from CORO2A. These findings uncover a CORO2A-actin-dependent mechanism for the de-repression of inflammatory response genes that can be differentially regulated by phosphorylation and by nuclear receptor signalling pathways that control immunity and homeostasis.	[Huang, Wendy; Ghisletti, Serena; Saijo, Kaoru; Zhang, Dawn X.; Yao, Joyee; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Huang, Wendy; Zhang, Dawn X.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Gandhi, Meghal; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA; [Aouadi, Myriam; Tesz, Greg J.; Czech, Michael P.] Univ Massachusetts, Program Mol Med, Sch Med, Worcester, MA 01605 USA; [Czech, Michael P.; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Brandeis University; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Ghisletti, Serena/AAO-6437-2021; Huang, Wendy Jia Men/AAF-2030-2021; Glass, Christopher/AAI-3933-2021	Huang, Wendy Jia Men/0000-0001-7425-8280; Glass, Christopher/0000-0003-4344-3592; Ghisletti, Serena/0000-0002-7087-5553	NRSA [1F31DK083913]; National Institutes of Health [CA52599, DK074868, HC088093, DK085853]; Leducq Foundation Transatlantic Network; NATIONAL CANCER INSTITUTE [R01CA097134, R01CA052599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445, P50HL056989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R37DK039949, F31DK083913, R01DK091183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation Transatlantic Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Amano for preparation of GeRP delivery spheres. We thank L. Bautista for assistance with preparation of the manuscript. W.H. was supported by NRSA 1F31DK083913. These studies were supported by National Institutes of Health grants CA52599, DK074868, HC088093 and DK085853 and a Leducq Foundation Transatlantic Network Grant. M.G.R. is an investigator of the Howard Hughes Medical Institute.	Amarzguioui M, 2006, CLIN CANCER RES, V12, P4055, DOI 10.1158/1078-0432.CCR-05-2482; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blaschke F, 2006, CIRC RES, V99, pE88, DOI 10.1161/01.RES.0000252878.34269.06; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gandhi M, 2010, J BIOL CHEM, V285, P34899, DOI 10.1074/jbc.M110.171496; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Gonsior SM, 1999, J CELL SCI, V112, P797; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120	30	119	126	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					414	U25		10.1038/nature09703	http://dx.doi.org/10.1038/nature09703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331046	Green Accepted			2022-12-28	WOS:000287409100046
J	Bennett, WL; Maruthur, NM; Singh, S; Segal, JB; Wilson, LM; Chatterjee, R; Marinopoulos, SS; Puhan, MA; Ranasinghe, P; Block, L; Nicholson, WK; Hutfless, S; Bass, EB; Bolen, S				Bennett, Wendy L.; Maruthur, Nisa M.; Singh, Sonal; Segal, Jodi B.; Wilson, Lisa M.; Chatterjee, Ranee; Marinopoulos, Spyridon S.; Puhan, Milo A.; Ranasinghe, Padmini; Block, Lauren; Nicholson, Wanda K.; Hutfless, Susan; Bass, Eric B.; Bolen, Shari			Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations	ANNALS OF INTERNAL MEDICINE			English	Review							GLUCOSE CONTROL; MYOCARDIAL-INFARCTION; GLYCEMIC CONTROL; ROSIGLITAZONE; METFORMIN; MELLITUS; THERAPY; METAANALYSIS; PROGRESSION; TRIALS	Background: Given the increase in medications for type 2 diabetes mellitus, clinicians and patients need information about their effectiveness and safety to make informed choices. Purpose: To summarize the benefits and harms of metformin, second-generation sulfonylureas, thiazolidinediones, meglitinides, dipeptidyl peptidase-4 (DPP-4) inhibitors, and glucagon-like peptide-1 receptor agonists, as monotherapy and in combination, to treat adults with type 2 diabetes. Data Sources: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched from inception through April 2010 for English-language observational studies and trials. The MEDLINE search was updated to December 2010 for long-term clinical outcomes. Study Selection: Two reviewers independently screened reports and identified 140 trials and 26 observational studies of head-to-head comparisons of monotherapy or combination therapy that reported intermediate or long-term clinical outcomes or harms. Data Extraction: Two reviewers following standardized protocols serially extracted data, assessed applicability, and independently evaluated study quality. Data Synthesis: Evidence on long-term clinical outcomes (all-cause mortality, cardiovascular disease, nephropathy, and neuropathy) was of low strength or insufficient. Most medications decreased the hemoglobin A(1c) level by about 1 percentage point and most 2-drug combinations produced similar reductions. Metformin was more efficacious than the DPP-4 inhibitors, and compared with thiazolidinediones or sulfonylureas, the mean differences in body weight were about -2.5 kg. Metformin decreased low-density lipoprotein cholesterol levels compared with pioglitazone, sulfonylureas, and DPP-4 inhibitors. Sulfonylureas had a 4-fold higher risk for mild or moderate hypoglycemia than metformin alone and, in combination with metformin, had more than a 5-fold increased risk compared with metformin plus thiazolidinediones. Thiazolidinediones increased risk for congestive heart failure compared with sulfonylureas and increased risk for bone fractures compared with metformin. Diarrhea occurred more often with metformin than with thiazolidinediones. Limitations: Only English-language publications were reviewed. Some studies may have selectively reported outcomes. Many studies were small, were of short duration, and had limited ability to assess clinically important harms and benefits. Conclusion: Evidence supports metformin as a first-line agent to treat type 2 diabetes. Most 2-drug combinations similarly reduce hemoglobin A(1c) levels, but some increased risk for hypoglycemia and other adverse events.	[Bennett, Wendy L.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Case Western Reserve Univ, Ctr Hlth Care Res & Policy, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Case Western Reserve University	Bennett, WL (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, 2024 E Monument St,Room 2-611, Baltimore, MD 21205 USA.	wbennet5@jhmi.edu	Puhan, Milo/ABE-6298-2020; Singh, Sonal/A-4614-2008	Puhan, Milo/0000-0003-4721-1879; Singh, Sonal/0000-0003-0912-941X; Bass, Eric/0000-0001-9106-527X; Bennett, Wendy/0000-0001-9828-0706; Hutfless, Susan/0000-0002-6311-2611	Agency for Healthcare Research and Quality; Johns Hopkins University Evidence-based Practice Center [290-02-0018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL098476] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Johns Hopkins University Evidence-based Practice Center(Johns Hopkins University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Primary Funding Source: Agency for Healthcare Research and Quality.r This article is based on research conducted by the Johns Hopkins University Evidence-based Practice Center under contract to the AHRQ, Rockville, Maryland (contract 290-02-0018).	*AG HEALTHC RES QU, 2007, GUID COND COMP EFF R; Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; Bailey CJ, 2005, CLIN THER, V27, P1548, DOI 10.1016/j.clinthera.2005.10.012; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bennett WL, 2011, ORAL DIABETES MEDICA; Black C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004654.pub2; Bolen S, 2007, AHRQ PUBLICATION; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fonseca V, 2000, JAMA-J AM MED ASSOC, V283, P1695, DOI 10.1001/jama.283.13.1695; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gomez-Perez FJ, 2002, DIABETES-METAB RES, V18, P127, DOI 10.1002/dmrr.264; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jones TA, 2003, DIABETES OBES METAB, V5, P163, DOI 10.1046/j.1463-1326.2003.00258.x; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Monami M, 2008, DIABETES RES CLIN PR, V79, P196, DOI 10.1016/j.diabres.2007.08.024; Monami M, 2009, EUR J ENDOCRINOL, V160, P909, DOI 10.1530/EJE-09-0101; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; National Institute of Diabetes and Digestive and Kidney Diseases, 2008, NAT DIAB STAT 2007 F; NISSEN SE, 2010, ARCH INTERN MED; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Phung OJ, 2010, JAMA-J AM MED ASSOC, V303, P1410, DOI 10.1001/jama.2010.405; Richter B, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006739.pub2; Richter B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006063; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Rosen CJ, 2010, NEW ENGL J MED, V363, P803, DOI 10.1056/NEJMp1008233; Rosenstock J, 2006, DIABETES OBES METAB, V8, P650, DOI 10.1111/j.1463-1326.2006.00659.x; Segal JB, 2009, AHRQ PUBLICATION; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; Shichiri M, 2000, DIABETES CARE, V23, pB21; Stewart MW, 2006, DIABETIC MED, V23, P1069, DOI 10.1111/j.1464-5491.2006.01942.x; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; TURNER RC, 1985, DIABETES, V34, P793; United Kingdom Prospective Diabetes Study (UKPDS), 1995, BMJ-BRIT MED J, V310, P83, DOI DOI 10.1136/BMJ.310.6972.83; *US FDA, 2010, JUL 13 14 2010 M END; Wani JH, 2008, CARDIOL CLIN, V26, P639, DOI 10.1016/j.ccl.2008.06.008; Weissman P, 2005, CURR MED RES OPIN, V21, P2029, DOI 10.1185/030079905X74844; Williams-Herman D, 2010, DIABETES OBES METAB, V12, P442, DOI 10.1111/j.1463-1326.2010.01204.x; Woodcock J, 2010, NEW ENGL J MED, V363, P1489, DOI 10.1056/NEJMp1010788; Wright A, 1998, ANN INTERN MED, V128, P165, DOI 10.7326/0003-4819-128-3-199802010-00001	56	401	414	0	59	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					602	613		10.7326/0003-4819-154-9-201105030-00336	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00336			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21403054	Green Accepted			2022-12-28	WOS:000290112300004
J	Wechsler, T; Newman, S; West, SC				Wechsler, Thomas; Newman, Scott; West, Stephen C.			Aberrant chromosome morphology in human cells defective for Holliday junction resolution	NATURE			English	Article							STRUCTURE-SPECIFIC NUCLEASES; MUS81-EME1; MECHANISM; BLM; HELICASE; REPAIR; IDENTIFICATION; REPLICATION; RESOLVASE; COMPLEX	In somatic cells, Holliday junctions can be formed between sister chromatids during the recombinational repair of DNA breaks or after replication fork demise. A variety of processes act upon Holliday junctions to remove them from DNA, in events that are critical for proper chromosome segregation. In human cells, the BLM protein, inactivated in individuals with Bloom's syndrome, acts in combination with topoisomerase III alpha, RMI1 and RMI2 (BTR complex) to promote the dissolution of double Holliday junctions(1,2). Cells defective for BLM exhibit elevated levels of sister chromatid exchanges (SCEs) and patients with Bloom's syndrome develop a broad spectrum of early-onset cancers caused by chromosome instability(3). MUS81-EME1 (refs 4-7), SLX1-SLX4 (refs 8-11) and GEN1 (refs 12, 13) also process Holliday junctions but, in contrast to the BTR complex, do so by endonucleolytic cleavage. Here we deplete these nucleases from Bloom's syndrome cells to analyse human cells compromised for the known Holliday junction dissolution/resolution pathways. We show that depletion of MUS81 and GEN1, or SLX4 and GEN1, from Bloom's syndrome cells results in severe chromosome abnormalities, such that sister chromatids remain interlinked in a side-by-side arrangement and the chromosomes are elongated and segmented. Our results indicate that normally replicating human cells require Holliday junction processing activities to prevent sister chromatid entanglements and thereby ensure accurate chromosome condensation. This phenotype was not apparent when both MUS81 and SLX4 were depleted from Bloom's syndrome cells, suggesting that GEN1 can compensate for their absence. Additionally, we show that depletion of MUS81 or SLX4 reduces the high frequency of SCEs in Bloom's syndrome cells, indicating that MUS81 and SLX4 promote SCE formation, in events that may ultimately drive the chromosome instabilities that underpin early-onset cancers associated with Bloom's syndrome.	[Wechsler, Thomas; West, Stephen C.] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, London Res Inst, S Mimms EN6 3LD, Herts, England; [Newman, Scott] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Cancer Research UK; University of Cambridge	West, SC (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK, London Res Inst, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk	Newman, Scott/B-4843-2012	West, Stephen/0000-0001-8848-9418	Cancer Research UK; Louis-Jeantet Foundation; European Research Council; Swiss Bridge Foundation; Breast Cancer Campaign; UK Medical Research Council; Cancer Research UK [11582] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Louis-Jeantet Foundation; European Research Council(European Research Council (ERC)European Commission); Swiss Bridge Foundation; Breast Cancer Campaign; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	We thank I. Hickson for providing the Bloom's syndrome cell lines and advice, P. Edwards for help and providing facilities for chromosome painting, S. Horswell for the statistical analysis, S. Ip for the GEN1 antibody, M.G. Blanco for assistance with SCE scoring and our laboratory colleagues for their encouragement and suggestions. We further thank K. Cimprich, the Cimprich laboratory members, and C. Wang, W. Johnson and A. Straight. This work was supported by Cancer Research UK, the Louis-Jeantet Foundation, the European Research Council, the Swiss Bridge Foundation and the Breast Cancer Campaign. S.N. was supported by a studentship from the UK Medical Research Council.	Alsop AE, 2006, CANCER GENET CYTOGEN, V164, P97, DOI 10.1016/j.cancergencyto.2005.09.011; Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bayani J., 2005, CURR PROTOC CELL BIO, P7; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Breger KS, 2004, CANCER RES, V64, P8231, DOI 10.1158/0008-5472.CAN-04-0879; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Ellis NA, 1999, AM J HUM GENET, V65, P1368, DOI 10.1086/302616; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Gaillard PHL, 2003, MOL CELL, V12, P747, DOI 10.1016/S1097-2765(03)00342-3; Gaymes TJ, 2002, ONCOGENE, V21, P2525, DOI 10.1038/sj.onc.1205331; Hearst JE, 1998, TRENDS GENET, V14, P244, DOI 10.1016/S0168-9525(98)01481-4; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tay YD, 2010, J BIOL CHEM, V285, P11427, DOI 10.1074/jbc.M110.108399; Taylor ER, 2008, P NATL ACAD SCI USA, V105, P3757, DOI 10.1073/pnas.0710291105; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	30	161	165	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					642	U126		10.1038/nature09790	http://dx.doi.org/10.1038/nature09790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21399624	Green Accepted			2022-12-28	WOS:000288951200044
J	Rohwer, T; Hellmann, S; Wiesenmayer, M; Sohrt, C; Stange, A; Slomski, B; Carr, A; Liu, YW; Miaja-Avila, L; Kallane, M; Mathias, S; Kipp, L; Rossnagel, K; Bauer, M				Rohwer, Timm; Hellmann, Stefan; Wiesenmayer, Martin; Sohrt, Christian; Stange, Ankatrin; Slomski, Bartosz; Carr, Adra; Liu, Yanwei; Miaja-Avila, Luis; Kallaene, Matthias; Mathias, Stefan; Kipp, Lutz; Rossnagel, Kai; Bauer, Michael			Collapse of long-range charge order tracked by time-resolved photoemission at high momenta	NATURE			English	Article							SUPERLATTICE FORMATION; ELECTRONIC-STRUCTURE; DENSITY-WAVE; PHASE; SUPERCONDUCTIVITY; DIFFRACTION; EXCITATION; SCATTERING; PARTICLE; PULSES	Intense femtosecond (10(-15) s) light pulses can be used to transform electronic, magnetic and structural order in condensed-matter systems on timescales of electronic and atomic motion(1,2,3). This technique is particularly useful in the study(4,5) and in the control(6) of materials whose physical properties are governed by the interactions between multiple degrees of freedom. Time- and angle-resolved photoemission spectroscopy is in this context a direct and comprehensive, energy- and momentum-selective probe of the ultrafast processes that couple to the electronic degrees of freedom(7-10). Previously, the capability of such studies to access electron momentum space away from zero momentum was, however, restricted owing to limitations of the available probing photon energy(10,11). Here, using femtosecond extreme-ultraviolet pulses delivered by a high-harmonic-generation source, we use time- and angle-resolved photoemission spectroscopy to measure the photoinduced vaporization of a charge-ordered state in the potential excitonic insulator 1T-TiSe(2) (refs 12, 13). By way of stroboscopic imaging of electronic band dispersions at large momentum, in the vicinity of the edge of the first Brillouin zone, we reveal that the collapse of atomic-scale periodic long-range order happens on a timescale as short as 20 femtoseconds. The surprisingly fast response of the system is assigned to screening by the transient generation of free charge carriers. Similar screening scenarios are likely to be relevant in other photoinduced solid-state transitions and may generally determine the response times. Moreover, as electron states with large momenta govern fundamental electronic properties in condensed matter systems(14), we anticipate that the experimental advance represented by the present study will be useful to study the ultrafast dynamics and microscopic mechanisms of electronic phenomena in a wide range of materials.	[Rohwer, Timm; Hellmann, Stefan; Wiesenmayer, Martin; Sohrt, Christian; Stange, Ankatrin; Slomski, Bartosz; Kallaene, Matthias; Kipp, Lutz; Rossnagel, Kai; Bauer, Michael] Univ Kiel, Inst Expt & Appl Phys, D-24118 Kiel, Germany; [Carr, Adra; Mathias, Stefan] Univ Colorado, JILA, Boulder, CO 80309 USA; [Carr, Adra; Mathias, Stefan] NIST, Boulder, CO 80309 USA; [Liu, Yanwei] Univ Calif Berkeley, NSF ERC Extreme Ultraviolet Sci & Technol, Berkeley, CA 94720 USA; [Liu, Yanwei] Univ Calif Berkeley, Lawrence Berkeley Lab, Ctr Xray Opt, Berkeley, CA 94720 USA; [Miaja-Avila, Luis] Univ Texas Austin, Ctr Nano & Mol Sci, Austin, TX 78722 USA; [Mathias, Stefan] Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany; [Mathias, Stefan] Univ Kaiserslautern, Res Ctr OPTIMAS, D-67663 Kaiserslautern, Germany	University of Kiel; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; National Science Foundation (NSF); NSF - Engineering Research Centers (ERC); University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Texas System; University of Texas Austin; University of Kaiserslautern; University of Kaiserslautern	Bauer, M (corresponding author), Univ Kiel, Inst Expt & Appl Phys, Olshaussenstr 40, D-24118 Kiel, Germany.	rossnagel@physik.uni-kiel.de; bauer@physik.uni-kiel.de	Avila, Luis Miaja/H-5505-2018; Rossnagel, Kai/F-8822-2011; Rohwer, Timm/AAA-2419-2020; Bauer, Michael/G-5111-2016; Mathias, Stefan/I-4679-2012	Avila, Luis Miaja/0000-0003-0864-8357; Rossnagel, Kai/0000-0001-5107-0090; Rohwer, Timm/0000-0002-7567-5868; Bauer, Michael/0000-0002-4391-9899; Mathias, Stefan/0000-0002-1255-521X	JILA Physics Frontier Center; German Science Foundation (DFG) [SFB 855]; European Community [GA 253316]; US Department of Energy, Office of Basic Energy Sciences; NSF EUV ERC	JILA Physics Frontier Center; German Science Foundation (DFG)(German Research Foundation (DFG)); European Community(European Commission); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF EUV ERC	M.B. and S.M. thank M. Aeschlimann for support and discussion. M.B. and S.M. also thank M. Murnane and H. Kapteyn for their support through the NSF EUV ERC. A.C. acknowledges support from the JILA Physics Frontier Center. This work was supported by the German Science Foundation (DFG) within the SFB 855 (C.S., M.B., L.K., K.R.) and by the European Community's FP7 under Marie Curie International Outgoing Fellowship GA 253316 (S.M.). Operation of the Advanced Light Source is supported by the US Department of Energy, Office of Basic Energy Sciences.	Anisimov S I, 1974, SOV PHYS JETP, V39, P375, DOI DOI 10.1016/J.JMATPROTEC.2009.05.031; ASHCROFT NW, 1976, SOLID STATE PHYS, pCH1; Banyai L, 1998, PHYS REV LETT, V81, P882, DOI 10.1103/PhysRevLett.81.882; Bargheer M, 2006, CHEMPHYSCHEM, V7, P783, DOI 10.1002/cphc.200500591; Bauer M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.025501; Bigot JY, 2009, NAT PHYS, V5, P515, DOI 10.1038/NPHYS1285; Cavalleri A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.161102; Cercellier H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.146403; Chollet M, 2005, SCIENCE, V307, P86, DOI 10.1126/science.1105067; Demsar J, 1999, PHYS REV LETT, V83, P800, DOI 10.1103/PhysRevLett.83.800; DISALVO FJ, 1976, PHYS REV B, V14, P4321, DOI 10.1103/PhysRevB.14.4321; ELSAYED K, 1994, PHYS REV B, V49, P7337, DOI 10.1103/PhysRevB.49.7337; FANN WS, 1992, PHYS REV B, V46, P13592, DOI 10.1103/PhysRevB.46.13592; HAIGHT R, 1989, PHYS REV LETT, V62, P815, DOI 10.1103/PhysRevLett.62.815; HOLY JA, 1977, PHYS REV B, V16, P3628, DOI 10.1103/PhysRevB.16.3628; Huber R, 2001, NATURE, V414, P286, DOI 10.1038/35104522; Kidd TE, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.226402; Kondo T, 2009, NATURE, V457, P296, DOI 10.1038/nature07644; Miaja-Avila L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.113604; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Perfetti L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.067402; Rini M, 2007, NATURE, V449, P72, DOI 10.1038/nature06119; Rossnagel K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.235101; Rundquist A, 1998, SCIENCE, V280, P1412, DOI 10.1126/science.280.5368.1412; Schmitt F, 2008, SCIENCE, V321, P1649, DOI 10.1126/science.1160778; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; Wall S, 2011, NAT PHYS, V7, P114, DOI [10.1038/nphys1831, 10.1038/NPHYS1831]; Yonemitsu K, 2008, PHYS REP, V465, P1, DOI 10.1016/j.physrep.2008.04.008	30	337	338	3	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					490	+		10.1038/nature09829	http://dx.doi.org/10.1038/nature09829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21389987				2022-12-28	WOS:000288702200057
J	Watanabe, T; Suzuki, A; Minobe, S; Kawashima, T; Kameo, K; Minoshima, K; Aguilar, YM; Wani, R; Kawahata, H; Sowa, K; Nagai, T; Kase, T				Watanabe, Tsuyoshi; Suzuki, Atsushi; Minobe, Shoshiro; Kawashima, Tatsunori; Kameo, Koji; Minoshima, Kayo; Aguilar, Yolanda M.; Wani, Ryoji; Kawahata, Hodaka; Sowa, Kohki; Nagai, Takaya; Kase, Tomoki			Permanent El Nino during the Pliocene warm period not supported by coral evidence	NATURE			English	Article							SEA-SURFACE TEMPERATURE; SOUTHERN-OSCILLATION; TROPICAL PACIFIC; CLIMATE; VARIABILITY; PRECIPITATION; PATTERNS; EPOCH	The El Nino/Southern Oscillation (ENSO) system during the Pliocene warm period (PWP; 3-5 million years ago) may have existed in a permanent El Nino state with a sharply reduced zonal sea surface temperature (SST) gradient in the equatorial Pacific Ocean(1). This suggests that during the PWP, when global mean temperatures and atmospheric carbon dioxide concentrations were similar to those projected for near-term climate change(2), ENSO variability-and related global climate teleconnections-could have been radically different from that today. Yet, owing to a lack of observational evidence on seasonal and interannual SST variability from crucial low-latitude sites, this fundamental climate characteristic of the PWP remains controversial(1,3-10). Here we show that permanent El Nino conditions did not exist during the PWP. Our spectral analysis of the delta(18)O SST and salinity proxy, extracted from two 35-year, monthly resolved PWP Porites corals in the Philippines, reveals variability that is similar to present ENSO variation. Although our fossil corals cannot be directly compared with modern ENSO records, two lines of evidence suggest that Philippine corals are appropriate ENSO proxies. First, delta(18)O anomalies from a nearby live Porites coral are correlated with modern records of ENSO variability. Second, negative-delta(18)O events in the fossil corals closely resemble the decreases in delta(18)O seen in the live coral during El Nino events. Prior research advocating a permanent El Nino state may have been limited by the coarse resolution of many SST proxies, whereas our coral-based analysis identifies climate variability at the temporal scale required to resolve ENSO structure firmly.	[Watanabe, Tsuyoshi; Minobe, Shoshiro; Kawashima, Tatsunori; Sowa, Kohki; Nagai, Takaya] Hokkaido Univ, Dept Nat Hist Sci, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Suzuki, Atsushi; Minoshima, Kayo] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Kameo, Koji] Chiba Univ, Dept Earth Sci, Fac Sci, Chiba 2638522, Japan; [Aguilar, Yolanda M.] Mines & Geosci Bur, Petrolab, Quezon City 1101, Philippines; [Wani, Ryoji] Yokohama Natl Univ, Interdisciplinary Res Ctr, Yokohama, Kanagawa 2408501, Japan; [Kawahata, Hodaka] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2775564, Japan; [Kase, Tomoki] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tokyo 1690073, Japan	Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST); Chiba University; Yokohama National University; University of Tokyo; National Museum of Nature and Science	Watanabe, T (corresponding author), Hokkaido Univ, Dept Nat Hist Sci, Fac Sci, Sapporo, Hokkaido 0600810, Japan.	nabe@mail.sci.hokudai.ac.jp	Watanabe, Tsuyoshi/A-5741-2012; Sowa, Kohki/T-7332-2019; Nagai, Takaya/C-3428-2011; Minobe, Shoshiro/E-2997-2010; KAWAHATA, HODAKA/F-9065-2016; Suzuki, Atsushi/L-6120-2018	Minobe, Shoshiro/0000-0002-9487-9006; KAWAHATA, HODAKA/0000-0003-4236-7356; Suzuki, Atsushi/0000-0002-0266-5765; Wani, Ryoji/0000-0002-3733-769X				Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; COLE JE, 1993, SCIENCE, V260, P1790, DOI 10.1126/science.260.5115.1790; Correge T, 2004, NATURE, V428, P927, DOI 10.1038/nature02506; Dai A, 2000, GEOPHYS RES LETT, V27, P1283, DOI 10.1029/1999GL011140; Dowsett HJ, 2009, PHILOS T R SOC A, V367, P109, DOI 10.1098/rsta.2008.0206; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Fedorov AV, 2010, NATURE, V463, P1066, DOI 10.1038/nature08831; Haywood AM, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001323; Lawrence KT, 2006, SCIENCE, V312, P79, DOI 10.1126/science.1120395; Mix A.C., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P371, DOI 10.2973/odp.proc.sr.138.120.1995; Molnar P, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000663; Molnar P, 2007, GEOSPHERE, V3, P337, DOI 10.1130/GES00103.1; PHILANDER SG, 1990, NINO NINA SO OSCILLA, P9; Raffi I, 2006, QUATERNARY SCI REV, V25, P3113, DOI 10.1016/j.quascirev.2006.07.007; RASMUSSON EM, 1982, MON WEATHER REV, V110, P354, DOI 10.1175/1520-0493(1982)110<0354:VITSST>2.0.CO;2; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Rickaby REM, 2005, SCIENCE, V307, P1948, DOI 10.1126/science.1104666; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Urban FE, 2000, NATURE, V407, P989, DOI 10.1038/35039597; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Watanabe T, 2003, GEOCHIM COSMOCHIM AC, V67, P1349, DOI 10.1016/S0016-7037(02)01221-8	23	88	93	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					209	211		10.1038/nature09777	http://dx.doi.org/10.1038/nature09777			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390128				2022-12-28	WOS:000288170200035
J	Giuliari, GP; Connor, A; Simpson, ER				Giuliari, Gian Paolo; Connor, Allan; Simpson, E. Rand			Amelanotic choroidal melanoma	LANCET			English	Editorial Material									[Giuliari, Gian Paolo; Connor, Allan; Simpson, E. Rand] Univ Toronto, Princess Margaret Hosp, Toronto, ON M5G1H4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Giuliari, GP (corresponding author), Univ Toronto, Princess Margaret Hosp, 77 Elm St,Apt 903, Toronto, ON M5G1H4, Canada.	gpgiuliari@gmail.com							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 5	2011	377	9768					848	848		10.1016/S0140-6736(10)60815-X	http://dx.doi.org/10.1016/S0140-6736(10)60815-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GO	21354612				2022-12-28	WOS:000288628500032
J	Sun, TT; Aceto, N; Meerbrey, KL; Kessler, JD; Zhou, CS; Migliaccio, I; Nguyen, DX; Pavlova, NN; Botero, M; Huang, JA; Bernardi, RJ; Schmitt, E; Hu, GA; Li, MZ; Dephoure, N; Gygi, SP; Rao, M; Creighton, CJ; Hilsenbeck, SG; Shaw, CA; Muzny, D; Gibbs, RA; Wheeler, DA; Osborne, CK; Schiff, R; Bentires-Alj, M; Elledge, SJ; Westbrook, TF				Sun, Tingting; Aceto, Nicola; Meerbrey, Kristen L.; Kessler, Jessica D.; Zhou, Chunshui; Migliaccio, Ilenia; Nguyen, Don X.; Pavlova, Natalya N.; Botero, Maria; Huang, Jian; Bernardi, Ronald J.; Schmitt, Earlene; Hu, Guang; Li, Mamie Z.; Dephoure, Noah; Gygi, Steven P.; Rao, Mitchell; Creighton, Chad J.; Hilsenbeck, Susan G.; Shaw, Chad A.; Muzny, Donna; Gibbs, Richard A.; Wheeler, David A.; Osborne, C. Kent; Schiff, Rachel; Bentires-Alj, Mohamed; Elledge, Stephen J.; Westbrook, Thomas F.			Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase	CELL			English	Article							PHOSPHOTYROSINE INTERACTION DOMAIN; PROTEIN; PEST; DIFFERENTIATION; SUBSTRATE; ONCOGENE; RECEPTOR; IDENTIFICATION; ASSOCIATION; EXPRESSION	Among breast cancers, triple-negative breast cancer (TNBC) is the most poorly understood and is refractory to current targeted therapies. Using a genetic screen, we identify the PTPN12 tyrosine phosphatase as a tumor suppressor in TNBC. PTPN12 potently suppresses mammary epithelial cell proliferation and transformation. PTPN12 is frequently compromised in human TNBCs, and we identify an upstream tumor-suppressor network that posttranscriptionally controls PTPN12. PTPN12 suppresses transformation by interacting with and inhibiting multiple oncogenic tyrosine kinases, including HER2 and EGFR. The tumorigenic and metastatic potential of PTPN12-deficient TNBC cells is severely impaired upon restoration of PTPN12 function or combined inhibition of PTPN12-regulated tyrosine kinases, suggesting that TNBCs are dependent on the proto-oncogenic tyrosine kinases constrained by PTPN12. Collectively, these data identify PTPN12 as a commonly inactivated tumor suppressor and provide a rationale for combinatorially targeting proto-oncogenic tyrosine kinases in TNBC and other cancers based on their profile of tyrosine-phosphatase activity.	[Sun, Tingting; Meerbrey, Kristen L.; Kessler, Jessica D.; Schmitt, Earlene; Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Meerbrey, Kristen L.; Kessler, Jessica D.; Schmitt, Earlene; Rao, Mitchell; Shaw, Chad A.; Gibbs, Richard A.; Westbrook, Thomas F.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bernardi, Ronald J.; Westbrook, Thomas F.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Creighton, Chad J.; Hilsenbeck, Susan G.] Baylor Coll Med, Div Biostat, Houston, TX 77030 USA; [Creighton, Chad J.; Hilsenbeck, Susan G.; Gibbs, Richard A.; Wheeler, David A.; Osborne, C. Kent; Schiff, Rachel; Westbrook, Thomas F.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Migliaccio, Ilenia; Botero, Maria; Huang, Jian; Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Osborne, C. Kent; Schiff, Rachel] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Muzny, Donna; Gibbs, Richard A.; Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Aceto, Nicola; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland; [Zhou, Chunshui; Pavlova, Natalya N.; Hu, Guang; Li, Mamie Z.; Elledge, Stephen J.] Harvard Univ, Howard Hughes Med Inst, Dept Genet, Sch Med,Div Genet,Brigham & Womens Hosp, Boston, MA 02115 USA; [Dephoure, Noah; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Nguyen, Don X.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Friedrich Miescher Institute for Biomedical Research; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Yale University	Westbrook, TF (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	thomasw@bcm.edu	Hu, Guang/E-7474-2016; Mohamed, Bentires-Alj/F-4484-2015; Wheeler, David A/M-9740-2018; Dephoure, Noah/N-7818-2014; Aceto, Nicola/O-2484-2014	Hu, Guang/0000-0003-0437-4723; Mohamed, Bentires-Alj/0000-0001-6344-1127; Wheeler, David A/0000-0002-9056-6299; Dephoure, Noah/0000-0001-5802-2657; Aceto, Nicola/0000-0001-9579-6918; Shaw, Chad/0000-0001-7267-5398; Hartman, Jessica/0000-0003-1578-3389	Susan G. Komen for the Cure [KG090355, P50 CA058183, HG3456]; U.S. Army [W81XWH0410197]; Novartis Research Foundation; European Research Council (ERC); Swiss Cancer League; Krebsliga Beider Basel; NATIONAL CANCER INSTITUTE [P50CA058183, P30CA125123] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102745] Funding Source: NIH RePORTER	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); U.S. Army(United States Department of DefenseUnited States Army); Novartis Research Foundation; European Research Council (ERC)(European Research Council (ERC)); Swiss Cancer League; Krebsliga Beider Basel; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J. Luo, J. Rosen, and A. Lee for suggestions and critical reading of the manuscript. We are grateful to A. Lee, J. LaBaer, O. Lee, Z. Songyang, and J. Qin for providing reagents, and A. Elia for help with phosphopeptide analysis. This work was supported by a Susan G. Komen for the Cure Career Catalyst Award (KG090355) to T. F. W., S. P. O. R. E developmental grant (P50 CA058183) to T. F. W., S. P. O. R. E. grant (P50 CA058183) to R. S. and C. K. O., grant HG3456 to S. P. G., and a U.S. Army Innovator Award (W81XWH0410197) to S. J. E. Research in the laboratory of M.B.-A. is supported by the Novartis Research Foundation, the European Research Council (ERC starting grant), the Swiss Cancer League, and the Krebsliga Beider Basel. S. J. E. is an Investigator with the Howard Hughes Medical Institute. T. F. W. is a scholar of The V Foundation and Mary Kay Ash Foundation for Cancer Research.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; BATZER AG, 1995, MOL CELL BIOL, V15, P4403; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Brandt R, 2000, ONCOGENE, V19, P2129, DOI 10.1038/sj.onc.1203520; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Hurvitz SA, 2009, FUTURE ONCOL, V5, P1015, DOI 10.2217/FON.09.68; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Markova B, 2003, BIOCHEMISTRY-US, V42, P2691, DOI 10.1021/bi0265574; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Pao LI, 2007, ANNU REV IMMUNOL, V25, P473, DOI 10.1146/annurev.immunol.23.021704.115647; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SONGYANG Z, 1995, J BIOL CHEM, V270, P14863, DOI 10.1074/jbc.270.25.14863; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; YANG Q, 1993, J BIOL CHEM, V268, P6622; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139	41	212	222	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					703	718		10.1016/j.cell.2011.02.003	http://dx.doi.org/10.1016/j.cell.2011.02.003			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376233	Bronze, Green Accepted			2022-12-28	WOS:000288007100010
J	Christiani, DC				Christiani, David C.			Combating Environmental Causes of Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Christiani, David C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Christiani, DC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009; Hiatt, Robert/AAQ-1537-2021	Colditz, Graham/0000-0002-7307-0291; 				*IARC, IARC MON EV CARC RIS; *NAT CANC I PRES C, 2010, RED ENV CANC RISK WH; THOMAS DB, 1987, CANCER RES, V47, P5771; Tomatis L, 1997, CARCINOGENESIS, V18, P97, DOI 10.1093/carcin/18.1.97; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055	5	17	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					791	793		10.1056/NEJMp1006634	http://dx.doi.org/10.1056/NEJMp1006634			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366471				2022-12-28	WOS:000287928400002
J	Lerman, L				Lerman, Liz			The Genome Dances	SCIENCE			English	Editorial Material											Lerman, L (corresponding author), Liz Lerman Dance Exchange, Takoma Pk, MD USA.								0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1027	1027		10.1126/science.1203459	http://dx.doi.org/10.1126/science.1203459			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350168				2022-12-28	WOS:000287699000051
J	Ramamurthi, KS				Ramamurthi, Kumaran S.			mRNA Delivers the Goods	SCIENCE			English	Editorial Material							PROTEINS; MEMBRANES		NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ramamurthi, KS (corresponding author), NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	ramamurthiks@mail.nih.gov	Ramamurthi, Kumaran/P-3516-2015		NATIONAL CANCER INSTITUTE [ZIABC011211] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; LANDE MA, 1975, J CELL BIOL, V65, P513, DOI 10.1083/jcb.65.3.513; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685	9	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1021	1022		10.1126/science.1201001	http://dx.doi.org/10.1126/science.1201001			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350158	Green Accepted			2022-12-28	WOS:000287699000042
J	Schooler, J				Schooler, Jonathan			Unpublished results hide the decline effect	NATURE			English	Editorial Material									Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Schooler, J (corresponding author), Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.	schooler@psych.ucsb.edu	Schooler, Jonathan/ABE-6434-2020; Schooler, Jonathan/AAZ-3977-2020						0	205	204	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					437	437		10.1038/470437a	http://dx.doi.org/10.1038/470437a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725NT	21350443	Bronze			2022-12-28	WOS:000287652900004
J	Evans, JP; Meslin, EM; Marteau, TM; Caulfield, T				Evans, James P.; Meslin, Eric M.; Marteau, Theresa M.; Caulfield, Timothy			Deflating the Genomic Bubble	SCIENCE			English	Editorial Material							RISK; ASSOCIATION; PERFORMANCE; VARIANTS		[Evans, James P.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Evans, James P.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Meslin, Eric M.] Indiana Univ, Ctr Bioeth, Indianapolis, IN 46202 USA; [Marteau, Theresa M.] Kings Coll London, Hlth Psychol Sect, London SE1 9RT, England; [Caulfield, Timothy] Univ Alberta, Fac Law, Edmonton, AB T6G 2H5, Canada; [Caulfield, Timothy] Univ Alberta, Hlth Law Inst, Sch Publ Hlth, Edmonton, AB T6G 2H5, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Indiana University System; Indiana University-Purdue University Indianapolis; University of London; King's College London; University of Alberta; University of Alberta	Evans, JP (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	jpevans@med.unc.edu		Marteau, Theresa/0000-0003-3025-1129	Medical Research Council [G0500274] Funding Source: Medline; MRC [G0500274] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2010, NATURE, V464, P649, DOI 10.1038/464649a; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Carlsson B, 2009, IND CORP CHANGE, V18, P1193, DOI 10.1093/icc/dtp043; Caulfield T, 2004, PLOS MED, V1, P178, DOI 10.1371/journal.pmed.0010038; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Garrison LP, 2008, DRUG METAB REV, V40, P377, DOI 10.1080/03602530801952500 ; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; GOODMAN KW, 2003, ETHICS EVIDENCE BASE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Keeney RL, 2008, OPER RES, V56, P1335, DOI 10.1287/opre.1080.0588; Kimmelman J., 2009, GENE TRANSFER ETHICS; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Marteau TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007275.pub2; McClure JB, 2002, AM J PREV MED, V22, P200, DOI 10.1016/S0749-3797(01)00425-1; Navigenics Inc, GEN HLTH; Pedersen NL, 2010, JAMA-J AM MED ASSOC, V303, P1864, DOI 10.1001/jama.2010.609; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Petersen A, 2009, MONASH BIOETH REV, V28, P22, DOI 10.2104/mber0905; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Pohlhaus JR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-472; Pollack Andrew, 2010, NY TIMES, pB5; Silver H. J., 2008, 33 AAAS; Tucker G, 2004, BMJ-BRIT MED J, V329, P4, DOI 10.1136/bmj.329.7456.4; Varmus H., 2009, ART POLITICS SCI; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; WHO Regional Committee for Europe, 2008, RES BEH CHANG STRAT; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055	34	137	143	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					861	862		10.1126/science.1198039	http://dx.doi.org/10.1126/science.1198039			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330519				2022-12-28	WOS:000287455100031
J	Laurell, E; Beck, K; Krupina, K; Theerthagiri, G; Bodenmiller, B; Horvath, P; Aebersold, R; Antonin, W; Kutay, U				Laurell, Eva; Beck, Katja; Krupina, Ksenia; Theerthagiri, Gandhi; Bodenmiller, Bernd; Horvath, Peter; Aebersold, Ruedi; Antonin, Wolfram; Kutay, Ulrike			Phosphorylation of Nup98 by Multiple Kinases Is Crucial for NPC Disassembly during Mitotic Entry	CELL			English	Article							NUCLEAR-PORE COMPLEX; CYCLE-DEPENDENT PHOSPHORYLATION; NEK2 PROTEIN-KINASE; ENVELOPE BREAKDOWN; NIMA-FAMILY; NUCLEOPORIN; REVEALS; MITOSIS; ACTIVATION; DOMAINS	Disassembly of nuclear pore complexes (NPCs) is a decisive event during mitotic entry in cells undergoing open mitosis, yet the molecular mechanisms underlying NPC disassembly are unknown. Using chemical inhibition and depletion experiments we show that NPC disassembly is a phosphorylation-driven process, dependent on CDK1 activity and supported by members of the NIMA-related kinase (Nek) family. We identify phosphorylation of the GLFG-repeat nucleoporin Nup98 as an important step in mitotic NPC disassembly. Mitotic hyperphos-phorylation of Nup98 is accomplished by multiple kinases, including CDK1 and Neks. Nuclei carrying a phosphodeficient mutant of Nup98 undergo nuclear envelope breakdown slowly, such that both the dissociation of Nup98 from NPCs and the permeabilization of the nuclear envelope are delayed. Together, our data provide evidence for a phosphorylation-dependent mechanism underlying disintegration of NPCs during prophase. Moreover, we identify mitotic phosphorylation of Nup98 as a rate-limiting step in mitotic NPC disassembly.	[Laurell, Eva; Beck, Katja; Krupina, Ksenia; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Theerthagiri, Gandhi; Antonin, Wolfram] Friedrich Miescher Lab, D-72076 Tubingen, Germany; [Bodenmiller, Bernd; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Horvath, Peter] ETH, Light Microscopy Ctr, Dept Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Eberhard Karls University of Tubingen; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Kutay, U (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	ulrike.kutay@bc.biol.ethz.ch	Antonin, Wolfram/A-8656-2014; Antonin, Wolfram/P-3648-2019	Antonin, Wolfram/0000-0003-4669-379X; Antonin, Wolfram/0000-0003-4669-379X; T. K. Boopathy, Gandhi/0000-0002-1821-9540	DFG [KN 938/1-1]; SNF [3100AO-133135]	DFG(German Research Foundation (DFG)); SNF	We thank C. Ashiono for excellent technical assistance, S. Giese for help automating image analysis, J. Ellenberg, P. Lidsky, K. S. Fields, and C. R. Mena for reagents, P. Meraldi and A. Rothballer for critical reading, and P. Meraldi, H. Meyer, D. Gerlich, and M. Held for discussion. Imaging was performed on instruments of the ETH Light Microscopy Center. This work was supported by the DFG (KN 938/1-1) to K. B. and the SNF (3100AO-133135) to U.K.	Belham C, 2003, J BIOL CHEM, V278, P34897, DOI 10.1074/jbc.M303663200; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; Frey S, 2009, EMBO J, V28, P2554, DOI 10.1038/emboj.2009.199; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.e03-10-0743; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Jeganathan KB, 2005, NATURE, V438, P1036, DOI 10.1038/nature04221; Kiseleva E, 2001, J CELL SCI, V114, P3607; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li HC, 2010, P NATL ACAD SCI USA, V107, P14633, DOI 10.1073/pnas.1006615107; LU KP, 1994, EMBO J, V13, P2103, DOI 10.1002/j.1460-2075.1994.tb06486.x; LU KP, 1993, J BIOL CHEM, V268, P8769; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Muhlhausser P, 2007, J CELL BIOL, V178, P595, DOI 10.1083/jcb.200703002; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Onischenko EA, 2005, MOL BIOL CELL, V16, P5152, DOI 10.1091/mbc.E05-07-0642; OSMANI AH, 1991, CELL, V67, P283, DOI 10.1016/0092-8674(91)90180-7; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Schultz C, 1999, J MED CHEM, V42, P2909, DOI 10.1021/jm9900570; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Wu WJ, 2007, J BIOL CHEM, V282, P26431, DOI 10.1074/jbc.M704969200; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598	48	173	177	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					539	550		10.1016/j.cell.2011.01.012	http://dx.doi.org/10.1016/j.cell.2011.01.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335236	Bronze			2022-12-28	WOS:000287473100009
J	Baccarelli, A; Benjamin, EJ				Baccarelli, Andrea; Benjamin, Emelia J.			Triggers of MI for the individual and in the community	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; AIR-POLLUTION; DISEASE; UPDATE; HEALTH		[Baccarelli, Andrea] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, Boston, MA 02115 USA; [Benjamin, Emelia J.] NHLBI, Framingham, MA USA; [Benjamin, Emelia J.] Boston Univ, Framingham Heart Study, Framingham, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Prevent Med Sect, Boston, MA 02118 USA	Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; Boston University; Boston University	Baccarelli, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, Boston, MA 02115 USA.	abaccare@hsph.harvard.edu	; Benjamin, Emelia/E-7103-2011	Baccarelli, Andrea/0000-0002-3436-0640; Benjamin, Emelia/0000-0003-4076-2336	NIEHS NIH HHS [P30 ES000002-46, P30 ES000002] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Hart JE, 2009, ENVIRON HEALTH PERSP, V117, P1690, DOI 10.1289/ehp.0900840; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Mittleman MA, 1999, CIRCULATION, V99, P2737, DOI 10.1161/01.CIR.99.21.2737; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; UN Environment Programme, 2007, GEO4 ENV DEV STAT TR; WHO, 2005, WHO AIR QUAL GUID PA; WHO, 2010, METR POP ATTR FRACT	10	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2011	377	9767					694	696		10.1016/S0140-6736(10)62348-3	http://dx.doi.org/10.1016/S0140-6736(10)62348-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729JQ	21353302	Green Accepted			2022-12-28	WOS:000287946000005
J	Adriani, O; Barbarino, GC; Bazilevskaya, GA; Bellotti, R; Boezio, M; Bogomolov, EA; Bonechi, L; Bongi, M; Bonvicini, V; Borisov, S; Bottai, S; Bruno, A; Cafagna, F; Campana, D; Carbone, R; Carlson, P; Casolino, M; Castellini, G; Consiglio, L; De Pascale, MP; De Santis, C; De Simone, N; Di Felice, V; Galper, AM; Gillard, W; Grishantseva, L; Jerse, G; Karelin, AV; Koldashov, SV; Krutkov, SY; Kvashnin, AN; Leonov, A; Malakhov, V; Malvezzi, V; Marcelli, L; Mayorov, AG; Menn, W; Mikhailov, VV; Mocchiutti, E; Monaco, A; Mori, N; Nikonov, N; Osteria, G; Palma, F; Papini, P; Pearce, M; Picozza, P; Pizzolotto, C; Ricci, M; Ricciarini, SB; Rossetto, L; Sarkar, R; Simon, M; Sparvoli, R; Spillantini, P; Stozhkov, YI; Vacchi, A; Vannuccini, E; Vasilyev, G; Voronov, SA; Yurkin, YT; Wu, J; Zampa, G; Zampa, N; Zverev, VG				Adriani, O.; Barbarino, G. C.; Bazilevskaya, G. A.; Bellotti, R.; Boezio, M.; Bogomolov, E. A.; Bonechi, L.; Bongi, M.; Bonvicini, V.; Borisov, S.; Bottai, S.; Bruno, A.; Cafagna, F.; Campana, D.; Carbone, R.; Carlson, P.; Casolino, M.; Castellini, G.; Consiglio, L.; De Pascale, M. P.; De Santis, C.; De Simone, N.; Di Felice, V.; Galper, A. M.; Gillard, W.; Grishantseva, L.; Jerse, G.; Karelin, A. V.; Koldashov, S. V.; Krutkov, S. Y.; Kvashnin, A. N.; Leonov, A.; Malakhov, V.; Malvezzi, V.; Marcelli, L.; Mayorov, A. G.; Menn, W.; Mikhailov, V. V.; Mocchiutti, E.; Monaco, A.; Mori, N.; Nikonov, N.; Osteria, G.; Palma, F.; Papini, P.; Pearce, M.; Picozza, P.; Pizzolotto, C.; Ricci, M.; Ricciarini, S. B.; Rossetto, L.; Sarkar, R.; Simon, M.; Sparvoli, R.; Spillantini, P.; Stozhkov, Y. I.; Vacchi, A.; Vannuccini, E.; Vasilyev, G.; Voronov, S. A.; Yurkin, Y. T.; Wu, J.; Zampa, G.; Zampa, N.; Zverev, V. G.			PAMELA Measurements of Cosmic-Ray Proton and Helium Spectra	SCIENCE			English	Article							SOLAR MODULATION; ACCELERATION; PROPAGATION; GALAXY; MATTER; WAVES; BESS	Protons and helium nuclei are the most abundant components of the cosmic radiation. Precise measurements of their fluxes are needed to understand the acceleration and subsequent propagation of cosmic rays in our Galaxy. We report precision measurements of the proton and helium spectra in the rigidity range 1 gigavolt to 1.2 teravolts performed by the satellite-borne experiment PAMELA (payload for antimatter matter exploration and light-nuclei astrophysics). We find that the spectral shapes of these two species are different and cannot be described well by a single power law. These data challenge the current paradigm of cosmic-ray acceleration in supernova remnants followed by diffusive propagation in the Galaxy. More complex processes of acceleration and propagation of cosmic rays are required to explain the spectral structures observed in our data.	[Borisov, S.; Casolino, M.; De Pascale, M. P.; De Santis, C.; De Simone, N.; Di Felice, V.; Malvezzi, V.; Marcelli, L.; Nikonov, N.; Palma, F.; Picozza, P.; Sparvoli, R.] Ist Nazl Fis Nucl, Sez Rome Tor Vergata, I-00133 Rome, Italy; [Adriani, O.; Bonechi, L.; Mori, N.; Spillantini, P.] Univ Florence, Dept Phys, I-50019 Florence, Italy; [Adriani, O.; Bonechi, L.; Bongi, M.; Bottai, S.; Mori, N.; Papini, P.; Ricciarini, S. B.; Spillantini, P.; Vannuccini, E.] Ist Nazl Fis Nucl, Sez Florence, I-50019 Florence, Italy; [Barbarino, G. C.] Univ Naples Federico 2, Dept Phys, I-80126 Naples, Italy; [Barbarino, G. C.; Campana, D.; Carbone, R.; Consiglio, L.; Osteria, G.] Ist Nazl Fis Nucl, Sez Naples, I-80126 Naples, Italy; [Bazilevskaya, G. A.; Kvashnin, A. N.; Stozhkov, Y. I.] Lebedev Phys Inst, RU-119991 Moscow, Russia; [Bellotti, R.; Bruno, A.; Monaco, A.] Univ Bari, Dept Phys, I-70126 Bari, Italy; [Bellotti, R.; Bruno, A.; Cafagna, F.; Monaco, A.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Boezio, M.; Bonvicini, V.; Jerse, G.; Mocchiutti, E.; Pizzolotto, C.; Sarkar, R.; Vacchi, A.; Zampa, G.; Zampa, N.] Ist Nazl Fis Nucl, Sez Trieste, I-34149 Trieste, Italy; [Bogomolov, E. A.; Krutkov, S. Y.; Nikonov, N.; Vasilyev, G.] AF Ioffe Phys Tech Inst, RU-194021 St Petersburg, Russia; [Borisov, S.; Carbone, R.; De Pascale, M. P.; De Santis, C.; De Simone, N.; Nikonov, N.; Palma, F.; Picozza, P.; Sparvoli, R.] Univ Roma Tor Vergata, Dept Phys, I-00133 Rome, Italy; [Borisov, S.; Galper, A. M.; Grishantseva, L.; Karelin, A. V.; Koldashov, S. V.; Leonov, A.; Malakhov, V.; Mayorov, A. G.; Mikhailov, V. V.; Voronov, S. A.; Yurkin, Y. T.; Zverev, V. G.] Moscow Engn & Phys Inst, RU-11540 Moscow, Russia; [Carlson, P.; Gillard, W.; Pearce, M.; Rossetto, L.; Wu, J.] Kungliga Tekniska Hogskolan, Dept Phys, SE-10691 Stockholm, Sweden; [Carlson, P.; Gillard, W.; Pearce, M.; Rossetto, L.; Wu, J.] AlbaNova Univ Ctr, Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Castellini, G.] Ist Fis Applicata Nello Carrara, I-50019 Florence, Italy; [Jerse, G.] Univ Trieste, Dept Phys, I-34147 Trieste, Italy; [Menn, W.; Simon, M.] Univ Siegen, Dept Phys, D-57068 Siegen, Germany; [Ricci, M.] Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy	Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; Istituto Nazionale di Fisica Nucleare (INFN); University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; University of Rome Tor Vergata; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Royal Institute of Technology; Oskar Klein Centre; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisica Applicata "Nello Carrara" (IFAC-CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Trieste; Universitat Siegen; Istituto Nazionale di Fisica Nucleare (INFN)	Picozza, P (corresponding author), Ist Nazl Fis Nucl, Sez Rome Tor Vergata, I-00133 Rome, Italy.	picozza@roma2.infn.it	Voronov, Sergey A/P-9654-2016; Bazilevskaya, Galina/M-6175-2015; Casolino, Marco/ABI-1081-2020; Bongi, Massimo/AAA-9384-2022; Vasilyev, Gennady/E-4843-2014; Bongi, Massimo/L-9417-2015; Boezio, Mirko/ABC-4188-2020; Vacchi, Andrea G/C-1291-2010; Yuri, Stozhkov/ABG-7096-2021; Leonov, Alexey/E-4698-2016; Palma, Francesco/K-3224-2015; Ricciarini, Sergio Bruno/AAW-1098-2020; Osteria, Giuseppe/ABH-3196-2020; Barbarino, Giancarlo/L-2559-2015; De Santis, Cristian/C-1210-2011; Galper, Arkady M/M-9610-2015; Malakhov, Vitaly/Q-6730-2016; Mocchiutti, Emiliano/I-8049-2013; Mayorov, Andrey/AAU-2310-2020; Di Felice, Valeria/L-2989-2016; Kvashnin, Aleksandr N/M-8673-2015; S., Krutkov/E-7561-2014; Sparvoli, Roberta/H-8024-2018; Monaco, Alfonso/AGA-5911-2022; GILLARD, William/GQH-6424-2022; Karelin, Alexander/O-6576-2016; Stozhkov, Yuri/M-7433-2015; Mikhailov, Vladimir V/B-5368-2014; Osteria, Giuseppe/AAS-2038-2020; Vannuccini, Elena/ABH-4180-2020; Mori, Nicola/D-9459-2016; marcelli, laura/K-8860-2016; Pizzolotto, Cecilia/G-5821-2013; Cafagna, Francesco/A-9299-2010; Mayorov, Andrey/M-1207-2016; Castellini, Guido/C-6716-2018	Voronov, Sergey A/0000-0002-9209-0618; Bazilevskaya, Galina/0000-0003-3319-684X; Bongi, Massimo/0000-0002-6050-1937; Bongi, Massimo/0000-0002-6050-1937; Boezio, Mirko/0000-0002-8015-2981; Vacchi, Andrea G/0000-0003-3855-5856; Palma, Francesco/0000-0001-7076-8830; Ricciarini, Sergio Bruno/0000-0001-6176-3368; Osteria, Giuseppe/0000-0002-9871-8103; Barbarino, Giancarlo/0000-0001-9253-3397; De Santis, Cristian/0000-0002-7280-2446; Mocchiutti, Emiliano/0000-0001-7856-551X; Mayorov, Andrey/0000-0001-6283-0817; Kvashnin, Aleksandr N/0000-0001-7218-6738; Sparvoli, Roberta/0000-0002-6314-6117; Monaco, Alfonso/0000-0002-5968-8642; GILLARD, William/0000-0003-4744-9748; Stozhkov, Yuri/0000-0003-1917-0328; Mikhailov, Vladimir V/0000-0003-3851-2901; Osteria, Giuseppe/0000-0002-9871-8103; Mori, Nicola/0000-0003-2138-3787; marcelli, laura/0000-0002-3180-1228; Pizzolotto, Cecilia/0000-0003-0200-2408; Cafagna, Francesco/0000-0002-7450-4784; Papini, Paolo/0000-0003-4718-2895; Malakhov, Vitaly/0000-0002-4146-419X; Picozza, Piergiorgio/0000-0002-7986-3321; Castellini, Guido/0000-0002-0177-0643; casolino, marco/0000-0001-6067-5104; Bonvicini, Valter/0000-0003-1826-5843; Bellotti, Roberto/0000-0003-3198-2708; Vannuccini, Elena/0000-0002-8647-2804; Campana, Donatella/0000-0003-1504-9707	Italian Space Agency, Deutsches Zentrum fur Luft- und Raumfahrt; Swedish National Space Board; Swedish Research Council; Russian Space Agency (Roscosmos); Russian Foundation for Basic Research	Italian Space Agency, Deutsches Zentrum fur Luft- und Raumfahrt(Helmholtz AssociationGerman Aerospace Centre (DLR)Agenzia Spaziale Italiana (ASI)); Swedish National Space Board; Swedish Research Council(Swedish Research CouncilEuropean Commission); Russian Space Agency (Roscosmos); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	We thank P. Blasi, F. Donato, P. Lipari, and I. Moskalenko for helpful discussions concerning the interpretation of our results and D. Marinucci for helpful discussions on statistical methods. We acknowledge support from the Italian Space Agency, Deutsches Zentrum fur Luft- und Raumfahrt, the Swedish National Space Board, the Swedish Research Council, the Russian Space Agency (Roscosmos), and the Russian Foundation for Basic Research.	Adriani O, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.121101; Adriani O, 2009, NATURE, V458, P607, DOI 10.1038/nature07942; Adriani O, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.051101; Ahn HS, 2006, ADV SPACE RES, V37, P1950, DOI 10.1016/j.asr.2005.09.031; Ahn HS, 2010, ASTROPHYS J LETT, V714, pL89, DOI 10.1088/2041-8205/714/1/L89; Alcaraz J, 2000, PHYS LETT B, V490, P27, DOI 10.1016/S0370-2693(00)00970-9; Amenomori M, 2006, SCIENCE, V314, P439, DOI 10.1126/science.1131702; Arkani-Hamed N, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.015014; Asakimori K, 1998, ASTROPHYS J, V502, P278, DOI 10.1086/305882; Boezio M, 1999, ASTROPHYS J, V518, P457, DOI 10.1086/307251; Boezio M, 2003, ASTROPART PHYS, V19, P583, DOI 10.1016/S0927-6505(02)00267-0; CAPRIOLI D, 2010, ASTROPARTICLE PHYS; Casolino M, 2008, ADV SPACE RES, V42, P455, DOI 10.1016/j.asr.2007.07.023; Donato F, 2001, ASTROPHYS J, V563, P172, DOI 10.1086/323684; Ellison DC, 2007, ASTROPHYS J, V661, P879, DOI 10.1086/517518; Ginzburg V. L., 1964, ORIGIN COSMIC RAYS; GLEESON LJ, 1968, ASTROPHYS J, V154, P1011, DOI 10.1086/149822; Grimani C, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/23/235009; Haino S, 2004, PHYS LETT B, V594, P35, DOI 10.1016/j.physletb.2004.05.019; Hareyama M, 2006, J PHYS CONF SER, V31, P159, DOI 10.1088/1742-6596/31/1/032; JOKIPII JR, 1977, ASTROPHYS J, V213, P861, DOI 10.1086/155218; Jones FC, 2001, ASTROPHYS J, V547, P264, DOI 10.1086/318358; Kane G, 2009, PHYS LETT B, V681, P151, DOI 10.1016/j.physletb.2009.09.053; LAGAGE PO, 1983, ASTRON ASTROPHYS, V118, P223; Malkov MA, 2001, REP PROG PHYS, V64, P429, DOI 10.1088/0034-4885/64/4/201; Menn W, 2000, ASTROPHYS J, V533, P281, DOI 10.1086/308645; Picozza P, 2007, ASTROPART PHYS, V27, P296, DOI 10.1016/j.astropartphys.2006.12.002; Potgieter MS, 2008, J ATMOS SOL-TERR PHY, V70, P207, DOI 10.1016/j.jastp.2007.08.023; Sanuki T, 2001, ADV SPACE RES, V27, P761, DOI 10.1016/S0273-1177(01)00118-1; Strong AW, 2007, ANNU REV NUCL PART S, V57, P285, DOI 10.1146/annurev.nucl.57.090506.123011; Strong AW, 1998, ASTROPHYS J, V509, P212, DOI 10.1086/306470; VLADIMIROV AE, 2010, PREPRINT; Wefel J. P., 2008, P 30 INT COSM RAY C, V2, P31; Zatsepin VI, 2006, ASTRON ASTROPHYS, V458, P1, DOI 10.1051/0004-6361:20065108	34	595	604	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					69	72		10.1126/science.1199172	http://dx.doi.org/10.1126/science.1199172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21385721	Green Submitted, Green Published			2022-12-28	WOS:000289000000038
J	Chow, CK				Chow, Clara K.			Adding omeprazole to clopidogrel reduced GI events and did not increase CV events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chow, Clara K.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Chow, Clara K.] Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia	George Institute for Global Health; University of Sydney; University of Sydney	Chow, CK (corresponding author), Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia.							Gilard M, 2006, J THROMB HAEMOST, V4, P2508, DOI 10.1111/j.1538-7836.2006.02162.x; Gremmel T, 2010, J CARDIOVASC PHARM, V56, P532, DOI 10.1097/FJC.0b013e3181f68209; Gurbel PA, 2011, NAT REV CARDIOL, V8, P7, DOI 10.1038/nrcardio.2010.185; Lai KC, 2002, NEW ENGL J MED, V346, P2033, DOI 10.1056/NEJMoa012877; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821	6	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-7	10.7326/0003-4819-154-6-201103150-02007	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403070				2022-12-28	WOS:000208886200006
J	Koretz, R				Koretz, Ronald			Meta-analysis: Aspirin reduces risk for colon cancer and related mortality at 20 years, particularly when taken for >= 5 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Olive View UCLA Med Ctr, Sylmar, CA 91342 USA	University of California System; University of California Los Angeles	Koretz, R (corresponding author), Olive View UCLA Med Ctr, 14445 Olive View Dr, Sylmar, CA 91342 USA.							Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003	2	3	3	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-3	10.7326/0003-4819-154-6-201103150-02003	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403066				2022-12-28	WOS:000208886200002
J	Markenson, JA				Markenson, Joseph A.			Review: Glucosamine and chondroitin, alone or in combination, do not clinically improve knee or hip pain in osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Cornell Univ, Joan & Sanford Weill Med Coll, New York, NY 10021 USA	Cornell University	Markenson, JA (corresponding author), Cornell Univ, Joan & Sanford Weill Med Coll, New York, NY 10021 USA.							Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Hochberg MC, 2006, NEW ENGL J MED, V354, P858, DOI 10.1056/NEJMe058324; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	4	2	2	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-4	10.7326/0003-4819-154-6-201103150-02004	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403067				2022-12-28	WOS:000208886200003
J	Cortes, J; O'Shaughnessy, J; Loesch, D; Blum, JL; Vahdat, LT; Petrakova, K; Chollet, P; Manikas, A; Dieras, V; Delozier, T; Vladimirov, V; Cardoso, F; Koh, H; Bougnoux, P; Dutcus, CE; Seegobin, S; Mir, D; Meneses, N; Wanders, J; Twelves, C				Cortes, Javier; O'Shaughnessy, Joyce; Loesch, David; Blum, Joanne L.; Vahdat, Linda T.; Petrakova, Katarina; Chollet, Philippe; Manikas, Alexey; Dieras, Veronique; Delozier, Thierry; Vladimirov, Vladimir; Cardoso, Fatima; Koh, Han; Bougnoux, Philippe; Dutcus, Corina E.; Seegobin, Seth; Mir, Denis; Meneses, Nicole; Wanders, Jantien; Twelves, Chris		EMBRACE Eisai Metastatic Breast	Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study	LANCET			English	Article							IXABEPILONE PLUS CAPECITABINE; HALICHONDRIN B ANALOG; III TRIAL; SOLID TUMORS; ANTHRACYCLINE; E7389; MESYLATE; TAXANE; SURVIVAL; PROGRESSION	Background Treatments with survival benefit are greatly needed for women with heavily pretreated metastatic breast cancer. Eribulin mesilate is a non-taxane microtubule dynamics inhibitor with a novel mode of action. We aimed to compare overall survival of heavily pretreated patients receiving eribulin versus currently available treatments. Methods In this phase 3 open-label study, women with locally recurrent or metastatic breast cancer were randomly allocated (2:1) to eribulin mesilate (1.4 mg/m(2) administered intravenously during 2-5 min on days land 8 of a 21-day cycle) or treatment of physician's choice (TPC). Patients had received between two and five previous chemotherapy regimens (two or more for advanced disease), including an anthracycline and a taxane, unless contraindicated. Randomisation was stratified by geographical region, previous capecitabine treatment, and human epidermal growth factor receptor 2 status. Patients and investigators were not masked to treatment allocation. The primary endpoint was overall survival in the intention-to-treat population. This study is registered at ClinicalTrials.gov, number NCT00388726. Findings 762 women were randomly allocated to treatment groups (508 eribulin, 254 TPC). Overall survival was significantly improved in women assigned to eribulin (median 13.1 months, 95% CI 11.8-14.3) compared with TPC (10.6 months, 9.3-12.5; hazard ratio 0.81,95% CI 0.66-0.99; p=0.041). The most common adverse events in both groups were asthenia or fatigue (270 [54%] of 503 patients on eribulin and 98 [40%] of 247 patients on TPC at all grades) and neutropenia (260 [52%] patients receiving eribulin and 73 [30%] of those on TPC at all grades). Peripheral neuropathy was the most common adverse event leading to discontinuation from eribulin, occurring in 24 (5%) of 503 patients. Interpretation Eribulin showed a significant and clinically meaningful improvement in overall survival compared with TPC in women with heavily pretreated metastatic breast cancer. This finding challenges the notion that improved overall survival is an unrealistic expectation during evaluation of new anticancer therapies in the refractory setting.	[Twelves, Chris] Univ Leeds, Clin Canc Res Grp, Leeds, W Yorkshire, England; [Twelves, Chris] St Jamess Inst Oncol, Leeds, W Yorkshire, England; [Cortes, Javier] Vall dHebron Univ Hosp, Barcelona, Spain; [Cortes, Javier] Vall dHebron Inst Oncol, Barcelona, Spain; [O'Shaughnessy, Joyce; Blum, Joanne L.] Texas Oncol, Baylor Charles A Sammons Canc Ctr, Dallas, TX USA; [O'Shaughnessy, Joyce; Blum, Joanne L.] US Oncol, Dallas, TX USA; [Loesch, David] Caris Life Sci, Phoenix, AZ USA; [Vahdat, Linda T.] Weill Cornell Med Coll, New York, NY USA; [Petrakova, Katarina] Masaryk Mem Canc Inst, Brno, Czech Republic; [Chollet, Philippe] Ctr Jean Perrin, Clermont Ferrand, France; [Manikas, Alexey] St Petersburg City Oncol Ctr, St Petersburg, Russia; [Dieras, Veronique] Inst Curie, Paris, France; [Delozier, Thierry] Ctr Francois Baclesse, F-14021 Caen, France; [Vladimirov, Vladimir] Pyatigorsk Oncol Ctr, Pyatigorsk, Russia; [Cardoso, Fatima] Inst Jules Bordet, B-1000 Brussels, Belgium; [Koh, Han] So Calif Kaiser Permanente, Bellflower, CA USA; [Bougnoux, Philippe] CHU Bretonneau, HS Kaplan Canc Ctr, F-37044 Tours, France; [Dutcus, Corina E.; Meneses, Nicole] Eisai Inc, Woodcliff Lake, NJ USA; [Seegobin, Seth; Mir, Denis; Wanders, Jantien] Eisai Ltd, Hatfield, Herts, England	University of Leeds; Saint James's University Hospital; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Baylor University Medical Center; Texas Oncology; Texas Oncology-Baylor Charles A Sammons Cancer Center; US Oncology Network; Cornell University; Masaryk Memorial Cancer Institute; UNICANCER; Centre Jean Perrin; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Centre Francois Baclesse; Institut Jules Bordet; Kaiser Permanente; CHU Tours; Eisai Co Ltd; Eisai Co Ltd	Twelves, C (corresponding author), Univ Leeds, Clin Canc Res Grp, Leeds, W Yorkshire, England.			Bougnoux, Philippe/0000-0002-8717-055X; Cortes, Javier/0000-0001-7623-1583; Cardoso, Fatima/0000-0002-6692-2249; chollet, philippe/0000-0001-8457-7568; Vahdat, Linda/0000-0002-3522-7382	Roche; Eisai; Bristol-Myers Squibb; Bayer; AstraZeneca; Pfizer	Roche(Roche Holding); Eisai(Eisai Co Ltd); Bristol-Myers Squibb(Bristol-Myers Squibb); Bayer(Bayer AG); AstraZeneca(AstraZeneca); Pfizer(Pfizer)	JC has received consultancy fees from Roche and Eisai. JO'S received honorarium from an Eisai advisory board. JLB has received consultancy fees/honorarium from Eisai. LTV has received consultancy fees from Bristol-Myers Squibb, Bayer, and Eisai; as well as payment for lectures and a grant to her institution from Bristol-Myers Squibb. PC's institution received a grant from Eisai for clinical management. VD has received both a grant from Eisai and participated in an advisory board. FC has received consultancy fees from Eisai. PB has a patient for whom reimbursement for additional costs was received. CED, SS, DM, NM, and JW are employees of Eisai. CT reports receiving travel support from Eisai; consultancy fees from AstraZeneca, Pfizer, and Eisai; payment for lectures from Cephalon, Eisai, and Roche; payment for developing educational presentations from Bridgehead/Healthcare and Roche; travel and accommodation from Roche; and other support from Boehringer-Ingelheim, Celgene/Gloucester, and Sanofi-Aventis. DL, KP, AM, TD, VV, and HK declare that they have no conflicts of interest.	Barrios CH, 2010, BREAST CANCER RES TR, V121, P121, DOI 10.1007/s10549-010-0788-0; Burzykowski T, 2008, J CLIN ONCOL, V26, P1987, DOI 10.1200/JCO.2007.10.8407; Colozza M, 2007, ONCOLOGIST, V12, P253, DOI 10.1634/theoncologist.12-3-253; Cortes J, 2010, J CLIN ONCOL, V28, P3922, DOI 10.1200/JCO.2009.25.8467; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Goel S, 2009, CLIN CANCER RES, V15, P4207, DOI 10.1158/1078-0432.CCR-08-2429; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Jordan MA, 2005, MOL CANCER THER, V4, P1086, DOI 10.1158/1535-7163.MCT-04-0345; Kuznetsov G, 2004, CANCER RES, V64, P5760, DOI 10.1158/0008-5472.CAN-04-1169; Kuznetsov G, 2007, P AM ASSOC CANC RES, V48, P275; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Nabholtz JM, 1999, J CLIN ONCOL, V17, P1413, DOI 10.1200/JCO.1999.17.5.1413; O'Shaughnessy J, 2002, J CLIN ONCOL, V20, P2812, DOI 10.1200/JCO.2002.09.002; Okouneva T, 2008, MOL CANCER THER, V7, P2003, DOI 10.1158/1535-7163.MCT-08-0095; Saad ED, 2010, J CLIN ONCOL, V28, P1958, DOI 10.1200/JCO.2009.25.5414; Smith JA, 2010, BIOCHEMISTRY-US, V49, P1331, DOI 10.1021/bi901810u; Sparano JA, 2010, J CLIN ONCOL, V28, P3256, DOI 10.1200/JCO.2009.24.4244; Synold TW, 2005, J CLIN ONCOL, V23, p200S, DOI 10.1200/jco.2005.23.16_suppl.3036; Tan AR, 2009, CLIN CANCER RES, V15, P4213, DOI 10.1158/1078-0432.CCR-09-0360; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thomas ES, 2007, J CLIN ONCOL, V25, P5210, DOI 10.1200/JCO.2007.12.6557; Towle MJ, 2001, CANCER RES, V61, P1013; Vahdat LT, 2009, J CLIN ONCOL, V27, P2954, DOI 10.1200/JCO.2008.17.7618; Vandat L, 2008, J CLIN ONCOL S, V26, P62; Wozniak KM, 2010, P AM ASS CANC RES, V51	25	781	809	0	61	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2011	377	9769					914	923		10.1016/S0140-6736(11)60070-6	http://dx.doi.org/10.1016/S0140-6736(11)60070-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GR	21376385				2022-12-28	WOS:000288628800034
J	Brown, KR; Ospelkaus, C; Colombe, Y; Wilson, AC; Leibfried, D; Wineland, DJ				Brown, K. R.; Ospelkaus, C.; Colombe, Y.; Wilson, A. C.; Leibfried, D.; Wineland, D. J.			Coupled quantized mechanical oscillators	NATURE			English	Article							QUANTUM COMPUTER; IONS; STATE; ENTANGLEMENT; ATOM	The harmonic oscillator is one of the simplest physical systems but also one of the most fundamental. It is ubiquitous in nature, often serving as an approximation for a more complicated system or as a building block in larger models. Realizations of harmonic oscillators in the quantum regime include electromagnetic fields in a cavity(1-3) and the mechanical modes of a trapped atom(4) or macroscopic solid(5). Quantized interaction between two motional modes of an individual trapped ion has been achieved by coupling through optical fields(6), and entangled motion of two ions in separate locations has been accomplished indirectly through their internal states(7). However, direct controllable coupling between quantized mechanical oscillators held in separate locations has not been realized previously. Here we implement such coupling through the mutual Coulomb interaction of two ions held in trapping potentials separated by 40 mm (similar work is reported in a related paper(8)). By tuning the confining wells into resonance, energy is exchanged between the ions at the quantum level, establishing that direct coherent motional coupling is possible for separately trapped ions. The system demonstrates a building block for quantum information processing and quantum simulation. More broadly, this work is a natural precursor to experiments in hybrid quantum systems, such as coupling a trapped ion to a quantized macroscopic mechanical or electrical oscillator(9-13).	[Brown, K. R.; Ospelkaus, C.; Colombe, Y.; Wilson, A. C.; Leibfried, D.; Wineland, D. J.] NIST, Div Time & Frequency, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Brown, KR (corresponding author), NIST, Div Time & Frequency, 325 Broadway, Boulder, CO 80305 USA.	kenton.brown@nist.gov	Ospelkaus, Christian/C-3612-2009	Ospelkaus, Christian/0000-0002-4170-2936	IARPA; DARPA; ONR; NIST	IARPA; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ONR(Office of Naval Research); NIST(National Institute of Standards & Technology (NIST) - USA)	This work was supported by IARPA, DARPA, ONR and the NIST Quantum Information Program. We thank M. Biercuk, A. VanDevender, J. Amini, and R. B. Blakestad for their help in assembling parts of the experiment, and we thank U. Warring and R. Simmonds for comments. This paper, a submission of NIST, is not subject to US copyright.	Chiaverini J, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022324; Ciaramicoli G, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.017901; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Cirac JI, 2000, NATURE, V404, P579, DOI 10.1038/35007021; Daniilidis N, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/15/154012; Deslauriers L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.103007; Epstein RJ, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.033411; Haroche S., 2006, EXPLORING QUANTUM; HEINZEN DJ, 1990, PHYS REV A, V42, P2977, DOI 10.1103/PhysRevA.42.2977; Hensinger WK, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.041405; Houck AA, 2007, NATURE, V449, P328, DOI 10.1038/nature06126; IDZIASZEK Z, 2010, ION ASSISTED GROUND, P24311; Jost JD, 2009, NATURE, V459, P683, DOI 10.1038/nature08006; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Miller R, 2005, J PHYS B-AT MOL OPT, V38, pS551, DOI 10.1088/0953-4075/38/9/007; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; MONROE C, 1995, PHYS REV LETT, V75, P4011, DOI 10.1103/PhysRevLett.75.4011; MONROE C, 2001, ATOMIC PHYS, V17, P173; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schmied R, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/045017; Schmied R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.233002; Seidelin S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.253003; TAN JN, 2002, B AM PHYS SOC, V47, P103; Tian L, 2005, EUR PHYS J D, V32, P201, DOI 10.1140/epjd/e2004-00172-5; Tian L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.266403	30	191	192	4	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					196	199		10.1038/nature09721	http://dx.doi.org/10.1038/nature09721			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21346762	Green Submitted			2022-12-28	WOS:000288170200032
J	Simsek, D; Furda, A; Gao, Y; Artus, J; Brunet, E; Hadjantonakis, AK; Van Houten, B; Shuman, S; McKinnon, PJ; Jasin, M				Simsek, Deniz; Furda, Amy; Gao, Yankun; Artus, Jerome; Brunet, Erika; Hadjantonakis, Anna-Katerina; Van Houten, Bennett; Shuman, Stewart; McKinnon, Peter J.; Jasin, Maria			Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair	NATURE			English	Article							STRAND BREAK REPAIR; EMBRYONIC LETHALITY; GENE ENCODES; XRCC1; NUCLEAR; PROTEINS; BINDING; ALPHA; CELLS; CYCLE	Mammalian cells have three ATP-dependent DNA ligases, which are required for DNA replication and repair(1). Homologues of ligase I (Lig1) and ligase IV (Lig4) are ubiquitous in Eukarya, whereas ligase III (Lig3), which has nuclear and mitochondrial forms, appears to be restricted to vertebrates. Lig3 is implicated in various DNA repair pathways with its partner protein Xrcc1 (ref. 1). Deletion of Lig3 results in early embryonic lethality in mice, as well as apparent cellular lethality(2), which has precluded definitive characterization of Lig3 function. Here we used pre-emptive complementation to determine the viability requirement for Lig3 in mammalian cells and its requirement in DNA repair. Various forms of Lig3 were introduced stably into mouse embryonic stem (mES) cells containing a conditional allele of Lig3 that could be deleted with Cre recombinase. With this approach, we find that the mitochondrial, but not nuclear, Lig3 is required for cellular viability. Although the catalytic function of Lig3 is required, the zinc finger (ZnF) and BRCA1 carboxy (C)-terminal-related (BRCT) domains of Lig3 are not. Remarkably, the viability requirement for Lig3 can be circumvented by targeting Lig1 to the mitochondria or expressing Chlorella virus DNA ligase, the minimal eukaryal nick-sealing enzyme(3), or Escherichia coli LigA, an NAD(+)-dependent ligase(1). Lig3-null cells are not sensitive to several DNA-damaging agents that sensitize Xrcc1-deficient cells(4-6). Our results establish a role for Lig3 in mitochondria, but distinguish it from its interacting protein Xrcc1.	[Simsek, Deniz; Artus, Jerome; Brunet, Erika; Hadjantonakis, Anna-Katerina; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Simsek, Deniz; Hadjantonakis, Anna-Katerina; Shuman, Stewart; Jasin, Maria] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Furda, Amy; Van Houten, Bennett] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Furda, Amy; Van Houten, Bennett] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Gao, Yankun; McKinnon, Peter J.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Brunet, Erika] Museum Natl Hist Nat, F-75005 Paris, France; [Brunet, Erika] CNRS, UMR7196, F-75005 Paris, France; [Brunet, Erika] INSERM, U565, F-75005 Paris, France; [Shuman, Stewart] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Jude Children's Research Hospital; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); Memorial Sloan Kettering Cancer Center	Jasin, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA.	m-jasin@ski.mskcc.org	BRUNET, ERIKA/H-9297-2017; BRUNET, ERIKA/K-7154-2016; Van Houten, Bennett/K-2284-2019	BRUNET, ERIKA/0000-0002-1726-4673; BRUNET, ERIKA/0000-0002-1726-4673; Artus, Jerome/0000-0003-3423-8634; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124	PA CURE; National Institutes of Health [ES019566, NS37956, CA21765, GM54668]; NATIONAL CANCER INSTITUTE [P30CA021765, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037956, R01NS037956] Funding Source: NIH RePORTER	PA CURE; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Caldecott for the gift of the Lig3 expression vector, and M. Sanz for initial assistance with the SCE analysis. We also thank the members of Jasin laboratory, especially Y. Akamatsu, J. LaRocque, E. Kass and F. Vanoli, for discussions. This work was supported by PA CURE (to B.V.H.) and by National Institutes of Health grants ES019566 (to B.V.H.), NS37956 and CA21765 (to P.J.M.), and GM54668 (to M.J.).	BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bentley DJ, 1996, NAT GENET, V13, P489, DOI 10.1038/ng0896-489; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Chen X, 2009, DNA REPAIR, V8, P961, DOI 10.1016/j.dnarep.2009.06.002; Cotner-Gohara E, 2008, J BIOL CHEM, V283, P10764, DOI 10.1074/jbc.M708175200; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Leppard JB, 2003, MOL CELL BIOL, V23, P5919, DOI 10.1128/MCB.23.16.5919-5927.2003; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; PARK UE, 1989, J BACTERIOL, V171, P2173, DOI 10.1128/jb.171.4.2173-2180.1989; Puebla-Osorio N, 2006, MOL CELL BIOL, V26, P3935, DOI 10.1128/MCB.26.10.3935-3941.2006; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Willer M, 1999, CURR BIOL, V9, P1085, DOI 10.1016/S0960-9822(99)80477-1	26	165	167	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					245	U139		10.1038/nature09794	http://dx.doi.org/10.1038/nature09794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390132	Green Accepted			2022-12-28	WOS:000288170200043
J	Fan, J; Crooks, C; Creissen, G; Hill, L; Fairhurst, S; Doerner, P; Lamb, C				Fan, Jun; Crooks, Casey; Creissen, Gary; Hill, Lionel; Fairhurst, Shirley; Doerner, Peter; Lamb, Chris			Pseudomonas sax Genes Overcome Aliphatic Isothiocyanate-Mediated Non-Host Resistance in Arabidopsis	SCIENCE			English	Article							PV. TOMATO DC3000; GENOME SEQUENCE; PLANT DEFENSE; PATHOGENS; ACCUMULATION; METABOLITES; THALIANA; INSIGHTS; FAMILY	Most plant-microbe interactions do not result in disease; natural products restrict non-host pathogens. We found that sulforaphane (4-methylsulfinylbutyl isothiocyanate), a natural product derived from aliphatic glucosinolates, inhibits growth in Arabidopsis of non-host Pseudomonas bacteria in planta. Multiple sax genes (saxCAB/F/D/G) were identified in Pseudomonas species virulent on Arabidopsis. These sax genes are required to overwhelm isothiocyanate-based defenses and facilitate a disease outcome, especially in the young leaves critical for plant survival. Introduction of saxCAB genes into non-host strains enabled them to overcome these Arabidopsis defenses. Our study shows that aliphatic isothiocyanates, previously shown to limit damage by herbivores, are also crucial, robust, and developmentally regulated defenses that underpin non-host resistance in the Arabidopsis-Pseudomonas pathosystem.	[Fan, Jun; Crooks, Casey; Creissen, Gary; Hill, Lionel; Fairhurst, Shirley; Lamb, Chris] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Crooks, Casey] USDA, Forest Prod Lab, Madison, WI 53726 USA; [Doerner, Peter] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Doerner, Peter] INRA, CNRS, CEA, Physiol Cellulaire Vegetale Lab, F-38000 Grenoble, France; [Doerner, Peter] Univ Grenoble 1, F-38000 Grenoble, France	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; United States Department of Agriculture (USDA); United States Forest Service; University of Edinburgh; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fan, J (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	jun.fan@bbsrc.ac.uk; peter.doerner@ed.ac.uk	Creissen, Gary P/C-7481-2009	Creissen, Gary P/0000-0003-4992-8056; Fan, Jun/0000-0003-0591-0372; Doerner, Peter/0000-0001-7218-8469	UK Biotechnology and Biological Sciences Research Council	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Haas, C. Zipfel, K. Sohn, and D. J. Kliebenstein for providing the pME vectors, bacterial strains, and Arabidopsis myb mutants used in this study; B. Lee and S. Kopriva for help with the glucosinolate assay; and C. Zipfel, C. Dean, A. Maule, and V. Vitart for critical reading of earlier versions of the manuscript. Supported by a grant from the UK Biotechnology and Biological Sciences Research Council (C.L.). J.F., C.C., G.C., L.H., S.F., and P.D. dedicate this paper to the memory of Chris Lamb.	Agrawal AA, 2003, J CHEM ECOL, V29, P1403, DOI 10.1023/A:1024265420375; Almeida NF, 2009, MOL PLANT MICROBE IN, V22, P52, DOI 10.1094/MPMI-22-1-0052; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bednarek P, 2009, SCIENCE, V324, P746, DOI 10.1126/science.1171661; Beekwilder J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002068; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Ellis J, 2006, PLANT CELL, V18, P523, DOI 10.1105/tpc.105.040584; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Hipskind JD, 2000, MOL PLANT MICROBE IN, V13, P551, DOI 10.1094/MPMI.2000.13.5.551; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Sandrock RW, 2001, PHYSIOL MOL PLANT P, V58, P159, DOI 10.1006/pmpp.2001.0324; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wittstock U, 2004, P NATL ACAD SCI USA, V101, P4859, DOI 10.1073/pnas.0308007101; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2	26	136	137	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1185	1188		10.1126/science.1199707	http://dx.doi.org/10.1126/science.1199707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385714				2022-12-28	WOS:000287971200040
J	Xie, XD; Guan, KL				Xie, Xiaoduo; Guan, Kun-Liang			The Ribosome and TORC2: Collaborators for Cell Growth	CELL			English	Editorial Material							MTOR COMPLEX; PHOSPHORYLATION; ACTIVATION; RICTOR	The target of rapamycin complex 2 (TORC2) is a key regulator of cell growth. Zinzalla et al. (2011) now provide evidence that TORC2 is activated by direct association with the ribosome, which may ensure that TORC2 activity is calibrated to match the cell's intrinsic growth capacity.	[Xie, Xiaoduo; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Xie, Xiaoduo; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	xie, xiaoduo/B-8868-2012; Guan, Kun-Liang/ADK-7088-2022	xie, xiaoduo/0000-0003-0610-8007	NCI NIH HHS [R01 CA108941-09, R01 CA108941] Funding Source: Medline; NIGMS NIH HHS [R01 GM051586, R01 GM051586-13, R01 GM051586-19] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	10	11	11	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					640	+		10.1016/j.cell.2011.02.029	http://dx.doi.org/10.1016/j.cell.2011.02.029			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376227	Green Accepted, Bronze			2022-12-28	WOS:000288007100004
J	Bhutta, MF; Williamson, IG; Sudhoff, HH				Bhutta, Mahmood F.; Williamson, Ian G.; Sudhoff, Holger H.			Easily Missed? Cholesteatoma	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC OTITIS-MEDIA; MIDDLE-EAR CHOLESTEATOMA; PREDICTORS; MANAGEMENT; PALSY					m.bhutta@doctors.org.uk	Sudhoff, Holger/AAV-9741-2020	Sudhoff, Holger/0000-0002-9274-5645; Bhutta, Mahmood/0000-0002-4688-1670				BAIN J, 1988, BRIT MED J, V296, P1617, DOI 10.1136/bmj.296.6637.1617; Browning GG., 2008, SCOTT BROWNS OTORHIN, P3396; Ikeda M, 2006, ACTA OTO-LARYNGOL, V126, P95, DOI 10.1080/00016480500265950; Jung JY, 2002, ORL-J OTO-RHIN-LARYN, V64, P95, DOI 10.1159/000057787; Kemppainen HO, 1999, ACTA OTO-LARYNGOL, V119, P568; Lemmerling MM, 2008, EUR J RADIOL, V66, P363, DOI 10.1016/j.ejrad.2008.01.020; MILROY CM, 1989, J CLIN PATHOL, V42, P460, DOI 10.1136/jcp.42.5.460; NUNEZ DA, 1990, J LARYNGOL OTOL, V104, P468, DOI 10.1017/S0022215100112903; Olszewska E, 2004, EUR ARCH OTO-RHINO-L, V261, P6, DOI 10.1007/s00405-003-0623-x; Omran A, 2006, LARYNGOSCOPE, V116, P619, DOI 10.1097/01.mlg.0000208367.03963.ca; OREILLY BJ, 1991, J LARYNGOL OTOL, V105, P990, DOI 10.1017/S0022215100118031; ROSENFELD RM, 1992, ARCH OTOLARYNGOL, V118, P384; Sheahan P, 2001, J LARYNGOL OTOL, V115, P962; Siddiq MA, 2007, J LARYNGOL OTOL, V121, P114, DOI 10.1017/S0022215106003227; Smith JA, 2006, OTOLARYNG CLIN N AM, V39, P1237, DOI 10.1016/j.otc.2006.09.001; Syed I, 2008, BRIT J HOSP MED, V69, pM34, DOI 10.12968/hmed.2008.69.Sup3.28764; Vercruysse JP, 2009, B-ENT, V5, P233; WETMORE RF, 1987, INT J PEDIATR OTORHI, V14, P101, DOI 10.1016/0165-5876(87)90020-6	18	22	22	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 3	2011	342								d1088	10.1136/bmj.d1088	http://dx.doi.org/10.1136/bmj.d1088			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732EQ	21372073				2022-12-28	WOS:000288168200003
J	Gerstein, HC; Miller, ME; Genuth, S; Ismail-Beigi, F; Buse, JB; Goff, DC; Probstfield, JL; Cushman, WC; Ginsberg, HN; Bigger, JT; Grimm, RH; Byington, RP; Rosenberg, YD; Friedewald, WT				Gerstein, Hertzel C.; Miller, Michael E.; Genuth, Saul; Ismail-Beigi, Faramarz; Buse, John B.; Goff, David C., Jr.; Probstfield, Jeffrey L.; Cushman, William C.; Ginsberg, Henry N.; Bigger, J. Thomas; Grimm, Richard H., Jr.; Byington, Robert P.; Rosenberg, Yves D.; Friedewald, William T.		ACCORD Study Grp	Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLYCEMIA TREATMENT STRATEGIES; FOLLOW-UP; RISK; MORTALITY	BACKGROUND Intensive glucose lowering has previously been shown to increase mortality among persons with advanced type 2 diabetes and a high risk of cardiovascular disease. This report describes the 5-year outcomes of a mean of 3.7 years of intensive glucose lowering on mortality and key cardiovascular events. METHODS We randomly assigned participants with type 2 diabetes and cardiovascular disease or additional cardiovascular risk factors to receive intensive therapy (targeting a glycated hemoglobin level below 6.0%) or standard therapy (targeting a level of 7 to 7.9%). After termination of the intensive therapy, due to higher mortality in the intensive-therapy group, the target glycated hemoglobin level was 7 to 7.9% for all participants, who were followed until the planned end of the trial. RESULTS Before the intensive therapy was terminated, the intensive-therapy group did not differ significantly from the standard-therapy group in the rate of the primary outcome (a composite of nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes) (P = 0.13) but had more deaths from any cause (primarily cardiovascular) (hazard ratio, 1.21; 95% confidence interval [CI], 1.02 to 1.44) and fewer nonfatal myocardial infarctions (hazard ratio, 0.79; 95% CI, 0.66 to 0.95). These trends persisted during the entire follow-up period (hazard ratio for death, 1.19; 95% CI, 1.03 to 1.38; and hazard ratio for nonfatal myocardial infarction, 0.82; 95% CI, 0.70 to 0.96). After the intensive intervention was terminated, the median glycated hemoglobin level in the intensive-therapy group rose from 6.4% to 7.2%, and the use of glucose-lowering medications and rates of severe hypoglycemia and other adverse events were similar in the two groups. CONCLUSIONS As compared with standard therapy, the use of intensive therapy for 3.7 years to target a glycated hemoglobin level below 6% reduced 5-year nonfatal myocardial infarctions but increased 5-year mortality. Such a strategy cannot be recommended for high-risk patients with advanced type 2 diabetes.	[Gerstein, Hertzel C.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Gerstein, Hertzel C.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Miller, Michael E.; Goff, David C., Jr.; Byington, Robert P.] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Genuth, Saul; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Buse, John B.] Univ N Carolina, Chapel Hill, NC USA; [Probstfield, Jeffrey L.] Univ Washington, Seattle, WA 98195 USA; [Cushman, William C.] Memphis Vet Affairs Med Ctr, Memphis, TN USA; [Ginsberg, Henry N.; Bigger, J. Thomas; Friedewald, William T.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Grimm, Richard H., Jr.] Univ Minnesota, Berman Ctr Outcomes & Clin Res, Minneapolis, MN USA; [Rosenberg, Yves D.] NHLBI, Bethesda, MD 20892 USA	McMaster University; McMaster University; Wake Forest University; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Columbia University; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gerstein, HC (corresponding author), McMaster Univ, Dept Med, HSC 3V38,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	gerstein@mcmaster.ca	Force, Rex W/K-4094-2012; Hramiak, Irene/G-3305-2011; Friedewald, William T/C-8034-2011; Gerstein, Hertzel/ABB-8781-2020; Parsons, Mark W./G-3750-2014; Gerstein, Hertzel C/B-1235-2013; Bryan, R. Nick/P-1661-2014; Buse, John Bernard/J-9742-2019	Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836; Buse, John Bernard/0000-0002-9723-3876; Arrey, Frida/0000-0003-4543-4219; Yusuf, Salim/0000-0003-4776-5601	National Heart, Lung, and Blood Institute [N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, Y1-HC-9035, Y1-HC-1010]; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging; National Eye Institute; General Clinical Research Centers; Centers for Disease Control and Prevention; Massachusetts Institute of Technology; Novo Nordisk; Amylin; Becton Dickinson; Eli Lilly; Hoffmann-La Roche (now Genentech); Glyco-Mark; Wyeth; Daiichi Sankyo; Bristol-Myers Squibb; Bayhill Therapeutics; LipoScience; MannKind; Veritas; MicroIslet; GlaxoSmithKline; Abbott; Exsulin; Medtronic; Tolerex; Osiris; Halozyme; Hoffmann-La Roche; InterKrin; Merck; Dexcom; Sanofi-Aventis; Johnson Johnson; Fujisawa; American Academy of Family Practice Foundation; Takeda; King; Daiichi-Sankyo; Gilead; Theravance; Pharmacopeia; Sciele; Solvay; Regeneron/Sanofi-Aventis; Roche; Isis/Genzyme; Novartis; Pfizer; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095184, N01HC095182, N01HC095180, N01HC095179, N01HC095183, N01HC095181, N01HC095178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095181, R43HL095181] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); General Clinical Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Massachusetts Institute of Technology; Novo Nordisk(Novo Nordisk); Amylin; Becton Dickinson; Eli Lilly(Eli Lilly); Hoffmann-La Roche (now Genentech)(Hoffmann-La Roche); Glyco-Mark; Wyeth(Wyeth); Daiichi Sankyo(Daiichi Sankyo Company Limited); Bristol-Myers Squibb(Bristol-Myers Squibb); Bayhill Therapeutics; LipoScience; MannKind; Veritas; MicroIslet; GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Exsulin; Medtronic(Medtronic); Tolerex; Osiris; Halozyme; Hoffmann-La Roche(Hoffmann-La Roche); InterKrin; Merck(Merck & Company); Dexcom; Sanofi-Aventis(Sanofi-Aventis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Fujisawa; American Academy of Family Practice Foundation; Takeda(Takeda Pharmaceutical Company Ltd); King; Daiichi-Sankyo(Daiichi Sankyo Company Limited); Gilead(Gilead Sciences); Theravance; Pharmacopeia; Sciele; Solvay(Solvay SA); Regeneron/Sanofi-Aventis(Sanofi-Aventis); Roche(Roche Holding); Isis/Genzyme(Sanofi-AventisGenzyme Corporation); Novartis(Novartis); Pfizer(Pfizer); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Heart, Lung, and Blood Institute (contracts N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA#Y1-HC-9035, and IAA#Y1-HC-1010), and partially supported by the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Eye Institute and by General Clinical Research Centers at many sites; substudies within the ACCORD trial on cost-effectiveness and health-related quality of life were supported by the Centers for Disease Control and Prevention. The following companies provided study medications, equipment, or supplies: Abbott Laboratories, Amylin Pharmaceutical, AstraZeneca, Bayer HealthCare, Closer Healthcare, GlaxoSmithKline, King Pharmaceuticals, Merck, Novartis, Novo Nordisk, Omron Healthcare, Sanofi-Aventis, and Schering-Plough.; Dr. Bigger reports receiving consulting fees and travel support from Merck and Roche and patent fees and royalties from the Massachusetts Institute of Technology for risk-stratification software; Dr. Buse, receiving consulting fees from Novo Nordisk, Amylin, Becton Dickinson, Eli Lilly, Hoffmann-La Roche (now Genentech), Glyco-Mark, Wyeth, Daiichi Sankyo, Bristol-Myers Squibb, Bayhill Therapeutics, LipoScience, MannKind, Veritas, MicroIslet, GlaxoSmithKline, Abbott, Exsulin, and GI Dynamics and grant support from Amylin, Novo Nordisk, Medtronic, Eli Lilly, Novartis, Tolerex, Osiris, Halozyme, Pfizer, Hoffmann-La Roche, InterKrin, Merck, Sanofi-Aventis, Dexcom, Johnson & Johnson, Bristol-Myers Squibb, Fujisawa, and the American Academy of Family Practice Foundation, holding stock in Insulet, and providing expert testimony for Novo Nordisk; Dr. Cushman, receiving consulting fees from Novartis, Takeda, Sanofi-Aventis, Bristol-Myers Squibb, King, Daiichi-Sankyo, Gilead, Theravance, Pharmacopeia, and Sciele and institutional grant support to the Memphis Veterans Affairs Medical Center from Novartis, GlaxoSmithKline, and Merck; Dr. Genuth, receiving consulting fees from Merck and Daiichi Sankyo and holding stock in Novartis and Johnson & Johnson; Dr. Gerstein, receiving consulting fees from Sanofi-Aventis, GlaxoSmithKline, Eli Lilly, Novo Nordisk, AstraZeneca, Bristol-Myers Squibb, Roche, Medtronic, Merck, Bayer, Bioavail, and Janssen-Ortho, institutional grant support to McMaster University from Sanofi-Aventis, GlaxoSmithKline, Novo Nordisk, Merck, Pronova, Roche, Eli Lilly, and Boehringer Ingelheim, and lecture fees from Sanofi-Aventis, GlaxoSmithKline, Solvay, Boehringer Ingelheim, Servier, Bayer, Eli Lilly, Novo Nordisk, and Takeda; Dr. Ginsberg, being a member of the board of Merck and Schering-Plough and the global advisory board of Bristol-Myers Squibb/AstraZeneca and receiving consulting fees from GlaxoSmithKline, Merck, Bristol-Myers Squibb, AstraZeneca, Regeneron/Sanofi-Aventis, Abbott, Roche, Isis/Genzyme, Novartis, and Pfizer, institutional grant support to the Columbia University College of Physicians and Surgeons from Merck, Roche, Isis/Genzyme, and AstraZeneca, and payment from Pfizer for development of an educational presentation; Dr. Goff, being a member of the data and safety monitoring board for Takeda and receiving institutional grant support to the Wake Forest University School of Medicine from Merck; Dr. Grimm, being a member of the board of Pfizer, receiving consulting fees from Pfizer, Merck, and Novartis, personal and institutional grants to the University of Minnesota from Pfizer, Merck, and Novartis, lecture fees from Pfizer, Merck, Novartis, Forest, Schering-Plough, and Takeda, and travel support from Takeda and Roche, and attending the AstraZeneca symposium at the Cleveland Clinic and investigator meetings for Merck, Novartis, and Pfizer; Dr. Ismail-Beigi, receiving consulting fees from Eli Lilly; Dr. Miller, receiving consulting fees from Roche; and Dr. Probstfield, receiving institutional grant support to the University of Washington School of Medicine from SanofiAventis, Boehringer Ingelheim, and Abbott. No other potential conflict of interest relevant to this article was reported.	ACCORD Stud Group, 2010, NEW ENGL J MED, V1362, P1748; Bonds Denise E, 2010, BMJ, V340, pb4909, DOI 10.1136/bmj.b4909; Calles-Escandon J, 2010, DIABETES CARE, V33, P721, DOI 10.2337/dc09-1471; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2007, AM J CARDIOL, V99, p34I, DOI 10.1016/j.amjcard.2007.03.004; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Greenfield S, 2009, ANN INTERN MED, V151, P854, DOI 10.7326/0003-4819-151-12-200912150-00005; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Levitan EB, 2008, DIABETOLOGIA, V51, P267, DOI 10.1007/s00125-007-0882-y; MILLER ME, 2010, BRIT MED J, V340, DOI [DOI 10.1136/BMJ.B5444, 10.1136/bmj.b5444]; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Selvin E, 2005, ARCH INTERN MED, V165, P1910, DOI 10.1001/archinte.165.16.1910; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359	15	714	729	0	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					818	828						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366473	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000287928400007
J	Chiefari, E; Tanyolac, S; Paonessa, F; Pullinger, CR; Capula, C; Iiritano, S; Mazza, T; Forlin, M; Fusco, A; Durlach, V; Durlach, A; Malloy, MJ; Kane, JP; Heiner, SW; Filocamo, M; Foti, DP; Goldfine, ID; Brunetti, A				Chiefari, Eusebio; Tanyolac, Sinan; Paonessa, Francesco; Pullinger, Clive R.; Capula, Carmelo; Iiritano, Stefania; Mazza, Tommaso; Forlin, Michele; Fusco, Alfredo; Durlach, Vincent; Durlach, Anne; Malloy, Mary J.; Kane, John P.; Heiner, Steven W.; Filocamo, Mirella; Foti, Daniela P.; Goldfine, Ira D.; Brunetti, Antonio			Functional Variants of the HMGA1 Gene and Type 2 Diabetes Mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context High-mobility group A1 (HMGA1) protein is a key regulator of insulin receptor (INSR) gene expression. We previously identified a functional HMGA1 gene variant in 2 insulin-resistant patients with decreased INSR expression and type 2 diabetes mellitus (DM). Objective To examine the association of HMGA1 gene variants with type 2 DM. Design, Settings, and Participants Case-control study that analyzed the HMGA1 gene in patients with type 2 DM and controls from 3 populations of white European ancestry. Italian patients with type 2 DM(n=3278) and 2 groups of controls (n=3328) were attending the University of Catanzaro outpatient clinics and other health care sites in Calabria, Italy, during 2003-2009; US patients with type 2 DM (n=970) were recruited in Northern California clinics between 1994 and 2005 and controls (n=958) were senior athletes without DM collected in 2004 and 2009; and French patients with type 2 DM (n=354) and healthy controls (n=50) were enrolled at the University of Reims in 1992. Genomic DNA was either directly sequenced or analyzed for specific HMGA1 mutations. Messenger RNA and protein expression for HMGA1 and INSR were measured in both peripheral lymphomonocytes and cultured Epstein-Barr virus-transformed lymphoblasts from patients with type 2 DM and controls. Main Outcome Measures The frequency of HMGA1 gene variants among cases and controls. Odds ratios (ORs) for type 2 DM were estimated by logistic regression analysis. Results The most frequent functional HMGA1 variant, IVS5-13insC, was present in 7% to 8% of patients with type 2 DM in all 3 populations. The prevalence of IVS5-13insC variant was higher among patients with type 2 DM than among controls in the Italian population (7.23% vs 0.43% in one control group; OR, 15.77 [95% confidence interval {CI}, 8.57-29.03]; P<.001 and 7.23% vs 3.32% in the other control group; OR, 2.03 [95% CI, 1.51-3.43]; P<.001). In the US population, the prevalence of IVS5-13insC variant was 7.7% among patients with type 2 DM vs 4.7% among controls (OR, 1.64 [95% CI, 1.05-2.57]; P=.03). In the French population, the prevalence of IVS5-13insC variant was 7.6% among patients with type 2 DM and 0% among controls (P=.046). In the Italian population, 3 other functional variants were observed. When all 4 variants were analyzed, HMGA1 defects were present in 9.8% of Italian patients with type 2 DM and 0.6% of controls. In addition to the IVS5 C-insertion, the c. 310G>T (p.E104X) variant was found in 14 patients and no controls (Bonferroni-adjusted P=.01); the c.*82G>A variant (rs2780219) was found in 46 patients and 5 controls (Bonferroni-adjusted P<.001); the c.*369del variant was found in 24 patients and no controls (Bonferroni-adjusted P<.001). In circulating monocytes and Epstein-Barr virus-transformed lymphoblasts from patients with type 2 DM and the IVS5-13insC variant, the messenger RNA levels and protein content of both HMGA1 and the INSR were decreased by 40% to 50%, and these defects were corrected by transfection with HMGA1 complementary DNA. Conclusions Compared with healthy controls, the presence of functional HMGA1 gene variants in individuals of white European ancestry was associated with type 2 DM. JAMA. 2011;305(9):903-912 www.jama.com	[Chiefari, Eusebio; Paonessa, Francesco; Capula, Carmelo; Iiritano, Stefania; Foti, Daniela P.; Brunetti, Antonio] Univ Catanzaro Magna Graecia, Dipartimento Med Sperimentale & Clin G Salvatore, Catanzaro, Italy; [Brunetti, Antonio] Univ Catanzaro Magna Graecia, Cattedra Endocrinol, Catanzaro, Italy; [Tanyolac, Sinan; Malloy, Mary J.; Goldfine, Ira D.] Univ Calif San Francisco, Sch Nursing, Dept Med, San Francisco, CA 94143 USA; [Kane, John P.] Univ Calif San Francisco, Sch Nursing, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Pullinger, Clive R.] Univ Calif San Francisco, Sch Nursing, Dept Physiol Nursing, San Francisco, CA 94143 USA; [Tanyolac, Sinan; Goldfine, Ira D.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Pullinger, Clive R.; Malloy, Mary J.; Kane, John P.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Mazza, Tommaso; Forlin, Michele] Microsoft Res Univ Trento, Ctr Computat & Syst Biol, Trento, Italy; [Fusco, Alfredo] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Durlach, Vincent] Ctr Hosp Univ, Hop Robert Debre, Reims, France; [Durlach, Anne] Ctr Hosp Univ, Hop Maison Blanche, Lab Pol Bouin, Reims, France; [Heiner, Steven W.] Brigham Young Univ, Dept Hlth Sci, Provo, UT 84602 USA; [Filocamo, Mirella] Ist Giannina Gaslini, Lab Diagnosi Prepostnatale Malattie Metab, I-16148 Genoa, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Microsoft; University of Trento; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); CHU de Reims; CHU de Reims; Universite de Reims Champagne-Ardenne; Brigham Young University; University of Genoa; IRCCS Istituto Giannina Gaslini	Brunetti, A (corresponding author), Univ Catanzaro Magna Graecia, Viale Europa, I-88100 Germaneto Catanzaro, Italy.	brunetti@unicz.it	Brunetti, Antonio/K-7756-2016; Filocamo, Mirella/AAG-3948-2021; Mazza, Tommaso/H-6414-2016; Tanyolac, Sinan/AAP-5966-2021; Mazza, Tommaso/I-4531-2019; Foti, Daniela P/K-8038-2016; Chiefari, Eusebio/Y-2558-2019	Filocamo, Mirella/0000-0001-5505-8507; Mazza, Tommaso/0000-0003-0434-8533; Tanyolac, Sinan/0000-0003-4238-5132; Mazza, Tommaso/0000-0003-0434-8533; Chiefari, Eusebio/0000-0001-5329-3124; Foti, Daniela/0000-0002-9536-5736; Fusco, Alfredo/0000-0003-3332-5197; Paonessa, Francesco/0000-0002-4729-0928	Telethon-Italy [GGP04245]; MIUR Italy [2004062059-002]; National Institutes of Health [RO1DK056933]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056933] Funding Source: NIH RePORTER	Telethon-Italy(Fondazione Telethon); MIUR Italy(Ministry of Education, Universities and Research (MIUR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Brunetti received research funding from Telethon-Italy (grant GGP04245) and from MIUR Italy (protocol 2004062059-002). Dr Goldfine received research funding from National Institutes of Health grant RO1DK056933.	Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Borrmann L, 2001, ONCOGENE, V20, P4537, DOI 10.1038/sj.onc.1204577; Brunetti A, 1996, J CLIN INVEST, V97, P258, DOI 10.1172/JCI118400; Brunetti A, 2001, FASEB J, V15, P492, DOI 10.1096/fj.00-0190com; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chiefari E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1040; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Foti D, 2003, MOL CELL BIOL, V23, P2720, DOI 10.1128/MCB.23.8.2720-2732.2003; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; GOLDFINE ID, 1987, ENDOCR REV, V8, P235, DOI 10.1210/edrv-8-3-235; Goldfine ID, 2008, ENDOCR REV, V29, P62, DOI 10.1210/er.2007-0004; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groop L, 2008, CURR DIABETES REP, V8, P192, DOI 10.1007/s11892-008-0033-y; HARRIS M, 1979, DIABETES, V28, P1039; HOLLENBECK C, 1987, J CLIN ENDOCR METAB, V64, P1169, DOI 10.1210/jcem-64-6-1169; International Diabetes Federation, IDF DIAB ATL; Krolewski AS, 2005, JOSLINS DIABETES MEL; Lakka TA, 2004, DIABETES, V53, P1603, DOI 10.2337/diabetes.53.6.1603; Liu J, 2003, MOL REPROD DEV, V66, P81, DOI 10.1002/mrd.10323; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; O'Rahilly S, 2007, BIOCHEM SOC T, V35, P33, DOI 10.1042/BST0350033; OLEFSKY JM, 1977, DIABETES, V26, P680, DOI 10.2337/diab.26.7.680; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Roth J, 1975, Recent Prog Horm Res, V31, P95; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Smith RJ, 2010, J CLIN ENDOCR METAB, V95, P1566, DOI 10.1210/jc.2009-1966; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Tan K, 2007, DIABETES, V56, P714, DOI 10.2337/db06-0921; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TAYLOR SI, 1992, ENDOCR REV, V13, P566, DOI 10.1210/er.13.3.566; Unger RH, 2008, JAMA-J AM MED ASSOC, V299, P1185, DOI 10.1001/jama.299.10.1185; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171	43	69	71	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					903	912		10.1001/jama.2011.207	http://dx.doi.org/10.1001/jama.2011.207			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728DP	21364139	Bronze			2022-12-28	WOS:000287854700023
J	Wilson, JF				Wilson, Jennifer F.			Herpes Zoster	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OUTER RETINAL NECROSIS; LOW-DOSE ACYCLOVIR; POSTHERPETIC NEURALGIA; ORAL ACYCLOVIR; VARICELLA VACCINE; NATURAL-HISTORY; DOUBLE-BLIND; VIRUS; RISK; OPHTHALMICUS						Wareham, David W./A-3583-2008; Wilson, Jennifer/Q-3623-2019	Wareham, David W./0000-0003-4331-5224; Wilson, Jennifer/0000-0003-4025-3136				Asano-Mori Y, 2008, AM J HEMATOL, V83, P472, DOI 10.1002/ajh.21152; Baker CJ, 2010, ANN INTERN MED, V152, P36, DOI 10.7326/0003-4819-152-1-201001050-00008; Berry JD, 2005, NEUROLOGY, V65, P444, DOI 10.1212/01.WNL.0000168259.94991.8a; BEUTNER KR, 1995, ANTIMICROB AGENTS CH, V39, P1546, DOI 10.1128/AAC.39.7.1546; BLUMENKRANZ MS, 1986, OPHTHALMOLOGY, V93, P296; Bowsher D, 1997, J PAIN SYMPTOM MANAG, V13, P327, DOI 10.1016/S0885-3924(97)00077-8; CHEUNG WC, 1991, J INFECTION, V23, P169, DOI 10.1016/0163-4453(91)92132-O; COBO LM, 1986, OPHTHALMOLOGY, V93, P763; COBO M, 1987, CURR EYE RES, V6, P195, DOI 10.3109/02713688709020090; CRAPOTTA JA, 1994, RETINA-J RET VIT DIS, V14, P382, DOI 10.1097/00006982-199414040-00019; Dworkin RH, 2009, PAIN, V142, P209, DOI 10.1016/j.pain.2008.12.022; EIDELBERG D, 1986, ANN NEUROL, V19, P7, DOI 10.1002/ana.410190103; Galindez OA, 1996, CLIN INFECT DIS, V22, P149, DOI 10.1093/clinids/22.1.149; Garner Julia S., 1996, Infection Control and Hospital Epidemiology, V17, P53; Garweg J, 1997, CLIN INFECT DIS, V24, P603, DOI 10.1093/clind/24.4.603; GILDEN DH, 1994, NEUROLOGY, V44, P1818, DOI 10.1212/WNL.44.10.1818; Hambleton S, 2008, J INFECT DIS, V197, pS196, DOI 10.1086/522131; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; He L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005582.pub2; Helgason S, 2000, BRIT MED J, V321, P794, DOI 10.1136/bmj.321.7264.794; HERBORT CP, 1991, CURR EYE RES, V10, P171, DOI 10.3109/02713689109020375; Hornberger J, 2006, ANN INTERN MED, V145, P317, DOI 10.7326/0003-4819-145-5-200609050-00004; HUFF JC, 1988, AM J MED, V85, P84; Hurley LP, 2008, J INFECT DIS, V197, pS216, DOI 10.1086/522153; Hurley LP, 2010, ANN INTERN MED, V152, P555, DOI 10.7326/0003-4819-152-9-201005040-00005; Jumaan AO, 2005, J INFECT DIS, V191, P2002, DOI 10.1086/430325; Kerzner B, 2007, J AM GERIATR SOC, V55, P1499, DOI 10.1111/j.1532-5415.2007.01397.x; Kilgore Paul E., 2003, Journal of Medical Virology, V70, pS111, DOI 10.1002/jmv.10364; Kim DH, 2008, CLIN TRANSPLANT, V22, P770, DOI 10.1111/j.1399-0012.2008.00877.x; KUROIWA Y, 1981, NEUROLOGY, V31, P1030, DOI 10.1212/WNL.31.8.1030; Larussa P, 2000, PEDIATR INFECT DIS J, V19, P1037, DOI 10.1097/00006454-200011000-00002; Levin MJ, 1998, J INFECT DIS, V178, pS109, DOI 10.1086/514264; LI Q, 2009, COCHRANE DATABASE S; Liesegang TJ, 1999, MAYO CLIN PROC, V74, P983; MCKENDRICK MW, 1989, BRIT MED J, V298, P431, DOI 10.1136/bmj.298.6671.431; MORTON P, 1989, NEW ZEAL MED J, V102, P93; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Nagel MA, 2008, NEUROLOGY, V70, P853, DOI 10.1212/01.wnl.0000304747.38502.e8; *NAT COMPR CANC NE, 2011, GUIDELINES; Ormerod LD, 1998, CLIN INFECT DIS, V26, P34, DOI 10.1086/516285; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; PALAY DA, 1991, AM J OPHTHALMOL, V112, P250, DOI 10.1016/S0002-9394(14)76725-X; PETERSLUND NA, 1988, SCAND J INFECT DIS, V20, P583, DOI 10.3109/00365548809035658; RAGOZZINO MW, 1982, NEW ENGL J MED, V307, P393, DOI 10.1056/NEJM198208123070701; RESHEF E, 1985, J NEUROL NEUROSUR PS, V48, P122, DOI 10.1136/jnnp.48.2.122; Reynolds MA, 2008, J INFECT DIS, V197, pS224, DOI 10.1086/522162; Rimland D, 2010, CLIN INFECT DIS, V50, P1000, DOI 10.1086/651078; Rothberg MB, 2007, CLIN INFECT DIS, V44, P1280, DOI 10.1086/514342; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Sauerbrei A, 2006, J CLIN MICROBIOL, V44, P3094, DOI 10.1128/JCM.00719-06; SAWYER MH, 1994, J INFECT DIS, V169, P91, DOI 10.1093/infdis/169.1.91; Schliefer K, 1999, CLIN INFECT DIS, V29, P684, DOI 10.1086/598656; Schmader KE, 2008, J PAIN, V9, pS3, DOI 10.1016/j.jpain.2007.10.002; Shafran SD, 2004, J CLIN VIROL, V29, P248, DOI 10.1016/S1386-6532(03)00164-1; Sharrar RG, 2000, VACCINE, V19, P916, DOI 10.1016/S0264-410X(00)00297-8; Simberkoff MS, 2010, ANN INTERN MED, V152, P545, DOI 10.7326/0003-4819-152-9-201005040-00004; Strangfeld A, 2009, JAMA-J AM MED ASSOC, V301, P737, DOI 10.1001/jama.2009.146; THANH HX, 1992, OPHTHALMOLOGY, V99, P1062; Tseng HF, 2011, JAMA-J AM MED ASSOC, V305, P160, DOI 10.1001/jama.2010.1983; TYRING S, 1995, ANN INTERN MED, V123, P89, DOI 10.7326/0003-4819-123-2-199507150-00002; Tyring SK, 2000, ARCH FAM MED, V9, P863, DOI 10.1001/archfami.9.9.863; van Wijck AJM, 2006, LANCET, V367, P219, DOI 10.1016/S0140-6736(06)68032-X; VERGHESE A, 1986, J AM GERIATR SOC, V34, P309, DOI 10.1111/j.1532-5415.1986.tb04227.x; Vickrey E, 2009, CANCER-AM CANCER SOC, V115, P229, DOI 10.1002/cncr.24006; Whitley RJ, 1999, J INFECT DIS, V179, P9, DOI 10.1086/314562; Whitley RJ, 1996, ANN INTERN MED, V125, P376, DOI 10.7326/0003-4819-125-5-199609010-00004; WOOD MJ, 1994, NEW ENGL J MED, V330, P896, DOI 10.1056/NEJM199403313301304; Wood MJ, 1996, CLIN INFECT DIS, V22, P341, DOI 10.1093/clinids/22.2.341; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341; Yih WK, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-68	70	19	19	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					293	+	ITC3	10.7326/0003-4819-154-5-201103010-01003	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-01003			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357905				2022-12-28	WOS:000287799900015
J	Davies, HE; Wathen, CG; Gleeson, FV				Davies, H. E.; Wathen, C. G.; Gleeson, F. V.			The risks of radiation exposure related to diagnostic imaging and how to minimise them	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COMPUTED-TOMOGRAPHY; PULMONARY-EMBOLISM; CANCER-RISKS; APPROPRIATE					hedavies@doctors.net.uk		Gleeson, Fergus/0000-0002-5121-3917				Agnelli G, 2010, NEW ENGL J MED, V363, P266, DOI 10.1056/NEJMra0907731; *AM COLL RAD, 1993, ACR APPR CRIT; Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; BERRINGTON DG, 2004, SCIENCE, V363, P345; Bourjeily G, 2010, LANCET, V375, P500, DOI 10.1016/S0140-6736(09)60996-X; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, MED PHYS, V28, P2387, DOI 10.1118/1.1415074; Brent RL, 2009, AM J OBSTET GYNECOL, V200, P4, DOI 10.1016/j.ajog.2008.06.032; *C RAD CONTR PROGR, 2006, NAT EV XRAY TRENDS N; Campbell IA, 2003, THORAX, V58, P470; Cardis E, 2007, RADIAT RES, V167, P396, DOI 10.1667/RR0553.1; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Hughes JS, 2005, J RADIOL PROT, V25, P493, DOI 10.1088/0952-4746/25/4/010; IMV, 2006, IMV 2006 CT MARK SUM; *INT COMM RAD PROT, 2000, ANN ICRP, P3; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; National Radiological Protection Board (NRPB), 2001, XRAYS SAF AR THEY; National Research Council BEIR VII Committee, 2005, BEIR 7 HLTH RISKS EX; Patel C, 2010, LANCET, V375, P1778, DOI 10.1016/S0140-6736(10)60798-2; Pierce DA, 2007, RADIAT RES, V167, P735, DOI 10.1667/RR0349.1; Smith-Bindman R, 2010, NEW ENGL J MED, V363, P1, DOI 10.1056/NEJMp1002530; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Streffer C, 2003, Ann ICRP, V33, P5; The Royal College of Radiologists, 2007, MAK BEST US CLIN RAD; Winer-Muram HT, 2002, RADIOLOGY, V224, P487, DOI 10.1148/radiol.2242011581; 2008, GEN ASSEMBL OFFICAL, V46	29	52	55	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2011	342								d947	10.1136/bmj.d947	http://dx.doi.org/10.1136/bmj.d947			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729BG	21355025				2022-12-28	WOS:000287921300003
J	Potter, BA; Irish, JD; Reuther, JD; Gelvin-Reymiller, C; Holliday, VT				Potter, Ben A.; Irish, Joel D.; Reuther, Joshua D.; Gelvin-Reymiller, Carol; Holliday, Vance T.			A Terminal Pleistocene Child Cremation and Residential Structure from Eastern Beringia	SCIENCE			English	Article							COLONIZATION; ARCHAEOLOGY; MORPHOLOGY; ALASKA	The dearth of human remains and residential sites has constrained inquiry into Beringian lifeways at the transition of the late Pleistocene-early Holocene. We report on human skeletal remains and a residential structure from central Alaska dated to similar to 11,500 calendar years ago. The remains are from a similar to 3-year-old child who was cremated in a pit within a semisubterranean house. The burial-cremation and house have exceptional integrity and preservation and exhibit similarities and differences to both Siberian Upper Paleolithic and North American Paleoindian features.	[Potter, Ben A.; Irish, Joel D.; Gelvin-Reymiller, Carol] Univ Alaska Fairbanks, Dept Anthropol, Fairbanks, AK 99775 USA; [Reuther, Joshua D.; Holliday, Vance T.] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Reuther, Joshua D.; Holliday, Vance T.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA	University of Alaska System; University of Alaska Fairbanks; University of Arizona; University of Arizona	Potter, BA (corresponding author), Univ Alaska Fairbanks, Dept Anthropol, Fairbanks, AK 99775 USA.	bapotter@alaska.edu		Potter, Ben/0000-0002-4749-0428; Irish, Joel D./0000-0001-7857-8847	NSF [0813819, ARC-1057448]; Directorate For Geosciences [0813819, 1057448] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This project was funded by the NSF (grants 0813819 and ARC-1057448). We thank J. Polston, First Chief of Healy Lake Tribal Council, and J. Isaacs, president and CEO of Tanana Chiefs Conference, for their support. We also thank the Northern Land Use Research, Inc., for field support; O. Davis and C. Alix (wood identification); and K. Blood and R. Bowman (laboratory assistance). We thank D. Meltzer, J. Hoffecker, and an anonymous reviewer for their comments.	Bennett JL, 1999, J ARCHAEOL SCI, V26, P1, DOI 10.1006/jasc.1998.0283; Bever WR, 2001, ARCTIC ANTHROPOL, V38, P98; Bowers P. M., 1980, CARLO CREEK SITE GEO; Cook J. P., 1969, THESIS U WISCONSIN; Dikov Nikolai., 2004, EARLY CULTURES NE AS; Dixon E.J., 1997, GEOARCHAEOLOGY, V12, P689, DOI [10.1002/(SICI)1520-6548(199709)12:63.0.CO;2-V, DOI 10.1002/(SICI)1520-6548(199709)12:63.0.CO;2-V]; Dixon E. J., 2009, PROJECTILE POINT SEQ, P11; Dixon EJ, 1999, BONES BOATS BISON AR; Dyke AS, 2003, 1574 GEOL SURV CAN; Elias SA, 1996, NATURE, V382, P60, DOI 10.1038/382060a0; Goebel T, 2003, SCIENCE, V301, P501, DOI 10.1126/science.1086555; Goebel T., 1999, ICE AGE PEOPLES N AM, P104; Goebel T. E., 1991, CLOVIS ORIGINS ADAPT, P49; HADLEIGHWEST F, 1967, AM ANTIQUITY, V32, P360, DOI 10.2307/2694665; Hoffecker J. F., 2007, HUMAN ECOLOGY BERING; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Holmes CE, 2001, ARCTIC ANTHROPOL, V38, P154; Jones S., 1994, CURR RES PLEISTOCENE, V11, P42; KRANTZ G S, 1979, Northwest Anthropological Research Notes, V13, P159; Liversidge HM, 2004, AM J PHYS ANTHROPOL, V123, P172, DOI 10.1002/ajpa.10318; Loth SR, 2001, AM J PHYS ANTHROPOL, V115, P179, DOI 10.1002/ajpa.1067; Mayne Correia P., 1997, FORENSIC TAPHONOMY P, P275, DOI DOI 10.1201/9781439821923.CH18; MOORREES CF, 1963, AM J PHYS ANTHROPOL, V21, P205, DOI 10.1002/ajpa.1330210212; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; NICHOLSON RA, 1993, J ARCHAEOL SCI, V20, P411, DOI 10.1006/jasc.1993.1025; Owsley D. W., 2010, ARCH LAKE WOMAN; Potter B. A., 2007, J ANTHR, V5, P1; Potter BA, 2008, CURR RES PLEISTOCENE, V25, P132; Potter BA, 2008, RADIOCARBON, V50, P181, DOI 10.1017/S0033822200033518; Potter BA, 2007, ENVIRON ARCHAEOL, V12, P3, DOI 10.1179/174963107x172714; Powell J.F., 2005, 1 AM RACE EVOLUTION; Powers W. R., 1983, DRY CREEK ARCHEOLOGY; Rasic J.T., 2008, THESIS WASHINGTON ST; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Schutkowski H, 1987, INT J ANTHR, V2, P347, DOI DOI 10.1007/BF02443994; SHIPMAN P, 1984, J ARCHAEOL SCI, V11, P307, DOI 10.1016/0305-4403(84)90013-X; Slobodin S, 2001, ARCTIC ANTHROPOL, V38, P31; Slobodin S.B., 2006, U OREGON ANTHR PAPER, P9; TURNER CG, 1990, AM J PHYS ANTHROPOL, V82, P295, DOI 10.1002/ajpa.1330820308; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; Ubelaker D.H., 1989, HUMAN SKELETAL REMAI, V3rd; Walker PL, 2008, ANALYSIS OF BURNED HUMAN REMAINS, P129, DOI 10.1016/B978-012372510-3.50009-5; West Frederick H., 1996, P537; Wheeler Sydney M., 1997, NEVADA HIST SOC Q, V40, P15; Yesner DR, 2001, QUATERNARY SCI REV, V20, P315, DOI 10.1016/S0277-3791(00)00114-1	45	43	44	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1058	1062		10.1126/science.1201581	http://dx.doi.org/10.1126/science.1201581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350175				2022-12-28	WOS:000287699000061
J	Jellinek, AM; Bercovici, D				Jellinek, A. Mark; Bercovici, David			Seismic tremors and magma wagging during explosive volcanism	NATURE			English	Article							NEW-ZEALAND; SOURCE MECHANISM; ARENAL VOLCANO; COSTA-RICA; ERUPTION; RUAPEHU; FLOW	Volcanic tremor is a ubiquitous feature of explosive eruptions. This oscillation persists for minutes to weeks and is characterized by a remarkably narrow band of frequencies from about 0.5 Hz to 7 Hz (refs 1-4). Before major eruptions, tremor can occur in concert with increased gas flux and related ground deformation(5-7). Volcanic tremor is thus of particular value for eruption forecasting(6,8). Most models for volcanic tremor rely on specific properties of the geometry, structure and constitution of volcanic conduits as well as the gas content of the erupting magma. Because neither the initial structure nor the evolution of the magma-conduit system will be the same from one volcano to the next, it is surprising that tremor characteristics are so consistent among different volcanoes. Indeed, this universality of tremor properties remains a major enigma. Here we employ the contemporary view that silicic magma rises in the conduit as a columnar plug surrounded by a highly vesicular annulus of sheared bubbles(9,10). We demonstrate that, for most geologically relevant conditions, the magma column will oscillate or 'wag' against the restoring 'gas-spring' force of the annulus at observed tremor frequencies. In contrast to previous models, the magma-wagging oscillation is relatively insensitive to the conduit structure and geometry, which explains the narrow band of tremor frequencies observed around the world. Moreover, the model predicts that as an eruption proceeds there will be an upward drift in both the maximum frequency and the total signal frequency bandwidth, the nature of which depends on the explosivity of the eruption, as is often observed.	[Jellinek, A. Mark] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; [Bercovici, David] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA	University of British Columbia; Yale University	Jellinek, AM (corresponding author), Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada.	mjellinek@eos.ubc.ca	Jiao, Liqing/A-8821-2011	Bercovici, David/0000-0003-1993-0016	Canadian Institute for Advanced Research; NSERC; National Science Foundation	Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF))	A.M.J. acknowledges support from the Canadian Institute for Advanced Research and NSERC. D. B. acknowledges support from the National Science Foundation. This manuscript has benefited from discussions and comments from S. McNutt and C. Michaut. We thank S. McNutt, J. Neuberg, M. Hagerty, K. I. Konstantinou and M. Ibs-von Seht for data and preliminary figures that were incorporated into various versions of Fig. 1.	Bluth GJS, 2004, J VOLCANOL GEOTH RES, V136, P297, DOI 10.1016/j.jvolgeores.2004.06.001; Bryan CJ, 2003, B VOLCANOL, V65, P30, DOI 10.1007/s00445-002-0236-z; Chouet B, 1997, J GEOPHYS RES-SOL EA, V102, P15129, DOI 10.1029/97JB00953; Chouet BA, 1996, NATURE, V380, P309, DOI 10.1038/380309a0; Collier L, 2006, J VOLCANOL GEOTH RES, V153, P21, DOI 10.1016/j.jvolgeores.2005.08.009; Denlinger RP, 1999, GEOLOGY, V27, P459, DOI 10.1130/0091-7613(1999)027<0459:CEBOSV>2.3.CO;2; Dzurisin D, 2003, REV GEOPHYS, V41, DOI 10.1029/2001RG000107; EICHELBERGER JC, 1986, NATURE, V323, P598, DOI 10.1038/323598a0; Garces MA, 1998, GEOPHYS RES LETT, V25, P2293, DOI 10.1029/98GL01511; Gonnermann HM, 2007, ANNU REV FLUID MECH, V39, P321, DOI 10.1146/annurev.fluid.39.050905.110207; Goto A, 1999, GEOPHYS RES LETT, V26, P2541, DOI 10.1029/1999GL900569; Hagerty MT, 2000, J VOLCANOL GEOTH RES, V101, P27, DOI 10.1016/S0377-0273(00)00162-1; Hellweg M, 2000, J VOLCANOL GEOTH RES, V101, P183, DOI 10.1016/S0377-0273(00)00163-3; HURST AW, 1993, NEW ZEAL J GEOL GEOP, V36, P475, DOI 10.1080/00288306.1993.9514593; JULIAN BR, 1994, J GEOPHYS RES-SOL EA, V99, P11859, DOI 10.1029/93JB03129; Klug C, 1996, B VOLCANOL, V58, P87, DOI 10.1007/s004450050128; Konstantinou KI, 2003, J VOLCANOL GEOTH RES, V119, P161, DOI 10.1016/S0377-0273(02)00311-6; Lu Z, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006969; McNutt SR, 2005, ANNU REV EARTH PL SC, V33, P461, DOI 10.1146/annurev.earth.33.092203.122459; McNutt SR, 2008, J VOLCANOL GEOTH RES, V178, P10, DOI 10.1016/j.jvolgeores.2008.03.010; Neuberg J, 2000, PHILOS T ROY SOC A, V358, P1533, DOI 10.1098/rsta.2000.0602; Neuberg JW, 2006, J VOLCANOL GEOTH RES, V153, P37, DOI 10.1016/j.jvolgeores.2005.08.008; Rust AC, 2008, GEOL SOC SPEC PUBL, V307, P45, DOI 10.1144/SP307.4; Sherburn S, 1998, J VOLCANOL GEOTH RES, V83, P287, DOI 10.1016/S0377-0273(98)00022-5; Sherburn S, 1999, J VOLCANOL GEOTH RES, V88, P255, DOI 10.1016/S0377-0273(99)00014-1; Sparks RSJ, 2003, GEOL SOC SPEC PUBL, V213, P5, DOI 10.1144/GSL.SP.2003.213.01.02; Sparks RSJ, 2003, EARTH PLANET SC LETT, V210, P1, DOI 10.1016/S0012-821X(03)00124-9; Thompson G, 2002, B VOLCANOL, V64, P535, DOI 10.1007/s00445-002-0228-z; Tuffen H, 2008, NATURE, V453, P511, DOI 10.1038/nature06989; Wright HMN, 2009, EARTH PLANET SC LETT, V280, P93, DOI 10.1016/j.epsl.2009.01.023	30	69	69	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					522	U109		10.1038/nature09828	http://dx.doi.org/10.1038/nature09828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350484				2022-12-28	WOS:000287652900039
J	Patel, MS; Davis, MM; Lypson, ML				Patel, Mitesh S.; Davis, Matthew M.; Lypson, Monica L.			Advancing Medical Education by Teaching Health Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Patel, Mitesh S.] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Davis, Matthew M.; Lypson, Monica L.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Davis, Matthew M.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Lypson, Monica L.] Vet Affairs Healthcare Syst, Ann Arbor, MI USA	University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Patel, MS (corresponding author), Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA.			Lypson, Monica/0000-0002-1450-9380				Clancy T E, 1995, JAMA, V274, P1084, DOI 10.1001/jama.274.13.1084; Cooke M, 2010, NEW ENGL J MED, V362, P1253, DOI 10.1056/NEJMp0911502; Greysen SR, 2009, J GEN INTERN MED, V24, P1322, DOI 10.1007/s11606-009-1143-1; Iglehart JK, 2010, NEW ENGL J MED, V363, P584, DOI 10.1056/NEJMhpr1006115; Patel MS, 2009, ACAD MED, V84, P1301, DOI 10.1097/ACM.0b013e3181b17e3e	5	52	53	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					695	697		10.1056/NEJMp1009202	http://dx.doi.org/10.1056/NEJMp1009202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725NP	21345098				2022-12-28	WOS:000287652500002
J	Mathers, J; Sitch, A; Marsh, JL; Parry, J				Mathers, Jonathan; Sitch, Alice; Marsh, Jennifer L.; Parry, Jayne			Widening access to medical education for under-represented socioeconomic groups: population based cross sectional analysis of UK data, 2002-6	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GRADUATE ENTRY; SCHOOL ADMISSIONS; PARTICIPATION; SEX	Objective To determine whether new programmes developed to widen access to medicine in the United Kingdom have produced more diverse student populations. Design Population based cross sectional analysis. Setting 31 UK universities that offer medical degrees. Participants 34 407 UK medical students admitted to university in 2002-6. Main outcome measures Age, sex, socioeconomic status, and ethnicity of students admitted to traditional courses and newer courses (graduate entry courses (GEC) and foundation) designed to widen access and increase diversity. Results The demographics of students admitted to foundation courses were markedly different from traditional, graduate entry, and pre-medical courses. They were less likely to be white and to define their background as higher managerial and professional. Students on the graduate entry programme were older than students on traditional courses (25.5 v 19.2 years) and more likely to be white (odds ratio 3.74, 95% confidence interval 3.27 to 4.28; P<0.001) than those on traditional courses, but there was no difference in the ratio of men. Students on traditional courses at newer schools were significantly older by an average of 2.53 (2.41 to 2.65; P<0.001) years, more likely to be white (1.55, 1.41 to 1.71; P<0.001), and significantly less likely to have higher managerial and professional backgrounds than those at established schools (0.67, 0.61 to 0.73; P<0.001). There were marked differences in demographics across individual established schools offering both graduate entry and traditional courses. Conclusions The graduate entry programmes do not seem to have led to significant changes to the socioeconomic profile of the UK medical student population. Foundation programmes have increased the proportion of students from under-represented groups but numbers entering these courses are small.	[Mathers, Jonathan; Sitch, Alice; Marsh, Jennifer L.; Parry, Jayne] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Parry, J (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	J.M.Parry.1@bham.ac.uk	Sitch, Alice/L-9121-2019; Mathers, Jonathan/ABE-1164-2021	Sitch, Alice/0000-0001-7727-4497; Mathers, Jonathan/0000-0001-6651-6286	Department of Health; Higher Education Funding Council for England [0160056]	Department of Health; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	This study was funded by the Department of Health Policy Research Programme and the Higher Education Funding Council for England (Evaluation of the National Expansion of Medical Schools project; No 0160056). The design and conduct of the research and analysis and interpretation of data was undertaken independently by the authors.	Admissions to Higher Education Steering Group, 2004, FAIR ADM HIGH ED REC; [Anonymous], 2000, BBC NEWS        0526; [Anonymous], 2009, DAILY MAIL      0810; [Anonymous], 2009, DAILY MAIL      0822; [Anonymous], 2004, INDEPENDENT     0802; Boursicot K, 2009, HIGH EDUC POLICY, V22, P19, DOI DOI 10.1057/HEP.2008.35; British Medical Association, 2004, DEM MED SCH DISC PAP; British Medical Association, 2009, EQ DIV UK MED SCH; Carrasquillo O, 2008, JAMA-J AM MED ASSOC, V300, P1203, DOI 10.1001/jama.300.10.1203; Cohen JJ, 2003, JAMA-J AM MED ASSOC, V289, P1143, DOI 10.1001/jama.289.9.1143; Cohen JJ, 2006, JAMA-J AM MED ASSOC, V296, P1135, DOI 10.1001/jama.296.9.1135; Dabbs TR, 2011, BMJ; Directgov, 2011, U HIGH ED; Garlick PB, 2008, BMJ-BRIT MED J, V336, P1111, DOI 10.1136/bmj.39508.606157.BE; Greenhalgh T, 2004, BRIT MED J, V328, P1541, DOI 10.1136/bmj.328.7455.1541; Higher Education Funding Council for England, 2006, WID PART REV; Howe A, 2004, BRIT MED J, V329, P327, DOI 10.1136/bmj.329.7461.327; Ip H, 2008, BRIT MED J, V336, P1082, DOI 10.1136/bmj.39569.609641.80; James D, 2008, MED EDUC, V42, P294, DOI 10.1111/j.1365-2923.2008.03006.x; James D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c478; Mathers J, 2010, MED EDUC, V44, P1084, DOI 10.1111/j.1365-2923.2010.03731.x; Mathers J, 2009, MED EDUC, V43, P219, DOI 10.1111/j.1365-2923.2008.03274.x; McKinstry B, 2008, BRIT MED J, V336, P748, DOI 10.1136/bmj.39505.491065.94; Office for National Statistics, 2011, NAT STAT SOC CLASS; Parry J, 2006, BMJ-BRIT MED J, V332, P1005, DOI 10.1136/bmj.38768.590174.55; Powis D, 2004, MED EDUC, V38, P1147, DOI 10.1111/j.1365-2929.2004.01986.x; Rolfe IE, 2004, MED EDUC, V38, P778, DOI 10.1111/j.1365-2929.2004.01891.x; Saha S, 2008, JAMA-J AM MED ASSOC, V300, P1203; Searle J, 2004, MED EDUC, V38, P1130, DOI 10.1111/j.1365-2929.2004.01984.x; Secretary of State for Education, 2004, MED SCH DEL DOCT FUT; Seyan K, 2004, BRIT MED J, V328, P1545, DOI 10.1136/bmj.328.7455.1545; St George's University of London, 2011, WHY SOM STUD DES SPE; T Do PC, 2006, MED EDUC, V40, P750, DOI 10.1111/j.1365-2929.2006.02535.x; The Panel on Fair Access to the Professions, 2009, UNL ASP FIN REP PAN; UCAS, 2011, MAN APPL UK HIGH ED; University of Sheffield, 2011, SCH COLL COMM GROUPS	36	33	34	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2011	342								d918	10.1136/bmj.d918	http://dx.doi.org/10.1136/bmj.d918			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729AS	21343208	Green Published, hybrid			2022-12-28	WOS:000287919000008
J	Takemoto, T; Uchikawa, M; Yoshida, M; Bell, DM; Lovell-Badge, R; Papaioannou, VE; Kondoh, H				Takemoto, Tatsuya; Uchikawa, Masanori; Yoshida, Megumi; Bell, Donald M.; Lovell-Badge, Robin; Papaioannou, Virginia E.; Kondoh, Hisato			Tbx6-dependent Sox2 regulation determines neural or mesodermal fate in axial stem cells	NATURE			English	Article							MOUSE EMBRYO; PARAXIAL MESODERM; PRESOMITIC MESODERM; NERVOUS-SYSTEM; EXPRESSION; GENE; WNT; TBX6; GASTRULATION; ELEMENTS	The classical view of neural plate development held that it arises from the ectoderm, after its separation from the mesodermal and endodermal lineages. However, recent cell-lineage-tracing experiments indicate that the caudal neural plate and paraxial mesoderm are generated from common bipotential axial stem cells originating from the caudal lateral epiblast(1,2). Tbx6 null mutant mouse embryos which produce ectopic neural tubes at the expense of paraxial mesoderm(3) must provide a clue to the regulatory mechanism underlying this neural versus mesodermal fate choice. Here we demonstrate that Tbx6-dependent regulation of Sox2 determines the fate of axial stem cells. In wild-type embryos, enhancer N1 of the neural primordial gene Sox2 is activated in the caudal lateral epiblast, and the cells staying in the superficial layer sustain N1 activity and activate Sox2 expression in the neural plate(4-6). In contrast, the cells destined to become mesoderm activate Tbx6 and turn off enhancer N1 before migrating into the paraxial mesoderm compartment. In Tbx6 mutant embryos, however, enhancer N1 activity persists in the paraxial mesoderm compartment, eliciting ectopic Sox2 activation and transforming the paraxial mesoderm into neural tubes. An enhancer-N1-specific deletion mutation introduced into Tbx6 mutant embryos prevented this Sox2 activation in the mesodermal compartment and subsequent development of ectopic neural tubes, indicating that Tbx6 regulates Sox2 via enhancer N1. Tbx6-dependent repression of Wnt3a in the paraxial mesodermal compartment is implicated in this regulatory process. Paraxial mesoderm-specific misexpression of a Sox2 transgene in wild-type embryos resulted in ectopic neural tube development. Thus, Tbx6 represses Sox2 by inactivating enhancer N1 to inhibit neural development, and this is an essential step for the specification of paraxial mesoderm from the axial stem cells.	[Takemoto, Tatsuya; Uchikawa, Masanori; Yoshida, Megumi; Kondoh, Hisato] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Bell, Donald M.; Lovell-Badge, Robin] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Papaioannou, Virginia E.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Osaka University; MRC National Institute for Medical Research; Columbia University	Kondoh, H (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	kondohh@fbs.osaka-u.ac.jp		Bell, Donald/0000-0002-3788-1580; Lovell-Badge, Robin/0000-0001-9364-4179; Papaioannou, Virginia/0000-0001-7558-8601	MEXT Japan; NIH; MRC; MRC [MC_U117562207] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056248] Funding Source: NIH RePORTER; Medical Research Council [MC_U117562207] Funding Source: researchfish	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the members of Kondoh laboratory for discussions. This study was supported by Grants-in-Aid for Scientific Research from MEXT Japan to T.T. and H.K., an NIH grant to V.E.P., and MRC funding to R.L.-B.	Beckers J, 2000, MECH DEVELOP, V95, P23, DOI 10.1016/S0925-4773(00)00322-1; Bouillet P, 1996, MECH DEVELOP, V58, P141, DOI 10.1016/S0925-4773(96)00569-2; Brown JM, 2000, CURR BIOL, V10, P869, DOI 10.1016/S0960-9822(00)00601-1; Cambray N, 2007, DEVELOPMENT, V134, P2829, DOI 10.1242/dev.02877; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Conlon FL, 2001, DEVELOPMENT, V128, P3749; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Delfino-Machin M, 2005, DEVELOPMENT, V132, P4273, DOI 10.1242/dev.02009; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Dosch R, 1997, DEVELOPMENT, V124, P2325; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Hofmann M, 2004, GENE DEV, V18, P2712, DOI 10.1101/gad.1248604; KAMACHI Y, 1993, MOL CELL BIOL, V13, P5206, DOI 10.1128/MCB.13.9.5206; Kamachi Y, 2009, P JPN ACAD B-PHYS, V85, P55, DOI 10.2183/pjab.85.55; KATOH K, 1987, CELL STRUCT FUNCT, V12, P575, DOI 10.1247/csf.12.575; Kimura-Yoshida C, 2005, DEV CELL, V9, P639, DOI 10.1016/j.devcel.2005.09.011; KISPERT A, 1993, EMBO J, V12, P4898, DOI 10.1002/j.1460-2075.1993.tb06179.x; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Nagy A., 2003, MANIPULATING MOUSE E; NISWANDER L, 1992, DEVELOPMENT, V114, P755; ROELINK H, 1991, GENE DEV, V5, P381, DOI 10.1101/gad.5.3.381; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SASAKI H, 1993, DEVELOPMENT, V118, P47; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; SELLECK MAJ, 1991, DEVELOPMENT, V112, P615; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takemoto T, 2006, DEVELOPMENT, V133, P297, DOI 10.1242/dev.02196; Tonegawa A, 1998, DEV BIOL, V202, P172, DOI 10.1006/dbio.1998.8895; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Tzouanacou E, 2009, DEV CELL, V17, P365, DOI 10.1016/j.devcel.2009.08.002; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; White PH, 2005, GENESIS, V42, P193, DOI 10.1002/gene.20140; Wilkinson DG, 1992, SITU HYBRIDIZATION P; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Xu PX, 1999, DEVELOPMENT, V126, P383; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Yamaguchi Terry P., 2008, V468, P287, DOI 10.1007/978-1-59745-249-6_23; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Yasuhiko Y, 2008, DEVELOPMENT, V135, P3511, DOI 10.1242/dev.027144	43	174	175	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					394	398		10.1038/nature09729	http://dx.doi.org/10.1038/nature09729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331042	Green Accepted			2022-12-28	WOS:000287409100042
J	Sugg, R				Sugg, Richard			The art of medicine Prescientific death rites, vampires, and the human soul	LANCET			English	Editorial Material									Univ Durham, Dept English Studies, Durham DH1 3LZ, England	Durham University	Sugg, R (corresponding author), Univ Durham, Dept English Studies, Durham DH1 3LZ, England.	richard.sugg@durham.ac.uk						Barley N., 1997, DANCING GRAVE ENCOUN; BLUM R, 1970, DANGEROUS HOUR LORE; DUBOULAY J, 1982, MAN, V17, P219, DOI 10.2307/2801810; Merridale C., 2000, NIGHT STONE DEATH ME; Sugg R., 2011, MUMMIES CANNIBALS VA; Warner EA, 2000, FOLKLORE, V111, P67, DOI 10.1080/001558700360898; WARNER EA, 2000, FOLKLORE, V111, P255	7	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2011	377	9767					712	713		10.1016/S0140-6736(11)60259-6	http://dx.doi.org/10.1016/S0140-6736(11)60259-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	729JQ	21374901				2022-12-28	WOS:000287946000014
J	Sievert, KD				Sievert, Karl-Dietrich			The next step in urethral reconstruction	LANCET			English	Editorial Material							TISSUE; MATRIX; STRICTURES		Univ Tubingen, Dept Urol, Univ Clin, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Sievert, KD (corresponding author), Univ Tubingen, Dept Urol, Univ Clin, D-72076 Tubingen, Germany.	Karl.Sievert@med.uni-tuebingen.de						Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Bhargava S, 2008, EUR UROL, V53, P1263, DOI 10.1016/j.eururo.2008.01.061; Dorin RP, 2008, WORLD J UROL, V26, P323, DOI 10.1007/s00345-008-0316-6; El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101; El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8; Feil G, 2011, ADV DRUG DELIVER REV, V63, P375, DOI 10.1016/j.addr.2010.12.003; Fisch M, 2001, Curr Opin Urol, V11, P253; Nagele U, 2008, EUR UROL, V54, P1414, DOI 10.1016/j.eururo.2008.01.072; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Rourke KF, 2003, J UROLOGY, V169, P1818, DOI 10.1097/01.ju.0000056035.37591.9f; Sievert KD, 2007, EUR UROL, V52, P1580, DOI 10.1016/j.eururo.2007.08.051; Sievert KD, 2000, J UROLOGY, V163, P1958, DOI 10.1016/S0022-5347(05)67610-0; Sunay M, 2011, UROLOGY, V77, P706, DOI 10.1016/j.urology.2010.07.476; Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023	14	5	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1130	1131		10.1016/S0140-6736(11)60312-7	http://dx.doi.org/10.1016/S0140-6736(11)60312-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21388672				2022-12-28	WOS:000289539300006
J	Ballard, C; Gauthier, S; Corbett, A; Brayne, C; Aarsland, D; Jones, E				Ballard, Clive; Gauthier, Serge; Corbett, Anne; Brayne, Carol; Aarsland, Dag; Jones, Emma			Alzheimer's disease	LANCET			English	Article							TARGETING A-BETA; AMYLOID-BETA; COGNITIVE DECLINE; RISK-FACTOR; INCIDENT DEMENTIA; CONTROLLED-TRIAL; GENETIC-LINKAGE; CSF BIOMARKERS; BLOOD-PRESSURE; DOWN-SYNDROME	An estimated 24 million people worldwide have dementia, the majority of whom are thought to have Alzheimer's disease. Thus, Alzheimer's disease represents a major public health concern and has been identified as a research priority. Although there are licensed treatments that can alleviate symptoms of Alzheimer's disease, there is a pressing need to improve our understanding of pathogenesis to enable development of disease-modifying treatments. Methods for improving diagnosis are also moving forward, but a better consensus is needed for development of a panel of biological aneuroimaging biomarkers that support clinical diagnosis. There is now strong evidence of potential risk and protective factors for Alzheimer's disease, dementia, and cognitive decline, but further work is needed to understand these better and to establish whether interventions can substantially lower these risks. In this Seminar, we provide an overview of recent evidence regarding the epidemiology, pathogenesis, diagnosis, and treatment of Alzheimer's disease, and discuss potential ways to reduce the risk of developing the disease.	[Ballard, Clive; Jones, Emma] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England; [Gauthier, Serge] Douglas Mental Hlth Res Inst, McGill Ctr Studies Aging, Montreal, PQ, Canada; [Corbett, Anne] Alzheimers Soc, London, England; [Brayne, Carol] Univ Cambridge, Cambridge, England; [Aarsland, Dag] Univ Hosp Stavanger, Stavanger, Norway	University of London; King's College London; McGill University; University of Cambridge; Stavanger University Hospital	Ballard, C (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Wolfson Wing,Hodgkin Bldg,Guys Campus, London SE1 1UL, England.	clive.ballard@kcl.ac.uk	Brayne, Carol/AAA-4285-2020; Corbett, Anne/B-3223-2014	Brayne, Carol/0000-0001-5307-663X; Corbett, Anne/0000-0003-2015-0316; Ballard, Clive/0000-0003-0022-5632; Aarsland, Dag/0000-0001-6314-216X	Novartis; Lundbeck; Eisai; Acadia; Bristol-Myers Squibb; GE Healthcare; Merck-Serono; Alzheimer's Society (UK); Medical Research Council [G9901400] Funding Source: researchfish; MRC [G9901400] Funding Source: UKRI	Novartis(Novartis); Lundbeck(Lundbeck Corporation); Eisai(Eisai Co Ltd); Acadia; Bristol-Myers Squibb(Bristol-Myers Squibb); GE Healthcare(General ElectricGE Healthcare); Merck-Serono(Merck & Company); Alzheimer's Society (UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CBa has received consultancy fees from Novartis, Lundbeck, Eisai, Acadia, and Bristol-Myers Squibb; honoraria from Lundbeck, Novartis, Eisai, and Acadia; payment for manuscript preparation from Bristol-Myers Squibb; and travel and accommodation expenses from Lundbeck, Acadia, Novartis, Eisai, and Bristol-Myers Squibb. CB's institution has received grants from Lundbeck and Acadia and grants from Lundbeck, Novartis, Eisai, and Acadia. SG has received payment for acting as a scientific adviser for Affris, AstraZeneca, Elan, ExonHit, GE Healthcare, Lundbeck, Merz, Pfizer, Sanofi-Aventis, Schering-Plough, Servier, Sonexa, and United Biosource; a speaker for Affris; chair of the data and safety monitoring board for Bristol-Myers Squibb; an investigator for Lundbeck, Eli Lilly, Novartis, Pfizer, and Sonexa; and a speaker for Affiris and Lundbeck. DA has received consultancy fees from Lundbeck, GE Healthcare, and Merck-Serono; grants from Lundbeck and Merck-Serono; honoraria from Merck-Serono, Lundbeck, Novartis, GE Healthcare, and GlaxoSmithKline; and payments for development of educational presentations from Lundbeck. AC, CB, and EJ declare that they have no conflicts of interest.; The time spent preparing the seminar by CB and EJ was supported by the Alzheimer's Society (UK). EJ is an Alzheimer's Society Research Fellow. We thank the members of the BBC Think Smart panel, because this work greatly informed the composition of the risk factor section.	Aisen PS, 2007, CURR ALZHEIMER RES, V4, P473, DOI 10.2174/156720507781788882; [Anonymous], 2010, Lancet Neurol, V9, P643, DOI 10.1016/S1474-4422(10)70145-9; Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Ballard C, 2002, INT J GERIATR PSYCH, V17, P140, DOI 10.1002/gps.543; Ballard C., 2005, DEMENTIA, P24; Ballard C, 2006, NAT REV NEUROSCI, V7, P492, DOI 10.1038/nrn1926; Ballard C, 2009, LANCET NEUROL, V8, P151, DOI 10.1016/S1474-4422(08)70295-3; Ballard CG, 2009, NAT REV NEUROL, V5, P245, DOI 10.1038/nrneurol.2009.39; Bandiera T, 1997, CURR MED CHEM, V4, P159; Barnes J, 2009, NEUROBIOL AGING, V30, P1711, DOI 10.1016/j.neurobiolaging.2008.01.010; Beaglehole R., 2003, WORLD HLTH REPORT 20; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Birks J, 2009, COCHRANE DB SYST REV, V2; Bush AI, 2008, J ALZHEIMERS DIS, V15, P223; Caffrey TM, 2007, NEUROBIOL DIS, V27, P1, DOI 10.1016/j.nbd.2007.04.006; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chenoweth L, 2009, LANCET NEUROL, V8, P317, DOI 10.1016/S1474-4422(09)70045-6; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cohen-Mansfield J, 2007, J GERONTOL A-BIOL, V62, P908, DOI 10.1093/gerona/62.8.908; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dougall NJ, 2004, AM J GERIAT PSYCHIAT, V12, P554, DOI 10.1176/appi.ajgp.12.6.554; Downs M, 2006, BRIT MED J, V332, P692, DOI 10.1136/bmj.332.7543.692; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ertekin-Taner N, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt26; Esiri MM, 2001, LANCET, V357, P169; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Forsberg A, 2010, CURR ALZHEIMER RES, V7, P56, DOI 10.2174/156720510790274446; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Gauthier S, 2008, INT J GERIATR PSYCH, V23, P537, DOI 10.1002/gps.1949; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gray SL, 2008, J AM GERIATR SOC, V56, P291, DOI 10.1111/j.1532-5415.2007.01531.x; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hardy John, 2006, Current Alzheimer Research, V3, P71, DOI 10.2174/156720506775697098; Hardy J, 2004, NEURODEGENER DIS, V1, P213, DOI 10.1159/000080988; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hernandez F, 2009, BRAIN RES BULL, V80, P248, DOI 10.1016/j.brainresbull.2009.05.017; Heyman A, 1998, NEUROLOGY, V51, P159, DOI 10.1212/WNL.51.1.159; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kadir A, 2011, BRAIN, V134, P301, DOI 10.1093/brain/awq349; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Kivipelto M, 2006, ACTA NEUROL SCAND, V114, P50, DOI 10.1111/j.1600-0404.2006.00685.x; Kwok JBJ, 2008, ANN NEUROL, V64, P446, DOI 10.1002/ana.21476; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Laurin D, 2004, AM J EPIDEMIOL, V159, P959, DOI 10.1093/aje/kwh124; Lee Y, 2010, INT PSYCHOGERIATR, V22, P174, DOI 10.1017/S1041610209991189; Leroy K, 2010, J ALZHEIMERS DIS, V19, P705, DOI [10.3233/JAD-2010-1276, 10.3233/JAD-2009-1276]; Leung KK, 2010, NEUROIMAGE, V50, P516, DOI 10.1016/j.neuroimage.2009.12.059; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis H, 2006, NEUROPATH APPL NEURO, V32, P103, DOI 10.1111/j.1365-2990.2006.00696.x; Liu F, 2008, FASEB J, V22, P3224, DOI 10.1096/fj.07-104539; Lopez OL, 2009, J NEUROL NEUROSUR PS, V80, P600, DOI 10.1136/jnnp.2008.158964; Lovestone S, 2009, ANN NY ACAD SCI, V1180, P36, DOI 10.1111/j.1749-6632.2009.05064.x; Loy C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001747.pub3; Loy R, 2002, J MOL NEUROSCI, V19, P303; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Lutz MW, 2010, ALZHEIMERS DEMENT, V6, P125, DOI 10.1016/j.jalz.2010.01.011; Malouf R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004514.pub2; Martins RH, 1995, NEUROREPORT, V7, P217, DOI 10.1097/00001756-199512290-00052; Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180; MATTSSON N, 2009, JAMA-J AM MED ASSOC, V22, P385; Mattsson N, 2009, ANN NY ACAD SCI, V1180, P28, DOI 10.1111/j.1749-6632.2009.04944.x; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McGuinness B, 2008, J NEUROL NEUROSUR PS, V79, P4, DOI 10.1136/jnnp.2007.118505; MCGUINNESS B, 2009, COCHRANE DB SYST REV, V2, DOI DOI 10.001002/14651858.CD14003160.PUB14651852; McKeith I, 2007, LANCET NEUROL, V6, P305, DOI 10.1016/S1474-4422(07)70057-1; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Meraz-Rios MA, 2010, J NEUROCHEM, V112, P1353, DOI 10.1111/j.1471-4159.2009.06511.x; Miners JS, 2008, NEUROPATH APPL NEURO, V34, P181, DOI 10.1111/j.1365-2990.2007.00885.x; Morris HR, 1999, MOVEMENT DISORD, V14, P731, DOI 10.1002/1531-8257(199909)14:5<731::AID-MDS1004>3.0.CO;2-J; Morris R, 2006, NATURE, V440, P284, DOI 10.1038/440284a; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Nerelius C, 2010, BIOCHEM BIOPH RES CO, V396, P2, DOI 10.1016/j.bbrc.2010.02.105; *NICE SCIE, 2006, NICE SCIE GUID IMPR; Nordberg A, 2004, LANCET NEUROL, V3, P519, DOI 10.1016/S1474-4422(04)00853-1; Okello A, 2009, NEUROLOGY, V73, P754, DOI 10.1212/WNL.0b013e3181b23564; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Papp KV, 2009, ALZHEIMERS DEMENT, V5, P50, DOI 10.1016/j.jalz.2008.10.008; Patwardhan MB, 2004, RADIOLOGY, V231, P73, DOI 10.1148/radiol.2311021620; Pedersen NL, 2010, JAMA-J AM MED ASSOC, V303, P1864, DOI 10.1001/jama.2010.609; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; RAGHAVAN R, 1994, NEUROREPORT, V5, P1393, DOI 10.1097/00001756-199406000-00026; Ravaglia G, 2008, AM J CLIN NUTR, V87, P1306, DOI 10.1093/ajcn/87.5.1306; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Ritchie, 2004, ARCH NEUROL-CHICAGO, V61, P776; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Rockwood K, 2006, CAN MED ASSOC J, V174, P1099, DOI 10.1503/cmaj.051432; Rockwood K, 1996, NEUROEPIDEMIOLOGY, V15, P330, DOI 10.1159/000109923; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Roses AD, 2010, ARCH NEUROL-CHICAGO, V67, P536, DOI 10.1001/archneurol.2010.88; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Savva GM, 2010, STROKE, V41, pE41, DOI 10.1161/STROKEAHA.109.559880; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Small SA, 2008, NEURON, V60, P534, DOI 10.1016/j.neuron.2008.11.007; Snitz BE, 2009, JAMA-J AM MED ASSOC, V302, P2663, DOI 10.1001/jama.2009.1913; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Stephan BCM, 2010, NAT REV NEUROL, V6, P318, DOI 10.1038/nrneurol.2010.54; Sundstrom A, 2007, INT PSYCHOGERIATR, V19, P159, DOI 10.1017/S1041610206003498; Svedberg MM, 2009, NEUROCHEM INT, V54, P347, DOI 10.1016/j.neuint.2008.12.016; Takashima A, 2009, J ALZHEIMERS DIS, V17, P729, DOI 10.3233/JAD-2009-1090; Teri L, 2003, JAMA-J AM MED ASSOC, V290, P2015, DOI 10.1001/jama.290.15.2015; Thakker DR, 2009, P NATL ACAD SCI USA, V106, P4501, DOI 10.1073/pnas.0813404106; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Valenzuela M, 2009, AM J GERIAT PSYCHIAT, V17, P179, DOI 10.1097/JGP.0b013e3181953b57; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Wahlund LO, 2000, J NEUROL NEUROSUR PS, V69, P630, DOI 10.1136/jnnp.69.5.630; Waldemar G, 2007, EUR J NEUROL, V14, pE1, DOI 10.1111/j.1468-1331.2006.01605.x; WALDEMAR G, 2009, INT PSYCHOGERIATR, V21, P205; Weinmann S, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-14; Weintraub D, 2010, AM J GERIAT PSYCHIAT, V18, P332, DOI 10.1097/JGP.0b013e3181cc0333; Welge V, 2009, J NEURAL TRANSM, V116, P203, DOI 10.1007/s00702-008-0177-6; Wilcock GK, 2008, J CLIN PSYCHIAT, V69, P341, DOI 10.4088/JCP.v69n0302; Yu F, 2009, J GERONTOL NURS, V35, P23, DOI 10.3928/00989134-20090301-10	130	1640	1741	15	919	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2011	377	9770					1019	1031		10.1016/S0140-6736(10)61349-9	http://dx.doi.org/10.1016/S0140-6736(10)61349-9			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21371747				2022-12-28	WOS:000288775800031
J	Kegel, A; Betts-Lindroos, H; Kanno, T; Jeppsson, K; Strom, L; Katou, Y; Itoh, T; Shirahige, K; Sjogren, C				Kegel, Andreas; Betts-Lindroos, Hanna; Kanno, Takaharu; Jeppsson, Kristian; Strom, Lena; Katou, Yuki; Itoh, Takehiko; Shirahige, Katsuhiko; Sjogren, Camilla			Chromosome length influences replication-induced topological stress	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; TOPOISOMERASE-I; RECQ HELICASE; BUDDING YEAST; REPAIR; PROTEINS; COMPLEX; FORKS; DAMAGE	During chromosome duplication the parental DNA molecule becomes overwound, or positively supercoiled, in the region ahead of the advancing replication fork. To allow fork progression, this superhelical tension has to be removed by topoisomerases, which operate by introducing transient DNA breaks(1). Positive supercoiling can also be diminished if the advancing fork rotates along the DNA helix, but then sister chromatid intertwinings form in its wake(1,2). Despite these insights it remains largely unknown how replication-induced superhelical stress is dealt with on linear, eukaryotic chromosomes. Here we show that this stress increases with the length of Saccharomyces cerevisiae chromosomes. This highlights the possibility that superhelical tension is handled on a chromosome scale and not only within topologically closed chromosomal domains as the current view predicts. We found that inhibition of type I topoisomerases leads to a late replication delay of longer, but not shorter, chromosomes. This phenotype is also displayed by cells expressing mutated versions of the cohesin-and condensin-related Smc5/6 complex. The frequency of chromosomal association sites of the Smc5/6 complex increases in response to chromosome lengthening, chromosome circularization, or inactivation of topoisomerase 2, all having the potential to increase the number of sister chromatid intertwinings(3). Furthermore, nonfunctional Smc6 reduces the accumulation of intertwined sister plasmids after one round of replication in the absence of topoisomerase 2 function. Our results demonstrate that the length of a chromosome influences the need of superhelical tension release in Saccharomyces cerevisiae, and allow us to propose a model where the Smc5/6 complex facilitates fork rotation by sequestering nascent chromatid intertwinings that form behind the replication machinery.	[Kegel, Andreas; Betts-Lindroos, Hanna; Kanno, Takaharu; Jeppsson, Kristian; Strom, Lena; Sjogren, Camilla] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Katou, Yuki; Itoh, Takehiko] Tokyo Inst Technol, Grad Sch Biosci, Lab Silico Funct Genom, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Bunkyo Ku, Tokyo 1130032, Japan	Karolinska Institutet; Tokyo Institute of Technology; University of Tokyo	Sjogren, C (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Eulersvag 3, S-17177 Stockholm, Sweden.	camilla.sjogren@ki.se	Ström, Lena/AAJ-9025-2020; Itoh, Takehiko/E-8873-2014	Itoh, Takehiko/0000-0002-6113-557X; Lindroos, Hanna/0000-0002-8455-8452; Strom, Lena/0000-0002-8898-3675; Bjorkegren, Camilla/0000-0001-7354-9270; Shirahige, Katsuhiko/0000-0002-7862-1144	JST; SSF; Vinnova	JST(Japan Science & Technology Agency (JST)); SSF(Swedish Foundation for Strategic Research); Vinnova(Vinnova)	We thank K. Nasmyth, J. Haber, E. Green and X. Zhao for yeast strains and the BEA core facility at Karolinska Institutet for help with ChIP on chip. Financial support: Strategic Japanese-Swedish Cooperative Program from JST, SSF and Vinnova (C. S. and K. S.); please see Supplementary Information for additional support.	Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; HAMER L, 1995, P NATL ACAD SCI USA, V92, P11706, DOI 10.1073/pnas.92.25.11706; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; HIASA H, 1994, J BIOL CHEM, V269, P2093; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; KIM RA, 1989, J MOL BIOL, V208, P257, DOI 10.1016/0022-2836(89)90387-2; KJELDSEN E, 1992, J MOL BIOL, V228, P1025, DOI 10.1016/0022-2836(92)90310-G; KOSHLAND D, 1987, SCIENCE, V238, P1713, DOI 10.1126/science.3317838; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Outwin EA, 2009, MOL CELL BIOL, V29, P4363, DOI 10.1128/MCB.00377-09; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Rosenfeld S, 2009, GENE REGUL SYST BIO, V3, P159; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; SPELL RM, 1994, MOL CELL BIOL, V14, P1465, DOI 10.1128/MCB.14.2.1465; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	36	79	79	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					392	+		10.1038/nature09791	http://dx.doi.org/10.1038/nature09791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368764				2022-12-28	WOS:000288444000048
J	Riezebos, RK				Riezebos, Robert K.			Telemonitoring did not reduce readmissions or mortality in patients recently hospitalized for heart failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Onze Lieve Vrouw Hosp, Amsterdam, Netherlands	Onze Lieve Vrouwe Gasthuis Hospital	Riezebos, RK (corresponding author), Onze Lieve Vrouw Hosp, Amsterdam, Netherlands.							Clarke M, 2011, J TELEMED TELECARE, V17, P7, DOI 10.1258/jtt.2010.100113; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806	3	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-8	10.7326/0003-4819-154-6-201103150-02008	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403071				2022-12-28	WOS:000208886200007
J	Moschetti, I; Brandt, D; Perera, R; Clarke, M; Heneghan, C				Moschetti, Ivan; Brandt, Daniel; Perera, Rafael; Clarke, M.; Heneghan, Carl			Adequacy of reporting monitoring regimens of risk factors for cardiovascular disease in clinical guidelines: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PRIMARY PREVENTION; VASCULAR-DISEASE; ASSOCIATION; CHOLESTEROL; COUNTRIES; CORONARY; UPDATE	Objective To assess the reporting of monitoring recommendations in guidelines on the prevention and treatment of cardiovascular disease. Data sources Medline, Trip database, National Guideline Clearinghouse, and databases containing guidelines published from January 2002 to February 2010. Data selection Three major risk factors for cardiovascular disease: cholesterol level, smoking, and hypertension. The primary outcome was the frequency with which the guidelines dealt with monitoring of risk factors. Secondary outcomes were completeness of monitoring recommendations, defined by the presence of what to monitor, when to monitor, what to do if the targets or variables were not met, and the reported level or strength of the evidence. Results 117 guidelines were identified, 84 (72%) of which contained a section on lipids. Of those guidelines with a section on lipids, 53% (n=44) provided no information or specific recommendations on what to monitor, 51% (n=43) provided no information on when to monitor, and 64% (n=54) provided no guidance on what to do if the target was out of range. Guidelines for hypertension (n=79) and smoking (n=65) were little better, with 63% (n=50) and 54% (n=35), respectively, providing no recommendation for what to monitor. The number of guidelines that explicitly referenced the level of evidence for monitoring was low, with most of the recommendations based on weak levels of evidence. Conclusion Many guidelines for cardiovascular disease do not report clearly what to monitor and what to do if a change is detected. If no evidence is available to support a specific monitoring schedule, this should be explicit in the guideline, with a description of the new research that would fill the gap.	[Moschetti, Ivan; Perera, Rafael; Heneghan, Carl] Univ Oxford, Dept Primary Hlth Care, Oxford, England; [Brandt, Daniel] Univ Toronto, Dept Med, Toronto, ON, Canada; [Clarke, M.] UK Cochrane Ctr, Natl Inst Hlth Res, Oxford, England	University of Oxford; University of Toronto; Cochrane Centre	Heneghan, C (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford, England.	carl.heneghan@dphpc.ox.ac.uk	MOSCHETTI, IVAN/ABF-9728-2020	MOSCHETTI, IVAN/0000-0003-4047-6655; Perera, Rafael/0000-0003-2418-2091	National Institute for Health Research	National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by a National Institute for Health Research Health Technology Assessment programme.	Altman DG, 2008, LANCET, V371, P1149, DOI 10.1016/S0140-6736(08)60505-X; British Columbia Medical Association, 2008, CARD DIS PRIM PREV G; Burgers JS, 2003, INT J TECHNOL ASSESS, V19, P148, DOI 10.1017/S026646230300014X; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Campbell-Scherer DL, 2009, AM FAM PHYSICIAN, V79, P1080; Canadian Stroke Network and the Heart and Stroke Foundation of Canada, 2006, CAB BEST PRACT REC S; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Emberson JR, 2003, EUR HEART J, V24, P1719, DOI 10.1016/S0195-668X(03)00471-8; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Fulcher GR, 2004, MED J AUST S6, V181, pF4; Glasziou P, 2005, BMJ-BRIT MED J, V330, P644, DOI 10.1136/bmj.330.7492.644; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; JBS 2, 2005, HEART S5, V91, pv1; National Vascular Disease Prevention Alliance, 2004, Aust Fam Physician, V33, P235; Scottish Intercollegiate Guidelines Network (SIGN), 2007, RISK EST PREV CARD D; Smith SC, 2006, J AM COLL CARDIOL, V47, P2130, DOI 10.1016/j.jacc.2006.04.026; [University of Michigan Health System http://cme.med.umich.edu/pdf/guideline/dm08.pdf], 2008, MAN TYP 2 DIAB MELL; University of Michigan Health System, 2009, SEC PREV COR ART DIS; US Department of Health and Human Services, 2010, MED NAT COV DET MAN; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	25	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2011	342								d1289	10.1136/bmj.d1289	http://dx.doi.org/10.1136/bmj.d1289			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739EZ	21402669	hybrid			2022-12-28	WOS:000288697700003
J	Deodati, A; Cianfarani, S				Deodati, Annalisa; Cianfarani, Stefano			Impact of growth hormone therapy on adult height of children with idiopathic short stature: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FINAL HEIGHT; DEFICIENT CHILDREN; DEFINITION	Objective To systematically determine the impact of growth hormone therapy on adult height of children with idiopathic short stature. Design Systematic review. Data sources Cochrane Central Register of Controlled Trials, Medline, and the bibliographic references from retrieved articles of randomised and non-randomised controlled trials from 1985 to April 2010. Data extraction Height in adulthood (standard deviation score) and overall gain in height (SD score) from baseline measurement in childhood. Study selection Randomised and non-randomised controlled trials with height measurements for adults. Inclusion criteria were initial short stature (defined as height >2 SD score below the mean), peak growth hormone responses >10 mu g/L, prepubertal stage, no previous growth hormone therapy, and no comorbid conditions that would impair growth. Adult height was considered achieved when growth rate was <1.5 cm/year or bone age was 15 years in females and 16 years in males. Results Three randomised controlled trials (115 children) met the inclusion criteria. The adult height of the growth hormone treated children exceeded that of the controls by 0.65 SD score (about 4 cm). The mean height gain in treated children was 1.2 SD score compared with 0.34 SD score in untreated children. A slight difference of about 1.2 cm in adult height was observed between the two growth hormone dose regimens. In the seven non-randomised controlled trials the adult height of the growth hormone treated group exceeded that of the controls by 0.45 SD score (about 3 cm). Conclusions Growth hormone therapy in children with idiopathic short stature seems to be effective in partially reducing the deficit in height as adults, although the magnitude of effectiveness is on average less than that achieved in other conditions for which growth hormone is licensed. The individual response to therapy is highly variable, and additional studies are needed to identify the responders.	[Deodati, Annalisa; Cianfarani, Stefano] Univ Roma Tor Vergata, Mol Endocrinol Unit DPUO, Bambino Gesu Childrens Hosp, Rina Balducci Ctr Pediat Endocrinol, I-00133 Rome, Italy	IRCCS Bambino Gesu; University of Rome Tor Vergata	Cianfarani, S (corresponding author), Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, I-00133 Rome, Italy.	stefano.cianfarani@uniroma2.it	cianfarani, stefano/K-2079-2016; Geremia, Caterina/AAA-9380-2020	cianfarani, stefano/0000-0002-2580-8781; DEODATI, ANNALISA/0000-0001-8636-382X	Ipsen; Eli Lilly; Novo Nordisk; Pfizer; Merck-Serono; Ferring	Ipsen(Ipsen); Eli Lilly(Eli Lilly); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Merck-Serono(Merck & Company); Ferring(Ferring Pharmaceuticals)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; SC received lecture fees from Ipsen, Eli Lilly, Novo Nordisk, and Pfizer, consulting fees from Ipsen, Eli Lilly, and Pfizer, and research funds from Merck-Serono, Pfizer, Eli Lilly, and Ferring; no other relationships or activities that could appear to have influenced the submitted work.	Albertsson-Wikland K, 2008, J CLIN ENDOCR METAB, V93, P4342, DOI 10.1210/jc.2008-0707; Allen DB, 2010, J CLIN ENDOCR METAB, V95, P52, DOI 10.1210/jc.2009-2364; Baxter L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003887.pub2; Bernasconi S, 1997, CLIN ENDOCRINOL, V47, P261, DOI 10.1046/j.1365-2265.1997.2751082.x; Bryant J, 2007, COCHRANE DB SYST REV, V18, DOI DOI 10.1002/14651858; Buchlis JG, 1998, J CLIN ENDOCR METAB, V83, P1075, DOI 10.1210/jc.83.4.1075; Cohen P, 2008, J CLIN ENDOCR METAB, V93, P4210, DOI 10.1210/jc.2008-0509; Coutant R, 2001, J CLIN ENDOCR METAB, V86, P4649, DOI 10.1210/jc.86.10.4649; Finkelstein BS, 2002, ARCH PEDIAT ADOL MED, V156, P230, DOI 10.1001/archpedi.156.3.230; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Hindmarsh PC, 1996, LANCET, V348, P13, DOI 10.1016/S0140-6736(96)01038-0; Leschek EW, 2004, J CLIN ENDOCR METAB, V89, P3140, DOI 10.1210/jc.2003-031457; LOCHE S, 1994, J PEDIATR-US, V125, P196, DOI 10.1016/S0022-3476(94)70192-X; Lopez-Siguero JP, 2000, J PEDIATR ENDOCR MET, V13, P1595; Lopez-Siguero JP, 1996, ACTA PEDIAT, V85, P113; Maiorana A, 2009, PEDIATRICS, V124, pE519, DOI 10.1542/peds.2009-0293; McCaughey ES, 1998, LANCET, V351, P940; Ranke MB, 1996, HORM RES, V45, P64, DOI 10.1159/000184851; Ranke MB, 2007, HORM RES, V68, P53, DOI 10.1159/000098707; Schmitt K, 1997, EUR J PEDIATR, V156, P680, DOI 10.1007/s004310050689; Swiglo BA, 2008, J CLIN ENDOCR METAB, V93, P666, DOI 10.1210/jc.2007-1907; Wit CM, 2002, J CLIN ENDOCR METAB, V87, P604; Wit JM, 2008, GROWTH HORM IGF RES, V18, P89, DOI 10.1016/j.ghir.2007.11.004; Wit JM, 2005, J PEDIATR-US, V146, P45, DOI 10.1016/j.jpeds.2004.08.055; WIT JM, 1995, CLIN ENDOCRINOL, V42, P365, DOI 10.1111/j.1365-2265.1995.tb02644.x	25	65	67	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2011	342								c7157	10.1136/bmj.c7157	http://dx.doi.org/10.1136/bmj.c7157			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735VT	21398350	hybrid, Green Submitted			2022-12-28	WOS:000288449400004
J	Zeng, XB; Kieffer, R; Glettner, B; Nurnberger, C; Liu, F; Pelz, K; Prehm, M; Baumeister, U; Hahn, H; Lang, H; Gehring, GA; Weber, CHM; Hobbs, JK; Tschierske, C; Ungar, G				Zeng, Xiangbing; Kieffer, Robert; Glettner, Benjamin; Nuernberger, Constance; Liu, Feng; Pelz, Karsten; Prehm, Marko; Baumeister, Ute; Hahn, Harald; Lang, Heinrich; Gehring, Gillian A.; Weber, Christa H. M.; Hobbs, Jamie K.; Tschierske, Carsten; Ungar, Goran			Complex Multicolor Tilings and Critical Phenomena in Tetraphilic Liquid Crystals	SCIENCE			English	Article							MODEL; AMPHIPHILES; KAGOME	T-shaped molecules with a rod-like aromatic core and a flexible side chain form liquid crystal honeycombs with aromatic cell walls and a cell interior filled with the side chains. Here, we show how the addition of a second chain, incompatible with the first (X-shaped molecules), can form honeycombs with highly complex tiling patterns, with cells of up to five different compositions ("colors") and polygonal shapes. The complexity is caused by the inability of the side chains to separate cleanly because of geometric frustration. Furthermore, a thermoreversible transition was observed between a multicolor (phase-separated) and a single-color (mixed) honeycomb phase. This is analogous to the Curie transition in simple and frustrated ferro-and antiferromagnets; here spin flips are replaced by 180 reorientations of the molecules.	[Zeng, Xiangbing; Liu, Feng; Ungar, Goran] Univ Sheffield, Dept Mat Sci & Engn, Sheffield S1 3JD, S Yorkshire, England; [Kieffer, Robert; Glettner, Benjamin; Nuernberger, Constance; Pelz, Karsten; Prehm, Marko; Baumeister, Ute; Tschierske, Carsten] Univ Halle Wittenberg, Inst Chem, D-06120 Halle, Germany; [Hahn, Harald; Lang, Heinrich] Tech Univ Chemnitz, Inst Inorgan Chem, D-09111 Chemnitz, Germany; [Gehring, Gillian A.; Weber, Christa H. M.; Hobbs, Jamie K.] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Ungar, Goran] Seoul Natl Univ, Sch Chem & Biol Engn, World Class Univ Program Chem Convergence Energy, Seoul, South Korea	University of Sheffield; Martin Luther University Halle Wittenberg; Technische Universitat Chemnitz; University of Sheffield; Seoul National University (SNU)	Tschierske, C (corresponding author), Univ Halle Wittenberg, Inst Chem, Kurt Mothes Str 2, D-06120 Halle, Germany.	carsten.tschierske@chemie.uni-halle.de; g.ungar@shef.ac.uk	LIU, FENG/C-9382-2012	LIU, FENG/0000-0001-6224-5167; Ungar, Goran/0000-0002-9743-2656	European Science Foundation; Engineering and Physical Sciences Research Council; Deutsche Forschungsgemeinschaft (DFG); European Commission [NERASCT-2003-989409]; Ministry of Education, Science and Technology [R31-10013]; Engineering and Physical Sciences Research Council [EP/F000766/1, EP/F000375/1, EP/E033571/1] Funding Source: researchfish; EPSRC [EP/E033571/1, EP/F000766/1] Funding Source: UKRI	European Science Foundation(European Science Foundation (ESF)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported as part of the European Science Foundation Eurocores Program SONS 2 (Self-Organised NanoStructures 2), project SCALES, by the Engineering and Physical Sciences Research Council and Deutsche Forschungsgemeinschaft (DFG) and the European Commission Sixth Framework Programme (grant NERASCT-2003-989409); by the government of Saxonia-Anhalt in the framework of the Cluster of Excellence "Nanostructured Materials"; the DFG-funded Research Unit FG 1145; and the World Class University program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (grant R31-10013). For their help in setting up synchrotron experiments, we thank N. Terrill, C. Pizzey, S. Collins, and A. Bombardi at beamlines I22 and I16, Diamond Light Source, and D. Mannix, S. Brown, and P. Thompson at beamline BM28 at the European Synchrotron Research Facility. We are grateful to A. Perkins and B. Deme at beamline D16, Institut Laue-Langevin, for their help with neutron-scattering experiments.	Baerlocher C., DATABASE ZEOLITE STR; Bates MA, 2009, PHYS CHEM CHEM PHYS, V11, P1893, DOI 10.1039/b818926a; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; Chen B, 2005, SCIENCE, V307, P96, DOI 10.1126/science.1106719; Garcia R, 2002, SURF SCI REP, V47, P197, DOI 10.1016/S0167-5729(02)00077-8; Girardi M, 2003, PHYSICA A, V319, P421, DOI 10.1016/S0378-4371(02)01390-0; Glettner B, 2008, ANGEW CHEM INT EDIT, V47, P9063, DOI 10.1002/anie.200802957; Grunbaum B., 1987, TILINGS PATTERNS; Hamley I. W., 1998, PHYS BLOCK COPOLYMER; Han YL, 2008, NATURE, V456, P898, DOI 10.1038/nature07595; Hyde S.T., 1997, LANGUAGE SHAPE ROLE; ISRAELACHVILI JN, 1976, J CHEM SOC FARAD T 2, V72, P1525, DOI 10.1039/f29767201525; KANO K, 1953, PROG THEOR PHYS, V10, P158, DOI 10.1143/PTP.10.158; KARDAR M, 1982, PHYS REV LETT, V48, P1552, DOI 10.1103/PhysRevLett.48.1552; Matsushita Y, 2009, POLYMER, V50, P2191, DOI 10.1016/j.polymer.2009.02.047; Morris DJP, 2009, SCIENCE, V326, P411, DOI 10.1126/science.1178868; Pauling L., 1945, NATURE CHEM BOND; SENECHAL M., 1995, QUASICRYSTALS GEOMET; SHOEMAKER DP, 1986, ACTA CRYSTALLOGR B, V42, P3, DOI 10.1107/S0108768186098671; SYOZI I, 1951, PROG THEOR PHYS, V6, P306, DOI 10.1143/PTP.6.306; Tschierske C, 2007, CHEM SOC REV, V36, P1930, DOI 10.1039/b615517k; Wells A. F., 1977, 3 DIMENSIONAL NETS P; WOLF M, 1988, J PHYS A-MATH GEN, V21, P2195, DOI 10.1088/0305-4470/21/9/032; Yeomans J.M., 1992, STAT MECH PHASE TRAN, VVolume 19; Zeng XB, 2004, NATURE, V428, P157, DOI 10.1038/nature02368	25	81	82	4	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1302	1306		10.1126/science.1193052	http://dx.doi.org/10.1126/science.1193052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393540				2022-12-28	WOS:000288215200040
J	Hara, Y; Balci-Hayta, B; Yoshida-Moriguchi, T; Kanagawa, M; de Bernabe, DBV; Gundesli, H; Willer, T; Satz, JS; Crawford, RW; Burden, SJ; Kunz, S; Oldstone, MBA; Accardi, A; Talim, B; Muntoni, F; Topaloglu, H; Dincer, P; Campbell, KP				Hara, Yuji; Balci-Hayta, Burcu; Yoshida-Moriguchi, Takako; Kanagawa, Motoi; de Bernabe, Daniel Beltran-Valero; Gundesli, Hulya; Willer, Tobias; Satz, Jakob S.; Crawford, Robert W.; Burden, Steven J.; Kunz, Stefan; Oldstone, Michael B. A.; Accardi, Alessio; Talim, Beril; Muntoni, Francesco; Topaloglu, Haluk; Dincer, Pervin; Campbell, Kevin P.			BRIEF REPORT A Dystroglycan Mutation Associated with Limb-Girdle Muscular Dystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WALKER-WARBURG-SYNDROME; ALPHA-DYSTROGLYCAN; DEFECTIVE GLYCOSYLATION; ABNORMAL GLYCOSYLATION; MENTAL-RETARDATION; PROTEIN GENE; FORM; GLYCOSYLTRANSFERASE; EXPRESSION; DELETION	Dystroglycan, which serves as a major extracellular matrix receptor in muscle and the central nervous system, requires extensive O-glycosylation to function. We identified a dystroglycan missense mutation (Thr192. Met) in a woman with limb-girdle muscular dystrophy and cognitive impairment. A mouse model harboring this mutation recapitulates the immunohistochemical and neuromuscular abnormalities observed in the patient. In vitro and in vivo studies showed that the mutation impairs the receptor function of dystroglycan in skeletal muscle and brain by inhibiting the post-translational modification, mediated by the glycosyltransferase LARGE, of the phosphorylated O-mannosyl glycans on a-dystroglycan that is required for high-affinity binding to laminin.	[Hara, Yuji; Yoshida-Moriguchi, Takako; Kanagawa, Motoi; de Bernabe, Daniel Beltran-Valero; Willer, Tobias; Satz, Jakob S.; Crawford, Robert W.; Accardi, Alessio; Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Campbell, Kevin P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Balci-Hayta, Burcu; Gundesli, Hulya; Dincer, Pervin] Hacettepe Univ, Fac Med, Dept Med Biol, TR-06100 Ankara, Turkey; [Talim, Beril] Hacettepe Univ, Fac Med, Dept Pediat Pathol, TR-06100 Ankara, Turkey; [Topaloglu, Haluk] Hacettepe Univ, Fac Med, Dept Pediat Neurol, TR-06100 Ankara, Turkey; [Burden, Steven J.] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Mol Neurobiol Program, New York, NY USA; [Kunz, Stefan] Univ Lausanne, Lausanne, Switzerland; [Kunz, Stefan] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Oldstone, Michael B. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA USA; [Muntoni, Francesco] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Hacettepe University; Hacettepe University; Hacettepe University; New York University; University of Lausanne; Scripps Research Institute; University of London; University College London	Campbell, KP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, 285 Newton Rd,4283 CBRB, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Dincer, Pervin/AAL-6595-2021; TOPALOGLU, HALUK AYDIN/I-9318-2013; Gundesli, Hulya/ABE-8620-2020; Kunz, Stefan/K-5840-2017	GUNDESLI, HULYA/0000-0002-1638-9087; Accardi, Alessio/0000-0002-6584-0102; Burden, Steven/0000-0002-3550-6891; Kanagawa, Motoi/0000-0003-0984-6398; Kunz, Stefan/0000-0001-6030-9550; Campbell, Kevin/0000-0003-2066-5889	Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center [1U54NS053672]; Hacettepe University Research Fund [03.02.101.009, SBAG-1774]; National Institutes of Health [AI45927]; National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK 54759]; Muscular Dystrophy Campaign and Institute of Child Health Biomedical Research Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045927, R01AI009484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051315, P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER; MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish	Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center(Ohio State University); Hacettepe University Research Fund(Hacettepe University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Muscular Dystrophy Campaign and Institute of Child Health Biomedical Research Centre; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported in part by grants from the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (1U54NS053672, to Dr. Campbell), the Hacettepe University Research Fund (03.02.101.009, TUBITAK Project SBAG-1774, to Dr. Din er), the National Institutes of Health (AI45927, to Dr. Oldstone), the National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK 54759, to the University of Iowa Gene Transfer Vector Core), and the Muscular Dystrophy Campaign and Institute of Child Health Biomedical Research Centre (to Dr. Muntoni). Dr. Campbell is an investigator at the Howard Hughes Medical Institute.	Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bozic D, 2004, J BIOL CHEM, V279, P44812, DOI 10.1074/jbc.C400353200; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Dincer P, 2003, NEUROMUSCULAR DISORD, V13, P771, DOI 10.1016/S0960-8966(03)00161-5; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Mercuri E, 2003, ANN NEUROL, V53, P537, DOI 10.1002/ana.10559; Mercuri E, 2009, NEUROLOGY, V72, P1802, DOI 10.1212/01.wnl.0000346518.68110.60; Michele DE, 2009, CIRC RES, V105, P984, DOI 10.1161/CIRCRESAHA.109.199489; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Murakami T, 2006, ANN NEUROL, V60, P597, DOI 10.1002/ana.20973; Nishimune H, 2008, J CELL BIOL, V182, P1201, DOI 10.1083/jcb.200805095; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; van Reeuwijk J, 2007, HUM GENET, V121, P685, DOI 10.1007/s00439-007-0362-y; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; Yoshida-Moriguchi T, 2010, SCIENCE, V327, P88, DOI 10.1126/science.1180512	25	173	179	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					939	946		10.1056/NEJMoa1006939	http://dx.doi.org/10.1056/NEJMoa1006939			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21388311	Green Accepted			2022-12-28	WOS:000288170300010
J	Watts, G				Watts, Geoff			Genetics The hunt for the mystery genes	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]	1	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2011	342								d1463	10.1136/bmj.d1463	http://dx.doi.org/10.1136/bmj.d1463			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735VA	21393321				2022-12-28	WOS:000288447000009
J	Pearson, H				Pearson, Helen			Study of a LIFETIME	NATURE			English	News Item							BODY-MASS; COHORT; AGE								MRC [MC_U123092720] Funding Source: UKRI; Medical Research Council [MC_U123092720] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARKER DJP, 1989, LANCET, V2, P577; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Kuh D, 2005, MENOPAUSE, V12, P475, DOI 10.1097/01.GME.0000153889.40119.4C; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Kuh D, 2009, SOC SCI MED, V68, P1565, DOI 10.1016/j.socscimed.2009.02.006; Li L, 2008, AM J EPIDEMIOL, V168, P1008, DOI 10.1093/aje/kwn227; WADSWORTH MEJ, 1985, BRIT MED J, V291, P1534, DOI 10.1136/bmj.291.6508.1534	7	16	16	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					20	24		10.1038/471020a	http://dx.doi.org/10.1038/471020a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368799	Bronze			2022-12-28	WOS:000287924100010
J	Cardenas, ML; Gosling, WD; Sherlock, SC; Poole, I; Pennington, RT; Mothes, P				Cardenas, Macarena L.; Gosling, William D.; Sherlock, Sarah C.; Poole, Imogen; Pennington, R. Toby; Mothes, Patricia			The Response of Vegetation on the Andean Flank in Western Amazonia to Pleistocene Climate Change	SCIENCE			English	Article								A reconstruction of past environmental change from Ecuador reveals the response of lower montane forest on the Andean flank in western Amazonia to glacial-interglacial global climate change. Radiometric dating of volcanic ash indicates that deposition occurred similar to 324,000 to 193,000 years ago during parts of Marine Isotope Stages 9, 7, and 6. Fossil pollen and wood preserved within organic sediments suggest that the composition of the forest altered radically in response to glacial-interglacial climate change. The presence of Podocarpus macrofossils similar to 1000 meters below the lower limit of their modern distribution indicates a relative cooling of at least 5 degrees C during glacials and persistence of wet conditions. Interglacial deposits contain thermophilic palms suggesting warm and wet climates. Hence, global temperature change can radically alter vegetation communities and biodiversity in this region.	[Cardenas, Macarena L.; Gosling, William D.; Sherlock, Sarah C.] Open Univ, Dept Earth & Environm Sci, CEPSAR, Milton Keynes MK7 6AA, Bucks, England; [Poole, Imogen] Univ Aberdeen, Dept Geol & Petr Geol, Kings Coll, Aberdeen AB24 3UE, Scotland; [Pennington, R. Toby] Royal Bot Garden Edinburgh, Trop Biol Grp, Edinburgh EH3 5LR, Midlothian, Scotland; [Mothes, Patricia] Escuela Politec Nacl, Inst Geofis, Quito, Ecuador	Open University - UK; University of Aberdeen; Escuela Politecnica Nacional Ecuador	Cardenas, ML (corresponding author), Open Univ, Dept Earth & Environm Sci, CEPSAR, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	m.l.cardenas@open.ac.uk	Gosling, William/D-2459-2009; Gosling, William/AAB-2761-2020	Gosling, William/0000-0001-9903-8401; Gosling, William/0000-0001-9903-8401; Cardenas, Macarena/0000-0002-6500-2352; Pennington, Toby/0000-0002-8196-288X; Sherlock, Sarah/0000-0003-0494-6760	Open University; Royal Botanical Garden Edinburgh; Santander; British Ecological Society; University Utrecht	Open University; Royal Botanical Garden Edinburgh; Santander; British Ecological Society; University Utrecht	We thank M. Hall (Instituto Geofisico, Quito, Ecuador), A. Correa-Metrio and M. Bush (Florida Institute of Technology), and Erazo residents. We also thank the reviewers for their valuable comments. This work was supported by funding from The Open University, Royal Botanical Garden Edinburgh, Santander, British Ecological Society, and University Utrecht.	BUSH MB, 1990, QUATERNARY RES, V34, P330, DOI 10.1016/0033-5894(90)90045-M; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Gosling WD, 2008, PALAEOGEOGR PALAEOCL, V259, P35, DOI 10.1016/j.palaeo.2007.02.050; Gosling WD, 2009, J VEG SCI, V20, P1041, DOI 10.1111/j.1654-1103.2009.01102.x; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hooghiemstra H., 1984, VEGETATIONAL CLIMATI; Iversen J, 1989, J BIOGEOGR; Jorgensen P. M., 1999, CATALOGUE VASCULAR P; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kelley S. P., 2002, NOBLE GASES GEOCHEMI; Long CJ, 1998, CAN J FOREST RES, V28, P774, DOI 10.1139/cjfr-28-5-774; Moraes M, 1995, BIODIVERSITY AND CONSERVATION OF NEOTROPICAL MONTANE FORESTS, P473; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Niemann H, 2008, J QUATERNARY SCI, V23, P203, DOI 10.1002/jqs.1134; Pennington T. D., 2004, ILLUSTRATED GUIDE TR; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; Schwerdtfeger W., 1976, CLIMATES CENTRAL S A; Torres-Romero J. H., 1988, FLORA COLOMBIA; Weng CY, 2004, J TROP ECOL, V20, P113, DOI 10.1017/S0266467403001068	20	45	49	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1055	1058		10.1126/science.1197947	http://dx.doi.org/10.1126/science.1197947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350174				2022-12-28	WOS:000287699000060
J	Gano, S; Kinzler, R				Gano, Steve; Kinzler, Ro			Bringing the Museum into the Classroom	SCIENCE			English	Editorial Material									[Gano, Steve; Kinzler, Ro] Amer Museum Nat Hist, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Gano, S (corresponding author), Amer Museum Nat Hist, New York, NY 10024 USA.	gano@amnh.org			Direct For Education and Human Resources [0918583] Funding Source: National Science Foundation	Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))		Blumenfeld P., 1997, INT HDB TEACHERS TEA, P819; Mestre JP, 2002, LEARNING SCI SCI LEA, P13; Olson S., 2000, INQUIRY NATL SCI ED; SABELLI N, 2008, APPLYING WHAT WE KNO; Squire KD, 2003, SCI EDUC, V87, P468, DOI 10.1002/sce.10084; WYNER Y, 2010, 2010 ANN M AM ED RES; RESOURCES LEARNING	7	4	4	2	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1028	1029		10.1126/science.1197076	http://dx.doi.org/10.1126/science.1197076			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726DM	21350169				2022-12-28	WOS:000287699000052
J	Hodgman, SS; Dall, RG; Manning, AG; Baldwin, KGH; Truscott, AG				Hodgman, S. S.; Dall, R. G.; Manning, A. G.; Baldwin, K. G. H.; Truscott, A. G.			Direct Measurement of Long-Range Third-Order Coherence in Bose-Einstein Condensates	SCIENCE			English	Article							METASTABLE HELIUM; INTERFEROMETRY; COLLISIONS; GASES	A major advance in understanding the behavior of light was to describe the coherence of a light source by using correlation functions that define the spatio-temporal relationship between pairs and larger groups of photons. Correlations are also a fundamental property of matter. We performed simultaneous measurement of the second- and third-order correlation functions for atoms. Atom bunching in the arrival time for pairs and triplets of thermal atoms just above the Bose-Einstein condensation (BEC) temperature was observed. At lower temperatures, we demonstrated conclusively the long-range coherence of the BEC for correlation functions to third order, which supports the prediction that like coherent light, a BEC possesses long-range coherence to all orders.	[Hodgman, S. S.; Dall, R. G.; Manning, A. G.; Baldwin, K. G. H.; Truscott, A. G.] Australian Natl Univ, Res Sch Phys & Engn, Ctr Excellence Quantum Atom Opt, Australian Res Council, Canberra, ACT 0200, Australia	Australian National University	Truscott, AG (corresponding author), Australian Natl Univ, Res Sch Phys & Engn, Ctr Excellence Quantum Atom Opt, Australian Res Council, GPO Box 4, Canberra, ACT 0200, Australia.	andrew.truscott@anu.edu.au	Hodgman, Sean/AAV-2779-2021; Dall, Robert/A-7346-2011; Baldwin, Kenneth G H/A-4928-2008; Hodgman, Sean/B-1334-2015; Truscott, Andrew/A-8086-2011	Baldwin, Kenneth G H/0000-0002-2043-5330; Truscott, Andrew/0000-0003-2106-8613; Hodgman, Sean/0000-0002-2417-350X; Manning, Andrew/0000-0001-8410-8710	Australian Research Council Centre of Excellence for Quantum-Atom Optics	Australian Research Council Centre of Excellence for Quantum-Atom Optics(Australian Research Council)	The authors would like to acknowledge the support of the Australian Research Council Centre of Excellence for Quantum-Atom Optics.	Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; Assmann M, 2009, SCIENCE, V325, P297, DOI 10.1126/science.1174488; Baldwin KGH, 2005, CONTEMP PHYS, V46, P105, DOI 10.1080/00107510412331332798; Baym G, 1998, ACTA PHYS POL B, V29, P1839; BROWN RH, 1956, NATURE, V177, P27, DOI 10.1038/177027a0; Burt EA, 1997, PHYS REV LETT, V79, P337, DOI 10.1103/PhysRevLett.79.337; Dall RG, 2007, OPT COMMUN, V270, P255, DOI 10.1016/j.optcom.2006.09.031; Eckert K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.100404; Eckert K, 2008, NAT PHYS, V4, P50, DOI 10.1038/nphys776; Folling S, 2005, NATURE, V434, P481, DOI 10.1038/nature03500; GLAUBER RJ, 1963, PHYS REV, V130, P2529, DOI 10.1103/PhysRev.130.2529; Gomes JV, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.053607; Greiner M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.110401; HANBURYBROWN R, 1956, NATURE, V178, P1046, DOI DOI 10.1038/1781046A0; Hodgman SS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.053002; Horikiri T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.033307; Iannuzzi M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.080402; Jeltes T, 2007, NATURE, V445, P402, DOI 10.1038/nature05513; Kiesel H, 2002, NATURE, V418, P392, DOI 10.1038/nature00911; Kinoshita T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.190406; Korbicz JK, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.052319; Korbicz JK, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.120502; Manning AG, 2010, OPT EXPRESS, V18, P18712, DOI 10.1364/OE.18.018712; Manz S, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.031610; Moal S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.023203; Naraschewski M, 1999, PHYS REV A, V59, P4595, DOI 10.1103/PhysRevA.59.4595; Ottl A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090404; Schellekens M, 2005, SCIENCE, V310, P648, DOI 10.1126/science.1118024; Tolra BL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190401; Trotzky S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.265303; Yasuda M, 1996, PHYS REV LETT, V77, P3090, DOI 10.1103/PhysRevLett.77.3090; Zin P, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.023614	33	69	69	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1046	1049		10.1126/science.1198481	http://dx.doi.org/10.1126/science.1198481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350171				2022-12-28	WOS:000287699000057
J	Sackeyfio, A; Senthinathan, A; Kandaswamy, P; Barry, PW; Shaw, B; Baker, M				Sackeyfio, A.; Senthinathan, A.; Kandaswamy, P.; Barry, P. W.; Shaw, B.; Baker, M.		Guideline Dev Grp	Practice Guidelines Diagnosis and assessment of food allergy in children and young people: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Cianferoni Antonella, 2009, Allergology International, V58, P457, DOI 10.2332/allergolint.09-RAI-0138; *NAT I HLTH CLIN E, 2011, CLIN GUID, V116	2	22	22	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d747	10.1136/bmj.d747	http://dx.doi.org/10.1136/bmj.d747			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345912				2022-12-28	WOS:000287920100005
J	Hernandez, RD; Kelley, JL; Elyashiv, E; Melton, SC; Auton, A; McVean, G; Sella, G; Przeworski, M				Hernandez, Ryan D.; Kelley, Joanna L.; Elyashiv, Eyal; Melton, S. Cord; Auton, Adam; McVean, Gilean; Sella, Guy; Przeworski, Molly		1000 Genomes Project	Classic Selective Sweeps Were Rare in Recent Human Evolution	SCIENCE			English	Article							POSITIVE SELECTION; NATURAL-SELECTION; DELETERIOUS MUTATIONS; SOFT SWEEPS; ADAPTATION; POLYMORPHISM; DIVERSITY; SIGNATURE; GENETICS; SIZE	Efforts to identify the genetic basis of human adaptations from polymorphism data have sought footprints of "classic selective sweeps" (in which a beneficial mutation arises and rapidly fixes in the population). Yet it remains unknown whether this form of natural selection was common in our evolution. We examined the evidence for classic sweeps in resequencing data from 179 human genomes. As expected under a recurrent-sweep model, we found that diversity levels decrease near exons and conserved noncoding regions. In contrast to expectation, however, the trough in diversity around human-specific amino acid substitutions is no more pronounced than around synonymous substitutions. Moreover, relative to the genome background, amino acid and putative regulatory sites are not significantly enriched in alleles that are highly differentiated between populations. These findings indicate that classic sweeps were not a dominant mode of human adaptation over the past similar to 250,000 years.	[Hernandez, Ryan D.; Kelley, Joanna L.; Melton, S. Cord; Przeworski, Molly] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Elyashiv, Eyal; Sella, Guy] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, IL-91904 Jerusalem, Israel; [Auton, Adam; McVean, Gilean] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McVean, Gilean] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Przeworski, Molly] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Przeworski, Molly] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; Hebrew University of Jerusalem; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Przeworski, M (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	mfp@uchicago.edu	Kelley, Joanna L/H-1693-2012; Wang, Jun/A-7261-2013	Kelley, Joanna L/0000-0002-7731-605X; 	NSF; National Research Service [GM087069]; Wellcome Trust [WT086084MA]; Israeli Science Foundation [1492/10]; NIH [GM083228, GM20373, GM72861]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007644, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083228, R01GM072861, F32GM087069] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Research Service; Wellcome Trust(Wellcome TrustEuropean Commission); Israeli Science Foundation(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Coop, T. Long, G. McVicker, J. Pickrell, J. Pritchard, and K. Thornton for helpful discussions, and G. Coop, A. Di Rienzo, and J. Pritchard for comments. Supported by an NSF minority postdoctoral fellowship (R.D.H.), National Research Service Award postdoctoral fellowship GM087069 (J.L.K.), Wellcome Trust grant WT086084MA (G.M.), Israeli Science Foundation grant 1492/10 and NIH grant GM083228 (G.S.), and NIH grants GM20373 and GM72861 (M.P.). M.P. is a Howard Hughes Medical Institute Early Career Scientist.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Cai JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000336; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hellmann I, 2008, GENOME RES, V18, P1020, DOI 10.1101/gr.074187.107; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Innan H, 2008, GENETICS, V179, P1713, DOI 10.1534/genetics.108.086835; Keinan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000886; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Orr HA, 1998, GENETICS, V149, P2099; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Przeworski M, 2002, GENETICS, V160, P1179; Ralph P, 2010, GENETICS, V186, P647, DOI 10.1534/genetics.110.119594; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Santiago E, 2005, GENETICS, V169, P475, DOI 10.1534/genetics.104.032813; SANTIAGO E, 1995, GENETICS, V139, P1013; Sattath S., 2010, PLOS GENET, P1001302; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090	33	294	300	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					920	924		10.1126/science.1198878	http://dx.doi.org/10.1126/science.1198878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330547	Green Accepted			2022-12-28	WOS:000287455100060
J	Kauppi, L; Barchi, M; Baudat, F; Romanienko, PJ; Keeney, S; Jasin, M				Kauppi, Liisa; Barchi, Marco; Baudat, Frederic; Romanienko, Peter J.; Keeney, Scott; Jasin, Maria			Distinct Properties of the XY Pseudoautosomal Region Crucial for Male Meiosis	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; CHROMOSOME SYNAPSIS; MOUSE; RECOMBINATION; SPO11; SPERMATOCYTES; MICE; PROTEINS; PROPHASE; OOCYTES	Meiosis requires that each chromosome find its homologous partner and undergo at least one crossover. X-Y chromosome segregation hinges on efficient crossing-over in a very small region of homology, the pseudoautosomal region (PAR). We find that mouse PAR DNA occupies unusually long chromosome axes, potentially as shorter chromatin loops, predicted to promote double-strand break (DSB) formation. Most PARs show delayed appearance of RAD51/DMC1 foci, which mark DSB ends, and all PARs undergo delayed DSB-mediated homologous pairing. Analysis of Spo11 beta isoform-specific transgenic mice revealed that late RAD51/DMC1 foci in the PAR are genetically distinct from both early PAR foci and global foci and that late PAR foci promote efficient X-Y pairing, recombination, and male fertility. Our findings uncover specific mechanisms that surmount the unique challenges of X-Y recombination.	[Kauppi, Liisa; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Barchi, Marco; Baudat, Frederic; Romanienko, Peter J.; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Barchi, Marco] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Sect Anat, I-00133 Rome, Italy; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Rome Tor Vergata; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	s-keeney@ski.mskcc.org; m-jasin@ski.mskcc.org	Barchi, Marco/Q-9378-2019; Kauppi, Liisa/H-5845-2012; Keeney, Scott/GVR-8515-2022	Barchi, Marco/0000-0003-1104-6234; Kauppi, Liisa/0000-0002-6759-8997; Romanienko, Peter/0000-0001-6586-3841; Baudat, Frederic/0000-0003-2415-8366; Keeney, Scott/0000-0002-1283-6417	NIH [R01 HD040916]; International Grants in Cancer Research (AIRC) [4765]; Italian Ministry for Education, University and Research (MIUR); Lalor Foundation; American-Italian Cancer Foundation (AICF); Charles H. Revson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Grants in Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry for Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Lalor Foundation; American-Italian Cancer Foundation (AICF); Charles H. Revson Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grant R01 HD040916 (M.J. and S.K); International Grants in Cancer Research (AIRC) [My First AIRC Grant (MFAG) grant 4765], Italian Ministry for Education, University and Research (MIUR), the Lalor Foundation, and the American-Italian Cancer Foundation (AICF) (M.B.); and the Charles H. Revson Foundation (F.B.). We thank M. Leversha [Memorial Sloan-Kettering Cancer Center (MSKCC)], P. Bois (Scripps Florida), and K. Manova (MSKCC) for valuable advice and protocols. We are grateful to Keeney and Jasin lab members, especially I. Roig, E. de Boer, and F. Cole, and to N. Hunter (University of California, Davis) for insightful comments.	Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Cole F, 2010, GENE DEV, V24, P1201, DOI 10.1101/gad.1944710; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Eaker S, 2002, DEV BIOL, V249, P85, DOI 10.1006/dbio.2002.0708; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Hall H, 2006, CURR OPIN GENET DEV, V16, P323, DOI 10.1016/j.gde.2006.04.011; Hunter N, 2007, MOL GENETICS RECOMBI, P381; Keeney S, 1999, GENOMICS, V61, P170, DOI 10.1006/geno.1999.5956; Kleckner N, 2003, TRENDS GENET, V19, P623, DOI 10.1016/j.tig.2003.09.004; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Perry J, 2001, GENOME RES, V11, P1826, DOI 10.1101/gr.203001; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Romanienko P. J., 1997, THESIS CORNELL U ITH; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; Shi QH, 2001, AM J MED GENET, V99, P34, DOI 10.1002/1096-8628(20010215)99:1<34::AID-AJMG1106>3.0.CO;2-D; SORIANO P, 1987, P NATL ACAD SCI USA, V84, P7218, DOI 10.1073/pnas.84.20.7218; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	27	170	174	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					916	920		10.1126/science.1195774	http://dx.doi.org/10.1126/science.1195774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330546	Green Accepted			2022-12-28	WOS:000287455100059
J	Koos, E; Willenbacher, N				Koos, Erin; Willenbacher, Norbert			Capillary Forces in Suspension Rheology	SCIENCE			English	Article							CONCENTRATED SUSPENSIONS; COLLOIDAL SUSPENSIONS; LIQUID BRIDGE; PARTICLES; SPHERES; EMULSIONS; MEDIA; WATER	The rheology of suspensions (solid particles dispersed in a fluid) is controlled primarily through the volume fraction of solids. We show that the addition of small amounts of a secondary fluid, immiscible with the continuous phase of the suspension, causes agglomeration due to capillary forces and creates particle networks, dramatically altering the bulk rheological behavior from predominantly viscous or weakly elastic to highly elastic or gel-like. This universal phenomenon is observed for a rich variety of particle/liquid systems, independent of whether the second liquid wets the particles better or worse than the primary liquid. These admixtures form stable suspensions where settling would otherwise occur and may serve as a precursor for microporous polymer foams, or lightweight ceramics.	[Koos, Erin; Willenbacher, Norbert] Karlsruhe Inst Technol, Inst Mech Proc Engn & Mech, D-76131 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Koos, E (corresponding author), Karlsruhe Inst Technol, Inst Mech Proc Engn & Mech, Gotthard Franz Str 3,Bldg 50-31, D-76131 Karlsruhe, Germany.	erin.koos@kit.edu	Koos, Erin/C-2135-2012	Koos, Erin/0000-0002-2468-2312	German Research Foundation (Deutsche Forschungsgemeinschaft) [WI3138/6-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	We thank H. J. Butt for discussions and the German Research Foundation (Deutsche Forschungsgemeinschaft grant no. WI3138/6-1) for funding. We would also like to acknowledge the generous donation of materials we received from Henkel and Potters Europe.	ALLAIN C, 1995, PHYS REV LETT, V74, P1478, DOI 10.1103/PhysRevLett.74.1478; Aveyard R, 2003, ADV COLLOID INTERFAC, V100, P503, DOI 10.1016/S0001-8686(02)00069-6; Binks BP, 2002, LANGMUIR, V18, P1270, DOI 10.1021/la011420k; Bloomquist CR, 1940, IND ENG CHEM, V32, P827, DOI 10.1021/ie50366a019; Bocquet L, 1998, NATURE, V396, P735, DOI 10.1038/25492; BUSCALL R, 1987, J NON-NEWTON FLUID, V24, P183, DOI 10.1016/0377-0257(87)85009-7; CATTERMOLE AE, 1904, Patent No. 763259; Cavalier K, 2002, COLLOID SURFACE A, V197, P173, DOI 10.1016/S0927-7757(01)00889-5; Dijkstra M, 2001, CURR OPIN COLLOID IN, V6, P372, DOI 10.1016/S1359-0294(01)00106-6; EGGLETON AEJ, 1954, CAN J CHEM, V32, P86, DOI 10.1139/v54-015; ENNIS BJ, 1990, CHEM ENG SCI, V45, P3071, DOI 10.1016/0009-2509(90)80054-I; ENNIS BJ, 1991, POWDER TECHNOL, V65, P257, DOI 10.1016/0032-5910(91)80189-P; FARNAND JR, 1969, CAN MIN METALL BULL, V62, P267; Fraysse N, 1999, EUR PHYS J B, V11, P615, DOI 10.1007/s100510051189; Halsey TC, 1998, PHYS REV LETT, V80, P3141, DOI 10.1103/PhysRevLett.80.3141; Hochstein B, 2008, AIP CONF PROC, V1027, P761; HOWE PG, 1955, CAN J CHEM, V33, P1189, DOI 10.1139/v55-141; LANGSTROTH T, 1988, PIGMENT HDB, V6, pCH6; Lu PJ, 2008, NATURE, V453, P499, DOI 10.1038/nature06931; OSTWALD W, 1929, KOLLOID S, V29, P354; Perrot G. J., 1921, CHEM METALL ENG, V25, P182; PIETSCH W, 1967, CHEM-ING-TECH, V39, P885, DOI 10.1002/cite.330391502; Schubert H., 1982, KAPILLARITAT POROSEN; Seville JPK, 2000, POWDER TECHNOL, V113, P261, DOI 10.1016/S0032-5910(00)00309-0; TANZIL L, 2008, PRODUKTGESTALTUNG PA, V4, P67; TSAI SC, 1988, J RHEOL, V32, P737, DOI 10.1122/1.549988; VANKAO S, 1975, J COLLOID INTERF SCI, V53, P367, DOI 10.1016/0021-9797(75)90052-1; Zhou ZW, 2001, CHEM ENG SCI, V56, P2901, DOI 10.1016/S0009-2509(00)00473-5	28	222	229	15	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					897	900		10.1126/science.1199243	http://dx.doi.org/10.1126/science.1199243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330542				2022-12-28	WOS:000287455100053
J	Mueller, O; Haag, S; Sure, U; Naglatzki, R				Mueller, Oliver; Haag, Sebastian; Sure, Ulrich; Naglatzki, Ryan			A loose screw or two	LANCET			English	Editorial Material							ESOPHAGEAL-PERFORATION		[Mueller, Oliver; Sure, Ulrich; Naglatzki, Ryan] Univ Hosp Essen, Dept Neurosurg, D-45122 Essen, Germany; [Haag, Sebastian] Univ Hosp Essen, Dept Gastroenterol & Hepatol, D-45122 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Mueller, O (corresponding author), Univ Hosp Essen, Dept Neurosurg, Hufelandstr 55, D-45122 Essen, Germany.	oliver.mueller@uk-essen.de	Müller, Oliver/GQZ-2967-2022; Mueller, Oliver Marcus/E-3419-2014	Mueller, Oliver Marcus/0000-0003-4690-370X				Brinster CJ, 2004, ANN THORAC SURG, V77, P1475, DOI 10.1016/j.athoracsur.2003.08.037; Fountas KN, 2006, J SPINAL DISORD TECH, V19, P199, DOI 10.1097/01.bsd.0000164164.11277.49; NEWHOUSE KE, 1989, SPINE, V14, P1051, DOI 10.1097/00007632-198910000-00004; Pompili A., 2002, SPINE, V27, P499, DOI [DOI 10.1097/01.BRS.0000035309.04502.52, DOI 10.1097/00007632-200212010-00016]; Tew J M Jr, 1976, Clin Neurosurg, V23, P424	5	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2011	377	9767					782	782		10.1016/S0140-6736(10)61544-9	http://dx.doi.org/10.1016/S0140-6736(10)61544-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729JQ	21353904				2022-12-28	WOS:000287946000035
J	Britton, J				Britton, John			Taxing tobacco profits to prevent the smoking epidemic	LANCET			English	Editorial Material									[Britton, John] Univ Nottingham, City Hosp, UK Ctr Tobacco Control Studies, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Britton, J (corresponding author), Univ Nottingham, City Hosp, UK Ctr Tobacco Control Studies, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England.	j.britton@virgin.net	Britton, John R/G-9705-2011					Action on Smoking and Health (UK), 2008, BATS AFR FOOTPR; Callard C, 2010, TOB CONTROL, V19, P285, DOI 10.1136/tc.2009.035071; Gilmore AB, 2010, TOB CONTROL, V19, P423, DOI 10.1136/tc.2009.034470; Guindon G., 2003, CURRENT FUTURE TREND; International Monetary Fund, 2010, WORLD EC OUTL DAT; JOOSSENS L, 2004, PROGR TOBACCO CONTRO; National Cancer Institute, CANC TRENDS PROGR RE; Owusu-Dabo E, 2009, TOB CONTROL, V18, P206, DOI 10.1136/tc.2009.030601; Pollock JD, 2009, LANCET, V374, P513, DOI 10.1016/S0140-6736(09)60352-4; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, 2009, WHO REP GLOB TOB EP	11	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 18	2011	377	9783					2063	2064		10.1016/S0140-6736(10)62040-5	http://dx.doi.org/10.1016/S0140-6736(10)62040-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21377201				2022-12-28	WOS:000292117800007
J	Xiao, B; Sanders, MJ; Underwood, E; Heath, R; Mayer, FV; Carmena, D; Jing, C; Walker, PA; Eccleston, JF; Haire, LF; Saiu, P; Howell, SA; Aasland, R; Martin, SR; Carling, D; Gamblin, SJ				Xiao, Bing; Sanders, Matthew J.; Underwood, Elizabeth; Heath, Richard; Mayer, Faith V.; Carmena, David; Jing, Chun; Walker, Philip A.; Eccleston, John F.; Haire, Lesley F.; Saiu, Peter; Howell, Steven A.; Aasland, Rein; Martin, Stephen R.; Carling, David; Gamblin, Steven J.			Structure of mammalian AMPK and its regulation by ADP	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; LKB1-AMPK PATHWAY; SKELETAL-MUSCLE; PHOSPHORYLATION; BINDING	The heterotrimeric AMP-activated protein kinase (AMPK) has a key role in regulating cellular energy metabolism; in response to a fall in intracellular ATP levels it activates energy-producing pathways and inhibits energy-consuming processes(1). AMPK has been implicated in a number of diseases related to energy metabolism including type 2 diabetes, obesity and, most recently, cancer(2-6). AMPK is converted from an inactive form to a catalytically competent form by phosphorylation of the activation loop within the kinase domain(7): AMP binding to the c-regulatory domain promotes phosphorylation by the upstream kinase(8), protects the enzyme against dephosphorylation, as well as causing allosteric activation(9). Here we show that ADP binding to just one of the two exchangeable AXP (AMP/ADP/ATP) binding sites on the regulatory domain protects the enzyme from dephosphorylation, although it does not lead to allosteric activation. Our studies show that active mammalian AMPK displays significantly tighter binding to ADP than to MgATP, explaining how the enzyme is regulated under physiological conditions where the concentration of Mg-ATP is higher than that of ADP and much higher than that of AMP. We have determined the crystal structure of an active AMPK complex. The structure shows how the activation loop of the kinase domain is stabilized by the regulatory domain and how the kinase linker region interacts with the regulatory nucleotide-binding site that mediates protection against dephosphorylation. From our biochemical and structural data we develop a model for how the energy status of a cell regulates AMPK activity.	[Sanders, Matthew J.; Mayer, Faith V.; Carmena, David; Carling, David] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England; [Xiao, Bing; Underwood, Elizabeth; Heath, Richard; Jing, Chun; Walker, Philip A.; Eccleston, John F.; Haire, Lesley F.; Saiu, Peter; Howell, Steven A.; Aasland, Rein; Martin, Stephen R.; Gamblin, Steven J.] Natl Inst Med Res, MRC, London NW7 1AA, England	Imperial College London; MRC National Institute for Medical Research	Carling, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Hammersmith Hosp Campus,DuCane Rd, London W12 0NN, England.	david.carling@csc.mrc.ac.uk; sgambli@nimr.mrc.ac.uk	Carling, David/F-1943-2014; Carmena, David/S-4049-2019; Sanders, Matthew J/B-4077-2009	Carling, David/0000-0002-2316-1830; Carmena, David/0000-0002-4015-8553; Sanders, Matthew James/0000-0001-6185-6337; Gamblin, Steve/0000-0001-5331-639X	MRC; Medical Research Council [MC_U120027537, MC_U117584222] Funding Source: researchfish; MRC [MC_U117584222] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Webb for gift of coumarin nucleotides, J. Skehel for comments on the manuscript and S. Smerdon for discussion and assistance. Work in both laboratories is supported by the MRC and we gratefully acknowledge Diamond Light Source for synchrotron access.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; Hellsten Y, 1999, J PHYSIOL-LONDON, V520, P909, DOI 10.1111/j.1469-7793.1999.00909.x; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2007, STRUCTURE, V15, P1161, DOI 10.1016/j.str.2007.09.006; Littler DR, 2010, ACTA CRYSTALLOGR F, V66, P143, DOI 10.1107/S1744309109052543; McConell GK, 2005, J PHYSIOL-LONDON, V568, P665, DOI 10.1113/jphysiol.2005.089839; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Otwinowski Z., 1993, P CCP4 STUDY WEEKEND, P556; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	30	626	663	5	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					230	233		10.1038/nature09932	http://dx.doi.org/10.1038/nature09932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21399626	Green Accepted			2022-12-28	WOS:000289469100045
J	Singh, S				Singh, Sonal			Review: Daily aspirin reduces long-term risk for death due to some types of cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sch Med & Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University	Singh, S (corresponding author), Johns Hopkins Univ, Sch Med & Publ Hlth, Baltimore, MD 21218 USA.		Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X				Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Stafford RS, 2005, PLOS MED, V2, P1292, DOI 10.1371/journal.pmed.0020353	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-2	10.7326/0003-4819-154-6-201103150-02002	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403065				2022-12-28	WOS:000208886200001
J	Yamauchi, J; Ubara, Y; Ikeda, K; Takaichi, K				Yamauchi, Junji; Ubara, Yoshifumi; Ikeda, Kyoji; Takaichi, Kenmei			Retroperitoneal liposarcoma with lamellar bone inside	LANCET			English	Editorial Material									[Yamauchi, Junji] Toranomon Gen Hosp, Nephrol Ctr, Minato Ku, Tokyo 1058470, Japan; [Ikeda, Kyoji] Natl Ctr Geriatr & Gerontol, Dept Bone & Joint Dis, Tokyo, Japan	Toranomon Hospital; National Center for Geriatrics & Gerontology	Yamauchi, J (corresponding author), Toranomon Gen Hosp, Nephrol Ctr, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	yamauchizz-ycu@umin.ac.jp							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					941	941		10.1016/S0140-6736(10)60878-1	http://dx.doi.org/10.1016/S0140-6736(10)60878-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GR	21397767				2022-12-28	WOS:000288628800037
J	Apeloig, Y				Apeloig, Yitzhak			The Diamond Within a Silicon Analog of Cyclobutadiene	SCIENCE			English	Editorial Material									[Apeloig, Yitzhak] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel; [Apeloig, Yitzhak] Technion Israel Inst Technol, Lise Meitner Minerva Ctr Computat Quantum Chem, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Apeloig, Y (corresponding author), Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel.	apeloig@technion.ac.il						Alabugin IV, 2010, SCIENCE, V330, DOI 10.1126/science.1196188; BRESLOW R, 1973, ACCOUNTS CHEM RES, V6, P393, DOI 10.1021/ar50072a001; BROOK AG, 1981, J CHEM SOC CHEM COMM, P191, DOI 10.1039/c39810000191; CHAPMAN OL, 1973, J AM CHEM SOC, V95, P244, DOI 10.1021/ja00782a047; CRAM DJ, 1991, ANGEW CHEM INT EDIT, V30, P1024, DOI 10.1002/anie.199110241; Gellini C, 2010, SYMMETRY-BASEL, V2, P1846, DOI 10.3390/sym2041846; Lee VY, 2007, ANGEW CHEM INT EDIT, V46, P6596, DOI 10.1002/anie.200604869; Lee VY, 2010, DALTON T, V39, P9229, DOI 10.1039/c0dt00009d; LEE VY, 2010, ORGANIC COMPOUNDS LO; Legrand YM, 2010, SCIENCE, V330, DOI 10.1126/science.1195846; Legrand YM, 2010, SCIENCE, V329, P299, DOI 10.1126/science.1188002; MAIER G, 1974, ANGEW CHEM INT EDIT, V13, P425, DOI 10.1002/anie.197404251; Scheschkewitz D, 2010, SCIENCE, V330, DOI 10.1126/science.1195752; Schleyer PV, 2005, CHEM REV, V105, P3433, DOI 10.1021/cr030095y; Schleyer PV, 2001, CHEM REV, V101, P1115, DOI 10.1021/cr0103221; Sundberg R.J., 2007, ADV ORGANIC CHEM A; Suzuki K, 2011, SCIENCE, V331, P1306, DOI 10.1126/science.1199906; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343	18	9	9	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1277	1278		10.1126/science.1202157	http://dx.doi.org/10.1126/science.1202157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393535				2022-12-28	WOS:000288215200034
J	Chapais, B				Chapais, Bernard			The Deep Social Structure of Humankind	SCIENCE			English	Editorial Material									Univ Montreal, Dept Anthropol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Chapais, B (corresponding author), Univ Montreal, Dept Anthropol, POB 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	bernard.chapais@umontreal.ca						Chapais Bernard, 2008, PRIMEVAL KINSHIP PAI, DOI DOI 10.1111/btp.12564; Chapais Bernard, 2011, OXFORD HDB EVOLUTION, P37; Fox R., 1980, RED LAMP INCEST; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Rendall D, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P295; RODSETH L, 1991, CURR ANTHROPOL, V32, P221, DOI 10.1086/203952; Tomasello M, 2008, JEAN NICOD LECT, P1; Widdig A, 2007, BIOL REV, V82, P319, DOI 10.1111/j.1469-185X.2007.00011.x; Wrangham R.W., 1987, P51	10	45	45	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1276	1277		10.1126/science.1203281	http://dx.doi.org/10.1126/science.1203281			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732UM	21393534				2022-12-28	WOS:000288215200033
J	McLean, CY; Reno, PL; Pollen, AA; Bassan, AI; Capellini, TD; Guenther, C; Indjeian, VB; Lim, XH; Menke, DB; Schaar, BT; Wenger, AM; Bejerano, G; Kingsley, DM				McLean, Cory Y.; Reno, Philip L.; Pollen, Alex A.; Bassan, Abraham I.; Capellini, Terence D.; Guenther, Catherine; Indjeian, Vahan B.; Lim, Xinhong; Menke, Douglas B.; Schaar, Bruce T.; Wenger, Aaron M.; Bejerano, Gill; Kingsley, David M.			Human-specific loss of regulatory DNA and the evolution of human-specific traits	NATURE			English	Article							HUMAN GENOME; GENE; TESTOSTERONE; CHIMPANZEES; EXPRESSION; PATTERNS; THALAMUS; SEQUENCE; ENHANCER; AREA	Humans differ from other animals in many aspects of anatomy, physiology, and behaviour; however, the genotypic basis of most human-specific traits remains unknown(1). Recent whole-genome comparisons have made it possible to identify genes with elevated rates of amino acid change or divergent expression in humans, and non-coding sequences with accelerated base pair changes(2-5). Regulatory alterations may be particularly likely to produce phenotypic effects while preserving viability, and are known to underlie interesting evolutionary differences in other species(6-8). Here we identify molecular events particularly likely to produce significant regulatory changes in humans: complete deletion of sequences otherwise highly conserved between chimpanzees and other mammals. We confirm 510 such deletions in humans, which fall almost exclusively in non-coding regions and are enriched near genes involved in steroid hormone signalling and neural function. One deletion removes a sensory vibrissae and penile spine enhancer from the human androgen receptor (AR) gene, a molecular change correlated with anatomical loss of androgen-dependent sensory vibrissae and penile spines in the human lineage(9,10). Another deletion removes a forebrain subventricular zone enhancer near the tumour suppressor gene growth arrest and DNA-damage-inducible, gamma (GADD45G)(11,12), a loss correlated with expansion of specific brain regions in humans. Deletions of tissue-specific enhancers may thus accompany both loss and gain traits in the human lineage, and provide specific examples of the kinds of regulatory alterations(6-8) and inactivation events(13) long proposed to have an important role in human evolutionary divergence.	[McLean, Cory Y.; Wenger, Aaron M.; Bejerano, Gill] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Reno, Philip L.; Pollen, Alex A.; Bassan, Abraham I.; Capellini, Terence D.; Guenther, Catherine; Indjeian, Vahan B.; Lim, Xinhong; Menke, Douglas B.; Schaar, Bruce T.; Bejerano, Gill; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Reno, Philip L.; Guenther, Catherine; Indjeian, Vahan B.; Menke, Douglas B.; Kingsley, David M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Bejerano, G (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	bejerano@stanford.edu; kingsley@stanford.edu	Capellini, Terence/B-8316-2016	Reno, Philip/0000-0002-7053-0344; McLean, Cory/0000-0001-9928-8216; Menke, Douglas/0000-0002-7109-1451	Bio-X graduate fellowship; Ruth L. Kirschstein NRSA [1 F32 HD062137-01]; National Defense Science and Engineering; Agency of Science, Technology, and Research, Singapore; Stanford Graduate Fellowship; Edward Mallinckrodt, Jr. Foundation; National Institute of Health [R01 HD059862, R01 HG005058, P50 HG002568]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD062137] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568, R01HG005058] Funding Source: NIH RePORTER	Bio-X graduate fellowship; Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering; Agency of Science, Technology, and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Stanford Graduate Fellowship(Stanford University); Edward Mallinckrodt, Jr. Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. DeGusta for providing chimpanzee DNA, S. McConnell and P. Buckmaster for discussions, and M. Hiller and C. Barr for ontology analysis support. This work was supported in part by a Bio-X graduate fellowship (C.Y.M.), a Ruth L. Kirschstein NRSA post-doctoral fellowship (1 F32 HD062137-01, P.L.R.), a National Defense Science and Engineering Graduate fellowship (A.A.P.), a National Science Scholarship of the Agency of Science, Technology, and Research, Singapore (X.L.), a Stanford Graduate Fellowship (A.M.W.), an Edward Mallinckrodt, Jr. Foundation grant (G.B.), and National Institute of Health grants R01 HD059862 (G.B.), R01 HG005058 (G.B.) and P50 HG002568 (D.M.K.). G.B. is a Packard Fellow, Searle Scholar, Microsoft Faculty Fellow and an Alfred P. Sloan Fellow. D.M.K. is an investigator of the Howard Hughes Medical Institute.	Arcelli P, 1997, BRAIN RES BULL, V42, P27, DOI 10.1016/S0361-9230(96)00107-4; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Crocoll A, 1998, MECH DEVELOP, V72, P175, DOI 10.1016/S0925-4773(98)00007-0; DIXSON AF, 1976, FOLIA PRIMATOL, V26, P207, DOI 10.1159/000155751; Dixson AF, 1998, PRIMATE SEXUALITY; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Gohlke JM, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-15; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; HILL WCO, 1946, P ZOOL SOC LOND, V116, P129; IBRAHIM L, 1983, BRIT J DERMATOL, V108, P321, DOI 10.1111/j.1365-2133.1983.tb03971.x; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Muchlinski MN, 2010, J HUM EVOL, V58, P447, DOI 10.1016/j.jhevol.2010.01.012; MURAKAMI R, 1987, J ANAT, V153, P223; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vue TY, 2007, J COMP NEUROL, V505, P73, DOI 10.1002/cne.21467; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101; Zhang X, 2002, J CLIN ENDOCR METAB, V87, P1262, DOI 10.1210/jc.87.3.1262	30	307	312	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					216	219		10.1038/nature09774	http://dx.doi.org/10.1038/nature09774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390129	Green Accepted			2022-12-28	WOS:000288170200037
J	Sarewitz, D				Sarewitz, Daniel			Science agencies must bite innovation bullet	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA.	dsarewitz@gmail.com							0	4	4	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					137	137		10.1038/471137a	http://dx.doi.org/10.1038/471137a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FK	21390086	Bronze			2022-12-28	WOS:000288170200004
J	Teufel, JD; Li, D; Allman, MS; Cicak, K; Sirois, AJ; Whittaker, JD; Simmonds, RW				Teufel, J. D.; Li, Dale; Allman, M. S.; Cicak, K.; Sirois, A. J.; Whittaker, J. D.; Simmonds, R. W.			Circuit cavity electromechanics in the strong-coupling regime	NATURE			English	Article							NANOMECHANICAL MOTION; MECHANICAL RESONATOR; INDUCED TRANSPARENCY; GROUND-STATE; BACK-ACTION; RADIATION	Demonstrating and exploiting the quantum nature of macroscopic mechanical objects would help us to investigate directly the limitations of quantum-based measurements and quantum information protocols, as well as to test long-standing questions about macroscopic quantum coherence(1-3). Central to this effort is the necessity of long-lived mechanical states. Previous efforts have witnessed quantum behaviour(4), but for a low-quality-factor mechanical system. The field of cavity optomechanics and electromechanics(5,6), in which a high-quality-factor mechanical oscillator is parametrically coupled to an electromagnetic cavity resonance, provides a practical architecture for cooling, manipulation and detection of motion at the quantum level(1). One requirement is strong coupling(7-9), in which the interaction between the two systems is faster than the dissipation of energy from either system. Here, by incorporating a free-standing, flexible aluminium membrane into a lumped-element superconducting resonant cavity, we have increased the single-photon coupling strength between these two systems by more than two orders of magnitude, compared to previously obtained coupling strengths. A parametric drive tone at the difference frequency between the mechanical oscillator and the cavity resonance dramatically increases the overall coupling strength, allowing us to completely enter the quantum-enabled, strong-coupling regime. This is evidenced by a maximum normal-mode splitting of nearly six bare cavity linewidths. Spectroscopic measurements of these 'dressed states' are in excellent quantitative agreement with recent theoretical predictions(10,11). The basic circuit architecture presented here provides a feasible path to ground-state cooling and subsequent coherent control and measurement of long-lived quantum states of mechanical motion.	[Teufel, J. D.; Li, Dale; Allman, M. S.; Cicak, K.; Sirois, A. J.; Whittaker, J. D.; Simmonds, R. W.] NIST, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Teufel, JD (corresponding author), NIST, 325 Broadway, Boulder, CO 80305 USA.	john.teufel@nist.gov	Allman, Michael/E-5922-2011; Teufel, John D/A-8898-2010	Teufel, John D/0000-0002-1873-9941; Whittaker, Jed/0000-0002-0456-3244; Simmonds, Raymond/0000-0003-2217-2965				Agarwal GS, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.041803; Akram U, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083030; Blencowe MP, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014511; BOLLER KJ, 1991, PHYS REV LETT, V66, P2593, DOI 10.1103/PhysRevLett.66.2593; Bose S, 1997, PHYS REV A, V56, P4175, DOI 10.1103/PhysRevA.56.4175; Braginsky V. B., 1992, QUANTUM MEASUREMENT; BRAGINSKY VB, 1970, SOV PHYS JETP-USSR, V31, P829; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Cicak K, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3304168; DIEDRICH F, 1989, PHYS REV LETT, V62, P403, DOI 10.1103/PhysRevLett.62.403; Dobrindt JM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.263602; Ekinci KL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1927327; Groblacher S, 2009, NATURE, V460, P724, DOI 10.1038/nature08171; Hertzberg JB, 2010, NAT PHYS, V6, P213, DOI 10.1038/NPHYS1479; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; LINTHORNE NP, 1990, J PHYS D APPL PHYS, V23, P1, DOI 10.1088/0022-3727/23/1/001; Mancini S, 1997, PHYS REV A, V55, P3042, DOI 10.1103/PhysRevA.55.3042; Marquardt F., 2009, PHYSICS, V2, P40, DOI DOI 10.1103/PHYSICS.2.40; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Marshall W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130401; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Regal CA, 2011, J PHYS CONF SER, V264, DOI 10.1088/1742-6596/264/1/012025; Rocheleau T, 2010, NATURE, V463, P72, DOI 10.1038/nature08681; Teufel JD, 2009, NAT NANOTECHNOL, V4, P820, DOI [10.1038/NNANO.2009.343, 10.1038/nnano.2009.343]; Teufel JD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197203; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715; Weis S, 2010, SCIENCE, V330, P1520, DOI 10.1126/science.1195596; Wilson-Rae I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093901	30	615	628	3	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					204	208		10.1038/nature09898	http://dx.doi.org/10.1038/nature09898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390127	Green Submitted			2022-12-28	WOS:000288170200034
J	Butt, HJ				Butt, Hans-Juergen			Controlling the Flow of Suspensions	SCIENCE			English	Editorial Material							COLLOIDAL PARTICLES; CAPILLARY FORCES; RHEOLOGY; EMULSIONS; SPHERES; SOIL		Max Planck Inst Polymer Res, D-55128 Mainz, Germany	Max Planck Society	Butt, HJ (corresponding author), Max Planck Inst Polymer Res, D-55128 Mainz, Germany.	butt@mpip-mainz.mpg.de	Butt, Hans-Jürgen/C-4811-2011	Butt, Hans-Jürgen/0000-0001-5391-2618				Aveyard R, 2003, ADV COLLOID INTERFAC, V100, P503, DOI 10.1016/S0001-8686(02)00069-6; Butt HJ, 2009, ADV COLLOID INTERFAC, V146, P48, DOI 10.1016/j.cis.2008.10.002; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; EGGLETON AEJ, 1954, CAN J CHEM, V32, P86, DOI 10.1139/v54-015; Fisher RA, 1926, J AGR SCI, V16, P492, DOI 10.1017/S0021859600007838; Haines WB, 1927, J AGR SCI, V17, P264, DOI 10.1017/S0021859600018499; Herminghaus S, 2005, ADV PHYS, V54, P221, DOI 10.1080/00018730500167855; Koos E, 2011, SCIENCE, V331, P897, DOI 10.1126/science.1199243; Kruyt HR, 1943, RECL TRAV CHIM PAY-B, V62, P415; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Mitarai N, 2006, ADV PHYS, V55, P1, DOI 10.1080/00018730600626065; Pickering SU, 1907, J CHEM SOC, V91, P2001, DOI 10.1039/ct9079102001; VANKAO S, 1975, J COLLOID INTERF SCI, V53, P367, DOI 10.1016/0021-9797(75)90052-1; Velev OD, 1996, LANGMUIR, V12, P2374, DOI 10.1021/la9506786; Wagner CS, 2010, COLLOID POLYM SCI, V288, P487, DOI 10.1007/s00396-009-2169-y	15	33	33	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					868	869		10.1126/science.1201543	http://dx.doi.org/10.1126/science.1201543			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330524				2022-12-28	WOS:000287455100036
J	Toien, O; Blake, J; Edgar, DM; Grahn, DA; Heller, HC; Barnes, BM				Toien, Oivind; Blake, John; Edgar, Dale M.; Grahn, Dennis A.; Heller, H. Craig; Barnes, Brian M.			Hibernation in Black Bears: Independence of Metabolic Suppression from Body Temperature	SCIENCE			English	Article							DAILY TORPOR; ARCTIC HIBERNATOR; GROUND-SQUIRRELS; URSUS-AMERICANUS; CNS REGULATION; MARMOTA; MAMMALS; MUSCLE; PHYSIOLOGY; REDUCTION	Black bears hibernate for 5 to 7 months a year and, during this time, do not eat, drink, urinate, or defecate. We measured metabolic rate and body temperature in hibernating black bears and found that they suppress metabolism to 25% of basal rates while regulating body temperature from 30 degrees to 36 degrees C, in multiday cycles. Heart rates were reduced from 55 to as few as 9 beats per minute, with profound sinus arrhythmia. After returning to normal body temperature and emerging from dens, bears maintained a reduced metabolic rate for up to 3 weeks. The pronounced reduction and delayed recovery of metabolic rate in hibernating bears suggest that the majority of metabolic suppression during hibernation is independent of lowered body temperature.	[Toien, Oivind; Blake, John; Barnes, Brian M.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Edgar, Dale M.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Grahn, Dennis A.; Heller, H. Craig] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Alaska System; University of Alaska Fairbanks; Stanford University; Stanford University	Toien, O (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.	otoien@alaska.edu; bmbarnes@alaska.edu	Heller, H. Craig/C-9785-2011	Heller, H Craig/0000-0003-4479-5880; Toien, Oivind/0000-0001-5967-2483	U.S. Army Medical Research and Materiel Command [05178001]; NSF [9819540, 0076039, 0732755]; NIH [HD-00973]; American Heart Association [0020626Z]; Fulbright Program	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fulbright Program	This work was supported by U.S. Army Medical Research and Materiel Command grant 05178001; NSF grants 9819540, 0076039, and 0732755; NIH HD-00973; and gift funds to Stanford University, American Heart Association #0020626Z, and the Fulbright Program. We thank the Alaska Department of Fish and Game for providing bears, D. Ritter for technical assistance, and J. Kenagy and J. Duman for comments.	AZIZI F, 1979, AM J PHYSIOL, V237, pE224, DOI 10.1152/ajpendo.1979.237.3.E224; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255, DOI 10.1152/ajpregu.2000.279.1.R255; Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a; Donahue SW, 2003, J EXP BIOL, V206, P4233, DOI 10.1242/jeb.00671; Fedorov VB, 2009, PHYSIOL GENOMICS, V37, P108, DOI 10.1152/physiolgenomics.90398.2008; FLORANT GL, 1977, AM J PHYSIOL, V232, pR203, DOI 10.1152/ajpregu.1977.232.5.R203; Folk Jr G. E., 1980, BEARS THEIR BIOL MAN, P43; Folk Jr G. E., 1967, MAMMAL HIBERNAT, VIII, P75; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; GEISER F, 1988, J COMP PHYSIOL B, V158, P25, DOI 10.1007/BF00692726; Harlow HJ, 2004, J MAMMAL, V85, P414, DOI 10.1644/1545-1542(2004)085<0414:BSTOHB>2.0.CO;2; Harlow HJ, 2001, NATURE, V409, P997, DOI 10.1038/35059165; HAYSSEN V, 1985, COMP BIOCHEM PHYS A, V81, P741, DOI 10.1016/0300-9629(85)90904-1; HELDMAIER G, 1992, J COMP PHYSIOL B, V162, P696, DOI 10.1007/BF00301619; HELLER HC, 1974, AM J PHYSIOL, V227, P583, DOI 10.1152/ajplegacy.1974.227.3.583; Hissa R, 1997, ANN ZOOL FENN, V34, P267; Hock R. J., 1951, AAAS, V2, P310; Hume ID, 2002, J COMP PHYSIOL B, V172, P197, DOI 10.1007/s00360-001-0240-1; Lee TN, 2009, ETHOL ECOL EVOL, V21, P403, DOI 10.1080/08927014.2009.9522495; Lyman C.P., 1982, HIBERNATION TORPOR M; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Nelson OL, 2010, J COMP PHYSIOL B, V180, P465, DOI 10.1007/s00360-009-0421-x; Rausch RL., 1961, Z SAUGETIERKD, V26, P1; Shao CX, 2010, MOL CELL PROTEOMICS, V9, P313, DOI 10.1074/mcp.M900260-MCP200; SNAPP BD, 1981, PHYSIOL ZOOL, V54, P297, DOI 10.1086/physzool.54.3.30159944; von der Ohe CG, 2007, J NEUROSCI, V27, P84, DOI 10.1523/JNEUROSCI.4385-06.2007; WATTS P, 1988, ACTA PHYSIOL SCAND, V134, P149, DOI 10.1111/j.1748-1716.1988.tb08471.x	29	242	248	3	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					906	909		10.1126/science.1199435	http://dx.doi.org/10.1126/science.1199435			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330544				2022-12-28	WOS:000287455100056
J	Xu, F; Wu, HX; Katritch, V; Han, GW; Jacobson, KA; Gao, ZG; Cherezov, V; Stevens, RC				Xu, Fei; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Jacobson, Kenneth A.; Gao, Zhan-Guo; Cherezov, Vadim; Stevens, Raymond C.			Structure of an Agonist-Bound Human A(2A) Adenosine Receptor	SCIENCE			English	Article							CRYSTAL-STRUCTURE; ALLOSTERIC MODULATION; SUBTYPE-SELECTIVITY; BINDING-SITE; IDENTIFICATION; DOMAINS; GPCR	Activation of G protein-coupled receptors upon agonist binding is a critical step in the signaling cascade for this family of cell surface proteins. We report the crystal structure of the A(2A) adenosine receptor (A(2A)AR) bound to an agonist UK-432097 at 2.7 angstrom resolution. Relative to inactive, antagonist-bound A(2A)AR, the agonist-bound structure displays an outward tilt and rotation of the cytoplasmic half of helix VI, a movement of helix V, and an axial shift of helix III, resembling the changes associated with the active-state opsin structure. Additionally, a seesaw movement of helix VII and a shift of extracellular loop 3 are likely specific to A(2A)AR and its ligand. The results define the molecule UK-432097 as a "conformationally selective agonist" capable of receptor stabilization in a specific active-state configuration.	[Xu, Fei; Wu, Huixian; Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Katritch, Vsevolod] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Jacobson, Kenneth A.; Gao, Zhan-Guo] NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Han, Gye Won/GLQ-8724-2022; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8673-2022; Wu, Huixian/N-6353-2014; Han, Gye Won/GLT-1531-2022; Jacobson, Kenneth Alan/A-1530-2009; Katritch, Vsevolod/Q-8357-2016; soler, martha maricel m gomez/L-6025-2014; Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Y-2721-2019	Han, Gye Won/0000-0003-4107-835X; Cherezov, Vadim/0000-0002-5265-3914; Wu, Huixian/0000-0003-1357-9747; Jacobson, Kenneth Alan/0000-0001-8104-1493; Katritch, Vsevolod/0000-0003-3883-4505; soler, martha maricel m gomez/0000-0002-4412-8108; Stevens, Raymond/0000-0002-4522-8725; 	National Institute of Diabetes and Digestive and Kidney Diseases; NIH Roadmap Initiative [P50 GM073197]; NIH [GM075915]; NSF [IIS0308078]; Science Foundation Ireland [02-IN1-B266]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104];  [U54 GM094618]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089857, U54GM094618, P50GM073197, R01GM075915] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (K.A.J. and Z.-G.G.), PSI: Biology grant U54 GM094618 for structure production, and NIH Roadmap Initiative grant P50 GM073197 for technology development. R. C. S. thanks N. Dekker at AstraZeneca for suggesting the UK-432097 compound for biochemical and structural studies. We thank J. Velasquez for help on molecular biology; C. Cornillez-Ty, T. Trinh, and K. Allin for help on baculovirus expression; E. Chien and W. Liu for advice on protein purification and LCP crystallization; I. Wilson, M. Hanson, and A. IJzerman for careful review and scientific feedback on the manuscript; K. Kadyshevskaya for assistance with figure preparation; A. Walker for assistance with manuscript preparation; L. Heitman for A<INF>2A</INF>AR compounds used in thermal stability studies; Y. Zheng and M. Caffrey for use of an in meso robot (built with support from NIH grant GM075915, NSF grant IIS0308078, and Science Foundation Ireland grant 02-IN1-B266); and J. Smith, R. Fischetti, and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104. R. C. S. is a founder and member of the board of directors of Receptos, a GPCR structure-based drug discovery company. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3QAK.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Cristalli Gloria, 2009, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-540-89615-9_3; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gao ZG, 2003, MOL PHARMACOL, V63, P1021, DOI 10.1124/mol.63.5.1021; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Ivanov AA, 2009, J MED CHEM, V52, P3284, DOI 10.1021/jm801533x; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jaakola VP, 2010, J BIOL CHEM, V285, P13032, DOI 10.1074/jbc.M109.096974; Jiang QL, 1996, MOL PHARMACOL, V50, P512; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Katritch V, 2011, NEUROPHARMACOLOGY, V60, P108, DOI 10.1016/j.neuropharm.2010.07.009; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Mantell SJ, 2009, BIOORG MED CHEM LETT, V19, P4471, DOI 10.1016/j.bmcl.2009.05.027; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rieger JM, 2001, J MED CHEM, V44, P531, DOI 10.1021/jm0003642; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Sansuk K, 2011, MOL PHARMACOL, V79, P262, DOI 10.1124/mol.110.066068; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Tchilibon S, 2004, BIOORGAN MED CHEM, V12, P2021, DOI 10.1016/j.bmc.2004.02.037; Vanni S, 2010, J MOL BIOL, V397, P1339, DOI 10.1016/j.jmb.2010.01.060; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	36	638	655	0	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					322	327		10.1126/science.1202793	http://dx.doi.org/10.1126/science.1202793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21393508	Green Accepted			2022-12-28	WOS:000289516600036
J	Roostalu, J; Hentrich, C; Bieling, P; Telley, IA; Schiebel, E; Surrey, T				Roostalu, Johanna; Hentrich, Christian; Bieling, Peter; Telley, Ivo A.; Schiebel, Elmar; Surrey, Thomas			Directional Switching of the Kinesin Cin8 Through Motor Coupling	SCIENCE			English	Article							MITOTIC SPINDLE; BUDDING YEAST; EG5; PROTEINS; MOTILITY; MICROTUBULES; CONFORMATION; ORGANIZATION; SUPERFAMILY; ANAPHASE	Kinesin motor proteins are thought to move exclusively in either one or the other direction along microtubules. Proteins of the kinesin-5 family are tetrameric microtubule cross-linking motors important for cell division and differentiation in various organisms. Kinesin-5 motors are considered to be plus-end-directed. However, here we found that purified kinesin-5 Cin8 from budding yeast could behave as a bidirectional kinesin. On individual microtubules, single Cin8 motors were minus-end-directed motors, whereas they switched to plus-end-directed motility when working in a team of motors sliding antiparallel microtubules apart. This kinesin can thus change directionality of movement depending on whether it acts alone or in an ensemble.	[Roostalu, Johanna; Schiebel, Elmar] Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Allianz, D-69120 Heidelberg, Germany; [Hentrich, Christian; Bieling, Peter; Telley, Ivo A.; Surrey, Thomas] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Schiebel, E (corresponding author), Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Allianz, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	e.schiebel@zmbh.uni-heidelberg.de; thomas.surrey@cancer.org.uk	Telley, Ivo Andreas/D-2063-2011; Surrey, Thomas/AAC-4608-2021	Telley, Ivo Andreas/0000-0003-4444-1046; Roostalu, Johanna/0000-0002-6757-0468; Bieling, Peter/0000-0002-7458-4358; Hentrich, Christian/0000-0001-6697-5001; Surrey, Thomas/0000-0001-9082-1870	Deutsche Forschungsgemeinschaft; European Commission; Swiss National Science Foundation; Cancer Research UK [14256] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research UK(Cancer Research UK)	We thank D. Pellman and M. Knop for plasmids; I. Hagan, J. Ellenberg, and M. Kaksonen for critically reading the manuscript; and the Deutsche Forschungsgemeinschaft, the European Commission (Marie Curie Research Training Network "Spindle Dynamics"), and the Swiss National Science Foundation for financial support.	Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Cheerambathur DK, 2008, J CELL BIOL, V182, P429, DOI 10.1083/jcb.200804100; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Gheber L, 1999, J BIOL CHEM, V274, P9564, DOI 10.1074/jbc.274.14.9564; Guerin T, 2010, CURR OPIN CELL BIOL, V22, P14, DOI 10.1016/j.ceb.2009.12.012; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; HAGAN I, 1992, NATURE, V356, P74, DOI 10.1038/356074a0; Henningsen U, 1997, NATURE, V389, P93, DOI 10.1038/38022; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Hildebrandt ER, 2006, J BIOL CHEM, V281, P26004, DOI 10.1074/jbc.M604817200; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032	30	114	116	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					94	99		10.1126/science.1199945	http://dx.doi.org/10.1126/science.1199945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21350123				2022-12-28	WOS:000289000000045
J	El Masri, WS; Kumar, N				El Masri, Wagih Shafik; Kumar, Naveen			Traumatic spinal cord injuries	LANCET			English	Editorial Material							RECOVERY		[El Masri, Wagih Shafik; Kumar, Naveen] Keele Univ, Robert Jones & Agnes Hunt Orthopaed Hosp, Oswestry SY10 7AG, Shrops, England	Keele University	El Masri, WS (corresponding author), Keele Univ, Robert Jones & Agnes Hunt Orthopaed Hosp, Oswestry SY10 7AG, Shrops, England.	wagih.elmasri@rjah.nhs.uk		Kumar, Naveen/0000-0001-5932-8500				El Masri W, 2010, ACNR, V10, P34; El Masri WS, 2006, TRAUMA, V8, P29, DOI 10.1191/1460408606ta357oa; El Masri WS, 1992, SPINAL CORD DYSFUNCT, V2, P7; El Masri WS, 1992, SPINAL CORD TRAUMA, P55; ELMASRI WS, 1993, J NEUROTRAUMA S, V10, P70; FOLMAN Y, 1989, INJURY, V20, P92, DOI 10.1016/0020-1383(89)90148-4; Frankel H L, 1969, Paraplegia, V7, P179; Ibrahim A, 2006, LANCET NEUROL, V5, P453, DOI 10.1016/S1474-4422(06)70444-6; Katoh S, 1996, SPINE, V21, P2345, DOI 10.1097/00007632-199610150-00008; KATOH S, 1995, PARAPLEGIA, V33, P506, DOI 10.1038/sc.1995.110; Kirshblum S, 2004, ARCH PHYS MED REHAB, V85, P1811, DOI 10.1016/j.apmr.2004.03.015; Poynton AR, 1997, J BONE JOINT SURG BR, V79B, P952, DOI 10.1302/0301-620X.79B6.7939; van Middendorp JJ, 2011, LANCET, V377, P1004, DOI 10.1016/S0140-6736(10)62276-3	13	15	16	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2011	377	9770					972	974		10.1016/S0140-6736(11)60248-1	http://dx.doi.org/10.1016/S0140-6736(11)60248-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21377200	Green Published			2022-12-28	WOS:000288775800006
J	Oberst, A; Dillon, CP; Weinlich, R; McCormick, LL; Fitzgerald, P; Pop, C; Hakem, R; Salvesen, GS; Green, DR				Oberst, Andrew; Dillon, Christopher P.; Weinlich, Ricardo; McCormick, Laura L.; Fitzgerald, Patrick; Pop, Cristina; Hakem, Razq; Salvesen, Guy S.; Green, Douglas R.			Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis	NATURE			English	Article							CELL-DEATH; RIP1 KINASE; ACTIVATION; REQUIREMENT; APOPTOSIS; HOMEOSTASIS; EXPRESSION; RECEPTORS; REGULATOR; CLEAVAGE	Caspase-8 has two opposing biological functions-it promotes cell death by triggering the extrinsic pathway of apoptosis, but also has a survival activity, as it is required for embryonic development(1), T-lymphocyte activation(2), and resistance to necrosis induced by tumour necrosis factor-alpha (TNF-alpha) and related family ligands(3,4). Here we show that development of caspase-8-deficient mice is completely rescued by ablation of receptor interacting protein kinase-3 (RIPK3). Adult animals lacking both caspase-8 and RIPK3 display a progressive lymphoaccumulative disease resembling that seen with defects in CD95 or CD95-ligand (also known as FAS and FASLG, respectively), and resist the lethal effects of CD95 ligation in vivo. We have found that caspase-8 prevents RIPK3-dependent necrosis without inducing apoptosis by functioning in a proteolytically active complex with FLICE-like inhibitory protein long (FLIPL, also known as CFLAR), and this complex is required for the protective function.	[Oberst, Andrew; Dillon, Christopher P.; Weinlich, Ricardo; McCormick, Laura L.; Fitzgerald, Patrick; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Pop, Cristina; Salvesen, Guy S.] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Hakem, Razq] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	St Jude Children's Research Hospital; Sanford Burnham Prebys Medical Discovery Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Weinlich, Ricardo/G-9028-2013; Weinlich, Ricardo/AAW-3154-2020; Green, Douglas R/N-8083-2018; Dillon, Christopher/P-4457-2014; Weinlich, Ricardo/S-7495-2016	Weinlich, Ricardo/0000-0001-6822-7330; Green, Douglas R/0000-0002-7332-1417; Dillon, Christopher/0000-0002-9458-0266; Hakem, Razqallah/0000-0001-5948-7931	NIH [AI44828, CA69381]; CIHR [MOP 36537]; Sass Foundation for Medical Research; ALSAC; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Sass Foundation for Medical Research; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank W. J. Kaiser and E. S. Mocarski for their discussions and material support. We thank Ariad Pharmaceutical for providing the homo- and heterodimerization reagents. We thank the members of the St. Jude Immunology FACS core facility, as well as M. Johnson, L. Janke and the St. Jude Veterinary Pathology Core. We also thank the St. Jude Hartwell Center. This work was supported by NIH grant AI44828 to D. R. G. and CA69381 to G. S. S., as well as CIHR grant MOP 36537 to R. H. C. P. D. was supported by a fellowship grant from the Sass Foundation for Medical Research. This work was also supported by ALSAC.	Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chang David W, 2003, Sci STKE, V2003, pPL1, DOI 10.1126/stke.2003.167.pl1; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; QUAN LT, 1995, J BIOL CHEM, V270, P10377, DOI 10.1074/jbc.270.18.10377; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scharner D, 2009, ARTERIOSCL THROM VAS, V29, P571, DOI 10.1161/ATVBAHA.108.182006; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	32	875	885	8	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					363	+		10.1038/nature09852	http://dx.doi.org/10.1038/nature09852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368763	Green Accepted			2022-12-28	WOS:000288444000042
J	Davidoff, F				Davidoff, Frank			Music Lessons: What Musicians Can Teach Doctors (and Other Health Professionals)	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY IMPROVEMENT; CARE	Medicine is a learned profession, but clinical practice is above all a matter of performance, in the best and deepest sense of the word. Because music is, at its core, a pure distillate of real-time performance, musicians are in an excellent position to teach us about better ways to become and remain expert performers in health care and ways for our teachers and mentors to help us do that. Ten features of the professionalization of musicians offer us lessons on how the clinical practice of medicine might be learned, taught, and performed more effectively.			Davidoff, F (corresponding author), 143 Garden St, Wethersfield, CT 06109 USA.	fdavidoff@cox.net						Batalden P, 2007, JAMA-J AM MED ASSOC, V298, P1059, DOI 10.1001/jama.298.9.1059; Batalden PB, 2007, QUAL SAF HEALTH CARE, V16, P2, DOI 10.1136/qshc.2006.022046; Carraccio C, 2002, ACAD MED, V77, P361, DOI 10.1097/00001888-200205000-00003; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Cooke M, 2010, ED PHYS CALL REFORM; DAVIDOFF F, 1996, RIGHT HAND CLAUDE RE, P128; Davidoff Frank, 2008, Mens Sana Monogr, V6, P29, DOI 10.4103/0973-1229.37085; Dreyfus H. L., 1986, MIND MACHINE POWER H, P1; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Gawande A., 2010, CHECKLIST MANIFESTO, P103; Haidet P, 2007, ANN FAM MED, V5, P164, DOI 10.1370/afm.624; HUNTER KM, 1991, DOCTORS STORIES NARR, P25; Jackson GP, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4260; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; Mackenzie CF, 2003, QUAL SAF HEALTH CARE, V12, pII51, DOI 10.1136/qhc.12.suppl_2.ii51; Norman Geoffrey R, 2005, ACP J Club, V142, pA8; Pronovost PJ, 2010, JAMA-J AM MED ASSOC, V304, P1721, DOI 10.1001/jama.2010.1542; SACKS O, 2007, MUSICOPHILIA TALES M, P89; SACKS O, 2007, MUSICOPHILIA TALES M, P120; Sand Barbara Lourie, 2000, TEACHING GENIUS DORO; Schon D.A., 1987, ED REFLECTIVE PRACTI; Styron W., 2007, DARKNESS VISIBLE MEM	22	18	19	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					426	+		10.7326/0003-4819-154-6-201103150-00009	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734WA	21403078				2022-12-28	WOS:000288370000007
J	Monsonego, J				Monsonego, Joseph			Genital infection with HPV in men: research into practice	LANCET			English	Editorial Material							HUMAN-PAPILLOMAVIRUS-INFECTION; YOUNG-WOMEN; SEX; CIRCUMCISION; PARTNERS; DISEASE; CANCER		Inst Cervix, Dept Colposcopy, F-75017 Paris, France		Monsonego, J (corresponding author), Inst Cervix, Dept Colposcopy, F-75017 Paris, France.	jmonsonego@wanadoo.fr						Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Daling JR, 2005, INT J CANCER, V116, P606, DOI 10.1002/ijc.21009; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Hernandez BY, 2008, EMERG INFECT DIS, V14, P888, DOI 10.3201/eid1406.070616; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X; Kjaer SK, 2000, SEX TRANSM DIS, V27, P438, DOI 10.1097/00007435-200009000-00003; KREBS HB, 1990, OBSTET GYNECOL, V76, P660; Kreuter A, 2009, CURR OPIN INFECT DIS, V22, P109, DOI 10.1097/QCO.0b013e3283229fc8; Monsonego J, 2007, GYNECOL OBSTET FERTI, V35, P107, DOI 10.1016/j.gyobfe.2006.12.010; MONSONEGO J, 1993, INT J STD AIDS, V4, P13, DOI 10.1177/095646249300400104; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284	14	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					881	883		10.1016/S0140-6736(11)60277-8	http://dx.doi.org/10.1016/S0140-6736(11)60277-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GR	21367447				2022-12-28	WOS:000288628800007
J	Bland, JM; Altman, DG				Bland, J. Martin; Altman, Douglas G.			Correlation in restricted ranges of data	BMJ-BRITISH MEDICAL JOURNAL			English	Article												martin.bland@york.ac.uk						Goodwin LD, 2006, J EXP EDUC, V74, P251, DOI 10.3200/jexe.74.3.249-266; Nadas J, 2008, MED SCI MONITOR, V14, pCR15	2	97	97	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2011	342								d556	10.1136/bmj.d556	http://dx.doi.org/10.1136/bmj.d556			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41LI	21398359				2022-12-28	WOS:000209547300001
J	Rohde, JR				Rohde, John R.			Listeria Unwinds Host DNA	SCIENCE			English	Editorial Material							MONOCYTOGENES; INFECTION		Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS 75015, Canada	Dalhousie University	Rohde, JR (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS 75015, Canada.	john.rohde@dal.ca	Rohde, John/F-1479-2013					Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bierne H, 2009, P NATL ACAD SCI USA, V106, P13826, DOI 10.1073/pnas.0901259106; Chang PC, 2009, CANCER RES, V69, P5681, DOI 10.1158/0008-5472.CAN-08-4570; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Kamitani S, 2008, BIOCHEM BIOPH RES CO, V370, P366, DOI 10.1016/j.bbrc.2008.03.104; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Stockinger S, 2008, IMMUNOBIOLOGY, V213, P889, DOI 10.1016/j.imbio.2008.07.020; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026	16	3	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2011	331	6022					1271	1272		10.1126/science.1203271	http://dx.doi.org/10.1126/science.1203271			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393530				2022-12-28	WOS:000288215200029
J	Davidson, GH; Hamlat, CA; Rivara, FP; Koepsell, TD; Jurkovich, GJ; Arbabi, S				Davidson, Giana H.; Hamlat, Christian A.; Rivara, Frederick P.; Koepsell, Thomas D.; Jurkovich, Gregory J.; Arbabi, Saman			Long-term Survival of Adult Trauma Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIPLE IMPUTATION; NATIONAL EVALUATION; GERIATRIC-PATIENTS; INJURED PATIENTS; LATE DEATH; OUTCOMES; CARE; MORTALITY; SYSTEMS; DISCHARGE	Context Inpatient trauma case fatality rates may provide an incomplete assessment for overall trauma care effectiveness. To date, there have been few large studies evaluating long-term mortality in trauma patients and identifying predictors that increase risk for death following hospital discharge. Objectives To determine the long-term mortality of patients following trauma admission and to evaluate survivorship in relationship with discharge disposition. Design, Setting, and Patients Retrospective cohort study of 124 421 injured adult patients during January 1995 to December 2008 using the Washington State Trauma Registry linked to death certificate data. Main Outcome Measures Kaplan-Meier and Cox proportional hazards models were used to evaluate long-term mortality following hospital admission for trauma. Results Of the 124 421 trauma patients, 7243 died before hospital discharge and 21 045 died following hospital discharge. Cumulative mortality at 3 years postinjury was 16% (95% confidence interval [CI], 15.8%-16.2%) compared with the expected population cumulative mortality of 5.9% (95% CI, 5.9%-5.9%). In-hospital mortality improved during the 14-year study period from 8% (n=362) to 4.9% (n=600), whereas long-term cumulative mortality increased from 4.7% (95% CI, 4.1%-5.4%) to 7.4% (95% CI, 6.8%-8.1%). After adjustments for confounders, patients who were older and those who were discharged to a skilled nursing facility had the highest risk of death. The adjusted hazard ratios (HRs) for death after discharge to a skilled nursing facility compared with that after discharge home were 1.41 (95% CI, 0.72-2.76) for patients aged 18 to 30 years, 1.92 (95% CI, 1.36-2.73) for patients aged 31 to 45 years, 2.02 (95% CI, 1.39-2.93) for patients aged 46 to 55 years, 1.93 (95% CI, 1.40-2.64) for patients aged 56 to 65 years, 1.49 (95% CI, 1.14-1.94) for patients aged 66 to 75 years, 1.54 (95% CI, 1.27-1.87) for patients aged 76 to 80 years, and 1.38 (95% CI, 1.09-1.74) for patients older than 80 years. Other significant predictors of mortality after discharge included maximum head injury score on Abbreviated Injury Score scale (HR, 1.20; 95% CI, 1.13-1.26), Injury Severity Score (HR, 0.98; 95% CI, 0.97-0.98), Functional Independence Measure (HR, 0.89; 95% CI, 0.88-0.91), mechanism of injury being a fall (HR, 1.43; 95% CI, 1.30-1.58), and having Medicare (HR, 1.28; 95% CI, 1.15-1.43) or other government insurance (HR, 1.65; 95% CI, 1.47-1.85). Conclusions Among adults admitted for trauma in Washington State, 3-year cumulative mortality was 16% despite a decline in in-hospital deaths. Discharge to a skilled nursing facility at any age following trauma admission was associated with a higher risk of subsequent mortality. JAMA. 2011;305(10):1001-1007 www.jama.com	[Davidson, Giana H.; Hamlat, Christian A.; Jurkovich, Gregory J.; Arbabi, Saman] Univ Washington, Dept Surg, Seattle, WA 98104 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Rivara, Frederick P.; Koepsell, Thomas D.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Arbabi, Saman] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle	Arbabi, S (corresponding author), Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359796, Seattle, WA 98104 USA.	sarbabi@uw.edu			National Institute of Child Health and Human Development [1T32HD057822-01AZ]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057822] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institute of Child Health and Human Development grant 1T32HD057822-01AZ that was awarded to the Pediatric Injury Research Training Program.	Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Battistella FD, 1998, J TRAUMA, V44, P618, DOI 10.1097/00005373-199804000-00010; Claridge JA, 2010, J AM COLL SURGEONS, V210, P788, DOI 10.1016/j.jamcollsurg.2009.12.035; Clark DE, 2004, J AM GERIATR SOC, V52, P2023, DOI 10.1111/j.1532-5415.2004.52560.x; DEMARIA EJ, 1987, ANN SURG, V206, P738, DOI 10.1097/00000658-198712000-00009; FINELLI FC, 1989, J TRAUMA, V29, P541, DOI 10.1097/00005373-198905000-00001; Gubler KD, 1996, J TRAUMA, V41, P952, DOI 10.1097/00005373-199612000-00002; Gubler KD, 1997, ARCH SURG-CHICAGO, V132, P1010; Legner VJ, 2009, ANN SURG, V249, P250, DOI 10.1097/SLA.0b013e318195e12f; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mullins RJ, 1998, JAMA-J AM MED ASSOC, V279, P1727, DOI 10.1001/jama.279.21.1727; Munin MC, 2010, AM J PHYS MED REHAB, V89, P530, DOI 10.1097/PHM.0b013e3181e29f54; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Olson CJ, 2003, J TRAUMA, V55, P45, DOI 10.1097/01.TA.0000071291.17287.57; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Skaga NO, 2008, INJURY, V39, P612, DOI 10.1016/j.injury.2007.11.426; *US CDCP, MULT CAUS DEATH 2005; Utter GH, 2006, J TRAUMA, V60, P529, DOI 10.1097/01.ta.0000204022.36214.9e; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Winzelberg GS, 2003, ARCH INTERN MED, V163, P2552, DOI 10.1001/archinte.163.21.2552; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; ZIETLOW SP, 1994, J TRAUMA, V37, P985, DOI 10.1097/00005373-199412000-00020	26	186	188	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1001	1007		10.1001/jama.2011.259	http://dx.doi.org/10.1001/jama.2011.259			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386078	Bronze			2022-12-28	WOS:000288129600019
J	Kitsis, EA				Kitsis, Elizabeth A.			Shining a Light on Shadowing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kitsis, Elizabeth A.] Albert Einstein Coll Med, Montefiore Einstein Ctr Bioeth, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Kitsis, Elizabeth A.] Albert Einstein Coll Med, Montefiore Einstein Ctr Bioeth, Dept Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Kitsis, EA (corresponding author), Albert Einstein Coll Med, Montefiore Einstein Ctr Bioeth, Dept Epidemiol & Populat Hlth, Mazer Bldg 513,1300 Morris Pk Ave, Bronx, NY 10461 USA.	elizabeth.kitsis@einstein.yu.edu						Allen JG, 2009, ANN THORAC SURG, V87, P1816, DOI 10.1016/j.athoracsur.2009.03.007; *AMH COLL CAR CTR, SHAD HEALTHC; *EM, SHAD; Hernandez J, 2009, J AM COLL SURGEONS, V209, P62, DOI 10.1016/j.jamcollsurg.2009.02.065; LO B, 2009, RESOLVING ETHICAL DI, P179; O'Connell VA, 2006, MED ED ONLINE, V11, P12; STOECKLE JD, 1993, J GEN INTERN MED, V8, P561, DOI 10.1007/BF02599640; PHYS SHADOWING; HOSP SHADOWING	9	16	16	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1029	1030		10.1001/jama.2011.267	http://dx.doi.org/10.1001/jama.2011.267			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386080				2022-12-28	WOS:000288129600023
J	Bleijenberg, G; Knoop, H				Bleijenberg, Gijs; Knoop, Hans			Chronic fatigue syndrome: where to PACE from here?	LANCET			English	Editorial Material							COGNITIVE-BEHAVIOR THERAPY		[Bleijenberg, Gijs; Knoop, Hans] Radboud Univ Nijmegen, Expert Ctr Chron Fatigue, Med Ctr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Bleijenberg, G (corresponding author), Radboud Univ Nijmegen, Expert Ctr Chron Fatigue, Med Ctr, NL-6500 HB Nijmegen, Netherlands.	G.Bleijenberg@nkcv.umcn.nl	Knoop, Hans/D-3264-2009; Bleijenberg, Gijs/E-6984-2010	Knoop, Hans/0000-0001-7763-3517; 	Medical Research Council [G0200434] Funding Source: Medline; MRC [G0200434] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Heins MJ, 2010, PSYCHOTHER PSYCHOSOM, V79, P249, DOI 10.1159/000315130; Knoop H, 2007, PSYCHOTHER PSYCHOSOM, V76, P171, DOI 10.1159/000099844; Moss-Morris R, 2005, J HEALTH PSYCHOL, V10, P245, DOI 10.1177/1359105305049774; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Wiborg JF, 2010, PSYCHOL MED, V40, P1281, DOI 10.1017/S0033291709992212; WIBORG JF, 2011, J PSYCHOSOM RES	6	7	7	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 5	2011	377	9768					786	788		10.1016/S0140-6736(11)60172-4	http://dx.doi.org/10.1016/S0140-6736(11)60172-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GO	21334060				2022-12-28	WOS:000288628500005
J	Corbyn, Z				Corbyn, Zoe			Research on the reservation	NATURE			English	News Item																		Bunnell JE, 2010, J ENVIRON PUBLIC HEA, V2010, DOI 10.1155/2010/260525; Stevens Douglas K., 2009, Environmental Bioindicators, V4, P303, DOI 10.1080/15555270903404750	2	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					25	26		10.1038/471025a	http://dx.doi.org/10.1038/471025a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368800	Bronze			2022-12-28	WOS:000287924100011
J	Hussein, SM; Batada, NN; Vuoristo, S; Ching, RW; Autio, R; Narva, E; Ng, S; Sourour, M; Hamalainen, R; Olsson, C; Lundin, K; Mikkola, M; Trokovic, R; Peitz, M; Brustle, O; Bazett-Jones, DP; Alitalo, K; Lahesmaa, R; Nagy, A; Otonkoski, T				Hussein, Samer M.; Batada, Nizar N.; Vuoristo, Sanna; Ching, Reagan W.; Autio, Reija; Narva, Elisa; Ng, Siemon; Sourour, Michel; Hamalainen, Riikka; Olsson, Cia; Lundin, Karolina; Mikkola, Milla; Trokovic, Ras; Peitz, Michael; Bruestle, Oliver; Bazett-Jones, David P.; Alitalo, Kari; Lahesmaa, Riitta; Nagy, Andras; Otonkoski, Timo			Copy number variation and selection during reprogramming to pluripotency	NATURE			English	Article							EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; SELF-RENEWAL; FRAGILE SITES; DIFFERENTIATION; FIBROBLASTS; SUPPRESSION; ACTIVATION; INDUCTION; CULTURE	The mechanisms underlying the low efficiency of reprogramming somatic cells into induced pluripotent stem (iPS) cells are poorly understood. There is a clear need to study whether the reprogramming process itself compromises genomic integrity and, through this, the efficiency of iPS cell establishment. Using a high-resolution single nucleotide polymorphism array, we compared copy number variations (CNVs) of different passages of human iPS cells with their fibroblast cell origins and with human embryonic stem (ES) cells. Here we show that significantly more CNVs are present in early-passage human iPS cells than intermediate passage human iPS cells, fibroblasts or human ES cells. Most CNVs are formed de novo and generate genetic mosaicism in early-passage human iPS cells. Most of these novel CNVs rendered the affected cells at a selective disadvantage. Remarkably, expansion of human iPS cells in culture selects rapidly against mutated cells, driving the lines towards a genetic state resembling human ES cells.	[Hussein, Samer M.; Vuoristo, Sanna; Hamalainen, Riikka; Olsson, Cia; Lundin, Karolina; Mikkola, Milla; Trokovic, Ras; Otonkoski, Timo] Univ Helsinki, Biomedicum Stem Cell Ctr, Res Program Unit, FI-00014 Helsinki, Finland; [Hussein, Samer M.; Sourour, Michel; Hamalainen, Riikka; Nagy, Andras] Samuel Lunenfeld Res Inst, Toronto, ON M5T 3H7, Canada; [Batada, Nizar N.; Ng, Siemon] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Ching, Reagan W.; Bazett-Jones, David P.] Hosp Sick Children, Dept Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Autio, Reija; Narva, Elisa; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Autio, Reija; Narva, Elisa; Lahesmaa, Riitta] Abo Akad Univ, FIN-20520 Turku, Finland; [Autio, Reija] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Peitz, Michael; Bruestle, Oliver] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany; [Peitz, Michael; Bruestle, Oliver] Hertie Fdn, D-53127 Bonn, Germany; [Alitalo, Kari] Univ Helsinki, Lab Mol Canc Biol, FI-00014 Helsinki, Finland; [Alitalo, Kari] Univ Helsinki, Cent Hosp, FI-00014 Helsinki, Finland; [Nagy, Andras] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Otonkoski, Timo] Univ Helsinki, Childrens Hosp, FI-00029 Helsinki, Finland	University of Helsinki; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Turku; Abo Akademi University; Tampere University; University of Bonn; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Toronto; University of Helsinki	Otonkoski, T (corresponding author), Univ Helsinki, Biomedicum Stem Cell Ctr, Res Program Unit, FI-00014 Helsinki, Finland.	nagy@lunenfeld.ca; timo.otonkoski@helsinki.fi	Autio, Reija/D-2037-2014; Alitalo, Kari K/J-5013-2014; Närvä, Elisa Maarit/AAA-4885-2022; Martikainen, Riikka/AAR-8397-2020; Peitz, Michael/AHB-0741-2022; Nagy, Andras/G-6465-2013; Otonkoski, Timo/F-1189-2011; Trokovic, Ras/AAC-7309-2022	Alitalo, Kari K/0000-0002-7331-0902; Närvä, Elisa Maarit/0000-0003-0517-9436; Martikainen, Riikka/0000-0002-5102-0672; Nagy, Andras/0000-0003-4311-0413; Trokovic, Ras/0000-0002-3065-6663; Autio, Reija/0000-0002-6519-2715; Batada, Nizar/0000-0002-8007-1487	EU; Academy of Finland; Finnish Cancer Organizations; Helsinki University Hospital; Sigrid Juselius Foundation; Stem Cell Network Canada; GL2; CIHR; McEwen Centre for Regenerative Medicine; Ontario Institute for Cancer Research through the Ontario Ministry of Research and Innovation	EU(European Commission); Academy of Finland(Academy of Finland); Finnish Cancer Organizations; Helsinki University Hospital; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Stem Cell Network Canada; GL2; CIHR(Canadian Institutes of Health Research (CIHR)); McEwen Centre for Regenerative Medicine; Ontario Institute for Cancer Research through the Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	This work was supported by funding for the ESTOOLS consortium under the Sixth RFP of the EU (S.M.H., T.O., R.L. and O.B.), the Academy of Finland (T.O. and R.A.), the Finnish Cancer Organizations (R.L.), the Research Funds of the Helsinki University Hospital (T.O.), the Sigrid Juselius Foundation (T.O.), the Stem Cell Network Canada, GL2 and CIHR (A.N.). S.M.H. is a recipient of a McEwen Post-doctoral Fellowship from the McEwen Centre for Regenerative Medicine. N.N.B. is the recipient of a New Investigator Award from the Ontario Institute for Cancer Research, through the Ontario Ministry of Research and Innovation. A.N. is Tier 1 Canada Research Chair in Stem Cells and Regeneration. We are grateful to I. Rogers, M. Faiz and K. Nagy for critically reading and editing the manuscript, and J. Ustinov, H. Sariola and J. Palgi for skilled assistance in the characterization of human iPS cells. We thank N. Rahkonen for sample processing, as well as the Finnish Microarray and Sequencing Centre (http://www.btk.fi/), and the Institute of Human Genetics, University of Bonn, for array processing.	Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hagenkord JM, 2010, J MOL DIAGN, V12, P184, DOI 10.2353/jmoldx.2010.090118; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kulkarni A, 2010, MOL CELL BIOL, V30, P578, DOI 10.1128/MCB.01137-09; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Maimets T, 2008, ONCOGENE, V27, P5277, DOI 10.1038/onc.2008.166; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mikkola M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-40; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Riethman H, 2005, CHROMOSOME RES, V13, P505, DOI 10.1007/s10577-005-0998-1; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zschenker O, 2009, DNA REPAIR, V8, P886, DOI 10.1016/j.dnarep.2009.05.004	49	692	734	2	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					58	U67		10.1038/nature09871	http://dx.doi.org/10.1038/nature09871			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368824				2022-12-28	WOS:000287924100033
J	Xiong, W; Shi, CJ				Xiong, Wei; Shi, Chanjuan			Malignant Pericardial Effusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Xiong, Wei] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Shi, Chanjuan] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	University of Arkansas System; University of Arkansas Medical Sciences; Johns Hopkins University; Johns Hopkins Medicine	Xiong, W (corresponding author), Univ Arkansas Med Sci, Little Rock, AR 72205 USA.	wxiong2@uams.edu							0	1	1	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					E18	E18		10.1056/NEJMicm1009066	http://dx.doi.org/10.1056/NEJMicm1009066			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366469				2022-12-28	WOS:000287928400013
J	King, MC				King, Mary-Claire			A Healthy Son	SCIENCE			English	Editorial Material									Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	King, MC (corresponding author), Univ Washington, Seattle, WA 98195 USA.			King, Mary-Claire/0000-0001-9426-1743					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1026	1026		10.1126/science.1204088	http://dx.doi.org/10.1126/science.1204088			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350166	Bronze			2022-12-28	WOS:000287699000049
J	Addo, J; Bhalla, A; Crichton, S; Rudd, AG; McKevitt, C; Wolfe, CDA				Addo, Juliet; Bhalla, Ajay; Crichton, Siobhan; Rudd, Anthony G.; McKevitt, Christopher; Wolfe, Charles D. A.			Provision of acute stroke care and associated factors in a multiethnic population: prospective study with the South London Stroke Register	BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-CARE; ISCHEMIC-STROKE; SEX-DIFFERENCES; EUROPEAN PERSPECTIVE; THROMBOLYTIC THERAPY; NORTHERN-IRELAND; RISK-FACTORS; OUTCOMES; MANAGEMENT; GUIDELINES	Objectives To investigate time trends in receipt of effective acute stroke care and to determine the factors associated with provision of care. Design Population based stroke register. Setting South London. Participants 3800 patients with first ever ischaemic stroke or primary intracerebral haemorrhage registered between January 1995 and December 2009. Main outcome measures Acute care interventions, admission to hospital, care on a stroke unit, acute drugs, and inequalities in access to care. Results Between 2007 and 2009, 5% (33/620) of patients were still not admitted to a hospital after an acute stroke, particularly those with milder strokes, and 21% (124/584) of patients admitted to hospital were not admitted to a stroke unit. Rates of admission to stroke units and brain imaging, between 1995 and 2009, and for thrombolysis, between 2005 and 2009, increased significantly (P<0.001). Black patients compared with white patients had a significantly increased odds of admission to a stroke unit (odds ratio 1.76, 95% confidence interval 1.35 to 2.29, P<0.001) and of receipt of occupational therapy or physiotherapy (1.90, 1.21 to 2.97, P=0.01), independent of age or stroke severity. Patients with motor or swallowing deficits were also more likely to be admitted to a stroke unit (1.52, 1.12 to 2.06, P=0.001 and 1.32, 1.02 to 1.72, P<0.001, respectively). Length of stay in hospital decreased significantly between 1995 and 2009 (P<0.001). The odds of brain imaging were lowest in patients aged 75 or more years (P=0.004) and those of lower socioeconomic status (P<0.001). The likelihood of those with a functional deficit receiving rehabilitation increased significantly over time (P<0.001). Patients aged 75 or more were more likely to receive occupational therapy or physiotherapy (P=0.002). Conclusion Although the receipt of effective acute stroke care improved between 1995 and 2009, inequalities in its provision were significant, and implementation of evidence based care was not optimal.				Juliet.addo@kcl.ac.uk	mckevitt, christopher/AAN-7271-2021	MCKEVITT, CHRISTOPHER/0000-0002-5290-4613; Crichton, Siobhan/0000-0001-9962-083X; Wolfe, Charles/0000-0001-8264-0981	Guy's and St Thomas' Hospital Charity; Stroke Association; Department of Health, UK; National Institute for Health [RP-PG-0407-10184]; Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre [PB-PG-0407-13228]; Guy's and St Thomas' NHS Trust; National Institute for Health Research [RP-PG-0407-10184] Funding Source: researchfish	Guy's and St Thomas' Hospital Charity; Stroke Association; Department of Health, UK; National Institute for Health; Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Guy's and St Thomas' NHS Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by Guy's and St Thomas' Hospital Charity, The Stroke Association, Department of Health HQIP grants, UK, National Institute for Health Research programme grant (RP-PG-0407-10184). The authors (CW) acknowledge financial support from the Department of Health through the National Institute for Health Research (NIHR) Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and the NIHR research for patient benefit programme award (PB-PG-0407-13228). CDAW is a senior investigator for the NIHR. AR is funded by the Guy's and St Thomas' NHS Trust AHSC PA Scheme.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Alter DA, 2003, CAN MED ASSOC J, V168, P261; Aly N, 2000, BRIT MED J, V320, P1511, DOI 10.1136/bmj.320.7248.1511; [Anonymous], 2008, NAT CLIN GUID STROK; Arora S, 2005, STROKE, V36, P1232, DOI 10.1161/01.STR.0000165902.18021.5b; Beech R, 1996, STROKE, V27, P1958, DOI 10.1161/01.STR.27.11.1958; Bhalla A, 2004, AGE AGEING, V33, P618, DOI 10.1093/ageing/afh219; Bhalla A, 2003, EUR J NEUROL, V10, P25, DOI 10.1046/j.1468-1331.2003.00504.x; Bhalla A, 2001, AGE AGEING, V30, P197, DOI 10.1093/ageing/30.3.197; Bhalla A, 2010, J STROKE CEREBROVASC, V19, P357, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.005; Bray JE, 2006, INTERN MED J, V36, P483, DOI 10.1111/j.1445-5994.2006.01127.x; Carter KN, 2007, CEREBROVASC DIS, V23, P162, DOI 10.1159/000097054; Department of Health, 2001, NAT SERV FRAM OLD PE; Department of Health, 2007, NAT STROK STRAT; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Eriksson M, 2009, STROKE, V40, P909, DOI 10.1161/STROKEAHA.108.517581; Farooq MU, 2008, CEREBROVASC DIS, V25, P12, DOI 10.1159/000111494; Glader EL, 2003, STROKE, V34, P1970, DOI 10.1161/01.STR.0000083534.81284.C5; Govan L, 2007, COCHRANE DB SYST REV, V4; Grieve R, 2001, STROKE, V32, P1684, DOI 10.1161/01.STR.32.7.1684; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Heidrich J, 2007, EUR J NEUROL, V14, P255, DOI 10.1111/j.1468-1331.2006.01573.x; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Horner RD, 1997, STROKE, V28, P19, DOI 10.1161/01.STR.28.1.19; Irwin P, 2005, J EVAL CLIN PRACT, V11, P306, DOI 10.1111/j.1365-2753.2005.00529.x; Johnston SC, 2001, STROKE, V32, P1061, DOI 10.1161/01.STR.32.5.1061; Kapral MK, 2002, STROKE, V33, P268, DOI 10.1161/hs0102.101169; Kjellstrom T, 2007, CEREBROVASC DIS, V23, P231; Lees KR, 2008, QJM-INT J MED, V101, P863, DOI 10.1093/qjmed/hcn102; McKevitt C, 2005, STROKE, V36, P315, DOI 10.1161/01.STR.0000152332.32267.19; Meretoja A, 2010, STROKE, V41, P1102, DOI 10.1161/STROKEAHA.109.577718; *NAT STROK FDN, 2007, CLIN GUID AC STROK M; National Audit Office, 2005, RED BRAIN DAM FAST A; Quain DA, 2008, MED J AUSTRALIA, V189, P429, DOI 10.5694/j.1326-5377.2008.tb02114.x; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; *ROYAL COLL PHYS C, 2008, NAT SENT STROK AUD P; Rudd AG, 2011, J NEUROL NEUROSUR PS, V82, P14, DOI 10.1136/jnnp.2009.203174; Rudd AG, 2005, STROKE, V36, P103, DOI 10.1161/01.STR.0000149618.14922.8a; Saposnik G, 2009, STROKE, V40, P3328, DOI 10.1161/STROKEAHA.109.558759; Schwamm LH, 2010, CIRCULATION, V121, P1492, DOI 10.1161/CIRCULATIONAHA.109.881490; Stansbury JP, 2005, STROKE, V36, P374, DOI 10.1161/01.STR.0000153065.39325.fd; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Syme PD, 2005, STROKE, V36, P1837, DOI 10.1161/01.STR.0000177873.82478.1c; TEASDALE G, 1974, LANCET, V2, P81; Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351; Weir NU, 2001, STROKE, V32, P1370, DOI 10.1161/01.STR.32.6.1370; Wojner-Alexandrov AW, 2005, STROKE, V36, P1512, DOI 10.1161/01.STR.0000170700.45340.39; Wolfe C, 2001, BRIT MED J, V323, P5, DOI 10.1136/bmj.323.7303.5	49	36	36	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 24	2011	342								d744	10.1136/bmj.d744	http://dx.doi.org/10.1136/bmj.d744			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729BE	21349892	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000287920900009
J	Bustamante, C; Cheng, W; Meija, YX				Bustamante, Carlos; Cheng, Wei; Meija, Yara X.			Revisiting the Central Dogma One Molecule at a Time	CELL			English	Review							HEPATITIS-C VIRUS; SINGLE MYOSIN MOLECULE; TRANSFER-RNA SELECTION; SACCHAROMYCES-CEREVISIAE; FORCE GENERATION; DNA-REPLICATION; NS3 HELICASE; TRANSCRIPTION ELONGATION; DEOXYRIBONUCLEIC ACID; SEQUENCE COMPARISONS	The faithful relay and timely expression of genetic information depend on specialized molecular machines, many of which function as nucleic acid translocases. The emergence over the last decade of single-molecule fluorescence detection and manipulation techniques with nm and angstrom resolution and their application to the study of nucleic acid translocases are painting an increasingly sharp picture of the inner workings of these machines, the dynamics and coordination of their moving parts, their thermodynamic efficiency, and the nature of their transient intermediates. Here we present an overview of the main results arrived at by the application of single-molecule methods to the study of the main machines of the central dogma.	[Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Cheng, Wei] Univ Michigan, Dept Pharmaceut Sci, Coll Pharm, Ann Arbor, MI 48109 USA; [Meija, Yara X.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; Max Planck Society	Bustamante, C (corresponding author), Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073	NIH; DOE; HHMI; University of Michigan Ann Arbor	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); HHMI(Howard Hughes Medical Institute); University of Michigan Ann Arbor(University of Michigan System)	We thank Timothy M. Lohman at Washington University School of Medicine for a critical reading of the draft on helicases and many colleagues for stimulating discussions. The literature on nucleic acid translocases, in particular their single-molecule studies, is ever increasing. Due to space limitations and our coverage of selected topics, we would like to apologize to our colleagues who actively work on nucleic acid translocases yet whose work has not been cited here. C. B. was supported by NIH, DOE, and HHMI. W. C. was supported by Ara Paul Professorship fund at the University of Michigan Ann Arbor.	Aathavan K, 2009, NATURE, V461, P669, DOI 10.1038/nature08443; Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BESSMAN MJ, 1958, J BIOL CHEM, V233, P171; Betterton MD, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011904; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Calendar, 2006, BACTERIOPHAGES, P49; Catalano Carlos Enrique, 2005, P1; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; Dalal RV, 2006, MOL CELL, V23, P231, DOI 10.1016/j.molcel.2006.06.023; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Depken M, 2009, BIOPHYS J, V96, P2189, DOI 10.1016/j.bpj.2008.12.3918; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dhar A, 2005, J MOL BIOL, V347, P71, DOI 10.1016/j.jmb.2004.12.041; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Frick DN, 2003, DRUG NEWS PERSPECT, V16, P355, DOI 10.1358/dnp.2003.16.6.829307; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Galburt EA, 2007, NATURE, V446, P820, DOI 10.1038/nature05701; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grimes S, 2002, ADV VIRUS RES, V58, P255, DOI 10.1016/S0065-3527(02)58007-6; Grimes S, 1997, J MOL BIOL, V266, P901, DOI 10.1006/jmbi.1996.0843; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Ibarra B, 2009, EMBO J, V28, P2794, DOI 10.1038/emboj.2009.219; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Jankowsky E, 2006, NUCLEIC ACIDS RES, V34, P4181, DOI 10.1093/nar/gkl410; Jennings TA, 2009, J BIOL CHEM, V284, P4806, DOI 10.1074/jbc.M805540200; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; KOONIN EV, 1993, VIRUS GENES, V7, P89, DOI 10.1007/BF01702351; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; Koti JS, 2008, J MOL BIOL, V381, P1114, DOI 10.1016/j.jmb.2008.04.034; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lang MJ, 2004, NAT METHODS, V1, P133, DOI 10.1038/NMETH714; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; Lee TH, 2007, P NATL ACAD SCI USA, V104, P13661, DOI 10.1073/pnas.0705988104; LEHMAN IR, 1958, J BIOL CHEM, V233, P163; Liljas A, 2004, STRUCTURAL ASPECTS P; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lohman TM, 1998, CELL, V93, P9, DOI 10.1016/S0092-8674(00)81139-3; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; Margeat E, 2006, BIOPHYS J, V90, P1419, DOI 10.1529/biophysj.105.069252; Marshall RA, 2008, ANNU REV BIOCHEM, V77, P177, DOI 10.1146/annurev.biochem.77.070606.101431; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Mejia YX, 2008, J MOL BIOL, V382, P628, DOI 10.1016/j.jmb.2008.06.079; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Murakami A, 2002, NUCLEIC ACIDS RES, V30, P1056, DOI 10.1093/nar/30.4.1056; Muschielok A, 2008, NAT METHODS, V5, P965, DOI 10.1038/nmeth.1259; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Myong S, 2010, CURR OPIN STRUC BIOL, V20, P121, DOI 10.1016/j.sbi.2009.12.008; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; PALLADINO F, 1992, GENETICS, V132, P23; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Rickgauer J.P., 2006, P SPIE INT SOC OPTIC, P632623; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.3.CO;2-V; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; Sternberg SH, 2009, NAT STRUCT MOL BIOL, V16, P861, DOI 10.1038/nsmb.1622; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; STRANEY DC, 1987, J MOL BIOL, V193, P267, DOI 10.1016/0022-2836(87)90218-X; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Thomsen ND, 2008, MOL MICROBIOL, V69, P1071, DOI 10.1111/j.1365-2958.2008.06364.x; Tsay JM, 2010, J BIOL CHEM, V285, P24282, DOI 10.1074/jbc.M110.129395; Tsay JM, 2009, P NATL ACAD SCI USA, V106, P14355, DOI 10.1073/pnas.0904364106; TURNQUIST S, 1992, P NATL ACAD SCI USA, V89, P10479, DOI 10.1073/pnas.89.21.10479; Uemura S, 2007, NATURE, V446, P454, DOI 10.1038/nature05625; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Waksman G, 2000, NAT STRUCT BIOL, V7, P20, DOI 10.1038/71215; Walter W, 2003, J BIOL CHEM, V278, P36148, DOI 10.1074/jbc.M305647200; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Worrall JAR, 2008, J BIOL CHEM, V283, P5567, DOI 10.1074/jbc.M708620200; Wu JY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1033; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653	148	123	125	3	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					480	497		10.1016/j.cell.2011.01.033	http://dx.doi.org/10.1016/j.cell.2011.01.033			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335233	Green Accepted, Bronze			2022-12-28	WOS:000287473100005
J	Dubey, GP; Ben-Yehuda, S				Dubey, Gyanendra P.; Ben-Yehuda, Sigal			Intercellular Nanotubes Mediate Bacterial Communication	CELL			English	Article							BACILLUS-SUBTILIS; MECHANISMS; PROTEIN; CYANOBACTERIA; PEPTIDES; PLASMID; SYSTEM; CELLS	Bacteria are known to communicate primarily via secreted extracellular factors. Here we identify a previously uncharacterized type of bacterial communication mediated by nanotubes that bridge neighboring cells. Using Bacillus subtilis as a model organism, we visualized transfer of cytoplasmic fluorescent molecules between adjacent cells. Additionally, by coculturing strains harboring different antibiotic resistance genes, we demonstrated that molecular exchange enables cells to transiently acquire nonhereditary resistance. Furthermore, non-conjugative plasmids could be transferred from one cell to another, thereby conferring hereditary features to recipient cells. Electron microscopy revealed the existence of variously sized tubular extensions bridging neighboring cells, serving as a route for exchange of intracellular molecules. These nanotubes also formed in an interspecies manner, between B. subtilis and Staphylococcus aureus, and even between B. subtilis and the evolutionary distant bacterium Escherichia coli. We propose that nanotubes represent a major form of bacterial communication in nature, providing a network for exchange of cellular molecules within and between species.	[Dubey, Gyanendra P.; Ben-Yehuda, Sigal] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada IMRIC, Hadassah Med Sch, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Ben-Yehuda, S (corresponding author), Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada IMRIC, Hadassah Med Sch, POB 12272, IL-91120 Jerusalem, Israel.	sigalb@ekmd.huji.ac.il			European Research Council [209130]; Israel Science Foundation [696/07]	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	We thank I. Popov, E. Blayvas, N. Feinstein, and E. Rahamim (Hebrew University, IL) for technical support during EM studies. We are grateful to A. Rouvinski (Hebrew University, IL) for experimental advice and insightful discussions. We thank R. Losick (Harvard University, USA), M. Kassel (National Institutes of Health, USA), G. Bachrach (Hebrew University, IL), D. Kearns (Indiana University, USA), A. Taraboulos (Hebrew University, IL), and members of the Ben-Yehuda laboratory for valuable discussions and comments. We thank the National BioResource Project National Institute of Genetics, Japan (NIG, Japan) for providing B. subtilis mutant strains. This work was supported by the European Research Council Starting Grant (209130), and by the Israel Science Foundation (696/07) awarded to S. B-Y.	Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Bron S, 1998, J BIOTECHNOL, V64, P3, DOI 10.1016/S0168-1656(98)00099-6; Christensen BB, 2002, APPL ENVIRON MICROB, V68, P2495, DOI 10.1128/AEM.68.5.2495-2502.2002; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; GIDDINGS TH, 1981, ARCH MICROBIOL, V129, P295, DOI 10.1007/BF00414700; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Harwood C.R., 1990, MOL BIOL METHODS BAC; Haugland R.P., 2005, HDB A GUIDEBOOK FLUO; Heinlein M, 2004, INT REV CYTOL, V235, P93, DOI 10.1016/S0074-7696(04)35003-5; Hershey A.D., 1983, LAMBDA 2; Hurtig J, 2010, WIRES NANOMED NANOBI, V2, P260, DOI 10.1002/wnan.80; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kaiser D, 2008, ANNU REV GENET, V42, P109, DOI 10.1146/annurev.genet.42.110807.091615; Kearns DB, 2001, TRENDS MICROBIOL, V9, P126, DOI 10.1016/S0966-842X(01)01948-5; KOEHLER TM, 1987, J BACTERIOL, V169, P5271, DOI 10.1128/jb.169.11.5271-5278.1987; Kolter R, 2006, NATURE, V441, P300, DOI 10.1038/441300a; Kuchma SL, 2000, CURR OPIN BIOTECH, V11, P429, DOI 10.1016/S0958-1669(00)00123-3; Lazazzera BA, 2001, PEPTIDES, V22, P1519, DOI 10.1016/S0196-9781(01)00488-0; LEDERBERG J, 1946, NATURE, V158, P558, DOI 10.1038/158558a0; Lemon KP, 2008, CURR TOP MICROBIOL, V322, P1; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; Madigan M.T., 2006, BROCK BIOL MICROORGA; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Moons P, 2009, CRIT REV MICROBIOL, V35, P157, DOI 10.1080/10408410902809431; MULLIGAN ME, 1993, AM J MED, V94, P313, DOI 10.1016/0002-9343(93)90063-U; Mullineaux CW, 2008, EMBO J, V27, P1299, DOI 10.1038/emboj.2008.66; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; ROSENSHINE I, 1989, SCIENCE, V245, P1387, DOI 10.1126/science.2818746; Schara K, 2009, CELL MOL BIOL LETT, V14, P636, DOI 10.2478/s11658-009-0018-0; SCHLEPER C, 1995, J BACTERIOL, V177, P4417, DOI 10.1128/jb.177.15.4417-4426.1995; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Silverman PM, 1997, MOL MICROBIOL, V23, P423, DOI 10.1046/j.1365-2958.1997.2411604.x; Straight PD, 2009, ANNU REV MICROBIOL, V63, P99, DOI 10.1146/annurev.micro.091208.073248; TANAKA T, 1977, J BACTERIOL, V131, P699, DOI 10.1128/JB.131.2.699-701.1977; TOMASZ A, 1965, NATURE, V208, P155, DOI 10.1038/208155a0; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	44	356	381	12	186	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					590	600		10.1016/j.cell.2011.01.015	http://dx.doi.org/10.1016/j.cell.2011.01.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335240	Bronze			2022-12-28	WOS:000287473100013
J	Glezen, WP				Glezen, W. Paul			Cell-culture-derived influenza vaccine production	LANCET			English	Editorial Material							PANDEMIC INFLUENZA; A H1N1; EFFICACY		Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine	Glezen, WP (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	wglezen@bcm.edu						[Anonymous], COCHRANE DATABASE SY; Barrett PN, 2011, LANCET, V377, P751, DOI 10.1016/S0140-6736(10)62228-3; Frey S, 2010, CLIN INFECT DIS, V51, P997, DOI 10.1086/656578; *HLTH PEOPL, TOP OBJ IND HLTH PEO; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Koudstaal W, 2009, VACCINE, V27, P2588, DOI 10.1016/j.vaccine.2009.02.033; Minor PD, 2010, CLIN INFECT DIS, V50, P560, DOI 10.1086/650171; Palache A. M., 1997, Journal of Infectious Diseases, V176, pS20, DOI 10.1086/514169; ROCHA EP, 1993, J GEN VIROL, V74, P2513, DOI 10.1099/0022-1317-74-11-2513; WOOD JM, 1989, VIROLOGY, V171, P214, DOI 10.1016/0042-6822(89)90528-X; Wright PF, 2008, NEW ENGL J MED, V358, P2540, DOI 10.1056/NEJMp0803650	11	10	10	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2011	377	9767					698	700		10.1016/S0140-6736(11)60174-8	http://dx.doi.org/10.1016/S0140-6736(11)60174-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729JQ	21329970				2022-12-28	WOS:000287946000007
J	Xiong, F; Liao, AD; Estrada, D; Pop, E				Xiong, Feng; Liao, Albert D.; Estrada, David; Pop, Eric			Low-Power Switching of Phase-Change Materials with Carbon Nanotube Electrodes	SCIENCE			English	Article							CHANGE MEMORY; LOGIC APPLICATIONS; NONVOLATILE; TRANSISTORS	Phase-change materials (PCMs) are promising candidates for nonvolatile data storage and reconfigurable electronics, but high programming currents have presented a challenge to realize low-power operation. We controlled PCM bits with single-wall and small-diameter multi-wall carbon nanotubes. This configuration achieves programming currents of 0.5 microampere (set) and 5 microamperes (reset), two orders of magnitude lower than present state-of-the-art devices. Pulsed measurements enable memory switching with very low energy consumption. Analysis of over 100 devices finds that the programming voltage and energy are highly scalable and could be below 1 volt and single femtojoules per bit, respectively.	[Xiong, Feng; Liao, Albert D.; Estrada, David; Pop, Eric] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Xiong, Feng; Liao, Albert D.; Estrada, David; Pop, Eric] Univ Illinois, Micro & Nanotechnol Lab, Urbana, IL 61801 USA; [Pop, Eric] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Pop, E (corresponding author), Univ Illinois, Dept Elect & Comp Engn, 1406 W Green St, Urbana, IL 61801 USA.	epop@illinois.edu	Xiong, Feng/E-5935-2011; Pop, Eric/A-9475-2009; estrada, david/H-1679-2013	Xiong, Feng/0000-0001-8383-5182; Pop, Eric/0000-0003-0436-8534; Estrada, David/0000-0001-5894-0773	Materials Structures and Devices (MSD) Focus Center; Nanotechnology Research Initiative (NRI); NSF; Office of Naval Research (ONR)	Materials Structures and Devices (MSD) Focus Center; Nanotechnology Research Initiative (NRI); NSF(National Science Foundation (NSF)); Office of Naval Research (ONR)(Office of Naval Research)	We acknowledge valuable discussions with J. Abelson and D. Ielmini. This work was supported in part by the Materials Structures and Devices (MSD) Focus Center, under the Focus Center Research Program (FCRP), a Semiconductor Research Corporation entity. Additional funding was provided by the Nanotechnology Research Initiative (NRI) Fellowship (A.L.), a NSF Graduate Fellowship (D.E.), and the Office of Naval Research (ONR).	Aguirre CM, 2009, NANO LETT, V9, P1457, DOI 10.1021/nl8033152; Bruns G, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3191670; Burr GW, 2010, J VAC SCI TECHNOL B, V28, P223, DOI 10.1116/1.3301579; Chen IR, 2009, IEEE T ELECTRON DEV, V56, P1523, DOI 10.1109/TED.2009.2021364; Chen KN, 2008, IEEE ELECTR DEVICE L, V29, P131, DOI 10.1109/LED.2007.912016; Chen Y. C., 2006, INT EL DEV M 2006 IE, DOI [10.1109/IEDM.2006.346910, DOI 10.1109/IEDM.2006.346910]; Ielmini D, 2007, J APPL PHYS, V102, DOI 10.1063/1.2773688; Im D. H., 2008, INT EL DEV M 2008 IE, DOI [10.1109/IEDM.2008.4796654, DOI 10.1109/IEDM.2008.4796654]; Karpov VG, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.052201; Kolobov AV, 2004, NAT MATER, V3, P703, DOI 10.1038/nmat1215; Krebs D, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3210792; Lankhorst MHR, 2005, NAT MATER, V4, P347, DOI 10.1038/nmat1350; Lee JI, 2007, 2007 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P102, DOI 10.1109/VLSIT.2007.4339744; Lee SH, 2007, NAT NANOTECHNOL, V2, P626, DOI 10.1038/nnano.2007.291; Liao A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.205406; Liao A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.256804; Meister S, 2008, NANO LETT, V8, P4562, DOI 10.1021/nl802808f; Pop E, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717855; Qi PF, 2004, J AM CHEM SOC, V126, P11774, DOI 10.1021/ja045900k; Raoux S, 2010, CHEM REV, V110, P240, DOI 10.1021/cr900040x; Redaelli A, 2004, IEEE ELECTR DEVICE L, V25, P684, DOI 10.1109/LED.2004.836032; Wang WJ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2963196; Wong HSP, 2010, P IEEE, V98, P2201, DOI 10.1109/JPROC.2010.2070050; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Xiong F, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3273370; Yao J, 2009, SMALL, V5, P2910, DOI 10.1002/smll.200901100; Yoon SM, 2009, IEEE ELECTR DEVICE L, V30, P371, DOI 10.1109/LED.2009.2013879; Yu D, 2008, NANO LETT, V8, P3429, DOI 10.1021/nl802261s	28	416	431	11	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					568	570		10.1126/science.1201938	http://dx.doi.org/10.1126/science.1201938			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21393510				2022-12-28	WOS:000289991100042
J	D'Asaro, E; Lee, C; Rainville, L; Harcourt, R; Thomas, L				D'Asaro, Eric; Lee, Craig; Rainville, Luc; Harcourt, Ramsey; Thomas, Leif			Enhanced Turbulence and Energy Dissipation at Ocean Fronts	SCIENCE			English	Article							VERTICAL KINETIC-ENERGY; DEEP CONVECTION; LABRADOR SEA; MIXED-LAYER; WIND; PROPAGATION; VORTICITY; VELOCITY	The ocean surface boundary layer mediates air-sea exchange. In the classical paradigm and in current climate models, its turbulence is driven by atmospheric forcing. Observations at a 1-kilometer-wide front within the Kuroshio Current indicate that the rate of energy dissipation within the boundary layer is enhanced by one to two orders of magnitude, suggesting that the front, rather than the atmospheric forcing, supplied the energy for the turbulence. The data quantitatively support the hypothesis that winds aligned with the frontal velocity catalyzed a release of energy from the front to the turbulence. The resulting boundary layer is stratified in contrast to the classically well-mixed layer. These effects will be strongest at the intense fronts found in the Kuroshio Current, the Gulf Stream, and the Antarctic Circumpolar Current, all of which are key players in the climate system.	[D'Asaro, Eric; Lee, Craig; Rainville, Luc; Harcourt, Ramsey] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [D'Asaro, Eric; Lee, Craig; Rainville, Luc] Univ Washington, Sch Oceanog, Seattle, WA 98105 USA; [Thomas, Leif] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University	D'Asaro, E (corresponding author), Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA.	dasaro@apl.washington.edu			Office of Naval Research [N00014-05-1-0329/30/31, N00014-08-1-0445/10446/10447, N00014-09-1-0202]; Division Of Ocean Sciences [0934737] Funding Source: National Science Foundation	Office of Naval Research(Office of Naval Research); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the Office of Naval Research as part of the Assessing the Effects of Submesoscale Ocean Parameterizations program (grants N00014-05-1-0329/30/31, N00014-08-1-0445/10446/10447, and N00014-09-1-0202). This work would not have been possible without the efforts of staff at the Integrated Observations Group, the Ocean Engineering Department at the University of Washington Applied Physics Laboratory, and the crew and officers of the R/V Melville.	Capet X, 2008, J PHYS OCEANOGR, V38, P2256, DOI 10.1175/2008JPO3810.1; D'Asaro EA, 2003, J ATMOS OCEAN TECH, V20, P896, DOI 10.1175/1520-0426(2003)020<0896:POALF>2.0.CO;2; D'Asaro EA, 2003, J PHYS OCEANOGR, V33, P561, DOI 10.1175/1520-0485(2003)033<0561:TOBLBH>2.0.CO;2; D'Asaro EA, 2001, J PHYS OCEANOGR, V31, P3530, DOI 10.1175/1520-0485(2002)031<3530:TVKEIT>2.0.CO;2; D'Asaro E, 2007, J MARINE SYST, V66, P92, DOI 10.1016/j.jmarsys.2006.06.007; DASARO EA, 1985, J PHYS OCEANOGR, V15, P1043, DOI 10.1175/1520-0485(1985)015<1043:TEFFTW>2.0.CO;2; Fairall CW, 1996, J GEOPHYS RES-OCEANS, V101, P3747, DOI 10.1029/95JC03205; Ferrari R, 2009, ANNU REV FLUID MECH, V41, P253, DOI 10.1146/annurev.fluid.40.111406.102139; Haine TWN, 1998, J PHYS OCEANOGR, V28, P634, DOI 10.1175/1520-0485(1998)028<0634:GSABIO>2.0.CO;2; Harcourt RR, 2002, J PHYS OCEANOGR, V32, P493, DOI 10.1175/1520-0485(2002)032<0493:FLFILS>2.0.CO;2; KUNZE E, 1985, J PHYS OCEANOGR, V15, P544, DOI 10.1175/1520-0485(1985)015<0544:NIWPIG>2.0.CO;2; LEAMAN KD, 1975, J GEOPHYS RES, V80, P1975, DOI 10.1029/JC080i015p01975; Lien RC, 1998, J FLUID MECH, V362, P177, DOI 10.1017/S0022112098008787; Marshall D, 1997, J MAR RES, V55, P201, DOI 10.1357/0022240973224373; Molemaker MJ, 2010, J FLUID MECH, V654, P35, DOI 10.1017/S0022112009993272; PRICE JF, 1986, J GEOPHYS RES-OCEANS, V91, P8411, DOI 10.1029/JC091iC07p08411; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Steffen EL, 2002, J PHYS OCEANOGR, V32, P475, DOI 10.1175/1520-0485(2002)032<0475:DCITLS>2.0.CO;2; Taylor JR, 2010, J PHYS OCEANOGR, V40, P1222, DOI 10.1175/2010JPO4365.1; Taylor JR, 2009, J FLUID MECH, V622, P103, DOI 10.1017/S0022112008005272; Thomas LN, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044680; Thomas LN, 2005, J PHYS OCEANOGR, V35, P2457, DOI 10.1175/JPO2830.1; Tseng RS, 2004, J PHYS OCEANOGR, V34, P1984, DOI 10.1175/1520-0485(2004)034<1984:MOTVKE>2.0.CO;2	23	299	305	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2011	332	6027					318	322		10.1126/science.1201515	http://dx.doi.org/10.1126/science.1201515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AT	21393512				2022-12-28	WOS:000289516600035
J	Rappaport, B; Mellon, RD; Simone, A; Woodcock, J				Rappaport, Bob; Mellon, R. Daniel; Simone, Arthur; Woodcock, Janet			Defining Safe Use of Anesthesia in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COHORT		[Rappaport, Bob; Mellon, R. Daniel; Simone, Arthur] US FDA, Off New Drugs, Div Anesthesia & Analgesia Prod, Silver Spring, MD 20993 USA; [Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Rappaport, B (corresponding author), US FDA, Off New Drugs, Div Anesthesia & Analgesia Prod, Silver Spring, MD 20993 USA.							Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; JR SW, 2007, TOXICOL SCI, V98, P145; PAULE MG, 2011, NEUROTOXICOL TE 0115; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d	5	153	156	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1387	1390		10.1056/NEJMp1102155	http://dx.doi.org/10.1056/NEJMp1102155			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	749LD	21388302	Bronze			2022-12-28	WOS:000289467200002
J	Jalota, L; Kalira, V; George, E; Shi, YY; Hornuss, C; Radke, O; Pace, NL; Apfel, CC				Jalota, Leena; Kalira, Vicki; George, Elizabeth; Shi, Yung-Ying; Hornuss, Cyrill; Radke, Oliver; Pace, Nathan L.; Apfel, Christian C.		Perioperative Clinical Res Core	Prevention of pain on injection of propofol: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LONG-CHAIN TRIGLYCERIDE; IONTOPHORETICALLY APPLIED LIDOCAINE; PATIENT-CONTROLLED ANALGESIA; ADULT SURGICAL-PATIENTS; DOUBLE-BLIND; VENOUS OCCLUSION; REDUCES PAIN; FLURBIPROFEN AXETIL; INTRAVENOUS-INJECTION; NITROUS-OXIDE	Objective To systematically determine the most efficacious approach for preventing pain on injection of propofol. Design Systematic review and meta-analysis. Data sources PubMed, Embase, Cochrane Library, www.clinicaltrials.gov, and hand searching from the reference lists of identified papers. Study selection Randomised controlled trials comparing drug and non-drug interventions with placebo or another intervention to alleviate pain on injection of propofol in adults. Results Data were analysed from 177 randomised controlled trials totalling 25 260 adults. The overall risk of pain from propofol injection alone was about 60%. Using an antecubital vein instead of a hand vein was the most effective single intervention (relative risk 0.14, 95% confidence interval 0.07 to 0.30). Pretreatment using lidocaine (lignocaine) in conjunction with venous occlusion was similarly effective (0.29, 0.22 to 0.38). Other effective interventions were a lidocaine-propofol admixture (0.40, 0.33 to 0.48); pretreatment with lidocaine (0.47, 0.40 to 0.56), opioids (0.49, 0.41 to 0.59), ketamine (0.52, 0.46 to 0.57), or non-steroidal anti-inflammatory drugs (0.67, 0.49 to 0.91); and propofol emulsions containing medium and long chain triglycerides (0.75, 0.67 to 0.84). Statistical testing of indirect comparisons showed that use of the antecubital vein and pretreatment using lidocaine along with venous occlusion to be more efficacious than the other interventions. Conclusions The two most efficacious interventions to reduce pain on injection of propofol were use of the antecubital vein, or pretreatment using lidocaine in conjunction with venous occlusion when the hand vein was chosen. Under the assumption of independent efficacy a third practical alternative could be pretreatment of the hand vein with lidocaine or ketamine and use of a propofol emulsion containing medium and long chain triglycerides. Although not the most effective intervention on its own, a small dose of opioids before induction halved the risk of pain from the injection and thus can generally be recommended unless contraindicated.	[Jalota, Leena; Kalira, Vicki; George, Elizabeth; Shi, Yung-Ying; Hornuss, Cyrill; Radke, Oliver; Pace, Nathan L.; Apfel, Christian C.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94115 USA; [Kalira, Vicki] W Virginia Sch Med, Morgantown, WV 26506 USA; [Radke, Oliver] Tech Univ Dresden, Univ Hosp Carl Gustav Dresden, Dept Anaesthesia & Crit Care Med, Dresden, Germany; [Pace, Nathan L.] Univ Utah, Dept Anaesthesiol, Salt Lake City, UT USA	University of California System; University of California San Francisco; Technische Universitat Dresden; Utah System of Higher Education; University of Utah	Apfel, CC (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94115 USA.	apfelc@anesthesia.ucsf.edu		Radke, Oliver/0000-0003-4811-6128	University of California, San Francisco; Department of Anaesthesia and Perioperative Care, University of California, San Francisco	University of California, San Francisco(University of California System); Department of Anaesthesia and Perioperative Care, University of California, San Francisco(University of California System)	This study was funded by the Perioperative Clinical Research Core, University of California, San Francisco.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf and declare that LJ, VK, EG, YYS, CH, OR, and CCA have support from the Perioperative Clinical Research Core, Department of Anaesthesia and Perioperative Care, University of California, San Francisco, CA for the submitted work; LJ, VK, EG, YYS, CH, NLP, OR, and CCA have no relationships that might have an interest in the submitted work in the previous 3 years; their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and LJ, VK, EG, YYS, OR, and CCA have no non-financial interests; and NLP is an unpaid statistical editor for a Cochrane Collaborative Review Group.	Aantaa R, 1997, CURR THER RES CLIN E, V58, P38, DOI 10.1016/S0011-393X(97)80076-8; Adachi Hiroshi, 2002, Masui, V51, P983; Adam S, 2004, ANESTH ANALG, V99, P1076, DOI [10.1213/01.ANE.0000130344.17898.CD, 10.1213/01.ane.0000130344.17898.cd]; Agarwal A, 2004, ANAESTH INTENS CARE, V32, P657, DOI 10.1177/0310057X0403200508; Agarwal A, 2004, ANESTH ANALG, V99, P117, DOI 10.1213/01.ANE.0000117002.03919.49; Agarwal A, 2004, ANESTH ANALG, V98, P683, DOI 10.1213/01.ANE.0000103266.73568.18; Agarwal A, 2004, CAN J ANAESTH, V51, P130, DOI 10.1007/BF03018771; Ahmad N, 2008, Med J Malaysia, V63, P431; Akcaboy ZN, 2007, SAUDI MED J, V28, P1550; Al-Refal AR, 2007, MINERVA ANESTESIOL, V73, P219; Aldrete JA, 2010, ACTA ANAESTH SCAND, V54, P442, DOI 10.1111/j.1399-6576.2009.02174.x; Allford MA, 2006, EUR J ANAESTH, V23, P971, DOI 10.1017/S0265021506001049; Alyafi Walid A., 1996, Middle East Journal of Anesthesiology, V13, P613; Ambesh SP, 1999, ANESTH ANALG, V89, P197, DOI 10.1097/00000539-199907000-00035; Angst MS, 1997, J CLIN ANESTH, V9, P462, DOI 10.1016/S0952-8180(97)00101-3; Aouad MT, 2007, ANESTH ANALG, V104, P1540, DOI 10.1213/01.ane.0000261520.34879.09; Apiliogullari S, 2007, EUR J ANAESTH, V24, P235, DOI 10.1017/S026502150600202X; ARYA A, 2008, J ANESTHESIA CLIN PH, V24, P291; Asik I, 2003, EUR J ANAESTH, V20, P487; Auerswald K, 2005, ANASTH INTENSIV NOTF, V40, P259, DOI 10.1055/s-2005-861353; AUN CST, 1992, BRIT J ANAESTH, V68, P64, DOI 10.1093/bja/68.1.64; Austin JD, 2009, J CLIN ANESTH, V21, P44, DOI 10.1016/j.jclinane.2008.06.018; Ayoglu H, 2007, EUR J ANAESTH, V24, P541, DOI 10.1017/S0265021506002250; Ayuso M A, 2004, Rev Esp Anestesiol Reanim, V51, P531; Azma Toshiharu, 2004, Hiroshima Journal of Medical Sciences, V53, P13; Bachmann-Mennenga B, 2007, EUR J ANAESTH, V24, P33, DOI 10.1017/S0265021506000974; Bachmann-Mennenga B, 2003, ARZNEIMITTEL-FORSCH, V53, P621; Baker MT, 2005, ANESTHESIOLOGY, V103, P860, DOI 10.1097/00000542-200510000-00026; Barbi E, 2003, PAEDIATR ANAESTH, V13, P764, DOI 10.1046/j.1460-9592.2003.01150.x; BARKER P, 1991, ANAESTHESIA, V46, P1069, DOI 10.1111/j.1365-2044.1991.tb09927.x; Basaranoglu G, 2005, EUR J ANAESTH, V22, P890, DOI 10.1017/S0265021505231502; Basaranoglu G, 2002, ANESTH ANALG, V94, P1040, DOI 10.1097/00000539-200204000-00053; Batra YK, 2005, EUR J ANAESTH, V22, P69, DOI 10.1017/S0265021505220148; Batra YK, 2004, CAN J ANAESTH, V51, P519, DOI 10.1007/BF03018325; Beh T, 2002, CAN J ANAESTH, V49, P1061, DOI 10.1007/BF03017903; BEST N, 1991, ANAESTH INTENS CARE, V19, P50, DOI 10.1177/0310057X9101900109; Bilotta F, 2006, PEDIATR ANESTH, V16, P1232, DOI 10.1111/j.1460-9592.2006.01970.x; Borazan H, 2010, EUR J ANAESTH, V27, P253, DOI 10.1097/EJA.0b013e328330eca2; BORGEAT A, 1990, ANESTH ANALG, V71, P511; Borgeat A, 1997, BRIT J ANAESTH, V78, P433, DOI 10.1093/bja/78.4.433; BORGEAT A, 1992, ANESTH ANALG, V74, P539; Bouvet L, 2004, CAN J ANAESTH, V51, P122, DOI 10.1007/BF03018769; BOYSEN K, 1989, ACTA ANAESTH SCAND, V33, P689, DOI 10.1111/j.1399-6576.1989.tb02993.x; BRIGGS LP, 1985, POSTGRAD MED J, V61, P35; BRIGGS LP, 1982, BRIT J ANAESTH, V54, P303, DOI 10.1093/bja/54.3.303; Brock MF, 2010, J CLIN ANESTH, V22, P505, DOI 10.1016/j.jclinane.2009.11.004; BROWNLIE GS, 1991, ANAESTHESIA, V46, P775, DOI 10.1111/j.1365-2044.1991.tb09778.x; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; Burimsittichai Rattanaporn, 2006, J Med Assoc Thai, V89 Suppl 3, pS86; CAMERON E, 1992, ANAESTHESIA, V47, P604, DOI 10.1111/j.1365-2044.1992.tb02335.x; CAMPBELL WI, 1989, BRIT J ANAESTH, V62, P545, DOI 10.1093/bja/62.5.545; Canbay O, 2008, BRIT J ANAESTH, V100, P95, DOI 10.1093/bja/aem301; Canessa R, 1991, J Cardiothorac Vasc Anesth, V5, P566, DOI 10.1016/1053-0770(91)90007-G; Charuluxananan S, 2001, ANESTH ANALG, V93, P162; Cheng Kuang-I, 1998, Kaohsiung Journal of Medical Sciences, V14, P480; Cheong MA, 2002, ANESTH ANALG, V95, P1293, DOI 10.1097/00000539-200211000-00035; COLLINS LM, 1997, BR J ANAESTH, V79; Davies AF, 2002, ANAESTHESIA, V57, P557, DOI 10.1046/j.1365-2044.2002.02602.x; Dedic A, 2010, MINERVA ANESTESIOL, V76, P720; DEWANDRE J, 1994, ANAESTHESIA, V49, P8, DOI 10.1111/j.1365-2044.1994.tb03303.x; DIVATIA JV, 1999, J ANESTH CLIN PHARMA, V15, P279; Doenicke AW, 1997, ANESTH ANALG, V85, P1399, DOI 10.1097/00000539-199712000-00040; Dubey PK, 2005, ANESTH ANALG, V101, P1060, DOI 10.1213/01.ane.0000166951.72702.05; Dubey PK, 2003, CLIN J PAIN, V19, P121, DOI 10.1097/00002508-200303000-00007; Egan TD, 2003, ANESTH ANALG, V97, P72, DOI 10.1213/01.ANE.0000066019.42467.7A; Erdil Feray Akgul, 2007, Pain Clinic, V19, P21, DOI 10.1179/016911107X217437; Eriksson M, 1999, EUR J ANAESTH, V16, P315, DOI 10.1046/j.1365-2346.1999.00489.x; ERIKSSON M, 1995, ACTA ANAESTH SCAND, V39, P210, DOI 10.1111/j.1399-6576.1995.tb04045.x; Eriksson M, 1997, BRIT J ANAESTH, V78, P502, DOI 10.1093/bja/78.5.502; Eti Z, 1999, J Anesth, V13, P175, DOI 10.1007/s005400050051; Fahringer DL, 2010, PEDIATR ANESTH, V20, P545, DOI 10.1111/j.1460-9592.2010.03318.x; Fletcher GC, 1996, ANAESTHESIA, V51, P498, DOI 10.1111/j.1365-2044.1996.tb07802.x; FLETCHER JE, 1994, BRIT J ANAESTH, V72, P342, DOI 10.1093/bja/72.3.342; FRAGEN RJ, 1982, BRIT J ANAESTH, V54, P913; Fujii Y, 2005, CLIN DRUG INVEST, V25, P537, DOI 10.2165/00044011-200525080-00006; Fujii Y, 2005, CLIN THER, V27, P588, DOI 10.1016/j.clinthera.2005.05.003; Fujii Y, 2005, CAN J ANAESTH, V52, P474, DOI 10.1007/BF03016525; Fujii Y, 2004, CLIN DRUG INVEST, V24, P749, DOI 10.2165/00044011-200424120-00006; Fujii Y, 2004, CAN J ANAESTH, V51, P1047, DOI 10.1007/BF03018498; Fujii Y, 2004, ANAESTH INTENS CARE, V32, P653; Fujii Y, 2002, OBSTET GYNECOL, V99, P75, DOI 10.1016/S0029-7844(01)01641-6; Fujii Y, 2008, CLIN THER, V30, P280, DOI 10.1016/j.clinthera.2008.02.018; Fujii Y, 2007, CLIN THER, V29, P856, DOI 10.1016/j.clinthera.2007.05.019; Fujii Y, 2006, J CLIN ANESTH, V18, P526, DOI 10.1016/j.jclinane.2006.03.008; Fujii Y, 2006, CLIN DRUG INVEST, V26, P639, DOI 10.2165/00044011-200626110-00003; Fujii Y, 2006, CLIN THER, V28, P1116, DOI 10.1016/j.clinthera.2006.08.015; Fujii Y, 2009, CLIN THER, V31, P2107, DOI 10.1016/j.clinthera.2009.10.012; Fujii Y, 2009, CLIN THER, V31, P721, DOI 10.1016/j.clinthera.2009.04.014; Gajraj NM, 1996, J CLIN ANESTH, V8, P575, DOI 10.1016/S0952-8180(96)00133-X; GAJRAJ NM, 1995, ANAESTHESIA, V50, P187; Galvez-Escalera L, 2004, EUR J ANAESTH, V21, P579; GANTA R, 1992, BRIT J ANAESTH, V69, P316, DOI 10.1093/bja/69.3.316; GEHAN G, 1991, BRIT J ANAESTH, V66, P324, DOI 10.1093/bja/66.3.324; Ghai B, 2010, J CLIN ANESTH, V22, P88, DOI 10.1016/j.jclinane.2009.03.011; Gill PS, 2001, EUR J ANAESTH, V18, P166, DOI 10.1046/j.0265-0215.2000.00805.x; GOEL AV, 2005, J ANAESTH CLIN PHARM, V21, P389; GOLD MI, 1987, CAN J ANAESTH, V34, P478, DOI 10.1007/BF03014354; Goldmann R, 1997, ANASTH INTENSIV NOTF, V32, P98, DOI 10.1055/s-2007-995016; Grauers A, 2002, ACTA ANAESTH SCAND, V46, P361, DOI 10.1034/j.1399-6576.2002.460405.x; Gutmann A, 2006, PEDIATR ANESTH, V16, P266, DOI 10.1111/j.1460-9592.2005.01777.x; Hampl KF, 1996, ACTA ANAESTH SCAND, V40, P53, DOI 10.1111/j.1399-6576.1996.tb04388.x; Harmon D, 2003, EUR J ANAESTH, V20, P158, DOI 10.1097/00003643-200302000-00014; HAUGEN RD, 1995, CAN J ANAESTH, V42, P1108, DOI 10.1007/BF03015097; HEIM C, 1994, ANAESTHESIST, V43, P504, DOI 10.1007/s001010050085; HELBOHANSEN S, 1988, ACTA ANAESTH SCAND, V32, P502; Hellier C, 2003, ANAESTHESIA, V58, P802, DOI 10.1046/j.1365-2044.2003.03191.x; HELMERS JHJH, 1990, CAN J ANAESTH, V37, P267, DOI 10.1007/BF03005485; HILLER A, 1992, ACTA ANAESTH SCAND, V36, P564, DOI 10.1111/j.1399-6576.1992.tb03519.x; Ho CM, 1999, J CLIN ANESTH, V11, P296, DOI 10.1016/S0952-8180(99)00040-9; HONARMAND A, 2008, ACUTE PAIN, V10, P23, DOI DOI 10.1016/J.ACPAIN.2008.01.001]; Honarmand A, 2008, CLIN DRUG INVEST, V28, P27, DOI 10.2165/00044011-200828010-00004; HUANG CL, 1995, ANESTH ANALG, V81, P1087, DOI 10.1097/00000539-199511000-00033; Huang YW, 2002, ACTA ANAESTH SCAND, V46, P1021, DOI 10.1034/j.1399-6576.2002.460816.x; Hwang I, 2010, KOREAN J ANESTHESIOL, V59, P233, DOI 10.4097/kjae.2010.59.4.233; Hwang J, 2009, ANAESTH INTENS CARE, V37, P584, DOI 10.1177/0310057X0903700404; Inoue S, 1997, Masui, V46, P543; Ishiyama T, 2006, J CLIN ANESTH, V18, P211, DOI 10.1016/j.jclinane.2005.08.005; Iwama H, 2000, J Anesth, V14, P164, DOI 10.1007/s005400070028; Iwama H, 1998, BRIT J ANAESTH, V81, P963, DOI 10.1093/bja/81.6.963; Iwata M, 2010, J ANESTH, V24, P31, DOI 10.1007/s00540-009-0833-5; Iyilikci L, 2004, J CLIN ANESTH, V16, P499, DOI 10.1016/j.jclinane.2004.01.005; JOHNSON RA, 1990, ANAESTHESIA, V45, P439, DOI 10.1111/j.1365-2044.1990.tb14328.x; Jones D, 1999, ANAESTH INTENS CARE, V27, P346, DOI 10.1177/0310057X9902700403; Jung JA, 2010, BRIT J ANAESTH, V104, P563, DOI 10.1093/bja/aeq040; Kaabachi O, 2007, PEDIATR ANESTH, V17, P734, DOI 10.1111/j.1460-9592.2007.02242.x; Kajiyama Seiji, 2009, Masui, V58, P891; KAKINOHANA M, 2004, ACUTE PAIN, V5, P75; KALLELA H, 1994, ANESTH ANALG, V79, P512; Kam E, 2004, ANAESTHESIA, V59, P1167, DOI 10.1111/j.1365-2044.2004.03964.x; Kang HJ, 2010, KOREAN J ANESTHESIOL, V58, P239, DOI 10.4097/kjae.2010.58.3.239; Karasawa F, 2000, J Anesth, V14, P135, DOI 10.1007/s005400070020; Kau Y C, 2000, Acta Anaesthesiol Sin, V38, P9; Kaya F. N., 2006, Pain Clinic, V18, P361, DOI 10.1163/156856906778704704; KAYA K, 1995, BRIT J ANAESTH, V74, P140; Kaya S, 2008, CURR THER RES CLIN E, V69, P29, DOI 10.1016/j.curtheres.2008.02.005; Kazama T, 2000, ANESTHESIOLOGY, V92, P1017, DOI 10.1097/00000542-200004000-00019; Kim KM, 2007, ANESTHESIOLOGY, V106, P924, DOI 10.1097/01.anes.0000265151.78943.af; KING SY, 1992, ANESTH ANALG, V74, P246, DOI 10.1213/00000539-199202000-00013; Kinoshita Maho, 2006, Masui, V55, P338; KLEMENT W, 1991, BRIT J ANAESTH, V66, P189, DOI 10.1093/bja/66.2.189; KLEMENT W, 1991, BRIT J ANAESTH, V67, P281, DOI 10.1093/bja/67.3.281; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Knibbe CAJ, 1999, BRIT J CLIN PHARMACO, V47, P653, DOI 10.1046/j.1365-2125.1999.00942.x; Kobayashi Y, 1999, Masui, V48, P847; Kobayashi Y, 1999, Masui, V48, P852; Koo SW, 2006, ANESTH ANALG, V103, P1444, DOI 10.1213/01.ane.0000243334.83816.53; Kranke P, 2000, ANESTH ANALG, V90, P1004, DOI 10.1213/00000539-200004000-00053; Krobbuaban Banjong, 2005, Journal of the Medical Association of Thailand, V88, P1401; Kunitz O, 2004, ANASTH INTENSIV NOTF, V39, P10; Kwak HJ, 2009, BRIT J ANAESTH, V103, P410, DOI 10.1093/bja/aep163; Kwak K, 2007, EUR J ANAESTH, V24, P746, DOI 10.1017/S026502150600233X; Kwak KH, 2008, CLIN THER, V30, P1113, DOI 10.1016/j.clinthera.2008.05.019; LANGLEY MS, 1988, DRUGS, V35, P334, DOI 10.2165/00003495-198835040-00002; Larsen B, 2001, ANAESTHESIST, V50, P842, DOI 10.1007/s00101-001-0234-0; Larsen R, 2001, Anaesthesist, V50, P676; Lassnigg A, 2003, CAN J ANAESTH, V50, P964, DOI 10.1007/BF03018753; Lee JR, 2007, BRIT J ANAESTH, V99, P876, DOI 10.1093/bja/aem293; Lee P, 2004, ANAESTH INTENS CARE, V32, P482, DOI 10.1177/0310057X0403200432; LEE TW, 1994, ANAESTHESIA, V49, P817; LEES NW, 1985, POSTGRAD MED J, V61, P88; Leeson RM, 2007, REGION ANESTH PAIN M, V32, P303, DOI 10.1016/j.rapm.2006.07.010; Lembert N, 2002, ANN FR ANESTH, V21, P263, DOI 10.1016/S0750-7658(02)00588-9; Liaw WJ, 1999, ACTA ANAESTH SCAND, V43, P24, DOI 10.1034/j.1399-6576.1999.430106.x; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liljeroth E, 2007, ACTA ANAESTH SCAND, V51, P456, DOI 10.1111/j.1399-6576.2006.01256.x; Liljeroth E, 2005, ACTA ANAESTH SCAND, V49, P248, DOI 10.1111/j.1399-6576.2004.00573.x; Liljeroth E, 2001, ACTA ANAESTH SCAND, V45, P839, DOI 10.1034/j.1399-6576.2001.045007839.x; Lin S S, 1994, Acta Anaesthesiol Sin, V32, P73; Lyons B, 1996, ANAESTHESIA, V51, P394, DOI 10.1111/j.1365-2044.1996.tb07756.x; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Madenoglu H, 2003, CURR THER RES CLIN E, V64, P310, DOI 10.1016/S0011-393X(03)00066-3; Mallick A, 2007, EUR J ANAESTH, V24, P403, DOI 10.1017/S0265021506002298; Mamiya H, 1998, Anesth Prog, V45, P18; Marik PE, 2004, CURR PHARM DESIGN, V10, P3639, DOI 10.2174/1381612043382846; Marret E, 2005, ANESTHESIOLOGY, V102, P1249, DOI 10.1097/00000542-200506000-00027; Masago K, 1999, Masui, V48, P256; Massad IM, 2006, SAUDI MED J, V27, P997; MATTILA MAK, 1985, POSTGRAD MED J, V61, P162; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; McCluskey A, 2003, ANESTH ANALG, V97, P713, DOI 10.1213/01.ANE.0000074791.44467.D8; MCCRIRRICK A, 1990, ANAESTHESIA, V45, P443, DOI 10.1111/j.1365-2044.1990.tb14329.x; MCCULLOCH MJ, 1985, ANAESTHESIA, V40, P1117, DOI 10.1111/j.1365-2044.1985.tb10615.x; McDonald DS, 1996, ANAESTHESIA, V51, P878, DOI 10.1111/j.1365-2044.1996.tb12624.x; MECKLEM DWJ, 1994, ANAESTH INTENS CARE, V22, P568, DOI 10.1177/0310057X9402200511; Memis D, 2002, EUR J ANAESTH, V19, P47, DOI 10.1017/S0265021502000078; Memis D, 2002, ANESTH ANALG, V95, P606, DOI 10.1213/01.ANE.0000023204.79877.7A; Minogue SC, 2005, ANESTH ANALG, V100, P683, DOI 10.1213/01.ANE.0000148617.98716.EB; Mohta M, 2004, ANAESTH INTENS CARE, V32, P765, DOI 10.1177/0310057X0403200606; MOK MS, 1999, CLIN PHARM, V15, P37; Nagao N, 2005, CAN J ANAESTH, V52, P660, DOI 10.1007/BF03015789; Nakane M, 1999, BRIT J ANAESTH, V83, P397, DOI 10.1093/bja/83.3.397; Nakayama M, 2001, Masui, V50, P1213; Nakayama S, 2007, J ANESTH, V21, P19, DOI 10.1007/s00540-006-0466-x; Nathanson MH, 1996, ANESTH ANALG, V82, P469, DOI 10.1097/00000539-199603000-00006; Nathanson MH, 1998, ANAESTHESIA, V53, P608; NEWCOMBE GN, 1990, ANAESTH INTENS CARE, V18, P105, DOI 10.1177/0310057X9001800116; Niazi A, 2005, EUR J ANAESTH, V22, P299, DOI 10.1017/S0265021505000505; NICOLME, 1991, ANAESTHESIA, V46, P67; NIEVES GB, 1997, J SOC ANEST, V20, P53; Nishiyama Tomoki, 2005, J Anesth, V19, P273, DOI 10.1007/s00540-005-0331-3; Nonaka A, 1999, Masui, V48, P862; Nonaka A, 2000, Masui, V49, P1235; Nyman Y, 2005, BRIT J ANAESTH, V95, P222, DOI 10.1093/bja/aei156; OHara JF, 1997, ANESTH ANALG, V84, P865, DOI 10.1097/00000539-199704000-00030; Ohmizo H, 2005, CAN J ANAESTH, V52, P595, DOI 10.1007/BF03015768; OKA S, 2008, J JPN DENT SOC ANEST, V36, P21; Ong LB, 2000, ANAESTH INTENS CARE, V28, P527, DOI 10.1177/0310057X0002800507; Ozkocak I, 2005, EUR J ANAESTH, V22, P44, DOI 10.1017/S0265021505000104; Ozturk E, 1998, ANESTHESIOLOGY, V89, P1041, DOI 10.1097/00000542-199810000-00039; Pang W W, 1998, Acta Anaesthesiol Sin, V36, P133; Pang Wei-Wu, 2002, Acta Anaesthesiol Sin, V40, P65; Pang WW, 1998, ANESTH ANALG, V86, P382, DOI 10.1097/00000539-199802000-00031; Pang WW, 1998, REGION ANESTH PAIN M, V23, P580, DOI 10.1016/S1098-7339(98)90085-2; Pang WW, 1999, REGION ANESTH PAIN M, V24, P246, DOI 10.1016/S1098-7339(99)90136-0; Parmar AK, 1998, ANAESTHESIA, V53, P79, DOI 10.1111/j.1365-2044.1998.00248.x; Paul M, 2003, ANAESTHESIA, V58, P1056, DOI 10.1046/j.1365-2044.2003.03345.x; Pellegrini M, 2003, BRIT J ANAESTH, V90, P375, DOI 10.1093/bja/aeg056; Picard P, 2000, ANESTH ANALG, V90, P963; Pickford A, 2000, PAEDIATR ANAESTH, V10, P129, DOI 10.1046/j.1460-9592.2000.00461.x; PIOTROWSKI R, 1990, ANAESTHESIST, V39, P398; Piper SN, 2002, ANASTH INTENSIV NOTF, V37, P528, DOI 10.1055/s-2002-33767; Pollard RC, 2002, CAN J ANAESTH, V49, P1064, DOI 10.1007/BF03017904; Rau J, 2001, ANESTH ANALG, V93, P382, DOI 10.1097/00000539-200108000-00029; Reddy MS, 2001, ANAESTHESIA, V56, P902, DOI 10.1046/j.1365-2044.2001.02059-6.x; Rochette A, 2008, BRIT J ANAESTH, V101, P390, DOI 10.1093/bja/aen169; Roehm KD, 2003, ANAESTHESIA, V58, P165, DOI 10.1046/j.1365-2044.2003.02964_2.x; Rohm KD, 2003, ANASTH INTENSIV NOTF, V38, P643; Rucker G, 2008, STAT MED, V27, P746, DOI 10.1002/sim.2971; Ryu JH, 2008, J CLIN ANESTH, V20, P328, DOI 10.1016/j.jclinane.2007.12.015; Saadawy Iman, 2007, Middle East Journal of Anesthesiology, V19, P631; SAARNIVAARA L, 1991, ACTA ANAESTH SCAND, V35, P19, DOI 10.1111/j.1399-6576.1991.tb03235.x; Sadler PJ, 1999, BRIT J ANAESTH, V82, P432, DOI 10.1093/bja/82.3.432; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Schaub E, 2004, ANESTH ANALG, V99, P1699, DOI 10.1213/01.ANE.0000136848.54207.97; SCOTT RPF, 1988, ANAESTHESIA, V43, P492, DOI 10.1111/j.1365-2044.1988.tb06641.x; Seki S, 1999, Masui, V48, P62; Sethi Nitin, 2009, Middle East Journal of Anesthesiology, V20, P71; SHAH MH, 2008, J ANAESTHESIOL CLIN, V24, P197; Sharpe P, 2002, EUR J ANAESTH, V19, P170, DOI 10.1017/S0265021502000303; Siddik-Sayyid SM, 2005, ANESTH ANALG, V100, P1204, DOI 10.1213/01.ANE.0000148166.29749.3B; Sim JY, 2009, BRIT J CLIN PHARMACO, V67, P316, DOI 10.1111/j.1365-2125.2008.03358.x; Singh M, 2005, EUR J ANAESTH, V22, P888, DOI 10.1017/S0265021505221506; Sinha PK, 2005, ANAESTH INTENS CARE, V33, P235, DOI 10.1177/0310057X0503300213; Slavik VC, 2007, PHARMACOTHERAPY, V27, P1588, DOI 10.1592/phco.27.11.1588; Smith AJ, 1996, ANAESTHESIA, V51, P883, DOI 10.1111/j.1365-2044.1996.tb12626.x; SMITH I, 1993, ANESTH ANALG, V76, P1181, DOI 10.1213/00000539-199376060-00001; Soltesz S, 2007, ANESTHESIOLOGY, V106, P80, DOI 10.1097/00000542-200701000-00015; Song D, 2004, ANESTHESIOLOGY, V100, P1072, DOI 10.1097/00000542-200405000-00007; Song DJ, 2004, ANESTH ANALG, V98, P687, DOI 10.1213/01.ANE.0000103184.36451.D7; STARK RD, 1985, POSTGRAD MED J, V61, P152; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; STOKES DN, 1989, BRIT J ANAESTH, V62, P202, DOI 10.1093/bja/62.2.202; Sun NCH, 2005, ANESTH ANALG, V101, P675, DOI 10.1213/01.ANE.0000157564.91910.04; Sundarathiti Petchara, 2007, Journal of the Medical Association of Thailand, V90, P2683; Suzuki H, 2006, ACTA ANAESTH SCAND, V50, P568, DOI 10.1111/j.1399-6576.2006.00986.x; Suzuki Satomi, 2002, Masui, V51, P140; Tan CH, 1998, ANAESTHESIA, V53, P302, DOI 10.1046/j.1365-2044.1998.00287.x; Tan CH, 1998, ANAESTHESIA, V53, P468, DOI 10.1046/j.1365-2044.1998.00405.x; Tan HL, 2009, ANAESTH INTENS CARE, V37, P807, DOI 10.1177/0310057X0903700509; TARIQ MA, 2006, J POSTGRADUATE MED I, V20, P8; TARMIZ K, 2010, ANN FR ANESTH, V28, P171; THAM CS, 1995, ANAESTH INTENS CARE, V23, P154, DOI 10.1177/0310057X9502300204; Thompson N, 1996, BRIT J ANAESTH, V77, P213, DOI 10.1093/bja/77.2.213; Tramer MR, 2007, ANESTH ANALG, V104, P1374, DOI 10.1213/01.ane.0000263416.14948.dc; Tsubokura H, 2001, Masui, V50, P1196; Turan A, 2003, EUR J ANAESTH, V20, P170, DOI 10.1097/00003643-200302000-00020; TURAN A, 2002, TURK ANESTEZIYOLOJI, V30, P152; Uda R, 1998, Masui, V47, P843; Uda R, 1999, ANESTHESIOLOGY, V91, P591, DOI 10.1097/00000542-199908000-00058; Ueki R, 2007, J ANESTH, V21, P325, DOI 10.1007/s00540-007-0530-1; UZUN S, 2008, J ANAESTH CLIN PHARM, V24, P406; Varghese E, 2010, PEDIATR ANESTH, V20, P338, DOI 10.1111/j.1460-9592.2010.03272.x; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; VUKSANAJ D, 1992, J CLIN ANESTH, V4, P402, DOI 10.1016/0952-8180(92)90166-X; Wajima Z, 2002, ANAESTH INTENS CARE, V30, P742, DOI 10.1177/0310057X0203000604; WALL RJ, 1990, ANAESTH INTENS CARE, V18, P214, DOI 10.1177/0310057X9001800210; Wang HB, 2007, CURR OPIN ANESTHESIO, V20, P311, DOI 10.1097/ACO.0b013e3281667777; Weksler N, 2001, J CLIN ANESTH, V13, P321, DOI 10.1016/S0952-8180(01)00271-9; WILKINSON D, 1993, ANESTH ANALG, V77, P1139; Wong W. H., 2001, SMJ Singapore Medical Journal, V42, P193; Wrench IJ, 1996, BRIT J ANAESTH, V77, P162, DOI 10.1093/bja/77.2.162; Yamakage M, 2005, ANAESTH INTENS CARE, V33, P351, DOI 10.1177/0310057X0503300301; Yavascaoglu B, 2007, J CLIN ANESTH, V19, P413, DOI 10.1016/j.jclinane.2007.02.011; Yew WS, 2005, ANESTH ANALG, V100, P1693, DOI 10.1213/01.ANE.0000151718.58709.0B; Yokota S, 1997, ANESTH ANALG, V85, P672, DOI 10.1097/00000539-199709000-00034; Yoshikawa T, 2001, CAN J ANAESTH, V48, P538, DOI 10.1007/BF03016829; Yoshikawa T, 2001, BRIT J ANAESTH, V86, P874, DOI 10.1093/bja/86.6.874; Yoshimura Yasuhiro, 2003, Masui, V52, P1204; Yull DN, 2000, ANAESTHESIA, V55, P284, DOI 10.1046/j.1365-2044.2000.01320.x; Zahedi Hamid, 2009, Middle East Journal of Anesthesiology, V20, P401	290	128	136	2	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2011	342								d1110	10.1136/bmj.d1110	http://dx.doi.org/10.1136/bmj.d1110			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FA	21406529	hybrid			2022-12-28	WOS:000288698100004
J	Kudva, YC; Basu, A				Kudva, Yogish C.; Basu, Ananda			Ultra-long-acting insulins for a lifestyle-related pandemic	LANCET			English	Editorial Material									[Kudva, Yogish C.; Basu, Ananda] Mayo Clin, Coll Med, Rochester, MN 55905 USA	Mayo Clinic	Kudva, YC (corresponding author), Mayo Clin, Coll Med, Rochester, MN 55905 USA.	Kudva.yogish@mayo.edu						Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Diamant M, 2010, LANCET, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Johnson JA, 2010, DIABETES, V59, P1129, DOI 10.2337/db10-0334; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Russell LB, 2005, J FAM PRACTICE, V54, P52; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Food and Drug Administration, 2009, GUID IND DIAB MELL E; Zinman B, 2011, LANCET, V377, P924, DOI 10.1016/S0140-6736(10)62305-7	12	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2011	377	9769					880	881		10.1016/S0140-6736(11)60097-4	http://dx.doi.org/10.1016/S0140-6736(11)60097-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GR	21396704				2022-12-28	WOS:000288628800006
J	Zinman, B; Fulcher, G; Rao, PV; Thomas, N; Endahl, LA; Johansen, T; Lindh, R; Lewin, A; Rosenstock, J; Pinget, M; Mathieu, C				Zinman, Bernard; Fulcher, Greg; Rao, Paturi V.; Thomas, Nihal; Endahl, Lars A.; Johansen, Thue; Lindh, Rebecka; Lewin, Andrew; Rosenstock, Julio; Pinget, Michel; Mathieu, Chantal			Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial	LANCET			English	Article							CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; POPULATION	Background Insulin degludec is a new basal insulin that forms soluble multihexamer assemblies after subcutaneous injection, resulting in an ultra-long action profile. This study aimed to assess efficacy and safety of insulin degludec injected once a day or three times a week compared with insulin glargine once a day in insulin-naive people with type 2 diabetes, who were inadequately controlled with oral antidiabetic drugs. Methods In this 16-week, randomised, open-label, parallel-group phase 2 trial, participants aged 18-75 years with type 2 diabetes and glycosylated haemoglobin (HbA(1C)) of 7.0-11.0% were enrolled and treated at 28 clinical sites in Canada, India, South Africa, and the USA. Participants were randomly allocated in a 1:1:1:1 ratio by computer-generated block randomisation to receive insulin degludec either once a day or three times a week or insulin glargine once a day, all in combination with metformin. Investigators were masked to data until database release. The primary outcome was HbA(1C) after 16 weeks of treatment. Analyses were done by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00611884. Findings Of 367 patients screened, 245 were eligible for inclusion. 62 participants were randomly allocated to receive insulin degludec three times a week (starting dose 20 U per injection [1 U=9 nmol]), 60 to receive insulin degludec once a day (starting dose 10 U [1 U=6 nmol]; group A), 61 to receive insulin degludec once a day (starting dose 10 U [1 U=9 nmol]; group B), and 62 to receive insulin glargine (starting dose 10 U [1 U=6 nmol]) once a day. At study end, mean HbA(1C) levels were much the same across treatment groups, at 7.3% (SD 1.1), 7.4% (1.0), 7.5% (1.1), and 7.2% (0.9), respectively. Estimated mean HbA(1C) treatment differences from insulin degludec by comparison with insulin glargine were 0.08% (95% CI -0.23 to 0.40) for the three dose per week schedule, 0.17% (-0.15 to 0.48) for group A, and 0.28% (-0.04 to 0.59) for group B. Few participants had hypoglycaemia and the number of adverse events was much the same across groups, with no apparent treatment-specific pattern. Interpretation Insulin degludec provides comparable glycaemic control to insulin gjargine without additional adverse events and might reduce dosing frequency due to its ultra-long action profile.	[Zinman, Bernard] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Fulcher, Greg] Royal N Shore Hosp, Sydney, NSW, Australia; [Fulcher, Greg] Univ Sydney, Sydney, NSW 2006, Australia; [Rao, Paturi V.] Med Sci Univ, Nizams Inst, Hyderabad, Andhra Pradesh, India; [Thomas, Nihal] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Endahl, Lars A.; Johansen, Thue; Lindh, Rebecka] Novo Nordisk, Soborg, Denmark; [Lewin, Andrew] Natl Res Inst, Los Angeles, CA USA; [Rosenstock, Julio] Dallas Diabet & Endocrine Ctr Med City, Dallas, TX USA; [Pinget, Michel] Univ Hosp Strasbourg, Strasbourg, France; [Mathieu, Chantal] Katholieke Univ Leuven, UZ Gasthuisberg, Leuven, Belgium	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Royal North Shore Hospital; University of Sydney; University of Sydney; Christian Medical College & Hospital (CMCH) Vellore; Diabetes & Endocrine Center; CHU Strasbourg; KU Leuven; University Hospital Leuven	Zinman, B (corresponding author), Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 5-024-60 Murray St, Toronto, ON M5G 1X5, Canada.	zinman@lunenfeld.ca	mathieu, chantal/ABD-5505-2021; Zinman, Bernard/E-7266-2013	mathieu, chantal/0000-0002-4055-5233; 	Novo Nordisk; GlaxoSmithKline; Merck; Sanofi-Aventis; Eli Lilly; Merck/Schering-Plough; AstraZeneca; Novartis; Boehringer Ingelheim; Amylin; Daiichi-Sankyo; Forest Labs; Roche; Takeda; Pfizer; MannKind; Johnson and Johnson; Bristol-Myers Squibb; Medtronic MiniMed; Ypsomed; Novo Nordisk (Bagsvaerd, Denmark)	Novo Nordisk(Novo Nordisk); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Eli Lilly(Eli Lilly); Merck/Schering-Plough(Merck & CompanySchering Plough Corporation); AstraZeneca(AstraZeneca); Novartis(Novartis); Boehringer Ingelheim(Boehringer Ingelheim); Amylin; Daiichi-Sankyo(Daiichi Sankyo Company Limited); Forest Labs; Roche(Roche Holding); Takeda(Takeda Pharmaceutical Company Ltd); Pfizer(Pfizer); MannKind; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Bristol-Myers Squibb(Bristol-Myers Squibb); Medtronic MiniMed; Ypsomed; Novo Nordisk (Bagsvaerd, Denmark)(Novo Nordisk)	LAB, TJ, and RL are employees of Novo Nordisk and own stock in the company. BZ has received fees for consultancy and honoraria for membership of advisory boards from Novo Nordisk, GlaxoSmithKline, Merck, Eli Lilly, Amylin, and Boehringer Ingelheim and grant support from Novo Nordisk, GlaxoSmithKline, and Merck. BZ has also received travel and accommodation expenses from Novo Nordisk to attend an investigators' meeting and expense coverage from Novo Nordisk to attend scientific meetings. GF has received fees for consultancy and honoraria for membership of advisory boards from Novo Nordisk, Sanofi-Aventis, Eli Lilly, Merck/Schering-Plough, AstraZeneca, Novartis, and Boehringer Ingelheim. PVR has received research support, fees for consultancy, and honoraria for membership of advisory boards from Novo Nordisk and DiabetOmics; travel and accommodation expenses from Novo Nordisk to attend an investigators' meeting; and is a board member of DiabetOmics. AL has received fees for consultancy, honoraria for membership on advisory boards, and research support from Novo Nordisk, GlaxoSmithKline, Sanofi-Aventis, Merck, Daiichi-Sankyo, Forest Laboratories, Roche, Vivus, Abbott, Novartis, Takeda, Hollis-Eden, Phenomix, Surface Logix, Akros Pharma, ActivX Bioscience, and Amylin; and travel and accommodation expenses from Novo Nordisk to attend an investigators' meeting. JR received fees for consultancy, honoraria for membership of advisory boards, and research support from Novo Nordisk, GlaxoSmithKline, Sanofi-Aventis, Amylin, Daiichi-Sankyo, Forest Labs, Roche, Novartis, Takeda, Pfizer, Eli Lilly, MannKind, Johnson and Johnson, and Boehringer Ingelheim; research support from AstraZeneca, Merck, and Bristol-Myers Squibb; and travel and accommodation expenses from Novo Nordisk to attend an investigators' meeting. MP has received fees for consultancy and honoraria for membership of advisory boards from Novo Nordisk and Roche; fees for consultancy from Medtronic MiniMed and Ypsomed; and travel and accommodation expenses from Novo Nordisk to attend an investigator's meeting. CM has received fees for consultancy and honoraria for membership of advisory boards from Novo Nordisk, Pfizer, Eli Lilly, Sanofi-Aventis, Johnson and Johnson, Mannkind, and Novartis. NT has received travel and accommodation expenses from Novo Nordisk to attend an investigators' meeting.; This study was sponsored by Novo Nordisk (Bagsvaerd, Denmark). We thank the investigators, trial staff, and participants for their participation (see webappendix p 6 for principal investigators).	Barr ELM, 2009, DIABETOLOGIA, V52, P415, DOI 10.1007/s00125-008-1246-y; Brod M, 2006, QUAL LIFE RES, V15, P481, DOI 10.1007/s11136-005-1624-6; Bulsara MK, 2004, DIABETIC MED, V21, P914, DOI 10.1111/j.1464-5491.2004.01250.x; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; DeVries JH, 2007, DIABETES-METAB RES, V23, P441, DOI 10.1002/dmrr.762; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Heise T, 2007, DIABETES OBES METAB, V9, P648, DOI 10.1111/j.1463-1326.2007.00756.x; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; ICH, 1996, ICH HARM TRIP GUID G; Jonassen I, 2010, DIABETES, V59, pA11; Kilpatrick ES, 2008, CURR MED RES OPIN, V24, P2651, DOI [10.1185/03007990802347209, 10.1185/03007990802347209 ]; Lindholm A, 2002, DIABETES CARE, V25, P876, DOI 10.2337/diacare.25.5.876; Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002; Turner-Bowker DM, 1998, SF 36 HLTH SURVEY SF; Ware J.E., 2002, SCORE VERSION 2 SF 3; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; World Medical Association, 2008, SEOUL S KOR 59 WORLD; ZINMAN B, 1989, NEW ENGL J MED, V321, P363	20	96	107	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2011	377	9769					924	931		10.1016/S0140-6736(10)62305-7	http://dx.doi.org/10.1016/S0140-6736(10)62305-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GR	21396703				2022-12-28	WOS:000288628800035
J	Tenenbaum, JB; Kemp, C; Griffiths, TL; Goodman, ND				Tenenbaum, Joshua B.; Kemp, Charles; Griffiths, Thomas L.; Goodman, Noah D.			How to Grow a Mind: Statistics, Structure, and Abstraction	SCIENCE			English	Review							BAYESIAN-INFERENCE; PROBABILISTIC MODELS; CAUSAL INDUCTION; COGNITION; UNCERTAINTY; JUDGMENT; MEMORY; BIASES	In coming to understand the world-in learning concepts, acquiring language, and grasping causal relations-our minds make inferences that appear to go far beyond the data available. How do we do it? This review describes recent approaches to reverse-engineering human learning and cognitive development and, in parallel, engineering more humanlike machine learning systems. Computational models that perform probabilistic inference over hierarchies of flexibly structured representations can address some of the deepest questions about the nature and origins of human thought: How does abstract knowledge guide learning and reasoning from sparse data? What forms does our knowledge take, across different domains and tasks? And how is that abstract knowledge itself acquired?	[Tenenbaum, Joshua B.] MIT, Dept Brain & Cognit Sci, Comp Sci & Artificial Intelligence Lab CSAIL, Cambridge, MA 02139 USA; [Kemp, Charles] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Griffiths, Thomas L.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Goodman, Noah D.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Carnegie Mellon University; University of California System; University of California Berkeley; Stanford University	Tenenbaum, JB (corresponding author), MIT, Dept Brain & Cognit Sci, Comp Sci & Artificial Intelligence Lab CSAIL, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jbt@mit.edu		Kemp, Charles/0000-0001-9683-8737	Air Force Office of Scientific Research; Office of Naval Research; Army Research Office; NSF; Defense Advanced Research Projects Agency; Nippon Telephone and Telegraph Communication Sciences Laboratories; Qualcomm; Google; Schlumberger; James S. McDonnell Foundation	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Office of Naval Research(Office of Naval Research); Army Research Office; NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Nippon Telephone and Telegraph Communication Sciences Laboratories; Qualcomm; Google(Google Incorporated); Schlumberger(Schlumberger); James S. McDonnell Foundation	We gratefully acknowledge the suggestions of R. R. Saxe, M. Bernstein, and J. M. Tenenbaum on this manuscript and the collaboration of N. Chater and A. Yuille on a forthcoming joint book expanding on the methods and perspectives reviewed here. Grant support was provided by Air Force Office of Scientific Research, Office of Naval Research, Army Research Office, NSF, Defense Advanced Research Projects Agency, Nippon Telephone and Telegraph Communication Sciences Laboratories, Qualcomm, Google, Schlumberger, and the James S. McDonnell Foundation.	ANDERSON JR, 1991, PSYCHOL REV, V98, P409, DOI 10.1037/0033-295X.98.3.409; Atran S, 1998, BEHAV BRAIN SCI, V21, P547, DOI 10.1017/S0140525X98001277; Blei DM, 2010, J ACM, V57, DOI 10.1145/1667053.1667056; Brown SD, 2009, COGNITIVE PSYCHOL, V58, P49, DOI 10.1016/j.cogpsych.2008.09.002; Carey S., 1985, CONCEPTUAL CHANGE CH; Carey S., 2009, ORIGIN CONCEPTS; Chater N, 2006, TRENDS COGN SCI, V10, P335, DOI 10.1016/j.tics.2006.05.006; Chomsky N, 1980, RULES REPRESENTATION; Chomsky N, 1986, LANGUAGE PROBLEMS KN; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Ghahramani Z., 2005, ADV NEURAL INFORM PR, V18, P475; Godfrey- Smith P, 2003, THEORY AND REALITY; Goldwater S, 2009, COGNITION, V112, P21, DOI 10.1016/j.cognition.2009.03.008; Goodman N., 2008, UNCERTAINTY ARTIFICI, V22, P23; Goodman ND, 2011, PSYCHOL REV, V118, P110, DOI 10.1037/a0021336; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Gopnik A., 1997, WORDS THOUGHTS THEOR; Griffiths T. L., 2009, ADV NEURAL INFORM PR; Griffiths T. L., 2007, CAUSAL LEARNING PSYC, P323, DOI [DOI 10.1093/ACPROF:OSO/9780195176803.003.0021, 10.1093/acprof:oso/9780195176803.003.0021]; Griffiths TL, 2007, COGNITION, V103, P180, DOI 10.1016/j.cognition.2006.03.004; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; Griffiths TL, 2006, PSYCHOL SCI, V17, P767, DOI 10.1111/j.1467-9280.2006.01780.x; Griffiths TL, 2010, TRENDS COGN SCI, V14, P357, DOI 10.1016/j.tics.2010.05.004; Griffiths TL, 2005, COGNITIVE PSYCHOL, V51, P334, DOI 10.1016/j.cogpsych.2005.05.004; GRIFFITHS TL, 2008, PROBABILISTIC MIND; Jaynes E.T., 2003, PROBABILITY THEORY L; Johnson M., 2007, ADV NEURAL INFORM PR, P641; Kemp C., 2008, P 30 ANN C COGN SCI, P1606; Kemp C, 2008, P NATL ACAD SCI USA, V105, P10687, DOI 10.1073/pnas.0802631105; Kemp C, 2007, DEVELOPMENTAL SCI, V10, P307, DOI 10.1111/j.1467-7687.2007.00585.x; Kemp C, 2010, COGNITION, V114, P165, DOI 10.1016/j.cognition.2009.09.003; Kemp C, 2009, PSYCHOL REV, V116, P20, DOI 10.1037/a0014282; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Krynski TR, 2007, J EXP PSYCHOL GEN, V136, P430, DOI 10.1037/0096-3445.136.3.430; Levy R., 2009, ADV NEURAL INFORM PR, V2, P937; Lu HJ, 2008, PSYCHOL REV, V115, P955, DOI 10.1037/a0013256; Lucas CG., 2009, ADV NEURAL INFORM PR, P985; MacKay D. J. C., 2003, INFORM THEORY INFERE; Mansinghka Vikash, 2006, P 22 C ANN C UNC ART, P324; Markman E. M., 1989, CATEGORIZATION NAMIN; Marr D., 1982, VISION; MCALLESTER D, 1998, P 11 ANN C COMP LEAR, P234; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; McClelland JL, 2010, TRENDS COGN SCI, V14, P348, DOI 10.1016/j.tics.2010.06.002; MILCH B, 2004, ICML 2004 WORKSH STA, P67; Niyogi P, 2006, CURR STUD LINGUIST, V43, P1; Oaksford M, 2001, TRENDS COGN SCI, V5, P349, DOI 10.1016/S1364-6613(00)01699-5; PEARL, 1988, PROBABILISTIC REASON; Pinker S., 2007, STUFF THOUGHT LANGUA; Pinker S., 1999, WORDS RULES INGREDIE; Pinker S., 1997, MIND WORKS; Rasmussen CE, 2000, ADV NEUR IN, V12, P554; Rogers T. T., 2004, SEMANTIC COGNITION P; Russell S, 2009, ARTIFICIAL INTELLIGE; Sanborn A., 2006, P 28 ANN C COGNITIVE, P726; Schmidt L. A., 2009, THESIS MIT CAMBRIDGE; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; Shiffrin RM, 1997, PSYCHON B REV, V4, P145, DOI 10.3758/BF03209391; SPELKE ES, 1992, PSYCHOL REV, V99, P605, DOI 10.1037/0033-295X.99.4.605; Stenning, 2001, P 23 ANN C COGN SCI, P370; Steyvers M, 2006, TRENDS COGN SCI, V10, P327, DOI 10.1016/j.tics.2006.05.005; Tenebaum JB, 2001, BEHAV BRAIN SCI, V24, P629, DOI 10.1017/S0140525X01000061; Tenenbaum, 2006, P 28 ANN C COGN SCI, V6, P1382; Tenenbaum J.B, 2006, P 28 ANN C COGN SCI, P2146; Tenenbaum JB, 2001, ADV NEUR IN, V13, P59; Tenenbaum Joshua, 2001, P 23 ANN C COGN SCI, P1036; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Vul E., 2009, P 31 ANN C COGN SCI, P148; WELLMAN HM, 1992, ANNU REV PSYCHOL, V43, P337, DOI 10.1146/annurev.ps.43.020192.002005; Woodward James, 2005, MAKING THINGS HAPPEN; Xu F, 2007, PSYCHOL REV, V114, P245, DOI 10.1037/0033-295X.114.2.245; Xu F, 2007, DEVELOPMENTAL SCI, V10, P288, DOI 10.1111/j.1467-7687.2007.00590.x; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	75	771	779	14	447	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2011	331	6022					1279	1285		10.1126/science.1192788	http://dx.doi.org/10.1126/science.1192788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732UM	21393536				2022-12-28	WOS:000288215200035
J	Behravesh, CB; Mody, RK; Jungk, J; Gaul, L; Redd, JT; Chen, S; Cosgrove, S; Hedican, E; Sweat, D; Chavez-Hauser, L; Snow, SL; Hanson, H; Nguyen, TA; Sodha, SV; Boore, AL; Russo, E; Mikoleit, M; Theobald, L; Gerner-Smidt, P; Hoekstra, RM; Angulo, FJ; Swerdlow, DL; Tauxe, RV; Griffin, PM; Williams, IT				Behravesh, Casey Barton; Mody, Rajal K.; Jungk, Jessica; Gaul, Linda; Redd, John T.; Chen, Sanny; Cosgrove, Shaun; Hedican, Erin; Sweat, David; Chavez-Hauser, Lina; Snow, Sandra L.; Hanson, Heather; Nguyen, Thai-An; Sodha, Samir V.; Boore, Amy L.; Russo, Elizabeth; Mikoleit, Matthew; Theobald, Lisa; Gerner-Smidt, Peter; Hoekstra, Robert M.; Angulo, Frederick J.; Swerdlow, David L.; Tauxe, Robert V.; Griffin, Patricia M.; Williams, Ian T.		Salmonella Saintpaul Outbreak Inve	2008 Outbreak of Salmonella Saintpaul Infections Associated with Raw Produce	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; FRESH PRODUCE; TOMATOES; ILLNESS; BURDEN	BACKGROUND Raw produce is an increasingly recognized vehicle for salmonellosis. We investigated a nationwide outbreak that occurred in the United States in 2008. METHODS We defined a case as diarrhea in a person with laboratory-confirmed infection with the outbreak strain of Salmonella enterica serotype Saintpaul. Epidemiologic, trace-back, and environmental studies were conducted. RESULTS Among the 1500 case subjects, 21% were hospitalized, and 2 died. In three case-control studies of cases not linked to restaurant clusters, illness was significantly associated with eating raw tomatoes (matched odds ratio, 5.6; 95% confidence interval [CI], 1.6 to 30.3); eating at a Mexican-style restaurant (matched odds ratio, 4.6; 95% CI, 2.1 to 8) and eating pico de gallo salsa (matched odds ratio, 4.0; 95% CI, 1.5 to 17.8), corn tortillas (matched odds ratio, 2.3; 95% CI, 1.2 to 5.0), or salsa (matched odds ratio, 2.1; 95% CI, 1.1 to 3.9); and having a raw jalape no pepper in the household (matched odds ratio, 2.9; 95% CI, 1.2 to 7.6). In nine analyses of clusters associated with restaurants or events, jalapeno peppers were implicated in all three clusters with implicated ingredients, and jalapeno or serrano peppers were an ingredient in an implicated item in the other three clusters. Raw tomatoes were an ingredient in an implicated item in three clusters. The outbreak strain was identified in jalapeno peppers collected in Texas and in agricultural water and serrano peppers on a Mexican farm. Tomato tracebacks did not converge on a source. CONCLUSIONS Although an epidemiologic association with raw tomatoes was identified early in this investigation, subsequent epidemiologic and microbiologic evidence implicated jalape o and serrano peppers. This outbreak highlights the importance of preventing raw-produce contamination.	[Behravesh, Casey Barton; Mody, Rajal K.; Nguyen, Thai-An; Sodha, Samir V.; Boore, Amy L.; Russo, Elizabeth; Mikoleit, Matthew; Theobald, Lisa; Gerner-Smidt, Peter; Hoekstra, Robert M.; Angulo, Frederick J.; Swerdlow, David L.; Tauxe, Robert V.; Griffin, Patricia M.; Williams, Ian T.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Mody, Rajal K.; Chen, Sanny; Boore, Amy L.; Russo, Elizabeth] Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Jungk, Jessica] New Mexico Dept Hlth, Santa Fe, NM USA; [Gaul, Linda] Texas Dept State Hlth Serv, Austin, TX USA; [Chen, Sanny] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Redd, John T.] Indian Hlth Serv, Albuquerque, NM USA; [Cosgrove, Shaun] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Hedican, Erin] Minnesota Dept Hlth, St Paul, MN USA; [Sweat, David] N Carolina Div Publ Hlth, Raleigh, NC USA; [Chavez-Hauser, Lina] Missouri Dept Hlth & Senior Serv, Jefferson, AR USA; [Snow, Sandra L.] Arkansas Dept Hlth, Little Rock, AR 72205 USA; [Hanson, Heather] New York City Dept Hlth & Mental Hyg, New York, NY USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; New Mexico Department of Health; Texas Department of State Health Services; Arizona Department of Health Services; Colorado Department of Public Health & Environment; Minnesota Department of Health (MHD); New York City Department of Health & Mental Hygiene	Behravesh, CB (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd NE,MS A-38, Atlanta, GA 30333 USA.	cbartonbehravesh@cdc.gov	Jungk, Jessica/A-9958-2015; alzahrani, saud hamed/C-2014-2012; BARTON BEHRAVESH, Casey/HDL-8040-2022	Jungk, Jessica/0000-0001-7087-7623; BARTON BEHRAVESH, Casey/0000-0003-2270-5573; Mikoleit, Matthew/0000-0002-4582-6733; Ayers, Tracy/0000-0003-4140-3263; Hoekstra, Robert Michael/0000-0002-0340-8015; Biggerstaff, Matthew/0000-0001-5108-8311; Shanahan, Lisa/0000-0001-5048-9615				*C FOOD PROT, 2006, COUNC 3 ISS RES 3 00; *CDCP, 2008, SAL SURV ANN SUMM 20; Gallegos-Robles MA, 2008, J FOOD PROTECT, V71, P2217, DOI 10.4315/0362-028X-71.11.2217; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; Gupta SK, 2007, EPIDEMIOL INFECT, V135, P1165, DOI 10.1017/S0950268807007911; Gutierrez-Cogco E, 2000, SALUD PUBLICA MEXICO, V42, P490; Hedberg CW, 1999, EPIDEMIOL INFECT, V122, P385, DOI 10.1017/S0950268899002393; Kirkland E, 2009, J FOOD PROTECT, V72, P1692, DOI 10.4315/0362-028X-72.8.1692; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Ma L, 2010, J FOOD PROTECT, V73, P434, DOI 10.4315/0362-028X-73.3.434; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; *WHO COLL CTR REF, 2007, ANT FORM SALM SER; 2010, MMWR MORB MORTAL WKL, V59, P418	16	109	113	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					918	927		10.1056/NEJMoa1005741	http://dx.doi.org/10.1056/NEJMoa1005741			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21345092				2022-12-28	WOS:000288170300008
J	Roseman, M; Milette, K; Bero, LA; Coyne, JC; Lexchin, J; Turner, EH; Thombs, BD				Roseman, Michelle; Milette, Katherine; Bero, Lisa A.; Coyne, James C.; Lexchin, Joel; Turner, Erick H.; Thombs, Brett D.			Reporting of Conflicts of Interest in Meta-analyses of Trials of Pharmacological Treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CELL LUNG-CANCER; PHARMACEUTICAL-INDUSTRY; CARDIOVASCULAR-DISEASE; COMPETING INTERESTS; DIABETES-MELLITUS; FINANCIAL TIES; DRUG TRIALS; RISK; IMPACT; ASSOCIATION	Context Disclosure of conflicts of interest (COIs) from pharmaceutical industry study funding and author-industry financial relationships is sometimes recommended for randomized controlled trials (RCTs) published in biomedical journals. Authors of meta-analyses, however, are not required to report COIs disclosed in original reports of included RCTs. Objective To investigate whether meta-analyses of pharmacological treatments published in high-impact biomedical journals report COIs disclosed in included RCTs. Data Sources and Study Selection We selected the 3 most recent meta-analyses of patented pharmacological treatments published January 2009 through October 2009 in each general medicine journal with an impact factor of at least 10; in high-impact journals in each of the 5 specialty medicine areas with the greatest 2008 global therapeutic sales (oncology, cardiology, respiratory medicine, endocrinology, and gastroenterology); and in the Cochrane Database of Systematic Reviews. Data Extraction Two investigators independently extracted data on disclosed study funding, author-industry financial ties, and author employment from each meta-analysis, from RCTs included in each meta-analysis, and on whether meta-analyses reported disclosed COIs of included RCTs. Results Of 29 meta-analyses reviewed, which included 509 RCTs, only 2 meta-analyses (7%) reported RCT funding sources; and 0 reported RCT author-industry ties or employment by the pharmaceutical industry. Of 318 meta-analyzed RCTs that reported funding sources, 219 (69%) were industry funded; and 91 of 132 (69%) that reported author financial disclosures had 1 or more authors with pharmaceutical industry financial ties. In 7 of the 29 meta-analyses reviewed, 100% of included RCTs had at least 1 form of disclosed COI (pharmaceutical industry funding, author-industry financial ties, or employment), yet only 1 of these 7 meta-analyses reported RCT funding sources, and 0 reported RCT author-industry ties or employment. Conclusion Among a group of meta-analyses of pharmacological treatments published in high-impact biomedical journals, information concerning primary study funding and author COIs for the included RCTs were only rarely reported. JAMA. 2011;305(10):1008-1017 www.jama.com	[Roseman, Michelle; Milette, Katherine; Thombs, Brett D.] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E4, Canada; [Roseman, Michelle; Milette, Katherine; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Biostat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Bero, Lisa A.] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA; [Bero, Lisa A.] Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Coyne, James C.] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Coyne, James C.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Hlth Psychol Sect, NL-9700 AB Groningen, Netherlands; [Lexchin, Joel] Univ Toronto, Univ Hlth Network, Emergency Dept, Toronto, ON, Canada; [Lexchin, Joel] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Lexchin, Joel] York Univ, Sch Hlth Policy & Management, N York, ON M3J 1P3, Canada; [Turner, Erick H.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Turner, Erick H.] Portland VA Med Ctr, Portland, OR USA	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; University of Groningen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; York University - Canada; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Thombs, BD (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, 4333 Cote Ste Catherine Rd, Montreal, PQ H3T 1E4, Canada.	brett.thombs@mcgill.ca	Turner, Erick/A-4848-2008	Turner, Erick/0000-0002-3522-3357; Bero, Lisa/0000-0003-1893-6651; Thombs, Brett D./0000-0002-5644-8432	Canadian Institutes of Health Research; McGill University; Canadian Institutes of Health Research Strategic Training Initiative [SKI 83345]; Fonds de la Recherche en Sante Quebec; Etablissement de Jeunes Chercheurs	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill University; Canadian Institutes of Health Research Strategic Training Initiative(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec(Fonds de la Recherche en Sante du Quebec); Etablissement de Jeunes Chercheurs	Ms Roseman and Ms Milette were supported by Frederick Banting and Charles Best Canadian Graduate Scholarships-Master's Awards from the Canadian Institutes of Health Research. Ms Roseman was also supported by a McGill University Provost's Graduate Fellowship and a McGill University Principal's Graduate Fellowship. Ms. Milette was also supported by a Canadian Scleroderma Research Group Studentship (Canadian Institutes of Health Research Strategic Training Initiative in Health Research Grant, SKI 83345) and a McGill University Provost's Graduate Fellowship. Dr Thombs was supported by a New Investigator Award from the Canadian Institutes of Health Research and an Etablissement de Jeunes Chercheurs award from the Fonds de la Recherche en Sante Quebec. Funds from the Etablissement de Jeunes Chercheurs award supported this project.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Barkun AN, 2009, GASTROINTEST ENDOSC, V69, P786, DOI 10.1016/j.gie.2008.05.031; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623; Bero LA, 1996, INT J TECHNOL ASSESS, V12, P209, DOI 10.1017/S0266462300009582; Bero LA, 1999, BRIT MED J, V319, P653, DOI 10.1136/bmj.319.7211.653; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Caslake R, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006661.pub2; Chaudhry S, 2002, BRIT MED J, V325, P1391, DOI 10.1136/bmj.325.7377.1391; de Almeida JR, 2009, JAMA-J AM MED ASSOC, V302, P985, DOI 10.1001/jama.2009.1243; De Luca G, 2009, J AM COLL CARDIOL, V53, P1668, DOI 10.1016/j.jacc.2009.01.053; DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V299, P1833, DOI 10.1001/jama.299.15.1833; Di Maio M, 2009, J CLIN ONCOL, V27, P1836, DOI 10.1200/JCO.2008.17.5844; Drazen JM, 2010, JAMA-J AM MED ASSOC, V303, P75, DOI 10.1001/jama.2009.1542; Ford AC, 2009, GUT, V58, P367, DOI 10.1136/gut.2008.163162; Friedman LS, 2004, J GEN INTERN MED, V19, P51, DOI 10.1111/j.1525-1497.2004.30617.x; Fuccio L, 2009, ANN INTERN MED, V151, P121, DOI 10.7326/0003-4819-151-2-200907210-00009; Hauser W, 2009, JAMA-J AM MED ASSOC, V301, P198, DOI 10.1001/jama.2008.944; Hapani S, 2009, LANCET ONCOL, V10, P559, DOI 10.1016/S1470-2045(09)70112-3; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Hartweg J, 2009, CURR OPIN LIPIDOL, V20, P30, DOI 10.1097/MOL.0b013e328321b3be; Hayward G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2976; Heerspink HL, 2009, LANCET, V373, P1009, DOI 10.1016/S0140-6736(09)60212-9; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; Higgins JPT, COCHRANE HDB SYSTEMA; Ho KM, 2009, CIRCULATION, V119, P1853, DOI 10.1161/CIRCULATIONAHA.108.848218; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; *I SCI INF, J CIT REP 2008 JCR S; *IMS HLTH INC, 2008, TOP 15 GLOB THER CLA; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Koch MW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007150.pub2; Lasserson DS, 2009, DIABETOLOGIA, V52, P1990, DOI 10.1007/s00125-009-1468-7; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Licurse A, 2010, ARCH INTERN MED, V170, P675, DOI 10.1001/archinternmed.2010.39; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Perez MI, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006743.pub2; Quant EC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3354; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ravipati M, 2009, GASTROINTEST ENDOSC, V70, P658, DOI 10.1016/j.gie.2009.02.029; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Schroter S, 2004, BRIT MED J, V328, P742, DOI 10.1136/bmj.38035.705185.F6; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; Sin DD, 2009, LANCET, V374, P712, DOI 10.1016/S0140-6736(09)61250-2; Sindi A, 2009, CHEST, V136, P145, DOI 10.1378/chest.08-2149; Sismondo S, 2008, SOC SCI MED, V66, P1909, DOI 10.1016/j.socscimed.2008.01.010; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Soon YY, 2009, J CLIN ONCOL, V27, P3277, DOI 10.1200/JCO.2008.19.4522; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Tassinari D, 2009, CHEST, V135, P1596, DOI 10.1378/chest.08-1503; Tatsioni A, 2010, J GEN INTERN MED, V25, P914, DOI 10.1007/s11606-010-1360-7; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; US Food & Drug Administration, OR BOOK APPR DRUG PR; van Kolfschooten F, 2002, NATURE, V416, P360, DOI 10.1038/416360a; Verdecchia P, 2009, EUR HEART J, V30, P679, DOI 10.1093/eurheartj/ehn575; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344; West S, 2002, Evid Rep Technol Assess (Summ), P1; Wijesinghe M, 2009, EUR RESPIR J, V34, P803, DOI 10.1183/09031936.00159708; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE; Yaphe J, 2001, FAM PRACT, V18, P565, DOI 10.1093/fampra/18.6.565; 2006, NY TIMES        0723, pWK11	69	102	103	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1008	1017		10.1001/jama.2011.257	http://dx.doi.org/10.1001/jama.2011.257			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386079	Green Published			2022-12-28	WOS:000288129600020
J	Le Goff, L; Lecuit, T				Le Goff, Loic; Lecuit, Thomas			Gradient Scaling and Growth	SCIENCE			English	Editorial Material							WING IMAGINAL DISC; MORPHOGEN GRADIENT; DROSOPHILA; SIZE; DPP; MECHANISM; HEDGEHOG		[Le Goff, Loic; Lecuit, Thomas] Univ Aix Marseille 2, CNRS, UMR6216, Dev Biol Inst Marseilles Luminy, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Le Goff, L (corresponding author), Univ Aix Marseille 2, CNRS, UMR6216, Dev Biol Inst Marseilles Luminy, F-13288 Marseille 09, France.	thomas.lecuit@ibdml.univmed.fr		Le Goff, Loic/0000-0003-4114-971X				Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; ZECCA M, 1995, DEVELOPMENT, V121, P2265	11	6	6	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1141	1142		10.1126/science.1203270	http://dx.doi.org/10.1126/science.1203270			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385701				2022-12-28	WOS:000287971200025
J	Larschan, E; Bishop, EP; Kharchenko, PV; Core, LJ; Lis, JT; Park, PJ; Kuroda, MI				Larschan, Erica; Bishop, Eric P.; Kharchenko, Peter V.; Core, Leighton J.; Lis, John T.; Park, Peter J.; Kuroda, Mitzi I.			X chromosome dosage compensation via enhanced transcriptional elongation in Drosophila	NATURE			English	Article							MSL COMPLEX; H4-K16 ACETYLATION; ANALYSIS REVEALS; RNA-POLYMERASE; GENES; GENOME; MELANOGASTER; INITIATION; YEAST; MOF	The evolution of sex chromosomes has resulted innumerous species in which females inherit two X chromosomes but males have a single X, thus requiring dosage compensation. MSL (Male-specific lethal) complex increases transcription on the single X chromosome of Drosophila males to equalize expression of X-linked genes between the sexes(1). The biochemical mechanisms used for dosage compensation must function over a wide dynamic range of transcription levels and differential expression patterns. It has been proposed(2) that the MSL complex regulates transcriptional elongation to control dosage compensation, a model subsequently supported by mapping of the MSL complex and MSL-dependent histone 4 lysine 16 acetylation to the bodies of X-linked genes in males, with a bias towards 39 ends(3-7). However, experimental analysis of MSL function at the mechanistic level has been challenging owing to the small magnitude of the chromosome-wide effect and the lack of an in vitro system for biochemical analysis. Here we use global run-on sequencing (GRO-seq) 8 to examine the specific effect of the MSL complex on RNA Polymerase II (RNAP II) on a genome-wide level. Results indicate that the MSL complex enhances transcription by facilitating the progression of RNAP II across the bodies of active X-linked genes. Improving transcriptional output downstream of typical gene-specific controls may explain how dosage compensation can be imposed on the diverse set of genes along an entire chromosome.	[Larschan, Erica; Kuroda, Mitzi I.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Larschan, Erica; Kuroda, Mitzi I.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Larschan, Erica] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Bishop, Eric P.; Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Bishop, Eric P.; Kharchenko, Peter V.; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Bishop, Eric P.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Core, Leighton J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Boston University; Cornell University	Kuroda, MI (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	peter_park@harvard.edu; mkuroda@genetics.med.harvard.edu		Park, Peter/0000-0001-9378-960X	NIH [GM45744, GM082798, HG4845]; Medical Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045744, R01GM082798, R01GM045744] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. M. Winston, S. Buratowski, A. Alekseyenko, M. Gelbart, C. Wang and A. Gortchakov for comments on the manuscript, and are grateful to N. Gehlenborg for graphic design expertise. This work was supported by the following NIH grants: GM45744 (M.I.K.), GM082798 (P.J.P.) and HG4845 (J.T.L.). E.L. was supported by a Charles A. King Trust fellowship from the Medical Foundation.	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Bai XY, 2004, EMBO J, V23, P2853, DOI 10.1038/sj.emboj.7600299; BELOTE JM, 1980, GENETICS, V96, P165; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Oh K, 2003, GENE DEV, V17, P1334, DOI 10.1101/gad.1082003; Park Y, 2002, SCIENCE, V298, P1620, DOI 10.1126/science.1076686; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	28	136	135	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					115	U139		10.1038/nature09757	http://dx.doi.org/10.1038/nature09757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368835	Green Accepted			2022-12-28	WOS:000287924100045
J	Nandy, D; Munoz-Jaramillo, A; Martens, PCH				Nandy, Dibyendu; Munoz-Jaramillo, Andres; Martens, Petrus C. H.			The unusual minimum of sunspot cycle 23 caused by meridional plasma flow variations	NATURE			English	Article							FLUX-TRANSPORT; SOLAR DYNAMO; MAGNETIC-FIELD; MODEL; OSCILLATION; STRENGTH	Direct observations over the past four centuries(1) show that the number of sunspots observed on the Sun's surface varies periodically, going through successive maxima and minima. Following sunspot cycle 23, the Sun went into a prolonged minimum characterized by a very weak polar magnetic field(2,3) and an unusually large number of days without sunspots(4). Sunspots are strongly magnetized regions(5) generated by a dynamo mechanism(6) that recreates the solar polar field mediated through plasma flows(7). Here we report results from kinematic dynamo simulations which demonstrate that a fast meridional flow in the first half of a cycle, followed by a slower flow in the second half, reproduces both characteristics of the minimum of sunspot cycle 23. Our model predicts that, in general, very deep minima are associated with weak polar fields. Sunspots govern the solar radiative energy(8,9) and radio flux, and, in conjunction with the polar field, modulate the solar wind, the heliospheric open flux and, consequently, the cosmic ray flux at Earth(3,10,11).	[Nandy, Dibyendu] Indian Inst Sci Educ & Res, Dept Phys Sci, Mohanpur 741252, W Bengal, India; [Munoz-Jaramillo, Andres; Martens, Petrus C. H.] Montana State Univ, Dept Phys, Bozeman, MT 59717 USA; [Munoz-Jaramillo, Andres; Martens, Petrus C. H.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Indian Institute of Science Education & Research (IISER) - Kolkata; Montana State University System; Montana State University Bozeman; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Nandy, D (corresponding author), Indian Inst Sci Educ & Res, Dept Phys Sci, Mohanpur 741252, W Bengal, India.	dnandi@iiserkol.ac.in		Munoz-Jaramillo, Andres/0000-0002-4716-0840; Nandi, Dibyendu/0000-0001-5205-2302	Government of India at the Indian Institute of Science Education and Research, Kolkata; NASA; Montana State University	Government of India at the Indian Institute of Science Education and Research, Kolkata; NASA(National Aeronautics & Space Administration (NASA)); Montana State University	This work was supported through the Ramanujan Fellowship of the Government of India at the Indian Institute of Science Education and Research, Kolkata, and by a NASA Living With a Star grant to the Smithsonian Astrophysical Observatory and Montana State University. We are grateful to D. Hathaway for providing the observational data on days without sunspots; the analysis of these data is reported in Supplementary Fig. 1.	BABCOCK HW, 1961, ASTROPHYS J, V133, P572, DOI 10.1086/147060; Charbonneau P, 2010, LIVING REV SOL PHYS, V7, DOI 10.12942/lrsp-2010-3; CHOUDHURI AR, 1995, ASTRON ASTROPHYS, V303, pL29; Choudhuri AR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.131103; Dikpati M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025221; Durney BR, 1997, ASTROPHYS J, V486, P1065, DOI 10.1086/304546; Giles PM, 1997, NATURE, V390, P52, DOI 10.1038/36294; Hathaway DH, 2003, ASTROPHYS J, V589, P665, DOI 10.1086/374393; Hernandez IG, 2006, ASTROPHYS J, V638, P576, DOI 10.1086/498642; Hoyt DV, 1998, SOL PHYS, V179, P189, DOI 10.1023/A:1005007527816; Jiang J, 2010, ASTROPHYS J, V717, P597, DOI 10.1088/0004-637X/717/1/597; Krivova NA, 2007, ASTRON ASTROPHYS, V467, P335, DOI 10.1051/0004-6361:20066725; Lara A, 2005, ASTROPHYS J, V625, P441, DOI 10.1086/428565; Lean J, 1997, ANNU REV ASTRON ASTR, V35, P33, DOI 10.1146/annurev.astro.35.1.33; LEIGHTON RB, 1969, ASTROPHYS J, V156, P1, DOI 10.1086/149943; Munoz-Jaramillo A, 2010, ASTROPHYS J LETT, V720, pL20, DOI 10.1088/2041-8205/720/1/L20; Munoz-Jaramillo A, 2009, ASTROPHYS J, V698, P461, DOI 10.1088/0004-637X/698/1/461; Nandy D, 2002, SCIENCE, V296, P1671, DOI 10.1126/science.1070955; Nandy D, 2001, ASTROPHYS J, V551, P576, DOI 10.1086/320057; Rempel M, 2007, ASTROPHYS J, V655, P651, DOI 10.1086/509866; Schrijver CJ, 2008, SOL PHYS, V252, P19, DOI 10.1007/s11207-008-9240-6; Solanki SK, 2003, ASTRON ASTROPHYS REV, V11, P153, DOI 10.1007/s00159-003-0018-4; Solanki SK, 2000, NATURE, V408, P445, DOI 10.1038/35044027; Solar Influences Data Analysis Center, 2011, DAIL SUNSP; Svanda M, 2007, ASTROPHYS J, V670, pL69, DOI 10.1086/524059; Wang YM, 2009, ASTROPHYS J, V707, P1372, DOI 10.1088/0004-637X/707/2/1372; Yeates AR, 2008, ASTROPHYS J, V673, P544, DOI 10.1086/524352; Zhao JW, 2004, ASTROPHYS J, V603, P776, DOI 10.1086/381489	28	102	105	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					80	82		10.1038/nature09786	http://dx.doi.org/10.1038/nature09786			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368827	Green Submitted			2022-12-28	WOS:000287924100037
J	Spence, D				Spence, Des			From The Frontline Bad medicine: gynaecological examinations	BRITISH MEDICAL JOURNAL			English	Editorial Material							NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS					destwo@yahoo.co.uk						Chernesky MA, 2005, SEX TRANSM DIS, V32, P729, DOI 10.1097/01.olq.0000190057.61633.8d; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Fang JY, 2008, J PEDIATR ADOL GYNEC, V21, P355, DOI 10.1016/j.jpag.2008.03.010; Padilla LA, 2005, INT J GYNECOL OBSTET, V88, P84, DOI 10.1016/j.ijgo.2004.09.015; Simms I, 2003, SEX TRANSM INFECT, V79, P491, DOI 10.1136/sti.79.6.491	5	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2011	342								d1342	10.1136/bmj.d1342	http://dx.doi.org/10.1136/bmj.d1342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732EO	21367841				2022-12-28	WOS:000288167900003
J	Chou, R; Dana, T; Bougatsos, C; Fleming, C; Beil, T				Chou, Roger; Dana, Tracy; Bougatsos, Christina; Fleming, Craig; Beil, Tracy			Screening Adults Aged 50 Years or Older for Hearing Loss: A Review of the Evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; RANDOMIZED-TRIAL; WHISPERED VOICE; AID USE; IMPAIRMENT; ACCURACY; PREVALENCE; TESTS; AMPLIFICATION; EPIDEMIOLOGY	Background: Hearing loss is common in older adults. Screening could identify untreated hearing loss and lead to interventions to improve hearing-related function and quality of life. Purpose: To update the 1996 U.S. Preventive Services Task Force evidence review on screening for hearing loss in primary care settings in adults aged 50 years or older. Data Sources: MEDLINE (1950 and July 2010) and the Cochrane Library (through the second quarter of 2010). Study Selection: Randomized trials, controlled observational studies, and studies on diagnostic accuracy were selected. Data Extraction: Investigators abstracted details about the patient population, study design, data analysis, follow-up, and results and assessed quality by using predefined criteria. Data Synthesis: Evidence on benefits and harms of screening for and treatments of hearing loss was synthesized qualitatively. One large (2305 participants) randomized trial found that screening for hearing loss was associated with increased hearing aid use at 1 year, but screening was not associated with improvements in hearing-related function. Good-quality evidence suggests that common screening tests can help identify patients at higher risk for hearing loss. One good-quality randomized trial found that immediate hearing aids were effective compared with wait-list control in improving hearing-related quality of life in patients with mild or moderate hearing loss and severe hearing-related handicap. We did not find direct evidence on harms of screening or treatments with hearing aids. Limitation: Non-English-language studies were excluded, and studies of diagnostic accuracy in high-prevalence specialty settings were included. Conclusion: Additional research is needed to understand the effects of screening for hearing loss compared with no screening on health outcomes and to confirm benefits of treatment under conditions likely to be encountered in most primary care settings.	[Chou, Roger] Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Portland, OR 97239 USA; Kaiser Permanente Ctr Hlth Res, Portland, OR USA; Grp Hlth Cooperat, Olympia, WA USA	Oregon Health & Science University; Kaiser Permanente; Group Health Cooperative	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.			Chou, Roger/0000-0001-9889-8610	Agency for Healthcare Research and Quality [HHSA-290-2007-10057-I-EPC3]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By the Agency for Healthcare Research and Quality (contract HHSA-290-2007-10057-I-EPC3; Task Order 3).	Abyad A, 2004, GERIATRICS TODAY, V7, P43; Bagai A, 2006, JAMA-J AM MED ASSOC, V295, P416, DOI 10.1001/jama.295.4.416; Barton MB, 2007, ANN INTERN MED, V147, P123, DOI 10.7326/0003-4819-147-2-200707170-00171; BIENVENUE GR, 1985, EAR HEARING, V6, P251, DOI 10.1097/00003446-198509000-00005; Boatman DF, 2007, NEUROLOGY, V68, P1311, DOI 10.1212/01.wnl.0000259524.08148.16; BROWNING GG, 1989, J LARYNGOL OTOL, V103, P7, DOI 10.1017/S0022215100107923; Chou R, 2010, AHRQ PUBLICATION; CIURLIAGUY E, 1993, GERONTOLOGIST, V33, P644, DOI 10.1093/geront/33.5.644; Clark J G, 1981, ASHA, V23, P493; CLARK K, 1991, AM J EPIDEMIOL, V134, P704, DOI 10.1093/oxfordjournals.aje.a116147; Cruickshanks KJ, 1998, AM J EPIDEMIOL, V148, P879; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Eekhof JAH, 1996, BRIT J GEN PRACT, V46, P473; FRANK T, 1987, EAR HEARING, V8, P180, DOI 10.1097/00003446-198706000-00009; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GATES GA, 1990, EAR HEARING, V11, P247, DOI 10.1097/00003446-199008000-00001; Gates GA, 2003, J FAM PRACTICE, V52, P56; Goldstein D P, 1984, ASHA, V26, P24; Guirguis-Blake J, 2007, ANN INTERN MED, V147, P117, DOI 10.7326/0003-4819-147-2-200707170-00170; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Jerger J, 1996, EAR HEARING, V17, P490, DOI 10.1097/00003446-199612000-00005; Kohan D, 2004, LARYNGOSCOPE, V114, P317, DOI 10.1097/00005537-200402000-00026; KOIKE KJ, 1994, OTOLARYNG HEAD NECK, V111, P625, DOI 10.1016/S0194-5998(94)70531-3; Lear JT, 1998, CONTACT DERMATITIS, V38, P212, DOI 10.1111/j.1600-0536.1998.tb05710.x; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; LICHTENSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V259, P2875, DOI 10.1001/jama.259.19.2875; MACPHEE GJA, 1988, AGE AGEING, V17, P347, DOI 10.1093/ageing/17.5.347; MACRAE JH, 1991, J SPEECH HEAR RES, V34, P661, DOI 10.1044/jshr.3403.661; MCBRIDE WS, 1994, AM J MED SCI, V307, P40, DOI 10.1097/00000441-199401000-00007; McMahon CM, 2008, EAR HEARING, V29, P578, DOI 10.1097/AUD.0b013e31817349d6; MULROW CD, 1990, ANN INTERN MED, V113, P188, DOI 10.7326/0003-4819-113-3-188; MULROW CD, 1992, J SPEECH HEAR RES, V35, P1402, DOI 10.1044/jshr.3506.1402; Nondahl DM, 1998, AUDIOLOGY, V37, P295; Popelka MM, 1998, J AM GERIATR SOC, V46, P1075, DOI 10.1111/j.1532-5415.1998.tb06643.x; Rawool VW, 2008, J OTOLARYNGOL-HEAD N, V37, P27, DOI 10.2310/7070.2008.0004; Reuben DB, 1998, J AM GERIATR SOC, V46, P1008, DOI 10.1111/j.1532-5415.1998.tb02758.x; SEVER JC, 1989, PERCEPT MOTOR SKILL, V69, P511, DOI 10.2466/pms.1989.69.2.511; Sindhusake D, 2001, INT J EPIDEMIOL, V30, P1371, DOI 10.1093/ije/30.6.1371; Sood Apra, 2004, Dermatitis, V15, P48, DOI 10.2310/6620.2004.20441; SWAN IRC, 1985, J ROY COLL GEN PRACT, V35, P197; Tolson Debbie, 2002, Br J Nurs, V11, P1021; Torre P, 2006, INT J AUDIOL, V45, P559, DOI 10.1080/14992020600860935; *US PREV SERV TASK, 1996, SCREEN HEAR IMP OLD; Ventry I M, 1983, ASHA, V25, P37; VENTRY IM, 1982, EAR HEARING, V3, P128, DOI 10.1097/00003446-198205000-00006; VOEKS SK, 1993, J FAM PRACTICE, V36, P54; Wallhagen MI, 1997, AM J PUBLIC HEALTH, V87, P440, DOI 10.2105/AJPH.87.3.440; Weinstein B E, 1986, ASHA, V28, P41; Wiley T L, 2000, J Am Acad Audiol, V11, P67; Wu H. Y., 2004, SMJ Singapore Medical Journal, V45, P79; Yueh B, 2001, ARCH OTOLARYNGOL, V127, P1197, DOI 10.1001/archotol.127.10.1197; Yueh B, 2010, J AM GERIATR SOC, V58, P427, DOI 10.1111/j.1532-5415.2010.02738.x	53	99	106	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					347	+		10.7326/0003-4819-154-5-201103010-00009	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00009			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	727LA	21357912				2022-12-28	WOS:000287799900007
J	Huxley, RR; Jacobs, DR				Huxley, Rachel R.; Jacobs, David R., Jr.			Size still matters ... but not in the way we once thought	LANCET			English	Editorial Material							ADIPOSITY; RISK		[Huxley, Rachel R.; Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Huxley, Rachel R.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia	University of Minnesota System; University of Minnesota Twin Cities; George Institute for Global Health; University of Sydney	Huxley, RR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA.	rachux@gmail.com	Huxley, Rachel R/J-4638-2013; Huxley, Rachel R/C-7032-2013	Huxley, Rachel R/0000-0002-2705-6616; Huxley, Rachel R/0000-0002-2705-6616; Jacobs, David/0000-0002-7232-0543				COLE TJ, 1986, ANN HUM BIOL, V13, P433, DOI 10.1080/03014468600008621; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization, 2007, PREV CARD DIS GUID A; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	10	3	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2011	377	9771					1051	1052		10.1016/S0140-6736(11)60239-0	http://dx.doi.org/10.1016/S0140-6736(11)60239-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	743QY	21397321				2022-12-28	WOS:000289035000005
J	Vaidyanathan, S; Barnes, M; Williamson, P; Hopkinson, P; Donnan, PT; Lipworth, B				Vaidyanathan, Sriram; Barnes, Martyn; Williamson, Peter; Hopkinson, Pippa; Donnan, Peter T.; Lipworth, Brian			Treatment of Chronic Rhinosinusitis With Nasal Polyposis With Oral Steroids Followed by Topical Steroids A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							GLUCOCORTICOID-RECEPTOR; DOUBLE-BLIND; FLUTICASONE; SPRAY; STANDARDIZATION; BUDESONIDE; DIAGNOSIS; EFFICACY; RHINITIS; THERAPY	Background: Chronic rhinosinusitis (CRS) with nasal polyposis is common. The long-term efficacy and safety of approaches to medical management are not well-known. Objective: To evaluate the efficacy and safety of a 2-week regimen of oral steroid therapy followed by 26 weeks of sequential topical steroid maintenance therapy. Design: Parallel randomized trial with computer-generated block randomization and central allocation. Patients and investigators were blinded to group assignment. (ClinicalTrials.gov registration number: NCT00788749) Setting: A specialty rhinology clinic in Tayside, Scotland. Patients: 60 adults with CRS and moderate-sized or larger nasal polyps who were referred by their primary physicians for specialty care. Interventions: Patients were randomly assigned in a 1: 1 ratio to receive oral prednisolone, 25 mg/d, or placebo for 2 weeks, followed in both groups by fluticasone propionate nasal drops, 400 mu g twice daily, for 8 weeks and then fluticasone propionate nasal spray, 200 mu g twice daily, for 18 weeks. Measurements: Polyp grading (primary outcome), hyposmia score, quality of life, symptoms, nasal patency, adrenal function, and bone turnover. Results: The mean decrease in polyp grade from baseline to 2 weeks was 2.1 units (SD, 1.1) in the prednisolone group and 0.1 unit (SD, 1.0) in the placebo group (mean difference between groups, -1.8 units [95% CI, -2.4 to -1.2 units]; P < 0.001). The difference between groups was -1.08 units (CI, -1.74 to -0.42 unit; P = 0.001) at 10 weeks and -0.8 unit (CI, -1.8 to 0.2 unit; P = 0.11) at 28 weeks. The mean decrease in hyposmia score from baseline to 2 weeks was 31.12 mm (SD, 30.1) in the prednisolone group and 1.41 mm (SD, 30.6) in the placebo group (mean difference between groups, -28.33 mm [CI, -42.71 to -13.96 mm]; P = 0.002). The difference between groups was -16.06 mm (CI, -30.99 to -1.13 mm; P = 0.03) at 10 weeks and -12.13 mm (CI, -30.55 to 6.29 mm; P = 0.19) at 28 weeks. Prednisolone therapy resulted in transient suppression of adrenal function and increase in bone turnover after 2 weeks, with a return to baseline at 10 and 28 weeks. Limitations: Patients were referred from primary care to a single-center rhinology clinic, which limits the generalizability of results. Serial measurements of surrogates of nasal inflammation (such as nitric oxide or cytokine levels) were not performed. Conclusion: Initial oral steroid therapy followed by topical steroid therapy seems to be more effective over 6 months than topical steroid therapy alone in decreasing polyp size and improving olfaction in patients referred for specialty care of CRS with at least moderate nasal polyposis.	[Lipworth, Brian] Ninewells Hosp, Div Med Sci, Ctr Cardiovasc & Lung Biol, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland; Univ Dundee, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee	Lipworth, B (corresponding author), Ninewells Hosp, Div Med Sci, Ctr Cardiovasc & Lung Biol, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland.			Donnan, Peter/0000-0001-7828-0610	Chief Scientist Office, Scotland; National Health Service Tayside Small Grants Scheme; University of Dundee	Chief Scientist Office, Scotland; National Health Service Tayside Small Grants Scheme; University of Dundee	Grant Support: By the Chief Scientist Office, Scotland; National Health Service Tayside Small Grants Scheme; and an Anonymous Trust grant from University of Dundee.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Bachert C, 2009, ALLERGY, V64, P520, DOI 10.1111/j.1398-9995.2009.01964.x; Banerji A, 2007, AM J RHINOL, V21, P19, DOI 10.2500/ajr.2007.21.2979; Barnes ML, 2006, CLIN EXP ALLERGY, V36, P676, DOI 10.1111/j.1365-2222.2006.02478.x; Benitez P, 2006, LARYNGOSCOPE, V116, P770, DOI 10.1097/01.mlg.0000205218.37514.0f; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; Daley-Yates PT, 2001, BRIT J CLIN PHARMACO, V51, P103, DOI 10.1046/j.1365-2125.2001.01325.x; Fokkens W, 2007, RHINOLOGY, P1; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; HARDY JG, 1985, J PHARM PHARMACOL, V37, P294, DOI 10.1111/j.2042-7158.1985.tb05069.x; Hissaria P, 2006, J ALLERGY CLIN IMMUN, V118, P128, DOI 10.1016/j.jaci.2006.03.012; Jankowski R, 2009, ALLERGY, V64, P944, DOI 10.1111/j.1398-9995.2009.01938.x; Juniper EF, 2000, CLIN EXP ALLERGY, V30, P132; LILDHOLDT T, 1995, CLIN OTOLARYNGOL, V20, P26, DOI 10.1111/j.1365-2273.1995.tb00007.x; Mackay IS, 1998, BRIT MED J, V316, P917, DOI 10.1136/bmj.316.7135.917; Mann NM, 2004, OTOLARYNG CLIN N AM, V37, P289, DOI 10.1016/S0030-6665(03)00157-9; Meltzer EO, 2004, J ALLERGY CLIN IMMUN, V114, pS133, DOI 10.1016/j.jaci.2004.09.011; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mygind N, 1996, ALLERGY ASTHMA PROC, V17, P275, DOI 10.2500/108854196778662228; Nizankowska-Mogilnicka E, 2007, ALLERGY, V62, P1111, DOI 10.1111/j.1398-9995.2007.01409.x; Pujols L, 2008, ALLERGY, V63, P1377, DOI 10.1111/j.1398-9995.2008.01745.x; Ray NF, 1999, J ALLERGY CLIN IMMUN, V103, P408, DOI 10.1016/S0091-6749(99)70464-1; Robinson AM, 1998, LARYNGOSCOPE, V108, P1238, DOI 10.1097/00005537-199808000-00026; Tuncer U, 2003, AURIS NASUS LARYNX, V30, P263, DOI 10.1016/S0385-8146(03)00051-8; Valera FCP, 2009, CLIN EXP ALLERGY, V39, P81, DOI 10.1111/j.1365-2222.2008.03144.x; Vento SI, 2000, ANN ALLERG ASTHMA IM, V85, P209, DOI 10.1016/S1081-1206(10)62468-4; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005	28	116	126	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					293	302		10.7326/0003-4819-154-5-201103010-00003	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357906				2022-12-28	WOS:000287799900001
J	Lander, ES				Lander, Eric S.			GENOME-SEQUENCING ANNIVERSARY A Celebration of the Genome, Part IV	SCIENCE			English	Editorial Material									[Lander, Eric S.] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Lander, Eric S.] MIT, Cambridge, MA 02139 USA; [Lander, Eric S.] Council Advisors Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02138 USA.								0	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1024	1024		10.1126/science.1204037	http://dx.doi.org/10.1126/science.1204037			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350161				2022-12-28	WOS:000287699000044
J	Ressler, KJ; Mercer, KB; Bradley, B; Jovanovic, T; Mahan, A; Kerley, K; Norrholm, SD; Kilaru, V; Smith, AK; Myers, AJ; Ramirez, M; Engel, A; Hammack, SE; Toufexis, D; Braas, KM; Binder, EB; May, V				Ressler, Kerry J.; Mercer, Kristina B.; Bradley, Bekh; Jovanovic, Tanja; Mahan, Amy; Kerley, Kimberly; Norrholm, Seth D.; Kilaru, Varun; Smith, Alicia K.; Myers, Amanda J.; Ramirez, Manuel; Engel, Anzhelika; Hammack, Sayamwong E.; Toufexis, Donna; Braas, Karen M.; Binder, Elisabeth B.; May, Victor			Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor	NATURE			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; ADENYLATE-CYCLASE; SIGNAL-TRANSDUCTION; BRAIN-DEVELOPMENT; STRIA TERMINALIS; GENE-EXPRESSION; FEAR INHIBITION; BED NUCLEUS; AMYGDALA; PTSD	Pituitary adenylate cyclase-activating polypeptide (PACAP) is known to broadly regulate the cellular stress response. In contrast, it is unclear if the PACAP-PAC1 receptor pathway has a role in human psychological stress responses, such as post-traumatic stress disorder (PTSD). Here we find, in heavily traumatized subjects, a sex-specific association of PACAP blood levels with fear physiology, PTSD diagnosis and symptoms in females. We examined 44 single nucleotide polymorphisms (SNPs) spanning the PACAP (encoded by ADCYAP1) and PAC1 (encoded by ADCYAP1R1) genes, demonstrating a sex-specific association with PTSD. A single SNP in a putative oestrogen response element within ADCYAP1R1, rs2267735, predicts PTSD diagnosis and symptoms in females only. This SNP also associates with fear discrimination and with ADCYAP1R1 messenger RNA expression in human brain. Methylation of ADCYAP1R1 in peripheral blood is also associated with PTSD. Complementing these human data, ADCYAP1R1 mRNA is induced with fear conditioning or oestrogen replacement in rodent models. These data suggest that perturbations in the PACAP-PAC1 pathway are involved in abnormal stress responses underlying PTSD. These sex-specific effects may occur via oestrogen regulation of ADCYAP1R1. PACAP levels and ADCYAP1R1 SNPs may serve as useful biomarkers to further our mechanistic understanding of PTSD.	[Ressler, Kerry J.; Mercer, Kristina B.; Kerley, Kimberly] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Ressler, Kerry J.; Bradley, Bekh; Jovanovic, Tanja; Norrholm, Seth D.; Kilaru, Varun; Smith, Alicia K.; Binder, Elisabeth B.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Bradley, Bekh; Norrholm, Seth D.] Atlanta VA Med Ctr, Atlanta, GA 30033 USA; [Ressler, Kerry J.; Mahan, Amy; Toufexis, Donna] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Myers, Amanda J.; Ramirez, Manuel; Engel, Anzhelika] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Hammack, Sayamwong E.; Toufexis, Donna] Univ Vermont, Dept Psychol, Burlington, VT 05401 USA; [Braas, Karen M.; May, Victor] Univ Vermont, Coll Med, Dept Anat & Neurobiol, Burlington, VT 05401 USA; [Braas, Karen M.; May, Victor] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05401 USA; [Binder, Elisabeth B.] Max Planck Inst Psychiat, D-80804 Munich, Germany	Howard Hughes Medical Institute; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University of Miami; University of Vermont; University of Vermont; University of Vermont; Max Planck Society	Ressler, KJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	kressle@emory.edu	Smith, Alicia/W-6809-2019; Bradley, Bekh/H-8399-2012; Binder, Elisabeth B/K-8905-2014; Ressler, Kerry J/N-8741-2018; Norrholm, Seth/AAC-2464-2022; Myers, Amanda J/B-1796-2010	Smith, Alicia/0000-0002-8537-5156; Ressler, Kerry J/0000-0002-5158-1103; Myers, Amanda J/0000-0002-3100-9396	NIH [MH071537, DA019624, HD27468]; Emory and Grady Memorial Hospital General Clinical Research Center; NIH National Centers for Research Resources [M01RR00039, P20RR16435]; American Foundation for Suicide Prevention; Burroughs Wellcome Fund; National Institute on Aging [AG034504]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027468] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039, P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071537, R56MH071537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019624] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory and Grady Memorial Hospital General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Centers for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Foundation for Suicide Prevention; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was primarily supported by NIH grant MH071537 (K.J.R.), as well as DA019624 (K.J.R.) and HD27468 (V. M.). Support was also received from Emory and Grady Memorial Hospital General Clinical Research Center, NIH National Centers for Research Resources (M01RR00039 and P20RR16435), the American Foundation for Suicide Prevention (B. B.) and the Burroughs Wellcome Fund (K.J.R.). RNA samples were run using the Oncogenomics Core Facility at University of Miami. A.J.M. is supported by The National Institute on Aging (AG034504). We thank J.F. Cubells, Y. Tang and K. Conneely for discussions. We thank the Grady Trauma Project, including C. F. Gillespie, A. Schwartz, A. Wingo, D. A. Gutman and T. Weiss for medical support; A. Graham, A. Brown, J. Phifer, D. Crain, A. Kamkwalala, J. Poole, D. Cross, N. Fani and A. Smith for clinical research support; and K. Schutz, E. Reiser and C. Fitzgerald for molecular/genetics technical support. Methylation chip assays were performed by the Emory University Biomarkers Service Center.	Aenlle KK, 2009, NEUROBIOL AGING, V30, P932, DOI 10.1016/j.neurobiolaging.2007.09.004; Bangasser DA, 2010, MOL PSYCHIATR, V15, P896, DOI 10.1038/mp.2010.66; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dejda A, 2008, J MOL NEUROSCI, V36, P26, DOI 10.1007/s12031-008-9087-1; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Ghzili H, 2008, FRONT NEUROENDOCRIN, V29, P128, DOI 10.1016/j.yfrne.2007.10.001; Gillespie CF, 2009, GEN HOSP PSYCHIAT, V31, P505, DOI 10.1016/j.genhosppsych.2009.05.003; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Girard BA, 2006, J NEUROCHEM, V99, P499, DOI 10.1111/j.1471-4159.2006.04112.x; Grillon C, 1998, AM J PSYCHIAT, V155, P812; Hamelink C, 2002, P NATL ACAD SCI USA, V99, P461, DOI 10.1073/pnas.012608999; Hammack SE, 2009, PSYCHONEUROENDOCRINO, V34, P833, DOI 10.1016/j.psyneuen.2008.12.013; Hashimoto H, 2006, ANN NY ACAD SCI, V1070, P75, DOI 10.1196/annals.1317.038; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Jovanovic T, 2010, DEPRESS ANXIETY, V27, P244, DOI 10.1002/da.20663; LEDOUX JE, 1993, ANN NY ACAD SCI, V702, P149, DOI 10.1111/j.1749-6632.1993.tb17246.x; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MCEWEN BS, 1992, HORM RES, V37, P1, DOI 10.1159/000182393; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Shansky RM, 2010, CEREB CORTEX, V20, P2560, DOI 10.1093/cercor/bhq003; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Walker DL, 1997, J NEUROSCI, V17, P9375; Walker DL, 2002, PSYCHOPHARMACOLOGY, V159, P304, DOI 10.1007/s002130100913; Watanabe J, 2007, PEPTIDES, V28, P1713, DOI 10.1016/j.peptides.2007.06.029; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; ZHONG Y, 1995, NATURE, V375, P588, DOI 10.1038/375588a0	41	534	545	9	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					492	497		10.1038/nature09856	http://dx.doi.org/10.1038/nature09856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350482	Green Accepted			2022-12-28	WOS:000287652900033
J	Boivin, J; Griffiths, E; Venetis, CA				Boivin, J.; Griffiths, E.; Venetis, C. A.			Emotional distress in infertile women and failure of assisted reproductive technologies: meta-analysis of prospective psychosocial studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IN-VITRO FERTILIZATION; PUBLICATION BIAS; STRESS; IVF; PREGNANCY; DEPRESSION; FERTILITY; ANXIETY; SEEKING; LEVEL	Objective To examine whether pretreatment emotional distress in women is associated with achievement of pregnancy after a cycle of assisted reproductive technology. Design Meta-analysis of prospective psychosocial studies. Data sources PubMed, Medline, Embase, PsycINFO, PsychNET, ISI Web of Knowledge, and ISI Web of Science were searched for articles published from 1985 to March 2010 (inclusive). We also undertook a hand search of reference lists and contacted 29 authors. Eligible studies were prospective studies reporting a test of the association between pretreatment emotional distress (anxiety or depression) and pregnancy in women undergoing a single cycle of assisted reproductive technology. Review methods Two authors independently assessed the studies for eligibility and quality (using criteria adapted from the Newcastle-Ottawa quality scale) and extracted data. Authors contributed additional data not included in original publication. Results Fourteen studies with 3583 infertile women undergoing a cycle of fertility treatment were included in the meta-analysis. The effect size used was the standardised mean difference (adjusted for small sample size) in pretreatment anxiety or depression (priority on anxiety where both measured) between women who achieved a pregnancy (defined as a positive pregnancy test, positive fetal heart scan, or live birth) and those who did not. Pretreatment emotional distress was not associated with treatment outcome after a cycle of assisted reproductive technology (standardised mean difference -0.04, 95% confidence interval -0.11 to 0.03 (fixed effects model); heterogeneity I-2 = 14%, P = 0.30). Subgroup analyses according to previous experience of assisted reproductive technology, composition of the not pregnant group, and timing of the emotional assessment were not significant. The effect size did not vary according to study quality, but a significant subgroup analysis on timing of the pregnancy test, a contour enhanced funnel plot, and Egger's test indicated the presence of moderate publication bias. Conclusions The findings of this meta-analysis should reassure women and doctors that emotional distress caused by fertility problems or other life events co-occurring with treatment will not compromise the chance of becoming pregnant.	[Boivin, J.] Cardiff Univ, Cardiff Fertil Studies Res Grp, Sch Psychol, Cardiff, S Glam, Wales	Cardiff University	Boivin, J (corresponding author), Cardiff Univ, Cardiff Fertil Studies Res Grp, Sch Psychol, Tower Bldg,Pk Pl, Cardiff, S Glam, Wales.	boivin@cardiff.ac.uk	Venetis, Christos/G-3719-2013; Boivin, Jacky/A-1666-2010	Venetis, Christos/0000-0001-9591-7222; Boivin, Jacky/0000-0001-9498-1708				Agadjanian V, 2001, J S AFR STUD, V27, P329, DOI 10.1080/03057070120049985; Akyuz A, 2006, HUM REPROD, V21, pI72; Anderheim L, 2005, HUM REPROD, V20, P2969, DOI 10.1093/humrep/dei219; [Anonymous], 2016, NEWCASTLEOTTAWA SCAL; BOIVIN J, 1995, FERTIL STERIL, V64, P802, DOI 10.1016/S0015-0282(16)57858-3; Boivin J, 2010, WOMEN HLTH, V6, P1; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Boivin J, 2006, EVOL HUM BEHAV, V27, P345, DOI 10.1016/j.evolhumbehav.2006.03.004; Bowling A., 1995, MEASURING DIS; Bunting L, 2007, HUM REPROD, V22, P1662, DOI 10.1093/humrep/dem057; de Klerk C, 2008, HUM REPROD, V23, P112, DOI 10.1093/humrep/dem357; DECATANZARO D, 1992, NEUROSCI BIOBEHAV R, V16, P43, DOI 10.1016/S0149-7634(05)80050-8; Demyttenaere K, 1998, FERTIL STERIL, V69, P1026, DOI 10.1016/S0015-0282(98)00089-2; DEMYTTENAERE K, 1992, PSYCHONEUROENDOCRINO, V17, P655, DOI 10.1016/0306-4530(92)90024-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ebbesen SMS, 2009, HUM REPROD, V24, P2173, DOI 10.1093/humrep/dep185; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150; FRIDHANDLER BM, 1986, J PERS SOC PSYCHOL, V50, P169, DOI 10.1037/0022-3514.50.1.169; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; Hammerli K, 2009, HUM REPROD UPDATE, V15, P279, DOI 10.1093/humupd/dmp002; Hedges L. V., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Hedges LV, 2014, STAT METHODS META AN; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Human Fertilisation & Embryology Authority, 2008, FACTS FIG 2006 FERT; Klonoff-Cohen H, 2001, FERTIL STERIL, V76, P675, DOI 10.1016/S0015-0282(01)02008-8; Lancastle D, 2005, HEALTH PSYCHOL, V24, P171, DOI 10.1037/0278-6133.24.2.171; Lancastle D, 2008, HUM REPROD, V23, P2299, DOI 10.1093/humrep/den257; Lee A, 2006, FERTIL STERIL, V86, pS55, DOI 10.1016/j.fertnstert.2006.07.152; Leushuis E, 2009, HUM REPROD UPDATE, V15, P537, DOI 10.1093/humupd/dmp013; Li XF, 2004, J NEUROENDOCRINOL, V16, P620, DOI 10.1111/j.1365-2826.2004.01209.x; Lintsen A. M., 2009, HUM REPROD, V1, P1; Lord S, 2005, J REPROD INFANT PSYC, V23, P319, DOI 10.1080/02646830500273566; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Matthiesen S, 2010, THESIS AARHUS U; Merari D, 2002, PSYCHOL HEALTH, V17, P629, DOI 10.1080/08870440290025821; Mumford KR, 2004, THESIS U S FLORIDA; Nyboe Andersen A, 2009, Hum Reprod, V24, P1267, DOI 10.1093/humrep/dep035; Olivius C, 2004, FERTIL STERIL, V81, P258, DOI 10.1016/j.fertnstert.2003.06.029; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Sanders KA, 1999, HUM REPROD, V14, P1656, DOI 10.1093/humrep/14.6.1656; Sandi C, 2009, TRENDS NEUROSCI, V32, P312, DOI 10.1016/j.tins.2009.02.004; Smeenk JMJ, 2001, HUM REPROD, V16, P1420, DOI 10.1093/humrep/16.7.1420; Tennen H, 1991, INFERTILITY PERSPECT; Tuil WS, 2006, HUM REPROD, V21, P2955, DOI 10.1093/humrep/del214; Verhaak CM, 2007, HUM REPROD UPDATE, V13, P27, DOI 10.1093/humupd/dml040; Verhaak CM, 2001, FERTIL STERIL, V76, P525, DOI 10.1016/S0015-0282(01)01931-8; WASSER SK, 1983, Q REV BIOL, V58, P513, DOI 10.1086/413545; Zegers-Hochschild F, 2006, HUM REPROD, V21, P1968, DOI 10.1093/humrep/del171	49	190	194	2	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2011	342								d223	10.1136/bmj.d223	http://dx.doi.org/10.1136/bmj.d223			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345903	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000287920100008
J	Ely, EW				Ely, E. Wesley			The Leopard-Skin Bra	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												wes.ely@vanderbilt.edu	Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172					0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					756	757		10.1001/jama.2011.169	http://dx.doi.org/10.1001/jama.2011.169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21343568				2022-12-28	WOS:000287594300001
J	Liang, BA; Mackey, T				Liang, Bryan A.; Mackey, Timothy			Direct-to-Consumer Advertising With Interactive Internet Media Global Regulation and Public Health Issues	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Liang, Bryan A.; Mackey, Timothy] Calif Western Sch Law, Inst Hlth Law Studies, San Diego, CA 92101 USA; [Liang, Bryan A.] Univ Calif, San Diego Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA; [Liang, Bryan A.] Univ Calif, San Diego Sch Med, San Diego Ctr Patient Safety, La Jolla, CA 92093 USA; [Mackey, Timothy] Univ Calif, San Diego State Univ, San Diego Joint Program Global Hlth, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego	Liang, BA (corresponding author), Calif Western Sch Law, Inst Hlth Law Studies, 350 Cedar St, San Diego, CA 92101 USA.	baliang@alum.mit.edu	Mackey, Tim/H-9156-2013	Mackey, Tim/0000-0002-2191-7833; Liang, Bryan/0000-0001-7801-5673				Campbell S, 2009, PROMOTIONAL SPENDING; Frosch DL, 2010, AM J PUBLIC HEALTH, V100, P24, DOI 10.2105/AJPH.2008.153767; Greene JA, 2010, NEW ENGL J MED, V363, P2087, DOI 10.1056/NEJMp1004986; HARRIS M, 2010, CBS MONEYWATCH; HOBSON K, 2010, JAMA-J AM MED ASSOC, V303, P311; Liang BA, 2009, AM J LAW MED, V35, P125, DOI 10.1177/009885880903500104; Mintzes B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005699; *US FDA, 2009, FDA FTC ISS JOINT WA; 2010, DTC PERSPECTIVES SEP, V8, P1	9	81	84	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					824	825		10.1001/jama.2011.203	http://dx.doi.org/10.1001/jama.2011.203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724RQ	21343583				2022-12-28	WOS:000287594300028
J	Lim, C; Lee, J; Choi, C; Kilman, VL; Kim, J; Park, SM; Jang, SK; Allada, R; Choe, J				Lim, Chunghun; Lee, Jongbin; Choi, Changtaek; Kilman, Valerie L.; Kim, Juwon; Park, Sung Mi; Jang, Sung Key; Allada, Ravi; Choe, Joonho			The novel gene twenty-four defines a critical translational step in the Drosophila clock	NATURE			English	Article							MESSENGER-RNA TRANSLATION; CIRCADIAN-RHYTHMS; BINDING-PROTEIN; PERIOD PROTEIN; MOLECULAR OSCILLATIONS; EXPRESSION; NEURONS; SYSTEM; ABLATION; ORANGE	Daily oscillations of gene expression underlie circadian behaviours in multicellular organisms(1). While attention has been focused on transcriptional and post-translational mechanisms(1-3), other post-transcriptional modes have been less clearly delineated. Here we report mutants of a novel Drosophila gene twenty-four (tyf) that show weak behavioural rhythms. Weak rhythms are accompanied by marked reductions in the levels of the clock protein Period (PER) as well as more modest effects on Timeless (TIM). Nonetheless, PER induction in pacemaker neurons can rescue tyf mutant rhythms. TYF associates with a 5'-cap-binding complex, poly(A)-binding protein (PABP), as well as per and tim transcripts. Furthermore, TYF activates reporter expression when tethered to reporter messenger RNA even in vitro. Taken together, these data indicate that TYF potently activates PER translation in pacemaker neurons to sustain robust rhythms, revealing a new and important role for translational control in the Drosophila circadian clock.	[Lim, Chunghun; Kilman, Valerie L.; Allada, Ravi] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Lee, Jongbin; Choi, Changtaek; Kim, Juwon; Choe, Joonho] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Park, Sung Mi; Jang, Sung Key] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea	Northwestern University; Korea Advanced Institute of Science & Technology (KAIST); Pohang University of Science & Technology (POSTECH)	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-allada@northwestern.edu; jchoe@kaist.ac.kr	Lim, Chunghun/AAB-1253-2020; Jang, Sung K/P-1230-2017; Choe, Joonho/F-3066-2011	Lim, Chunghun/0000-0001-8473-9272; Lee, Jongbin/0000-0002-5868-7437	Ministry of Education, Science and Technology, the Republic of Korea; National Institutes of Health [R01NS059042, R01NS052903, R01MH067870]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059042, R01NS052903] Funding Source: NIH RePORTER	Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Edery, J. Hall, H. Keshishian, M. Rosbash, F. Rouyer, A. Sehgal, the Bloomington Drosophila stock center, Harvard Exelixis Drosophila stock collection, KAIST GenExel Drosophila library and the National Institute of Genetics for Drosophila strains; P. Hardin, E. Izaurralde, A. Nakamura, M. Rosbash and N. Sonenberg for antibodies; J. Lykke-Andersen for plasmids; K. E. Duncan for suggestions on in vitro translation assays. This work was supported by grants from the Brain Research Center of the 21st Century Frontier Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, the Republic of Korea (J.C.) and from the National Institutes of Health (R01NS059042, R01NS052903, R01MH067870; R.A.)	Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Castagnetti S, 2000, DEVELOPMENT, V127, P1063; Cheng YZ, 1998, MOL CELL BIOL, V18, P6505, DOI 10.1128/MCB.18.11.6505; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Houl JH, 2006, J BIOL RHYTHM, V21, P93, DOI 10.1177/0748730405283697; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Keryer-Bibens C, 2008, BIOL CELL, V100, P125, DOI 10.1042/BC20070067; Kim EY, 2007, MOL CELL BIOL, V27, P5014, DOI 10.1128/MCB.02339-06; Kula-Eversole E, 2010, P NATL ACAD SCI USA, V107, P13497, DOI 10.1073/pnas.1002081107; Lim C, 2007, CURR BIOL, V17, P1082, DOI 10.1016/j.cub.2007.05.039; Lim C, 2007, MOL CELL BIOL, V27, P4876, DOI 10.1128/MCB.02155-06; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Monzo K, 2006, P NATL ACAD SCI USA, V103, P18160, DOI 10.1073/pnas.0606508103; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Roy G, 2004, MOL CELL BIOL, V24, P1143, DOI 10.1128/MCB.24.3.1143-1154.2004; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Sofola O, 2008, J NEUROSCI, V28, P10200, DOI 10.1523/JNEUROSCI.2786-08.2008; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Suri V, 1999, EMBO J, V18, P675, DOI 10.1093/emboj/18.3.675; Suri V, 2000, J NEUROSCI, V20, P7547; Thoma Christian, 2004, Methods Mol Biol, V257, P171, DOI 10.1385/1-59259-750-5:171; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; ZENG HK, 1994, EMBO J, V13, P3590, DOI 10.1002/j.1460-2075.1994.tb06666.x; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658	51	63	64	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					399	U152		10.1038/nature09728	http://dx.doi.org/10.1038/nature09728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331043	Green Accepted			2022-12-28	WOS:000287409100043
J	Hirnschall, G; Schwartlander, B				Hirnschall, Gottfried; Schwartlaender, Bernhard			Treatment 2.0: catalysing the next phase of scale-up	LANCET			English	Editorial Material									[Schwartlaender, Bernhard] Joint United Nations Programme HIV AIDS, Evidence Strategy & Results Dept, CH-1211 Geneva, Switzerland; [Hirnschall, Gottfried] WHO, HIV Dept, CH-1211 Geneva, Switzerland	World Health Organization	Schwartlander, B (corresponding author), Joint United Nations Programme HIV AIDS, Evidence Strategy & Results Dept, CH-1211 Geneva, Switzerland.	schwartlanderb@unaids.org						GRUBB I, 2003, PUBLIC HLTH APPROACH; Kates J, 2010, FINANCING RESPONSE A; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; MIDDELKOOP K, 2009, 5 IAS C HIV PATH TRE; Siegfried N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008272.pub2; *UN GEN ASS, 2006, 2006 HIGH LEV M AIDS; *UNAIDS, 2007, RES NEEDS AIDS LOW M; UNAIDS, 2010, TREATM 2 0 IS THIS F; UNAIDS, 2010, GLOB REP UNAIDS REP; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2010, ANT THER HIV INF INF	12	34	34	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					209	211		10.1016/S0140-6736(11)60247-X	http://dx.doi.org/10.1016/S0140-6736(11)60247-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21353697				2022-12-28	WOS:000293201100009
J	Fang, TH; Li, WL; Tao, NR; Lu, K				Fang, T. H.; Li, W. L.; Tao, N. R.; Lu, K.			Revealing Extraordinary Intrinsic Tensile Plasticity in Gradient Nano-Grained Copper	SCIENCE			English	Article							NANOSTRUCTURED SURFACE-LAYER; ROOM-TEMPERATURE; NANOCRYSTALLINE MATERIALS; BOUNDARY MOTION; DEFORMATION; GROWTH; METAL; FILMS; CU; DUCTILITY	Nano-grained (NG) metals are believed to be strong but intrinsically brittle: Free-standing NG metals usually exhibit a tensile uniform elongation of a few percent. When a NG copper film is confined by a coarse-grained (CG) copper substrate with a gradient grain-size transition, tensile plasticity can be achieved in the NG film where strain localization is suppressed. The gradient NG film exhibits a 10 times higher yield strength and a tensile plasticity comparable to that of the CG substrate and can sustain a tensile true strain exceeding 100% without cracking. A mechanically driven grain boundary migration process with a substantial concomitant grain growth dominates plastic deformation of the gradient NG structure. The extraordinary intrinsic plasticity of gradient NG structures offers their potential for use as advanced coatings of bulk materials.	[Fang, T. H.; Li, W. L.; Tao, N. R.; Lu, K.] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Institute of Metal Research, CAS	Lu, K (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.	lu@imr.ac.cn			Ministry of Science and Technology of China [2005CB623604, 2010DFB54010]; National Natural Science Foundation [50890171, 50971122]; Danish-Chinese Center for Nanometals [50911130230]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Danish-Chinese Center for Nanometals	We thank X. Si for assistance in sample preparation and J. Tan for assistance in EBSD experiments. We are grateful for financial support of the Ministry of Science and Technology of China (grant 2005CB623604, 2010DFB54010), the National Natural Science Foundation (grants 50890171, 50971122), and the Danish-Chinese Center for Nanometals (grant 50911130230).	Brandstetter S, 2008, SCRIPTA MATER, V58, P61, DOI 10.1016/j.scriptamat.2007.08.042; Cahn JW, 2006, ACTA MATER, V54, P4953, DOI 10.1016/j.actamat.2006.08.004; Chen J, 2006, SCRIPTA MATER, V54, P1913, DOI 10.1016/j.scriptamat.2006.02.022; Fan GJ, 2006, ACTA MATER, V54, P4781, DOI 10.1016/j.actamat.2006.06.016; Gianola DS, 2006, ACTA MATER, V54, P2253, DOI 10.1016/j.actamat.2006.01.023; GLEITER H, 1989, PROG MATER SCI, V33, P223, DOI 10.1016/0921-5093(89)90083-X; Hasnaoui A, 2003, SCIENCE, V300, P1550, DOI 10.1126/science.1084284; Jin M, 2004, ACTA MATER, V52, P5381, DOI 10.1016/j.actamat.2004.07.044; Kumar KS, 2003, ACTA MATER, V51, P387, DOI 10.1016/S1359-6454(02)00421-4; Legros M, 2008, ACTA MATER, V56, P3380, DOI 10.1016/j.actamat.2008.03.032; Li JCM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.215506; Li WL, 2008, SCRIPTA MATER, V59, P546, DOI 10.1016/j.scriptamat.2008.05.003; Lu K, 2004, MAT SCI ENG A-STRUCT, V375, P38, DOI 10.1016/j.msea.2003.10.261; Lu L, 2000, SCIENCE, V287, P1463, DOI 10.1126/science.287.5457.1463; Lu NS, 2009, J MATER RES, V24, P379, DOI 10.1557/JMR.2009.0048; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Pan D, 2007, NANO LETT, V7, P2108, DOI 10.1021/nl071093m; Rupert TJ, 2009, SCIENCE, V326, P1686, DOI 10.1126/science.1178226; Schiotz J, 2004, MAT SCI ENG A-STRUCT, V375, P975, DOI 10.1016/j.msea.2003.10.175; Wang K, 2006, ACTA MATER, V54, P5281, DOI 10.1016/j.actamat.2006.07.013; Wang YM, 2003, SCRIPTA MATER, V48, P1581, DOI 10.1016/S1359-6462(03)00159-3; Wang YM, 2002, APPL PHYS LETT, V80, P2395, DOI 10.1063/1.1465528; Wang ZB, 2010, ACTA MATER, V58, P2376, DOI 10.1016/j.actamat.2009.12.024; Xiang Y, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2108110; Zhang K, 2004, APPL PHYS LETT, V85, P5197, DOI 10.1063/1.1828213	25	1054	1110	70	1351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1587	1590		10.1126/science.1200177	http://dx.doi.org/10.1126/science.1200177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21330487				2022-12-28	WOS:000288754500050
J	Park, K; Robbins, RA				Park, Kevin; Robbins, Richard A.			A COPD disease management program reduced a composite of hospitalizations or emergency department visits	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Park, Kevin] Banner Good Samaritan Med Ctr, Phoenix, AZ 85006 USA; VA Med Ctr, Phoenix, AZ USA	Banner Research; Banner Health	Park, K (corresponding author), Banner Good Samaritan Med Ctr, Phoenix, AZ 85006 USA.							Adams SG, 2007, ARCH INTERN MED, V167, P551, DOI 10.1001/archinte.167.6.551; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Hilleman DE, 2000, CHEST, V118, P1278, DOI 10.1378/chest.118.5.1278; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-5	10.7326/0003-4819-154-6-201103150-02005	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403068				2022-12-28	WOS:000208886200004
J	Hoskins, AA; Friedman, LJ; Gallagher, SS; Crawford, DJ; Anderson, EG; Wombacher, R; Ramirez, N; Cornish, VW; Gelles, J; Moore, MJ				Hoskins, Aaron A.; Friedman, Larry J.; Gallagher, Sarah S.; Crawford, Daniel J.; Anderson, Eric G.; Wombacher, Richard; Ramirez, Nicholas; Cornish, Virginia W.; Gelles, Jeff; Moore, Melissa J.			Ordered and Dynamic Assembly of Single Spliceosomes	SCIENCE			English	Article							PRE-MESSENGER-RNA; MOLECULE FLUORESCENCE; YEAST SPLICEOSOME; CATALYTIC STEPS; EXON DEFINITION; IN-VIVO; COMPLEX; SNRNP; U1; MACHINE	The spliceosome is the complex macromolecular machine responsible for removing introns from precursors to messenger RNAs (pre-mRNAs). We combined yeast genetic engineering, chemical biology, and multiwavelength fluorescence microscopy to follow assembly of single spliceosomes in real time in whole-cell extracts. We find that individual spliceosomal subcomplexes associate with pre-mRNA sequentially via an ordered pathway to yield functional spliceosomes and that association of every subcomplex is reversible. Further, early subcomplex binding events do not fully commit a pre-mRNA to splicing; rather, commitment increases as assembly proceeds. These findings have important implications for the regulation of alternative splicing. This experimental strategy should prove widely useful for mechanistic analysis of other macromolecular machines in environments approaching the complexity of living cells.	[Hoskins, Aaron A.; Friedman, Larry J.; Crawford, Daniel J.; Gelles, Jeff] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Gallagher, Sarah S.; Wombacher, Richard; Cornish, Virginia W.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Hoskins, Aaron A.; Crawford, Daniel J.; Anderson, Eric G.; Ramirez, Nicholas; Moore, Melissa J.] Univ Massachusetts, Howard Hughes Med Inst, Dept Biochem & Mol Pharmacol, Sch Med, Worcester, MA 01605 USA	Brandeis University; Columbia University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Gelles, J (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	gelles@brandeis.edu; melissa.moore@umassmed.edu	Wombacher, Richard/AAP-7591-2021; Wombacher, Richard/M-7117-2016	Wombacher, Richard/0000-0002-3027-7778; Wombacher, Richard/0000-0002-3027-7778; Friedman, Larry/0000-0003-4946-8731	NIH [RO1s GM043369, GM81648, GM053007, GM54469, RC1 GM091804, GM759628]; National Research Service Award fellowship [GM079971, K99/R00 GM086471]; National Defense Science and Engineering Graduate fellowship; Deutscher Akademischer Austausch Dienst fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043369, RC1GM091804, R01GM054469, R37GM043369, F32GM079971, T32GM007596, R01GM053007, R01GM081648, K99GM086471] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate fellowship; Deutscher Akademischer Austausch Dienst fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Chung, A. Okonechnikov, J. Yan, J. Haber, S. Lovett, I. Correa, M.-Q. Xu, Z. Chen, and B. Smith for helpful discussions and assistance. This work was supported by NIH RO1s GM043369 (J. G.), GM81648 (J. G.), GM053007 (M. J. M), GM54469 (V. W. C.), RC1 GM091804 (V. W. C), National Research Service Award fellowship GM079971 (A. A. H.), and K99/R00 GM086471 (A. A. H.). D. J. C., S. S. G., and R. W were supported by NIH training grant GM759628, a National Defense Science and Engineering Graduate fellowship, and a Deutscher Akademischer Austausch Dienst fellowship, respectively. M. J. M. is a Howard Hughes Medical Institute investigator. V. W. C. holds patents on the TMP-tag technology, and the technology is licensed and commercialized by Active Motif.	Abelson J, 2010, NAT STRUCT MOL BIOL, V17, P504, DOI 10.1038/nsmb.1767; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Crawford DJ, 2008, RNA, V14, P170, DOI 10.1261/rna.794808; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; DUNN SMJ, 1980, BIOCHEMISTRY-US, V19, P766, DOI 10.1021/bi00545a024; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Friedman LJ, 2006, BIOPHYS J, V91, P1023, DOI 10.1529/biophysj.106.084004; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; LEGRAIN P, 1988, MOL CELL BIOL, V8, P3755, DOI 10.1128/MCB.8.9.3755; Liu L, 2007, NAT STRUCT MOL BIOL, V14, P519, DOI 10.1038/nsmb1240; Miller LW, 2005, NAT METHODS, V2, P255, DOI 10.1038/NMETH749; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Ruby SW, 1997, J BIOL CHEM, V272, P17333, DOI 10.1074/jbc.272.28.17333; Schneider M, 2010, MOL CELL, V38, P223, DOI 10.1016/j.molcel.2010.02.027; SERAPHIN B, 1991, EMBO J, V10, P1209, DOI 10.1002/j.1460-2075.1991.tb08062.x; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Tseng CK, 2008, SCIENCE, V320, P1782, DOI 10.1126/science.1158993; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Xu YZ, 2004, EMBO J, V23, P376, DOI 10.1038/sj.emboj.7600050	23	201	205	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1289	1295		10.1126/science.1198830	http://dx.doi.org/10.1126/science.1198830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393538	Green Accepted			2022-12-28	WOS:000288215200037
J	Harlander, M; Lechner, R; Brownnutt, M; Blatt, R; Hansel, W				Harlander, M.; Lechner, R.; Brownnutt, M.; Blatt, R.; Haensel, W.			Trapped-ion antennae for the transmission of quantum information	NATURE			English	Article							ATOM; OSCILLATORS; DECOHERENCE; COMPUTATION; COMPUTER; PHOTON; CAVITY; STATE	More than 100 years ago, Hertz succeeded in transmitting signals over a few metres to a receiving antenna using an electromagnetic oscillator, thus proving the electromagnetic theory(1) developed by Maxwell. Since this seminal work, technology has developed, and various oscillators are now available at the quantum mechanical level. For quantized electromagnetic oscillations, atoms in cavities can be used to couple electric fields(2,3). However, a quantum mechanical link between two mechanical oscillators (such as cantilevers(4,5) or the vibrational modes of trapped atoms(6) or ions(7,8)) has been rarely demonstrated and has been achieved only indirectly. Examples include the mechanical transport of atoms carrying quantum information(9) or the use of spontaneously emitted photons(10). Here we achieve direct coupling between the motional dipoles of separately trapped ions over a distance of 54 micrometres, using the dipole-dipole interaction as a quantum mechanical transmission line(11). This interaction is small between single trapped ions, but the coupling is amplified by using additional trapped ions as antennae. With three ions in each well, the interaction is increased by a factor of seven compared to the single-ion case. This enhancement facilitates bridging of larger distances and relaxes the constraints on the miniaturization of trap electrodes. The system provides a building block for quantum computers and opportunities for coupling different types of quantum systems.	[Harlander, M.; Lechner, R.; Brownnutt, M.; Blatt, R.; Haensel, W.] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Blatt, R.; Haensel, W.] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria	University of Innsbruck; Austrian Academy of Sciences	Blatt, R (corresponding author), Univ Innsbruck, Inst Expt Phys, Technikerstr 25, A-6020 Innsbruck, Austria.	rainer.blatt@uibk.ac.at	Blatt, Rainer/H-9527-2014		EU; Austrian Science Fund (FWF); European Research Council (ERC); Institut fur Quanteninformation GmbH	EU(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC)European Commission); Institut fur Quanteninformation GmbH	We thank H. Haffner for discussions at an early state of the project. We acknowledge the support of the EU STREP project MICROTRAP, the Austrian Science Fund (FWF), the EU network SCALA, the European Research Council (ERC) and the Institut fur Quanteninformation GmbH.	Anetsberger G, 2009, NAT PHYS, V5, P909, DOI 10.1038/NPHYS1425; Benhelm J, 2008, NAT PHYS, V4, P463, DOI 10.1038/nphys961; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Cirac JI, 2000, NATURE, V404, P579, DOI 10.1038/35007021; Deslauriers L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.103007; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Gleyzes S, 2007, NATURE, V446, P297, DOI 10.1038/nature05589; HERTZ H, 1890, ANN PHYS CHEM, V277, P369; Jost JD, 2009, NATURE, V459, P683, DOI 10.1038/nature08006; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Kuhr S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2724816; Labaziewicz J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013001; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; Leibrandt D, 2007, QUANTUM INF COMPUT, V7, P52; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; Monroe C, 1996, SCIENCE, V272, P1131, DOI 10.1126/science.272.5265.1131; Raussendorf R, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.022312; Roos C, 1999, PHYS REV LETT, V83, P4713, DOI 10.1103/PhysRevLett.83.4713; Schliesser A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.243905; Schmid S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.133202; Schulz SA, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/045007; Seidelin S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.253003; Turchette QA, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063418; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; Zipkes C, 2010, NATURE, V464, P388, DOI 10.1038/nature08865	29	121	121	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					200	203		10.1038/nature09800	http://dx.doi.org/10.1038/nature09800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21346764	Green Submitted			2022-12-28	WOS:000288170200033
J	Septimus, EJ; Perlin, JB; Cormier, SB; Moody, JA; Hickok, JD				Septimus, Edward J.; Perlin, Jonathan B.; Cormier, Scott B.; Moody, Julia A.; Hickok, Jason D.			A Multifaceted Mandatory Patient Safety Program and Seasonal Influenza Vaccination of Health Care Workers in Community Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Septimus, Edward J.; Perlin, Jonathan B.; Cormier, Scott B.; Moody, Julia A.; Hickok, Jason D.] HCA Inc, Clin Serv Grp, Nashville, TN USA	Hospital Corporation of America	Septimus, EJ (corresponding author), HCA Inc, Clin Serv Grp, Nashville, TN USA.	jonathan.perlin@hcahealthcare.com						Babcock HM, 2010, CLIN INFECT DIS, V50, P459, DOI 10.1086/650752; *CDCP, SEAS INFL FREE RES; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Harris K. M., 2010, Morbidity and Mortality Weekly Report, V59, P357; Rakita RM, 2010, INFECT CONT HOSP EP, V31, P881, DOI 10.1086/656210	5	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					999	1000		10.1001/jama.2011.244	http://dx.doi.org/10.1001/jama.2011.244			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386077				2022-12-28	WOS:000288129600018
J	Arpaia, N; Godec, J; Lau, L; Sivick, KE; McLaughlin, LM; Jones, MB; Dracheva, T; Peterson, SN; Monack, DM; Barton, GM				Arpaia, Nicholas; Godec, Jernej; Lau, Laura; Sivick, Kelsey E.; McLaughlin, Laura M.; Jones, Marcus B.; Dracheva, Tatiana; Peterson, Scott N.; Monack, Denise M.; Barton, Gregory M.			TLR Signaling Is Required for Salmonella typhimurium Virulence	CELL			English	Article							TOLL-LIKE RECEPTORS; III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; PHAGOSOME MATURATION; SEROVAR TYPHIMURIUM; NATURAL-RESISTANCE; DENDRITIC CELLS; INTRACELLULAR PARASITES; ANTIMICROBIAL PEPTIDES; MACROPHAGE APOPTOSIS	Toll-like receptors (TLRs) contribute to host resistance to microbial pathogens and can drive the evolution of virulence mechanisms. We have examined the relationship between host resistance and pathogen virulence using mice with a functional allele of the nramp-1 gene and lacking combinations of TLRs. Mice deficient in both TLR2 and TLR4 were highly susceptible to the intracellular bacterial pathogen Salmonella typhimurium, consistent with reduced innate immune function. However, mice lacking additional TLRs involved in S. typhimurium recognition were less susceptible to infection. In these TLR-deficient cells, bacteria failed to upregulate Salmonella pathogenicity island 2 (SPI-2) genes and did not form a replicative compartment. We demonstrate that TLR signaling enhances the rate of acidification of the Salmonella-containing phagosome, and inhibition of this acidification prevents SPI-2 induction. Our results indicate that S. typhimurium requires cues from the innate immune system to regulate virulence genes necessary for intracellular survival, growth, and systemic infection.	[Arpaia, Nicholas; Godec, Jernej; Lau, Laura; Sivick, Kelsey E.; Barton, Gregory M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [McLaughlin, Laura M.; Monack, Denise M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Jones, Marcus B.; Dracheva, Tatiana; Peterson, Scott N.] J Craig Venter Inst, Pathogen Funct Genom Resource Ctr, Rockville, MD 20850 USA	University of California System; University of California Berkeley; Stanford University; J. Craig Venter Institute	Barton, GM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	barton@berkeley.edu	hongbo, yi/G-9615-2011; Arpaia, Nicholas/R-2549-2018	Barton, Gregory/0000-0002-3793-0100; Arpaia, Nicholas/0000-0002-0657-0528; Monack, Denise/0000-0003-3804-2209	NIH [P01-AI063302, Y1-AI-8401, T32-GM007232]; Burroughs Wellcome Fund; University of California Cancer Research Coordinating Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, R01AI008401, R01AI072429, R22AI008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); University of California Cancer Research Coordinating Committee(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Machen, P. Herzmark, J. Ross, and E. Peled for assistance with ratiometric imaging; members of the Barton lab, J. Ayres, and R. Vance for critical reading of this manuscript; C. Rae and N. Meyer-Morse for assistance with L. monocytogenes; M. Fontana and K. Monroe for assistance with L. pneumophila; R. Zalpuri and K. McDonald for assistance with EM; and H. Nolla for assistance with flow cytometry. This work was supported in part by grants from the NIH (P01-AI063302 to D. M. M. and G. M. B.; Y1-AI-8401 to S. N. P.), the Burroughs Wellcome Fund (D. M. M.), and the University of California Cancer Research Coordinating Committee (G. M. B.) and an NIH NRSA Trainee appointment on grant T32-GM007232 (N. A.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Cook P, 2007, IMMUNOLOGY, V122, P222, DOI 10.1111/j.1365-2567.2007.02631.x; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Detweiler CS, 2003, MOL MICROBIOL, V48, P385, DOI 10.1046/j.1365-2958.2003.03455.x; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hedrick SM, 2004, IMMUNITY, V21, P607, DOI 10.1016/j.immuni.2004.08.020; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kim CC, 2004, J BACTERIOL, V186, P4694, DOI 10.1128/JB.186.14.4694-4704.2004; LEUNG KY, 1991, P NATL ACAD SCI USA, V88, P11470, DOI 10.1073/pnas.88.24.11470; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; OBRIEN AD, 1980, J IMMUNOL, V124, P20; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pfeifer CG, 1999, INFECT IMMUN, V67, P5690, DOI 10.1128/IAI.67.11.5690-5698.1999; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rappl C, 2003, FEMS MICROBIOL LETT, V226, P363, DOI 10.1016/S0378-1097(03)00638-4; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Royle MCJ, 2003, J IMMUNOL, V170, P5445, DOI 10.4049/jimmunol.170.11.5445; Russell DG, 2007, NAT IMMUNOL, V8, P217, DOI 10.1038/ni0307-217a; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Silphaduang U, 2007, J BACTERIOL, V189, P3669, DOI 10.1128/JB.00002-07; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Valdez Y, 2008, CELL MICROBIOL, V10, P1646, DOI 10.1111/j.1462-5822.2008.01155.x; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Vidal SM, 1996, J IMMUNOL, V157, P3559; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Vijay-Kumar M, 2008, INFECT IMMUN, V76, P1276, DOI 10.1128/IAI.01491-07; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wong CE, 2009, INFECT IMMUN, V77, P4750, DOI 10.1128/IAI.00545-09; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; Zaharik ML, 2002, P NATL ACAD SCI USA, V99, P15705, DOI 10.1073/pnas.252415599	72	167	171	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					675	688		10.1016/j.cell.2011.01.031	http://dx.doi.org/10.1016/j.cell.2011.01.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376231	Green Accepted, Bronze			2022-12-28	WOS:000288007100008
J	Wartlick, O; Mumcu, P; Kicheva, A; Bittig, T; Seum, C; Julicher, F; Gonzalez-Gaitan, M				Wartlick, O.; Mumcu, P.; Kicheva, A.; Bittig, T.; Seum, C.; Juelicher, F.; Gonzalez-Gaitan, M.			Dynamics of Dpp Signaling and Proliferation Control	SCIENCE			English	Article							WING IMAGINAL DISC; CELL-PROLIFERATION; MORPHOGEN GRADIENT; DROSOPHILA; SIZE; GROWTH; HEDGEHOG; ROBUSTNESS; EXPRESSION; DIFFUSION	Morphogens, such as Decapentaplegic (Dpp) in the fly imaginal discs, form graded concentration profiles that control patterning and growth of developing organs. In the imaginal discs, proliferative growth is homogeneous in space, posing the conundrum of how morphogen concentration gradients could control position-independent growth. To understand the mechanism of proliferation control by the Dpp gradient, we quantified Dpp concentration and signaling levels during wing disc growth. Both Dpp concentration and signaling gradients scale with tissue size during development. On average, cells divide when Dpp signaling levels have increased by 50%. Our observations are consistent with a growth control mechanism based on temporal changes of cellular morphogen signaling levels. For a scaling gradient, this mechanism generates position-independent growth rates.	[Mumcu, P.; Bittig, T.; Juelicher, F.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Wartlick, O.; Kicheva, A.; Seum, C.; Gonzalez-Gaitan, M.] Univ Geneva, Fac Sci, Dept Biochem, CH-1211 Geneva, Switzerland; [Wartlick, O.; Kicheva, A.; Seum, C.; Gonzalez-Gaitan, M.] Univ Geneva, Fac Sci, Dept Mol Biol, CH-1211 Geneva, Switzerland	Max Planck Society; University of Geneva; University of Geneva	Julicher, F (corresponding author), Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany.	julicher@pks.mpg.de; marcos.gonzalez@unige.ch	Julicher, Frank/B-1828-2009	Julicher, Frank/0000-0003-4731-9185; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; Kicheva, Anna/0000-0003-4509-4998	Max-Planck-Gesellschaft; Geneva University; European Research Council; SystemsX (LipidX); Swiss National Science Foundation (SNF); National Centre of Competence in Research (NCCR)	Max-Planck-Gesellschaft(Max Planck Society); Geneva University; European Research Council(European Research Council (ERC)European Commission); SystemsX (LipidX); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); National Centre of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	We thank E. Sanchez-Herrero, S. Cohen, G. Campbell, and K. Irvine for reagents, and M. Milinkovitch, A. Martinez-Arias, T. Ferraro, and F. Naef for discussions. A.K. developed and performed the FRAP and P-Mad assays. O.W. generated all other experimental data and had a leading role to develop the quantitative methods to analyze it. P.M. had a leading role to develop the theoretical description of growth control, and he performed computer simulations. P.M. and T.B. developed a continuum theory of the Dpp gradient during growth and studied possible growth rules. C.S. generated reagents. O.W., P.M., A.K., T.B., F.J., and M.G.-G. developed the whole project synergistically and equally and wrote the paper together. P.M., T.B., and F.J. were supported by the Max-Planck-Gesellschaft. O.W., A.K., C.S., and M.G.-G. were supported by Geneva University and by European Research Council advanced investigator grant (SARA), SystemsX (LipidX), Swiss National Science Foundation (SNF), National Centre of Competence in Research (NCCR) chemical biology and Frontiers in Genetics and R'equip grants.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barkai N, 2009, FEBS J, V276, P1196, DOI 10.1111/j.1742-4658.2008.06854.x; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Burke R, 1996, DEVELOPMENT, V122, P2261; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Day SJ, 2000, DEVELOPMENT, V127, P2977; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; FAIN MJ, 1982, DEV BIOL, V92, P247, DOI 10.1016/0012-1606(82)90169-5; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Friedrich BM, 2007, P NATL ACAD SCI USA, V104, P13256, DOI 10.1073/pnas.0703530104; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GONZALEZGAITAN M, 1994, MECH DEVELOP, V46, P183, DOI 10.1016/0925-4773(94)90070-1; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; OTHMER HG, 1980, P NATL ACAD SCI-BIOL, V77, P4180, DOI 10.1073/pnas.77.7.4180; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Schwank G, 2008, DEVELOPMENT, V135, P4003, DOI 10.1242/dev.025635; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; Strigini M, 1997, DEVELOPMENT, V124, P4697; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715; Yao LC, 2008, DEVELOPMENT, V135, P2183, DOI 10.1242/dev.015826; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004307	39	233	236	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1154	1159		10.1126/science.1200037	http://dx.doi.org/10.1126/science.1200037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385708				2022-12-28	WOS:000287971200032
J	Dhalla, IA; Detsky, AS				Dhalla, Irfan A.; Detsky, Allan S.			Aligning Incentives for Academic Physicians to Improve Health Care Quality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dhalla, Irfan A.; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Dhalla, Irfan A.; Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Dhalla, Irfan A.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Dhalla, Irfan A.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Dhalla, IA (corresponding author), 30 Bond St, Toronto, ON M5B 1W8, Canada.	dhallai@smh.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Ayanian JZ, 2002, MILBANK Q, V80, P569, DOI 10.1111/1468-0009.00023; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Detsky AS, 2007, JAMA-J AM MED ASSOC, V298, P799, DOI 10.1001/jama.298.7.799; Dzau VJ, 2010, LANCET, V375, P949, DOI 10.1016/S0140-6736(09)61082-5; Emery SE, 2006, J BONE JOINT SURG AM, V88A, P2049, DOI 10.2106/JBJS.E.00243; Patel MR, 2007, AM J MED, V120, P40, DOI 10.1016/j.amjmed.2006.10.008; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2009, ACAD MED, V84, P1651, DOI 10.1097/ACM.0b013e3181bce0ee; Reece EA, 2008, ACAD MED, V83, P76, DOI 10.1097/ACM.0b013e31815c6508; Shojania KG, 2009, JAMA-J AM MED ASSOC, V301, P766, DOI 10.1001/jama.2009.140	10	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					932	933		10.1001/jama.2011.234	http://dx.doi.org/10.1001/jama.2011.234			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728DP	21364142				2022-12-28	WOS:000287854700027
J	Gallagher, J				Gallagher, Joe			Personal View Lost in translation: be aware of patients' lives	BRITISH MEDICAL JOURNAL			English	Editorial Material									Palms Surg, Gorey, Wexford, Ireland		Gallagher, J (corresponding author), Palms Surg, Gorey, Wexford, Ireland.	joejgallagher@gmail.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 28	2011	342								d1253	10.1136/bmj.d1253	http://dx.doi.org/10.1136/bmj.d1253			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732DK	21357349				2022-12-28	WOS:000288164200006
J	Botstein, D				Botstein, David			Fruits of Genome Sequences for Biology	SCIENCE			English	Editorial Material									Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University	Botstein, D (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.								0	3	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1025	1025		10.1126/science.1204038	http://dx.doi.org/10.1126/science.1204038			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350164				2022-12-28	WOS:000287699000046
J	Porrello, ER; Mahmoud, AI; Simpson, E; Hill, JA; Richardson, JA; Olson, EN; Sadek, HA				Porrello, Enzo R.; Mahmoud, Ahmed I.; Simpson, Emma; Hill, Joseph A.; Richardson, James A.; Olson, Eric N.; Sadek, Hesham A.			Transient Regenerative Potential of the Neonatal Mouse Heart	SCIENCE			English	Article							CELL-CYCLE CONTROL; MAMMALIAN CARDIOMYOCYTES; ZEBRAFISH; INJURY; PROLIFERATION; GROWTH	Certain fish and amphibians retain a robust capacity for cardiac regeneration throughout life, but the same is not true of the adult mammalian heart. Whether the capacity for cardiac regeneration is absent in mammals or whether it exists and is switched off early after birth has been unclear. We found that the hearts of 1-day-old neonatal mice can regenerate after partial surgical resection, but this capacity is lost by 7 days of age. This regenerative response in 1-day-old mice was characterized by cardiomyocyte proliferation with minimal hypertrophy or fibrosis, thereby distinguishing it from repair processes. Genetic fate mapping indicated that the majority of cardiomyocytes within the regenerated tissue originated from preexisting cardiomyocytes. Echocardiography performed 2 months after surgery revealed that the regenerated ventricular apex had normal systolic function. Thus, for a brief period after birth, the mammalian heart appears to have the capacity to regenerate.	[Porrello, Enzo R.; Hill, Joseph A.; Richardson, James A.; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mahmoud, Ahmed I.; Hill, Joseph A.; Sadek, Hesham A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Simpson, Emma; Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu; hesham.sadek@utsouthwestern.edu	Porrello, Enzo/G-9934-2012	Porrello, Enzo/0000-0001-6105-7463; Mahmoud, Ahmed/0000-0003-1528-7393	National Health and Medical Research Council; National Heart Foundation of Australia; American Heart Association; NIH [HL100401-01]; Donald W. Reynolds Center for Clinical Cardiovascular Research; Jon Holden DeHaan Foundation; Leducq Foundation; Robert A. Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093039, U01HL100401, R01HL115275, R01HL077439, R37HL053351] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; Jon Holden DeHaan Foundation; Leducq Foundation(Leducq Foundation); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Simsek, J. Shelton, and the UT Southwestern Histology Core for help with histology and immunostaining, and J. Cabrera for graphical assistance. Supported by an overseas postdoctoral fellowship from the National Health and Medical Research Council and National Heart Foundation of Australia (E.R.P.), a cardiovascular research scholar award from Gilead Sciences and a fellow-to-faculty award from the American Heart Association (H.A.S.), and NIH grant HL100401-01, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the American Heart Association, the Jon Holden DeHaan Foundation, the Leducq Foundation, and the Robert A. Welch Foundation (E.N.O.).	Ahuja P, 2004, J CELL SCI, V117, P3295, DOI 10.1242/jcs.01159; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005	15	1557	1629	8	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1078	1080		10.1126/science.1200708	http://dx.doi.org/10.1126/science.1200708			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350179	Green Accepted			2022-12-28	WOS:000287699000067
J	Merrikh, H; Machon, C; Grainger, WH; Grossman, AD; Soultanas, P				Merrikh, Houra; Machon, Cristina; Grainger, William H.; Grossman, Alan D.; Soultanas, Panos			Co-directional replication-transcription conflicts lead to replication restart	NATURE			English	Article							BACILLUS-SUBTILIS; DNA-REPLICATION; PROTEINS; PRIA; LOCALIZATION; INITIATION; REPLISOME; REP; RNA; RECOMBINATION	Head-on encounters between the replication and transcription machineries on the lagging DNA strand can lead to replication fork arrest and genomic instability(1,2). To avoid head-on encounters, most genes, especially essential and highly transcribed genes, are encoded on the leading strand such that transcription and replication are co-directional. Virtually all bacteria have the highly expressed ribosomal RNA genes co-directional with replication(3). In bacteria, co-directional encounters seem inevitable because the rate of replication is about 10-20-fold greater than the rate of transcription. However, these encounters are generally thought to be benign(2,4-9). Biochemical analyses indicate that head-on encounters(10) are more deleterious than co-directional encounters(8) and that in both situations, replication resumes without the need for any auxiliary restart proteins, at least in vitro. Here we show that in vivo, co-directional transcription can disrupt replication, leading to the involvement of replication restart proteins. We found that highly transcribed rRNA genes are hotspots for co-directional conflicts between replication and transcription in rapidly growing Bacillus subtilis cells. We observed a transcription-dependent increase in association of the replicative helicase and replication restart proteins where head-on and co-directional conflicts occur. Our results indicate that there are co-directional conflicts between replication and transcription in vivo. Furthermore, in contrast to the findings in vitro, the replication restart machinery is involved in vivo in resolving potentially deleterious encounters due to head-on and co-directional conflicts. These conflicts probably occur in many organisms and at many chromosomal locations and help to explain the presence of important auxiliary proteins involved in replication restart and in helping to clear a path along the DNA for the replisome.	[Merrikh, Houra; Grossman, Alan D.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Machon, Cristina; Grainger, William H.; Soultanas, Panos] Univ Nottingham, Sch Chem, Ctr Biomol Sci, Nottingham NG7 2RD, England	Massachusetts Institute of Technology (MIT); University of Nottingham	Grossman, AD (corresponding author), MIT, Dept Biol, Bldg 68-530, Cambridge, MA 02139 USA.	adg@mit.edu; Panos.Soultanas@nottingham.ac.uk	Sobrado, Cristina Machón/K-1634-2014	Sobrado, Cristina Machón/0000-0001-5363-2958; Soultanas, Panos/0000-0003-3578-5699	Biotechnology and Biological Sciences Research Council [BB/E006450/1]; Wellcome Trust [091968/Z/10/Z]; NIH [GM41934, GM093408]; Royal Society; BBSRC [BB/E006450/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041934, R01GM041934, F32GM093408] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Grainger, C. Lee, T. Baker, and W. K. Smits for discussions, W. K. Smits for constructing the priA-ssrA* mutant, and C. Lee, C. Bonilla, S. P. Bell, and J. D. Wang for comments on the manuscript. Work in the P. S. laboratory was supported by Biotechnology and Biological Sciences Research Council grant BB/E006450/1 and a Wellcome Trust grant 091968/Z/10/Z. Work in the A. D. G. laboratory was supported by NIH grant GM41934 and H. M. was supported in part by NIH postdoctoral fellowship GM093408. The Biotechnology and Biological Sciences Research Council and the Royal Society provided funds for a sabbatical visit of P. S. in the A. D. G. laboratory.	Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Bruand C, 2005, MOL MICROBIOL, V55, P1138, DOI 10.1111/j.1365-2958.2004.04451.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Grainger WH, 2010, NUCLEIC ACIDS RES, V38, P2851, DOI 10.1093/nar/gkp1236; Griffith KL, 2008, MOL MICROBIOL, V70, P1012, DOI 10.1111/j.1365-2958.2008.06467.x; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Harwood C.R., 1990, MOL BIOL METHODS BAC; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Imai Y, 2000, MOL MICROBIOL, V36, P1037, DOI 10.1046/j.1365-2958.2000.01928.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Mahdi AA, 2006, GENE DEV, V20, P2135, DOI 10.1101/gad.382306; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; Meile JC, 2006, PROTEOMICS, V6, P2135, DOI 10.1002/pmic.200500512; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; Olavarrieta L, 2002, J MOL BIOL, V322, P1, DOI 10.1016/S0022-2836(02)00740-4; Polard P, 2002, NUCLEIC ACIDS RES, V30, P1593, DOI 10.1093/nar/30.7.1593; Pomerantz RT, 2010, CELL CYCLE, V9, P2537, DOI 10.4161/cc.9.13.12122; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rokop ME, 2004, MOL MICROBIOL, V52, P1757, DOI 10.1111/j.1365-2958.2004.04091.x; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Smits WK, 2010, MOL MICROBIOL, V75, P452, DOI 10.1111/j.1365-2958.2009.06999.x; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Wang JD, 2007, P NATL ACAD SCI USA, V104, P5608, DOI 10.1073/pnas.0608999104	34	123	124	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					554	U147		10.1038/nature09758	http://dx.doi.org/10.1038/nature09758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350489	Green Accepted, Green Submitted			2022-12-28	WOS:000287652900046
J	Dahabreh, IJ; Kent, DM				Dahabreh, Issa J.; Kent, David M.			Index Event Bias as an Explanation for the Paradoxes of Recurrence Risk Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATENT FORAMEN OVALE; OUTCOMES; STROKE; TERM		[Dahabreh, Issa J.; Kent, David M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	Tufts Medical Center	Kent, DM (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, 800 Washington St,Box 63, Boston, MA 02111 USA.	dkent1@tuftsmedicalcenter.org			NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062153] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR025752] Funding Source: Medline; NINDS NIH HHS [R01 NS062153] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adamopoulos C, 2011, EUR J HEART FAIL, V13, P200, DOI 10.1093/eurjhf/hfq159; Baglin T, 2010, J THROMB HAEMOST, V8, P228, DOI 10.1111/j.1538-7836.2009.03702.x; BARBASH GI, 1995, J AM COLL CARDIOL, V26, P1222, DOI 10.1016/0735-1097(95)00299-5; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Kent DM, 2010, STROKE, V41, pS26, DOI 10.1161/STROKEAHA.110.595140; Krasuski RA, 2009, JAMA-J AM MED ASSOC, V302, P290, DOI 10.1001/jama.2009.1012; Rich JD, 2010, J AM COLL CARDIOL, V56, P1376, DOI 10.1016/j.jacc.2010.06.028; VanderWeele TJ, 2008, EPIDEMIOLOGY, V19, P720, DOI 10.1097/EDE.0b013e3181810e29; Weimar C, 2009, CEREBROVASC DIS, V28, P349, DOI 10.1159/000229553	10	198	200	1	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					822	823		10.1001/jama.2011.163	http://dx.doi.org/10.1001/jama.2011.163			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21343582	Green Accepted			2022-12-28	WOS:000287594300027
J	Jiang, H; Shukla, A; Wang, XL; Chen, WY; Bernstein, BE; Roeder, RG				Jiang, Hao; Shukla, Abhijit; Wang, Xiaoling; Chen, Wei-yi; Bernstein, Bradley E.; Roeder, Robert G.			Role for Dpy-30 in ES Cell-Fate Specification by Regulation of H3K4 Methylation within Bivalent Domains	CELL			English	Article							EMBRYONIC STEM-CELLS; ELEGANS DOSAGE COMPENSATION; HISTONE H3; DEVELOPMENTAL REGULATORS; CHROMATIN SIGNATURES; GROUP PROTEINS; POLYCOMB; PLURIPOTENT; DIFFERENTIATION; TRITHORAX	Histone H3K4 methylation is associated with active genes and, along with H3K27 methylation, is part of a bivalent chromatin mark that typifies poised developmental genes in embryonic stem cells (ESCs). However, its functional roles in ESC maintenance and differentiation are not established. Here we show that mammalian Dpy-30, a core subunit of the SET1/MLL histone methyltransferase complexes, modulates H3K4 methylation in vitro, and directly regulates chromosomal H3K4 trimethylation (H3K4me3) throughout the mammalian genome. Depletion of Dpy-30 does not affect ESC self-renewal, but significantly alters the differentiation potential of ESCs, particularly along the neural lineage. The differentiation defect is accompanied by defects in gene induction and in H3K4 methylation at key developmental loci. Our results strongly indicate an essential functional role for Dpy-30 and SET1/MLL complex-mediated H3K4 methylation, as a component of the bivalent mark, at developmental genes during the ESC fate transitions.	[Jiang, Hao; Wang, Xiaoling; Chen, Wei-yi; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA; [Shukla, Abhijit; Bernstein, Bradley E.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Shukla, Abhijit; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Shukla, Abhijit; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Rockefeller University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA.	roeder@mail.rockefeller.edu	Wang, Xiaoling/D-4208-2013	Chen, Wei-Yi/0000-0002-0661-6899	Tri-Institutional Starr Stem Cell Scholars fellowship; NIH [DK071900]; Starr Cancer Consortium [I2-A88]; Leukemia and Lymphoma Society [7132-08]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	Tri-Institutional Starr Stem Cell Scholars fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Yali Dou for baculoviruses encoding RbBP5, WDR5 and Ash2L, Cristina Hughes (David Allis lab), and Eric McIntush (Bethyl Laboratories) for Dpy-30 antibody, Joanna Wysocka for WDR5 antibody, Aaron Goldberg (David Allis lab) for LIF, Shannon Lauberth and Zhanyun Tang for providing supporting data, Zheng-Yuan Fu for technical assistance, Esther Rheinbay, Jing Wang and Xiaojian Sun for data analyses, and Bing Ren (UCSD) and Xiangdong Lu for insightful discussions of the project. H.J. and W.-Y.C. are Leukemia and Lymphoma Society Fellows. X. W. is a recipient of a Tri-Institutional Starr Stem Cell Scholars fellowship. This work was supported by NIH (DK071900), Starr Cancer Consortium (I2-A88), and Leukemia and Lymphoma Society (7132-08) grants to R.G.R.	Andreu-Vieyra CV, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000453; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; HSU DR, 1995, DEVELOPMENT, V121, P3323; HSU DR, 1994, GENETICS, V137, P999; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lubitz S, 2007, MOL BIOL CELL, V18, P2356, DOI 10.1091/mbc.E06-11-1060; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wang X, 2008, J VIS EXP; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	44	206	223	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					513	525		10.1016/j.cell.2011.01.020	http://dx.doi.org/10.1016/j.cell.2011.01.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335234	Green Accepted, Bronze			2022-12-28	WOS:000287473100007
J	Elyada, E; Pribluda, A; Goldstein, RE; Morgenstern, Y; Brachya, G; Cojocaru, G; Snir-Alkalay, I; Burstain, I; Haffner-Krausz, R; Jung, S; Wiener, Z; Alitalo, K; Oren, M; Pikarsky, E; Ben-Neriah, Y				Elyada, Ela; Pribluda, Ariel; Goldstein, Robert E.; Morgenstern, Yael; Brachya, Guy; Cojocaru, Gady; Snir-Alkalay, Irit; Burstain, Ido; Haffner-Krausz, Rebecca; Jung, Steffen; Wiener, Zoltan; Alitalo, Kari; Oren, Moshe; Pikarsky, Eli; Ben-Neriah, Yinon			CKI alpha ablation highlights a critical role for p53 in invasiveness control	NATURE			English	Article							ONCOGENE-INDUCED SENESCENCE; INTESTINAL EPITHELIUM; MOUSE MODEL; EXPRESSION; INVASION; TUMORIGENESIS; TRANSGENE; MUTATIONS; APOPTOSIS; BIOLOGY	The mature gut renews continuously and rapidly throughout adult life, often in a damage-inflicting micro-environment. The major driving force for self-renewal of the intestinal epithelium is the Wnt-mediated signalling pathway, and Wnt signalling is frequently hyperactivated in colorectal cancer(1). Here we show that casein kinase I alpha (CKI alpha), a component of the beta-catenin-destruction complex(1), is a critical regulator of the Wnt signalling pathway. Inducing the ablation of Csnk1a1 (the gene encoding CKI alpha) in the gut triggers massive Wnt activation, surprisingly without causing tumorigenesis. CKI alpha-deficient epithelium shows many of the features of human colorectal tumours in addition to Wnt activation, in particular the induction of the DNA damage response and cellular senescence, both of which are thought to provide a barrier against malignant transformation(2). The epithelial DNA damage response in mice is accompanied by substantial activation of p53, suggesting that the p53 pathway may counteract the pro-tumorigenic effects of Wnt hyperactivation. Notably, the transition from benign adenomas to invasive colorectal cancer in humans is typically linked to p53 inactivation, underscoring the importance of p53 as a safeguard against malignant progression(3); however, the mechanism of p53-mediated tumour suppression is unknown. We show that the maintenance of intestinal homeostasis inCKI alpha-deficient gut requires p53-mediated growth control, because the combined ablation of Csnk1a1 and either p53 or its target gene p21 (also known as Waf1, Cip1, Sdi1 and Cdkn1a) triggered high-grade dysplasia with extensive proliferation. Unexpectedly, these ablations also induced non-proliferating cells to invade the villous lamina propria rapidly, producing invasive carcinomas throughout the small bowel. Furthermore, in p53-deficient gut, loss of heterozygosity of the gene encoding CKI alpha caused a highly invasive carcinoma, indicating that CKI alpha functions as a tumour suppressor when p53 is inactivated. We identified a set of genes (the p53-suppressed invasiveness signature, PSIS) that is activated by the loss of both p53 and CKI alpha and which probably accounts for the brisk induction of invasiveness. PSIS transcription and tumour invasion were suppressed by p21, independently of cell cycle control. Restraining tissue invasion through suppressing PSIS expression is thus a novel tumour-suppressor function of wild-type p53.	[Elyada, Ela; Pribluda, Ariel; Goldstein, Robert E.; Morgenstern, Yael; Brachya, Guy; Cojocaru, Gady; Snir-Alkalay, Irit; Burstain, Ido; Pikarsky, Eli; Ben-Neriah, Yinon] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel; [Haffner-Krausz, Rebecca] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Wiener, Zoltan; Alitalo, Kari] Univ Helsinki, Biomedicum Helsinki, Mol Canc Biol Program, FIN-00014 Helsinki, Finland; [Wiener, Zoltan; Alitalo, Kari] Univ Helsinki, Biomedicum Helsinki, Inst Mol Med Finland, FIN-00014 Helsinki, Finland; [Oren, Moshe] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Pathol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science; Weizmann Institute of Science; University of Helsinki; University of Helsinki; Weizmann Institute of Science; Hebrew University of Jerusalem	Ben-Neriah, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Lautenberg Ctr Immunol, IL-91120 Jerusalem, Israel.	peli@hadassah.org.il; yinon@cc.huji.ac.il	Ben-Neriah, Yinon/L-6285-2019; pikarsky, eli/GXV-7099-2022; Jung, Steffen/K-1409-2012; Alitalo, Kari K/J-5013-2014	Jung, Steffen/0000-0003-4290-5716; Alitalo, Kari K/0000-0002-7331-0902; Oren, Moshe/0000-0003-4311-7172; pikarsky, eli/0000-0003-4186-7105	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation; RUBICON EC Network of Excellence; Israel Cancer Research Fund; Deutsches Krebsforschungszentrum-Ministry of Science and Technology (DKFZ-MOST); Marie-Curie Intra-European Fellowship	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF); Israel Science Foundation(Israel Science Foundation); RUBICON EC Network of Excellence; Israel Cancer Research Fund; Deutsches Krebsforschungszentrum-Ministry of Science and Technology (DKFZ-MOST); Marie-Curie Intra-European Fellowship(European Commission)	We thank S. Robine for the Vil1-Cre-ER<SUP>T2</SUP> mice, O. Sansom and B. Romagnolo for intestinal sections of Apc<SUP>Delta gut</SUP> mice, K. Rajewsky for the pGEM-loxP-Neo-loxP and pCA-NLS-Cre vectors; and E. Horwitz, M. Farago, D. Naor, N. Asherie and D. Knigin for providing expertise and reagents. We are grateful to A. Yaron for critical reading of the manuscript. This work was supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF), the Israel Science Foundation, the RUBICON EC Network of Excellence, the Israel Cancer Research Fund and Deutsches Krebsforschungszentrum-Ministry of Science and Technology (DKFZ-MOST). Z.W. is supported by a Marie-Curie Intra-European Fellowship.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Andreu P, 2006, CANCER RES, V66, P1949, DOI 10.1158/0008-5472.CAN-05-2731; Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; BEDENNE L, 1992, CANCER, V69, P883, DOI 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO;2-B; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; DAVALLI AM, 1995, TRANSPLANTATION, V59, P817, DOI 10.1097/00007890-199503270-00003; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1994, COLD SPRING HARB SYM, V59, P67, DOI 10.1101/SQB.1994.059.01.010; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fazeli A, 1997, P NATL ACAD SCI USA, V94, P10199, DOI 10.1073/pnas.94.19.10199; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hatano H, 2008, CLIN CANCER RES, V14, P6097, DOI 10.1158/1078-0432.CCR-07-4761; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Ko CH, 2005, MOL CANCER THER, V4, P281; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Reed KR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-162; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Tabach Y, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100030; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Valentin-Vega YA, 2009, DIFFERENTIATION, V77, P442, DOI 10.1016/j.diff.2009.03.001; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; YIN J, 1993, GASTROENTEROLOGY, V104, pA464	42	143	160	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					409	U208		10.1038/nature09673	http://dx.doi.org/10.1038/nature09673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331045				2022-12-28	WOS:000287409100045
J	Puel, A; Cypowyj, S; Bustamante, J; Wright, JF; Liu, LY; Lim, HK; Migaud, M; Israel, L; Chrabieh, M; Audry, M; Gumbleton, M; Toulon, A; Bodemer, C; El-Baghdadi, J; Whitters, M; Paradis, T; Brooks, J; Collins, M; Wolfman, NM; Al-Muhsen, S; Galicchio, M; Abel, L; Picard, C; Casanova, JL				Puel, Anne; Cypowyj, Sophie; Bustamante, Jacinta; Wright, Jill F.; Liu, Luyan; Lim, Hye Kyung; Migaud, Melanie; Israel, Laura; Chrabieh, Maya; Audry, Magali; Gumbleton, Matthew; Toulon, Antoine; Bodemer, Christine; El-Baghdadi, Jamila; Whitters, Matthew; Paradis, Theresa; Brooks, Jonathan; Collins, Mary; Wolfman, Neil M.; Al-Muhsen, Saleh; Galicchio, Miguel; Abel, Laurent; Picard, Capucine; Casanova, Jean-Laurent			Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity	SCIENCE			English	Article							HOST-DEFENSE; TH17 CELLS; BACTERIAL-INFECTION; IL-17F; DIFFERENTIATION; MUTATIONS; CYTOKINE; IL-22	Chronic mucocutaneous candidiasis disease (CMCD) is characterized by recurrent or persistent infections of the skin, nails, and oral and genital mucosae caused by Candida albicans and, to a lesser extent, Staphylococcus aureus, in patients with no other infectious or autoimmune manifestations. We report two genetic etiologies of CMCD: autosomal recessive deficiency in the cytokine receptor, interleukin-17 receptor A (IL-17RA), and autosomal dominant deficiency of the cytokine interleukin-17F (IL-17F). IL-17RA deficiency is complete, abolishing cellular responses to IL-17A and IL-17F homo-and heterodimers. By contrast, IL-17F deficiency is partial, with mutant IL-17F-containing homo-and heterodimers displaying impaired, but not abolished, activity. These experiments of nature indicate that human IL-17A and IL-17F are essential for mucocutaneous immunity against C. albicans, but otherwise largely redundant.	[Puel, Anne; Bustamante, Jacinta; Liu, Luyan; Migaud, Melanie; Israel, Laura; Chrabieh, Maya; Abel, Laurent; Picard, Capucine; Casanova, Jean-Laurent] INSERM, Lab Human Genet Infect Dis, Necker Branch, U980, F-75015 Paris, France; [Puel, Anne; Bustamante, Jacinta; Liu, Luyan; Migaud, Melanie; Israel, Laura; Chrabieh, Maya; Abel, Laurent; Picard, Capucine; Casanova, Jean-Laurent] Univ Paris 05, Necker Med Sch, F-75015 Paris, France; [Cypowyj, Sophie; Lim, Hye Kyung; Audry, Magali; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Wright, Jill F.; Whitters, Matthew; Paradis, Theresa; Brooks, Jonathan; Collins, Mary; Wolfman, Neil M.] Pfizer Res, Inflammat & Immunol, Cambridge, MA 02140 USA; [Gumbleton, Matthew] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Toulon, Antoine; Bodemer, Christine] Hop Necker Enfants Malad, Dermatol Unit, F-75015 Paris, France; [El-Baghdadi, Jamila] Mil Hosp Instruct Mohamed V, Genet Unit, Rabat 10000, Morocco; [Al-Muhsen, Saleh; Casanova, Jean-Laurent] King Saud Univ, Dept Pediat, Coll Med, Prince Naif Ctr Immunol Res, Riyadh 11461, Saudi Arabia; [Galicchio, Miguel] Victor J Vilela Childrens Hosp, RA-2000 Rosario, Santa Fe, Argentina; [Picard, Capucine] Hop Necker Enfants Malad, Ctr Study Primary Immunodeficiencies, F-75015 Paris, France; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Hematol Immunol Unit, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Pfizer; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; King Saud University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Puel, A (corresponding author), INSERM, Lab Human Genet Infect Dis, Necker Branch, U980, F-75015 Paris, France.	anne.puel@inserm.fr; jean-laurent.casanova@rockefeller.edu	Bustamante, Jacinta/H-7877-2017; Puel, Anne/H-7305-2017; chrabieh, maya/H-7370-2017; Al-muhsen, saleh/E-9315-2014; Picard, Capucine/H-3914-2017; Abel, Laurent/H-8888-2017; Casanova, Jean-Laurent/I-3418-2017; Migaud, Mélanie/H-8044-2017	Bustamante, Jacinta/0000-0002-3439-2482; Puel, Anne/0000-0003-2603-0323; chrabieh, maya/0000-0003-0772-4805; Al-muhsen, saleh/0000-0003-3698-9968; Picard, Capucine/0000-0001-8788-5056; Abel, Laurent/0000-0001-7016-6493; Migaud, Mélanie/0000-0003-3062-1214; Gumbleton, Matthew/0000-0003-4882-4116; Casanova, Jean-Laurent/0000-0002-7782-4169	INSERM; University Paris Descartes; Rockefeller University; Rockefeller University CTSA [5UL1RR024143-04]; St. Giles Foundation; Candidoser association; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Descartes; Rockefeller University; Rockefeller University CTSA; St. Giles Foundation; Candidoser association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the patients, their families, and their clinicians. We also thank all members of the laboratory for helpful discussions and T. Kochetkov for keratinocyte culture. This work was supported by institutional funding from INSERM, University Paris Descartes, the Rockefeller University, the Rockefeller University CTSA grant number 5UL1RR024143-04, the St. Giles Foundation, and the Candidoser association awarded to J.-L.C. Genomic DNA sequences of the mutations IL-17RA (JF305973) and IL-17F (JF305974) can be found in GenBank. The following reagents are available under a Materials Transfer Agreement: human IL-17A homodimer (-mutation) purified protein, human IL-17F homodimer (+/-mutation) purified protein, human IL-17A-IL-17F heterodimer (+/-mutation) purified protein, and antibody against human IL-17F.	Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; CANALES L, 1969, LANCET, V2, P567; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; CHILGREN RA, 1967, LANCET, V2, P688; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Henningsson L, 2010, INFECT IMMUN, V78, P3783, DOI 10.1128/IAI.00385-10; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153; Kawaguchi M, 2006, J ALLERGY CLIN IMMUN, V117, P795, DOI 10.1016/j.jaci.2005.12.1346; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; LEROY D, 1989, DERMATOLOGICA, V178, P43, DOI 10.1159/000248386; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2009, J EXP MED, V206, P1291, DOI 10.1084/jem.20082767; Puel A, 2010, CURR OPIN IMMUNOL, V22, P467, DOI 10.1016/j.coi.2010.06.009; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; WELLS RS, 1972, J MED GENET, V9, P302, DOI 10.1136/jmg.9.3.302; WILLIAMSON DM, 1969, BRIT J DERMATOL, V81, P125, DOI 10.1111/j.1365-2133.1969.tb15992.x; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799	30	716	733	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					65	68		10.1126/science.1200439	http://dx.doi.org/10.1126/science.1200439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21350122	Green Accepted			2022-12-28	WOS:000289000000037
J	Choe, HW; Kim, YJ; Park, JH; Morizumi, T; Pai, EF; Krauss, N; Hofmann, KP; Scheerer, P; Ernst, OP				Choe, Hui-Woog; Kim, Yong Ju; Park, Jung Hee; Morizumi, Takefumi; Pai, Emil F.; Krauss, Norbert; Hofmann, Klaus Peter; Scheerer, Patrick; Ernst, Oliver P.			Crystal structure of metarhodopsin II	NATURE			English	Article							HELIX MOVEMENT; RHODOPSIN; ACTIVATION; TRANSDUCIN; LIGAND; DISPLACEMENT; CONFORMATION; SPECTROSCOPY; OPSIN; LIGHT	G-protein-coupled receptors (GPCRs) are seven transmembrane helix (TM) proteins that transduce signals into living cells by binding extracellular ligands and coupling to intracellular heterotrimeric Gproteins (G alpha beta gamma)(1). The photoreceptor rhodopsin couples to transducin and bears its ligand 11-cis-retinal covalently bound via a protonated Schiff base to the opsin apoprotein(2). Absorption of a photon causes retinal cis/trans isomerization and generates the agonist all-trans-retinal in situ. After early photoproducts, the active G-protein-binding intermediate metarhodopsin II (Meta II) is formed, in which the retinal Schiff base is still intact but deprotonated. Dissociation of the proton from the Schiff base breaks a major constraint in the protein and enables further activating steps, including an outward tilt of TM6 and formation of a large cytoplasmic crevice for uptake of the interacting C terminus of the G alpha subunit(3-5). Owing to Schiff base hydrolysis, Meta II is short-lived and notoriously difficult to crystallize. We therefore soaked opsin crystals with all-trans-retinal to form Meta II, presuming that the crystal's high concentration of opsin in an active conformation (Ops*)(6,7) may facilitate all-trans-retinal uptake and Schiff base formation. Here we present the 3.0 angstrom and 2.85 angstrom crystal structures, respectively, of Meta II alone or in complex with an 11-amino-acid C-terminal fragment derived from G alpha (G alpha CT2). G alpha CT2 binds in a large crevice at the cytoplasmic side, akin to the binding of a similar G alpha-derived peptide to Ops* (ref. 7). In the Meta II structures, the electron density from the retinal ligand seamlessly continues into the Lys 296 side chain, reflecting proper formation of the Schiff base linkage. The retinal is in a relaxed conformation and almost undistorted compared with pure crystalline all-trans-retinal. By comparison with early photoproducts we propose how retinal translocation and rotation induce the gross conformational changes characteristic for Meta II. The structures can now serve as models for the large GPCR family.	[Choe, Hui-Woog; Kim, Yong Ju; Park, Jung Hee; Morizumi, Takefumi; Hofmann, Klaus Peter; Scheerer, Patrick; Ernst, Oliver P.] Charite, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Choe, Hui-Woog] Chonbuk Natl Univ, Coll Nat Sci, Dept Chem, Chonju 561756, South Korea; [Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Krauss, Norbert] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jeonbuk National University; University of Toronto; University of Toronto; University of Toronto; University of London; Queen Mary University London; Humboldt University of Berlin	Choe, HW (corresponding author), Charite, Inst Med Phys & Biophys CC2, Charite Pl 1, D-10117 Berlin, Germany.	hwchoe@jbnu.ac.kr; klaus_peter.hofmann@charite.de; oliver.ernst@utoronto.ca	Morizumi, Takefumi/AAA-2063-2021; Pai, Emil/R-8908-2019; Pai, Emil F/D-2526-2013	Morizumi, Takefumi/0000-0002-2785-209X; Pai, Emil/0000-0002-1162-7242; Krauss, Norbert/0000-0002-7128-4632; Scheerer, Patrick/0000-0001-5028-2075	DFG [Sfb449, Sfb740]; ERC; Canada Research Chairs Program; Ministry of Education, Science and Technology [2010-0002738]; CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); Canada Research Chairs Program(Canada Research Chairs); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	We thank J. Engelmann, C. Koch and B. Bauer for technical assistance, and F. Siebert and W. Hubbell for critically reading the manuscript. We are grateful to the European Synchrotron Radiation Facility (ESRF, Grenoble), D. von Stetten and A. Royant of the ID29S-Cryobench (ESRF, Grenoble) and U. Muller and the scientific staff of the BESSY-MX/Helmholtz Zentrum Berlin fur Materialien und Energie at beamlines BL 14.1 and BL 14.2, where the data were collected, for continuous support. This work was supported by the DFG Sfb449 (to O.P.E.), Sfb740 (to O.P.E. and K.P.H.) and an Advanced Investigator ERC grant (to K.P.H.) and by the Canada Research Chairs Program (to E.F.P.). H.-W.C. gratefully acknowledges the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0002738) and CBNU funds for overseas research 2009. Y.J.K. thanks the Leibniz Graduate School of Molecular Biophysics, Berlin, for a scholarship.	Ahuja S, 2009, J AM CHEM SOC, V131, P15160, DOI 10.1021/ja9034768; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Brown MF, 2010, BBA-BIOMEMBRANES, V1798, P177, DOI 10.1016/j.bbamem.2009.08.013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe HW, 2011, NEUROPHARMACOLOGY, V60, P52, DOI 10.1016/j.neuropharm.2010.07.018; Crocker E, 2006, J MOL BIOL, V357, P163, DOI 10.1016/j.jmb.2005.12.046; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Ernst OP, 2000, METHOD ENZYMOL, V315, P471; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Fujimoto Y, 2001, CHEM-EUR J, V7, P4198, DOI 10.1002/1521-3765(20011001)7:19<4198::AID-CHEM4198>3.0.CO;2-X; Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knierim B, 2008, J BIOL CHEM, V283, P4967, DOI 10.1074/jbc.M703059200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau PW, 2007, J MOL BIOL, V372, P906, DOI 10.1016/j.jmb.2007.06.047; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Ludeke S, 2005, J MOL BIOL, V353, P345, DOI 10.1016/j.jmb.2005.08.039; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nakamichi H, 2006, ANGEW CHEM INT EDIT, V45, P4270, DOI 10.1002/anie.200600595; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Salgado GFJ, 2006, J AM CHEM SOC, V128, P11067, DOI 10.1021/ja058738+; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Siebert F, 1995, ISRAEL J CHEM, V35, P309; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948	43	521	525	3	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					651	U137		10.1038/nature09789	http://dx.doi.org/10.1038/nature09789			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21389988				2022-12-28	WOS:000288951200046
J	Curry, LA; Spatz, E; Cherlin, E; Thompson, JW; Berg, D; Ting, HH; Decker, C; Krumholz, HM; Bradley, EH				Curry, Leslie A.; Spatz, Erica; Cherlin, Emily; Thompson, Jennifer W.; Berg, David; Ting, Henry H.; Decker, Carole; Krumholz, Harlan M.; Bradley, Elizabeth H.			What Distinguishes Top-Performing Hospitals in Acute Myocardial Infarction Mortality Rates? A Qualitative Study	ANNALS OF INTERNAL MEDICINE			English	Article							ELDERLY-PATIENTS; OF-CARE; UNITED-STATES; OUTCOMES; CONSEQUENCES; ALLIANCE; FAILURE; IMPROVE; CULTURE; PROJECT	Background: Mortality rates for patients with acute myocardial infarction (AMI) vary substantially across hospitals, even when adjusted for patient severity; however, little is known about hospital factors that may influence this variation. Objective: To identify factors that may be related to better performance in AMI care, as measured by risk-standardized mortality rates. Design: Qualitative study that used site visits and in-depth interviews. Setting: Eleven U.S. hospitals that ranked in either the top or the bottom 5% in risk-standardized mortality rates for 2 recent years of data from the Centers for Medicare & Medicaid Services (2005 to 2006 and 2006 to 2007), with diversity among hospitals in key characteristics. Participants: 158 members of hospital staff, all of whom were involved with AMI care at the 11 hospitals. Measurements: Site visits and in-depth interviews conducted with hospital staff during 2009. A multidisciplinary team performed analyses by using the constant comparative method. Results: Hospitals in the high-performing and low-performing groups differed substantially in the domains of organizational values and goals, senior management involvement, broad staff presence and expertise in AMI care, communication and coordination among groups, and problem solving and learning. Participants described diverse protocols or processes for AMI care (such as rapid response teams, clinical guidelines, use of hospitalists, and medication reconciliation); however, these did not systematically differentiate high-performing from low-performing hospitals. Limitation: The qualitative design informed the generation of hypotheses, and statistical associations could not be assessed. Conclusion: High-performing hospitals were characterized by an organizational culture that supported efforts to improve AMI care across the hospital. Evidence-based protocols and processes, although important, may not be sufficient for achieving high hospital performance in care for patients with AMI.			Curry, LA (corresponding author), 60 Coll St,Box 208034, New Haven, CT 06520 USA.	leslie.curry@yale.edu	, Harlan/AAI-2875-2020; curry, leslie/AAA-6100-2022	curry, leslie/0000-0002-3419-4654	Agency for Healthcare Research and Quality [R01-HS-016929]; United Health Foundation; Commonwealth Fund [20090565]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS016929] Funding Source: NIH RePORTER; FOOD AND DRUG ADMINISTRATION [U01FD004585] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); United Health Foundation; Commonwealth Fund; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	Grant Support: By the Agency for Healthcare Research and Quality (R01-HS-016929), United Health Foundation, and the Commonwealth Fund (20090565).	Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; Baldwin LM, 2004, J RURAL HEALTH, V20, P99, DOI 10.1111/j.1748-0361.2004.tb00015.x; Bradley EH, 2005, MED CARE, V43, P282, DOI 10.1097/00005650-200503000-00011; Bradley Elizabeth H, 2007, Crit Pathw Cardiol, V6, P91, DOI 10.1097/HPC.0b013e31812da7bc; Bradley EH, 2010, AM J CARDIOL, V106, P1108, DOI 10.1016/j.amjcard.2010.06.014; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Bradley EH, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-25; CLARITAS N, 2009, POPULATION FACTS 200; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Glaser B.G., 1965, AWARENESS DYING; GORDON GG, 1992, J MANAGE STUD, V29, P783, DOI 10.1111/j.1467-6486.1992.tb00689.x; Horwitz LI, 2008, ARCH INTERN MED, V168, P1755, DOI 10.1001/archinte.168.16.1755; Inui TS, 1996, ANN INTERN MED, V125, P770, DOI 10.7326/0003-4819-125-9-199611010-00012; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Lincoln Y, 1985, NATURALISTIC ENQUIRY; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Marsh DR, 2004, BMJ-BRIT MED J, V329, P1177, DOI 10.1136/bmj.329.7475.1177; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Miles M., 2013, QUALITATIVE DATA ANA; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Normand SLT, 1996, JAMA-J AM MED ASSOC, V275, P1322, DOI 10.1001/jama.275.17.1322; Patterson ES, 2004, INT J QUAL HEALTH C, V16, P125, DOI 10.1093/intqhc/mzh026; Patton MQ., 2015, QUALITATIVE RES EVAL, V3; Popescu I, 2009, CIRC-CARDIOVASC QUAL, V2, P221, DOI 10.1161/CIRCOUTCOMES.108.813790; Rathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002; Ross JS, 2007, HEALTH AFFAIR, V26, P238, DOI 10.1377/hlthaff.26.1.238; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Sofaer S, 1999, HEALTH SERV RES, V34, P1101; SPEAR SJ, 1999, HARVARD BUS REV, P96; Sternin J, 2000, HARVARD BUS REV, V78, P14; SUDMAN S., 1996, THINKING ANSWERS APP; Sutcliffe KM, 2004, ACAD MED, V79, P186, DOI 10.1097/00001888-200402000-00019; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; van Dyck C, 2005, J APPL PSYCHOL, V90, P1228, DOI 10.1037/0021-9010.90.6.1228	39	225	225	1	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					384	+		10.7326/0003-4819-154-6-201103150-00003	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	734WA	21403074	Green Accepted			2022-12-28	WOS:000288370000002
J	Fuller, J; Wright, A				Fuller, John; Wright, Andrew			A Patient's Journey Adult atopic eczema	BRITISH MEDICAL JOURNAL			English	Editorial Material												somersettalk@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 14	2011	342								d644	10.1136/bmj.d644	http://dx.doi.org/10.1136/bmj.d644			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739EZ	21402667				2022-12-28	WOS:000288697700004
J	de Gouw, JA; Middlebrook, AM; Warneke, C; Ahmadov, R; Atlas, EL; Bahreini, R; Blake, DR; Brock, CA; Brioude, J; Fahey, DW; Fehsenfeld, FC; Holloway, JS; Le Henaff, M; Lueb, RA; McKeen, SA; Meagher, JF; Murphy, DM; Paris, C; Parrish, DD; Perring, AE; Pollack, IB; Ravishankara, AR; Robinson, AL; Ryerson, TB; Schwarz, JP; Spackman, JR; Srinivasan, A; Watts, LA				de Gouw, J. A.; Middlebrook, A. M.; Warneke, C.; Ahmadov, R.; Atlas, E. L.; Bahreini, R.; Blake, D. R.; Brock, C. A.; Brioude, J.; Fahey, D. W.; Fehsenfeld, F. C.; Holloway, J. S.; Le Henaff, M.; Lueb, R. A.; McKeen, S. A.; Meagher, J. F.; Murphy, D. M.; Paris, C.; Parrish, D. D.; Perring, A. E.; Pollack, I. B.; Ravishankara, A. R.; Robinson, A. L.; Ryerson, T. B.; Schwarz, J. P.; Spackman, J. R.; Srinivasan, A.; Watts, L. A.			Organic Aerosol Formation Downwind from the Deepwater Horizon Oil Spill	SCIENCE			English	Article								A large fraction of atmospheric aerosols are derived from organic compounds with various volatilities. A National Oceanic and Atmospheric Administration (NOAA) WP-3D research aircraft made airborne measurements of the gaseous and aerosol composition of air over the Deepwater Horizon (DWH) oil spill in the Gulf of Mexico that occurred from April to August 2010. A narrow plume of hydrocarbons was observed downwind of DWH that is attributed to the evaporation of fresh oil on the sea surface. A much wider plume with high concentrations of organic aerosol (>25 micrograms per cubic meter) was attributed to the formation of secondary organic aerosol (SOA) from unmeasured, less volatile hydrocarbons that were emitted from a wider area around DWH. These observations provide direct and compelling evidence for the importance of formation of SOA from less volatile hydrocarbons.	[de Gouw, J. A.; Middlebrook, A. M.; Warneke, C.; Ahmadov, R.; Bahreini, R.; Brock, C. A.; Brioude, J.; Fahey, D. W.; Fehsenfeld, F. C.; Holloway, J. S.; McKeen, S. A.; Meagher, J. F.; Murphy, D. M.; Parrish, D. D.; Perring, A. E.; Pollack, I. B.; Ravishankara, A. R.; Ryerson, T. B.; Schwarz, J. P.; Spackman, J. R.; Watts, L. A.] NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA; [de Gouw, J. A.; Warneke, C.; Ahmadov, R.; Bahreini, R.; Brioude, J.; Fehsenfeld, F. C.; Holloway, J. S.; McKeen, S. A.; Perring, A. E.; Pollack, I. B.; Schwarz, J. P.; Spackman, J. R.; Watts, L. A.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Atlas, E. L.; Le Henaff, M.; Paris, C.; Srinivasan, A.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Blake, D. R.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [Lueb, R. A.] Natl Ctr Atmospher Res, Div Atmospher Chem, Earth Syst Lab, Boulder, CO 80301 USA; [Robinson, A. L.] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Miami; University of California System; University of California Irvine; National Center Atmospheric Research (NCAR) - USA; Carnegie Mellon University	de Gouw, JA (corresponding author), NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA.	joost.degouw@noaa.gov	Ahmadov, Ravan/F-2036-2011; Watts, Laurel A/G-4532-2013; Atlas, Elliot/AAE-4605-2021; Brioude, Jerome/E-4629-2011; Robinson, Allen L/M-3046-2014; Middlebrook, Ann M/E-4831-2011; McKeen, Stuart A/H-9516-2013; Atlas, Elliot/J-8171-2015; Ryerson, Tom/AAA-8399-2021; Ravishankara, Akkihebbal R/A-2914-2011; Fahey, David W/G-4499-2013; de Gouw, Joost/A-9675-2008; Warneke, Carsten/E-7174-2010; Affiliate, Anne Perring - NOAA/G-4597-2013; Le Hénaff, Matthieu/P-8480-2018; Pollack, Ilana B/F-9875-2012; Parrish, David/E-8957-2010; Murphy, Daniel/J-4357-2012; Brock, Charles/G-3406-2011; Holloway, John S/F-9911-2012; Robinson, Allen/I-5713-2012; Fehsenfeld, Frederick C/I-4876-2013; Ryerson, Thomas/C-9611-2009	Ahmadov, Ravan/0000-0002-6996-7071; Watts, Laurel A/0000-0002-0834-3329; Robinson, Allen L/0000-0002-1819-083X; Middlebrook, Ann M/0000-0002-2984-6304; McKeen, Stuart A/0000-0001-9700-6166; Fahey, David W/0000-0003-1720-0634; de Gouw, Joost/0000-0002-0385-1826; Affiliate, Anne Perring - NOAA/0000-0003-2231-7503; Pollack, Ilana B/0000-0001-7151-9756; Parrish, David/0000-0001-6312-2724; Murphy, Daniel/0000-0002-8091-7235; Brock, Charles/0000-0002-4033-4668; Holloway, John S/0000-0002-4585-9594; Robinson, Allen/0000-0003-1053-7090; Ryerson, Thomas/0000-0003-2800-7581; Blake, Donald/0000-0002-8283-5014; Atlas, Elliot/0000-0003-3847-5346; Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334	NASA; NSF [1048697]; U.S. Coast Guard Pollution Removal Funding	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); U.S. Coast Guard Pollution Removal Funding	We thank the flight crew of the NOAA WP-3D, as well as NOAA's National Environmental Satellite, Data, and Information Service, for the oil spill maps in Fig. 1. Supported by the NASA Radiation Sciences Program ( D. W. F., A. E. P., J.P.S., J.R.S., and L. A. W.), NSF grant 1048697 ( C. P., M. L. H., and A. S.) and a U.S. Coast Guard Pollution Removal Funding Authorization to NOAA for flights over the oil spill made by the NOAA WP-3D.	[Anonymous], SAT DER SURF OIL AN; Baker AK, 2008, ATMOS ENVIRON, V42, P170, DOI 10.1016/j.atmosenv.2007.09.007; Chassignet EP, 2009, OCEANOGRAPHY, V22, P64, DOI 10.5670/oceanog.2009.39; Counillon F, 2009, OCEAN DYNAM, V59, P83, DOI 10.1007/s10236-008-0167-0; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; de Gouw JA, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005623; De Gouw J, 2009, ENVIRON SCI TECHNOL, V43, P7614, DOI 10.1021/es9006004; Donahue NM, 2009, ATMOS ENVIRON, V43, P94, DOI 10.1016/j.atmosenv.2008.09.055; Johnson D, 2006, ATMOS CHEM PHYS, V6, P403, DOI 10.5194/acp-6-403-2006; Jordan CE, 2008, ATMOS ENVIRON, V42, P8015, DOI 10.1016/j.atmosenv.2008.06.017; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005; Matsui H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010164; Ng NL, 2007, ATMOS CHEM PHYS, V7, P3909, DOI 10.5194/acp-7-3909-2007; Robinson AL, 2007, SCIENCE, V315, P1259, DOI 10.1126/science.1133061; Ryerson TB, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046726; *SL ROSS ENV RES L, 2010, ENT052210178 SL ROSS; Spracklen DV, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033359; Volkamer R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026899; Warneke C, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007930; WHITE WH, 1976, SCIENCE, V194, P187, DOI 10.1126/science.959846; Zhang Q, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029979	21	124	124	4	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2011	331	6022					1295	1299		10.1126/science.1200320	http://dx.doi.org/10.1126/science.1200320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393539	Green Submitted			2022-12-28	WOS:000288215200038
J	Moore, DD				Moore, David D.			Crise de Foie, Redux?	SCIENCE			English	Editorial Material							REV-ERB-ALPHA; LIVER		Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	moore@bcm.edu						Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Chopra AR, 2011, CELL METAB, V13, P35, DOI 10.1016/j.cmet.2010.12.001; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Filipski E, 2005, JNCI-J NATL CANCER I, V97, P507, DOI 10.1093/jnci/dji083; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Ma K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006843; Mukai M, 2002, DIGEST DIS SCI, V47, P549, DOI 10.1023/A:1017959801493; Nakamura K, 1998, IND HEALTH, V36, P218, DOI 10.2486/indhealth.36.218; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	13	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2011	331	6022					1275	1276		10.1126/science.1203194	http://dx.doi.org/10.1126/science.1203194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393533				2022-12-28	WOS:000288215200032
J	Carter, AP; Cho, C; Jin, L; Vale, RD				Carter, Andrew P.; Cho, Carol; Jin, Lan; Vale, Ronald D.			Crystal Structure of the Dynein Motor Domain	SCIENCE			English	Article							MICROTUBULE-BINDING DOMAIN; ENERGY TRANSDUCTION; COILED-COIL; MECHANISMS; ATPASE; PROCESSIVITY; HYDROLYSIS; RESOLUTION; REVEALS; MOTIONS	Dyneins are microtubule-based motor proteins that power ciliary beating, transport intracellular cargos, and help to construct the mitotic spindle. Evolved from ring-shaped hexameric AAA-family adenosine triphosphatases (ATPases), dynein's large size and complexity have posed challenges for understanding its structure and mechanism. Here, we present a 6 angstrom crystal structure of a functional dimer of two similar to 300-kilodalton motor domains of yeast cytoplasmic dynein. The structure reveals an unusual asymmetric arrangement of ATPase domains in the ring-shaped motor domain, the manner in which the mechanical element interacts with the ATPase ring, and an unexpected interaction between two coiled coils that create a base for the microtubule binding domain. The arrangement of these elements provides clues as to how adenosine triphosphate-driven conformational changes might be transmitted across the motor domain.	[Carter, Andrew P.; Cho, Carol; Jin, Lan; Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Carter, Andrew P.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Howard Hughes Medical Institute; University of California System; University of California San Francisco; MRC Laboratory Molecular Biology	Carter, AP (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, 600 16th St, San Francisco, CA 94158 USA.	cartera@mrc-lmb.cam.ac.uk; vale@cmp.ucsf.edu		Carter, Andrew/0000-0001-7292-5430; Cho, Carol/0000-0003-4070-6561	NIH; Jane Coffin Child Foundation; Lymphoma and Leukemia Foundation; American Heart Association; Genentech; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097312] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A025_1011] Funding Source: researchfish; MRC [MC_UP_A025_1011] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Child Foundation; Lymphoma and Leukemia Foundation; American Heart Association(American Heart Association); Genentech(Roche HoldingGenentech); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank N. Zhang (UCSF), J. Holton (Advanced Light Source), H. Schmidt (MRC), E. Gleave (MRC), and M. Sirajuddin (UCSF) for their assistance and helpful discussions. This work was supported by the NIH (R.D.V.), Jane Coffin Child Foundation (A.P.C.), Lymphoma and Leukemia Foundation (A.P.C.), American Heart Association (C.C.), and Genentech Graduate Student Fellowship (C.C.). The PDB accession number for this dynein dimer structure is 3QMZ.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Bushnell DA, 2001, STRUCTURE, V9, pR11, DOI 10.1016/S0969-2126(00)00554-2; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Koonce MP, 1997, J BIOL CHEM, V272, P19714, DOI 10.1074/jbc.272.32.19714; Neuwald AF, 1999, GENOME RES, V9, P27; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Serohijos AWR, 2006, P NATL ACAD SCI USA, V103, P18540, DOI 10.1073/pnas.0602867103; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Ulbrich C, 2009, CELL, V138, P911, DOI 10.1016/j.cell.2009.06.045; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X	37	173	175	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1159	1165		10.1126/science.1202393	http://dx.doi.org/10.1126/science.1202393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21330489	Green Accepted			2022-12-28	WOS:000287971200033
J	Elsasser, SJ; Allis, CD; Lewis, PW				Elsaesser, Simon J.; Allis, C. David; Lewis, Peter W.			New Epigenetic Drivers of Cancers	SCIENCE			English	Editorial Material							SOMATIC MUTATIONS; HISTONE CHAPERONE; RENAL-CARCINOMA; H3.3; ARID1A; ATRX; DAXX		[Elsaesser, Simon J.; Allis, C. David; Lewis, Peter W.] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA	Rockefeller University	Elsasser, SJ (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	plewis@rockefeller.edu	Elsässer, Simon/AAM-3986-2020; Lewis, Peter/C-4348-2008; Elsässer, Simon/B-8911-2014	Elsässer, Simon/0000-0001-8724-4849; Elsässer, Simon/0000-0001-8724-4849; Lewis, Peter/0000-0002-9816-7823				Baumann C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001137; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hu Wenwei, 2010, Genes Cancer, V1, P360; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109	17	53	57	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1145	1146		10.1126/science.1203280	http://dx.doi.org/10.1126/science.1203280			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385704				2022-12-28	WOS:000287971200028
J	Wilkinson, K; Wilson, H				Wilkinson, Kathy; Wilson, Helen			Should physicians routinely be involved in the care of elderly surgical patients? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GERIATRIC-MEDICINE; FUTURE					kathy.wilkinson@nnuh.nhs.uk						British Orthopaedic Association and the British Geriatric Society, 2007, CAR PAT FRAG FRACT; Devlin N., 2010, GETTING MOST OUT PRO; Ellis G, 2004, BRIT MED BULL, V71, P45, DOI 10.1093/bmb/ldh033; Evans JG, 1997, BMJ-BRIT MED J, V315, P1075, DOI 10.1136/bmj.315.7115.1075; Goddard AF, 2010, CLIN MED, V10, P548, DOI 10.7861/clinmedicine.10-6-548; Gordon AL, 2010, AGE AGEING, V39, P385, DOI 10.1093/ageing/afq011; Harari D, 2007, AGE AGEING, V36, P190, DOI 10.1093/ageing/afl163; Johansen A, 2010, AGE AGEING, V39, P664, DOI 10.1093/ageing/afq120; McGory ML, 2009, ANN SURG, V250, P338, DOI 10.1097/SLA.0b013e3181ae575a; *NAT HIP FRACT DAT, NAT REP 2010; National Confidential Enquiry into Perioperative Deaths, 2010, AG OLD PROBL REV CAR; National Hip Fracture Database, 2010, BEST PRACT TAR FRAG; NHS Institute for Innovation and Improvement, 2006, DEL QUAL VAL FOC FRA; Story DA, 2010, ANAESTHESIA, V65, P1022, DOI 10.1111/j.1365-2044.2010.06478.x; Van Craen K, 2010, J AM GERIATR SOC, V58, P83, DOI 10.1111/j.1532-5415.2009.02621.x	15	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2011	342								d1070	10.1136/bmj.d1070	http://dx.doi.org/10.1136/bmj.d1070			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732EU	21378068				2022-12-28	WOS:000288168600010
J	Lin, YJ; Jimenez-Garcia, K; Spielman, IB				Lin, Y. -J.; Jimenez-Garcia, K.; Spielman, I. B.			Spin-orbit-coupled Bose-Einstein condensates	NATURE			English	Article							INSULATOR; STATE	Spin-orbit (SO) coupling-the interaction between a quantum particle's spin and its momentum-is ubiquitous in physical systems. In condensed matter systems, SO coupling is crucial for the spin-Hall effect(1,2) and topological insulators(3-5); it contributes to the electronic properties of materials such as GaAs, and is important for spintronic devices(6). Quantum many-body systems of ultracold atoms can be precisely controlled experimentally, and would therefore seem to provide an ideal platform on which to study SO coupling. Although an atom's intrinsic SO coupling affects its electronic structure, it does not lead to coupling between the spin and the centre-of-mass motion of the atom. Here, we engineer SO coupling (with equal Rashba(7) and Dresselhaus(8) strengths) in a neutral atomic Bose-Einstein condensate by dressing two atomic spin states with a pair of lasers(9). Such coupling has not been realized previously for ultracold atomic gases, or indeed any bosonic system. Furthermore, in the presence of the laser coupling, the interactions between the two dressed atomic spin states are modified, driving a quantum phase transition from a spatially spin-mixed state (lasers off) to a phase-separated state (above a critical laser intensity). We develop a many-body theory that provides quantitative agreement with the observed location of the transition. The engineered SO coupling-equally applicable for bosons and fermions-sets the stage for the realization of topological insulators in fermionic neutral atom systems.	[Lin, Y. -J.; Jimenez-Garcia, K.; Spielman, I. B.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Lin, Y. -J.; Jimenez-Garcia, K.; Spielman, I. B.] Univ Maryland, Gaithersburg, MD 20899 USA; [Jimenez-Garcia, K.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fis, Mexico City 07360, DF, Mexico	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Spielman, IB (corresponding author), NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA.	ian.spielman@nist.gov	Lin, Yu-Ju/F-7917-2012	Lin, Yu-Ju/0000-0002-9095-4523	ONR; ARO; DARPA OLE; NSF through the Physics Frontier Center at the Joint Quantum Institute	ONR(Office of Naval Research); ARO; DARPA OLE(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF through the Physics Frontier Center at the Joint Quantum Institute	We thank E. Demler, T.-L. Ho and H. Zhai for conceptual input; and we appreciate conversations with J. V. Porto and W. D. Phillips. This work was partially supported by ONR, ARO with funds from the DARPA OLE programme, and the NSF through the Physics Frontier Center at the Joint Quantum Institute. K.J.-G. acknowledges CONACYT.	Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Chang MS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.140403; Dalibard J., 2010, ARTIFICIAL GAUGE POT; Erhard M, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.032705; Goldman N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.255302; Hall DS, 1998, PHYS REV LETT, V81, P1539, DOI 10.1103/PhysRevLett.81.1539; Higbie J, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.053605; Ho T.-L., 2010, BOSE EINSTEIN CONDEN; Ho TL, 1998, PHYS REV LETT, V81, P742, DOI 10.1103/PhysRevLett.81.742; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Kobayashi M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.115301; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Lin YJ, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063631; Lin YJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.130401; Lin Y.-J., 2010, NATURE IN PRESS; Liu XJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.046402; Quay CHL, 2010, NAT PHYS, V6, P336, DOI 10.1038/NPHYS1626; Ruseckas J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010404; Sau JD, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214509; Stanescu TD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.110403; Stenger J, 1998, NATURE, V396, P345, DOI 10.1038/24567; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Widera A, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/152; Zhang CW, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.160401	30	1554	1576	10	385	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					83	U99		10.1038/nature09887	http://dx.doi.org/10.1038/nature09887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368828	Green Submitted			2022-12-28	WOS:000287924100038
J	Wertz, IE; Kusam, S; Lam, C; Okamoto, T; Sandoval, W; Anderson, DJ; Helgason, E; Ernst, JA; Eby, M; Liu, JF; Belmont, LD; Kaminker, JS; O'Rourke, KM; Pujara, K; Kohli, PB; Johnson, AR; Chiu, ML; Lill, JR; Jackson, PK; Fairbrother, WJ; Seshagiri, S; Ludlam, MJC; Leong, KG; Dueber, EC; Maecker, H; Huang, DCS; Dixit, VM				Wertz, Ingrid E.; Kusam, Saritha; Lam, Cynthia; Okamoto, Toru; Sandoval, Wendy; Anderson, Daniel J.; Helgason, Elizabeth; Ernst, James A.; Eby, Mike; Liu, Jinfeng; Belmont, Lisa D.; Kaminker, Josh S.; O'Rourke, Karen M.; Pujara, Kanan; Kohli, Pawan Bir; Johnson, Adam R.; Chiu, Mark L.; Lill, Jennie R.; Jackson, Peter K.; Fairbrother, Wayne J.; Seshagiri, Somasekar; Ludlam, Mary J. C.; Leong, Kevin G.; Dueber, Erin C.; Maecker, Heather; Huang, David C. S.; Dixit, Vishva M.			Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7	NATURE			English	Article							UBIQUITIN LIGASE; MITOTIC EXIT; CANCER; CELLS; APOPTOSIS; RESISTANCE; CATALYZES; PROTEINS; DIVISION	Microtubules have pivotal roles in fundamental cellular processes and are targets of antitubulin chemotherapeutics(1). Microtubule-targeted agents such as Taxol and vincristine are prescribed widely for various malignancies, including ovarian and breast adenocarcinomas, non-small-cell lung cancer, leukaemias and lymphomas(1). These agents arrest cells in mitosis and subsequently induce cell death through poorly defined mechanisms(2). The strategies that resistant tumour cells use to evade death induced by antitubulin agents are also unclear(2). Here we show that the pro-survival protein MCL1 (ref. 3) is a crucial regulator of apoptosis triggered by antitubulin chemotherapeutics. During mitotic arrest, MCL1 protein levels decline markedly, through a post-translational mechanism, potentiating cell death. Phosphorylation of MCL1 directs its interaction with the tumour-suppressor protein FBW7, which is the substrate-binding component of a ubiquitin ligase complex. The polyubiquitylation of MCL1 then targets it for proteasomal degradation. The degradation of MCL1 was blocked in patient-derived tumour cells that lacked FBW7 or had loss-of-function mutations in FBW7, conferring resistance to antitubulin agents and promoting chemotherapeutic-induced polyploidy. Additionally, primary tumour samples were enriched for FBW7 inactivation and elevated MCL1 levels, underscoring the prominent roles of these proteins in oncogenesis. Our findings suggest that profiling the FBW7 and MCL1 status of tumours, in terms of protein levels, messenger RNA levels and genetic status, could be useful to predict the response of patients to antitubulin chemotherapeutics.	[Wertz, Ingrid E.; Kusam, Saritha; Lam, Cynthia; Helgason, Elizabeth; Ernst, James A.; Fairbrother, Wayne J.; Dueber, Erin C.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Okamoto, Toru; Huang, David C. S.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Sandoval, Wendy; Ernst, James A.; Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Anderson, Daniel J.; Eby, Mike; Belmont, Lisa D.; Jackson, Peter K.; Ludlam, Mary J. C.; Leong, Kevin G.; Maecker, Heather] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Liu, Jinfeng; Kaminker, Josh S.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [O'Rourke, Karen M.; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Pujara, Kanan; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kohli, Pawan Bir; Johnson, Adam R.] Genentech Inc, Dept Biochem Pharmacol, San Francisco, CA 94080 USA; [Chiu, Mark L.] Abbott Labs, Dept Biol Struct, Abbott Pk, IL 60064 USA; [Huang, David C. S.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Roche Holding; Genentech; Walter & Eliza Hall Institute; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Abbott Laboratories; University of Melbourne	Wertz, IE (corresponding author), Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA.	ingrid@gene.com	dixit, vishva m/A-4496-2012; Huang, David C. S./C-7586-2013; chiu, mark/AAK-2756-2021	dixit, vishva m/0000-0001-6983-0326; Huang, David C. S./0000-0002-3101-4873; Jackson, Peter/0000-0002-1742-2539; Seshagiri, Somasekar/0000-0003-4272-6443; Chiu, Mark/0000-0001-6300-404X; Anderson, Daniel/0000-0002-3249-2439; Liu, Jinfeng/0000-0002-0343-8222; Maecker, Heather/0000-0002-5378-1141; Helgason, Elizabeth/0000-0002-0397-9125	National Health and Medical Research Council [461221, 361646]; Leukemia and Lymphoma Society [SCOR 7413]; National Institutes of Health [CA043540, CA80188]; Australian Cancer Research Foundation; Australian Research Council; NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Cancer Research Foundation; Australian Research Council(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Ekert for FDM cell lines, J. Stinson for sequencing assistance, S. Johnson and C. Santos for assistance with obtaining patient samples, P. Haverty for bioinformatics analysis, C. Grimaldi for cloning assistance, J. Dynek for TaqMan advice, D. French for tumour analysis, C. Quan and J. Tom for peptide synthesis, I. Zilberleyb and the Baculovirus Expression Group for cloning and protein production, S. Charuvu for generating MCL1 point mutants, A. Bruce for graphics assistance, the Genentech Cancer Genome Project Team, Z. Modrusan, R. Soriano and the microarray lab for ovarian tumour data sets, K. Newton for editorial assistance, W. Wei for sharing unpublished results, and A. Eldridge, D. Kirkpatrick, D. Vucic, E. Varfolomeev, T. Goncharov, A. Cochran, O. Huang, A. Huang, Y. Pereg, A. Loktev, D. Phillips, J. Wu, M. van Delft, D. Eaton, E. Shaulian, T. Hunter, S. Cory, J. Adams, A. Strasser, R. Deshaies and G. Evan for discussions. Work in the Huang laboratory is supported by the National Health and Medical Research Council (program grant #461221, IRIISS grant #361646 and a fellowship to D.C.S.H.), the Leukemia and Lymphoma Society (SCOR 7413), the National Institutes of Health (grants CA043540 and CA80188), the Australian Cancer Research Foundation, and an Australian Research Council Australian Postdoctoral fellowship to T.O. We apologize to our colleagues whose primary work could not be cited owing to space constraints.	Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Finkin S, 2008, ONCOGENE, V27, P4411, DOI 10.1038/onc.2008.77; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Mesquita B, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-101; Ozalp SS, 2002, EUR J GYNAECOL ONCOL, V23, P337; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	20	594	619	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					110	114		10.1038/nature09779	http://dx.doi.org/10.1038/nature09779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368834				2022-12-28	WOS:000287924100044
J	Kuepper, R; van Os, J; Lieb, R; Wittchen, HU; Hofler, M; Henquet, C				Kuepper, Rebecca; van Os, Jim; Lieb, Roselind; Wittchen, Hans-Ulrich; Hoefler, Michael; Henquet, Cecile			Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study	BRITISH MEDICAL JOURNAL			English	Article							INTERNATIONAL DIAGNOSTIC INTERVIEW; EARLY DEVELOPMENTAL-STAGES; BEHAVIORAL SENSITIZATION; GENERAL-POPULATION; CROSS-SENSITIZATION; SWEDISH CONSCRIPTS; USE DISORDERS; SCHIZOPHRENIA; PSYCHOPATHOLOGY; RELIABILITY	Objective To determine whether use of cannabis in adolescence increases the risk for psychotic outcomes by affecting the incidence and persistence of subclinical expression of psychosis in the general population (that is, expression of psychosis below the level required for a clinical diagnosis). Design Analysis of data from a prospective population based cohort study in Germany (early developmental stages of psychopathology study). Setting Population based cohort study in Germany. Participants 1923 individuals from the general population, aged 14-24 at baseline. Main outcome measure Incidence and persistence of subthreshold psychotic symptoms after use of cannabis in adolescence. Cannabis use and psychotic symptoms were assessed at three time points (baseline, T2 (3.5 years), T3 (8.4 years)) over a 10 year follow-up period with the Munich version of the composite international diagnostic interview (M-CIDI). Results In individuals who had no reported lifetime psychotic symptoms and no reported lifetime cannabis use at baseline, incident cannabis use over the period from baseline to T2 increased the risk of later incident psychotic symptoms over the period from T2 to T3 (adjusted odds ratio 1.9, 95% confidence interval 1.1 to 3.1; P=0.021). Furthermore, continued use of cannabis increased the risk of persistent psychotic symptoms over the period from T2 to T3 (2.2, 1.2 to 4.2; P=0.016). The incidence rate of psychotic symptoms over the period from baseline to T2 was 31% (152) in exposed individuals versus 20% (284) in non-exposed individuals; over the period from T2 to T3 these rates were 14% (108) and 8% (49), respectively. Conclusion Cannabis use is a risk factor for the development of incident psychotic symptoms. Continued cannabis use might increase the risk for psychotic disorder by impacting on the persistence of symptoms.	[Kuepper, Rebecca; van Os, Jim; Henquet, Cecile] Maastricht Univ, Med Ctr, Dept Psychiat & Neuropsychol,EURON, S Limburg Mental Hlth Res & Teaching Network, NL-6200 MD Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England; [Lieb, Roselind] Univ Basel, Dept Psychol, Div Epidemiol & Hlth Psychol, CH-4003 Basel, Switzerland; [Lieb, Roselind; Wittchen, Hans-Ulrich] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wittchen, Hans-Ulrich; Hoefler, Michael] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany	Maastricht University; University of London; King's College London; University of Basel; Max Planck Society; Technische Universitat Dresden	van Os, J (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat & Neuropsychol,EURON, S Limburg Mental Hlth Res & Teaching Network, POB 616, NL-6200 MD Maastricht, Netherlands.	j.vanos@sp.unimaas.nl	Wittchen, Hans-Ulrich/ABA-8901-2020; Wittchen, Hans-Ulrich/A-8507-2014; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; van Os, Jim/I-9496-2012; Hofler, Michael/A-8153-2014	Wittchen, Hans-Ulrich/0000-0002-6311-7711; van Os, Jim/0000-0002-7245-1586; van Os, Jim/0000-0002-7245-1586; Hofler, Michael/0000-0001-7646-8265	German Ministry of Research, Education and Technology [01EB9405/6, 01EB9901/6]; Deutsche Forschungsgemeinschaft (DFG); NIH [RO1DA016977-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016977] Funding Source: NIH RePORTER	German Ministry of Research, Education and Technology; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The EDSP study is funded by grants of the German Ministry of Research, Education and Technology (01EB9405/6 and 01EB9901/6) and the Deutsche Forschungsgemeinschaft (DFG), and this paper is part of NIH grant RO1DA016977-01, PL.	ANDREASSON S, 1987, LANCET, V2, P1483, DOI 10.1016/s0140-6736(87)92620-1; Arseneault L, 2004, BRIT J PSYCHIAT, V184, P110, DOI 10.1192/bjp.184.2.110; Cadoni C, 2001, PSYCHOPHARMACOLOGY, V158, P259, DOI 10.1007/s002130100875; Cadoni C, 2008, J NEUROCHEM, V106, P1586, DOI 10.1111/j.1471-4159.2008.05503.x; Collip D, 2008, SCHIZOPHRENIA BULL, V34, P220, DOI 10.1093/schbul/sbm163; COTTLER LB, 1991, DRUG ALCOHOL DEPEN, V29, P17, DOI 10.1016/0376-8716(91)90018-T; Cougnard A, 2007, PSYCHOL MED, V37, P513, DOI 10.1017/S0033291706009731; Degenhardt L, 2003, DRUG ALCOHOL DEPEN, V71, P37, DOI 10.1016/S0376-8716(03)00064-4; Degenhardt L, 2006, CAN J PSYCHIAT, V51, P556, DOI 10.1177/070674370605100903; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Ferdinand RF, 2005, ADDICTION, V100, P612, DOI 10.1111/j.1360-0443.2005.01070.x; Fisher HL, 2009, SCHIZOPHR B     1007; Grech A, 2005, EUR PSYCHIAT, V20, P349, DOI 10.1016/j.eurpsy.2004.09.013; *GROUP INV, 2010, ARCH GEN PSYCHI 1004; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63; Howes OD, 2004, INT J NEUROPSYCHOPH, V7, pS7, DOI 10.1017/S1461145704004122; Johns LC, 2001, CLIN PSYCHOL REV, V21, P1125, DOI 10.1016/S0272-7358(01)00103-9; Keshavan M, 2008, SCHIZOPHR RES, V103, P114, DOI 10.1016/j.schres.2008.03.006; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Lieb R, 2000, EUR ADDICT RES, V6, P170, DOI 10.1159/000052043; McGrath J, 2010, ARCH GEN PSYCHIAT, V67, P440, DOI 10.1001/archgenpsychiatry.2010.6; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Niemi LT, 2003, SCHIZOPHR RES, V60, P239, DOI 10.1016/S0920-9964(02)00234-7; O'Daly O. G., 2005, J DUAL DIAGN, V1, P11; Perkonigg A, 2008, ADDICTION, V103, P439, DOI 10.1111/j.1360-0443.2007.02064.x; Polanczyk G, 2010, ARCH GEN PSYCHIAT, V67, P328, DOI 10.1001/archgenpsychiatry.2010.14; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rossler W, 2007, SCHIZOPHR RES, V92, P1, DOI 10.1016/j.schres.2007.01.002; Semple DM, 2005, J PSYCHOPHARMACOL, V19, P187, DOI 10.1177/0269881105049040; Spauwen J, 2006, PSYCHOL MED, V36, P407, DOI 10.1017/S0033291705006902; van Os J, 2002, AM J EPIDEMIOL, V156, P319, DOI 10.1093/aje/kwf043; van Os J, 2005, CURR OPIN PSYCHIATR, V18, P141, DOI 10.1097/00001504-200503000-00006; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Van Rossum I, 2009, SCHIZOPHR B     0930, DOI 101093/schbul/sbp101; Verdoux H, 2002, SCHIZOPHR RES, V54, P59, DOI 10.1016/S0920-9964(01)00352-8; Wittchen HU, 2007, DRUG ALCOHOL DEPEN, V88, pS60, DOI 10.1016/j.drugalcdep.2006.12.013; Wittchen HU, 2009, DRUG ALCOHOL DEPEN, V102, P151, DOI 10.1016/j.drugalcdep.2009.02.012; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1; WITTCHEN HU, 1991, BRIT J PSYCHIAT, V159, P645, DOI 10.1192/bjp.159.5.645; Wittchen HU, 1998, EUR ADDICT RES, V4, P18, DOI 10.1159/000018921; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Zammit S, 2002, BRIT MED J, V325, P1199, DOI 10.1136/bmj.325.7374.1199	46	183	186	0	45	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 1	2011	342								d738	10.1136/bmj.d738	http://dx.doi.org/10.1136/bmj.d738			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732ED	21363868	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000288166600010
J	Luo, JH; Margolis, KL; Wactawski-Wende, J; Horn, K; Messina, C; Stefanick, ML; Tindle, HA; Tong, E; Rohan, TE				Luo, Juhua; Margolis, Karen L.; Wactawski-Wende, Jean; Horn, Kimberly; Messina, Catherine; Stefanick, Marcia L.; Tindle, Hilary A.; Tong, Elisa; Rohan, Thomas E.			Association of active and passivesmoking with risk of breast cancer among postmenopausal women: a prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; AROMATIC DNA-ADDUCTS; CIGARETTE-SMOKING; CALIFORNIA TEACHERS; RECEPTOR STATUS; EXPOSURE; HEALTH; TISSUE; POLYMORPHISMS; METAANALYSIS	Objective To examine the association between smoking and risk of invasive breast cancer using quantitative measures of lifetime passive and active smoking exposure among postmenopausal women. Design Prospective cohort study. Setting 40 clinical centres in the United States. Participants 79 990 women aged 50-79 enrolled in the Women's Health Initiative Observational Study during 1993-8. Main outcome measures Self reported active and passive smoking, pathologically confirmed invasive breast cancer. Results In total, 3520 incident cases of invasive breast cancer were identified during an average of 10.3 years of follow-up. Compared with women who had never smoked, breast cancer risk was elevated by 9% among former smokers (hazard ratio 1.09 (95% CI 1.02 to 1.17)) and by 16% among current smokers (hazard ratio 1.16 (1.00 to 1.34)). Significantly higher breast cancer risk was observed in active smokers with high intensity and duration of smoking, as well as with initiation of smoking in the teenage years. The highest breast cancer risk was found among women who had smoked for >= 50 years or more (hazard ratio 1.35 (1.03 to1.77) compared with all lifetime non-smokers, hazard ratio 1.45 (1.06 to 1.98) compared with lifetime non-smokers with no exposure to passive smoking). An increased risk of breast cancer persisted for up to 20 years after smoking cessation. Among women who had never smoked, after adjustment for potential confounders, those with the most extensive exposure to passive smoking (>= 10 years' exposure in childhood, >= 20 years' exposure as an adult at home, and >= 10 years' exposure as an adult at work) had a 32% excess risk of breast cancer compared with those who had never been exposed to passive smoking (hazard ratio 1.32 (1.04 to 1.67)). However, there was no significant association in the other groups with lower exposure and no clear dose response to cumulative passive smoking exposure. Conclusions Active smoking was associated with an increase in breast cancer risk among postmenopausal women. There was also a suggestion of an association between passive smoking and increased risk of breast cancer.	[Margolis, Karen L.] HealthPartners Res Fdn, Minneapolis, MN 55440 USA; [Luo, Juhua; Horn, Kimberly] W Virginia Univ, Dept Community Med, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Horn, Kimberly] W Virginia Univ, WV Prevent Res Ctr, Morgantown, WV 26506 USA; [Messina, Catherine] SUNY Stony Brook, Dept Prevent, Stony Brook, NY USA; [Stefanick, Marcia L.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Tindle, Hilary A.] Univ Pittsburgh, Div Gen Internal Med, Ctr Res Hlth Care, Pittsburgh, PA USA; [Tong, Elisa] Calif State Univ Sacramento, Davis Med Ctr, Div Gen Internal Med, Sacramento, CA 95819 USA; [Rohan, Thomas E.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	HealthPartners Institute for Education & Research; West Virginia University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; West Virginia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; California State University System; California State University Sacramento; Yeshiva University; Albert Einstein College of Medicine	Margolis, KL (corresponding author), HealthPartners Res Fdn, Box 1524,Mailstop 21111R, Minneapolis, MN 55440 USA.	Karen.L.Margolis@HealthPartners.com	Wactawski-Wende, Jean/AGH-5457-2022	Wactawski-Wende, Jean/0000-0003-3096-9595; luo, juhua/0000-0002-8901-4462; Margolis, Karen/0000-0003-1862-7402	National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; NATIONAL CANCER INSTITUTE [R01CA141596] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032111, N01WH042129, N01WH032100, N01WH032122, N01WH032108, N01WH032118, N01WH032105, N01WH022110, N01WH042107, N01WH032115] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Women's Health Initiative is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services (contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221). The funding source had no role in the collection, analysis, or interpretation of the data, in the preparation of the manuscript, or its submission for publication.	Al-Delaimy WK, 2004, CANCER EPIDEM BIOMAR, V13, P398; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Ambrosone CB, 1996, JAMA-J AM MED ASSOC, V276, P1494, DOI 10.1001/jama.276.18.1494; Ambrosone CB, 2008, CANCER EPIDEM BIOMAR, V17, P15, DOI 10.1158/1055-9965.EPI-07-0598; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; [Anonymous], 2004, N S W PUBLIC HLTH B, V15, P107; Band PR, 2002, LANCET, V360, P1044, DOI 10.1016/S0140-6736(02)11140-8; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Collishaw NE, 2009, CANADIAN EXPERT PANE; Conway K, 2002, CANCER RES, V62, P1987; COOPER JA, 1989, BRIT J CANCER, V59, P119, DOI 10.1038/bjc.1989.24; Cui Y, 2006, BREAST CANCER RES TR, V100, P293, DOI 10.1007/s10549-006-9255-3; Egan KM, 2002, EPIDEMIOLOGY, V13, P138, DOI 10.1097/00001648-200203000-00007; Faraglia B, 2003, CARCINOGENESIS, V24, P719, DOI 10.1093/carcin/bgg013; Firozi PF, 2002, CARCINOGENESIS, V23, P301, DOI 10.1093/carcin/23.2.301; Gram IT, 2005, CANCER EPIDEM BIOMAR, V14, P61; Ha M, 2007, AM J EPIDEMIOL, V166, P55, DOI 10.1093/aje/kwm045; HAMMOND SK, 1995, JAMA-J AM MED ASSOC, V274, P956, DOI 10.1001/jama.274.12.956; Hammond SK, 1999, ENVIRON HEALTH PERSP, V107, P329, DOI 10.2307/3434425; Hanaoka T, 2005, INT J CANCER, V114, P317, DOI 10.1002/ijc.20709; HARRIS CC, 1989, CARCINOGENESIS, V10, P1563, DOI 10.1093/carcin/10.9.1563; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; International Agency of Research on Cancer, 2004, IARC MON EV CARC RIS; Jee SH, 1999, INT J EPIDEMIOL, V28, P824, DOI 10.1093/ije/28.5.824; Johnson KC, 2005, INT J CANCER, V117, P619, DOI 10.1002/ijc.21150; Johnson KC, 2000, CANCER CAUSE CONTROL, V11, P211, DOI 10.1023/A:1008906105790; Kabat GC, 2010, AM J EPIDEMIOL, V172, P591, DOI 10.1093/aje/kwq159; KOPANS DB, 1992, RADIOL CLIN N AM, V30, P257; Kropp S, 2002, AM J EPIDEMIOL, V156, P616, DOI 10.1093/aje/kwf093; Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4; Li CI, 2005, CANCER CAUSE CONTROL, V16, P975, DOI 10.1007/s10552-005-2906-6; Li DH, 1996, CANCER RES, V56, P287; Li DH, 1999, CANCER DETECT PREV, V23, P454, DOI 10.1046/j.1525-1500.1999.99059.x; Lissowska J, 2006, INT J CANCER, V119, P1961, DOI 10.1002/ijc.22044; LONDON SJ, 1989, JNCI-J NATL CANCER I, V81, P1625, DOI 10.1093/jnci/81.21.1625; Manjer J, 2001, INT J CANCER, V91, P580, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1091>3.3.CO;2-M; Miller MD, 2007, PREV MED, V44, P93, DOI 10.1016/j.ypmed.2006.08.015; Morabia A, 1996, AM J EPIDEMIOL, V143, P918, DOI 10.1093/oxfordjournals.aje.a008835; Olson JE, 2005, MAYO CLIN PROC, V80, P1423, DOI 10.4065/80.11.1423; PALMER JR, 1993, EPIDEMIOL REV, V15, P145, DOI 10.1093/oxfordjournals.epirev.a036098; PALMER JR, 1991, AM J EPIDEMIOL, V134, P1; PERERA FP, 1995, CANCER EPIDEM BIOMAR, V4, P233; Pirie K, 2008, INT J EPIDEMIOL, V37, P1069, DOI 10.1093/ije/dyn110; Reynolds P, 2004, JNCI-J NATL CANCER I, V96, P29, DOI 10.1093/jnci/djh002; Reynolds P, 2009, CANCER EPIDEM BIOMAR, V18, P3389, DOI 10.1158/1055-9965.EPI-09-0936; Rosenberg LU, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1378; Rundle A, 2000, CARCINOGENESIS, V21, P1281, DOI 10.1093/carcin/21.7.1281; SMITH SJ, 1994, BRIT J CANCER, V70, P112, DOI 10.1038/bjc.1994.258; *SURV EP END RES, 1998, SEER EXT DIS 1988 CO; Terry PD, 2002, CANCER EPIDEM BIOMAR, V11, P953; U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; Wartenberg D, 2000, J NATL CANCER I, V92, P1666, DOI 10.1093/jnci/92.20.1666; WELLS AJ, 1991, AM J EPIDEMIOL, V133, P208, DOI 10.1093/oxfordjournals.aje.a115859; Yoo KY, 1997, AM J EPIDEMIOL, V146, P307, DOI 10.1093/oxfordjournals.aje.a009271; Zhao Y, 1999, Zhonghua Liu Xing Bing Xue Za Zhi, V20, P91	56	123	126	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2011	342								d1016	10.1136/bmj.d1016	http://dx.doi.org/10.1136/bmj.d1016			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732ED	21363864	Green Published, hybrid			2022-12-28	WOS:000288166600009
J	Wendler, D; Rid, A				Wendler, David; Rid, Annette			Systematic Review: The Effect on Surrogates of Making Treatment Decisions for Others	ANNALS OF INTERNAL MEDICINE			English	Review							INTENSIVE-CARE-UNIT; OF-LIFE CARE; INTERNATIONAL CONSENSUS CONFERENCE; FAMILY-MEMBERS; ADVANCE DIRECTIVES; HEALTH-CARE; SUSTAINING TREATMENTS; POSTTRAUMATIC STRESS; QUALITATIVE RESEARCH; CRITICALLY-ILL	Background: Clinical practice relies on surrogates to make or help to make treatment decisions for incapacitated adults; however, the effect of this practice on surrogates has not been evaluated. Purpose: To assess the effect on surrogates of making treatment decisions for adults who cannot make their own decisions. Data Sources: Empirical studies published in English and listed in MEDLINE, EMBASE, CINAHL, BIOETHICSLINE, PsycINFO, or Scopus before 1 July 2010. Study Selection: Eligible studies provided quantitative or qualitative empirical data, by evaluating surrogates, regarding the effect on surrogates of making treatment decisions for an incapacitated adult. Data Extraction: Information on study location, number and type of surrogates, timing of data collection, type of decisions, patient setting, methods, main findings, and limitations. Data Synthesis: 40 studies, 29 using qualitative and 11 using quantitative methods, provided data on 2854 surrogates, more than one half of whom were family members of the patient. Most surrogates were surveyed several months to years after making treatment decisions, the majority of which were end-of-life decisions. The quantitative studies found that at least one third of surrogates experienced a negative emotional burden as the result of making treatment decisions. The qualitative studies reported that many or most surrogates experienced negative emotional burden. The negative effects on surrogates were often substantial and typically lasted months or, in some cases, years. The most common negative effects cited by surrogates were stress, guilt over the decisions they made, and doubt regarding whether they had made the right decisions. Nine of the 40 studies also reported beneficial effects on a few surrogates, the most common of which were supporting the patient and feeling a sense of satisfaction. Knowing which treatment is consistent with the patient's preferences was frequently cited as reducing the negative effect on surrogates. Limitations: Thirty-two of the 40 articles reported data collected in the United States. Because the study populations were relatively homogenous, it is unclear whether the findings apply to other groups. In some cases, the effect of making treatment decisions could not be isolated from that of other stressors, such as grief or prognostic uncertainty. Nine of the studies had a response rate less than 50%, and 9 did not report a response rate. Many of the studies had a substantial interval between the treatment decisions and data collection. Conclusion: Making treatment decisions has a negative emotional effect on at least one third of surrogates, which is often substantial and typically lasts months (or sometimes years). Future research should evaluate ways to reduce this burden, including methods to identify which treatment options are consistent with the patient's preferences.	[Wendler, David] NIH, Bethesda, MD 20892 USA; Univ Zurich, Inst Biomed Eth, CH-8032 Zurich, Switzerland	National Institutes of Health (NIH) - USA; University of Zurich	Wendler, D (corresponding author), NIH, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	dwendler@nih.gov			National Institutes of Health; Swiss National Science Foundation [PA00B-117505/2]; National Institutes of Health Clinical Center	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Primary Funding Source: National Institutes of Health.r Grant Support: By the National Institutes of Health Clinical Center. Dr. Rid is supported by a grant from the Swiss National Science Foundation (PA00B-117505/2).	Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Beauchamp Tom L., 2019, PRINCIPLES BIOMEDICA, V8th; Braun UK, 2008, J GEN INTERN MED, V23, P267, DOI 10.1007/s11606-007-0487-7; Buchanan Allen E., 1989, DECIDING OTHERS ETHI; Buckey JW, 2010, J SOC WORK END-LIFE, V6, P27, DOI 10.1080/15524256.2010.489221; Butcher HK, 2001, RES NURS HEALTH, V24, P470, DOI 10.1002/nur.10005; Carlet J, 2004, INTENS CARE MED, V30, P770, DOI 10.1007/s00134-004-2241-5; Caron CD, 2005, J APPL GERONTOL, V24, P231, DOI 10.1177/0733464805275766; Caron CD., 2005, DEMENTIA, V4, P113, DOI [10.1177/1471301205049193, DOI 10.1177/1471301205049193]; Chambers-Evans J, 2005, J CLIN ETHIC, V16, P28; Colclough YY, 2007, J FAM NURS, V13, P201, DOI 10.1177/1074840707300761; Coppola KM, 2001, ARCH INTERN MED, V161, P431, DOI 10.1001/archinte.161.3.431; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Davis BA, 2005, J HOSP PALLIAT NURS, V7, P219; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Dreyer A, 2009, J MED ETHICS, V35, P672, DOI 10.1136/jme.2009.030668; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Forbes S, 2000, J NURS SCHOLARSHIP, V32, P251, DOI 10.1111/j.1547-5069.2000.00251.x; Giacomini M, 2009, CRIT CARE MED, V37, P1475, DOI 10.1097/CCM.0b013e31819d6495; Green MJ, 2009, HEALTH EXPECT, V12, P60, DOI 10.1111/j.1369-7625.2008.00517.x; Gries CJ, 2008, CHEST, V133, P704, DOI 10.1378/chest.07-1773; Gries CJ, 2010, CHEST, V137, P280, DOI 10.1378/chest.09-1291; Handy Catherine M, 2008, Palliat Support Care, V6, P13, DOI 10.1017/S1478951508000035; Hansen L, 2004, J NURS SCHOLARSHIP, V36, P233, DOI 10.1111/j.1547-5069.2004.04043.x; Hansen Lissi, 2005, J Gerontol Nurs, V31, P28; Harden A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4254; HAYES CM, 2003, J HOSP PALLIAT NURS, V5, P91; Heyland DK, 2001, J CRIT CARE, V16, P142, DOI 10.1053/jcrc.2001.30163; Heyland DK, 2003, INTENS CARE MED, V29, P75, DOI 10.1007/s00134-002-1569-y; Jacob D A, 1998, Am J Crit Care, V7, P30; Jacobson JA, 1997, J CLIN ETHIC, V8, P359; Jeffers B R, 1998, Medsurg Nurs, V7, P357; Kirchhoff KT, 2002, AM J CRIT CARE, V11, P200, DOI 10.4037/ajcc2002.11.3.200; Levy MM, 2004, CRIT CARE MED, V32, P1966, DOI 10.1097/01.CCM.0000140089.67373.0B; Limerick MH, 2007, ONCOL NURS FORUM, V34, P331, DOI 10.1188/07.ONF.331-339; Lynn J, 1991, Law Med Health Care, V19, P101; Martin DK, 2000, LANCET, V356, P1672, DOI 10.1016/S0140-6736(00)03168-8; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; MEAD GE, 1995, J ROY COLL PHYS LOND, V29, P295; Meeker MA, 2004, QUAL HEALTH RES, V14, P204, DOI 10.1177/1049732303260501; Meeker Mary Ann, 2005, Palliat Support Care, V3, P131; Meeker MA, 2009, J CLIN NURS, V18, P163, DOI 10.1111/j.1365-2702.2008.02465.x; Norton SA, 2003, AM J CRIT CARE, V12, P548, DOI 10.4037/ajcc2003.12.6.548; OUSLANDER JG, 1989, ARCH INTERN MED, V149, P1367, DOI 10.1001/archinte.149.6.1367; Penrod J, 1998, WESTERN J NURS RES, V20, P706, DOI 10.1177/019394599802000604; Pochard F, 2001, CRIT CARE MED, V29, P1893, DOI 10.1097/00003246-200110000-00007; Popay J, 1998, QUAL HEALTH RES, V8, P341, DOI 10.1177/104973239800800305; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; Radwany S, 2009, AM J HOSP PALLIAT ME, V26, P376, DOI 10.1177/1049909109338515; Raymont V, 2004, LANCET, V364, P1421, DOI 10.1016/S0140-6736(04)17224-3; Rid A, 2010, HASTINGS CENT REP, V40, P36; Robinson E M, 2000, J Nurs Law, V7, P21; ROTHCHILD E, 1994, GEN HOSP PSYCHIAT, V16, P251, DOI 10.1016/0163-8343(94)90004-3; RUARK JE, 1988, NEW ENGL J MED, V318, P25, DOI 10.1056/NEJM198801073180106; SECKLER AB, 1991, ANN INTERN MED, V115, P92, DOI 10.7326/0003-4819-115-2-92; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; Silberfeld M, 1996, Int Psychogeriatr, V8, P589, DOI 10.1017/S1041610296002906; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Singer PA, 1998, ARCH INTERN MED, V158, P879, DOI 10.1001/archinte.158.8.879; SMEDIRA NG, 1990, NEW ENGL J MED, V322, P309, DOI 10.1056/NEJM199002013220506; Sood J., 2006, RES SOCIAL SCI STUDY, V16, P221; Swigart V, 1996, HEART LUNG, V25, P483, DOI 10.1016/S0147-9563(96)80051-3; Terry PB, 1999, J CLIN ETHIC, V10, P286; Thompson BT, 2004, CRIT CARE MED, V32, P1781, DOI 10.1097/01.CCM.0000126895.66850.14; Tilden V. P., 1999, J FAM NURS, V5, P426, DOI DOI 10.1177/107484079900500405; TILDEN VP, 1995, ARCH INTERN MED, V155, P633, DOI 10.1001/archinte.155.6.633; Tilden VP, 2001, NURS RES, V50, P105, DOI 10.1097/00006199-200103000-00006; Vig EK, 2007, J GEN INTERN MED, V22, P1274, DOI 10.1007/s11606-007-0252-y; Waekerbarth S, 1999, QUAL HEALTH RES, V9, P294; Wiegand D, 2008, J PALLIAT MED, V11, P1115, DOI 10.1089/jpm.2008.0015; Wiegand DLM, 2006, J FAM NURS, V12, P165, DOI 10.1177/1074840706287686	74	403	409	0	56	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					336	+		10.7326/0003-4819-154-5-201103010-00008	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00008			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	727LA	21357911				2022-12-28	WOS:000287799900006
J	Rabeharisoa, V				Rabeharisoa, Vololona			Socializing Genetic Diseases	SCIENCE			English	Editorial Material									MINES ParisTech, Ctr Sociol Innovat, Paris, France	UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech	Rabeharisoa, V (corresponding author), MINES ParisTech, Ctr Sociol Innovat, Paris, France.								0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1026	1027		10.1126/science.1203631	http://dx.doi.org/10.1126/science.1203631			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350165				2022-12-28	WOS:000287699000050
J	Aziz, T; Stein, J				Aziz, Tipu; Stein, John			POINT Somebody has to speak out	NATURE			English	Editorial Material									[Aziz, Tipu] John Radcliffe Hosp, Dept Neurosurg, Oxford OX3 9DU, England; [Stein, John] Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Aziz, T (corresponding author), John Radcliffe Hosp, Dept Neurosurg, Oxford OX3 9DU, England.	john.stein@dpag.ox.ac.uk		Stein, John/0000-0001-5843-8986					0	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					457	458		10.1038/470457a	http://dx.doi.org/10.1038/470457a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725NT	21350463	Bronze			2022-12-28	WOS:000287652900013
J	Gardy, JL; Johnston, JC; Sui, SJH; Cook, VJ; Shah, LN; Brodkin, E; Rempel, S; Moore, R; Zhao, YJ; Holt, R; Varhol, R; Birol, I; Lem, M; Sharma, MK; Elwood, K; Jones, SJM; Brinkman, FSL; Brunham, RC; Tang, P				Gardy, Jennifer L.; Johnston, James C.; Sui, Shannan J. Ho; Cook, Victoria J.; Shah, Lena; Brodkin, Elizabeth; Rempel, Shirley; Moore, Richard; Zhao, Yongjun; Holt, Robert; Varhol, Richard; Birol, Inanc; Lem, Marcus; Sharma, Meenu K.; Elwood, Kevin; Jones, Steven J. M.; Brinkman, Fiona S. L.; Brunham, Robert C.; Tang, Patrick			Whole-Genome Sequencing and Social-Network Analysis of a Tuberculosis Outbreak	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR EPIDEMIOLOGY; CONTACT INVESTIGATIONS; CRACK COCAINE; RISK-FACTORS; DRUG-USERS; TRANSMISSION	BACKGROUND An outbreak of tuberculosis occurred over a 3-year period in a medium-size community in British Columbia, Canada. The results of mycobacterial interspersed repetitive unit-variable-number tandem-repeat (MIRU-VNTR) genotyping suggested the outbreak was clonal. Traditional contact tracing did not identify a source. We used whole-genome sequencing and social-network analysis in an effort to describe the outbreak dynamics at a higher resolution. METHODS We sequenced the complete genomes of 32 Mycobacterium tuberculosis outbreak isolates and 4 historical isolates (from the same region but sampled before the outbreak) with matching genotypes, using short-read sequencing. Epidemiologic and genomic data were overlaid on a social network constructed by means of interviews with patients to determine the origins and transmission dynamics of the outbreak. RESULTS Whole-genome data revealed two genetically distinct lineages of M. tuberculosis with identical MIRU-VNTR genotypes, suggesting two concomitant outbreaks. Integration of social-network and phylogenetic analyses revealed several transmission events, including those involving "superspreaders." Both lineages descended from a common ancestor and had been detected in the community before the outbreak, suggesting a social, rather than genetic, trigger. Further epidemiologic investigation revealed that the onset of the outbreak coincided with a recorded increase in crack cocaine use in the community. CONCLUSIONS Through integration of large-scale bacterial whole-genome sequencing and social-network analysis, we show that a socioenvironmental factor - most likely increased crack cocaine use - triggered the simultaneous expansion of two extant lineages of M. tuberculosis that was sustained by key members of a high-risk social network. Genotyping and contact tracing alone did not capture the true dynamics of the outbreak. (Funded by Genome British Columbia and others.)	[Gardy, Jennifer L.; Johnston, James C.; Cook, Victoria J.; Shah, Lena; Rempel, Shirley; Elwood, Kevin; Brunham, Robert C.; Tang, Patrick] British Columbia Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada; [Gardy, Jennifer L.; Cook, Victoria J.; Elwood, Kevin; Brunham, Robert C.; Tang, Patrick] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Moore, Richard; Zhao, Yongjun; Holt, Robert; Varhol, Richard; Birol, Inanc; Jones, Steven J. M.] Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Shah, Lena] Publ Hlth Agcy Canada, Canadian Field Epidemiol Program, Vancouver, BC, Canada; [Lem, Marcus] Hlth Canada, Vancouver, BC, Canada; [Sui, Shannan J. Ho; Jones, Steven J. M.; Brinkman, Fiona S. L.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Brodkin, Elizabeth] Fraser Hlth Author, Surrey, BC, Canada; [Sharma, Meenu K.] Natl Microbiol Lab, Winnipeg, MB, Canada	University of British Columbia; Public Health Agency of Canada; Health Canada; Simon Fraser University	Tang, P (corresponding author), British Columbia Ctr Dis Control, 655 W 12th Ave, Vancouver, BC V5Z 4R4, Canada.	patrick.tang@bccdc.ca	Jones, Steven J/C-3621-2009; Birol, Inanc/G-5440-2011; Sharma, Meenu/GWM-5030-2022; Sharma, Meenu/AAE-2536-2022; Holt, Robert A/C-3303-2009; Brinkman, Fiona/N-3195-2013	Jones, Steven J/0000-0003-3394-2208; Birol, Inanc/0000-0003-0950-7839; Sharma, Meenu/0000-0002-6020-9995; Holt, Robert A/0000-0002-7259-1247; Brinkman, Fiona/0000-0002-0584-4099; Tang, Patrick/0000-0003-1583-5484; /0000-0002-6191-4709	Genome British Columbia, Health Canada; Simon Fraser University Community Trust; British Columbia Lung Association; Canadian Cystic Fibrosis Foundation; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research	Genome British Columbia, Health Canada; Simon Fraser University Community Trust; British Columbia Lung Association; Canadian Cystic Fibrosis Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by grants from Genome British Columbia, Health Canada, and the Simon Fraser University Community Trust, as well as from the British Columbia Lung Association (to Dr. Johnston), the Canadian Cystic Fibrosis Foundation (to Dr. Ho Sui), and the Michael Smith Foundation for Health Research and the Canadian Institutes of Health Research (to Dr. Brinkman).	[Anonymous], 2007, CAN TUB STAND; [Anonymous], 2009, TUB CAN 2007; Asghar RJ, 2009, J URBAN HEALTH, V86, P776, DOI 10.1007/s11524-009-9378-z; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P485; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Cook VJ, 2007, J INFECT DIS, V196, P1517, DOI 10.1086/523109; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Fenner L, 2009, INT J EPIDEMIOL, V38, P1425, DOI 10.1093/ije/dyp367; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Grimes CZ, 2007, INT J TUBERC LUNG D, V11, P1183; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Howard AA, 2002, CLIN INFECT DIS, V35, P1183, DOI 10.1086/343827; Malakmadze N, 2005, CLIN INFECT DIS, V40, P366, DOI 10.1086/427112; McElroy RD, 2003, INT J TUBERC LUNG D, V7, pS486; Nguyen LN, 2004, RESPIROLOGY, V9, P313, DOI 10.1111/j.1440-1843.2004.00603.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Story A, 2008, EMERG INFECT DIS, V14, P1466, DOI 10.3201/eid1409.070654; World Health Organization, 2002, WHOCDSTB2002297; World Health Organization (WHO), 2009, WHOHTMTB2009420	20	522	534	4	128	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					730	739		10.1056/NEJMoa1003176	http://dx.doi.org/10.1056/NEJMoa1003176			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345102	Green Published			2022-12-28	WOS:000287652500007
J	Schertzer, JW; Whiteley, M				Schertzer, Jeffrey W.; Whiteley, Marvin			Microbial Communication Superhighways	CELL			English	Editorial Material							MEMBRANE-VESICLES; ESCHERICHIA-COLI	Exchange of information is critical for bacterial social behaviors. Now Dubey and Ben-Yehuda (2011) provide evidence for bacterial "nanotube'' conduits that allow microbes to directly exchange cytoplasmic factors. Protein and DNA transfer between distantly related species raises the prospect of a new, widely distributed mechanism of bacterial communication.	[Schertzer, Jeffrey W.; Whiteley, Marvin] Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Whiteley, M (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cell & Mol Biol, Austin, TX 78712 USA.	mwhiteley@mail.utexas.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075068] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI075068, R01 AI075068-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHTMAN M, 1978, J BACTERIOL, V135, P1053, DOI 10.1128/JB.135.3.1053-1061.1978; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mullineaux CW, 2008, EMBO J, V27, P1299, DOI 10.1038/emboj.2008.66; Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133	10	10	16	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					469	470		10.1016/j.cell.2011.02.001	http://dx.doi.org/10.1016/j.cell.2011.02.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335231	Bronze, Green Accepted			2022-12-28	WOS:000287473100003
J	Sweatt, JD				Sweatt, J. David			Creating Stable Memories	SCIENCE			English	Editorial Material							HIPPOCAMPAL REGION; ACTIVATION; DAMAGE		[Sweatt, J. David] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Sweatt, J. David] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	dsweatt@nrc.uab.edu		Sweatt, J. David/0000-0003-3567-485X				Alvarez P, 2001, LEARN MEMORY, V8, P79, DOI 10.1101/lm.38201; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Bunsey M, 1995, HIPPOCAMPUS, V5, P546, DOI 10.1002/hipo.450050606; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Clark RE, 2002, J NEUROSCI, V22, P4663, DOI 10.1523/JNEUROSCI.22-11-04663.2002; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Lesburgueres E, 2011, SCIENCE, V331, P924, DOI 10.1126/science.1196164; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Ross RS, 2006, J NEUROSCI, V26, P4852, DOI 10.1523/JNEUROSCI.0659-06.2006; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015	15	7	8	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					869	870		10.1126/science.1202283	http://dx.doi.org/10.1126/science.1202283			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330525				2022-12-28	WOS:000287455100037
J	Wang, FY; Lin, JS; Liu, KP				Wang, Fengyan; Lin, Jui-San; Liu, Kopin			Steric Control of the Reaction of CH Stretch-Excited CHD3 with Chlorine Atom	SCIENCE			English	Article							CHEMICAL-REACTIONS; MOLECULES; PRODUCTS; DYNAMICS; METHANE; BEAM	Exciting the CH-stretching mode of CHD3 (where D is deuterium) is known to promote the C-H bond's reactivity toward chlorine (Cl) atom. Conventional wisdom ascribes the vibrational-rate enhancement to a widening of the cone of acceptance (i.e., the collective Cl approach trajectories that lead to reaction). A previous study of this reaction indicated an intriguing alignment effect by infrared laser-excited reagents, which on intuitive grounds is not fully compatible with the above interpretation. We report here an in-depth experimental study of reagent alignment effects in this reaction. Pronounced impacts are evident not only in total reactivity but also in product state and angular distributions. By contrasting the data with previously reported stereodynamics in reactions of unpolarized, excited CHD3 with fluorine (F) and O(P-3), we elucidate the decisive role of long-range anisotropic interactions in steric control of this chemical reaction.	[Wang, Fengyan; Lin, Jui-San; Liu, Kopin] Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan; [Liu, Kopin] Natl Taiwan Univ, Dept Phys, Taipei 10617, Taiwan; Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Tsing Hua University	Liu, KP (corresponding author), Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan.	kliu@po.iams.sinica.edu.tw	Liu, Kopin/F-7929-2012	Liu, Kopin/0000-0001-7499-2397	National Science Council [NSC-99-2113-M-011-016]; Academia Sinica; Air Force Office of Scientific Research [AOARD-10-4034]	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	We are indebted to S. Yan for earlier attempts of this project and to J. Lam for help with the experiment. This work was supported by National Science Council (NSC-99-2113-M-011-016), Academia Sinica, and the Air Force Office of Scientific Research (AOARD-10-4034).	Alexander AJ, 1998, CHEM SOC REV, V27, P405; ALTKORN R, 1985, MOL PHYS, V55, P1, DOI 10.1080/00268978500101121; CLARY DC, 1990, ANNU REV PHYS CHEM, V41, P61; Corchado JC, 2000, J CHEM PHYS, V112, P9375, DOI 10.1063/1.481602; Crim FF, 2008, P NATL ACAD SCI USA, V105, P12654, DOI 10.1073/pnas.0803010105; Czako G, 2009, J AM CHEM SOC, V131, P17534, DOI 10.1021/ja906886z; DUNCAN WT, 1995, J CHEM PHYS, V103, P9642, DOI 10.1063/1.470731; HASE WL, 1994, SCIENCE, V266, P998, DOI 10.1126/science.266.5187.998; LEVINE RD, 1990, J PHYS CHEM-US, V94, P8872, DOI 10.1021/j100389a006; LEVINE RD, 1987, MOL REACTION DYNAMIC; Lin JJ, 2003, SCIENCE, V300, P966, DOI 10.1126/science.1083672; Lin JJ, 2003, REV SCI INSTRUM, V74, P2495, DOI 10.1063/1.1561604; Martinez R, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2762210; Nyman G, 2007, ISR J CHEM, V47, P1, DOI 10.1560/IJC.47.1.1; ORREWING AJ, 1994, ANNU REV PHYS CHEM, V45, P315, DOI 10.1146/annurev.physchem.45.1.315; SCHECHTER I, 1989, J CHEM SOC FARAD T 2, V85, P1059, DOI 10.1039/f29898501059; SIMPSON WR, 1995, J CHEM PHYS, V103, P7313, DOI 10.1063/1.470305; Ulenikov ON, 2010, MOL PHYS, V108, P1209, DOI 10.1080/00268976.2010.483131; Wang FY, 2010, CHEM SCI, V1, P126, DOI 10.1039/c0sc00186d; Yan S, 2008, P NATL ACAD SCI USA, V105, P12667, DOI 10.1073/pnas.0800220105; Yan S, 2007, SCIENCE, V316, P1723, DOI 10.1126/science.1142313; Yoder BL, 2010, SCIENCE, V329, P553, DOI 10.1126/science.1191751; ZARE RN, 1982, BER BUNSEN PHYS CHEM, V86, P422, DOI 10.1002/bbpc.19820860516; Zhou J, 2005, MOL PHYS, V103, P1757, DOI 10.1080/00268970500064838	24	110	109	0	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					900	903		10.1126/science.1199771	http://dx.doi.org/10.1126/science.1199771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330543	Green Submitted			2022-12-28	WOS:000287455100054
J	Yamanaka, S				Yamanaka, Shinya			Of Mice and Humans	SCIENCE			English	Editorial Material									Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan	Kyoto University	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan.								0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					873	873		10.1126/science.1203707	http://dx.doi.org/10.1126/science.1203707			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330532				2022-12-28	WOS:000287455100041
J	Pall, P; Aina, T; Stone, DA; Stott, PA; Nozawa, T; Hilberts, AGJ; Lohmann, D; Allen, MR				Pall, Pardeep; Aina, Tolu; Stone, Daithi A.; Stott, Peter A.; Nozawa, Toru; Hilberts, Arno G. J.; Lohmann, Dag; Allen, Myles R.			Anthropogenic greenhouse gas contribution to flood risk in England and Wales in autumn 2000	NATURE			English	Article							CLIMATE-CHANGE; PRECIPITATION EXTREMES; UK; ATTRIBUTION; EMISSIONS; RAINFALL; TRENDS; MODEL	Interest in attributing the risk of damaging weather-related events to anthropogenic climate change is increasing(1). Yet climate models used to study the attribution problem typically do not resolve the weather systems associated with damaging events(2) such as the UK floods of October and November 2000. Occurring during the wettest autumn in England and Wales since records began in 1766(3,4), these floods damaged nearly 10,000 properties across that region, disrupted services severely, and caused insured losses estimated at 1.3 pound billion (refs 5, 6). Although the flooding was deemed a 'wakeup call' to the impacts of climate change at the time(7), such claims are typically supported only by general thermodynamic arguments that suggest increased extreme precipitation under global warming, but fail(8,9) to account fully for the complex hydrometeorology(4,10) associated with flooding. Here we present a multi-step, physically based 'probabilistic event attribution' framework showing that it is very likely that global anthropogenic greenhouse gas emissions substantially increased the risk of flood occurrence in England and Wales in autumn 2000. Using publicly volunteered distributed computing(11,12), we generate several thousand seasonal-forecast-resolution climate model simulations of autumn 2000 weather, both under realistic conditions, and under conditions as they might have been had these greenhouse gas emissions and the resulting large-scale warming never occurred. Results are fed into a precipitation-runoff model that is used to simulate severe daily river runoff events in England and Wales (proxy indicators of flood events). The precise magnitude of the anthropogenic contribution remains uncertain, but in nine out of ten cases our model results indicate that twentieth-century anthropogenic greenhouse gas emissions increased the risk of floods occurring in England and Wales in autumn 2000 by more than 20%, and in two out of three cases by more than 90%.	[Pall, Pardeep] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Pall, Pardeep; Stone, Daithi A.; Allen, Myles R.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England; [Aina, Tolu] Univ Oxford, Oxford E Res Ctr, Oxford OX1 3QG, England; [Stone, Daithi A.; Allen, Myles R.] Oxford Univ Ctr Environm, Tyndall Ctr Oxford, Oxford OX1 3QY, England; [Stott, Peter A.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Nozawa, Toru] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Hilberts, Arno G. J.; Lohmann, Dag] Risk Management Solut Ltd, London EC3R 8NB, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford; University of Oxford; University of Oxford; Met Office - UK; Hadley Centre; National Institute for Environmental Studies - Japan	Pall, P (corresponding author), Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland.	pardeep.pall@env.ethz.ch	Scott, Peter/GYA-5335-2022; Stott, Peter/N-1228-2016; Allen, Myles R/A-5172-2012	Stott, Peter/0000-0003-4853-7686; Stone, Daithi/0000-0002-2518-100X	NERC; Risk Management Solutions Ltd; WWF International; UK Department for Environment, Food, and Rural Affairs; Joint DECC and Defra Integrated Climate Programme-DECC/Defra [GA01101]; Japanese Ministry of Education, Culture, Sports, Science and Technology; US National Oceanic and Atmospheric Administration's Office; US Department of Energy; European Union [036946]; Smith School of Enterprise and the Environment	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Risk Management Solutions Ltd; WWF International; UK Department for Environment, Food, and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Joint DECC and Defra Integrated Climate Programme-DECC/Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Oceanic and Atmospheric Administration's Office; US Department of Energy(United States Department of Energy (DOE)); European Union(European Commission); Smith School of Enterprise and the Environment	We thank all members of the public who ran HadAM3-N144 climate model simulations using the BOINC open source computing platform, and the climateprediction. net team for their technical support; M. Collins, N. Rayner, A. Jones and C. Johnson for originally supplying the HadAM3-N144 model, observed SSTs and sea ice, sulphate fields, and ozone fields, respectively; G. Meehl and T. Knutson for permission to use NCARPCM1 and GFDLR30 temperature data, respectively; S. Hay and I. Tracey for assistance with beta tests; C. Lee for technical advice; and W. Ingram and D. Rowlands for scientific advice. P.P. was supported by a NERC CASE studentship with Risk Management Solutions Ltd, by WWF International, and by NCCR climate. D.A.S. and P.P. received partial support from the UK Department for Environment, Food, and Rural Affairs. P.A.S. was supported by the Joint DECC and Defra Integrated Climate Programme-DECC/Defra (GA01101). T.N. was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology. D.A.S. and M.R.A. received additional support from the Climate Change Detection and Attribution Project jointly funded by the US National Oceanic and Atmospheric Administration's Office of Global Programs and the US Department of Energy. This research was also supported by the European Union (FP6) funded Integrated Project WATCH (contract number 036946) and the Smith School of Enterprise and the Environment.	Alexander LV, 2000, ATMOS SCI LETT, V1, P142, DOI 10.1006/asle.2001.0025; Allen M, 2003, NATURE, V421, P891, DOI 10.1038/421891a; Allen M, 1999, NATURE, V401, P642, DOI 10.1038/44266; [Anonymous], 2005, TRENDS COMPENDIUM DA; Association of British Insurers, 2001, FLOOD PARTN APPR PRO; Beven K. J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Blackburn M., 2001, ATMOSPHERIC VARIABIL; Department for Environment Food and Rural Affairs, 2001, FD2304 DEFRA; Environment Agency, 2001, LESS LEARN AUT 2000; Fowler HJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017327; Fowler HJ, 2003, INT J CLIMATOL, V23, P1313, DOI 10.1002/joc.943; Hannaford J, 2008, INT J CLIMATOL, V28, P1325, DOI 10.1002/joc.1643; Hegerl GC, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Lenderink G, 2008, NAT GEOSCI, V1, P511, DOI 10.1038/ngeo262; Lohmann D, 1996, TELLUS A, V48, P708, DOI 10.1034/j.1600-0870.1996.t01-3-00009.x; Maraun D, 2008, INT J CLIMATOL, V28, P833, DOI 10.1002/joc.1672; Marsh TJ, 2002, J CHART INST WATER E, V16, P180; Massacand A. C., 2003, 415 ECMWF; Massey N., 2006, ADV GEOSCI, V8, P49, DOI DOI 10.5194/ADGE0-8-49-2006); Meehl GA, 2004, J CLIMATE, V17, P3721, DOI 10.1175/1520-0442(2004)017<3721:CONAAF>2.0.CO;2; Natural Environmental Research Council - Centre for Ecology & Hydrology, 2010, NAT RIV FLOW ARCH; Nozawa T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023540; O'Gorman PA, 2009, P NATL ACAD SCI USA, V106, P14773, DOI 10.1073/pnas.0907610106; Pitt M., 2008, PITT REV LESSONS LEA, VVolume 505; Pope VD, 2002, CLIM DYNAM, V19, P211, DOI 10.1007/s00382-001-0222-8; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Robson AJ, 2002, PHILOS T ROY SOC A, V360, P1327, DOI 10.1098/rsta.2002.1003; Sexton DMH, 2001, CLIM DYNAM, V17, P669, DOI 10.1007/s003820000141; Stone DA, 2005, CLIMATIC CHANGE, V71, P303, DOI 10.1007/s10584-005-6778-2; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Stott PA, 2006, J CLIMATE, V19, P3055, DOI 10.1175/JCLI3802.1; Stott PA, 2010, WIRES CLIM CHANGE, V1, P192, DOI 10.1002/wcc.34; United Nations Framework Convention on Climate Change (UNFCCC), 2007, FCCCKPCMP200610; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Wilby RL, 2008, HYDROL PROCESS, V22, P2511, DOI 10.1002/hyp.6847	37	589	604	11	359	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					382	385		10.1038/nature09762	http://dx.doi.org/10.1038/nature09762			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331040				2022-12-28	WOS:000287409100039
J	Sheron, N; Hawkey, C; Gilmore, I				Sheron, Nick; Hawkey, Chris; Gilmore, Ian			Projections of alcohol deaths-a wake-up call	LANCET			English	Editorial Material							POLICY		[Sheron, Nick] Univ Southampton, Fac Med, Div Infect Inflammat & Immun, Southampton SO16 6YD, Hants, England; [Hawkey, Chris] Univ Nottingham Hosp, Queens Med Ctr, Fac Med & Hlth Sci, Nottingham NG7 2UH, England; [Gilmore, Ian] Royal Liverpool Hosp, Liverpool L7 8XP, Merseyside, England; [Gilmore, Ian] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of Southampton; University of Nottingham; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Sheron, N (corresponding author), Univ Southampton, Fac Med, Div Infect Inflammat & Immun, Southampton SO16 6YD, Hants, England.	Nick.Sheron@soton.ac.uk		Sheron, Nick/0000-0002-6156-8367; Sheron, Nick/0000-0001-5232-8292				Abel EL, 2001, ALCOHOL ALCOHOLISM, V36, P401, DOI 10.1093/alcalc/36.5.401; Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; BROWN RH, 2003, FORBIDDEN SUBSTANCES, pCH6; Department of Health, 2008, SAF SENS SOC CONS FU; DUFFY JC, 2010, J R STAT SOC, V149, P44; House of Commons Health Committee, 2010, ALC 1 REP SESS 2009; Jernigan DH, 2000, B WORLD HEALTH ORGAN, V78, P491; Jewell J, 2010, CLIN MED, V10, P259, DOI 10.7861/clinmedicine.10-3-259; JOLIFFE N, 1949, Q J STUD ALCOHOL, V2, P544; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; TERRIS M, 1967, AM J PUBLIC HEALTH, V57, P2067; The NHS Information Centre, 2009, STAT ALC ENGL 2009; WHO, 2004, GLOB STAT REP ALC 20; *WHO, 2008, HLTH STAT INF SYST G; World Health Organization, 2009, WHO EUR HLTH ALL DAT	15	35	36	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1297	1299		10.1016/S0140-6736(11)60022-6	http://dx.doi.org/10.1016/S0140-6736(11)60022-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21334738				2022-12-28	WOS:000289962900008
J	Martin, C				Martin, Colin			Lunch with The Lancet Drew Berry	LANCET			English	Editorial Material												cmpubrel@aol.com							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					895	895		10.1016/S0140-6736(11)60338-3	http://dx.doi.org/10.1016/S0140-6736(11)60338-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GR	21397753				2022-12-28	WOS:000288628800017
J	Minke, B; Peters, M				Minke, Baruch; Peters, Maximilian			Rhodopsin as Thermosensor?	SCIENCE			English	Editorial Material							PHOSPHOLIPASE-C; DROSOPHILA; PHOTORECEPTORS		[Minke, Baruch] Hebrew Univ Jerusalem, Dept Med Neurobiol, Inst Med Res Israel Canada IMRIC, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Kuhne Minerva Ctr Studies Visual Transduct, Fac Med, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci ELSC, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Minke, B (corresponding author), Hebrew Univ Jerusalem, Dept Med Neurobiol, Inst Med Res Israel Canada IMRIC, IL-91120 Jerusalem, Israel.	baruchm@ekmd.huji.ac.il	Peters, Maximilian/B-7406-2008; Peters, Maximilian/AAA-3509-2020					Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Katz B, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.002.2009; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; OZAKI K, 1993, NEURON, V10, P1113, DOI 10.1016/0896-6273(93)90059-Z; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; YAU KW, 1979, NATURE, V279, P806, DOI 10.1038/279806a0	8	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2011	331	6022					1272	1273		10.1126/science.1203482	http://dx.doi.org/10.1126/science.1203482			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393531				2022-12-28	WOS:000288215200030
J	Ruiz-Primo, MA; Briggs, D; Iverson, H; Talbot, R; Shepard, LA				Ruiz-Primo, Maria Araceli; Briggs, Derek; Iverson, Heidi; Talbot, Robert; Shepard, Lorrie A.			Impact of Undergraduate Science Course Innovations on Learning	SCIENCE			English	Editorial Material							INSTRUCTION; PERFORMANCE; MECHANICS		[Ruiz-Primo, Maria Araceli; Briggs, Derek; Iverson, Heidi; Talbot, Robert; Shepard, Lorrie A.] Univ Colorado Denver, Sch Educ & Human Dev, Denver, CO 80217 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ruiz-Primo, MA (corresponding author), Univ Colorado Denver, Sch Educ & Human Dev, Denver, CO 80217 USA.	maria.ruiz-primo@ucdenver.edu	Briggs, Derek/R-6174-2019	Briggs, Derek/0000-0003-1628-4661				BEICHNER RJ, 2007, REV PHYS ED RES PER; Casavant D. P, 2001, POWERFUL IDEAS PHYS; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; FREEMAN S, 2007, ED LIFE SCI ED, V6, P132; Giuliodori MJ, 2006, ADV PHYSIOL EDUC, V30, P168, DOI 10.1152/advan.00013.2006; Glass G.V., 1976, ED RES, V5, P3, DOI [DOI 10.3102/0013189X005010003, 10.2307/1174772ISSN0536-1036]; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; HALLOUN IA, 1985, AM J PHYS, V53, P1043, DOI 10.1119/1.14030; Hestenes D, 1998, AM J PHYS, V66, P465, DOI 10.1119/1.18898; Liang LL, 2005, INT J SCI EDUC, V27, P1143, DOI 10.1080/09500690500069442; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; Mazur E., 1997, SERIES ED INNOVATION; McDermott L.C., 1998, TUTORIALS INTRO PHYS; MCDERMOTT LC, 1994, AM J PHYS, V62, P46, DOI 10.1119/1.17740; McDermott LC, 1999, AM J PHYS, V67, P755, DOI 10.1119/1.19122; Rao SP, 2000, ADV PHYSIOL EDUC, V24, P51, DOI 10.1152/advances.2000.24.1.51; Springer L, 1999, REV EDUC RES, V69, P21, DOI 10.3102/00346543069001021; Wiesner TF, 2004, J ENG EDUC, V93, P195, DOI 10.1002/j.2168-9830.2004.tb00806.x	18	130	134	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2011	331	6022					1269	1270		10.1126/science.1198976	http://dx.doi.org/10.1126/science.1198976			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732UM	21393529	Green Published			2022-12-28	WOS:000288215200028
J	Barreiro, JT; Muller, M; Schindler, P; Nigg, D; Monz, T; Chwalla, M; Hennrich, M; Roos, CF; Zoller, P; Blatt, R				Barreiro, Julio T.; Mueller, Markus; Schindler, Philipp; Nigg, Daniel; Monz, Thomas; Chwalla, Michael; Hennrich, Markus; Roos, Christian F.; Zoller, Peter; Blatt, Rainer			An open-system quantum simulator with trapped ions	NATURE			English	Article							MULTIPARTICLE ENTANGLEMENT; INFORMATION; STATES; COMPUTATION; PHYSICS; DRIVEN; SPINS	The control of quantum systems is of fundamental scientific interest and promises powerful applications and technologies. Impressive progress has been achieved in isolating quantum systems from the environment and coherently controlling their dynamics, as demonstrated by the creation and manipulation of entanglement in various physical systems. However, for open quantum systems, engineering the dynamics of many particles by a controlled coupling to an environment remains largely unexplored. Here we realize an experimental toolbox for simulating an open quantum system with up to five quantum bits (qubits). Using a quantum computing architecture with trapped ions, we combine multi-qubit gates with optical pumping to implement coherent operations and dissipative processes. We illustrate our ability to engineer the open-system dynamics through the dissipative preparation of entangled states, the simulation of coherent many-body spin interactions, and the quantum non-demolition measurement of multi-qubit observables. By adding controlled dissipation to coherent operations, this work offers novel prospects for open-system quantum simulation and computation.	[Mueller, Markus; Chwalla, Michael; Roos, Christian F.; Zoller, Peter; Blatt, Rainer] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria; [Barreiro, Julio T.; Schindler, Philipp; Nigg, Daniel; Monz, Thomas; Chwalla, Michael; Hennrich, Markus; Roos, Christian F.; Blatt, Rainer] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Mueller, Markus; Zoller, Peter] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria	Austrian Academy of Sciences; University of Innsbruck; University of Innsbruck	Zoller, P (corresponding author), Austrian Acad Sci, Inst Quantenopt & Quanteninformat, Technikerstr 21A, A-6020 Innsbruck, Austria.	Peter.Zoller@uibk.ac.at; Rainer.Blatt@uibk.ac.at	Zoller, Peter/O-1639-2014; Blatt, Rainer/H-9527-2014; Müller, Markus/I-6530-2012; Roos, Christian F/D-8475-2011; Monz, Thomas/E-1285-2017; Müller, Markus/AAV-2927-2020; Barreiro, Julio T/P-2540-2018; Hennrich, Markus/D-2475-2009; Schindler, Philipp/AAB-4803-2019; Schindler, Philipp/E-1485-2017	Zoller, Peter/0000-0003-4014-1505; Roos, Christian F/0000-0001-7121-8259; Müller, Markus/0000-0002-2813-3097; Barreiro, Julio T/0000-0002-1957-8211; Hennrich, Markus/0000-0003-2955-7980; Schindler, Philipp/0000-0002-9461-9650; Schindler, Philipp/0000-0002-9461-9650; Monz, Thomas/0000-0001-7410-4804	Austrian Science Fund; European Commission; Institut fur Quanteninformation GmbH; European Community	Austrian Science Fund(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Institut fur Quanteninformation GmbH; European Community(European Commission)	We thank K. Hammerer, I. Chuang, and O. Guhne for discussions and T. Northup for critically reading the manuscript. We acknowledge support by the Austrian Science Fund (FOQUS), the European Commission (AQUTE), the Institut fur Quanteninformation GmbH, and a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme.	Bacon D, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.062302; Barreiro JT, 2010, NAT PHYS, V6, P943, DOI 10.1038/NPHYS1781; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Buluta I, 2009, SCIENCE, V326, P108, DOI 10.1126/science.1177838; Cho JY, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.020504; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; Diehl S, 2008, NAT PHYS, V4, P878, DOI 10.1038/nphys1073; Dur W, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.052325; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Fleming G. R., 2010, NEW J PHYS, V12; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Gilchrist A, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.062310; Goldstein G., 2010, ENV ASSISTED PRECISI; Guhne O, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053002; Haffner H, 2008, PHYS REP, V469, P155, DOI 10.1016/j.physrep.2008.09.003; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Jones J.A., 2010, QUANTUM COMPUTING NM; JOZSA R, 1994, J MOD OPTIC, V41, P2315, DOI 10.1080/09500349414552171; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Krauter H., 2010, ENTANGLEMENT GENERAT; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Lloyd S, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.010101; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Molmer K, 1999, PHYS REV LETT, V82, P1835, DOI 10.1103/PhysRevLett.82.1835; Monz T., 2010, COHERENCE LARGE SCAL; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Neeley M, 2010, NATURE, V467, P570, DOI 10.1038/nature09418; Nielsen Michael A., 2002, QUANTUM COMPUTATION; O'Brien JL, 2007, SCIENCE, V318, P1567, DOI 10.1126/science.1142892; PASTAWSKI F, 2010, QUANTUM MEMORIES BAS; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Ralph TC, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012113; Riebe M, 2008, NAT PHYS, V4, P839, DOI 10.1038/nphys1107; Roos CF, 2004, SCIENCE, V304, P1478, DOI 10.1126/science.1097522; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Schmidt-Kaler F, 2003, APPL PHYS B-LASERS O, V77, P789, DOI 10.1007/s00340-003-1346-9; Schoelkopf RJ, 2008, NATURE, V451, P664, DOI 10.1038/451664a; Steane AM, 1999, NATURE, V399, P124, DOI 10.1038/20127; Verstraete F, 2009, NAT PHYS, V5, P633, DOI 10.1038/NPHYS1342; Viola L, 2001, SCIENCE, V293, P2059, DOI 10.1126/science.1064460; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Wiseman HM, 2009, QUANTUM MEASUREMENT; Wrachtrup J, 2006, J PHYS-CONDENS MAT, V18, pS807, DOI 10.1088/0953-8984/18/21/S08	48	682	689	2	155	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					486	491		10.1038/nature09801	http://dx.doi.org/10.1038/nature09801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350481	Green Submitted			2022-12-28	WOS:000287652900032
J	Lamont, T; Harrison, S; Panesar, S; Surkitt-Parr, M				Lamont, Tara; Harrison, Simon; Panesar, Sukhmeet; Surkitt-Parr, Michael			Safety Alerts Safer insertion of suprapubic catheters: summary of a safety report from the National Patient Safety Agency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tara.lamont@npsa.nhs.uk						Ahluwalia RS, 2006, ANN ROY COLL SURG, V88, P210, DOI 10.1308/003588406X95101; Harrison SCW, 2011, BJU INT, V107, P77, DOI 10.1111/j.1464-410X.2010.09762.x; Khan A, 2009, BJU INT, V103, P640, DOI 10.1111/j.1464-410X.2008.08125.x; National Patient Safety Agency, 2010, NPSA2009RRR005; NHS Technology Adoption Centre, WHY GUID; Sheriff MKM, 1998, SPINAL CORD, V36, P171, DOI 10.1038/sj.sc.3100536	6	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2011	342								d924	10.1136/bmj.d924	http://dx.doi.org/10.1136/bmj.d924			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729BE	21349899				2022-12-28	WOS:000287920900013
J	Volkow, ND; Tomasi, D; Wang, GJ; Vaska, P; Fowler, JS; Telang, F; Alexoff, D; Logan, J; Wong, C				Volkow, Nora D.; Tomasi, Dardo; Wang, Gene-Jack; Vaska, Paul; Fowler, Joanna S.; Telang, Frank; Alexoff, Dave; Logan, Jean; Wong, Christopher			Effects of Cell Phone Radiofrequency Signal Exposure on Brain Glucose Metabolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CEREBRAL-BLOOD-FLOW; MOBILE PHONES; ELECTROMAGNETIC-FIELDS; MAGNETIC STIMULATION; TELEPHONE USE; PET; ACTIVATION; RADIATION; HUMANS; CORTEX	Context The dramatic increase in use of cellular telephones has generated concern about possible negative effects of radiofrequency signals delivered to the brain. However, whether acute cell phone exposure affects the human brain is unclear. Objective To evaluate if acute cell phone exposure affects brain glucose metabolism, a marker of brain activity. Design, Setting, and Participants Randomized crossover study conducted between January 1 and December 31, 2009, at a single US laboratory among 47 healthy participants recruited from the community. Cell phones were placed on the left and right ears and positron emission tomography with ((18)F) fluorodeoxyglucose injection was used to measure brain glucose metabolism twice, once with the right cell phone activated (sound muted) for 50 minutes ("on" condition) and once with both cell phones deactivated ("off" condition). Statistical parametric mapping was used to compare metabolism between on and off conditions using paired t tests, and Pearson linear correlations were used to verify the association of metabolism and estimated amplitude of radiofrequency-modulated electromagnetic waves emitted by the cell phone. Clusters with at least 1000 voxels (volume >8 cm(3)) and P<.05 (corrected for multiple comparisons) were considered significant. Main Outcome Measure Brain glucose metabolism computed as absolute metabolism (mu mol/100 g per minute) and as normalized metabolism (region/whole brain). Results Whole-brain metabolism did not differ between on and off conditions. In contrast, metabolism in the region closest to the antenna (orbitofrontal cortex and temporal pole) was significantly higher for on than off conditions (35.7 vs 33.3 mu mol/100 g per minute; mean difference, 2.4 [95% confidence interval, 0.67-4.2]; P=.004). The increases were significantly correlated with the estimated electromagnetic field amplitudes both for absolute metabolism (R=0.95, P<.001) and normalized metabolism (R=0.89; P<.001). Conclusions In healthy participants and compared with no exposure, 50-minute cell phone exposure was associated with increased brain glucose metabolism in the region closest to the antenna. This finding is of unknown clinical significance. JAMA. 2011; 305(8): 808-814	[Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD 20892 USA; [Volkow, Nora D.; Tomasi, Dardo; Telang, Frank; Wong, Christopher] NIAAA, Bethesda, MD USA; [Wang, Gene-Jack; Vaska, Paul; Fowler, Joanna S.; Alexoff, Dave; Logan, Jean] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory	Volkow, ND (corresponding author), Natl Inst Drug Abuse, 6001 Execut Blvd,Room 5274, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Tomasi, Dardo/J-2127-2015	Logan, Jean/0000-0002-6993-9994	National Institutes of Health (NIH); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was carried out at Brookhaven National Laboratory (BNL) and was supported by the Intramural Research Program of the National Institutes of Health (NIH) and by infrastructure support from the Department of Energy.	Aalto S, 2006, J CEREBR BLOOD F MET, V26, P885, DOI 10.1038/sj.jcbfm.9600279; BLOMQVIST G, 1994, ACTA PHYSIOL SCAND, V151, P29, DOI 10.1111/j.1748-1716.1994.tb09718.x; Cardis E, 2008, PHYS MED BIOL, V53, P2771, DOI 10.1088/0031-9155/53/11/001; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Cotgreave IA, 2005, ARCH BIOCHEM BIOPHYS, V435, P227, DOI 10.1016/j.abb.2004.12.004; Devor A, 2008, J NEUROSCI, V28, P14347, DOI 10.1523/JNEUROSCI.4307-08.2008; Dubey RB, 2010, J COMPUT ASSIST TOMO, V34, P799, DOI 10.1097/RCT.0b013e3181ed9b54; Ferreri F, 2006, ANN NEUROL, V60, P188, DOI 10.1002/ana.20906; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Haarala C, 2003, NEUROREPORT, V14, P2019, DOI 10.1097/00001756-200311140-00003; Hardell L, 2009, INT J ONCOL, V35, P5, DOI 10.3892/ijo_00000307; Huber R, 2005, EUR J NEUROSCI, V21, P1000, DOI 10.1111/j.1460-9568.2005.03929.x; Huber R, 2002, J SLEEP RES, V11, P289, DOI 10.1046/j.1365-2869.2002.00314.x; Hyland GJ, 2000, LANCET, V356, P1833, DOI 10.1016/S0140-6736(00)03243-8; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Inskip PD, 2001, NEW ENGL J MED, V344, P79, DOI 10.1056/NEJM200101113440201; Inskip PD, 2010, NEURO-ONCOLOGY, V12, P1147, DOI 10.1093/neuonc/noq077; Kleinlogel H, 2008, BIOELECTROMAGNETICS, V29, P488, DOI 10.1002/bem.20418; Lehrer S, 2011, J NEURO-ONCOL, V101, P505, DOI 10.1007/s11060-010-0280-z; Mizuno Y, 2009, BIOELECTROMAGNETICS, V30, P536, DOI 10.1002/bem.20508; Myung SK, 2009, J CLIN ONCOL, V27, P5565, DOI 10.1200/JCO.2008.21.6366; Nittby H, 2008, ELECTROMAGN BIOL MED, V27, P103, DOI 10.1080/15368370802061995; Sanganahalli BG, 2008, NMR BIOMED, V21, P410, DOI 10.1002/nbm.1259; Schonborn F, 1998, HEALTH PHYS, V74, P160, DOI 10.1097/00004032-199802000-00002; Siebner HR, 2001, HUM BRAIN MAPP, V12, P157, DOI 10.1002/1097-0193(200103)12:3<157::AID-HBM1012>3.0.CO;2-V; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Soderqvist F, 2009, TOXICOL LETT, V189, P63, DOI 10.1016/j.toxlet.2009.04.027; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; van Rongen E, 2009, J TOXICOL ENV HEAL B, V12, P572, DOI 10.1080/10937400903458940; Vlassenko AG, 2006, NEUROIMAGE, V33, P1036, DOI 10.1016/j.neuroimage.2006.06.065; Volkow ND, 2010, NEUROIMAGE, V51, P623, DOI 10.1016/j.neuroimage.2010.02.015; Wainwright P, 2000, PHYS MED BIOL, V45, P2363, DOI 10.1088/0031-9155/45/8/321; WANG GJ, 1993, RADIOLOGY, V186, P59, DOI 10.1148/radiology.186.1.8416587; Yakymenko I., 2010, Experimental Oncology, V32, P54	36	168	179	1	49	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					808	813		10.1001/jama.2011.186	http://dx.doi.org/10.1001/jama.2011.186			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21343580	Green Accepted			2022-12-28	WOS:000287594300024
J	Ataide, SF; Schmitz, N; Shen, KA; Ke, AL; Shan, SO; Doudna, JA; Ban, NN				Ataide, Sandro F.; Schmitz, Nikolaus; Shen, Kuang; Ke, Ailong; Shan, Shu-ou; Doudna, Jennifer A.; Ban, Nenad			The Crystal Structure of the Signal Recognition Particle in Complex with Its Receptor	SCIENCE			English	Article							SRP GTPASES FFH; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; TRANSLATING RIBOSOME; NUCLEOTIDE SPECIFICITY; 4.5S RNA; FTSY; BINDING; DOMAIN; CORE	Cotranslational targeting of membrane and secretory proteins is mediated by the universally conserved signal recognition particle (SRP). Together with its receptor (SR), SRP mediates the guanine triphosphate (GTP)-dependent delivery of translating ribosomes bearing signal sequences to translocons on the target membrane. Here, we present the crystal structure of the SRP: SR complex at 3.9 angstrom resolution and biochemical data revealing that the activated SRP: SR guanine triphosphatase (GTPase) complex binds the distal end of the SRP hairpin RNA where GTP hydrolysis is stimulated. Combined with previous findings, these results suggest that the SRP: SR GTPase complex initially assembles at the tetraloop end of the SRP RNA and then relocalizes to the opposite end of the RNA. This rearrangement provides a mechanism for coupling GTP hydrolysis to the handover of cargo to the translocon.	[Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Ataide, Sandro F.; Schmitz, Nikolaus; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Shen, Kuang; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich; California Institute of Technology; Cornell University	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	doudna@berkeley.edu; ban@mol.biol.ethz.ch	Shen, Kuang/H-9441-2016	Dietz, Nikolaus/0000-0001-7300-4342; F Ataide, Sandro/0000-0003-1807-5708	Howard Hughes Medical Institute; ETH; Boehringer Ingelheim Fonds; NIH [GM078024]; Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR) of the SNSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078024, R01GM086766] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); ETH(ETH Zurich); Boehringer Ingelheim Fonds(Boehringer Ingelheim); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR) of the SNSF(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Zhou for excellent technical assistance and help with crystal preparation during the early stages of the project. Initial crystallographic analysis was performed at beamline 8.2.2 at the Advanced Light Source (ALS), Lawrence Berkeley National Laboratory; we acknowledge C. Ralston for outstanding technical assistance at the ALS. Crystallographic data were collected at the beamline X06SA at the Swiss Light Source (SLS). We thank A. Brunger for the prerelease version of CNS and for helpful comments on the refinement, C. Schulze-Briese and T. Tomizaki for their outstanding support at the SLS, T. Maier and S. Klinge for critical discussion and reading of the manuscript, and T. Maier and M. Leibundgut for help and assistance with data collection and solving the structure. S.F.A. was funded initially by the Howard Hughes Medical Institute and currently by an ETH postdoctoral fellowship, N.S. is funded by Boehringer Ingelheim Fonds, and K.S. is funded by NIH grant GM078024 to S.S. This work was supported in part by the Howard Hughes Medical Institute (J.A.D.) and by the Swiss National Science Foundation (SNSF) and the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF. Atomic coordinates and structure factors for the SRP:SR crystal structure have been deposited with the Protein Data Bank under accession code 2xxa.	Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Batey RT, 2002, BIOCHEMISTRY-US, V41, P11703, DOI 10.1021/bi026163c; Bradshaw N, 2007, MOL BIOL CELL, V18, P2728, DOI 10.1091/mbc.e07-02-0117; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; Buskiewicz I, 2005, J MOL BIOL, V351, P417, DOI 10.1016/j.jmb.2005.06.023; Doudna JA, 2004, ANNU REV BIOCHEM, V73, P539, DOI 10.1146/annurev.biochem.73.011303.074048; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; Focia PJ, 2006, J MOL BIOL, V360, P631, DOI 10.1016/j.jmb.2006.05.031; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Gawronski-Salerno J, 2007, J STRUCT BIOL, V158, P122, DOI 10.1016/j.jsb.2006.10.025; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; Jagath JR, 2001, RNA, V7, P293, DOI 10.1017/S1355838201002205; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Neher SB, 2008, NAT STRUCT MOL BIOL, V15, P916, DOI 10.1038/nsmb.1467; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Reyes CL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000607; Rosendal KR, 2003, P NATL ACAD SCI USA, V100, P14701, DOI 10.1073/pnas.2436132100; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Schmitz U, 1996, RNA, V2, P1213; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shan SO, 2005, BIOCHEMISTRY-US, V44, P6214, DOI 10.1021/bi0500980; Shan SO, 2003, P NATL ACAD SCI USA, V100, P4480, DOI 10.1073/pnas.0737693100; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Spanggord RJ, 2005, NAT STRUCT MOL BIOL, V12, P1116, DOI 10.1038/nsmb1025; Weiche B, 2008, J MOL BIOL, V377, P761, DOI 10.1016/j.jmb.2008.01.040; WOOD H, 1992, NUCLEIC ACIDS RES, V20, P5919, DOI 10.1093/nar/20.22.5919; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; ZWIEB C, 1992, NUCLEIC ACIDS RES, V20, P2207, DOI 10.1093/nar/20.suppl.2207	39	108	111	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					881	886		10.1126/science.1196473	http://dx.doi.org/10.1126/science.1196473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330537	Green Accepted			2022-12-28	WOS:000287455100048
J	Sims, JK; Wade, PA				Sims, Jennifer K.; Wade, Paul A.			SnapShot: Chromatin Remodeling: CHD	CELL			English	Editorial Material							COMPLEXES; MI-2/NURD; CELLS		[Sims, Jennifer K.; Wade, Paul A.] Lab Mol Carcinogenesis, NIEHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)			Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X	Intramural Research Program of the National Institute of Environmental Health Science, NIH [Z01ES101965]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101965, Z01ES101965] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Environmental Health Science, NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institute of Environmental Health Science, NIH (project number Z01ES101965 to PAW). We gratefully acknowledge helpful suggestions from S. Khorasanizadeh, T. Kutateladze, S. Venkatachalam, J. Wysocka, and members of the Wade laboratory.	Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Benayahu D, 2007, CRIT REV EUKAR GENE, V17, P103, DOI 10.1615/CritRevEukarGeneExpr.v17.i2.20; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108	8	23	26	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					626	627		10.1016/j.cell.2011.02.019	http://dx.doi.org/10.1016/j.cell.2011.02.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335242	Bronze			2022-12-28	WOS:000287473100016
J	Wilson, S; James, D; Forrester, A				Wilson, Simon; James, David; Forrester, Andrew			The medium-secure project and criminal justice mental health	LANCET			English	Editorial Material							PSYCHOSIS; IMPACT		[Wilson, Simon] Oxleas NHS Fdn Trust, London SE5 8AF, England; [Wilson, Simon] Inst Psychiat, Dept Forens & Neurodev Sci, London SE5 8AF, England; [James, David] Chase Farm Hosp, N London Forens Serv, Middlesex, England; [Forrester, Andrew] Maudsley NHS Fdn Trust, London, England; [Forrester, Andrew] HM Prison Brixton, Inst Psychiat, Healthcare Dept, London, England	University of London; King's College London; University of London; University College London; Royal Free London NHS Foundation Trust; South London & Maudsley NHS Trust; University of London; King's College London	Wilson, S (corresponding author), Oxleas NHS Fdn Trust, London SE5 8AF, England.	simon.wilson@kcl.ac.uk		Forrester, Andrew/0000-0003-2510-1249				Bradley Lord., 2009, BRADL REP LORD BRADL; Brugha T, 2005, AM J PSYCHIAT, V162, P774, DOI 10.1176/appi.ajp.162.4.774; CUMMING I, 2010, PSYCHIAT PRISONS COM, P40; Department of Health, 1999, NAT SERV FRAM MENT H; Department of Health, 2010, EQ EXC LIB NHS; Department of Health and Social Security, 1975, REP COMM MENT ABN OF; Department of Health/HM Prison Service (DH/HMPS), 1999, FUT ORG PRIS HEALTHC; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Forrester A, 2009, PSYCHIATR BULL, V33, P409, DOI 10.1192/pb.bp.108.022780; Howard John, 1784, STATE PRISONS ENGLAN; Mental Health Strategies, 2010, 2009 10 NAT SURV INV; Ministry of Justice, 2008, CRIM STAT ENGL WAL 2; Ministry of Justice, 2009, STAT MENT DIS OFF 20; SCOTT PD, 1974, BRIT MED J, V4, P640, DOI 10.1136/bmj.4.5945.640; Valmaggia LR, 2009, PSYCHOL MED, V39, P1617, DOI 10.1017/S0033291709005613	16	23	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 9	2011	378	9786					110	111		10.1016/S0140-6736(10)62268-4	http://dx.doi.org/10.1016/S0140-6736(10)62268-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	795CJ	21397939				2022-12-28	WOS:000292948800009
J	Fischer, MG; Suttle, CA				Fischer, Matthias G.; Suttle, Curtis A.			A Virophage at the Origin of Large DNA Transposons	SCIENCE			English	Article							EUKARYOTES; EVOLUTION; ELEMENTS; INTEGRASES; MIMIVIRUS; VIRUSES; PRD1	DNA transposons are mobile genetic elements that have shaped the genomes of eukaryotes for millions of years, yet their origins remain obscure. We discovered a virophage that, on the basis of genetic homology, likely represents an evolutionary link between double-stranded DNA viruses and Maverick/Polinton eukaryotic DNA transposons. The Mavirus virophage parasitizes the giant Cafeteria roenbergensis virus and encodes 20 predicted proteins, including a retroviral integrase and a protein-primed DNA polymerase B. On the basis of our data, we conclude that Maverick/Polinton transposons may have originated from ancient relatives of Mavirus, and thereby influenced the evolution of eukaryotic genomes, although we cannot rule out alternative evolutionary scenarios.	[Fischer, Matthias G.; Suttle, Curtis A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Suttle, CA (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 1365-2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	csuttle@eos.ubc.ca	Fischer, Matthias G/Q-2738-2017; Suttle, Curtis A/C-3150-2008; suttle, c/N-1144-2019	Fischer, Matthias G/0000-0002-4014-3626; Suttle, Curtis A/0000-0002-0372-0033; suttle, c/0000-0002-0372-0033	Natural Science and Engineering Research Council of Canada (NSERC); Tula Foundation through the Centre for Microbial Diversity and Evolution; Gottlieb Daimler- and Karl Benz-Foundation, Germany; University of British Columbia	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tula Foundation through the Centre for Microbial Diversity and Evolution; Gottlieb Daimler- and Karl Benz-Foundation, Germany; University of British Columbia	We thank B.N. Ross and G. D. Martens of the UBC Bioimaging Facility and A. M. Chan for assistance with electron microscopy; E. Zaikova for qPCR assistance; and E. J. Pritham, J. Davies, and E. Nomis for constructive comments. Supported by the Natural Science and Engineering Research Council of Canada (NSERC) Discovery Grants Program, the Tula Foundation through the Centre for Microbial Diversity and Evolution, and fellowships awarded to M. G. F. by the Gottlieb Daimler- and Karl Benz-Foundation, Germany, and the University of British Columbia. The genome sequence of Mavirus has been deposited in GenBank under the accession number HQ712116.	Bao WD, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-3; Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Claverie JM, 2009, ANNU REV GENET, V43, P49, DOI 10.1146/annurev-genet-102108-134255; Feschotte C, 2005, TRENDS GENET, V21, P551, DOI 10.1016/j.tig.2005.07.007; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Gao X, 2005, TRENDS GENET, V21, P133, DOI 10.1016/j.tig.2005.01.006; Johnson WE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001210; Kapitonov VV, 2006, P NATL ACAD SCI USA, V103, P4540, DOI 10.1073/pnas.0600833103; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; Krupovic M, 2008, NAT REV MICROBIOL, V6, P941, DOI 10.1038/nrmicro2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Legendre M, 2010, GENOME RES, V20, P664, DOI 10.1101/gr.102582.109; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Pritham EJ, 2009, J HERED, V100, P648, DOI 10.1093/jhered/esp065; Stromsten NJ, 2005, J MOL BIOL, V348, P617, DOI 10.1016/j.jmb.2005.03.002	18	184	194	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					231	234		10.1126/science.1199412	http://dx.doi.org/10.1126/science.1199412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21385722				2022-12-28	WOS:000289251100050
J	Sousa-Nunes, R; Yee, LL; Gould, AP				Sousa-Nunes, Rita; Yee, Lih Ling; Gould, Alex P.			Fat cells reactivate quiescent neuroblasts via TOR and glial insulin relays in Drosophila	NATURE			English	Article							NEURAL STEM-CELLS; PHOSPHOINOSITIDE 3-KINASE; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; TEMPORAL IDENTITY; NERVOUS-SYSTEM; GROWTH; PROLIFERATION; RECEPTOR; SIZE	Many stem, progenitor and cancer cells undergo periods of mitotic quiescence from which they can be reactivated(1-5). The signals triggering entry into and exit from this reversible dormant state are not well understood. In the developing Drosophila central nervous system, multipotent self-renewing progenitors called neuroblasts(6-9) undergo quiescence in a stereotypical spatiotemporal pattern(10). Entry into quiescence is regulated by Hox proteins and an internal neuroblast timer(11-13). Exit from quiescence (reactivation) is subject to a nutritional checkpoint requiring dietary amino acids(14). Organ co-cultures also implicate an unidentified signal from an adipose/hepatic-like tissue called the fat body(14). Here we provide in vivo evidence that Slimfast amino-acid sensing and Target of rapamycin (TOR) signalling(15) activate a fat-body-derived signal (FDS) required for neuroblast reactivation. Downstream of this signal, Insulin-like receptor signalling and the Phosphatidylinositol 3-kinase (PI3K)/TOR network are required in neuroblasts for exit from quiescence. We demonstrate that nutritionally regulated glial cells provide the source of Insulin-like peptides (ILPs) relevant for timely neuroblast reactivation but not for overall larval growth. Conversely, ILPs secreted into the haemolymph by median neurosecretory cells systemically control organismal size(16-18) but do not reactivate neuroblasts. Drosophila thus contains two segregated ILP pools, one regulating proliferation within the central nervous system and the other controlling tissue growth systemically. Our findings support a model in which amino acids trigger the cell cycle re-entry of neural progenitors via a fat-body-glia-neuroblasts relay. This mechanism indicates that dietary nutrients and remote organs, as well as local niches, are key regulators of transitions in stem-cell behaviour.	[Sousa-Nunes, Rita; Yee, Lih Ling; Gould, Alex P.] Natl Inst Med Res, MRC, Div Dev Neurobiol, London NW7 1AA, England	MRC National Institute for Medical Research	Gould, AP (corresponding author), Natl Inst Med Res, MRC, Div Dev Neurobiol, London NW7 1AA, England.	agould@nimr.mrc.ac.uk	Gould, Alex/A-7479-2010; Gould, Alex/M-5353-2019; Sousa-Nunes, Rita/AAE-4628-2020	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985; Sousa-Nunes, Rita/0000-0002-7401-8081	Medical Research Council [U117584237]; MRC [MC_U117584237] Funding Source: UKRI; Medical Research Council [MC_U117584237] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to A. Brand, S. Cohen, B. Edgar, U. Gaul, E. Hafen, C. Klambt, T. Lee, S. Leevers, P. Leopold, F. Matsuzaki, I. Miguel-Aliaga, T. Neufeld, R. Palmer, L. Partridge, L. Pick, E. Sanchez-Herrero, H. Stocker, N. Tapon and T. Xu, and also to the Bloomington stock centre and Kyoto National Institute of Genetics (NIG) for Drosophila stocks, antibodies and plasmids. We also acknowledge I. Salecker, J.-P. Vincent, A. Bailey, E. Cinnamon, L. Cheng, R. Makki, A. Matheu, P. Pachnis, P. Serpente and I. Stefana for providing advice, reagents and critical reading of the manuscript. The authors were supported by the Medical Research Council (U117584237).	Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Chen E, 2009, CELL STEM CELL, V5, P451, DOI 10.1016/j.stem.2009.10.011; Coller HA, 2007, NAT REV MOL CELL BIO, V8, P667, DOI 10.1038/nrm2223; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; de Navas LF, 2006, DEVELOPMENT, V133, P4495, DOI 10.1242/dev.02609; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; FERNANDEZALMONACID R, 1987, MOL CELL BIOL, V7, P2718, DOI 10.1128/MCB.7.8.2718; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hacker U, 2003, P NATL ACAD SCI USA, V100, P7720, DOI 10.1073/pnas.1230526100; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Hodge RD, 2004, J NEUROSCI, V24, P10201, DOI 10.1523/JNEUROSCI.3246-04.2004; Huang H, 1999, DEVELOPMENT, V126, P5365; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Miguel-Aliaga I, 2008, PLOS BIOL, V6, P538, DOI 10.1371/journal.pbio.0060058; Moline MM, 1999, DEVELOPMENT, V126, P4375; Neufeld TP, 2003, MECH DEVELOP, V120, P1283, DOI 10.1016/j.mod.2003.07.003; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sanchez-Garcia I, 2007, BIOESSAYS, V29, P1269, DOI 10.1002/bies.20679; Scholz H, 1997, MECH DEVELOP, V64, P137; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Silies M, 2007, J NEUROSCI, V27, P13130, DOI 10.1523/JNEUROSCI.3583-07.2007; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Tsuji T, 2008, DEVELOPMENT, V135, P3859, DOI 10.1242/dev.025189; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	54	264	267	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					508	+		10.1038/nature09867	http://dx.doi.org/10.1038/nature09867			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21346761	Green Accepted			2022-12-28	WOS:000288702200061
J	Tye, KM; Prakash, R; Kim, SY; Fenno, LE; Grosenick, L; Zarabi, H; Thompson, KR; Gradinaru, V; Ramakrishnan, C; Deisseroth, K				Tye, Kay M.; Prakash, Rohit; Kim, Sung-Yon; Fenno, Lief E.; Grosenick, Logan; Zarabi, Hosniya; Thompson, Kimberly R.; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl			Amygdala circuitry mediating reversible and bidirectional control of anxiety	NATURE			English	Article							CONDITIONED FEAR; CENTRAL NUCLEUS; RAT; DISORDERS; BEHAVIOR; BRAIN; CAT; PROJECTIONS; COMPLEX; MICE	Anxiety-a sustained state of heightened apprehension in the absence of immediate threat-becomes severely debilitating in disease states(1). Anxiety disorders represent the most common of psychiatric diseases (28% lifetime prevalence) 2 and contribute to the aetiology of major depression and substance abuse(3,4). Although it has been proposed that the amygdala, a brain region important for emotional processing(5-8), has a role in anxiety(9-13), the neural mechanisms that control anxiety remain unclear. Here we explore the neural circuits underlying anxiety-related behaviours by using optogenetics with two-photon microscopy, anxiety assays in freely moving mice, and electrophysiology. With the capability of optogenetics(14-16) to control not only cell types but also specific connections between cells, we observed that temporally precise optogenetic stimulation of basolateral amygdala (BLA) terminals in the central nucleus of the amygdala (CeA)-achieved by viral transduction of the BLA with a codon-optimized channelrhodopsin followed by restricted illumination in the downstream CeA-exerted an acute, reversible anxiolytic effect. Conversely, selective optogenetic inhibition of the same projection with a third-generation halorhodopsin(15) (eNpHR3.0) increased anxiety-related behaviours. Importantly, these effects were not observed with direct optogenetic control of BLA somata, possibly owing to recruitment of antagonistic downstream structures. Together, these results implicate specific BLACeA projections as critical circuit elements for acute anxiety control in the mammalian brain, and demonstrate the importance of optogenetically targeting defined projections, beyond simply targeting cell types, in the study of circuit function relevant to neuropsychiatric disease.	[Tye, Kay M.; Prakash, Rohit; Kim, Sung-Yon; Fenno, Lief E.; Grosenick, Logan; Zarabi, Hosniya; Thompson, Kimberly R.; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Prakash, Rohit; Kim, Sung-Yon; Fenno, Lief E.; Grosenick, Logan; Gradinaru, Viviana; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Fenno, Lief/AAK-2924-2020; Kim, Sung-Yon/AAO-8405-2020; Fenno, Lief/AAF-9638-2019; Core, Vector/CAF-4832-2022; Tye, Kay/J-6158-2013	Kim, Sung-Yon/0000-0003-0791-7308; Tye, Kay/0000-0002-2435-0182; Ramakrishnan, Charu/0000-0002-3474-6332	NIMH [1F32MH088010-01]; NARSAD; Samsung; NSF [0801700]; Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery [N66001-10-C-2010]; Alice Woo Foundation; Albert Yu Foundation; Snyder Foundation; McKnight Foundation; NIDA; NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH088010, R01MH075957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020794] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD(NARSAD); Samsung(Samsung); NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery; Alice Woo Foundation; Albert Yu Foundation; Snyder Foundation; McKnight Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank P. Janak, H. Fields, G. Stuber, E. Thomas, F. Zhang, I. Witten, V. Sohal, T. Davidson and M. Warden as well as J. Mattis, R. Durand, M. Mogri, J. Mirzabekov and E. Steinberg for discussions, and the entire K. D. laboratory for their support. All viruses were packaged at University of North Carolina (UNC) Vector Core. Supported by NIMH (1F32MH088010-01, K. M. T.), NARSAD (K. R. T.), Samsung Scholarship (S.-Y.K.), NSF IGERT Award 0801700 (L. G.) and the Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery (N66001-10-C-2010), the Alice Woo, Albert Yu, Snyder, and McKnight Foundations, as well as NIDA, NIMH and the NIH Pioneer Award (K. D.)	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CARLSEN J, 1988, J COMP NEUROL, V273, P513, DOI 10.1002/cne.902730407; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Davis M., 2000, AMYGDALA, P213; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Deisseroth K, 2010, SCI AM, V303, P48, DOI 10.1038/scientificamerican1110-48; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gray J A, 1996, Nebr Symp Motiv, V43, P61; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koob GF, 2009, BRAIN RES, V1293, P61, DOI 10.1016/j.brainres.2009.03.038; KRETTEK JE, 1978, J COMP NEUROL, V178, P255, DOI 10.1002/cne.901780205; KRETTEK JE, 1978, J COMP NEUROL, V178, P225, DOI 10.1002/cne.901780204; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lesscher HMB, 2008, GENES BRAIN BEHAV, V7, P323, DOI 10.1111/j.1601-183X.2007.00356.x; Lieb R, 2005, HANDB EXP PHARM, V169, P405; Lyons AM, 2010, PEPTIDES, V31, P2193, DOI 10.1016/j.peptides.2010.09.009; MCDONALD AJ, 1982, J COMP NEUROL, V208, P401, DOI 10.1002/cne.902080409; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Pitkanen A., 2000, AMYGDALA FUNCTIONAL, V2; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; SMITH Y, 1994, J COMP NEUROL, V342, P232, DOI 10.1002/cne.903420207; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; WEISKRANTZ L, 1956, J COMP PHYSIOL PSYCH, V49, P381, DOI 10.1037/h0088009; WOODS JH, 1992, PHARMACOL REV, V44, P151	30	787	846	5	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					358	362		10.1038/nature09820	http://dx.doi.org/10.1038/nature09820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21389985	Green Accepted			2022-12-28	WOS:000288444000041
J	Baldwin, D; Woods, R; Lawson, R; Taylor, D				Baldwin, David; Woods, Robert; Lawson, Richard; Taylor, David			Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PLACEBO-CONTROLLED TRIAL; VENLAFAXINE EXTENDED-RELEASE; DOUBLE-BLIND; PRIMARY-CARE; PHARMACOLOGICAL-TREATMENT; SERTRALINE TREATMENT; PARALLEL-GROUP; ADULT PATIENTS; SAFETY; PREGABALIN	Objective To appraise the evidence for comparative efficacy and tolerability of drug treatments in patients with generalised anxiety disorder. Design Systematic review of randomised controlled trials. Primary Bayesian probabilistic mixed treatment meta-analyses allowed pharmacological treatments to be ranked for effectiveness for each outcome measure, given as percentage probability of being the most effective treatment. Secondary frequentist mixed treatment meta-analyses conducted with random effects model; effect size reported as odds ratio and 95% confidence interval. Data sources Medline, Embase, BIOSIS, PsycINFO, Health Economic Evaluations Database, National Health Service Economic Evaluation Database, and Database of Abstracts of Reviews of Effects via DataStar, and Cochrane Database of Systematic Reviews via Cochrane Library (January 1980 to February 2009). Eligibility criteria Double blind placebo controlled randomised controlled trials; published systematic reviews and meta-analyses of randomised controlled trials. Randomised controlled trials including adult participants (aged >= 18) receiving any pharmacological treatment for generalised anxiety disorder. Data abstraction methods Titles or abstracts reviewed initially, followed by review of full text publications for citations remaining after first pass. A three person team conducted screening; an independent reviewer checked a random selection (10%) of articles screened. Data extracted for meta-analysis were also independently reviewed. Main outcome measures Proportion of participants experiencing >= 50% reduction from baseline score on Hamilton anxiety scale (HAM-A) (response), proportion with final HAM-A score <= 7 (remission), proportion withdrawing from trial because of adverse events (tolerability). Results The review identified 3249 citations, and 46 randomised controlled trials met inclusion criteria; 27 trials contained sufficient or appropriate data for inclusion in the analysis. Analyses compared nine drugs (duloxetine, escitalopram, fluoxetine, lorazepam, paroxetine, pregabalin, sertraline, tiagabine, and venlafaxine). In the primary probabilistic mixed treatment meta-analyses, fluoxetine was ranked first for response and remission (probability of 62.9% and 60.6%, respectively) and sertraline was ranked first for tolerability (49.3%). In a subanalysis ranking treatments for generalised anxiety disorder currently licensed in the United Kingdom, duloxetine was ranked first for response (third across all treatments; 2.7%), escitalopram was ranked first for remission (second across all treatments; 26.7%), and pregabalin was ranked first for tolerability (second across all treatments; 7.7%). Conclusions Though the frequentist analysis was inconclusive because of a high level of uncertainty in effect sizes (based on the relatively small number of comparative trials), the probabilistic analysis, which did not rely on significant outcomes, showed that fluoxetine (in terms of response and remission) and sertraline (in terms of tolerability) seem to have some advantages over other treatments. Among five UK licensed treatments, duloxetine, escitalopram, and pregabalin might offer some advantages over venlafaxine and paroxetine.	[Baldwin, David] Univ Southampton, Fac Med, Univ Dept Psychiat, Acad Ctr, Southampton SO14 3DT, Hants, England; [Woods, Robert; Lawson, Richard] Complete Med Grp, Macclesfield SK10 1AQ, Cheshire, England; [Taylor, David] Kings Coll London, London SE1 9NH, England	University of Southampton; University of London; King's College London	Baldwin, D (corresponding author), Univ Southampton, Fac Med, Univ Dept Psychiat, Acad Ctr, Southampton SO14 3DT, Hants, England.	D.S.Baldwin@soton.ac.uk		Taylor, David/0000-0002-2557-1710; Baldwin, David/0000-0003-3343-0907	Lundbeck; Cephalon; Eli Lilly; F Hoffmann-La Roche; GlaxoSmithKline; Organon; Pfizer; Pharmacia; Wyeth; Servier; AstraZeneca	Lundbeck(Lundbeck Corporation); Cephalon; Eli Lilly(Eli Lilly); F Hoffmann-La Roche(Hoffmann-La Roche); GlaxoSmithKline(GlaxoSmithKline); Organon; Pfizer(Pfizer); Pharmacia; Wyeth(Wyeth); Servier(Servier); AstraZeneca(AstraZeneca)	This study was funded by Lundbeck, who commissioned RL, RW, and Gillian Sibbring at Complete Medical Group to conduct the systematic review and meta-analysis, and prepare the manuscript. Lundbeck had input in the concept and design of the study, but it was conducted and reported independently of the company and the authors had final responsibility for the decision to submit for publication.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that DT, RL, and RW have support from Lundbeck for the submitted work; DB holds or has held research grants (on behalf of the University of Southampton) from Cephalon, Eli Lilly, F Hoffmann-La Roche, GlaxoSmithKline, Lundbeck, Organon, Pfizer, Pharmacia, and Wyeth; he has neither received nor will seek financial reimbursement for his role in this study; DT holds or has held research grants (on behalf of King's College London) from Servier; he has received financial recompense for the time spent away from his paid employment to contribute to this study; when the work was conducted, both RL and RW were employees of Complete Medical Group, who received funding from Lundbeck to conduct the study and prepare the manuscript (RL is no longer an employee of Complete Medical Group). DB has had specified relationships in the previous 3 years with Asahi Kasei Pharma, AstraZeneca, Cephalon, Eli Lilly, F Hoffmann-La Roche, GlaxoSmithKline, Lundbeck, Organon, Pharmacia, Pierre Fabre, Pfizer, Servier, Sumitomo, and Wyeth; DT has had specified relationships in the previous 3 years with Eli Lilly, Informa Healthcare, Lundbeck, Pfizer, and Servier. As an employee of Complete Medical Group, RL has received funding in the previous 3 years from AstraZeneca.	ADAMS JB, 1995, J CLIN PSYCHOPHARM, V15, P428, DOI 10.1097/00004714-199512000-00007; Aliyev NA, 2008, EUR PSYCHIAT, V23, P109, DOI 10.1016/j.eurpsy.2007.08.001; Allgulander C, 2006, EUR NEUROPSYCHOPHARM, V16, pS101, DOI 10.1016/j.euroneuro.2006.04.002; Andreatini R, 2002, PHYTOTHER RES, V16, P650, DOI 10.1002/ptr.1027; [Anonymous], 2009, COCHR HDB SYST REV I; ANSSEAU M, 1991, PSYCHOPHARMACOLOGY, V104, P439, DOI 10.1007/BF02245646; Baldwin DS, 2006, BRIT J PSYCHIAT, V189, P264, DOI 10.1192/bjp.bp.105.012799; Baldwin DS, 2011, INT J NEUROPSYCHOPH, V14, P697, DOI 10.1017/S1461145710001434; Ball SG, 2005, J CLIN PSYCHIAT, V66, P94, DOI 10.4088/JCP.v66n0113; Bandelow B, 2008, WORLD J BIOL PSYCHIA, V9, P248, DOI 10.1080/15622970802465807; Bielski Robert J, 2005, Ann Clin Psychiatry, V17, P65, DOI 10.1080/10401230590932326; Boerner RJ, 2003, PHYTOMEDICINE, V10, P38, DOI 10.1078/1433-187X-00309; BOURIN M, 1995, PROG NEURO-PSYCHOPH, V19, P567, DOI 10.1016/0278-5846(95)00102-2; Brawman-Mintzer O, 2005, J CLIN PSYCHIAT, V66, P1321, DOI 10.4088/JCP.v66n1016; Brawman-Mintzer O, 2006, J CLIN PSYCHIAT, V67, P874, DOI 10.4088/JCP.v67n0603; Bystritsky A, 2008, PSYCHOPHARMACOL BULL, V41, P46; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Datastar, 2009, DIAL DATASTAR; Davidson JRT, 2004, DEPRESS ANXIETY, V19, P234, DOI 10.1002/da.10146; Davidson JRT, 1999, J CLIN PSYCHIAT, V60, P528, DOI 10.4088/JCP.v60n0805; Dunayevich E, 2008, NEUROPSYCHOPHARMACOL, V33, P1603, DOI 10.1038/sj.npp.1301531; Feltner DE, 2003, J CLIN PSYCHOPHARM, V23, P240, DOI 10.1097/00004714-200306000-00005; General Medical Council, 2008, GOOD PRACT PRESCR ME; Hartford J, 2007, INT CLIN PSYCHOPHARM, V22, P167, DOI 10.1097/YIC.0b013e32807fb1b2; Hartford James T, 2008, Prim Care Companion J Clin Psychiatry, V10, P197; Hoffman DL, 2008, DEPRESS ANXIETY, V25, P72, DOI 10.1002/da.20257; Hoffman EJ, 2008, MT SINAI J MED, V75, P248, DOI 10.1002/msj.20041; Koponen Hannu, 2007, Prim Care Companion J Clin Psychiatry, V9, P100; Lee ST, 2005, HEADACHE, V45, P1004, DOI 10.1111/j.1526-4610.2005.05181.x; Lenox-Smith AJ, 2003, BRIT J GEN PRACT, V53, P772; Linden M, 1997, HUM PSYCHOPHARM CLIN, V12, P445, DOI 10.1002/(SICI)1099-1077(199709/10)12:5<445::AID-HUP887>3.3.CO;2-U; Llorca PM, 2002, J CLIN PSYCHIAT, V63, P1020, DOI 10.4088/JCP.v63n1112; Lundbeck H., 2005, SCTMD05; Lundbeck H., 2005, SCTMD06; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Maier W, 2000, ACTA PSYCHIAT SCAND, V101, P29, DOI 10.1034/j.1600-0447.2000.101001029.x; Mandos L.A., 2009, ACHIEVING REMISSION; Martin JLR, 2007, J PSYCHOPHARMACOL, V21, P774, DOI 10.1177/0269881107077355; Mitte K, 2005, J CLIN PSYCHOPHARM, V25, P141, DOI 10.1097/01.jcp.0000155821.74832.f9; Montgomery S, 2008, BRIT J PSYCHIAT, V193, P389, DOI 10.1192/bjp.bp.107.037788; Montgomery SA, 2006, J CLIN PSYCHIAT, V67, P771, DOI 10.4088/JCP.v67n0511; National Institute for Health and Care Excellence (NICE), 2019, GEN ANX DIS PAN DIS; National Institute for Health and Clinical Excellence, 2007, NICE CLIN GUID 22 AM; Naukkarinen H, 2005, EUR NEUROPSYCHOPHARM, V15, P617, DOI 10.1016/j.euroneuro.2005.03.002; Nicolini H, 2009, PSYCHOL MED, V39, P267, DOI 10.1017/S0033291708003401; Nimatoudis I, 2004, INT CLIN PSYCHOPHARM, V19, P331, DOI 10.1097/00004850-200411000-00003; Pande AC, 2003, AM J PSYCHIAT, V160, P533, DOI 10.1176/appi.ajp.160.3.533; Piercy MA, 1996, ANN PHARMACOTHER, V30, P1013, DOI 10.1177/106002809603000917; Pollack MH, 2008, J CLIN PSYCHOPHARM, V28, P308, DOI 10.1097/JCP.0b013e318172b45f; Pollack MH, 2006, BIOL PSYCHIAT, V59, P211, DOI 10.1016/j.biopsych.2005.07.005; Pollack MH, 2005, J CLIN PSYCHIAT, V66, P1401, DOI 10.4088/JCP.v66n1109; Pollack MH, 2001, J CLIN PSYCHIAT, V62, P20; Pollack MH, 2001, J CLIN PSYCHIAT, V62, P350, DOI 10.4088/JCP.v62n0508; Rickels K, 2003, AM J PSYCHIAT, V160, P749, DOI 10.1176/appi.ajp.160.4.749; Rickels K, 2005, ARCH GEN PSYCHIAT, V62, P1022, DOI 10.1001/archpsyc.62.9.1022; Rynn M, 2008, DEPRESS ANXIETY, V25, P182, DOI 10.1002/da.20271; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Schmitt Ricardo, 2005, Rev. Bras. Psiquiatr., V27, P18, DOI 10.1590/S1516-44462005000100007; Silverstone PH, 2001, J CLIN PSYCHIAT, V62, P523, DOI 10.4088/JCP.v62n07a04; Simon NM, 2008, PSYCHOPHARMACOLOGY, V197, P675, DOI 10.1007/s00213-008-1087-x; Sramek JJ, 1996, J CLIN PSYCHIAT, V57, P287; Stein DJ, 2008, J CLIN PSYCHOPHARM, V28, P561, DOI 10.1097/JCP.0b013e318184ff5b; Steiner M, 2005, HUM PSYCHOPHARM CLIN, V20, P3, DOI 10.1002/hup.648; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Wan GJ, 2006, CURR MED RES OPIN, V22, P587, DOI 10.1185/030079906X96245; Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24	67	124	130	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2011	342								d1199	10.1136/bmj.d1199	http://dx.doi.org/10.1136/bmj.d1199			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735VT	21398351	hybrid			2022-12-28	WOS:000288449400005
J	Sinaiko, AD; Rosenthal, MB				Sinaiko, Anna D.; Rosenthal, Meredith B.			Increased Price Transparency in Health Care - Challenges and Potential Effects	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sinaiko, Anna D.; Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Sinaiko, AD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.			Rosenthal, Meredith/0000-0003-3410-0184				Hsu J, 2008, JAMA-J AM MED ASSOC, V299, P1929, DOI 10.1001/jama.299.16.1929; *MA DIV HEALTHC FI, MEAS HEALTHC QUAL CO; SINAIKO AD, 2010, HLTH SERV RES   1209; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016	4	93	93	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					891	894		10.1056/NEJMp1100041	http://dx.doi.org/10.1056/NEJMp1100041			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732FL	21388306				2022-12-28	WOS:000288170300002
J	Hawkes, N				Hawkes, Nigel			Body Politic Talking therapies: can the centre hold?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2011	342								d1459	10.1136/bmj.d1459	http://dx.doi.org/10.1136/bmj.d1459			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735UZ	21389064				2022-12-28	WOS:000288446900003
J	Masoni, M; Guelfi, MR; Gensini, GF				Masoni, Marco; Guelfi, Maria Renza; Gensini, Gian Franco			Medicine and the Media Online healthcare advertising needs regulation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FDA					m.masoni@med.unifi.it	Masoni, Marco/M-5047-2016	Masoni, Marco/0000-0001-5943-8689				Bowen AM, 2007, HEALTH EDUC RES, V22, P120, DOI 10.1093/her/cyl057; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1001; Hersh WR, 2002, JAMA-J AM MED ASSOC, V288, P1955, DOI 10.1001/jama.288.16.1955; Masoni M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1083; Milazzo S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005476.pub2; Osborne R, 2009, NAT BIOTECHNOL, V27, P405, DOI 10.1038/nbt0509-405; Ulbricht Catherine, 2009, J Soc Integr Oncol, V7, P73; Vastag B, 2005, J NATL CANCER I, V97, P1806, DOI 10.1093/jnci/dji457	8	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2011	342								c5778	10.1136/bmj.c5778	http://dx.doi.org/10.1136/bmj.c5778			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732EQ	21372072	Green Submitted			2022-12-28	WOS:000288168200006
J	Fang, WG; Vega-Rodriguez, J; Ghosh, AK; Jacobs-Lorena, M; Kang, A; St Leger, RJ				Fang, Weiguo; Vega-Rodriguez, Joel; Ghosh, Anil K.; Jacobs-Lorena, Marcelo; Kang, Angray; St Leger, Raymond J.			Development of Transgenic Fungi That Kill Human Malaria Parasites in Mosquitoes	SCIENCE			English	Article							ENTOMOPATHOGENIC FUNGUS; METARHIZIUM-ANISOPLIAE; ANOPHELINE MOSQUITOS; TRANSMISSION; SPOROZOITES; STRATEGIES; SCORPINE; DISEASE; VECTOR	Metarhizium anisopliae infects mosquitoes through the cuticle and proliferates in the hemolymph. To allow M. anisopliae to combat malaria in mosquitoes with advanced malaria infections, we produced recombinant strains expressing molecules that target sporozoites as they travel through the hemolymph to the salivary glands. Eleven days after a Plasmodium-infected blood meal, mosquitoes were treated with M. anisopliae expressing salivary gland and midgut peptide 1 (SM1), which blocks attachment of sporozoites to salivary glands; a single-chain antibody that agglutinates sporozoites; or scorpine, which is an antimicrobial toxin. These reduced sporozoite counts by 71%, 85%, and 90%, respectively. M. anisopliae expressing scorpine and an [SM1](8):scorpine fusion protein reduced sporozoite counts by 98%, suggesting that Metarhizium-mediated inhibition of Plasmodium development could be a powerful weapon for combating malaria.	[Fang, Weiguo; St Leger, Raymond J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Vega-Rodriguez, Joel; Ghosh, Anil K.; Jacobs-Lorena, Marcelo] Johns Hopkins Sch Publ Hlth, Dept Mol Microbiol & Immunol, Malaria Res Inst, Baltimore, MD 21205 USA; [Kang, Angray] Univ Westminster, Sch Life Sci, Dept Mol & Appl Biosci, Antibody Technol Grp, London W1W 6UW, England	University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Roehampton University; University of Westminster	St Leger, RJ (corresponding author), Univ Maryland, Dept Entomol, 4112 Plant Sci Bldg, College Pk, MD 20742 USA.	stleger@umd.edu	hongbo, yi/G-9615-2011; St. Leger, Raymond/N-3219-2013; Fang, Weiguo/G-6680-2012; weiguo, fang/F-5933-2010	Fang, Weiguo/0000-0002-8431-8256; Kang, Angray/0000-0002-4672-4114	NIH [5R21A1079429-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079429, R21AI088033, R01AI031478] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant 5R21A1079429-02. The GenBank accession numbers of the sequences used in the study are P56972 (scorpine) and HQ833020 (PfNPNA-1).	Alves SB, 2002, J APPL ENTOMOL, V126, P504, DOI 10.1046/j.1439-0418.2002.00674.x; BEIER JC, 1991, MED VET ENTOMOL, V5, P71, DOI 10.1111/j.1365-2915.1991.tb00523.x; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Boyd MF, 1933, AM J HYG, V17, P666, DOI 10.1093/oxfordjournals.aje.a117932; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; Chappel JA, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-28; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Farenhorst M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012081; Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265; Hancock PA, 2009, P ROY SOC B-BIOL SCI, V276, P71, DOI 10.1098/rspb.2008.0689; Hancock PA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000525; Howard AFV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-168; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; James AA, 2003, J EXP BIOL, V206, P3817, DOI 10.1242/jeb.00616; James S. P., 1936, Proceedings of the Royal Society of Medicine London, V29; Knols BGJ, 2010, FUTURE MICROBIOL, V5, P339, DOI [10.2217/fmb.10.11, 10.2217/FMB.10.11]; Koella JC, 2009, EVOL APPL, V2, P469, DOI 10.1111/j.1752-4571.2009.00072.x; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; Maniania NK, 2002, BIOCONTROL SCI TECHN, V12, P59, DOI 10.1080/09583150120110662; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Riehle MA, 2005, INSECT BIOCHEM MOLEC, V35, P699, DOI 10.1016/j.ibmb.2005.02.008; Rio RVM, 2004, TRENDS MICROBIOL, V12, P325, DOI 10.1016/j.tim.2004.05.001; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638; Thomson R, 2009, P NATL ACAD SCI USA, V106, P19509, DOI 10.1073/pnas.0905669106; Wang CS, 2007, NAT BIOTECHNOL, V25, P1455, DOI 10.1038/nbt1357; *WHO, 2009, WORLD MAL REP; Zhioua E, 1997, J PARASITOL, V83, P815, DOI 10.2307/3284273	30	185	199	8	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1074	1077		10.1126/science.1199115	http://dx.doi.org/10.1126/science.1199115			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350178	Green Accepted			2022-12-28	WOS:000287699000066
J	Nevo-Dinur, K; Nussbaum-Shochat, A; Ben-Yehuda, S; Amster-Choder, O				Nevo-Dinur, Keren; Nussbaum-Shochat, Anat; Ben-Yehuda, Sigal; Amster-Choder, Orna			Translation-Independent Localization of mRNA in E. coli	SCIENCE			English	Article							ESCHERICHIA-COLI; INTRACELLULAR-LOCALIZATION; BACILLUS-SUBTILIS; GLOBAL ANALYSIS; MEMBRANE; TRANSCRIPTION; PROTEINS; BINDING; CELLS; CHLORAMPHENICOL	Understanding the organization of a bacterial cell requires the elucidation of the mechanisms by which proteins localize to particular subcellular sites. Thus far, such mechanisms have been suggested to rely on embedded features of the localized proteins. Here, we report that certain messenger RNAs (mRNAs) in Escherichia coli are targeted to the future destination of their encoded proteins, cytoplasm, poles, or inner membrane in a translation-independent manner. Cis-acting sequences within the transmembrane-coding sequence of the membrane proteins are necessary and sufficient for mRNA targeting to the membrane. In contrast to the view that transcription and translation are coupled in bacteria, our results show that, subsequent to their synthesis, certain mRNAs are capable of migrating to particular domains in the cell where their future protein products are required.	[Nevo-Dinur, Keren; Nussbaum-Shochat, Anat; Ben-Yehuda, Sigal; Amster-Choder, Orna] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Amster-Choder, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Microbiol & Mol Genet, POB 12272, IL-91120 Jerusalem, Israel.	amster@cc.huji.ac.il			Israel Science Foundation; European Research Council [209130]	Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission)	We acknowledge members of S.B.-Y.'s group for help with fluorescence microscopy, members of O.A.-C.'s group for stimulating discussions, and E. Bibi and E.S. Bochkareva for technical advice on cell fractionation. We thank the following individuals for their gifts: I. Golding for pIG-K33, R. H. Singer for pSL-MS2 6, and Z. Livneh for purified single-stranded DNA binding protein (SSB) and anti-SSB serum. We are grateful to A. Wright, E. Bibi, and R. Losick for critically reading our manuscript. This research was supported by a research grant (awarded to O.A.-C.) by the Israel Science Foundation founded by the Israel Academy of Sciences and Humanities. S.B.-Y. is supported by the European Research Council starting grant (209130).	Amster-Choder O, 2005, CURR OPIN MICROBIOL, V8, P127, DOI 10.1016/j.mib.2005.02.014; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; CHEN MW, 1993, J BACTERIOL, V175, P5697, DOI 10.1128/JB.175.17.5697-5700.1993; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Ebersbach G, 2007, TRENDS MICROBIOL, V15, P101, DOI 10.1016/j.tim.2007.01.004; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; GOLDMAN E, 1995, J MOL BIOL, V245, P467, DOI 10.1006/jmbi.1994.0038; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; Janakiraman A, 2004, TRENDS MICROBIOL, V12, P518, DOI 10.1016/j.tim.2004.09.003; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Llopis PM, 2010, NATURE, V466, P77, DOI 10.1038/nature09152; Lopian L, 2003, P NATL ACAD SCI USA, V100, P7099, DOI 10.1073/pnas.1037608100; Lopian L, 2010, EMBO J, V29, P3630, DOI 10.1038/emboj.2010.240; LUNDBERG U, 1988, GENE, V72, P141, DOI 10.1016/0378-1119(88)90136-9; Palacios IM, 2007, SEMIN CELL DEV BIOL, V18, P163, DOI 10.1016/j.semcdb.2007.01.008; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Schluenzen F, 2006, NAT STRUCT MOL BIOL, V13, P871, DOI 10.1038/nsmb1145; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Sorg JA, 2005, CELL MICROBIOL, V7, P1217, DOI 10.1111/j.1462-5822.2005.00563.x; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Valencia-Burton M, 2009, P NATL ACAD SCI USA, V106, P16399, DOI 10.1073/pnas.0907495106; WEISBERGER AS, 1967, ANNU REV MED, V18, P483, DOI 10.1146/annurev.me.18.020167.002411	29	187	191	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1081	1084		10.1126/science.1195691	http://dx.doi.org/10.1126/science.1195691			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350180				2022-12-28	WOS:000287699000068
J	Liu, JN; Steiner, M; Dunlop, JA; Keupp, H; Shu, DG; Ou, QA; Han, JA; Zhang, ZF; Zhang, XL				Liu, Jianni; Steiner, Michael; Dunlop, Jason A.; Keupp, Helmut; Shu, Degan; Ou, Qiang; Han, Jian; Zhang, Zhifei; Zhang, Xingliang			An armoured Cambrian lobopodian from China with arthropod-like appendages	NATURE			English	Article							CHENGJIANG LAGERSTATTE; ANOMALOCARIS; EVOLUTION; ORIGIN; FAUNA	Cambrian fossil Lagerstatten preserving soft-bodied organisms have contributed much towards our understanding of metazoan origins(1-3). Lobopodians are a particularly interesting group that diversified and flourished in the Cambrian seas. Resembling 'worms with legs', they have long attracted much attention in that they may have given rise to both Onychophora (velvet worms)(4-6) and Tardigrada (water bears)(7,8), as well as to arthropods in general(9-12). Here we describe Diania cactiformis gen. et sp. nov. as an 'armoured' lobopodian from the Chengjiang fossil Lagerstatte (Cambrian Stage 3), Yunnan, southwestern China. Although sharing features with other typical lobopodians, it is remarkable for possessing robust and probably sclerotized appendages, with what appear to be articulated elements. In terms of limb morphology it is therefore closer to the arthropod condition, to our knowledge, than any lobopodian recorded until now. Phylogenetic analysis recovers it in a derived position, close to Arthropoda; thus, it seems to belong to a grade of organization close to the point of becoming a true arthropod. Further, D. cactiformis could imply that arthropodization (sclerotization of the limbs) preceded arthrodization (sclerotization of the body). Comparing our fossils with other lobopodian appendage morphologies-see Kerygmachela(9,10), Jianshanopodia(13) and Megadictyon(12)-reinforces the hypothesis that the group as a whole is paraphyletic, with different taxa expressing different grades of arthropodization.	[Liu, Jianni; Shu, Degan; Han, Jian; Zhang, Zhifei; Zhang, Xingliang] NW Univ Xian, Dept Geol, State Key Lab Continental Dynam, Early Life Inst, Xian 710069, Peoples R China; [Liu, Jianni; Steiner, Michael; Keupp, Helmut] Free Univ Berlin, Dept Earth Sci, D-12249 Berlin, Germany; [Dunlop, Jason A.] Humboldt Univ, Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, D-10115 Berlin, Germany; [Shu, Degan; Ou, Qiang] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China	Northwest University Xi'an; Free University of Berlin; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; China University of Geosciences	Liu, JN (corresponding author), NW Univ Xian, Dept Geol, State Key Lab Continental Dynam, Early Life Inst, Xian 710069, Peoples R China.	liujianni@126.com	Dunlop, Jason A./AAC-8042-2019; Han, Jian/AAU-4500-2021	Han, Jian/0000-0002-2134-4078; Ou, Qiang/0000-0002-1142-5114; Dunlop, Jason/0000-0002-0179-6640	Alexander von Humboldt Foundation at the Freie Universitat Berlin; National Science Foundation of China [40802011, 40830208]; State Key Laboratory of Continental Dynamics, Northwest University; DFG [Forschergruppe 736]	Alexander von Humboldt Foundation at the Freie Universitat Berlin(Alexander von Humboldt Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Continental Dynamics, Northwest University; DFG(German Research Foundation (DFG))	This work was supported by a Research Scholarship from the Alexander von Humboldt Foundation at the Freie Universitat Berlin, the National Science Foundation of China (grants 40802011 and 40830208) and the MOST Special Fund from the State Key Laboratory of Continental Dynamics, Northwest University (to J.L.), and a DFG grant within the Forschergruppe 736 (to H. K. and M. S.). We thank M. G. Chi for the reconstruction, J. Evers and M. Y. Sun for photography and table, and local workers for their strenuous field work.	Bergstrom J, 2008, GFF, V130, P189; BUDD G, 1993, NATURE, V364, P709, DOI 10.1038/364709a0; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; Budd GE, 2001, ZOOL ANZ, V240, P265, DOI 10.1078/0044-5231-00034; Chen Junyuan, 1997, Bulletin of the National Museum of Natural Science (Taichung), V10, P11; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; Delle Cave L., 1975, Monitore Zoologico Italiano (NS), V9, P67; DZIK J, 1989, LETHAIA, V22, P169, DOI 10.1111/j.1502-3931.1989.tb01679.x; Edgecombe GD, 2010, ARTHROPOD STRUCT DEV, V39, P74, DOI 10.1016/j.asd.2009.10.002; HOU XG, 1995, ZOOL J LINN SOC-LOND, V114, P3, DOI 10.1006/zjls.1995.0014; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; HOU XG, 1991, ZOOL SCR, V20, P395; Kuhl G, 2009, SCIENCE, V323, P771, DOI 10.1126/science.1166586; Liu JN, 2007, ACTA ZOOL-STOCKHOLM, V88, P279, DOI 10.1111/j.1463-6395.2007.00281.x; Liu JN, 2006, ACTA PALAEONTOL POL, V51, P215; Liu JN, 2004, CHINESE SCI BULL, V49, P1063, DOI 10.1360/04wd0052; Ma XY, 2009, ARTHROPOD STRUCT DEV, V38, P271, DOI 10.1016/j.asd.2009.03.001; Maas A, 2007, CHINESE SCI BULL, V52, P3385, DOI 10.1007/s11434-007-0515-3; Ramskold L, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P107; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Wang XQ, 2004, CHINESE SCI BULL, V49, P49, DOI 10.1360/03wd0329; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Willmer P., 1991, INVERTEBRATE RELATIO, P273	24	50	59	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					526	530		10.1038/nature09704	http://dx.doi.org/10.1038/nature09704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350485				2022-12-28	WOS:000287652900040
J	Gambardella, A; Curcio, A; Labate, A; Mumoli, L; Indolfi, C; Quattrone, A				Gambardella, Antonio; Curcio, Antonio; Labate, Angelo; Mumoli, Laura; Indolfi, Ciro; Quattrone, Aldo			Blocking out the real diagnosis	LANCET			English	Editorial Material							EPILEPSY		[Gambardella, Antonio] Magna Graecia Univ Catanzaro, Cattedra & UO Neurol, Div Neurol, I-88100 Catanzaro, Italy; [Gambardella, Antonio; Labate, Angelo; Quattrone, Aldo] CNR, Inst Neurol Sci, Mangone Cosenza, Italy; [Curcio, Antonio; Indolfi, Ciro] Magna Graecia Univ Catanzaro, Div Cardiol, I-88100 Catanzaro, Italy	Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR); Magna Graecia University of Catanzaro	Gambardella, A (corresponding author), Magna Graecia Univ Catanzaro, Cattedra & UO Neurol, Div Neurol, I-88100 Catanzaro, Italy.	a.gambardella@unicz.it	QUATTRONE, Aldo/A-6734-2016; Gambardella, Antonio/F-5295-2012; Curcio, Antonio/K-4822-2018; labate, Angelo/G-6723-2011	QUATTRONE, Aldo/0000-0003-2001-957X; Gambardella, Antonio/0000-0001-7384-3074; Curcio, Antonio/0000-0003-3213-4436; INDOLFI, Ciro/0000-0003-1241-6487; Labate, Angelo/0000-0002-8827-7324				Brodie MJ, 2005, BMJ-BRIT MED J, V331, P1317, DOI 10.1136/bmj.331.7528.1317; GOTMAN J, 1985, ANN NEUROL, V17, P597, DOI 10.1002/ana.410170612; Lee S, 2009, HEART RHYTHM, V6, P1229, DOI 10.1016/j.hrthm.2009.04.001; Schuele SU, 2007, NEUROLOGY, V69, P434, DOI 10.1212/01.wnl.0000266595.77885.7f; Zaidi A, 2000, J AM COLL CARDIOL, V36, P181, DOI 10.1016/S0735-1097(00)00700-2	5	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 19	2011	377	9766					690	690		10.1016/S0140-6736(10)61496-1	http://dx.doi.org/10.1016/S0140-6736(10)61496-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727DB	21334537				2022-12-28	WOS:000287776600039
J	Encalada, SE; Szpankowski, L; Xia, CH; Goldstein, LSB				Encalada, Sandra E.; Szpankowski, Lukasz; Xia, Chun-hong; Goldstein, Lawrence S. B.			Stable Kinesin and Dynein Assemblies Drive the Axonal Transport of Mammalian Prion Protein Vesicles	CELL			English	Article							TUG-OF-WAR; HEAVY-CHAIN; CYTOPLASMIC DYNEIN; MOLECULAR MOTORS; TARGETED DISRUPTION; IN-VITRO; DYNACTIN; GENES; MITOCHONDRIA; REQUIRES	Kinesin and dynein are opposite-polarity microtubule motors that drive the tightly regulated transport of a variety of cargoes. Both motors can bind to cargo, but their overall composition on axonal vesicles and whether this composition directly modulates transport activity are unknown. Here we characterize the intracellular transport and steady-state motor subunit composition of mammalian prion protein (PrPC) vesicles. We identify Kinesin-1 and cytoplasmic dynein as major PrPC vesicle motor complexes and show that their activities are tightly coupled. Regulation of normal retrograde transport by Kinesin-1 is independent of dynein-vesicle attachment and requires the vesicle association of a complete Kinesin-1 heavy and light chain holoenzyme. Furthermore, motor subunits remain stably associated with stationary as well as with moving vesicles. Our data suggest a coordination model wherein PrPC vesicles maintain a stable population of associated motors whose activity is modulated by regulatory factors instead of by structural changes to motor-cargo associations.	[Encalada, Sandra E.; Szpankowski, Lukasz; Xia, Chun-hong; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Szpankowski, Lukasz] Univ Calif San Diego, Sch Med, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Szpankowski, Lukasz; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Encalada, SE (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	sencalada@ucsd.edu; lgoldstein@ucsd.edu			UCSD [P30 NS047101]; NIH-NIA [AG032180]; Investigator of the Howard Hughes Medical Institute; NIH [T32 GM008806, AG000216]; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032180, T32AG000216] Funding Source: NIH RePORTER	UCSD; NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Ge Yang, Gaudenz Danuser, Khuloud Jaqaman, and Daniel Whisler for assistance with the development of software; Liz Roberts and Eileen Westerman for technical assistance; Jennifer Meerloo for assistance with imaging (UCSD Neuroscience Microscopy Shared Facility Grant P30 NS047101); Anne-Marie Craig (University of British Columbia) for the synaptophysin-mCherry construct; Anthony Williamson and Laura Solforosi (The Scripps Research Institute) for the HuM-D13 anti-PrP<SUP>C</SUP> antibody; Scott T. Brady for the KLC1/2 (63-90) antibody; Nancy Jenkins (Institute of Molecular and Cell Biology, Singapore) and Jiandong Huang (University of Hong Kong) for the Kinesin-1B mice; Tony Orth at the Genomics Institute of the Novartis Foundation for help with design and construction of shRNA lentiviral constructs; and Jeff W. Kelly (The Scripps Research Institute) for critical feedback on the manuscript. This work was supported in part by NIH-NIA grant AG032180 to L. S. B. G., who is an Investigator of the Howard Hughes Medical Institute. L. S. was supported by NIH Bioinformatics Training Grant T32 GM008806, and S. E. E. was supported by a Damon Runyon Cancer Research Foundation Postdoctoral Fellowship and NIH Neuroplasticity Training Grant AG000216.	Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075; [Anonymous], 2005, INTRO PRACTICE STAT; BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; BORCHELT DR, 1994, J BIOL CHEM, V269, P14711; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Butowt R, 2006, MOL CELL NEUROSCI, V31, P97, DOI 10.1016/j.mcn.2005.09.004; Butowt R, 2007, J NEUROSCI RES, V85, P2567, DOI 10.1002/jnr.21229; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Cui J, 2011, DIABETES, V60, P320, DOI 10.2337/db09-1078; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Fraley C, 1999, J CLASSIF, V16, P297, DOI 10.1007/s003579900058; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055; Harris DA, 2003, BRIT MED BULL, V66, P71, DOI 10.1093/bmb/66.1.71; HENDRICKS AG, 2010, CURR BIOL; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Howard J., 2001, MECH MOTOR PROTEINS; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Lu HL, 2009, TRAFFIC, V10, P1429, DOI 10.1111/j.1600-0854.2009.00964.x; Lyman MG, 2009, J VIROL, V83, P2058, DOI 10.1128/JVI.01718-08; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Mazumdar M, 1996, P NATL ACAD SCI USA, V93, P6552, DOI 10.1073/pnas.93.13.6552; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Moya KL, 2004, J NEUROCHEM, V88, P155, DOI 10.1046/j.1471-4159.2003.02150.x; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Plitz T, 2001, MOL CELL BIOL, V21, P6044, DOI 10.1128/MCB.21.17.6044-6055.2001; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rodolfo K, 1999, NEUROREPORT, V10, P3639, DOI 10.1097/00001756-199911260-00032; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Xia CH, 1998, GENOMICS, V52, P209, DOI 10.1006/geno.1998.5427; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026	55	128	129	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					551	565		10.1016/j.cell.2011.01.021	http://dx.doi.org/10.1016/j.cell.2011.01.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335237	Green Accepted, Bronze			2022-12-28	WOS:000287473100010
J	Jang, HW; Felker, DA; Bark, CW; Wang, Y; Niranjan, MK; Nelson, CT; Zhang, Y; Su, D; Folkman, CM; Baek, SH; Lee, S; Janicka, K; Zhu, Y; Pan, XQ; Fong, DD; Tsymbal, EY; Rzchowski, MS; Eom, CB				Jang, H. W.; Felker, D. A.; Bark, C. W.; Wang, Y.; Niranjan, M. K.; Nelson, C. T.; Zhang, Y.; Su, D.; Folkman, C. M.; Baek, S. H.; Lee, S.; Janicka, K.; Zhu, Y.; Pan, X. Q.; Fong, D. D.; Tsymbal, E. Y.; Rzchowski, M. S.; Eom, C. B.			Metallic and Insulating Oxide Interfaces Controlled by Electronic Correlations	SCIENCE			English	Article							HETEROSTRUCTURE; SUPERLATTICES; TRANSITIONS	The formation of two-dimensional electron gases (2DEGs) at complex oxide interfaces is directly influenced by the oxide electronic properties. We investigated how local electron correlations control the 2DEG by inserting a single atomic layer of a rare-earth oxide (RO) [(R is lanthanum (La), praseodymium (Pr), neodymium (Nd), samarium (Sm), or yttrium (Y)] into an epitaxial strontium titanate oxide (SrTiO3) matrix using pulsed-laser deposition with atomic layer control. We find that structures with La, Pr, and Nd ions result in conducting 2DEGs at the inserted layer, whereas the structures with Sm or Y ions are insulating. Our local spectroscopic and theoretical results indicate that the interfacial conductivity is dependent on electronic correlations that decay spatially into the SrTiO3 matrix. Such correlation effects can lead to new functionalities in designed heterostructures.	[Jang, H. W.; Bark, C. W.; Folkman, C. M.; Baek, S. H.; Lee, S.; Eom, C. B.] Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA; [Felker, D. A.; Rzchowski, M. S.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Wang, Y.; Niranjan, M. K.; Janicka, K.; Tsymbal, E. Y.] Univ Nebraska, Dept Phys & Astron, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA; [Nelson, C. T.; Zhang, Y.; Pan, X. Q.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Zhang, Y.] Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Peoples R China; [Zhang, Y.] Nanjing Univ, Dept Mat Sci & Engn, Nanjing 210093, Peoples R China; [Su, D.; Zhu, Y.] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Fong, D. D.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Nebraska System; University of Nebraska Lincoln; University of Michigan System; University of Michigan; Nanjing University; Nanjing University; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Eom, CB (corresponding author), Univ Wisconsin, Dept Mat Sci & Engn, 1509 Univ Ave, Madison, WI 53706 USA.	eom@engr.wisc.edu	Wang, Yong/F-7019-2010; Tsymbal, Evgeny/G-3493-2013; Rzchowski, Mark S/X-3600-2019; Pan, Xiaoqing/ABF-4088-2020; Baek, Seung-Hyub/B-9189-2013; Lee, Sanghan/AAH-1105-2019; Zhang, Yi/H-4678-2017; Jang, Ho Won/D-9866-2011; Bark, Chung Wung/B-9534-2014; Eom, Chang-Beom/I-5567-2014; Su, Dong/A-8233-2013; Zhu, Ye/A-1844-2011	Wang, Yong/0000-0002-0248-9757; Tsymbal, Evgeny/0000-0002-6728-5480; Pan, Xiaoqing/0000-0002-0965-8568; Lee, Sanghan/0000-0002-5807-864X; Jang, Ho Won/0000-0002-6952-7359; Bark, Chung Wung/0000-0002-9394-4240; Su, Dong/0000-0002-1921-6683; Baek, Seung-Hyub/0000-0002-3187-6596; Zhu, Ye/0000-0002-5217-493X; Niranjan, Manish/0000-0002-4417-5107	National Science Foundation [DMR-0906443, EPS-1010674]; David and Lucile Packard Fellowship; Materials Research Science and Engineering Center (NSF) [DMR-0820521]; Nanoelectronics Research Initiative of the Semiconductor Research Corporation; Nebraska Research Initiative; U.S. Department of Energy (DOE) [DE-FG02-07ER46416]; National Center for Electron Microscopy at Lawrence Berkeley National Laboratory for their support under DOE [DE-AC02-05CH11231]; DOE Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Center for Functional Nanomaterials [DE-AC02-98CH10886]; DOE/BES/MSE	National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); Materials Research Science and Engineering Center (NSF)(National Science Foundation (NSF)); Nanoelectronics Research Initiative of the Semiconductor Research Corporation; Nebraska Research Initiative; U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Center for Electron Microscopy at Lawrence Berkeley National Laboratory for their support under DOE; DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Center for Functional Nanomaterials; DOE/BES/MSE(United States Department of Energy (DOE))	We thank D. G. Schlom and D. A. Muller for fruitful discussions. This work was supported by the National Science Foundation under grant DMR-0906443 and a David and Lucile Packard Fellowship (C.B.E.). The research at University of Nebraska was supported by the Materials Research Science and Engineering Center (NSF grant DMR-0820521), the Nanoelectronics Research Initiative of the Semiconductor Research Corporation, the National Science Foundation (grant EPS-1010674), and the Nebraska Research Initiative. Work at the University of Michigan was supported by the U.S. Department of Energy (DOE) under grant DE-FG02-07ER46416. We thank the National Center for Electron Microscopy at Lawrence Berkeley National Laboratory for their support under DOE grant DE-AC02-05CH11231 for user facilities. Work at Argonne and use of the Advanced Photon Source were supported by the DOE Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Work at Brookhaven National Laboratory was sponsored by DOE/BES/MSE and the Center for Functional Nanomaterials under contract DE-AC02-98CH10886. J. Karapetrova's assistance at beamline 33-BM of the Advanced Photon Source is gratefully acknowledged.	Bousquet E, 2008, NATURE, V452, P732, DOI 10.1038/nature06817; Breitschaft M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.153414; Brinkman A, 2007, NAT MATER, V6, P493, DOI 10.1038/nmat1931; Cen C, 2008, NAT MATER, V7, P298, DOI 10.1038/nmat2136; Cen C, 2009, SCIENCE, V323, P1026, DOI 10.1126/science.1168294; Garcia V, 2009, NATURE, V460, P81, DOI 10.1038/nature08128; Hotta Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236805; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Ishida H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115350; Janicka K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.106803; Kotliar G, 2006, REV MOD PHYS, V78, P865, DOI 10.1103/RevModPhys.78.865; Kozuka Y, 2009, NATURE, V462, P487, DOI 10.1038/nature08566; KROEMER H, 1983, SURF SCI, V132, P543, DOI 10.1016/0039-6028(83)90561-7; Mannhart J, 2010, SCIENCE, V327, P1607, DOI 10.1126/science.1181862; Nakagawa N, 2006, NAT MATER, V5, P204, DOI 10.1038/nmat1569; Ohtomo A, 2002, NATURE, V419, P378, DOI 10.1038/nature00977; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Okamoto S, 2004, NATURE, V428, P630, DOI 10.1038/nature02450; OKAMOTO S, 2006, PHYS REV LETT, V97, DOI DOI 10.1103/PHYSREVLETT.94.176805; Okatov S, 2005, EUROPHYS LETT, V70, P499, DOI 10.1209/epl/i2004-10513-x; OKIMOTO Y, 1995, PHYS REV B, V51, P9581, DOI 10.1103/PhysRevB.51.9581; Pentcheva R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.016802; Popovic ZS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.176805; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; SI QM, 1994, PHYS REV LETT, V72, P2761, DOI 10.1103/PhysRevLett.72.2761; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; Warusawithana MP, 2009, SCIENCE, V324, P367, DOI 10.1126/science.1169678; Warusawithana MP, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.036802; Wong FJ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161101; Yamada H, 2004, SCIENCE, V305, P646, DOI 10.1126/science.1098867; Zhou HD, 2005, J PHYS-CONDENS MAT, V17, P7395, DOI 10.1088/0953-8984/17/46/023	31	198	201	4	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					886	889		10.1126/science.1198781	http://dx.doi.org/10.1126/science.1198781			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330538	Green Published			2022-12-28	WOS:000287455100049
J	Min, SK; Zhang, XB; Zwiers, FW; Hegerl, GC				Min, Seung-Ki; Zhang, Xuebin; Zwiers, Francis W.; Hegerl, Gabriele C.			Human contribution to more-intense precipitation extremes	NATURE			English	Article							CLIMATE; TEMPERATURE; MODEL; INCREASES	Extremes of weather and climate can have devastating effects on human society and the environment(1,2). Understanding past changes in the characteristics of such events, including recent increases in the intensity of heavy precipitation events over a large part of the Northern Hemisphere land area(3-5), is critical for reliable projections of future changes. Given that atmospheric water-holding capacity is expected to increase roughly exponentially with temperature-and that atmospheric water content is increasing in accord with this theoretical expectation(6-11)-it has been suggested that human-influenced global warming may be partly responsible for increases in heavy precipitation(3,5,7). Because of the limited availability of daily observations, however, most previous studies have examined only the potential detectability of changes in extreme precipitation through model-model comparisons(12-15). Here we show that human-induced increases in greenhouse gases have contributed to the observed intensification of heavy precipitation events found over approximately two-thirds of data-covered parts of Northern Hemisphere land areas. These results are based on a comparison of observed and multi-model simulated changes in extreme precipitation over the latter half of the twentieth century analysed with an optimal fingerprinting technique. Changes in extreme precipitation projected by models, and thus the impacts of future changes in extreme precipitation, may be underestimated because models seem to underestimate the observed increase in heavy precipitation with warming(16).	[Min, Seung-Ki; Zhang, Xuebin; Zwiers, Francis W.] Environm Canada, Div Climate Res, Toronto, ON M3H 5T4, Canada; [Hegerl, Gabriele C.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland	Environment & Climate Change Canada; University of Edinburgh	Min, SK (corresponding author), Environm Canada, Div Climate Res, Toronto, ON M3H 5T4, Canada.	seung-ki.min@ec.gc.ca; fwzwiers@uvic.ca	Zhang, Xuebin/ABD-7511-2021; Min, Seung-Ki/B-1431-2010	Min, Seung-Ki/0000-0002-6749-010X; Hegerl, Gabriele/0000-0002-4159-1295	International Detection and Attribution Group (IDAG) by the US Department of Energy's Office of Science, Office of Biological and Environmental Research; National Oceanic and Atmospheric Administration's Climate Program Office; Canadian International Polar Year (IPY) programme; NSF [ATM-0296007]; Natural Environment Research Council [ncas10009] Funding Source: researchfish	International Detection and Attribution Group (IDAG) by the US Department of Energy's Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Oceanic and Atmospheric Administration's Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); Canadian International Polar Year (IPY) programme; NSF(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank N. Gillett and B. Yu for comments, M. Wehner for provision of CCSM3 data, and J. Penner and M. Sugiyama for discussion. We acknowledge the modelling groups, the Program for Climate Model Diagnosis and Intercomparison (PCMDI) and the World Climate Research Programme's (WCRP's) Working Group on Coupled Modelling (WGCM) for their roles in making available the WCRP CMIP3 multi-model data set. Support for this data set is provided by the Office of Science, US Department of Energy. We acknowledge the support of the International Detection and Attribution Group (IDAG) by the US Department of Energy's Office of Science, Office of Biological and Environmental Research and the National Oceanic and Atmospheric Administration's Climate Program Office. S.-K.M. was supported by the Canadian International Polar Year (IPY) programme. G.C.H. was supported by the NSF (grant ATM-0296007).	Alexander LV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006290; Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Allen MR, 2003, CLIM DYNAM, V21, P477, DOI 10.1007/s00382-003-0313-9; Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; Durman CF, 2001, Q J ROY METEOR SOC, V127, P1005, DOI 10.1002/qj.49712757316; Emori S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023272; Groisman PY, 2005, J CLIMATE, V18, P1326, DOI 10.1175/JCLI3339.1; Hegerl GC, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Hegerl GC, 2004, J CLIMATE, V17, P3683, DOI 10.1175/1520-0442(2004)017<3683:DOACIA>2.0.CO;2; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Kharin VV, 2005, J CLIMATE, V18, P1156, DOI 10.1175/JCLI3320.1; Kiktev D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029539; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Min SK, 2008, SCIENCE, V320, P518, DOI 10.1126/science.1153468; Min SK, 2009, CLIM DYNAM, V32, P95, DOI 10.1007/s00382-008-0376-8; O'Gorman PA, 2009, P NATL ACAD SCI USA, V106, P14773, DOI 10.1073/pnas.0907610106; Pall P, 2007, CLIM DYNAM, V28, P351, DOI 10.1007/S00382-006-0180-2; Parry M. L., 2007, CLIMATE CHANGE 2007; Peterson T.C., 2008, WEATHER CLIM EXTREME, P11; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Santer BD, 2007, P NATL ACAD SCI USA, V104, P15248, DOI 10.1073/pnas.0702872104; Sugiyama M, 2010, P NATL ACAD SCI USA, V107, P571, DOI 10.1073/pnas.0903186107; Tebaldi C, 2006, CLIMATIC CHANGE, V79, P185, DOI 10.1007/s10584-006-9051-4; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Wentz FJ, 2000, NATURE, V403, P414, DOI 10.1038/35000184; Willett KM, 2007, NATURE, V449, P710, DOI 10.1038/nature06207; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025; Zwiers FW, 1998, J CLIMATE, V11, P2200, DOI 10.1175/1520-0442(1998)011<2200:CITEOT>2.0.CO;2	30	1335	1392	23	678	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					378	381		10.1038/nature09763	http://dx.doi.org/10.1038/nature09763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331039				2022-12-28	WOS:000287409100038
J	Tsaytler, P; Harding, HP; Ron, D; Bertolotti, A				Tsaytler, Pavel; Harding, Heather P.; Ron, David; Bertolotti, Anne			Selective Inhibition of a Regulatory Subunit of Protein Phosphatase 1 Restores Proteostasis	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; STRESS; DEPHOSPHORYLATION; EIF2-ALPHA; GUANABENZ; DEATH	Many biological processes are regulated through the selective dephosphorylation of proteins. Protein serine-threonine phosphatases are assembled from catalytic subunits bound to diverse regulatory subunits that provide substrate specificity and subcellular localization. We describe a small molecule, guanabenz, that bound to a regulatory subunit of protein phosphatase 1, PPP1R15A/GADD34, selectively disrupting the stress-induced dephosphorylation of the a subunit of translation initiation factor 2 (eIF2 alpha). Without affecting the related PPP1R15B-phosphatase complex and constitutive protein synthesis, guanabenz prolonged eIF2 alpha phosphorylation in human stressed cells, adjusting the protein production rates to levels manageable by available chaperones. This favored protein folding and thereby rescued cells from protein misfolding stress. Thus, regulatory subunits of phosphatases are drug targets, a property used here to restore proteostasis in stressed cells.	[Tsaytler, Pavel; Bertolotti, Anne] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Harding, Heather P.; Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; University of Cambridge	Bertolotti, A (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	aberto@mrc-lmb.cam.ac.uk		Harding, Heather P/0000-0002-7359-7974; Ron, David/0000-0002-3014-5636	UK Medical Research Council; MRC [MC_U105185860] Funding Source: UKRI; Medical Research Council [G0600717B, MC_U105185860] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Merritt and C. Wallace for biotinylated guanabenz, J. Hastie for purified recombinant PP1c, anonymous reviewers for suggestions, and M. Goedert for advice on the manuscript. Supported by the UK Medical Research Council. D. R. is a Wellcome Trust Principal Research Fellow. A. B. is a co-inventor on patent WO/2008/041133.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; HOLMES B, 1983, DRUGS, V26, P212, DOI 10.2165/00003495-198326030-00003; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431	15	374	392	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					91	94		10.1126/science.1201396	http://dx.doi.org/10.1126/science.1201396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21385720				2022-12-28	WOS:000289000000044
J	Rizzo, M				Rizzo, Matthew			Impaired Driving From Medical Conditions A 70-Year-Old Man Trying to Decide if He Should Continue Driving	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPWORTH SLEEPINESS SCALE; TRIGGERED VIDEO INTERVENTION; SIMULATED CAR CRASHES; ALZHEIMER-DISEASE; OLDER DRIVERS; DEPRESSIVE SYMPTOMS; PARKINSONS-DISEASE; COGNITIVE FUNCTION; HYPOGLYCEMIA; RISK	Some medical disorders can impair performance, increasing the risk of driving safety errors that can lead to vehicle crashes. The causal pathway often involves a concatenation of factors or events, some of which can be prevented or controlled. Effective interventions can operate before, during, or after a crash occurs at the levels of driver capacity, vehicle and road design, and public policy. A variety of systemic, neurological, psychiatric, and developmental disorders put drivers at potential increased risk of a car crash in the short or long term. Medical diagnosis and age alone are usually insufficient criteria for determining fitness to drive. Strategies are needed for determining what types and levels of reduced function provide a threshold for disqualification in drivers with medical disorders. Evidence of decreased mileage, self-restriction to driving in certain situations, collisions, moving violations, aggressive driving, sleepiness, alcohol abuse, metabolic disorders, and multiple medications may trigger considerations of driver safety. A general framework for evaluating driver fitness relies on a functional evaluation of multiple domains (cognitive, motor, perceptual, and psychiatric) that are important for safe driving and can be applied across many disorders, including conditions that have rarely been studied with respect to driving, and in patients with multiple conditions and medications. Neurocognitive tests, driving simulation, and road tests provide complementary sources of evidence to evaluate driver safety. No single test is sufficient to determine who should drive and who should not. JAMA. 2011;305(10):1018-1026 www.jama.com	[Rizzo, Matthew] Univ Iowa, Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA; [Rizzo, Matthew] Univ Iowa, Div Neuroergon, Iowa City, IA 52242 USA; [Rizzo, Matthew] Univ Iowa, Inst Aging Mind & Brain Initiat, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Rizzo, M (corresponding author), Univ Iowa, Carver Coll Med, Dept Neurol, 200 Hawkins Dr, Iowa City, IA 52242 USA.	matthew-rizzo@uiowa.edu			National Institute on Aging [RO1 AG 17707, R01 AG026027, RO1 AG 15071]; National Heart, Lung, and Blood Institute [RO1 HL091917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017177, R01AG026027, R01AG015071] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging grants RO1 AG 17707, R01 AG026027, and RO1 AG 15071 and National Heart, Lung, and Blood Institute grant RO1 HL091917.	*AM AC OPHTH, 2006, POL STAT VIS REQ DRI; *AM MED ASS NAT HI, 2003, PHYS GUID ASS COUNS; [Anonymous], 2009, DRIV FITN MED GUID; Arnulf I, 2008, CURR OPIN NEUROL, V21, P472, DOI 10.1097/WCO.0b013e328305044d; BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; Barrash J, 2010, J INT NEUROPSYCH SOC, V16, P679, DOI 10.1017/S1355617710000470; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Berson F, 2008, EXPERT PANEL RECOMME; Borkenstein R.F., 1974, BLUTALKOHOL, V11, P1; Bragd J, 2008, DIABETES METAB, V34, P612, DOI 10.1016/j.diabet.2008.04.005; Carney C, 2010, AM J PUBLIC HEALTH, V100, P1101, DOI 10.2105/AJPH.2009.165829; Carr D. B., 2010, PHYS GUIDE ASSESSING, V2nd; Carr DB, 2010, JAMA-J AM MED ASSOC, V303, P1632, DOI 10.1001/jama.2010.481; Chin K, 2004, SLEEP, V27, P490; Cox DJ, 2009, DIABETES CARE, V32, P2177, DOI 10.2337/dc08-1510; Cryer PE, 2004, NEW ENGL J MED, V350, P2272, DOI 10.1056/NEJMra031354; Dawson JD, 2009, NEUROLOGY, V72, P521, DOI 10.1212/01.wnl.0000341931.35870.49; DeCarlo DK, 2003, OPTOMETRY VISION SCI, V80, P207, DOI 10.1097/00006324-200303000-00010; DEMENT WC, 1978, SLEEP APNEA SYNDROME, V27, P465; Dingus T. A., 2006, NATL HIGHW TRAFFIC S; DINGUS TA, 1987, ACCIDENT ANAL PREV, V19, P271, DOI 10.1016/0001-4575(87)90062-5; DRACHMAN DA, 1988, ANN NEUROL, V24, P787, DOI 10.1002/ana.410240614; Dula CS, 2003, J APPL SOC PSYCHOL, V33, P263, DOI 10.1111/j.1559-1816.2003.tb01896.x; Edlund W, 2005, CLIN PRACTICE GUIDEL; Edwards JD, 2010, GERONTOLOGIST, V50, P393, DOI 10.1093/geront/gnp127; Engleman HM, 1997, THORAX, V52, P114, DOI 10.1136/thx.52.2.114; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Fonda SJ, 2001, J GERONTOL B-PSYCHOL, V56, pS343, DOI 10.1093/geronb/56.6.S343; Furuta H, 1999, PSYCHIAT CLIN NEUROS, V53, P301, DOI 10.1046/j.1440-1819.1999.00511.x; GOLDBERG D, 1972, GHQ SELECTION PSYCHI; Goodman M, 2005, NATL HIGHW TRAFFIC S; HADDON W, 1972, J TRAUM, V12, P193, DOI 10.1097/00005373-197203000-00002; Heinrich H.W., 1980, IND ACCIDENT PREVENT; Heller SR, 1996, DIABETIC MED, V13, P607, DOI 10.1002/(SICI)1096-9136(199607)13:7<607::AID-DIA159>3.0.CO;2-I; Hickman J. S., 2009, INT DRIV S HUM FACT, P38; Iverson DJ, 2010, NEUROLOGY, V74, P1316, DOI 10.1212/WNL.0b013e3181da3b0f; JETTE AM, 1992, HUM FACTORS, V34, P25, DOI 10.1177/001872089203400104; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; LEGER D, 1994, SLEEP, V17, P84, DOI 10.1093/sleep/17.1.84; Lobmann R, 2000, J CLIN ENDOCR METAB, V85, P2758, DOI 10.1210/jc.85.8.2758; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202, DOI 10.1111/j.1532-5415.1997.tb04508.x; MAROTTOLI RA, 1994, ANN INTERN MED, V121, P842, DOI 10.7326/0003-4819-121-11-199412010-00003; Maycock G., 1997, TRAFFIC TRANSPORT PS, P65; McGarraugh Geoffrey, 2010, J Diabetes Sci Technol, V4, P41; McGehee DV, 2007, J SAFETY RES, V38, P215, DOI 10.1016/j.jsr.2007.02.009; *NAT HIGHW TRAFF S, 2008, 810992 DOT HS NAT HI; Owsley C, 2004, AM J PREV MED, V26, P222, DOI 10.1016/j.amepre.2003.12.005; PELLI DG, 1988, CLIN VISION SCI, V2, P187; Pietras TA, 2006, PERCEPT MOTOR SKILL, V102, P632, DOI 10.2466/PMS.102.3.632-644; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Reston J.T., EXECUTIVE SUMMARY TR; Rizzo M, 2001, ALZ DIS ASSOC DIS, V15, P10, DOI 10.1097/00002093-200101000-00002; Rizzo M, 1997, ARCH NEUROL-CHICAGO, V54, P545, DOI 10.1001/archneur.1997.00550170027011; Rizzo M, 2007, NEUROERGONOMICS BRAI, P113; RIZZO M, 2002, GERONTECHNOLOGY, V1, P291; Rizzo M., 2010, NEUROPSYCHOLOGY EVER, P168; Runyan C W, 1998, Inj Prev, V4, P302; STUTTS JC, 1999, WHY DO PEOPLE HAVE D, P5944; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Tiller M., 2007, EXECUTIVE SUMMARY SE; Tregear S.J., 2006, EXECUTIVE SUMMARY DI; Tregear S.J., 2007, EXECUTIVE SUMMARY OB; Tregear S.J., 2007, EXECUTIVE SUMMARY CA; Tregear S.J., 2007, P 4 INT DRIV S HUM F, P343; Tregear S, 2009, J CLIN SLEEP MED, V5, P573; Uc EY, 2006, NEUROLOGY, V67, P1774, DOI 10.1212/01.wnl.0000245086.32787.61; Uc EY, 2009, NEUROLOGY, V73, P2112, DOI 10.1212/WNL.0b013e3181c67b77; Uc EY, 2010, NEUROLOGY, V74, pA58; Volna J, 2006, Prague Med Rep, V107, P290; Weinger K, 1999, AM J MED, V107, P246, DOI 10.1016/S0002-9343(99)00221-1; Wickens C.D., 1992, ENG PSYCHOL HUMAN PE, V2nd ed.; Wright RJ, 2009, DIABETES CARE, V32, P1503, DOI 10.2337/dc09-0212; Zador PL, 2000, J STUD ALCOHOL, V61, P387, DOI 10.15288/jsa.2000.61.387	76	51	51	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1018	1026		10.1001/jama.2011.252	http://dx.doi.org/10.1001/jama.2011.252			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	731SM	21364126	Green Accepted			2022-12-28	WOS:000288129600021
J	Burden, SJ				Burden, Steven J.			SnapShot: Neuromuscular Junction	CELL			English	Editorial Material							MUSCLE; DOK-7; MUSK		[Burden, Steven J.] New York Univ Med Sch, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University				Burden, Steven/0000-0002-3550-6891				Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Farrugia ME, 2010, CURR OPIN NEUROL, V23, P489, DOI 10.1097/WCO.0b013e32833cc968; Hallock PT, 2010, GENE DEV, V24, P2451, DOI 10.1101/gad.1977710; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711	10	37	37	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					826	827		10.1016/j.cell.2011.02.037	http://dx.doi.org/10.1016/j.cell.2011.02.037			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376240	Bronze			2022-12-28	WOS:000288007100022
J	Sinnott, M; Shaban, RZ				Sinnott, Michael; Shaban, Ramon Z.			Personal View Can we have a culture of patient safety without one of staff safety?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sinnott, Michael; Shaban, Ramon Z.] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Sinnott, Michael] Univ Queensland, Brisbane, Qld, Australia; [Shaban, Ramon Z.] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia	University of Queensland; Griffith University; Menzies Health Institute Queensland	Sinnott, M (corresponding author), Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.	michael_sinnott@health.qld.gov.au	Sinnott, Michael/D-1155-2012	Sinnott, Michael/0000-0002-2338-3126; Shaban, Ramon/0000-0002-5203-0557				Occupational Safety and Health Administration, 2008, OCC SAF HLTH STAND; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; SINNOTT M, 2010, PERIOPERAT NURS CLIN, V5, P59; *SOC THOR SURG, 2009, HIST PAT SAF PAT SAF; Tseng D, 2005, INFECT DIS HEALTH, V10, P89, DOI 10.1071/HI05089	5	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2011	342								c6171	10.1136/bmj.c6171	http://dx.doi.org/10.1136/bmj.c6171			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732EU	21378073	Green Published			2022-12-28	WOS:000288168600001
J	Othonos, N; Sulaiman, R; D'Costa, D; Gama, R				Othonos, Nantia; Sulaiman, Raashda; D'Costa, Domnick; Gama, Rousseau			Case report Weight loss and hyponatraemia The final diagnosis in this patient was panhypopituitarism and empty sella syndrome, secondary to either Sheehan's syndrome or lymphocytic hypophysitis	BRITISH MEDICAL JOURNAL			English	Editorial Material							PARAVENTRICULAR NUCLEUS; PITUITARY-GLAND; VASOPRESSIN; ADRENALECTOMY		[Othonos, Nantia; Sulaiman, Raashda; Gama, Rousseau] New Cross Hosp, Dept Clin Chem, Wolverhampton, England; [D'Costa, Domnick] New Cross Hosp, Dept Gen Med & Care Elderly, Wolverhampton, England; [Gama, Rousseau] Wolverhampton Univ, Res Inst, Wolverhampton, England	New Cross Hospital; New Cross Hospital; University of Wolverhampton	Othonos, N (corresponding author), New Cross Hosp, Dept Clin Chem, Wolverhampton, England.	nadia.othonos@nhs.net		Gama, Rousseau/0000-0001-7483-9253				Arlt W, 2008, CLIN MED, V8, P211, DOI 10.7861/clinmedicine.8-2-211; Ball SG, 2007, ANN CLIN BIOCHEM, V44, P417, DOI 10.1258/000456307781646030; BERGLAND RM, 1968, J NEUROSURG, V28, P93, DOI 10.3171/jns.1968.28.2.0093; CHUNG TT, 2009, ENDOTEXT; DAVIS LG, 1986, P NATL ACAD SCI USA, V83, P1145, DOI 10.1073/pnas.83.4.1145; Fried LF, 1997, MED CLIN N AM, V81, P585, DOI 10.1016/S0025-7125(05)70535-6; KOVACS K, 1986, NEUROENDOCRINOLOGY, V44, P229, DOI 10.1159/000124650; MCLACHLAN MS, 1968, BRIT J RADIOL, V41, P323, DOI 10.1259/0007-1285-41-485-323; OHTA M, 1968, TOHOKU J EXP MED, V28, P93; SAWCHENKO PE, 1987, J NEUROSCI, V7, P1093	10	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 3	2011	342								d405	10.1136/bmj.d405	http://dx.doi.org/10.1136/bmj.d405			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732EQ	21367838				2022-12-28	WOS:000288168200010
J	Donnelly, P				Donnelly, Peter			Making Sense of the Data	SCIENCE			English	Editorial Material									Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics	Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.			Donnelly, Peter/0000-0001-9495-3408					0	5	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1024	1025		10.1126/science.1204089	http://dx.doi.org/10.1126/science.1204089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350160				2022-12-28	WOS:000287699000045
J	Kasturi, SP; Skountzou, I; Albrecht, RA; Koutsonanos, D; Hua, T; Nakaya, HI; Ravindran, R; Stewart, S; Alam, M; Kwissa, M; Villinger, F; Murthy, N; Steel, J; Jacob, J; Hogan, RJ; Garcia-Sastre, A; Compans, R; Pulendran, B				Kasturi, Sudhir Pai; Skountzou, Ioanna; Albrecht, Randy A.; Koutsonanos, Dimitrios; Hua, Tang; Nakaya, Helder I.; Ravindran, Rajesh; Stewart, Shelley; Alam, Munir; Kwissa, Marcin; Villinger, Francois; Murthy, Niren; Steel, John; Jacob, Joshy; Hogan, Robert J.; Garcia-Sastre, Adolfo; Compans, Richard; Pulendran, Bali			Programming the magnitude and persistence of antibody responses with innate immunity	NATURE			English	Article							MEMORY B-CELLS; YELLOW-FEVER VACCINE; DERMAL DENDRITIC CELLS; TOLL-LIKE RECEPTORS; GERMINAL CENTER; IN-VIVO; T-CELLS; LANGERHANS CELLS; EXPRESSION; ANTIGEN	Many successful vaccines induce persistent antibody responses that can last a lifetime. The mechanisms by which they do so remain unclear, but emerging evidence indicates that they activate dendritic cells via Toll-like receptors (TLRs)(1,2). For example, the yellow fever vaccine YF-17D, one of the most successful empiric vaccines ever developed(3), activates dendritic cells via multiple TLRs to stimulate proinflammatory cytokines(4,5). Triggering specific combinations of TLRs in dendritic cells can induce synergistic production of cytokines(6), which results in enhanced T-cell responses, but its impact on antibody responses remain unknown. Learning the critical parameters of innate immunity that program such antibody responses remains a major challenge in vaccinology. Here we demonstrate that immunization of mice with synthetic nanoparticles containing antigens plus ligands that signal through TLR4 and TLR7 induces synergistic increases in antigen-specific, neutralizing antibodies compared to immunization with nanoparticles containing antigens plus a single TLR ligand. Consistent with this there was enhanced persistence of germinal centres and of plasma-cell responses, which persisted in the lymph nodes for >1.5 years. Surprisingly, there was no enhancement of the early short-lived plasma-cell response relative to that observed with single TLR ligands. Molecular profiling of activated B cells, isolated 7 days after immunization, indicated that there was early programming towards B-cell memory. Antibody responses were dependent on direct triggering of both TLRs on B cells and dendritic cells, as well as on T-cell help. Immunization protected completely against lethal avian and swine influenza virus strains in mice, and induced robust immunity against pandemic H1N1 influenza in rhesus macaques.	[Kasturi, Sudhir Pai; Skountzou, Ioanna; Hua, Tang; Nakaya, Helder I.; Ravindran, Rajesh; Kwissa, Marcin; Villinger, Francois; Jacob, Joshy; Compans, Richard; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Kasturi, Sudhir Pai; Hua, Tang; Nakaya, Helder I.; Ravindran, Rajesh; Kwissa, Marcin; Villinger, Francois; Jacob, Joshy; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Skountzou, Ioanna; Koutsonanos, Dimitrios; Jacob, Joshy; Compans, Richard] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Albrecht, Randy A.; Steel, John; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Stewart, Shelley; Alam, Munir] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Villinger, Francois; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Murthy, Niren] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Hogan, Robert J.] Univ Georgia, Dept Anat & Radiol, Coll Vet Med, Athens, GA 30602 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA	Emory University; Emory University; Emory University; Icahn School of Medicine at Mount Sinai; Duke University; Emory University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; University of Georgia; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.	bpulend@emory.edu	Alam, S. Munir/AAC-6711-2019; Skountzou, Ioanna/A-4454-2010; Albrecht, Randy A./H-5119-2019; Compans, Richard W/I-4087-2013; Nakaya, Helder I/A-1397-2010; Pulendran, Bali/AAW-9550-2021; Nakaya, Helder/AAF-1738-2020	Skountzou, Ioanna/0000-0002-6429-244X; Albrecht, Randy A./0000-0003-4008-503X; Compans, Richard W/0000-0003-2360-335X; Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Pulendran, Bali/0000-0001-6517-4333; Garcia-Sastre, Adolfo/0000-0002-6551-1827	National Institutes of Health [U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025, U19AI090023, HHSN266200700010C, U54AI57158, U01AI070469]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R37AI048638, U54AI057157, R56AI048638, U01AI070469, R01AI048638, U19AI057266, N01AI050025, U19AI090023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Ahmed and B. Rouse for discussion and comments on the manuscript. We thank B. Norris for assistance with FACS analysis, and H. Oluoch for assistance with cryostat sectioning. The work in the laboratory of B. P. was supported by grants U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025 and U19AI090023 from the National Institutes of Health and a grant from the Bill & Melinda Gates Foundation. Work in A.G.-S. laboratories was partly funded by grants HHSN266200700010C, U54AI57158) and U01AI070469 from the National Institutes of Health.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Airoldi I, 2004, CLIN CANCER RES, V10, P144, DOI 10.1158/1078-0432.CCR-1026-3; Airoldi I, 2000, J IMMUNOL, V165, P6880, DOI 10.4049/jimmunol.165.12.6880; Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259; Badr G, 2010, CELL IMMUNOL, V263, P31, DOI 10.1016/j.cellimm.2010.02.012; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Chen GL, 2009, CURR TOP MICROBIOL, V333, P109, DOI 10.1007/978-3-540-92165-3_5; Chin AID, 1999, MOL CELL BIOL, V19, P6665; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; COMPANS RW, 1974, J VIROL, V14, P1307, DOI 10.1128/JVI.14.5.1307-1309.1974; den Haan JMM, 2007, J IMMUNOL, V178, P5429, DOI 10.4049/jimmunol.178.9.5429; Dorner M, 2009, IMMUNOLOGY, V128, P573, DOI 10.1111/j.1365-2567.2009.03143.x; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Hikida M, 2009, J EXP MED, V206, P681, DOI 10.1084/jem.20082100; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kano G, 2008, LEUKEMIA LYMPHOMA, V49, P965, DOI 10.1080/10428190801993462; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kazzaz J, 2006, J CONTROL RELEASE, V110, P566, DOI 10.1016/j.jconrel.2005.10.010; Ke N, 2001, J BIOL CHEM, V276, P12481, DOI 10.1074/jbc.C000871200; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nera KP, 2006, SCAND J IMMUNOL, V64, P190, DOI 10.1111/j.1365-3083.2006.01809.x; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sah HK, 1997, J PHARM SCI, V86, P1315, DOI 10.1021/js960363q; Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Staats HF, 2007, INFECT IMMUN, V75, P5443, DOI 10.1128/IAI.00529-07; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Thibault DL, 2008, J CLIN INVEST, V118, P1417, DOI 10.1172/JCI30065; Tovey MG, 2008, BIOL CHEM, V389, P541, DOI 10.1515/BC.2008.051; van Essen D, 2000, J IMMUNOL, V165, P3640; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Young JAT, 2002, SCI AM, V286, P48, DOI 10.1038/scientificamerican0302-48; Zhou G, 2005, EXP MOL PATHOL, V78, P25, DOI 10.1016/j.yexmp.2004.08.008; Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106	56	688	717	4	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					543	U136		10.1038/nature09737	http://dx.doi.org/10.1038/nature09737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350488	Green Accepted			2022-12-28	WOS:000287652900044
J	Moore, CL; Copel, JA				Moore, Christopher L.; Copel, Joshua A.			CURRENT CONCEPTS Point-of-Care Ultrasonography	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FOCUSED ASSESSMENT; THORACIC ULTRASOUND; TRAUMA; SONOGRAPHY; TIME; ANESTHESIA		[Moore, Christopher L.] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06519 USA; [Copel, Joshua A.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06519 USA	Yale University; Yale University	Moore, CL (corresponding author), Yale Univ, Sch Med, Dept Emergency Med, 464 Congress Ave,Suite 260, New Haven, CT 06519 USA.	chris.moore@yale.edu	Moore, Christopher/I-4802-2017	Moore, Christopher/0000-0002-6972-2787	SonoSite; Philips; Siemens; World Class CME; Institute for Advanced Medical Education; Educational Symposia	SonoSite; Philips; Siemens(Siemens AG); World Class CME; Institute for Advanced Medical Education; Educational Symposia	Dr. Moore reports receiving consulting fees from SonoSite and Philips; and Dr. Copel, speaking fees from Siemens, World Class CME, the Institute for Advanced Medical Education, and Educational Symposia, grant support from Philips, and reimbursement for travel expenses from Philips and Esaote and serving as a paid member of the editorial board of Contemporary OB/GYN at modernmedicine.com. No other potential conflict of interest relevant to this article was reported.	Adler RS, 2007, ANESTH ANALG, V105, P1530, DOI 10.1213/01.ane.0000286177.86527.3a; Alpert JS, 2009, AM J MED, V122, P1, DOI 10.1016/j.amjmed.2008.05.013; [Anonymous], 2009, AID MEM DIAGN IM SER; [Anonymous], 2007, SCREEN CAR ART STEN; [Anonymous], 2008, GAO08452; [Anonymous], 2010 POINT OF CAR US; [Anonymous], AHRQ PUBL; Barnett SB, 2002, SEMIN ULTRASOUND CT, V23, P387, DOI 10.1016/S0887-2171(02)90009-0; Beck-Razi N, 2007, J ULTRAS MED, V26, P1149, DOI 10.7863/jum.2007.26.9.1149; Bree Robert L, 2004, Ultrasound Q, V20, P19, DOI 10.1097/00013644-200403000-00004; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brooks AJ, 2005, EMERG MED J, V22, P263, DOI 10.1136/emj.2004.014308; Calonge N, 2005, ANN INTERN MED, V142, P198, DOI 10.7326/0003-4819-142-3-200502010-00011; DONALD I, 1958, LANCET, V1, P1188; Dulchavsky SA, 2001, J TRAUMA, V50, P201, DOI 10.1097/00005373-200102000-00003; Dussik KT, 1942, Z GESAMTE NEUROL PSY, V174, P153, DOI 10.1007/BF02877929; Edler I, 2004, ULTRASOUND MED BIOL, V30, P1565, DOI 10.1016/S0301-5629(99)00056-3; Filly RA, 2003, J ULTRAS MED, V22, P323, DOI 10.7863/jum.2003.22.4.323; GLUCKMAN JL, 1993, AM J OTOLARYNG, V14, P307, DOI 10.1016/0196-0709(93)90088-O; Greenbaum LD, 2003, J ULTRAS MED, V22, P321, DOI 10.7863/jum.2003.22.4.321; Greenbaum Lennard D, 2004, J Ultrasound Med, V23, P1249; HILLMAN BJ, 1992, JAMA-J AM MED ASSOC, V268, P2050, DOI 10.1001/jama.268.15.2050; Hind D, 2003, BMJ-BRIT MED J, V327, P361, DOI 10.1136/bmj.327.7411.361; Hosek WT, 2007, ANN EMERG MED, V50, P619, DOI 10.1016/j.annemergmed.2007.04.032; Kirkpatrick AW, 2004, J TRAUMA, V57, P288, DOI 10.1097/01.TA.0000133565.88871.E4; Kumar A, 2009, BEST PRACT RES-CLIN, V23, P299, DOI 10.1016/j.bpa.2009.02.006; Lichtenstein D, 1997, AM J RESP CRIT CARE, V156, P1640, DOI 10.1164/ajrccm.156.5.96-07096; Lichtenstein D, 2004, ANESTHESIOLOGY, V100, P9, DOI 10.1097/00000542-200401000-00006; Liteplo AS, 2009, ACAD EMERG MED, V16, P201, DOI 10.1111/j.1553-2712.2008.00347.x; Liu SS, 2009, REGION ANESTH PAIN M, V34, P47, DOI 10.1097/AAP.0b013e3181933ec3; Maitino AJ, 2003, RADIOLOGY, V228, P795, DOI 10.1148/radiol.2283021254; Melanson SW, 2003, ULTRASONOGRAPHY TRAU, P127; Melniker LA, 2006, ANN EMERG MED, V48, P227, DOI 10.1016/j.annemergmed.2006.01.008; MILLER ME, 2005, MEDPAC RECOMMENDATIO; Moore C, 2008, ACAD EMERG MED, V15, P278, DOI 10.1111/j.1553-2712.2008.00052.x; Nelson BP, 2008, INT J EMERG MED, V1, P253, DOI 10.1007/s12245-008-0075-6; Nicolaou S, 2007, CRIT CARE MED, V35, pS186, DOI 10.1097/01.CCM.0000260630.68855.DF; Noble VE, 2009, CHEST, V135, P1433, DOI 10.1378/chest.08-1811; Ortega R, 2010, NEW ENGL J MED, V362; Otto C, 2009, WILD ENVIRON MED, V20, P283, DOI 10.1580/08-WEME-BR-228R2.1; Payne JW, 2005, WASHINGTON POST 0719; Randolph AG, 1996, CRIT CARE MED, V24, P2053, DOI 10.1097/00003246-199612000-00020; RANTANEN NW, 1986, VET CLIN N AM-EQUINE, V2, P49, DOI 10.1016/S0749-0739(17)30732-0; Rao S, 2008, J ULTRAS MED, V27, P745, DOI 10.7863/jum.2008.27.5.745; Rose JS, 2006, ANN EMERG MED, V48, P237, DOI 10.1016/j.annemergmed.2006.03.009; Sargsyan AE, 2005, J TRAUMA, V58, P35, DOI 10.1097/01.TA.0000145083.47032.78; Scalea TM, 1999, J TRAUMA, V46, P466, DOI 10.1097/00005373-199903000-00022; Schoen C, 2007, BENDING CURVE OPTION; Thompson SG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2307; Vance S, 2007, ANN EMERG MED, V49, P364, DOI 10.1016/j.annemergmed.2006.10.002	50	992	1022	8	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					749	757		10.1056/NEJMra0909487	http://dx.doi.org/10.1056/NEJMra0909487			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345104				2022-12-28	WOS:000287652500009
J	Al-Gazali, L				Al-Gazali, Lihadh			Human Genome Sequencing: Celebrating 10 years	SCIENCE			English	Editorial Material									United Arab Emirates Univ, Dept Pediat, Al Ain, U Arab Emirates	United Arab Emirates University	Al-Gazali, L (corresponding author), United Arab Emirates Univ, Dept Pediat, Al Ain, U Arab Emirates.								0	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					873	873		10.1126/science.1203266	http://dx.doi.org/10.1126/science.1203266			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722SO	21330531				2022-12-28	WOS:000287455100042
J	Lesburgueres, E; Gobbo, OL; Alaux-Cantin, S; Hambucken, A; Trifilieff, P; Bontempi, B				Lesburgueres, Edith; Gobbo, Oliviero L.; Alaux-Cantin, Stephanie; Hambucken, Anne; Trifilieff, Pierre; Bontempi, Bruno			Early Tagging of Cortical Networks Is Required for the Formation of Enduring Associative Memory	SCIENCE			English	Article							LONG-TERM-MEMORY; TRANSMITTED FOOD PREFERENCES; ORBITOFRONTAL CORTEX; SYNAPTIC PLASTICITY; REMOTE MEMORY; CONSOLIDATION; HIPPOCAMPUS; ACTIVATION; CASCADE; STORAGE	Although formation and stabilization of long-lasting associative memories are thought to require time-dependent coordinated hippocampal-cortical interactions, the underlying mechanisms remain unclear. Here, we present evidence that neurons in the rat cortex must undergo a "tagging process" upon encoding to ensure the progressive hippocampal-driven rewiring of cortical networks that support remote memory storage. This process was AMPA-and N-methyl-D-aspartate receptor-dependent, information-specific, and capable of modulating remote memory persistence by affecting the temporal dynamics of hippocampal-cortical interactions. Post-learning reinforcement of the tagging process via time-limited epigenetic modifications resulted in improved remote memory retrieval. Thus, early tagging of cortical networks is a crucial neurobiological process for remote memory formation whose functional properties fit the requirements imposed by the extended time scale of systems-level memory consolidation.	[Bontempi, Bruno] Univ Bordeaux 1, CNRS, UMR 5293, Inst Malad Neurodegenerat, F-33405 Talence, France; Univ Bordeaux 2, CNRS, UMR 5293, Inst Malad Neurodegenerat, F-33405 Talence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Bontempi, B (corresponding author), Univ Bordeaux 1, CNRS, UMR 5293, Inst Malad Neurodegenerat, Ave Fac, F-33405 Talence, France.	bruno.bontempi@u-bordeaux2.fr	Gobbo, Oliviero L/R-1763-2016; Gobbo, Oliviero/S-2043-2019; Trifilieff, Pierre/ABB-4317-2020	Gobbo, Oliviero L/0000-0003-4629-9485; Gobbo, Oliviero/0000-0003-4629-9485; Trifilieff, Pierre/0000-0002-7893-9697	CNRS, Fondation Simone et Cino del Duca; Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche (ANR) [09-MNPS-005-01]	CNRS, Fondation Simone et Cino del Duca(Centre National de la Recherche Scientifique (CNRS)); Federation pour la Recherche sur le Cerveau; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	We thank T. Durkin for comments on earlier drafts of the manuscript and T. Maviel, L. Restivo, M. Ammassari-Teule, C. Saugier, L. Decorte, and A. Faugere for their experimental contribution or technical advice. This work was supported by the CNRS, Fondation Simone et Cino del Duca (B.B. and O.L.G.), Federation pour la Recherche sur le Cerveau (B.B.), and the Agence Nationale de la Recherche (ANR grant 09-MNPS-005-01 to B.B.).	Alvarez P, 2001, LEARN MEMORY, V8, P79, DOI 10.1101/lm.38201; Barco A, 2008, NEUROSCI BIOBEHAV R, V32, P831, DOI 10.1016/j.neubiorev.2008.01.002; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Galef BG, 2003, LEARN BEHAV, V31, P160; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Smith CA, 2010, BEHAV BRAIN RES, V208, P243, DOI 10.1016/j.bbr.2009.12.001; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Teyler TJ, 2007, HIPPOCAMPUS, V17, P1158, DOI 10.1002/hipo.20350; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wittenberg GM, 2002, TRENDS NEUROSCI, V25, P501, DOI 10.1016/S0166-2236(02)02231-2	28	216	218	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					924	928		10.1126/science.1196164	http://dx.doi.org/10.1126/science.1196164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330548				2022-12-28	WOS:000287455100061
J	Hillegass, WB				Hillegass, William B.			Review: Third-generation P2Y(12) inhibitors reduce mortality after PCI more than clopidogrel	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Alabama Birmingham, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Hillegass, WB (corresponding author), Univ Alabama Birmingham, Birmingham, AL 35294 USA.							Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Wiviott SD, 2008, CIRCULATION, V118, P1626, DOI 10.1161/CIRCULATIONAHA.108.791061	2	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-6	10.7326/0003-4819-154-6-201103150-02006	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403069				2022-12-28	WOS:000208886200005
J	Zakar, T; Mesiano, S				Zakar, Tamas; Mesiano, Sam			How Does Progesterone Relax the Uterus in Pregnancy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zakar, Tamas] John Hunter Hosp, Dept Obstet & Gynaecol, Newcastle, NSW, Australia; [Zakar, Tamas] Univ Newcastle, Mothers & Babies Res Ctr, Newcastle, NSW 2308, Australia; [Mesiano, Sam] Case Western Reserve Univ, Dept Reprod Biol, Cleveland, OH 44106 USA	John Hunter Hospital; University of Newcastle; Case Western Reserve University	Zakar, T (corresponding author), John Hunter Hosp, Dept Obstet & Gynaecol, Newcastle, NSW, Australia.		Zakar, Tamas/G-7507-2013	Zakar, Tamas/0000-0002-1690-1159				Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107	2	49	51	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					972	973		10.1056/NEJMcibr1100071	http://dx.doi.org/10.1056/NEJMcibr1100071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21388317	Green Published			2022-12-28	WOS:000288170300017
J	Felker, GM; Lee, KL; Bull, DA; Redfield, MM; Stevenson, LW; Goldsmith, SR; LeWinter, MM; Deswal, A; Rouleau, JL; Ofili, EO; Anstrom, KJ; Hernandez, AF; McNulty, SE; Velazquez, EJ; Kfoury, AG; Chen, HH; Givertz, MM; Semigran, MJ; Bart, BA; Mascette, AM; Braunwald, E; O'Connor, CM				Felker, G. Michael; Lee, Kerry L.; Bull, David A.; Redfield, Margaret M.; Stevenson, Lynne W.; Goldsmith, Steven R.; LeWinter, Martin M.; Deswal, Anita; Rouleau, Jean L.; Ofili, Elizabeth O.; Anstrom, Kevin J.; Hernandez, Adrian F.; McNulty, Steven E.; Velazquez, Eric J.; Kfoury, Abdallah G.; Chen, Horng H.; Givertz, Michael M.; Semigran, Marc J.; Bart, Bradley A.; Mascette, Alice M.; Braunwald, Eugene; O'Connor, Christopher M.		NHLBI Heart Failure Clinical Res N	Diuretic Strategies in Patients with Acute Decompensated Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTINUOUS-INFUSION; LOOP DIURETICS; INTRAVENOUS DIURETICS; RENAL-FUNCTION; FUROSEMIDE; OUTCOMES; DIURESIS; DYSPNEA; DISEASE; SCALES	BACKGROUND Loop diuretics are an essential component of therapy for patients with acute decompensated heart failure, but there are few prospective data to guide their use. METHODS In a prospective, double-blind, randomized trial, we assigned 308 patients with acute decompensated heart failure to receive furosemide administered intravenously by means of either a bolus every 12 hours or continuous infusion and at either a low dose (equivalent to the patient's previous oral dose) or a high dose (2.5 times the previous oral dose). The protocol allowed specified dose adjustments after 48 hours. The coprimary end points were patients' global assessment of symptoms, quantified as the area under the curve (AUC) of the score on a visual-analogue scale over the course of 72 hours, and the change in the serum creatinine level from baseline to 72 hours. RESULTS In the comparison of bolus with continuous infusion, there was no significant difference in patients' global assessment of symptoms (mean AUC, 4236 +/- 1440 and 4373 +/- 1404, respectively; P = 0.47) or in the mean change in the creatinine level (0.05 +/- 0.3 mg per deciliter [4.4 +/- 26.5 mu mol per liter] and 0.07 +/- 0.3 mg per deciliter [6.2 +/- 26.5 mu mol per liter], respectively; P = 0.45). In the comparison of the high-dose strategy with the low-dose strategy, there was a nonsignificant trend toward greater improvement in patients' global assessment of symptoms in the high-dose group (mean AUC, 4430 +/- 1401 vs. 4171 +/- 1436; P = 0.06). There was no significant difference between these groups in the mean change in the creatinine level (0.08 +/- 0.3 mg per deciliter [7.1 +/- 26.5 mu mol per liter] with the high-dose strategy and 0.04 +/- 0.3 mg per deciliter [3.5 +/- 26.5 mu mol per liter] with the low-dose strategy, P = 0.21). The high-dose strategy was associated with greater diuresis and more favorable outcomes in some secondary measures but also with transient worsening of renal function. CONCLUSIONS Among patients with acute decompensated heart failure, there were no significant differences in patients' global assessment of symptoms or in the change in renal function when diuretic therapy was administered by bolus as compared with continuous infusion or at a high dose as compared with a low dose.	[Felker, G. Michael; Lee, Kerry L.; Anstrom, Kevin J.; Hernandez, Adrian F.; McNulty, Steven E.; Velazquez, Eric J.] Duke Clin Res Inst, Durham, NC 27705 USA; [Felker, G. Michael; O'Connor, Christopher M.] Duke Univ, Sch Med, Durham, NC USA; [Felker, G. Michael; O'Connor, Christopher M.] Duke Univ, Med Ctr, Duke Heart Ctr, Durham, NC 27710 USA; [Bull, David A.; Kfoury, Abdallah G.] Univ Utah, Salt Lake City, UT USA; [Redfield, Margaret M.; Chen, Horng H.] Mayo Clin, Rochester, MN USA; [Stevenson, Lynne W.; Givertz, Michael M.; Braunwald, Eugene] Brigham & Womens Hosp, Boston, MA 02115 USA; [Semigran, Marc J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Goldsmith, Steven R.; Bart, Bradley A.] Univ Minnesota, Minneapolis, MN USA; [LeWinter, Martin M.] Univ Vermont, Burlington, VT 05405 USA; [Deswal, Anita] Baylor Coll Med, Houston, TX 77030 USA; [Deswal, Anita] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Rouleau, Jean L.] Univ Montreal, Montreal, PQ, Canada; [Rouleau, Jean L.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Ofili, Elizabeth O.] Morehouse Sch Med, Atlanta, GA 30310 USA; [Mascette, Alice M.] NHLBI, Bethesda, MD 20892 USA	Duke University; Duke University; Duke University; Utah System of Higher Education; University of Utah; Mayo Clinic; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Vermont; Baylor College of Medicine; Baylor College of Medicine; Universite de Montreal; Universite de Montreal; Morehouse School of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Felker, GM (corresponding author), Duke Clin Res Inst, 2400 Pratt St,Rm 0311 Terrace Level, Durham, NC 27705 USA.	michael.felker@duke.edu	Hernandez, Adrian F/A-7818-2016; Hug, Balthasar L./G-1568-2010; Felker, Michael/AAX-2288-2021	Hernandez, Adrian F/0000-0003-3387-9616; Felker, Gary/0000-0002-5931-1239	National Heart, Lung, and Blood Institute [HL084861, HL084875, HL084877, HL084889, HL084890, HL084891, HL084899, HL084904, HL084907, HL084931]; Amgen; Cytokinetics; Corthera; Otsuka; Novartis; Roche Diagnostics; Medtronic; Johnson Johnson; Pfizer; Boehringer Ingelheim; XDx; Scios; Anexon; Nile Therapeutics; GE Healthcare; Forest Pharmaceuticals; Novella Clinical; Medpace; Roche; Actelion Pharmaceuticals; Trevena; Martek Biosciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR011104, U54RR026137] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL084904, U01HL084891, U01HL084875, U01HL084904, U01HL084907, U01HL084877, U01HL084899, U01HL084890, U01HL084861, U01HL084889, U01HL084931] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Amgen(Amgen); Cytokinetics; Corthera; Otsuka(Otsuka Pharmaceutical); Novartis(Novartis); Roche Diagnostics; Medtronic(Medtronic); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); XDx; Scios; Anexon; Nile Therapeutics; GE Healthcare(General ElectricGE Healthcare); Forest Pharmaceuticals; Novella Clinical; Medpace; Roche(Roche Holding); Actelion Pharmaceuticals; Trevena; Martek Biosciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Heart Failure Clinical Research Network is supported by grants (HL084861, HL084875, HL084877, HL084889, HL084890, HL084891, HL084899, HL084904, HL084907, and HL084931) from the National Heart, Lung, and Blood Institute.; Dr. Felker reports receiving consulting fees from Amgen, Cytokinetics, Corthera, Otsuka, Novartis, and Roche Diagnostics and grant support from Amgen, Cytokinetics, Otsuka, and Roche Diagnostics; Dr. LeWinter, receiving consulting fees from Novartis, grant support from Medtronic, and lecture fees from Medtronic and Novartis; Dr. Anstrom, receiving consulting fees from Johnson & Johnson and Pfizer; Dr. Hernandez, receiving consulting fees from Amgen and grant support from Johnson & Johnson and serving on a clinical end points committee for Corthera; Dr. Velazquez, receiving consulting fees from Novartis and Boehringer Ingelheim, grant support from Johnson & Johnson, and lecture fees from Novartis; Dr. Kfoury, receiving grant support from Novartis and XDx; Dr. Chen, receiving grant support from Scios, Anexon, and Nile Therapeutics, being named as a coinventor on patents for chimeric natriuretic peptides, and receiving royalties from Nile Therapeutics; and Dr. O'Connor, receiving consulting fees from Merck, GE Healthcare, Forest Pharmaceuticals, Medtronic, Novella Clinical, Medpace, Roche, Actelion Pharmaceuticals, Amgen, Trevena, and Martek Biosciences and grant support from Johnson & Johnson. No other potential conflict of interest relevant to this article was reported.	ABILDGAARD U, 1985, EUR HEART J, V6, P1040, DOI 10.1093/oxfordjournals.eurheartj.a061807; Allen LA, 2010, AM J CARDIOL, V105, P1794, DOI 10.1016/j.amjcard.2010.01.355; Allen LA, 2008, J CARD FAIL, V14, P777, DOI 10.1016/j.cardfail.2008.07.188; Aronson D, 2010, J CARD FAIL, V16, P541, DOI 10.1016/j.cardfail.2010.02.001; Butler J, 2004, AM HEART J, V147, P331, DOI 10.1016/j.ahj.2003.08.012; Cooper HA, 1999, CIRCULATION, V100, P1311, DOI 10.1161/01.CIR.100.12.1311; COPELAND JG, 1983, AM J SURG, V146, P796, DOI 10.1016/0002-9610(83)90344-6; Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073; Dormans TPJ, 1996, J AM COLL CARDIOL, V28, P376, DOI 10.1016/0735-1097(96)00161-1; Emerman CL, 2004, J CARD FAIL, V10, pS116, DOI 10.1016/j.cardfail.2004.06.367; Felker GM, 2009, CIRC-HEART FAIL, V2, P56, DOI 10.1161/CIRCHEARTFAILURE.108.821785; Grant S, 1999, CHEST, V116, P1208, DOI 10.1378/chest.116.5.1208; Hasselblad V, 2007, EUR J HEART FAIL, V9, P1064, DOI 10.1016/j.ejheart.2007.07.011; Heart Failure Society Of America, 2006, J Card Fail, V12, pe1; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; LAWSON DH, 1978, BRIT MED J, V2, P476, DOI 10.1136/bmj.2.6135.476; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; MAGOVERN JA, 1990, ANN THORAC SURG, V50, P482, DOI 10.1016/0003-4975(90)90505-Z; Metra M, 2010, EUR J HEART FAIL, V12, P499, DOI [10.1093/eurjhf/hfq021, 10.1093/eurjhf/hfq186]; Pang PS, 2009, EUR HEART J, V30, P2233, DOI 10.1093/eurheartj/ehp253; RUDY DW, 1991, ANN INTERN MED, V115, P360, DOI 10.7326/0003-4819-115-5-360; Salvador DR, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003178.PUB3; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Testani JM, 2010, CIRCULATION, V122, P265, DOI 10.1161/CIRCULATIONAHA.109.933275; Thomson MR, 2010, J CARD FAIL, V16, P188, DOI 10.1016/j.cardfail.2009.11.005; VANMEYEL JJM, 1994, J INTERN MED, V235, P329	26	938	988	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					797	805		10.1056/NEJMoa1005419	http://dx.doi.org/10.1056/NEJMoa1005419			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366472	Green Accepted			2022-12-28	WOS:000287928400005
J	Tsibris, AMN; Shepard, JAO; Zukerberg, LR				Tsibris, Athe M. N.; Shepard, Jo-Anne O.; Zukerberg, Lawrence R.			Case 6-2011: A 77-Year-Old Man with Dyspnea, Weakness, and Diaphoresis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; SURVEILLANCE; FEVER; BLOOD		[Tsibris, Athe M. N.] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA; [Shepard, Jo-Anne O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Tsibris, Athe M. N.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Shepard, Jo-Anne O.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Zukerberg, Lawrence R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Tsibris, AMN (corresponding author), Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA.							[Anonymous], EHRL STAT; [Anonymous], 2008, AN HG HGA SURV MASS; [Anonymous], 2009, NEW ENGL J MED, V361, P1189; Baddour, 2005, CIRCULATION, V112, P2373, DOI 10.1161/CIRCULATIONHA.105.167942; Baddour LM, 2008, CIRCULATION, V118, pE496, DOI 10.1161/CIRCULATIONAHA.108.190867; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Bakken JS, 2008, INFECT DIS CLIN N AM, V22, P433, DOI 10.1016/j.idc.2008.03.011; Bakken JS, 1996, CLIN INFECT DIS, V23, P198, DOI 10.1093/clinids/23.1.198; BAKKEN JS, 1994, JAMA-J AM MED ASSOC, V272, P212, DOI 10.1001/jama.272.3.212; Biedenbach DJ, 2004, DIAGN MICR INFEC DIS, V50, P59, DOI 10.1016/j.diagmicrobio.2004.05.003; Centers for Disease Control and Prevention, ROCK MOUNT SPOTT FEV; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Holman MS, 2004, EMERG INFECT DIS, V10, P744, DOI 10.3201/eid1004.030566; Horowitz HW, 1998, NEW ENGL J MED, V339, P375, DOI 10.1056/NEJM199808063390604; LEW JF, 1991, JAMA-J AM MED ASSOC, V265, P3280, DOI 10.1001/jama.265.24.3280; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; *NAT CTR HLTH STAT, 2008, HLTH US 2008 SPEC FE; Panda A, 2009, TRENDS IMMUNOL, V30, P325, DOI 10.1016/j.it.2009.05.004; SEXTON DJ, 1992, CLIN INFECT DIS, V15, P439, DOI 10.1093/clind/15.3.439; Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001; The Centers for Disease Control and Prevention, AN STAT; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447	22	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					759	767		10.1056/NEJMcpc1011320	http://dx.doi.org/10.1056/NEJMcpc1011320			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345106				2022-12-28	WOS:000287652500013
J	Yuan, XL; Chen, Z; Xiao, SH; Zhou, CM; Hua, H				Yuan, Xunlai; Chen, Zhe; Xiao, Shuhai; Zhou, Chuanming; Hua, Hong			An early Ediacaran assemblage of macroscopic and morphologically differentiated eukaryotes	NATURE			English	Article							DOUSHANTUO FORMATION; EVOLUTION; OXYGENATION; OXIDATION	The deep-water Avalon biota (about 579 to 565 million years old) is often regarded as the earliest-known fossil assemblage with macroscopic and morphologically complex life forms(1). It has been proposed that the rise of the Avalon biota was triggered by the oxygenation of mid-Ediacaran deep oceans(2). Here we report a diverse assemblage of morphologically differentiated benthic macrofossils that were preserved largely in situ as carbonaceous compressions in black shales of the Ediacaran Lantian Formation (southern Anhui Province, South China). The Lantian biota, probably older than and taxonomically distinct from the Avalon biota, suggests that morphological diversification of macroscopic eukaryotes may have occurred in the early Ediacaran Period, perhaps shortly after the Marinoan glaciation, and that the redox history of Ediacaran oceans was more complex than previously thought.	[Yuan, Xunlai; Chen, Zhe; Zhou, Chuanming] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Peoples R China; [Xiao, Shuhai] Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA; [Hua, Hong] NW Univ Xian, State Key Lab Continental Dynam, Xian 710069, Peoples R China; [Hua, Hong] NW Univ Xian, Dept Geol, Xian 710069, Peoples R China	Chinese Academy of Sciences; Virginia Polytechnic Institute & State University; Northwest University Xi'an; Northwest University Xi'an	Yuan, XL (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Peoples R China.	xlyuan@nigpas.ac.cn; xiao@vt.edu	Xiao, Shuhai/A-2190-2009; Zhou, Chuanming/E-5313-2010	Xiao, Shuhai/0000-0003-4655-2663; 	Chinese Academy of Sciences; National Natural Science Foundation of China; Chinese Ministry of Science and Technology; National Science Foundation; NASA; Guggenheim Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Guggenheim Foundation	This research was supported by the Chinese Academy of Sciences, the National Natural Science Foundation of China, the Chinese Ministry of Science and Technology, the National Science Foundation, the NASA Exobiology and Evolutionary Biology Program and the Guggenheim Foundation. We thank G. Jiang for useful discussions.	Boyle RA, 2007, GEOBIOLOGY, V5, P337, DOI 10.1111/j.1472-4669.2007.00115.x; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Catling DC, 2005, ASTROBIOLOGY, V5, P415, DOI 10.1089/ast.2005.5.415; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Izaguirre I, 2004, HYDROBIOLOGIA, V511, P25, DOI 10.1023/B:HYDR.0000014016.89127.ca; Jiang GQ, 2007, EARTH PLANET SC LETT, V261, P303, DOI 10.1016/j.epsl.2007.07.009; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Liu PJ, 2009, CHINESE SCI BULL, V54, P1058, DOI 10.1007/s11434-008-0589-6; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; McFadden KA, 2009, PRECAMBRIAN RES, V173, P170, DOI 10.1016/j.precamres.2009.03.009; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Ries JB, 2009, GEOLOGY, V37, P743, DOI 10.1130/G25775A.1; Rohl HJ, 2001, PALAEOGEOGR PALAEOCL, V169, P271, DOI 10.1016/S0031-0182(01)00224-3; Sharma M, 2009, PRECAMBRIAN RES, V173, P105, DOI 10.1016/j.precamres.2009.05.002; Shen B, 2008, SCIENCE, V319, P81, DOI 10.1126/science.1150279; Shen YN, 2008, P NATL ACAD SCI USA, V105, P7376, DOI 10.1073/pnas.0802168105; Wynne MJ, 1985, INTRO ALGAE; Xiao SH, 2002, J PALEONTOL, V76, P347, DOI 10.1666/0022-3360(2002)076<0347:MCCIAT>2.0.CO;2; Yan Y., 1992, B NANJING I GEOL MIN, V12, P1; Yuan XL, 2002, GEOLOGY, V30, P363, DOI 10.1130/0091-7613(2002)030<0363:TSIAEC>2.0.CO;2; Yuan XL, 2001, PRECAMBRIAN RES, V107, P253, DOI 10.1016/S0301-9268(00)00144-3; Yuan XL, 1999, LETHAIA, V32, P143; Zhao YY, 2010, CHEM GEOL, V271, P86, DOI 10.1016/j.chemgeo.2009.12.014; Zhou C., 2001, J STRATIGRAP, V25, P247; Zhou CM, 2007, CHEM GEOL, V237, P89, DOI 10.1016/j.chemgeo.2006.06.021; Zhu B., 2010, GEOL SOC AM PROGRAMS, V42, P463; Zhu MY, 2007, PALAEOGEOGR PALAEOCL, V254, P7, DOI 10.1016/j.palaeo.2007.03.025	30	233	278	11	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					390	393		10.1038/nature09810	http://dx.doi.org/10.1038/nature09810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331041				2022-12-28	WOS:000287409100041
J	Liu, GH; Barkho, BZ; Ruiz, S; Diep, D; Qu, J; Yang, SL; Panopoulos, AD; Suzuki, K; Kurian, L; Walsh, C; Thompson, J; Boue, S; Fung, HL; Sancho-Martinez, I; Zhang, K; Yates, J; Belmonte, JCI				Liu, Guang-Hui; Barkho, Basam Z.; Ruiz, Sergio; Diep, Dinh; Qu, Jing; Yang, Sheng-Lian; Panopoulos, Athanasia D.; Suzuki, Keiichiro; Kurian, Leo; Walsh, Christopher; Thompson, James; Boue, Stephanie; Fung, Ho Lim; Sancho-Martinez, Ignacio; Zhang, Kun; Yates, John, III; Izpisua Belmonte, Juan Carlos			Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome	NATURE			English	Article							MUSCLE-CELL SENESCENCE; HUMAN SOMATIC-CELLS; TUMOR-SUPPRESSOR; YEAST PROTEOME; LAMIN; PRELAMIN; DEFECTS; ATHEROSCLEROSIS; DIFFERENTIATION; PHENOTYPE	Hutchinson-Gilford progeria syndrome (HGPS) is a rare and fatal human premature ageing disease(1-5), characterized by premature arteriosclerosis and degeneration of vascular smooth muscle cells (SMCs)(6-8). HGPS is caused by a single point mutation in the lamin A (LMNA) gene, resulting in the generation of progerin, a truncated splicing mutant of lamin A. Accumulation of progerin leads to various ageing-associated nuclear defects including disorganization of nuclear lamina and loss of heterochromatin(9-12). Here we report the generation of induced pluripotent stem cells (iPSCs) from fibroblasts obtained from patients with HGPS. HGPS-iPSCs show absence of progerin, and more importantly, lack the nuclear envelope and epigenetic alterations normally associated with premature ageing. Upon differentiation of HGPS-iPSCs, progerin and its ageing-associated phenotypic consequences are restored. Specifically, directed differentiation of HGPS-iPSCs to SMCs leads to the appearance of premature senescence phenotypes associated with vascular ageing. Additionally, our studies identify DNA-dependent protein kinase catalytic subunit (DNAPKcs, also known as PRKDC) as a downstream target of progerin. The absence of nuclear DNAPK holoenzyme correlates with premature as well as physiological ageing. Because progerin also accumulates during physiological ageing(6,12,13), our results provide an in vitro iPSC-based model to study the pathogenesis of human premature and physiological vascular ageing.	[Liu, Guang-Hui; Barkho, Basam Z.; Ruiz, Sergio; Qu, Jing; Yang, Sheng-Lian; Panopoulos, Athanasia D.; Suzuki, Keiichiro; Kurian, Leo; Walsh, Christopher; Sancho-Martinez, Ignacio; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Diep, Dinh; Fung, Ho Lim; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Thompson, James; Yates, John, III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Boue, Stephanie; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain	Salk Institute; University of California System; University of California San Diego; Scripps Research Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Ruiz, Sergio/G-1561-2016; Zhang, Kun/ABE-6349-2020; Qu, Jing/ABB-9088-2020; Kurian, Leo/M-1598-2014	Ruiz, Sergio/0000-0002-0177-6965; Zhang, Kun/0000-0002-7596-5224; Kurian, Leo/0000-0001-7466-5169; qu, jing/0000-0002-3988-5067; Sancho-Martinez, Ignacio/0000-0003-4348-1038; Liu, Guang-Hui/0000-0001-9289-8177; Panopoulos, Athanasia/0000-0002-9610-2604; Suzuki, Keiichiro/0000-0001-5603-9105; Boue, Stephanie/0000-0003-0680-4168	CIRM [TG2-01158]; AFAR/Ellison Medical Foundation; NIH [T32 CA009370, R01-DA025779, P41 RR011823]; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; Ellison Medical Foundation; MICINN; Fundacion Cellex (JCIB); NATIONAL CANCER INSTITUTE [T32CA009370] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025779] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); AFAR/Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); Ellison Medical Foundation(Lawrence Ellison Foundation); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Cellex (JCIB); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Comai for providing experimental material, M. Hetzer, J. Karlseder, J.-F. Deleuze, M. J. Barrero, C. Rodriguez Esteban and L. Gerace for helpful discussions, M. Marti for teratoma analysis, M. C. Llach for karyotyping, T. Berggren, M. Lutz, I. Dubova, S. Stewart, R. Dev, M. Li, L. Laricchia-Robbio, A. M. Goebl and J. Kim for technical help, and M. Schwarz for administrative help. G.-H.L. and L.K. were partially supported by a CIRM grant (TG2-01158), J.Q. was partially supported by an AFAR/Ellison Medical Foundation postdoctoral fellowship; A.D.P. was partially supported by a NIH training grant T32 CA009370. This study was supported by grants from NIH R01-DA025779 (K.Z.), and NIH P41 RR011823 (J.Y.); the G. Harold and Leila Y. Mathers Charitable Foundation, Sanofi-Aventis, Ellison Medical Foundation, MICINN and Fundacion Cellex (JCIB).	Bern M, 2004, BIOINFORMATICS, V20, P49, DOI 10.1093/bioinformatics/bth947; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Candelario J, 2011, EXP CELL RES, V317, P319, DOI 10.1016/j.yexcr.2010.10.014; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004; Han XJ, 2008, NAT CELL BIOL, V10, P1333, DOI 10.1038/ncb1792; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang SR, 2005, HUM GENET, V118, P444, DOI 10.1007/s00439-005-0051-7; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Liu GH, 2009, MOL CELL BIOL, V29, P5800, DOI 10.1128/MCB.00684-09; Lu SJ, 2009, REGEN MED, V4, P37, DOI 10.2217/17460751.4.1.37; McClintock D, 2006, P NATL ACAD SCI USA, V103, P2154, DOI 10.1073/pnas.0511133103; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002	41	403	420	0	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					221	225		10.1038/nature09879	http://dx.doi.org/10.1038/nature09879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21346760	Green Accepted			2022-12-28	WOS:000289469100043
J	Navin, N; Kendall, J; Troge, J; Andrews, P; Rodgers, L; McIndoo, J; Cook, K; Stepansky, A; Levy, D; Esposito, D; Muthuswamy, L; Krasnitz, A; McCombie, WR; Hicks, J; Wigler, M				Navin, Nicholas; Kendall, Jude; Troge, Jennifer; Andrews, Peter; Rodgers, Linda; McIndoo, Jeanne; Cook, Kerry; Stepansky, Asya; Levy, Dan; Esposito, Diane; Muthuswamy, Lakshmi; Krasnitz, Alex; McCombie, W. Richard; Hicks, James; Wigler, Michael			Tumour evolution inferred by single-cell sequencing	NATURE			English	Article							WHOLE GENOME AMPLIFICATION; COPY-NUMBER ALTERATIONS; BREAST-CANCER; CARCINOMAS; HETEROGENEITY; PROGRESSION; METASTASIS; PHENOTYPE; VARIANTS	Genomic analysis provides insights into the role of copy number variation in disease, but most methods are not designed to resolve mixed populations of cells. In tumours, where genetic heterogeneity is common(1-3), very important information may be lost that would be useful for reconstructing evolutionary history. Here we show that with flow-sorted nuclei, whole genome amplification and next generation sequencing we can accurately quantify genomic copy number within an individual nucleus. We apply single-nucleus sequencing to investigate tumour population structure and evolution in two human breast cancer cases. Analysis of 100 single cells from a polygenomic tumour revealed three distinct clonal subpopulations that probably represent sequential clonal expansions. Additional analysis of 100 single cells from a monogenomic primary tumour and its liver metastasis indicated that a single clonal expansion formed the primary tumour and seeded the metastasis. In both primary tumours, we also identified an unexpectedly abundant subpopulation of genetically diverse 'pseudodiploid' cells that do not travel to the metastatic site. In contrast to gradual models of tumour progression, our data indicate that tumours grow by punctuated clonal expansions with few persistent intermediates.	[Navin, Nicholas; Kendall, Jude; Troge, Jennifer; Andrews, Peter; Rodgers, Linda; McIndoo, Jeanne; Cook, Kerry; Stepansky, Asya; Levy, Dan; Esposito, Diane; Krasnitz, Alex; McCombie, W. Richard; Hicks, James; Wigler, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Navin, Nicholas] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Muthuswamy, Lakshmi] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada	Cold Spring Harbor Laboratory; University of Texas System; UTMD Anderson Cancer Center; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Wigler, M (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	wigler@cshl.edu	Yang, Chen/G-1379-2010	Wigler, Michael/0000-0003-4396-1971; McCombie, W. Richard/0000-0003-1899-0682	NCI; Department of the Army [W81XWH04-1-0477]; Breast Cancer Research Foundation; Simons Foundation; American Cancer Society; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of the Army; Breast Cancer Research Foundation; Simons Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Ronemus, T. Spencer, A. Leotta, J. Meth, M. Kramer, L. Gelley, E. Ghiban. We also thank P. Blake and N. Navin at Sophic Systems Alliance. This work was supported by the NCI T32 Fellowship to N.N., and grants to M.W. and J.H. from the Department of the Army (W81XWH04-1-0477), the Breast Cancer Research Foundation, and the Simons Foundation. M.W. is an American Cancer Society Research Professor.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Farabegoli F, 2001, CYTOMETRY, V46, P50, DOI 10.1002/1097-0320(20010215)46:1<50::AID-CYTO1037>3.0.CO;2-T; Fuhrmann C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn101; Geigl JB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp526; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Heng HHQ, 2006, J CELL PHYSIOL, V208, P461, DOI 10.1002/jcp.20685; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Huang J, 2009, J MOL DIAGN, V11, P109, DOI 10.2353/jmoldx.2009.080143; Hughes S, 2004, CYTOGENET GENOME RES, V105, P18, DOI 10.1159/000078004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; LOEB LA, 1974, CANCER RES, V34, P2311; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Pugh TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn378; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Talseth-Palmer Bente A, 2008, BMC Res Notes, V1, P56, DOI 10.1186/1756-0500-1-56; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	25	1714	1801	11	487	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					90	U119		10.1038/nature09807	http://dx.doi.org/10.1038/nature09807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21399628	Green Accepted			2022-12-28	WOS:000289199400043
J	Flynn, RL; Centore, RC; O'Sullivan, RJ; Rai, R; Tse, A; Zhou, SY; Chang, S; Karlseder, J; Zou, L				Flynn, Rachel Litman; Centore, Richard C.; O'Sullivan, Roderick J.; Rai, Rekha; Tse, Alice; Zhou Songyang; Chang, Sandy; Karlseder, Jan; Zou, Lee			TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA	NATURE			English	Article							REPLICATION PROTEIN-A; REPEAT-CONTAINING RNA; FISSION YEAST; CHROMOSOME ENDS; BINDING PROTEIN; ATR; DAMAGE; POT1; RPA; ELONGATION	Maintenance of telomeres requires both DNA replication and telomere 'capping' by shelterin. These two processes use two single-stranded DNA (ssDNA)-binding proteins, replication protein A (RPA) and protection of telomeres 1 (POT1). Although RPA and POT1 each have a critical role at telomeres, how they function in concert is not clear. POT1 ablation leads to activation of the ataxia telangiectasia and Rad3-related (ATR) checkpoint kinase at telomeres(1,2), suggesting that POT1 antagonizes RPA binding to telomeric ssDNA. Unexpectedly, we found that purified POT1 and its functional partner TPP1 are unable to prevent RPA binding to telomeric ssDNA efficiently. In cell extracts, we identified a novel activity that specifically displaces RPA, but not POT1, from telomeric ssDNA. Using purified protein, here we show that the heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) recapitulates the RPA displacing activity. The RPA displacing activity is inhibited by the telomeric repeat-containing RNA (TERRA) in early S phase, but is then unleashed in late S phase when TERRA levels decline at telomeres(3). Interestingly, TERRA also promotes POT1 binding to telomeric ssDNA by removing hnRNPA1, suggesting that the reaccumulation of TERRA after S phase helps to complete the RPA-to-POT1 switch on telomeric ssDNA. Together, our data suggest that hnRNPA1, TERRA and POT1 act in concert to displace RPA from telomeric ssDNA after DNA replication, and promote telomere capping to preserve genomic integrity.	[Flynn, Rachel Litman; Centore, Richard C.; Tse, Alice; Zou, Lee] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; [Zou, Lee] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [O'Sullivan, Roderick J.; Karlseder, Jan] Salk Inst Biol Studies, Mol & Cellular Lab, La Jolla, CA 92037 USA; [Rai, Rekha; Chang, Sandy] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Zhou Songyang] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Salk Institute; Yale University; Baylor College of Medicine	Zou, L (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA.	zou.lee@mgh.harvard.edu	rai, rekha/A-3680-2012		National Institutes of Health (NIH) [5T32CA009216-28, F32-GM089150, CA133249, CA129037, GM06525, AG025837, GM076388]; American Cancer Society [0902501]; George E. Hewitt Foundation for Medical Research; Welch Foundation [Q-1673]; ACS [RSG-08-297]; NATIONAL CANCER INSTITUTE [R01CA129037, T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076388, F32GM089150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025837] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); George E. Hewitt Foundation for Medical Research; Welch Foundation(The Welch Foundation); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. de Lange, A. Krainer, B. Chabot and M. Wold for reagents, and members of the Zou laboratory for discussion. L.Z. is an Ellison New Scholar on Aging. R.L.F. is supported by National Institutes of Health (NIH) fellowship 5T32CA009216-28 and American Cancer Society fellowship 0902501. R.C.C. is supported by NIH fellowship F32-GM089150. R.J.O. is supported by the George E. Hewitt Foundation for Medical Research. This work is supported by a Welch Foundation grant (Q-1673) to Z.S., an ACS grant (RSG-08-297) to L.Z., and NIH grants CA133249 to Z.S., CA129037 to S.C., GM06525 and AG025837 to J.K. and GM076388 to L.Z.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Ding JZ, 1999, GENE DEV, V13, P1102, DOI 10.1101/gad.13.9.1102; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; Kibe T, 2007, MOL BIOL CELL, V18, P2378, DOI 10.1091/mbc.E06-12-1084; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; de Silanes IL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1032; McGee JS, 2010, NAT STRUCT MOL BIOL, V17, P1438, DOI 10.1038/nsmb.1947; MCKAY SJ, 1992, NUCLEIC ACIDS RES, V20, P6461, DOI 10.1093/nar/20.24.6461; McNees CJ, 2010, J CELL BIOL, V188, P639, DOI 10.1083/jcb.200908136; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Redon S, 2010, NUCLEIC ACIDS RES, V38, P5797, DOI 10.1093/nar/gkq296; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Zhang QS, 2006, RNA, V12, P1116, DOI 10.1261/rna.58806; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	30	240	247	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					532	+		10.1038/nature09772	http://dx.doi.org/10.1038/nature09772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21399625	Green Accepted			2022-12-28	WOS:000288702200066
J	Baxter, J; Sen, N; Martinez, VL; De Carandini, MEM; Schvartzman, JB; Diffley, JFX; Aragon, L				Baxter, J.; Sen, N.; Lopez Martinez, V.; Monturus De Carandini, M. E.; Schvartzman, J. B.; Diffley, J. F. X.; Aragon, L.			Positive Supercoiling of Mitotic DNA Drives Decatenation by Topoisomerase II in Eukaryotes	SCIENCE			English	Article							INTERTWINED CATENATED DIMERS; CHROMOSOME CONDENSATION; REPLICATION; YEAST; SEGREGATION; SEPARATION; CLEAVAGE; COHESIN	DNA topoisomerase II completely removes DNA intertwining, or catenation, between sister chromatids before they are segregated during cell division. How this occurs throughout the genome is poorly understood. We demonstrate that in yeast, centromeric plasmids undergo a dramatic change in their topology as the cells pass through mitosis. This change is characterized by positive supercoiling of the DNA and requires mitotic spindles and the condensin factor Smc2. When mitotic positive supercoiling occurs on decatenated DNA, it is rapidly relaxed by topoisomerase II. However, when positive supercoiling takes place in catenated plasmid, topoisomerase II activity is directed toward decatenation of the molecules before relaxation. Thus, a topological change on DNA drives topoisomerase II to decatenate molecules during mitosis, potentially driving the full decatenation of the genome.	[Baxter, J.; Sen, N.; Aragon, L.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Cell Cycle Grp, Med Res Council MRC Clin Sci Ctr, London W12 0NN, England; [Lopez Martinez, V.; Monturus De Carandini, M. E.; Schvartzman, J. B.] CSIC, Ctr Invest Biol, Dept Cell Proliferat & Dev, E-28040 Madrid, Spain; [Baxter, J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Diffley, J. F. X.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Sussex; Cancer Research UK	Baxter, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Cell Cycle Grp, Med Res Council MRC Clin Sci Ctr, Du Cane Rd, London W12 0NN, England.	Jon.Baxter@sussex.ac.uk; luis.aragon@csc.mrc.ac.uk	Lopez, Virginia/AAC-1321-2021; Schvartzman, Jorge B/J-9171-2014	Lopez, Virginia/0000-0002-0065-7999; Baxter, Jonathan/0000-0002-4455-9717; Diffley, John/0000-0001-5184-7680	European Research Council [202337]; Royal Society; Spanish government [BFU2008-00408/BMC]; Cancer Research UK; MRC UK; MRC [MC_U120074328] Funding Source: UKRI; Medical Research Council [MC_U120074328, G0801130B] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Spanish government(Spanish GovernmentEuropean Commission); Cancer Research UK(Cancer Research UK); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the Aragon laboratory, M. Merkenschlager, A. Carr, and J. Murray for discussions and critical reading of the manuscript. We also thank K. Nasmyth and S. Henikoff for helpful discussions, as well as anonymous referees for useful suggestions. This work was funded by European Research Council starting grant 202337 (L. A. and J. B.), the Royal Society (J. B.), the Spanish government grant BFU2008-00408/BMC (J. B. S.), Cancer Research UK (J. F. X. D.), and the MRC UK (L. A.). Extended figure legends are available in the supporting online material.	Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Hardy CD, 2004, PHILOS T R SOC B, V359, P39, DOI 10.1098/rstb.2003.1363; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Martinez-Robles ML, 2009, NUCLEIC ACIDS RES, V37, P5126, DOI 10.1093/nar/gkp530; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Zechiedrich EL, 1997, GENE DEV, V11, P2580, DOI 10.1101/gad.11.19.2580	15	106	106	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 11	2011	331	6022					1328	1332		10.1126/science.1201538	http://dx.doi.org/10.1126/science.1201538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393545				2022-12-28	WOS:000288215200048
J	Kumar, V; Ogilvy, CS				Kumar, Vishesh; Ogilvy, Christopher S.			Giant Intracranial Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kumar, Vishesh] N Shore Med Ctr, Salem, MA USA; [Ogilvy, Christopher S.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Kumar, V (corresponding author), N Shore Med Ctr, Salem, MA USA.	vkumar3@partners.org							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					956	956		10.1056/NEJMicm1008509	http://dx.doi.org/10.1056/NEJMicm1008509			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21388313				2022-12-28	WOS:000288170300012
J	Yusuf, S; Healey, JS; Pogue, J; Chrolavicius, S; Flather, M; Hart, RG; Hohnloser, SH; Joyner, CD; Pfeffer, MA; Connolly, SJ				Yusuf, Salim; Healey, Jeff S.; Pogue, Janice; Chrolavicius, Susan; Flather, Marcus; Hart, Robert G.; Hohnloser, Stefan H.; Joyner, Campbell D.; Pfeffer, Marc A.; Connolly, Stuart J.		ACTIVE I Investigators	Irbesartan in Patients with Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVERTING-ENZYME-INHIBITORS; CHRONIC HEART-FAILURE; BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; RECURRENT STROKE; RISK; PERINDOPRIL; TELMISARTAN; CANDESARTAN; PREVENTION	BACKGROUND The risk of cardiovascular events among patients with atrial fibrillation is high. We evaluated whether irbesartan, an angiotensin-receptor blocker, would reduce this risk. METHODS We randomly assigned patients with a history of risk factors for stroke and a systolic blood pressure of at least 110 mm Hg to receive either irbesartan at a target dose of 300 mg once daily or double-blind placebo. These patients were already enrolled in one of two trials (of clopidogrel plus aspirin versus aspirin alone or versus oral anticoagulants). The first coprimary outcome was stroke, myocardial infarction, or death from vascular causes; the second was this composite outcome plus hospitalization for heart failure. RESULTS A total of 9016 patients were enrolled and followed for a mean of 4.1 years. The mean reduction in systolic blood pressure was 2.9 mm Hg greater in the irbesartan group than in the placebo group, and the mean reduction in diastolic blood pressure was 1.9 mm Hg greater. The first coprimary outcome occurred at a rate of 5.4% per 100 person-years in both groups (hazard ratio with irbesartan, 0.99; 95% confidence interval [CI], 0.91 to 1.08; P = 0.85). The second coprimary outcome occurred at a rate of 7.3% per 100 person-years among patients receiving irbesartan and 7.7% per 100 person-years among patients receiving placebo (hazard ratio, 0.94; 95% CI, 0.87 to 1.02; P = 0.12). The rates of first hospitalization for heart failure (a prespecified secondary outcome) were 2.7% per 100 person-years among patients receiving irbesartan and 3.2% per 100 person-years among patients receiving placebo (hazard ratio, 0.86; 95% CI, 0.76 to 0.98). Among patients who were in sinus rhythm at baseline, there was no benefit of irbesartan in preventing hospitalization for atrial fibrillation or atrial fibrillation recorded on 12-lead electrocardiography, nor was there a benefit in a subgroup that underwent transtelephonic monitoring. More patients in the irbesartan group than in the placebo group had symptomatic hypotension (127 vs. 64) and renal dysfunction (43 vs. 24). CONCLUSIONS Irbesartan did not reduce cardiovascular events in patients with atrial fibrillation.	[Yusuf, Salim; Healey, Jeff S.; Pogue, Janice; Chrolavicius, Susan; Connolly, Stuart J.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Flather, Marcus] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Hart, Robert G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Hohnloser, Stefan H.] Goethe Univ Frankfurt, Frankfurt, Germany; [Joyner, Campbell D.] Sunnybrook Hlth Sci Ctr, Div Cardiol, Toronto, ON M4N 3M5, Canada; [Pfeffer, Marc A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	McMaster University; Population Health Research Institute; Royal Brompton & Harefield NHS Foundation Trust; University of Texas System; University of Texas Health San Antonio; Goethe University Frankfurt; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Brigham & Women's Hospital	Yusuf, S (corresponding author), Hamilton Hlth Sci, Populat Hlth Res Inst, David Braley Cardiac Vasc & Stroke Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Turazza, Fabio/AAB-8736-2020; Colquhoun, David M/F-9078-2013; LEYS, Didier/G-2955-2016; Hankey, Graeme J/H-4968-2014; De Caterina, Raffaele/K-3857-2016; Suslina, Zinaida Aleksandrovna/C-7453-2012; Villacastín, Julián P/F-8469-2016; Mareev, Vyacheslav Yurievich/Q-1375-2017	Turazza, Fabio/0000-0002-2348-5309; LEYS, Didier/0000-0003-4408-4392; Hankey, Graeme J/0000-0002-6044-7328; De Caterina, Raffaele/0000-0003-1637-574X; Villacastín, Julián P/0000-0002-4867-3912; Talajic, Mario/0000-0001-8469-4748; Jorstad, Harald/0000-0003-3617-3256; Mareev, Vyacheslav Yurievich/0000-0002-7285-2048; HEDDLE, WILLIAM/0000-0001-8167-2826; Yusuf, Salim/0000-0003-4776-5601; Golitsyn, Sergey/0000-0001-9913-9974; wein, theodore/0000-0002-8994-8628; Lanas, Fernando/0000-0003-3595-9759; Fox, Keith/0000-0002-0140-2752	Bristol-Myers Squibb; Sanofi-Aventis	Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis)	Funded by Bristol-Myers Squibb and Sanofi-Aventis; ClinicalTrials.gov number, NCT00249795.	Arima H, 2005, STROKE, V36, P2164, DOI 10.1161/01.STR.0000181115.59173.42; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Chapman N, 2004, STROKE, V35, P116, DOI 10.1161/01.STR.0000106480.76217.6F; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Fox KM, 2003, LANCET, V362, P782; Gerdts E, 2007, HYPERTENSION, V49, P311, DOI 10.1161/01.HYP.0000254322.96189.85; *GISSI AF INV, 2009, NEW ENGL J MED, V360, P2379; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Holman RR, 2010, NEW ENGL J MED, V362, P1748; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Moreno I, 2003, J PHARMACOL EXP THER, V304, P862, DOI 10.1124/jpet.102.042325; Neal B, 2000, LANCET, V356, P1955; Shi YF, 2002, CARDIOVASC RES, V54, P456, DOI 10.1016/S0008-6363(02)00243-2; Sleight P, 2009, J HYPERTENS, V27, P1360, DOI 10.1097/HJH.0b013e32832d7370; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593	29	163	165	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					928	938						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21388310				2022-12-28	WOS:000288170300009
J	Shah, SM; Carey, IM; Harris, T; DeWilde, S; Cook, DG				Shah, Sunil M.; Carey, Iain M.; Harris, Tess; DeWilde, Stephen; Cook, Derek G.			Quality of chronic disease care for older people in care homes and the community in a primary care pay for performance system: retrospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-FAILURE; NURSING-HOMES; OF-CARE; RESIDENTS; MANAGEMENT; HEALTH	Objective To describe the quality of care for chronic diseases among older people in care homes (nursing and residential) compared with the community in a pay for performance system. Design Retrospective analysis of The Health Improvement Network (THIN), a large primary care database. Setting 326 English and Welsh general practices, 2008-9. Participants 10 387 residents of care homes and 403 259 residents in the community aged 65 to 104 and registered for 90 or more days with their general practitioner. Main outcome measure 16 process quality indicators for chronic disease management appropriate for vulnerable older people for conditions included in the UK Quality and Outcomes Framework. Results After adjustment for age, sex, dementia, and length of registration, attainment of quality indicators was significantly lower for residents of care homes than for those in the community for 14 of 16 indicators. The largest differences were for prescribing in heart disease (beta blockers in coronary heart disease, relative risk 0.70, 95% confidence interval 0.65 to 0.75) and monitoring of diabetes (retinal screening, 0.75, 0.71 to 0.80). Monitoring hypothyroidism (0.93, 0.90 to 0.95), blood pressure in people with stroke (0.92, 0.90 to 0.95), and electrolytes for those receiving loop diuretics (0.89, 0.87 to 0.92) showed smaller differences. Attainment was lower in nursing homes than in residential homes. Residents of care homes were more likely to be identified by their doctor as unsuitable or non-consenting for all Quality and Outcomes Framework indicators for a condition allowing their exclusion from targets; 33.7% for stroke and 34.5% for diabetes. Conclusion There is scope for improving the management of chronic diseases in care homes, but high attainment of some indicators shows that pay for performance systems do not invariably disadvantage residents of care homes compared with those living in the community. High use of exception reporting may compromise care for vulnerable patient groups. The Quality and Outcomes Framework, and other pay for performance systems, should monitor attainment and exception reporting in vulnerable populations such as residents of care homes and consider measures that deal with the specific needs of older people.	[Shah, Sunil M.; Carey, Iain M.; Harris, Tess; DeWilde, Stephen; Cook, Derek G.] Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England	University of London	Shah, SM (corresponding author), Univ London, Div Populat Hlth Sci & Educ, London SW17 0RE, England.	sushah@sgul.ac.uk	Carey, Iain/O-6973-2014	Carey, Iain/0000-0003-1099-8460; Harris, Tess/0000-0002-8671-1553; Cook, Derek/0000-0002-9723-5759; DeWilde, Stephen/0000-0002-4238-4474	BUPA Foundation	BUPA Foundation	This study was funded by a grant from the BUPA Foundation, an independent medical research charity. The funder had no involvement in the study design; collection, analysis, and interpretation of the data; writing of the article; or decision to submit the article for publication.	[Anonymous], 2007, J AM GERIATR SOC, V55, pS464; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bourke Alison, 2004, Inform Prim Care, V12, P171; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Fahey T, 2003, BRIT MED J, V326, P580, DOI 10.1136/bmj.326.7389.580; Feldman SM, 2009, J AM MED DIR ASSOC, V10, P354, DOI 10.1016/j.jamda.2009.02.010; Heckman GA, 2004, CAN J CARDIOL, V20, P963; Lester Helen, 2010, Qual Prim Care, V18, P103; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Litaker JR, 2003, CLIN THER, V25, P1918, DOI 10.1016/S0149-2918(03)80196-0; McMurdo MET, 2007, BRIT MED J, V334, P913, DOI 10.1136/bmj.39191.405833.80; NHS Employers, 2006, GUID EXC REC; Petrovic M, 2010, BRIT J CLIN PHARMACO, V69, P713; Resnick HE, 2008, DIABETES CARE, V31, P287, DOI 10.2337/dc07-1425; Rochon PA, 1999, JAMA-J AM MED ASSOC, V282, P113, DOI 10.1001/jama.282.2.113; Saliba Debra, 2004, J Am Med Dir Assoc, V5, P297, DOI 10.1016/S1525-8610(04)70019-5; Shah SM, 2010, AGE AGEING, V39, P617, DOI 10.1093/ageing/afq086; Shah SM, 2008, BRIT J GEN PRACT, V58, P862, DOI 10.3399/bjgp08X376195; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Steel N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a957; Steel N, 2007, BRIT J GEN PRACT, V57, P449; Wenger NS, 2007, J AM GERIATR SOC, V55, pS457, DOI 10.1111/j.1532-5415.2007.01375.x; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Zingmond DS, 2009, MED CARE, V47, P536, DOI 10.1097/MLR.0b013e318190cd8b	25	40	40	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2011	342								d912	10.1136/bmj.d912	http://dx.doi.org/10.1136/bmj.d912			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UY	21385803	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000288446800007
J	Woolf, K; Potts, HWW; McManus, IC				Woolf, Katherine; Potts, Henry W. W.; McManus, I. C.			Ethnicity and academic performance in UK trained doctors and medical students: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NOTTINGHAM-UNIVERSITY; SCHOOL; SUCCESS; COHORT; MINORITIES; PREDICTORS; APPLICANTS; AUDIT; RATIO; MRCGP	Objective To determine whether the ethnicity of UK trained doctors and medical students is related to their academic performance. Design Systematic review and meta-analysis. Data sources Online databases PubMed, Scopus, and ERIC; Google and Google Scholar; personal knowledge; backwards and forwards citations; specific searches of medical education journals and medical education conference abstracts. Study selection The included quantitative reports measured the performance of medical students or UK trained doctors from different ethnic groups in undergraduate or postgraduate assessments. Exclusions were non-UK assessments, only non-UK trained candidates, only self reported assessment data, only dropouts or another non-academic variable, obvious sampling bias, or insufficient details of ethnicity or outcomes. Results 23 reports comparing the academic performance of medical students and doctors from different ethnic groups were included. Meta-analyses of effects from 22 reports (n=23 742) indicated candidates of "non-white" ethnicity underperformed compared with white candidates (Cohen's d=-0.42, 95% confidence interval -0.50 to -0.34; P<0.001). Effects in the same direction and of similar magnitude were found in meta-analyses of undergraduate assessments only, postgraduate assessments only, machine marked written assessments only, practical clinical assessments only, assessments with pass/fail outcomes only, assessments with continuous outcomes only, and in a meta-analysis of white v Asian candidates only. Heterogeneity was present in all meta-analyses. Conclusion Ethnic differences in academic performance are widespread across different medical schools, different types of exam, and in undergraduates and postgraduates. They have persisted for many years and cannot be dismissed as atypical or local problems. We need to recognise this as an issue that probably affects all of UK medical and higher education. More detailed information to track the problem as well as further research into its causes is required. Such actions are necessary to ensure a fair and just method of training and of assessing current and future doctors.	[Woolf, Katherine; McManus, I. C.] UCL Div Med Educ, Acad Ctr Med Educ, London N19 5LW, England; [Potts, Henry W. W.] UCL Div Populat Hlth, Ctr Hlth Informat & Multiprofess Educ, London N19 5LW, England	University of London; University College London; University of London; University College London	Woolf, K (corresponding author), UCL Div Med Educ, Acad Ctr Med Educ, London N19 5LW, England.	k.woolf@medsch.ucl.ac.uk	Woolf, Katherine/AAD-8043-2021; Potts, Henry WW/B-9597-2008	Woolf, Katherine/0000-0003-4915-0715; Potts, Henry WW/0000-0002-6200-8804; McManus, Ian/0000-0003-3510-4814				[Anonymous], 2008, NMRCGP REP RES 2008; [Anonymous], 1985, REPORT COMMITTEE ENQ; Arulampalam W, 2007, MED EDUC, V41, P385, DOI 10.1111/j.1365-2929.2007.02710.x; Bessant R, 2006, POSTGRAD MED J, V82, P145, DOI 10.1136/pmj.2005.035998; BHATTACHARYYA G., 2003, RTP0103 DEP ED SKILL; British Medical Association, 2006, EX EQ SURV ROYAL COL; Broecke S, 2007, RW92 DEP ED SKILLS; Brown CA, 2003, MED TEACH, V25, P649, DOI 10.1080/0142159031000137445; Brown CA, 2001, MED TEACH, V23, P605, DOI 10.1080/01421590120091069; Calvert MJ, 2009, J ROY SOC MED, V102, P425, DOI 10.1258/jrsm.2009.090121; Carroll M, 2010, ASS STUD MED ED ASME; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Department for Education and Skills, 2005, RTP0105 DEP ED SKILL; Department of Health, 2004, SHAR CHALL SHAR BEN; Dewhurst NG, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-8; DILLNER L, 1995, BRIT MED J, V310, P209, DOI 10.1136/bmj.310.6974.209; Elston MA, 2009, WOMEN MED FUTURE; Ferguson E, 2002, BMJ-BRIT MED J, V324, P952, DOI 10.1136/bmj.324.7343.952; Fielding A., 2008, DEGREE ATTAINMENT ET; Gill PS, 2001, KINGS FUND, P99; Goldacre MJ, 2004, BRIT MED J, V329, P597, DOI 10.1136/bmj.38202.364271.BE; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Haq I, 2005, MED EDUC, V39, P1126, DOI 10.1111/j.1365-2929.2005.02319.x; Hedges L. V., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higher Education Funding Council for England, 2007, HEFCE EQ SCH; James D, 2001, MED EDUC, V35, P1056, DOI 10.1046/j.1365-2923.2001.01042.x; James D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c478; Kilminster S, MED TEACH IN PRESS; Kitchen RE, 2008, ASS STUD MED ED ANN; Lumb AB, 2004, MED EDUC, V38, P1002, DOI 10.1111/j.1365-2929.2004.01912.x; Lynch B, 2009, MED EDUC, V43, P1203, DOI 10.1111/j.1365-2923.2009.03535.x; Malik Kenan, 2008, STRANGE FRUIT WHY BO; McManus IC, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-5; McManus IC, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-21; McManus IC, 2005, BRIT MED J, V331, P555, DOI 10.1136/bmj.331.7516.555; McManus IC, 2004, BRIT MED J, V329, P800, DOI 10.1136/bmj.329.7469.800-c; McManus IC, 1996, MED EDUC, V30, P195, DOI 10.1111/j.1365-2923.1996.tb00742.x; MCMANUS IC, 1995, BRIT MED J, V310, P496, DOI 10.1136/bmj.310.6978.496; MCMANUS IC, 1986, BRIT MED J, V293, P124, DOI 10.1136/bmj.293.6539.124; NHS Staff Statistics, 2011, MED DENT STAFF 1999; Oyebode F, 2007, PSYCHIATR BULL, V31, P61, DOI 10.1192/pb.bp.105.009035; Platt L, 2009, 576 DEP WORK PENS; Plint S, 2009, ASS MED ED EUR ANN C; Richardson J. T., 2008, DEGREE ATTAINMENT ET; Ricketts C, 2010, ADV HEALTH SCI EDUC, V15, P265, DOI 10.1007/s10459-009-9197-8; Roberts C, 2000, BRIT MED J, V320, P370, DOI 10.1136/bmj.320.7231.370; SENIOR PA, 1994, BRIT MED J, V309, P327, DOI 10.1136/bmj.309.6950.327; Seyan K, 2004, BRIT MED J, V328, P1545, DOI 10.1136/bmj.328.7455.1545; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Tyrer SP., 2002, PSYCHIATR BULL, V26, P257, DOI [DOI 10.1192/PB.26.7.257, 10.1192/pb.26.7.257]; UCAS Statistics, 2009, ANN UK DAT ETHN SOC; UK Clinical Aptitude Test, 2008, UKCAT ANN REP 2008; UK Clinical Aptitude Test, 2006, UKCAT ANN REP 2006; UK Clinical Aptitude Test, 2007, UKCAT ANN REP 2007; WAKEFORD R, 1992, BRIT MED J, V305, P92, DOI 10.1136/bmj.305.6845.92; Wass V, 2003, BRIT MED J, V326, P800, DOI 10.1136/bmj.326.7393.800; Woolf K, 2009, THESIS U LONDON; Woolf K, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-35; Woolf K, 2008, ADV HEALTH SCI EDUC, V13, P607, DOI 10.1007/s10459-007-9067-1; Yates J, 2006, BMJ-BRIT MED J, V332, P1009, DOI 10.1136/bmj.38730.678310.63; Yates J, 2007, MED EDUC, V41, P65, DOI 10.1111/j.1365-2929.2006.02648.x; Yates J, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-55; Yates J, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-5	65	149	151	0	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2011	342								d901	10.1136/bmj.d901	http://dx.doi.org/10.1136/bmj.d901			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UY	21385802	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000288446800006
J	White, PD; Goldsmith, KA; Johnson, AL; Potts, L; Walwyn, R; DeCesare, JC; Baber, HL; Burgess, M; Clark, LV; Cox, DL; Bavinton, J; Angus, BJ; Murphy, G; Murphy, M; O'Dowd, H; Wilks, D; McCrone, P; Chalder, T; Sharpe, M				White, P. D.; Goldsmith, K. A.; Johnson, A. L.; Potts, L.; Walwyn, R.; DeCesare, J. C.; Baber, H. L.; Burgess, M.; Clark, L. V.; Cox, D. L.; Bavinton, J.; Angus, B. J.; Murphy, G.; Murphy, M.; O'Dowd, H.; Wilks, D.; McCrone, P.; Chalder, T.; Sharpe, M.		PACE Trial Management Grp	Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial	LANCET			English	Article							HEALTH SURVEY; SCALE; SF-36; TESTS	Background Trial findings show cognitive behaviour therapy (CBT) and graded exercise therapy (GET) can be effective treatments for chronic fatigue syndrome, but patients' organisations have reported that these treatments can be harmful and favour pacing and specialist health care. We aimed to assess effectiveness and safety of all four treatments. Methods In our parallel-group randomised trial, patients meeting Oxford criteria for chronic fatigue syndrome were recruited from six secondary-care clinics in the UK and randomly allocated by computer-generated sequence to receive specialist medical care (SMC) alone or with adaptive pacing therapy (APT), CBT, or GET Primary outcomes were fatigue (measured by Chalder fatigue questionnaire score) and physical function (measured by short form-36 subscale score) up to 52 weeks after randomisation, and safety was assessed primarily by recording all serious adverse events, including serious adverse reactions to trial treatments. Primary outcomes were rated by participants, who were necessarily unmasked to treatment assignment; the statistician was masked to treatment assignment for the analysis of primary outcomes. We used longitudinal regression models to compare SMC alone with other treatments, APT with CBT, and APT with GET The final analysis included all participants for whom we had data for primary outcomes. This trial is registered at http://isrctn.org, number ISRCTN54285094. Findings We recruited 641 eligible patients, of whom 160 were assigned to the APT group, 161 to the CBT group, 160 to the GET group, and 160 to the SMC-alone group. Compared with SMC alone, mean fatigue scores at 52 weeks were 3-4 (95% CI 1.8 to 5.0) points lower for CBT (p=0.0001) and 3.2 (1.7 to 4.8) points lower for GET (p=0.0003), but did not differ for APT (0.7 [-0.9 to 2-3] points lower; p=0.38). Compared with SMC alone, mean physical function scores were 7.1 (2.0 to 12.1) points higher for CBT (p=0.0068) and 9.4 (4.4 to 14.4) points higher for GET (p=0.0005), but did not differ for APT (3.4 [-1.6 to 8.4] points lower; p=0.18). Compared with APT, CBT and GET were associated with less fatigue (CBT p=0.0027; GET p=0.0059) and better physical function (CBT p=0.0002; GET p<0.0001). Subgroup analysis of 427 participants meeting international criteria for chronic fatigue syndrome and 329 participants meeting London criteria for myalgic encephalomyelitis yielded equivalent results. Serious adverse reactions were recorded in two (1%) of 159 participants in the APT group, three (2%) of 161 in the CBT group, two (1%) of 160 in the GET group, and two (1%) of 160 in the SMC-alone group. Interpretation CBT and GET can safely be added to SMC to moderately improve outcomes for chronic fatigue syndrome, but APT is not an effective addition.	[White, P. D.; DeCesare, J. C.; Baber, H. L.; Clark, L. V.] Queen Mary Univ London, Barts & London Sch Med, Wolfson Inst Prevent Med, London, England; [Goldsmith, K. A.; Potts, L.; Walwyn, R.] Kings Coll London, Inst Psychiat, Mental Hlth & Neurosci Clin Trials Unit, London WC2R 2LS, England; [Johnson, A. L.] Univ Cambridge, Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 1TN, England; [Johnson, A. L.] MRC, Clin Trials Unit, London, England; [Burgess, M.] S London & Maudsley NHS Fdn Trust, London, England; [Cox, D. L.] Univ Cumbria, Fac Hlth & Well Being, Lancaster, England; [Angus, B. J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England; [Murphy, G.] Royal Free Hosp NHS Trust, London, England; [Bavinton, J.; Murphy, M.] Baits & London NHS Trust, London, England; [O'Dowd, H.] Frenchay Hosp NHS Trust, Bristol, Avon, England; [Wilks, D.] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [McCrone, P.] Kings Coll London, Ctr Econ Mental Hlth Serv & Populat, London WC2R 2LS, England; [Chalder, T.] Kings Coll London, Acad Dept Psychol Med, London WC2R 2LS, England; [Sharpe, M.] Univ Edinburgh, Sch Mol & Clin Med, Edinburgh, Midlothian, Scotland	University of London; Queen Mary University London; University of London; King's College London; MRC Biostatistics Unit; University of Cambridge; Medical Research Council Clinical Trials Unit; South London & Maudsley NHS Trust; University of Cumbria; University of Oxford; University of London; University College London; University of Edinburgh; University of London; King's College London; University of London; King's College London; University of Edinburgh	White, PD (corresponding author), St Bartholomews Hosp, London EC1A 7BE, England.	p.d.white@qmul.ac.uk	Cox, Diane/O-7326-2014; Angus, Brian/L-9246-2019; Goldsmith, Kimberley/B-9107-2011; Chalder, Trudie/A-5717-2011	Cox, Diane/0000-0003-2691-6423; Angus, Brian/0000-0003-3598-7784; Goldsmith, Kimberley/0000-0002-0620-7868; Wilks, David/0000-0001-8284-5610; Clark, Lucy/0000-0001-7162-0512; sharpe, michael/0000-0002-6474-9980; White, Peter/0000-0002-8193-5355	UK Medical Research Council [MRC G0200434]; Department of Health for England; UK Department for Work and Pensions; Chief Scientist Office of the Scottish Government Health Directorates; Department of Health; MRC [G0200434] Funding Source: UKRI; Medical Research Council [G0200434] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health for England; UK Department for Work and Pensions; Chief Scientist Office of the Scottish Government Health Directorates; Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The PACE trial was funded by the UK Medical Research Council (MRC G0200434), the Department of Health for England, the UK Department for Work and Pensions, and the Chief Scientist Office of the Scottish Government Health Directorates, The Department of Health and the Chief Scientist Office provided excess treatment and service support costs for the trial therapists and doctors. We thank the participants who took part in the PACE trial, staff from all the centres (including all PACE research nurses or assistants: Susan Begg, Matteo Cella, Sally Cregeen, Sarah Home, Chris James, Julie Richards, Joanna Smee, and Vicky Toghill; data managers: Victoria Bates, Ann M Doust, Emma Hartley, Kate Lievesley, Sandy Smith, and Olga Zielona; therapists: Mary Barker, Jen Bobrow, Laura Butler, Nathan Butler, Richard-John Chippindall, Ruth Cowlishaw, Vincent Deary, Caroline J Heading, Lindsey Hume, Vicky Johnson, Sally Ludlam, Lorraine Maher-Edwards, Louise Mason, Christina Michailidou, Stacey Millet-Clay, Karen Shute, CM Simpson, Sheena E Spence, Valerie Suarez, Brendan Thomas, Tracey Turner, Rebecca Van Klinken, S M Wagner, Sue Wilkins, Giselle Withers, Fiona Wright, and Daniel Zahl; and specialist medical care doctors: Janet Andrews, Michael Broughton, Frauke Fehse, Eleanor Feldman, Janet Gray, Michael E. Jones, Tara Lawn, Brian Marien, Tim Peto, Angharad Ruttley, Alastair Santhouse, Adrian Vos, and Simon Wessely. Kathy Fulcher, Tom Meade, C L Murphy, Anthony J Pinching, and Rajesh Shah contributed and provided advice about the study, and Kurt Kroenke, Jan Scott, Peter Tyrer, and Simon Wessely commented on an early draft of the report.	Action for ME, PAC PEOPL ME; Action for ME, 2008, ME 2008 WHAT PROGR A; [Anonymous], 1994, REP CHRON FAT SYNDR; Bagnall A-M, 22 CRD; Bowling A, 1999, J PUBLIC HEALTH MED, V21, P255, DOI 10.1093/pubmed/21.3.255; BUTLAND RJA, 1982, BRIT MED J, V284, P1607, DOI 10.1136/bmj.284.6329.1607; Cairns R, 2005, OCCUP MED-OXFORD, V55, P20, DOI 10.1093/occmed/kqi013; Cella M, 2010, J PSYCHOSOM RES, V69, P17, DOI 10.1016/j.jpsychores.2009.10.007; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Cox DL, 2009, LEARN HLTH SOC CARE, V8, P301; Deale A, 1997, AM J PSYCHIAT, V154, P408; Edmonds M, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003200.PUB2; First MB, 2002, STRUCTURED CLIN INTE; Fulcher KY, 1997, BRIT MED J, V314, P1647, DOI 10.1136/bmj.314.7095.1647; Guy W., 1976, ASSESSMENT MANUAL PS, P218, DOI DOI 10.1186/1471-244X-7-7; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; Heins MJ, 2010, PSYCHOTHER PSYCHOSOM, V79, P249, DOI 10.1159/000315130; Jason LA, 2000, J HUMAN BEHAV SOCIAL, V3, P59; Jason LA, 2007, J CLIN PSYCHOL MED S, V14, P275, DOI 10.1007/s10880-007-9090-7; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Malouff JA, 2008, CLIN PSYCHOL REV, V28, P736, DOI 10.1016/j.cpr.2007.10.004; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; ME Association, MAN MY ME WHAT PEOPL; Mitchell E, 2008, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858; Moss-Morris R, 2005, J HEALTH PSYCHOL, V10, P245, DOI 10.1177/1359105305049774; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; National Institute for Health and Clinical Excellence, CG53 NIH CLIN EXC; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Prins JB, 2001, LANCET, V357, P841, DOI 10.1016/S0140-6736(00)04198-2; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; Sharpe M, 1996, BRIT MED J, V312, P22, DOI 10.1136/bmj.312.7022.22; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Wearden AJ, 1998, BRIT J PSYCHIAT, V172, P485, DOI 10.1192/bjp.172.6.485; Wearden AJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1777; White PD, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-6; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	555	561	2	162	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2011	377	9768					823	836		10.1016/S0140-6736(11)60096-2	http://dx.doi.org/10.1016/S0140-6736(11)60096-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GO	21334061	Green Accepted, Green Published			2022-12-28	WOS:000288628500030
J	Maxmen, A				Maxmen, Amy			Exome Sequencing Deciphers Rare Diseases	CELL			English	News Item																			0	26	29	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					635	637		10.1016/j.cell.2011.02.033	http://dx.doi.org/10.1016/j.cell.2011.02.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376225	Bronze			2022-12-28	WOS:000288007100002
J	Penny, DJ; Vick, GW				Penny, Daniel J.; Vick, G. Wesley, III			Ventricular septal defect	LANCET			English	Article							CONGENITAL HEART-DISEASE; PULMONARY ARTERIAL-HYPERTENSION; CHAMBERED RIGHT VENTRICLE; EISENMENGER-SYNDROME; MAGNETIC-RESONANCE; COLOR DOPPLER; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CARDIOVASCULAR-DISEASE; TRANSCATHETER CLOSURE; SCIENTIFIC STATEMENT	Ventricular septal defects account for up to 40% of all congenital cardiac malformations. The diagnosis encompasses a broad range of anomalies, including isolated defects and those associated with other congenital cardiac malformations. Presentation, symptoms, natural history, and management of ventricular septal defects depend on size and anatomical associations of the anomaly, patient's age, and local diagnostic and interventional expertise. In this Seminar, we describe the anatomical range of ventricular septal defects and discuss present management of these malformations. Genetic determinants, diagnostic techniques, physiological considerations, and management challenges are examined in detail. Unfortunately, in many circumstances, evidence on which to guide optimum management is scarce. We present some longer term considerations of ventricular septal defects in adolescents and adults, with particular emphasis on patients with raised pulmonary vascular resistance and Eisenmenger's syndrome.	[Penny, Daniel J.; Vick, G. Wesley, III] Texas Childrens Hosp, Houston, TX 77303 USA; [Penny, Daniel J.] Royal Childrens Hosp, Dept Cardiol, Melbourne, Vic, Australia; [Penny, Daniel J.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Vick, G. Wesley, III] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Baylor College of Medicine	Penny, DJ (corresponding author), Texas Childrens Hosp, 6621 Fannin, Houston, TX 77303 USA.	djpenny@texaschildrens.org						Ammash N, 1996, J AM COLL CARDIOL, V28, P768, DOI 10.1016/0735-1097(96)00196-9; Axt-Fliedner R, 2006, ULTRASOUND OBST GYN, V27, P266, DOI 10.1002/uog.2716; Ayres NA, 2005, J AM SOC ECHOCARDIOG, V18, P91, DOI 10.1016/j.echo.2004.11.004; Bajolle F, 2009, ARCH CARDIOVASC DIS, V102, P59, DOI 10.1016/j.acvd.2008.06.020; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Bedard E, 2009, EUR HEART J, V30, P256, DOI 10.1093/eurheartj/ehn597; Beerbaum P, 2001, CIRCULATION, V103, P2476; Beghetti M, 2009, J AM COLL CARDIOL, V53, P733, DOI 10.1016/j.jacc.2008.11.025; Benson DW, 2010, PEDIATR CARDIOL, V31, P422, DOI 10.1007/s00246-009-9607-y; Benson LN, 2009, PAEDIAT CARDIOLOGY, P591; Bezold LI, 1996, TEX HEART I J, V23, P108; Bizzarro M, 2005, COCHRANE DB SYST REV, V4; Brown S, 2010, EUR J CARDIO-THORAC, V37, P296, DOI 10.1016/j.ejcts.2009.06.056; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; CHEATHAM JP, 1981, AM J CARDIOL, V47, P85, DOI 10.1016/0002-9149(81)90294-0; Chen FL, 2006, ECHOCARDIOGR-J CARD, V23, P562, DOI 10.1111/j.1540-8175.2006.00277.x; Collins Nicholas J, 2008, J Invasive Cardiol, V20, pE200; Contreras-Ramos A, 2008, ANAT HISTOL EMBRYOL, V37, P344, DOI 10.1111/j.1439-0264.2008.00852.x; Crossland DS, 2008, CATHETER CARDIO INTE, V72, P386, DOI 10.1002/ccd.21640; de la Cruz MV, 1998, CARDIOVAS MOL MORPH, P121; Deanfield J, 2003, EUR HEART J, V24, P1035, DOI 10.1016/S0195-668X(03)00131-3; Diller GP, 2008, CIRCULATION, V117, P3020, DOI 10.1161/CIRCULATIONAHA.108.769646; Diller GP, 2007, CIRCULATION, V115, P1039, DOI 10.1161/CIRCULATIONAHA.105.592386; Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800; Dimopoulos K, 2008, INT J CARDIOL, V129, P163, DOI 10.1016/j.ijcard.2008.02.004; Dimopoulos K, 2010, CIRCULATION, V121, P20, DOI 10.1161/CIRCULATIONAHA.109.883876; Dranenkiene A, 2004, DEUT MED WOCHENSCHR, V129, pS35, DOI 10.1055/s-2004-824842; Duffels MGJ, 2007, INT J CARDIOL, V120, P198, DOI 10.1016/j.ijcard.2006.09.017; Dumitrescu A, 2007, HEART, V93, P867, DOI 10.1136/hrt.2007.119461; Eroglu AG, 2003, PEDIATR CARDIOL, V24, P31, DOI 10.1007/s00246-002-1345-3; FASULES JW, 1994, J APPL PHYSIOL, V77, P867, DOI 10.1152/jappl.1994.77.2.867; Fine N, 2009, CAN J CARDIOL, V25, pE63, DOI 10.1016/S0828-282X(09)70041-8; Gabriel HM, 2002, J AM COLL CARDIOL, V39, P1066, DOI 10.1016/S0735-1097(02)01706-0; Galie N, 2008, DRUGS, V68, P1049, DOI 10.2165/00003495-200868080-00004; Galie N, 2006, CIRCULATION, V114, P48, DOI 10.1161/CIRCULATIONAHA.106.630715; Gan HL, 2010, J THORAC CARDIOV SUR, V139, P950, DOI 10.1016/j.jtcvs.2009.05.047; Gantenbein MH, 2008, J PERINAT MED, V36, P448, DOI 10.1515/JPM.2008.064; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gatzoulis MA, 2008, INT J CARDIOL, V127, P27, DOI 10.1016/j.ijcard.2007.04.078; Goland S, 2010, CARDIOLOGY, V115, P205, DOI 10.1159/000287638; GOOR DA, 1970, CHEST, V58, P453, DOI 10.1378/chest.58.5.453; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P103, DOI 10.1007/BF00801907; HOUSTON AB, 1988, BRIT HEART J, V60, P50; Hovels-Gurich HH, 2006, ANN THORAC SURG, V81, P958, DOI 10.1016/j.athoracsur.2005.09.010; Jacobs J P, 2000, Ann Thorac Surg, V69, pS25; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Jonas Richard A, 2008, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P3, DOI 10.1053/j.pcsu.2007.12.001; Kilner PJ, 2010, EUR HEART J, V31, P794, DOI 10.1093/eurheartj/ehp586; Kleinman CS, 2007, J PEDIATR-US, V150, P583, DOI 10.1016/j.jpeds.2007.02.065; Korperich H, 2004, CIRCULATION, V109, P1987, DOI 10.1161/01.CIR.0000126494.66859.A2; Kostolny M, 2006, THORAC CARDIOV SURG, V54, P512, DOI 10.1055/s-2006-924326; Kumar RK, 2009, CARDIOL YOUNG, V19, P622, DOI 10.1017/S1047951109990783; Li QY, 1997, NAT GENET, V15, P21; Lim DS, 2007, CATHETER CARDIO INTE, V70, P740, DOI 10.1002/ccd.21267; Limsuwan A, 2009, CATHETER CARDIO INTE, V73, P98, DOI 10.1002/ccd.21793; Liu CX, 2009, CHINESE MED J-PEKING, V122, P30, DOI 10.3760/cma.j.issn.0366-6999.2009.01.006; LUDOMIRSKY A, 1986, CIRCULATION, V74, P1317, DOI 10.1161/01.CIR.74.6.1317; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; Mehta PK, 2008, TEX HEART I J, V35, P256; Minette MS, 2006, CIRCULATION, V114, P2190, DOI 10.1161/CIRCULATIONAHA.106.618124; Muthurangu V, 2004, CIRCULATION, V110, P826, DOI 10.1161/01.CIR.0000138741.72946.84; Namachivayam P, 2006, AM J RESP CRIT CARE, V174, P1042, DOI 10.1164/rccm.200605-694OC; NORA JJ, 1968, CIRCULATION, V38, P604, DOI 10.1161/01.CIR.38.3.604; Novick WM, 2005, ANN THORAC SURG, V79, P21, DOI 10.1016/j.athoracsur.2004.06.107; Oishi PE, 2008, AM J PHYSIOL-LUNG C, V295, pL756, DOI 10.1152/ajplung.00146.2007; ORTIZ E, 1985, BRIT HEART J, V54, P53; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Raap GB, 2007, EUR J CARDIO-THORAC, V32, P215, DOI 10.1016/j.ejcts.2007.04.023; Rabinovitch M, 1999, J HEART LUNG TRANSPL, V18, P1041, DOI 10.1016/S1053-2498(99)00015-7; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; ROGUIN N, 1995, J AM COLL CARDIOL, V26, P1545, DOI 10.1016/0735-1097(95)00358-4; Rudolph AM, 1971, BR HEART J S, V33, P32; Sato Y, 2007, INT J CARDIOL, V119, pE14, DOI 10.1016/j.ijcard.2007.01.079; Scully BB, 2010, ANN THORAC SURG, V89, P544, DOI 10.1016/j.athoracsur.2009.10.057; Silversides Candice K, 2009, Curr Cardiol Rep, V11, P298; SOMMER RJ, 1990, J AM COLL CARDIOL, V16, P1437, DOI 10.1016/0735-1097(90)90389-7; SOTO B, 1980, BRIT HEART J, V43, P332; SOTO B, 1989, J AM COLL CARDIOL, V14, P1291, DOI 10.1016/0735-1097(89)90430-0; Spence MS, 2007, LANCET, V370, P1530, DOI 10.1016/S0140-6736(07)61647-X; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Srivastava D, 2006, ANNU REV PATHOL-MECH, V1, P199, DOI 10.1146/annurev.pathol.1.110304.100039; SUTHERLAND GR, 1982, BRIT HEART J, V47, P316; Tay ELW, 2011, INT J CARDIOL, V149, P372, DOI 10.1016/j.ijcard.2010.02.020; Telagh R, 2008, CARDIOL YOUNG, V18, P268, DOI 10.1017/S1047951108001984; Turner SW, 2002, CARDIOL YOUNG, V12, P357, DOI 10.1017/S1047951100012968; Tweddell James S, 2006, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P147; Van de Bruaene A, 2009, ACTA CARDIOL, V64, P447, DOI 10.2143/AC.64.4.2041608; van Loon RLE, 2007, AM HEART J, V154, P776, DOI 10.1016/j.ahj.2007.06.003; VANPRAAGH R, 1989, J AM COLL CARDIOL, V14, P1298, DOI 10.1016/0735-1097(89)90431-2; Vick GW, 2003, CURR OPIN PEDIATR, V15, P454, DOI 10.1097/00008480-200310000-00002; VOGEL M, 1988, AM J CARDIOL, V61, P857, DOI 10.1016/0002-9149(88)91079-X; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; Wort SJ, 2007, INT J CARDIOL, V120, P314, DOI 10.1016/j.ijcard.2007.03.136; Zhang WM, 2009, CHINESE MED J-PEKING, V122, P416, DOI 10.3760/cma.j.issn.0366-6999.2009.04.0011; Zhang WM, 2008, EUR J MED GENET, V51, P527, DOI 10.1016/j.ejmg.2008.06.005	97	153	174	3	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2011	377	9771					1103	1112		10.1016/S0140-6736(10)61339-6	http://dx.doi.org/10.1016/S0140-6736(10)61339-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	743QY	21349577				2022-12-28	WOS:000289035000032
J	Selvin, E; Steffes, MW; Ballantyne, CM; Hoogeveen, RC; Coresh, J; Brancati, FL				Selvin, Elizabeth; Steffes, Michael W.; Ballantyne, Christie M.; Hoogeveen, Ron C.; Coresh, Josef; Brancati, Frederick L.			Racial Differences in Glycemic Markers: A Cross-sectional Analysis of Community-Based Data	ANNALS OF INTERNAL MEDICINE			English	Article							3RD NATIONAL-HEALTH; HISPANIC WHITE ADULTS; HEMOGLOBIN A(1C); ATHEROSCLEROSIS RISK; CARDIOVASCULAR RISK; AFRICAN-AMERICAN; HBA(1C) LEVELS; BLOOD-GLUCOSE; A1C; 1,5-ANHYDROGLUCITOL	Background: Although differences between black and white persons in hemoglobin A(1c) (HbA(1c)) values are well established, recent studies suggest that this might not reflect differences in glycemia. Objective: To investigate racial disparities in glycemic markers, including those that reflect biological processes independent of hemoglobin glycation and erythrocyte turnover. Design: Cross-sectional. Setting: Community-based. Participants: 1376 nondiabetic and 343 diabetic adults in a sub-study of the Atherosclerosis Risk in Communities Study. Measurements: Hemoglobin A1c, fasting glucose, glycated albumin, fructosamine, and 1,5-anhydroglucitol levels. Results: Among persons with and without diabetes, black persons had significantly higher HbA1c, glycated albumin, and fructosamine levels than white persons before and after adjustment for covariates and fasting glucose concentration. Serum 1,5-anhydroglucitol levels, which are reduced in the setting of hyperglycemia-induced glycosuria, were lower in black persons than in white persons, although this difference was statistically significant only in nondiabetic adults. Limitation: The design was cross-sectional, a limited number of participants with a history of diabetes was included, and the study did not include integrated measures of circulating nonfasting glycemia. Conclusion: Differences between black and white persons in glycated albumin, fructosamine, and 1,5-anhydroglucitol levels parallel differences between these groups in HbA(1c) values. Racial differences in hemoglobin glycation and erythrocyte turnover cannot explain racial disparities in these serum markers. The possibility that black persons have systematically higher levels of nonfasting glycemia warrants further study.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Minnesota, Minneapolis, MN USA; Baylor Coll Med, Houston, TX 77030 USA; Methodist DeBakey Heart & Vasc Ctr, Houston, TX USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Brancati, FL (corresponding author), Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-600, Baltimore, MD 21287 USA.	lselvin@jhsph.edu	Ballantyne, Christie/A-6599-2008	Hoogeveen, Ron/0000-0003-2399-4653; Ballantyne, Christie/0000-0002-6432-1730	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) [R21 DK080294, K01 DK076595, K24 DK62222]; Johns Hopkins Diabetes Research and Training Center (NIDDK) [P60 DK079637]; National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055022, N01HC055016, N01HC055019, N01HC055020, N01HC055021, N01HC055018] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055019, R42HL055018, R41HL055018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK062222, R21DK080294, R01DK089174, P60DK079637, K01DK076595] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Johns Hopkins Diabetes Research and Training Center (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: By the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) (grants R21 DK080294 and K01 DK076595 [Dr. Selvin] and K24 DK62222 [Dr. Brancati]) and by the Johns Hopkins Diabetes Research and Training Center (NIDDK grant P60 DK079637 [Dr. Brancati]). The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bloomgarden Zachary T, 2009, Diabetes Care, V32, pe141, DOI 10.2337/dc09-zb12; Borg R, 2010, DIABETES, V59, P1585, DOI [10.2337/db09-1774, 10.2337/db10-0777]; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Cohen RM, 2007, DIABETES CARE, V30, P2756, DOI 10.2337/dc07-1301; Dagogo-Jack S, 2010, NAT REV ENDOCRINOL, V6, P589, DOI 10.1038/nrendo.2010.126; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Fagot-Campagna A, 2001, DIABETES CARE, V24, P834, DOI 10.2337/diacare.24.5.834; Gama R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5648; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2010, ANN INTERN MED, V152, P815, DOI 10.7326/0003-4819-152-12-201006150-00011; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Hu YQ, 2009, J AM COLL NUTR, V28, P636, DOI 10.1080/07315724.2009.10719796; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Kamps JL, 2010, DIABETES CARE, V33, P1025, DOI 10.2337/dc09-1440; Kirk JK, 2005, ANN PHARMACOTHER, V39, P1489, DOI 10.1345/aph.1E685; Kirk JK, 2008, DIABETES CARE, V31, P240, DOI 10.2337/dc07-0382; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nguyen QM, 2008, METABOLISM, V57, P1487, DOI 10.1016/j.metabol.2008.04.011; Olabi B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4354; Pal A, 2010, DIABETES CARE, V33, P252, DOI 10.2337/dc09-1246; Saaddine JB, 2002, DIABETES CARE, V25, P1326, DOI 10.2337/diacare.25.8.1326; Selvin E, 2011, DIABETES, V60, P298, DOI 10.2337/db10-1198; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Selvin E, 2009, DIABETES CARE, V32, P828, DOI 10.2337/dc08-1699; SIMON D, 1989, DIABETOLOGIA, V32, P864, DOI 10.1007/BF00297451; Stettler C, 2008, DIABETES CARE, V31, P1534, DOI 10.2337/dc08-0385; Steven J, 2002, DIABETES CARE, V25, P1715, DOI 10.2337/diacare.25.10.1715; Suwa T, 2010, ENDOCR J, V57, P135, DOI 10.1507/endocrj.K09E-234; True Mark W, 2009, J Diabetes Sci Technol, V3, P743; Viberti G, 2006, DIABETIC MED, V23, P1289, DOI 10.1111/j.1464-5491.2006.02022.x; Wagenknecht L, 2009, CIRC-CARDIOVASC IMAG, V2, P314, DOI 10.1161/CIRCIMAGING.108.823922; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Won JC, 2009, DIABETES RES CLIN PR, V84, P51, DOI 10.1016/j.diabres.2009.01.002; YAMANOUCHI T, 1989, DIABETES, V38, P723, DOI 10.2337/diabetes.38.6.723; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	39	140	142	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5								10.7326/0003-4819-154-5-201103010-00004	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357907	Green Accepted			2022-12-28	WOS:000287799900002
J	George, PM; Banya, W; Pareek, N; Bilton, D; Cullinan, P; Hodson, ME; Simmonds, NJ				George, P. M.; Banya, W.; Pareek, N.; Bilton, D.; Cullinan, P.; Hodson, M. E.; Simmonds, N. J.			Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RECOMBINANT HUMAN DNASE; PSEUDOMONAS-AERUGINOSA; CONTROLLED-TRIAL; DORNASE-ALPHA; MORTALITY; TRANSPLANTATION; CF	Objectives To evaluate the survival of patients with cystic fibrosis whose lung function has deteriorated to a forced expiratory volume in one second (FEV1) below 30% predicted in the recent treatment era and to explore factors associated with any change in survival. Design Cohort study. Setting Adult cystic fibrosis unit in London. Participants 276 patients (147 (53%) male) whose FEV1 was first observed to be less than 30% predicted between 1 January 1990 and 31 December 2003. Main outcome measure Survival during follow-up to 31 December 2007 in two year sub-cohorts. Results Median survival improved from 1.2 years in the 1990-1 group to 5.3 years in the 2002-3 group, with a marked improvement in survival from 1994. The use of nebulised recombinant human DNase was significantly associated with a reduced risk of death (hazard ratio 0.59, 95% confidence interval 0.44 to 0.79). Significantly increased risks were associated with a body mass index under 19 (hazard ratio 1.52, 1.10 to 2.10), long term oxygen therapy (3.52, 2.49 to 4.99), and nebulised antibiotics (1.84, 1.05 to 3.22). Conclusion A marked improvement has occurred in the survival of patients with cystic fibrosis with an FEV1 less than 30% predicted. Secondary analyses suggest that some of this improvement may be due to use of recombinant human DNase.	[George, P. M.; Pareek, N.; Bilton, D.; Hodson, M. E.; Simmonds, N. J.] Royal Brompton Hosp, Dept Cyst Fibrosis, London SW3 6NP, England; [Banya, W.] Royal Brompton Hosp, Dept Res & Dev, London SW3 6NP, England; [Bilton, D.; Cullinan, P.; Hodson, M. E.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Royal Brompton Hospital; Royal Brompton Hospital; Imperial College London	Simmonds, NJ (corresponding author), Royal Brompton Hosp, Dept Cyst Fibrosis, London SW3 6NP, England.	n.simmonds@rbht.nhs.uk		Bilton, Diana/0000-0002-1913-9171	Respiratory Biomedical Research Unit (BRU) at the Royal Brompton Hospital; National Institute for Health Research [CL-2008-16-001] Funding Source: researchfish	Respiratory Biomedical Research Unit (BRU) at the Royal Brompton Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by the Respiratory Biomedical Research Unit (BRU) at the Royal Brompton Hospital; MEH, DB, and NJS are part of the Chronic Suppurative Lung Disease (CSLD) research consortium of the Respiratory BRU. We acknowledge the input of Khin Gyi for supporting the data collection process that proved invaluable to the study.	Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; Doershuk CF, 1999, CHEST, V115, P782, DOI 10.1378/chest.115.3.782; ELBORN JS, 1991, THORAX, V46, P881, DOI 10.1136/thx.46.12.881; Elkins MR, 2006, NEW ENGL J MED, V354, P229, DOI 10.1056/NEJMoa043900; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; FINKELSTEIN SM, 1988, J PEDIATR-US, V112, P373, DOI 10.1016/S0022-3476(88)80315-9; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; GIBSON GJ, 1993, EUR RESPIR J, V6, P155; Hodson ME, 2008, J CYST FIBROS, V7, P537, DOI 10.1016/j.jcf.2008.06.003; Jones AP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001127.pub2; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Liou TG, 2001, JAMA-J AM MED ASSOC, V286, P2683, DOI 10.1001/jama.286.21.2683; Madden BP, 2002, EUR RESPIR J, V19, P310, DOI 10.1183/09031936.02.00218502; Mahadeva R, 1998, BMJ-BRIT MED J, V316, P1771, DOI 10.1136/bmj.316.7147.1771; Milla CE, 2005, DIABETES CARE, V28, P2141, DOI 10.2337/diacare.28.9.2141; Milla CE, 1998, CHEST, V113, P1230, DOI 10.1378/chest.113.5.1230; MISCHLER EH, 1982, AM J DIS CHILD, V136, P1060, DOI 10.1001/archpedi.1982.03970480026006; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Paul K, 2004, AM J RESP CRIT CARE, V169, P719, DOI 10.1164/rccm.200307-959OC; Quan JM, 2001, J PEDIATR-US, V139, P813, DOI 10.1067/mpd.2001.118570; RAMSEY BW, 1993, NEW ENGL J MED, V328, P1740, DOI 10.1056/NEJM199306173282403; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; SHAH PL, 1995, THORAX, V50, P333, DOI 10.1136/thx.50.4.333; Steinkamp G, 2002, THORAX, V57, P596, DOI 10.1136/thorax.57.7.596; UK Cystic Fibrosis Trust Nutrition Working Group, 2002, NUTR MAN CYST FIBR; Wark P, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001506.pub3	28	77	81	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2011	342								d1008	10.1136/bmj.d1008	http://dx.doi.org/10.1136/bmj.d1008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732DK	21357627	Green Published, hybrid			2022-12-28	WOS:000288164200003
J	Nadeau, JH; Dudley, AM				Nadeau, Joseph H.; Dudley, Aimee M.			Systems Genetics	SCIENCE			English	Editorial Material									[Nadeau, Joseph H.; Dudley, Aimee M.] Inst Syst Biol, Seattle, WA 98103 USA	Institute for Systems Biology (ISB)	Nadeau, JH (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	jnadeau@systemsbiology.org; adudley@systemsbiology.org	Dudley, Aimee/K-3163-2019	Dudley, Aimee/0000-0003-3644-0625	NCRR NIH HHS [P40 RR012305, RR12305] Funding Source: Medline; NICHD NIH HHS [DP1 HD075624] Funding Source: Medline; NIGMS NIH HHS [R01 GM089978, P50 GM076547, R01GM089978, P50GM076547] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075624] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089978, P50GM076547] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Clee SM, 2006, NAT GENET, V38, P688, DOI 10.1038/ng1796; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Nadeau JH, 2003, GENOME RES, V13, P2082, DOI 10.1101/gr.1186603; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Newman M.E.J., 2010, NETWORKS INTRO; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Shipley B., 2002, CAUSE CORRELATION US	12	58	61	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1015	1016		10.1126/science.1203869	http://dx.doi.org/10.1126/science.1203869			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350153	Green Accepted			2022-12-28	WOS:000287699000037
J	Su, CC; Long, F; Zimmermann, MT; Rajashankar, KR; Jernigan, RL; Yu, EW				Su, Chih-Chia; Long, Feng; Zimmermann, Michael T.; Rajashankar, Kanagalaghatta R.; Jernigan, Robert L.; Yu, Edward W.			Crystal structure of the CusBA heavy-metal efflux complex of Escherichia coli	NATURE			English	Article							MEMBRANE-FUSION PROTEIN; MULTIDRUG EFFLUX; PSEUDOMONAS-AERUGINOSA; PERIPLASMIC COMPONENT; PUMP; ACRB; SYSTEM; TRANSPORTER; SOFTWARE; CRYSTALLOGRAPHY	Gram-negative bacteria, such as Escherichia coli, expel toxic chemicals through tripartite efflux pumps that span both the inner and outer membrane. The three parts are an inner membrane, substrate-binding transporter; a membrane fusion protein; and an outer-membrane-anchored channel. The fusion protein connects the transporter to the channel within the periplasmic space. A crystallographic model of this tripartite efflux complex has been unavailable because co-crystallization of the various components of the system has proven to be extremely difficult. We previously described the crystal structures of both the inner membrane transporter CusA(1) and the membrane fusion protein CusB(2) of the CusCBA efflux system(3,4) of E. coli. Here we report the co-crystal structure of the CusBA efflux complex, showing that the transporter (or pump) CusA, which is present as a trimer, interacts with six CusB protomers and that the periplasmic domain of CusA is involved in these interactions. The six CusB molecules seem to form a continuous channel. The affinity of the CusA and CusB interaction was found to be in the micromolar range. Finally, we have predicted a three-dimensional structure for the trimeric CusC outer membrane channel and developed a model of the tripartite efflux assemblage. This CusC(3)-CusB(6)-CusA(3) model shows a 750-kilodalton efflux complex that spans the entire bacterial cell envelope and exports Cu I and Ag I ions.	[Su, Chih-Chia; Long, Feng; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Zimmermann, Michael T.; Jernigan, Robert L.; Yu, Edward W.] Iowa State Univ, Bioinformat & Computat Biol Interdept Grad Progra, Ames, IA 50011 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, NE CAT, Argonne, IL 60439 USA; [Jernigan, Robert L.; Yu, Edward W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA	Iowa State University; Iowa State University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Iowa State University; Iowa State University	Yu, EW (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	ewyu@iastate.edu	Long, Feng/F-5475-2011; Jernigan, Robert L/A-5421-2012	Long, Feng/0000-0001-6313-8558; Jernigan, Robert L/0000-0003-0996-8360; Zimmermann, Michael/0000-0001-7073-0525	National Institutes of Health [R01GM074027, R01GM086431, R01GM081680, R01GM072014]; National Center for Research Resources at the National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086431, R01GM072014, R01GM074027, R01GM081680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grants R01GM074027 (E.W.Y.), R01GM086431 (E.W.Y.), R01GM081680 (R.L.J.) and R01GM072014 (R.L.J.). This work is based on research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; Bagai I, 2007, J BIOL CHEM, V282, P35695, DOI 10.1074/jbc.M703937200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Gerken H, 2004, MOL MICROBIOL, V54, P620, DOI 10.1111/j.1365-2958.2004.04301.x; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Su CC, 2006, J BACTERIOL, V188, P7290, DOI 10.1128/JB.00684-06; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Xue Y, 2008, NAT CHEM BIOL, V4, P107, DOI 10.1038/nchembio.2007.57	33	160	161	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					558	U153		10.1038/nature09743	http://dx.doi.org/10.1038/nature09743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350490	Green Accepted, Green Submitted			2022-12-28	WOS:000287652900047
J	Park-Wyllie, LY; Mamdani, MM; Juurlink, DN; Hawker, GA; Gunraj, N; Austin, PC; Whelan, DB; Weiler, PJ; Laupacis, A				Park-Wyllie, Laura Y.; Mamdani, Muhammad M.; Juurlink, David N.; Hawker, Gillian A.; Gunraj, Nadia; Austin, Peter C.; Whelan, Daniel B.; Weiler, Peter J.; Laupacis, Andreas			Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION ATTRIBUTABLE FRACTION; HIP FRACTURE; RANDOMIZED-TRIAL; DIAPHYSEAL FEMUR; ALENDRONATE; OSTEOPOROSIS; PERSISTENCE; MORTALITY; THERAPY; TRENDS	Context Osteoporosis is associated with significant morbidity and mortality. Oral bisphosphonates have become a mainstay of treatment, but concerns have emerged that long-term use of these drugs may suppress bone remodeling, leading to unusual fractures. Objective To determine whether prolonged bisphosphonate therapy is associated with an increased risk of subtrochanteric or femoral shaft fracture. Design, Setting, and Patients A population-based, nested case-control study to explore the association between bisphosphonate use and fractures in a cohort of women aged 68 years or older from Ontario, Canada, who initiated therapy with an oral bisphosphonate between April 1, 2002, and March 31, 2008. Cases were those hospitalized with a subtrochanteric or femoral shaft fracture and were matched to up to 5 controls with no such fracture. Study participants were followed up until March 31, 2009. Main Outcome Measures The primary analysis examined the association between hospitalization for a subtrochanteric or femoral shaft fracture and duration of bisphosphonate exposure. To test the specificity of the findings, the association between bisphosphonate use and fractures of the femoral neck or intertrochanteric region, which are characteristic of osteoporotic fractures, was also examined. Results We identified 716 women who sustained a subtrochanteric or femoral shaft fracture following initiation of bisphosphonate therapy and 9723 women who sustained a typical osteoporotic fracture of the intertrochanteric region or femoral neck. Compared with transient bisphosphonate use, treatment for 5 years or longer was associated with an increased risk of subtrochanteric or femoral shaft fracture (adjusted odds ratio, 2.74; 95% confidence interval, 1.25-6.02). A reduced risk of typical osteoporotic fractures occurred among women with more than 5 years of bisphosphonate therapy (adjusted odds ratio, 0.76; 95% confidence interval, 0.63-0.93). Among 52 595 women with at least 5 years of bisphosphonate therapy, a subtrochanteric or femoral shaft fracture occurred in 71 (0.13%) during the subsequent year and 117 (0.22%) within 2 years. Conclusion Among older women, treatment with a bisphosphonate for more than 5 years was associated with an increased risk of subtrochanteric or femoral shaft fractures; however, the absolute risk of these fractures is low. JAMA. 2011; 305(8): 783-789	[Park-Wyllie, Laura Y.; Mamdani, Muhammad M.; Laupacis, Andreas] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Park-Wyllie, Laura Y.; Mamdani, Muhammad M.; Juurlink, David N.; Hawker, Gillian A.; Gunraj, Nadia; Austin, Peter C.; Laupacis, Andreas] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.; Juurlink, David N.; Hawker, Gillian A.; Austin, Peter C.; Laupacis, Andreas] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5B 1W8, Canada; [Juurlink, David N.; Hawker, Gillian A.; Laupacis, Andreas] Univ Toronto, Dept Med, Toronto, ON M5B 1W8, Canada; [Whelan, Daniel B.; Weiler, Peter J.] Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON M5B 1W8, Canada; [Hawker, Gillian A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada; [Mamdani, Muhammad M.; Laupacis, Andreas] King Saud Univ, Dept Med, Riyadh, Saudi Arabia	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Womens College Hospital; King Saud University	Park-Wyllie, LY (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	parkwylliel@smh.ca	Walter, Henrik/O-2612-2013	Austin, Peter/0000-0003-3337-233X	Novartis; Janssen-Ortho; Pfizer; Boehringer Ingelheim; Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario	Novartis(Novartis); Janssen-Ortho; Pfizer(Pfizer); Boehringer Ingelheim(Boehringer Ingelheim); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported. Dr Mamdani reported that he has has participated in paid advisory board meetings and received consulting fees from Novartis, Janssen-Ortho, Pfizer, and Boehringer Ingelheim. No other disclosures were reported.; This study was funded by the Ontario Ministry of Health and Long-Term Care. Dr Park-Wyllie was supported by a Fellowship Award from the Canadian Institutes of Health Research. Dr Austin was supported by a Career Investigator Award from the Heart and Stroke Foundation of Ontario.	Abrahamsen B, 2009, J BONE MINER RES, V24, P1095, DOI [10.1359/JBMR.081247, 10.1359/jbmr.081247]; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Canadian Institute for Health Information, 2003, INT STAT CLASS DIS R; Colon-Emeric CS, 2006, JAMA-J AM MED ASSOC, V296, P2968, DOI 10.1001/jama.296.24.2968; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; Curtis JR, 2008, OSTEOPOROSIS INT, V19, P1613, DOI 10.1007/s00198-008-0604-4; Evans JG, 1997, J EPIDEMIOL COMMUN H, V51, P424, DOI 10.1136/jech.51.4.424; Geusens Piet, 2009, Curr Osteoporos Rep, V7, P12; Glazier RH, 2003, CAN J PUBLIC HEALTH, V94, P140, DOI 10.1007/BF03404588; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Ioannidis G, 2009, CAN MED ASSOC J, V181, P265, DOI 10.1503/cmaj.081720; Kelsey JL., 1996, METHODS OBSERVATIONA; Kennel KA, 2009, MAYO CLIN PROC, V84, P632, DOI 10.1016/S0025-6196(11)60752-0; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Lofthus CM, 2005, J CLIN EPIDEMIOL, V58, P280, DOI 10.1016/j.jclinepi.2004.07.003; Mamdani M, 2007, OSTEOPOROSIS INT, V18, P1595, DOI 10.1007/s00198-007-0446-5; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Melo M, 2006, J AM GERIATR SOC, V54, P1015, DOI 10.1111/j.1532-5415.2006.00758.x; Neviaser AS, 2008, J ORTHOP TRAUMA, V22, P346, DOI 10.1097/BOT.0b013e318172841c; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Papaioannou A, 2009, OSTEOPOROSIS INT, V20, P703, DOI 10.1007/s00198-008-0743-7; Park-Wyllie LY, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000157; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Rizzoli R, 2011, OSTEOPOROSIS INT, V22, P373, DOI 10.1007/s00198-010-1453-5; ROBINS JM, 1986, BIOMETRICS, V42, P293, DOI 10.2307/2531050; Rockhill B, 1998, AM J EPIDEMIOL, V147, P826, DOI 10.1093/oxfordjournals.aje.a009535; Rothman K., 1998, MODERN EPIDEMIOLOGY; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneider JP, 2009, GERIATRICS-US, V64, P18; Seeman E, 2009, OSTEOPOROSIS INT, V20, P187, DOI 10.1007/s00198-008-0813-x; Shane E, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.253; Shane Elizabeth, 2010, NEW ENGL J MED, V362, P1761; US Food and Drug Administration, 2010, ONG SAF REV OR BISPH; Wang MH, 2009, CANCER EPIDEM BIOMAR, V18, P706, DOI 10.1158/1055-9965.EPI-08-0839; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2	41	313	331	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					783	789		10.1001/jama.2011.190	http://dx.doi.org/10.1001/jama.2011.190			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21343577	Bronze			2022-12-28	WOS:000287594300021
J	Raby, AM				Raby, Adrian M.			Practice A Patient's Journey Alcoholism	BRITISH MEDICAL JOURNAL			English	Editorial Material												a.raby@imperial.ac.uk						Kaner EFS, 1999, ALCOHOL ALCOHOLISM, V34, P559, DOI 10.1093/alcalc/34.4.559; National Audit Office, 2008, RED ALC HARM HLTH SE	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d956	10.1136/bmj.d956	http://dx.doi.org/10.1136/bmj.d956			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345906				2022-12-28	WOS:000287920100002
J	Hoal, E				Hoal, Eileen			Famine in the Presence of the Genomic Data Feast	SCIENCE			English	Editorial Material									Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci, ZA-7505 Tygerberg, South Africa	Stellenbosch University	Hoal, E (corresponding author), Univ Stellenbosch, Fac Hlth Sci, Dept Biomed Sci, ZA-7505 Tygerberg, South Africa.								0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					874	874		10.1126/science.1203261	http://dx.doi.org/10.1126/science.1203261			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330533				2022-12-28	WOS:000287455100045
J	Smith, DM; Fraga, H; Reis, C; Kafri, G; Goldberg, AL				Smith, David M.; Fraga, Hugo; Reis, Christian; Kafri, Galit; Goldberg, Alfred L.			ATP Binds to Proteasomal ATPases in Pairs with Distinct Functional Effects, Implying an Ordered Reaction Cycle	CELL			English	Article							20S PROTEASOME; REGULATORY PARTICLE; CRYSTAL-STRUCTURE; 26S PROTEASOME; PROTEIN; HYDROLYSIS; MECHANISM; PAN; UBIQUITIN; GATE	In the eukaryotic 26S proteasome, the 20S particle is regulated by six AAA ATPase subunits and, in archaea, by a homologous ring complex, PAN. To clarify the role of ATP in proteolysis, we studied how nucleotides bind to PAN. Although PAN has six identical subunits, it binds ATPs in pairs, and its subunits exhibit three conformational states with high, low, or no affinity for ATP. When PAN binds two ATP gamma S molecules or two ATP gamma S plus two ADP molecules, it is maximally active in binding protein substrates, associating with the 20S particle, and promoting 20S gate opening. However, binding of four ATP gamma S molecules reduces these functions. The 26S proteasome shows similar nucleotide dependence. These findings imply an ordered cyclical mechanism in which two ATPase subunits bind ATP simultaneously and dock into the 20S. These results can explain how these hexameric ATPases interact with and "wobble'' on top of the heptameric 20S proteasome.	[Smith, David M.; Fraga, Hugo; Reis, Christian; Kafri, Galit; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Smith, DM (corresponding author), W Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA.	dsmith2@hsc.wvu.edu; alfred_goldberg@hms.harvard.edu	Smith, David/AAL-7662-2020; Fraga, Hugo/X-4850-2019	Smith, David/0000-0002-1502-676X; Fraga, Hugo/0000-0001-7677-4086	NIH [GM051923-09]; Multiple Myeloma Foundation; Fundacao para a Ciencia e Tecnologia, Lisboa, Portugal [SFRH/26490/2006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Foundation; Fundacao para a Ciencia e Tecnologia, Lisboa, Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by a grant from the NIH (GM051923-09) to A. L. G., by the Multiple Myeloma Foundation to A. L. G., and by a fellowship (SFRH/26490/2006) from Fundacao para a Ciencia e Tecnologia, Lisboa, Portugal to H.F.	Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Fontes R, 1998, FEBS LETT, V438, P190, DOI 10.1016/S0014-5793(98)01301-5; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goldberg AL, 2005, NEURON, V45, P339, DOI 10.1016/j.neuron.2005.01.019; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; MENON AS, 1987, J BIOL CHEM, V262, P14921; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Park Sang-Hyun, 2004, Methods Mol Biol, V261, P161; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Schumacher J, 2008, J MOL BIOL, V381, P1, DOI 10.1016/j.jmb.2008.05.075; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022	43	151	153	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					526	538		10.1016/j.cell.2011.02.005	http://dx.doi.org/10.1016/j.cell.2011.02.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335235	Bronze, Green Accepted			2022-12-28	WOS:000287473100008
J	Barrett, PN; Berezuk, G; Fritsch, S; Aichinger, G; Hart, MK; El-Amin, W; Kistner, O; Ehrlich, HJ				Barrett, P. Noel; Berezuk, Gregory; Fritsch, Sandor; Aichinger, Gerald; Hart, Mary Kate; El-Amin, Wael; Kistner, Otfried; Ehrlich, Hartmut J.			Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled, trial	LANCET			English	Article							CLINICAL-TRIAL; TOLERABILITY; PREVENTION; ADULTS; EGGS	Background The use of cell-culture technologies for the manufacture of influenza vaccines might contribute to improved strain selection and robust vaccine supplies. We investigated the safety, immunogenicity, and protective efficacy of a Vero-cell-culture-derived influenza vaccine, and assessed the correlation between vaccine efficacy and haemagglutination inhibition antibody titre. Methods In a double-blind, placebo-controlled, phase 3 trial undertaken in 36 centres in the USA, healthy adults (aged 18-49 years) were randomly assigned in a 1:1 ratio to one injection of either placebo or Vero-cell-culture-derived influenza vaccine during the 2008-09 season. Randomisation was done in blocks by use of the random number generator algorithm, and participants were allocated by use of a centralised telephone system. The primary objective was the efficacy of the vaccine in preventing cell-culture-confirmed influenza infection with viruses that were antigenically matched to one of the vaccine strains. Analysis was by intention to treat. The study is registered with ClinicalTrials.gov, number NCT00566345. Findings 7250 participants were randomly assigned to vaccine (n=3626) and placebo (n=3624). 7236 were analysed for the primary outcome (n=3619 and n=3617, respectively). Overall protective efficacy for antigenically matched influenza infection was 78.5% (95% CI 60.8-88.2). The vaccine was well tolerated with no treatment-related serious adverse events. Adverse events were mainly mild and transient. An HI titre of at least 1:15 provided a reliable correlate of cell-culture-derived influenza vaccine-induced protection; no additional benefit was noted with titres greater than 1:30. Interpretation The data indicate that existing correlates of protection afforded with egg-derived seasonal influenza vaccines also apply to this vaccine.	[Barrett, P. Noel; Kistner, Otfried] Baxter BioSci, Global Res & Dev, Biomed Res Ctr, A-2304 Orth, Austria; [Berezuk, Gregory] Baxter BioSci, Global Res & Dev, Beltsville, MD USA; [Fritsch, Sandor; Aichinger, Gerald; Ehrlich, Hartmut J.] Baxter BioSci, Global Res & Dev, Vienna, Austria; [Hart, Mary Kate; El-Amin, Wael] DynPort Vaccine Co, Frederick, MD USA		Barrett, PN (corresponding author), Baxter BioSci, Global Res & Dev, Biomed Res Ctr, Uferstr 15, A-2304 Orth, Austria.	noel_barrett@baxter.com			Office for Preparedness and Response, Biomedical Advanced Research and Development Authority [HHS0100200600013C]; US Government	Office for Preparedness and Response, Biomedical Advanced Research and Development Authority; US Government	This project has been funded in whole with federal (US Government) funds from the Office for Preparedness and Response, Biomedical Advanced Research and Development Authority, under contract number HHS0100200600013C, to DynPort Vaccine Company Pursuant to Section 507 of PL 104-208 and Section 508 of PL 105-78, 100% of the total of this project's costs are financed with federal (US Government) money. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products, or organisations imply endorsement by the US Government. We thank the members of the Baxter research and development team (Roman Bobrovsky, Julie McClaren, Borislava Pavlova, Miranda Schneider, Julia Singer, Leopold Grillberger, Keith Howard, Wolfgang Mundt, Manfred Reiter, Helga Savidis-Dacho, ChristaTauer, and Walter Wodal) for their role in this study, and members of the DynPort Vaccine Company (Cheryl Main, Aparna Kolhekar, and Patti Postal) for their support of this study; acknowledge the support of Alexander Klimov, Xiyan Xu, and Nancy Cox at CDC, Atlanta, GA, USA, for the virus typing by use of the HI assay, and Franz X Heinz, Monika Redlberger-Fritz, and Therese Popow-Kraupp at the Institute of Virology, Medical University Vienna, Austria, for assessment of genetic lineage of the B strains; and thank Daniel Portsmouth for assistance in preparation of the report.	Ambrozaitis A, 2009, VACCINE, V27, P6022, DOI 10.1016/j.vaccine.2009.07.083; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P369; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P749; [Anonymous], COCHRANE DATABASE SY; [Anonymous], 2008, WHO MALV M; Barford K, 2006, P 11 INT S VET EP EC; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Beran J, 2009, J INFECT DIS, V200, P1861, DOI 10.1086/648406; Beran J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-2; Cai T, 2006, J BIOPHARM STAT, V16, P517, DOI 10.1080/10543400600719483; Centers for Disease Prevention and Control, 2010, 2008 2009 INFL SEAS; Committee for Proprietary Medicinal Products, 1997, NOT GUID HARM REQ IN; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Ehrlich HJ, 2009, J INFECT DIS, V200, P1113, DOI 10.1086/605608; [FDA CBER], 2010, GUID IND CLIN DAT NE; Fink Sheri, 2004, IAVI Rep, V9, P10; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Frey S, 2003, VACCINE, V21, P4234, DOI 10.1016/S0264-410X(03)00456-0; Frey S, 2010, CLIN INFECT DIS, V51, P997, DOI 10.1086/656578; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Groth N, 2009, VACCINE, V27, P786, DOI 10.1016/j.vaccine.2008.11.003; Jackson LA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-71; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Mcleod A, 1985, APPL STAT, V121, P811; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Palache AM, 1997, J INFECT DIS S1, V176, pS20; Patriarcha PA, 2007, USE CELL LINES PROPA; Reisinger KS, 2009, J INFECT DIS, V200, P849, DOI 10.1086/605506; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Szymczakiewicz-Multanowska A, 2009, J INFECT DIS, V200, P841, DOI 10.1086/605505; Talbot HK, 2008, VACCINE, V26, P4057, DOI 10.1016/j.vaccine.2008.05.024; Voordouw ACG, 2009, VACCINE, V28, P392, DOI 10.1016/j.vaccine.2009.09.138; WICHMANN BA, 1982, J R STAT SOC C-APPL, V31, P188; WOOD JM, 1994, VACCINE, V12, P167, DOI 10.1016/0264-410X(94)90056-6	41	77	81	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2011	377	9767					751	759		10.1016/S0140-6736(10)62228-3	http://dx.doi.org/10.1016/S0140-6736(10)62228-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729JQ	21329971				2022-12-28	WOS:000287946000032
J	Steidl, C; Shah, SP; Woolcock, BW; Rui, LX; Kawahara, M; Farinha, P; Johnson, NA; Zhao, YJ; Telenius, A; Ben Neriah, S; McPherson, A; Meissner, B; Okoye, UC; Diepstra, A; van den Berg, A; Sun, M; Leung, G; Jones, SJ; Connors, JM; Huntsman, DG; Savage, KJ; Rimsza, LM; Horsman, DE; Staudt, LM; Steidl, U; Marra, MA; Gascoyne, RD				Steidl, Christian; Shah, Sohrab P.; Woolcock, Bruce W.; Rui, Lixin; Kawahara, Masahiro; Farinha, Pedro; Johnson, Nathalie A.; Zhao, Yongjun; Telenius, Adele; Ben Neriah, Susana; McPherson, Andrew; Meissner, Barbara; Okoye, Ujunwa C.; Diepstra, Arjan; van den Berg, Anke; Sun, Mark; Leung, Gillian; Jones, Steven J.; Connors, Joseph M.; Huntsman, David G.; Savage, Kerry J.; Rimsza, Lisa M.; Horsman, Douglas E.; Staudt, Louis M.; Steidl, Ulrich; Marra, Marco A.; Gascoyne, Randy D.			MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers	NATURE			English	Article							B-CELL LYMPHOMA; POOR PATIENT SURVIVAL; REED-STERNBERG CELLS; HODGKIN LYMPHOMA; PROTEIN EXPRESSION; LINE; JAK2; TRANSLOCATION; ABERRATIONS; RESOLUTION	Chromosomal translocations are critically involved in the molecular pathogenesis of B-cell lymphomas, and highly recurrent and specific rearrangements have defined distinct molecular subtypes linked to unique clinicopathological features(1,2). In contrast, several well-characterized lymphoma entities still lack disease-defining translocation events. To identify novel fusion transcripts resulting from translocations, we investigated two Hodgkin lymphoma cell lines by whole-transcriptome paired-end sequencing (RNA-seq). Here we show a highly expressed gene fusion involving the major histocompatibility complex (MHC) class II transactivator CIITA (MHC2TA) in KM-H2 cells. In a subsequent evaluation of 263 B-cell lymphomas, we also demonstrate that genomic CIITA breaks are highly recurrent in primary mediastinal B-cell lymphoma (38%) and classical Hodgkin lymphoma (cHL) (15%). Furthermore, we find that CIITA is a promiscuous partner of various in-frame gene fusions, and we report that CIITA gene alterations impact survival in primary mediastinal B-cell lymphoma (PMBCL). As functional consequences of CIITA gene fusions, we identify downregulation of surface HLA class II expression and overexpression of ligands of the receptor molecule programmed cell death 1 (CD274/PDL1 and CD273/PDL2). These receptor-ligand interactions have been shown to impact anti-tumour immune responses in several cancers(3), whereas decreased MHC class II expression has been linked to reduced tumour cell immunogenicity(4). Thus, our findings suggest that recurrent rearrangements of CIITA may represent a novel genetic mechanism underlying tumour-microenvironment interactions across a spectrum of lymphoid cancers.	[Steidl, Christian; Shah, Sohrab P.; Woolcock, Bruce W.; Farinha, Pedro; Johnson, Nathalie A.; Telenius, Adele; Ben Neriah, Susana; McPherson, Andrew; Meissner, Barbara; Sun, Mark; Leung, Gillian; Huntsman, David G.; Horsman, Douglas E.; Gascoyne, Randy D.] Ctr Lymphoid Cancers, Dept Pathol & Lab Med, Vancouver, BC V5Z 4E6, Canada; [Steidl, Christian; Shah, Sohrab P.; Woolcock, Bruce W.; Farinha, Pedro; Johnson, Nathalie A.; Telenius, Adele; Ben Neriah, Susana; McPherson, Andrew; Meissner, Barbara; Sun, Mark; Leung, Gillian; Huntsman, David G.; Horsman, Douglas E.; Gascoyne, Randy D.] Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; [Rui, Lixin; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Kawahara, Masahiro; Okoye, Ujunwa C.; Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Kawahara, Masahiro; Okoye, Ujunwa C.; Steidl, Ulrich] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; [Zhao, Yongjun; Jones, Steven J.; Marra, Marco A.] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Diepstra, Arjan; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9700 AB Groningen, Netherlands; [Connors, Joseph M.; Savage, Kerry J.] BC Canc Agcy Ctr Lymphoid Canc, Div Med Oncol, Vancouver, BC V5Z 4E6, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; British Columbia Cancer Agency; University of Groningen; University of Arizona; University of British Columbia	Gascoyne, RD (corresponding author), Ctr Lymphoid Cancers, Dept Pathol & Lab Med, Vancouver, BC V5Z 4E6, Canada.	rgascoyn@bccancer.bc.ca	Staudt, Louis/AAC-5324-2019; li, rui/GSD-4367-2022; Huntsman, David/ABE-6082-2020; Jones, Steven J/C-3621-2009; Marra, Marco A/B-5987-2008; rui, li/GYR-3791-2022; Gascoyne, Randy D/A-6009-2013; Connors, Joseph/AAF-5284-2019; Savage, Kerry/HCH-5539-2022; van den Berg, Anke/H-1718-2011	Jones, Steven J/0000-0003-3394-2208; Marra, Marco A/0000-0001-7146-7175; Gascoyne, Randy D/0000-0002-2610-5690; Connors, Joseph/0000-0002-1361-7531; van den Berg, Anke/0000-0002-8894-2638; Diepstra, Arjan/0000-0001-9239-1050; Okoye-Okafor, Ujunwa/0000-0001-8824-1666; Farinha, Pedro/0000-0001-9364-9391	Cancer Research Society; Michael Smith Foundation for Health Research; Lymphoma Research Foundation; Canadian Breast Cancer Foundation; Canadian Institutes of Health Research [178536]; Terry Fox Foundation [019001]; Genome Canada/Genome BC; National Institutes of Health/National Cancer Institute [R00CA131503]; Leukemia Research Foundation; National Health and Medical Research Council of Australia; NATIONAL CANCER INSTITUTE [ZIABC011008, ZIABC011006, R00CA131503] Funding Source: NIH RePORTER	Cancer Research Society; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Lymphoma Research Foundation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; Genome Canada/Genome BC(Genome Canada); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by a postdoctoral fellowship of the Cancer Research Society (Steven E. Drabin Fellowship) to C. S., the Michael Smith Foundation for Health Research to C. S. and S. P. S., the Lymphoma Research Foundation to C. S. and the Canadian Breast Cancer Foundation to S. P. S. Operational funds were available through the Canadian Institutes of Health Research, grant number 178536 to R. D. G. R. D. G., J.M.C., M. A. M. and D. E. H. are also supported by the Terry Fox Foundation ( number 019001). This work was in part supported by an infrastructure grant of Genome Canada/Genome BC. U. S. is the recipient of a Howard Temin Award of the National Institutes of Health/National Cancer Institute (R00CA131503), a new investigator award of the Leukemia Research Foundation, and is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research of the Albert Einstein College of Medicine. We thank G. Simkin, C. Polumbo and T. Vogler for technical support. L. R. is the recipient of a CJ Martin Fellowship from the National Health and Medical Research Council of Australia.	Amini RM, 2002, LEUKEMIA LYMPHOMA, V43, P2179, DOI 10.1080/1042819021000032917; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Blank C, 2005, CANCER IMMUNOL IMMUN, V54, P307, DOI 10.1007/s00262-004-0593-x; Chin KC, 1997, J IMMUNOL, V159, P2789; Cressman DE, 1999, IMMUNITY, V10, P163, DOI 10.1016/S1074-7613(00)80017-5; Diepstra A, 2007, J CLIN ONCOL, V25, P3101, DOI 10.1200/JCO.2006.10.0917; Dyer MJS, 2003, INT J HEMATOL, V77, P315, DOI 10.1007/BF02982637; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Joos S, 2003, INT J CANCER, V103, P489, DOI 10.1002/ijc.10845; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lennon AM, 1997, IMMUNOGENETICS, V45, P266, DOI 10.1007/s002510050202; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lestou VS, 2003, BRIT J HAEMATOL, V122, P745, DOI 10.1046/j.1365-2141.2003.04502.x; Martin-Subero JI, 2006, CANCER RES, V66, P10332, DOI 10.1158/0008-5472.CAN-06-1992; Martinez-Ramirez A, 2004, LEUKEMIA, V18, P348, DOI 10.1038/sj.leu.2403230; Masternak K, 2000, GENE DEV, V14, P1156; Melzner I, 2006, INT J CANCER, V118, P1941, DOI 10.1002/ijc.21485; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Roberts RA, 2006, BLOOD, V108, P311, DOI 10.1182/blood-2005-11-4742; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Sambade C, 2006, INT J CANCER, V118, P555, DOI 10.1002/ijc.21417; Savage KJ, 2006, ANN ONCOL, V17, P123, DOI 10.1093/annonc/mdj030; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Shah SP, 2006, BIOINFORMATICS, V22, pE431, DOI 10.1093/bioinformatics/btl238; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Shustik J, 2010, HAEMATOL-HEMATOL J, V95, P96, DOI 10.3324/haematol.2009.007203; SILACCI P, 1994, J EXP MED, V180, P1329, DOI 10.1084/jem.180.4.1329; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Yamamoto R, 2008, BLOOD, V111, P3220, DOI 10.1182/blood-2007-05-085159; Zhou H, 1997, J IMMUNOL, V158, P4741	41	408	425	5	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					377	+		10.1038/nature09754	http://dx.doi.org/10.1038/nature09754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368758	Green Accepted			2022-12-28	WOS:000288444000045
J	Mirza, DM; Hashim, MJ; Sheikh, A				Mirza, Deen M.; Hashim, Muhammad Jawad; Sheikh, Aziz			10-Minute Consultation Malaria	BRITISH MEDICAL JOURNAL			English	Editorial Material												deenmirza@doctors.org.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Hashim, Muhammad Jawad/0000-0002-9280-9709				Chiodini P, 2007, GUIDELINES MALARIA P	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 15	2011	342								d1149	10.1136/bmj.d1149	http://dx.doi.org/10.1136/bmj.d1149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FA	21406530	Green Submitted			2022-12-28	WOS:000288698100016
J	Bronikowski, AM; Altmann, J; Brockman, DK; Cords, M; Fedigan, LM; Pusey, A; Stoinski, T; Morris, WF; Strier, KB; Alberts, SC				Bronikowski, Anne M.; Altmann, Jeanne; Brockman, Diane K.; Cords, Marina; Fedigan, Linda M.; Pusey, Anne; Stoinski, Tara; Morris, William F.; Strier, Karen B.; Alberts, Susan C.			Aging in the Natural World: Comparative Data Reveal Similar Mortality Patterns Across Primates	SCIENCE			English	Article							COMPARATIVE DEMOGRAPHY; HUMAN LONGEVITY; RATES; POPULATIONS; VERTEBRATES; CHIMPANZEES; COMPETITION; EVOLUTION; HUMANS; AGES	Human senescence patterns-late onset of mortality increase, slow mortality acceleration, and exceptional longevity-are often described as unique in the animal world. Using an individual-based data set from longitudinal studies of wild populations of seven primate species, we show that contrary to assumptions of human uniqueness, human senescence falls within the primate continuum of aging; the tendency for males to have shorter life spans and higher age-specific mortality than females throughout much of adulthood is a common feature in many, but not all, primates; and the aging profiles of primate species do not reflect phylogenetic position. These findings suggest that mortality patterns in primates are shaped by local selective forces rather than phylogenetic history.	[Altmann, Jeanne; Alberts, Susan C.] Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya; [Altmann, Jeanne] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ USA; [Bronikowski, Anne M.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Brockman, Diane K.] Univ N Carolina, Dept Anthropol, Charlotte, NC 28223 USA; [Strier, Karen B.] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Morris, William F.; Alberts, Susan C.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Pusey, Anne] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Cords, Marina] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Fedigan, Linda M.] Univ Calgary, Dept Anthropol, Calgary, AB T2N 1N4, Canada; [Stoinski, Tara] Dian Fossey Gorilla Fund Int & Zoo Atlanta, Atlanta, GA 30315 USA	Princeton University; Iowa State University; University of North Carolina; University of North Carolina Charlotte; University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University; Columbia University; University of Calgary	Alberts, SC (corresponding author), Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya.	alberts@duke.edu	Strier, Karen B./AAJ-3482-2020	Bronikowski, Anne/0000-0001-6432-298X; Strier, Karen/0000-0003-2520-9110; Pusey, Anne/0000-0002-2280-8954	National Evolutionary Synthesis Center (NESCent); National Center for Ecological Analysis and Synthesis (NCEAS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034513] Funding Source: NIH RePORTER; Division Of Environmental Biology [0846532] Funding Source: National Science Foundation	National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Center for Ecological Analysis and Synthesis (NCEAS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Evolutionary Synthesis Center (NESCent) and the National Center for Ecological Analysis and Synthesis (NCEAS) jointly supported the Primate Life Histories Working Group. H. Lapp and X. Liu at NESCent provided expert assistance in designing and implementing the Primate Life Histories Database (PLHD). J. Moorad commented on the manuscript. The governments of Brazil, Costa Rica, Kenya, Madagascar, Rwanda, and Tanzania provided permission for our field studies, and all research complied with guidelines in the host countries. For study-specific acknowledgments and Institutional Animal Care and Use Committee compliance, see http://demo.plhdb.org. The nonhuman primate data used in these analyses are available in the Dryad database (http://dx.doi.org/10.5061/dryad.8682).	Allman J, 1998, P NATL ACAD SCI USA, V95, P6866, DOI 10.1073/pnas.95.12.6866; ANDERSON RN, 1999, NATL VITAL STAT REPO, V47; [Anonymous], 1997, ZEUS SALMON BIODEMOG; Arias E, 2007, NATL VITAL STAT REPO, V56; Bronikowski AM, 2005, TRENDS ECOL EVOL, V20, P271, DOI 10.1016/j.tree.2005.03.011; Bronikowski AM, 2002, P NATL ACAD SCI USA, V99, P9591, DOI 10.1073/pnas.142675599; Brunet-Rossinni A.K., 2006, HDB BIOL AGING, VSixth, P243; Clutton-Brock TH, 2007, P ROY SOC B-BIOL SCI, V274, P3097, DOI 10.1098/rspb.2007.1138; Clutton-Brock T, 2010, SCIENCE, V327, P1207, DOI 10.1126/science.1187796; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; FINCH CE, 1990, SCIENCE, V249, P902, DOI 10.1126/science.2392680; Finch CE, 1990, LONGEVITY SENESCENCE; Gage TB, 1998, ANNU REV ANTHROPOL, V27, P197, DOI 10.1146/annurev.anthro.27.1.197; Gavrilova NS, 1998, HUM BIOL, V70, P799; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; Hawkes K, 2009, AM J HUM BIOL, V21, P578, DOI 10.1002/ajhb.20890; Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469; Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a; Lawler RR, 2005, J HUM EVOL, V48, P259, DOI 10.1016/j.jhevol.2004.11.005; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Mitani JC, 1996, AM NAT, V147, P966, DOI 10.1086/285888; Morris WF, 2011, AM NAT, V177, pE14, DOI 10.1086/657443; Pletcher SD, 1999, J EVOLUTION BIOL, V12, P430, DOI 10.1046/j.1420-9101.1999.00058.x; Promislow DEL, 1996, GENETICS, V143, P839; Rau R, 2008, POPUL DEV REV, V34, P747, DOI 10.1111/j.1728-4457.2008.00249.x; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P10314, DOI 10.1073/pnas.1005862107; SACHER GA, 1977, HDB BIOL AGING, P582; Sanderson WC, 2010, SCIENCE, V329, P1287, DOI 10.1126/science.1193647; Strier KB, 2010, METHODS ECOL EVOL, V1, P199, DOI 10.1111/j.2041-210X.2010.00023.x; STRIER KB, 1994, BEHAVIOUR, V130, P151, DOI 10.1163/156853994X00505; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Wachter KW, 2003, POPUL DEV REV, V29, P270; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519	34	152	158	2	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1325	1328		10.1126/science.1201571	http://dx.doi.org/10.1126/science.1201571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393544	Green Accepted			2022-12-28	WOS:000288215200047
J	Feng, D; Liu, T; Sun, Z; Bugge, A; Mullican, SE; Alenghat, T; Liu, XS; Lazar, MA				Feng, Dan; Liu, Tao; Sun, Zheng; Bugge, Anne; Mullican, Shannon E.; Alenghat, Theresa; Liu, X. Shirley; Lazar, Mitchell A.			A Circadian Rhythm Orchestrated by Histone Deacetylase 3 Controls Hepatic Lipid Metabolism	SCIENCE			English	Article							RECEPTOR COREPRESSOR; TRANSCRIPTION; LIVER; CLOCK; MICE; TISSUE	Disruption of the circadian clock exacerbates metabolic diseases, including obesity and diabetes. We show that histone deacetylase 3 ( HDAC3) recruitment to the genome displays a circadian rhythm in mouse liver. Histone acetylation is inversely related to HDAC3 binding, and this rhythm is lost when HDAC3 is absent. Although amounts of HDAC3 are constant, its genomic recruitment in liver corresponds to the expression pattern of the circadian nuclear receptor Rev-erb alpha. Rev-erb alpha colocalizes with HDAC3 near genes regulating lipid metabolism, and deletion of HDAC3 or Rev-erb alpha in mouse liver causes hepatic steatosis. Thus, genomic recruitment of HDAC3 by Rev-erb alpha directs a circadian rhythm of histone acetylation and gene expression required for normal hepatic lipid homeostasis.	[Feng, Dan; Sun, Zheng; Bugge, Anne; Mullican, Shannon E.; Alenghat, Theresa; Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA; [Feng, Dan; Sun, Zheng; Bugge, Anne; Mullican, Shannon E.; Alenghat, Theresa; Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab IDOM, Philadelphia, PA 19104 USA; [Liu, Tao; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Tao; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	University of Pennsylvania; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Lazar, MA (corresponding author), Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Liu, Tao/G-3585-2010; Liu, Tao/AAO-6310-2021; Feng, Dan/F-7205-2013; Lazar, Mitchell A/AAF-3738-2019; Sun, Zheng/C-1146-2012	Liu, Tao/0000-0002-8818-8313; Liu, Tao/0000-0002-8818-8313; Sun, Zheng/0000-0002-6858-0633; Feng, Dan/0000-0001-5926-8894; Liu, Tao/0000-0003-0446-9001; Bugge, Anne/0000-0001-5885-4541	NIH [DK19525, DK49210, DK45586, DK43806, RC1DK08623, HG4069]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086239, P01DK049210, R37DK043806, P30DK019525, R01DK043806, R01DK045586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ChIP-seq and microarray data have been deposited in the Gene Expression Omnibus (GSE25937 and GSE26345) database. We thank B. Vennstrom for providing Rev-erba KO mice; M. Brown, D. Steger, and members of the Lazar lab for helpful discussions; D. Zhuo for technical assistance; the Penn IDOM Metabolism Resource (J. Millar) for help with de novo lipogenesis experiments; the Functional Genomics Core (J. Schug and K. Kaestner) and the Viral Vector Core (J. Johnston) of the Penn Diabetes Endocrinology Research Center (NIH DK19525) for deep sequencing and virus preparation; the Morphology Core (J. Katz and G. Swain) (NIH DK49210) for tissue preparation and staining; and the Penn Bioinformatics Core (J. Tobias) and Microarray Core (D. Baldwin) for gene expression analysis. Supported by the Cox Institute, NIH DK45586, DK43806, and RC1DK08623 (to M. A. L.) and NIH HG4069 (to X. S. L.).	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Chomez P, 2000, DEVELOPMENT, V127, P1489; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Goodson Michael, 2005, Nucl Recept Signal, V3, pe003; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; HEMS DA, 1975, BIOCHEM J, V150, P167, DOI 10.1042/bj1500167; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pietroiusti A, 2010, OCCUP ENVIRON MED, V67, P54, DOI 10.1136/oem.2009.046797; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Sookoian S, 2007, WORLD J GASTROENTERO, V13, P4242, DOI 10.3748/wjg.v13.i31.4242; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Zamir I, 1996, MOL CELL BIOL, V16, P5458	30	478	493	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1315	1319		10.1126/science.1198125	http://dx.doi.org/10.1126/science.1198125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393543	Green Accepted			2022-12-28	WOS:000288215200044
J	Briggman, KL; Helmstaedter, M; Denk, W				Briggman, Kevin L.; Helmstaedter, Moritz; Denk, Winfried			Wiring specificity in the direction-selectivity circuit of the retina	NATURE			English	Article							STARBURST AMACRINE CELLS; GANGLION-CELLS; RABBIT RETINA; ACETYLCHOLINE-RECEPTORS; DENDRITIC STRUCTURE; CALCIUM SIGNALS; IMAGE MOTION; MECHANISMS; GABA; CONNECTIONS	The proper connectivity between neurons is essential for the implementation of the algorithms used in neural computations, such as the detection of directed motion by the retina. The analysis of neuronal connectivity is possible with electron microscopy, but technological limitations have impeded the acquisition of high-resolution data on a large enough scale. Here we show, using serial block-face electron microscopy and two-photon calcium imaging, that the dendrites of mouse starburst amacrine cells make highly specific synapses with direction-selective ganglion cells depending on the ganglion cell's preferred direction. Our findings indicate that a structural (wiring) asymmetry contributes to the computation of direction selectivity. The nature of this asymmetry supports some models of direction selectivity and rules out others. It also puts constraints on the developmental mechanisms behind the formation of synaptic connections. Our study demonstrates how otherwise intractable neurobiological questions can be addressed by combining functional imaging with the analysis of neuronal connectivity using large-scale electron microscopy.	[Briggman, Kevin L.; Helmstaedter, Moritz; Denk, Winfried] Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany	Max Planck Society	Briggman, KL (corresponding author), Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany.	briggman@mpimf-heidelberg.mpg.de	denk, winfried/I-6627-2012					BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Blankenship AG, 2009, NEURON, V62, P230, DOI 10.1016/j.neuron.2009.03.015; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; BRIGGMAN KL, J NEUROPHYS IN PRESS; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Chen YC, 2008, J COMP NEUROL, V508, P175, DOI 10.1002/cne.21677; Chiao CC, 2002, J NEUROSCI, V22, P10509; Dacheux RF, 2003, J COMP NEUROL, V456, P267, DOI 10.1002/cne.10521; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denk W, 1999, P NATL ACAD SCI USA, V96, P7035, DOI 10.1073/pnas.96.12.7035; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dmitrieva NA, 2003, J COMP NEUROL, V456, P167, DOI 10.1002/cne.10520; Dmitrieva NA, 2007, J HISTOCHEM CYTOCHEM, V55, P461, DOI 10.1369/jhc.6A7116.2006; Dong W, 2004, J PHYSIOL-LONDON, V556, P11, DOI 10.1113/jphysiol.2004.060715; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; Fahmy A., 1967, P ELECTRON MICROSCOP, P148; Famiglietti EV, 2002, VISUAL NEUROSCI, V19, P145, DOI 10.1017/S0952523802191139; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; GLAUERT AM, 1998, PRACTICAL METHODS EL, V21; Granstedt AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006923; Grzywacz NM, 1997, VISUAL NEUROSCI, V14, P39, DOI 10.1017/S0952523800008749; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; He SG, 1999, J NEUROSCI, V19, P8049; Karnovsky M.J., 1971, P 11 M AM SOC CELL B, P146; Keeley PW, 2007, J COMP NEUROL, V505, P539, DOI 10.1002/cne.21518; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; Mumm JS, 2005, PROG BRAIN RES, V147, P155, DOI 10.1016/S0079-6123(04)47012-5; Oesch NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012447; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OYSTER CW, 1993, VISION RES, V33, P579, DOI 10.1016/0042-6989(93)90181-U; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Schachter MJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000899; Schlichtenbrede FC, 2009, INVEST OPHTH VIS SCI, V50, P5880, DOI 10.1167/iovs.08-3078; SELIGMAN AM, 1966, J CELL BIOL, V30, P424, DOI 10.1083/jcb.30.2.424; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; WALTON J, 1979, J HISTOCHEM CYTOCHEM, V27, P1337, DOI 10.1177/27.10.512319; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Yamada ES, 2003, J COMP NEUROL, V461, P76, DOI 10.1002/cne.10672; YANG G, 1994, J NEUROSCI, V14, P5267; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	55	537	542	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					183	U67		10.1038/nature09818	http://dx.doi.org/10.1038/nature09818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390125				2022-12-28	WOS:000288170200030
J	Brown, RE				Brown, Raeford E., Jr.			A Door Closes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rbrow1@email.uky.edu	Brown, Raeford/I-1211-2019	Brown, Raeford/0000-0002-2295-2657					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					977	978		10.1001/jama.2011.254	http://dx.doi.org/10.1001/jama.2011.254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386070				2022-12-28	WOS:000288129600001
J	Aragon-Ching, JB				Aragon-Ching, Jeanny B.			Unravelling the role of denosumab in prostate cancer	LANCET			English	Editorial Material							ZOLEDRONIC ACID; BISPHOSPHONATES; OSTEONECROSIS; TRIAL; JAW		George Washington Univ, Med Ctr, Div Hematol & Oncol, Washington, DC 20037 USA	George Washington University	Aragon-Ching, JB (corresponding author), George Washington Univ, Med Ctr, Div Hematol & Oncol, Washington, DC 20037 USA.	jaragonching@mfa.gwu.edu	Aragon-Ching, Jeanny/AAJ-4969-2020; Aragon-Ching, Jeanny/AAL-2501-2020	Aragon-Ching, Jeanny/0000-0002-6714-141X; Aragon-Ching, Jeanny/0000-0002-6714-141X				Aragon-Ching JB, 2009, CANCER INVEST, V27, P221, DOI 10.1080/07357900802208608; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Carlin Bruce I., 2000, Cancer, V88, P2989, DOI 10.1002/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.3.CO;2-H; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Fizazi K, 2009, J CLIN ONCOL, V27, P1564, DOI 10.1200/JCO.2008.19.2146; Reed SD, 2004, J UROLOGY, V171, P1537, DOI 10.1097/01.ju.0000116777.94426.60; Saad F, 2002, JNCI-J NATL CANCER I, V94, P1458, DOI 10.1093/jnci/94.19.1458; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003	9	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 5	2011	377	9768					785	786		10.1016/S0140-6736(11)60100-1	http://dx.doi.org/10.1016/S0140-6736(11)60100-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GO	21353698				2022-12-28	WOS:000288628500004
J	Pan, J; Sasaki, M; Kniewel, R; Murakami, H; Blitzblau, HG; Tischfield, SE; Zhu, X; Neale, MJ; Jasin, M; Socci, ND; Hochwagen, A; Keeney, S				Pan, Jing; Sasaki, Mariko; Kniewel, Ryan; Murakami, Hajime; Blitzblau, Hannah G.; Tischfield, Sam E.; Zhu, Xuan; Neale, Matthew J.; Jasin, Maria; Socci, Nicholas D.; Hochwagen, Andreas; Keeney, Scott			A Hierarchical Combination of Factors Shapes the Genome-wide Topography of Yeast Meiotic Recombination Initiation	CELL			English	Article							DOUBLE-STRAND BREAKS; TRANSCRIPTION FACTOR; CHROMATIN-STRUCTURE; GENE CONVERSION; GLOBAL ANALYSIS; CHROMOSOME-III; DNA REVEALS; IN-VIVO; SITES; CROSSOVERS	The nonrandom distribution of meiotic recombination influences patterns of inheritance and genome evolution, but chromosomal features governing this distribution are poorly understood. Formation of the DNA double-strand breaks (DSBs) that initiate recombination results in the accumulation of Spo11 protein covalently bound to small DNA fragments. By sequencing these fragments, we uncover a genome-wide DSB map of unprecedented resolution and sensitivity. We use this map to explore how DSB distribution is influenced by large-scale chromosome structures, chromatin, transcription factors, and local sequence composition. Our analysis offers mechanistic insight into DSB formation and early processing steps, supporting the view that the recombination terrain is molded by combinatorial and hierarchical interaction of factors that work on widely different size scales. This map illuminates the occurrence of DSBs in repetitive DNA elements, repair of which can lead to chromosomal rearrangements. We also discuss implications for evolutionary dynamics of recombination hot spots.	[Pan, Jing; Sasaki, Mariko; Kniewel, Ryan; Murakami, Hajime; Tischfield, Sam E.; Zhu, Xuan; Neale, Matthew J.; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Sasaki, Mariko; Kniewel, Ryan; Zhu, Xuan] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Blitzblau, Hannah G.; Hochwagen, Andreas] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tischfield, Sam E.] Cornell Univ, Triinst Training Program Computat Biol & Med, New York, NY 10065 USA; [Neale, Matthew J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Cornell University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Cornell University; University of Sussex	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	s-keeney@ski.mskcc.org	Murakami, Hajime/AAX-9411-2021; Keeney, Scott/GVR-8515-2022; Sasaki, Mariko/AAF-3414-2019; Sasaki, Mariko/AAT-6090-2020; Sasaki, Mariko/K-6217-2017	Keeney, Scott/0000-0002-1283-6417; Sasaki, Mariko/0000-0003-4208-1251; Kniewel, Ryan/0000-0003-3462-6450; Zhu, Xuan/0000-0002-8422-2828; Neale, Matthew/0000-0002-6453-1877; Hochwagen, Andreas/0000-0002-6184-443X; Murakami, Hajime/0000-0002-7022-6887	NIH [GM58673, HD53855, T32 GM008539]; Royal Society; MRC; HFSP; Leukemia and Lymphoma Society; Medical Research Council [G0800005] Funding Source: researchfish; MRC [G0800005] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673, T32GM008539] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HFSP(Human Frontier Science Program); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Viale (MSKCC Genomics Core Laboratory) for sequencing; S. Shuman and J. Nandakumar (MSKCC) for generous gifts of RNA ligase; and M. Lichten (NCI), I. Whitehouse (MSKCC), and G. Smith (Fred Hutchinson Cancer Research Center) for comments on the manuscript. This work was supported in part by NIH grants GM58673 (S. K.) and HD53855 (S. K. and M. J.). M. J. N. is supported by a Royal Society University Research Fellowship, an MRC New Investigator Grant, and an HFSP Career Development Award. J. P. was supported by a Leukemia and Lymphoma Society Fellowship. R. K. was supported by NIH training grant T32 GM008539. S. K. is an Investigator of the Howard Hughes Medical Institute.	Ahmed NT, 2009, MOL CELL BIOL, V29, P4352, DOI 10.1128/MCB.00305-09; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Barton AB, 2008, GENETICS, V179, P1221, DOI 10.1534/genetics.107.083493; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Ben-Aroya S, 2004, MOL CELL, V15, P221, DOI 10.1016/j.molcel.2004.06.002; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 1999, MOL CELL BIOL, V19, P4832; Borde V, 2004, MOL CELL, V13, P389, DOI 10.1016/S1097-2765(04)00034-6; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; Gabriel A, 2006, PLOS GENET, V2, P2026, DOI 10.1371/journal.pgen.0020212; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; HOROWITZ H, 1984, MOL CELL BIOL, V4, P2509, DOI 10.1128/MCB.4.11.2509; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mieczkowski PA, 2006, MOL CELL BIOL, V26, P1014, DOI 10.1128/MCB.26.3.1014-1027.2006; Murakami H, 2009, MOL CELL BIOL, V29, P3500, DOI 10.1128/MCB.00088-09; Neale MJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-104; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; PETES TD, 1977, P NATL ACAD SCI USA, V74, P5091, DOI 10.1073/pnas.74.11.5091; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Schlecht U, 2008, MOL BIOL CELL, V19, P2193, DOI 10.1091/mbc.E07-12-1242; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Xu F, 1996, GENETICS, V143, P1115	50	350	352	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					719	731		10.1016/j.cell.2011.02.009	http://dx.doi.org/10.1016/j.cell.2011.02.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376234	Green Accepted, Bronze			2022-12-28	WOS:000288007100011
J	Tehrani, MRM; Aalaa, M				Tehrani, Mohammad Reza Mohajeri; Aalaa, Maryam			Papules on the Eyelids, Lips, and Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tehrani, Mohammad Reza Mohajeri; Aalaa, Maryam] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran	Tehran University of Medical Sciences	Tehrani, MRM (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran.	mrmohajeri@sina.tums.ac.ir		Aalaa, Maryam/0000-0001-8664-3733					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					870	870		10.1056/NEJMicm1003203	http://dx.doi.org/10.1056/NEJMicm1003203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366478				2022-12-28	WOS:000287928400012
J	Vaidya, A; Kaiser, UB; Levy, BD; Loscalzo, J				Vaidya, Anand; Kaiser, Ursula B.; Levy, Bruce D.; Loscalzo, Joseph			Lying Low	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ISLET-CELL TUMORS; FUNCTIONING INSULINOMA; HYPOGLYCEMIC DISORDERS; LOCALIZATION; MANAGEMENT; PANCREAS		[Levy, Bruce D.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Dept Med, Harvard Inst Med Bldg,Ave Louis Pasteur HIM855, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021					Cryer PE, 1999, ENDOCRIN METAB CLIN, V28, P495, DOI 10.1016/S0889-8529(05)70084-0; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; Gill GV, 1997, POSTGRAD MED J, V73, P640, DOI 10.1136/pgmj.73.864.640; Guettier JM, 2009, J CLIN ENDOCR METAB, V94, P1074, DOI 10.1210/jc.2008-1986; Hirshberg B, 2000, J CLIN ENDOCR METAB, V85, P3222, DOI 10.1210/jc.85.9.3222; Kauhanen S, 2007, J CLIN ENDOCR METAB, V92, P1237, DOI 10.1210/jc.2006-1479; McLean AM, 2005, BEST PRACT RES CL EN, V19, P177, DOI 10.1016/j.beem.2004.11.012; Noone TC, 2005, BEST PRACT RES CL EN, V19, P195, DOI 10.1016/j.beem.2004.11.013; Placzkowski KA, 2009, J CLIN ENDOCR METAB, V94, P1069, DOI 10.1210/jc.2008-2031; SERVICE FJ, 1995, NEW ENGL J MED, V332, P1144, DOI 10.1056/NEJM199504273321707; SERVICE FJ, 1991, MAYO CLIN PROC, V66, P711, DOI 10.1016/S0025-6196(12)62083-7; SERVICE FJ, 1976, MAYO CLIN PROC, V51, P417; Virgolini I, 2005, BEST PRACT RES CL EN, V19, P213, DOI 10.1016/j.beem.2004.09.001; Whipple AO, 1938, J INT CHIR, V3, P237	14	3	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					871	875		10.1056/NEJMcps0903869	http://dx.doi.org/10.1056/NEJMcps0903869			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366479				2022-12-28	WOS:000287928400014
J	Mathews, SC; Pronovost, PJ				Mathews, Simon C.; Pronovost, Peter J.			The Need for Systems Integration in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mathews, Simon C.; Pronovost, Peter J.] Johns Hopkins Qual & Safety Res Grp, Baltimore, MD 21231 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Hlth Policy Management, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Pronovost, PJ (corresponding author), Johns Hopkins Qual & Safety Res Grp, Union Wharf Bldg,1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu	Mathews, Simon/AAU-9176-2020					Clark T, IMPACT CLIN ALARMS P; Cutler D, 2010, HEALTH AFFAIR, V29, P1131, DOI 10.1377/hlthaff.2010.0416; Espicom Business Intelligence, MED DEV MARK US; Jones H, 2010, FMIS CONSTRUCTION OU, P1; Kabachinski Jeff, 2006, Biomed Instrum Technol, V40, P375, DOI 10.2345/i0899-8205-40-5-375.1	5	25	25	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					934	935		10.1001/jama.2011.237	http://dx.doi.org/10.1001/jama.2011.237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728DP	21364143				2022-12-28	WOS:000287854700028
J	Wormser, D; Kaptoge, S; Di Angelantonio, E; Wood, AM; Pennells, L; Thompson, A; Sarwar, N; Kizer, JR; Lawlor, DA; Nordestgaard, BG; Ridker, P; Salomaa, V; Stevens, J; Woodward, M; Sattar, N; Collins, R; Thompson, SG; Whitlock, G; Danesh, J				Wormser, David; Kaptoge, Stephen; Di Angelantonio, Emanuele; Wood, Angela M.; Pennells, Lisa; Thompson, Alex; Sarwar, Nadeem; Kizer, Jorge R.; Lawlor, Debbie A.; Nordestgaard, Borge G.; Ridker, Paul; Salomaa, Veikko; Stevens, June; Woodward, Mark; Sattar, Naveed; Collins, Rory; Thompson, Simon G.; Whitlock, Gary; Danesh, John		Emerging Risk Factors	Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies	LANCET			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; WAIST CIRCUMFERENCE; RISK; COUNTRIES; OBESITY; CURVE; DEATH; MEN	Background Guidelines differ about the value of assessment of adiposity measures for cardiovascular disease risk prediction when information is available for other risk factors. We studied the separate and combined associations of body-mass index (BMI), waist circumference, and waist-to-hip ratio with risk of first-onset cardiovascular disease. Methods We used individual records from 58 cohorts to calculate hazard ratios (HRs) per 1 SD higher baseline values (4.56 kg/m(2) higher BMI, 12.6 cm higher waist circumference, and 0 083 higher waist-to-hip ratio) and measures of risk discrimination and reclassification. Serial adiposity assessments were used to calculate regression dilution ratios. Results Individual records were available for 221 934 people in 17 countries (14 297 incident cardiovascular disease outcomes; 1.87 million person-years at risk). Serial adiposity assessments were made in up to 63 821 people (mean interval 5.7 years [SD 3.9]). In people with BMI of 20 kg/m2 or higher, HRs for cardiovascular disease were 1.23 (95% CI 1.17-1.29) with BMI, 1.27 (1.20-1.33) with waist circumference, and 1.25 (1.19-1.31) with waist-to-hip ratio, after adjustment for age, sex, and smoking status. After further adjustment for baseline systolic blood pressure, history of diabetes, and total and HDL cholesterol, corresponding HRs were 1 07 (1.03-1.11) with BMI, 1.10 (1.05-1.14) with waist circumference, and 1.12 (1.08-1.15) with waist-to-hip ratio. Addition of information on BMI, waist circumference, or waist-to-hip ratio to a cardiovascular disease risk prediction model containing conventional risk factors did not importantly improve risk discrimination (C-index changes of -0.0001, -0.0001, and 0.0008, respectively), nor classification of participants to categories of predicted 10-year risk (net reclassification improvement -0.19%, -0.05%, and -0.05%, respectively). Findings were similar when adiposity measures were considered in combination. Reproducibility was greater for BMI (regression dilution ratio 0.95, 95% CI 0.93-0.97) than for waist circumference (0.86, 0.83-0.89) or waist-to-hip ratio (0.63, 0.57-0.70). Interpretation BMI, waist circumference, and waist-to-hip ratio, whether assessed singly or in combination, do not importantly improve cardiovascular disease risk prediction in people in developed countries when additional information is available for systolic blood pressure, history of diabetes, and lipids.	[Wormser, David] Univ Cambridge, Dept Publ Hlth & Primary Care, Emerging Risk Factors Collaborat Coordinating Ctr, Strangeways Res Lab, Cambridge CB1 8RN, England; [Kizer, Jorge R.] Weill Cornell Med Coll, New York, NY USA; [Lawlor, Debbie A.] Univ Bristol, Bristol, Avon, England; [Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen, Denmark; [Ridker, Paul] Brigham & Womens Hosp, Boston, MA 02115 USA; [Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Stevens, June] Univ N Carolina, Chapel Hill, NC USA; [Woodward, Mark] Univ Sydney, Sydney, NSW 2006, Australia; [Sattar, Naveed] Univ Glasgow, Glasgow, Lanark, Scotland; [Collins, Rory; Whitlock, Gary] Univ Oxford, Oxford, England; [Thompson, Simon G.] MRC, Biostat Unit, Cambridge CB2 2BW, England	University of Cambridge; Cornell University; University of Bristol; University of Copenhagen; Harvard University; Brigham & Women's Hospital; Finland National Institute for Health & Welfare; University of North Carolina; University of North Carolina Chapel Hill; University of Sydney; University of Glasgow; University of Oxford; MRC Biostatistics Unit	Wormser, D (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Emerging Risk Factors Collaborat Coordinating Ctr, Strangeways Res Lab, Cambridge CB1 8RN, England.		Brunner, Eric/H-2114-2011; Lennon, Lucy/ABB-9433-2020; Nordestgaard, Borge Gronne/ABF-1310-2020; Dankner, Rachel/Q-5245-2019; Woodward, Mark/D-8492-2015; Stefanadis, Christodoulos/ABH-2232-2020; DiAngelantonio, Emanuele/ABE-6852-2020; Rubio, Miguel Angel/GRJ-0134-2022; Sundström, Johan/A-6286-2009; Davey Smith, George/A-7407-2013; de la Camara, Agustin Gomez/S-7123-2018; Woodward, Mark/L-6817-2017; Bakker, Stephan J. L./J-4023-2015; Meisinger, Christine/B-5358-2014; PALMIERI, LUIGI/O-1845-2017; Ärnlöv, Johan/AAF-2746-2019; Collins, Rory/ABA-8487-2020; Gao, Pei/AAF-3065-2019; Gao, Pei/R-4794-2018; Shaffer, Jonathan A/B-2783-2013; Wood, Angela/GZA-5762-2022; Sakurai, Masaru/AAC-6551-2021; Ferrieres, Jean/S-7993-2016	Brunner, Eric/0000-0002-0595-4474; Lennon, Lucy/0000-0002-1738-1351; Dankner, Rachel/0000-0001-6454-6000; Stefanadis, Christodoulos/0000-0001-5974-6454; Rubio, Miguel Angel/0000-0002-0495-6240; Sundström, Johan/0000-0003-2247-8454; Davey Smith, George/0000-0002-1407-8314; Bakker, Stephan J. L./0000-0003-3356-6791; PALMIERI, LUIGI/0000-0002-4298-2642; Ärnlöv, Johan/0000-0002-6933-4637; Gao, Pei/0000-0001-8649-1290; Gao, Pei/0000-0001-8649-1290; Wood, Angela/0000-0002-7937-304X; Sakurai, Masaru/0000-0002-4929-3225; Davidson, Karina/0000-0002-9162-477X; Di Angelantonio, Emanuele/0000-0001-8776-6719; Tiemeier, Henning/0000-0002-4395-1397; Zimmet, Paul/0000-0003-0627-0776; Pennells, Lisa Anne/0000-0002-8594-3061; Koenig, Wolfgang/0000-0002-2064-9603; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Ferrieres, Jean/0000-0001-6144-1297; Sutherland, Susan/0000-0001-7184-8920; Stehouwer, Coen/0000-0001-8752-3223; Korin, Maya/0000-0002-8010-7769; Nietert, Paul/0000-0002-3933-4986; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Ramachandran, Vasan/0000-0001-7357-5970; Whincup, Peter/0000-0002-5589-4107; Woodward, Mark/0000-0001-9800-5296; Amouyel, Philippe/0000-0001-9088-234X; Morris, Richard/0000-0001-7240-4563; Lawlor, Debbie A/0000-0002-6793-2262; Butterworth, Adam/0000-0002-6915-9015; Lewington, Sarah/0000-0002-4496-4771; Franco, Oscar/0000-0002-4606-4929; Nordestgaard, Borge/0000-0002-1954-7220; Haycock, Philip/0000-0001-5001-3350; Lochen, Maja-Lisa/0000-0002-8532-6573; Kirkland, Susan/0000-0002-8182-2369	National Heart, Lung and Blood Institute; diaDexus; Merck; Department of Health; British Heart Foundation [RG/08/014]; National Institutes of Health; National Cancer Institute; AstraZeneca; Novartis; Bristol-Myers Squibb; Schering-Plough; Bayer; Solvay; BUPA Foundation; Denka; European Union; Evelyn Trust; Fogarty International Centre; GlaxoSmithKline; Pfizer; Roche; UK Biobank; UK Medical Research Council; Wellcome Trust; Allergan; National Institute of Neurological Disorders and Stroke; British Heart Foundation [RG/08/014/24067, PG/09/002/26056] Funding Source: researchfish; Medical Research Council [MC_U105260792, G1000143, G0600705, G0701619, G0701113, MC_U137686857, G0401527] Funding Source: researchfish; MRC [MC_U137686857, G0701619, G0701113, G0600705, MC_U105260792] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); diaDexus; Merck(Merck & Company); Department of Health; British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AstraZeneca(AstraZeneca); Novartis(Novartis); Bristol-Myers Squibb(Bristol-Myers Squibb); Schering-Plough(Merck & CompanySchering Plough Corporation); Bayer(Bayer AG); Solvay(Solvay SA); BUPA Foundation; Denka; European Union(European Commission); Evelyn Trust; Fogarty International Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Roche(Roche Holding); UK Biobank; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Allergan(AbbVieAllergan); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	AT has been a consultant for GlaxoSmithKline, and is now an employee of Roche. JRK and his institution have received research grants from the National Heart, Lung and Blood Institute, and diaDexus; and JRK has received payment for lectures from Merck. DAL's institution has received funding from Department of Health Policy Research Programme and the British Heart Foundation. PR's institution has received research grants from the National Institutes of Health, the National Cancer Institute, AstraZeneca, Novartis, and Merck. PR is listed as a co-inventor on patents relating to the use of inflammatory biomarkers in cardiovascular disease that are held by the Brigham and Women's Hospital and have been licensed to Siemens and AstraZeneca; and has served as a consultant to Genzyme, Vascular Biogenics, Boerringher Ingelheim, and Amylin. NSat's institution has received research grants from Allergan. RC and GW's institution has received research funding from Merck, AstraZeneca, Bristol-Myers Squibb, Schering-Plough, Novartis, Bayer, and Solvay. RC's institution has also received travel and accommodation expenses from Merck. JD has been a board member for Merck and Novartis; and has been a consultant for Novartis, Merck, GlaxoSmithKline, and Pfizer. JD's institution has received research grants from the British Heart Foundation, BUPA Foundation, Denka, diaDexus, European Union, Evelyn Trust, Fogarty International Centre, GlaxoSmithKline, Merck, National Heart, Lung and Blood Institute, National Institute of Neurological Disorders and Stroke, Novartis, Pfizer, Roche, UK Biobank, UK Medical Research Council, and Wellcome Trust. All Other members of the writing committee declare that they have no conflicts of interest.; The Emerging Risk Factors Collaboration Coordinating Centre is underpinned by a programme grant from the British Heart Foundation (RG/08/014) and grants from the UK Medical Research Council. Various sources have supported recruitment, follow-up, and laboratory measurements in the 122 cohorts contributing to the Emerging Risk Factors Collaboration. Investigators of several of these studies have contributed to a list naming some of these funding sources.	[Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Bell AC, 2002, AM J EPIDEMIOL, V155, P346, DOI 10.1093/aje/155.4.346; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Danesh J, 2009, STAT MED, V28, P389, DOI 10.1002/sim.3378; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kizer JR, 2011, AM J EPIDEMIOL, V173, P10, DOI 10.1093/aje/kwq311; Lemieux I, 2007, CAN J CARDIOL, V23, p23B, DOI 10.1016/S0828-282X(07)71007-3; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Logue J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c154; Mhurchu CN, 2006, ASIA PAC J CLIN NUTR, V15, P287; National Institutes of Health, 1998, OBES RES S2, V6, p51S, DOI DOI 10.1002/J.1550-8528.1998.TB00690.X; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Steptoe A, 1999, BRIT MED J, V319, P943, DOI 10.1136/bmj.319.7215.943; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization Consultation on Obesity, 2000, OB PREV MAN GLOB EP; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	38	705	725	3	69	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2011	377	9771					1085	1095		10.1016/S0140-6736(11)60105-0	http://dx.doi.org/10.1016/S0140-6736(11)60105-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	743QY	21397319	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000289035000029
J	Gandotra, S; Le Dour, C; Bottomley, W; Cervera, P; Giral, P; Reznik, Y; Charpentier, G; Auclair, M; Delepine, M; Barroso, I; Semple, RK; Lathrop, M; Lascols, O; Capeau, J; O'Rahilly, S; Magre, J; Savage, DB; Vigouroux, C				Gandotra, Sheetal; Le Dour, Caroline; Bottomley, William; Cervera, Pascale; Giral, Philippe; Reznik, Yves; Charpentier, Guillaume; Auclair, Martine; Delepine, Marc; Barroso, Ines; Semple, Robert K.; Lathrop, Mark; Lascols, Olivier; Capeau, Jacqueline; O'Rahilly, Stephen; Magre, Jocelyne; Savage, David B.; Vigouroux, Corinne			Perilipin Deficiency and Autosomal Dominant Partial Lipodystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEIP CONGENITAL LIPODYSTROPHY; INSULIN-RESISTANCE; LIPID DROPLETS; ADIPOSE-TISSUE; LIPOLYSIS; ADIPONECTIN; METABOLISM; MUTATIONS; OBESITY; ABSENCE	Perilipin is the most abundant adipocyte-specific protein that coats lipid droplets, and it is required for optimal lipid incorporation and release from the droplet. We identified two heterozygous frameshift mutations in the perilipin gene (PLIN1) in three families with partial lipodystrophy, severe dyslipidemia, and insulin-resistant diabetes. Subcutaneous fat from the patients was characterized by smaller-than-normal adipocytes, macrophage infiltration, and fibrosis. In contrast to wild-type perilipin, mutant forms of the protein failed to increase triglyceride accumulation when expressed heterologously in preadipocytes. These findings define a novel dominant form of inherited lipodystrophy and highlight the serious metabolic consequences of a primary defect in the formation of lipid droplets in adipose tissue.	[Gandotra, Sheetal; Barroso, Ines; Semple, Robert K.; O'Rahilly, Stephen; Savage, David B.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 0QQ, England; [Bottomley, William; Barroso, Ines] Wellcome Trust Sanger Inst, Metab Dis Grp, Hinxton, England; [Le Dour, Caroline; Cervera, Pascale; Auclair, Martine; Lascols, Olivier; Capeau, Jacqueline; Magre, Jocelyne; Vigouroux, Corinne] Univ Paris 06, INSERM, UMR S938, Paris, France; [Le Dour, Caroline; Cervera, Pascale; Auclair, Martine; Lascols, Olivier; Capeau, Jacqueline; Magre, Jocelyne; Vigouroux, Corinne] Ctr Rech St Antoine, Paris, France; [Cervera, Pascale] Hop St Antoine, Serv Anatomopathol, Serv Biochim & Hormonol, F-75571 Paris, France; [Lascols, Olivier] Lab Commun Biol & Genet Mol, Paris, France; [Giral, Philippe] Grp Hosp Pitie Salpetriere, Serv Endocrinol Metab, F-75634 Paris, France; [Reznik, Yves] Ctr Hosp Univ Cote Nacre, Serv Endocrinol & Malad Metab, Caen, France; [Charpentier, Guillaume] Ctr Hosp Sud Francilien, Serv Diabetol Endocrinol, Corbeil Essonnes, France; [Delepine, Marc; Lathrop, Mark] Ctr Natl Genotypage, Evry, France	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Centre Hospitalier Sud Francilien; CEA; UDICE-French Research Universities; Universite Paris Saclay	Savage, DB (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Hills Rd, Cambridge CB2 0QQ, England.	dbs23@medschl.cam.ac.uk; corinne.vigouroux@inserm.fr	Semple, Robert/AAB-2948-2019; MAGRE, Jocelyne/D-4788-2015; O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Auclair, Martine/0000-0003-3600-1999; Semple, Robert Kenneth/0000-0001-6539-3069; Barroso, Ines/0000-0001-5800-4520; Savage, David Bousfield/0000-0002-7857-7032; Le Dour, Caroline/0000-0001-8647-3252	Wellcome Trust [077016/Z/05/Z]; U.K. National Institute for Health Research Cambridge Biomedical Research Centre; Medical Research Council Center for Obesity and Related Metabolic Disease; Societe Francophone du Diabete (Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques); INSERM; French Ministere de l'Enseignement Superieur et de la Recherche; Medical Research Council [G0600717B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); U.K. National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council Center for Obesity and Related Metabolic Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Societe Francophone du Diabete (Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Ministere de l'Enseignement Superieur et de la Recherche; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Wellcome Trust (077016/Z/05/Z, to Drs. Gandotra, Bottomley, Barroso, Semple, O'Rahilly, and Savage), GlaxoSmithKline (to Dr. Savage), the U.K. National Institute for Health Research Cambridge Biomedical Research Centre, the Medical Research Council Center for Obesity and Related Metabolic Disease, Societe Francophone du Diabete (Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques) (to Dr. Magre), INSERM (to Drs. Cervera, Lascols, Capeau, Magre, and Vigouroux), and the French Ministere de l'Enseignement Superieur et de la Recherche (to Dr. Le Dour).	Antuna-Puente B, 2010, J CLIN ENDOCR METAB, V95, P1463, DOI 10.1210/jc.2009-1824; Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Decaudain A, 2007, J CLIN ENDOCR METAB, V92, P4835, DOI 10.1210/jc.2007-0654; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Garcia A, 2004, J BIOL CHEM, V279, P8409, DOI 10.1074/jbc.M311198200; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Haque WA, 2002, J CLIN ENDOCR METAB, V87, P2395, DOI 10.1210/jc.87.5.2395; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106, DOI 10.1093/ajcn/51.6.1106; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Saha PK, 2004, J BIOL CHEM, V279, P35150, DOI 10.1074/jbc.M405499200; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Subramanian V, 2004, J LIPID RES, V45, P1983, DOI 10.1194/jlr.M400291-JLR200; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200	25	191	203	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					740	748		10.1056/NEJMoa1007487	http://dx.doi.org/10.1056/NEJMoa1007487			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345103	Green Accepted			2022-12-28	WOS:000287652500008
J	Pilling, S; Yesufu-Udechuku, A; Taylor, C; Drummond, C				Pilling, Stephen; Yesufu-Udechuku, Amina; Taylor, Clare; Drummond, Colin		Guideline Dev Grp	Diagnosis, assessment, and management of harmful drinking and alcohol dependence: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material												s.pilling@ucl.ac.uk	Drummond, Colin/O-9141-2019	Drummond, Colin/0000-0001-9379-5452; Mavranezouli, Ifigeneia/0000-0001-9095-3566	National Institute for Health Research [RP-PG-0609-10162] Funding Source: researchfish; MRC [G0701681, G0701818] Funding Source: UKRI; Medical Research Council [G0701681, G0701818] Funding Source: Medline; Department of Health [RP-PG-0609-10162] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; *DEP HLTH, 2006, MOD CAR ALC MIS; Drummond C, 1990, BR J ADDICT, V85, P357; Drummond DC, 2005, ALCOHOL NEEDS ASSESS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuller E., 2008, DRUG USE SMOKING DRI; *N W PUBL HLTH OBS, 2010, N W PUBL HLTH OBS LO; *NAT I HLTH CLIN E, 2009, GUID MAN NAT I HLTH; *NAT I HLTH CLIN E, 2005, CLIN GUID, V31; *NAT I HLTH CLIN E, 2005, CLIN GUID, V26; National Institute for Health and Care Excellence (NICE), 2011, ALCOHOL USE DISORDER; National Institute for Health and Clinical Excellence, 2009, CLIN GUID; National Institute for Health and Clinical Excellence, 2011, CLIN GUID; National Institute for Health and Clinical Excellence, 2010, ALC US DIS PREV DEV; National Institute for Health and Clinical Excellence, 2010, CLIN GUID, V94; RAISTRICK D, 1994, ADDICTION, V89, P563, DOI 10.1111/j.1360-0443.1994.tb03332.x; Stockwell T, 1979, BR J ADDICT ALCOHOL, V74, P78	17	24	25	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d700	10.1136/bmj.d700	http://dx.doi.org/10.1136/bmj.d700			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345905				2022-12-28	WOS:000287920100006
J	van Weel, C; Roberts, R; De Maeseneer, J; van der Velden, K				van Weel, Chris; Roberts, Richard; De Maeseneer, Jan; van der Velden, Koos			Public health: profession, health system, government control	LANCET			English	Editorial Material									[van Weel, Chris; van der Velden, Koos] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Roberts, Richard] Univ Wisconsin, Dept Family Med, Sch Med & Publ Hlth, Madison, WI USA; [De Maeseneer, Jan] Univ Ghent, Dept Family Med & Primary Hlth Care, B-9000 Ghent, Belgium	Radboud University Nijmegen; University of Wisconsin System; University of Wisconsin Madison; Ghent University	van Weel, C (corresponding author), Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, NL-6500 HB Nijmegen, Netherlands.	c.vanweel@elg.umcn.nl	van der Velden, J./H-8101-2014; van Weel, Chris/D-4375-2009; Mindell, Jennifer/G-2241-2011	van Weel, Chris/0000-0003-3653-4701; Mindell, Jennifer/0000-0002-7604-6131; Raine, Rosalind/0000-0003-0904-749X				Boelen Charles, 2004, Educ Health (Abingdon), V17, P223, DOI 10.1080/13576280410001711049; De Maeseneer J, 2010, LANCET, V375, P1588, DOI 10.1016/S0140-6736(10)60658-7; De Maeseneer JM, 2003, LANCET, V362, P1314, DOI 10.1016/S0140-6736(03)14576-X; MACKENBACH JW, 1992, FATHERS ICARUS; McKee M, 2011, LANCET, V378, P536, DOI 10.1016/S0140-6736(11)60241-9; Rhyne R, 1998, COMMUNITY ORIENTED P; WHO, 2008, PHARMAFORUM 0121	7	2	2	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 6	2011	378	9790					468	469		10.1016/S0140-6736(11)60275-4	http://dx.doi.org/10.1016/S0140-6736(11)60275-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	809SO	21354609				2022-12-28	WOS:000294077200009
J	Raya-Rivera, A; Esquiliano, DR; Yoo, JJ; Lopez-Bayghen, E; Soker, S; Atala, A				Raya-Rivera, Atlantida; Esquiliano, Diego R.; Yoo, James J.; Lopez-Bayghen, Esther; Soker, Shay; Atala, Anthony			Tissue-engineered autologous urethras for patients who need reconstruction: an observational study	LANCET			English	Article							COLLAGEN MATRIX; BUCCAL MUCOSAL; GRAFTS; VASCULARIZATION; REPLACEMENT; MANAGEMENT; ANTERIOR; STENOSIS; BLADDER	Background Complex urethral problems can occur as a result of injury, disease, or congenital defects and treatment options are often limited. Urethras, similar to other long tubularised tissues, can stricture after reconstruction. We aimed to assess the effectiveness of tissue-engineered urethras using patients' own cells in patients who needed urethral reconstruction. Methods Five boys who had urethral defects were included in the study. A tissue biopsy was taken from each patient, and the muscle and epithelial cells were expanded and seeded onto tubularised polyglycolic acid:poly(lactide-co-glycolide acid) scaffolds. Patients then underwent urethral reconstruction with the tissue-engineered tubularised urethras. We took patient history, asked patients to complete questionnaires from the International Continence Society (ICS), and did urine analyses, cystourethroscopy, cystourethrography, and flow measurements at 3, 6, 12, 24, 36, 48, 60, and 72 months after surgery. We did serial endoscopic cup biopsies at 3, 12, and 36 months, each time in a different area of the engineered urethras. Findings Patients had surgery between March 19, 2004, and July 20, 2007. Follow-up was completed by July 31, 2010. Median age was 11 years (range 10-14) at time of surgery and median follow-up was 71 months (range 36-76 months). AE1/AE3, alpha actin, desmin, and myosin antibodies confirmed the presence of cells of epithelial and muscle lineages on all cultures. The median end maximum urinary flow rate was 27.1 mL/s (range 16-28), and serial radiographic and endoscopic studies showed the maintenance of wide urethral calibres without strictures. Urethral biopsies showed that the engineered grafts had developed a normal appearing architecture by 3 months after implantation. Interpretation Tubularised urethras can be engineered and remain functional in a clinical setting for up to 6 years. These engineered urethras can be used in patients who need complex urethral reconstruction.	[Raya-Rivera, Atlantida; Yoo, James J.; Lopez-Bayghen, Esther; Soker, Shay; Atala, Anthony] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA; [Raya-Rivera, Atlantida; Yoo, James J.; Lopez-Bayghen, Esther; Soker, Shay; Atala, Anthony] Wake Forest Univ, Sch Med, Dept Urol, Winston Salem, NC 27157 USA; [Raya-Rivera, Atlantida; Esquiliano, Diego R.; Lopez-Bayghen, Esther] Metropolitan Autonomous Univ, HIMFG Tissue Engn Lab, Mexico City, DF, Mexico; [Raya-Rivera, Atlantida; Esquiliano, Diego R.; Lopez-Bayghen, Esther] IPN, CINVESTAV, Mexico City 07738, DF, Mexico	Wake Forest University; Wake Forest University; Universidad Autonoma Metropolitana - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Atala, A (corresponding author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.	aatala@wfubmc.edu	Yoo, James J./L-4850-2017; Lopez-Bayghen, Esther/A-8006-2008	Lopez-Bayghen, Esther/0000-0002-2849-7587; Atala, Anthony/0000-0001-8186-2160	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [AA- P50DKO65289]; Conacyt; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065298] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (AA- P50DKO65289). ARR and DE were recipients of a Conacyt Doctoral Fellowship. We thank R Fierro-Pastrana and P Valencia for their scientific expertise and contributions, and J Olson for editorial assistance.	Al-Qudah Hosam S., 2005, Int. braz j urol., V31, P459, DOI 10.1590/S1677-55382005000500007; Asif A, 2005, KIDNEY INT, V67, P1986, DOI 10.1111/j.1523-1755.2005.00299.x; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9; ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5; Bhargava S, 2008, EUR UROL, V53, P1263, DOI 10.1016/j.eururo.2008.01.061; Brandes S, 2006, UROL CLIN N AM, V33, P87, DOI 10.1016/j.ucl.2005.10.001; Caldamone AA, 1998, UROLOGY, V51, P15, DOI 10.1016/S0090-4295(98)00088-0; Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X; De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1016/S0022-5347(05)64414-X; Dorin RP, 2008, WORLD J UROL, V26, P323, DOI 10.1007/s00345-008-0316-6; El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101; El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8; Joseph D., 2009, AM UR ASS ANN M CHIC; Kajbafzadeh Abdol-Mohammad, 2005, BMC Urol, V5, P3, DOI 10.1186/1471-2490-5-3; Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006; KANTERMAN RY, 1995, RADIOLOGY, V195, P135, DOI 10.1148/radiology.195.1.7892454; Koraitim MM, 2004, UROLOGY, V64, P228, DOI 10.1016/j.urology.2004.03.019; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mundy AR, 2006, POSTGRAD MED J, V82, P489, DOI 10.1136/pgmj.2005.042945; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Pansadoro Vito, 2002, Curr Opin Urol, V12, P223, DOI 10.1097/00042307-200205000-00008; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Sander EA, 2004, J BIOMED MATER RES A, V70A, P506, DOI 10.1002/jbm.a.30109; Sarkar S, 2007, MED BIOL ENG COMPUT, V45, P327, DOI 10.1007/s11517-007-0176-z; Zinman L, 2000, Curr Urol Rep, V1, P180, DOI 10.1007/s11934-000-0017-1	26	322	349	1	87	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1175	1182		10.1016/S0140-6736(10)62354-9	http://dx.doi.org/10.1016/S0140-6736(10)62354-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21388673	Green Accepted			2022-12-28	WOS:000289539300033
J	Laurance, J				Laurance, Jeremy			On Reflection Somebody's mother	LANCET			English	Editorial Material												j.Laurance@independent.co.uk							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					895	895		10.1016/S0140-6736(11)60337-1	http://dx.doi.org/10.1016/S0140-6736(11)60337-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GR	21397754				2022-12-28	WOS:000288628800016
J	Graf, A; Weihermuller, L; Huisman, JA; Herbst, M; Vereecken, H				Graf, Alexander; Weihermueller, Lutz; Huisman, Johan A.; Herbst, Michael; Vereecken, Harry			Comment on "Global Convergence in the Temperature Sensitivity of Respiration at Ecosystem Level"	SCIENCE			English	Editorial Material							SOIL RESPIRATION; DEPENDENCE; DEPTH	Mahecha et al. (Reports, 13 August 2010, p. 838) estimated the temperature sensitivity of ecosystem respiration (Q(10)) and showed that temperature sensitivity and its site-to-site variability are lower than previously reported. We demonstrate that their Q(10) value of 1.4 is an underestimate if interpreted as the averaged sensitivities of all ecosystem components, because fast temperature fluctuations penetrate poorly into the soil.	[Graf, Alexander; Weihermueller, Lutz; Huisman, Johan A.; Herbst, Michael; Vereecken, Harry] Forschungszentrum Juelich, Agrosphere Inst IBG 3, Inst Bio & Geosci, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Graf, A (corresponding author), Forschungszentrum Juelich, Agrosphere Inst IBG 3, Inst Bio & Geosci, D-52425 Julich, Germany.	a.graf@fz-juelich.de	Huisman, J.A./I-7078-2012; Graf, Alexander/D-1963-2009	Huisman, J.A./0000-0002-1327-0945; Graf, Alexander/0000-0003-4870-7622; Migliavacca, Mirco/0000-0003-3546-8407; Herbst, Michael/0000-0003-1371-4208; Vereecken, Harry/0000-0002-8051-8517				Aubinet M, 2009, AGR FOREST METEOROL, V149, P407, DOI 10.1016/j.agrformet.2008.09.003; Bahn M, 2008, ECOSYSTEMS, V11, P1352, DOI 10.1007/s10021-008-9198-0; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Briones MJI, 2009, NATO SCI PEACE SECUR, P317, DOI 10.1007/978-90-481-2636-1_14; Graf A, 2008, BIOGEOSCIENCES, V5, P1175, DOI 10.5194/bg-5-1175-2008; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Pavelka M, 2007, PLANT SOIL, V292, P171, DOI 10.1007/s11104-007-9213-9; Phillips CL, 2011, GLOBAL CHANGE BIOL, V17, P515, DOI 10.1111/j.1365-2486.2010.02250.x; Pingintha N, 2010, TELLUS B, V62, P47, DOI 10.1111/j.1600-0889.2009.00445.x; Reich PB, 2010, SCIENCE, V329, P774, DOI 10.1126/science.1194353; Reichstein M, 2008, J PLANT NUTR SOIL SC, V171, P344, DOI 10.1002/jpln.200700075; Subke JA, 2010, SOIL BIOL BIOCHEM, V42, P1653, DOI 10.1016/j.soilbio.2010.05.026; Van Wijk W.R., 1963, PHYS PLANT ENV, P62, DOI [10.1002/qj.49709038628, DOI 10.1002/QJ.49709038628]; Zha TS, 2007, ANN BOT-LONDON, V99, P345, DOI 10.1093/aob/mcl266	15	9	10	10	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1265	+		10.1126/science.1196948	http://dx.doi.org/10.1126/science.1196948			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393526				2022-12-28	WOS:000288215200024
J	Belloni, B; Andres, C				Belloni, Benedetta; Andres, Christian			Extravasation of Peripherally Administered Parenteral Nutrition	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Belloni, Benedetta; Andres, Christian] Tech Univ Munich, Munich, Germany	Technical University of Munich	Belloni, B (corresponding author), Tech Univ Munich, Munich, Germany.	benedetta.belloni@lrz.tum.de							0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					E20	E20		10.1056/NEJMicm1006399	http://dx.doi.org/10.1056/NEJMicm1006399			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21388305				2022-12-28	WOS:000288170300013
J	Haller, H; Ito, S; Izzo, JL; Januszewicz, A; Katayama, S; Menne, J; Mimran, A; Rabelink, TJ; Ritz, E; Ruilope, LM; Rump, LC; Viberti, G				Haller, Hermann; Ito, Sadayoshi; Izzo, Joseph L., Jr.; Januszewicz, Andrzej; Katayama, Shigehiro; Menne, Jan; Mimran, Albert; Rabelink, Ton J.; Ritz, Eberhard; Ruilope, Luis M.; Rump, Lars C.; Viberti, Giancarlo		ROADMAP Trial Investigators	Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOWERING BLOOD-PRESSURE; HYPERTENSION; LOSARTAN; ALBUMINURIA; NEPHROPATHY; TELMISARTAN; MORTALITY; OUTCOMES; DISEASE; RISK	BACKGROUND Microalbuminuria is an early predictor of diabetic nephropathy and premature cardiovascular disease. We investigated whether treatment with an angiotensin-receptor blocker (ARB) would delay or prevent the occurrence of microalbuminuria in patients with type 2 diabetes and normoalbuminuria. METHODS In a randomized, double-blind, multicenter, controlled trial, we assigned 4447 patients with type 2 diabetes to receive olmesartan ( at a dose of 40 mg once daily) or placebo for a median of 3.2 years. Additional antihypertensive drugs ( except angiotensin-converting-enzyme inhibitors or ARBs) were used as needed to lower blood pressure to less than 130/80 mm Hg. The primary outcome was the time to the first onset of microalbuminuria. The times to the onset of renal and cardiovascular events were analyzed as secondary end points. RESULTS The target blood pressure (< 130/80 mm Hg) was achieved in nearly 80% of the patients taking olmesartan and 71% taking placebo; blood pressure measured in the clinic was lower by 3.1/1.9 mm Hg in the olmesartan group than in the placebo group. Microalbuminuria developed in 8.2% of the patients in the olmesartan group (178 of 2160 patients who could be evaluated) and 9.8% in the placebo group (210 of 2139); the time to the onset of microalbuminuria was increased by 23% with olmesartan (hazard ratio for onset of microalbuminuria, 0.77; 95% confidence interval, 0.63 to 0.94; P = 0.01). The serum creatinine level doubled in 1% of the patients in each group. Slightly fewer patients in the olmesartan group than in the placebo group had nonfatal cardiovascular events - 81 of 2232 patients (3.6%) as compared with 91 of 2215 patients (4.1%) (P = 0.37) - but a greater number had fatal cardiovascular events - 15 patients (0.7%) as compared with 3 patients (0.1%) (P = 0.01), a difference that was attributable in part to a higher rate of death from cardiovascular causes in the olmesartan group than in the placebo group among patients with preexisting coronary heart disease (11 of 564 patients [2.0%] vs. 1 of 540 [0.2%], P = 0.02). CONCLUSIONS Olmesartan was associated with a delayed onset of microalbuminuria, even though blood-pressure control in both groups was excellent according to current standards. The higher rate of fatal cardiovascular events with olmesartan among patients with preexisting coronary heart disease is of concern.	[Haller, Hermann; Menne, Jan] Hannover Med Sch, Dept Nephrol & Hypertens, D-30625 Hannover, Germany; [Ritz, Eberhard] Heidelberg Univ, Dept Nephrol, Heidelberg, Germany; [Rump, Lars C.] Univ Dusseldorf, Dept Nephrol, D-4000 Dusseldorf, Germany; [Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Dept Clin Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan; [Katayama, Shigehiro] Saitama Med Sch, Dept Endocrinol & Diabet, Iruma, Saitama, Japan; [Izzo, Joseph L., Jr.] SUNY Buffalo, Dept Med, Sch Med & Biomed Sci, Buffalo, NY 14260 USA; [Januszewicz, Andrzej] Inst Cardiol, Dept Hypertens, Warsaw, Poland; [Mimran, Albert] Hosp Lapeyronie, Montpellier, France; [Rabelink, Ton J.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Rabelink, Ton J.] Leiden Univ, Med Ctr, Einthoven Lab Vasc Med, Leiden, Netherlands; [Ruilope, Luis M.] Hosp 12 Octubre, Div Hypertens, E-28041 Madrid, Spain; [Viberti, Giancarlo] Guys Hosp, Sch Med, Kings Coll London, London SE1 9RT, England	Hannover Medical School; Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; Tohoku University; Saitama Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Institute of Cardiology - Poland; Universite de Montpellier; CHU de Montpellier; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hospital Universitario 12 de Octubre; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Haller, H (corresponding author), Hannover Med Sch, Dept Nephrol & Hypertens, Carl Neuberg Str 1, D-30625 Hannover, Germany.	haller.hermann@mh-hannover.de	Broz, Jan/E-6919-2018; Lember, Margus/H-2306-2015; Genovese, Stefano/F-9706-2017; Cífková, Renata/O-5731-2017; Chazova, Irina/B-8688-2017; Ponikowski, Piotr/O-6454-2015; Kuznetsova, Tatiana/ABI-5662-2020; Zadionchenko, Vladimir/A-7445-2016; Rabelink, Ton J./A-5316-2008; Ito, Sadayoshi/A-3933-2015; Remuzzi, Giuseppe/V-9766-2017	Broz, Jan/0000-0003-2465-7333; Genovese, Stefano/0000-0002-6085-437X; Cífková, Renata/0000-0003-2765-3821; Chazova, Irina/0000-0002-9822-4357; Ponikowski, Piotr/0000-0002-3391-7064; Kuznetsova, Tatiana/0000-0003-4293-4576; Zadionchenko, Vladimir/0000-0003-2377-5266; Rabelink, Ton J./0000-0001-6780-5186; Keymeulen, Bart/0000-0002-8671-4527; Ruilope, Luis M/0000-0001-6278-7951; Ito, Sadayoshi/0000-0002-5092-3626; Narkiewicz, Krzysztof/0000-0001-5949-5018; Remuzzi, Giuseppe/0000-0002-6194-3446; DIVISON GARROTE, JUAN ANTONIO/0000-0001-9947-8423; Yena, Larisa/0000-0001-9633-1848; Persu, Alexandre/0000-0002-4007-9695; Pozzilli, Paolo/0000-0001-5090-636X; Ametov, A.S./0000-0002-7936-7619	Daiichi Sankyo; Bayer Schering Pharma; Roche; Menarini; Amgen; Novartis Pharmaceuticals; Takeda Pharmaceutical; Tohoku University Graduate School of Medicine; Astellas Pharma; Boehringer Ingelheim; Shionogi; Dainippon Sumitomo Pharma; Banyu Pharmaceutical; Adamed; Bayer Healthcare; Sanofi-Aventis; Sandoz; Merck; Krka; Berlin-Chemie; Servier	Daiichi Sankyo(Daiichi Sankyo Company Limited); Bayer Schering Pharma(Bayer AG); Roche(Roche Holding); Menarini(Menarini Group); Amgen(Amgen); Novartis Pharmaceuticals(Novartis); Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd); Tohoku University Graduate School of Medicine; Astellas Pharma(Astellas Pharmaceuticals); Boehringer Ingelheim(Boehringer Ingelheim); Shionogi; Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Banyu Pharmaceutical; Adamed; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Sanofi-Aventis(Sanofi-Aventis); Sandoz(Novartis); Merck(Merck & Company); Krka; Berlin-Chemie; Servier(Servier)	Funded by Daiichi Sankyo; ClinicalTrials.gov number, NCT00185159.; Dr. Haller reports receiving payment for board membership from Novartis, consulting fees from Bayer Schering Pharma and Daiichi Sankyo, lecture fees from Bayer Schering Pharma, Roche, and Menarini, payment for development of educational presentations from Daiichi Sankyo and Bayer Schering Pharma, and travel support from Amgen and Daiichi Sankyo; Dr. Ito, consulting fees from Novartis Pharmaceuticals and Takeda Pharmaceutical, grant support paid to his institution, Tohoku University Graduate School of Medicine, from Banyu Pharmaceutical, Takeda Pharmaceutical, Astellas Pharma, Boehringer Ingelheim, Novartis Pharmaceuticals, Shionogi, and Dainippon Sumitomo Pharma, and lecture fees from Banyu Pharmaceutical, Takeda Pharmaceutical, Astellas Pharma, Boehringer Ingelheim, Novartis Pharmaceuticals, Shionogi, and Dainippon Sumitomo Pharma; Dr. Izzo, consulting and lecture fees from Daiichi Sankyo; Dr. Januszewicz, lecture fees from Boehringer Ingelheim, Novartis, Adamed, Bayer Healthcare, Sanofi-Aventis, Sandoz, Merck, and Krka; Dr. Katayama, grant support from Daiichi Sankyo, Merck, Novartis, and Boehringer Ingelheim and lecture fees from Daiichi Sankyo, Merck, Novartis, and Astellas Pharma; Dr. Menne, lecture fees from Berlin-Chemie, Novartis, and Daiichi Sankyo; Dr. Mimran, payment for board membership and consulting fees from Daiichi Sankyo and Servier; Dr. Ruilope, payment for board membership and consulting and lecture fees from Daiichi Sankyo; Dr. Rump, consulting and lecture fees from Daiichi Sankyo; Dr. Viberti, payment for board membership from GlaxoSmithKline, Novartis, and Pfizer and lecture fees from Guidotti and Malesci; and Dr. Ritz, payment for board membership and lecture fees from Abbott and consulting fees from Hexal. No other potential conflict of interest relevant to this article was reported.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; [Anonymous], 2003, Am J Kidney Dis, V42, P1; Bakris GL, 2000, AM J KIDNEY DIS, V36, P646, DOI 10.1053/ajkd.2000.16225; Bilous R, 2009, ANN INTERN MED, V151, P11, DOI 10.7326/0003-4819-151-1-200907070-00120; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; de Galan BE, 2009, J AM SOC NEPHROL, V20, P883, DOI 10.1681/ASN.2008070667; de Zeeuw D, 2006, J AM SOC NEPHROL, V17, P2100, DOI 10.1681/ASN.2006050517; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Haller H, 2006, J HYPERTENS, V24, P403, DOI 10.1097/01.hjh.0000202820.56201.e6; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Mann JFE, 2003, J AM SOC NEPHROL, V14, P641, DOI 10.1097/01.ASN.0000051594.21922.99; Mann JFE, 2009, ANN INTERN MED, V151, P1, DOI 10.7326/0003-4819-151-1-200907070-00122; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; MOGENSEN CE, 1971, SCAND J CLIN LAB INV, V28, P182, DOI 10.3109/00365517109086899; Newman DJ, 2005, HEALTH TECHNOL ASSES, V9, P1; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 2006, J AM SOC NEPHROL, V17, P3472, DOI 10.1681/ASN.2006060560; Sleight P, 2009, J HYPERTENS, V27, P1360, DOI 10.1097/HJH.0b013e32832d7370; VIBERTI GC, 1982, LANCET, V1, P1430; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	26	555	590	0	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					907	917		10.1056/NEJMoa1007994	http://dx.doi.org/10.1056/NEJMoa1007994			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21388309	Green Published			2022-12-28	WOS:000288170300007
J	Budde, K; Becker, T; Arns, W; Sommerer, C; Reinke, P; Eisenberger, U; Kramer, S; Fischer, W; Gschaidmeier, H; Pietruck, F				Budde, Klemens; Becker, Thomas; Arns, Wolfgang; Sommerer, Claudia; Reinke, Petra; Eisenberger, Ute; Kramer, Stefan; Fischer, Wolfgang; Gschaidmeier, Harald; Pietruck, Frank		ZEUS Study Investigators	Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial	LANCET			English	Article							REDUCED-EXPOSURE CYCLOSPORINE; RENAL-ALLOGRAFT RECIPIENTS; GLOMERULAR-FILTRATION-RATE; MYCOPHENOLATE-MOFETIL; PRIMARY IMMUNOSUPPRESSION; SERUM CREATININE; SIROLIMUS; EFFICACY; SAFETY; TACROLIMUS	Background Non-nephrotoxic immunosuppressive strategies that allow reduction of calcineurin-inhibitor exposure without compromising safety or efficacy remain a goal in kidney transplantation. Immunosuppression based on the mammalian-target-of-rapamycin inhibitor everolimus was assessed as a strategy for elimination of calcineurin-inhibitor exposure and optimisation of renal-graft function while maintaining efficacy. Methods In the ZEUS multicentre, open-label study, 503 patients (aged 18-65 years) who had received de-novo kidney transplants were enrolled. After initial treatment with ciclosporin, based on trough concentrations, and enteric-coated mycophenolate sodium (1440 mg/day, orally), corticosteroids (>= 5 mg/day prednisolone or equivalent, orally), and basiliximab induction (20 mg, intravenously, on day 0 [2 h before transplantation], and on day 4), 300 (60%) patients were randomly assigned at 4.5 months in a 1:1 ratio to undergo calcineurin-inhibitor elimination (everolimus-based regimen that was based on trough concentrations [6-10 ng/mL] and enteric-coated mycophenolate sodium [1440 mg/day] with corticosteroids), or continue standard ciclosporin-based treatment. Randomisation was done by use of a central, validated system that automated the random assignment of treatment groups to randomisation numbers. The primary objective was to show better renal function (glomerular filtration rate [GFR]; Nankivell formula) with the calcineurin-inhibitor-free everolimus regimen at 12 months after transplantation. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00154310. Findings 118 (76%) of 155 everolimus-treated patients and 117 (81%) of 145 cic_losporin-treated patients completed treatment with study drug up to 12 months after transplantation. At this timepoint, the everolimus regimen was associated with a significant improvement in GFR versus the ciclosporin regimen (71.8 mL/min per 1.73 m(2) vs 61.9 mL/min per 1.73 m(2), respectively; mean difference 9.8 mL/min per 1.73 m(2), 95% CI -12.2 to -7.5). Rates of biopsy-proven acute rejection were higher in the everolimus group than in the ciclosporin group after randomisation (15 [10%] of 154 vs five [3%] of 146; p=0.036), but similar for the full study period (23 [15%] vs 22 [15%]). Compared with the ciclosporin regimen, higher mean lipid concentrations, slightly increased urinary protein excretion, and lower haemoglobin concentrations were noted with the everolimus regimen; thrombocytopenia, aphthous stomatitis, and diarrhoea also occurred more often in the everolimus group. A higher incidence of hyperuricaemia was noted with ciclosporin. Interpretation Early elimination of calcineurin inhibitor by use of everolimus-based immunosuppression improved renal function at 12 months while maintaining efficacy and safety, indicating that this strategy may facilitate improved long-term outcomes in selected patients.	[Budde, Klemens] Charite, Med Klin, Schwerpunkt Nephrol, Dept Nephrol, D-10117 Berlin, Germany; [Becker, Thomas] Hannover Med Sch, Dept Visceral & Transplant Surg, D-3000 Hannover, Germany; [Arns, Wolfgang] Cologne Gen Hosp, Transplant Ctr Cologne, Cologne, Germany; [Sommerer, Claudia] Heidelberg Univ, Dept Nephrol, Heidelberg, Germany; [Eisenberger, Ute] Univ Bern, Inselspital, Dept Hypertens & Nephrol, CH-3010 Bern, Switzerland; [Kramer, Stefan; Gschaidmeier, Harald] Novartis Pharmaceut, Nurnberg, Germany; [Fischer, Wolfgang] Novartis Pharma Schweiz, Bern, Switzerland; [Pietruck, Frank] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; Ruprecht Karls University Heidelberg; University of Bern; University Hospital of Bern; Novartis; Novartis; University of Duisburg Essen	Budde, K (corresponding author), Charite, Med Klin, Schwerpunkt Nephrol, Dept Nephrol, Charitepl 1, D-10117 Berlin, Germany.	klemens.budde@charite.de	Budde, Klemens/AAD-2170-2020; ieong, bee/C-5840-2012; Eisenberger, Ute/AAJ-6032-2020	Budde, Klemens/0000-0002-7929-5942; Eisenberger, Ute/0000-0003-3862-6933; Reinke, Petra/0000-0003-0771-4375	Astellas Pharma; Hoffmann-La Roche; Novartis Pharma; Wyeth; Novartis; Astellas	Astellas Pharma(Astellas Pharmaceuticals); Hoffmann-La Roche(Hoffmann-La Roche); Novartis Pharma; Wyeth(Wyeth); Novartis(Novartis); Astellas(Astellas Pharmaceuticals)	WA has received fees for scientific advice from Novartis Pharma, and honoraria and travel or accommodation expenses from Novartis Pharma, Roche, and Wyeth. TB has received consultancy fees and travel or accommodation expenses from Astellas Pharma, Hoffmann-La Roche, Novartis Pharma, and Wyeth; and grants from Astellas Pharma, Hoffmann-La Roche, and Novartis Pharma. KB has consultancy agreements with Bristol-Myers Squibb, LifeCycle Pharma, Novartis Pharma, and Wyeth Pharma; and has received research grants for clinical studies, speaker's fees, honoraria, travel expenses, and payment for development of educational presentations from Bristol-Myers Squibb, LifeCycle Pharma, Novartis Pharma, Roche AG, and Wyeth Pharma. UE has received consultancy fees from Novartis Pharma and travel expenses from Novartis Phanna, Roche, Abbott, and Amgen. WF is an employee of Novartis Pharma and holds stock options. NG is an employee of Novartis Pharma and holds stock options. SK is an employee of Novartis Pharma and holds stock options. CS has received research grants from Novartis and Astellas. FP and PR declare that they have no conflicts of interests.; This study was funded by Novartis Pharma. We thank the investigators, staff, and patients at all participating centres for their contribution to the study, Eva-Maria Vogel (project leader) and Christoph May (trial statistician) for their support. Tim Mitchell and Caroline Barnett from Real Science Communications provided medical writing support on behalf of Novartis.	Budde K, 2007, CLIN NEPHROL, V67, P164; Buchler M, 2007, AM J TRANSPLANT, V7, P2522, DOI 10.1111/j.1600-6143.2007.01976.x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Demirbas A, 2009, TRANSPL INT, V22, P1172, DOI 10.1111/j.1432-2277.2009.00937.x; Eisen HJ, 2005, J HEART LUNG TRANSPL, V24, P517, DOI 10.1016/j.healun.2005.02.002; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Fangmann J, 2010, NEPHROL DIAL TRANSPL, V25, P283, DOI 10.1093/ndt/gfp468; Flechner S, 2007, AM J TRANSPLANT, V7, P160; Flechner SM, 2009, TRANSPLANTATION, V87, pS1, DOI 10.1097/TP.0b013e3181a059a1; Guerra G, 2007, TRANSPL INT, V20, P813, DOI 10.1111/j.1432-2277.2007.00528.x; Hamdy AF, 2005, AM J TRANSPLANT, V5, P2531, DOI 10.1111/j.1600-6143.2005.01064.x; Hamdy AF, 2008, J AM SOC NEPHROL, V19, P1225, DOI 10.1681/ASN.2007091001; Hariharan S, 2004, AM J TRANSPLANT, V4, P1179, DOI 10.1111/j.1600-6143.2004.00484.x; Kuypers DRJ, 2005, DRUG SAFETY, V28, P153, DOI 10.2165/00002018-200528020-00006; Larson TS, 2006, AM J TRANSPLANT, V6, P514, DOI 10.1111/j.1600-6143.2005.01177.x; Lehmkuhl HB, 2009, TRANSPLANTATION, V88, P115, DOI 10.1097/TP.0b013e3181aacd22; Letavernier Emmanuel, 2008, Transplant Rev (Orlando), V22, P125, DOI 10.1016/j.trre.2007.12.001; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Nankivell BJ, 2004, TRANSPLANTATION, V78, P557, DOI 10.1097/01.TP.0000128636.70499.6E; NANKIVELL BJ, 1995, TRANSPLANTATION, V59, P1683, DOI 10.1097/00007890-199506270-00007; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Oberbauer R, 2003, TRANSPLANTATION, V76, P364, DOI 10.1097/01.TP.0000074360.62032.39; Oberbauer R, 2009, TRANSPLANTATION, V87, pS7, DOI 10.1097/TP.0b013e3181a0582a; Pascual J, 2005, TRANSPLANTATION, V79, pS76, DOI 10.1097/01.TP.0000162434.62591.F3; Schena FP, 2009, TRANSPLANTATION, V87, P233, DOI 10.1097/TP.0b013e3181927a41; Silva HT, 2007, AM J TRANSPLANT, V7, P595, DOI 10.1111/j.1600-6143.2007.01661.x; Stephany BR, 2006, TRANSPLANTATION, V82, P368, DOI 10.1097/01.tp.0000228921.43200.f7; Tedesco-Silva H, 2007, TRANSPL INT, V20, P27, DOI 10.1111/j.1432-2277.2006.00414.x; Vincenti F, 2007, AM J TRANSPLANT, V7, P1506, DOI 10.1111/j.1600-6143.2007.01749.x; Vitko S, 2005, AM J TRANSPLANT, V5, P2521, DOI 10.1111/j.1600-6143.2005.01063.x; Vitko S, 2004, AM J TRANSPLANT, V4, P626, DOI 10.1111/j.1600-6143.2004.00389.x; Webster AC, 2005, BMJ-BRIT MED J, V331, P810, DOI 10.1136/bmj.38569.471007.AE; Webster AC, 2006, TRANSPLANTATION, V81, P1234, DOI 10.1097/01.tp.0000219703.39149.85; World Medical Association Ethics Unit, 2007, DECL HELS	35	288	296	1	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2011	377	9768					837	847		10.1016/S0140-6736(10)62318-5	http://dx.doi.org/10.1016/S0140-6736(10)62318-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GO	21334736				2022-12-28	WOS:000288628500031
J	Kleinman, A				Kleinman, Arthur			The art of medicine The divided self, hidden values, and moral sensibility in medicine	LANCET			English	Editorial Material									[Kleinman, Arthur] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Cambridge, MA 02138 USA; [Kleinman, Arthur] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Kleinman, A (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Cambridge, MA 02138 USA.								0	21	25	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2011	377	9768					804	805		10.1016/S0140-6736(11)60295-X	http://dx.doi.org/10.1016/S0140-6736(11)60295-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GO	21391316	Green Submitted			2022-12-28	WOS:000288628500014
J	Shetty, P				Shetty, Priya			Exhibition Celebrating 65 years of the NSHD cohort	LANCET			English	Editorial Material												priya4876@gmail.com			Medical Research Council [MC_U123092720] Funding Source: Medline; MRC [MC_U123092720] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 5	2011	377	9768					802	802		10.1016/S0140-6736(11)60293-6	http://dx.doi.org/10.1016/S0140-6736(11)60293-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GO	21391336	Bronze			2022-12-28	WOS:000288628500012
J	Dimiev, A; Kosynkin, DV; Sinitskii, A; Slesarev, A; Sun, ZZ; Tour, JM				Dimiev, Ayrat; Kosynkin, Dmitry V.; Sinitskii, Alexander; Slesarev, Alexander; Sun, Zhengzong; Tour, James M.			Layer-by-Layer Removal of Graphene for Device Patterning	SCIENCE			English	Article							RAMAN-SPECTROSCOPY; GRAPHITE OXIDE; FILMS; SHEETS; TRANSPORT; VACANCY; ENERGY; ATOMS	The patterning of graphene is useful in fabricating electronic devices, but existing methods do not allow control of the number of layers of graphene that are removed. We show that sputter-coating graphene and graphene-like materials with zinc and dissolving the latter with dilute acid removes one graphene layer and leaves the lower layers intact. The method works with the four different types of graphene and graphene-like materials: graphene oxide, chemically converted graphene, chemical vapor-deposited graphene, and micromechanically cleaved ("clear-tape") graphene. On the basis of our data, the top graphene layer is damaged by the sputtering process, and the acid treatment removes the damaged layer of carbon. When used with predesigned zinc patterns, this method can be viewed as lithography that etches the sample with single-atomic-layer resolution.	[Tour, James M.] Rice Univ, Dept Chem, Dept Mech Engn & Mat Sci, Dept Comp Sci, Houston, TX 77005 USA; Rice Univ, Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA	Rice University; Rice University	Tour, JM (corresponding author), Rice Univ, Dept Chem, Dept Mech Engn & Mat Sci, Dept Comp Sci, MS-222,6100 Main St, Houston, TX 77005 USA.	tour@rice.edu	Sun, Zhengzong/C-5292-2014; Sinitskii, Alexander/J-6619-2015; Dimiev, Ayrat/J-2088-2017; Kosynkin, Dmitry/AAX-1108-2021	Sinitskii, Alexander/0000-0002-8688-3451; Dimiev, Ayrat/0000-0001-7497-1211; Sun, Zhengzong/0000-0002-3710-4001; Tour, James/0000-0002-8479-9328				Banhart F, 1999, REP PROG PHYS, V62, P1181, DOI 10.1088/0034-4885/62/8/201; Campos LC, 2009, NANO LETT, V9, P2600, DOI 10.1021/nl900811r; Chen JH, 2009, SOLID STATE COMMUN, V149, P1080, DOI 10.1016/j.ssc.2009.02.042; Datta SS, 2008, NANO LETT, V8, P1912, DOI 10.1021/nl080583r; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Gao LB, 2009, J AM CHEM SOC, V131, P13934, DOI 10.1021/ja906610e; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gomez-Navarro C, 2007, NANO LETT, V7, P3499, DOI 10.1021/nl072090c; Hahn JR, 1996, PHYS REV B, V53, pR1725, DOI 10.1103/PhysRevB.53.R1725; Hahn JR, 1999, PHYS REV B, V60, P6007, DOI 10.1103/PhysRevB.60.6007; Hao YF, 2010, SMALL, V6, P195, DOI 10.1002/smll.200901173; Hayakawa S., 1991, HDB SPUTTER DEPOSITI; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Kovtyukhova NI, 1999, CHEM MATER, V11, P771, DOI 10.1021/cm981085u; Larachi F, 2004, ENERG FUEL, V18, P1744, DOI 10.1021/ef049951e; LESPADE P, 1984, CARBON, V22, P375, DOI 10.1016/0008-6223(84)90009-5; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lu G, 2010, LANGMUIR, V26, P6164, DOI 10.1021/la101077t; Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368; MARTON D, 1993, PHYS REV B, V48, P6757, DOI 10.1103/PhysRevB.48.6757; Mattevi C, 2009, ADV FUNCT MATER, V19, P2577, DOI 10.1002/adfm.200900166; MONTET GL, 1971, CARBON, V9, P179, DOI 10.1016/0008-6223(71)90129-1; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Poncharal P, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.113407; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; SZYMONSKI M, 1980, APPL PHYS, V23, P89, DOI 10.1007/BF00899575; Tung VC, 2009, NAT NANOTECHNOL, V4, P25, DOI 10.1038/NNANO.2008.329; Unarunotai S, 2010, ACS NANO, V4, P5591, DOI 10.1021/nn101896a; Xu T, 2018, WOODH PUB SER ELECT, P137, DOI 10.1016/B978-0-08-102053-1.00005-3	31	203	209	8	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1168	1172		10.1126/science.1199183	http://dx.doi.org/10.1126/science.1199183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385709				2022-12-28	WOS:000287971200035
J	Mackin, P; Thomas, SHL				Mackin, Paul; Thomas, Simon H. L.			Therapeutics Atypical antipsychotic drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; 2ND-GENERATION; SCHIZOPHRENIA					paul.mackin@ncl.ac.uk	Thomas, Simon/AAK-9674-2021					Agid O, 2007, NEUROPSYCHOPHARMACOL, V32, P1209, DOI 10.1038/sj.npp.1301242; Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; Bushe Chris, 2008, J Psychopharmacol, V22, P46, DOI 10.1177/0269881107088435; Citrome L, 2006, INT J CLIN PRACT, V60, P933, DOI 10.1111/j.1742-1241.2006.01044.x; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; FARAH A, 2005, J CLIN PSYCHIAT, V7, P268, DOI DOI 10.4088/PCC.V07N0602; Grunder G, 2009, NAT REV DRUG DISCOV, V8, P197, DOI 10.1038/nrd2806; Hedges D, 2003, DRUG TODAY, V39, P551, DOI 10.1358/dot.2003.39.7.799445; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; Kesselheim AS, 2007, JAMA-J AM MED ASSOC, V297, P308, DOI 10.1001/jama.297.3.308; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lewis SW, 2006, SCHIZOPHRENIA BULL, V32, P715, DOI 10.1093/schbul/sbj067; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Mackin P, 2008, HUM PSYCHOPHARM CLIN, V23, P3, DOI 10.1002/hup.915; *NAT HLTH SERV BUS, PRESCR REV APR JUN 2; Newham JJ, 2008, BRIT J PSYCHIAT, V192, P333, DOI 10.1192/bjp.bp.107.041541; *NIH CLIN EXC, 2009, 82 NIH CLIN EXC; Osborn DPJ, 2007, ARCH GEN PSYCHIAT, V64, P242, DOI 10.1001/archpsyc.64.2.242; Stanniland C, 2000, DRUG SAFETY, V22, P195, DOI 10.2165/00002018-200022030-00004; Tanne JH, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4422; Verdoux H, 2010, ACTA PSYCHIAT SCAND, V121, P4, DOI 10.1111/j.1600-0447.2009.01425.x	21	14	15	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2011	342								d1126	10.1136/bmj.d1126	http://dx.doi.org/10.1136/bmj.d1126			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732EU	21378070				2022-12-28	WOS:000288168600002
J	Spudich, JA				Spudich, James A.			Molecular Motors, Beauty in Complexity	SCIENCE			English	Editorial Material							DYNEIN; PROTEIN		Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Spudich, JA (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	jspudich@stanford.edu			NIGMS NIH HHS [R01 GM033289] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033289] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; GIBBONS IR, 1965, SCIENCE, V149, P424, DOI 10.1126/science.149.3682.424; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Kull F. J., 1996, NATURE, V380, P6574; Mocz G, 2001, STRUCTURE, V9, P93, DOI 10.1016/S0969-2126(00)00557-8; Neuwald AF, 1999, GENOME RES, V9, P27; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; Rayment I., 1993, SCIENCE, V261, P5117; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833	12	20	20	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1143	1144		10.1126/science.1203978	http://dx.doi.org/10.1126/science.1203978			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385703	Green Accepted			2022-12-28	WOS:000287971200027
J	Deriano, L; Chaumeil, J; Coussens, M; Multani, A; Chou, YF; Alekseyenko, AV; Chang, S; Skok, JA; Roth, DB				Deriano, Ludovic; Chaumeil, Julie; Coussens, Marc; Multani, Asha; Chou, Yifan; Alekseyenko, Alexander V.; Chang, Sandy; Skok, Jane A.; Roth, David B.			The RAG2 C terminus suppresses genomic instability and lymphomagenesis	NATURE			English	Article							DOUBLE-STRAND BREAKS; ATM-DEFICIENT MICE; V(D)J RECOMBINATION; LYMPHOCYTE DEVELOPMENT; GENE AMPLIFICATION; THYMIC LYMPHOMA; B-CELL; REPAIR; ROLES; TRANSLOCATIONS	Misrepair of DNA double-strand breaks produced by the V(D)J recombinase (the RAG1/RAG2 proteins) at immunoglobulin (Ig) and T cell receptor (Tcr) loci has been implicated in pathogenesis of lymphoid malignancies in humans(1) and in mice(2-7). Defects in DNA damage response factors such as ataxia telangiectasia mutated (ATM) protein and combined deficiencies in classical non-homologous end joining and p53 predispose to RAG-initiated genomic rearrangements and lymphomagenesis(2-11). Although we showed previously that RAG1/RAG2 shepherd the broken DNA ends to classical non-homologous end joining for proper repair(12,13), roles for the RAG proteins in preserving genomic stability remain poorly defined. Here we show that the RAG2 carboxy (C) terminus, although dispensable for recombination(14,15), is critical for maintaining genomic stability. Thymocytes from 'core' Rag2 homozygotes (Rag2(c/c) mice) show dramatic disruption of Tcr alpha/delta locus integrity. Furthermore, all Rag2(c/c) p53(-/-) mice, unlike Rag1(c/c) p53(-/-) and p53(-/-) animals, rapidly develop thymic lymphomas bearing complex chromosomal translocations, amplifications and deletions involving the Tcra/delta and Igh loci. We also find these features in lymphomas from Atm(-/-) mice. We show that, like ATM-deficiency(3), core RAG2 severely destabilizes the RAG post-cleavage complex. These results reveal a novel genome guardian role for RAG2 and suggest that similar 'end release/end persistence' mechanisms underlie genomic instability and lymphomagenesis in Rag2(c/c) p53(-/-) and Atm(-/-) mice.	[Deriano, Ludovic; Chaumeil, Julie; Coussens, Marc; Chou, Yifan; Skok, Jane A.; Roth, David B.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Multani, Asha] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Alekseyenko, Alexander V.] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, Div Clin Pharmacol,Dept Med, New York, NY 10016 USA; [Chang, Sandy] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Skok, Jane A.] UCL, Div Infect & Immun, Dept Immunol & Mol Pathol, London W1T 4JF, England	New York University; University of Texas System; UTMD Anderson Cancer Center; New York University; Yale University; University of London; University College London	Roth, DB (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	david.roth@nyumc.org	Skok, Jane/ABF-7249-2020; Deriano, Ludovic/D-2048-2019	Skok, Jane/0000-0002-4145-1516; Deriano, Ludovic/0000-0002-9673-9525; Alekseyenko, Alexander/0000-0002-5748-2085; CHAUMEIL, Julie/0000-0002-8976-2890	National Institutes of Health Roadmap Initiative in Nanomedicine through a Nanomedicine Development Center [1PN2EY018244]; National Institutes of Health [CA104588, R01GM086852]; Irene Diamond Fund; National Center for Research Resources, National Institutes of Health [1UL1RR029893]; NCI [R01CA145746-01]; Leukemia and Lymphoma Scholar Award; Wellcome trust [085096]; NATIONAL CANCER INSTITUTE [R01CA104588, RC1CA145746] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086852] Funding Source: NIH RePORTER	National Institutes of Health Roadmap Initiative in Nanomedicine through a Nanomedicine Development Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene Diamond Fund; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Scholar Award(Leukemia and Lymphoma Society); Wellcome trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Schlissel for the gift of core Rag2 mice, F. Alt for the gift of core Rag1 mice and S. Hewitt for the Igh BAC probes. D.B.R. was supported by National Institutes of Health Roadmap Initiative in Nanomedicine through a Nanomedicine Development Center award (1PN2EY018244), a National Institutes of Health grant CA104588 and the Irene Diamond Fund. L.D. is a Fellow of The Leukemia and Lymphoma Society. A.V.A. was supported in part by grant 1UL1RR029893 from the National Center for Research Resources, National Institutes of Health. J.A.S. was supported by a National Institutes of Health grant R01GM086852, a National Institutes of Health Challenge grant NCI R01CA145746-01, a Leukemia and Lymphoma Scholar Award and a Wellcome trust project grant 085096.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Arnal SM, 2010, NUCLEIC ACIDS RES, V38, P2944, DOI 10.1093/nar/gkp1252; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Callen E, 2009, CELL CYCLE, V8, P2408, DOI 10.4161/cc.8.15.9085; Corneo B, 2007, NATURE, V449, P483, DOI 10.1038/nature06168; Curry JD, 2008, NUCLEIC ACIDS RES, V36, P5750, DOI 10.1093/nar/gkn553; Deriano L, 2009, MOL CELL, V34, P13, DOI 10.1016/j.molcel.2009.03.009; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; FORSTER A, 1980, NATURE, V286, P897, DOI 10.1038/286897a0; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jones JM, 2009, ARCH IMMUNOL THER EX, V57, P105, DOI 10.1007/s00005-009-0011-3; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Matei IR, 2007, BLOOD, V109, P1887, DOI 10.1182/blood-2006-05-020917; Multani AS, 2000, NEOPLASIA, V2, P339, DOI 10.1038/sj.neo.7900105; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; PATHAK S, 1976, J REPROD MED, V17, P25; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; R Development Core Team, 2006, R LANG ENV STAT COMP; Ryu CJ, 2006, CANCER CELL, V9, P109, DOI 10.1016/j.ccr.2006.01.004; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Steen SB, 1999, MOL CELL BIOL, V19, P3010; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Theunissen JWF, 2006, METHOD ENZYMOL, V409, P251, DOI 10.1016/S0076-6879(05)09015-4; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zha S, 2010, J EXP MED, V207, P1369, DOI 10.1084/jem.20100285; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	39	78	80	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					119	U145		10.1038/nature09755	http://dx.doi.org/10.1038/nature09755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368836	Green Accepted			2022-12-28	WOS:000287924100046
J	Edgerton, D				Edgerton, David			In praise of Luddism	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Ctr Hist Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Edgerton, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Hist Sci Technol & Med, London SW7 2AZ, England.	d.edgerton@imperial.ac.uk	Edgerton, David e/E-9687-2012					BLACKETT P, 1943, NOTE CERTAIN ASPECTS; GOODEVE C, 1951, TIMES           0419	2	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 3	2011	471	7336					27	29		10.1038/471027a	http://dx.doi.org/10.1038/471027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729BY	21368801	Bronze			2022-12-28	WOS:000287924100012
J	Kucher, N				Kucher, Nils			Deep-Vein Thrombosis of the Upper Extremities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CATHETER-DIRECTED THROMBOLYSIS; WEIGHT HEPARIN DALTEPARIN; CENTRAL VENOUS CATHETERS; RISK-FACTORS; PULMONARY-EMBOLISM; POSTTHROMBOTIC SYNDROME; THORACIC OUTLET; CANCER; RECURRENCE; THROMBOEMBOLISM	A 58-year-old woman presents with a 3-day history of pain, heaviness, and functional impairment in her left arm. She has received chemotherapy for ovarian cancer through an implanted port and catheter (Port-a-Cath) on the left side. Physical examination reveals a swollen and erythematous left arm and visible venous collaterals at the neck, shoulder, and chest. Compression ultrasonography reveals a patent left distal subclavian vein, but there is an abnormal Doppler-flow pattern suggestive of a more proximal thrombosis. How should this case be further evaluated and managed?	[Kucher, Nils] Univ Hosp Bern, Inselspital, Div Cardiovasc, Dept Angiol, CH-3010 Bern, Switzerland; [Kucher, Nils] Univ Hosp Bern, Inselspital, Div Cardiovasc, Dept Cardiol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Kucher, N (corresponding author), Univ Hosp Bern, Inselspital, Div Cardiovasc, Dept Angiol, CH-3010 Bern, Switzerland.	nils.kucher@insel.ch			EKOS	EKOS	Dr. Kucher reports receiving grant support from EKOS and honoraria from Sanofi-Aventis, GlaxoSmithKline, Boehringer Ingelheim, and EKOS and being named as coinventor of a method used to determine whether to issue an alert to consider prophylaxis in a patient at risk for venous thromboembolism (patented by Brigham and Women's Hospital) and as coinventor of a method to detect neointimal coverage of a coronary stent (patented by SIS Medical). No other potential conflict of interest relevant to this article was reported.	Akl EA, 2008, CANCER-AM CANCER SOC, V112, P2483, DOI 10.1002/cncr.23479; Alesh I, 2007, CATHETER CARDIO INTE, V70, P143, DOI 10.1002/ccd.21079; ANDERSON AJ, 1989, CHEST, V95, P71, DOI 10.1378/chest.95.1.71; [Anonymous], 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001100.pub2, DOI 10.1002/14651858.CD001100.PUB2]; AZIZ S, 1986, AM J SURG, V152, P57, DOI 10.1016/0002-9610(86)90141-8; Baarslag HJ, 2004, ACTA RADIOL, V45, P38, DOI 10.1080/02841850410003428; BAGLIN TP, 1986, BRIT J HAEMATOL, V63, P606, DOI 10.1111/j.1365-2141.1986.tb07541.x; Constans J, 2008, THROMB HAEMOSTASIS, V99, P202, DOI 10.1160/TH07-08-0485; Di Nisio M, 2010, J THROMB HAEMOST, V8, P684, DOI 10.1111/j.1538-7836.2010.03771.x; Druy EM, 1996, J VASC SURG, V24, P981; EASTRIDGE BJ, 1995, J CLIN ONCOL, V13, P233, DOI 10.1200/JCO.1995.13.1.233; Elman EE, 2006, THROMB RES, V117, P609, DOI 10.1016/j.thromres.2005.05.029; Elsharawy M, 2002, EUR J VASC ENDOVASC, V24, P209, DOI 10.1053/ejvs.2002.1665; FABRI PJ, 1984, JPEN-PARENTER ENTER, V8, P705, DOI 10.1177/0148607184008006705; Flinterman LE, 2008, CIRCULATION, V118, P1366, DOI 10.1161/CIRCULATIONAHA.107.748699; Gallieni M, 2008, CA-CANCER J CLIN, V58, P323, DOI 10.3322/CA.2008.0015; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Hingorani A, 2001, CARDIOVASC SURG, V9, P472, DOI 10.1016/S0967-2109(01)00039-4; Hsieh CC, 2009, WORLD J GASTROENTERO, V15, P4709, DOI 10.3748/wjg.15.4709; HV J, 2004, CIRCULATION, V110, P1605; Illig KA, 2010, J VASC SURG, V51, P1538, DOI 10.1016/j.jvs.2009.12.022; Isma N, 2010, THROMB RES, V125, pE335, DOI 10.1016/j.thromres.2010.03.005; Karabay O, 2004, J INT MED RES, V32, P429, DOI 10.1177/147323000403200413; Kearon C, 2008, CHEST, V134, P892, DOI DOI 10.1378/CHEST.08-0658; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kim HC, 2003, KOREAN J RADIOL, V4, P146, DOI 10.3348/kjr.2003.4.3.146; Kovacs MJ, 2007, J THROMB HAEMOST, V5, P1650, DOI 10.1111/j.1538-7836.2007.02613.x; Kucher N, 2005, THROMB HAEMOSTASIS, V93, P494, DOI 10.1160/TH04-09-0587; Lee AYY, 2006, J CLIN ONCOL, V24, P1404, DOI 10.1200/JCO.2005.03.5600; Lee JT, 2006, J VASC SURG, V43, P1236, DOI 10.1016/j.jvs.2006.02.005; Lee WA, 2000, J VASC SURG, V32, P57, DOI 10.1067/mva.2000.107313; Lin PH, 2006, AM J SURG, V192, P782, DOI 10.1016/j.amjsurg.2006.08.045; Linnemann B, 2008, THROMB HAEMOSTASIS, V100, P440, DOI 10.1160/TH08-03-0196; Lobo BL, 2009, J HOSP MED, V4, P417, DOI 10.1002/jhm.442; MACHLEDER HI, 1993, J VASC SURG, V17, P305, DOI 10.1016/0741-5214(93)90416-J; Martinelli I, 2004, CIRCULATION, V110, P566, DOI 10.1161/01.CIR.0000137123.55051.9B; Meier GH, 1996, J VASC SURG, V24, P974, DOI 10.1016/S0741-5214(96)70043-5; Merminod T, 2006, BLOOD COAGUL FIBRIN, V17, P225, DOI 10.1097/01.mbc.0000220248.04789.79; Mewissen MW, 1999, RADIOLOGY, V211, P39, DOI 10.1148/radiology.211.1.r99ap4739; Munoz FJ, 2008, CHEST, V133, P143, DOI 10.1378/chest.07-1432; Oderich GSC, 2000, J VASC SURG, V32, P760, DOI 10.1067/mva.2000.107988; Owens CA, 2010, J VASC INTERV RADIOL, V21, P779, DOI 10.1016/j.jvir.2010.02.021; PLATE G, 1984, J VASC SURG, V1, P867, DOI 10.1067/mva.1984.avs0010867; Prandoni P, 2004, BMJ-BRIT MED J, V329, P484, DOI 10.1136/bmj.38167.684444.3A; Sajid MS, 2007, ACTA HAEMATOL-BASEL, V118, P10, DOI 10.1159/000101700; Savage KJ, 1999, THROMB HAEMOSTASIS, V82, P1008, DOI 10.1055/s-0037-1614319; Schneider DB, 2004, J VASC SURG, V40, P599, DOI 10.1016/j.jvs.2004.07.028; Schulman S, 2006, J THROMB HAEMOST, V4, P734, DOI 10.1111/j.1538-7836.2006.01795.x; Stein PD, 2010, AM J MED, V123, P426, DOI 10.1016/j.amjmed.2009.09.037; Urschel HC, 2003, ANN THORAC SURG, V75, P1693, DOI 10.1016/S0003-4975(03)00116-4; Urschel HC, 1998, ANN SURG, V228, P609, DOI 10.1097/00000658-199810000-00017; van Rooden CJ, 2005, J CLIN ONCOL, V23, P2655, DOI 10.1200/JCO.2005.05.002; Van Rooden CJ, 2004, J CARDIOVASC ELECTR, V15, P1258, DOI 10.1046/j.1540-8167.2004.04081.x; Verso M, 2003, J CLIN ONCOL, V21, P3665, DOI 10.1200/JCO.2003.08.008; Verso M, 2008, INTERN EMERG MED, V3, P117, DOI 10.1007/s11739-008-0125-3; Vik A, 2009, CARDIOVASC INTER RAD, V32, P980, DOI 10.1007/s00270-009-9655-y	56	174	188	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					861	869		10.1056/NEJMcp1008740	http://dx.doi.org/10.1056/NEJMcp1008740			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366477				2022-12-28	WOS:000287928400011
J	Croon, MB; Hillier, JK; Sclater, JG				Croon, Marcel B.; Hillier, John K.; Sclater, John G.			Comment on "Mantle Flow Drives the Subsidence of Oceanic Plates"	SCIENCE			English	Editorial Material							PACIFIC-OCEAN; DEPTH; AGE; GRAVITY		[Croon, Marcel B.; Sclater, John G.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA; [Hillier, John K.] Univ Loughborough, Dept Geog, Loughborough LE11 3TU, Leics, England	University of California System; University of California San Diego; Scripps Institution of Oceanography; Loughborough University	Croon, MB (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr, San Diego, CA 92093 USA.	mcroon@ucsd.edu	Hillier, John K/D-1484-2009	Hillier, John K/0000-0002-0221-8383				Adam C, 2010, SCIENCE, V328, P83, DOI 10.1126/science.1185906; Crosby AG, 2006, GEOPHYS J INT, V166, P553, DOI 10.1111/j.1365-246X.2006.03015.x; CROUGH ST, 1978, GEOPHYS J ROY ASTR S, V55, P451, DOI 10.1111/j.1365-246X.1978.tb04282.x; DAVIS EE, 1974, EARTH PLANET SC LETT, V21, P405, DOI 10.1016/0012-821X(74)90180-0; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; HEESTAND RL, 1981, J GEOPHYS RES, V86, P6107, DOI 10.1029/JB086iB07p06107; Hillier JK, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB005994; Hillier JK, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003041; Hillier JK, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003406; Korenaga T, 2008, EARTH PLANET SC LETT, V268, P41, DOI 10.1016/j.epsl.2007.12.022; MARTY JC, 1989, EARTH PLANET SC LETT, V94, P301, DOI 10.1016/0012-821X(89)90148-9; MCKENZIE DP, 1967, J GEOPHYS RES, V72, P6261, DOI 10.1029/JZ072i024p06261; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Patriat M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013913; SCHROEDER W, 1984, J GEOPHYS RES, V89, P9873, DOI 10.1029/JB089iB12p09873; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956	16	2	2	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020								10.1126/science.1193587	http://dx.doi.org/10.1126/science.1193587			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350152	Green Accepted, Green Published			2022-12-28	WOS:000287699000033
J	Jamal, SA; Hamilton, CJ; Eastell, R; Cummings, SR				Jamal, Sophie A.; Hamilton, Celeste J.; Eastell, Richard; Cummings, Steven R.			Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OXIDE DONOR NITROGLYCERIN; NITRIC-OXIDE; OSTEOPOROTIC FRACTURES; VERTEBRAL FRACTURES; PARATHYROID-HORMONE; MINERAL DENSITY; CLINICAL-TRIAL; ALENDRONATE; RISK; MICROARCHITECTURE	Context Nitroglycerin stimulates bone formation and inhibits bone resorption, is inexpensive, and is widely available. Its effects on bone density, bone structure, and bone strength are unknown. Objectives To determine if nitroglycerin increases lumbar spine bone mineral density (BMD) and to evaluate changes in hip BMD, bone geometry, and density at the radius and tibia, and markers of bone turnover. Design, Setting, and Participants A single-center, double-blind, placebo-controlled randomized trial conducted in Toronto, Ontario, Canada, for 24 months starting in November 2005 and completed in March 2010, of 243 postmenopausal women with lumbar spine T scores of between 0 and -2.0 who completed a 1-week run-in period taking nitroglycerin ointment. Intervention Nitroglycerin ointment (15 mg/d) or placebo applied at bedtime for 24 months. Main Outcome Measures Areal BMD at the lumbar spine, femoral neck, and total hip. Secondary outcomes included indices of bone geometry and strength at the distal radius and tibia, and biomarkers of bone formation (bone-specific alkaline phosphatase) and bone resorption (urine N-telopeptide). Results At 2 years, women randomized to the nitroglycerin group had significant increases in areal BMD at the lumbar spine (from 1.05 to 1.14 g/cm(2) vs placebo from 1.06 to 1.08 g/cm(2); percentage change, 6.7%; 95% confidence interval [CI], 5.2%-8.2%; P<.001); total hip (from 0.92 to 0.97 g/cm(2) vs placebo from 0.93 to 0.92 g/cm(2); 6.2%; 95% CI, 5.6%-7.0%; P<.001); and femoral neck (from 0.88 to 0.93 g/cm(2) vs placebo from 0.87 to 0.86 g/cm(2); 7.0%; 95% CI, 5.5%-8.5%; P<.001). At 2 years, nitroglycerin also increased volumetric trabecular BMD (11.9% and 8.5%), cortical thickness (13.9% and 24.6%), periosteal circumference (7.4% and 2.9%), polar section modulus (10.7% and 9.8%), and polar moment of inertia (7.3% and 14.5%) at the radius and tibia, respectively (all P<.001); and increased bone-specific alkaline phosphatase by 34.8% and decreased urine N-telopeptide by 54.0% (P<.001). Incidence of serious adverse events did not differ between nitroglycerin (5 [4.2%]) and placebo (5 [4.3%]) groups. Among those women who continued treatment for 24 months, headaches were reported by 40 (35%) in nitroglycerin and 6 (5.4%) in placebo groups during the first month, decreasing substantially after 12 months. Conclusion Among postmenopausal women, nitroglycerin ointment modestly increased BMD and decreased bone resorption.	[Jamal, Sophie A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Hamilton, Celeste J.] Univ Toronto, Dept Exercise Sci, Toronto, ON, Canada; [Eastell, Richard] Univ Sheffield, Sheffield, S Yorkshire, England; [Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, San Francisco, CA USA; [Cummings, Steven R.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Toronto; University of Toronto; University of Sheffield; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco	Jamal, SA (corresponding author), Womens Coll Res Inst, 790 Bay St,7th Floor, Toronto, ON M5G 1N8, Canada.	sophie.jamal@utoronto.ca	Eastell, Richard/G-5851-2011	Eastell, Richard/0000-0002-0323-3366	AstraZeneca; Unilever; Amgen; Department of Health NIHR; Procter Gamble; Unipath Limited; Pfizer; Eli Lilly; Novartis; Osteologix; Medical Research Council UK; Arthritis Research Council; Crescent Diagnostics; Nittoboseki Company Limited; Nestle Foundation; Sanofi Aventis; Organon Laboratories; Takeda; National Osteoporosis Foundation; GlaxoSmithKline Nutrition; Roche; Fonterra Brands; Medtronics; Ono Pharma; Servier; Tethys; SPD; International Osteoporosis Foundation; Canadian Institute of Health Research (CIHR); Physicians' Services Incorporated; National Institute of Health Research, England; Warner-Chilcott	AstraZeneca(AstraZeneca); Unilever(Unilever); Amgen(Amgen); Department of Health NIHR(National Institute for Health Research (NIHR)); Procter Gamble(Procter & Gamble); Unipath Limited; Pfizer(Pfizer); Eli Lilly(Eli Lilly); Novartis(Novartis); Osteologix; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research Council; Crescent Diagnostics; Nittoboseki Company Limited; Nestle Foundation(Nestle SA); Sanofi Aventis(Sanofi-Aventis); Organon Laboratories; Takeda(Takeda Pharmaceutical Company Ltd); National Osteoporosis Foundation; GlaxoSmithKline Nutrition; Roche(Roche Holding); Fonterra Brands(Fonterra); Medtronics; Ono Pharma; Servier(Servier); Tethys; SPD; International Osteoporosis Foundation; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Physicians' Services Incorporated; National Institute of Health Research, England(National Institute for Health Research (NIHR)); Warner-Chilcott	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Jamal reported receiving support for board membership from Novartis, Amgen, and Warner-Chilcott and being a consultant for Genzyme, Warner-Chilcott, Novartis, and Shire. Dr Eastell reported being on the Procter & Gamble National Advisory Board; being a consultant for Amgen, AstraZeneca, GlaxoSmithKline, Medtronics, Nastech, Nestle, Fonterra Brands, Novartis, Ono Pharma, Osteologix, Pfizer, Eli Lilly, Sanofi Aventis, Tethys, Unilever, Unipath, and Inverness Medical; receiving grants from AstraZeneca, Unilever, Amgen, Department of Health NIHR, Procter & Gamble, Unipath Limited, Pfizer, Eli Lilly, Novartis, Osteologix, Medical Research Council UK, Arthritis Research Council, Crescent Diagnostics, Nittoboseki Company Limited, Nestle Foundation, Sanofi Aventis, and Organon Laboratories; receiving payment for lectures including service on speakers bureaus from Takeda, Eli Lilly, Amgen, National Osteoporosis Foundation, Procter & Gamble, GlaxoSmithKline Nutrition, and Roche; and receiving travel, accommodations, or meeting expenses from Novartis, Procter & Gamble, GlaxoSmithKline Nutrition, Fonterra Brands, Amgen, AstraZeneca, Medtronics, Unilever, Ono Pharma, Servier, Tethys, Eli Lilly, SPD, and International Osteoporosis Foundation. Dr Cummings reported being a consultant for Amgen, Eli Lilly, and Merck; giving expert testimony from Amgen and Eli Lilly; receiving grants from Eli Lilly and Amgen; and payment for lectures including service on speakers bureau from Amgen. Ms Hamilton reported no financial disclosures.; The Canadian Institute of Health Research (CIHR) and the Physicians' Services Incorporated funded the study. Dr Jamal received salary support from a CIHR New Investigator Award during the conduct of the study. Dr Eastell is funded by the National Institute of Health Research, England.	ABSHAGEN U, 1981, EUR J CLIN PHARMACOL, V19, P423, DOI 10.1007/BF00548586; Ahlborg HG, 2003, NEW ENGL J MED, V349, P327, DOI 10.1056/NEJMoa022464; Ake Yasushi, 1994, Kobe Journal of Medical Sciences, V40, P125; [Anonymous], 2011, OST NTX UR PROD DESC; Black DM, 2008, J BONE MINER RES, V23, P1326, DOI 10.1359/JBMR.080316; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; BRANDI ML, 1995, P NATL ACAD SCI USA, V92, P2954, DOI 10.1073/pnas.92.7.2954; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Burghardt AJ, 2010, J BONE MINER RES, V25, P2282, DOI 10.1002/jbmr.157; Chow JWM, 1998, J BONE MINER RES, V13, P1039, DOI 10.1359/jbmr.1998.13.6.1039; COLLINOSDOBY P, 1995, J CELL BIOCHEM, V57, P399, DOI 10.1002/jcb.240570305; Cummings SR, 2000, JAMA-J AM MED ASSOC, V283, P1318, DOI 10.1001/jama.283.10.1318; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1995, AM J MED, V98, pS24, DOI 10.1016/S0002-9343(05)80041-5; Cummings SR, 2006, JAMA-J AM MED ASSOC, V296, P2601, DOI 10.1001/jama.296.21.2601; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Jamal SA, 2004, J BONE MINER RES, V19, P1512, DOI 10.1359/JBMR.040716; Jamal SA, 1998, J BONE MINER RES, V13, P1755, DOI 10.1359/jbmr.1998.13.11.1755; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; KASTEN TP, 1994, P NATL ACAD SCI USA, V91, P3569, DOI 10.1073/pnas.91.9.3569; LOWIK CWGM, 1994, J CLIN INVEST, V93, P1465, DOI 10.1172/JCI117124; Macdonald HM, 2011, OSTEOPOROSIS INT, V22, P357, DOI 10.1007/s00198-010-1226-1; MACINTYRE I, 1991, P NATL ACAD SCI USA, V88, P2936, DOI 10.1073/pnas.88.7.2936; Metra BAP, 2002, EIA KIT, P8012; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Ralston SH, 1997, BRIT J RHEUMATOL, V36, P831; Rejnmark L, 2006, J BONE MINER RES, V21, P1811, DOI 10.1359/JBMR.060804; Seeman E, 2010, J BONE MINER RES, V25, P1886, DOI 10.1002/jbmr.81; Sornay-Rendu E, 2007, J BONE MINER RES, V22, P425, DOI 10.1359/JBMR.061206; vantHof RJ, 1997, J BONE MINER RES, V12, pP35; Vico L, 2008, J BONE MINER RES, V23, P1741, DOI 10.1359/JBMR.080704; WALLIN J, 1981, CLIN THER, V3, P450; Wimalawansa S, 2000, J BONE MINER RES, V15, P1119, DOI 10.1359/jbmr.2000.15.6.1119; Wimalawansa SJ, 1997, BONE, V21, P275, DOI 10.1016/S8756-3282(97)00125-7; Wimalawansa SJ, 1996, BONE, V18, P301, DOI 10.1016/8756-3282(96)00005-1; Wimalawansa SJ, 2009, J CLIN ENDOCR METAB, V94, P3356, DOI 10.1210/jc.2008-2225	44	48	49	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					800	807		10.1001/jama.2011.176	http://dx.doi.org/10.1001/jama.2011.176			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21343579	Bronze			2022-12-28	WOS:000287594300023
J	Parish, IA; Kaech, SM				Parish, Ian A.; Kaech, Susan M.			IL-7 Knocks the Socs Off Chronic Viral Infection	CELL			English	Editorial Material							PERSISTENCE IN-VIVO; T-CELLS	Chronic viral infections represent a major burden to human health, and modulation of the immune system is emerging as a novel approach to fighting such infections. Pellegrini et al. (2011) demonstrate that treatment with the cytokine IL-7 may reinvigorate the immune response to persistent infection by targeting immunosuppressive Socs3 proteins.	[Parish, Ian A.; Kaech, Susan M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Kaech, Susan M.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Kaech, SM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	susan.kaech@yale.edu		Parish, Ian/0000-0003-3528-478X	NIAID NIH HHS [R01 AI066232, R01 AI074699] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066232, R01AI074699] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Johnston JA, 2003, NAT IMMUNOL, V4, P507, DOI 10.1038/ni0603-507; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	10	8	11	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					467	468		10.1016/j.cell.2011.01.038	http://dx.doi.org/10.1016/j.cell.2011.01.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335230	Green Accepted, Bronze			2022-12-28	WOS:000287473100002
J	Tuite, AR; Tien, J; Eisenberg, M; Earn, DJD; Ma, JL; Fisman, DN				Tuite, Ashleigh R.; Tien, Joseph; Eisenberg, Marisa; Earn, David J. D.; Ma, Junling; Fisman, David N.			Cholera Epidemic in Haiti, 2010: Using a Transmission Model to Explain Spatial Spread of Disease and Identify Optimal Control Interventions	ANNALS OF INTERNAL MEDICINE			English	Article							INFECTIOUS-DISEASE; UNITED-STATES; INFLUENZA; DYNAMICS; TIME	Background: Haiti is in the midst of a cholera epidemic. Surveillance data for formulating models of the epidemic are limited, but such models can aid understanding of epidemic processes and help define control strategies. Objective: To predict, by using a mathematical model, the sequence and timing of regional cholera epidemics in Haiti and explore the potential effects of disease-control strategies. Design: Compartmental mathematical model allowing person-to-person and waterborne transmission of cholera. Within-and between-region epidemic spread was modeled, with the latter dependent on population sizes and distance between regional centroids (a "gravity" model). Setting: Haiti, 2010 to 2011. Data Sources: Haitian hospitalization data, 2009 census data, literature-derived parameter values, and model calibration. Measurements: Dates of epidemic onset and hospitalizations. Results: The plausible range for cholera's basic reproductive number (R-o, defined as the number of secondary cases per primary case in a susceptible population without intervention) was 2.06 to 2.78. The order and timing of regional cholera outbreaks predicted by the gravity model were closely correlated with empirical observations. Analysis of changes in disease dynamics over time suggests that public health interventions have substantially affected this epidemic. A limited vaccine supply provided late in the epidemic was projected to have a modest effect. Limitations: Assumptions were simplified, which was necessary for modeling. Projections are based on the initial dynamics of the epidemic, which may change. Conclusion: Despite limited surveillance data from the cholera epidemic in Haiti, a model simulating between-region disease transmission according to population and distance closely reproduces reported disease patterns. This model is a tool that planners, policy-makers, and medical personnel seeking to manage the epidemic could use immediately.	[Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; Ohio State Univ, Columbus, OH 43210 USA; McMaster Univ, Hamilton, ON, Canada; Univ Victoria, Victoria, BC, Canada	University of Toronto; University System of Ohio; Ohio State University; McMaster University; University of Victoria	Fisman, DN (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St,Room 678, Toronto, ON M5T 3M7, Canada.	david.fisman@utoronto.ca	Ma, Junling/I-7349-2012	Ma, Junling/0000-0002-0197-2317; Earn, David/0000-0002-7562-1341	Institute of Population and Public Health of the Canadian Institutes of Health Research [22228]; National Science Foundation [0635561]; Natural Sciences and Engineering Research Council of Canada; James S. McDonnell Foundation	Institute of Population and Public Health of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); James S. McDonnell Foundation	Ms. Tuite and Dr. Fisman are supported by a grant from the Institute of Population and Public Health of the Canadian Institutes of Health Research (PH2-#22228). Dr. Eisenberg is supported by the National Science Foundation (agreement 0635561). Dr. Earn receives support from the Natural Sciences and Engineering Research Council of Canada and the James S. McDonnell Foundation.	Albert M. John, 1997, World Health Statistics Quarterly, V50, P111; ANDERSON RM, 1991, CMAJ; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1586; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1473; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; BHARTI N, 2008, NEW ENGL J MED, V3; BROWNSTEIN JS, 2008, MMWR-MORBID MORTAL W, V5, pE151; CAMPBELLMCINTYRE R, 1979, LANCET, V1, P311; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1411; CHIN CS, 2011, WKLY EPIDEMIOL REC, V364, P33; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Crepey P, 2007, AM J EPIDEMIOL, V166, P1244, DOI 10.1093/aje/kwm266; Eggo RM, 2011, J R SOC INTERFACE, V8, P233, DOI 10.1098/rsif.2010.0216; Graves PM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000974.pub2; Griffith DC, 2006, AM J TROP MED HYG, V75, P973, DOI 10.4269/ajtmh.2006.75.973; Guthmann JP, 1995, J TROP MED HYG, V98, P419; HOOD MA, 1981, APPL ENVIRON MICROB, V41, P559, DOI 10.1128/AEM.41.2.559-560.1981; Institut Haitien de Statistique et d'Informatique, 2009, POP TOT POP 18 ANS P; *INT MON FUND, 2009, HAIT ENH IN HEAV IND; IVERS LC, 2010, J R SOC INTERFACE, V376, P2048; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; JOHANNESSON M, 1994, MED DECIS MAKING, V14, P188, DOI 10.1177/0272989X9401400212; KEELING MJ, 2009, PLOS MED, P233; KNOX R, 2010, DOCTORS URGE CHOLERA; *MIN SANT PUBL POP, 2010, DOC HAIT CHOL EP; Misch A, 1991, World Watch, V4, P37; Mishra S, 2011, J EPIDEMIOL COMMUN H, V65, P87, DOI 10.1136/jech.2009.097113; Moghadas S, 2009, CAN MED ASSOC J, V181, P171, DOI 10.1503/cmaj.090885; NEILAN RLM, 2010, J R SOC INTERFACE, V72, P2004; PASCUAL M, 2006, CMAJ, V3, pE280; *PUBL HLTH AG CAN, 2006, CAN IMM GUID, P158; RABBANI GH, 1999, LANCET, V17, P1; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Sontag Deborah, 2010, NY TIMES, pA1; TAUXE RV, 1998, BACTERIAL INFECT HUM, P223; TIEN JH, 2010, PLOS MED; Tien JH, 2010, B MATH BIOL, V72, P1506, DOI 10.1007/s11538-010-9507-6; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; 2008, WKLY EPIDEMIOL REC, V83, P269; 2007, WKLY EPIDEMIOL REC, V82, P273	41	172	175	1	71	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					593	601		10.7326/0003-4819-154-9-201105030-00334	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00334			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21383314				2022-12-28	WOS:000290112300003
J	Upadhyay, A; Earley, A; Haynes, SM; Uhlig, K				Upadhyay, Ashish; Earley, Amy; Haynes, Shana M.; Uhlig, Katrin			Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier	ANNALS OF INTERNAL MEDICINE			English	Review							CHRONIC RENAL-DISEASE; SUBGROUP ANALYSIS; PROGRESSION; PEOPLE; DIET; PREVENTION; TRIALS	Background: The optimal blood pressure target in patients with chronic kidney disease (CKD) is unclear. Purpose: To summarize trials comparing lower versus higher blood pressure targets in adult patients with CKD and focus on proteinuria as an effect modifier. Data Sources: MEDLINE and the Cochrane Central Register of Controlled Trials (July 2001 through January 2011) were searched for reports from randomized, controlled trials with no language restriction. Study Selection: Authors screened abstracts to identify reports from trials comparing blood pressure targets in adults with CKD that had more than 50 participants per group; at least 1-year follow-up; and outcomes of death, kidney failure, cardiovascular events, change in kidney function, number of antihypertensive agents, and adverse events. Data Extraction: Reviewers extracted data on study design, methods, sample characteristics, interventions, comparators, outcomes, number of medications, and adverse events and rated study quality and quality of analyses for proteinuria subgroups. Data Synthesis: Three trials with a total of 2272 participants were included. Overall, trials did not show that a blood pressure target of less than 125/75 to 130/80 mm Hg is more beneficial than a target of less than 140/90 mm Hg. Lower-quality evidence suggests that a low target may be beneficial in subgroups with proteinuria greater than 300 to 1000 mg/d. Participants in the low target groups needed more antihypertensive medications and had a slightly higher rate of adverse events. Limitations: No study included patients with diabetes. Trial duration may have been too short to detect differences in clinically important outcomes, such as death and kidney failure. Ascertainment and reporting of adverse events was not uniform. Conclusion: Available evidence is inconclusive but does not prove that a blood pressure target of less than 130/80 mm Hg improves clinical outcomes more than a target of less than 140/90 mm Hg in adults with CKD. Whether a lower target benefits patients with proteinuria greater than 300 to 1000 mg/d requires further study.	[Uhlig, Katrin] Tufts Med Ctr, Tufts Ctr Kidney Dis Guideline Dev & Implementat, William B Schwartz Div Nephrol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Uhlig, K (corresponding author), Tufts Med Ctr, Tufts Ctr Kidney Dis Guideline Dev & Implementat, William B Schwartz Div Nephrol, 800 Washington St,391, Boston, MA 02111 USA.	kuhlig@tuftsmedicalcenter.org		Upadhyay, Ashish/0000-0002-0536-5776	KDIGO	KDIGO	The authors are supported by KDIGO to conduct systematic reviews and provide methods support for developing KDIGO guidelines.	Agarwal R, 2010, AM J NEPHROL, V32, P379, DOI 10.1159/000319639; Agarwal R, 2010, AM J NEPHROL, V32, P374, DOI 10.1159/000319637; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Arguedas JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004349.pub2; Balk E, 2006, ANN INTERN MED, V145, P901, DOI 10.7326/0003-4819-145-12-200612190-00143; BECK GJ, 1991, CONTROL CLIN TRIALS, V12, P566, DOI 10.1016/0197-2456(91)90069-X; Bria E, 2007, J CLIN ONCOL, V25, P605, DOI 10.1200/JCO.2006.09.0365; Brookes S T, 2001, Health Technol Assess, V5, P1; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; *CLINICALTRIALS, SPRINT SYST BLOOD PR, P81268; *CLINICALTRIALS, HALT PROGR POL KIDN, P81268; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Harris D, 2006, NEPHROLOGY, V11, pS2, DOI 10.1111/j.1440-1797.2006.00505.x; *K DOQI, 2004, AM J KIDNEY DIS S, V43, pS1; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Lazarus JM, 1997, HYPERTENSION, V29, P641, DOI 10.1161/01.HYP.29.2.641; Lewis JB, 2010, J AM SOC NEPHROL, V21, P1086, DOI 10.1681/ASN.2010030236; Luft FC, 2010, AM J NEPHROL, V32, P381, DOI 10.1159/000319662; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Norris K, 2006, AM J KIDNEY DIS, V48, P739, DOI 10.1053/j.ajkd.2006.08.004; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; *REN ASS, 2010, UK CDK EGUIDE HYP, P81268; Rosendorff C, 2009, CURR OPIN CARDIOL, V24, P318, DOI 10.1097/HCO.0b013e32832bfb48; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Roy M, 2010, CURR ATHEROSCLER REP, V12, P134, DOI 10.1007/s11883-010-0094-7; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Sleight Peter, 2000, Curr Control Trials Cardiovasc Med, V1, P25, DOI 10.1186/CVM-1-1-025; Toto RD, 2010, AM J NEPHROL, V32, P370, DOI 10.1159/000319636; Toto RD, 2010, AM J NEPHROL, V32, P377, DOI 10.1159/000319638; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; 1997, ARCH INTERN MED, V157, P2413	38	231	240	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					541	548		10.7326/0003-4819-154-8-201104190-00335	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00335			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21403055				2022-12-28	WOS:000289622000017
J	Adams, KN; Takaki, K; Connolly, LE; Wiedenhoft, H; Winglee, K; Humbert, O; Edelstein, PH; Cosma, CL; Ramakrishnan, L				Adams, Kristin N.; Takaki, Kevin; Connolly, Lynn E.; Wiedenhoft, Heather; Winglee, Kathryn; Humbert, Olivier; Edelstein, Paul H.; Cosma, Christine L.; Ramakrishnan, Lalita			Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism	CELL			English	Article							ANTITUBERCULOSIS DRUGS; ANTIBIOTIC-RESISTANCE; MARINUM INFECTION; INITIAL TREATMENT; TUBERCULOSIS; PUMP; EXPRESSION; STRESS; GENES; SUSCEPTIBILITY	Treatment of tuberculosis, a complex granulomatous disease, requires long-term multidrug therapy to overcome tolerance, an epigenetic drug resistance that is widely attributed to nonreplicating bacterial subpopulations. Here, we deploy Mycobacterium marinum-infected zebrafish larvae for in vivo characterization of antitubercular drug activity and tolerance. We describe the existence of multidrug-tolerant organisms that arise within days of infection, are enriched in the replicating intracellular population, and are amplified and disseminated by the tuberculous granuloma. Bacterial efflux pumps that are required for intracellular growth mediate this macrophage-induced tolerance. This tolerant population also develops when Mycobacterium tuberculosis infects cultured macrophages, suggesting that it contributes to the burden of drug tolerance in human tuberculosis. Efflux pump inhibitors like verapamil reduce this tolerance. Thus, the addition of this currently approved drug or more specific efflux pump inhibitors to standard antitubercular therapy should shorten the duration of curative treatment.	[Adams, Kristin N.; Takaki, Kevin; Wiedenhoft, Heather; Winglee, Kathryn; Humbert, Olivier; Cosma, Christine L.; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Connolly, Lynn E.; Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Edelstein, Paul H.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	lalitar@uw.edu	Edelstein, Paul/I-5527-2019	Edelstein, Paul/0000-0002-4069-5279; Ramakrishnan, Lalita/0000-0003-0692-5533; Takaki, Kevin/0000-0002-4790-4598; Winglee, Kathryn/0000-0002-3623-0700	Gates Foundation; University of Washington; Burroughs Wellcome Foundation; NIH [RO1 AI036396, RO1 AI54503, U54AI057141, T32 AI55396, K08 AI076620, 5R21 AI073328-02, 5R21 AI078189-02]; Levinson Emerging Scholars Program; Mary Gates Endowment Grant; Washington NASA; Pfizer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055396, K08AI076620, R01AI054503, R21AI073328, R21AI078189, U54AI057141, R01AI036396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099901] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); University of Washington(University of Washington); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Levinson Emerging Scholars Program; Mary Gates Endowment Grant; Washington NASA; Pfizer(Pfizer); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. R. Sherman for the gift of pBP10, advice, and the use of the BSL-3 facilities at Seattle BioMed; the members of his laboratory, especially R. Liao and J. Pang, for help in using the BSL-3 facilities; M. Nixon for advice in analyzing the unstable plasmid data; W. R. Bishai and G. Lamichhane for providing the Mtb Rv1258c mutants through the Tuberculosis Animal Research and Gene Evaluation Taskforce (NIH/NIAID N01 AI30036); E. Nuermberger and P. Donald for sharing knowledge and insights about TB drugs; B. Cormack and M. Troll for discussion; J. M. Davis and C. T. Yang for technical advice; J. Ray and H. Volkman for figure design and preparation; and S. Phillips and T. Pecor for technical assistance. This work was supported by a Gates Foundation TB drug accelerator grant; a University of Washington Royalty Research Fund Grant; a Burroughs Wellcome Foundation Pathogenesis of Infectious Diseases award; NIH grants RO1 AI036396, RO1 AI54503, and U54AI057141 to L. R.; NIH grant T32 AI55396 to K.N.A.; a Levinson Emerging Scholars Program Grant, a Mary Gates Endowment Grant, and a Washington NASA Space Grant to K. W.; a Pfizer Fellowship in Infectious Diseases and NIH grant K08 AI076620 to L. E. C.; and NIH grants 5R21 AI073328-02 and 5R21 AI078189-02 to P. H. E. L. R. is a recipient of the NIH Director's Pioneer Award and a consultant for Sanofi Aventis.	Akira M, 2000, J COMPUT ASSIST TOMO, V24, P426, DOI 10.1097/00004728-200005000-00014; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Aubry A, 2002, ARCH INTERN MED, V162, P1746, DOI 10.1001/archinte.162.15.1746; BARKER J, 1995, ANTIMICROB AGENTS CH, V39, P2684, DOI 10.1128/AAC.39.12.2684; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; BOBROWITZ ID, 1980, AM REV RESPIR DIS, V121, P735; Canetti G., 1955, TUBERCLE BACILLUS PU; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Cosma C. L., 2006, CURRENT PROTOCOLS MI, DOI 10.1002/; Cosma CL, 2006, INFECT IMMUN, V74, P3125, DOI 10.1128/IAI.02061-05; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; Dannenberg AM, 2003, TUBERCULOSIS, V83, P251, DOI 10.1016/S1472-9792(03)00048-9; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; de Steenwinkel JEM, 2010, J ANTIMICROB CHEMOTH, V65, P2582, DOI 10.1093/jac/dkq374; Decostere A, 2004, VET MICROBIOL, V99, P159, DOI 10.1016/j.vetmic.2003.07.011; Donald PR, 2008, TUBERCULOSIS, V88, pS75, DOI 10.1016/S1472-9792(08)70038-6; Duits LA, 2001, BIOCHEM BIOPH RES CO, V280, P522, DOI 10.1006/bbrc.2000.4157; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Fontan PA, 2008, J INFECT DIS, V198, P877, DOI 10.1086/591098; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Grange, 2009, TUBERCULOSIS COMPREH, P608, DOI [10.1016/B978-1-4160-3988-4.00059-7, DOI 10.1016/B978-1-4160-3988-4.00059-7]; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Ibrahim M, 2009, AM J RESP CRIT CARE, V180, P553, DOI 10.1164/rccm.200807-1152OC; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Nguyen L, 2006, TRENDS MICROBIOL, V14, P304, DOI 10.1016/j.tim.2006.05.005; Paramasivan CN, 2005, ANTIMICROB AGENTS CH, V49, P627, DOI 10.1128/AAC.49.2.627-631.2005; Ramon-Garcia S, 2009, ANTIMICROB AGENTS CH, V53, P3675, DOI 10.1128/AAC.00550-09; Rich AR, 1946, PATHOGENESIS TUBERCU; Rivas-Santiago B, 2008, INFECT IMMUN, V76, P935, DOI 10.1128/IAI.01218-07; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; ROOK GAW, 1987, EUR J RESPIR DIS, V71, P286; Sacchettini JC, 2008, NAT REV MICROBIOL, V6, P41, DOI 10.1038/nrmicro1816; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sharma S, 2010, J ANTIMICROB CHEMOTH, V65, P1694, DOI 10.1093/jac/dkq186; Siddiqi N, 2004, INFECTION, V32, P109, DOI 10.1007/s15010-004-3097-x; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Viveiros M, 2002, ANTIMICROB AGENTS CH, V46, P2804, DOI 10.1128/AAC.46.9.2804-2810.2002; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Zahner D, 2010, ANTIMICROB AGENTS CH, V54, P3516, DOI 10.1128/AAC.01756-09	58	364	373	6	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					39	53		10.1016/j.cell.2011.02.022	http://dx.doi.org/10.1016/j.cell.2011.02.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21376383	Green Accepted, Bronze			2022-12-28	WOS:000289053900008
J	Schaller, MF; Wright, JD; Kent, DV				Schaller, Morgan F.; Wright, James D.; Kent, Dennis V.			Atmospheric P-CO2 Perturbations Associated with the Central Atlantic Magmatic Province	SCIENCE			English	Article							OXYGEN ISOTOPIC COMPOSITION; FLOOD-BASALT ERUPTIONS; PEDOGENIC CARBONATE; MASS-EXTINCTION; FOSSIL PLANTS; NEW-MEXICO; CO2; BOUNDARY; IMPACT; STRATIGRAPHY	The effects of a large igneous province on the concentration of atmospheric carbon dioxide (P-CO2) are mostly unknown. In this study, we estimate P-CO2 from stable isotopic values of pedogenic carbonates interbedded with volcanics of the Central Atlantic Magmatic Province (CAMP) in the Newark Basin, eastern North America. We find pre-CAMP P-CO2 values of similar to 2000 parts per million (ppm), increasing to similar to 4400 ppm immediately after the first volcanic unit, followed by a steady decrease toward pre-eruptive levels over the subsequent 300 thousand years, a pattern that is repeated after the second and third flow units. We interpret each P-CO2 increase as a direct response to magmatic activity (primary outgassing or contact metamorphism). The systematic decreases in P-CO2 after each magmatic episode probably reflect consumption of atmospheric CO2 by weathering of silicates, stimulated by fresh CAMP volcanics.	[Schaller, Morgan F.; Wright, James D.; Kent, Dennis V.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA; [Kent, Dennis V.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Rutgers State University New Brunswick; Columbia University	Schaller, MF (corresponding author), Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA.	schaller@rci.rutgers.edu	Wright, James/AAF-7180-2019	Wright, James/0000-0001-5212-9146; Kent, Dennis/0000-0002-7677-2993; Schaller, Morgan/0000-0003-2742-2126	Geological Society of America; Society of Economic Mineralogists and Petrologists; NSF [EAR 0958867]; Directorate For Geosciences [0958867] Funding Source: National Science Foundation	Geological Society of America; Society of Economic Mineralogists and Petrologists; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We are grateful to J. Quade and P. E. Olsen for their numerous helpful discussions and L. Godfrey for her technical lab assistance. This research was supported by 2009 Geological Society of America and the Society of Economic Mineralogists and Petrologists Graduate Research Awards and NSF grant EAR 0958867. This work is Lamont-Doherty Earth Observatory Contribution #7432.	Arens NC, 2000, PALEOBIOLOGY, V26, P137, DOI 10.1666/0094-8373(2000)026&lt;0137:CCPFRT&gt;2.0.CO;2; Beerling D, 2002, NATURE, V415, P386, DOI 10.1038/415386a; Beerling DJ, 2002, P NATL ACAD SCI USA, V99, P7836, DOI 10.1073/pnas.122573099; Beerling DJ, 2002, ANNU REV EARTH PL SC, V30, P527, DOI 10.1146/annurev.earth.30.091201.141413; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Breecker DO, 2009, GEOL SOC AM BULL, V121, P630, DOI 10.1130/B26413.1; CALDEIRA K, 1990, GEOPHYS RES LETT, V17, P1299, DOI 10.1029/GL017i009p01299; Cerling TE, 1999, PALAEOWEATHERING PAL, V27, P43, DOI DOI 10.1002/9781444304190.CH2; Cerling TE, 1992, GLOBAL BIOGEOCHEM CY, V6, P307, DOI 10.1029/92GB01102; Cleveland DM, 2008, GEOL SOC AM BULL, V120, P1408, DOI 10.1130/B26332.1; Cleveland DM, 2007, J SEDIMENT RES, V77, P909, DOI 10.2110/jsr.2007.082; COFFIN MF, 1993, GEOLOGY, V21, P515, DOI 10.1130/0091-7613(1993)021<0515:STSEDO>2.3.CO;2; Cohen AS, 2007, PALAEOGEOGR PALAEOCL, V244, P374, DOI 10.1016/j.palaeo.2006.06.036; Courtillot V, 1999, EARTH PLANET SC LETT, V166, P177, DOI 10.1016/S0012-821X(98)00282-9; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Dessert C, 2001, EARTH PLANET SC LETT, V188, P459, DOI 10.1016/S0012-821X(01)00317-X; Dessert C, 2003, CHEM GEOL, V202, P257, DOI 10.1016/j.chemgeo.2002.10.001; Dworkin SI, 2005, EARTH PLANET SC LETT, V237, P56, DOI 10.1016/j.epsl.2005.06.054; Fedosh M. S., 1988, US GEOL SURV B, V1776, P19; Fowell S.J., 1994, GEOLOGICAL SOC AM SP, V288, P197, DOI [DOI 10.1130/SPE288-P197, 10.1130/SPE288-p197]; Grard A, 2005, EARTH PLANET SC LETT, V234, P207, DOI 10.1016/j.epsl.2005.02.027; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; HOLBROOK WS, 1993, NATURE, V364, P433, DOI 10.1038/364433a0; Kent DV, 1996, B GEOL SOC DENMARK, V42, P121; Kent DV, 1999, J GEOPHYS RES-SOL EA, V104, P12831, DOI 10.1029/1999JB900076; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McHone JG, 2003, GEOPH MONOG SERIES, V136, P241; Nordt L, 2002, GEOLOGY, V30, P703, DOI 10.1130/0091-7613(2002)030<0703:PBIEFI>2.0.CO;2; Olsen P. E., 1988, US GEOL SURV B, V1776, P6; Olsen P. E., 1996, MUSEUM NO ARIZONA B, V60, P11; Olsen PE, 2003, GEOPH MONOG SERIES, V136, P7; Olsen PE, 1996, GEOL SOC AM BULL, V108, P40, DOI 10.1130/0016-7606(1996)108<0040:HRSOTN>2.3.CO;2; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; POLLACK JB, 1976, J GEOPHYS RES-OC ATM, V81, P1071, DOI 10.1029/JC081i006p01071; QUADE J, 1989, GEOL SOC AM BULL, V101, P464, DOI 10.1130/0016-7606(1989)101&lt;0464:SVITCA&gt;2.3.CO;2; RAMPINO MR, 1985, NATURE, V313, P272, DOI 10.1038/313272a0; Retallack GJ, 2002, NATURE, V415, P387, DOI 10.1038/415387a; Retallack GJ, 2001, NATURE, V411, P287, DOI 10.1038/35077041; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; Self S, 2006, EARTH PLANET SC LETT, V248, P518, DOI 10.1016/j.epsl.2006.05.041; SUCHECKI RK, 1988, J SEDIMENT PETROL, V58, P801; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; Tanner L. H., 2003, GREAT RIFT VALLEYS P; Tanner LH, 2001, NATURE, V411, P675, DOI 10.1038/35079548; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; Whiteside JH, 2007, PALAEOGEOGR PALAEOCL, V244, P345, DOI 10.1016/j.palaeo.2006.06.035; Whiteside JH, 2010, P NATL ACAD SCI USA, V107, P6721, DOI 10.1073/pnas.1001706107; Wignall PB, 2001, EARTH-SCI REV, V53, P1, DOI 10.1016/S0012-8252(00)00037-4	50	164	165	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1404	1409		10.1126/science.1199011	http://dx.doi.org/10.1126/science.1199011			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21330490	Green Published			2022-12-28	WOS:000288504000032
J	Arie, S				Arie, Sophie			Health Systems French healthcare: the high cost of excellence	BRITISH MEDICAL JOURNAL			English	Editorial Material												ariesophie@yahoo.co.uk						Joumard I., 2010, EC DEP WORKING PAPER, V769, P25; *OECD, OECD HLTH DAT 2010 P; OECD, 2009, HLTH GLANC 2009 OECD, DOI [10.1787/health_glance-2009-en, DOI 10.1787/HEALTH_GLANCE-2009-EN]; OECD / European Union, 2018, HLTH GLANC EUR 2018, DOI [10.1787/health_glance-2010-en, DOI 10.1787/HEALTH_GLANCE-2010-EN]; OR Z, 2010, HLTH POLICY MONI OCT; World Health Organization, 2001, WORLD HLTH REP 2000	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 15	2011	342								d1524	10.1136/bmj.d1524	http://dx.doi.org/10.1136/bmj.d1524			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FA	21406531				2022-12-28	WOS:000288698100007
J	Schattner, A				Schattner, Ami			Anti-tumor necrosis factor therapy was not associated with greater risk for mortality than standard therapy in rheumatoid arthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Schattner, A (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Jerusalem, Israel.		Schattner, Ami/ABI-1894-2020	Schattner, Ami/0000-0002-1413-8858				Gonzalez A, 2007, ARTHRITIS RHEUM, V56, P3583, DOI 10.1002/art.22979; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-13	10.7326/0003-4819-154-6-201103150-02013	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403064				2022-12-28	WOS:000208886200012
J	Mou, D; Sarma, A; Sethi, R; Merryman, R				Mou, David; Sarma, Aartik; Sethi, Roshan; Merryman, Reid			The State of Health Policy Education in US Medical Schools	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ENVIRONMENT		[Mou, David; Sarma, Aartik; Sethi, Roshan; Merryman, Reid] Harvard Univ, Sch Med, Boston, MA 02163 USA	Harvard University; Harvard Medical School	Mou, D (corresponding author), Harvard Univ, Sch Med, Boston, MA 02163 USA.			Sarma, Aartik/0000-0002-7508-7345; Merryman, Reid/0000-0002-6360-3234				Halpern R, 2001, ACAD MED, V76, P606, DOI 10.1097/00001888-200106000-00009; Rabinowitz HK, 2001, ACAD MED, V76, P587, DOI 10.1097/00001888-200106000-00007	2	30	31	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10								10.1056/NEJMp1101603	http://dx.doi.org/10.1056/NEJMp1101603			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732FL	21345091				2022-12-28	WOS:000288170300005
J	Leach, OA; Gilbert, EJ; Evans, A; van Boxel, GI				Leach, OA; Gilbert, EJ; Evans, A; van Boxel, GI			Case Report: A young woman with rigors and abdominal pain The fever and rigors suggest infection, and viral illnesses should be considered in the absence of objective evidence of a bacterial infection.	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BARR-VIRUS INFECTION; SPONTANEOUS SPLENIC RUPTURE; NONOPERATIVE MANAGEMENT; MONONUCLEOSIS; HETEROPHILE; SPECIFICITY; SENSITIVITY; DIAGNOSIS; TESTS		[Leach, OA; Evans, A; van Boxel, GI] Cheltenham Gen Hosp, Dept Endocrine Med, Cheltenham GL53 7AN, Glos, England; [Gilbert, EJ] Yeovil Dist Hosp, Dept Resp Med, Yeovil, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital	van Boxel, GI (corresponding author), Cheltenham Gen Hosp, Dept Endocrine Med, Cheltenham GL53 7AN, Glos, England.	gijs.vanboxel@glos.nhs.uk						Attarbaschi T, 2003, EUR CYTOKINE NETW, V14, P34; BASSON V, 1969, J CLIN PATHOL, V22, P324, DOI 10.1136/jcp.22.3.324; Bolden K J, 1972, J R Coll Gen Pract, V22, P87; Bosman G, 2009, NETH J MED, V67, P364; Brichkov I, 2006, AM SURGEON, V72, P401; Brigden ML, 1999, ARCH PATHOL LAB MED, V123, P875; Byard RW, 2002, J FORENSIC SCI, V47, P202; Candy B, 2002, BRIT J GEN PRACT, V52, P844; COOK L, 1987, J CLIN MICROBIOL, V25, P2391, DOI 10.1128/JCM.25.12.2391-2394.1987; Ebell MH, 2004, AM FAM PHYSICIAN, V70, P1279; Epstein MA, 1979, EPSTEIN BARR VIRUS; EVANS AS, 1975, J INFECT DIS, V132, P546, DOI 10.1093/infdis/132.5.546; FLEISHER GR, 1983, J CLIN MICROBIOL, V17, P619, DOI 10.1128/JCM.17.4.619-624.1983; Fujimoto H, 2003, INTERNAL MED, V42, P33, DOI 10.2169/internalmedicine.42.33; Glynn FJ, 2007, EUR J EMERG MED, V14, P41, DOI 10.1097/01.mej.0000224431.36376.71; Gulley ML, 2010, CLIN MICROBIOL REV, V23, P350, DOI 10.1128/CMR.00006-09; HANKEY GJ, 1987, J NEUROL NEUROSUR PS, V50, P1713, DOI 10.1136/jnnp.50.12.1713; HEATH CW, 1972, AM J EPIDEMIOL, V95, P46, DOI 10.1093/oxfordjournals.aje.a121369; HENKE CE, 1973, AM J EPIDEMIOL, V98, P483, DOI 10.1093/oxfordjournals.aje.a121577; HOAGLAND R J, 1965, Med Times, V93, P663; Hoagland R J, 1975, Prim Care, V2, P295; HOAGLAND RJ, 1955, AM J MED SCI, V229, P262; HOAGLAND RJ, 1952, AM J MED, V13, P158, DOI 10.1016/0002-9343(52)90154-X; Hojberg L, 2005, SCAND J INFECT DIS, V37, P522, DOI 10.1080/00365540510038514; Jappe U, 2007, ALLERGY, V62, P1474, DOI 10.1111/j.1398-9995.2007.01518.x; Jenson HB, 2000, CURR OPIN PEDIATR, V12, P263, DOI 10.1097/00008480-200006000-00016; Kean S, 2009, SCIENCE, V326, P215, DOI 10.1126/science.326_215a; LeClaire AC, 2004, ANN PHARMACOTHER, V38, P996, DOI 10.1345/aph.1D378; Luzuriaga K, 2010, NEW ENGL J MED, V362, P1993, DOI 10.1056/NEJMcp1001116; Macsween KF, 2010, CLIN INFECT DIS, V50, P699, DOI 10.1086/650456; Milone MC, 2005, BLOOD, V105, P994, DOI 10.1182/blood-2004-07-2965; *NAT CTR INFECT DI, EPST BARR VIR INFECT; Partel A., 1986, CONN DENT STUD J, V6, P12; Roy M, 2004, ARCH PEDIAT ADOL MED, V158, P250, DOI 10.1001/archpedi.158.3.250; Stephenson JT, 2007, PEDIATRICS, V120, pE432, DOI 10.1542/peds.2006-3071; Torre D, 1999, SCAND J INFECT DIS, V31, P543, DOI 10.1080/00365549950164409; Waninger KN, 2005, CLIN J SPORT MED, V15, P410, DOI 10.1097/01.jsm.0000187077.82230.64; WHITELAW F, 1995, BRIT J CLIN PRACT, V49, P212	38	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2011	342								d689	10.1136/bmj.d689	http://dx.doi.org/10.1136/bmj.d689			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UZ	21389069				2022-12-28	WOS:000288446900008
J	Fizazi, K; Carducci, M; Smith, M; Damiao, R; Brown, J; Karsh, L; Milecki, P; Shore, N; Rader, M; Wang, HI; Jiang, Q; Tadros, S; Dansey, R; Goessl, C				Fizazi, Karim; Carducci, Michael; Smith, Matthew; Damiao, Ronaldo; Brown, Janet; Karsh, Lawrence; Milecki, Piotr; Shore, Neal; Rader, Michael; Wang, Huei; Jiang, Qi; Tadros, Sylvia; Dansey, Roger; Goessl, Carsten			Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study	LANCET			English	Article							PHASE-II TRIAL; BREAST-CANCER; SKELETAL COMPLICATIONS; LONG-TERM; THERAPY; MULTICENTER; PREVENTION; SURVIVAL; EFFICACY; DISEASE	Background Bone metastases are a major burden in men with advanced prostate cancer. We compared denosumab, a human monoclonal antibody against RANKL, with zoledronic acid for prevention of skeletal-related events in men with bone metastases from castration-resistant prostate cancer. Methods In this phase 3 study, men with castration-resistant prostate cancer and no previous exposure to intravenous bisphosphonate were enrolled from 342 centres in 39 countries. An interactive voice response system was used to assign patients (1:1 ratio), according to a computer-generated randomisation sequence, to receive 120 mg subcutaneous denosumab plus intravenous placebo, or 4 mg intravenous zoledronic acid plus subcutaneous placebo, every 4 weeks until the primary analysis cutoff date. Randomisation was stratified by previous skeletal-related event, prostate-specific antigen concentration, and chemotherapy for prostate cancer within 6 weeks before randomisation. Supplemental calcium and vitamin D were strongly recommended. Patients, study staff, and investigators were masked to treatment assignment. The primary endpoint was time to first on-study skeletal. related event (pathological fracture, radiation therapy, surgery to bone, or spinal cord compression), and was assessed for non-inferiority. The same outcome was further assessed for superiority as a secondary endpoint. Efficacy analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00321620, and has been completed. Findings 1904 patients were randomised, of whom 950 assigned to denosumab and 951 assigned to receive zoledronic acid were eligible for the efficacy analysis. Median duration on study at primary analysis cutoff date was 12.2 months (IQR 5.9-18.5) for patients on denosumab and 11.2 months (IQR 5.6-17.4) for those on zoledronic acid. Median time to first on-study skeletal-related event was 20.7 months (95% CI 18.8-24.9) with denosumab compared with 17.1 months (15-0-19.4) with zoledronic acid (hazard ratio 0.82, 95% CI 0.71-0.95; p=0.0002 for non-inferiority; p=0.008 for superiority). Adverse events were recorded in 916 patients (97%) on denosumab and 918 patients (97%) on zoledronic acid, and serious adverse events were recorded in 594 patients (63%) on denosumab and 568 patients (60%) on zoledronic acid. More events of hypocalcaemia occurred in the denosumab group (121 [13%]) than in the zoledronic acid group (55 [6%]; p<0.0001). Osteonecrosis of the jaw occurred infrequently (22 [2%] vs 12 [1%]; p=0.09). Interpretation Denosumab was better than zoledronic acid for prevention of skeletal-related events, and potentially represents a novel treatment option in men with bone metastases from castration-resistant prostate cancer.	[Fizazi, Karim] Univ Paris 11, Inst Gustave Roussy, Dept Canc Med, F-94805 Villejuif, France; [Carducci, Michael] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Smith, Matthew] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Damiao, Ronaldo] Hosp Univ Pedro Ernesto, Rio De Janeiro, Brazil; [Brown, Janet] Canc Res UK Clin Ctr, Leeds, W Yorkshire, England; [Karsh, Lawrence] Urol Ctr Colorado, Denver, CO USA; [Milecki, Piotr] Wielkopolskie Ctr Onkol, Poznan, Poland; [Shore, Neal] Carolina Urol Res Ctr, Myrtle Beach, SC USA; [Rader, Michael] Nyack Hosp, Union State Bank, Ctr Canc, Nyack, NY USA; [Wang, Huei; Jiang, Qi; Tadros, Sylvia; Dansey, Roger; Goessl, Carsten] Amgen Inc, Thousand Oaks, CA USA	UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Massachusetts General Hospital; Cancer Research UK; University of Leeds; Wielkopolskie Centrum Onkologii; Carolina Urologic Research Center; Amgen	Fizazi, K (corresponding author), Univ Paris 11, Inst Gustave Roussy, Dept Canc Med, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	fizazi@igr.fr	Carducci, Michael/R-8164-2019	Krainer, Michael/0000-0002-7011-4957; Milecki, Piotr/0000-0002-2215-3695	Amgen; Novartis; Center of Research in Urology Sergio Aguinaga (CEPUSA); Amgen, Thousand Oaks, CA, USA; The Francis Crick Institute [10048] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K24CA121990] Funding Source: NIH RePORTER	Amgen(Amgen); Novartis(Novartis); Center of Research in Urology Sergio Aguinaga (CEPUSA); Amgen, Thousand Oaks, CA, USA(Amgen); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	KF has received consultancy fees and travel support from Amgen for this study and from Novartis; participated in speakers' bureaux and advisory boards for Amgen and Novartis; and provided expert testimony for Amgen. MC has received consultancy fees from Amgen for this study and for other agents in development, and from Novartis; and received research funding from Amgen. MS has received consultancy fees from Amgen; and participated in sponsored clinical research with Amgen and Novartis. RDam has received research funding from Amgen and the Center of Research in Urology Sergio Aguinaga (CEPUSA). JB has received travel support and payment for lectures from Amgen and Novartis; JB has received payment for membership of advisory boards from Amgen. Novartis, and GlaxoSmithKline; and JB and JB's institution have received consultancy fees from Amgen. LK has received consultancy fees, travel support, and honoraria for lectures and development of educational presentations from Amgen; and LK's institution has received research funding from Amgen. PM has received research funding from Amgen; and been a board member and principal investigator for, and received travel support from, Amgen. NS has received consultancy fees and travel support from Amgen for this study; and received research funding and honoraria from Amgen. MR has received travel support and honoraria for membership of advisory boards and lectures from Amgen; and MR's institution has received research funding from Amgen for this study. HW, QJ, ST, RDan, and CG are employees of Amgen, and have received stock or stock options from Amgen.; We thank the patients and investigators at all participating sites who made important contributions to this study; Geoffrey Smith, supported by Amgen, for medical writing assistance in preparation of this report; and the DMC for its diligence in monitoring of the study. The DMC wishes to remain anonymous because it is monitoring other trials of denosumab. This report is presented in memory of study investigator Lina Barbosa Cassol and study coordinator Carla Fioratti. This study was funded by Amgen, Thousand Oaks, CA, USA. Primary results of the data in this report were presented on June, 6, 2010, at the American Society of Clinical Oncology Annual Meeting in Chicago, IL, USA.	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown JE, 2005, JNCI-J NATL CANCER I, V97, P59, DOI 10.1093/jnci/dji002; Dearnaley DP, 2009, LANCET ONCOL, V10, P872, DOI 10.1016/S1470-2045(09)70201-3; Demers LM, 2003, CANCER-AM CANCER SOC, V97, P874, DOI 10.1002/cncr.11127; Ellis GK, 2008, J CLIN ONCOL, V26, P4875, DOI 10.1200/JCO.2008.16.3832; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Fizazi K, 2003, CLIN CANCER RES, V9, P2587; Fizazi K, 2010, BJU INT, V105, P748, DOI 10.1111/j.1464-410X.2010.09236.x; Fizazi K, 2009, J CLIN ONCOL, V27, P1564, DOI 10.1200/JCO.2008.19.2146; Fizazi K, 2009, J CLIN ONCOL, V27, P2429, DOI 10.1200/JCO.2008.18.9811; Henry D, J CLIN ONCO IN PRESS; Hung HMJ, 2003, STAT MED, V22, P213, DOI 10.1002/sim.1315; James ND, 2009, EUR UROL, V55, P1112, DOI 10.1016/j.eururo.2008.11.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lee RJ, 2011, BONE, V48, P88, DOI 10.1016/j.bone.2010.05.038; Lipton A, 2007, J CLIN ONCOL, V25, P4431, DOI 10.1200/JCO.2007.11.8604; Nilsson S, 2007, LANCET ONCOL, V8, P587, DOI 10.1016/S1470-2045(07)70147-X; Novartis, 2009, ZOM ZOL ACID PACK IN; Olson Karin, 2007, J Oncol Pharm Pract, V13, P223, DOI 10.1177/1078155207080806; PERCIVAL RC, 1987, EUR J SURG ONCOL, V13, P41; Roudier MP, 2008, J UROLOGY, V180, P1154, DOI 10.1016/j.juro.2008.04.140; Saad F, 2002, JNCI-J NATL CANCER I, V94, P1458, DOI 10.1093/jnci/94.19.1458; Saad F, 2004, J NATL CANCER I, V96, P879, DOI 10.1093/jnci/djh141; Saad F, 2008, CANCER TREAT REV, V34, P183, DOI 10.1016/j.ctrv.2007.10.002; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Schulman KL, 2007, CANCER-AM CANCER SOC, V109, P2334, DOI 10.1002/cncr.22678; Small EJ, 2003, J CLIN ONCOL, V21, P4277, DOI 10.1200/JCO.2003.05.147; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Walter C, 2008, EUR UROL, V54, P1066, DOI 10.1016/j.eururo.2008.06.070; Westfall P.H., 1999, MULTIPLE COMPARISONS; Zhang J, 2003, CANCER RES, V63, P7883	33	1330	1366	4	196	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2011	377	9768					813	822		10.1016/S0140-6736(10)62344-6	http://dx.doi.org/10.1016/S0140-6736(10)62344-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GO	21353695	Green Accepted			2022-12-28	WOS:000288628500029
J	Chiolo, I; Minoda, A; Colmenares, SU; Polyzos, A; Costes, SV; Karpen, GH				Chiolo, Irene; Minoda, Aki; Colmenares, Serafin U.; Polyzos, Aris; Costes, Sylvain V.; Karpen, Gary H.			Double-Strand Breaks in Heterochromatin Move Outside of a Dynamic HP1a Domain to Complete Recombinational Repair	CELL			English	Article							DNA-DAMAGE; PROTEIN-1; GENE; STABILITY; TELOMERES; MEIOSIS; FAMILY; YEAST; SUMO; RPA	Double-strand breaks (DSBs) in heterochromatic repetitive DNAs pose significant threats to genome integrity, but information about how such lesions are processed and repaired is sparse. We observe dramatic expansion and dynamic protrusions of the heterochromatin domain in response to ionizing radiation (IR) in Drosophila cells. We also find that heterochromatic DSBs are repaired by homologous recombination (HR) but with striking differences from euchromatin. Proteins involved in early HR events (resection) are rapidly recruited to DSBs within heterochromatin. In contrast, Rad51, which mediates strand invasion, only associates with DSBs that relocalize outside of the domain. Heterochromatin expansion and relocalization of foci require checkpoint and resection proteins. Finally, the Smc5/6 complex is enriched in heterochromatin and is required to exclude Rad51 from the domain and prevent abnormal recombination. We propose that the spatial and temporal control of DSB repair in heterochromatin safeguards genome stability by preventing aberrant exchanges between repeats.	[Chiolo, Irene; Minoda, Aki; Colmenares, Serafin U.; Polyzos, Aris; Costes, Sylvain V.; Karpen, Gary H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA; [Karpen, Gary H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chiolo, I (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Dynam, Berkeley, CA 94720 USA.	iechiolo@lbl.gov; karpen@fruitfly.org	Minoda, Aki/Q-4454-2019; Minoda, Aki/D-5335-2017; Costes, Sylvain V/D-2522-2013	Minoda, Aki/0000-0002-2927-5791; Minoda, Aki/0000-0002-2927-5791; Costes, Sylvain V/0000-0002-8542-2389; Chiolo, Irene/0000-0002-3080-550X; Polyzos, Aris/0000-0002-9542-5807	FIRC; Unesco; Ruth Kirchstein NIH [1F32GM086111]; U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086613, F32GM086111] Funding Source: NIH RePORTER	FIRC(Fondazione AIRC per la ricerca sul cancro); Unesco; Ruth Kirchstein NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by postdoctoral fellowships from FIRC and Unesco to I. C., by Ruth Kirchstein NIH Postdoctoral Fellowship to S. U. C. (1F32GM086111), and by the Low Dose Radiation Research Program U.S. Department of Energy (DOE) (DE-AC02-05CH11231) to S. V. C. and G. H. K. We are grateful to P.-O. Mari for assistance with the NIR experiments and to S. Elgin, J. Kadonaga, B. Mellone, and D. Rio for reagents. We thank H. V. Le, R. Kunitake, and C. Pham for their help; A. Dernburg, E. Dunleavy, J. Swenson, and W. Zhang for comments on the manuscript; S. Langley for advice on ChIP-array data analysis; C-Y. Chen for software development; and the Karpen lab for sharing reagents and helpful discussions.	Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Chuang CH, 2006, CURR BIOL, V16, P825, DOI 10.1016/j.cub.2006.03.059; COSTES SV, 2009, MUTAT RES, V704, P78; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Dernburg AF, 1996, CELL, V86, P135, DOI 10.1016/S0092-8674(00)80084-7; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Digilio FA, 1996, DEV BIOL, V178, P90, DOI 10.1006/dbio.1996.0200; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Dronamraju R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000473; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Hughes SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000348; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; KELLUM R, 1995, J CELL SCI, V108, P1407; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Kusano K, 1999, GENETICS, V151, P1027; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pebernard S, 2008, EMBO J, V27, P3011, DOI 10.1038/emboj.2008.220; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Royou A, 2010, CELL, V140, P235, DOI 10.1016/j.cell.2009.12.043; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sato A, 2009, CELL, V139, P907, DOI 10.1016/j.cell.2009.10.039; Shin DM, 2011, GERONTOLOGY, V57, P76, DOI 10.1159/000281882; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Soutoglou Evi, 2008, J Natl Cancer Inst Monogr, P16, DOI 10.1093/jncimonographs/lgn017; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Westphal T, 2002, GENETICS, V160, P609; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	47	371	376	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					732	744		10.1016/j.cell.2011.02.012	http://dx.doi.org/10.1016/j.cell.2011.02.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21353298	Bronze, Green Accepted			2022-12-28	WOS:000288007100012
J	Hoffmann, AA; Sgro, CM				Hoffmann, Ary A.; Sgro, Carla M.			Climate change and evolutionary adaptation	NATURE			English	Review							ENVIRONMENTAL-CHANGE; DROSOPHILA-MELANOGASTER; PHENOTYPIC PLASTICITY; GENETIC ADAPTATION; ADAPTIVE EVOLUTION; PREVENT EXTINCTION; THERMAL TOLERANCE; NATURAL-SELECTION; WYEOMYIA-SMITHII; RAPID EVOLUTION	Evolutionary adaptation can be rapid and potentially help species counter stressful conditions or realize ecological opportunities arising from climate change. The challenges are to understand when evolution will occur and to identify potential evolutionary winners as well as losers, such as species lacking adaptive capacity living near physiological limits. Evolutionary processes also need to be incorporated into management programmes designed to minimize biodiversity loss under rapid climate change. These challenges can be met through realistic models of evolutionary change linked to experimental data across a range of taxa.	[Hoffmann, Ary A.] Univ Melbourne, Inst Bio21, Dept Zool, Melbourne, Vic 3010, Australia; [Hoffmann, Ary A.] Univ Melbourne, Inst Bio21, Dept Genet, Melbourne, Vic 3010, Australia; [Sgro, Carla M.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Sgro, Carla M.] Monash Univ, Australian Ctr Biodivers, Clayton, Vic 3800, Australia	University of Melbourne; University of Melbourne; Monash University; Monash University	Hoffmann, AA (corresponding author), Univ Melbourne, Inst Bio21, Dept Zool, Melbourne, Vic 3010, Australia.	ary@unimelb.edu.au	Sgro, Carla M/G-5166-2010; Hoffmann, Ary/C-2961-2011; Hoffmann, Ary/R-2972-2019; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Hoffmann, Ary/0000-0001-9497-7645; 	ARC; Commonwealth Environment Research Facility	ARC(Australian Research Council); Commonwealth Environment Research Facility	A.A.H. was supported by an ARC Australian Laureate Fellowship. C. M. S. was supported by an ARC Australian Research Fellowship. A. A. H. and C. M. S. were also supported by funding provided by the Commonwealth Environment Research Facility. We thank P. Griffin, A. Miller and C. Robin for comments that improved the manuscript.	Angert AL, 2008, EVOLUTION, V62, P2660, DOI 10.1111/j.1558-5646.2008.00471.x; Ayrinhac A, 2004, FUNCT ECOL, V18, P700, DOI 10.1111/j.0269-8463.2004.00904.x; Beatty GE, 2010, DIVERS DISTRIB, V16, P1, DOI 10.1111/j.1472-4642.2009.00616.x; Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Bennett AF, 2007, P NATL ACAD SCI USA, V104, P8649, DOI 10.1073/pnas.0702117104; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Bjorklund M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004521; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Bradshaw WE, 1998, ECOLOGY, V79, P1458, DOI 10.1890/0012-9658(1998)079[1458:FCOHDI]2.0.CO;2; Bridle JR, 2010, ECOL LETT, V13, P485, DOI 10.1111/j.1461-0248.2010.01442.x; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Carroll SP, 2008, MOL ECOL, V17, P361, DOI 10.1111/j.1365-294X.2007.03484.x; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Collins S, 2006, ECOL LETT, V9, P129, DOI 10.1111/j.1461-0248.2005.00854.x; Collins S, 2004, NATURE, V431, P566, DOI 10.1038/nature02945; Collins S, 2009, EVOLUTION, V63, P2952, DOI 10.1111/j.1558-5646.2009.00770.x; Cooper VS, 2001, EVOLUTION, V55, P889, DOI 10.1554/0014-3820(2001)055[0889:EOTDOG]2.0.CO;2; Crispo E, 2010, EVOL ECOL RES, V12, P47; Dahlhoff EP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P718, DOI 10.1086/590165; Dawson MN, 2010, MOL ECOL, V19, P1585, DOI 10.1111/j.1365-294X.2010.04588.x; Donovan LA, 2010, J EVOLUTION BIOL, V23, P805, DOI 10.1111/j.1420-9101.2010.01950.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Etterson JR, 2004, EVOLUTION, V58, P1446, DOI 10.1111/j.0014-3820.2004.tb01726.x; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Gardner JL, 2009, P ROY SOC B-BIOL SCI, V276, P3845, DOI 10.1098/rspb.2009.1011; Garroway CJ, 2010, GLOBAL CHANGE BIOL, V16, P113, DOI 10.1111/j.1365-2486.2009.01948.x; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Grant PR, 2010, PHILOS T R SOC B, V365, P1065, DOI 10.1098/rstb.2009.0283; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Hadfield JD, 2010, AM NAT, V175, P116, DOI 10.1086/648604; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hoffmann AA, 2005, FUNCT ECOL, V19, P222, DOI 10.1111/j.1365-2435.2005.00959.x; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2010, AUST J ENTOMOL, V49, P93, DOI 10.1111/j.1440-6055.2010.00744.x; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Jones TA, 2009, FRONT ECOL ENVIRON, V7, P541, DOI 10.1890/080028; Jump AS, 2008, GLOBAL CHANGE BIOL, V14, P637, DOI 10.1111/j.1365-2486.2007.01521.x; Kanarek AR, 2010, EVOL APPL, V3, P122, DOI 10.1111/j.1752-4571.2009.00112.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Kingsolver JG, 2007, J EVOLUTION BIOL, V20, P892, DOI 10.1111/j.1420-9101.2007.01318.x; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Klenner W, 2009, FOREST ECOL MANAG, V258, pS5, DOI 10.1016/j.foreco.2009.08.035; Kristensen TN, 2007, P ROY SOC B-BIOL SCI, V274, P771, DOI 10.1098/rspb.2006.0247; Kuparinen A, 2010, FOREST ECOL MANAG, V259, P1003, DOI 10.1016/j.foreco.2009.12.006; Larsen PF, 2007, MOL ECOL, V16, P4674, DOI 10.1111/j.1365-294X.2007.03530.x; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Loehr J, 2010, J EVOLUTION BIOL, V23, P783, DOI 10.1111/j.1420-9101.2010.01948.x; Lynch M., 1993, BIOTIC INTERACTIONS; Mace GM, 2008, MOL ECOL, V17, P9, DOI 10.1111/j.1365-294X.2007.03455.x; Maloney SK, 2009, BIOL LETTERS, V5, P826, DOI 10.1098/rsbl.2009.0424; Michalski SG, 2010, THEOR APPL GENET, V120, P1151, DOI 10.1007/s00122-009-1242-8; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; MORITZ C, 2009, PHYLOGENY CONSERVATI, P243; Muhlfeld CC, 2009, BIOL LETTERS, V5, P328, DOI 10.1098/rsbl.2009.0033; Orr HA, 2008, AM NAT, V172, P160, DOI 10.1086/589460; Orr HA, 2010, PHILOS T R SOC B, V365, P1195, DOI 10.1098/rstb.2009.0282; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Pulido F, 2010, P NATL ACAD SCI USA, V107, P7341, DOI 10.1073/pnas.0910361107; Ragland GJ, 2008, EVOLUTION, V62, P1345, DOI 10.1111/j.1558-5646.2008.00367.x; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; Sheldon BC, 2003, EVOLUTION, V57, P406; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Teplitsky C, 2010, J EVOLUTION BIOL, V23, P935, DOI 10.1111/j.1420-9101.2010.01959.x; Tonsor SJ, 2008, MOL ECOL, V17, P1614, DOI 10.1111/j.1365-294X.2008.03690.x; van Asch M, 2007, GLOBAL CHANGE BIOL, V13, P1596, DOI 10.1111/j.1365-2486.2007.01400.x; Van Der Jeugd HP, 2009, GLOBAL CHANGE BIOL, V15, P1057, DOI 10.1111/j.1365-2486.2008.01804.x; Van Doorslaer W, 2009, EVOLUTION, V63, P1867, DOI 10.1111/j.1558-5646.2009.00679.x; Vandergast AG, 2008, BIOL CONSERV, V141, P1648, DOI 10.1016/j.biocon.2008.04.009; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Walsh B, 2009, ANNU REV ECOL EVOL S, V40, P41, DOI 10.1146/annurev.ecolsys.110308.120232; Watters JV, 2003, BIOL CONSERV, V112, P435, DOI 10.1016/S0006-3207(02)00343-9; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Willi Y, 2009, J EVOLUTION BIOL, V22, P124, DOI 10.1111/j.1420-9101.2008.01631.x; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878	90	1875	1909	42	1884	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					479	485		10.1038/nature09670	http://dx.doi.org/10.1038/nature09670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350480				2022-12-28	WOS:000287652900031
J	Marimuthu, MPA; Jolivet, S; Ravi, M; Pereira, L; Davda, JN; Cromer, L; Wang, LL; Nogue, F; Chan, SWL; Siddiqi, I; Mercier, R				Marimuthu, Mohan P. A.; Jolivet, Sylvie; Ravi, Maruthachalam; Pereira, Lucie; Davda, Jayeshkumar N.; Cromer, Laurence; Wang, Lili; Nogue, Fabien; Chan, Simon W. L.; Siddiqi, Imran; Mercier, Raphael			Synthetic Clonal Reproduction Through Seeds	SCIENCE			English	Article									[Ravi, Maruthachalam; Wang, Lili; Chan, Simon W. L.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Marimuthu, Mohan P. A.; Davda, Jayeshkumar N.; Siddiqi, Imran] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Jolivet, Sylvie; Pereira, Lucie; Cromer, Laurence; Nogue, Fabien; Mercier, Raphael] INRA, UMR1318, Inst Jean Pierre Bourgin, F-78026 Versailles, France	University of California System; University of California Davis; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chan, SWL (corresponding author), Univ Calif Davis, Dept Plant Biol, 1 Shields Ave, Davis, CA 95616 USA.	srchan@ucdavis.edu; imran@ccmb.res.in; raphael.mercier@versailles.inra.fr	mercier, Raphael/L-1497-2016; wang, lili/HDL-7210-2022; cromer, Laurence/I-4814-2014	mercier, Raphael/0000-0001-6508-6608; Maruthachalam, Ravi/0000-0003-0036-3330; Nogue, Fabien/0000-0003-0619-4638	Agence Nationale de la Recherche [ANR-09-EBIO-011]; INRA GAP Department; NSF [IOS-1026094]; March of Dimes; CSIR; Department of Biotechnology	Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA GAP Department; NSF(National Science Foundation (NSF)); March of Dimes(March of Dimes); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	We thank D. Singh for fluorescent in situ hybridization analysis; E. Gugan and N. Shukla for technical assistance; and L. Comai, O. Loudet, J. P. Vielle-Calzada, W. Lucas, and V. Sundaresan for comments on the manuscript. This research was funded by Agence Nationale de la Recherche (ANR-09-EBIO-011 to R.M.), INRA GAP Department (R.M.), NSF (IOS-1026094 to S.W. L.C.), the Basil O'Connor Starter Scholar Program from the March of Dimes (S.W.L.C.), a targeted allocation grant from CSIR (I.S.), and a Centre of Excellence grant from Department of Biotechnology (I. S.). Two provisional patent applications based on the work have been filed jointly by INRA and UC Davis (USA 61/418,792) and jointly by CSIR and UC Davis (India 619/DEL/2010).	d'Erfurth I, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000124; Dilkes BP, 2008, PLOS BIOL, V6, P2707, DOI 10.1371/journal.pbio.0060308; Pichot C, 2001, NATURE, V412, P39, DOI 10.1038/35083687; Ravi M, 2008, NATURE, V451, P1121, DOI 10.1038/nature06557; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Spillane C, 2004, NAT BIOTECHNOL, V22, P687, DOI 10.1038/nbt976	6	91	103	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					876	876		10.1126/science.1199682	http://dx.doi.org/10.1126/science.1199682			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330535				2022-12-28	WOS:000287455100046
J	Choi, M; Lee, SH; Kim, Y; Kang, SB; Shin, J; Kwak, MH; Kang, KY; Lee, YH; Park, N; Min, B				Choi, Muhan; Lee, Seung Hoon; Kim, Yushin; Kang, Seung Beom; Shin, Jonghwa; Kwak, Min Hwan; Kang, Kwang-Young; Lee, Yong-Hee; Park, Namkyoo; Min, Bumki			A terahertz metamaterial with unnaturally high refractive index	NATURE			English	Article							NEGATIVE-INDEX; CLOAK; FREQUENCIES	Controlling the electromagnetic properties of materials, going beyond the limit that is attainable with naturally existing substances, has become a reality with the advent of metamaterials(1-3). The range of various structured artificial 'atoms' has promised a vast variety of otherwise unexpected physical phenomena(3-17), among which the experimental realization of a negative refractive index has been one of the main foci thus far. Expanding the refractive index into a high positive regime will complete the spectrum of achievable refractive index and provide more design flexibility for transformation optics(9-14). Naturally existing transparent materials possess small positive indices of refraction, except for a few semiconductors and insulators, such as lead sulphide or strontium titanate, that exhibit a rather high peak refractive index at mid- and far-infrared frequencies(18). Previous approaches using metamaterials were not successful in realizing broadband high refractive indices(19-21). A broadband high-refractive-index metamaterial structure was theoretically investigated only recently(22), but the proposed structure does not lend itself to easy implementation. Here we demonstrate that a broadband, extremely high index of refraction can be realized from large-area, free-standing, flexible terahertz metamaterials composed of strongly coupled unit cells. By drastically increasing the effective permittivity through strong capacitive coupling and decreasing the diamagnetic response with a thin metallic structure in the unit cell, a peak refractive index of 38.6 along with a low-frequency quasi-static value of over 20 were experimentally realized for a single-layer terahertz metamaterial, while maintaining low losses. As a natural extension of these single-layer metamaterials, we fabricated quasi-three-dimensional high-refractive-index metamaterials, and obtained a maximum bulk refractive index of 33.2 along with a value of around 8 at the quasi-static limit.	[Choi, Muhan; Lee, Seung Hoon; Kim, Yushin; Min, Bumki] Korea Adv Inst Sci & Technol, Dept Mech Engn, Taejon 305751, South Korea; [Kang, Seung Beom; Kwak, Min Hwan; Kang, Kwang-Young] Elect & Telecommun Res Inst, Convergence Components & Mat Res Lab, Taejon 305700, South Korea; [Shin, Jonghwa; Lee, Yong-Hee] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305751, South Korea; [Park, Namkyoo] Seoul Natl Univ, Sch Elect Engn & Comp Sci, Seoul 151744, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Electronics & Telecommunications Research Institute - Korea (ETRI); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU)	Min, B (corresponding author), Korea Adv Inst Sci & Technol, Dept Mech Engn, Taejon 305751, South Korea.	bmin@kaist.ac.kr	Park, Namkyoo/M-4669-2017; Min, Bumki/A-1294-2007; Shin, Jonghwa/H-5817-2011; Lee, Yong Hee/C-2015-2011	Park, Namkyoo/0000-0003-0197-7633; Shin, Jonghwa/0000-0003-0712-464X; 	Korean government [2009-0069459, 2008-0062235, 2010-0012058, GRL K20815000003, 2010-0001859]; MKE/KEIT [2006-S-005-04]; National Research Foundation of Korea [2007-0093863]	Korean government(Korean Government); MKE/KEIT(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	We thank B. Kang for help in the fabrication of micrometre-gap metamaterials, J. S. Chang for proofreading the manuscript before submission, and D. S. Kim for discussions. This work was supported by National Research Foundation of Korea grants funded by the Korean government (numbers 2009-0069459, 2008-0062235 and 2010-0012058). K.-Y.K. acknowledges support by the IT Research and Development programme of MKE/KEIT (number 2006-S-005-04). Y.-H.L. acknowledges support from the National Research Foundation of Korea (number 2007-0093863) and N.P. acknowledges support from National Research Foundation (numbers GRL K20815000003 and 2010-0001859), funded by the Korean government.	Cai WS, 2007, NAT PHOTONICS, V1, P224, DOI 10.1038/nphoton.2007.28; Chen XD, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016608; Eleftheriades GV, 2002, IEEE T MICROW THEORY, V50, P2702, DOI 10.1109/TMTT.2002.805197; Enkrich C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.203901; Gabrielli LH, 2009, NAT PHOTONICS, V3, P461, DOI 10.1038/NPHOTON.2009.117; Liu R, 2009, SCIENCE, V323, P366, DOI 10.1126/science.1166949; Liu ZW, 2007, SCIENCE, V315, P1686, DOI 10.1126/science.1137368; Palik E, 1998, HDB OPTICAL CONSTANT, V2; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Shen JT, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197401; Shin J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.093903; Sievenpiper DF, 1998, PHYS REV LETT, V80, P2829, DOI 10.1103/PhysRevLett.80.2829; Smith DR, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036617; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; Smolyaninov II, 2007, SCIENCE, V315, P1699, DOI 10.1126/science.1138746; Tao H, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/23/232004; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Valentine J, 2009, NAT MATER, V8, P568, DOI [10.1038/nmat2461, 10.1038/NMAT2461]; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Xiao SM, 2010, NATURE, V466, P735, DOI 10.1038/nature09278; Zhang S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.023901	25	471	483	15	360	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2011	470	7334					369	373		10.1038/nature09776	http://dx.doi.org/10.1038/nature09776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331038				2022-12-28	WOS:000287409100036
J	Ferrari, R; Rapezzi, C				Ferrari, Roberto; Rapezzi, Claudio			The Mediterranean diet: a cultural journey	LANCET			English	Editorial Material							ADHERENCE		[Ferrari, Roberto] Univ Ferrara, Dept Cardiol, I-44121 Ferrara, Italy; [Ferrari, Roberto] IRCCS, Salvatore Maugeri Fdn, Lumezzane, Italy; [Rapezzi, Claudio] Univ Bologna, Policlin S Orsola Malpighi, Inst Cardiol, Bologna, Italy	University of Ferrara; Istituti Clinici Scientifici Maugeri IRCCS; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Ferrari, R (corresponding author), Univ Ferrara, Dept Cardiol, I-44121 Ferrara, Italy.	fri@unife.it	FERRARI, ROBERTO/ABD-5169-2020	Ferrari, Roberto/0000-0003-2046-9175; Rapezzi, Claudio/0000-0002-9198-2657				KEYS A, 1970, CIRCULATION, V41, pI1; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Vernaglione L, 2009, J NEPHROL, V22, pS149	4	13	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2011	377	9779					1730	1731		10.1016/S0140-6736(11)60316-4	http://dx.doi.org/10.1016/S0140-6736(11)60316-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	771AS	21397318				2022-12-28	WOS:000291130200010
J	Shin, K; Lee, J; Guo, N; Kim, J; Lim, A; Qu, LS; Mysorekar, IU; Beachy, PA				Shin, Kunyoo; Lee, John; Guo, Nini; Kim, James; Lim, Agnes; Qu, Lishu; Mysorekar, Indira U.; Beachy, Philip A.			Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder	NATURE			English	Article							URINARY-TRACT-INFECTION; ESCHERICHIA-COLI; CANCER; DIFFERENTIATION; METASTASIS; NEOPLASIA; PATTERNS; AUTOPSY; RENEWAL; ORGAN	Epithelial integrity in metazoan organs is maintained through the regulated proliferation and differentiation of organ-specific stem and progenitor cells. Although the epithelia of organs such as the intestine regenerate constantly and thus remain continuously proliferative(1), other organs, such as the mammalian urinary bladder, shift from near-quiescence to a highly proliferative state in response to epithelial injury(2-4). The cellular and molecular mechanisms underlying this injury-induced mode of regenerative response are poorly defined. Here we show in mice that the proliferative response to bacterial infection or chemical injury within the bladder is regulated by signal feedback between basal cells of the urothelium and the stromal cells that underlie them. We demonstrate that these basal cells include stem cells capable of regenerating all cell types within the urothelium, and are marked by expression of the secreted protein signal Sonic hedgehog (Shh). On injury, Shh expression in these basal cells increases and elicits increased stromal expression of Wnt protein signals, which in turn stimulate the proliferation of both urothelial and stromal cells. The heightened activity of this signal feedback circuit and the associated increase in cell proliferation appear to be required for restoration of urothelial function and, in the case of bacterial injury, may help clear and prevent further spread of infection. Our findings provide a conceptual framework for injury-induced epithelial regeneration in endodermal organs, and may provide a basis for understanding the roles of signalling pathways in cancer growth and metastasis.	[Shin, Kunyoo; Lee, John; Kim, James; Lim, Agnes; Qu, Lishu; Beachy, Philip A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA; [Guo, Nini] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Stanford University; Johns Hopkins University; Washington University (WUSTL)	Beachy, PA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA.	kunyoos@stanford.edu; pbeachy@stanford.edu	Mysorekar, Indira U./GRS-4574-2022	Mysorekar, Indira U./0000-0003-3917-8677; Lim, Agnes/0000-0002-6618-2500; Shin, Kunyoo/0000-0002-1519-9839	Department of Defense; National Institutes of Health; Pathway to Independence Award [K99/R00]	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Oro and J. Brooks for their critical reading of the manuscript, and the Stanford Center for Digestive Diseases for help with laser capture microdissection. This research was supported in part by grants from the Department of Defense and from the National Institutes of Health (P.A.B.) and a Pathway to Independence Award (K99/R00) to I.U.M. P.A.B. is an investigator of the Howard Hughes Medical Institute.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Bai CB, 2002, DEVELOPMENT, V129, P4753; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Fendrich V, 2008, GASTROENTEROLOGY, V135, P621, DOI 10.1053/j.gastro.2008.04.011; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; HAGBERG L, 1983, INFECT IMMUN, V40, P273, DOI 10.1128/IAI.40.1.273-283.1983; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Ibla JC, 2006, METH MOL B, V341, P111; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Klumpp DJ, 2006, INFECT IMMUN, V74, P5106, DOI 10.1128/IAI.00376-06; Kurzrock EA, 2005, J UROLOGY, V173, P281, DOI 10.1097/01.ju.0000141585.17953.fa; Kurzrock EA, 2008, AM J PHYSIOL-RENAL, V294, pF1415, DOI 10.1152/ajprenal.00533.2007; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; Mysorekar IU, 2009, CELL HOST MICROBE, V5, P463, DOI 10.1016/j.chom.2009.04.005; Nicolle LE, 2008, UROL CLIN N AM, V35, P1, DOI 10.1016/j.ucl.2007.09.004; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wallmeroth A, 1999, UROL INT, V62, P69, DOI 10.1159/000030361; WU XR, 1993, J CELL SCI, V106, P31; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	32	322	335	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					110	U145		10.1038/nature09851	http://dx.doi.org/10.1038/nature09851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21389986	Green Accepted			2022-12-28	WOS:000289199400047
J	Lindley, MC; Lorick, SA; Spinner, JR; Krull, AR; Mootrey, GT; Ahmed, F; Myers, R; Bednash, GP; Cymet, TC; Maeshiro, R; Raines, CF; Shannon, SC; Sondheimer, HM; Strikas, RA				Lindley, Megan C.; Lorick, Suchita A.; Spinner, Jovonni R.; Krull, Andrea R.; Mootrey, Gina T.; Ahmed, Faruque; Myers, Rosa; Bednash, Geraldine P.; Cymet, Tyler C.; Maeshiro, Rika; Raines, C. Fay; Shannon, Stephen C.; Sondheimer, Henry M.; Strikas, Raymond A.			Student Vaccination Requirements of US Health Professional Schools: A Survey	ANNALS OF INTERNAL MEDICINE			English	Article							IMMUNIZATION PRACTICES ACIP; ADVISORY-COMMITTEE HICPAC; HEPATITIS-B VACCINATION; INFLUENZA VACCINATION; UNITED-STATES; INFECTION-CONTROL; CARE WORKERS; NOSOCOMIAL PERTUSSIS; ATTITUDES; RECOMMENDATIONS	Background: Unvaccinated health care personnel are at increased risk for transmitting vaccine-preventable diseases to their patients. The Advisory Committee on Immunization Practices (ACIP) recommends that health care personnel, including students, receive measles, mumps, rubella, hepatitis B, varicella, influenza, and pertussis vaccines. Prematriculation vaccination requirements of health professional schools represent an early opportunity to ensure that health care personnel receive recommended vaccines. Objective: To examine prematriculation vaccination requirements and related policies at selected health professional schools in the United States and compare requirements with current ACIP recommendations. Design: Cross-sectional study using an Internet-based survey. Setting: Medical and baccalaureate nursing schools in the United States and its territories. Participants: Deans of accredited medical schools granting MD (n = 130) and DO (n = 26) degrees and of baccalaureate nursing programs (n = 603). Measurements: Proportion of MD-granting and DO-granting schools and baccalaureate nursing programs that require that entering students receive vaccines recommended by the ACIP for health care personnel. Results: 563 schools (75%) responded. More than 90% of all school types required measles, mumps, rubella, and hepatitis B vaccines for entering students; varicella vaccination also was commonly required. Tetanus, diphtheria, and acellular pertussis vaccination was required by 66%, 70%, and 75% of nursing, MD-granting, and DO-granting schools, respectively. Nursing and DO-granting schools (31% and 45%, respectively) were less likely than MD-granting schools (78%) to offer students influenza vaccines free of charge. Limitations: Estimates were conservative, because schools that reported that they did not require proof of immunity for a given vaccine were considered not to require that vaccine. Estimates also were restricted to schools that train physicians and nurses. Conclusion: The majority of schools now require most ACIP-recommended vaccines for students. Medical and nursing schools should adopt policies on student vaccination and serologic testing that conform to ACIP recommendations and should encourage annual influenza vaccination by offering influenza vaccination to students at no cost.	[Lindley, Megan C.; Lorick, Suchita A.; Mootrey, Gina T.; Ahmed, Faruque; Strikas, Raymond A.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Spinner, Jovonni R.] NIH, Bethesda, MD 20892 USA; [Krull, Andrea R.] US Dept HHS, Washington, DC 20201 USA; [Myers, Rosa] Off Womens Hlth Reg 3, Philadelphia, PA 19106 USA; [Bednash, Geraldine P.] Coll Nursing, Amer Assoc, Washington, DC 20036 USA; [Cymet, Tyler C.; Shannon, Stephen C.] Coll Osteopath Med, Amer Assoc, Chevy Chase, MD 20815 USA; [Maeshiro, Rika] Assoc Amer Med Coll, Washington, DC 20037 USA; [Raines, C. Fay] Univ Alabama, Coll Nursing, Huntsville, AL 35899 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; Association of American Medical Colleges; University of Alabama System; University of Alabama Huntsville	Lindley, MC (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E-52, Atlanta, GA 30333 USA.	MLindley@cdc.gov	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Lindley, Megan/0000-0002-8368-7375				*AM COLL HLTH ASS, 2009, REC I PREM IMM; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Anonymous, 2010, Morbidity and Mortality Weekly Report, V58, P1; Baggett HC, 2007, INFECT CONT HOSP EP, V28, P537, DOI 10.1086/513497; BAUGHMAN AL, 1994, JAMA-J AM MED ASSOC, V272, P1127, DOI 10.1001/jama.272.14.1127; Bernstein HH, 2010, PEDIATRICS, V126, P809, DOI 10.1542/peds.2010-2376; Bonebrake AL, 2010, EMERG INFECT DIS, V16, P426, DOI 10.3201/eid1603.090198; Bryant KA, 2006, INFECT CONT HOSP EP, V27, P541, DOI 10.1086/505666; Calugar A, 2006, CLIN INFECT DIS, V42, P981, DOI 10.1086/500321; *CDC, 1986, MMWR-MORBID MORTAL W, V35, P331; *CDCP, 2007, QUAL ASS FACT INFL I; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P1283; Centers for Disease Control (CDC), 1986, MMWR Morb Mortal Wkly Rep, V35, P317; Centers for Disease Control Prevention, 2010, MMWR RECOMM REP, V59, P1, DOI DOI 10.1123/TSP.6.2.111; Chi RC, 2004, AM J MED SCI, V327, P113, DOI 10.1097/00000441-200403000-00001; Cowan AE, 2006, AM J INFECT CONTROL, V34, P164, DOI 10.1016/j.ajic.2005.09.007; DIEKEMA DJ, 1995, J GEN INTERN MED, V10, P1, DOI 10.1007/BF02599567; Elder AG, 1996, BRIT MED J, V313, P1241, DOI 10.1136/bmj.313.7067.1241; Freeman VA, 1999, AM J PREV MED, V17, P153, DOI 10.1016/S0749-3797(99)00063-X; GOETZ A, 1992, AM J INFECT CONTROL, V20, P115, DOI 10.1016/S0196-6553(05)80175-0; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Hood J. L., 2008, Morbidity and Mortality Weekly Report, V57, P600; Joint Commission on Accreditation of Healthcare Organizations, 2006, Jt Comm Perspect, V26, P10; Kimura A. C., 2005, Morbidity and Mortality Weekly Report, V54, P196; LaVela SL, 2004, INFECT CONT HOSP EP, V25, P933, DOI 10.1086/502323; Lester RT, 2003, INFECT CONT HOSP EP, V24, P839, DOI 10.1086/502146; Lindley MC, 2006, AM J PREV MED, V31, P281, DOI 10.1016/j.amepre.2006.06.025; Lu PJ, 2008, VACCINE, V26, P1786, DOI 10.1016/j.vaccine.2008.01.040; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Mallari J, 2007, J AM PHARM ASSOC, V47, P498, DOI 10.1331/JAPhA.2007.07018; MALLET L, 1994, ANN PHARMACOTHER, V28, P1153, DOI 10.1177/106002809402801003; Matthews E, 2008, J CONTIN EDUC NURS, V39, P419, DOI 10.3928/00220124-20080901-06; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Nichol KL, 2001, ARCH INTERN MED, V161, P2702, DOI 10.1001/archinte.161.22.2702; *OCC SAF HLTH ADM, OCC SAF HLTH STAND T; Pickering LK, 2009, RED BOOK 2009 REPORT; POLAND GA, 1990, ANN INTERN MED, V113, P628, DOI 10.7326/0003-4819-113-8-628; POLAND GA, 1990, ARCH INTERN MED, V150, P44, DOI 10.1001/archinte.150.1.44; Polgreen PM, 2008, CLIN INFECT DIS, V46, P14, DOI 10.1086/523586; Polgreen PM, 2010, INFECT CONT HOSP EP, V31, P893, DOI 10.1086/655466; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; ROSENBAUM PR, 1987, J AM STAT ASSOC, V82, P387, DOI 10.2307/2289440; ROSENTHAL SL, 2010, VACCINE; Salgado CD, 2004, INFECT CONT HOSP EP, V25, P923, DOI 10.1086/502321; Samoff E, 2004, SEX TRANSM DIS, V31, P415, DOI [10.1097/01.OLQ.0000130533.53987.78, 10.1097/01.olq.0000130533.53987.78]; Sartor C, 2002, INFECT CONT HOSP EP, V23, P615, DOI 10.1086/501981; Schaefer M E, 1983, J Dent Educ, V47, P550; SERWINT J, 1993, PEDIATR INFECT DIS J, V12, P956, DOI 10.1097/00006454-199311000-00014; Simard EP, 2007, INFECT CONT HOSP EP, V28, P783, DOI 10.1086/518730; STRIKAS RA, 2010, 5 DEC INT C HEALTHC; Talbot TR, 2010, INFECT CONT HOSP EP, V31, P987, DOI 10.1086/656558; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; Toy WC, 2005, AM J INFECT CONTROL, V33, P473, DOI 10.1016/j.ajic.2005.06.003; United States Department of Health and Human Services, 2000, HLTH PEOPL 2010, V1; United States Department of Health and Human Services, 2000, HLTH PEOPL 2010, V2; WEBER DJ, 1991, J PEDIATR-US, V119, P322, DOI 10.1016/S0022-3476(05)80753-X; WHARTON M, 1990, ARCH INTERN MED, V150, P47, DOI 10.1001/archinte.150.1.47; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908	59	31	31	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					391	+		10.7326/0003-4819-154-6-201103150-00004	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734WA	21403075				2022-12-28	WOS:000288370000003
J	Casarett, DJ				Casarett, David J.			Rethinking Hospice Eligibility Criteria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PALLIATIVE CARE; CANCER		[Casarett, David J.] Univ Penn, Sch Med, Ctr Bioeth, Philadelphia, PA 19104 USA; [Casarett, David J.] Univ Penn, Sch Med, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Casarett, DJ (corresponding author), Univ Penn, Sch Med, Ctr Bioeth, 3615 Chestnut St, Philadelphia, PA 19104 USA.	casarett@mail.med.upenn.edu						Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Casarett DJ, 2009, J CLIN ONCOL, V27, P953, DOI 10.1200/JCO.2008.17.8079; Fishman J, 2009, CANCER-AM CANCER SOC, V115, P689, DOI 10.1002/cncr.24046; Johnson KS, 2008, ARCH INTERN MED, V168, P218, DOI 10.1001/archinternmed.2007.36; National Hospice and Palliative Care Organization Facts and Figures, 2010, HOSP CAR AM; Rickerson E, 2005, J AM GERIATR SOC, V53, P819, DOI 10.1111/j.1532-5415.2005.53259.x; Schockett ER, 2005, J PAIN SYMPTOM MANAG, V30, P400, DOI 10.1016/j.jpainsymman.2005.04.013; Taylor DH, 2007, SOC SCI MED, V65, P1466, DOI 10.1016/j.socscimed.2007.05.028; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	9	28	28	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1031	1032		10.1001/jama.2011.271	http://dx.doi.org/10.1001/jama.2011.271			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	731SM	21386081				2022-12-28	WOS:000288129600024
J	Gan, QA; Ferrand, Y; Bao, CY; Kauffmann, B; Grelard, A; Jiang, H; Huc, I				Gan, Quan; Ferrand, Yann; Bao, Chunyan; Kauffmann, Brice; Grelard, Axelle; Jiang, Hua; Huc, Ivan			Helix-Rod Host-Guest Complexes with Shuttling Rates Much Faster than Disassembly	SCIENCE			English	Article							THERMODYNAMIC CONTROL; MOLECULAR MACHINES; OLIGOMERS; MOTION; ASSOCIATION; FOLDAMERS; MECHANISM; INVERSION; KINETICS; SINGLE	Dynamic assembly is a powerful fabrication method of complex, functionally diverse molecular architectures, but its use in synthetic nanomachines has been hampered by the difficulty of avoiding reversible attachments that result in the premature breaking apart of loosely held moving parts. We show that molecular motion can be controlled in dynamically assembled systems through segregation of the disassembly process and internal translation to time scales that differ by four orders of magnitude. Helical molecular tapes were designed to slowly wind around rod-like guests and then to rapidly slide along them. The winding process requires helix unfolding and refolding, as well as a strict match between helix length and anchor points on the rods. This modular design and dynamic assembly open up promising capabilities in molecular machinery.	[Gan, Quan; Jiang, Hua] Chinese Acad Sci, Inst Chem, CAS Key Lab Photochem, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China; [Gan, Quan; Ferrand, Yann; Bao, Chunyan; Kauffmann, Brice; Grelard, Axelle; Huc, Ivan] Univ Bordeaux, Inst Europeen Chim & Biol, CNRS, UMR5248, F-33607 Pessac, France; [Gan, Quan; Ferrand, Yann; Bao, Chunyan; Kauffmann, Brice; Grelard, Axelle; Huc, Ivan] Univ Bordeaux, Inst Europeen Chim & Biol, CNRS, UMS3033, F-33607 Pessac, France; [Gan, Quan] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Chemistry, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, H (corresponding author), Chinese Acad Sci, Inst Chem, CAS Key Lab Photochem, Beijing Natl Lab Mol Sci, Beijing 100190, Peoples R China.	hjiang@iccas.ac.cn; i.huc@iecb.u-bordeaux.fr	Bao, Chunyan/AHA-3817-2022; Kauffmann, Brice/L-6029-2015; Bao, Chunyan/H-2319-2011	Bao, Chunyan/0000-0002-7160-3007; Kauffmann, Brice/0000-0002-2932-3255; GAN, quan/0000-0003-4612-2268; Ferrand, Yann/0000-0002-6552-6914; GRELARD, Axelle/0000-0002-6708-2253	CNRS; Conseil Regional d'Aquitaine; Chinese Academy of Sciences; National Natural Science Foundation of China [20772127, 20972164]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the CNRS, the Conseil Regional d'Aquitaine, the Chinese Academy of Sciences, and the National Natural Science Foundation of China (20772127, 20972164). We thank C. Muller-Dieckmann for beamtime and help during data collection on ID29 at the European Synchrotron Radiation Facility. Crystallographic data for (3)<INF>2</INF>, (2)<INF>2</INF>, 2 superset of 6, 1 superset of 7, 1 superset of 5, and 1 superset of 8 have been deposited with the Cambridge Crystallographic Data Centre under reference numbers CCDC-797906, 797911, 797907, 797908, 797910, and 797909, respectively.	Badjic JD, 2004, SCIENCE, V303, P1845, DOI 10.1126/science.1094791; Bao C, 2008, ANGEW CHEM INT EDIT, V47, P4153, DOI 10.1002/anie.200800625; Baptiste B, 2010, CHEM-ASIAN J, V5, P1364, DOI 10.1002/asia.200900713; Berl V, 2000, NATURE, V407, P720, DOI 10.1038/35037545; Berni E, 2008, CHEM COMMUN, P1968, DOI 10.1039/b719712h; Browne WR, 2006, NAT NANOTECHNOL, V1, P25, DOI 10.1038/nnano.2006.45; Chang SY, 2003, CHEM-EUR J, V9, P1535, DOI 10.1002/chem.200390176; Cohen Y, 2005, ANGEW CHEM INT EDIT, V44, P520, DOI 10.1002/anie.200300637; Delsuc N, 2008, CHEMPHYSCHEM, V9, P1882, DOI 10.1002/cphc.200800310; Fletcher SP, 2005, SCIENCE, V310, P80, DOI 10.1126/science.1117090; Glink PT, 2001, ANGEW CHEM INT EDIT, V40, P1870, DOI 10.1002/1521-3773(20010518)40:10<1870::AID-ANIE1870>3.0.CO;2-Z; Green JE, 2007, NATURE, V445, P414, DOI 10.1038/nature05462; Hiraoka S, 2008, J AM CHEM SOC, V130, P9089, DOI 10.1021/ja8014583; Horn M, 2003, CHEM-EUR J, V9, P4046, DOI 10.1002/chem.200204479; Huc I, 2004, EUR J ORG CHEM, V2004, P17, DOI 10.1002/ejoc.200300495; Hunter CA, 2001, ANGEW CHEM INT EDIT, V40, P2678, DOI 10.1002/1521-3773(20010716)40:14<2678::AID-ANIE2678>3.0.CO;2-U; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Kinbara K, 2005, CHEM REV, V105, P1377, DOI 10.1021/cr030071r; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Miwa K, 2010, NAT CHEM, V2, P444, DOI [10.1038/NCHEM.649, 10.1038/nchem.649]; Mobian P, 2004, ANGEW CHEM INT EDIT, V43, P2392, DOI 10.1002/anie.200352522; Muraoka T, 2006, NATURE, V440, P512, DOI 10.1038/nature04635; Nishinaga T, 2002, J AM CHEM SOC, V124, P5934, DOI 10.1021/ja025698q; Panman MR, 2010, SCIENCE, V328, P1255, DOI 10.1126/science.1187967; PERRIN CL, 1990, CHEM REV, V90, P935, DOI 10.1021/cr00104a002; Petitjean A, 2008, J ORG CHEM, V73, P2481, DOI 10.1021/jo702495u; Serreli V, 2007, NATURE, V445, P523, DOI 10.1038/nature05452; Tanatani A, 2002, ANGEW CHEM INT EDIT, V41, P325, DOI 10.1002/1521-3773(20020118)41:2<325::AID-ANIE325>3.0.CO;2-1	28	200	202	4	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1172	1175		10.1126/science.1200143	http://dx.doi.org/10.1126/science.1200143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385710				2022-12-28	WOS:000287971200036
J	Gunlycke, D; Sheehan, PE				Gunlycke, Daniel; Sheehan, Paul E.			Local Peeling of Graphene	SCIENCE			English	Editorial Material									[Gunlycke, Daniel; Sheehan, Paul E.] USN, Res Lab, Div Chem, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Gunlycke, D (corresponding author), USN, Res Lab, Div Chem, Washington, DC 20375 USA.	sheehan@nrl.navy.mil	Sheehan, Paul E/B-4793-2010	Sheehan, Paul E/0000-0003-2668-4124				Areshkin DA, 2007, NANO LETT, V7, P204, DOI 10.1021/nl062132h; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; de Saint-Exupery Antoine, 1992, WIND SAND STARS; Dimiev A, 2011, SCIENCE, V331, P1168, DOI 10.1126/science.1199183; Robinson JT, 2010, NANO LETT, V10, P3001, DOI 10.1021/nl101437p; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105	6	8	8	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1146	1147		10.1126/science.1200779	http://dx.doi.org/10.1126/science.1200779			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385705				2022-12-28	WOS:000287971200029
J	Zarin, DA; Tse, T; Williams, RJ; Califf, RM; Ide, NC				Zarin, Deborah A.; Tse, Tony; Williams, Rebecca J.; Califf, Robert M.; Ide, Nicholas C.			The ClinicalTrials.gov Results Database - Update and Key Issues	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRIALS; GLOBALIZATION; BIAS	BACKGROUND The ClinicalTrials.gov trial registry was expanded in 2008 to include a database for reporting summary results. We summarize the structure and contents of the results database, provide an update of relevant policies, and show how the data can be used to gain insight into the state of clinical research. METHODS We analyzed ClinicalTrials.gov data that were publicly available between September 2009 and September 2010. RESULTS As of September 27, 2010, ClinicalTrials.gov received approximately 330 new and 2000 revised registrations each week, along with 30 new and 80 revised results submissions. We characterized the 79,413 registry and 2178 results of trial records available as of September 2010. From a sample cohort of results records, 78 of 150 (52%) had associated publications within 2 years after posting. Of results records available publicly, 20% reported more than two primary outcome measures and 5% reported more than five. Of a sample of 100 registry record outcome measures, 61% lacked specificity in describing the metric used in the planned analysis. In a sample of 700 results records, the mean number of different analysis populations per study group was 2.5 (median, 1; range, 1 to 25). Of these trials, 24% reported results for 90% or less of their participants. CONCLUSIONS ClinicalTrials.gov provides access to study results not otherwise available to the public. Although the database allows examination of various aspects of ongoing and completed clinical trials, its ultimate usefulness depends on the research community to submit accurate, informative data.	[Zarin, Deborah A.; Tse, Tony; Williams, Rebecca J.; Ide, Nicholas C.] NIH, Lister Hill Natl Ctr Biomed Commun, Natl Lib Med, Bethesda, MD 20894 USA; [Califf, Robert M.] Duke Univ, Duke Translat Med Inst, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Duke University	Zarin, DA (corresponding author), NIH, Lister Hill Natl Ctr Biomed Commun, Natl Lib Med, Bldg 38A,8600 Rockville Pike, Bethesda, MD 20894 USA.	dzarin@mail.nih.gov		Tse, Tony/0000-0002-9906-6864	NATIONAL LIBRARY OF MEDICINE [ZIHLM200888, ZIALM008926] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Claire B, 2000, NEW ENGL J MED, V343, P1520, DOI [DOI 10.1056/NEJME058314, 10.1056/NEJM200011233432103]; *CLIN TRIALS TRANS, IMPR PUBL INT US AGG; *CLINICALTRIALS GO, 2010, PROT DAT EL IN PRESS; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; European Commission, 2009, OFFICIAL J EUROPEAN; European Commission, 2008, OFFICIAL J EUROPEAN; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Ide NC, 2007, J AM MED INFORM ASSN, V14, P253, DOI 10.1197/jamia.M2233; *INT C HARM, TECHN REQ REG PHARM; Kassab S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004845.pub2; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; MARUSIC A, 2006, CLIN TRIAL REGISTRIE, P13; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P1532; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; *NAT LIB MED, 2009, CLIN TRIAL REG NUMB; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Scoggins JF, 2009, CONTEMP CLIN TRIALS, V30, P289, DOI 10.1016/j.cct.2009.02.005; The CONSORT Group, CONS STAND REP TRIAL; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441; Tse T, 2009, CHEST, V136, P295, DOI 10.1378/chest.08-3022; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; World Health Organization, WHO TRIAL REG DAT SE; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	29	466	471	1	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					852	860		10.1056/NEJMsa1012065	http://dx.doi.org/10.1056/NEJMsa1012065			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366476	Green Accepted			2022-12-28	WOS:000287928400010
J	Moore, W				Moore, Wendy			Past Caring All the world's knowledge	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com						CONRAD LI, 1993, COMPANION ENCY HIST, P676; GHALIOUNGUI P, 1981, 27 C INT HIST MED 19, P245	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 28	2011	342								d1272	10.1136/bmj.d1272	http://dx.doi.org/10.1136/bmj.d1272			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732DK	21357350				2022-12-28	WOS:000288164200002
J	Hyman, SE				Hyman, Steven E.			The Meaning of the Human Genome Project for Neuropsychiatric Disorders	SCIENCE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Hyman, SE (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.								0	6	6	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1026	1026		10.1126/science.1203544	http://dx.doi.org/10.1126/science.1203544			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350167				2022-12-28	WOS:000287699000048
J	Lal, A; Goldrich, ML; Haines, DA; Azimi, M; Singer, ST; Vichinsky, EP				Lal, Ashutosh; Goldrich, Michael L.; Haines, Drucilla A.; Azimi, Mahin; Singer, Sylvia T.; Vichinsky, Elliott P.			Heterogeneity of Hemoglobin H Disease in Childhood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOUTHEAST-ASIAN POPULATIONS; ALPHA-THALASSEMIA; CLINICAL-FEATURES; NORTH-AMERICA; SEVERE FORM; GENE; CALIFORNIA; BLACKS	BACKGROUND Early diagnosis during newborn screening or infancy has enabled the observation of the natural history of hemoglobin H disease, a subtype of alpha-thalassemia. METHODS We analyzed longitudinal clinical data for patients with hemoglobin H disease arising from the deletion of three of four a-globin genes (HbH) and from hemoglobin H Constant Spring (HCS), caused by the deletion of two a-globin genes and the Constant Spring mutation. RESULTS We identified 86 patients with hemoglobin H disease (48 through newborn screening). Of these patients, 60 (70%) had HbH, 23 (27%) had HCS, and 3 (3%) had other, nondeletional forms of hemoglobin H disease. The parental ethnic background was Asian in 81% of patients, Hispanic in 5%, and African American in 3%, whereas mixed ancestry was observed in 10% of patients. Among the patients with deletional hemoglobin H disease, 15% had one or both parents with African-American ancestry. Growth was normal in patients with HbH during the first decade, but growth deficits began during infancy in those with HCS. Anemia was more severe in patients with HCS at all ages (P<0.001). Acute worsening of anemia with infections requiring urgent blood transfusion was observed in patients with HCS but not in those with HbH. The probability of receiving at least one transfusion by the age of 20 years was 3% for patients with HbH and 80% for those with HCS (P<0.001). Among patients with HCS, transfusions occurred in 13% of infants and 50% of children under the age of 6 years; splenectomy was associated with a significant improvement in hemoglobin levels (P = 0.01) and a reduction in the number of transfusions. CONCLUSIONS HCS should be recognized as a distinct thalassemia syndrome with a high risk of life-threatening anemia during febrile illnesses. HbH was not associated with an increased rate of severe anemia with infections and was managed without blood transfusions. Many patients with these disorders had mixed ethnic backgrounds, which highlights the need for extended newborn screening in populations that are traditionally considered to be at low risk for hemoglobin H disease.	[Lal, Ashutosh; Azimi, Mahin] Childrens Hosp & Res Ctr Oakland, Hemoglobinopathy Reference Lab, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Lal, A (corresponding author), Childrens Hosp & Res Ctr Oakland, Hemoglobinopathy Reference Lab, 747 52nd St, Oakland, CA 94609 USA.	alal@mail.cho.org	Vichinsky, Elliott P/F-8541-2011	Vichinsky, Elliott P/0000-0002-0500-9579	Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services [57480]	Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	Supported in part by Project no. 57480 from the Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services.	Census Bureau, AM COMM SURV 2006 AS; Charoenkwan P, 2005, HEMOGLOBIN, V29, P133, DOI 10.1081/HEM-200058583; Chen FE, 2000, NEW ENGL J MED, V343, P544, DOI 10.1056/NEJM200008243430804; Chui DHK, 2003, BLOOD, V101, P791, DOI 10.1182/blood-2002-07-1975; DOZY AM, 1979, NATURE, V280, P605, DOI 10.1038/280605a0; Fucharoen Suthat, 2009, Hematology Am Soc Hematol Educ Program, P26, DOI 10.1182/asheducation-2009.1.26; GALANELLO R, 1983, ACTA HAEMATOL-BASEL, V69, P56, DOI 10.1159/000206840; Higgs DR, 2009, CELL MOL LIFE SCI, V66, P1154, DOI 10.1007/s00018-008-8529-9; Knapp A, 2010, EVIDENCE REV HEMOGLO; LAIG M, 1990, HUM GENET, V84, P188; Laosombat V, 2009, ANN HEMATOL, V88, P1185, DOI 10.1007/s00277-009-0743-5; Lorey F, 2001, GENET TEST, V5, P93, DOI 10.1089/109065701753145538; Michlitsch J, 2009, PEDIATR BLOOD CANCER, V52, P486, DOI 10.1002/pbc.21883; Origa R, 2007, BRIT J HAEMATOL, V136, P326, DOI 10.1111/j.1365-2141.2006.06423.x; Pakbaz Z, 2007, PEDIATR BLOOD CANCER, V49, P329, DOI 10.1002/pbc.21275; Savongsy O, 2008, ANN HEMATOL, V87, P647, DOI 10.1007/s00277-008-0490-z; Schrier SL, 1997, BLOOD, V89, P1762, DOI 10.1182/blood.V89.5.1762.1762_1762_1769; Singer ST, 2009, AM J HEMATOL, V84, P759, DOI 10.1002/ajh.21523; Singsanan S, 2007, ANN HEMATOL, V86, P665, DOI 10.1007/s00277-007-0310-x; Sobota A, 2011, AM J HEMATOL, V86, P92, DOI 10.1002/ajh.21896; STEINBERG MH, 1986, BLOOD, V68, P985; Styles LA, 1997, INT J PEDIAT HEM ONC, V4, P69; Vichinsky EP, 2005, PEDIATRICS, V116, pE818, DOI 10.1542/peds.2005-0843	23	102	114	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					710	718		10.1056/NEJMoa1010174	http://dx.doi.org/10.1056/NEJMoa1010174			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345100	Bronze			2022-12-28	WOS:000287652500005
J	Evans-Brown, M; Bellis, MA; McVeigh, J				Evans-Brown, Michael; Bellis, Mark A.; McVeigh, Jim			Should "legal highs" be regulated as medicinal products?	BRITISH MEDICAL JOURNAL			English	Editorial Material							UK					m.j.evans-brown@ljmu.ac.uk	Bellis, Mark A./HGA-2019-2022; McVeigh, Jim/O-7851-2019	Evans-Brown, Michael/0000-0002-2695-5740; McVeigh, Jim/0000-0001-5319-6885				Ben-Yehudah Nahman., 2009, SOCIAL CONSTRUCTION; BIRCH R, 2010, NEW LAW J, V160; BIRCH R, 2009, NEW LAW J, V159; Brandt SD, 2010, DRUG TEST ANAL, V2, P377, DOI 10.1002/dta.155; Csizmadi I, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P791; *EUR UN, 2004, OFFICIAL J EUROPEAN, V47, P34; European Monitoring Centre for Drugs and Drug Addiction, 2009, UND SPIC PHEN, DOI [10.2810/27063, DOI 10.2810/27063]; European Monitoring Centre for Drugs and Drug Addiction, 2010, RISK ASS REP NEW PSY; European Parliament, 2001, OFF J EUR COMMUNITIE, V311, P67; Gunningham N., 2010, OXFORD HDB REGULATIO, P120; *HOUS COMM, 2010, HOUS COMM OFF REP HA, pC149; *HOUS LORD, 1984, HOUS LORDS OFF REP H; House of Commons Science and Technology Committee, 2006, DRUG CLASS MAK HASH; *MED HEALTHC PROD, 2007, 8 MHRA; MONAGHAN M, 2010, EVIDENCE VERSUS POLI; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; STEPHENS M, 2004, STEPHENS DETECTION N, P63; TYLER TOM R., 2006, CONTEMP SOCIOL, DOI [DOI 10.2307/2076193, 10.1515/9781400828609]	18	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 23	2011	342								d1101	10.1136/bmj.d1101	http://dx.doi.org/10.1136/bmj.d1101			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729AZ	21345907				2022-12-28	WOS:000287920100020
J	Manchado, E; Malumbres, M				Manchado, Eusebio; Malumbres, Marcos			Targeting Aneuploidy for Cancer Therapy	CELL			English	Editorial Material							CHROMOSOMAL INSTABILITY; CELLS; YEAST	Tumor cells frequently display an abnormal number of chromosomes, a phenomenon known as aneuploidy. Tang et al. (2011) now show that aneuploid cells are particularly sensitive to compounds that induce proteotoxic and energy stress. Could this vulnerability lead to new cancer therapies?	[Manchado, Eusebio; Malumbres, Marcos] Spanish Natl Canc Res Ctr CNIO, Cell Div, E-28029 Madrid, Spain; [Manchado, Eusebio; Malumbres, Marcos] Spanish Natl Canc Res Ctr CNIO, Canc Grp, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Malumbres, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Cell Div, E-28029 Madrid, Spain.	malumbres@cnio.es	Malumbres, Marcos/E-8834-2011	Malumbres, Marcos/0000-0002-0829-6315				Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058	10	16	16	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					465	466		10.1016/j.cell.2011.01.037	http://dx.doi.org/10.1016/j.cell.2011.01.037			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335229	Bronze			2022-12-28	WOS:000287473100001
J	Neurohr, G; Naegeli, A; Titos, I; Theler, D; Greber, B; Diez, J; Gabaldon, T; Mendoza, M; Barral, Y				Neurohr, Gabriel; Naegeli, Andreas; Titos, Iris; Theler, Dominik; Greber, Basil; Diez, Javier; Gabaldon, Toni; Mendoza, Manuel; Barral, Yves			A Midzone-Based Ruler Adjusts Chromosome Compaction to Anaphase Spindle Length	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CONDENSATION; SEPARASE; PROTEIN; KINASE; ANEUPLOIDY; CANCER; CDC14; GENE	Partitioning of chromatids during mitosis requires that chromosome compaction and spindle length scale appropriately with each other. However, it is not clear whether chromosome condensation and spindle elongation are linked. Here, we find that yeast cells could cope with a 45% increase in the length of their longest chromosome arm by increasing its condensation. The spindle midzone, aurora/Ipl1 activity, and Ser10 of histone H3 mediated this response. Thus, the anaphase spindle may function as a ruler to adapt the condensation of chromatids, promoting their segregation regardless of chromosome or spindle length.	[Neurohr, Gabriel; Titos, Iris; Diez, Javier; Gabaldon, Toni; Mendoza, Manuel] Ctr Genom Regulat, Barcelona, Spain; [Neurohr, Gabriel; Titos, Iris; Diez, Javier; Gabaldon, Toni; Mendoza, Manuel] Univ Pompeu Fabra, Barcelona, Spain; [Neurohr, Gabriel; Naegeli, Andreas; Theler, Dominik; Greber, Basil; Mendoza, Manuel; Barral, Yves] ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mendoza, M (corresponding author), Ctr Genom Regulat, Barcelona, Spain.	manuel.mendoza@crg.es; yves.barral@bc.biol.ethz.ch	Mendoza, Manuel/AAE-8987-2021; Mendoza, Manuel/M-9679-2015; Gabaldón, Toni/A-7336-2008	Mendoza, Manuel/0000-0001-5522-4878; Gabaldón, Toni/0000-0003-0019-1735; Naegeli, Andreas/0000-0002-5938-9124; Greber, Basil/0000-0001-9379-7159; Barral, Yves/0000-0002-0989-3373; Diez Perez, Javier/0000-0001-5032-4976; Neurohr, Gabriel/0000-0003-1728-5498; Titos, Iris/0000-0002-5542-3794	La Caixa; Spanish Ministry of Science [BFU09-09168, BFU09-08213]; Swiss National Science Foundation	La Caixa(La Caixa Foundation); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank P. Meraldi, Z. Shcheprova, C. Weirich, and S. Buvelot for helpful comments and critical reading of the manuscript; D. Clarke (University of Minnesota) for reagents; C. Iannone and R. Tejedor for help with qPCR; F. Campelo for help with statistical analysis; the ETH Light Microscopy Center; the CRG Advanced Light Microscopy Unit; and the CRG Ultrasequencing Unit. This project was supported by grants from La Caixa to G. N., the Spanish Ministry of Science to T. G. (BFU09-09168) and M. M. (BFU09-08213), and the Swiss National Science Foundation to Y.B.	Bouck DC, 2008, ANNU REV GENET, V42, P335, DOI 10.1146/annurev.genet.42.110807.091620; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Harrison BD, 2009, CHROMOSOMA, V118, P633, DOI 10.1007/s00412-009-0224-6; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Nash RS, 2001, GENETICS, V157, P1469; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; SULLIVAN W, 1993, MOL BIOL CELL, V4, P885, DOI 10.1091/mbc.4.9.885; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Vas ACJ, 2007, MOL BIOL CELL, V18, P557, DOI 10.1091/mbc.E06-05-0454	20	69	70	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					465	468		10.1126/science.1201578	http://dx.doi.org/10.1126/science.1201578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21393511				2022-12-28	WOS:000289784900043
J	Misra, S; Hancock, M; Meeran, K; Dornhorst, A; Oliver, NS				Misra, Shivani; Hancock, Maggie; Meeran, Karim; Dornhorst, Anne; Oliver, Nick S.			HbA(1c): an old friend in new clothes	LANCET			English	Editorial Material							HEMOGLOBIN		[Misra, Shivani; Meeran, Karim; Dornhorst, Anne; Oliver, Nick S.] Imperial Healthcare NHS Trust, Dept Metab Med, London W6 8RF, England; [Misra, Shivani; Hancock, Maggie] Imperial Healthcare NHS Trust, Dept Clin Biochem, London W6 8RF, England		Misra, S (corresponding author), Imperial Healthcare NHS Trust, Dept Metab Med, London W6 8RF, England.	smisra@imperial.ac.uk	Oliver, Nick S/G-9109-2016	Oliver, Nick S/0000-0003-3525-3633; Misra, Shivani/0000-0003-2886-0726				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; *ASS CLIN BIOCH, HBA1C STAND LAB PROF; Barth JH, 2008, ANN CLIN BIOCHEM, V45, P343, DOI 10.1258/acb.2008.200815; Berg AH, 2008, J CLIN PATHOL, V61, P983, DOI 10.1136/jcp.2007.049205; Davidson MB, 2010, DIABETES RES CLIN PR, V87, P415, DOI 10.1016/j.diabres.2009.12.013; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; Kilpatrick ES, 2009, BMJ-BRIT MED J, V339, P1288; Little Randie R, 2003, Diabetes Technol Ther, V5, P979, DOI 10.1089/152091503322641024; Little RR, 2009, CURR OPIN ENDOCRINOL, V16, P113, DOI 10.1097/MED.0b013e328327728d; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Glycohemoglobin Standardization Program (NGSP), FACT INT HBA1C TEST; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Weykamp C, 2008, CLIN CHEM, V54, P240, DOI 10.1373/clinchem.2007.097402; World Health Organization, 2011, US GLYC HAEM HBA1C D	16	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2011	377	9776					1476	1477		10.1016/S0140-6736(10)61858-2	http://dx.doi.org/10.1016/S0140-6736(10)61858-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21354611				2022-12-28	WOS:000290419400010
J	Lewiecki, EM; Miller, SA				Lewiecki, E. Michael; Miller, Sara A.			Time to Reconsider	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												elewieck@unm.edu; miller@molbio.mgh.harvard.edu	Lewiecki, E. Michael/B-3706-2018	Lewiecki, E. Michael/0000-0003-2026-9587					0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1070	1071		10.1001/jama.2011.258	http://dx.doi.org/10.1001/jama.2011.258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734ZF	21406638				2022-12-28	WOS:000288381900001
J	Giuliano, AR; Lee, JH; Fulp, W; Villa, LL; Lazcano, E; Papenfuss, MR; Abrahamsen, M; Salmeron, J; Anic, GM; Rollison, DE; Smith, D				Giuliano, Anna R.; Lee, Ji-Hyun; Fulp, William; Villa, Luisa L.; Lazcano, Eduardo; Papenfuss, Mary R.; Abrahamsen, Martha; Salmeron, Jorge; Anic, Gabriella M.; Rollison, Dana E.; Smith, Danelle			Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study	LANCET			English	Article							UNITED-STATES; CERVICAL-CANCER; SEXUAL-BEHAVIOR; HPV INFECTION; RISK-FACTORS; PREVALENCE; WOMEN; ACQUISITION; PERSISTENCE; DETERMINANTS	Background Human papillomaviruses (HPVs) cause genital warts and cancers in men. The natural history of HPV infection in men is largely unknown, and that information is needed to inform prevention strategies. The goal in this study was to estimate incidence and clearance of type-specific genital HPV infection in men, and to assess the associated factors. Methods Men (aged 18-70 years), residing in Brazil, Mexico, and the USA, who were HIV negative and reported no history of cancer were recruited from the general population, universities, and organised health-care systems. They were assessed every 6 months for a median follow-up of 27.5 months (18.0-31.2). Specimens from the coronal sulcus, glans penis, shaft, and scrotum were obtained for the assessment of the status of HPV genotypes. Findings In 1159 men, the incidence of a new genital HPV infection was 38.4 per 1000 person months (95% CI 34.3-43-0). Oncogenic HPV infection was significantly associated with having a high number of lifetime female sexual partners (hazard ratio 2-40, 1-38-4-18, for at least 50 partners vs not more than one partner), and number of male anal-sexual partners (2.57, 1.46-4.49, for at least three male partners vs no recent partners). Median duration of HPV infection was 7-52 months (6.80-8.61) for any HPV and 12.19 months (7.16-18.17) for HPV 16. Clearance of oncogenic HPV infection decreased in men with a high number of lifetime female partners (0.49, 0.31-0.76, for at least 50 female partners vs not more than one partner), and in men in Brazil (0.71, 0.56-0.91) and Mexico (0.73, 0.57-0.94) compared with the USA. Clearance of oncogenic HPV was more rapid with increasing age (1.02, 1.01-1.03). Interpretation The data from this study are useful for the development of realistic cost-effectiveness models for male HPV vaccination internationally.	[Giuliano, Anna R.; Lee, Ji-Hyun; Fulp, William; Papenfuss, Mary R.; Abrahamsen, Martha; Anic, Gabriella M.; Rollison, Dana E.; Smith, Danelle] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Villa, Luisa L.] Ludwig Inst Canc Res, Sao Paulo, Brazil; [Lazcano, Eduardo; Salmeron, Jorge] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Ludwig Institute for Cancer Research; Instituto Nacional de Salud Publica	Giuliano, AR (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Risk Assessment Detect & Intervent Program,MRC CA, 12902 Magnolia Dr, Tampa, FL 33612 USA.	anna.giuliano@moffitt.org	Fulp, William/AAD-2369-2022; VILLA, LUISA/AAH-4761-2019	VILLA, LUISA/0000-0003-4074-2335; Salmeron, Jorge/0000-0002-5113-299X; Fulp, William/0000-0001-6888-0794	Merck; National Cancer Institute, National Institutes of Health [CA RO1CA098803]; NATIONAL CANCER INSTITUTE [R01CA098803, P30CA076292] Funding Source: NIH RePORTER	Merck(Merck & Company); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	ARC receives support from Merck, the manufacturer of the HPV vaccine, for the phase 3 Quadrivalent HPV Vaccine Trial among Men (Tampa, FL, USA); and is also a consultant to Merck, a member of the Merck Male HPV Advisory Board, and is on the speaker's bureau for Merck. LLV is a consultant for Merck. The other authors declare that they have no potential conflicts of interest.; This project was supported through a grant from the National Cancer Institute, National Institutes of Health (CA RO1CA098803). We thank the Tissue Core staff of the Moffitt Cancer Center for their help in managing biological samples from the US site.	AGARWAL SS, 1993, CANCER, V72, P1666, DOI 10.1002/1097-0142(19930901)72:5<1666::AID-CNCR2820720528>3.0.CO;2-M; American Cancer Society, 2022, CANC FACTS FIGURES 2; Bosch FX, 1996, JNCI-J NATL CANCER I, V88, P1060, DOI 10.1093/jnci/88.15.1060; BUCKLEY JD, 1981, LANCET, V2, P1010; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Flores R, 2008, J VIROL METHODS, V149, P136, DOI 10.1016/j.jviromet.2007.12.010; Giuliano AR, 2008, J INFECT DIS, V198, P827, DOI 10.1086/591095; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Giuliano AR, 2009, INT J CANCER, V124, P1251, DOI 10.1002/ijc.24097; Gravitt PE, 1998, J CLIN MICROBIOL, V36, P3020, DOI 10.1128/JCM.36.10.3020-3027.1998; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Kjaer SK, 2005, CANCER EPIDEM BIOMAR, V14, P1528, DOI 10.1158/1055-9965.EPI-04-0754; Kjaer SK, 2009, CANCER PREV RES, V2, P868, DOI 10.1158/1940-6207.CAPR-09-0031; Koshiol JE, 2004, SEX TRANSM DIS, V31, P748, DOI 10.1097/01.olq.0000145851.76025.ad; Lajous M, 2005, CANCER EPIDEM BIOMAR, V14, P1710, DOI 10.1158/1055-9965.EPI-04-0926; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Markowitz LE, 2009, J INFECT DIS, V200, P1059, DOI 10.1086/604729; Munoz N, 2004, J INFECT DIS, V190, P2077, DOI 10.1086/425907; Nyitray AG, 2009, AM J EPIDEMIOL, V170, P965, DOI 10.1093/aje/kwp225; Partridge JM, 2007, J INFECT DIS, V196, P1128, DOI 10.1086/521192; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; VANDOORNUM GJJ, 1994, GENITOURIN MED, V70, P240; Wikstrom A, 2000, INT J STD AIDS, V11, P80, DOI 10.1258/0956462001915417; ZUNZUNEGUI MV, 1986, AM J EPIDEMIOL, V123, P302, DOI 10.1093/oxfordjournals.aje.a114238; 2007, IARC MONOGR EVAL CAR, V90, P16	30	334	356	0	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					932	940		10.1016/S0140-6736(10)62342-2	http://dx.doi.org/10.1016/S0140-6736(10)62342-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GR	21367446	Green Accepted			2022-12-28	WOS:000288628800036
J	Schimmack, S; Schmitz-Winnenthal, H; Bergmann, F; Buchler, MW; Seiler, CM				Schimmack, Simon; Schmitz-Winnenthal, Hubertus; Bergmann, Frank; Buechler, Markus W.; Seiler, Christoph M.			Rupture without warning	LANCET			English	Editorial Material									[Schimmack, Simon; Schmitz-Winnenthal, Hubertus; Buechler, Markus W.; Seiler, Christoph M.] Univ Heidelberg, Dept Gen Visceral & Transplantat Surg, D-69120 Heidelberg, Germany; [Bergmann, Frank] Univ Heidelberg, Dept Pathol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Seiler, CM (corresponding author), Univ Heidelberg, Dept Gen Visceral & Transplantat Surg, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.	christoph.seiler@med.uni-heidelberg.de	Seiler, Christoph/AAG-7056-2021					Bradley W I, 1896, J Exp Med, V1, P401, DOI 10.1084/jem.1.3.401; de Benoist B, 2003, LANCET, V362, P1859, DOI 10.1016/S0140-6736(03)14920-3; McGregor JK, 1932, CAN MED ASSOC J, V26, P711; Saylam B, 2009, WEST J EMERG MED, V10, P247; Testini M, 2008, INT SURG, V93, P158	5	2	2	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2011	377	9769					966	966		10.1016/S0140-6736(10)61962-9	http://dx.doi.org/10.1016/S0140-6736(10)61962-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GR	21397768				2022-12-28	WOS:000288628800040
J	Cataldo, VD; Gibbons, DL; Perez-Soler, R; Quintas-Cardama, A				Cataldo, Vince D.; Gibbons, Don L.; Perez-Soler, Roman; Quintas-Cardama, Alfonso			Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDERMAL-GROWTH-FACTOR; PHASE-III TRIAL; PREVIOUSLY TREATED PATIENTS; FACTOR-RECEPTOR; ACQUIRED-RESISTANCE; T790M MUTATIONS; SUPPORTIVE CARE; EGFR MUTATIONS; CARBOPLATIN; PACLITAXEL		[Cataldo, Vince D.] Louisiana State Univ, Dept Hematol & Oncol, Hlth Sci Ctr, Baton Rouge, LA 70805 USA; [Cataldo, Vince D.] Hematol Oncol Clin, Baton Rouge, LA USA; [Gibbons, Don L.; Quintas-Cardama, Alfonso] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Perez-Soler, Roman] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA	Louisiana State University System; Louisiana State University; Louisiana State University Health Sciences Center at Shreveport; University of Texas System; UTMD Anderson Cancer Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Cataldo, VD (corresponding author), Louisiana State Univ, Dept Hematol & Oncol, Hlth Sci Ctr, 5825 Airline Hwy, Baton Rouge, LA 70805 USA.	vincelsu@aol.com			NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Boone SL, 2007, ONCOLOGY-BASEL, V72, P152, DOI 10.1159/000112795; Choong NW, 2008, J THORAC ONCOL, V3, P1003, DOI 10.1097/JTO.0b013e31818396a4; CLARK GM, 2003, P AN M AM SOC CLIN, V22, P196; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Gridelli C, 2008, CRIT REV ONCOL HEMAT, V66, P155, DOI 10.1016/j.critrevonc.2007.10.004; HAINSWORTH J, 2008, MULT S THOR ONC CHIC; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Jackman DM, 2006, CLIN CANCER RES, V12, P3908, DOI 10.1158/1078-0432.CCR-06-0462; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li J, 2007, CLIN CANCER RES, V13, P3731, DOI 10.1158/1078-0432.CCR-07-0088; Liu WT, 2007, CLIN GASTROENTEROL H, V5, P917, DOI 10.1016/j.cgh.2007.04.014; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Miller AA, 2007, J CLIN ONCOL, V25, P3055, DOI 10.1200/JCO.2007.11.6210; Miller VA, 2009, J CLIN ONCOL, V27; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Ready N, 2010, J THORAC ONCOL, V5, P1382, DOI 10.1097/JTO.0b013e3181eba657; Riely GJ, 2008, J THORAC ONCOL, V3, pS146, DOI 10.1097/JTO.0b013e318174e96e; Riely GJ, 2007, CLIN CANCER RES, V13, P5150, DOI 10.1158/1078-0432.CCR-07-0560; Riely GJ, 2006, CLIN CANCER RES, V12, P7232, DOI 10.1158/1078-0432.CCR-06-0658; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Rudin CM, 2008, J CLIN ONCOL, V26, P1119, DOI 10.1200/JCO.2007.13.1128; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shah NT, 2005, J CLIN ONCOL, V23, P165, DOI 10.1200/JCO.2005.04.057; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; TODARO GJ, 1976, NATURE, V264, P26, DOI 10.1038/264026a0; Wacker B, 2007, CLIN CANCER RES, V13, P3913, DOI 10.1158/1078-0432.CCR-06-2610; Wheatley-Price P, 2008, J CLIN ONCOL, V26, P2350, DOI 10.1200/JCO.2007.15.2280; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; IRESSA GEFITINIB PAC; TARCEVA ERLOTINIB PA	53	314	340	3	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					947	955		10.1056/NEJMct0807960	http://dx.doi.org/10.1056/NEJMct0807960			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	732FL	21388312				2022-12-28	WOS:000288170300011
J	Wakil, A; Ng, JM; Atkin, SL				Wakil, Ammar; Ng, Jen Min; Atkin, Stephen L.			Rational Testing Investigating hyponatraemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERNATREMIA; WATER					ammar.wakil@gmail.com	Atkin, stephen/ABE-7047-2020; atkin, stephen/D-7400-2014	atkin, stephen/0000-0002-5887-7257				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Clayton JA, 2006, QJM-INT J MED, V99, P505, DOI 10.1093/qjmed/hcl071; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; Hawkins RC, 2003, CLIN CHIM ACTA, V337, P169, DOI 10.1016/j.cccn.2003.08.001; Milionis HJ, 2002, CAN MED ASSOC J, V166, P1056; Schrier RW, 2006, J AM SOC NEPHROL, V17, P1820, DOI 10.1681/ASN.2006030240; Verbalis JG, 2007, AM J MED, V120, pS1, DOI 10.1016/j.amjmed.2007.09.001; Yeates KE, 2004, CAN MED ASSOC J, V170, P365; Zenenberg Robert D, 2010, Hosp Pract (1995), V38, P89	9	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2011	342								d1118	10.1136/bmj.d1118	http://dx.doi.org/10.1136/bmj.d1118			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UV	21382929				2022-12-28	WOS:000288446500005
J	Mihlbachler, MC; Rivals, F; Solounias, N; Semprebon, GM				Mihlbachler, Matthew C.; Rivals, Florent; Solounias, Nikos; Semprebon, Gina M.			Dietary Change and Evolution of Horses in North America	SCIENCE			English	Article							FOSSIL HORSES; STABLE-ISOTOPES; GREAT-PLAINS; OPEN-HABITAT; HYPSODONTY; MAMMALS; CARBON; COEVOLUTION; ADAPTATION; GRASSES	The evolution of high-crowned molars among horses (Family Equidae) is thought to be an adaptation for abrasive diets associated with the spread of grasslands. The sharpness and relief of the worn cusp apices of teeth (mesowear) are a measure of dietary abrasion. We collected mesowear data for North American Equidae for the past 55.5 million years to test the association of molar height and dietary abrasion. Mesowear trends in horses are reflective of global cooling and associated vegetation changes. There is a strong correlation between mesowear and crown height in horses; however, most horse paleopopulations had highly variable amounts of dietary abrasion, suggesting that selective pressures for crown height may have been weak much of the time. However, instances of higher abrasion were observed in some paleopopulations, suggesting intervals of stronger selection for the evolution of dentitions, including the early Miocene shortly before the first appearance of Equinae, the horse subfamily in which high-crowned dentitions evolved.	[Mihlbachler, Matthew C.; Solounias, Nikos] New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Mihlbachler, Matthew C.; Solounias, Nikos] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Rivals, Florent] Univ Rovira & Virgili, ICREA, Inst Catala Paleoecol Humana & Evolucio Social, Tarragona 43002, Spain; [Semprebon, Gina M.] Bay Path Coll, Dept Biol, Longmeadow, MA 01106 USA	New York Institute Technology; American Museum of Natural History (AMNH); ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES)	Mihlbachler, MC (corresponding author), New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA.	mmihlbac@nyit.edu	Rivals, Florent/B-7962-2014	Rivals, Florent/0000-0001-8074-9254	NSF [EAR-0824657]; ICREA Funding Source: Custom	NSF(National Science Foundation (NSF)); ICREA(ICREA)	We thank B. Beatty, C. Norris, R. O'Leary, and H. Galiano for assistance. We thank NSF (grant EAR-0824657) for support to M.C.M. and N.S.	DeMiguel D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-13; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; Eronen JT, 2010, EVOL ECOL RES, V12, P217; Eronen JT, 2010, EVOLUTION, V64, P398, DOI 10.1111/j.1558-5646.2009.00830.x; Feranec RS, 2003, PALEOBIOLOGY, V29, P230, DOI 10.1666/0094-8373(2003)029<0230:SIHATP>2.0.CO;2; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; Fox DL, 2004, PALAEOGEOGR PALAEOCL, V207, P305, DOI 10.1016/j.palaeo.2003.09.030; Janis Christine, 2008, V195, P21, DOI 10.1007/978-3-540-72422-3_2; Jernvall J, 2002, NATURE, V417, P538, DOI 10.1038/417538a; MacFadden BJ, 2005, SCIENCE, V307, P1728, DOI 10.1126/science.1105458; Matthew WD, 1926, Q REV BIOL, V1, P139, DOI 10.1086/394242; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Mihlbachler Matthew C., 2006, Journal of Mammalian Evolution, V13, P11, DOI 10.1007/s10914-005-9001-3; Passey BH, 2002, J GEOL, V110, P123, DOI 10.1086/338280; Retallack GJ, 1992, EOCENE OLIGOCENE CLI, P382; Rivals F, 2007, QUATERNARY RES, V68, P338, DOI 10.1016/j.yqres.2007.07.012; Secord R, 2008, PALEOBIOLOGY, V34, P282, DOI 10.1666/0094-8373(2008)034[0282:SIIEEM]2.0.CO;2; Simpson, 1951, HORSES STORY HORSE F; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; STEBBINS GL, 1981, ANN MO BOT GARD, V68, P75, DOI 10.2307/2398811; STIRTON RA, 1947, EVOLUTION, V1, P32, DOI 10.2307/2405401; Stromberg CAE, 2006, PALEOBIOLOGY, V32, P236, DOI 10.1666/0094-8373(2006)32[236:EOHIET]2.0.CO;2; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; WANG Y, 1994, PALAEOGEOGR PALAEOCL, V107, P269, DOI 10.1016/0031-0182(94)90099-X; Williams Susan H., 2001, Journal of Mammalian Evolution, V8, P207, DOI 10.1023/A:1012231829141; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zanazzi A, 2007, NATURE, V445, P639, DOI 10.1038/nature05551	28	197	203	4	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1178	1181		10.1126/science.1196166	http://dx.doi.org/10.1126/science.1196166			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385712				2022-12-28	WOS:000287971200038
J	Oury, F; Sumara, G; Sumara, O; Ferron, M; Chang, HX; Smith, CE; Hermo, L; Suarez, S; Roth, BL; Ducy, P; Karsenty, G				Oury, Franck; Sumara, Grzegorz; Sumara, Olga; Ferron, Mathieu; Chang, Haixin; Smith, Charles E.; Hermo, Louis; Suarez, Susan; Roth, Bryan L.; Ducy, Patricia; Karsenty, Gerard			Endocrine Regulation of Male Fertility by the Skeleton	CELL			English	Article							MOUSE LEYDIG-CELLS; PROTEIN-COUPLED RECEPTOR; RAT SEMINIFEROUS TUBULES; RNA HELICASE GRTH/DDX25; BONE MASS; METABOLIC SYNDROME; ENERGY-METABOLISM; GENETIC-CONTROL; EXPRESSION; SERUM	Interactions between bone and the reproductive system have until now been thought to be limited to the regulation of bone remodeling by the gonads. We now show that, in males, bone acts as a regulator of fertility. Using coculture assays, we demonstrate that osteoblasts are able to induce testosterone production by the testes, though they fail to influence estrogen production by the ovaries. Analyses of cell-specific loss- and gain-of-function models reveal that the osteoblast-derived hormone osteocalcin performs this endocrine function. By binding to a G protein-coupled receptor expressed in the Leydig cells of the testes, osteocalcin regulates in a CREB-dependent manner the expression of enzymes that is required for testosterone synthesis, promoting germ cell survival. This study expands the physiological repertoire of osteocalcin and provides the first evidence that the skeleton is an endocrine regulator of reproduction.	[Oury, Franck; Sumara, Grzegorz; Sumara, Olga; Ferron, Mathieu; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Ducy, Patricia] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Chang, Haixin; Suarez, Susan] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Smith, Charles E.; Hermo, Louis] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Roth, Bryan L.] Univ N Carolina, Dept Pharmacol Med Chem & Nat Prod, Sch Med, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Sch Med, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Sch Pharm, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Chapel Hill, NC 27599 USA; [Roth, Bryan L.] Univ N Carolina, Sch Pharm, Dept Pharmacol Med Chem & Nat Prod, Chapel Hill, NC 27599 USA	Columbia University; Columbia University; Cornell University; McGill University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Karsenty, G (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	Roth, Bryan L/F-3928-2010; Ferron, Mathieu/M-7794-2013; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520; Sumara, Grzegorz/0000-0003-1502-6265; Sumara, Olga/0000-0002-0845-3720; OURY, FRANCK/0000-0003-0562-9900	NIH; Fond de la recherche en sante du Quebec; HFSP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065439] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fond de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); HFSP(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Drs. Behringer and Ko for generously providing the Amh-mis-Cre and Cyp17-iCre mice; Dr. Hampson for generously providing us Gprc6a antibody; Dr. A. F. Parlow for measurements of LH in serum (National Hormone and Peptide Program); Drs. Przedborski and Jackson-Lewis for gracious help with stereological analysis; Drs. Mark, Yadav, Yoshizawa, Allen, and Setola for critical experimental advice; and G. Ren for mouse genotyping. This work was supported by grants from the NIH (G. K.), Fond de la recherche en sante du Quebec (M. F.), and HFSP (G. S. and F. O.).	Basura GJ, 2008, HEARING RES, V244, P45, DOI 10.1016/j.heares.2008.07.009; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; BRINKWORTH MH, 1995, J REPROD FERTIL, V105, P25, DOI 10.1530/jrf.0.1050025; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Dacquin R, 2004, DEV DYNAM, V229, P826, DOI 10.1002/dvdy.20003; Dakhova O, 2009, ENDOCRINOLOGY, V150, P404, DOI 10.1210/en.2008-0673; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Dufau ML, 2007, TRENDS ENDOCRIN MET, V18, P314, DOI 10.1016/j.tem.2007.09.001; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fukumoto S, 2007, BONE, V40, P1190, DOI 10.1016/j.bone.2006.12.062; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; GRAY A, 1991, J CLIN EPIDEMIOL, V44, P671, DOI 10.1016/0895-4356(91)90028-8; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HENRIKSEN K, 1995, ENDOCRINOLOGY, V136, P3285, DOI 10.1210/en.136.8.3285; Hikim APS, 1999, REV REPROD, V4, P38; HUNTER MG, 1982, MOL CELL ENDOCRINOL, V25, P35, DOI 10.1016/0303-7207(82)90167-8; Jamin SP, 2003, MOL CELL ENDOCRINOL, V211, P15, DOI 10.1016/j.mce.2003.09.006; KANAZAWA I, 2010, BONE IN PRESS, DOI DOI 10.1016/J.BONE.2010.12.020; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Khosla S, 2001, J CLIN ENDOCR METAB, V86, P3555, DOI 10.1210/jc.86.8.3555; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Powlin SS, 1998, TOXICOL SCI, V46, P61, DOI 10.1093/toxsci/46.1.61; Quigley CA, 2002, J CLIN ENDOCR METAB, V87, P24, DOI 10.1210/jc.87.1.24; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Saleem U, 2010, ARTERIOSCL THROM VAS, V30, P1474, DOI 10.1161/ATVBAHA.110.204859; SCHUMACHER M, 1978, FEBS LETT, V91, P333, DOI 10.1016/0014-5793(78)81204-6; SHARPE RM, 1992, J ANDROL, V13, P172; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; Simpson E, 2000, TRENDS ENDOCRIN MET, V11, P184, DOI 10.1016/S1043-2760(00)00254-X; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; SUAREZ SS, 1987, BIOL REPROD, V36, P1191, DOI 10.1095/biolreprod36.5.1191; Tsai-Morris CH, 2007, MOL HUM REPROD, V13, P887, DOI 10.1093/molehr/gam065; Tsai-Morris CH, 2010, J CELL BIOCHEM, V109, P1142, DOI 10.1002/jcb.22493; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017; Wang GM, 2003, ENDOCRINOLOGY, V144, P5058, DOI 10.1210/en.2003-0563; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; Yeap BB, 2010, EUR J ENDOCRINOL, V163, P265, DOI 10.1530/EJE-10-0414; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	52	419	451	0	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					796	809		10.1016/j.cell.2011.02.004	http://dx.doi.org/10.1016/j.cell.2011.02.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21333348	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000288007100017
J	Shin, JH; Ko, HS; Kang, H; Lee, Y; Lee, YI; Pletinkova, O; Troconso, JC; Dawson, VL; Dawson, TM				Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yunjong; Lee, Yun-Il; Pletinkova, Olga; Troconso, Juan C.; Dawson, Valina L.; Dawson, Ted M.			PARIS (ZNF746) Repression of PGC-1 alpha Contributes to Neurodegeneration in Parkinson's Disease	CELL			English	Article							ZINC-FINGER PROTEINS; MITOCHONDRIAL BIOGENESIS; UBIQUITIN; BINDING; IDENTIFICATION; SUBSTRATE; INTERACTS; INSULIN; LIGASE; DOMAIN	A hallmark of Parkinson's disease (PD) is the preferential loss of substantia nigra dopamine neurons. Here, we identify a new parkin interacting substrate, PARIS (ZNF746), whose levels are regulated by the ubiquitin proteasome system via binding to and ubiquitination by the E3 ubiquitin ligase, parkin. PARIS is a KRAB and zinc finger protein that accumulates in models of parkin inactivation and in human PD brain. PARIS represses the expression of the transcriptional coactivator, PGC-1 alpha and the PGC-1 alpha target gene, NRF-1 by binding to insulin response sequences in the PGC-1 alpha promoter. Conditional knockout of parkin in adult animals leads to progressive loss of dopamine (DA) neurons in a PARIS-dependent manner. Moreover, overexpression of PARIS leads to the selective loss of DA neurons in the substantia nigra, and this is reversed by either parkin or PGC-1 alpha coexpression. The identification of PARIS provides a molecular mechanism for neurodegeneration due to parkin inactivation.	[Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yunjong; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, NeuroRegenerat Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yunjong; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Shin, Joo-Ho; Ko, Han Seok; Kang, Hochul; Lee, Yun-Il; Troconso, Juan C.; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Lee, Yunjong; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Pletinkova, Olga; Troconso, Juan C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, NeuroRegenerat Program, Inst Cell Engn, Baltimore, MD 21205 USA.	tdawson@jhmi.edu	Shin, Joo-Ho/P-1417-2018; Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970; Lee, Yunjong/0000-0003-0182-2279	Bachmann Strauss Dystonia and Parkinson's Disease Foundation; Samsung Scholarship Foundation;  [NS38377];  [NS048206];  [NS051764]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377, R01NS048206, R01NS051764] Funding Source: NIH RePORTER	Bachmann Strauss Dystonia and Parkinson's Disease Foundation; Samsung Scholarship Foundation(Samsung); ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NS38377, NS048206, NS051764, and the Bachmann Strauss Dystonia and Parkinson's Disease Foundation. Y. L. is supported by Samsung Scholarship Foundation. T. M. D. is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The authors thank Drs. Xin Guo, Sathya Siram, and members of the Dawson laboratory for assistance and contributions to the manuscript. We also thank Drs. Alex Kolodkin, David Ginty, and Solomon H. Snyder for helpful suggestions.	Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Dawson TM, 2010, MOVEMENT DISORD, V25, pS32, DOI 10.1002/mds.22798; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; FUNK WD, 1992, P NATL ACAD SCI USA, V89, P9484, DOI 10.1073/pnas.89.20.9484; Gasser T, 2007, MOVEMENT DISORD, V22, pS343, DOI 10.1002/mds.21676; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Mounier C, 2006, CAN J PHYSIOL PHARM, V84, P713, DOI 10.1139/Y05-152; O'Brien RM, 2001, BIOCHEM SOC T, V29, P552, DOI 10.1042/BST0290552; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Vives-Bauza C, 2010, AUTOPHAGY, V6, P315, DOI 10.4161/auto.6.2.11199; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; Voz ML, 2000, CANCER RES, V60, P106; Winklhofer KF, 2003, J BIOL CHEM, V278, P47199, DOI 10.1074/jbc.M306769200; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	38	669	692	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					689	702		10.1016/j.cell.2011.02.010	http://dx.doi.org/10.1016/j.cell.2011.02.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376232	Green Accepted, Bronze			2022-12-28	WOS:000288007100009
J	Ege, MJ; Mayer, M; Normand, AC; Genuneit, J; Cookson, WOCM; Braun-Fahrlander, C; Heederik, D; Piarroux, R; von Mutius, E				Ege, Markus J.; Mayer, Melanie; Normand, Anne-Cecile; Genuneit, Jon; Cookson, William O. C. M.; Braun-Fahrlaender, Charlotte; Heederik, Dick; Piarroux, Renaud; von Mutius, Erika		GABRIELA Transregio 22 Study Grp	Exposure to Environmental Microorganisms and Childhood Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SCHOOL-AGE-CHILDREN; IN-HOUSE DUST; ATOPIC SENSITIZATION; ALLERGIC DISEASES; FARM CHILDREN; MATTRESS DUST; ENDOTOXIN; BACTERIAL; INFLAMMATION; ASSOCIATION	BACKGROUND Children who grow up in environments that afford them a wide range of microbial exposures, such as traditional farms, are protected from childhood asthma and atopy. In previous studies, markers of microbial exposure have been inversely related to these conditions. METHODS In two cross-sectional studies, we compared children living on farms with those in a reference group with respect to the prevalence of asthma and atopy and to the diversity of microbial exposure. In one study - PARSIFAL (Prevention of Allergy - Risk Factors for Sensitization in Children Related to Farming and Anthroposophic Lifestyle) - samples of mattress dust were screened for bacterial DNA with the use of single-strand conformation polymorphism (SSCP) analyses to detect environmental bacteria that cannot be measured by means of culture techniques. In the other study - GABRIELA (Multidisciplinary Study to Identify the Genetic and Environmental Causes of Asthma in the European Community [GABRIEL] Advanced Study) - samples of settled dust from children's rooms were evaluated for bacterial and fungal taxa with the use of culture techniques. RESULTS In both studies, children who lived on farms had lower prevalences of asthma and atopy and were exposed to a greater variety of environmental microorganisms than the children in the reference group. In turn, diversity of microbial exposure was inversely related to the risk of asthma (odds ratio for PARSIFAL, 0.62; 95% confidence interval [CI], 0.44 to 0.89; odds ratio for GABRIELA, 0.86; 95% CI, 0.75 to 0.99). In addition, the presence of certain more circumscribed exposures was also inversely related to the risk of asthma; this included exposure to species in the fungal taxon eurotium (adjusted odds ratio, 0.37; 95% CI, 0.18 to 0.76) and to a variety of bacterial species, including Listeria monocytogenes, bacillus species, corynebacterium species, and others (adjusted odds ratio, 0.57; 95% CI, 0.38 to 0.86). CONCLUSIONS Children living on farms were exposed to a wider range of microbes than were children in the reference group, and this exposure explains a substantial fraction of the inverse relation between asthma and growing up on a farm. (Funded by the Deutsche Forschungsgemeinschaft and the European Commission.)	[Ege, Markus J.; von Mutius, Erika] Univ Childrens Hosp Munich, Munich, Germany; [Mayer, Melanie] Tech Univ Munich, Inst Anim Hyg, D-8050 Freising Weihenstephan, Germany; [Genuneit, Jon] Univ Ulm, Inst Epidemiol, Ulm, Germany; [Normand, Anne-Cecile] Univ Franche Comte, Chronoenvironm Lab, F-25030 Besancon, France; [Piarroux, Renaud] Assistance Publ Hop Marseille, Dept Parasitol & Mycol, Marseille, France; [Piarroux, Renaud] Univ Aix Marseille 2, Marseille, France; [Cookson, William O. C. M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Braun-Fahrlaender, Charlotte] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Braun-Fahrlaender, Charlotte] Univ Basel, Basel, Switzerland; [Heederik, Dick] Univ Utrecht, Inst Risk Assessment, Div Environm Epidemiol, Utrecht, Netherlands	University of Munich; Technical University of Munich; Ulm University; Universite de Franche-Comte; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Utrecht University	Ege, MJ (corresponding author), Univ Munich, Childrens Hosp, Lindwurmstr 4, D-80337 Munich, Germany.	markus.ege@med.uni-muenchen.de	Cookson, William/HHC-1790-2022; Genuneit, Jon/I-9323-2012; Ege, Markus/C-1962-2012; Loss, Georg/F-1557-2013; Normand, Anne-Cécile/V-4271-2018; Fahimifar, Sepideh/M-5303-2019; Latzin, Philipp/F-2206-2017	Genuneit, Jon/0000-0001-5764-1528; Ege, Markus/0000-0001-6643-3923; Normand, Anne-Cécile/0000-0002-9589-4603; von Mutius, Erika/0000-0002-8893-4515; Heederik, Dick/0000-0002-4550-1437; Latzin, Philipp/0000-0002-5239-1571; Wouters, Inge M./0000-0001-7834-9390; Pershagen, Goran/0000-0002-9701-1130; Loss, Georg/0000-0003-1090-812X; piarroux, renaud/0000-0002-4151-4134	Deutsche Forschungsgemeinschaft [SFB Transregio 22, A1]; European Commission [LSH-2004-1.2.5-1, QLRT 1999-01391]; Medical Research Council [G1000758, G0801056B, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by grants from Deutsche Forschungsgemeinschaft (SFB Transregio 22 Pulmonary Allergies, Project A1) and the European Commission (LSH-2004-1.2.5-1 and QLRT 1999-01391).	Alfven T, 2006, ALLERGY, V61, P414, DOI 10.1111/j.1398-9995.2005.00939.x; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Hansen G, 2000, J IMMUNOL, V164, P223, DOI 10.4049/jimmunol.164.1.223; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kalliomaki M, 2008, ADV EXP MED BIOL, V635, P57, DOI 10.1007/978-0-387-09550-9_5; Korthals M, 2008, ENVIRON RES, V107, P299, DOI 10.1016/j.envres.2008.02.007; Korthals M, 2008, J MICROBIOL METH, V73, P49, DOI 10.1016/j.mimet.2008.01.010; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Normand AC, 2009, APPL ENVIRON MICROB, V75, P7617, DOI 10.1128/AEM.01414-09; Noss I, 2008, APPL ENVIRON MICROB, V74, P5621, DOI 10.1128/AEM.00619-08; Pakarinen J, 2008, ENVIRON MICROBIOL, V10, P3317, DOI 10.1111/j.1462-2920.2008.01723.x; Sahakian NM, 2008, IMMUNOL ALLERGY CLIN, V28, P485, DOI 10.1016/j.iac.2008.03.009; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schram-Bijkerk D, 2005, CLIN EXP ALLERGY, V35, P1272, DOI 10.1111/j.1365-2222.2005.02339.x; Sordillo JE, 2010, CLIN EXP ALLERGY, V40, P902, DOI 10.1111/j.1365-2222.2010.03509.x; van Strien RT, 2004, J ALLERGY CLIN IMMUN, V113, P860, DOI 10.1016/j.jaci.2004.01.078; Vartiainen E, 2002, J ALLERGY CLIN IMMUN, V109, P643, DOI 10.1067/mai.2002.123307; Vogel K, 2008, J ALLERGY CLIN IMMUN, V122, P307, DOI 10.1016/j.jaci.2008.05.016; von Mutius E, 2008, IMMUNOL ALLERGY CLIN, V28, P631, DOI 10.1016/j.iac.2008.03.010; Williams LK, 2005, ANN ALLERG ASTHMA IM, V94, P323, DOI 10.1016/S1081-1206(10)60983-0	27	1012	1053	8	229	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					701	709		10.1056/NEJMoa1007302	http://dx.doi.org/10.1056/NEJMoa1007302			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345099	Green Published			2022-12-28	WOS:000287652500004
J	Martin, DA; Senanayake, S				Martin, Deborah A.; Senanayake, Sanjaya			Myositis Ossificans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Martin, Deborah A.; Senanayake, Sanjaya] Canberra Hosp, Canberra, ACT, Australia	Australian National University; Canberra Hospital	Martin, DA (corresponding author), Canberra Hosp, Canberra, ACT, Australia.	deborah.martin@act.gov.au							0	6	6	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					758	758		10.1056/NEJMicm1005605	http://dx.doi.org/10.1056/NEJMicm1005605			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345105	Green Published			2022-12-28	WOS:000287652500011
J	Mattick, JS				Mattick, John S.			The Genomic Foundation Is Shifting	SCIENCE			English	Editorial Material									Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Mattick, JS (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.		Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012	Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527					0	9	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					874	874		10.1126/science.1203703	http://dx.doi.org/10.1126/science.1203703			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330534				2022-12-28	WOS:000287455100044
J	Lang, T; Cheah, PY; White, NJ				Lang, Trudie; Cheah, Phaik Yeong; White, Nicholas J.			Clinical research: time for sensible global guidelines	LANCET			English	Editorial Material							TRIALS		[Cheah, Phaik Yeong; White, Nicholas J.] Mahidol Univ, Fac Trop Med, Wellcome Trust Mahidol Univ Oxford Trop Med Res P, Bangkok, Thailand; [Lang, Trudie] Kemri Wellcome Res Programme, Kilifi, Kenya; [Lang, Trudie; Cheah, Phaik Yeong; White, Nicholas J.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford OX3 7LJ, England	Mahidol University; University of Oxford	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, Wellcome Trust Mahidol Univ Oxford Trop Med Res P, Bangkok, Thailand.	nickw@tropmedres.ac	White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	White, Nick/0000-0002-1897-1978; Cheah, Phaik Yeong/0000-0001-6327-3266; Lang, Trudie/0000-0003-2273-5975	Wellcome Trust [093956] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bosch X, 2005, NAT MED, V11, P1260, DOI 10.1038/nm1205-1260b; De Angelis C, 2004, LANCET, V364, P911, DOI 10.1016/S0140-6736(04)17034-7; Editorial, 2010, NY TIMES        0424; Grimes DA, 2005, LANCET, V366, P172, DOI 10.1016/S0140-6736(05)66875-4; Hemminki A, 2006, BMJ-BRIT MED J, V332, P501, DOI 10.1136/bmj.332.7540.501; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996, INT C HARM TECHN R E, VE6; McMahon AD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000131; Morice AH, 2003, LANCET, V361, P1568, DOI 10.1016/S0140-6736(03)13211-4; Shuchman M, 2007, NEW ENGL J MED, V357, P1365, DOI 10.1056/NEJMp078176; White NJ, 2006, TROP MED INT HEALTH, V11, P1483, DOI 10.1111/j.1365-3156.2006.01765.x; World Health Organization, 2005, HDB GOOD CLIN RES PR; Yusuf S, 2008, CLIN TRIALS, V5, P283, DOI 10.1177/1740774508094666	12	26	26	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2011	377	9777					1553	1555		10.1016/S0140-6736(10)62052-1	http://dx.doi.org/10.1016/S0140-6736(10)62052-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	763IJ	21334737				2022-12-28	WOS:000290549700009
J	Ito, H; Gaubert, H; Bucher, E; Mirouze, M; Vaillant, I; Paszkowski, J				Ito, Hidetaka; Gaubert, Herve; Bucher, Etienne; Mirouze, Marie; Vaillant, Isabelle; Paszkowski, Jerzy			An siRNA pathway prevents transgenerational retrotransposition in plants subjected to stress	NATURE			English	Article							DNA-METHYLATION; TRANSPOSABLE ELEMENTS; EPIGENETIC REGULATION; REPETITIVE ELEMENTS; GENOME SIZE; ARABIDOPSIS; DEMETHYLATION; EXPRESSION; DYNAMICS	Eukaryotic genomes consist to a significant extent of retrotransposons that are suppressed by host epigenetic mechanisms, preventing their uncontrolled propagation(1,2). However, it is not clear how this is achieved. Here we show that in Arabidopsis seedlings subjected to heat stress, a copia-type retrotransposon named ONSEN (Japanese 'hot spring') not only became transcriptionally active but also synthesized extrachromosomal DNA copies. Heat-induced ONSEN accumulation was stimulated in mutants impaired in the biogenesis of small interfering RNAs (siRNAs); however, there was no evidence of transposition occurring in vegetative tissues. After stress, both ONSEN transcripts and extrachromosomal DNA gradually decayed and were no longer detected after 20-30 days. Surprisingly, a high frequency of new ONSEN insertions was observed in the progeny of stressed plants deficient in siRNAs. Insertion patterns revealed that this transgenerational retrotransposition occurred during flower development and before gametogenesis. Therefore in plants with compromised siRNA biogenesis, memory of stress was maintained throughout development, priming ONSEN to transpose during differentiation of generative organs. Retrotransposition was not observed in the progeny of wild-type plants subjected to stress or in non-stressed mutant controls, pointing to a crucial role of the siRNA pathway in restricting retrotransposition triggered by environmental stress. Finally, we found that natural and experimentally induced variants in ONSEN insertions confer heat responsiveness to nearby genes, and therefore mobility bursts may generate novel, stress-responsive regulatory gene networks.	[Ito, Hidetaka; Gaubert, Herve; Bucher, Etienne; Mirouze, Marie; Vaillant, Isabelle; Paszkowski, Jerzy] Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland	University of Geneva	Paszkowski, J (corresponding author), Univ Geneva, Dept Plant Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jerzy.paszkowski@unige.ch	Mirouze, Marie/AAG-8128-2022; Mirouze, Marie/AFL-9387-2022; Mirouze, Marie/AFL-8165-2022; Bucher, Etienne/E-7681-2013; Ito, Hidetaka/Y-2865-2018	Mirouze, Marie/0000-0002-0514-1270; Mirouze, Marie/0000-0002-0514-1270; Bucher, Etienne/0000-0002-3114-3763; 	Swiss National Science Foundation [31003A-125005]; European Commission [FP7 226477]; RECBREED consortium [FP7 227190]; Epigenome Network of Excellence [FP6 503433]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); RECBREED consortium; Epigenome Network of Excellence	We thank all members of the J.P. laboratory and R. L. Fisher for discussions, L. Broger, M. Freyre, J. Nicolet, C. Megies for technical assistance and P. King and J. Reinders for editing of the manuscript. This work was supported by grants from the Swiss National Science Foundation (31003A-125005) and the European Commission through the AENEAS collaborative project (FP7 226477), the RECBREED consortium (FP7 227190) and The Epigenome Network of Excellence (FP6 503433).	Ammiraju JSS, 2007, PLANT J, V52, P342, DOI 10.1111/j.1365-313X.2007.03242.x; Feuerbach F, 1997, J VIROL, V71, P4005, DOI 10.1128/JVI.71.5.4005-4015.1997; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; HIROCHIKA H, 1995, GENE, V165, P229, DOI 10.1016/0378-1119(95)00581-P; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Johnson LM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000280; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lim CJ, 2006, J PLANT RES, V119, P373, DOI 10.1007/s10265-006-0285-z; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pecinka A, 2010, PLANT CELL, V22, P3118, DOI 10.1105/tpc.110.078493; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tittel-Elmer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001175; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	30	392	404	1	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					115	U151		10.1038/nature09861	http://dx.doi.org/10.1038/nature09861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21399627				2022-12-28	WOS:000289199400048
J	Coe, H				Coe, Hugh			Aerosol Chemistry and the Deepwater Horizon Spill	SCIENCE			English	Editorial Material							ORGANIC AEROSOLS		Univ Manchester, Ctr Atmospher Sci, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England	University of Manchester	Coe, H (corresponding author), Univ Manchester, Ctr Atmospher Sci, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.	hugh.coe@manchester.ac.uk	Coe, Hugh/C-8733-2013	Coe, Hugh/0000-0002-3264-1713				Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; de Gouw JA, 2011, SCIENCE, V331, P1295, DOI 10.1126/science.1200320; Donahue NM, 2009, ATMOS ENVIRON, V43, P94, DOI 10.1016/j.atmosenv.2008.09.055; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Grieshop A.P., 2008, ATMOSPHERIC CHEM PHY, V8, P17095, DOI [10.5194/acpd-8-17095-2008, DOI 10.5194/ACPD-8-17095-2008]; Heald CL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023831; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; *NAT COMM BP DEEPW, FIN REP NAT COMM BP; Robinson AL, 2007, SCIENCE, V315, P1259, DOI 10.1126/science.1133061; Volkamer R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026899; Weitkamp EA, 2007, ENVIRON SCI TECHNOL, V41, P6969, DOI 10.1021/es070193r; Zhang Q, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029979	12	6	6	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1273	1274		10.1126/science.1203019	http://dx.doi.org/10.1126/science.1203019			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393532				2022-12-28	WOS:000288215200031
J	Kim, M; Hohman, JN; Cao, Y; Houk, KN; Ma, H; Jen, AKY; Weiss, PS				Kim, Moonhee; Hohman, J. Nathan; Cao, Yang; Houk, Kendall N.; Ma, Hong; Jen, Alex K. -Y.; Weiss, Paul S.			Creating Favorable Geometries for Directing Organic Photoreactions in Alkanethiolate Monolayers	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; MOLECULAR ELECTRONICS; SINGLE MOLECULES; LIGHT; ANTHRACENES; AU(111); GOLD; PHOTOCHEMISTRY; ENVIRONMENTS; DIMERIZATION	The products of photoreactions of conjugated organic molecules may be allowed by selection rules but not observed in solution reactions because of unfavorable reaction geometries. We have used defect sites in self-assembled alkanethiolate monolayers on gold surfaces to direct geometrically unfavorable photochemical reactions between individual organic molecules. High conductivity and stochastic switching of anthracene-terminated phenylethynylthiolates within alkanethiolate monolayers, as well as in situ photochemical transformations, have been observed and distinguished with the scanning tunneling microscope (STM). Ultraviolet light absorbed during imaging increases the apparent heights of excited molecules in STM images, a direct manifestation of probing electronically excited states.	[Kim, Moonhee; Hohman, J. Nathan; Cao, Yang; Houk, Kendall N.; Weiss, Paul S.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Kim, Moonhee; Hohman, J. Nathan; Cao, Yang; Houk, Kendall N.; Weiss, Paul S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Kim, Moonhee; Hohman, J. Nathan; Weiss, Paul S.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Kim, Moonhee; Hohman, J. Nathan; Weiss, Paul S.] Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16802 USA; [Ma, Hong; Jen, Alex K. -Y.] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA; [Weiss, Paul S.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles	Houk, KN (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.	houk@chem.ucla.edu; ajen@u.washington.edu; psw@cnsi.ucla.edu	Weiss, Paul S/A-2575-2011; Weiss, Paul/P-8016-2019; JEN, Alex/E-5957-2012	Weiss, Paul S/0000-0001-5527-6248; Weiss, Paul/0000-0001-5527-6248; JEN, Alex/0000-0002-9219-7749	U.S. Department of Energy [DE-FG02-07ER15877]; NSF; Air Force Office of Scientific Research; Kavli Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Kavli Foundation	We thank S. Claridge for insightful discussions and the U.S. Department of Energy (no. DE-FG02-07ER15877), the NSF, the Air Force Office of Scientific Research, and the Kavli Foundation for financial support.	Anthony JE, 2006, CHEM REV, V106, P5028, DOI 10.1021/cr050966z; BECKER HD, 1984, J PHOTOCHEM, V26, P75, DOI 10.1016/0047-2670(84)85029-7; BECKER HD, 1993, CHEM REV, V93, P145, DOI 10.1021/cr00017a008; Berlman I.B., 1971, HDB FLUORESCENCE SPE; Bouas-Laurent H, 2000, CHEM SOC REV, V29, P43, DOI 10.1039/a801821i; Brewer NJ, 2005, J PHYS CHEM B, V109, P11247, DOI 10.1021/jp0443299; Browne WR, 2008, J PHYS CHEM C, V112, P1183, DOI 10.1021/jp0766508; Chen C, 2009, SCIENCE, V325, P981, DOI 10.1126/science.1174592; Cygan MT, 1998, J AM CHEM SOC, V120, P2721, DOI 10.1021/ja973448h; Delamarche E, 1996, ADV MATER, V8, P719, DOI 10.1002/adma.19960080903; Donhauser ZJ, 2001, SCIENCE, V292, P2303, DOI 10.1126/science.1060294; Donhauser ZJ, 2003, J AM CHEM SOC, V125, P11462, DOI 10.1021/ja035036g; Dou RF, 2006, LANGMUIR, V22, P3049, DOI 10.1021/la052987u; Fox MA, 1997, LANGMUIR, V13, P7099, DOI 10.1021/la970894+; FOX MA, 1979, SCIENCE, V205, P582, DOI 10.1126/science.205.4406.582; Gittins DI, 2000, NATURE, V408, P67, DOI 10.1038/35040518; Gonzalez C, 2000, CHEM PHYS LETT, V322, P382, DOI 10.1016/S0009-2614(00)00451-6; Iancu V, 2006, P NATL ACAD SCI USA, V103, P13718, DOI 10.1073/pnas.0603643103; Ishida T, 1997, LANGMUIR, V13, P3261, DOI 10.1021/la962022y; James DK, 2004, CHEM MATER, V16, P4423, DOI 10.1021/cm049648r; Kafer D, 2006, J AM CHEM SOC, V128, P1723, DOI 10.1021/ja0571592; Kumar AS, 2008, NANO LETT, V8, P1644, DOI 10.1021/nl080323+; Lewis PA, 2004, J AM CHEM SOC, V126, P12214, DOI 10.1021/ja038622i; MAULDING DR, 1969, J ORG CHEM, V34, P1734, DOI 10.1021/jo01258a045; MEADOR MA, 1989, J ORG CHEM, V54, P2336, DOI 10.1021/jo00271a018; Moore AM, 2006, J AM CHEM SOC, V128, P1959, DOI 10.1021/ja055761m; Moore AM, 2005, NANO LETT, V5, P2292, DOI 10.1021/nl051717t; Moore AM, 2007, J AM CHEM SOC, V129, P10352, DOI 10.1021/ja0745153; Nielsen JU, 2001, LANGMUIR, V17, P3454, DOI 10.1021/la001775o; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Reichert J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.176804; Smith RK, 2006, J AM CHEM SOC, V128, P9266, DOI 10.1021/ja061040r; Sullivan SP, 2005, LANGMUIR, V21, P1322, DOI 10.1021/la048586g; Vaish A, 2010, ACS CHEM NEUROSCI, V1, P495, DOI 10.1021/cn1000205; van der Molen SJ, 2009, NANO LETT, V9, P76, DOI 10.1021/nl802487j; Weiss PS, 2008, ACCOUNTS CHEM RES, V41, P1772, DOI 10.1021/ar8001443; WEISS PS, 1993, PHYS REV LETT, V71, P3139, DOI 10.1103/PhysRevLett.71.3139; WOLFF T, 1983, J PHOTOCHEM, V22, P61, DOI 10.1016/0047-2670(93)80009-E; Wu SW, 2006, SCIENCE, V312, P1362, DOI 10.1126/science.1124881; Ye T, 2010, ACS NANO, V4, P3697, DOI 10.1021/nn100545r; Zareie MH, 2006, J PHYS CHEM B, V110, P15951, DOI 10.1021/jp062489+; Zareie MH, 2003, NANO LETT, V3, P139, DOI 10.1021/nl025833x	42	77	78	2	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1312	1315		10.1126/science.1200830	http://dx.doi.org/10.1126/science.1200830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393542				2022-12-28	WOS:000288215200043
J	Wolfe, I; Cass, H; Thompson, MJ; Craft, A; Peile, E; Wiegersma, PA; Janson, S; Chambers, TL; Mckee, M				Wolfe, Ingrid; Cass, Hilary; Thompson, Matthew J.; Craft, Alan; Peile, Ed; Wiegersma, Pieter A.; Janson, Staffan; Chambers, T. L.; McKee, Martin			Improving child health services in the UK: insights from Europe and their implications for the NHS reforms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; INTEGRATION					Ingrid.Wolfe@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Cass, Hilary/L-6780-2019; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Cass, Hilary/0000-0001-8598-9134; Mckee, Martin/0000-0002-0121-9683; Wolfe, Ingrid/0000-0002-4717-7634	National Institute for Health Research [CDF-2011-04-052] Funding Source: researchfish; Department of Health [CDF-2011-04-052] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Ahgren B., 2003, INT J INTEGR CARE, V3, P1, DOI [10.5334/ijic.88, DOI 10.5334/IJIC.88]; Asthma-UK, 2007, ASTHM DIV IN EM CAR; Baerlocher MO, 2009, JAMA-J AM MED ASSOC, V301, P858, DOI 10.1001/jama.2009.223; Chevreul K., 2010, HLTH SYST TRANSIT, V12, P1, DOI DOI 10.1038/KI.2015.25; COURT D, 1976, FIT FUTURE COMMITTEE; *EUR SOC AMB PAED, 2006, EUR AC PAED WHAT AMB; Gatta G, 2003, ANN ONCOL, V14, pV119, DOI 10.1093/annonc/mdg755; Ham C, 2008, BRIT MED J, V336, P805, DOI 10.1136/bmj.39532.445197.AD; Healthcare Commission, 2007, IMPR SERV CHILDR HOS; Hippisley-Cox J, 2007, TRENDS CONSULTATION; *IST, 2009, DAT SET HLTH; Jewkes F, 2006, ARCH DIS CHILD, V91, P462, DOI 10.1136/adc.2005.092858; Kennedy I, 2010, GETTING IT RIGHT CHI; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; Marmot M, 2010, FAIR SOC HLTH LIVES; MILNE C, 2010, ARCH DIS CHILD S, V95, pA71; *NAT DIAB AUD, 2007, KEY FIND QUAL CAR CH; Nolte E, 2008, CARING PEOPLE CHRONI; Pearson G.A., 2008, WHY CHILDREN PILOT S; *REP ALL, 2003, BRIDG GAP COMM DEL H; *ROYAL COL PAED CH, CURR; *ROYAL COLL PAED C, 2007, RESP OUR NHS OUR FUT; Royal College of Paediatrics and Child Health, 2008, DEV WORKF CHILDR RCP; Saxena S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007484; SCHAFER W, 2010, HLTH SYST TRANSIT, V12, pR1; Schoen C, 2010, HEALTH AFFAIR, V29, P2323, DOI 10.1377/hlthaff.2010.0862; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; van der Linden BA, 2001, HEALTH POLICY, V55, P111, DOI 10.1016/S0168-8510(00)00125-1; *WHO REG OFF EUR, EUR DET MORT DAT; WHO Regional Office for Europe, 2010, EUR HLTH ALL DAT	30	59	59	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2011	342								d1277	10.1136/bmj.d1277	http://dx.doi.org/10.1136/bmj.d1277			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735UY	21385800	Green Accepted, Green Submitted			2022-12-28	WOS:000288446800013
J	Flechner, SM				Flechner, Stuart M.			Immunosuppression without calcineurin inhibition: by ZEUS	LANCET			English	Editorial Material							KIDNEY-TRANSPLANTATION; SIROLIMUS; CYCLOSPORINE; CONVERSION; RECIPIENTS; EFFICACY; THERAPY		Cleveland Clin Fdn, Glickman Urol & Kidney Inst Q10, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Flechner, SM (corresponding author), Cleveland Clin Fdn, Glickman Urol & Kidney Inst Q10, 9500 Euclid Ave, Cleveland, OH 44195 USA.	flechns@ccf.org						Budde K, 2011, LANCET, V377, P837, DOI 10.1016/S0140-6736(10)62318-5; Flechner SM, 2004, AM J TRANSPLANT, V4, P1776, DOI 10.1111/j.1600-6143.2004.00627.x; Flechner SM, 2009, TRANSPLANTATION, V87, pS1, DOI 10.1097/TP.0b013e3181a059a1; Lebranchu Y, 2009, AM J TRANSPLANT, V9, P1115, DOI 10.1111/j.1600-6143.2009.02615.x; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; PALESTINE AG, 1986, NEW ENGL J MED, V314, P1293, DOI 10.1056/NEJM198605153142005; Schena FP, 2009, TRANSPLANTATION, V87, P233, DOI 10.1097/TP.0b013e3181927a41; Webster AC, 2006, TRANSPLANTATION, V81, P1234, DOI 10.1097/01.tp.0000219703.39149.85; Weir MR, 2011, KIDNEY INT, V79, P897, DOI 10.1038/ki.2010.492; Weir MR, 2010, TRANSPL INT, V23, P447, DOI 10.1111/j.1432-2277.2010.01051.x	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 5	2011	377	9768					788	789		10.1016/S0140-6736(10)62236-2	http://dx.doi.org/10.1016/S0140-6736(10)62236-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GO	21334739				2022-12-28	WOS:000288628500006
J	Suzuki, M; Konno, C; Takahashi, S; Uchiyama, M				Suzuki, Masahiro; Konno, Chisato; Takahashi, Sakae; Uchiyama, Makoto			Hidden harm	LANCET			English	Editorial Material							PHEOCHROMOCYTOMA		[Uchiyama, Makoto] Nihon Univ, Sch Med, Dept Psychiat, Itabashi Ku, Tokyo 1738610, Japan	Nihon University	Uchiyama, M (corresponding author), Nihon Univ, Sch Med, Dept Psychiat, Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.	uchiyama.makoto@nihon-u.ac.jp						Lenders JWM, 2002, JAMA-J AM MED ASSOC, V287, P1427, DOI 10.1001/jama.287.11.1427; Mannelli M, 1999, EUR J ENDOCRINOL, V141, P619, DOI 10.1530/eje.0.1410619; Pacak K, 2005, ENDOCRINOLOGY, P2501; Seelen MAJ, 1997, ANN INTERN MED, V126, P333, DOI 10.7326/0003-4819-126-4-199702150-00021	4	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2011	377	9768					874	874		10.1016/S0140-6736(10)61542-5	http://dx.doi.org/10.1016/S0140-6736(10)61542-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GO	21377572				2022-12-28	WOS:000288628500035
J	Herd, B				Herd, Barbara			Should physicians be routinely involved in the care of elderly surgical patients? No	BRITISH MEDICAL JOURNAL			English	Editorial Material												barbara.herd@nth.nhs.uk						AYLETT V, 2010, ORTHOGERIATRIC MODEL; British Orthopaedic Association and the British Geriatric Society, 2007, CAR PAT FRAG FRACT; DHESI J, 2010, BR GERIATR SOC N DEC, P18; National Confidential Enquiry into Perioperative Deaths, 2010, AG OLD PROBL REV CAR; *ROYAL COLL PHYS, 2009 CENS; 2010, LANCET, V376, P1711	6	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 4	2011	342								d1072	10.1136/bmj.d1072	http://dx.doi.org/10.1136/bmj.d1072			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732EU	21378069				2022-12-28	WOS:000288168600008
J	Kim, KY; Levin, DE				Kim, Ki-Young; Levin, David E.			Mpk1 MAPK Association with the Paf1 Complex Blocks Sen1-Mediated Premature Transcription Termination	CELL			English	Article							RNA-POLYMERASE-II; ACTIVATED PROTEIN-KINASE; CELL-CYCLE REGULATOR; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; NONCATALYTIC MECHANISM; HISTONE METHYLATION; ELONGATION-FACTORS; 3'-END FORMATION; BINDING PROTEIN	The Mpk1 MAPK of the yeast cell wall integrity pathway uses a noncatalytic mechanism to activate transcription of stress-induced genes by recruitment of initiation factors to target promoters. We show here that Mpk1 additionally serves a function in transcription elongation that is also independent of its catalytic activity. This function is mediated by an interaction between Mpk1 and the Paf1 subunit of the Paf1C elongation complex. A mutation in Paf1 that blocks this interaction causes a specific defect in transcription elongation of an Mpk1-induced gene, which results from Sen1-dependent premature termination through a Nab3-binding site within the promoter-proximal region of the gene. Our findings reveal a regulatory mechanism in which Mpk1 overcomes transcriptional attenuation by blocking recruitment of the Sen1-Nrd1-Nab3 termination complex to the elongating polymerase. Finally, we demonstrate that this mechanism is conserved in an interaction between the human ERK5 MAPK and human Paf1.	[Kim, Ki-Young; Levin, David E.] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Levin, David E.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Boston University; Boston University	Levin, DE (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA.	delevin@bu.edu	Kim, Ki-Young/AAK-7142-2020	Levin, David/0000-0003-0696-2860	NIH [GM48533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102136, R01GM048533] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Judith Jaehning for comments on the manuscript; Steve Buratowski for helpful discussions; David Brow for the ACT1-CUP1 reporter system; Michael Culbertson for the sen1-1 mutant; Peter Piper for two-hybrid fusions; Elizabeth Yranski for assistance with strain construction; and two anonymous reviewers for insightful comments. This work was supported by a grant from the NIH (GM48533) to D.E.L.	Abe J, 1996, J BIOL CHEM, V271, P16586, DOI 10.1074/jbc.271.28.16586; ANDREWS BJ, 1992, P NATL ACAD SCI USA, V89, P11852, DOI 10.1073/pnas.89.24.11852; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Baetz K, 2001, MOL CELL BIOL, V21, P6515, DOI 10.1128/MCB.21.19.6515-6528.2001; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Costa PJ, 2000, GENETICS, V156, P535; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; DICOMO CJ, 1995, MOL CELL BIOL, V15, P1835; Dodou E, 1997, MOL CELL BIOL, V17, P1848, DOI 10.1128/MCB.17.4.1848; Finkel JS, 2010, GENETICS, V184, P107, DOI 10.1534/genetics.109.110031; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Kim KY, 2010, YEAST, V27, P541, DOI 10.1002/yea.1782; KLIS FM, 1994, YEAST, V10, P851, DOI 10.1002/yea.320100702; Koch C, 1999, NUCLEIC ACIDS RES, V27, P2126, DOI 10.1093/nar/27.10.2126; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sedgwick SG, 1998, J MOL BIOL, V281, P763, DOI 10.1006/jmbi.1998.1996; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; SIDOROVA J, 1993, MOL CELL BIOL, V13, P1069, DOI 10.1128/MCB.13.2.1069; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Truman AW, 2006, EUKARYOT CELL, V5, P1914, DOI 10.1128/EC.00263-06; Truman AW, 2009, MOL CELL BIOL, V29, P6449, DOI 10.1128/MCB.00794-09; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013	59	74	75	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					745	756		10.1016/j.cell.2011.01.034	http://dx.doi.org/10.1016/j.cell.2011.01.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376235	Green Accepted, Bronze			2022-12-28	WOS:000288007100013
J	Stamm, LM; Goldberg, MB				Stamm, Luisa M.; Goldberg, Marcia B.			Establishing the Secretion Hierarchy	SCIENCE			English	Editorial Material							III SECRETION; SALMONELLA-TYPHIMURIUM; SYSTEM		[Stamm, Luisa M.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Stamm, LM (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Cambridge, MA 02139 USA.	mgoldberg1@partners.org	Goldberg, Marcia/U-8604-2019		NIAID NIH HHS [T32 AI007061, R01 AI081724] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081724, T32AI007061] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Collazo CM, 1996, INFECT IMMUN, V64, P3524, DOI 10.1128/IAI.64.9.3524-3531.1996; Deane JE, 2010, CELL MOL LIFE SCI, V67, P1065, DOI 10.1007/s00018-009-0230-0; Johnson S, 2008, FEMS MICROBIOL LETT, V286, P274, DOI 10.1111/j.1574-6968.2008.01284.x; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Marlovits TC, 2010, CURR OPIN MICROBIOL, V13, P47, DOI 10.1016/j.mib.2009.11.001; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358	9	14	16	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1147	1148		10.1126/science.1203195	http://dx.doi.org/10.1126/science.1203195			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385706				2022-12-28	WOS:000287971200030
J	Barnosky, AD; Matzke, N; Tomiya, S; Wogan, GOU; Swartz, B; Quental, TB; Marshall, C; McGuire, JL; Lindsey, EL; Maguire, KC; Mersey, B; Ferrer, EA				Barnosky, Anthony D.; Matzke, Nicholas; Tomiya, Susumu; Wogan, Guinevere O. U.; Swartz, Brian; Quental, Tiago B.; Marshall, Charles; McGuire, Jenny L.; Lindsey, Emily L.; Maguire, Kaitlin C.; Mersey, Ben; Ferrer, Elizabeth A.			Has the Earth's sixth mass extinction already arrived?	NATURE			English	Review							FUTURE; BIODIVERSITY; CLIMATE; RISK; DIVERSITY; DYNAMICS; QUATERNARY; SPECIATION; IMPACTS; RATES	Palaeontologists characterize mass extinctions as times when the Earth loses more than three-quarters of its species in a geologically short interval, as has happened only five times in the past 540 million years or so. Biologists now suggest that a sixth mass extinction may be under way, given the known species losses over the past few centuries and millennia. Here we review how differences between fossil and modern data and the addition of recently available palaeontological information influence our understanding of the current extinction crisis. Our results confirm that current extinction rates are higher than would be expected from the fossil record, highlighting the need for effective conservation measures.	[Barnosky, Anthony D.; Matzke, Nicholas; Tomiya, Susumu; Wogan, Guinevere O. U.; Swartz, Brian; Quental, Tiago B.; Marshall, Charles; McGuire, Jenny L.; Lindsey, Emily L.; Maguire, Kaitlin C.; Mersey, Ben; Ferrer, Elizabeth A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Barnosky, Anthony D.; Tomiya, Susumu; Swartz, Brian; Quental, Tiago B.; Marshall, Charles; McGuire, Jenny L.; Lindsey, Emily L.; Maguire, Kaitlin C.; Ferrer, Elizabeth A.] Univ Calif Museum Paleontol, Berkeley, CA USA; [Barnosky, Anthony D.; Tomiya, Susumu; Wogan, Guinevere O. U.; McGuire, Jenny L.] Univ Calif Museum Vertebrate Zool, Berkeley, CA USA; [Mersey, Ben] Human Evolut Res Ctr, Berkeley, CA USA	University of California System; University of California Berkeley	Barnosky, AD (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	barnosky@berkeley.edu	Matzke, Nicholas/L-4109-2015; Lobo, Diele/I-9106-2012; McGuire, Jenny L./G-8819-2011; Quental, Tiago B/C-7077-2013; Wogan, Guinevere O.U./C-4613-2013	Matzke, Nicholas/0000-0002-8698-7656; McGuire, Jenny L./0000-0002-0663-6902; Wogan, Guinevere O.U./0000-0003-1877-0591; Tomiya, Susumu/0000-0001-6038-899X	NSF [EAR-0720387, DEB-0919451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069801] Funding Source: NIH RePORTER; Division Of Environmental Biology [0919124] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	S. Beissinger, P. Ehrlich, E. Hadly, A. Hubbe, D. Jablonski, S. Pimm and D. Wake provided constructive comments. Paleobiology Database data were contributed by M. Carrano, J. Alroy, M. Uhen, R. Butler, J. Mueller, L. van den Hoek Ostende, J. Head, E. Fara, D. Croft, W. Clyde, K. Behrensmeyer, J. Hunter, R. Whatley and W. Kiessling. The work was funded in part by NSF grants EAR-0720387 (to A.D.B.) and DEB-0919451 (supporting N.M.). This is University of California Museum of Paleontology Contribution 2024.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Algeo TJ, 2000, PLANTS INVADE LAND E, P213; Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Archibald JD, 2010, SCIENCE, V328, P973, DOI 10.1126/science.328.5981.973-a; Arens NC, 2008, PALEOBIOLOGY, V34, P456, DOI 10.1666/07034.1; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; Barnosky A. D., 2009, HEATSTROKE NATURE AG, P1; Barnosky AD, 2008, P NATL ACAD SCI USA, V105, P11543, DOI 10.1073/pnas.0801918105; Barnosky AD, 2010, QUATERN INT, V217, P10, DOI 10.1016/j.quaint.2009.11.017; Berner RA, 2002, P NATL ACAD SCI USA, V99, P4172, DOI 10.1073/pnas.032095199; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Carrasco MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008331; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; Faith JT, 2009, P NATL ACAD SCI USA, V106, P20641, DOI 10.1073/pnas.0908153106; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; FOOTE M, 1994, PALEOBIOLOGY, V20, P424, DOI 10.1017/S0094837300012914; Foote M, 1996, PALEOBIOLOGY, V22, P121, DOI 10.1017/S0094837300016134; Foote M, 1997, PALEOBIOLOGY, V23, P278, DOI 10.1017/S0094837300019692; GBO3, 2010, BLOB BIOD OUTL 3, P94; Hesselbo SP, 2007, PALAEOGEOGR PALAEOCL, V244, P1, DOI 10.1016/j.palaeo.2006.06.020; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; *IUCN, 2010, INT UN CONS NAT RED; Jablonski D., 1986, P183; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; JABLONSKI D, 1994, PHILOS T R SOC B, V344, P11, DOI 10.1098/rstb.1994.0045; Jablonski D, 2008, P NATL ACAD SCI USA, V105, P11528, DOI 10.1073/pnas.0801919105; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Keller G, 2008, CRETACEOUS RES, V29, P754, DOI 10.1016/j.cretres.2008.05.030; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Leakey R, 1992, 6 EXTINCTION PATTERN; Lu PJ, 2006, P NATL ACAD SCI USA, V103, P2736, DOI 10.1073/pnas.0511083103; Mace G.M., 2005, ECOSYSTEMS HUMAN WEL, P77; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; MacPhee R.D.E., 1999, EXTINCTIONS NEAR TIM; May Robert M., 1995, P1; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; McGhee G.R.J., 1996, LATE DEVONIAN MASS E, P1; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Mukhopadhyay S, 2001, SCIENCE, V291, P1952, DOI 10.1126/science.291.5510.1952; Murphy AE, 2000, GEOLOGY, V28, P427, DOI 10.1130/0091-7613(2000)28<427:EBDOTM>2.0.CO;2; Myers N., 1990, PALAEOGEOGR PALAEOCL, V82, P175; NEOMAP, 2010, NEOGENE MAMMAL MAPPI; Novacek M.J., 2001, BIODIVERSITY CRISIS; Orlova L. A., 2008, Doklady Akademii Nauk, V423, P133; Payne JL, 2010, P NATL ACAD SCI USA, V107, P8543, DOI 10.1073/pnas.0914065107; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Pimm SL, 1997, NATURE HUMAN SOC QUE, P46; Pimm S, 2006, P NATL ACAD SCI USA, V103, P10941, DOI 10.1073/pnas.0604181103; Prauss ML, 2009, PALAEOGEOGR PALAEOCL, V283, P195, DOI 10.1016/j.palaeo.2009.09.024; Purvis A, 2000, BIOESSAYS, V22, P1123, DOI 10.1002/1521-1878(200012)22:12<1123::AID-BIES10>3.0.CO;2-C; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Ramakrishnan U, 2009, MOL ECOL, V18, P1310, DOI 10.1111/j.1365-294X.2009.04092.x; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; RAUP DM, 1991, PALEOBIOLOGY, V17, P37, DOI 10.1017/S0094837300010332; RAUP DM, 1993, SCIENCE, V260, P971, DOI 10.1126/science.11537491; Regan HM, 2001, AM NAT, V157, P1, DOI 10.1086/317005; Reumer JWF, 2003, J VERTEBR PALEONTOL, V23, P260, DOI 10.1671/0272-4634(2003)23[260:LPSOTS]2.0.CO;2; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rosenzweig ML, 2001, P NATL ACAD SCI USA, V98, P5404, DOI 10.1073/pnas.101092798; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Sandberg CA, 2002, GEOL SOC AM SPEC PAP, V356, P473; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Sengor AMC, 2008, P NATL ACAD SCI USA, V105, P13736, DOI 10.1073/pnas.0805482105; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Sheehan PM, 2001, ANNU REV EARTH PL SC, V29, P331, DOI 10.1146/annurev.earth.29.1.331; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; STEADMAN DW, 2006, EXT BIOG TROP PAC, pR9; Stork NE, 2010, BIODIVERS CONSERV, V19, P357, DOI 10.1007/s10531-009-9761-9; Surovell T, 2005, P NATL ACAD SCI USA, V102, P6231, DOI 10.1073/pnas.0501947102; Sutcliffe OE, 2000, GEOLOGY, V28, P967, DOI 10.1130/0091-7613(2000)028<0967:CTLOGA>2.3.CO;2; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Turvey ST, 2009, HOLOCENE EXTINCTIONS; Vie J-C, 2009, WILDLIFE CHANGING WO, DOI [10.2305/IUCN.CH.2009.17.en, DOI 10.2305/IUCN.CH.2009.17.EN]; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Ward PD, 2001, SCIENCE, V292, P1148, DOI 10.1126/science.1058574; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590	96	2040	2147	102	2615	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					51	57		10.1038/nature09678	http://dx.doi.org/10.1038/nature09678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368823				2022-12-28	WOS:000287924100032
J	Thompson, AM; Hu, TA; Eshelbrenner, CL; Reynolds, K; He, JA; Bazzano, LA				Thompson, Angela M.; Hu, Tian; Eshelbrenner, Carrie L.; Reynolds, Kristi; He, Jiang; Bazzano, Lydia A.			Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CONVERTING-ENZYME-INHIBITOR; ACUTE MYOCARDIAL-INFARCTION; BLOOD-PRESSURE REDUCTION; LEFT-VENTRICULAR DYSFUNCTION; HEART-FAILURE; DOUBLE-BLIND; CORONARY-DISEASE; RECURRENT STROKE; CONTROLLED-TRIAL; GLOBAL BURDEN	Context Cardiovascular disease (CVD) risk increases beginning at systolic blood pressure levels of 115 mm Hg. Use of antihypertensive medications among patients with a history of CVD or diabetes and without hypertension has been debated. Objective To evaluate the effect of antihypertensive treatment on secondary prevention of CVD events and all-cause mortality among persons without clinically defined hypertension. Data Sources Meta-analysis with systematic search of MEDLINE (1950 to week 3 of January 2011), EMBASE, and the Cochrane Collaboration Central Register of Controlled Clinical Trials and manual examination of references in selected articles and studies. Study Selection From 874 potentially relevant publications, 25 trials that fulfilled the predetermined inclusion and exclusion criteria were included in the meta-analysis. Data Extraction Information on participant characteristics, trial design and duration, treatment drug, dose, control, and clinical events were extracted using a standardized protocol. Outcomes included stroke, myocardial infarction (MI), congestive heart failure (CHF), composite CVD outcomes, CVD mortality, and all-cause mortality. Results Compared with controls, participants receiving antihypertensive medications had a pooled relative risk of 0.77 (95% confidence interval [CI], 0.61 to 0.98) for stroke, 0.80 (95% CI, 0.69 to 0.93) for MI, 0.71 (95% CI, 0.65 to 0.77) for CHF, 0.85 (95% CI, 0.80 to 0.90) for composite CVD events, 0.83 (95% CI, 0.69 to 0.99) for CVD mortality, and 0.87 (95% CI, 0.80 to 0.95) for all-cause mortality from random-effects models. The corresponding absolute risk reductions per 1000 persons were -7.7 (95% CI, -15.2 to -0.3) for stroke, -13.3 (95% CI, -28.4 to 1.7) for MI, -43.6 (95% CI, -65.2 to -22.0) for CHF events, -27.1(95% CI, -40.3 to -13.9) for composite CVD events, -15.4 (95% CI, -32.5 to 1.7) for CVD mortality, and -13.7 (95% CI, -24.6 to -2.8) for all-cause mortality. Results did not differ according to trial characteristics or subgroups defined by clinical history. Conclusions Among patients with clinical history of CVD but without hypertension, antihypertensive treatment was associated with decreased risk of stroke, CHF, composite CVD events, and all-cause mortality. Additional randomized trial data are necessary to assess these outcomes in patients without CVD clinical recommendations. JAMA. 2011;305(9):913-922 www.jama.com	[Thompson, Angela M.; Hu, Tian; He, Jiang; Bazzano, Lydia A.] Tulane Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, New Orleans, LA 70112 USA; [Eshelbrenner, Carrie L.; He, Jiang; Bazzano, Lydia A.] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Reynolds, Kristi] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA USA	Tulane University; Tulane University; Kaiser Permanente	Bazzano, LA (corresponding author), Tulane Univ, Dept Epidemiol, Sch Publ Hlth & Trop Med, 1440 Canal St,SL 18, New Orleans, LA 70112 USA.	lbazzano@tulane.edu	Thompson-Paul, Angela/N-7067-2016; He, Jiang/AAF-5303-2020; Reynolds, Kristi/AAN-1434-2021	Thompson-Paul, Angela/0000-0003-1186-9150; He, Jiang/0000-0002-8286-9652; Reynolds, Kristi/0000-0001-7619-1649	Tulane University; National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health [R01 HL087263, R01 HL090682]; NHLBI [K08 HL091108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090682, K08HL091108, R01HL087263] Funding Source: NIH RePORTER	Tulane University; National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Ms Thompson is supported by a grant from the Research Enhancement Fund of Tulane University. Dr He is supported by research grants R01 HL087263 and R01 HL090682 from the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health. Dr Bazzano is supported by grant K08 HL091108 from the NHLBI.	AMBROSIONI E, 1995, NEW ENGL J MED, V332, P80, DOI 10.1056/NEJM199501123320203; Ambrosioni Ettore, 1994, Controlled Clinical Trials, V15, P201, DOI 10.1016/0197-2456(94)90057-4; [Anonymous], 2001, J Hypertens Suppl, V19, pS21; [Anonymous], 1990, Am J Cardiol, V66, P315; [Anonymous], 1975, Br Med J, V3, P735; Arima H, 2006, J HYPERTENS, V24, P1201, DOI 10.1097/01.hjh.0000226212.34055.86; BABER NS, 1980, BRIT HEART J, V44, P96; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Borghi C, 1999, AM J HYPERTENS, V12, P665, DOI 10.1016/S0895-7061(99)00042-4; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Chalmers J, 1996, J HYPERTENS, V14, pS41; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi KM, 2006, J HYPERTENS, V24, P1515, DOI 10.1097/01.hjh.0000239286.02389.0f; CLELAND JGF, 1993, J CARDIOVASC PHARM, V22, pS22, DOI 10.1097/00005344-199306229-00006; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diener HC, 2007, CEREBROVASC DIS, V23, P368, DOI 10.1159/000100105; Egan BM, 2008, CURR HYPERTENS REP, V10, P359, DOI 10.1007/s11906-008-0068-0; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Estacio RO, 1996, CONTROL CLIN TRIALS, V17, P242, DOI 10.1016/0197-2456(95)00154-9; Fox KM, 2003, LANCET, V362, P782; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Gerstein HC, 2000, LANCET, V355, P253; Gomma AH, 2001, CARDIOVASC DRUG THER, V15, P169, DOI 10.1023/A:1011131130922; Greenlund KJ, 2004, ARCH INTERN MED, V164, P2113, DOI 10.1001/archinte.164.19.2113; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gustafsson F, 1997, J HYPERTENS, V15, P793, DOI 10.1097/00004872-199715070-00012; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Kenchaiah S, 2004, AM HEART J, V148, P356, DOI 10.1016/j.ahj.2004.02.011; Kiely AE, 2009, BLOOD PRESSURE, V18, P300, DOI 10.3109/08037050903444024; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; KOSTIS JB, 1995, AM J HYPERTENS, V8, P909, DOI 10.1016/0895-7061(95)00156-J; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu LS, 2009, HYPERTENS RES, V32, P1032, DOI 10.1038/hr.2009.139; Liu LS, 2001, CHINESE MED J-PEKING, V114, P115; Liu LS, 1997, CHINESE MED J-PEKING, V110, P834; Luders S, 2008, J HYPERTENS, V26, P1487, DOI 10.1097/HJH.0b013e3282ff8864; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; Mcinnes GT, 2009, BLOOD PRESSURE, V18, P304, DOI 10.3109/08037050903416436; Mindlen F, 1996, CAN J CARDIOL, V12, P127; Mitka M, 2006, JAMA-J AM MED ASSOC, V295, P2125, DOI 10.1001/jama.295.18.2125; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; [National Heart Lung and Blood Institute Biologic Specimen and Data Repository Information Coordinating Center], PEACE STUD FORM DAT; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Papadopoulos DP, 2008, HYPERTENS RES, V31, P1681, DOI 10.1291/hypres.31.1681; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfeffer MA, 1998, AM J CARDIOL, V82, p25H; Pimenta E, 2010, NAT REV NEPHROL, V6, P21, DOI 10.1038/nrneph.2009.191; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Remme WJ, 2009, CARDIOVASC DRUG THER, V23, P161, DOI 10.1007/s10557-008-6143-6; Rouleau JL, 2004, J AM COLL CARDIOL, V43, P1423, DOI 10.1016/j.jacc.2003.11.037; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; SCHUTZ W, 1983, EUR HEART J, V4, P367; Sleight P, 2001, LANCET, V358, P2130, DOI 10.1016/S0140-6736(01)07186-0; Spargias KS, 1999, J HUM HYPERTENS, V13, P511, DOI 10.1038/sj.jhh.1000883; SWEDBERG K, 1992, NEW ENGL J MED, V327, P678, DOI 10.1056/NEJM199209033271002; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; WHELTON PK, 2004, CLIN TRIALS CARDIOVA, P282; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S., 1992, NEW ENGL J MED, V327, P685, DOI [DOI 10.1056/NEJM199209033271003, 10.1056/NEJM199209033271003.Erratumin]; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Yusuf S, 2010, HYPERTENSION, V55, P832, DOI 10.1161/HYPERTENSIONAHA.109.142349	75	156	164	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					913	922		10.1001/jama.2011.250	http://dx.doi.org/10.1001/jama.2011.250			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728DP	21364140	Green Accepted			2022-12-28	WOS:000287854700024
J	Van Wieren, AJ				Van Wieren, Andrew J.			Shall We Pray?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												andrew_van_wieren@brown.edu							0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					865	866		10.1001/jama.2011.205	http://dx.doi.org/10.1001/jama.2011.205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728DP	21364129				2022-12-28	WOS:000287854700001
J	Thuiller, W; Lavergne, S; Roquet, C; Boulangeat, I; Lafourcade, B; Araujo, MB				Thuiller, Wilfried; Lavergne, Sebastien; Roquet, Cristina; Boulangeat, Isabelle; Lafourcade, Bruno; Araujo, Miguel. B.			Consequences of climate change on the tree of life in Europe	NATURE			English	Article							PHYLOGENETIC SIGNAL; EXTINCTION RISK; BIODIVERSITY; PREDICTORS; TRAITS; NICHE	Many species are projected to become vulnerable to twenty-first-century climate changes(1,2), with consequent effects on the tree of life. If losses were not randomly distributed across the tree of life, climate change could lead to a disproportionate loss of evolutionary history(3-5). Here we estimate the consequences of climate change on the phylogenetic diversities of plant, bird and mammal assemblages across Europe. Using a consensus across ensembles of forecasts for 2020, 2050 and 2080 and high-resolution phylogenetic trees, we show that species vulnerability to climate change clusters weakly across phylogenies. Such phylogenetic signal in species vulnerabilities does not lead to higher loss of evolutionary history than expected with a model of random extinctions. This is because vulnerable species have neither fewer nor closer relatives than the remaining clades. Reductions in phylogenetic diversity will be greater in southern Europe, and gains are expected in regions of high latitude or altitude. However, losses will not be offset by gains and the tree of life faces a trend towards homogenization across the continent.	[Thuiller, Wilfried; Lavergne, Sebastien; Roquet, Cristina; Boulangeat, Isabelle; Lafourcade, Bruno] Univ Grenoble 1, Lab Ecol Alpine, CNRS, UMR 5553, FR-38041 Grenoble 9, France; [Araujo, Miguel. B.] CSIC, Natl Museum Nat Sci, Dept Biodivers & Evolutionary Biol, E-28006 Madrid, Spain; [Araujo, Miguel. B.] Univ Evora, CIBIO, Rui Nabeiro Biodivers Chair, P-7000 Evora, Portugal	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Consejo Superior de Investigaciones Cientificas (CSIC); University of Evora	Thuiller, W (corresponding author), Univ Grenoble 1, Lab Ecol Alpine, CNRS, UMR 5553, BP 53, FR-38041 Grenoble 9, France.	wilfried.thuiller@ujf-grenoble.fr	Thuiller, Wilfried/G-3283-2010; Roquet, Cristina/AAB-4031-2019; Araújo, Miguel B/B-6117-2008	Thuiller, Wilfried/0000-0002-5388-5274; Araújo, Miguel B/0000-0002-5107-7265; Roquet, Cristina/0000-0001-8748-3743	EU [GOCE-CT-2007-036866, ANR-2007-BDIV-014]; Fundacion Ramon Areces; Rhone-Alpes region [CPER07-13 CIRA]	EU(European Commission); Fundacion Ramon Areces; Rhone-Alpes region(Region Auvergne-Rhone-Alpes)	This research was funded by the EU ECOCHANGE (GOCE-CT-2007-036866) and DIVERSITALP (ANR-2007-BDIV-014) projects. C. R. was supported by a grant from Fundacion Ramon Areces. We thank P. Pearman and A. Mooers for comments on earlier drafts. Computations were performed using the CIMENT infrastructure (https://ciment.ujf-grenoble.fr), supported by the Rhone-Alpes region (GRANT CPER07-13 CIRA).	[Anonymous], 2000, SPECIAL REPORT EMISS; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Bambach RK, 2006, ANNU REV EARTH PL SC, V34, P127, DOI 10.1146/annurev.earth.33.092203.122654; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Chown SL, 2000, TRENDS ECOL EVOL, V15, P311, DOI 10.1016/S0169-5347(00)01910-8; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Nee S., 1997, SCIENCE, V288, P328; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Thuiller W, 2007, NATURE, V448, P550, DOI 10.1038/448550a; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; WITTING L, 1995, BIOL CONSERV, V71, P205, DOI 10.1016/0006-3207(94)00041-N	26	374	394	5	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					531	534		10.1038/nature09705	http://dx.doi.org/10.1038/nature09705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21326204				2022-12-28	WOS:000287652900041
J	Gallio, M; Ofstad, TA; Macpherson, LJ; Wang, JW; Zuker, CS				Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Wang, Jing W.; Zuker, Charles S.			The Coding of Temperature in the Drosophila Brain	CELL			English	Article							MICE LACKING; TRP CHANNEL; CAPSAICIN-RECEPTOR; ION-CHANNEL; EXPRESSION; HEAT; MECHANISMS; NEURONS; THERMOSENSATION; HYGROSENSATION	Thermosensation is an indispensable sensory modality. Here, we study temperature coding in Drosophila, and show that temperature is represented by a spatial map of activity in the brain. First, we identify TRP channels that function in the fly antenna to mediate the detection of cold stimuli. Next, we identify the hot-sensing neurons and show that hot and cold antennal receptors project onto distinct, but adjacent glomeruli in the Proximal-Antennal-Protocerebrum (PAP) forming a thermotopic map in the brain. We use two-photon imaging to reveal the functional segregation of hot and cold responses in the PAP, and show that silencing the hot-or cold-sensing neurons produces animals with distinct and discrete deficits in their behavioral responses to thermal stimuli. Together, these results demonstrate that dedicated populations of cells orchestrate behavioral responses to different temperature stimuli, and reveal a labeled-line logic for the coding of temperature information in the brain.	[Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Wang, Jing W.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Wang, Jing W.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Zuker, Charles S.] Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, Columbia Coll Phys & Surg, New York, NY 10032 USA; [Gallio, Marco; Ofstad, Tyler A.; Macpherson, Lindsey J.; Zuker, Charles S.] Columbia Univ, Dept Neurosci, Howard Hughes Med Inst, Columbia Coll Phys & Surg, New York, NY 10032 USA; [Ofstad, Tyler A.; Zuker, Charles S.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Howard Hughes Medical Institute	Zuker, CS (corresponding author), Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA.	cz2195@columbia.edu	Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Gallio, Marco/0000-0003-2132-0639; Macpherson, Lindsey/0000-0002-1089-3733	Wenner-Grens Stiftelse; Human Frontiers Science Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009597] Funding Source: NIH RePORTER	Wenner-Grens Stiftelse; Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Cahir O'Kane for UAS-TeNT flies; Paul Garrity for dTRPA1<SUP>KO</SUP> flies; and especially Michael Reiser for invaluable help with designing and implementing the behavioral arenas and assays. We also thank David Julius and Avi Priel for their help and kindness hosting us (M. G.) in our efforts to express Brv channels in Xenopus oocytes. Wilson Kwan, George Gallardo, and Lisa Ha provided expert help with fly husbandry. We are grateful to Hojoon Lee, Dimitri Trankner, and Robert Barretto for help with experiments and data analysis; and Nick Ryba, Michael Reiser, and members of the Zuker lab for critical comments on the manuscript. We also thank Kevin Moses, Gerry Rubin, and the Janelia Farm Visitor Program. M. G. was supported by a Wenner-Grens Stiftelse and a Human Frontiers Science Program long term fellowship. L.J.M. is a fellow of the Jane Coffin Childs Foundation. C.S.Z. is an investigator of the Howard Hughes Medical Institute and a Senior Fellow at Janelia Farm Research Campus. Author contributions: M. G. and C.S.Z. conceived all the experiments and wrote the paper. M. G. performed all the experiments presented in this paper, except the in situ hybridizations (T.A.O.). T.A.O. also helped with the set up for 2-choice behavioral assays, and J.W.W. helped design and setup the custom imaging system. L.J.M., M. G., and T.A.O. carried out extensive efforts to heterologously express Brv channels (data not shown).	ALTNER H, 1985, ANNU REV ENTOMOL, V30, P273, DOI 10.1146/annurev.en.30.010185.001421; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BUCHNER E, 1988, CELL TISSUE RES, V253, P357, DOI 10.1007/BF00222292; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Darian-Smith I.D.R.W., 1971, PERIPHERAL NEURAL ME; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; FOELIX RF, 1989, CELL TISSUE RES, V258, P277, DOI 10.1007/BF00239448; Guler AD, 2002, J NEUROSCI, V22, P6408; Ha TS, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.010.2009; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hensel H, 1981, THERMORECEPTION TEMP; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; McKemy D.D., 2007, TEMPERATURE SENSING; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Plant T. D., 2007, V179, P189; ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Till BJ, 2003, METH MOL B, V236, P205; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194	58	162	164	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					614	624		10.1016/j.cell.2011.01.028	http://dx.doi.org/10.1016/j.cell.2011.01.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21335241	Bronze, Green Accepted			2022-12-28	WOS:000287473100015
J	Wan, WJ; Chong, YD; Ge, L; Noh, H; Stone, AD; Cao, H				Wan, Wenjie; Chong, Yidong; Ge, Li; Noh, Heeso; Stone, A. Douglas; Cao, Hui			Time-Reversed Lasing and Interferometric Control of Absorption	SCIENCE			English	Article							WEAK-LOCALIZATION; PHOTODETECTORS; SUPERLATTICE; MODULATOR; SYSTEMS; LIGHT; LASER	In the time-reversed counterpart to laser emission, incident coherent optical fields are perfectly absorbed within a resonator that contains a loss medium instead of a gain medium. The incident fields and frequency must coincide with those of the corresponding laser with gain. We demonstrated this effect for two counterpropagating incident fields in a silicon cavity, showing that absorption can be enhanced by two orders of magnitude, the maximum predicted by theory for our experimental setup. In addition, we showed that absorption can be reduced substantially by varying the relative phase of the incident fields. The device, termed a "coherent perfect absorber," functions as an absorptive interferometer, with potential practical applications in integrated optics.	[Wan, Wenjie; Chong, Yidong; Ge, Li; Noh, Heeso; Stone, A. Douglas; Cao, Hui] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	Yale University	Cao, H (corresponding author), Yale Univ, Dept Appl Phys, POB 208284, New Haven, CT 06520 USA.	hui.cao@yale.edu	Wan, Wenjie/O-3626-2015; Ge, Li/A-5171-2012; Noh, Heeso/F-4803-2012; Cao, Hui/F-4815-2012; Chong, Yidong/B-6995-2011; Chong, Yidong/E-1375-2012; Chong, Yidong/AAG-5144-2020	Wan, Wenjie/0000-0002-9743-3480; Noh, Heeso/0000-0002-6086-9109; Chong, Yidong/0000-0002-8649-7884; Chong, Yidong/0000-0002-8649-7884; Chong, Yidong/0000-0002-8649-7884; Ge, Li/0000-0002-1922-4464	NSF [DMR-0808937, DMR-0908437]; Yale NSF-MRSEC [DMR-0520495]	NSF(National Science Foundation (NSF)); Yale NSF-MRSEC	Supported by NSF grants DMR-0808937 and DMR-0908437 and by seed funding from the Yale NSF-MRSEC (DMR-0520495). We thank E. Dufresne for use of his laser facility, and D. Miller and J. Bleuse for drawing our attention to the literature on asymmetric Fabry-Perot modulators and resonant cavity-enhanced photodetectors, respectively.	BERGMANN G, 1984, PHYS REP, V107, P1, DOI 10.1016/0370-1573(84)90103-0; Cai M, 2000, PHYS REV LETT, V85, P74, DOI 10.1103/PhysRevLett.85.74; Chong YD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053901; de Rosny J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.124301; Fink M, 2000, REP PROG PHYS, V63, P1933, DOI 10.1088/0034-4885/63/12/202; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; HAMEL WA, 1989, PHYS REV A, V40, P2785, DOI 10.1103/PhysRevA.40.2785; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; HEFFERNAN JF, 1991, APPL PHYS LETT, V58, P2877, DOI 10.1063/1.104734; KISHINO K, 1991, IEEE J QUANTUM ELECT, V27, P2025, DOI 10.1109/3.83412; KUGA Y, 1984, J OPT SOC AM A, V1, P831, DOI 10.1364/JOSAA.1.000831; LAW KK, 1990, APPL PHYS LETT, V56, P1886, DOI 10.1063/1.103077; LAW KK, 1990, APPL PHYS LETT, V57, P1345, DOI 10.1063/1.103479; Lerosey G, 2007, SCIENCE, V315, P1120, DOI 10.1126/science.1134824; LEWENKOPF CH, 1991, ANN PHYS-NEW YORK, V212, P53, DOI 10.1016/0003-4916(91)90372-F; Lipson M, 2005, J LIGHTWAVE TECHNOL, V23, P4222, DOI 10.1109/JLT.2005.858225; Longhi S, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.031801; SIEGMAN AE, 1989, PHYS REV A, V39, P1253, DOI 10.1103/PhysRevA.39.1253; Tischler JR, 2006, OPT LETT, V31, P2045, DOI 10.1364/OL.31.002045; UNLU MS, 1992, J APPL PHYS, V71, P4049, DOI 10.1063/1.350829; VANALBADA MP, 1985, PHYS REV LETT, V55, P2692, DOI 10.1103/PhysRevLett.55.2692; WOLF PE, 1985, PHYS REV LETT, V55, P2696, DOI 10.1103/PhysRevLett.55.2696; YAN RH, 1989, IEEE PHOTONIC TECH L, V1, P273, DOI 10.1109/68.43343; Yariv A, 2002, IEEE PHOTONIC TECH L, V14, P483, DOI 10.1109/68.992585	24	558	568	15	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					889	892		10.1126/science.1200735	http://dx.doi.org/10.1126/science.1200735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330539				2022-12-28	WOS:000287455100050
J	Morris, K				Morris, Kelly			Babatunde Osotimehin: New Executive Director of UNFPA Profile	LANCET			English	Biographical-Item												kellyvitalwriter@gmail.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2011	377	9767					711	711		10.1016/S0140-6736(11)60258-4	http://dx.doi.org/10.1016/S0140-6736(11)60258-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729JQ	21353892				2022-12-28	WOS:000287946000013
J	Nawrot, TS; Perez, L; Kunzli, N; Munters, E; Nemery, B				Nawrot, Tim S.; Perez, Laura; Kuenzli, Nino; Munters, Elke; Nemery, Benoit			Public health importance of triggers of myocardial infarction: a comparative risk assessment	LANCET			English	Article							CASE-CROSSOVER ANALYSIS; PARTICULATE AIR-POLLUTION; HEAVY PHYSICAL EXERTION; ISCHEMIC-HEART-DISEASE; ACUTE CORONARY SYNDROMES; CARDIOVASCULAR-DISEASE; HOSPITAL ADMISSIONS; EUROPEAN CITIES; SEXUAL-ACTIVITY; EMERGENCY ADMISSIONS	Background Acute myocardial infarction is triggered by various factors, such as physical exertion, stressful events, heavy meals, or increases in air pollution. However, the importance and relevance of each trigger are uncertain We compared triggers of myocardial infarction at an individual and population level. Methods We searched PubMed and the Web of Science citation databases to identify studies of triggers of non-fatal myocardial infarction to calculate population attributable fractions (PAP). When feasible, we did a meta-regression analysis for studies of the same trigger. Findings Of the epidemiologic studies reviewed, 36 provided sufficient details to be considered. In the studied populations, the exposure prevalence for triggers in the relevant control time window ranged from 0.04% for cocaine use to 100% for air pollution. The reported odds ratios (OR) ranged from 1.05 to 23.7. Ranking triggers from the highest to the lowest OR resulted in the following order: use of cocaine, heavy meal, smoking of marijuana, negative emotions, physical exertion, positive emotions, anger, sexual activity, traffic exposure, respiratory infections, coffee consumption, air pollution (based on a difference of 30 mu g/m(3) in particulate matter with a diameter <10 mu m [PM10]). Taking into account the OR and the prevalences of exposure, the highest PAF was estimated for traffic exposure (7.4%), followed by physical exertion (6.2%), alcohol (5.0%), coffee (5.0%), a difference of 30 mu g/m(3) in PM10 (4.8%), negative emotions (3.9%), anger (3.1%), heavy meal (2.7%), positive emotions (2.4%), sexual activity (2.2%), cocaine use (0.9%), marijuana smoking (0.8%) and respiratory infections (0.6%). Interpretation In view of both the magnitude of the risk and the prevalence in the population, air pollution is an important trigger of myocardial infarction, it is of similar magnitude (PAF 5-7%) as other well accepted triggers such as physical exertion, alcohol, and coffee. Our work shows that ever-present small risks might have considerable public health relevance.	[Nawrot, Tim S.; Munters, Elke] Hasselt Univ, Ctr Environm Sci, B-3590 Diepenbeek, Belgium; [Nawrot, Tim S.; Nemery, Benoit] Katholieke Univ Leuven, Sch Publ Hlth Occupat & Environm Med, Louvain, Belgium; [Perez, Laura; Kuenzli, Nino] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Perez, Laura; Kuenzli, Nino] Univ Basel, Basel, Switzerland	Hasselt University; KU Leuven; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Nawrot, TS (corresponding author), Hasselt Univ, Ctr Environm Sci, Agoralaan Gebouw D, B-3590 Diepenbeek, Belgium.	tim.nawrot@uhasselt.be	Nawrot, Tim/AAA-4531-2019; Nemery, Benoit/N-3155-2019; Kuenzli, Nino/F-7195-2014; Nemery, Benoit/D-1224-2013	Nemery, Benoit/0000-0003-0571-4689; Kuenzli, Nino/0000-0001-8360-080X; Nawrot, Tim/0000-0002-3583-3593	Flemish Scientific Fund (FWO, Krediet aan navorsers); tUL; bijzonder onderzoeksfonds (BOF); Katholieke Universiteit Leuven; BELSPO (Belgian Science Policy)	Flemish Scientific Fund (FWO, Krediet aan navorsers)(FWO); tUL; bijzonder onderzoeksfonds (BOF); Katholieke Universiteit Leuven(KU Leuven); BELSPO (Belgian Science Policy)(Belgian Federal Science Policy Office)	The research on air pollution and health at Hasselt University is supported by a grant from the Flemish Scientific Fund (FWO, Krediet aan navorsers), tUL-impulse financing, and bijzonder onderzoeksfonds (BOF) and at the Katholieke Universiteit Leuven by the sustainable development programme of BELSPO (Belgian Science Policy).	Alfaro-Moreno E, 2007, CURR OPIN PULM MED, V13, P98, DOI 10.1097/MCP.0b013e328013f47e; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Ballester F, 2008, J EPIDEMIOL COMMUN H, V62, P98, DOI 10.1136/jech.2007.059857; Barnett AG, 2006, ENVIRON HEALTH PERSP, V114, P1018, DOI 10.1289/ehp.8674; Baylin A, 2007, ANN EPIDEMIOL, V17, P112, DOI 10.1016/j.annepidem.2006.05.004; Baylin A, 2006, EPIDEMIOLOGY, V17, P506, DOI 10.1097/01.ede.0000229444.55718.96; BERGOVEC M, 1992, LANCET, V339, P303, DOI 10.1016/0140-6736(92)91370-N; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Carroll D, 2002, BRIT MED J, V325, P1439, DOI 10.1136/bmj.325.7378.1439; Cendon S, 2006, REV SAUDE PUBL, V40, P414, DOI 10.1590/S0034-89102006000300008; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; Clayton TC, 2008, EUR HEART J, V29, P96, DOI 10.1093/eurheartj/ehm516; D'Ippoliti D, 2003, EPIDEMIOLOGY, V14, P528, DOI 10.1097/01.ede.0000082046.22919.72; Danet S, 1999, CIRCULATION, V100, pE11, DOI 10.1161/01.CIR.100.1.e1; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Etches V, 2006, ANNU REV PUBL HEALTH, V27, P29, DOI 10.1146/annurev.publhealth.27.021405.102141; Forastiere F, 2005, AM J RESP CRIT CARE, V172, P1549, DOI 10.1164/rccm.200412-1726OC; Gerlich MG, 2009, EUR ADDICT RES, V15, P143, DOI 10.1159/000213641; Hallqvist J, 2000, AM J EPIDEMIOL, V151, P459, DOI 10.1093/oxfordjournals.aje.a010231; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Jacobs L, 2010, ENVIRON HEALTH PERSP, V118, P191, DOI 10.1289/ehp.0900942; Juster HR, 2007, AM J PUBLIC HEALTH, V97, P2035, DOI 10.2105/AJPH.2006.099994; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; Kloner RA, 2006, PROG CARDIOVASC DIS, V48, P285, DOI 10.1016/j.pcad.2005.07.001; Koken PJM, 2003, ENVIRON HEALTH PERSP, V111, P1312, DOI 10.1289/ehp.5957; Kunzli N, 2008, EPIDEMIOLOGY, V19, P179, DOI 10.1097/EDE.0b013e3181633c2f; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Lanki T, 2006, OCCUP ENVIRON MED, V63, P844, DOI 10.1136/oem.2005.023911; Linn WS, 2000, ENVIRON HEALTH PERSP, V108, P427, DOI 10.2307/3454383; Lipovetzky N, 2004, ISR MED ASSOC J, V6, P728; Lipovetzky N, 2007, ISR MED ASSOC J, V9, P310; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Maitre A, 2006, EUR HEART J, V27, P2275, DOI 10.1093/eurheartj/ehl162; Mann JK, 2002, ENVIRON HEALTH PERSP, V110, P1247, DOI 10.1289/ehp.021101247; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; MEISEL SR, 1991, LANCET, V338, P660, DOI 10.1016/0140-6736(91)91234-L; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Mittleman MA, 1999, CIRCULATION, V99, P2737, DOI 10.1161/01.CIR.99.21.2737; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; Mittleman MA, 2001, CIRCULATION, V103, P2805; Moller J, 2005, J EPIDEMIOL COMMUN H, V59, P23, DOI 10.1136/jech.2003.019349; Moller J, 1999, PSYCHOSOM MED, V61, P842; Moller J, 2001, HEART, V86, P387, DOI 10.1136/heart.86.4.387; Muller JE, 1996, JAMA-J AM MED ASSOC, V275, P1405, DOI 10.1001/jama.275.18.1405; Nawrot TS, 2006, EUR HEART J, V27, P2269, DOI 10.1093/eurheartj/ehl221; Nawrot TS, 2005, EUR J EPIDEMIOL, V20, P407, DOI 10.1007/s10654-005-1068-x; Nawrot TS, 2002, J HUM HYPERTENS, V16, P123, DOI 10.1038/sj.jhh.1001300; NEEDLEMAN HL, 1990, JAMA-J AM MED ASSOC, V263, P673, DOI 10.1001/jama.263.5.673; Perez L, 2009, INT J PUBLIC HEALTH, V54, P45, DOI 10.1007/s00038-008-8025-x; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Peters A, 2001, CIRCULATION, V103, P2810; Peters Annette, 2005, Res Rep Health Eff Inst, P1; Pope CA, 2006, CIRCULATION, V114, P2443, DOI 10.1161/CIRCULATIONAHA.106.636977; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Ruidavets JB, 2005, CIRCULATION, V111, P563, DOI 10.1161/01.CIR.0000154546.32135.6E; Schwartz LM, 2006, BMJ-BRIT MED J, V333, P1248, DOI 10.1136/bmj.38985.564317.7C; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Steptoe A, 2006, BIOL PSYCHIAT, V60, P837, DOI 10.1016/j.biopsych.2006.03.041; Strike PC, 2006, HEART, V92, P1035, DOI 10.1136/hrt.2005.077362; Sullivan J, 2005, EPIDEMIOLOGY, V16, P41, DOI 10.1097/01.ede.0000147116.34813.56; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116; von Klot S, 2008, EUR HEART J, V29, P1881, DOI 10.1093/eurheartj/ehn235; WILLICH SN, 1993, NEW ENGL J MED, V329, P1684, DOI 10.1056/NEJM199312023292302; Ye F, 2001, ENVIRON HEALTH PERSP, V109, P355, DOI 10.2307/3454894; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550; Zanobetti A, 2006, J EPIDEMIOL COMMUN H, V60, P890, DOI 10.1136/jech.2005.039834; Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58	75	362	366	1	80	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2011	377	9767					732	740		10.1016/S0140-6736(10)62296-9	http://dx.doi.org/10.1016/S0140-6736(10)62296-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729JQ	21353301				2022-12-28	WOS:000287946000030
J	von Ballmoos, MW; Haring, B; Juillerat, P; Alkadhi, H				von Ballmoos, Moritz Wyler; Haring, Bernhard; Juillerat, Pascal; Alkadhi, Hatem			Meta-analysis: Diagnostic Performance of Low-Radiation-Dose Coronary Computed Tomography Angiography	ANNALS OF INTERNAL MEDICINE			English	Review							CT ANGIOGRAPHY; SYSTEMATIC REVIEWS; ARTERY-DISEASE; IMAGE QUALITY; ACCURACY	Background: A new radiation dose-saving technique for noninvasive coronary artery imaging with computed tomography (CT) is available. Purpose: To summarize current evidence about the ability of low-dose coronary CT angiography to rule out coronary artery disease (CAD) in symptomatic adults. Data Sources: Online databases, including MEDLINE, EMBASE, and the Cochrane Library, from inception through 31 October 2010; abstract databases; gray literature; reference lists of identified articles; and experts. No language restrictions were applied. Study Selection: All investigators screened and selected studies that compared prospective electrocardiography-gated coronary CT angiography with catheter coronary angiography (the reference standard) in symptomatic patients with suspected CAD. Data Extraction: Two investigators independently extracted patient and study protocol characteristics and rated methodological quality; differences were resolved by consensus or by a third reader. Multivariate random-effects models were used to obtain pooled estimates. Data Synthesis: 16 studies, comprising 960 patients, were found (7 studies of single-source, 64-slice CT; 4 of dual-source, 64-slice CT; 2 of single-source, 320-slice CT; 1 dual-source, 128-slice CT; 1 of single-source, 128-slice CT; and 1 of single-source, 256-slice CT). On average, 2.4% of the coronary arterial segments were of non-diagnostic image quality, and 1 or more segments were nondiagnostic in 9.5% of the patients. The patient-level sensitivity and specificity of CT angiography were 1.00 (95% Cl, 0.98 to 1.00) and 0.89 (Cl, 0.85 to 0.92), respectively. The pooled vessel-and segment-level estimates showed lower sensitivity and higher specificity than the patient-level estimates. Statistically significant heterogeneity was found between studies for vessel-and segment-level estimates, which seemed to be associated with body mass index and prevalence of CAD but not with CT scanner characteristics. Limitations: The small number of studies, half of which were from a single tertiary center, limits generalizability. The potential harms of the imaging tests were not well-evaluated. Conclusion: Early evidence suggests that low-dose coronary CT angiography matches the sensitivity of catheter-based angiography, has low radiation exposure, and is a potentially valid alternative to catheter angiography for triaging symptomatic patients with a clinical suspicion of CAD.	[von Ballmoos, Moritz Wyler] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiac Surg, Boston, MA 02115 USA; [Haring, Bernhard] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Inst Cardiovasc, Boston, MA 02215 USA; [Juillerat, Pascal] Harvard Univ, Sch Med, Crohns & Colitis Ctr, Boston, MA 02114 USA; [Alkadhi, Hatem] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; University of Zurich; University Zurich Hospital	von Ballmoos, MW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiac Surg, 300 Longwood Ave, Boston, MA 02115 USA.	wylervonballmoos@gmail.com	Reardon, Michael/ABF-8880-2021					Alkadhi H, 2010, HEART, V96, P933, DOI 10.1136/hrt.2009.189100; Arnoldi E, 2010, RADIOLOGE, V50, P500, DOI 10.1007/s00117-010-1985-x; Austen W G, 1975, Circulation, V51, P5; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Carrascosa P, 2010, J CARDIOVASC COMPUT, V4, P197, DOI 10.1016/j.jcct.2010.04.001; Chao SP, 2010, EUR HEART J, V31, P1916, DOI 10.1093/eurheartj/ehq072; de Graaf FR, 2010, EUR HEART J, V31, P1908, DOI 10.1093/eurheartj/ehp571; Dewey M, 2009, CIRCULATION, V120, P867, DOI 10.1161/CIRCULATIONAHA.109.859280; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gatsonis C, 2006, AM J ROENTGENOL, V187, P271, DOI 10.2214/AJR.06.0226; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Hausleiter J, 2009, JAMA-J AM MED ASSOC, V301, P500, DOI 10.1001/jama.2009.54; Herzog BA, 2009, HEART, V95, P1656, DOI 10.1136/hrt.2008.162420; Herzog BA, 2008, EUR HEART J, V29, P3037, DOI 10.1093/eurheartj/ehn485; Hirai N, 2008, RADIOLOGY, V248, P424, DOI 10.1148/radiol.2482071804; HONG YJ, 2010, INT J CARDIOVASC IMA; Hsieh J, 2006, MED PHYS, V33, P4236, DOI 10.1118/1.2361078; Husmann L, 2010, ACAD RADIOL, V17, P201, DOI 10.1016/j.acra.2009.09.007; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Maruyama T, 2008, J AM COLL CARDIOL, V52, P1450, DOI 10.1016/j.jacc.2008.07.048; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mowatt G, 2008, HEART, V94, P1386, DOI 10.1136/hrt.2008.145292; National Council on Radiation Protection and Measurements, 2009, 160 NCRP; Pontone G, 2009, J AM COLL CARDIOL, V54, P346, DOI 10.1016/j.jacc.2009.04.027; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Riley RD, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-3; Rybicki FJ, 2008, INT J CARDIOVAS IMAG, V24, P535, DOI 10.1007/s10554-008-9308-2; Scheffel H, 2008, HEART, V94, P1132, DOI 10.1136/hrt.2008.149971; Scheffel H, 2010, INT J CARDIOVAS IMAG, V26, P579, DOI 10.1007/s10554-010-9595-2; Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008; STOLZMANN P, 2010, EUR J RADIOL; Stolzmann P, 2008, AM J ROENTGENOL, V191, P1684, DOI 10.2214/AJR.07.4040; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9	40	123	125	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					413	+		10.7326/0003-4819-154-6-201103150-00007	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734WA	21403076				2022-12-28	WOS:000288370000005
J	Bock, DD; Lee, WCA; Kerlin, AM; Andermann, ML; Hood, G; Wetzel, AW; Yurgenson, S; Soucy, ER; Kim, HS; Reid, RC				Bock, Davi D.; Lee, Wei-Chung Allen; Kerlin, Aaron M.; Andermann, Mark L.; Hood, Greg; Wetzel, Arthur W.; Yurgenson, Sergey; Soucy, Edward R.; Kim, Hyon Suk; Reid, R. Clay			Network anatomy and in vivo physiology of visual cortical neurons	NATURE			English	Article							INHIBITORY NEURONS; SYNAPTIC CONNECTIONS; ELECTRON-MICROSCOPY; PYRAMIDAL NEURONS; TRANSGENIC MICE; RAT NEOCORTEX; CORTEX; CAT; CELLS; MAP	In the cerebral cortex, local circuits consist of tens of thousands of neurons, each of which makes thousands of synaptic connections. Perhaps the biggest impediment to understanding these networks is that we have no wiring diagrams of their interconnections. Even if we had a partial or complete wiring diagram, however, understanding the network would also require information about each neuron's function. Here we show that the relationship between structure and function can be studied in the cortex with a combination of in vivo physiology and network anatomy. We used two-photon calcium imaging to characterize a functional property-the preferred stimulus orientation-of a group of neurons in the mouse primary visual cortex. Large-scale electron microscopy of serial thin sections was then used to trace a portion of these neurons' local network. Consistent with a prediction from recent physiological experiments, inhibitory interneurons received convergent anatomical input from nearby excitatory neurons with a broad range of preferred orientations, although weak biases could not be rejected.	[Bock, Davi D.; Lee, Wei-Chung Allen; Kerlin, Aaron M.; Andermann, Mark L.; Yurgenson, Sergey; Kim, Hyon Suk; Reid, R. Clay] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Bock, Davi D.; Lee, Wei-Chung Allen; Soucy, Edward R.; Kim, Hyon Suk; Reid, R. Clay] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Hood, Greg; Wetzel, Arthur W.] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA	Harvard University; Harvard Medical School; Harvard University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reid, RC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	clay_reid@hms.harvard.edu		Lee, Wei-Chung/0000-0002-4618-295X	Center for Brain Science; Center for Brain Science at Harvard University; Microsoft Research; NIH though the NEI [EY10115, EY18742]; NIH though NRBSC [P41 RR06009]; Harvard Center of Neurodegeneration and Repair; NEI [EY18532]; Pittsburgh Supercomputing Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010115, F32EY018532, R01EY018742] Funding Source: NIH RePORTER	Center for Brain Science; Center for Brain Science at Harvard University; Microsoft Research(Microsoft); NIH though the NEI; NIH though NRBSC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Center of Neurodegeneration and Repair; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Pittsburgh Supercomputing Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank E. Raviola for discussions and technical advice on all aspects of EM; J. Stiles for support and advice concerning the alignment and stitching effort at The Pittsburgh Supercomputing Center; J. Lichtman for discussions and, along with K. Blum and J. Sanes, support from the Center for Brain Science; A. Cardona for help with TrakeEM2, and many modifications of it; and H. Pfister and S. Warfield for discussions and help with computational issues. We also thank S. Butterfield for programming, and L. Benecchi and Harvard Medical School EM Core Facility for technical support. For technical help with EM and its interpretation, we thank K. Harris, M. Bickford, M. Ellisman, K. Martin and T. Reese. We thank J. Assad, R. Born, J. Maunsell, J. Stiles, E. Raviola, and members of the Reid laboratory for critical reading of the manuscript. This work was supported by the Center for Brain Science at Harvard University, Microsoft Research, and the NIH though the NEI to R.C.R. (EY10115 and EY18742) and through resources provided by the NRBSC (P41 RR06009), which is part of The Pittsburgh Supercomputing Center; and by fellowships from Harvard Center of Neurodegeneration and Repair to D.D.B. and the NEI to W.-C.A.L. (EY18532).	Ahmed B, 1997, J COMP NEUROL, V380, P230; Alitto HJ, 2010, CURR OPIN NEUROBIOL, V20, P340, DOI 10.1016/j.conb.2010.02.012; Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; ANDERSON JC, 1994, J COMP NEUROL, V341, P25, DOI 10.1002/cne.903410104; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Cajal S. R., 1904, TEXTURA SISTEMA NERV, V2; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; DACHEUX RF, 1986, J NEUROSCI, V6, P331; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Ellisman M, 2005, MICROSC MICROANAL, V11, P610; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; Grewe BF, 2009, CURR OPIN NEUROBIOL, V19, P520, DOI 10.1016/j.conb.2009.09.003; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; KISVARDAY ZF, 1986, EXP BRAIN RES, V64, P541, DOI 10.1007/BF00340492; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Martone ME, 2002, J STRUCT BIOL, V138, P145, DOI 10.1016/S1047-8477(02)00006-0; MASON A, 1991, J NEUROSCI, V11, P72; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; PETERS A, 1985, J COMP NEUROL, V234, P242, DOI 10.1002/cne.902340209; Peters A., 1991, FINE STRUCTURE NERVO; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Ringach DL, 2002, J NEUROSCI, V22, P5639; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sorra KE, 1998, J NEUROSCI, V18, P658; Stepanyants A, 2008, CEREB CORTEX, V18, P13, DOI 10.1093/cercor/bhm027; STERLING P, 1983, ANNU REV NEUROSCI, V6, P149, DOI 10.1146/annurev.ne.06.030183.001053; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tamas G, 1998, J NEUROSCI, V18, P4255; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Turaga SC, 2010, NEURAL COMPUT, V22, P511, DOI 10.1162/neco.2009.10-08-881; White E.L., 1989, CORTICAL CIRCUITS SY; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	57	552	558	0	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					177	U59		10.1038/nature09802	http://dx.doi.org/10.1038/nature09802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390124	Green Accepted			2022-12-28	WOS:000288170200029
J	Brooks, MA; Tarini, BA				Brooks, M. Alison; Tarini, Beth A.			Genetic Testing and Youth Sports	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE; FITNESS		[Brooks, M. Alison] Univ Wisconsin, Dept Orthoped & Pediat, Madison, WI 53706 USA; [Tarini, Beth A.] Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan	Brooks, MA (corresponding author), 1685 Highland Ave, Madison, WI 53705 USA.	brooks@ortho.wisc.edu		Tarini, Beth/0000-0003-4272-8668	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD057994, K12HD055894] Funding Source: NIH RePORTER; NICHD NIH HHS [K23 HD057994, K12 HD055894, K23HD057994, K12HD055894] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*ATL SPORTS GEN, ATL 1; Burdette HL, 2005, ARCH PEDIAT ADOL MED, V159, P46, DOI 10.1001/archpedi.159.1.46; Ciske DJ, 2001, PEDIATRICS, V107, P699, DOI 10.1542/peds.107.4.699; *CYGENE, OPT ATHL PERF DNA AN; National Collegiate Athletic Association, EST PROB COMP ATHL H; Rankinen T, 2010, MED SCI SPORT EXER, V42, P835, DOI 10.1249/MSS.0b013e3181d86cec; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; Williams AG, 2009, MED SPORT SCI, V54, P176, DOI 10.1159/000235704; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Yang N, 2009, MED SPORT SCI, V54, P88, DOI 10.1159/000235698	10	8	9	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2011	305	10					1033	1034		10.1001/jama.2011.286	http://dx.doi.org/10.1001/jama.2011.286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	731SM	21386082				2022-12-28	WOS:000288129600025
J	Glanville, J; Kendrick, T; McNally, R; Campbell, J; Hobbs, FDR				Glanville, Julie; Kendrick, Tony; McNally, Rosalind; Campbell, John; Hobbs, F. D. Richard			Research output on primary care in Australia, Canada, Germany, the Netherlands, the United Kingdom, and the United States: bibliometric analysis	BRITISH MEDICAL JOURNAL			English	Article								Objective To compare the volume and quality of original research in primary care published by researchers from primary care in the United Kingdom against five countries with well established academic primary care. Design Bibliometric analysis. Setting United Kingdom, United States, Australia, Canada, Germany, and the Netherlands. Studies reviewed Research publications relevant to comprehensive primary care and authored by researchers from primary care, recorded in Medline and Embase, with publication dates 2001-7 inclusive. Main outcome measures Volume of published activity of generalist primary care researchers and the quality of the research output by those publishing the most using citation metrics: numbers of cited papers, proportion of cited papers, and mean citation scores. Results 82 169 papers published between 2001 and 2007 in the six countries were classified as research on primary care. In a 15% pragmatic random sample of these records, 40% of research on primary care from the United Kingdom and 46% from the Netherlands was authored by researchers employed in a primary care setting or employed in academic departments of primary care. The 141 researchers with the highest volume of publications reporting research findings published between 2001 and 2007 (inclusive) authored or part authored 8.3% of the total sample of papers. For authors with the highest proportion of publications cited at least five times, the best performers came from the United States (n=5), United Kingdom (n=4), and the Netherlands (n=2). In the top 10 of authors with the highest proportions of publications achieving 20 or more citations, six were from the United Kingdom and four from the United States. The mean Hirsch index (measure of a researcher's productivity and impact of the published work) was 14 for the Netherlands, 13 for the United Kingdom, 12 for the United States, 7 for Canada, 4 for Australia, and 3 for Germany. Conclusion This international comparison of the volume and citation rates of papers by researchers from primary care consistently placed UK researchers among the best performers internationally.	[Hobbs, F. D. Richard] Univ Birmingham, Dept Primary Care Clin Sci, Birmingham B15 2TT, W Midlands, England; [Glanville, Julie] Univ York, York Hlth Econ Consortium, York YO10 5DD, N Yorkshire, England; [Kendrick, Tony] Univ Southampton, Dept Primary Care, Southampton SO9 5NH, Hants, England; [McNally, Rosalind] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England	University of Birmingham; University of York - UK; University of Southampton; University of Manchester	Hobbs, FDR (corresponding author), Univ Birmingham, Dept Primary Care Clin Sci, Primary Care Clin Sci Bldg, Birmingham B15 2TT, W Midlands, England.	f.d.r.hobbs@bham.ac.uk	Kendrick, Tony/H-8558-2014	Kendrick, Tony/0000-0003-1618-9381; hobbs, richard/0000-0001-7976-7172; Campbell, John/0000-0002-6752-3493; Glanville, Julie/0000-0002-1253-8524; McNally, Rosalind/0000-0001-7631-1436	Society for Academic Primary Care; National Institute for Health Research (NIHR) National School for Primary Care Research	Society for Academic Primary Care; National Institute for Health Research (NIHR) National School for Primary Care Research(National Institute for Health Research (NIHR))	This study was jointly funded by the Society for Academic Primary Care and the National Institute for Health Research (NIHR) National School for Primary Care Research.	Adams J., 2000, ROLE SELECTIVITY CHA; Buscemi N, 2006, J CLIN EPIDEMIOL, V59, P697, DOI 10.1016/j.jclinepi.2005.11.010; DONALDSON MS, 1996, AM HLTH NEW ERA; *HIGH ED FUND COUN, DAT QUAL REL RES QR; *HIGH ED STAT AG, REL 2007 08 HESA FIN; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; *HITH ED FUND COUN, 2010, RES EXC FRAM; KATZ J, OECD MAIN SCI TECHNO; LEHVO A, 2006, FINN SCI INT COMP BI; *NAT SCI BOARD, DIG KEY SCI ENG IND; *OECD, 2007, STATEXTRACTS; *RAE 2008, QUAL PROF; *RES ASS EX, UN ASS 8 PRIM CAR OT; *RESEARCHERID COM, 2009, GLOB COMM RES CONN; Rippon I, 2005, THORAX, V60, P63, DOI 10.1136/thx.2004.031229; Seglen P. O., 1997, BRIT MED J, V314, P497, DOI DOI 10.1136/BMJ.314.7079.497; Smith R, 2006, INT J EPIDEMIOL, V35, P1129, DOI 10.1093/ije/dyl191; Starfield B., 1992, PRIMARY CARE CONCEPT; Sypsa V, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-33; *THOMS REUT, 2008, ISI WEB SCI J CIT RE; WHO, 2010, WOR HEALT REP, P1; 2003, LANCET, V361, P9362	22	83	84	2	27	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 8	2011	342								d1028	10.1136/bmj.d1028	http://dx.doi.org/10.1136/bmj.d1028			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UY	21385804	hybrid, Green Published			2022-12-28	WOS:000288446800003
J	Bezzi, P; Volterra, A				Bezzi, Paola; Volterra, Andrea			Astrocytes: Powering Memory	CELL			English	Editorial Material							BRAIN; SYNAPSES	Creating long-term memory requires a cellular program in neurons involving gene expression, protein synthesis, and formation of new synaptic connections. Suzuki et al. (2011) show that astrocytes, glial cells of the brain, play a necessary role in this program by converting glycogen to lactate and transporting it to neurons.	[Bezzi, Paola; Volterra, Andrea] Univ Lausanne, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland	University of Lausanne	Volterra, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.	andrea.volterra@unil.ch	Bezzi, Paola/AAP-2440-2020	Volterra, Andrea/0000-0003-1069-1602				Attwell D, 2005, NAT REV NEUROSCI, V6, P841, DOI 10.1038/nrn1784; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722	10	25	26	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					644	645		10.1016/j.cell.2011.02.027	http://dx.doi.org/10.1016/j.cell.2011.02.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376229	Bronze			2022-12-28	WOS:000288007100006
J	Nagler, J; Krauss, B				Nagler, Joshua; Krauss, Baruch			Intraosseous Catheter Placement in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACCESS		[Nagler, Joshua; Krauss, Baruch] Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp Boston,Div Emergency Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Nagler, J (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp Boston,Div Emergency Med, Boston, MA 02115 USA.		Krauss, Baruch/U-6182-2019					Garcia CT, 1996, PEDIATR EMERG CARE, V12, P94, DOI 10.1097/00006565-199604000-00007; KANTER RK, 1986, AM J DIS CHILD, V140, P132, DOI 10.1001/archpedi.1986.02140160050030; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Levitan RM, 2009, ANN EMERG MED, V54, P692, DOI 10.1016/j.annemergmed.2009.06.012; Ong MEH, 2009, AM J EMERG MED, V27, P8, DOI 10.1016/j.ajem.2008.01.025; ORLOWSKI JP, 1989, ANN EMERG MED, V18, P1062, DOI 10.1016/S0196-0644(89)80932-1; ROSETTI VA, 1985, ANN EMERG MED, V14, P885, DOI 10.1016/S0196-0644(85)80639-9; SIMMONS CM, 1994, ANN EMERG MED, V23, P363, DOI 10.1016/S0196-0644(94)70053-2; Tsung JW, 2009, RESUSCITATION, V80, P665, DOI 10.1016/j.resuscitation.2009.03.009	9	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					E14	U76		10.1056/NEJMvcm0900916	http://dx.doi.org/10.1056/NEJMvcm0900916			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345096				2022-12-28	WOS:000287652500010
J	Finch, J				Finch, Jacqueline			The art of medicine The ancient origins of prosthetic medicine	LANCET			English	Editorial Material									Univ Manchester, KNH Ctr Biomed Egyptol, Manchester M13 9PT, Lancs, England	University of Manchester	Finch, J (corresponding author), Univ Manchester, KNH Ctr Biomed Egyptol, Manchester M13 9PT, Lancs, England.								0	37	37	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 12	2011	377	9765					548	549		10.1016/S0140-6736(11)60190-6	http://dx.doi.org/10.1016/S0140-6736(11)60190-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	724DQ	21341402	Bronze			2022-12-28	WOS:000287556700013
J	Tang, W; Lu, Y; Tian, QY; Zhang, Y; Guo, FJ; Liu, GY; Syed, NM; Lai, YJ; Lin, EA; Kong, L; Su, J; Yin, FF; Ding, AH; Zanin-Zhorov, A; Dustin, ML; Tao, J; Craft, J; Yin, ZN; Feng, JQ; Abramson, SB; Yu, XP; Liu, CJ				Tang, Wei; Lu, Yi; Tian, Qing-Yun; Zhang, Yan; Guo, Feng-Jin; Liu, Guang-Yi; Syed, Nabeel Muzaffar; Lai, Yongjie; Lin, Edward Alan; Kong, Li; Su, Jeffrey; Yin, Fangfang; Ding, Ai-Hao; Zanin-Zhorov, Alexandra; Dustin, Michael L.; Tao, Jian; Craft, Joseph; Yin, Zhinan; Feng, Jian Q.; Abramson, Steven B.; Yu, Xiu-Ping; Liu, Chuan-Ju			The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice	SCIENCE			English	Article							OLIGOMERIC MATRIX PROTEIN; GRANULIN-EPITHELIN PRECURSOR; TUMOR-NECROSIS-FACTOR; TRANSCRIPTION FACTOR; HOST-DEFENSE; ADAMTS-7; MUTATIONS; GENE; PSEUDOACHONDROPLASIA; DEGRADATION	The growth factor progranulin (PGRN) has been implicated in embryonic development, tissue repair, tumorigenesis, and inflammation, but its receptors remain unidentified. We report that PGRN bound directly to tumor necrosis factor receptors (TNFRs) and disturbed the TNF alpha-TNFR interaction. PGRN-deficient mice were susceptible to collagen-induced arthritis, and administration of PGRN reversed inflammatory arthritis. Atsttrin, an engineered protein composed of three PGRN fragments, exhibited selective TNFR binding. PGRN and Atsttrin prevented inflammation in multiple arthritis mouse models and inhibited TNF alpha-activated intracellular signaling. Collectively, these findings demonstrate that PGRN is a ligand of TNFR, an antagonist of TNF alpha signaling, and plays a critical role in the pathogenesis of inflammatory arthritis in mice. They also suggest new potential therapeutic interventions for various TNF alpha-mediated pathologies and conditions, including rheumatoid arthritis.	[Tang, Wei; Lu, Yi; Tian, Qing-Yun; Zhang, Yan; Guo, Feng-Jin; Liu, Guang-Yi; Syed, Nabeel Muzaffar; Lai, Yongjie; Lin, Edward Alan; Kong, Li; Liu, Chuan-Ju] NYU, Dept Orthopaed Surg, Sch Med, New York, NY 10003 USA; [Tang, Wei; Lu, Yi; Tian, Qing-Yun; Zhang, Yan; Guo, Feng-Jin; Liu, Guang-Yi; Syed, Nabeel Muzaffar; Lai, Yongjie; Lin, Edward Alan; Kong, Li; Abramson, Steven B.; Liu, Chuan-Ju] NYU, Hosp Joint Dis, New York, NY 10003 USA; [Tang, Wei; Lu, Yi; Yu, Xiu-Ping] Shandong Univ, Sch Med, Inst Pathogen Biol, Jinan 250012, Shandong, Peoples R China; [Su, Jeffrey] Cytovance Biol, Oklahoma City, OK 73104 USA; [Yin, Fangfang; Ding, Ai-Hao] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Zanin-Zhorov, Alexandra; Dustin, Michael L.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Tao, Jian; Craft, Joseph] Yale Univ, Sch Med, Dept Med, Rheumatol Sect, New Haven, CT 06520 USA; [Yin, Zhinan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Feng, Jian Q.] Texas A&M Hlth Sci Ctr, Baylor Coll Dent, Dallas, TX 75246 USA; [Abramson, Steven B.] NYU, Sch Med, Div Rheumatol, New York, NY 10003 USA; [Liu, Chuan-Ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Shandong University; Cornell University; New York University; Yale University; Nankai University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; New York University; New York University	Liu, CJ (corresponding author), NYU, Dept Orthopaed Surg, Sch Med, New York, NY 10003 USA.	chuanju.liu@med.nyu.edu	Dustin, Michael/AAM-4611-2020; Liu, Chuan-ju/AAT-8165-2021; Tian, Qingyun/L-7723-2014; Tang, Wei/A-6254-2016	Tang, Wei/0000-0002-4573-3502; liu, chuanju/0000-0002-7181-8032; Syed, Nabeel/0000-0001-8901-5601; Abramson, Steven/0000-0002-0668-6344; Dustin, Michael/0000-0003-4983-6389	NIH [AR050620, AR053210, GM061710, AI43542, AR040072]; Arthritis National Research Foundation; National Nature Science Foundation of China [30870121]; NSFC [30725015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043542, R01AI030165, R37AI043542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040072, K01AR053210, R37AR040072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061710] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis National Research Foundation(National Research Foundation of Korea); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Lengyel, J. Vilcek, and T. C. Caskey for critical reading and comments. We also thank G. Wisniewski for assisting with the CIA model, M. E. Dorf and A. Mukundan for reagents, and A. Martin and J. Quinn for assistance in Surface Plasmon Resonance assay. This work was funded by NIH grants AR050620 and AR053210 (to C.-J.L.), GM061710 (to A.-H. D), AI43542 (to M. L. D), and AR040072 (to J. C.); by a grant from Arthritis National Research Foundation (to C.-J.L.); by a National Nature Science Foundation of China Grant 30870121 (to X. P. Y); and by a National Outstanding Young Scientist Award of NSFC 30725015 (to Z.N.Y). Patents have been filed by NYU that claim peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods, and uses thereof [WO/2010/120374 (C.-J.L.) and PCT/US2010/001137 (C.-J.L.)]. TNFR2 (TNFRSF1B/CD120b) accession number: NM_130426. A full list of author contributions is available in the SOM.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Deng GM, 2005, NAT MED, V11, P1066, DOI 10.1038/nm1304; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Guo FJ, 2010, ARTHRITIS RHEUM-US, V62, P2023, DOI 10.1002/art.27491; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Liu CJ, 2006, FASEB J, V20, P988, DOI 10.1096/fj.05-3877fje; Liu CJ, 2006, J BIOL CHEM, V281, P15800, DOI 10.1074/jbc.M513433200; Liu CJ, 2009, NAT CLIN PRACT RHEUM, V5, P38, DOI 10.1038/ncprheum0961; Luan Y, 2008, OSTEOARTHR CARTILAGE, V16, P1413, DOI 10.1016/j.joca.2008.03.017; Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603; Netterwald James, 2009, Nat Biotechnol, V27, P495, DOI 10.1038/nbt0609-495; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Taylor PC, 2009, NAT CLIN PRACT RHEUM, V5, P126, DOI 10.1038/ncprheum1022; Thwin MM, 2004, ARTHRITIS RES THER, V6, pR282, DOI 10.1186/ar1179; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	35	510	541	5	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					478	484		10.1126/science.1199214	http://dx.doi.org/10.1126/science.1199214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21393509	Green Accepted			2022-12-28	WOS:000289784900047
J	Burguillos, MA; Deierborg, T; Kavanagh, E; Persson, A; Hajji, N; Garcia-Quintanilla, A; Cano, J; Brundin, P; Englund, E; Venero, JL; Joseph, B				Burguillos, Miguel A.; Deierborg, Tomas; Kavanagh, Edel; Persson, Annette; Hajji, Nabil; Garcia-Quintanilla, Albert; Cano, Josefina; Brundin, Patrik; Englund, Elisabet; Venero, Jose L.; Joseph, Bertrand			Caspase signalling controls microglia activation and neurotoxicity	NATURE			English	Article							KINASE-C-DELTA; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; ENDOTOXIC-SHOCK; NITRIC-OXIDE; CELL-DEATH	Activation of microglia and inflammation-mediated neurotoxicity are suggested to play a decisive role in the pathogenesis of several neurodegenerative disorders. Activated microglia release pro-inflammatory factors that may be neurotoxic. Here we show that the orderly activation of caspase-8 and caspase-3/7, known executioners of apoptotic cell death, regulate microglia activation through a protein kinase C (PKC)-delta-dependent pathway. We find that stimulation of microglia with various inflammogens activates caspase-8 and caspase-3/7 in microglia without triggering cell death in vitro and in vivo. Knockdown or chemical inhibition of each of these caspases hindered microglia activation and consequently reduced neurotoxicity. We observe that these caspases are activated in microglia in the ventral mesencephalon of Parkinson's disease (PD) and the frontal cortex of individuals with Alzheimer's disease (AD). Taken together, we show that caspase-8 and caspase-3/7 are involved in regulating microglia activation. We conclude that inhibition of these caspases could be neuroprotective by targeting the microglia rather than the neurons themselves.	[Burguillos, Miguel A.; Kavanagh, Edel; Hajji, Nabil; Joseph, Bertrand] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden; [Burguillos, Miguel A.; Cano, Josefina; Venero, Jose L.] Univ Seville, Dept Bioquim & Biol Mol, Fac Farm, E-41012 Seville, Spain; [Burguillos, Miguel A.; Cano, Josefina; Venero, Jose L.] Inst Biomed Sevilla, Seville 41012, Spain; [Burguillos, Miguel A.; Deierborg, Tomas; Brundin, Patrik] Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, S-22184 Lund, Sweden; [Persson, Annette; Englund, Elisabet] Univ Lund Hosp, Div Neuropathol, Dept Pathol, S-22185 Lund, Sweden; [Garcia-Quintanilla, Albert] Univ Seville, Serv Biol, CITIUS, Ctr Invest Tecnol & Innovac, E-41012 Seville, Spain	Karolinska Institutet; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Lund University; Skane University Hospital; University of Sevilla	Joseph, B (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden.	jlvenero@us.es; bertrand.joseph@ki.se	Venero, Jose/E-9979-2015; Burguillos, Miguel/N-4806-2019; IBIS, ENVEJECIMIENTO/O-9381-2015; hajji, nabil/AAV-1435-2020; Garcia-Quintanilla, Albert/AAE-3247-2020; Deierborg, Tomas/P-6345-2015; Garcia-Quintanilla, Albert/F-1463-2015	Venero, Jose/0000-0003-1137-8706; Burguillos, Miguel/0000-0002-3165-9997; Deierborg, Tomas/0000-0002-3651-3444; Garcia-Quintanilla, Albert/0000-0001-9617-1354; Joseph, Bertrand/0000-0001-5655-9979; Englund, Elisabet/0000-0002-2708-2443	Spanish Ministerio de Ciencia y Tecnologia [SAF2006-04119, 2009-13778]; Swedish Research Council; Parkinson Foundation of Sweden; Swedish Alzheimer Foundation; Swedish Cancer Society; Medical Research Council [G0801056B] Funding Source: researchfish	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinson Foundation of Sweden; Swedish Alzheimer Foundation; Swedish Cancer Society(Swedish Cancer Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Gorman, O. Hermanson, M. Malewicz, S. Orrenius, T. Panaretakis and B. Zhivotovsky for discussion, and L. Hjortsberg, M. Reyland and S. Ceccatelli for providing us with reagents. M. Carballo, JL. Ribas, A. Fernandez and B. Haraldsson provided qualified technical support. This work has been supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (SAF2006-04119 and 2009-13778), the Swedish Research Council, the Parkinson Foundation of Sweden, the Swedish Alzheimer Foundation and the Swedish Cancer Society. M. A. B., T. D. and P. B. are members of Neurofortis and Bagadilico, both of which are research environments sponsored by the Swedish Research Council.	Aarli JA, 2003, CURR MED CHEM, V10, P1931, DOI 10.2174/0929867033456918; Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; Balistreri CR, 2008, CURR PHARM DESIGN, V14, P2672, DOI 10.2174/138161208786264089; Bilsland James, 2002, Curr Opin Investig Drugs, V3, P1745; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; Castano A, 1998, J NEUROCHEM, V70, P1584; CHAO CC, 1992, J IMMUNOL, V149, P2736; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cutillas B, 1999, NEUROREPORT, V10, P2605, DOI 10.1097/00001756-199908200-00030; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Depino AM, 2003, EUR J NEUROSCI, V18, P2731, DOI 10.1111/j.1460-9568.2003.03014.x; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Jordan J, 2008, CURR PHARM DESIGN, V14, P3549, DOI 10.2174/138161208786848766; Joseph B, 2003, P NATL ACAD SCI USA, V100, P15619, DOI 10.1073/pnas.2635658100; Joseph B, 2002, ONCOGENE, V21, P65, DOI 10.1038/sj/onc/1205018; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schulz JB, 1998, CELL DEATH DIFFER, V5, P847, DOI 10.1038/sj.cdd.4400420; Schumann RR, 1998, BLOOD, V91, P577, DOI 10.1182/blood.V91.2.577.577_577_584; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Vancurova I, 2001, J BIOL CHEM, V276, P19746, DOI 10.1074/jbc.M100234200; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	47	412	438	2	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					319	U214		10.1038/nature09788	http://dx.doi.org/10.1038/nature09788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21389984				2022-12-28	WOS:000289724600033
J	Kudva, YC; Basu, A				Kudva, Yogish C.; Basu, Ananda			Elevated HbA(1c) levels (5.7% to 6.4%) had low accuracy for diagnosing prediabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kudva, Yogish C.; Basu, Ananda] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Kudva, YC (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							Cohen RM, 2010, J CLIN ENDOCR METAB, V95, P5203, DOI 10.1210/jc.2010-2352; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gallego PH, 2008, DIABETES CARE, V31, P1585, DOI 10.2337/dc07-2236; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Perreault L, 2008, AM J PHYSIOL-ENDOC M, V295, pE428, DOI 10.1152/ajpendo.90354.2008; StewartBrown S, 1997, BRIT MED J, V314, P533, DOI 10.1136/bmj.314.7080.533	7	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6							JC3-11	10.7326/0003-4819-154-6-201103150-02011	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LX	21403062				2022-12-28	WOS:000208886200010
J	Trouillet, JL; Luyt, CE; Guiguet, M; Ouattara, A; Vaissier, E; Makri, R; Nieszkowska, A; Leprince, P; Pavie, A; Chastre, J; Combes, A				Trouillet, Jean-Louis; Luyt, Charles-Edouard; Guiguet, Marguerite; Ouattara, Alexandre; Vaissier, Elisabeth; Makri, Ralouka; Nieszkowska, Ania; Leprince, Pascal; Pavie, Alain; Chastre, Jean; Combes, Alain			Early Percutaneous Tracheotomy Versus Prolonged Intubation of Mechanically Ventilated Patients After Cardiac Surgery A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; EARLY TRACHEOSTOMY; ENDOTRACHEAL INTUBATION; PNEUMONIA; OUTCOMES; TRANSLARYNGEAL; INTERRUPTION; METAANALYSIS; MORBIDITY; DURATION	Background: Whether early percutaneous tracheotomy in patients who require prolonged mechanical ventilation can shorten mechanical ventilation duration and lower mortality remains controversial. Objective: To compare the outcomes of severely ill patients who require prolonged mechanical ventilation randomly assigned to early percutaneous tracheotomy or prolonged intubation. Design: Prospective, randomized, controlled, single-center trial (ClinicalTrials.gov registration number: NCT00347321). Setting: Academic center. Patients: 216 adults requiring mechanical ventilation 4 or more days after cardiac surgery. Intervention: Immediate early percutaneous tracheotomy or prolonged intubation with tracheotomy 15 days after randomization. Measurements: The primary end point was the number of ventilator-free days during the first 60 days after randomization. Secondary outcomes included 28-, 60-, or 90-day mortality rates; durations of mechanical ventilation, intensive care unit stay, and hospitalization; sedative, analgesic, and neuroleptic use; ventilator-associated pneumonia rate; unscheduled extubations; comfort and ease of care; and long-term health-related quality of life (HRQoL) and psychosocial evaluations. Results: There was no difference in ventilator-free days during the first 60 days after randomization between early percutaneous tracheotomy and prolonged intubation groups (mean, 30.4 days [SD, 22.4] vs. 28.3 days [SD, 23.7], respectively; absolute difference, 2.1 days [95% CI, -4.1 to 8.3 days]) nor in 28-, 60-, or 90-day mortality rates (16% vs. 21%, 26% vs. 28%, and 30% vs. 30%, respectively). The durations of mechanical ventilation and hospitalization, as well as frequencies of ventilator-associated pneumonia and other severe infections, were also similar. However, early percutaneous tracheotomy was associated with less intravenous sedation; less time of heavy sedation; less haloperidol use for agitation, delirium, or both; fewer unscheduled extubations; better comfort and ease of care; and earlier resumption of oral nutrition. After a median follow-up of 873 days, between-group survival, psychosocial evaluations, and HRQoL were similar. Limitation: The prolonged intubation group had more ventilator-free days during days 1 to 60 than what was hypothesized (mean, 23.0 days [SD, 17.0]). Conclusion: Early tracheotomy provided no benefit in terms of mechanical ventilation and length of hospital stay, rates of mortality or infectious complications, and long-term HRQoL for patients who require prolonged mechanical ventilation after cardiac surgery. However, the well-tolerated procedure was associated with less sedation, better comfort, and earlier resumption of autonomy.	[Trouillet, Jean-Louis; Luyt, Charles-Edouard; Nieszkowska, Ania; Chastre, Jean; Combes, Alain] Inst Cardiol, Serv Reanimat, Grp Hosp Pitie Salpetriere, F-75651 Paris 13, France; [Guiguet, Marguerite] Inst Natl Sante & Rech Med, U943, F-75013 Paris, France; [Guiguet, Marguerite] Univ Paris 06, Unite Mixte Rech Sante 943, F-75013 Paris, France; [Ouattara, Alexandre] Hop Haut Leveque, Serv Anesthesie Reanimat 2, F-33600 Pessac, France; [Vaissier, Elisabeth; Makri, Ralouka] Inst Cardiol, Dept Anesthesie & Reanimat, Grp Hosp Pitie Salpetriere, F-75651 Paris 13, France; [Leprince, Pascal; Pavie, Alain] Inst Cardiol, Serv Chirurg Thorac & Cardiovasc, Grp Hosp Pitie Salpetriere, F-75651 Paris 13, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Trouillet, JL (corresponding author), Inst Cardiol, Serv Reanimat, Grp Hosp Pitie Salpetriere, 47 Blvd Hop, F-75651 Paris 13, France.	jean-louis.trouillet@psl.aphp.fr	Guiguet, Marguerite/L-8480-2018	Ouattara, Alexandre/0000-0002-7346-7539	French Ministry of Health; French Ministry of Health, Department de la Recherche Clinique et du Developpement [P051013]; Unite de Recherche Clinique; Pitie-Salpetriere Hospital; Institut National de la Sante et de la Recherche Medicale U943; Pfizer; Kalobios; Janssen-Cilag; Brahms; Merck Sharp Dohme; bioMerieux; Assistance Publique-Hopitaux de Paris; Endotis; Abbott; Astellas; Sanofi-Aventis; Nektar-Bayer; Programme Hospitalier de Recherche Clinique regional	French Ministry of Health; French Ministry of Health, Department de la Recherche Clinique et du Developpement; Unite de Recherche Clinique; Pitie-Salpetriere Hospital; Institut National de la Sante et de la Recherche Medicale U943; Pfizer(Pfizer); Kalobios; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Brahms; Merck Sharp Dohme(Merck & Company); bioMerieux; Assistance Publique-Hopitaux de Paris; Endotis; Abbott(Abbott Laboratories); Astellas(Astellas Pharmaceuticals); Sanofi-Aventis(Sanofi-Aventis); Nektar-Bayer; Programme Hospitalier de Recherche Clinique regional	Primary Funding Source: French Ministry of Health.; The Early Percutaneous Tracheotomy for Cardiac Surgery Trial received a research grant from the French Ministry of Health, Department de la Recherche Clinique et du Developpement (Programme Hospitalier de Recherche Clinique regional P051013-Appel d'Offre Regionale 0511, institutional review board authorization number,Comite Consultatif de Protection des Personnes dans la Recherche Biomedicale 6-06).; Dr. Trouillet: Grants received (money to institution): Unite de Recherche Clinique, Pitie-Salpetriere Hospital, Institut National de la Sante et de la Recherche Medicale U943. Dr. Luyt: Grants received/pending (money to institution): Pfizer, Kalobios, Janssen-Cilag; Payment for lectures including service on speakers bureaus: Brahms, Merck Sharp & Dohme, bioMerieux. Dr. Guiguet: Grants received (money to institution): Assistance Publique-Hopitaux de Paris. Dr. Ouattara: Consultancy (money to institution): Endotis, Abbott. Dr. Nieszkowska: Grants received (money to institution): Pitie-Salpetriere Hospital, Institut National de la Sante et de la Recherche Medicale U943. Dr. Chastre: Grants received (money to institution): French Ministry of Health, Department de la Recherche Clinique et du Developpement; Board membership: Pfizer, Astellas, Sanofi-Aventis, Nektar-Bayer; Payment for lectures including service on speakers bureaus: Pfizer, Astellas, Sanofi-Aventis, Nektar-Bayer. Dr. Combes: Grants received (money to institution): Programme Hospitalier de Recherche Clinique regional. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum = M10-1771.	Antonelli M, 2005, CRIT CARE MED, V33, P1015, DOI 10.1097/01.CCM.0000163401.77581.86; ASTRACHAN DI, 1988, LARYNGOSCOPE, V98, P1165; Barquist ES, 2006, J TRAUMA, V60, P91, DOI 10.1097/01.ta.0000196743.37261.3f; Blot F, 2005, CHEST, V127, P1347, DOI 10.1378/chest.127.4.1347; Blot F, 2008, INTENS CARE MED, V34, P1779, DOI 10.1007/s00134-008-1195-4; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; CASAGRANDE JT, 1978, BIOMETRICS, V34, P483, DOI 10.2307/2530613; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Combes A, 2003, CRIT CARE MED, V31, P1373, DOI 10.1097/01.CCM.0000065188.87029.C3; Combes A, 2007, CRIT CARE MED, V35, P802, DOI 10.1097/01.CCM.0000256721.60517.B1; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; De Leyn P, 2007, EUR J CARDIO-THORAC, V32, P412, DOI 10.1016/j.ejcts.2007.05.018; Diehl JL, 1999, AM J RESP CRIT CARE, V159, P383, DOI 10.1164/ajrccm.159.2.9707046; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; Engoren M, 2000, CRIT CARE MED, V28, P2742, DOI 10.1097/00003246-200008000-00010; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Freeman BD, 2005, CRIT CARE MED, V33, P2513, DOI 10.1097/01.CCM.0000186369.91799.44; Frutos-Vivar F, 2005, CRIT CARE MED, V33, P290, DOI 10.1097/01.CCM.0000150026.85210.13; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; Higgins KM, 2007, LARYNGOSCOPE, V117, P447, DOI 10.1097/01.mlg.0000251585.31778.c9; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kollef MH, 1999, CRIT CARE MED, V27, P1714, DOI 10.1097/00003246-199909000-00003; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Murthy SC, 2007, J THORAC CARDIOV SUR, V134, P484, DOI 10.1016/j.jtcvs.2007.03.006; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nielsen D, 1997, CRIT CARE MED, V25, P52, DOI 10.1097/00003246-199701000-00012; Nieszkowska A, 2005, CRIT CARE MED, V33, P2527, DOI 10.1097/01.CCM.0000186898.58709.AA; Nseir S, 2007, EUR RESPIR J, V30, P314, DOI 10.1183/09031936.06.00024906; Perneger, 2001, QUESTIONNAIRE MOS SF; Riker RR, 2005, PHARMACOTHERAPY, V25, p8S, DOI 10.1592/phco.2005.25.5_Part_2.8S; RODRIGUEZ JL, 1990, SURGERY, V108, P655; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Saffle JR, 2002, J BURN CARE REHABIL, V23, P431, DOI 10.1097/00004630-200211000-00009; Scales DC, 2008, CRIT CARE MED, V36, P2547, DOI 10.1097/CCM.0b013e31818444a5; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Trouillet JL, 2009, J THORAC CARDIOV SUR, V138, P948, DOI 10.1016/j.jtcvs.2009.05.034; WEINBERG PF, 1984, AM REV RESPIR DIS, V130, P791; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; TRACHEOSTOMY MANAGEM	51	150	159	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					373	W128		10.7326/0003-4819-154-6-201103150-00002	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00002			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734WA	21403073				2022-12-28	WOS:000288370000001
J	Lee, BH; Kim, N				Lee, Byoung Hwan; Kim, Nayoung			Quadruple or triple therapy to eradicate H pylori	LANCET			English	Editorial Material							ANTIBIOTIC-RESISTANCE; INFECTION; METAANALYSIS; KOREA		[Lee, Byoung Hwan; Kim, Nayoung] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea; [Kim, Nayoung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; [Kim, Nayoung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, N (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea.	nayoungkim49@empal.com	Kim, Nayoung/J-5387-2012	Kim, Nayoung/0000-0002-9397-0406				Choi Woo Hyuk, 2008, Korean J Gastroenterol, V51, P280; Essa AS, 2009, HELICOBACTER, V14, P109, DOI 10.1111/j.1523-5378.2009.00671.x; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Kim JM, 2006, INT J ANTIMICROB AG, V28, P6, DOI 10.1016/j.ijantimicag.2006.02.015; Kwon JH, 2010, HELICOBACTER, V15, P148, DOI 10.1111/j.1523-5378.2010.00748.x; Laine L, 2003, AM J GASTROENTEROL, V98, P562, DOI [10.1016/S0002-9270(02)06010-0, 10.1111/j.1572-0241.2003.t01-1-07288.x]; Lee BH, 2010, HELICOBACTER, V15, P38, DOI 10.1111/j.1523-5378.2009.00735.x; Luther J, 2010, AM J GASTROENTEROL, V105, P65, DOI 10.1038/ajg.2009.508; Malfertheiner P, 2011, LANCET, V377, P905, DOI 10.1016/S0140-6736(11)60020-2; Sanchez-Delgado J, 2008, AM J GASTROENTEROL, V103, P2220, DOI 10.1111/j.1572-0241.2008.01924.x; Wu DC, 2010, CLIN GASTROENTEROL H, V8, P36, DOI 10.1016/j.cgh.2009.09.030	11	4	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2011	377	9769					877	878		10.1016/S0140-6736(11)60168-2	http://dx.doi.org/10.1016/S0140-6736(11)60168-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738GR	21345486				2022-12-28	WOS:000288628800004
J	Dickinson, DJ; Nelson, WJ; Weis, WI				Dickinson, Daniel J.; Nelson, W. James; Weis, William I.			A Polarized Epithelium Organized by beta- and alpha-Catenin Predates Cadherin and Metazoan Origins	SCIENCE			English	Article							CELL POLARITY; COMPLEX; DICTYOSTELIUM; ADHESION; EVOLUTION; MEMBRANE; ANCESTRY; ACTIN; GENE	A fundamental characteristic of metazoans is the formation of a simple, polarized epithelium. In higher animals, the structural integrity and functional polarization of simple epithelia require a cell-cell adhesion complex that contains a classical cadherin, the Wnt-signaling protein beta-catenin and the actin-binding protein alpha-catenin. We show that the non-metazoan Dictyostelium discoideum forms a polarized epithelium that is essential for multicellular development. Although D. discoideum lacks a cadherin homolog, we identify an alpha-catenin ortholog that binds a beta-catenin-related protein. Both proteins are essential for formation of the epithelium, polarized protein secretion, and proper multicellular morphogenesis. Thus, the organizational principles of metazoan multicellularity may be more ancient than previously recognized, and the role of the catenins in cell polarity predates the evolution of Wnt signaling and classical cadherins.	[Dickinson, Daniel J.; Nelson, W. James; Weis, William I.] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Nelson, W. James; Weis, William I.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Nelson, WJ (corresponding author), Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA.	wjnelson@stanford.edu; bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Dickinson, Daniel J./0000-0003-2651-2584	Stanford Graduate Fellowship; NSF; NIH [GM035527, GM56169]; U.S. Department of Energy; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM035527, R01GM056169] Funding Source: NIH RePORTER	Stanford Graduate Fellowship(Stanford University); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank numerous colleagues for reagents (9); T. Soldati for sharing Sec15 antibodies before publication; C. Carswell-Crumpton, N. Ghori, J. Perrino, and T. Weiss for technical assistance; and D. Ehrhardt, N. King, D. N. Robinson, T. Soldati, J. A. Spudich, M. Tsujioka, H. Warrick, and members of the Nelson and Weis laboratories for discussions. This work was supported by a Stanford Graduate Fellowship and an NSF Graduate Research Fellowship (D. J. D.), NIH GM035527 (W. J. N.), and NIH GM56169 (W. I. W.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, supported by the U.S. Department of Energy and the National Institute of General Medical Sciences.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Blanton RL, 2000, P NATL ACAD SCI USA, V97, P2391, DOI 10.1073/pnas.040565697; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coates JC, 2002, MECH DEVELOP, V116, P117, DOI 10.1016/S0925-4773(02)00152-1; Grimson MJ, 2000, NATURE, V408, P727, DOI 10.1038/35047099; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; MCROBBIE SJ, 1988, DEV BIOL, V125, P59, DOI 10.1016/0012-1606(88)90058-9; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Urushihara H, 2008, DEV GROWTH DIFFER, V50, pS277, DOI 10.1111/j.1440-169X.2008.01013.x; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Williams HP, 2003, CURR OPIN MICROBIOL, V6, P621, DOI 10.1016/j.mib.2003.10.008; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893	22	98	99	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1336	1339		10.1126/science.1199633	http://dx.doi.org/10.1126/science.1199633			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393547	Green Accepted			2022-12-28	WOS:000288215200050
J	Hill, KR; Walker, RS; Bozicevic, M; Eder, J; Headland, T; Hewlett, B; Hurtado, AM; Marlowe, FW; Wiessner, P; Wood, B				Hill, Kim R.; Walker, Robert S.; Bozicevic, Miran; Eder, James; Headland, Thomas; Hewlett, Barry; Hurtado, A. Magdalena; Marlowe, Frank W.; Wiessner, Polly; Wood, Brian			Co-Residence Patterns in Hunter-Gatherer Societies Show Unique Human Social Structure	SCIENCE			English	Article							EVOLUTION; INTELLIGENCE; COOPERATION; DEMOGRAPHY; ACHE	Contemporary humans exhibit spectacular biological success derived from cumulative culture and cooperation. The origins of these traits may be related to our ancestral group structure. Because humans lived as foragers for 95% of our species' history, we analyzed co-residence patterns among 32 present-day foraging societies (total n = 5067 individuals, mean experienced band size = 28.2 adults). We found that hunter-gatherers display a unique social structure where (i) either sex may disperse or remain in their natal group, (ii) adult brothers and sisters often co-reside, and (iii) most individuals in residential groups are genetically unrelated. These patterns produce large interaction networks of unrelated adults and suggest that inclusive fitness cannot explain extensive cooperation in hunter-gatherer bands. However, large social networks may help to explain why humans evolved capacities for social learning that resulted in cumulative culture.	[Hill, Kim R.; Bozicevic, Miran; Eder, James; Hurtado, A. Magdalena] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Walker, Robert S.] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA; [Headland, Thomas] SIL Int, Dept Anthropol, Dallas, TX 75236 USA; [Headland, Thomas] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Hewlett, Barry] Hawassa Univ, Dept Anthropol, Hawassa, Ethiopia; [Hewlett, Barry] Washington State Univ, Dept Anthropol, Vancouver, WA 98686 USA; [Marlowe, Frank W.] Univ Durham, Dept Anthropol, Durham DH1 3LE, England; [Wiessner, Polly] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Wood, Brian] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA	Arizona State University; Arizona State University-Tempe; University of Missouri System; University of Missouri Columbia; Southern Methodist University; Hawassa University; Washington State University; Durham University; Utah System of Higher Education; University of Utah; Stanford University	Hill, KR (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	kim.hill@asu.edu; walkerro@missouri.edu	Wood, Brian/AAQ-4410-2020; Marlowe, Frank/G-9752-2012; Carroll, Joseph/D-1158-2011	Wood, Brian/0000-0002-8187-9429; Carroll, Joseph/0000-0003-2656-1378				Allen-Arave W, 2008, EVOL HUM BEHAV, V29, P305, DOI 10.1016/j.evolhumbehav.2008.03.002; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; Boyd R, 2007, SCIENCE, V316, P1858, DOI 10.1126/science.1144339; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; Chapais Bernard, 2008, PRIMEVAL KINSHIP PAI, DOI DOI 10.1111/btp.12564; CHUDEK M, 2010, SIGNALING COMMITMENT, P1; Csibra G, 2007, TRENDS COGN SCI, V11, P95, DOI 10.1016/j.tics.2006.12.001; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; HELM J, 1968, MAN HUNTER, P118; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Hill K, 2002, HUM NATURE-INT BIOS, V13, P105, DOI 10.1007/s12110-002-1016-3; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hill K, 2009, EVOL ANTHROPOL, V18, P187, DOI 10.1002/evan.20224; Hill K, 2009, P ROY SOC B-BIOL SCI, V276, P3863, DOI 10.1098/rspb.2009.1061; Hrdy, 2009, MOTHERS OTHERS; Ivey PK, 2005, HUNTER GATHERER CHIL, P191; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; KLEIN MA, 2010, P BIOL SCI, V277, P2559; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Service E.R., 1962, PRIMITIVE SOCIAL ORG; Silk Joan B, 2006, Science, V311, P1248, DOI 10.1126/science.1125141; WIESSNER P, 1983, AM ANTIQUITY, V48, P253, DOI 10.2307/280450	28	454	459	0	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1286	1289		10.1126/science.1199071	http://dx.doi.org/10.1126/science.1199071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732UM	21393537				2022-12-28	WOS:000288215200036
J	Suzuki, K; Matsuo, T; Hashizume, D; Fueno, H; Tanaka, K; Tamao, K				Suzuki, Katsunori; Matsuo, Tsukasa; Hashizume, Daisuke; Fueno, Hiroyuki; Tanaka, Kazuyoshi; Tamao, Kohei			A Planar Rhombic Charge-Separated Tetrasilacyclobutadiene	SCIENCE			English	Article							MAIN-GROUP ELEMENTS; STABLE COMPOUND; DOUBLE-BOND; CYCLOBUTADIENE; MATRIX; RINGS; ATOM	The cyclobutadiene (CBD) molecule C4H4 deviates from a high-symmetry square geometry to compensate for its antiaromatic electronic structure. Here, we report a CBD silicon analog, Si-4(EMind)(4) (1), stabilized by the bulky 1,1,7,7-tetraethyl-3,3,5,5-tetramethyl-s-hydrindacen-4-yl (EMind) groups, obtained as air-and moisture-sensitive orange crystals by the reduction of (EMind)SiBr3 with three equivalents of lithium naphthalenide. X-ray crystallography reveals a planar and rhombic structure of the Si-4 four-membered ring, with alternating pyramidal and planar configurations at the silicon atoms. The large Si-29 chemical shift differences (Delta delta > 350 parts per million) in the solid-state nuclear magnetic resonance spectra suggest a contribution of an alternately charge-separated structure. The rhombic-shaped charge-separated singlet state of compound 1 thus stabilizes its cyclic 4 pi-electron antiaromaticity in a manner that contrasts sharply with the bond-length alternation, characterizing the rectangular distortion of carbon-based CBD.	[Suzuki, Katsunori; Matsuo, Tsukasa; Tamao, Kohei] RIKEN, Adv Sci Inst, Funct Elementoorgan Chem Unit, Wako, Saitama 3510198, Japan; [Hashizume, Daisuke] RIKEN, Adv Sci Inst, Adv Technol Support Div, Wako, Saitama 3510198, Japan; [Fueno, Hiroyuki; Tanaka, Kazuyoshi] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan	RIKEN; RIKEN; Kyoto University	Matsuo, T (corresponding author), RIKEN, Adv Sci Inst, Funct Elementoorgan Chem Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsuo@riken.jp; tamao@riken.jp	Hashizume, Daisuke/D-3187-2013; Matsuo, Tsukasa/G-2324-2011	Hashizume, Daisuke/0000-0001-7152-4408; Suzuki, Katsunori/0000-0002-7971-5863	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19002008]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by a Grant-in-Aid for Specially Promoted Research (19002008) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Numerical calculations were partly performed at the Supercomputer Laboratory, Institute for Chemical Research, Kyoto University. We thank Y. Hongo and T. Nakamura (RIKEN) for their kind help with the mass spectrometry and solid-state NMR spectroscopy. We also thank J. Michl, R. Noyori, A. Sekiguchi, and R. West for their valuable discussions. Metric data for the solid-state structure of 1 are available from the Cambridge Crystallographic Data Centre under reference number CCDC-786049.	Abersfelder K, 2010, SCIENCE, V327, P564, DOI 10.1126/science.1181771; ARNOLD BR, 1991, J AM CHEM SOC, V113, P692, DOI 10.1021/ja00002a058; BALKOVA A, 1994, J CHEM PHYS, V101, P8972, DOI 10.1063/1.468025; BALLY T, 1980, TETRAHEDRON, V36, P343, DOI 10.1016/0040-4020(80)87003-7; Bally T, 2006, ANGEW CHEM INT EDIT, V45, P6616, DOI 10.1002/anie.200602279; BONACICKOUTECKY V, 1987, ANGEW CHEM INT EDIT, V26, P170, DOI 10.1002/anie.198701701; BROOK AG, 1981, J CHEM SOC CHEM COMM, P191, DOI 10.1039/c39810000191; Chen ZF, 2005, CHEM REV, V105, P3842, DOI 10.1021/cr030088+; CRAM DJ, 1991, ANGEW CHEM INT EDIT, V30, P1024, DOI 10.1002/anie.199110241; DELBAERE LTJ, 1975, J AM CHEM SOC, V97, P1973, DOI 10.1021/ja00840a072; Deniz AA, 1999, SCIENCE, V286, P1119, DOI 10.1126/science.286.5442.1119; Fattahi A, 2006, ANGEW CHEM INT EDIT, V45, P4984, DOI 10.1002/anie.200600839; Fischer RC, 2010, CHEM REV, V110, P3877, DOI 10.1021/cr100133q; Fukazawa A, 2007, J AM CHEM SOC, V129, P14164, DOI 10.1021/ja0764207; Ichinohe M, 2003, J AM CHEM SOC, V125, P13328, DOI 10.1021/ja0305050; IRNGARTINGER H, 1974, ANGEW CHEM INT EDIT, V13, P740, DOI 10.1002/anie.197407401; Ishida S, 2003, NATURE, V421, P725, DOI 10.1038/nature01380; Kim KC, 2002, SCIENCE, V297, P825, DOI 10.1126/science.1073540; KIMLING H, 1972, ANGEW CHEM INT EDIT, V11, P932, DOI 10.1002/anie.197209321; KUTZELNIGG W, 1984, ANGEW CHEM INT EDIT, V23, P272, DOI 10.1002/anie.198402721; Lee VY, 2004, J AM CHEM SOC, V126, P4758, DOI 10.1021/ja030662z; Legrand YM, 2010, SCIENCE, V329, P299, DOI 10.1126/science.1188002; Li B, 2009, CLIN IMMUNOL, V131, pS113, DOI 10.1016/j.clim.2009.03.334; LIN CY, 1972, J CHEM SOC CHEM COMM, P1111, DOI 10.1039/c39720001111; MAIER G, 1978, ANGEW CHEM INT EDIT, V17, P520, DOI 10.1002/anie.197805201; MAIER G, 1988, ANGEW CHEM INT EDIT, V27, P309, DOI 10.1002/anie.198803093; ORENDT AM, 1988, J AM CHEM SOC, V110, P2648, DOI 10.1021/ja00216a049; Petersson EJ, 1997, J AM CHEM SOC, V119, P11122, DOI 10.1021/ja971930u; Sekiguchi A, 2004, SCIENCE, V305, P1755, DOI 10.1126/science.1102209; Takanashi K, 2005, J AM CHEM SOC, V127, P5768, DOI 10.1021/ja050938y; Wakita K, 2000, ANGEW CHEM INT EDIT, V39, P634, DOI 10.1002/(SICI)1521-3773(20000204)39:3<634::AID-ANIE634>3.0.CO;2-#; Wang YZ, 2008, SCIENCE, V321, P1069, DOI 10.1126/science.1160768; WATTS L, 1965, J AM CHEM SOC, V87, P3253, DOI 10.1021/ja01092a049; Weidenbruch M, 1997, ANGEW CHEM INT EDIT, V36, P2503, DOI 10.1002/anie.199725031; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343; WIBERG N, 1993, ANGEW CHEM INT EDIT, V32, P1054, DOI 10.1002/anie.199310541; Wu JI, 2010, ORG LETT, V12, P768, DOI 10.1021/ol902866n; YATES BF, 1988, CHEM PHYS LETT, V143, P421, DOI 10.1016/0009-2614(88)87389-5	38	100	100	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1306	1309		10.1126/science.1199906	http://dx.doi.org/10.1126/science.1199906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393541				2022-12-28	WOS:000288215200041
J	Mullighan, CG; Zhang, JH; Kasper, LH; Lerach, S; Payne-Turner, D; Phillips, LA; Heatley, SL; Holmfeldt, L; Collins-Underwood, JR; Ma, J; Buetow, KH; Pui, CH; Baker, SD; Brindle, PK; Downing, JR				Mullighan, Charles G.; Zhang, Jinghui; Kasper, Lawryn H.; Lerach, Stephanie; Payne-Turner, Debbie; Phillips, Letha A.; Heatley, Sue L.; Holmfeldt, Linda; Collins-Underwood, J. Racquel; Ma, Jing; Buetow, Kenneth H.; Pui, Ching-Hon; Baker, Sharyn D.; Brindle, Paul K.; Downing, James R.			CREBBP mutations in relapsed acute lymphoblastic leukaemia	NATURE			English	Article							RUBINSTEIN-TAYBI SYNDROME; GENETIC ALTERATIONS; BINDING PROTEIN; GENOMIC ANALYSIS; P300; CBP; CANCER; REVEALS; CELLS; COACTIVATOR	Relapsed acute lymphoblastic leukaemia (ALL) is a leading cause of death due to disease in young people, but the biological determinants of treatment failure remain poorly understood. Recent genome-wide profiling of structural DNA alterations in ALL have identified multiple submicroscopic somatic mutations targeting key cellular pathways(1,2), and have demonstrated substantial evolution in genetic alterations from diagnosis to relapse(3). However, DNA sequence mutations in ALL have not been analysed in detail. To identify novel mutations in relapsed ALL, we resequenced 300 genes in matched diagnosis and relapse samples from 23 patients with ALL. This identified 52 somatic non-synonymous mutations in 32 genes, many of which were novel, including the transcriptional coactivators CREBBP and NCOR1, the transcription factors ERG, SPI1, TCF4 and TCF7L2, components of the Ras signalling pathway, histone genes, genes involved in histone modification (CREBBP and CTCF), and genes previously shown(1,2) to be targets of recurring DNA copy number alteration in ALL. Analysis of an extended cohort of 71 diagnosis-relapse cases and 270 acute leukaemia cases that did not relapse found that 18.3% of relapse cases had sequence or deletion mutations of CREBBP, which encodes the transcriptional coactivator and histone acetyltransferase CREB-binding protein (CREBBP, also known as CBP)(4). The mutations were either present at diagnosis or acquired at relapse, and resulted in truncated alleles or deleterious substitutions in conserved residues of the histone acetyltransferase domain. Functionally, the mutations impaired histone acetylation and transcriptional regulation of CREBBP targets, including glucocorticoid responsive genes. Several mutations acquired at relapse were detected in subclones at diagnosis, suggesting that the mutations may confer resistance to therapy. These results extend the landscape of genetic alterations in leukaemia, and identify mutations targeting transcriptional and epigenetic regulation as a mechanism of resistance in ALL.	[Mullighan, Charles G.; Payne-Turner, Debbie; Phillips, Letha A.; Heatley, Sue L.; Holmfeldt, Linda; Collins-Underwood, J. Racquel; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Zhang, Jinghui] St Jude Childrens Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Kasper, Lawryn H.; Lerach, Stephanie; Brindle, Paul K.] St Jude Childrens Hosp, Dept Biochem, Memphis, TN 38105 USA; [Ma, Jing] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Buetow, Kenneth H.] NCI, Ctr Bioinformat, Rockville, MD 20892 USA; [Buetow, Kenneth H.] NCI, Lab Populat Genet, NIH, Bethesda, MD 20892 USA; [Pui, Ching-Hon] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Baker, Sharyn D.] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Mullighan, CG (corresponding author), St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA.	charles.mullighan@stjude.org	Downing, James R./N-8102-2018; Kasper, Lawryn/GWV-5700-2022; Pui, Ching-Hon/N-8076-2018; Mullighan, Charles/H-3253-2011; Zhang, Jing/GWZ-7332-2022; Zhang, Jing/HII-4294-2022; Heatley, Susan/AGP-2179-2022	Pui, Ching-Hon/0000-0003-0303-5658; Mullighan, Charles/0000-0002-1871-1850; Baker, Sharyn/0000-0003-3062-3252; Heatley, Susan/0000-0001-7497-6477; Holmfeldt, Linda/0000-0003-4140-3423; Brindle, Paul/0000-0001-7172-8478	ALSAC of St Jude and Cancer Center [P30 CA021765, DE018183]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018183] Funding Source: NIH RePORTER	ALSAC of St Jude and Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank T. Jeevan, S. Orwick and A. Gibson for technical assistance, B. Schulman for assistance with structural modelling, and B. Woolf and J. Hartigan of Beckman Coulter Genomics for assistance with sequencing. We thank the Tissue Resources Facility of St Jude Children's Research Hospital for providing samples, and the following St Jude core facilities: Vector Development and Production, Flow Cytometry and Cell Sorting, Cell and Tissue Imaging, the Animal Resource Center, and the DNA sequencing and Macromolecular Synthesis laboratories of the Hartwell Center for Bioinformatics and Biotechnology. This study was supported by ALSAC of St Jude and Cancer Center support grant P30 CA021765, and grant number DE018183 (P.K.B.). C.G.M. is a Pew Scholar in the Biomedical Sciences.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bordoli L, 2001, NUCLEIC ACIDS RES, V29, P4462, DOI 10.1093/nar/29.21.4462; DeLano W.L, PYMOL MOL GRAPHICS S; Dordelmann M, 1999, BLOOD, V94, P1209, DOI 10.1182/blood.V94.4.1209.416k05_1209_1217; Drexler HG., 2001, LEUKEMIA LYMPHOMA CE, P2, DOI [10.1016/B978-012221970-2/50002-4, DOI 10.1016/B978-012221970-2/50002-4]; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Goodman RH, 2000, GENE DEV, V14, P1553; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Harrison CJ, 2009, BRIT J HAEMATOL, V144, P147, DOI 10.1111/j.1365-2141.2008.07417.x; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kishimoto M, 2005, CLIN CANCER RES, V11, P512; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Kuiper RP, 2010, LEUKEMIA, V24, P1258, DOI 10.1038/leu.2010.87; Kung AL, 2000, GENE DEV, V14, P272; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; MANABE A, 1994, BLOOD, V83, P1731, DOI 10.1182/blood.V83.7.1731.bloodjournal8371731; MILLER RW, 1995, AM J MED GENET, V56, P112, DOI 10.1002/ajmg.1320560125; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; Schorry EK, 2008, AM J MED GENET A, V146A, P2512, DOI 10.1002/ajmg.a.32424; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shigeno K, 2004, CANCER LETT, V213, P11, DOI 10.1016/S0304-3835(03)00442-7; Tsapis M, 2007, INT J BIOCHEM CELL B, V39, P1500, DOI 10.1016/j.biocel.2007.03.009; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053; Zhang JH, 2002, NUCLEIC ACIDS RES, V30, P5213, DOI 10.1093/nar/gkf654; Zhang J, 2007, GENOME RES, V17, P1111, DOI 10.1101/gr.5963407	42	426	444	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					235	U127		10.1038/nature09727	http://dx.doi.org/10.1038/nature09727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21390130	Green Accepted			2022-12-28	WOS:000288170200041
J	Osterholm, MT				Osterholm, Michael T.			Foodborne Disease in 2011-The Rest of the Story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES; ILLNESS; PATHOGENS		Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Osterholm, MT (corresponding author), Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN 55455 USA.							Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; 2010, MMWR MORB MORTAL WKL, V59, P418	4	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2011	364	10					889	891		10.1056/NEJMp1010907	http://dx.doi.org/10.1056/NEJMp1010907			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732FL	21345094				2022-12-28	WOS:000288170300001
J	Watson, JM; Kang'ombe, AR; Soares, MO; Chuang, LH; Worthy, G; Bland, JM; Iglesias, C; Cullum, N; Torgerson, D; Nelson, EA				Watson, Judith M.; Kang'ombe, Arthur R.; Soares, Marta O.; Chuang, Ling-Hsiang; Worthy, Gill; Bland, J. Martin; Iglesias, Cynthia; Cullum, Nicky; Torgerson, David; Nelson, E. Andrea		VenUS III Team	Use of weekly, low dose, high frequency ultrasound for hard to heal venous leg ulcers: the VenUS III randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the clinical effectiveness of weekly delivery of low dose, high frequency therapeutic ultrasound in conjunction with standard care for hard to heal venous leg ulcers. Design Multicentre, pragmatic, two arm randomised controlled trial. Setting Community and district nurse led services, community leg ulcer clinics, and hospital outpatient leg ulcer clinics in 12 urban and rural settings (11 in the United Kingdom and one in the Republic of Ireland). Participants 337 patients with at least one venous leg ulcer of >6 months' duration or >5 cm(2) area and an ankle brachial pressure index of >= 0.8. Interventions Weekly administration of low dose, high frequency ultrasound therapy (0.5 W/cm(2), 1 MHz, pulsed pattern of 1: 4) for up to 12 weeks plus standard care compared with standard care alone. Main outcome measures Primary outcome was time to healing of the largest eligible leg ulcer. Secondary outcomes were proportion of patients healed by 12 months, percentage and absolute change in ulcer size, proportion of time participants were ulcer-free, health related quality of life, and adverse events. Results The two groups showed no significant difference in the time to healing of the reference leg ulcer (log rank test, P=0.61). After adjustment for baseline ulcer area, baseline ulcer duration, use of compression bandaging, and study centre, there was still no evidence of a difference in time to healing (hazard ratio 0.99 (95% confidence interval 0.70 to 1.40), P=0.97). The median time to healing of the reference leg ulcer was inestimable. There was no significant difference between groups in the proportion of participants with all ulcers healed by 12 months (72/168 in ultrasound group v 78/169 in standard care group, P=0.39 for Fisher's exact test) nor in the change in ulcer size at four weeks by treatment group (model estimate 0.05 (95% CI -0.09 to 0.19)). There was no difference in time to complete healing of all ulcers (log rank test, P=0.61), with median time to healing of 328 days (95% CI 235 to inestimable) with standard care and 365 days (224 days to inestimable) with ultrasound. There was no evidence of a difference in rates of recurrence of healed ulcers (17/31 with ultrasound v 14/31 with standard care, P=0.68 for Fisher's exact test). There was no difference between the two groups in health related quality of life, both for the physical component score (model estimate 0.69 (-1.79 to 3.08)) and the mental component score (model estimate -0.93 (-3.30 to 1.44)), but there were significantly more adverse events in the ultrasound group (model estimate 0.30 (0.01 to 0.60)). There was a significant relation between time to ulcer healing and baseline ulcer area (hazard ratio 0.64 (0.55 to 0.75)) and baseline ulcer duration (hazard ratio 0.59 (0.50 to 0.71)), with larger and older ulcers taking longer to heal. In addition, those centres with high recruitment rates had the highest healing rates. Conclusions Low dose, high frequency ultrasound administered weekly for 12 weeks during dressing changes in addition to standard care did not increase ulcer healing rates, affect quality of life, or reduce ulcer recurrence.	[Nelson, E. Andrea] Univ Leeds, Sch Healthcare, Leeds LS2 9JT, W Yorkshire, England; [Torgerson, David] Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England; [Worthy, Gill] Escrick, Kleijnen Systemat Reviews, York, N Yorkshire, England	University of Leeds; University of York - UK; Kleijnen Systematic Reviews	Nelson, EA (corresponding author), Univ Leeds, Sch Healthcare, Leeds LS2 9JT, W Yorkshire, England.	e.a.nelson@leeds.ac.uk	Cullum, Nicky A/F-2438-2011; Nelson, Andrea/K-2733-2012; Riet, Gerben ter/A-6943-2011; Torgerson, David/L-4566-2019; Watson, Judith/H-5821-2019; Cullum, Nicky/AAT-5888-2020	Cullum, Nicky A/0000-0003-2631-123X; Nelson, Andrea/0000-0001-6741-3078; Riet, Gerben ter/0000-0002-2231-7637; Torgerson, David/0000-0002-1667-4275; Watson, Judith/0000-0003-0694-3854; Cullum, Nicky/0000-0003-2631-123X; Adderley, Una/0000-0003-1894-3755; McGinnis, Elizabeth/0000-0002-2848-9149; Soares, Marta Ferreira Oliveira/0000-0003-1579-8513	UK National Institute for Health Research (NIHR) [02/37/03]; National Institute for Health Research [02/37/03] Funding Source: researchfish	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the UK National Institute for Health Research (NIHR) Health Technology Assessment Programme (project No 02/37/03), and it will be published in full in the journal Health Technology Assessment. The NIHR had no role in the data collection, statistical analysis, or writing of this article or the decision to submit for publication. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Department of Health. EMS Physio supplied the SoLo Therasonic 355 ultrasound machines at a discounted price, but had no role in the design of the trial or in the collection, analysis, and interpretation of the data.	*AAWC, 2005, SUMM ALG VEN ULC CAR; Agresti A, 2003, CATEGORICAL DATA ANA; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Briggs M, 2007, J ADV NURS, V59, P319, DOI 10.1111/j.1365-2648.2007.04348.x; Busse JW, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b351; Collett, 2003, MODELLING SURVIVAL D; CULLUM N, 2001, HEALTH TECHNOL ASSES, P51; CULLUM NA, 2010, COCHRANE DB SYST REV, V6; DALE JJ, 1983, HLTH B EDINB, V41, P311; Dumville JC, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13550; Etris M B, 1994, Ostomy Wound Manage, V40, P44; FLEMMING K, 2000, COCHRANE DB SYST REV, V4; Graham Ian D, 2003, Adv Skin Wound Care, V16, P305, DOI 10.1097/00129334-200311000-00013; Iglesias C, 2004, HEALTH TECHNOL ASSES, V8, P1; Iglesias CP, 2005, QUAL LIFE RES, V14, P1705, DOI 10.1007/s11136-005-2751-9; Margolis DJ, 2000, AM J MED, V109, P15, DOI 10.1016/S0002-9343(00)00379-X; Moffatt C., 2007, LEG ULCER MANAGEMENT; *NAT ARCH, 2004, MED HUM US CLIN TRIA; O'Meara S, 2008, COCHRANE DB SYST REV, V4; *RNAO, 2007, ASS MAN VEN LEG ULC; SARI ABA, 2006, COCHRANE DB SYST REV, V3; Speed CA, 2001, RHEUMATOLOGY, V40, P1331, DOI 10.1093/rheumatology/40.12.1331; Tan J, 2007, EUR J VASC ENDOVASC, V33, P234, DOI 10.1016/j.ejvs.2006.09.027; Taylor R J, 1997, J Wound Care, V6, P123; ter Haar G, 1999, Eur J Ultrasound, V9, P3; WATSON JM, HLTH TECHNO IN PRESS; Watson T, 2008, ULTRASONICS, V48, P321, DOI 10.1016/j.ultras.2008.02.004; *WOCN SOC, 2005, GUID MAN WOUNDS PAT	28	36	36	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2011	342								d1092	10.1136/bmj.d1092	http://dx.doi.org/10.1136/bmj.d1092			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735UY	21385806	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000288446800004
J	Shetty, P				Shetty, Priya			Adrienne Germain: helping to shape policy for women's health Profile	LANCET			English	Biographical-Item												priya4876@gmail.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 5	2011	377	9768					803	803		10.1016/S0140-6736(11)60294-8	http://dx.doi.org/10.1016/S0140-6736(11)60294-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GO	21377559	Bronze			2022-12-28	WOS:000288628500013
J	Hanahan, D; Weinberg, RA				Hanahan, Douglas; Weinberg, Robert A.			Hallmarks of Cancer: The Next Generation	CELL			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; DNA-DAMAGE RESPONSE; DOUBLE-EDGED-SWORD; STEM-CELLS; TGF-BETA; TUMOR PROGRESSION; TELOMERE LENGTH; ENDOGENOUS INHIBITORS; LINKING INFLAMMATION; CELLULAR SENESCENCE	The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions. Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metabolism and evading immune destruction. In addition to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment." Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.	[Hanahan, Douglas] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Hanahan, Douglas] UCSF, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Weinberg, Robert A.] Ludwig MIT Ctr Mol Oncol, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Weinberg, Robert A.] MIT Dept Biol, Cambridge, MA 02142 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute	Hanahan, D (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, CH-1015 Lausanne, Switzerland.	dh@epfl.ch; weinberg@wi.mit.edu	duan, chris/J-2484-2015		U.S. National Cancer Institute	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Terry Schoop (OFC Graphics, Kensington, CA, USA) for exceptional efforts in preparing the figures. And we thank Gerard Evan (Cambridge, UK), Erwin Wagner (Madrid, ESP), and Zena Werb (San Francisco, USA) for valuable comments and suggestions on the manuscript. D. H. and R. A. W. are American Cancer Society Research Professors. Research in the authors' laboratories has been largely supported by the U.S. National Cancer Institute. Due to space limitations, many primary and historical publications have not been cited, particularly in cases where topical reviews are available.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Ahmed Zubair, 2009, V467, P3, DOI 10.1007/978-1-59745-241-0_1; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; AMARAVADI RK, 2007, NAT GENET, V39, P503; Apel A, 2009, INT J CANCER, V125, P991, DOI 10.1002/ijc.24500; Artandi SE, 2000, NAT MED, V6, P852, DOI 10.1038/78595; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Azam F, 2010, EUR J CANCER, V46, P1323, DOI 10.1016/j.ejca.2010.02.020; Baeriswyl V, 2009, SEMIN CANCER BIOL, V19, P329, DOI 10.1016/j.semcancer.2009.05.003; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bindea G, 2010, CURR OPIN IMMUNOL, V22, P215, DOI 10.1016/j.coi.2010.02.006; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cheng N, 2008, MOL CANCER RES, V6, P1521, DOI 10.1158/1541-7786.MCR-07-2203; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Coffelt SB, 2010, AM J PATHOL, V176, P1564, DOI 10.2353/ajpath.2010.090786; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Cong YS, 2008, CELL RES, V18, P725, DOI 10.1038/cr.2008.74; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Dirat B, 2010, ENDOCR DEV, V19, P45, DOI 10.1159/000316896; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; El Hallani S, 2010, BRAIN, V133, P973, DOI 10.1093/brain/awq044; Ellis LM, 2009, NATURE, V458, P290, DOI 10.1038/458290a; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Fang ST, 2011, J MOL CELL CARDIOL, V50, P290, DOI 10.1016/j.yjmcc.2010.10.024; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Ferrone C, 2010, J CLIN ONCOL, V28, P4045, DOI 10.1200/JCO.2010.27.9992; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gabhann FM, 2008, MICROCIRCULATION, V15, P715, DOI 10.1080/10739680802095964; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gerhardt H, 2008, J MOL MED, V86, P135, DOI 10.1007/s00109-007-0258-2; Ghebranious N, 1998, ONCOGENE, V17, P3385, DOI 10.1038/sj.onc.1202573; Giaccia AJ, 2010, CURR TOP MICROBIOL, V345, P31, DOI 10.1007/82_2010_73; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansel DE, 2006, MODERN PATHOL, V19, P772, DOI 10.1038/modpathol.3800591; Hardee ME, 2009, CURR MOL MED, V9, P435, DOI 10.2174/156652409788167122; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hlubek F, 2007, INT J CANCER, V121, P1941, DOI 10.1002/ijc.22916; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Johansson M, 2008, IMMUNOL REV, V222, P145, DOI 10.1111/j.1600-065X.2008.00600.x; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kang HJ, 2004, J NEUROSCI, V24, P1280, DOI 10.1523/JNEUROSCI.4082-03.2004; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karnoub Antoine E, 2006, Breast Dis, V26, P75; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kastan MB, 2008, MOL CANCER RES, V6, P517, DOI 10.1158/1541-7786.MCR-08-0020; Kawai T, 2007, AM J CLIN PATHOL, V127, P254, DOI 10.1309/91PY0RBD9W8Y5GNX; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Kenific CM, 2010, CURR OPIN CELL BIOL, V22, P241, DOI 10.1016/j.ceb.2009.10.008; Kennedy KM, 2010, FUTURE ONCOL, V6, P127, DOI [10.2217/fon.09.145, 10.2217/FON.09.145]; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Korkola J, 2010, CURR OPIN GENET DEV, V20, P4, DOI 10.1016/j.gde.2009.11.005; Kovacic JC, 2009, STEM CELL RES, V2, P2, DOI 10.1016/j.scr.2008.05.005; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Luebeck EG, 2010, NATURE, V467, P1053, DOI 10.1038/4671053a; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McGowan PM, 2009, FUTURE ONCOL, V5, P1083, DOI [10.2217/fon.09.73, 10.2217/FON.09.73]; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Naumov GN, 2008, APMIS, V116, P569, DOI 10.1111/j.1600-0463.2008.01213.x; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nelson BH, 2008, IMMUNOL REV, V222, P101, DOI 10.1111/j.1600-065X.2008.00614.x; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Partanen JI, 2009, CELL CYCLE, V8, P716, DOI 10.4161/cc.8.5.7786; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Patenaude A, 2010, MICROVASC RES, V79, P217, DOI 10.1016/j.mvr.2010.01.007; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Perona Rosario, 2006, Clin Transl Oncol, V8, P77, DOI 10.1007/s12094-006-0162-1; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; POTTER VR, 1958, FED PROC, V17, P691; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Raica M, 2009, EUR J CANCER, V45, P1924, DOI 10.1016/j.ejca.2009.04.007; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Raynaud CM, 2010, AM J CLIN ONCOL-CANC, V33, P341, DOI 10.1097/COC.0b013e3181b0c4c2; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ribatti D, 2009, LEUKEMIA RES, V33, P638, DOI 10.1016/j.leukres.2008.11.019; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Salk JJ, 2010, ANNU REV PATHOL-MECH, V5, P51, DOI 10.1146/annurev-pathol-121808-102113; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Seppinen L, 2008, MATRIX BIOL, V27, P535, DOI 10.1016/j.matbio.2008.03.003; Shaw RJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286pe55; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Shimoda M, 2010, SEMIN CELL DEV BIOL, V21, P19, DOI 10.1016/j.semcdb.2009.10.002; Sigal A, 2000, CANCER RES, V60, P6788; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; SINHA S, 1927, ONCOGENE S1, V27, pS137; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; SODA Y, 2011, P NATL ACAD SCI US; Strauss DC, 2010, LANCET ONCOL, V11, P790, DOI 10.1016/S1470-2045(10)70024-3; Sudarsanam S, 2010, CURR OPIN DRUG DISC, V13, P31; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Teng MWL, 2008, J LEUKOCYTE BIOL, V84, P988, DOI 10.1189/jlb.1107774; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Townson JL, 2006, CELL CYCLE, V5, P1744, DOI 10.4161/cc.5.16.2864; Turner HE, 2003, ENDOCR REV, V24, P600, DOI 10.1210/er.2002-0008; Vajdic CM, 2009, INT J CANCER, V125, P1747, DOI 10.1002/ijc.24439; Verhoeff JJC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-444; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O.H., 1930, METABOLISM TUMOURS I; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zee YK, 2010, NAT REV UROL, V7, P69, DOI 10.1038/nrurol.2009.262; Zhang H, 2004, ONCOGENE, V23, P6193, DOI 10.1038/sj.onc.1207834; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506; Zumsteg A, 2009, CURR OPIN ONCOL, V21, P60, DOI 10.1097/CCO.0b013e32831bed7e	246	39793	41426	516	11250	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					646	674		10.1016/j.cell.2011.02.013	http://dx.doi.org/10.1016/j.cell.2011.02.013			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376230	Green Submitted, Bronze			2022-12-28	WOS:000288007100007
J	Matthews, KR				Matthews, Keith R.			Controlling and Coordinating Development in Vector-Transmitted Parasites	SCIENCE			English	Review							LIFE-CYCLE DIFFERENTIATION; TRYPANOSOMA-BRUCEI; GENETIC EXCHANGE; CELL-CYCLE; MALARIA; PROTEIN; SURFACE; MECHANISM; GRANULES; MOSQUITO	Vector-borne parasites cause major human diseases of the developing world, including malaria, human African trypanosomiasis, Chagas disease, leishmaniasis, filariasis, and schistosomiasis. Although the life cycles of these parasites were defined over 100 years ago, the strategies they use to optimize their successful transmission are only now being understood in molecular terms. Parasites are now known to monitor their environment in both their host and vector and in response to other parasites. This allows them to adapt their developmental cycles and to counteract any unfavorable conditions they encounter. Here, I review the interactions that parasites engage in with their hosts and vectors to maximize their survival and spread.	Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res,Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Matthews, KR (corresponding author), Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res,Ashworth Labs, Kings Bldg, Edinburgh EH9 3JT, Midlothian, Scotland.			Matthews FRS FMedSci FRSE, Professor Keith/0000-0003-0309-9184	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Work in K.M.'s laboratory is funded by the Wellcome Trust. I thank my colleagues in the Centre for Immunity, Infection and Evolution for many useful discussions and insights that have informed several of the ideas in this review, and J. Allen and R. Carter for comments on the manuscript. I apologize to all those whose research could not be individually cited due to space constraints.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Babayan SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000525; Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Chandra M, 2004, INSECT BIOCHEM MOLEC, V34, P1163, DOI 10.1016/j.ibmb.2004.07.004; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Erickson SM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000529; Fang J, 2002, NATURE, V418, P742, DOI 10.1038/418742a; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; Garcia AB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001115; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Haines LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000793; Herman M, 2008, AUTOPHAGY, V4, P294, DOI 10.4161/auto.5443; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Jensen RE, 2008, TRENDS PARASITOL, V24, P428, DOI 10.1016/j.pt.2008.06.007; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Morrison LJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000557; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Oberle M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001023; Reece SE, 2008, NATURE, V453, P609, DOI 10.1038/nature06954; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Roditi I, 2008, CURR OPIN MICROBIOL, V11, P345, DOI 10.1016/j.mib.2008.06.006; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Rogers ME, 2004, NATURE, V430, P463, DOI 10.1038/nature02675; Rotureau B, 2009, CELL MICROBIOL, V11, P710, DOI 10.1111/j.1462-5822.2009.01295.x; Szoor B, 2010, GENE DEV, V24, P1306, DOI 10.1101/gad.570310; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; Van Den Abbeele J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000926; Vassella E, 1997, J CELL SCI, V110, P2661; Yassine H, 2010, CELL MICROBIOL, V12, P1, DOI 10.1111/j.1462-5822.2009.01388.x	39	70	71	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 4	2011	331	6021					1149	1153		10.1126/science.1198077	http://dx.doi.org/10.1126/science.1198077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385707	Green Accepted			2022-12-28	WOS:000287971200031
J	Simon, JI; Hutcheon, ID; Simon, SB; Matzel, JEP; Ramon, EC; Weber, PK; Grossman, L; DePaolo, DJ				Simon, Justin I.; Hutcheon, Ian D.; Simon, Steven B.; Matzel, Jennifer E. P.; Ramon, Erick C.; Weber, Peter K.; Grossman, Lawrence; DePaolo, Donald J.			Oxygen Isotope Variations at the Margin of a CAI Records Circulation Within the Solar Nebula	SCIENCE			English	Article							SHOCK-WAVE MODEL; REFRACTORY INCLUSIONS; CARBONACEOUS CHONDRITES; PROTOPLANETARY NEBULA; RICH INCLUSIONS; CHONDRULE; ALLENDE; DISKS; TRANSPORT; COMPONENT	Micrometer-scale analyses of a calcium-, aluminum-rich inclusion (CAI) and the characteristic mineral bands mantling the CAI reveal that the outer parts of this primitive object have a large range of oxygen isotope compositions. The variations are systematic; the relative abundance of O-16 first decreases toward the CAI margin, approaching a planetary-like isotopic composition, then shifts to extremely O-16-rich compositions through the surrounding rim. The variability implies that CAIs probably formed from several oxygen reservoirs. The observations support early and short-lived fluctuations of the environment in which CAIs formed, either because of transport of the CAIs themselves to distinct regions of the solar nebula or because of varying gas composition near the proto-Sun.	[Simon, Justin I.] NASA, Lyndon B Johnson Space Ctr, Astromat Res Off KR111, Houston, TX 77058 USA; [Simon, Justin I.; DePaolo, Donald J.] Univ Calif Berkeley, Ctr Isotope Geochem, Berkeley, CA 94720 USA; [Hutcheon, Ian D.; Matzel, Jennifer E. P.; Ramon, Erick C.; Weber, Peter K.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Simon, Steven B.; Grossman, Lawrence] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Chicago	Simon, JI (corresponding author), NASA, Lyndon B Johnson Space Ctr, Astromat Res Off KR111, Houston, TX 77058 USA.	justin.i.simon@nasa.gov	Simon, Justin/D-7015-2011; Weber, Peter Kilian/AAP-9517-2020	Weber, Peter Kilian/0000-0001-6022-6050; Matzel, Jennifer/0000-0003-2898-2790	Institute of Geophysics and Planetary Physics at LLNL; NASA; U.S. Department of Energy at LLNL [DE-AC52-07NA27344]	Institute of Geophysics and Planetary Physics at LLNL; NASA(National Aeronautics & Space Administration (NASA)); U.S. Department of Energy at LLNL	This work was supported by grants from the Institute of Geophysics and Planetary Physics at LLNL (J.I.S. and D.J.D.), the NASA Origins program (I.D.H., J.E.P.M., and J.I.S.), and the NASA Cosmochemistry program (L.G. and I.D.H.). Work was performed under the auspices of the U.S. Department of Energy at LLNL under contract DE-AC52-07NA27344.	Alexander CMO, 2004, GEOCHIM COSMOCHIM AC, V68, P3943, DOI 10.1016/j.gca.2004.03.030; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Ciesla FJ, 2009, ICARUS, V200, P655, DOI 10.1016/j.icarus.2008.12.009; CLAYTON RN, 1977, EARTH PLANET SC LETT, V34, P209, DOI 10.1016/0012-821X(77)90005-X; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Connolly HC, 1998, SCIENCE, V280, P62, DOI 10.1126/science.280.5360.62; Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904; Cuzzi JN, 2008, ASTROPHYS J, V687, P1432, DOI 10.1086/591239; Cuzzi JN, 2003, ICARUS, V166, P385, DOI 10.1016/j.icarus.2003.08.016; Grossman L, 2000, GEOCHIM COSMOCHIM AC, V64, P2879, DOI 10.1016/S0016-7037(00)00396-3; HOOD LL, 1993, ICARUS, V106, P179, DOI 10.1006/icar.1993.1165; Krot AN, 2008, GEOCHIM COSMOCHIM AC, V72, P2534, DOI 10.1016/j.gca.2008.02.011; Krot AN, 2002, SCIENCE, V295, P1051, DOI 10.1126/science.1068200; MACPHERSON GJ, 1981, EARTH PLANET SC LETT, V52, P16, DOI 10.1016/0012-821X(81)90203-X; McKeegan KD, 1998, SCIENCE, V280, P414, DOI 10.1126/science.280.5362.414; RYERSON FJ, 1994, GEOCHIM COSMOCHIM AC, V58, P3713, DOI 10.1016/0016-7037(94)90161-9; Simon JI, 2005, EARTH PLANET SC LETT, V238, P272, DOI 10.1016/j.epsl.2005.08.004; Simon SB, 2007, GEOCHIM COSMOCHIM AC, V71, P3098, DOI 10.1016/j.gca.2007.03.027; Simon SB, 1999, GEOCHIM COSMOCHIM AC, V63, P1233, DOI 10.1016/S0016-7037(99)00046-0; Wark D. A., 1977, P 8 LUN SCI C, V8, P95; Wood JA, 1996, METORIT PLANET SCI, V31, P641, DOI 10.1111/j.1945-5100.1996.tb02037.x; Young ED, 2005, SCIENCE, V308, P223, DOI 10.1126/science.1108140; Young ED, 2001, PHILOS T ROY SOC A, V359, P2095, DOI 10.1098/rsta. 2001.0900	27	78	78	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1175	1178		10.1126/science.1197970	http://dx.doi.org/10.1126/science.1197970			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385711				2022-12-28	WOS:000287971200037
J	Temme, K; Osborne, TJ; Vollbrecht, KG; Poulin, D; Verstraete, F				Temme, K.; Osborne, T. J.; Vollbrecht, K. G.; Poulin, D.; Verstraete, F.			Quantum Metropolis sampling	NATURE			English	Article							COMPUTATION; ALGORITHMS; COMPLEXITY; SYSTEMS	The original motivation to build a quantum computer came from Feynman(1), who imagined a machine capable of simulating generic quantum mechanical systems-a task that is believed to be intractable for classical computers. Such a machine could have far-reaching applications in the simulation of many-body quantum physics in condensed-matter, chemical and high-energy systems. Part of Feynman's challenge was met by Lloyd(2), who showed how to approximately decompose the time evolution operator of interacting quantum particles into a short sequence of elementary gates, suitable for operation on a quantum computer. However, this left open the problem of how to simulate the equilibrium and static properties of quantum systems. This requires the preparation of ground and Gibbs states on a quantum computer. For classical systems, this problem is solved by the ubiquitous Metropolis algorithm(3), a method that has basically acquired a monopoly on the simulation of interacting particles. Here we demonstrate how to implement a quantum version of the Metropolis algorithm. This algorithm permits sampling directly from the eigenstates of the Hamiltonian, and thus evades the sign problem present in classical simulations. A small-scale implementation of this algorithm should be achievable with today's technology.	[Temme, K.; Verstraete, F.] Univ Vienna, Fak Phys, Vienna Ctr Quantum Sci & Technol, A-1090 Vienna, Austria; [Osborne, T. J.] Leibniz Univ Hannover, Inst Theoret Phys, D-30167 Hannover, Germany; [Vollbrecht, K. G.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Poulin, D.] Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada	University of Vienna; Leibniz University Hannover; Max Planck Society; University of Sherbrooke	Verstraete, F (corresponding author), Univ Vienna, Fak Phys, Vienna Ctr Quantum Sci & Technol, Waehringer Guertel 18, A-1090 Vienna, Austria.	fverstraete@gmail.com	Poulin, David/A-1481-2010; Verstraete, Frank/F-1306-2014; Temme, Kristan/O-9221-2016; Osborne, Tobias J./D-3271-2014; Osborne, Tobias J./X-9977-2019	Verstraete, Frank/0000-0003-0270-5592; Osborne, Tobias J./0000-0002-0688-2345	FWF; EPSRC; DFG [FG 635]; NSERC; MITACS; FQRNT; European grant QUEVADIS; ERC; Engineering and Physical Sciences Research Council [EP/G045771/1] Funding Source: researchfish; EPSRC [EP/G045771/1] Funding Source: UKRI	FWF(Austrian Science Fund (FWF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); DFG(German Research Foundation (DFG)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); MITACS; FQRNT(FQRNT); European grant QUEVADIS; ERC(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We would like to thank S. Bravyi, C. Dellago, J. Kempe and H. Verschelde for discussions. Part of this work was done during a workshop at the Erwin Schrodinger Institute for Mathematical Physics. K.T. was supported by the FWF programme CoQuS. T.J.O. was supported, in part, by EPSRC. K.G.V. is supported by DFG FG 635. D.P. is partly funded by NSERC, MITACS and FQRNT. F.V. is supported by the FWF grants FoQuS and ViCoM, by the European grant QUEVADIS and by the ERC grant QUERG.	Abrams DS, 1997, PHYS REV LETT, V79, P2586, DOI 10.1103/PhysRevLett.79.2586; Abrams DS, 1999, PHYS REV LETT, V83, P5162, DOI 10.1103/PhysRevLett.83.5162; Aharonov D., 2002, QUANTUM NP SURVEY; Aharonov D, 2009, COMMUN MATH PHYS, V287, P41, DOI 10.1007/s00220-008-0710-3; Aspuru-Guzik A, 2005, SCIENCE, V309, P1704, DOI 10.1126/science.1113479; Binder K., 1995, MONTE CARLO MOL DYNA; Durr S, 2008, SCIENCE, V322, P1224, DOI 10.1126/science.1163233; Evertz HG, 2003, ADV PHYS, V52, P1, DOI 10.1080/0001873021000049195; Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Jordan P, 1928, Z PHYS, V47, P631, DOI 10.1007/BF01331938; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kitaev AY., 2002, CLASSICAL QUANTUM CO, V47; Liu JW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.035504; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Marriott C, 2005, COMPUT COMPLEX, V14, P122, DOI 10.1007/s00037-005-0194-x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Oliveira R, 2008, QUANTUM INF COMPUT, V8, P900; Poulin D, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.220502; Schuch N, 2009, NAT PHYS, V5, P732, DOI 10.1038/NPHYS1370; Somma RD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.130504; Suzuki M., 1987, SPRINGER SER SOLID S, V74; SWENDSEN RH, 1987, PHYS REV LETT, V58, P86, DOI 10.1103/PhysRevLett.58.86; Szegedy M, 2004, ANN IEEE SYMP FOUND, P32, DOI 10.1109/FOCS.2004.53; Terhal BM, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.022301; Verstraete F, 2009, NAT PHYS, V5, P633, DOI 10.1038/NPHYS1342; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0	30	135	135	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					87	90		10.1038/nature09770	http://dx.doi.org/10.1038/nature09770			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368829	Green Published, Green Submitted			2022-12-28	WOS:000287924100039
J	Keil, FC				Keil, Frank C.			Science Starts Early	SCIENCE			English	Editorial Material							ORIGINS; LEARN		Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Keil, FC (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	frank.keil@yale.edu			NICHD NIH HHS [R37 HD023922, R37-HD023922] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD023922] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ahn WK, 2002, MEM COGNITION, V30, P107, DOI 10.3758/BF03195270; Bloom P, 2007, SCIENCE, V316, P996, DOI 10.1126/science.1133398; Carey S., 2009, ORIGIN CONCEPTS; Duschl R. A., 2007, TAKING SCI SCH LEARN, DOI DOI 10.17226/11625; Frank MC, 2009, DEVELOPMENTAL SCI, V12, P504, DOI 10.1111/j.1467-7687.2008.00794.x; Gelman S. A., 2009, ESSENTIAL CHILD ORIG; GILPEREZ D, 1990, SCI EDUC, V74, P531, DOI 10.1002/sce.3730740504; Griffiths TL, 2009, PSYCHOL REV, V116, P661, DOI 10.1037/a0017201; Inagaki K, 2006, CURR DIR PSYCHOL SCI, V15, P177, DOI 10.1111/j.1467-8721.2006.00431.x; LESLIE AM, 1987, COGNITION, V25, P265, DOI 10.1016/S0010-0277(87)80006-9; Newman GE, 2008, COGNITIVE PSYCHOL, V57, P262, DOI 10.1016/j.cogpsych.2008.02.003; Newman GE, 2010, P NATL ACAD SCI USA, V107, P17140, DOI 10.1073/pnas.0914056107; Schulz LE, 2007, DEVELOPMENTAL SCI, V10, P322, DOI 10.1111/j.1467-7687.2007.00587.x; Shtulman A, 2008, COGNITIVE SCI, V32, P1049, DOI 10.1080/03640210801897864; Sobel DM, 2010, CHILD DEV, V81, P669, DOI 10.1111/j.1467-8624.2009.01422.x; Strevens M., 2009, DEPTH ACCOUNT SCI EX	16	23	23	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1022	1023		10.1126/science.1195221	http://dx.doi.org/10.1126/science.1195221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726DM	21350159				2022-12-28	WOS:000287699000043
J	Cressey, D				Cressey, Daniel			BATTLE SCARS	NATURE			English	News Item																			0	18	19	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					452	453		10.1038/470452a	http://dx.doi.org/10.1038/470452a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350461	Bronze			2022-12-28	WOS:000287652900011
J	Fawcett, PJ; Werne, JP; Anderson, RS; Heikoop, JM; Brown, ET; Berke, MA; Smith, SJ; Goff, F; Donohoo-Hurley, L; Cisneros-Dozal, LM; Schouten, S; Damste, JSS; Huang, YS; Toney, J; Fessenden, J; WoldeGabriel, G; Atudorei, V; Geissman, JW; Allen, CD				Fawcett, Peter J.; Werne, Josef P.; Anderson, R. Scott; Heikoop, Jeffrey M.; Brown, Erik T.; Berke, Melissa A.; Smith, Susan J.; Goff, Fraser; Donohoo-Hurley, Linda; Cisneros-Dozal, Luz M.; Schouten, Stefan; Damste, Jaap S. Sinninghe; Huang, Yongsong; Toney, Jaime; Fessenden, Julianna; WoldeGabriel, Giday; Atudorei, Viorel; Geissman, John W.; Allen, Craig D.			Extended megadroughts in the southwestern United States during Pleistocene interglacials	NATURE			English	Article							CLIMATE VARIABILITY; DROUGHT; RECONSTRUCTIONS; MONSOON; AFRICA; MEXICO; RECORD	The potential for increased drought frequency and severity linked to anthropogenic climate change in the semi-arid regions of the southwestern United States (US) is a serious concern(1). Multi-year droughts during the instrumental period(2) and decadal-length droughts of the past two millennia(1,3) were shorter and climatically different from the future permanent, 'dust-bowl-like' mega-drought conditions, lasting decades to a century, that are predicted as a consequence of warming(4). So far, it has been unclear whether or not such megadroughts occurred in the southwestern US, and, if so, with what regularity and intensity. Here we show that periods of aridity lasting centuries to millennia occurred in the southwestern US during mid-Pleistocene interglacials. Using molecular palaeo-temperature proxies(5) to reconstruct the mean annual temperature (MAT) in mid-Pleistocene lacustrine sediment from the Valles Caldera, New Mexico, we found that the driest conditions occurred during the warmest phases of interglacials, when the MAT was comparable to or higher than the modern MAT. A collapse of drought-tolerant C-4 plant communities during these warm, dry intervals indicates a significant reduction in summer precipitation, possibly in response to a poleward migration of the subtropical dry zone. Three MAT cycles similar to 2 degrees C in amplitude occurred within Marine Isotope Stage (MIS) 11 and seem to correspond to the muted precessional cycles within this interglacial. In comparison with MIS 11, MIS 13 experienced higher precessional-cycle amplitudes, larger variations in MAT (4-6 degrees C) and a longer period of extended warmth, suggesting that local insolation variations were important to interglacial climatic variability in the southwestern US. Comparison of the early MIS 11 climate record with the Holocene record shows many similarities and implies that, in the absence of anthropogenic forcing, the region should be entering a cooler and wetter phase.	[Fawcett, Peter J.; Goff, Fraser; Donohoo-Hurley, Linda; Atudorei, Viorel; Geissman, John W.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Werne, Josef P.] Univ Minnesota, Dept Chem & Biochem, Duluth, MN 55812 USA; [Werne, Josef P.; Brown, Erik T.; Berke, Melissa A.] Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA; [Brown, Erik T.; Berke, Melissa A.] Univ Minnesota, Dept Geol Sci, Duluth, MN 55812 USA; [Werne, Josef P.] Univ Western Australia, Ctr Water Res, Crawley, WA 6009, Australia; [Werne, Josef P.] Curtin Univ Technol, WA Organ & Isotope Geochem Ctr, Bentley, WA 6845, Australia; [Anderson, R. Scott; Fessenden, Julianna; WoldeGabriel, Giday] Univ Arizona, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA; [Anderson, R. Scott; Smith, Susan J.] Univ Arizona, Bilby Res Ctr, Lab Paleoecol, Flagstaff, AZ 86011 USA; [Heikoop, Jeffrey M.; Cisneros-Dozal, Luz M.; Toney, Jaime] Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA; [Schouten, Stefan; Damste, Jaap S. Sinninghe] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Netherlands; [Huang, Yongsong] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Allen, Craig D.] USGS Ft Collins Sci Ctr, Jemez Mt Field Stn, Los Alamos, NM 87544 USA	University of New Mexico; University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth; University of Western Australia; Curtin University; University of Arizona; University of Arizona; United States Department of Energy (DOE); Los Alamos National Laboratory; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Brown University; United States Department of the Interior; United States Geological Survey	Fawcett, PJ (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.	fawcett@unm.edu	Toney, Jaime L./I-5083-2012; Heikoop, Jeffrey M/C-1163-2011; Berke, Melissa A/H-3819-2016; Allen, Craig D./K-1121-2019; Damste, Jaap S Sinninghe/F-6128-2011	Toney, Jaime L./0000-0003-3182-6887; Heikoop, Jeffrey M/0000-0001-7648-3385; Allen, Craig D./0000-0002-8777-5989; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Brown, Erik T/0000-0001-7154-2729; Cisneros-Dozal, Luz Maria/0000-0002-4595-5607; Berke, Melissa/0000-0003-4810-3773; Werne, Josef/0000-0002-7019-6024	NSF; IGPP LANL; USGS Western Mountain Initiative; Gledden Fellowship; Division Of Earth Sciences [0903016] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); IGPP LANL; USGS Western Mountain Initiative; Gledden Fellowship; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank A. Mets for analytical support, W. McIntosh for the Ar-Ar age determination, T. Wawrzyniec and A. Ellwein for drilling help, and the Valles Caldera Trust for permission to drill in the Valle Grande. Core assistance was provided by LRC/LacCore. This work was supported by the NSF Paleoclimate and P2C2 programs, IGPP LANL and the USGS Western Mountain Initiative. Support from the Gledden Fellowship is acknowledged. This work forms contribution 2399-JW at the Centre for Water Research, The University of Western Australia and contribution 131 at the Laboratory of Paleoecology, Northern Arizona University.	Anderson RS, 2008, QUATERNARY RES, V69, P263, DOI 10.1016/j.yqres.2007.12.002; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; DOUGLAS MW, 1993, J CLIMATE, V6, P1665, DOI 10.1175/1520-0442(1993)006<1665:TMM>2.0.CO;2; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; ENZEL Y, 1989, NATURE, V341, P44, DOI 10.1038/341044a0; Guo ZT, 2009, CLIM PAST, V5, P21, DOI 10.5194/cp-5-21-2009; Huang Y, 2001, SCIENCE, V293, P1647, DOI 10.1126/science.1060143; Jimenez-Moreno G, 2008, QUATERNARY SCI REV, V27, P1442, DOI 10.1016/j.quascirev.2008.04.004; Johnson DW, 1998, WATER AIR SOIL POLL, V105, P251, DOI 10.1023/A:1005039711434; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kutzbach J. E., 2000, QUATERNARY SCI REV, V17, P473; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Loutre MF, 2003, GLOBAL PLANET CHANGE, V36, P209, DOI 10.1016/S0921-8181(02)00186-8; McCabe GJ, 2004, P NATL ACAD SCI USA, V101, P4136, DOI 10.1073/pnas.0306738101; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Meyers PA, 2003, ORG GEOCHEM, V34, P261, DOI 10.1016/S0146-6380(02)00168-7; Namias J., 1955, MON WEA REV, V83, P199, DOI [https://doi.org/10.1175/1520-0493(1955)0832.0.CO;2, DOI 10.1175/1520-0493(1955)083<0199:SMAOD>2.0.CO;2]; Poore RZ, 2005, GEOLOGY, V33, P209, DOI 10.1130/G21040.1; Prokopenko AA, 1999, EARTH PLANET SC LETT, V172, P239, DOI 10.1016/S0012-821X(99)00203-4; Prokopenko AA, 2002, NATURE, V418, P65, DOI 10.1038/nature00886; Rossignol-Strick M, 1998, NATURE, V392, P269, DOI 10.1038/32631; Schubert SD, 2004, SCIENCE, V303, P1855, DOI 10.1126/science.1095048; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Weijers JWH, 2007, SCIENCE, V315, P1701, DOI 10.1126/science.1138131; Weijers JWH, 2007, GEOCHIM COSMOCHIM AC, V71, P703, DOI 10.1016/j.gca.2006.10.003; Woodhouse CA, 2010, P NATL ACAD SCI USA, V107, P21283, DOI 10.1073/pnas.0911197107	28	96	104	9	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					518	521		10.1038/nature09839	http://dx.doi.org/10.1038/nature09839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350483				2022-12-28	WOS:000287652900038
J	Sandberg, MK; Al-Doujaily, H; Sharps, B; Clarke, AR; Collinge, J				Sandberg, Malin K.; Al-Doujaily, Huda; Sharps, Bernadette; Clarke, Anthony R.; Collinge, John			Prion propagation and toxicity in vivo occur in two distinct mechanistic phases	NATURE			English	Article							MOUSE SCRAPIE; MICE; DISEASE; PROTEIN; PRP; REPLICATION; PATHOGENESIS; INFECTIVITY; RESISTANT; STRAINS	Mammalian prions cause fatal neurodegenerative conditions including Creutzfeldt-Jakob disease in humans and scrapie and bovine spongiform encephalopathy in animals(1). Prion infections are typically associated with remarkably prolonged but highly consistent incubation periods followed by a rapid clinical phase. The relationship between prion propagation, generation of neurotoxic species and clinical onset has remained obscure. Prion incubation periods in experimental animals are known to vary inversely with expression level of cellular prion protein. Here we demonstrate that prion propagation in brain proceeds via two distinct phases: a clinically silent exponential phase not rate-limited by prion protein concentration which rapidly reaches a maximal prion titre, followed by a distinct switch to a plateau phase. The latter determines time to clinical onset in a manner inversely proportional to prion protein concentration. These findings demonstrate an uncoupling of infectivity and toxicity. We suggest that prions themselves are not neurotoxic but catalyse the formation of such species from PrPC. Production of neurotoxic species is triggered when prion propagation saturates, leading to a switch from autocatalytic production of infectivity (phase 1) to a toxic (phase 2) pathway.	[Sandberg, Malin K.; Al-Doujaily, Huda; Sharps, Bernadette; Clarke, Anthony R.; Collinge, John] UCL Inst Neurol, MRC Prion Unit, London WC1N 3BG, England; [Sandberg, Malin K.; Al-Doujaily, Huda; Sharps, Bernadette; Clarke, Anthony R.; Collinge, John] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Collinge, J (corresponding author), UCL Inst Neurol, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk			UK Medical Research Council; MRC [MC_U123192748, MC_U123160656] Funding Source: UKRI; Medical Research Council [MC_U123192748, MC_U123160656] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council. We thank J. Wadsworth for critical review of the manuscript, S. Walker for statistical advice, staff of our Biological Services Facility for animal care and technical assistance and R. Young for preparation of figures.	Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; CZUB M, 1986, J GEN VIROL, V67, P2005, DOI 10.1099/0022-1317-67-9-2005; DICKINSON AG, 1975, GENETICS, V79, P387; DICKINSON AG, 1972, NATURE-NEW BIOL, V237, P244, DOI 10.1038/newbio237244a0; DICKINSON AG, 1969, J COMP PATHOL, V79, P15, DOI 10.1016/0021-9975(69)90021-8; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hill AF, 2003, TRENDS MICROBIOL, V11, P578, DOI 10.1016/j.tim.2003.10.007; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Thackray AM, 2003, J VIROL, V77, P7991, DOI 10.1128/JVI.77.14.7991-7998.2003; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002	30	221	222	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					540	542		10.1038/nature09768	http://dx.doi.org/10.1038/nature09768			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21350487				2022-12-28	WOS:000287652900043
J	Zheng, W; McLerran, DF; Rolland, B; Zhang, XL; Inoue, M; Matsuo, K; He, JA; Gupta, PC; Ramadas, K; Tsugane, S; Irie, F; Tamakoshi, A; Gao, YT; Wang, RW; Shu, XO; Tsuji, I; Kuriyama, S; Tanaka, H; Satoh, H; Chen, CJ; Yuan, JM; Yoo, KY; Ahsan, H; Pan, WH; Gu, DF; Pednekar, MS; Sauvaget, C; Sasazuki, S; Sairenchi, T; Yang, G; Xiang, YB; Nagai, M; Suzuki, T; Nishino, Y; You, SL; Koh, WP; Park, SK; Chen, Y; Shen, CY; Thornquist, M; Feng, ZD; Kang, DH; Boffetta, P; Potter, JD				Zheng, Wei; McLerran, Dale F.; Rolland, Betsy; Zhang, Xianglan; Inoue, Manami; Matsuo, Keitaro; He, Jiang; Gupta, Prakash Chandra; Ramadas, Kunnambath; Tsugane, Shoichiro; Irie, Fujiko; Tamakoshi, Akiko; Gao, Yu-Tang; Wang, Renwei; Shu, Xiao-Ou; Tsuji, Ichiro; Kuriyama, Shinichi; Tanaka, Hideo; Satoh, Hiroshi; Chen, Chien-Jen; Yuan, Jian-Min; Yoo, Keun-Young; Ahsan, Habibul; Pan, Wen-Harn; Gu, Dongfeng; Pednekar, Mangesh Suryakant; Sauvaget, Catherine; Sasazuki, Shizuka; Sairenchi, Toshimi; Yang, Gong; Xiang, Yong-Bing; Nagai, Masato; Suzuki, Takeshi; Nishino, Yoshikazu; You, San-Lin; Koh, Woon-Puay; Park, Sue K.; Chen, Yu; Shen, Chen-Yang; Thornquist, Mark; Feng, Ziding; Kang, Daehee; Boffetta, Paolo; Potter, John D.			Association between Body-Mass Index and Risk of Death in More Than 1 Million Asians	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROSPECTIVE COHORT; MORTALITY; OBESITY; OVERWEIGHT; WEIGHT; WOMEN; MEN	BACKGROUND Most studies that have evaluated the association between the body-mass index (BMI) and the risks of death from any cause and from specific causes have been conducted in populations of European origin. METHODS We performed pooled analyses to evaluate the association between BMI and the risk of death among more than 1.1 million persons recruited in 19 cohorts in Asia. The analyses included approximately 120,700 deaths that occurred during a mean follow-up period of 9.2 years. Cox regression models were used to adjust for confounding factors. RESULTS In the cohorts of East Asians, including Chinese, Japanese, and Koreans, the lowest risk of death was seen among persons with a BMI (the weight in kilograms divided by the square of the height in meters) in the range of 22.6 to 27.5. The risk was elevated among persons with BMI levels either higher or lower than that range - by a factor of up to 1.5 among those with a BMI of more than 35.0 and by a factor of 2.8 among those with a BMI of 15.0 or less. A similar U-shaped association was seen between BMI and the risks of death from cancer, from cardiovascular diseases, and from other causes. In the cohorts comprising Indians and Bangladeshis, the risks of death from any cause and from causes other than cancer or cardiovascular disease were increased among persons with a BMI of 20.0 or less, as compared with those with a BMI of 22.6 to 25.0, whereas there was no excess risk of either death from any cause or cause-specific death associated with a high BMI. CONCLUSIONS Underweight was associated with a substantially increased risk of death in all Asian populations. The excess risk of death associated with a high BMI, however, was seen among East Asians but not among Indians and Bangladeshis.	[Zheng, Wei; Zhang, Xianglan; Shu, Xiao-Ou; Yang, Gong] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Med, Div Epidemiol, Nashville, TN 37203 USA; [McLerran, Dale F.; Rolland, Betsy; Thornquist, Mark; Feng, Ziding; Potter, John D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Inoue, Manami; Tsugane, Shoichiro; Sasazuki, Shizuka] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 104, Japan; [Matsuo, Keitaro; Tanaka, Hideo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Suzuki, Takeshi] Nagoya City Univ, Grad Sch Med Sci, Dept Med Oncol & Immunol, Nagoya, Aichi, Japan; [Irie, Fujiko] Ibaraki Prefectural Govt, Dept Hlth & Social Serv, Ibaraki, Japan; [Tamakoshi, Akiko] Aichi Med Univ, Sch Med, Dept Publ Hlth, Aichi, Japan; [Tsuji, Ichiro; Kuriyama, Shinichi; Nagai, Masato] Tohoku Univ, Grad Sch Med, Dept Publ Hlth & Forens Med, Div Epidemiol, Sendai, Miyagi 980, Japan; [Sairenchi, Toshimi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Nishino, Yoshikazu] Miyagi Canc Ctr, Res Inst, Div Epidemiol, Ishinomaki, Miyagi, Japan; [He, Jiang] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Gupta, Prakash Chandra; Pednekar, Mangesh Suryakant] Healis Sekhsaria Inst Publ Hlth, Bombay, Maharashtra, India; [Ramadas, Kunnambath] Reg Canc Ctr, Div Radiat Oncol, Trivandrum 695011, Kerala, India; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Wang, Renwei; Yuan, Jian-Min] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Chen, Chien-Jen; You, San-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taiwan Biobank, Taipei 115, Taiwan; [Chen, Chien-Jen; Pan, Wen-Harn] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan; [Pan, Wen-Harn] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Shen, Chen-Yang] China Med Univ, Grad Inst Environm Sci, Taichung, Taiwan; [Yoo, Keun-Young; Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Inst Hlth Policy & Management, Seoul, South Korea; [Ahsan, Habibul] Univ Chicago, Dept Hlth Studies Med & Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA; [Gu, Dongfeng] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100037, Peoples R China; [Gu, Dongfeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China; [Gu, Dongfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gu, Dongfeng] China Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Sauvaget, Catherine] Int Agcy Res Canc, Prevent & Early Detect Sect, Screening Grp, F-69372 Lyon, France; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [Koh, Woon-Puay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Chen, Yu] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA	Vanderbilt University; Fred Hutchinson Cancer Center; National Cancer Center - Japan; Aichi Cancer Center; Nagoya City University; Aichi Medical University; Tohoku University; Dokkyo Medical University; Miyagi Cancer Center; Tulane University; Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; China Medical University Taiwan; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Chicago; University of Chicago; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; World Health Organization; International Agency for Research on Cancer (IARC); National University of Singapore; New York University; Icahn School of Medicine at Mount Sinai	Zheng, W (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Epidemiol Ctr, 2525 W End Ave,8th Fl, Nashville, TN 37203 USA.	wei.zheng@vanderbilt.edu	Tanaka, Hideo/A-8145-2016; Shen, CY/F-6271-2010; Boffetta, Paolo/AAI-7767-2021; Chen, Chien-Jen/C-6976-2008; Gao, Yu/HGE-1937-2022; gao, yi/HCI-8298-2022; Matsuo, Keitaro/H-6758-2019; Kang, Dae Hee/E-8631-2012; Tsugane, Shoichiro/A-2424-2015; Park, Sue Kyung/J-2757-2012; Yoo, Keun-Young/J-5548-2012; He, Jiang/AAF-5303-2020; Chen, Chien-Jen/N-4723-2019; Nagai, Masato/ABC-6862-2020; Gao, Y./GWZ-3665-2022; zhang, weihua/GXV-1334-2022; Tamakoshi, Akiko/D-5105-2012; Zheng, Wei/O-3351-2013	Boffetta, Paolo/0000-0002-3811-2791; Matsuo, Keitaro/0000-0003-1761-6314; Tsugane, Shoichiro/0000-0003-4105-2774; He, Jiang/0000-0002-8286-9652; Nagai, Masato/0000-0003-0818-3158; Zheng, Wei/0000-0003-1226-070X; Potter, John/0000-0001-5439-1500; Kang, Daehee/0000-0003-4031-5878; Sairenchi, Toshimi/0000-0001-8896-6501; Chen, Yu/0000-0002-1519-4894; Yuan, Jian-Min/0000-0002-4620-3108; Pednekar, Mangesh/0000-0001-6266-5356; Sauvaget, Catherine/0000-0002-8053-4963	CDC Foundation for Global Adult Tobacco Survey; World Lung Foundation for advancing tobacco control in India; Institute for Community Research; NATIONAL CANCER INSTITUTE [R01CA082729, R37CA070867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017541] Funding Source: NIH RePORTER	CDC Foundation for Global Adult Tobacco Survey; World Lung Foundation for advancing tobacco control in India; Institute for Community Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Dr. Gupta reports receiving consulting fees from the CDC Foundation for Global Adult Tobacco Survey. His institution, Healis-Sekhsaria Institute for Public Health, has received grants from the World Lung Foundation for advancing tobacco control in India and consulting fees from the Institute for Community Research for a project on the use of smokeless tobacco in an urban slum in Mumbai, India. No other potential conflict of interest relevant to this article was reported.	Abelson P, 2004, SCIENCE, V304, P1413, DOI 10.1126/science.304.5676.1413; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Lewis CE, 2009, CIRCULATION, V119, P3263, DOI 10.1161/CIRCULATIONAHA.109.192574; Lopez-Jimenez F, 2009, LANCET, V373, P1055, DOI 10.1016/S0140-6736(09)60628-0; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Pischon T, 2010, NEW ENGL J MED, V362, P2433; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Zhang X, 2008, INT J OBESITY, V32, P1130, DOI 10.1038/ijo.2008.63; Zhang XL, 2007, ARCH INTERN MED, V167, P886, DOI 10.1001/archinte.167.9.886	21	581	616	1	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					719	729		10.1056/NEJMoa1010679	http://dx.doi.org/10.1056/NEJMoa1010679			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345101	Green Accepted, Green Submitted			2022-12-28	WOS:000287652500006
J	Jasanoff, S				Jasanoff, Sheila			A Living Constitution	SCIENCE			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University	Jasanoff, S (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.								0	2	3	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					872	872		10.1126/science.1203467	http://dx.doi.org/10.1126/science.1203467			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722SO	21330528				2022-12-28	WOS:000287455100039
J	Rikken, GLJA				Rikken, Geert L. J. A.			A New Twist on Spintronics	SCIENCE			English	Editorial Material									CNRS INSA UJF UPS, Lab Natl Champs Magnet Intenses, F-31400 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse	Rikken, GLJA (corresponding author), CNRS INSA UJF UPS, Lab Natl Champs Magnet Intenses, 143 Ave Rangueil, F-31400 Toulouse, France.	geert.rikken@lncmi.cnrs.fr						Bader SD, 2010, ANNU REV CONDEN MA P, V1, P71, DOI 10.1146/annurev-conmatphys-070909-104123; Furusho Y, 2009, J POLYM SCI POL CHEM, V47, P5195, DOI 10.1002/pola.23596; Gohler B, 2011, SCIENCE, V331, P894, DOI 10.1126/science.1199339; LASSAILLY Y, 1994, PHYS REV B, V50, P13054, DOI 10.1103/PhysRevB.50.13054; MAYER S, 1995, PHYS REV LETT, V74, P4803, DOI 10.1103/PhysRevLett.74.4803; Rikken GLJA, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.236602; Robbie K, 1996, NATURE, V384, P616, DOI 10.1038/384616a0	7	33	34	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					864	865		10.1126/science.1201663	http://dx.doi.org/10.1126/science.1201663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330521				2022-12-28	WOS:000287455100033
J	Kollatschny, W; Zetzl, M				Kollatschny, Wolfram; Zetzl, Matthias			Broad-line active galactic nuclei rotate faster than narrow-line ones	NATURE			English	Article							SUPERMASSIVE BLACK-HOLES; GALAXIES; PROFILE; REGION; REVERBERATION; QUASARS; MASSES	The super-massive black holes of 10(6)M(circle dot) to 10(9)M(circle dot) that reside in the nuclei of active galaxies(1) (AGN) are surrounded by a region emitting broad lines, probably associated with an accretion disk. The diameters of the broad-line regions range from a few light-days to more than a hundred light-days(1), and cannot be resolved spatially. The relative significance of inflow, outflow, rotational or turbulent motions in the broad-line regions as well as their structure (spherical, thin or thick accretion disk) are unknown despite intensive studies over more than thirty years(2,3). Here we report a fundamental relation between the observed emission linewidth full-width at half-maximum (FWHM) and the emission line shape FWHM/sigma(line) in AGN spectra. From this relation we infer that the predominant motion in the broad-line regions is Keplerian rotation in combination with turbulence. The geometry of the inner region varies systematically with the rotation velocity: it is flattest for the fast-rotating broad-line objects, whereas slow-rotating narrow-line AGN have a more spherical structure. Superimposed is the trend that the line-emitting region becomes geometrically thicker towards the centre within individual galaxies. Knowing the rotational velocities, we can derive the central black-hole masses more accurately; they are two to ten times smaller than has been estimated previously.	[Kollatschny, Wolfram; Zetzl, Matthias] Univ Gottingen, Inst Astrophys, D-37077 Gottingen, Germany	University of Gottingen	Kollatschny, W (corresponding author), Univ Gottingen, Inst Astrophys, Friedrich Hund Pl 1, D-37077 Gottingen, Germany.	wkollat@astro.physik.uni-goettingen.de	Kollatschny, Wolfram/AAH-7346-2021		Niedersachsen-Israel Research Cooperation Program [ZN2318]	Niedersachsen-Israel Research Cooperation Program	We acknowledge discussions with W. Glatzel and S. Dreizler. This work has been supported by the Niedersachsen-Israel Research Cooperation Program ZN2318.	Baskin A, 2005, MON NOT R ASTRON SOC, V356, P1029, DOI 10.1111/j.1365-2966.2004.08525.x; Bevington PR., 2002, DATA REDUCTION ERROR; Blandford R.D., 1990, ACTIVE GALACTIC NUCL, P161; BLUMENTHAL GR, 1975, ASTROPHYS J, V198, P517, DOI 10.1086/153628; Collin S, 2006, ASTRON ASTROPHYS, V456, P75, DOI 10.1051/0004-6361:20064878; Elvis M, 2000, ASTROPHYS J, V545, P63, DOI 10.1086/317778; HUBENY I, 1985, B ASTRON I CZECH, V36, P214; Hubeny I., 1994, NEWSLETTER ANAL ASTR, P30; Kollatschny W, 2003, ASTRON ASTROPHYS, V412, pL61, DOI 10.1051/0004-6361:20034611; Kollatschny W, 2003, ASTRON ASTROPHYS, V407, P461, DOI 10.1051/0004-6361:20030928; Netzer H, 2003, ASTROPHYS J, V583, pL5, DOI 10.1086/368012; Netzer H, 2007, ASTROPHYS J, V671, P1256, DOI 10.1086/523035; Peterson BM, 2004, ASTROPHYS J, V613, P682, DOI 10.1086/423269; Peterson BM, 1999, ASTROPHYS J, V521, pL95, DOI 10.1086/312190; PRESS WH, 1992, NUMERICAL RECIPES C, pCH15; PRINGLE JE, 1981, ANNU REV ASTRON ASTR, V19, P137, DOI 10.1146/annurev.aa.19.090181.001033; Sulentic JW, 2000, ANNU REV ASTRON ASTR, V38, P521, DOI 10.1146/annurev.astro.38.1.521; Sulentic JW, 2000, ASTROPHYS J, V536, pL5, DOI 10.1086/312717; Zamfir S, 2010, MON NOT R ASTRON SOC, V403, P1759, DOI 10.1111/j.1365-2966.2009.16236.x	19	52	52	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2011	470	7334					366	368		10.1038/nature09761	http://dx.doi.org/10.1038/nature09761			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21331037				2022-12-28	WOS:000287409100035
J	Zhang, HB; Zhou, XH; McQuade, T; Li, JH; Chan, FKM; Zhang, JK				Zhang, Haibing; Zhou, Xiaohui; McQuade, Thomas; Li, Jinghe; Chan, Francis Ka-Ming; Zhang, Jianke			Functional complementation between FADD and RIP1 in embryos and lymphocytes	NATURE			English	Article							RECEPTOR-INTERACTING PROTEIN; DEATH DOMAIN PROTEIN; CELL-DEATH; KINASE RIP; PROGRAMMED NECROSIS; FAS; APOPTOSIS; REGULATOR; FAS/APO1	FADD is a common adaptor shared by several death receptors for signalling apoptosis through recruitment and activation of caspase 8 (refs 1-3). Death receptors are essential for immune homeostasis, but dispensable during embryogenesis. Surprisingly, Fadd(-/-) mice die in utero(4,5) and conditional deletion of FADD leads to impaired lymphocyte proliferation(6,7). How FADD regulates embryogenesis and lymphocyte responses has been a long-standing enigma. FADD could directly bind to RIP1 (also known as RIPK1), a serine/threonine kinase that mediates both necrosis and NF-kappa B activation. Here we show that Fadd(-/-) embryos contain raised levels of RIP1 and exhibit massive necrosis. To investigate a potential in vivo functional interaction between RIP1 and FADD, null alleles of RIP1 were crossed into Fadd(-/-) mice. Notably, RIP1 deficiency allowed normal embryogenesis of Fadd(-/-) mice. Conversely, the developmental defect of Rip1(-/-) lymphocytes was partially corrected by FADD deletion. Furthermore, RIP1 deficiency fully restored normal proliferation in Fadd(-/-) T cells but not in Fadd(-/-) B cells. Fadd(-/-)Rip1(-/-) double-knockout T cells are resistant to death induced by Fas or TNF-alpha and show reduced NF-kappa B activity. Therefore, our data demonstrate an unexpected cell-type-specific interplay between FADD and RIP1, which is critical for the regulation of apoptosis and necrosis during embryogenesis and lymphocyte function.	[Zhang, Haibing; Zhou, Xiaohui; Li, Jinghe; Zhang, Jianke] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [McQuade, Thomas; Chan, Francis Ka-Ming] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	Jefferson University; University of Massachusetts System; University of Massachusetts Worcester	Zhang, JK (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	francis.chan@umassmed.edu; jzhang@mail.jci.tju.edu	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; Zhang, Haibing/0000-0002-8814-7378; Zhang, Jianke/0000-0002-5822-2226	NIH [CA95454, AI083915, AI076788, AI083497, AI017672]; W. W. Smith Charitable Trust grant; TJU Enhancement grant; CONCERN Foundation; NATIONAL CANCER INSTITUTE [R01CA095454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017672, R03AI076788, R01AI083497, R01AI017672, R21AI083915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Charitable Trust grant; TJU Enhancement grant; CONCERN Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Kelliher for providing Rip1<SUP>-/-</SUP> mice, S. Rosenberg, S. Waggoner, R. Welsh, V. Vanguri and Y. Liu for advice and technical assistance, X. Lin for discussions and suggestions, C. E. Calkins and K. Reinersmann for critical reading of the manuscript, and Z. Zhong for help with histology analysis. This study was supported in part by NIH grants CA95454, AI083915 and AI076788 awarded to J.Z. and AI083497 awarded to F. K.-M. C.; a W. W. Smith Charitable Trust grant, a TJU Enhancement grant, and a CONCERN Foundation grant awarded to J.Z. F. K.-M. C. is a member of the UMass DERC (DK32520) and is also supported in part by an NIH grant (AI017672).	BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cusson N, 2002, J EXP MED, V196, P15, DOI 10.1084/jem.20011470; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Rosenberg S, 2011, J IMMUNOL, V186, P203, DOI 10.4049/jimmunol.1000648; Shen HM, 2004, MOL CELL BIOL, V24, P5914, DOI 10.1128/MCB.24.13.5914-5922.2004; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang J, 1996, MOL CELL BIOL, V16, P2756; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang YH, 2005, J IMMUNOL, V175, P3033, DOI 10.4049/jimmunol.175.5.3033	23	334	336	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					373	+		10.1038/nature09878	http://dx.doi.org/10.1038/nature09878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368761	Green Accepted			2022-12-28	WOS:000288444000044
J	Burgisser, A; Bergantz, GW				Burgisser, Alain; Bergantz, George W.			A rapid mechanism to remobilize and homogenize highly crystalline magma bodies	NATURE			English	Article							PRANDTL NUMBERS; REJUVENATION; EVOLUTION; BODY; EMPLACEMENT; CONVECTION; GENERATION; VISCOSITY; COLORADO; PLUTONS	The largest products of magmatic activity on Earth, the great bodies of granite and their corresponding large eruptions, have a dual nature: homogeneity at the large scale and spatial and temporal heterogeneity at the small scale(1-4). This duality calls for a mechanism that selectively removes the large-scale heterogeneities associated with the incremental assembly(4) of these magmatic systems and yet occurs rapidly despite crystal-rich, viscous conditions seemingly resistant to mixing(2,5). Here we show that a simple dynamic template can unify a wide range of apparently contradictory observations from both large plutonic bodies and volcanic systems by a mechanism of rapid remobilization (unzipping) of highly viscous crystal-rich mushes. We demonstrate that this remobilization can lead to rapid overturn and produce the observed juxtaposition of magmatic materials with very disparate ages and complex chemical zoning. What distinguishes our model is the recognition that the process has two stages. Initially, a stiff mushy magma is reheated from below, producing a reduction in crystallinity that leads to the growth of a subjacent buoyant mobile layer. When the thickening mobile layer becomes sufficiently buoyant, it penetrates the overlying viscous mushy magma. This second stage rapidly exports homogenized material from the lower mobile layer to the top of the system, and leads to partial overturn within the viscous mush itself as an additional mechanism of mixing. Model outputs illustrate that unzipping can rapidly produce large amounts of mobile magma available for eruption. The agreement between calculated and observed unzipping rates for historical eruptions at Pinatubo and at Montserrat demonstrates the general applicability of the model. This mechanism furthers our understanding of both the formation of periodically homogenized plutons (crust building) and of ignimbrites by large eruptions.	[Burgisser, Alain] Univ Tours, Univ Orleans, CNRS INSU, Inst Sci Terre Orleans, F-45071 Orleans 2, France; [Bergantz, George W.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Orleans; Universite de Tours; University of Washington; University of Washington Seattle	Burgisser, A (corresponding author), Univ Tours, Univ Orleans, CNRS INSU, Inst Sci Terre Orleans, 1A Rue Ferolerie, F-45071 Orleans 2, France.	burgisse@cnrs-orleans.fr		Burgisser, Alain/0000-0002-9263-622X	ERC [202844]	ERC(European Research Council (ERC)European Commission)	We thank O. Bachmann and C. Huber for discussions. The work was funded partially by the ERC grant 202844 under the European FP7.	Annen C, 2002, EARTH PLANET SC LETT, V203, P937, DOI 10.1016/S0012-821X(02)00929-9; Bachmann O, 2006, J VOLCANOL GEOTH RES, V149, P85, DOI 10.1016/j.jvolgeores.2005.06.002; Bachmann O, 2003, GEOLOGY, V31, P789, DOI 10.1130/G19764.1; Bachmann O, 2002, J PETROL, V43, P1469, DOI 10.1093/petrology/43.8.1469; Bachmann O, 2008, REV MINERAL GEOCHEM, V69, P651, DOI 10.2138/rmg.2008.69.17; Boyce JW, 2008, GEOLOGY, V36, P63, DOI 10.1130/G24184A.1; CANRIGHT D, 1993, J FLUID MECH, V255, P349, DOI 10.1017/S0022112093002514; Charlier BLA, 2007, J PETROL, V48, P1875, DOI 10.1093/petrology/egm043; Couch S, 2001, NATURE, V411, P1037, DOI 10.1038/35082540; CRANK J, 1975, J MATH DIFFUSION; Davidson JP, 2005, J VOLCANOL GEOTH RES, V140, P157, DOI 10.1016/j.jvolgeores.2004.07.019; de Silva SL, 2007, J VOLCANOL GEOTH RES, V167, P320, DOI 10.1016/j.jvolgeores.2007.07.015; Devine JD, 2003, J PETROL, V44, P1375, DOI 10.1093/petrology/44.8.1375; Grossmann S, 2001, PHYS REV LETT, V86, P3316, DOI 10.1103/PhysRevLett.86.3316; Hildreth W, 2004, J VOLCANOL GEOTH RES, V136, P169, DOI 10.1016/j.jvolgeores.2004.05.019; Huber C, 2010, J VOLCANOL GEOTH RES, V195, P97, DOI 10.1016/j.jvolgeores.2010.06.006; Huber C, 2009, EARTH PLANET SC LETT, V283, P38, DOI 10.1016/j.epsl.2009.03.029; HUPPERT HE, 1988, J PETROL, V29, P599, DOI 10.1093/petrology/29.3.599; Ke Y, 2004, PHYS FLUIDS, V16, P1059, DOI 10.1063/1.1648638; MAHOOD GA, 1990, EARTH PLANET SC LETT, V99, P395, DOI 10.1016/0012-821X(90)90145-N; Manga M, 1999, PHYS FLUIDS, V11, P2969, DOI 10.1063/1.870156; Michaut C, 2006, EARTH PLANET SC LETT, V250, P38, DOI 10.1016/j.epsl.2006.07.019; MILLER CF, TECTONOPHYS IN PRESS, DOI DOI 10.1016/J.TECTO.2009.07.011; Miller JS, 2007, J VOLCANOL GEOTH RES, V167, P282, DOI 10.1016/j.jvolgeores.2007.04.019; Ruprecht P, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002022; Scaillet B, 2000, T ROY SOC EDIN-EARTH, V91, P61, DOI 10.1017/S026359330000729X; Schaeffer N, 2001, GEOPHYS RES LETT, V28, P455, DOI 10.1029/2000GL012215; Self S, 1996, FIRE AND MUD, P1089; Wallace PJ, 2005, J VOLCANOL GEOTH RES, V140, P217, DOI 10.1016/j.jvolgeores.2004.07.023; Wiebe RA, 1998, J STRUCT GEOL, V20, P1273, DOI 10.1016/S0191-8141(98)00059-5	30	179	186	4	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 10	2011	471	7337					212	U97		10.1038/nature09799	http://dx.doi.org/10.1038/nature09799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21368760	Green Submitted			2022-12-28	WOS:000288170200036
J	Metcalfe, D; Holt, PJE; Thompson, MM				Metcalfe, David; Holt, Peter J. E.; Thompson, Matt M.			The management of abdominal aortic aneurysms	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ENDOVASCULAR REPAIR; TRIAL; MORTALITY; MASS; METAANALYSIS; PREVALENCE; EVAR; MEN; AGE					pholt@sgul.ac.uk	Metcalfe, David/D-9699-2012; Holt, Peter J.E./B-2003-2013	Metcalfe, David/0000-0003-1008-3105; Holt, Peter J.E./0000-0002-5739-2813	Department of Health [NIHR-CS-011-008] Funding Source: Medline; National Institute for Health Research [CL-2007-16-002] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Ballard DJ, 2008, COCHRANE DB SYST REV, V4; Bown MJ, 2002, BRIT J SURG, V89, P714, DOI 10.1046/j.1365-2168.2002.02122.x; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Brown LC, 1999, ANN SURG, V230, P289; Brown LC, 1999, ANN SURG, V230, P289; Cosford PA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002945.pub2; Golledge J, 2007, EUR J VASC ENDOVASC, V34, P267, DOI 10.1016/j.ejvs.2007.03.006; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1872, DOI 10.1056/NEJMoa0911056; Holt PJE, 2007, BRIT J SURG, V94, P395, DOI 10.1002/bjs.5710; Holt PJE, 2007, BRIT J SURG, V94, P441, DOI 10.1002/bjs.5725; Holt PJE, 2010, BRIT J SURG, V97, P496, DOI 10.1002/bjs.6911; Kim LG, 2004, J MED SCREEN, V11, P50, DOI 10.1258/096914104772950772; Lederle FA, 1999, JAMA-J AM MED ASSOC, V281, P77, DOI 10.1001/jama.281.1.77; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Lindholt JS, 2006, EUR J VASC ENDOVASC, V32, P608, DOI 10.1016/j.ejvs.2006.06.008; Lindholt JS, 2005, BMJ-BRIT MED J, V330, P750, DOI 10.1136/bmj.38369.620162.82; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Powell JT, 2011, EUR J VASC ENDOVASC, V41, P2, DOI 10.1016/j.ejvs.2010.09.005; Powell JT, 1998, LANCET, V352, P1649; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; SCOTT RAP, 1995, BRIT J SURG, V82, P1066, DOI 10.1002/bjs.1800820821; Takagi H, 2010, J VASC SURG, V52, P1103, DOI 10.1016/j.jvs.2010.02.283; Thompson SG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2307; Vardulaki KA, 2000, BRIT J SURG, V87, P195, DOI 10.1046/j.1365-2168.2000.01353.x; Vardulaki KA, 1999, J MED SCREEN, V6, P50, DOI 10.1136/jms.6.1.50; Winterborn RJ, 2009, J VASC SURG, V49, P576, DOI 10.1016/j.jvs.2008.09.012	31	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2011	342								d1384	10.1136/bmj.d1384	http://dx.doi.org/10.1136/bmj.d1384			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735VA	21393335				2022-12-28	WOS:000288447000010
J	Sheehan, M				Sheehan, Mark			Personal View It's unethical for general practitioners to be commissioners	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Ethox Ctr, Oxford BRC Eth, Oxford OX1 2JD, England	University of Oxford	Sheehan, M (corresponding author), Univ Oxford, Ethox Ctr, Oxford BRC Eth, Oxford OX1 2JD, England.	mark.sheehan@ethox.ox.ac.uk		Sheehan, Mark/0000-0002-7191-901X					0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2011	342								d1430	10.1136/bmj.d1430	http://dx.doi.org/10.1136/bmj.d1430			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735VA	21393319				2022-12-28	WOS:000288447000007
J	Gore, A; Li, Z; Fung, HL; Young, JE; Agarwal, S; Antosiewicz-Bourget, J; Canto, I; Giorgetti, A; Israel, MA; Kiskinis, E; Lee, JH; Loh, YH; Manos, PD; Montserrat, N; Panopoulos, AD; Ruiz, S; Wilbert, ML; Yu, JY; Kirkness, EF; Belmonte, JCI; Rossi, DJ; Thomson, JA; Eggan, K; Daley, GQ; Goldstein, LSB; Zhang, K				Gore, Athurva; Li, Zhe; Fung, Ho-Lim; Young, Jessica E.; Agarwal, Suneet; Antosiewicz-Bourget, Jessica; Canto, Isabel; Giorgetti, Alessandra; Israel, Mason A.; Kiskinis, Evangelos; Lee, Je-Hyuk; Loh, Yuin-Han; Manos, Philip D.; Montserrat, Nuria; Panopoulos, Athanasia D.; Ruiz, Sergio; Wilbert, Melissa L.; Yu, Junying; Kirkness, Ewen F.; Izpisua Belmonte, Juan Carlos; Rossi, Derrick J.; Thomson, James A.; Eggan, Kevin; Daley, George Q.; Goldstein, Lawrence S. B.; Zhang, Kun			Somatic coding mutations in human induced pluripotent stem cells	NATURE			English	Article							FIBROBLASTS; GENERATION; EFFICIENT; VARIANTS	Defined transcription factors can induce epigenetic reprogramming of adult mammalian cells into induced pluripotent stem cells. Although DNA factors are integrated during some reprogramming methods, it is unknown whether the genome remains unchanged at the single nucleotide level. Here we show that 22 human induced pluripotent stem (hiPS) cell lines reprogrammed using five different methods each contained an average of five protein-coding point mutations in the regions sampled (an estimated six protein-coding point mutations per exome). The majority of these mutations were non-synonymous, nonsense or splice variants, and were enriched in genes mutated or having causative effects in cancers. At least half of these reprogramming-associated mutations pre-existed in fibroblast progenitors at low frequencies, whereas the rest occurred during or after reprogramming. Thus, hiPS cells acquire genetic modifications in addition to epigenetic modifications. Extensive genetic screening should become a standard procedure to ensure hiPS cell safety before clinical use.	[Young, Jessica E.; Canto, Isabel; Israel, Mason A.; Wilbert, Melissa L.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Young, Jessica E.; Canto, Isabel; Israel, Mason A.; Wilbert, Melissa L.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Gore, Athurva; Li, Zhe; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Inst Genom Med, Dept Bioengn, La Jolla, CA 92093 USA; [Gore, Athurva; Li, Zhe; Fung, Ho-Lim; Zhang, Kun] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Agarwal, Suneet; Loh, Yuin-Han; Manos, Philip D.; Daley, George Q.] Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; Manos, Philip D.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Antosiewicz-Bourget, Jessica; Yu, Junying; Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53705 USA; [Giorgetti, Alessandra; Montserrat, Nuria; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med, Barcelona 08003, Spain; [Kiskinis, Evangelos; Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Lee, Je-Hyuk] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02135 USA; [Panopoulos, Athanasia D.; Ruiz, Sergio; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Kirkness, Ewen F.] J Craig Venter Inst, Rockville, MD 20850 USA; [Rossi, Derrick J.] Childrens Hosp Boston, Immune Dis Inst, Boston, MA 02115 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Wisconsin System; University of Wisconsin Madison; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Salk Institute; J. Craig Venter Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Goldstein, LSB (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lgoldstein@ucsd.edu; kzhang@bioeng.ucsd.edu	Zhang, Kun/ABE-6349-2020; Eggan, Kevin/P-7119-2018; Montserrat, Nuria/F-3136-2016; Giorgetti, Alessandra/D-3784-2016; Loh, Yuin-Han/E-1096-2014; Ruiz, Sergio/G-1561-2016; Giorgetti, Alessandra/AAB-5870-2019	Zhang, Kun/0000-0002-7596-5224; Montserrat, Nuria/0000-0002-1603-1755; Giorgetti, Alessandra/0000-0002-2747-6514; Loh, Yuin-Han/0000-0002-4715-6454; Ruiz, Sergio/0000-0002-0177-6965; Giorgetti, Alessandra/0000-0001-5803-3567; Panopoulos, Athanasia/0000-0002-9610-2604; Israel, Mason/0000-0003-0867-0626	NIH [R01 HL094963]; UCSD; California Institute for Regenerative Medicine [TG2-01154]; CIRM [RC1-00116]; Focht-Powell Fellowship; National Institute of General Medical Sciences [T32 GM008666]; A*Star Institute of Medical Biology; Singapore Stem Cell Consortium; MICINN; Sanofi-Aventis; G. Harold and Leila Y. Mathers Foundation; Cellex Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, R01HL094963, K08HL089150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); CIRM(California Institute for Regenerative Medicine); Focht-Powell Fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); A*Star Institute of Medical Biology(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Sanofi-Aventis(Sanofi-Aventis); G. Harold and Leila Y. Mathers Foundation; Cellex Foundation(Foundation CELLEX); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. M. Akey, G. M. Church, S. Ding, J. B. Li and J. Shendure for discussions and suggestions, S. Vassallo for assistance with DNA shearing, and G. L. Boulting and S. Ratansirintrawoot for assistance with hiPS cell culture. This study is supported by NIH R01 HL094963 and a UCSD new faculty start-up fund (to K.Z.), a training grant from the California Institute for Regenerative Medicine (TG2-01154) and a CIRM grant (RC1-00116) (to L.S.B.G.). L.S.B.G. is an Investigator of the Howard Hughes Medical Institute. A. Gore is supported by the Focht-Powell Fellowship and a CIRM predoctoral fellowship. M.L.W. is supported by an institutional training grant from the National Institute of General Medical Sciences (T32 GM008666). Y.-H.L. is supported by the A*Star Institute of Medical Biology and the Singapore Stem Cell Consortium. Work in the laboratory of J.C.I.B. was supported by grants from MICINN, Sanofi-Aventis, the G. Harold and Leila Y. Mathers Foundation and the Cellex Foundation. G.Q.D. is an investigator of the Howard Hughes Medical Institute and supported by grants from the NIH.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Bashiardes S, 2005, NAT METHODS, V2, P63, DOI 10.1038/nmeth0105-63; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	41	916	968	3	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					63	U76		10.1038/nature09805	http://dx.doi.org/10.1038/nature09805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21368825	Green Accepted, Green Submitted			2022-12-28	WOS:000287924100034
J	Pickstone, JV				Pickstone, John V.			The rule of ignorance: a polemic on medicine, English health service policy, and history	BRITISH MEDICAL JOURNAL			English	Editorial Material												john.pickstone@manchester.ac.uk							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 3	2011	342								d997	10.1136/bmj.d997	http://dx.doi.org/10.1136/bmj.d997			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732EQ	21372078				2022-12-28	WOS:000288168200009
J	Gladwin, MT; Kato, GJ; Weiner, D; Onyekwere, OC; Dampier, C; Hsu, L; Hagar, RW; Howard, T; Nuss, R; Okam, MM; Tremonti, CK; Berman, B; Villella, A; Krishnamurti, L; Lanzkron, S; Castro, O; Gordeuk, VR; Coles, WA; Peters-Lawrence, M; Nichols, J; Hall, MK; Hildesheim, M; Blackwelder, WC; Baldassarre, J; Casella, JF				Gladwin, Mark T.; Kato, Gregory J.; Weiner, Debra; Onyekwere, Onyinye C.; Dampier, Carlton; Hsu, Lewis; Hagar, R. Ward; Howard, Thomas; Nuss, Rachelle; Okam, Maureen M.; Tremonti, Carole K.; Berman, Brian; Villella, Anthony; Krishnamurti, Lakshmanan; Lanzkron, Sophie; Castro, Oswaldo; Gordeuk, Victor R.; Coles, Wynona A.; Peters-Lawrence, Marlene; Nichols, James; Hall, Mary K.; Hildesheim, Mariana; Blackwelder, William C.; Baldassarre, James; Casella, James F.		DeNOVO Investigators	Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Inhaled nitric oxide has shown evidence of efficacy in mouse models of sickle cell disease (SCD), case series of patients with acute chest syndrome, and 2 small placebo-controlled trials for treatment of vaso-occlusive pain crisis (VOC). Objective To determine whether inhaled nitric oxide gas reduces the duration of painful crisis in patients with SCD who present to the emergency department or hospital for care. Design, Setting, and Participants Prospective, multicenter, double-blind, randomized, placebo-controlled clinical trial for up to 72 hours of inhaled nitric oxide gas vs inhaled nitrogen placebo in 150 participants presenting with VOC of SCD at 11 centers between October 5, 2004, and December 22, 2008. Intervention Inhaled nitric oxide gas vs inhaled nitrogen placebo. Main Outcome Measures The primary end point was the time to resolution of painful crisis, defined by (1) freedom from parenteral opioid use for 5 hours; (2) pain relief as assessed by visual analog pain scale scores of 6 cm or lower (on 0-10 scale); (3) ability to walk; and (4) patient's and family's decision, with physician consensus, that the remaining pain could be managed at home. Results There was no significant change in the primary end point between the nitric oxide and placebo groups, with a median time to resolution of crisis of 73.0 hours (95% confidence interval [CI], 46.0-91.0) and 65.5 hours (95% CI, 48.1-84.0), respectively (P=.87). There were no significant differences in secondary outcome measures, including length of hospitalization, visual analog pain scale scores, cumulative opioid usage, and rate of acute chest syndrome. Inhaled nitric oxide was well tolerated, with no increase in serious adverse events. Increases in venous methemoglobin concentration confirmed adherence and randomization but did not exceed 5% in any study participant. Significant increases in plasma nitrate occurred in the treatment group, but there were no observed increases in plasma or whole blood nitrite. Conclusion Among patients with SCD hospitalized with VOC, the use of inhaled nitric oxide compared with placebo did not improve time to crisis resolution.	[Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Kato, Gregory J.; Coles, Wynona A.; Peters-Lawrence, Marlene; Nichols, James; Hildesheim, Mariana] NHLBI, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Hall, Mary K.; Blackwelder, William C.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Weiner, Debra] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Emergency Med, Boston, MA USA; [Okam, Maureen M.; Tremonti, Carole K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA; [Onyekwere, Onyinye C.; Castro, Oswaldo; Gordeuk, Victor R.] Howard Univ Hosp, Washington, DC USA; [Dampier, Carlton] Emory Univ, Sch Med, Atlanta, GA USA; [Dampier, Carlton] Childrens Healthcare Atlanta, Atlanta, GA USA; [Hagar, R. Ward] Childrens Hosp Oakland, Oakland, CA USA; [Hsu, Lewis] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Howard, Thomas] Univ Alabama, Birmingham, AL USA; [Nuss, Rachelle] Univ Colorado, Hlth Sci Ctr, Pediat Branch, Colorado Sickle Cell Treatment & Res Ctr, Denver, CO USA; [Berman, Brian; Villella, Anthony] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Lanzkron, Sophie] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Hematol & Oncol, Baltimore, MD 21205 USA; [Casella, James F.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD 21205 USA; [Baldassarre, James] Dept Clin Res, Clinton, NJ USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard University; Emory University; Children's Healthcare of Atlanta (CHOA); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's National Health System; University of Alabama System; University of Alabama Birmingham; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Johns Hopkins University; Johns Hopkins University	Gladwin, MT (corresponding author), Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Vasc Med Inst, 3459 5th Ave,628 NW, Pittsburgh, PA 15213 USA.	gladwinmt@upmc.edu	Krishnamurti, Lakshmanan/F-7637-2011; Kato, Gregory J/I-7615-2014; Lanzkron, Sophie/AAD-7584-2022; Dampier, Carlton/Q-2967-2019; Gordeuk, Victor/AAG-6577-2019; Lanzkron, Sophie/AFU-9516-2022; Hsu, Lewis L/H-8001-2019	Kato, Gregory J/0000-0003-4465-3217; Lanzkron, Sophie/0000-0002-2878-0251; Dampier, Carlton/0000-0002-7738-2620; Lanzkron, Sophie/0000-0002-2878-0251; Hsu, Lewis L/0000-0002-3156-2378; Krishnamurti, Lakshmanan/0000-0003-3242-0037	US government; Institute of Transfusion Medicine; Hemophilia Center of Western Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH [R01HL098032, RO1HL096973, RC1DK085852, P30AR058910]; NIH; Ikaria/INO Therapeutics; Division of Intramural Research of the NIH; Food and Drug Administration; Novartis Pharmaceuticals; Eli Lilly; Icagen/McNeil; NIH/NHLBI; Anthera Pharmaceuticals; Icagen; BioMarin Pharmaceuticals; NIH [U54HL070585, U10HL083705, R21HD049244, N01HB07159]; NHLBI [HB-06-06]; Cytrex Corporation [188]; Ikaria; Intramural Research Division of the NHLBI, NIH, US Department of Health and Human Services (DHHS); Vascular Medicine Institute; Institute for Transfusion Medicine; NCRR, NIH [UL1RR025005]; NIH Roadmap for Medical Research; Biomarin; TRF Pharma; Emmaus Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD049244] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096973, U54HL070585, R01HL098032, ZIAHL005110, U10HL083705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK085852] Funding Source: NIH RePORTER	US government; Institute of Transfusion Medicine; Hemophilia Center of Western Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ikaria/INO Therapeutics; Division of Intramural Research of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food and Drug Administration(United States Department of Health & Human Services); Novartis Pharmaceuticals(Novartis); Eli Lilly(Eli Lilly); Icagen/McNeil; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Anthera Pharmaceuticals; Icagen; BioMarin Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cytrex Corporation; Ikaria; Intramural Research Division of the NHLBI, NIH, US Department of Health and Human Services (DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Vascular Medicine Institute; Institute for Transfusion Medicine; NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomarin; TRF Pharma; Emmaus Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gladwin reported having received research support in the form of a collaborative research and development agreement between the US government and Ikaria/INO Therapeutics and being listed as a co-inventor on a US patent for the use of nitrite salts for cardiovascular indications. Dr Gladwin reported receiving grant support from the Institute of Transfusion Medicine and the Hemophilia Center of Western Pennsylvania and federal funding from the National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes and Digestive and Kidney Diseases; and National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH (R01HL098032, RO1HL096973, RC1DK085852, P30AR058910). Dr Kato reported having received research grant support from a cooperative research and development agreement between the NIH and Ikaria/INO Therapeutics and from the Division of Intramural Research of the NIH. Dr Weiner reported having received research support from the Food and Drug Administration Orphan Product Development Grant Program. Dr Onyekwere reported having received research support from Novartis Pharmaceuticals, Eli Lilly, Icagen/McNeil, NIH/NHLBI, and Anthera Pharmaceuticals. Dr Dampier reported having received research grant support during the period of this study from Icagen, BioMarin Pharmaceuticals, and the NIH (U54HL070585, U10HL083705, R21HD049244, N01HB07159). Dr Dampier reported having had consulting relationships with Anthera Pharmaceuticals, GlycoMimetics, and Wyeth Pharmaceuticals. Dr Krishnamurti reported having received research support from the NHLBI (HB-06-06). Dr Gordeuk reported having received research support from Biomarin, TRF Pharma, and Emmaus Pharmaceuticals. Dr Baldassarre reported being an employee of Ikaria. Dr Casella reported having received research support from the NIH, NHLBI, National Institute of Neurological Disorders and Stroke, National Center for Research Resources (NCRR), Maternal and Child Health Bureau, and Maryland Department of Health and Mental Hygiene. Dr Casella reported receiving past research support from Cytrex Corporation for the investigation of a drug (poloxamer 188) for use in vaso-occlusive crisis. The results of these studies have been reported. No ongoing relationship exists. No other conflicts were reported.; This project was collaboratively supported and funded by Ikaria and the Intramural Research Division of the NHLBI, NIH, US Department of Health and Human Services (DHHS). The data and safety monitoring board was assembled and supported by the Intramural Research Division of the NHLBI, NIH, US DHHS. Statistical analysis was supported and independently conducted by the investigators using funds from the Vascular Medicine Institute, Hemophilia Center of Western Pennsylvania, and the Institute for Transfusion Medicine (M.T.G.). This study also received support from grant UL1RR025005 to JHU from the NCRR, a component of the NIH and the NIH Roadmap for Medical Research.	Aslan M, 2001, P NATL ACAD SCI USA, V98, P15215, DOI 10.1073/pnas.221292098; Atz AM, 1997, ANESTHESIOLOGY, V87, P988, DOI 10.1097/00000542-199710000-00037; Ballas SK, 2005, AM J HEMATOL, V79, P17, DOI 10.1002/ajh.20336; Belcher JD, 2000, BLOOD, V96, P2451, DOI 10.1182/blood.V96.7.2451.h8002451_2451_2459; Belcher JD, 2005, AM J PHYSIOL-HEART C, V288, pH2715, DOI 10.1152/ajpheart.00986.2004; Belcher JD, 2003, BLOOD, V101, P3953, DOI 10.1182/blood-2002-10-3313; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dasgupta T, 2006, FREE RADICAL BIO MED, V41, P1771, DOI 10.1016/j.freeradbiomed.2006.08.025; de Franceschi L, 2003, BLOOD, V102, P1087, DOI 10.1182/blood-2002-07-2135; de Franceschi L, 2006, AM J PHYSIOL-LUNG C, V291, pL457, DOI 10.1152/ajplung.00462.2005; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Fasipe Francisca R, 2004, Hematology, V9, P301, DOI 10.1080/10245330410001714185; Frenette PS, 2002, CURR OPIN HEMATOL, V9, P101, DOI 10.1097/00062752-200203000-00003; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 1999, J CLIN INVEST, V104, P937, DOI 10.1172/JCI7637; Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8; Glover RE, 1999, MOL PHARMACOL, V55, P1006, DOI 10.1124/mol.55.6.1006; Hataishi R, 2006, AM J PHYSIOL-HEART C, V291, pH379, DOI 10.1152/ajpheart.01172.2005; Head CA, 2010, AM J HEMATOL, V85, P800, DOI 10.1002/ajh.21832; Head CA, 1997, J CLIN INVEST, V100, P1193, DOI 10.1172/JCI119631; IGNARRO LJ, 1988, NATURE, V333, P664; Kaul DK, 2004, J CLIN INVEST, V114, P1136, DOI 10.1172/JCI200421633; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Lang JD, 2007, J CLIN INVEST, V117, P2583, DOI 10.1172/JCI31892; Lopez BL, 1996, ACAD EMERG MED, V3, P1098, DOI 10.1111/j.1553-2712.1996.tb03367.x; Martinez-Ruiz R, 2001, ANESTHESIOLOGY, V94, P1113, DOI 10.1097/00000542-200106000-00028; Mathru M, 2007, ANESTHESIOLOGY, V106, P275, DOI 10.1097/00000542-200702000-00015; Morris CR, 2000, BRIT J HAEMATOL, V111, P498, DOI 10.1046/j.1365-2141.2000.02403.x; Nath KA, 2000, AM J PHYSIOL-REG I, V279, pR1949, DOI 10.1152/ajpregu.2000.279.6.R1949; Oppert M, 2004, SWISS MED WKLY, V134, P165; Orringer EP, 2001, JAMA-J AM MED ASSOC, V286, P2099, DOI 10.1001/jama.286.17.2099; PANZA JA, 1993, CIRCULATION, V87, P1468, DOI 10.1161/01.CIR.87.5.1468; Platt OS, 2000, J CLIN INVEST, V106, P337, DOI 10.1172/JCI10726; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; REES DC, 1995, BRIT J HAEMATOL, V91, P834, DOI 10.1111/j.1365-2141.1995.tb05397.x; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Reiter CD, 2003, CURR OPIN HEMATOL, V10, P99, DOI 10.1097/00062752-200303000-00001; Romero JR, 2002, BLOOD, V99, P1103, DOI 10.1182/blood.V99.4.1103; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Steiner C, 2004, SICKLE CELL DIS PATI; Sullivan KJ, 1999, CRIT CARE MED, V27, P2563, DOI 10.1097/00003246-199911000-00039; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697; Weiner DL, 2003, JAMA-J AM MED ASSOC, V289, P1136, DOI 10.1001/jama.289.9.1136	46	134	140	2	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					893	902		10.1001/jama.2011.235	http://dx.doi.org/10.1001/jama.2011.235			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728DP	21364138	Bronze, Green Accepted			2022-12-28	WOS:000287854700022
J	Moye, J; Naik, AD				Moye, Jennifer; Naik, Aanand D.			Preserving Rights for Individuals Facing Guardianship	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Moye, Jennifer] VA Boston Healthcare Syst, Boston, MA USA; [Moye, Jennifer] Harvard Univ, Sch Med, Boston, MA USA; [Naik, Aanand D.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Naik, Aanand D.] Baylor Coll Med, Houston, TX 77030 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Baylor College of Medicine; Baylor College of Medicine	Moye, J (corresponding author), VA Boston Healthcare Syst, Psychiat, Brockton Campus,940 Belmont St, Brockton, MA 02301 USA.	jennifer.moye@va.gov	Moye, Jennifer/AAM-1282-2021; Moye, Jennifer A/F-2240-2017; Naik, Aanand D./K-2400-2019	Moye, Jennifer/0000-0002-3434-347X; Moye, Jennifer A/0000-0002-3434-347X; Naik, Aanand D./0000-0001-6936-7984	NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH057104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG027144] Funding Source: NIH RePORTER; NIA NIH HHS [K23AG027144, K23 AG027144] Funding Source: Medline; NIMH NIH HHS [R29 MH057104] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Bar Association; American Psychological Association, 2008, ASS OLD AD DIM CAP H; American Bar Association and the American Psychological Association, 2006, JUD DET CAP OLD AD G; BULCROFT K, 1991, GERONTOLOGIST, V31, P156, DOI 10.1093/geront/31.2.156; Dudley Kenneth C, 2003, J Aging Soc Policy, V15, P97, DOI 10.1300/J031v15n01_06; Lisi L.B., 1994, NATL STUDY GUARDIANS; Moye J, 2003, PERSPECT LAW PSYCHOL, V16, P309; Moye J, 2007, GERONTOLOGIST, V47, P604, DOI 10.1093/geront/47.5.604; Moye J, 2007, GERONTOLOGIST, V47, P591, DOI 10.1093/geront/47.5.591; Skelton F, 2010, ARCH GERONTOL GERIAT, V50, P300, DOI 10.1016/j.archger.2009.04.016	9	28	28	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					936	937		10.1001/jama.2011.247	http://dx.doi.org/10.1001/jama.2011.247			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	728DP	21364144	Green Published, Green Accepted			2022-12-28	WOS:000287854700029
J	Ostera, GR; Gostin, LO				Ostera, Graciela R.; Gostin, Lawrence O.			Biosafety Concerns Involving Genetically Modified Mosquitoes to Combat Malaria and Dengue in Developing Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Ostera, Graciela R.] Georgetown Univ, Dept Microbiol & Immunol, Washington, DC 20001 USA	Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Alsop Z, 2007, LANCET, V370, P925, DOI 10.1016/S0140-6736(07)61428-7; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Enserink M, 2010, SCIENCE, V330, P1460, DOI 10.1126/science.330.6010.1460; Enserink M, 2010, SCIENCE, V330, P1030, DOI 10.1126/science.330.6007.1030; Fang J, 2010, NATURE, V466, P432, DOI 10.1038/466432a; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Marshall JM, 2010, NAT BIOTECHNOL, V28, P896, DOI 10.1038/nbt0910-896; Secretariat of the Convention on Biological Diversity, CART PROT BIOS CONV; Taylor SM, 2010, JAMA-J AM MED ASSOC, V304, P2048, DOI 10.1001/jama.2010.1578; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3	10	19	21	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					930	931		10.1001/jama.2011.246	http://dx.doi.org/10.1001/jama.2011.246			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	728DP	21364141	Green Published			2022-12-28	WOS:000287854700026
J	Clase, CM; Gao, P; Tobe, SW; McQueen, MJ; Grosshennig, A; Teo, KK; Yusuf, S; Mann, JFE				Clase, Catherine M.; Gao, Peggy; Tobe, Sheldon W.; McQueen, Matthew J.; Grosshennig, Anja; Teo, Koon K.; Yusuf, Salim; Mann, Johannes F. E.		ONTARGET Investigators; TRANSCEND Investigators	Estimated Glomerular Filtration Rate and Albuminuria as Predictors of Outcomes in Patients With High Cardiovascular Risk A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; GENERAL-POPULATION; ADVERSE OUTCOMES; ALL-CAUSE; MORTALITY; EVENTS; MICROALBUMINURIA; CLASSIFICATION; INDIVIDUALS	Background: Glomerular filtration rate and albuminuria are risk factors for cardiovascular disease and markers of renal function. Objective: To examine the contribution of estimated glomerular filtration rate (eGFR) and urinary albumin-creatinine ratio beyond that of traditional cardiovascular risk factors to classification of patient risk for cardiovascular and renal outcomes. Design: Prospective cohort study that pooled all patients of ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in Angiotensin-Converting-Enzyme-Inhibitor Intolerant Subjects with Cardiovascular Disease). Patients: 27 620 patients older than 55 years with documented cardiovascular disease, who were followed for a mean of 4.6 years. Measurements: Baseline eGFR, urinary albumin-creatinine ratio, and cardiovascular risk factors. Outcomes were all-cause mortality; a composite of cardiovascular death, myocardial infarction, stroke, and hospitalization for heart failure; long-term dialysis; and a composite of long-term dialysis and doubling of serum creatinine level. Results: Lower eGFRs and higher urinary albumin-creatinine ratios were associated with the primary cardiovascular composite outcome (for example, an adjusted hazard ratio of 2.53 [95% CI, 1.61 to 3.99] for an eGFR <30 mL/min per 1.73 m(2) and a very high urinary albumin-creatinine ratio). However, adding information about eGFR and urinary albumin-creatinine ratio to the risk reclassification analyses led to no meaningful decrease in the proportion of patients assigned to the intermediate-risk category (31% without vs. 32% with renal information). In contrast, eGFR and urinary albumin-creatinine ratio were strongly associated with risk for long-term dialysis and greatly improved both model calibration and risk stratification capacity when added to traditional cardiovascular risk factors (65% assigned to intermediate-risk categories without renal information vs. 18% with renal information). Limitation: Creatinine levels were not standardized. Conclusion: In patients with high vascular risk, eGFR and urinary albumin-creatinine ratio add little to traditional cardiovascular risk factors for stratifying cardiovascular risk but greatly improve risk stratification for renal outcomes.	McMaster Univ, Hamilton, ON, Canada; Populat Hlth Res Inst, Hamilton, ON, Canada; Univ Toronto, Toronto, ON, Canada; Schwabing Gen Hosp, Munich, Germany; KfH Kidney Ctr, Munich, Germany; Univ Erlangen Nurnberg, Erlangen, Germany	McMaster University; Population Health Research Institute; University of Toronto; University of Erlangen Nuremberg	Clase, CM (corresponding author), St Josephs Healthcare Hamilton, 50 Charlton Ave E, Hamilton, ON L8P 4A6, Canada.	clase@mcmaster.ca	Mann, Johannes/AAI-8803-2020	Clase, Catherine/0000-0002-4538-5958; Teo, Koon/0000-0002-3731-0956	Boehringer Ingelheim; Population Health Research Institute; European Commission [241544]	Boehringer Ingelheim(Boehringer Ingelheim); Population Health Research Institute; European Commission(European CommissionEuropean Commission Joint Research Centre)	Grant Support: By Boehringer Ingelheim, the Population Health Research Institute, and the European Commission (grant 241544, SysKid; Dr. Mann). Dr. Clase is supported by the clinical work of her colleagues.	Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Brantsma AH, 2008, J AM SOC NEPHROL, V19, P1785, DOI 10.1681/ASN.2007101065; *CAN ORG REPL REG, 2010, ANN REP 2008 CAN I H, P18853; Foster MC, 2007, ARCH INTERN MED, V167, P1386, DOI 10.1001/archinte.167.13.1386; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Levey AS, 2009, AM J KIDNEY DIS, V54, P205, DOI 10.1053/j.ajkd.2009.04.029; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Teo KK, 2004, AM HEART J, V148, P52, DOI 10.1016/j.ahj.2004.03.020; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Tonelli M, 2006, BMJ-BRIT MED J, V332, P1426, DOI 10.1136/bmj.38814.566019.2F; Vlek ALM, 2008, J INTERN MED, V264, P351, DOI 10.1111/j.1365-2796.2008.01970.x; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Warram JH, 1996, J AM SOC NEPHROL, V7, pA0606; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8	25	62	65	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					310	318		10.7326/0003-4819-154-5-201103010-00005	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357908				2022-12-28	WOS:000287799900003
J	Ascunce, MS; Yang, CC; Oakey, J; Calcaterra, L; Wu, WJ; Shih, CJ; Goudet, J; Ross, KG; Shoemaker, D				Ascunce, Marina S.; Yang, Chin-Cheng; Oakey, Jane; Calcaterra, Luis; Wu, Wen-Jer; Shih, Cheng-Jen; Goudet, Jerome; Ross, Kenneth G.; Shoemaker, DeWayne			Global Invasion History of the Fire Ant Solenopsis invicta	SCIENCE			English	Article							POPULATION-GENETICS; UNITED-STATES; HYMENOPTERA; FORMICIDAE; TRANSPORT; PATHWAYS; ROUTES; TRADE	The fire ant Solenopsis invicta is a significant pest that was inadvertently introduced into the southern United States almost a century ago and more recently into California and other regions of the world. An assessment of genetic variation at a diverse set of molecular markers in 2144 fire ant colonies from 75 geographic sites worldwide revealed that at least nine separate introductions of S. invicta have occurred into newly invaded areas and that the main southern U.S. population is probably the source of all but one of these introductions. The sole exception involves a putative serial invasion from the southern United States to California to Taiwan. These results illustrate in stark fashion a severe negative consequence of an increasingly massive and interconnected global trade and travel system.	[Ascunce, Marina S.; Yang, Chin-Cheng; Shoemaker, DeWayne] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Ascunce, Marina S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Yang, Chin-Cheng; Wu, Wen-Jer; Shih, Cheng-Jen] Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan; [Oakey, Jane] Biosecur Queensland, Brisbane, Qld, Australia; [Calcaterra, Luis] USDA ARS S Amer Biol Control Lab, Buenos Aires, DF, Argentina; [Goudet, Jerome] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Ross, Kenneth G.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; National Taiwan University; Queensland Department of Agriculture & Fisheries; University of Lausanne; University System of Georgia; University of Georgia	Shoemaker, D (corresponding author), ARS, USDA, Ctr Med Agr & Vet Entomol, 1600-1700 SW 23rd Dr, Gainesville, FL USA.	dewayne.shoemaker@ars.usda.gov	Ascunce, Marina/AAW-2139-2020; Calcaterra, Luis/AAM-7370-2020; Goudet, Jerome/A-9730-2012	Goudet, Jerome/0000-0002-5318-7601; Ascunce, Marina/0000-0002-5239-3585; Shoemaker, DeWayne/0000-0003-3659-8393	National Research Initiative of the USDA National Institute of Food and Agriculture [2006-35302-16561, 58-6615-7-137]; Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan [98AS-9.1.2-BQ-B1(1)]; National Science Council Executive Yuan, Taiwan [NSC97-2917-I-002-103]	National Research Initiative of the USDA National Institute of Food and Agriculture; Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan; National Science Council Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan)	We thank numerous individuals responsible for fire ant collections (see table S1) and the University of Florida Interdisciplinary Center for Biotechnology Research and Genetics Institute Fisher Bioinformatics Cluster for technical and computer support. We are grateful to S. Porter and D. Gotzek for reviewing an earlier draft of the manuscript. This work was supported by the National Research Initiative of the USDA National Institute of Food and Agriculture (grant no. 2006-35302-16561: Agreement No. 58-6615-7-137); the Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Executive Yuan, Taiwan [grant no. 98AS-9.1.2-BQ-B1(1)]; and the National Science Council Executive Yuan, Taiwan (grant no. NSC97-2917-I-002-103). Sequence data have been deposited in GenBank (accession nos. HM231195-96, HM231200, and HM241155-65).	Caldera EJ, 2008, BIOL INVASIONS, V10, P1457, DOI 10.1007/s10530-008-9219-0; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Henshaw MT, 2005, AUST J ENTOMOL, V44, P37, DOI 10.1111/j.1440-6055.2005.00421.x; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lard CF., 2006, EC IMPACT IMPORTED F; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; MARKIN G P, 1971, Journal of the Georgia Entomological Society, V6, P145; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Morrison LW, 2004, BIOL INVASIONS, V6, P183, DOI 10.1023/B:BINV.0000022135.96042.90; Perrings C, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P1; Sax D. F., 2005, SPECIES INVASIONS IN; Shoemaker DD, 2006, ANN ENTOMOL SOC AM, V99, P1213, DOI 10.1603/0013-8746(2006)99[1213:PGOTIF]2.0.CO;2; Tschinkel WR, 2006, FIRE ANTS; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Yang CC, 2008, INSECT SOC, V55, P54, DOI 10.1007/s00040-007-0969-y	21	304	339	17	233	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1066	1068		10.1126/science.1198734	http://dx.doi.org/10.1126/science.1198734			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350177				2022-12-28	WOS:000287699000063
J	Godley, LA; Mondragon, A				Godley, Lucy A.; Mondragon, Alfonso			Preference by Exclusion	SCIENCE			English	Editorial Material							DNA; BASE		[Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Mondragon, Alfonso] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	University of Chicago; Northwestern University	Godley, LA (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA.	lgodley@medi-cine.bsd.uchicago.edu; a-mondragon@northwestern.edu						Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380	8	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1017	1018		10.1126/science.1202090	http://dx.doi.org/10.1126/science.1202090			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350155				2022-12-28	WOS:000287699000039
J	Gratton, E				Gratton, Enrico			Deeper Tissue Imaging with Total Detection	SCIENCE			English	Editorial Material							FLUORESCENCE MICROSCOPY		Univ Calif Irvine, Irvine, CA 92679 USA	University of California System; University of California Irvine	Gratton, E (corresponding author), Univ Calif Irvine, Irvine, CA 92679 USA.	egratton22@yahoo.com						Combs CA, 2011, J MICROSC-OXFORD, V241, P153, DOI 10.1111/j.1365-2818.2010.03411.x; Combs CA, 2007, J MICROSC-OXFORD, V228, P330, DOI 10.1111/j.1365-2818.2007.01851.x; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; FISHKIN JB, 1993, J OPT SOC AM A, V10, P127, DOI 10.1364/JOSAA.10.000127; Zimmerley M, 2009, APPL OPTICS, V48, pD79, DOI 10.1364/AO.48.000D79	5	19	22	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1016	1017		10.1126/science.1201542	http://dx.doi.org/10.1126/science.1201542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350154	Green Published			2022-12-28	WOS:000287699000038
J	Pokrovski, GS; Dubrovinsky, LS				Pokrovski, Gleb S.; Dubrovinsky, Leonid S.			The S-3(-) Ion Is Stable in Geological Fluids at Elevated Temperatures and Pressures	SCIENCE			English	Article							BLUE SOLUTIONS; HYDROTHERMAL SYSTEMS; ALKALI POLYSULFIDES; ELEMENTAL SULFUR; AQUEOUS SULFIDE; DEGREES-C; WATER; HEXAMETHYLPHOSPHORAMIDE; INCLUSIONS; KINETICS	The chemical speciation of sulfur in geological fluids is a controlling factor in a number of processes on Earth. The two major chemical forms of sulfur in crustal fluids over a wide range of temperature and pressure are believed to be sulfate and sulfide; however, we use in situ Raman spectroscopy to show that the dominant stable form of sulfur in aqueous solution above 250 degrees C and 0.5 gigapascal is the trisulfur ion S-3(-). The large stability range of S-3(-) enables efficient transport and concentration of sulfur and gold by geological fluids in deep metamorphic and subduction-zone settings. Furthermore, the formation of S-3(-) requires a revision of sulfur isotope-fractionation models between sulfides and sulfates in natural fluids.	[Pokrovski, Gleb S.] Univ Toulouse 3, CNRS, UMR 5563, eX LMTG, F-31400 Toulouse, France; [Dubrovinsky, Leonid S.] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); University of Bayreuth	Pokrovski, GS (corresponding author), Univ Toulouse 3, CNRS, UMR 5563, eX LMTG, 14 Ave Edouard Belin, F-31400 Toulouse, France.	gleb.pokrovski@get.obs-mip.fr	Pokrovski, Gleb S./G-8020-2018	Pokrovski, Gleb S./0000-0003-0906-1689; Dubrovinsky, Leonid/0000-0002-3717-7585	Institut National des Sciences de l'Univers-CNRS [3F, SOUMET, CO2MET]; European High-Pressure Facility of Bayerisches Geoinstitut; Deutscher Akademischer Austausch Dienst-Partenariat Hubert Curien [PROCOPE]	Institut National des Sciences de l'Univers-CNRS(Centre National de la Recherche Scientifique (CNRS)); European High-Pressure Facility of Bayerisches Geoinstitut; Deutscher Akademischer Austausch Dienst-Partenariat Hubert Curien	This work was supported by Institut National des Sciences de l'Univers-CNRS grants 3F, SOUMET, and CO2MET; a transnational access grant to the European High-Pressure Facility of Bayerisches Geoinstitut; and a Deutscher Akademischer Austausch Dienst-Partenariat Hubert Curien linkage grant PROCOPE. We thank L. Kison-Herzing, S. Linhardt, S. Ubelhack, D. Krausse, and C. Cavare-Hester for technical and logistical support and J. Schott, A. Borisova, N. Dubrovinskaia, Y. Shvarov, and H. Keppler for advice. The article benefited from comments of three anonymous reviewers.	Barnes H., 1997, GEOCHEMISTRY HYDROTH; BERNDT ME, 1994, GEOCHIM COSMOCHIM AC, V58, P587, DOI 10.1016/0016-7037(94)90490-1; Bondarenko GV, 1997, GEOCHIM COSMOCHIM AC, V61, P1413, DOI 10.1016/S0016-7037(97)00020-3; CHIVERS T, 1974, NATURE, V252, P32, DOI 10.1038/252032a0; CHIVERS T, 1982, INORG CHEM, V21, P453, DOI 10.1021/ic00131a089; CHIVERS T, 1972, INORG CHEM, V11, P2525, DOI 10.1021/ic50116a047; Chu X, 2004, CHEM GEOL, V211, P217, DOI 10.1016/j.chemgeo.2004.06.013; CLARK RJH, 1978, INORG CHEM, V17, P3169, DOI 10.1021/ic50189a042; Dadze T.P., 1993, GEOCHEM INT, V30, P38; de Hoog JCM, 2001, GEOCHIM COSMOCHIM AC, V65, P3147, DOI 10.1016/S0016-7037(01)00634-2; Farquhar J, 2007, NATURE, V449, P706, DOI 10.1038/nature06202; GIGGENBACH W, 1971, INORG CHEM, V10, P1306, DOI 10.1021/ic50100a043; HEDENQUIST JW, 1994, NATURE, V370, P519, DOI 10.1038/370519a0; JOHNSON JW, 1992, COMPUT GEOSCI-UK, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; Kelley KA, 2009, SCIENCE, V325, P605, DOI 10.1126/science.1174156; Kusakabe M, 2000, J VOLCANOL GEOTH RES, V97, P287, DOI 10.1016/S0377-0273(99)00161-4; Loucks RR, 1999, SCIENCE, V284, P2159, DOI 10.1126/science.284.5423.2159; Mandeville CW, 2010, ELEMENTS, V6, P75, DOI 10.2113/gselements.6.2.75; Mikucki EJ, 1998, ORE GEOL REV, V13, P307, DOI 10.1016/S0169-1368(97)00025-5; OHMOTO H, 1982, GEOCHIM COSMOCHIM AC, V46, P1727, DOI 10.1016/0016-7037(82)90113-2; Ohmoto H, 2006, NATURE, V442, P908, DOI 10.1038/nature05044; Philippot P, 2007, SCIENCE, V317, P1534, DOI 10.1126/science.1145861; Pokrovski GS, 2008, EARTH PLANET SC LETT, V266, P345, DOI 10.1016/j.epsl.2007.11.023; Pokrovski GS, 2009, GEOCHIM COSMOCHIM AC, V73, P5406, DOI 10.1016/j.gca.2009.06.007; Reinen D, 1999, CHEM SOC REV, V28, P75, DOI 10.1039/a704920j; Seo JH, 2009, EARTH PLANET SC LETT, V282, P323, DOI 10.1016/j.epsl.2009.03.036; Tomkins AG, 2010, GEOCHIM COSMOCHIM AC, V74, P3246, DOI 10.1016/j.gca.2010.03.003; Winther KT, 1998, AM MINERAL, V83, P1141, DOI 10.2138/am-1998-11-1201	28	134	145	7	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1052	1054		10.1126/science.1199911	http://dx.doi.org/10.1126/science.1199911			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350173				2022-12-28	WOS:000287699000059
J	Houssami, N; Abraham, LA; Miglioretti, DL; Sickles, EA; Kerlikowske, K; Buist, DSM; Geller, BM; Muss, HB; Irwig, L				Houssami, Nehmat; Abraham, Linn A.; Miglioretti, Diana L.; Sickles, Edward A.; Kerlikowske, Karla; Buist, Diana S. M.; Geller, Berta M.; Muss, Hyman B.; Irwig, Les			Accuracy and Outcomes of Screening Mammography in Women With a Personal History of Early-Stage Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLLOW-UP; PERFORMANCE BENCHMARKS; SURVEILLANCE; SOCIETY; GUIDELINES; RECURRENCE; ULTRASOUND; PROGNOSIS; UPDATE; IMPACT	Context Women with a personal history of breast cancer (PHBC) are at risk of developing another breast cancer and are recommended for screening mammography. Few high-quality data exist on screening performance in PHBC women. Objective To examine the accuracy and outcomes of mammography screening in PHBC women relative to screening of similar women without PHBC. Design and Setting Cohort of PHBC women, mammogram matched to non-PHBC women, screened through facilities (1996-2007) affiliated with the Breast Cancer Surveillance Consortium. Participants There were 58 870 screening mammograms in 19 078 women with a history of early-stage (in situ or stage I-II invasive) breast cancer and 58 870 matched (breast density, age group, mammography year, and registry) screening mammograms in 55 315 non-PHBC women. Main Outcome Measures Mammography accuracy based on final assessment, cancer detection rate, interval cancer rate, and stage at diagnosis. Results Within 1 year after screening, 655 cancers were observed in PHBC women(499 invasive, 156 in situ) and 342 cancers (285 invasive, 57 in situ) in non-PHBC women. Screening accuracy and outcomes in PHBC relative to non-PHBC women were cancer rates of 10.5 per 1000 screens(95% CI, 9.7-11.3) vs 5.8 per 1000 screens(95% CI, 5.2-6.4), cancer detection rate of 6.8 per 1000 screens(95% CI, 6.2-7.5) vs 4.4 per 1000 screens(95% CI, 3.9-5.0), interval cancer rate of 3.6 per 1000 screens(95% CI, 3.2-4.1) vs 1.4 per 1000 screens (95% CI, 1.1-1.7), sensitivity 65.4% (95% CI, 61.5%-69.0%) vs 76.5% (95% CI, 71.7%-80.7%), specificity 98.3%(95% CI, 98.2%-98.4%) vs 99.0%(95% CI, 98.9%-99.1%), abnormal mammogram results in 2.3% (95% CI, 2.2%-2.5%) vs 1.4% (95% CI, 1.3%-1.5%)(all comparisons P<.001). Screening sensitivity in PHBC women was higher for detection of in situ cancer(78.7%; 95% CI, 71.4%-84.5%) than invasive cancer (61.1%; 95% CI, 56.6%-65.4%), P<.001; lower in the initial 5 years (60.2%; 95% CI, 54.7%-65.5%) than after 5 years from first cancer (70.8%; 95% CI, 65.4%-75.6%), P=.006; and was similar for detection of ipsilateral cancer (66.3%; 95% CI, 60.3%-71.8%) and contralateral cancer (66.1%; 95% CI, 60.9%-70.9%), P=.96. Screen-detected and interval cancers in women with and without PHBC were predominantly early stage. Conclusion Mammography screening in PHBC women detects early-stage second breast cancers but has lower sensitivity and higher interval cancer rate, despite more evaluation and higher underlying cancer rate, relative to that in non-PHBC women. JAMA. 2011; 305(8): 790-799	[Houssami, Nehmat; Irwig, Les] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia; [Abraham, Linn A.; Miglioretti, Diana L.] Grp Hlth Res Inst, Biostat Unit, Seattle, WA USA; [Miglioretti, Diana L.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Buist, Diana S. M.] Univ Washington, Grp Hlth Res Inst, Seattle, WA 98195 USA; [Buist, Diana S. M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Buist, Diana S. M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Sickles, Edward A.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kerlikowske, Karla] Univ Calif San Francisco, Dept Vet Affairs, Gen Internal Med Sect, San Francisco, CA USA; [Geller, Berta M.] Univ Vermont, Dept Family Med, Burlington, VT USA; [Geller, Berta M.] Univ Vermont, Dept Radiol, Burlington, VT USA; [Muss, Hyman B.] Univ N Carolina, Dept Med, Chapel Hill, NC USA	University of Sydney; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Vermont; University of Vermont; University of North Carolina; University of North Carolina Chapel Hill	Houssami, N (corresponding author), Univ Sydney, Sydney Med Sch, Sch Publ Hlth A27, Screening & Test Evaluat Program, Sydney, NSW 2006, Australia.	nehmath@med.usyd.edu.au	Houssami, Nehmat/ABC-1103-2020	Houssami, Nehmat/0000-0002-3641-952X	National Cancer Institute (NCI) [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040]; Australia's National Health and Medical Research Council [402764]; NATIONAL CANCER INSTITUTE [U01CA086082, U01CA070040, U01CA069976, P01CA154292, U01CA063736, U01CA070013, U01CA086076, U01CA063740, U01CA063731] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI)-funded BCSC cooperative agreement (U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040). The collection of cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of these sources, see http://www.breastscreening.cancer.gov/work/acknowledgement.html. This work was also partly funded by Australia's National Health and Medical Research Council program grant 402764 to the Screening and Test Evaluation Program.	*AM JOINT COMM CAN, 1997, AJCC CANC STAG MAN; American College of Radiology, 1998, BREAST IM REP DAT SY, V3rd; [Anonymous], 2010, PERF BENCHM SCREEN M; Assoc Breast Surg, 2005, EJSO-EUR J SURG ONC, V31, pS1, DOI 10.1016/j.ejso.2005.02.006; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Buist DSM, 2010, BREAST CANCER RES TR, V124, P863, DOI 10.1007/s10549-010-1106-6; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Ciatto S, 2004, EUR J CANCER, V40, P1496, DOI 10.1016/j.ejca.2004.03.010; DERSHAW DD, 1992, CANCER-AM CANCER SOC, V70, P493, DOI 10.1002/1097-0142(19920715)70:2<493::AID-CNCR2820700219>3.0.CO;2-3; FOWBLE B, 1990, INT J RADIAT ONCOL, V19, P833, DOI 10.1016/0360-3016(90)90002-2; Grunfeld E, 2002, BREAST, V11, P228, DOI 10.1054/brst.2001.0404; Hayes DF, 2007, NEW ENGL J MED, V356, P2505, DOI 10.1056/NEJMcp067260; Houssami N, 2009, ANN ONCOL, V20, P1505, DOI 10.1093/annonc/mdp037; Houssami N, 2010, BREAST, V19, P439, DOI 10.1016/j.breast.2010.05.010; Khatcheressian JL, 2006, J CLIN ONCOL, V24, P5091, DOI 10.1200/JCO.2006.08.8575; Lash TL, 2007, J CLIN ONCOL, V25, P3001, DOI 10.1200/JCO.2006.09.9572; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Lu WL, 2009, BREAST CANCER RES TR, V114, P403, DOI 10.1007/s10549-008-0023-4; Lu WL, 2009, EUR J CANCER, V45, P3000, DOI 10.1016/j.ejca.2009.08.007; Montgomery DA, 2007, BRIT J CANCER, V97, P1632, DOI 10.1038/sj.bjc.6604065; Punglia RS, 2010, J CLIN ONCOL, V28, P4108, DOI 10.1200/JCO.2010.30.0350; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schwartz GF, 2006, J AM COLL SURGEONS, V203, P198, DOI 10.1016/j.jamcollsurg.2006.04.009; Sickles EA, 2005, RADIOLOGY, V235, P775, DOI 10.1148/radiol.2353040738; STOMPER PC, 1987, AM J ROENTGENOL, V148, P39, DOI 10.2214/ajr.148.1.39; Temple LKF, 1999, CAN MED ASSOC J, V161, P1001	27	105	107	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					790	799		10.1001/jama.2011.188	http://dx.doi.org/10.1001/jama.2011.188			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21343578	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000287594300022
J	Bouchon, M; Karabulut, H; Aktar, M; Ozalaybey, S; Schmittbuhl, J; Bouin, MP				Bouchon, Michel; Karabulut, Hayrullah; Aktar, Mustafa; Ozalaybey, Serdar; Schmittbuhl, Jean; Bouin, Marie-Paule			Extended Nucleation of the 1999 M-w 7.6 Izmit Earthquake	SCIENCE			English	Article							TURKEY EARTHQUAKE; RUPTURE PROCESS; SLIP; FAULT; PROPAGATION; AFTERSHOCKS; TREMOR; DEPTH; MODEL; LAW	Laboratory and theoretical studies suggest that earthquakes are preceded by a phase of developing slip instability in which the fault slips slowly before accelerating to dynamic rupture. We report here that one of the best-recorded large earthquakes to date, the 1999 moment magnitude (M-w) 7.6 Izmit (Turkey) earthquake, was preceded by a seismic signal of long duration that originated from the hypocenter. The signal consisted of a succession of repetitive seismic bursts, accelerating with time, and increased low-frequency seismic noise. These observations show that the earthquake was preceded for 44 minutes by a phase of slow slip occurring at the base of the brittle crust. This slip accelerated slowly initially, and then rapidly accelerated in the 2 minutes preceding the earthquake.	[Bouchon, Michel] CNRS, ISTerre, BP 53, F-38041 Grenoble, France; [Bouchon, Michel] Univ Grenoble 1, ISTerre, F-38041 Grenoble, France; [Karabulut, Hayrullah; Aktar, Mustafa] Bogazici Univ, Kandilli Observ, TR-81220 Istanbul, Turkey; [Karabulut, Hayrullah; Aktar, Mustafa] Bogazici Univ, Earthquake Res Inst, TR-81220 Istanbul, Turkey; [Ozalaybey, Serdar] Marmara Res Ctr, Earth & Marine Sci Inst, TUBITAK, TR-41470 Gebze, Kocaeli, Turkey; [Schmittbuhl, Jean] CNRS, F-67084 Strasbourg, France; [Schmittbuhl, Jean] Univ Strasbourg, Ecole Sci Terre, F-67084 Strasbourg, France; [Schmittbuhl, Jean] Univ Strasbourg, Observ Sci Terre, F-67084 Strasbourg, France; [Bouin, Marie-Paule] CNRS, F-97113 Gourbeyre, Guadeloupe, France; [Bouin, Marie-Paule] Observ Volcanol & Sismol Guadeloupe, Inst Phys Globe Paris, F-97113 Gourbeyre, Guadeloupe, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; Bogazici University; Bogazici University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Bouchon, M (corresponding author), CNRS, ISTerre, BP 53, F-38041 Grenoble, France.	Michel.Bouchon@ujf-grenoble.fr	Schmittbuhl, Jean/AAE-3196-2021; OZALAYBEY, SERDAR/L-3498-2019	Schmittbuhl, Jean/0000-0002-7000-0618				Abercrombie RE, 1995, B SEISMOL SOC AM, V85, P1873; Abercrombie RE, 1995, J GEOPHYS RES-SOL EA, V100, P24015, DOI 10.1029/95JB02397; Aktar M., 1989, CAH CENT EUR GEODYN, V1, P11; Ampuero JP, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005082; Barka A, 2002, B SEISMOL SOC AM, V92, P43, DOI 10.1785/0120000841; Beroza GC, 2009, SCIENCE, V324, P1025, DOI 10.1126/science.1171231; Bouchon M, 2002, B SEISMOL SOC AM, V92, P256, DOI 10.1785/0120000845; Cakir Z, 2003, GEOPHYS J INT, V155, P93, DOI 10.1046/j.1365-246X.2003.02001.x; Campillo M, 2001, J GEOPHYS RES-SOL EA, V106, P16307, DOI 10.1029/2000JB900467; Cocco M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013999; DAS S, 1981, J GEOPHYS RES, V86, P6039, DOI 10.1029/JB086iB07p06039; DIETERICH JH, 1992, TECTONOPHYSICS, V211, P115, DOI 10.1016/0040-1951(92)90055-B; ELLSWORTH WL, 1995, SCIENCE, V268, P851, DOI 10.1126/science.268.5212.851; Favreau P, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000448; Ide S, 2007, NATURE, V447, P76, DOI 10.1038/nature05780; Imanishi K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019420; Lapusta N, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000793; Lengline O, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006118; MADARIAGA R, 1976, B SEISMOL SOC AM, V66, P639; MARONE C, 1995, GEOPHYS RES LETT, V22, P3095, DOI 10.1029/95GL03076; Nadeau RM, 1999, SCIENCE, V285, P718, DOI 10.1126/science.285.5428.718; OHNAKA M, 1993, J PHYS EARTH, V41, P45, DOI 10.4294/jpe1952.41.45; Ohnaka M, 1999, J GEOPHYS RES-SOL EA, V104, P817, DOI 10.1029/1998JB900007; Ozalaybey S, 2002, B SEISMOL SOC AM, V92, P376, DOI 10.1785/0120000838; Polat O, 2002, B SEISMOL SOC AM, V92, P361, DOI 10.1785/0120000816; Reilinger R, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004051; RICE JR, 1993, J GEOPHYS RES-SOL EA, V98, P9885, DOI 10.1029/93JB00191; Schaff DP, 1998, GEOPHYS RES LETT, V25, P4549, DOI 10.1029/1998GL900192; Scholz C. H., 1990, MECH EARTHQUAKES FAU; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Shibazaki B, 1998, GEOPHYS J INT, V132, P14, DOI 10.1046/j.1365-246x.1998.00409.x; Toksoz M., 1999, SEISMOL RES LETT, V70, P669, DOI [10.1785/gssrl.70.6.669, DOI 10.1785/GSSRL.70.6.669]; VIDALE JE, 1994, NATURE, V368, P624, DOI 10.1038/368624a0; Zigone D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045603	35	183	194	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					877	880		10.1126/science.1197341	http://dx.doi.org/10.1126/science.1197341			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330536				2022-12-28	WOS:000287455100047
J	Cook-Deegan, R				Cook-Deegan, Robert			Gene Patents: The Shadow of Uncertainty	SCIENCE			English	Editorial Material									Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University	Cook-Deegan, R (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.			Cook-Deegan, Robert/0000-0002-8251-4237	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003391] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					873	874		10.1126/science.1203458	http://dx.doi.org/10.1126/science.1203458			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722SO	21330530				2022-12-28	WOS:000287455100043
J	Ali, MK; Grund, JM; Koplan, JP				Ali, Mohammed K.; Grund, Jonathan M.; Koplan, Jeffrey P.		Emory Global Hlth Case Competition	Case competitions to engage students in global health	LANCET			English	Editorial Material									[Ali, Mohammed K.; Grund, Jonathan M.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Koplan, Jeffrey P.] Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University	Ali, MK (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	mkali@emory.edu	Ali, Mohammed K/N-9833-2013	Ali, Mohammed/0000-0001-7266-2503				Ali MK, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.2035; *COP BUS SCH, CAS COMP 2011; Dewey J., 1938, EXPERIENCE ED; *EM GLOB HLTH I, 2011 EM GLOB HLTH CA; Geier R, 2008, J RES SCI TEACH, V45, P922, DOI 10.1002/tea.20248; Hmelo-Silver CE, 2004, EDUC PSYCHOL REV, V16, P235, DOI 10.1023/B:EDPR.0000034022.16470.f3; Hmelo-Silver CE, 2007, EDUC PSYCHOL-US, V42, P99, DOI 10.1080/00461520701263368; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; Lynch S, 2005, J RES SCI TEACH, V42, P912, DOI 10.1002/tea.20080; SCHMIDT HG, 1993, MED EDUC, V27, P422, DOI 10.1111/j.1365-2923.1993.tb00296.x; SWELLER J, 1988, COGNITIVE SCI, V12, P257, DOI 10.1207/s15516709cog1202_4; *U WA MG FOST SCH, GLOB BUS CAS COMP	12	11	11	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2011	377	9776					1473	1474		10.1016/S0140-6736(10)62186-1	http://dx.doi.org/10.1016/S0140-6736(10)62186-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	761RX	21333350				2022-12-28	WOS:000290419400008
J	Bhutta, Z; Frenk, J; Horton, R; Lopez, A; de Souza, FM; Mills, A; Piot, P; Murray, C; Sankoh, O; Shibuya, K; Zewdie, D				Bhutta, Zulfiqar; Frenk, Julio; Horton, Richard; Lopez, Alan; de Souza, Fatima Marinho; Mills, Anne; Piot, Peter; Murray, Christopher; Sankoh, Osman; Shibuya, Kenji; Zewdie, Debrework		GHME Conference Organizing Comm	Shared innovations in measurement and evaluation	LANCET			English	Editorial Material									[Bhutta, Zulfiqar] Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan; [Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Horton, Richard] The Lancet, London NW1 7BY, England; [Lopez, Alan] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [de Souza, Fatima Marinho] Pan Amer Hlth Org, Washington, DC USA; [Mills, Anne; Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Murray, Christopher] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Sankoh, Osman] INDEPTH Network, Accra, Ghana; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Zewdie, Debrework] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [GHME Conference Organizing Comm] Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA	Aga Khan University; Harvard University; Harvard T.H. Chan School of Public Health; University of Queensland; Pan American Health Organization; University of London; London School of Hygiene & Tropical Medicine; Institute for Health Metrics & Evaluation; INDEPTH Network; University of Tokyo; Institute for Health Metrics & Evaluation	Bhutta, Z (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan.		Lopez, Alan/AAA-2734-2022; Sankoh, Osman/ABB-3755-2020; Lopez, Alan D/F-1487-2010	Sankoh, Osman/0000-0003-4405-9808; Lopez, Alan D/0000-0001-5818-6512; Pomeroy-Stevens, Amanda/0000-0003-3738-4653; Checchi, Francesco/0000-0001-9030-5382				ALVARADO MR, 2011, GLOBAL HLTH METRICS; BENNETT A, 2011, GLOBAL HLTH METRICS; CAMPBELL OMR, 2011, GLOBAL HLTH METRICS; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; KNAUL FM, 2011, GLOBAL HLTH METRICS; MARCUS J, 2011, GLOBAL HLTH METRICS; MORENOSERRA R, 2011, GLOBAL HLTH METRICS; NUTLEY T, 2011, GLOBAL HLTH METRICS; SETHI RC, 2011, GLOBAL HLTH METRICS; VERGUET S, 2011, GLOBAL HLTH METRICS	10	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2011	377	9770					969	970		10.1016/S0140-6736(11)60169-4	http://dx.doi.org/10.1016/S0140-6736(11)60169-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	740FA	21397940	Green Submitted			2022-12-28	WOS:000288775800004
J	McDonough, WF				McDonough, William F.			Meteoritic Clues Point Chromium Toward Earth's Core	SCIENCE			English	Editorial Material							HF-W CHRONOMETRY; ACCRETION; TUNGSTEN		[McDonough, William F.] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [McDonough, William F.] Univ Dar Es Salaam, Dept Geol, Dar Es Salaam, Tanzania	University System of Maryland; University of Maryland College Park; University of Dar es Salaam	McDonough, WF (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	mcdonoug@geol.umd.edu	McDonough, William F/I-7720-2012; McDonough, William F/C-4791-2009	McDonough, William F/0000-0001-9154-3673; McDonough, William F/0000-0001-9154-3673				ANDERS E, 1964, SPACE SCI REV, V3, P583; Brandon AD, 2005, EARTH PLANET SC LETT, V232, P211, DOI 10.1016/j.epsl.2005.01.034; Chambers JE, 2004, EARTH PLANET SC LETT, V223, P241, DOI 10.1016/j.epsl.2004.04.031; Ireland TJ, 2009, GEOCHIM COSMOCHIM AC, V73, P4517, DOI 10.1016/j.gca.2009.04.016; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Moynier F, 2011, SCIENCE, V331, P1417, DOI 10.1126/science.1199597; Schersten A, 2004, NATURE, V427, P234, DOI 10.1038/nature02221; Wanke H., 1984, ARCHAEAN GEOCHEMISTR, P1, DOI [10.1007/978-3-642-70001-9_1, DOI 10.1007/978-3-642-70001-9_1]; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995; Ziegler K, 2010, EARTH PLANET SC LETT, V295, P487, DOI 10.1016/j.epsl.2010.04.030	10	5	5	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1397	1398		10.1126/science.1203353	http://dx.doi.org/10.1126/science.1203353			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21350125				2022-12-28	WOS:000288504000028
J	Kaiser, WJ; Upton, JW; Long, AB; Livingston-Rosanoff, D; Daley-Bauer, LP; Hakem, R; Caspary, T; Mocarski, ES				Kaiser, William J.; Upton, Jason W.; Long, Alyssa B.; Livingston-Rosanoff, Devon; Daley-Bauer, Lisa P.; Hakem, Razqallah; Caspary, Tamara; Mocarski, Edward S.			RIP3 mediates the embryonic lethality of caspase-8-deficient mice	NATURE			English	Article							RECEPTOR-INTERACTING PROTEIN; HOMOTYPIC INTERACTION MOTIF; CELL-DEATH; PROGRAMMED NECROSIS; IMMUNE-SYSTEM; TNF-ALPHA; T-CELLS; IN-VIVO; CASPASE-8; EXPRESSION	Apoptosis and necroptosis are complementary pathways controlled by common signalling adaptors, kinases and proteases; among these, caspase-8 (Casp8) is critical for death receptor-induced apoptosis. This caspase has also been implicated in non-apoptotic pathways that regulate Fas-associated via death domain (FADD)dependent signalling and other less defined biological processes as diverse as innate immune signalling and myeloid or lymphoid differentiation patterns(1). Casp8 suppresses RIP3-RIP1 (also known as RIPK3-RIPK1) kinase complex-dependent(2-4) necroptosis(5) that follows death receptor activation as well as a RIP3-dependent, RIP(1)-independent necrotic pathway that has emerged as a host defence mechanism against murine cytomegalovirus(6). Disruption of Casp8 expression leads to embryonic lethality in mice between embryonic days 10.5 and 11.5 (ref. 7). Thus, Casp8 may naturally hold alternative RIP3-dependent death pathways in check in addition to promoting apoptosis. We find that RIP3 is responsible for the mid-gestational death of Casp8-deficient embryos. Remarkably, Casp8(-/-)Rip3(-/-) double mutant mice are viable and mature into fertile adults with a full immune complement of myeloid and lymphoid cell types. These mice seem immunocompetent but develop lymphadenopathy by four months of age marked by accumulation of abnormal T cells in the periphery, a phenotype reminiscent of mice with Fas-deficiency (lpr/lpr; also known as Fas). Thus, Casp8 contributes to homeostatic control in the adult immune system; however, RIP3 and Casp8 are together completely dispensable for mammalian development.	[Kaiser, William J.; Upton, Jason W.; Livingston-Rosanoff, Devon; Daley-Bauer, Lisa P.; Mocarski, Edward S.] Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Long, Alyssa B.; Caspary, Tamara] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Hakem, Razqallah] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Hakem, Razqallah] Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Emory University; Emory University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kaiser, WJ (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	wkaiser@emory.edu	Kaiser, William/A-3079-2012; Long, Alyssa/AAN-8497-2020; Mocarski, Edward/ABC-2893-2020; Caspary, Tamara/AAH-5625-2020	Long, Alyssa/0000-0002-4467-4213; Caspary, Tamara/0000-0002-6579-7589; Daley-Bauer, Lisa/0000-0002-3377-7989; Hakem, Razqallah/0000-0001-5948-7931; Upton, Jason/0000-0002-4218-4026	Georgia Cancer Coalition; NIH [R01 AI20211, AI30363]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI030363, R01AI030363, R01AI020211, R21AI030363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012198] Funding Source: NIH RePORTER	Georgia Cancer Coalition; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge D. Green, A. Oberst and C. Dillon for their discussions and material support. We thank V. Dixit and K. Newton for RIP32/2 mice, A. Kowalczyk, R. Oas, S. Speck and R. Ahmed for providing reagents, T. Kaufmann for technical advice, C. Strauss for editing, and A. L. McCormick for discussion and comments on the manuscript. Additionally, we appreciate M. Dowdy and J. Perry for mouse colony maintenance. This work was supported by the Georgia Cancer Coalition and the NIH (PHS grants R01 AI20211 and AI30363 to E. S. M.).	Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; LAOUAR Y, 1994, J IMMUNOL, V153, P3948; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; McCormick AL, 2003, VIROLOGY, V316, P221, DOI 10.1016/j.virol.2003.07.003; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	30	741	764	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					368	+		10.1038/nature09857	http://dx.doi.org/10.1038/nature09857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368762	Green Accepted			2022-12-28	WOS:000288444000043
J	Wang, F; Mei, ZQ; Qi, YT; Yan, CY; Hu, Q; Wang, JW; Shi, YG				Wang, Feng; Mei, Ziqing; Qi, Yutao; Yan, Chuangye; Hu, Qi; Wang, Jiawei; Shi, Yigong			Structure and mechanism of the hexameric MecA-ClpC molecular machine	NATURE			English	Article							RAY-DIFFRACTION DATA; CRYSTAL-STRUCTURE; HSP100 CHAPERONE; PROTEIN; ADAPTER; DOMAIN; RECOGNITION; COMPETENCE; COMPLEX; DISAGGREGATION	Regulated proteolysis by ATP-dependent proteases is universal in all living cells. Bacterial ClpC, a member of the Clp/Hsp100 family of AAA1 proteins (ATPases associated with diverse cellular activities) with two nucleotide-binding domains (D1 and D2), requires the adaptor protein MecA for activation and substrate targeting. The activated, hexameric MecA-ClpC molecular machine harnesses the energy of ATP binding and hydrolysis to unfold specific substrate proteins and translocate the unfolded polypeptide to the ClpP protease for degradation. Here we report three relatedcrystal structures: a heterodimer between MecA and the amino domain of ClpC, a heterododecamer between MecA and D2-deleted ClpC, and a hexameric complex between MecA and full-length ClpC. In conjunction with biochemical analyses, these structures reveal the organizational principles behind the hexameric MecA-ClpC complex, explain the molecular mechanisms for MecA-mediated ClpC activation and provide mechanistic insights into the function of the MecA-ClpC molecular machine. These findings have implications for related Clp/Hsp100 molecular machines.	[Wang, Feng; Mei, Ziqing; Qi, Yutao; Yan, Chuangye; Hu, Qi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China; [Wang, Feng; Mei, Ziqing; Qi, Yutao; Yan, Chuangye; Hu, Qi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Wang, JW (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China.	jwwang@tsinghua.edu.cn; shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021; Wang, Feng/AAC-6221-2022; Mei, Ziqing/AHD-6788-2022; Wang, Jiawei/D-1144-2010	Wang, Feng/0000-0002-9403-4337; Mei, Ziqing/0000-0001-8554-6309; Wang, Jiawei/0000-0001-9893-8539; Yan, Chuangye/0000-0001-9338-8048; Shi, Yigong/0000-0003-2030-168X	National Natural Science Foundation of China [30888001]; China Postdoctoral Science Foundation [023201058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank J. He and S. Huang at Shanghai Synchrotron Radiation Source and staff at the SPring-8 beamline BL41XU for help. This work was supported by Project 30888001 of the National Natural Science Foundation of China (Y.S.) and Postdoctoral Fellowship # 023201058 from the China Postdoctoral Science Foundation (Z.M.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Barends TRM, 2010, CURR OPIN STRUC BIOL, V20, P46, DOI 10.1016/j.sbi.2009.12.014; Bruker, 2003, SAINT SADABS XPREP S; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLano W.L., 2002, PYMOL MOL VIEWER; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Lee S, 2004, J STRUCT BIOL, V146, P99, DOI 10.1016/j.jsb.2003.11.016; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mei ZQ, 2009, J BIOL CHEM, V284, P34366, DOI 10.1074/jbc.M109.053017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 1998, EMBO J, V17, P6730; Wang F, 2009, J BIOL CHEM, V284, P34376, DOI 10.1074/jbc.M109.053033; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2010, BIOCHEM CELL BIOL, V88, P89, DOI [10.1139/O09-164, 10.1139/o09-164]; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	49	103	106	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					331	+		10.1038/nature09780	http://dx.doi.org/10.1038/nature09780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21368759				2022-12-28	WOS:000288444000035
J	Shen, WL; Kwon, Y; Adegbola, AA; Luo, JJ; Chess, A; Montell, C				Shen, Wei L.; Kwon, Young; Adegbola, Abidemi A.; Luo, Junjie; Chess, Andrew; Montell, Craig			Function of Rhodopsin in Temperature Discrimination in Drosophila	SCIENCE			English	Article							NUCLEOTIDE-GATED CHANNEL; PHOSPHOLIPASE-C; G-PROTEIN; THERMOSENSATION; PHOTOTRANSDUCTION; RECEPTOR	Many animals, including the fruit fly, are sensitive to small differences in ambient temperature. The ability of Drosophila larvae to choose their ideal temperature (18 degrees C) over other comfortable temperatures (19 degrees to 24 degrees C) depends on a thermosensory signaling pathway that includes a heterotrimeric guanine nucleotide-binding protein (G protein), a phospholipase C, and the transient receptor potential TRPA1 channel. We report that mutation of the gene (ninaE) encoding a classical G protein-coupled receptor (GPCR), Drosophila rhodopsin, eliminates thermotactic discrimination in the comfortable temperature range. This role for rhodopsin in thermotaxis toward 18 degrees C was light-independent. Introduction of mouse melanopsin restored normal thermotactic behavior in ninaE mutant larvae. We propose that rhodopsins represent a class of evolutionarily conserved GPCRs that are required for initiating thermosensory signaling cascades.	[Shen, Wei L.; Kwon, Young; Luo, Junjie; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Shen, Wei L.; Kwon, Young; Luo, Junjie; Montell, Craig] Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Adegbola, Abidemi A.; Chess, Andrew] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Adegbola, Abidemi A.; Chess, Andrew] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA; [Chess, Andrew] Broad Inst, Cambridge, MA 02142 USA; [Chess, Andrew] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Chess, Andrew] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	cmontell@jhmi.edu	Montell, Craig/AAH-3357-2021; Luo, Junjie/L-3285-2019; shen, wei/C-2311-2013	Montell, Craig/0000-0001-5637-1482; Kwon, Young/0000-0002-8937-3182	National Institute of General Medical Sciences, NIH [GM085335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085335] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Liu for advice with the statistical analyses, the Bloomington Stock Center, FlyBase, and the Harvard TRiP. A. A. A. received support from a NARSAD Young Investigator Award. This study was supported by a grant to C. M. from the National Institute of General Medical Sciences, NIH (GM085335).	Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Filip M, 2009, PHARMACOL REP, V61, P761, DOI 10.1016/S1734-1140(09)70132-X; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; Kwon Y, 2010, J NEUROSCI, V30, P10465, DOI 10.1523/JNEUROSCI.1631-10.2010; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; STRANGE PH, 1961, J EXP BIOL, V38, P237; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081	21	148	153	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1333	1336		10.1126/science.1198904	http://dx.doi.org/10.1126/science.1198904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21393546				2022-12-28	WOS:000288215200049
J	Cheung, ACM; Cramer, P				Cheung, Alan C. M.; Cramer, Patrick			Structural basis of RNA polymerase II backtracking, arrest and reactivation	NATURE			English	Article							CLEAVAGE FACTOR TFIIS; TRANSCRIPT-CLEAVAGE; ELONGATION COMPLEX; DNA HYBRID; ANGSTROM RESOLUTION; TRIGGER LOOP; MECHANISM; SITE; TRANSLOCATION; ARCHITECTURE	During gene transcription, RNA polymerase (Pol) II moves forwards along DNA and synthesizes messenger RNA. However, at certain DNA sequences, Pol II moves backwards, and such backtracking can arrest transcription. Arrested Pol II is reactivated by transcription factor IIS (TFIIS), which induces RNA cleavage that is required for cell viability(1). Pol II arrest and reactivation are involved in transcription through nucleosomes(2,3) and in promoter-proximal gene regulation(4-6). Here we present X-ray structures at 3.3 angstrom resolution of an arrested Saccharomyces cerevisiae Pol II complex with DNA and RNA, and of a reactivation intermediate that additionally contains TFIIS. In the arrested complex, eight nucleotides of backtracked RNA bind a conserved 'backtrack site' in the Pol II pore and funnel, trapping the active centre trigger loop and inhibiting mRNA elongation. In the reactivation intermediate, TFIIS locks the trigger loop away from backtracked RNA, displaces RNA from the backtrack site, and complements the polymerase active site with a basic and two acidic residues that may catalyse proton transfers during RNA cleavage. The active site is demarcated from the backtrack site by a 'gating tyrosine' residue that probably delimits backtracking. These results establish the structural basis of Pol II backtracking, arrest and reactivation, and provide a framework for analysing gene regulation during transcription elongation.	[Cheung, Alan C. M.; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich, Gene Ctr, D-81377 Munich, Germany; [Cheung, Alan C. M.; Cramer, Patrick] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de		Cheung, Alan/0000-0001-6430-5127	Deutsche Forschungsgemeinschaft [SFB646, TR5, FOR1068]; NIM; Bioimaging Network BIN; Jung-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIM; Bioimaging Network BIN; Jung-Stiftung	We thank F. Brueckner, G. Damsma, K. Kinkelin, D. Kostrewa, L. Lariviere, E. Lehmann, F. Martinez, S. Sainsbury and J. Sydow. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institut, Villigen, Switzerland. P.C. was supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, FOR1068, NIM, Bioimaging Network BIN, and the Jung-Stiftung.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; GU WG, 1993, J BIOL CHEM, V268, P25604; Hawryluk PJ, 2004, NUCLEIC ACIDS RES, V32, P1904, DOI 10.1093/nar/gkh505; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; SLUDER AE, 1988, J BIOL CHEM, V263, P9917; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	30	240	242	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					249	253		10.1038/nature09785	http://dx.doi.org/10.1038/nature09785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21346759				2022-12-28	WOS:000288170200044
J	Schraidt, O; Marlovits, TC				Schraidt, Oliver; Marlovits, Thomas C.			Three-Dimensional Model of Salmonella's Needle Complex at Subnanometer Resolution	SCIENCE			English	Article							III SECRETION SYSTEM; TRANSMISSION ELECTRON-MICROSCOPY; PHAGE PIV MULTIMER; STRUCTURAL INSIGHTS; SHIGELLA-FLEXNERI; APPARATUS; ORGANIZATION; TYPHIMURIUM; COMPONENT; REVEALS	Type III secretion systems (T3SSs) are essential virulence factors used by many Gram-negative bacteria to inject proteins that make eukaryotic host cells accessible to invasion. The T3SS core structure, the needle complex (NC), is a similar to 3.5 megadalton-sized, oligomeric, membrane-embedded complex. Analyzing cryo-electron microscopy images of top views of NCs or NC substructures from Salmonella typhimurium revealed a 24-fold symmetry for the inner rings and a 15-fold symmetry for the outer rings, giving an overall C3 symmetry. Local refinement and averaging showed the organization of the central core and allowed us to reconstruct a subnanometer composite structure of the NC, which together with confident docking of atomic structures reveal insights into its overall organization and structural requirements during assembly.	[Schraidt, Oliver; Marlovits, Thomas C.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Schraidt, Oliver; Marlovits, Thomas C.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Marlovits, TC (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	marlovits@imp.ac.at	Marlovits, Thomas/A-3568-2019; Schraidt, Oliver/ABE-3650-2020	Marlovits, Thomas/0000-0001-8106-4038; Schraidt, Oliver/0000-0001-8114-3713	Boehringer Ingelheim Fonds; Zentrum fur Innovation und Technologie (ZIT); Center for Molecular and Cellular Nanostructure Vienna (CMCN)	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Zentrum fur Innovation und Technologie (ZIT); Center for Molecular and Cellular Nanostructure Vienna (CMCN)	We would like to thank G. Resch for collaborating on the development of a semi-automated image acquisition software, the Institute of Molecular Pathology/Institute of Molecular Biotechnology/Gregor Mendel Institute (IMP/IMBA/GMI) EM and bioinformatics facility for technical support, W. Weber for generating and analyzing the mutational analysis, and all members of the Marlovits laboratory for critically reading the manuscript. We furthermore would like to thank J. E. Galan (Yale University) and members of his laboratory for continuous discussion, generous support, and materials. This work was supported by a Ph.D. fellowship from Boehringer Ingelheim Fonds (to O.S.) and a research grant from the Zentrum fur Innovation und Technologie (ZIT), Center for Molecular and Cellular Nanostructure Vienna (CMCN) (to T.C.M.). Accession numbers are EMD-1871, EMD-1874, EMD-1875, and PDB ID code 2Y9K and 2Y9J.	Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Coburn B, 2007, CLIN MICROBIOL REV, V20, P535, DOI 10.1128/CMR.00013-07; Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Diepold A, 2010, EMBO J, V29, P1928, DOI 10.1038/emboj.2010.84; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galkin VE, 2010, J MOL BIOL, V396, P1392, DOI 10.1016/j.jmb.2010.01.001; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Linderoth NA, 1997, SCIENCE, V278, P1635, DOI 10.1126/science.278.5343.1635; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Sani M, 2007, MICRON, V38, P291, DOI 10.1016/j.micron.2006.04.007; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554	24	162	164	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1192	1195		10.1126/science.1199358	http://dx.doi.org/10.1126/science.1199358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21385715				2022-12-28	WOS:000287971200042
J	Zinzalla, V; Stracka, D; Oppliger, W; Hall, MN				Zinzalla, Vittoria; Stracka, Daniele; Oppliger, Wolfgang; Hall, Michael N.			Activation of mTORC2 by Association with the Ribosome	CELL			English	Article							ENDOPLASMIC-RETICULUM; MAMMALIAN TARGET; CELL-GROWTH; COMPLEX 2; TRANSLATION INITIATION; MOTIF PHOSPHORYLATION; AKT PHOSPHORYLATION; BINDING PARTNER; KINASE-B; RAPAMYCIN	The target of rapamycin (TOR) is a highly conserved protein kinase and a central controller of growth. Mammalian TOR complex 2 (mTORC2) regulates AGC kinase family members and is implicated in various disorders, including cancer and diabetes. Here, we investigated the upstream regulation of mTORC2. A genetic screen in yeast and subsequent studies in mammalian cells revealed that ribosomes, but not protein synthesis, are required for mTORC2 signaling. Active mTORC2 was physically associated with the ribosome, and insulin-stimulated PI3K signaling promoted mTORC2-ribosome binding, suggesting that ribosomes activate mTORC2 directly. Findings with melanoma and colon cancer cells suggest that mTORC2-ribosome association is important in oncogenic PI3K signaling. Thus, TORC2-ribosome interaction is a likely conserved mechanism of TORC2 activation that is physiologically relevant in both normal and cancer cells. As ribosome content determines growth capacity of a cell, this mechanism of TORC2 regulation ensures that TORC2 is active only in growing cells.	[Zinzalla, Vittoria; Stracka, Daniele; Oppliger, Wolfgang; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	m.hall@unibas.ch		Hall, Michael N/0000-0002-2998-0757	Swiss National Science Foundation, SystemsX.ch; Swiss Cancer League; Louis Jeantet Foundation; Canton of Basel	Swiss National Science Foundation, SystemsX.ch(Swiss National Science Foundation (SNSF)); Swiss Cancer League; Louis Jeantet Foundation; Canton of Basel	We thank Rachel Idol and Stefano Grosso for valuable discussions and technical assistance and Giulio Spagnoli for the melanoma cell lines. We acknowledge support from the Swiss National Science Foundation, SystemsX.ch, the Swiss Cancer League, the Louis Jeantet Foundation, and the Canton of Basel. We declare that no competing interests exist.	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Certa U, 2001, BRIT J CANCER, V85, P107, DOI 10.1054/bjoc.2001.1865; Chiocchetti A, 2005, HAEMATOLOGICA, V90, P1453; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DESCHODTLANCKMAN M, 1990, INT J CANCER, V46, P1124, DOI 10.1002/ijc.2910460629; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gervois N, 1996, J EXP MED, V183, P2403, DOI 10.1084/jem.183.5.2403; Grosso S, 2008, BIOCHEM J, V415, P77, DOI 10.1042/BJ20080463; Grossso S, 2008, BIOCHEM BIOPH RES CO, V376, P65, DOI 10.1016/j.bbrc.2008.08.118; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He HN, 2010, CANCER LETT, V295, P38, DOI 10.1016/j.canlet.2010.02.011; Helliwell SB, 1998, GENETICS, V148, P99; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stahl JM, 2003, CANCER RES, V63, P2881; Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001	71	482	509	0	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					757	768		10.1016/j.cell.2011.02.014	http://dx.doi.org/10.1016/j.cell.2011.02.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376236	Bronze			2022-12-28	WOS:000288007100014
J	Moss, AJ; Francis, CW; Ryan, D				Moss, Arthur J.; Francis, Charles W.; Ryan, Daniel			Collaborative Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Moss, Arthur J.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	University of Rochester	Moss, AJ (corresponding author), Univ Rochester, Med Ctr, Rochester, NY 14642 USA.							[Anonymous], 2010, NY TIMES        0812; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; DS ECHT, 1991, NEW ENGL J MED, V324, P781; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Stewart AK, 2010, BLOOD, V116, P674, DOI 10.1182/blood-2010-04-281212	5	17	17	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					789	791		10.1056/NEJMp1013194	http://dx.doi.org/10.1056/NEJMp1013194			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729DJ	21366470				2022-12-28	WOS:000287928400001
J	Seshasai, SRK; Kaptoge, S; Thompson, A; Di Angelantonio, E; Gao, P; Sarwar, N; Whincup, PH; Mukamal, KJ; Gillum, RF; Holme, I; Njolstad, I; Fletcher, A; Nilsson, P; Lewington, S; Collins, R; Gudnason, V; Thompson, SG; Sattar, N; Selvin, E; Hu, FB; Danesh, J				Seshasai, Sreenivasa Rao Kondapally; Kaptoge, Stephen; Thompson, Alexander; Di Angelantonio, Emanuele; Gao, Pei; Sarwar, Nadeem; Whincup, Peter H.; Mukamal, Kenneth J.; Gillum, Richard F.; Holme, Ingar; Njolstad, Inger; Fletcher, Astrid; Nilsson, Peter; Lewington, Sarah; Collins, Rory; Gudnason, Vilmundur; Thompson, Simon G.; Sattar, Naveed; Selvin, Elizabeth; Hu, Frank B.; Danesh, John		Emerging Risk Factors Collabora	Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANCER-MORTALITY; ASSOCIATION; METAANALYSIS; INSULIN	BACKGROUND The extent to which diabetes mellitus or hyperglycemia is related to risk of death from cancer or other nonvascular conditions is uncertain. METHODS We calculated hazard ratios for cause-specific death, according to baseline diabetes status or fasting glucose level, from individual-participant data on 123,205 deaths among 820,900 people in 97 prospective studies. RESULTS After adjustment for age, sex, smoking status, and body-mass index, hazard ratios among persons with diabetes as compared with persons without diabetes were as follows: 1.80 (95% confidence interval [CI], 1.71 to 1.90) for death from any cause, 1.25 (95% CI, 1.19 to 1.31) for death from cancer, 2.32 (95% CI, 2.11 to 2.56) for death from vascular causes, and 1.73 (95% CI, 1.62 to 1.85) for death from other causes. Diabetes (vs. no diabetes) was moderately associated with death from cancers of the liver, pancreas, ovary, colorectum, lung, bladder, and breast. Aside from cancer and vascular disease, diabetes (vs. no diabetes) was also associated with death from renal disease, liver disease, pneumonia and other infectious diseases, mental disorders, nonhepatic digestive diseases, external causes, intentional self-harm, nervous-system disorders, and chronic obstructive pulmonary disease. Hazard ratios were appreciably reduced after further adjustment for glycemia measures, but not after adjustment for systolic blood pressure, lipid levels, inflammation or renal markers. Fasting glucose levels exceeding 100 mg per deciliter (5.6 mmol per liter), but not levels of 70 to 100 mg per deciliter (3.9 to 5.6 mmol per liter), were associated with death. A 50-year-old with diabetes died, on average, 6 years earlier than a counterpart without diabetes, with about 40% of the difference in survival attributable to excess nonvascular deaths. CONCLUSIONS In addition to vascular disease, diabetes is associated with substantial premature death from several cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, independent of several major risk factors. (Funded by the British Heart Foundation and others.)	[Whincup, Peter H.] St Georges Univ London, London, England; [Gillum, Richard F.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Holme, Ingar] Ullevaal Univ Hosp, Oslo, Norway; [Njolstad, Inger] Univ Tromso, Tromso, Norway; [Fletcher, Astrid] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Nilsson, Peter] Lund Univ, Lund, Sweden; [Lewington, Sarah; Collins, Rory] Univ Oxford, F Med Sci, Oxford, England; [Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Gudnason, Vilmundur] Iceland Heart Assoc, Reykjavik, Iceland; [Thompson, Simon G.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Sattar, Naveed] Univ Glasgow, Glasgow, Lanark, Scotland; [Selvin, Elizabeth] Johns Hopkins Univ, Baltimore, MD USA; [Hu, Frank B.] Harvard Univ, Boston, MA 02115 USA	St Georges University London; Centers for Disease Control & Prevention - USA; University of Oslo; UiT The Arctic University of Tromso; University of London; London School of Hygiene & Tropical Medicine; Lund University; University of Oxford; University of Iceland; Icelandic Heart Association; MRC Biostatistics Unit; University of Glasgow; Johns Hopkins University; Harvard University			Bakker, Stephan J. L./J-4023-2015; de la Camara, Agustin Gomez/S-7123-2018; Dankner, Rachel/Q-5245-2019; Gudnason, Vilmundur/K-6885-2015; vhmpp, aks/F-9756-2012; Gudnason, Vilmundur/AAE-7126-2019; Gao, Pei/R-4794-2018; Marmot, M G/Y-3920-2019; Njolstad, Inger/X-3784-2019; Tanne, David/F-2560-2010; Mukamal, Kenneth/GVR-7978-2022; Ulmer, Hanno/S-6615-2019; DiAngelantonio, Emanuele/ABE-6852-2020; Gao, Pei/AAF-3065-2019; Lennon, Lucy/ABB-9433-2020; Benn, Marianne/O-4164-2019; Rubio, Miguel Angel/GRJ-0134-2022; Meisinger, Christine/B-5358-2014; Brunner, Eric/H-2114-2011; Shaffer, Jonathan A/B-2783-2013; Stefanadis, Christodoulos/ABH-2232-2020	Bakker, Stephan J. L./0000-0003-3356-6791; Dankner, Rachel/0000-0001-6454-6000; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Gao, Pei/0000-0001-8649-1290; Marmot, M G/0000-0002-2431-6419; Tanne, David/0000-0002-6699-2220; Ulmer, Hanno/0000-0001-5911-1002; Gao, Pei/0000-0001-8649-1290; Lennon, Lucy/0000-0002-1738-1351; Benn, Marianne/0000-0002-1701-595X; Rubio, Miguel Angel/0000-0002-0495-6240; Brunner, Eric/0000-0002-0595-4474; Woodward, Mark/0000-0001-9800-5296; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Tiemeier, Henning/0000-0002-4395-1397; Pennells, Lisa Anne/0000-0002-8594-3061; Ramachandran, Vasan/0000-0001-7357-5970; Lewington, Sarah/0000-0002-4496-4771; Stehouwer, Coen/0000-0001-8752-3223; Amouyel, Philippe/0000-0001-9088-234X; Nordestgaard, Borge/0000-0002-1954-7220; Whincup, Peter/0000-0002-5589-4107; Bladbjerg, Else Marie/0000-0003-0912-2437; Jorgensen, Torben/0000-0001-9453-2830; Engstrom, Gunnar/0000-0002-8618-9152; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Rothenbacher, Dietrich/0000-0002-3563-2791; Stefanadis, Christodoulos/0000-0001-5974-6454; Jespersen, Jorgen/0000-0002-3059-2356; Di Angelantonio, Emanuele/0000-0001-8776-6719; Lawlor, Debbie A/0000-0002-6793-2262	British Heart Foundation [RG/08/014]; U.K. Medical Research Council; Pfizer; Gates Cambridge Trust; Overseas Research Studentship Award; Addenbrooke's Charitable Trust; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL085083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023629] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/014/24067, PG/09/002/26056, RG/07/008/23674, RG/08/013/25942] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [G0401527, G19/35, G0600705, G8802774, G0902037, G0100222, G1000143, MC_U105260792, MC_U137686857] Funding Source: researchfish; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0902037, MC_U105260792, G0600705] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Gates Cambridge Trust; Overseas Research Studentship Award; Addenbrooke's Charitable Trust; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the British Heart Foundation (RG/08/014), the U.K. Medical Research Council, and Pfizer (to the ERFC Coordinating Centre), as well as the Gates Cambridge Trust Scholarship, an Overseas Research Studentship Award, and an Addenbrooke's Charitable Trust Clinical Research Fellowship (to Dr. Kondapally Seshasai). Various sources have supported recruitment, follow-up, and laboratory measurements in the cohorts contributing to the ERFC. Investigators of several of these studies have contributed to a list (http://ceu.phpc.cam.ac.uk/research/erfc/studies) naming relevant funding sources.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; Batty GD, 2004, CANCER CAUSE CONTROL, V15, P873, DOI 10.1007/s10552-004-1050-z; Chen SL, 2009, J UROLOGY, V182, pS51, DOI 10.1016/j.juro.2009.07.090; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dormandy J, 2009, DRUG SAFETY, V32, P187, DOI 10.2165/00002018-200932030-00002; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Emerging Risk Factors Collaboration, 2007, EUR J EPIDEMIOL, V22, P839, DOI DOI 10.1007/SL0654-007-9165-7; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Gulliford MC, 2009, AM J EPIDEMIOL, V169, P455, DOI 10.1093/aje/kwn342; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Jawa A, 2004, MED CLIN N AM, V88, P1001, DOI 10.1016/j.mcna.2004.04.012; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Pannala R, 2009, AM J GASTROENTEROL, V104, P2318, DOI 10.1038/ajg.2009.253; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Thompson S, 2010, INT J EPIDEMIOL, V39, P1345, DOI 10.1093/ije/dyq063; UN Population Division, 2005, WORLD POP PROSP; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Waters KM, 2009, AM J EPIDEMIOL, V169, P937, DOI 10.1093/aje/kwp003; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; World Health Organization, 2007, WHO STAT INF SYST WH; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7	37	1757	1814	8	224	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					829	841		10.1056/NEJMoa1008862	http://dx.doi.org/10.1056/NEJMoa1008862			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21366474	Bronze, Green Accepted			2022-12-28	WOS:000287928400008
J	Ioannou, GN				Ioannou, George N.			Hepatitis B Virus in the United States: Infection, Exposure, and Immunity Rates in a Nationally Representative Survey	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM IMMUNOGENICITY; VACCINATION; PREVENTION; DISEASES; BOOSTER; HEALTH	Background: Up-to-date estimates of the prevalence of hepatitis B virus (HBV) infection, exposure, and immunity are necessary to assess the effectiveness of ongoing programs aimed at preventing HBV transmission. Objective: To determine the prevalence and associations of chronic HBV infection, past exposure, and immunity in the United States from 1999 to 2008. Design: Nationally representative, cross-sectional household survey. Setting: U.S. civilian, noninstitutionalized population. Participants: 39 787 participants in the National Health and Nutrition Examination Survey (1999 to 2008) aged 2 years or older. Measurements: Chronic HBV infection was defined by presence of serum HBV surface antigen and past exposure by serum antibody to hepatitis B core antigen among persons aged 6 years or older. Infant immunity was defined by presence of serum antibody to hepatitis B surface antigen among children aged 2 years. Results: Among persons aged 6 years or older, 0.27% (95% CI, 0.20% to 0.34%) had chronic HBV infection (corresponding to approximately 704 000 persons nationwide), and 4.6% (CI, 4.1% to 5.0%) had been exposed to HBV (approximately 11 993 000 persons). These estimates are lower (P < 0.001) than estimates of HBV infection (0.42%) and exposure (5.1%) in the United States reported from 1988 to 1994. Infection and past exposure were very uncommon among persons aged 6 to 19 years. Children aged 2 years have high rates of immunity (68.6% [CI, 64.1% to 73.2%]). Adults, including those at high risk for infection, have much lower rates of immunity. Limitations: Incarcerated and homeless persons were not sampled. Categorization of race or ethnicity did not identify high-risk groups, such as persons of Asian and Pacific Islander descent. Conclusion: A cohort of children and adolescents is growing up in the United States with high rates of immunity against HBV and very low rates of infection. Vaccination of high-risk adults should continue to be emphasized.	[Ioannou, George N.] Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Ioannou, George N.] Univ Washington, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Ioannou, GN (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, S-111 Gastro,1660 S Columbian Way, Seattle, WA 98108 USA.	georgei@medicine.washington.edu			Veterans Affairs Research Enhancement Award Program	Veterans Affairs Research Enhancement Award Program	Grant Support: By the Veterans Affairs Research Enhancement Award Program.	Alter MJ, 2003, SEMIN LIVER DIS, V23, P39, DOI 10.1055/s-2003-37583; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; Bauer T, 2006, VACCINE, V24, P572, DOI 10.1016/j.vaccine.2005.08.058; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; *CDCP, 1995, MMWR-MORBID MORTAL W, V44, P574; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P997; Cheung RC, 2002, J CLIN GASTROENTEROL, V34, P476, DOI 10.1097/00004836-200204000-00021; Dorell C., 2010, Morbidity and Mortality Weekly Report, V59, P1018; Gabbuti A, 2007, VACCINE, V25, P3129, DOI 10.1016/j.vaccine.2007.01.045; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Goldstein ST, 2002, J INFECT DIS, V185, P713, DOI 10.1086/339192; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hall AJ, 2010, HEPATOLOGY, V51, P1485, DOI 10.1002/hep.23674; Ioannou GN, 2007, CLIN GASTROENTEROL H, V5, P938, DOI 10.1016/j.cgh.2007.02.039; Kao JH, 2005, LANCET, V366, P1337, DOI 10.1016/S0140-6736(05)67544-7; Kaplan JE, 2009, MMWR RECOMM REP, V58, pCE1; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Lin YC, 2003, J INFECT DIS, V187, P134, DOI 10.1086/345871; Lu CY, 2008, J INFECT DIS, V197, P1419, DOI 10.1086/587695; McMahon BJ, 2005, ANN INTERN MED, V142, P333, DOI 10.7326/0003-4819-142-5-200503010-00008; McQuillan GM, 1999, AM J PUBLIC HEALTH, V89, P14, DOI 10.2105/AJPH.89.1.14; Molinari N. A., 2009, Morbidity and Mortality Weekly Report, V58, P921; *NHANES, LAB PROC MAN ANT HEP; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048; The National Health and Nutrition Examination Survey (NHANES), AN REP GUID; Urbani S, 2010, CLIN CHEM LAB MED, V48, P23, DOI 10.1515/CCLM.2010.002; US Census Bureau, US CENS 2000; Van Damme P, 2009, J MED VIROL, V81, P1710, DOI 10.1002/jmv.21568; Van Damme Pierre, 2007, Travel Med Infect Dis, V5, P79, DOI 10.1016/j.tmaid.2006.04.004; Wooten K. G., 2010, Morbidity and Mortality Weekly Report, V59, P1171; Zanetti AR, 2005, LANCET, V366, P1379, DOI 10.1016/S0140-6736(05)67568-X	32	122	124	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 1	2011	154	5					319	328		10.7326/0003-4819-154-5-201103010-00006	http://dx.doi.org/10.7326/0003-4819-154-5-201103010-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727LA	21357909				2022-12-28	WOS:000287799900004
J	Scepaniak, JJ; Vogel, CS; Khusniyarov, MM; Heinemann, FW; Meyer, K; Smith, JM				Scepaniak, Jeremiah J.; Vogel, Carola S.; Khusniyarov, Marat M.; Heinemann, Frank W.; Meyer, Karsten; Smith, Jeremy M.			Synthesis, Structure, and Reactivity of an Iron(V) Nitride	SCIENCE			English	Article							SPECTROSCOPIC CHARACTERIZATION; INTERSTITIAL ATOM; FEMO-COFACTOR; COMPLEX; NITROGENASE; MOSSBAUER; CATALYSIS; FIXATION; LIGAND; ENDOR	Despite being implicated as important intermediates, iron(V) compounds have proven very challenging to isolate and characterize. Here, we report the preparation of the iron(V) nitrido complex, [PhB((t)BuIm)(3)Fe-V N]BArF24 (PhB((t)BuIm)(3)(-) = phenyltris(3-tert-butylimidazol-2-ylidene)borato, BArF24 = B(3,5-(CF3)(2)C6H3)(4)(-)), by one electron oxidation of the iron(IV) nitrido precursor. Single-crystal x-ray diffraction of the iron(V) complex reveals a four-coordinate metal ion with a terminal nitrido ligand. Mossbauer and electron paramagnetic resonance spectroscopic characterization, supported by electronic structure calculations, provide evidence for a d(3) iron(V) metal center in a low spin (S = 1/2) electron configuration. Low-temperature reaction of the iron(V) nitrido complex with water under reducing conditions leads to high yields of ammonia with concomitant formation of an iron(II) species.	[Vogel, Carola S.; Khusniyarov, Marat M.; Heinemann, Frank W.; Meyer, Karsten] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91058 Erlangen, Germany; [Scepaniak, Jeremiah J.; Smith, Jeremy M.] New Mexico State Univ, Dept Chem & Biochem, MSC 3C, Las Cruces, NM 88003 USA	University of Erlangen Nuremberg; New Mexico State University	Meyer, K (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Egerlandstr 1, D-91058 Erlangen, Germany.	KMeyer@chemie.uni-erlangen.de; jesmith@nmsu.edu	Khusniyarov, Marat/O-7723-2016; Smith, Jeremy M/H-5043-2012; Heinemann, Frank Wilhelm/AAC-3062-2022; Meyer, Karsten/G-2570-2012; Scepaniak, Jeremiah/I-5920-2015	Khusniyarov, Marat/0000-0002-2034-421X; Smith, Jeremy M/0000-0002-3206-4725; Heinemann, Frank Wilhelm/0000-0002-9007-8404; Meyer, Karsten/0000-0002-7844-2998; Scepaniak, Jeremiah/0000-0002-0135-3954	Friedrich-Alexander-University Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie; Department of Energy Office of Basic Energy Sciences [DE-FG02-08ER15996]; Camille and Henry Dreyfus Foundation	Friedrich-Alexander-University Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Camille and Henry Dreyfus Foundation	We acknowledge funding from Friedrich-Alexander-University Erlangen-Nuremberg and the Deutsche Forschungsgemeinschaft (K.M.); Fonds der Chemischen Industrie (M.M.K.); and the Department of Energy Office of Basic Energy Sciences (DE-FG02-08ER15996) and the Camille and Henry Dreyfus Foundation (J.M.S.). J. Sutter is gratefully acknowledged for collecting the spectroscopic data, and K. Wieghardt and E. Bill (Max-Planck-Institut for Bioinorganic Chemistry, Mulheim/Ruhr, Germany) for helpful discussions. The crystallographic data CCDC-786059 (2 at 35 K) and CCDC-786060 (2 at 100 K) can be obtained free at www.ccdc.cam.ac.uk/data_request/cif (or from Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, UK; fax: ++44-1223-336-033; e-mail: deposit@ccdc.cam.ac.uk).	Aliaga-Alcalde N, 2005, ANGEW CHEM INT EDIT, V44, P2908, DOI 10.1002/anie.200462368; Berry JF, 2006, SCIENCE, V312, P1937, DOI 10.1126/science.1128506; BERTHELOT MPE, 1959, REP CHEM APPL, V1, P284, DOI DOI 10.1056/NEJMOA1708131; Betley TA, 2004, J AM CHEM SOC, V126, P6252, DOI 10.1021/ja048713v; Chen K, 2002, J AM CHEM SOC, V124, P3026, DOI 10.1021/ja0120025; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Ertl G, 2001, CHEM REC, V1, P33; ERTL G, 1990, ANGEW CHEM INT EDIT, V29, P1219, DOI 10.1002/anie.199012191; Hendrich MP, 2006, P NATL ACAD SCI USA, V103, P17107, DOI 10.1073/pnas.0604402103; Herber R. H., 1984, CHEM MOSSBAUER SPECT; Hoffman BM, 2009, ACCOUNTS CHEM RES, V42, P609, DOI 10.1021/ar8002128; Jackson TA, 2008, J AM CHEM SOC, V130, P12394, DOI 10.1021/ja8022576; Lukoyanov D, 2007, INORG CHEM, V46, P11437, DOI 10.1021/ic7018814; Meyer K, 1999, J AM CHEM SOC, V121, P4859, DOI 10.1021/ja983454t; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Scepaniak JJ, 2008, J AM CHEM SOC, V130, P10515, DOI 10.1021/ja8027372; SCHULZ CE, 1987, J CHEM PHYS, V87, P5077, DOI 10.1063/1.453675; de Oliveira FT, 2007, SCIENCE, V315, P835, DOI 10.1126/science.1133417; Vogel C, 2008, ANGEW CHEM INT EDIT, V47, P2681, DOI 10.1002/anie.200800600; Yang TC, 2005, J AM CHEM SOC, V127, P12804, DOI 10.1021/ja0552489; YOUSIF AA, 1989, J PHYS-CONDENS MAT, V1, P7103, DOI 10.1088/0953-8984/1/39/022	22	227	229	5	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1049	1052		10.1126/science.1198315	http://dx.doi.org/10.1126/science.1198315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350172				2022-12-28	WOS:000287699000058
J	Hawley, RS				Hawley, R. Scott			Hitting a Tiny Target in the Dark	SCIENCE			English	Editorial Material							CHROMOSOME SYNAPSIS; RECOMBINATION; SPO11		[Hawley, R. Scott] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Hawley, R. Scott] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Hawley, RS (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	rsh@stowers.org		Hawley, R. Scott/0000-0002-6478-0494				Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Henzel JV, 2011, GENETICS, V187, P685, DOI 10.1534/genetics.110.124958; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Kleckner N, 2003, TRENDS GENET, V19, P623, DOI 10.1016/j.tig.2003.09.004; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; Thomas NS, 2003, HUM REPROD UPDATE, V9, P309, DOI 10.1093/humupd/dmg028	9	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					870	871		10.1126/science.1202373	http://dx.doi.org/10.1126/science.1202373			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330526				2022-12-28	WOS:000287455100038
J	Heldmaier, G				Heldmaier, Gerhard			Life on Low Flame in Hibernation	SCIENCE			English	Editorial Material							DAILY TORPOR; MAMMALIAN HIBERNATION; HYPOMETABOLISM; TEMPERATURE; METABOLISM		Univ Marburg, D-35043 Marburg, Hessen, Germany	Philipps University Marburg	Heldmaier, G (corresponding author), Univ Marburg, D-35043 Marburg, Hessen, Germany.	heldmaier@staff.uni-marburg.de	Heldmaier, Gerhard/AAI-3286-2020					Andrews MT, 2007, BIOESSAYS, V29, P431, DOI 10.1002/bies.20560; Arnold W, 2004, AM J PHYSIOL-REG I, V286, pR174, DOI 10.1152/ajpregu.00593.2002; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255, DOI 10.1152/ajpregu.2000.279.1.R255; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Dausmann KH, 2009, J COMP PHYSIOL B, V179, P345, DOI 10.1007/s00360-008-0318-0; GEISER F, 1995, PHYSIOL ZOOL, V68, P935, DOI 10.1086/physzool.68.6.30163788; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; HELDMAIER G, 2004, LIFE COLD, P185; Morin P, 2009, INT J DEV BIOL, V53, P433, DOI 10.1387/ijdb.082643pm; Ruediger J, 2007, SYNAPSE, V61, P343, DOI 10.1002/syn.20380; Staples JF, 2008, J COMP PHYSIOL B, V178, P811, DOI 10.1007/s00360-008-0282-8; Stieler JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014530; Toien O, 2011, SCIENCE, V331, P906, DOI 10.1126/science.1199435; van Breukelen F, 2002, J COMP PHYSIOL B, V172, P355, DOI 10.1007/s00360-002-0256-1	14	14	14	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					866	867		10.1126/science.1203192	http://dx.doi.org/10.1126/science.1203192			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330523				2022-12-28	WOS:000287455100035
J	van Middendorp, JJ; Hosman, AJF; Donders, ART; Pouw, MH; Ditunno, JF; Curt, A; Geurts, ACH; Van de Meent, H				van Middendorp, Joost J.; Hosman, Allard J. F.; Donders, A. Rogier T.; Pouw, Martin H.; Ditunno, John F., Jr.; Curt, Armin; Geurts, Alexander C. H.; Van de Meent, Hendrik		EM-SCI Study Grp	A clinical prediction rule for ambulation outcomes after traumatic spinal cord injury: a longitudinal cohort study	LANCET			English	Article							OPERATING CHARACTERISTIC CURVES; INDEPENDENCE MEASURE; NEUROLOGIC RECOVERY; PROGNOSIS; VALIDATION; CAPACITY; WALKING; VERSION; TRIALS; AREAS	Background Traumatic spinal cord injury is a serious disorder in which early prediction of ambulation is important to counsel patients and to plan rehabilitation. We developed a reliable, validated prediction rule to assess a patient's chances of walking independently after such injury. Methods We undertook a longitudinal cohort study of adult patients with traumatic spinal cord injury, with early (within the first 15 days after injury) and late (1-year follow-up) clinical examinations, who were admitted to one of 19 European centres between July, 2001, and June, 2008. A clinical prediction rule based on age and neurological variables was derived from the international standards for neurological classification of spinal cord injury with a multivariate logistic regression model. Primary outcome measure 1 year after injury was independent indoor walking based on the Spinal Cord Independence Measure. Model performances were quantified with respect to discrimination (area under receiver-operating-characteristics curve [AUC]). Temporal validation was done in a second group of patients from July, 2008, to December, 2009. Findings Of 1442 patients with spinal cord injury, 492 had available outcome measures. A combination of age (<65 vs >= 65 years), motor scores of the quadriceps femoris (L3), gastrocsoleus (S1) muscles, and light touch sensation of dermatomes L3 and S1 showed excellent discrimination in distinguishing independent walkers from dependent walkers and non-walkers (AUC 0.956, 95% CI 0.936-0.976, p<0.0001). Temporal validation in 99 patients confirmed excellent discriminating ability of the prediction rule (AUC 0.967, 0.939-0.995, p<0.0001). Interpretation Our prediction rule, including age and four neurological tests, can give an early prognosis of an individual's ability to walk after traumatic spinal cord injury, which can be used to set rehabilitation goals and might improve the ability to stratify patients in interventional trials.	[van Middendorp, Joost J.; Hosman, Allard J. F.; Pouw, Martin H.] Radboud Univ Nijmegen, Med Ctr, Dept Orthopaed, Spine Unit, NL-6500 HB Nijmegen, Netherlands; [Donders, A. Rogier T.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6500 HB Nijmegen, Netherlands; [Geurts, Alexander C. H.; Van de Meent, Hendrik] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil Med, NL-6500 HB Nijmegen, Netherlands; [Ditunno, John F., Jr.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA; [Curt, Armin] Balgrist Univ Hosp, Spinal Cord Injury Ctr, Zurich, Switzerland	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Jefferson University; University of Zurich	van Middendorp, JJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Orthopaed, Spine Unit, POB 9101, NL-6500 HB Nijmegen, Netherlands.	jvanmiddendorp@gmail.com	Pouw, Martin/B-6432-2018; Donders, A.R.T./L-4277-2015; Geurts, Alexander/H-8032-2014; van Middendorp, Joost J./C-7493-2011; Hosman, A.J.F./L-4393-2015; Meent, H./L-4509-2015	Pouw, Martin/0000-0002-2253-0227; Donders, A.R.T./0000-0002-0484-1419; Geurts, Alexander/0000-0001-7478-1119; van Middendorp, Joost J./0000-0003-4822-521X; 	Internationale Stiftung fur Forschung in Paraplegie (IFP), Zurich, Switzerland	Internationale Stiftung fur Forschung in Paraplegie (IFP), Zurich, Switzerland	This work was supported by a grant from the Internationale Stiftung fur Forschung in Paraplegie (IFP), Zurich, Switzerland. All spinal cord injury centres participating in the EM-SCI network contributed to the study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; American Spinal Injury Association, 2002, INT STAND NEUR CLASS; Burns SP, 1997, ARCH PHYS MED REHAB, V78, P1169, DOI 10.1016/S0003-9993(97)90326-9; Catz A, 2007, SPINAL CORD, V45, P275, DOI 10.1038/sj.sc.3101960; Catz A, 2001, DISABIL REHABIL, V23, P263; CROZIER KS, 1991, ARCH PHYS MED REHAB, V72, P119; CROZIER KS, 1992, PARAPLEGIA, V30, P762, DOI 10.1038/sc.1992.147; Curt A, 1997, ARCH PHYS MED REHAB, V78, P39, DOI 10.1016/S0003-9993(97)90007-1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ditunno PL, 2008, SPINAL CORD, V46, P500, DOI 10.1038/sj.sc.3102172; Furlan JC, 2009, J NEUROTRAUM, V26, P1707, DOI [10.1089/neu.2009.0888, 10.1089/neu.2009-0888]; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HUSSEY RW, 1973, ARCH PHYS MED REHAB, V54, P544; Kirshblum S, 2004, ARCH PHYS MED REHAB, V85, P1811, DOI 10.1016/j.apmr.2004.03.015; Kirshblum SC, 1998, ARCH PHYS MED REHAB, V79, P1456, DOI 10.1016/S0003-9993(98)90244-1; Kirshblum SC, 2007, ARCH PHYS MED REHAB, V88, pS62, DOI 10.1016/j.apmr.2006.12.003; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Marino RJ, 2004, ARCH PHYS MED REHAB, V85, P1804, DOI 10.1016/j.apmr.2004.04.026; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Oleson CV, 2005, ARCH PHYS MED REHAB, V86, P988, DOI 10.1016/j.apmr.2004.09.031; PENROD LE, 1990, ARCH PHYS MED REHAB, V71, P963; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Steeves JD, 2007, SPINAL CORD, V45, P206, DOI 10.1038/sj.sc.3102008; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; van Hedel HJA, 2009, NEUROREHAB NEURAL RE, V23, P117, DOI 10.1177/1545968308320640; van Hedelt HJA, 2008, NEUROL RES, V30, P61, DOI 10.1179/016164107X230775; van Middendorp JJ, 2009, SPINAL CORD, V47, P809, DOI 10.1038/sc.2009.44; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P756; Widerstrom-Noga EG, 1999, ARCH PHYS MED REHAB, V80, P580, DOI 10.1016/S0003-9993(99)90203-4; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	31	160	161	2	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					1004	1010		10.1016/S0140-6736(10)62276-3	http://dx.doi.org/10.1016/S0140-6736(10)62276-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21377202				2022-12-28	WOS:000288775800029
J	Albeck, JG; Brugge, JS				Albeck, John G.; Brugge, Joan S.			Uncovering a Tumor Suppressor for Triple-Negative Breast Cancers	CELL			English	Editorial Material								"Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.	[Albeck, John G.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu						Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Streit S, 2006, CANCER GENET CYTOGEN, V170, P48, DOI 10.1016/j.cancergencyto.2006.05.013; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003	6	18	20	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2011	144	5					638	640		10.1016/j.cell.2011.02.030	http://dx.doi.org/10.1016/j.cell.2011.02.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376226	Bronze			2022-12-28	WOS:000288007100003
J	Schlegelmilch, K; Mohseni, M; Kirak, O; Pruszak, J; Rodriguez, JR; Zhou, DW; Kreger, BT; Vasioukhin, V; Avruch, J; Brummelkamp, TR; Camargo, FD				Schlegelmilch, Karin; Mohseni, Morvarid; Kirak, Oktay; Pruszak, Jan; Rodriguez, J. Renato; Zhou, Dawang; Kreger, Bridget T.; Vasioukhin, Valera; Avruch, Joseph; Brummelkamp, Thijn R.; Camargo, Fernando D.			Yap1 Acts Downstream of alpha-Catenin to Control Epidermal Proliferation	CELL			English	Article							ORGAN SIZE CONTROL; TUMOR-SUPPRESSOR; CELL-PROLIFERATION; PROMOTES APOPTOSIS; SIGNALING PATHWAY; HIPPO PATHWAY; PROGENITOR CELLS; TEAD/TEF FAMILY; PROTEIN-KINASE; GROWTH-CONTROL	During development and regeneration, proliferation of tissue-specific stem cells is tightly controlled to produce organs of a predetermined size. The molecular determinants of this process remain poorly understood. Here, we investigate the function of Yap1, the transcriptional effector of the Hippo signaling pathway, in skin biology. Using gain- and loss-of-function studies, we show that Yap1 is a critical modulator of epidermal stem cell proliferation and tissue expansion. Yap1 mediates this effect through interaction with TEAD transcription factors. Additionally, our studies reveal that alpha-catenin, a molecule previously implicated in tumor suppression and cell density sensing in the skin, is an upstream negative regulator of Yap1. alpha-catenin controls Yap1 activity and phosphorylation by modulating its interaction with 14-3-3 and the PP2A phosphatase. Together, these data identify Yap1 as a determinant of the proliferative capacity of epidermal stem cells and as an important effector of a "crowd control" molecular circuitry in mammalian skin.	[Schlegelmilch, Karin; Mohseni, Morvarid; Camargo, Fernando D.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Schlegelmilch, Karin; Mohseni, Morvarid; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Schlegelmilch, Karin; Mohseni, Morvarid; Pruszak, Jan; Camargo, Fernando D.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Schlegelmilch, Karin] FU Berlin, Inst Chem Biochem, D-14195 Berlin, Germany; [Kirak, Oktay; Pruszak, Jan; Rodriguez, J. Renato; Brummelkamp, Thijn R.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Zhou, Dawang; Avruch, Joseph] Massachusetts Gen Hosp, Dept Mol & Cellular Biol, Boston, MA 02114 USA; [Kreger, Bridget T.; Vasioukhin, Valera] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Free University of Berlin; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Fred Hutchinson Cancer Center	Camargo, FD (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	fernando.camargo@childrens.harvard.edu	Kirak, Oktay/H-6347-2013; Pruszak, Jan/G-6972-2015	Kirak, Oktay/0000-0002-6524-4685; Pruszak, Jan/0000-0003-4297-4009; Vasioukhin, Valeri/0000-0002-6730-0281; Schlegelmilch, Karin/0000-0003-3173-0914; Zhou, Dawang/0000-0002-9053-5249	Stand Up to Cancer-AACR initiative, NIH [R01 CA131426]; Whitehead Institute; NATIONAL CANCER INSTITUTE [R01CA131426] Funding Source: NIH RePORTER	Stand Up to Cancer-AACR initiative, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehead Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Shrestha and S. Zaghlul for their technical assistance; L. Zon and A. von Giese and members of the Camargo lab for critical discussion; and members of the Gregory laboratory for advice on mass spectrometry experiments. This work was supported by grants from the Stand Up to Cancer-AACR initiative, NIH grant R01 CA131426, and funds from the Whitehead Institute Fellows Program. F. D. C. is a V Foundation Scholar and Pew Scholar in the Biomedical Sciences.	Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Benjamin JM, 2008, SEMIN CANCER BIOL, V18, P53, DOI 10.1016/j.semcancer.2007.08.003; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chen CL, 2010, P NATL ACAD SCI USA, V107, P15810, DOI 10.1073/pnas.1004060107; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dellambra E, 2000, J CELL BIOL, V149, P1117, DOI 10.1083/jcb.149.5.1117; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hariharan IK, 2006, CURR BIOL, V16, pR1037, DOI 10.1016/j.cub.2006.11.012; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Herron BJ, 2005, NAT GENET, V37, P1210, DOI 10.1038/ng1652; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Tinkle CL, 2008, P NATL ACAD SCI USA, V105, P15405, DOI 10.1073/pnas.0807374105; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XU TA, 1995, DEVELOPMENT, V121, P1053; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	58	749	780	0	97	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 4	2011	144	5					782	795		10.1016/j.cell.2011.02.031	http://dx.doi.org/10.1016/j.cell.2011.02.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	730CE	21376238	Green Accepted, Bronze			2022-12-28	WOS:000288007100016
J	Learner, S				Learner, Sue			Child Protection After Baby P: can GPs follow child protection guidance?	BRITISH MEDICAL JOURNAL			English	Editorial Material												suelearner@journalist.com							0	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 2	2011	342								d707	10.1136/bmj.d707	http://dx.doi.org/10.1136/bmj.d707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	732EO	21367842				2022-12-28	WOS:000288167900001
J	Manceau, M; Domingues, VS; Mallarino, R; Hoekstra, HE				Manceau, Marie; Domingues, Vera S.; Mallarino, Ricardo; Hoekstra, Hopi E.			The Developmental Role of Agouti in Color Pattern Evolution	SCIENCE			English	Article							SIGNAL PROTEIN; COAT COLOR; MOUSE COAT; PIGMENTATION; MELANOCYTES; MUTATIONS; GENETICS; STRIPES; GENES; LOCUS	Animal color patterns can affect fitness in the wild; however, little is known about the mechanisms that control their formation and subsequent evolution. We took advantage of two locally camouflaged populations of Peromyscus mice to show that the negative regulator of adult pigmentation, Agouti, also plays a key developmental role in color pattern evolution. Genetic and functional analyses showed that ventral-specific embryonic expression of Agouti establishes a prepattern by delaying the terminal differentiation of ventral melanocytes. Moreover, a skin-specific increase in both the level and spatial domain of Agouti expression prevents melanocyte maturation in a regionalized manner, resulting in a novel and adaptive color pattern. Thus, natural selection favors late-acting, tissue-specific changes in embryonic Agouti expression to produce large changes in adult color pattern.	[Manceau, Marie; Domingues, Vera S.; Mallarino, Ricardo; Hoekstra, Hopi E.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Manceau, Marie; Domingues, Vera S.; Hoekstra, Hopi E.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Harvard University; Harvard University	Hoekstra, HE (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	hoekstra@oeb.harvard.edu	Hoekstra, Hopi E/I-6690-2012	Hoekstra, Hopi E/0000-0003-1431-1769	Portuguese Foundation for Science and Technology; NSF [DEB-0919190]; Direct For Biological Sciences [0919190] Funding Source: National Science Foundation	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Kanadia, C. Punzo, E. McGlinn, J. Gros, A. Abzhanov, and C. Tabin for technical assistance; G. Barsh for helpful discussions; V. Hearing for antibodies to Trp1/Trp2; and C. Desplan, C. Tabin, A. Abzhanov, C. Linnen, and J. Gros for comments on the manuscript. In situ hybridizations on sections and in utero injections were conducted in the Abzhanov and Tabin/Cepko laboratories, respectively. Supported by the Portuguese Foundation for Science and Technology (V.S.D.) and by NSF grant DEB-0919190 (H.E.H.).	Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Botchkareva NV, 2003, J INVEST DERM SYMP P, V8, P76, DOI 10.1046/j.1523-1747.2003.12176.x; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen YR, 1996, GENETICS, V144, P265; Cott H.B., 1940, ADAPTIVE COLORATION; Hirobe T, 1998, EUR J CELL BIOL, V75, P184, DOI 10.1016/S0171-9335(98)80060-5; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Kopp A, 2009, EVOLUTION, V63, P2771, DOI 10.1111/j.1558-5646.2009.00761.x; Le Pape E, 2009, P NATL ACAD SCI USA, V106, P1802, DOI 10.1073/pnas.0806753106; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Mills MG, 2009, SEMIN CELL DEV BIOL, V20, P72, DOI 10.1016/j.semcdb.2008.11.012; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Parichy DM, 2003, CURR BIOL, V13, pR947, DOI 10.1016/j.cub.2003.11.038; Punzo C, 2008, DEV DYNAM, V237, P1034, DOI 10.1002/dvdy.21500; Rawls JF, 2001, DEV BIOL, V240, P301, DOI 10.1006/dbio.2001.0418; Sakai C, 1997, EMBO J, V16, P3544, DOI 10.1093/emboj/16.12.3544; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x	24	150	155	0	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1062	1065		10.1126/science.1200684	http://dx.doi.org/10.1126/science.1200684			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21350176	Green Submitted			2022-12-28	WOS:000287699000062
J	Korn, BS; Zhang, K				Korn, Bobby S.; Zhang, Kang			Carotid-Cavernous Sinus Fistula	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Korn, Bobby S.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Zhang, Kang] Sichuan Univ, W China Hosp, Chengdu, Sichuan, Peoples R China	University of California System; University of California San Diego; Sichuan University	Korn, BS (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.		Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697	NEI NIH HHS [R01 EY021374, R01 EY018660] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY021374, R01EY018660] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))			0	0	0	2	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					E15	E15		10.1056/NEJMicm1006035	http://dx.doi.org/10.1056/NEJMicm1006035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725NP	21345097	Green Accepted			2022-12-28	WOS:000287652500012
J	Kereszt, A; Kondorosi, E				Kereszt, Attila; Kondorosi, Eva			Unlocking the Door to Invasion	SCIENCE			English	Editorial Material							SYMBIOSIS; FUNGAL; REQUIRES		[Kereszt, Attila; Kondorosi, Eva] Bay Zoltan Fdn Appl Res, Inst Plant Genom Human Biotechnol & Bioenergy, Szeged, Hungary; [Kereszt, Attila] Karoly Robert Coll, Gyongyos, Hungary; [Kondorosi, Eva] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Kereszt, A (corresponding author), Bay Zoltan Fdn Appl Res, Inst Plant Genom Human Biotechnol & Bioenergy, Derkovits Fasor 2, Szeged, Hungary.	kereszta@baygen.hu; eva.kondorosi@isv.cnrs-gif.fr		Kondorosi, Eva/0000-0002-4065-8515; Kereszt, Attila/0000-0002-4421-6554				Chen CY, 2007, PLANT PHYSIOL, V145, P1619, DOI 10.1104/pp.107.109876; den Camp RO, 2011, SCIENCE, V331, P909, DOI 10.1126/science.1198181; Harrison MJ, 1999, ANNU REV PLANT PHYS, V50, P361, DOI 10.1146/annurev.arplant.50.1.361; Kistner C, 2005, PLANT CELL, V17, P2217, DOI 10.1105/tpc.105.032714; Kosuta S, 2008, P NATL ACAD SCI USA, V105, P9823, DOI 10.1073/pnas.0803499105; Kouchi H, 2010, PLANT CELL PHYSIOL, V51, P1381, DOI 10.1093/pcp/pcq107; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647	10	3	4	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					865	866		10.1126/science.1202342	http://dx.doi.org/10.1126/science.1202342			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330522				2022-12-28	WOS:000287455100034
J	Zhao, BS; Meijer, G; Schollkopf, W				Zhao, Bum Suk; Meijer, Gerard; Schoellkopf, Wieland			Quantum Reflection of He-2 Several Nanometers Above a Grating Surface	SCIENCE			English	Article							HELIUM DIMER; MOLECULAR-BEAMS; DIFFRACTION; BOND	Quantum reflection allows an atom or molecule to be reflected from a solid before it reaches the region where it would encounter the repulsive potential of the surface. We observed nondestructive scattering of the helium dimer (He-2), which has a binding energy of 10(-7) electron volt, from a solid reflection grating. We scattered a beam containing the dimer as well as atomic helium and larger clusters, but could differentiate the dimer by its diffraction angle. Helium dimers are quantum reflected tens of nanometers above the surface, where the surface-induced forces are too weak to dissociate the fragile bond.	[Zhao, Bum Suk; Meijer, Gerard; Schoellkopf, Wieland] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany	Max Planck Society; Fritz Haber Institute of the Max Planck Society	Zhao, BS (corresponding author), Max Planck Gesell, Fritz Haber Inst, Faradayweg 4-6, D-14195 Berlin, Germany.	zhao@fhi-berlin.mpg.de	Schöllkopf, Wieland/AAI-2477-2019; Meijer, Gerard/D-2141-2009; Zhao, Bum Suk/B-2476-2012	Meijer, Gerard/0000-0001-9669-8340; Zhao, Bum Suk/0000-0003-0470-6396; Schollkopf, Wieland/0000-0003-0564-203X	Alexander von Humboldt Foundation; Korean Government [KRF-2005-214-C00188]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Korean Government(Korean Government)	We thank J. R. Manson for insightful discussions. B.S.Z. acknowledges support by the Alexander von Humboldt Foundation and by the Korea Research Foundation Grant funded by the Korean Government (KRF-2005-214-C00188).	Bruch LW, 2002, J CHEM PHYS, V117, P1544, DOI 10.1063/1.1486442; Druzhinina V, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.193202; Estermann I, 1930, Z PHYS, V61, P95, DOI 10.1007/BF01340293; Friedrich H, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.032902; Grisenti RE, 2000, PHYS REV LETT, V85, P2284, DOI 10.1103/PhysRevLett.85.2284; Knauer F, 1929, Z PHYS, V53, P779, DOI 10.1007/BF01341278; LUO F, 1993, J CHEM PHYS, V98, P3564, DOI 10.1063/1.464079; Oberst H, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.052901; SCHOLLKOPF W, 1994, SCIENCE, V266, P1345, DOI 10.1126/science.266.5189.1345; Shimizu F, 2001, PHYS REV LETT, V86, P987, DOI 10.1103/PhysRevLett.86.987; TANG KT, 1995, PHYS REV LETT, V74, P1546, DOI 10.1103/PhysRevLett.74.1546; Zhao BS, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.010902	13	36	36	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					892	894		10.1126/science.1200911	http://dx.doi.org/10.1126/science.1200911			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21330540				2022-12-28	WOS:000287455100051
J	Wood, B; Harrison, T				Wood, Bernard; Harrison, Terry			The evolutionary context of the first hominins	NATURE			English	Review							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; MIDDLE AWASH; GREAT APE; MIOCENE; MORPHOLOGY; HOMINOIDS; HUMANS; CHARACTERS; IMPACT	The relationships among the living apes and modern humans have effectively been resolved, but it is much more difficult to locate fossil apes on the tree of life because shared skeletal morphology does not always mean shared recent evolutionary history. Sorting fossil taxa into those that belong on the branch of the tree of life that leads to modern humans from those that belong on other closely related branches is a considerable challenge.	[Wood, Bernard] George Washington Univ, CASHP, Washington, DC 20052 USA; [Harrison, Terry] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA	George Washington University; New York University	Wood, B (corresponding author), George Washington Univ, CASHP, 2110 G St NW, Washington, DC 20052 USA.	bernardawood@gmail.com			GW Vice-President for Academic Affairs; NSF [BCS-0309513]	GW Vice-President for Academic Affairs; NSF(National Science Foundation (NSF))	Support was provided by the GW Vice-President for Academic Affairs and to the GW Selective Excellence Program(to Provost and B.W.) and the NSF (BCS-0309513) (to T.H.). We thank R. Bernstein, J. DeSilva, T. Kivell, D. Pilbeam and B. Richmond for their critical comments and suggestions.	Andrews Peter, 2005, P103; [Anonymous], 2003, EVOL ANTHROPOL, DOI DOI 10.1002/evan.10110; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bernor Raymond L., 2010, P685; Bradley BJ, 2008, J ANAT, V212, P337, DOI 10.1111/j.1469-7580.2007.00840.x; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Collard M, 2000, P NATL ACAD SCI USA, V97, P5003, DOI 10.1073/pnas.97.9.5003; Collard M, 2007, J HUM EVOL, V52, P573, DOI 10.1016/j.jhevol.2006.11.018; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Galik K, 2004, SCIENCE, V305, P1450, DOI 10.1126/science.1098807; Gatesy J, 1997, MOL PHYLOGENET EVOL, V7, P303, DOI 10.1006/mpev.1997.0402; Gibbs S, 2000, P NATL ACAD SCI USA, V97, P11130, DOI 10.1073/pnas.190252697; Gibbs S, 2002, J ANAT, V200, P3, DOI 10.1046/j.0021-8782.2001.00001.x; Godfrey L.R., 2010, CENOZOIC MAMMALS AFR; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Harrison T, 2002, J HUM EVOL, V43, P207, DOI 10.1006/jhev.2002.0570; Harrison Terry, 1997, P327; Harrison Terry, 2010, P429; Harrison T, 2010, SCIENCE, V327, P532, DOI 10.1126/science.1184703; Harrison T, 2006, DEV PRIMATOL, P331; Harvati K, 2007, VERTEBR PALEOBIOL PA, P239; Hurzeler J., 1958, Verhandlungen der Naturforschenden Gesellschaft in Basel, V69, P1; Hurzeler J., 1954, Verhandlungen der Naturforschenden Gesellschaft in Basel, V65, P88; Jablonski N.G., 2008, KOOBI FORA RES PROJE, V6; Kelley J, 2002, CAM S BIO EVOL ANTHR, V33, P369; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lacruz RS, 2008, J ANAT, V213, P148, DOI 10.1111/j.1469-7580.2008.00938.x; Lankester E.R., 1870, ANN MAG NAT HIST, V6, P34, DOI [DOI 10.1080/00222937008696201, 10.1080/00222937008696201]; Lockwood CA, 2004, P NATL ACAD SCI USA, V101, P4356, DOI 10.1073/pnas.0306235101; Lockwood CA, 2000, J HUM EVOL, V39, P23, DOI 10.1006/jhev.2000.0401; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; McCollum MA, 1999, SCIENCE, V284, P301, DOI 10.1126/science.284.5412.301; Nakatsukasa M, 2008, J HUM EVOL, V55, P581, DOI 10.1016/j.jhevol.2008.04.009; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; PILBEAM D, 1982, NATURE, V295, P232, DOI 10.1038/295232a0; Pilbeam DR, 2002, CAM S BIO EVOL ANTHR, V33, P303; Rafferty KL, 1998, J HUM EVOL, V34, P361, DOI 10.1006/jhev.1997.0202; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; Rein TR, 2007, AM J PHYS ANTHROPOL, P197; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; SARMIENTO E E, 1987, American Museum Novitates, P1; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Shreeve J., 2010, NAT GEOGR MAG, V218, P63; SIMONS ELWYN L., 1961, POSTILLA [YALE PEABODY MUS], V57, P1; Skinner MM, 2008, J HUM EVOL, V55, P979, DOI 10.1016/j.jhevol.2008.08.013; Smith TM, 2008, EVOL ANTHROPOL, V17, P213, DOI 10.1002/evan.20176; Sola SM, 1997, CR ACAD SCI II A, V324, P141; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Straus Jr W.L., 1963, CLASSIFICATION HUMAN, P146; Suwa G., 2009, SCIENCE, V326, p68e1, DOI DOI 10.1126/SCIENCE.1175825; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Todd NE, 2010, ANAT REC, V293, P74, DOI 10.1002/ar.21010; Van Valkenburgh B, 2007, INTEGR COMP BIOL, V47, P147, DOI 10.1093/icb/icm016; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; White Tim D., 2009, P122; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Wood B.A., 1988, P269; Wood B, 2010, P NATL ACAD SCI USA, V107, P8902, DOI 10.1073/pnas.1001649107; Young NM, 2003, J HUM EVOL, V45, P441, DOI 10.1016/j.jhevol.2003.09.001; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397; Zuckerkandl E, 1963, CLASSIFICATION HUMAN, P243	67	142	147	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					347	352		10.1038/nature09709	http://dx.doi.org/10.1038/nature09709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	722CS	21331035				2022-12-28	WOS:000287409100032
